FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Collie, AMB
   Bota, PCS
   Johns, RE
   Maier, RV
   Stayton, PS
AF Collie, Angela M. B.
   Bota, Paige C. S.
   Johns, Rachel E.
   Maier, Ronald V.
   Stayton, Patrick S.
TI Differential monocyte/macrophage interleukin-1 beta production due to
   biomaterial topography requires the beta 2 integrin signaling pathway
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE monocyte; macrophage; biomaterial; topography; integrin
ID GIANT-CELL FORMATION; TITANIUM SURFACE-TOPOGRAPHY; PRIMARY HUMAN
   MONOCYTES; KAPPA-B ACTIVATION; SELECTIVE-INHIBITION; IN-VITRO;
   MACROPHAGES; RECEPTOR; ADHESION; EXPRESSION
AB Monocytes/macrophages are crucial mediators of the host response to biomaterials, and their level of activation can be directly affected by material characteristics. Previous work has demonstrated that primary human monocytes cultured on polytetrafluoroethylene materials of varying topography but identical surface chemistry are differentially affected. Monocytes/macrophages on biaxially-expanded polytetrafluoroethylene with an average intranodal distance of 4.4 mu m (4.4-ePTFE) produced higher levels of the inflammatory cytokine interleukin-1 beta (IL-1 beta) compared with monocytes/macrophages on nonporous polytetrafluoroethylene (np-PTFE). The current study provides a mechanistic understanding of this response. Scanning electron microscopy revealed that monocytes/macrophages cultured on np-PTFE were more spread than those on 4.4-ePTFE. In addition, the actin cytoskeleton and intact beta 2 integrin receptors were necessary for IL-1 beta production by monocytes/macrophages on 4.4-ePTFE. This IL-1 beta production also required the transcription factor nuclear factor kappa-B, another component of the beta 2 integrin signaling pathway, although it may not be the primary transcription factor involved. These studies demonstrate the importance of several beta 2 integrin signaling components to the monocyte/macrophage response to biomaterial topography. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 162-169, 2011.
C1 [Collie, Angela M. B.; Bota, Paige C. S.; Johns, Rachel E.; Stayton, Patrick S.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Maier, Ronald V.] Univ Washington, Dept Surg, Seattle, WA 98104 USA.
RP Collie, AMB (reprint author), Cleveland Clin, Pathol & Lab Med Inst, Mail Code L25,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM bookwaam@hotmail.com
FU Whitaker Foundation; Medical Scientist Training Program [NIH GM07266];
   NSF UWEB ERC [EEC 9529161]; Engineered Biomaterials Training Program
   [NIH GM065098]
FX Contract grant sponsor: Whitaker Foundation (to P.C.S.B); Contract grant
   sponsor: Medical Scientist Training Program; contract grant number: NIH
   GM07266 (to A.M.B.C.); Contract grant sponsor: Engineered Biomaterials
   Training Program; contract grant number: NIH GM065098 (to A.M.B.C.);
   Contract grant sponsor: NSF UWEB ERC; contract grant number: EEC 9529161
CR Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   CARLOS TM, 1994, BLOOD, V84, P2068
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x
   DeNichilo MO, 1996, J BIOL CHEM, V271, P11016, DOI 10.1074/jbc.271.18.11016
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Grainger DW, 2003, J BIOMAT SCI-POLYM E, V14, P973, DOI 10.1163/156856203322381456
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054
   KATZ DA, 1995, SURGERY, V118, P154, DOI 10.1016/S0039-6060(05)80318-6
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   Perez RL, 1999, AM J RESP CELL MOL, V20, P1059, DOI 10.1165/ajrcmb.20.5.3281
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rezzonico R, 2000, BLOOD, V95, P3868
   Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Schuler P, 2003, CELL COMMUN ADHES, V10, P17, DOI 10.1080/15419060390220440
   Shi C, 2001, CIRC RES, V89, P859, DOI 10.1161/hh2201.099166
   Sitrin RG, 1998, J IMMUNOL, V161, P1462
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   YAHARA I, 1982, J CELL BIOL, V92, P69, DOI 10.1083/jcb.92.1.69
NR 38
TC 16
Z9 17
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2011
VL 96A
IS 1
BP 162
EP 169
DI 10.1002/jbm.a.32963
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 690WX
UT WOS:000285041400019
PM 21105164
DA 2018-10-19
ER

PT J
AU Kou, PM
   Babensee, JE
AF Kou, Peng Meng
   Babensee, Julia E.
TI Macrophage and dendritic cell phenotypic diversity in the context of
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE macrophages; dendritic cells; biomaterials
ID TOLL-LIKE RECEPTORS; FOREIGN-BODY RESPONSE; REGULATORY T-CELLS;
   ALTERNATIVELY ACTIVATED MACROPHAGES; SELF-ASSEMBLED MONOLAYERS;
   ANTIGEN-PRESENTING CELLS; INNATE IMMUNE-RESPONSES; HOST TISSUE
   RESPONSES; NECROSIS-FACTOR-ALPHA; IN-VIVO
AB Macrophages (W Phi)) and dendritic cells (DCs) are critical antigen presenting cells that play pivotal roles in host responses to biomaterial implants. Although M Phi s have been widely studied for their roles in the inflammatory responses against biomaterials, the roles that DCs play in the host responses toward implanted materials have only recently been explored. DCs are of significant research interest because of the emergence of a large number of combination products that cross-traditional medical device boundaries. These products combine biomaterials with biologics, including cells, nucleic acids, and/or proteins. The biomaterial component may evoke an inflammatory response, primarily mediated by neutrophils and M Phi s, whereas the biologic component may elicit an immunogenic immune response, initiated by DCs involving lymphocyte activation. Control of M Phi phenotypic balance from proinflammatory M1 to reparative M2 is a goal of investigators to optimize the host response to biomaterials. Similarly, control of DC phenotype from proinflammatory to toleragenic is of interest in vaccine delivery and tissue engineering/transplantation situations, respectively. This review discusses the interconnection between innate and adaptive immunity, the comparative and contrasting phenotypes and roles of M Phi s and DCs in immunity, their responses to biomaterials and the strategies to modulate their phenotype for applications in tissue engineering and vaccine delivery. Furthermore, the collaboration between and unique roles of DCs and M Phi s needs to be addressed in future studies to gain a more complete picture of host responses toward combination products. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 239-260, 2011.
C1 [Kou, Peng Meng; Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Kou, Peng Meng; Babensee, Julia E.] Emory Univ, Atlanta, GA 30332 USA.
   [Kou, Peng Meng; Babensee, Julia E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2009, BIOMATERIALS, V30, P4168, DOI 10.1016/j.biomaterials.2009.04.032
   Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716
   Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   ALBINA JE, 1995, J IMMUNOL, V155, P4391
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Alving CR, 2002, VACCINE, V20, pS56, DOI 10.1016/S0264-410X(02)00174-3
   Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x
   Anderson AE, 2008, J LEUKOCYTE BIOL, V84, P124, DOI 10.1189/jlb.1107744
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bajtay Z, 2006, IMMUNOL LETT, V104, P46, DOI 10.1016/j.imlet.2005.11.023
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008
   BECKER S, 1987, J IMMUNOL, V139, P3703
   Benencia F, 1999, IMMUNOLOGY, V98, P363
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005
   Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772
   Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J
   Braun D, 2006, J IMMUNOL, V177, P8550, DOI 10.4049/jimmunol.177.12.8550
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Brown KA, 1997, CLIN EXP IMMUNOL, V107, P601, DOI 10.1046/j.1365-2249.1997.d01-951.x
   Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007
   Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163
   Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046
   Chang DT, 2009, CELL MOL BIOENG, V2, P573, DOI 10.1007/s12195-009-0088-0
   Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763
   Cravens PD, 2002, IMMUNOL CELL BIOL, V80, P497, DOI 10.1046/j.1440-1711.2002.01118.x
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DEVITA VT, 2008, CANC PRINCIPLES PRAC, P3200
   Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240
   Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037
   Eckhardt A, 2009, BIOMATERIALS, V30, P1665, DOI 10.1016/j.biomaterials.2008.09.024
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8
   Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184
   ESSNER R, 1989, J IMMUNOL, V142, P3857
   EZEKOWITZ RAB, 1984, CONTEMP TOP IMMUNOBI, V13, P33
   Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723
   Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729
   Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6
   Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558
   Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784
   Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331
   Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x
   Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7
   GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O
   Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035
   Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200
   HARDING CV, 1994, J IMMUNOL, V153, P4925
   Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200
   Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533
   Hilf N, 2002, BLOOD, V99, P3676, DOI 10.1182/blood.V99.10.3676
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36
   Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829
   Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001
   Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200
   Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC
   Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086
   Janeway CA, 1999, CURR BIOL, V9, pR342, DOI 10.1016/S0960-9822(99)80209-7
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   JANEWAY CA, 2004, IMMUNOBIOLOGY THE IM
   Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2008, J BIOMED MATER RES A, V86A, P261, DOI 10.1002/jbm.a.31660
   Joyce DA, 1996, CYTOKINE, V8, P49, DOI 10.1006/cyto.1996.0007
   Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   KATO K, 1989, MED MICROBIOL IMMUN, V178, P337
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kindt TJ, 2007, KUBY IMMUNOLOGY
   Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0
   Kou PM, 2010, ACTA BIOMATER, V6, P2621, DOI 10.1016/j.actbio.2010.01.023
   KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942
   Kwissa M, 2007, EXPERT REV VACCINES, V6, P673, DOI 10.1586/14760584.6.5.673
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868
   Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x
   Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013
   Li H, 2006, EMBO J, V25, P4097, DOI 10.1038/sj.emboj.7601289
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Ludewig B, 1998, J VIROL, V72, P3812
   MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097
   MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   Mahnke K, 1996, J LEUKOCYTE BIOL, V60, P465
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X
   Mariani TJ, 1998, MOL BIOL CELL, V9, P1411, DOI 10.1091/mbc.9.6.1411
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5
   Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526
   Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8
   MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Muller G, 2002, J INVEST DERMATOL, V119, P836, DOI 10.1046/j.1523-1747.2002.00496.x
   MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443
   Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954
   Murthy N, 2003, BIOCONJUGATE CHEM, V14, P412, DOI 10.1021/bc020056d
   Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   NORTON LW, 2009, INNATE ADAPTIVE IMMU
   Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8
   Pannetier D, 2004, J VIROL, V78, P10516, DOI 10.1128/JVI.78.19.10516-10524.2004
   PARK J, CONTROL DENDRI UNPUB
   PARK J, BIOMATERIAL DE UNPUB
   Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071
   Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165
   Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060
   Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x
   Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245
   Reis ES, 2008, MOL IMMUNOL, V45, P1952, DOI 10.1016/j.molimm.2007.10.031
   Reis ES, 2007, IMMUNOBIOLOGY, V212, P151, DOI 10.1016/j.imbio.2006.11.010
   Reis ES, 2006, INFLAMM RES, V55, P179, DOI 10.1007/s00011-006-0068-y
   Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x
   Riboldi E, 2005, J IMMUNOL, V175, P2788, DOI 10.4049/jimmunol.175.5.2788
   Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   Roos A, 2004, EUR J IMMUNOL, V34, P921, DOI 10.1002/eji.200424904
   Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1487, DOI 10.1002/jbm.a.32487
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Shen H, 2003, J CONTROL RELEASE, V86, P339, DOI 10.1016/S0168-3659(02)00354-1
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821
   Shi ZC, 2009, J BIOL CHEM, V284, P20540, DOI 10.1074/jbc.M109.022541
   Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746
   Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Singh A, 2008, MOL THER, V16, P2011, DOI 10.1038/mt.2008.206
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720
   SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672
   Sodhi A, 2002, J INTERF CYTOK RES, V22, P517, DOI 10.1089/10799900252981990
   Stacey KJ, 2000, CURR TOP MICROBIOL, V247, P41
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142
   STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   STEINMAN RM, 2006, DENDRITIC CELLS TRAN, P17
   Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Thacker RI, 2008, EXP MOL PATHOL, V84, P122, DOI 10.1016/j.yexmp.2008.01.001
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   Underhill DM, 2003, EUR J IMMUNOL, V33, P1767, DOI 10.1002/eji.200324037
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276
   Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101
   Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376
   Volkmann A, 1997, J IMMUNOL, V158, P693
   Wang X, 2008, J MED VIROL, V80, P11, DOI 10.1002/jmv.21029
   Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x
   Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x
   Werling D, 2004, IMMUNOLOGY, V111, P41, DOI [10.1111/j.1365-2567.2004.01781.x, 10.1046/j.1365-2567.2003.01781.x]
   West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831
   Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089
   Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130
   Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588
   Zingarelli B, 1996, J IMMUNOL, V156, P350
   Zugates GT, 2005, ISRAEL J CHEM, V45, P477, DOI 10.1560/7C67-5X19-PEJ8-PXUN
NR 240
TC 95
Z9 99
U1 3
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2011
VL 96A
IS 1
BP 239
EP 260
DI 10.1002/jbm.a.32971
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 690WX
UT WOS:000285041400028
PM 21105173
DA 2018-10-19
ER

PT J
AU Wang, YB
   Zheng, YF
   Wei, SC
   Li, M
AF Wang, Y. B.
   Zheng, Y. F.
   Wei, S. C.
   Li, M.
TI In vitro study on Zr-based bulk metallic glasses as potential
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Zr-based bulk metallic glasses; in vitro biocompatibility; corrosion
   resistance; electrochemical measurements; cytotoxicity
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ZR65AL7.5NI10CU17.5 AMORPHOUS
   ALLOY; PHOSPHATE-BUFFERED SOLUTION; CORROSION BEHAVIOR; POLARIZATION
   BEHAVIOR; MECHANICAL-PROPERTIES; ANODIC-POLARIZATION; TI-6AL-7NB ALLOY;
   STAINLESS-STEEL; HANKS-SOLUTION
AB With pure Ti and pure Zr as controls, the corrosion resistance, ion release behavior, and in vitro biocompatibility of Be-containing Zr(41)Ti(14)Cu(12)Ni(10)Be(23) bulk metallic glass (BMG) (LM1), Zr(44)Ti(11)Cu(10)Ni(10)Be(25) BMG (LM1b), and Be-free Zr(57)Nb(5)Cu(15.4)Ni(12.6)Al(10) BMG (LM106) were investigated in terms of electrochemical measurements in simulated body fluid (SBF) with pH value 7.4 and artificial saliva (AS) with pH value 6.3, and 3-[4,4-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay using L929 and NIH3T3 cells, aiming to assess the feasibility of Zr-based BMGs as potential biomaterial. It was found that LM1b showed superior corrosion resistance to LM106 and LM1 in both SBF and AS, and comparable with pure Ti and pure Zr. After 7200 s immersion, a two-layer structure oxide film was formed on LM1, LM1b, and pure Zr surfaces, while one-layer structure oxide film was formed on LM106 and pure Ti surfaces. The pitting corrosion potentials of LM1b were much higher than that of LM1, LM106, and pure Zr, resulting in very few ions releasing into the electrolytes. No Be ion could be detected but a little amount of Cu ion was detected for LM106, LM1, and LM1b after immersion in Dulbecco's modified Eagle's medium for 72 h at 37 degrees C. The indirect cytotoxicity results show that LM106, LM1, and LM1b extracts had no cytotoxicity to L929 and NIH3T3 cells. The direct cytotoxicity results show that cells could adhere well on the Zr-based BMG surface as in pure Ti and Zr. Lower cell proliferation rate of LM106 and LM1 is observed when compared with LM1b, which was found to be caused by Cu ion releasing rather than by Be ion. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 96B: 34-46,2011.
C1 [Wang, Y. B.; Zheng, Y. F.] Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Wang, Y. B.; Zheng, Y. F.; Wei, S. C.] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
   [Wei, S. C.] Peking Univ, Sch Stomatol, Beijing 100081, Peoples R China.
   [Wei, S. C.] Peking Univ, Hosp Stomatol, Beijing 100081, Peoples R China.
   [Li, M.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Wang, Yanbo/E-8046-2010; BAI, JIE/D-7448-2016
OI Zheng, Yufeng/0000-0002-7402-9979; Wang, Yanbo/0000-0002-3184-4201; 
FU National Natural Science Foundation of China [30770580]; National Key
   Scientific Program-Nanoscience and Nanotechnology [2007CB936103];
   Program for New Century Excellent Talents in University [NCET-07-0033]
FX Contract grant sponsor: The National Natural Science Foundation of
   China; contract grant number: 30770580; Contract grant sponsor: The
   National Key Scientific Program-Nanoscience and Nanotechnology; contract
   grant number: 2007CB936103; Contract grant sponsor: Program for New
   Century Excellent Talents in University; contract grant number:
   NCET-07-0033
CR Bai L, 2008, J NON-CRYST SOLIDS, V354, P3935, DOI 10.1016/j.jnoncrysol.2008.05.015
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   Colic M, 2009, ACTA BIOMATER, V6, P308
   Colic M, 2010, J BIOMATER APPL, V25, P269, DOI 10.1177/0885328209354613
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V102, P129, DOI 10.1385/BTER:102:1-3:129
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   Green BA, 2008, CORROS SCI, V50, P1825, DOI 10.1016/j.corsci.2008.03.011
   Hayami T, 2007, MATER LETT, V61, P2667, DOI 10.1016/j.matlet.2006.10.019
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   Hiromoto S, 2002, ELECTROCHIM ACTA, V47, P1343, DOI 10.1016/S0013-4686(01)00876-3
   Hiromoto S, 2000, CORROS SCI, V42, P2193, DOI 10.1016/S0010-938X(00)00056-1
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Inoue A, 1997, MAT SCI ENG A-STRUCT, V226, P401, DOI 10.1016/S0921-5093(97)80051-2
   Jiang WH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2762282
   Karakecili AG, 2007, J BIOSCI BIOENG, V104, P69, DOI 10.1263/jbb.104.69
   KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lavos-Valereto C, 2002, J BIOMED MATER RES, V63, P664, DOI 10.1002/jbm.10351
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   Lewis G, 2007, BIO-MED MATER ENG, V17, P97
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   Liu L, 2007, MAT SCI ENG A-STRUCT, V449, P193, DOI 10.1016/j.msea.2006.02.255
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   Mockers O, 2002, DENT MATER, V18, P311, DOI 10.1016/S0109-5641(01)00055-0
   Morrison ML, 2007, J NON-CRYST SOLIDS, V353, P2115, DOI 10.1016/j.jnoncrysol.2007.03.012
   Morrison ML, 2005, J BIOMED MATER RES A, V74A, P430, DOI 10.1002/jbm.a.30361
   Morrison ML, 2004, INTERMETALLICS, V12, P1177, DOI 10.1016/j.intermet.2004.04.005
   Oak JJ, 2007, MAT SCI ENG A-STRUCT, V449, P220, DOI 10.1016/j.msea.2006.02.307
   Oak JJ, 2009, MAT SCI ENG C-BIO S, V29, P322, DOI 10.1016/j.msec.2008.07.009
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PEKER A, 1993, APPL PHYS LETT, V63, P2342, DOI 10.1063/1.110520
   Qiu CL, 2005, J BIOMED MATER RES A, V75A, P950, DOI 10.1002/jbm.a.30502
   Rondelli G, 2006, J BIOMED MATER RES B, V79B, P320, DOI 10.1002/jbm.b.30545
   Salimon AI, 2004, MAT SCI ENG A-STRUCT, V375, P385, DOI 10.1016/j.msea.2003.10.167
   Schroeder V, 1998, SCRIPTA MATER, V38, P1481, DOI 10.1016/S1359-6462(98)00089-X
   Scully JR, 2007, J MATER RES, V22, P302, DOI 10.1557/JMR.2007.0051
   Sharma SK, 2008, J MATER SCI, V43, P5495, DOI 10.1007/s10853-008-2834-4
   Shim HM, 2005, J BIOMED MATER RES B, V73B, P252, DOI 10.1002/jbm.b.30206
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Telford M, 2004, MATER TODAY, V7, P36, DOI 10.1016/S1369-7021(04)00124-5
   Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   WONG D, 1988, YALE J BIOL MED, V61, P1
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   ZELIKOFF JT, 1986, CELL BIOL TOXICOL, V2, P369, DOI 10.1007/BF00121852
   Zhai QW, 2000, J CELL PHYSIOL, V184, P161, DOI 10.1002/1097-4652(200008)184:2<161::AID-JCP3>3.3.CO;2-E
NR 48
TC 33
Z9 33
U1 1
U2 36
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2011
VL 96B
IS 1
BP 34
EP 46
DI 10.1002/jbm.b.31725
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693LL
UT WOS:000285225500005
PM 21061358
DA 2018-10-19
ER

PT J
AU Yang, B
   Gong, CY
   Qian, ZY
   Zhao, X
   Li, ZY
   Zhou, ST
   Qi, XR
   Zhong, QA
   Luo, F
   Wei, YQ
AF Yang, Bing
   Gong, Chang Yang
   Qian, Zhi Yong
   Zhao, Xia
   Li, Zheng Yu
   Zhou, Sheng Tao
   Qi, Xiao Rong
   Zhong, Qian
   Luo, Feng
   Wei, Yu Quan
TI Prevention of abdominal adhesion formation by thermosensitive
   PECE-hydrogel in a rat uterine horn model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adhesion prevention; uterine horn model; PECE-hydrogel; thermosensitive;
   biocompatible
ID POSTSURGICAL ADHESIONS; HYALURONAN HYDROGELS; MESOTHELIAL CELLS; RABBIT
   MODEL; MULTICENTER; REDUCTION; PATHOPHYSIOLOGY; REGENERATION;
   REFORMATION; OBSTRUCTION
AB In this work, we investigated the efficacy of PECE-hydrogel in preventing postsurgical peritoneal adhesions in the rat uterine horn model. Standardized surgical traumas were applied to the peritoneum of the abdominal wall and the uterine horns. PECE hydrogel was applied to the two wound surfaces. Animals were euthanized at different times after surgery, and the gross necropsy findings were documented. Adhesion formation was assessed according to adhesion extent and adhesion severity, and the hydrogel degradation and healing of peritoneal wounds were observed. The remesothelialization was dynamically observed by scanning electron microscope. The results showed that none of the animals in the hydrogel-treated group (n = 12) developed adhesion. In contrast, all untreated animals (n = 12) had adhesions that could only be separated by sharp dissection (p < 0.001). The hydrogel could adhere to the peritoneal wounds and gradually disappear from the wounds within 7-9 days and transformed into viscous fluid being completely absorbed within 12 days. The injured parietal and visceral peritoneum was remesothelialized in about 7 and 9 days, respectively. This work confirmed that PECE hydrogel holds promise as a novel absorbable biomaterial for the reduction of postoperative adhesions after laparotomy. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 96B: 57-66, 2011.
C1 [Qian, Zhi Yong] Sichuan Univ, W China Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Peoples R China.
   Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
   Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, W China Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Peoples R China.
EM anderson-qian@163.com; xia-zhao@126.com
RI Gong, Changyang/D-7911-2012; Qian, Zhiyong/C-2706-2009
FU National 863 Project [2007AA021804, 2007AA021902]; National Natural
   Science Foundation [NSFC20704027]; Chinese Key Basic Research Program
   [2010CB529906]
FX Contract grant sponsor: National 863 Project; contract grant numbers:
   2007AA021804, 2007AA021902; Contract grant sponsor: National Natural
   Science Foundation; contract grant number: NSFC20704027; Contract grant
   sponsor: Chinese Key Basic Research Program; contract grant number:
   2010CB529906
CR [Anonymous], 1995, FERTIL STERIL, V63, P709
   Arnold PB, 2000, FERTIL STERIL, V73, P157, DOI 10.1016/S0015-0282(99)00464-1
   Attard JAP, 2007, CAN J SURG, V50, P291
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   DELACO PA, 1998, FERTIL STERIL, V69, P318
   Diamond MP, 1998, FERTIL STERIL, V69, P1067, DOI 10.1016/S0015-0282(98)00057-0
   Diamond MP, 2001, HUM REPROD UPDATE, V7, P567, DOI 10.1093/humupd/7.6.567
   Dijkstra FR, 2000, SCAND J GASTROENTE S, V232, P52
   DIZEREGA GS, 1994, FERTIL STERIL, V61, P219
   Foley-Comer AJ, 2002, J CELL SCI, V115, P1383
   FOTEV Z, 1987, J PATHOL, V151, P209, DOI 10.1002/path.1711510309
   Gong CY, 2009, J BIOMED MATER RES B, V91B, P26, DOI 10.1002/jbm.b.31370
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   HANEY AF, 1992, FERTIL STERIL, V57, P202
   Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2
   Holmdahl Lena, 1999, European Journal of Surgery, V165, P1012
   Interceed(TC7) Adhesion Barrier Study Group, 1989, FERTIL STERIL, V51, P933
   Leach RE, 1998, FERTIL STERIL, V69, P415, DOI 10.1016/S0015-0282(97)00573-6
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   Liu YC, 2005, FERTIL STERIL, V83, P1275, DOI 10.1016/j.fertnstert.2004.09.038
   Marana R, 1997, HUM REPROD, V12, P1935, DOI 10.1093/humrep/12.9.1935
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   Mutsaers SE, 1997, EUR J CELL BIOL, V72, P24
   Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x
   Mutsaers SE, 2000, J PATHOL, V190, P86
   Nishioka Y, 2008, RENAL FAILURE, V30, P97, DOI 10.1080/08860220701741619
   Osada H, 1999, J INT MED RES, V27, P233, DOI 10.1177/030006059902700503
   Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141
   Rout UK, 2003, FERTIL STERIL, V79, P138, DOI 10.1016/S0015-0282(02)04569-7
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SULEIMAN H, 2002, BIOCHEM SOC T, V30, P126
   Ustun C, 1998, GYNECOL OBSTET INVES, V46, P202, DOI 10.1159/000010034
   Wallwiener M, 2006, FERTIL STERIL, V86, P1266, DOI 10.1016/j.fertnstert.2006.05.023
   Yeo Y, 2007, ANN SURG, V245, P819, DOI 10.1097/01.sla.0000251519.49405.55
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
NR 35
TC 11
Z9 11
U1 1
U2 25
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2011
VL 96B
IS 1
BP 57
EP 66
DI 10.1002/jbm.b.31739
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693LL
UT WOS:000285225500007
PM 20967774
DA 2018-10-19
ER

PT J
AU Floden, EW
   Malak, SFF
   Basil-Jones, MM
   Negron, L
   Fisher, JN
   Lun, S
   Dempsey, SG
   Haverkamp, RG
   Ward, BR
   May, BCH
AF Floden, Evan W.
   Malak, Sharif F. F.
   Basil-Jones, Melissa M.
   Negron, Leonardo
   Fisher, James N.
   Lun, Stan
   Dempsey, Sandi G.
   Haverkamp, Richard G.
   Ward, Brian R.
   May, Barnaby C. H.
TI Biophysical characterization of ovine forestomach extracellular matrix
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE extracellular matrix; forestomach propria submucosa; SAXS; biophysical;
   tissue engineering; wound healing
ID BIAXIAL MECHANICAL-BEHAVIOR; X-RAY-DIFFRACTION; INTESTINAL SUBMUCOSA;
   URINARY-BLADDER; HERNIA REPAIR; CROSS-LINKING; SCAFFOLDS; TISSUE; BONE;
   ALLODERM
AB Ovine forestomach matrix (OFM) is a native and functional decellularized extracellular matrix biomaterial that supports cell adhesion and proliferation and is remodeled during the course of tissue regeneration. Small angle X-ray scattering demonstrated that OFM retains a native collagen architecture (d spacing = 63.5 +/- 0.2 nm, orientation index = 20 degrees). The biophysical properties of OFM were further defined using ball-burst, uniaxial and suture retention testing, as well as a quantification of aqueous permeability. OFM biomaterial was relatively strong (yield stress = 10.15 +/- 1.81 MPa) and elastic (modulus = 0.044 +/- 0.009 GPa). Lamination was used to generate new OFM-based biomaterials with a range of biophysical properties. The resultant multi-ply OFM biomaterials had suitable biophysical characteristics for clinical applications where the grafted biomaterial is under load. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 968: 67 75, 2011.
C1 [Floden, Evan W.; Negron, Leonardo; Fisher, James N.; Lun, Stan; Dempsey, Sandi G.; Ward, Brian R.; May, Barnaby C. H.] Mesynthes Ltd, Lower Hutt 5040, New Zealand.
   [Malak, Sharif F. F.] Univ Auckland, Auckland Bioengn Inst, Auckland 1010, New Zealand.
   [Basil-Jones, Melissa M.; Haverkamp, Richard G.] Massey Univ, Sch Engn & Adv Technol, Palmerston North 4442, New Zealand.
RP May, BCH (reprint author), Mesynthes Ltd, Lower Hutt 5040, New Zealand.
EM barnaby.may@mesynthes.com
RI Haverkamp, Richard/H-1149-2012; Floden, Evan/H-2115-2015
OI Haverkamp, Richard/0000-0002-3890-7105; Floden,
   Evan/0000-0002-5431-190X; Fisher, James Neil/0000-0002-1876-088X;
   Negron, Leonardo/0000-0003-3852-3002
FU Foundation for Research Science and Technology (New Zealand) [MSMA0701]
FX We acknowledge the Foundation for Research Science and Technology (New
   Zealand) MSMA0701 for funding this project. SAXS analysis was undertaken
   on the SAXS/WAXS beamline at the Australian Synchrotron, Victoria,
   Australia. Author Disclosure: E.W.F., S.L., B.R.W., and B.C.H.M. are
   shareholders of Mesynthes Limited.
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   BADYLAK JS, 2000, PURDUE RES FDN ASSIG
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012
   Basil-Jones MM, 2010, J AGR FOOD CHEM, V58, P5286, DOI 10.1021/jf100436c
   Cameron GJ, 2002, J STRUCT BIOL, V137, P15, DOI 10.1006/jsbi.2002.4459
   Cedola A, 2006, PHYS MED BIOL, V51, pN109, DOI 10.1088/0031-9155/51/6/N02
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   GUIDOIN R, 1987, J BIOMED MATER RES, V21, P65, DOI 10.1002/jbm.820210111
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Jiang T, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025012
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   Lin HJ, 2009, AM J SURG, V197, P603
   Lin HJ, 2009, AM J SURG, V197, P599, DOI 10.1016/j.amjsurg.2008.12.022
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   *MILL RES GROUP, US MARK SOFT TISS RE
   Misra S, 2008, HERNIA, V12, P247, DOI 10.1007/s10029-007-0319-z
   Morgan Adam S, 2004, Arch Facial Plast Surg, V6, P308, DOI 10.1001/archfaci.6.5.308
   NAIMARK WA, 1995, J MATER SCI-MATER M, V6, P235, DOI 10.1007/BF00146862
   Nguyen TD, 2009, TISSUE ENG PT A, V15, P957, DOI 10.1089/ten.tea.2007.0384
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Runza M, 1999, ANESTH ANALG, V88, P1317, DOI 10.1097/00000539-199906000-00022
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van't Riet M, 2004, SURG ENDOSC, V18, P681, DOI 10.1007/s00464-003-9054-4
   Vural E, 2006, LARYNGOSCOPE, V116, P394, DOI 10.1097/01.mlg.0000194691.32551.24
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   Yoder JH, 2010, CLIN BIOMECH, V25, P378, DOI 10.1016/j.clinbiomech.2010.01.004
NR 37
TC 18
Z9 18
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2011
VL 96B
IS 1
BP 67
EP 75
DI 10.1002/jbm.b.31740
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693LL
UT WOS:000285225500008
PM 21053262
DA 2018-10-19
ER

PT J
AU Nishat, N
   Rasool, R
   Khan, SA
   Parveen, S
AF Nishat, Nahid
   Rasool, Raza
   Khan, Shamim Ahmad
   Parveen, Shadma
TI Synthesis and characterization of metal-incorporated aniline
   formaldehyde resin modified by amino acid for antimicrobial applications
SO JOURNAL OF COORDINATION CHEMISTRY
LA English
DT Article
DE Amino acid; Coordination polymers; Thermogravimetric analysis;
   Antimicrobial activity
ID COORDINATION POLYMERS; SCHIFF-BASE; BIOLOGICAL-ACTIVITY;
   TRANSITION-METALS; CHELATE POLYMERS; COMPLEXES; ANTIBACTERIAL;
   COPPER(II); NICKEL(II); COBALT(II)
AB Advances in metal incorporated resins are now an active field of research. To develop resin having better antimicrobial and thermal activity, a series of metal-chelated resins have been synthesized by the condensation of (4-aminobenzene-1,3-diyl) dimethanol with 2,6-diaminohexanoic acid in alkaline medium and then this polymeric ligand further reacts with transition metal ions forming various coordination polymers. (4-Aminobenzene-1,3-diyl) dimethanol was initially prepared by the reaction of aniline and formaldehyde in 1 : 2 molar ratio in alkaline medium. The analytical data reveal that the polymer metal complexes of Mn(II), Co(II), and Ni(II) are coordinated with two water molecules, which are further supported by FTIR spectra and TGA data. Comparative analyses of the polymer metal complexes in thermal curves show better thermal stability than the polymeric ligand. Since these resins are relatively stable at high temperatures, they can be used for medical and biomaterial applications requiring thermal sterilization, solvent-resist coating materials because of their insoluble nature, and antifouling coating materials owing to antimicrobial activity in fields such as life-saving medical devices and the bottoms of ships.
C1 [Nishat, Nahid; Rasool, Raza; Khan, Shamim Ahmad; Parveen, Shadma] Jamia Millia Islamia, Dept Chem, Mat Res Lab, New Delhi 110025, India.
RP Nishat, N (reprint author), Jamia Millia Islamia, Dept Chem, Mat Res Lab, New Delhi 110025, India.
EM nishat_nchem08@yahoo.com
FU UGC-CSIR (New Delhi, India); Third World Academy of Sciences, Italy' for
   UV-Visible spectrophotometer [EZ-201, 00-047 RG/CHE/AS]
FX R. Rasool is thankful to UGC-CSIR (New Delhi, India) for Enancial
   assistance. The authors express their sincere thanks to "The Third World
   Academy of Sciences, Italy'' for UV-Visible spectrophotometer EZ-201
   (Perkin Elmer) through research grant scheme No. 00-047 RG/CHE/AS.
CR Ahmad T., 2007, APPL ORGANOMET CHEM, V21, P1013
   Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013
   Cazacu M, 2004, J ORGANOMET CHEM, V689, P3005, DOI 10.1016/j.jorganchem.2004.05.051
   Chen R, 2011, CHEM COMMUN, V47, P8136, DOI 10.1039/c1cc11837d
   Chohan ZH, 2007, APPL ORGANOMET CHEM, V21, P294, DOI 10.1002/aoc.1200
   El-Gahami MA, 2004, J INORG ORGANOMET P, V14, P117, DOI 10.1023/B:JOIP.0000028090.36100.0f
   Ganguly R, 2008, COORDIN CHEM REV, V252, P1027, DOI 10.1016/j.ccr.2008.01.005
   Hasnain S, 2011, J COORD CHEM, V64, P952, DOI 10.1080/00958972.2011.559230
   HASSAN MU, 2002, MAIN GROUP MET CHEM, V25, P291
   Ibrahim Y, 2003, TRANSIT METAL CHEM, V28, P399
   Islam M.B., 2007, BANGLADESH J SCI IND, V42, P475
   Jayakumar R, 2004, J APPL POLYM SCI, V92, P710, DOI 10.1002/app.13674
   Kaliyappan T, 2000, PROG POLYM SCI, V25, P343, DOI 10.1016/S0079-6700(00)00005-8
   Kaminski W, 1997, SEPAR SCI TECHNOL, V32, P2659, DOI 10.1080/01496399708006962
   Kemp W., 1996, PROTON NMR SPECTRA N
   Kitagawa S, 2005, CHEM SOC REV, V34, P109, DOI 10.1039/b313997m
   Kumar D, 2011, J COORD CHEM, V64, P590, DOI 10.1080/00958972.2011.552108
   Lever A. B. P., 1984, INORGANIC ELECT SPEC
   Liu WS, 2004, J AM CHEM SOC, V126, P2280, DOI 10.1021/ja036635q
   Marcu M, 2003, APPL ORGANOMET CHEM, V17, P693, DOI 10.1002/aoc.486
   Mart H, 2005, J MACROMOL SCI PURE, VA42, P1197, DOI 10.1080/10601320500189471
   Nishat N, 2008, J APPL POLYM SCI, V110, P3305, DOI 10.1002/app.28752
   Nishat N, 2011, J INORG ORGANOMET P, V21, P673, DOI 10.1007/s10904-011-9457-y
   Nishat N, 2011, J APPL POLYM SCI, V122, P2756, DOI 10.1002/app.34100
   Nishat N, 2011, J THERM ANAL CALORIM, V105, P969, DOI 10.1007/s10973-011-1442-8
   Nishat N, 2010, J COORD CHEM, V63, P3944, DOI 10.1080/00958972.2010.526207
   Nishat N, 2010, J COORD CHEM, V63, P1273, DOI 10.1080/00958971003728296
   Patel SH, 2007, J MACROMOL SCI A, V44, P599, DOI 10.1080/10601320701284881
   Qu ZR, 2003, INORG CHEM, V42, P7710, DOI 10.1021/ic034685q
   Raman N, 2003, P INDIAN AS-CHEM SCI, V115, P161
   Rivas BL, 2000, POLYM BULL, V44, P445, DOI 10.1007/s002890070064
   Shulman A., 1964, CHELATING AGENTS MET
   Slenters TV, 2008, J MATER CHEM, V18, P5359, DOI 10.1039/b813026d
   Tharmaraj P, 2009, J COORD CHEM, V62, P2220, DOI 10.1080/00958970902783576
   Ward MD, 2005, J SOLID STATE ELECTR, V9, P778, DOI 10.1007/s10008-005-0668-4
   WINTERTON N, 2000, ANNU REP PROG CHEM A, V96, P557
   Xue W, 2011, CHEM COMMUN, V47, P10233, DOI 10.1039/c1cc12852c
NR 37
TC 10
Z9 10
U1 1
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0095-8972
J9 J COORD CHEM
JI J. Coord. Chem.
PY 2011
VL 64
IS 23
BP 4054
EP 4065
DI 10.1080/00958972.2011.636426
PG 12
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 881GT
UT WOS:000299471300002
DA 2018-10-19
ER

PT J
AU Du, MC
   Song, WX
   Cui, Y
   Yang, Y
   Li, JB
AF Du, Mingchun
   Song, Weixing
   Cui, Yue
   Yang, Yang
   Li, Junbai
TI Fabrication and biological application of nano-hydroxyapatite
   (nHA)/alginate (ALG) hydrogel as scaffolds
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; MECHANICAL-PROPERTIES;
   FUTURE-DIRECTIONS; CELL-ADHESION; SILK FIBROIN; IN-VITRO; ALGINATE;
   GELATIN; BIOMATERIALS; DELIVERY
AB We have fabricated tubular hydrogel scaffolds of nano-hydroxyapatite (nHA)/alginate (ALG) via a layer-by-layer (LbL) technique. Using Ca2+ as a crosslinker, nHA was assembled with ALG to form a hydrogel network. The inner diameter of scaffolds could be controlled from 0.5 mm to 7 mm by varying the assembled layer numbers of nHA/ALG pairs. By changing the nHA concentration, we can also control the crosslinking degree of the hydrogel network, and further change the mechanical properties, swelling behavior, permeability and diffusivity of the scaffolds. The elastic modulus of the hydrogel scaffolds was regulated from 0.98 +/- 0.05 MPa to 2.78 +/- 0.08 MPa as the concentration of nHA was changed from 50 mg mL(-1) to 300 mg mL(-1), which reached the requirements of avascular soft tissue. The diffusion coefficient was tuned from 23.84 x 10(-7) cm(2) s(-1) to 9.92 x 10(-7) cm(2) s(-1) for controlled mass transport in the hydrogel network. Moreover, human embryo skin fibroblast (ESF) culture experiments prove that nHA can improve cellular adhesion on the hydrogel surface. These results thus suggest that the assembled nHA/ALG hydrogel scaffolds are an attractive biomaterial for great potential application in soft tissue engineering.
C1 [Du, Mingchun; Cui, Yue; Li, Junbai] Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, BNLMS,Int Joint Lab, Beijing 100190, Peoples R China.
   [Song, Weixing; Yang, Yang] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China.
RP Li, JB (reprint author), Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, BNLMS,Int Joint Lab, Bei Yi Jie 2, Beijing 100190, Peoples R China.
EM jbli@iccas.ac.cn
RI Li, Junbai/M-4351-2016
OI Li, Junbai/0000-0001-9575-3125
FU National Basic Research Program of China (973 program) [2007CB35900];
   National Natural Science Foundation of China [NNSFC 20833010]
FX This work was financially supported by National Basic Research Program
   of China (973 program 2007CB35900) and National Natural Science
   Foundation of China (NNSFC 20833010).
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bolter M, 2002, BIOL FERT SOILS, V36, P249, DOI 10.1007/s00374-002-0537-6
   Bouhadir KH, 2001, BIOMATERIALS, V22, P2625, DOI 10.1016/S0142-9612(01)00003-5
   Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g
   Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008
   Chu C, 2009, TISSUE ENG PT A, V15, P255, DOI 10.1089/ten.tea.2008.0100
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Correlo VM, 2005, MACROMOL MATER ENG, V290, P1157, DOI 10.1002/mame.200500163
   Desrochers J., 2007, J ARMITAGE SIEINT SO, V6796, P79607
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dunkers JP, 2003, OPT EXPRESS, V11, P3074, DOI 10.1364/OE.11.003074
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Harris JR, 2002, J OTOLARYNGOL, V31, P89, DOI 10.2310/7070.2002.18928
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kima H. W., 2005, BIOMATERIALS, V26, P5221
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   Li JS, 2008, J BIOMED MATER RES B, V86B, P381, DOI 10.1002/jbm.b.31031
   Li JJ, 2009, MAT SCI ENG C-BIO S, V29, P1207, DOI 10.1016/j.msec.2008.09.038
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mohamed KR, 2008, MAT SCI ENG C-BIO S, V28, P1087, DOI 10.1016/j.msec.2007.04.040
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Pascual B, 1999, BIOMATERIALS, V20, P465, DOI 10.1016/S0142-9612(98)00192-6
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Schumann R, 1998, MAR ECOL PROG SER, V163, P77, DOI 10.3354/meps163077
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sikorski P, 2007, BIOMACROMOLECULES, V8, P2098, DOI 10.1021/bm0701503
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Su P. J., 2008, SPIEINT SOC OPT ENG, V6858, pH8580
   Sun JS, 2005, BIOMATERIALS, V26, P3953, DOI 10.1016/j.biomaterials.2004.10.016
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Teng SH, 2008, J BIOMED MATER RES B, V87B, P132, DOI 10.1002/jbm.b.31082
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Willenberg BJ, 2006, J BIOMED MATER RES A, V79A, P440, DOI 10.1002/jbm.a.30942
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wilson J. C., 2005, TISSUE ENG, V11, P1
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   WOO S, 1988, AM AC ORTH SURG S, P401
   Yang DZ, 2008, J APPL POLYM SCI, V110, P3328, DOI 10.1002/app.28829
   Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6
   Yang Y, 2007, BIOMATERIALS, V28, P3083, DOI 10.1016/j.biomaterials.2007.03.019
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 54
TC 26
Z9 26
U1 5
U2 86
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 7
BP 2228
EP 2236
DI 10.1039/c0jm02869j
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 714UN
UT WOS:000286834600032
DA 2018-10-19
ER

PT J
AU Jang, JH
   Choi, YM
   Choi, YY
   Joo, MK
   Park, MH
   Choi, BG
   Kang, EY
   Jeong, B
AF Jang, Ji Hye
   Choi, Yoon Mi
   Choi, Yun Young
   Joo, Min Kyung
   Park, Min Hee
   Choi, Bo Gyu
   Kang, Eun Young
   Jeong, Byeongmoon
TI pH/temperature sensitive chitosan-g-(PA-PEG) aqueous solutions as new
   thermogelling systems
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID BLOCK-COPOLYMER HYDROGELS; CHITOSAN-BASED HYDROGELS; DRUG-DELIVERY;
   IN-SITU; SECONDARY STRUCTURE; PHYSICAL GELATION; THERMAL GELATION;
   POLYPEPTIDE; PEG; TEMPERATURE
AB As a new thermal gelling polymer aqueous solution, we are reporting a poly(ethylene glycol)-poly (alanine) grafted chitosan (CS-g-(PA-PEG)) system. The sol-gel transition temperature and the modulus of the in situ-formed thermal gel at 37 degrees C changed 17 -> 27 -> 32 degrees C and 396 -> 241 -> 43 Pa, respectively, as the pH increased from 3.0 to 6.5 and to 9.0. The mechanism of such a pH/temperature sensitive behaviour of the CS-g-(PA-PEG) aqueous solution was investigated by studying changes in the conformation of chitosan, polyalanine and PEG of the CS-g-(PA-PEG). As the temperature increased, ammonium groups of the chitosan partially deprotonated to a neutral form, the a-helical content of the polyalanine increased and molecular motion of the PEG decreased. Such changes cooperatively increase the hydrophobicity and viscosity of CS-g-(PA-PEG), resulting in the sol-gel transition of the polymer aqueous solution with increasing temperature. As the pH increased, ammonium groups of the chitosan deprotonated to a neutral form and the alpha-helical content of polyalanine decreased, which induce a change in the nanoassembly of the polymer. CS-g-(PA-PEG) significantly increased the gel modulus of a previously reported PEG grafted chitosan (CS-g-PEG) thermal gel by incorporating the alpha-helical polyalanine moieties between CS and PEG. The CS-g-(PA-PEG) could be a promising biomaterial as a new robust thermogel with pH and temperature sensitivity.
C1 [Jang, Ji Hye; Choi, Yoon Mi; Choi, Yun Young; Joo, Min Kyung; Park, Min Hee; Choi, Bo Gyu; Kang, Eun Young; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci WCU, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci WCU, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU MEST of Korea [2010-0000832, 2010-0001487, R31-2008-000-10010-0]; Seoul
   RBD Program [10816]
FX This work was supported by the National Research Foundation grant funded
   by the MEST of Korea (Grant number: 2010-0000832, 2010-0001487 and
   R31-2008-000-10010-0) and the Seoul R&BD Program (10816).
CR Ayres L, 2005, MACROMOLECULES, V38, P1699, DOI 10.1021/ma047923p
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Barbosa JS, 2010, ADV ENG MATER, V12, pB37, DOI 10.1002/adem.200980152
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Booth C, 2000, MACROMOL RAPID COMM, V21, P501, DOI 10.1002/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R
   Casettari L, 2010, BIOMACROMOLECULES, V11, P2854, DOI 10.1021/bm100522c
   Censi R, 2009, J CONTROL RELEASE, V140, P230, DOI 10.1016/j.jconrel.2009.06.003
   Chae SY, 2005, J CONTROL RELEASE, V102, P383, DOI 10.1016/j.jconrel.2004.10.012
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   Choi BG, 2011, SOFT MATTER, V7, P456, DOI 10.1039/c0sm00611d
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Choi YY, 2010, J MATER CHEM, V20, P3416, DOI 10.1039/b922956f
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Couto DS, 2009, ACTA BIOMATER, V5, P115, DOI 10.1016/j.actbio.2008.08.006
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Filion D, 2007, BIOMACROMOLECULES, V8, P3224, DOI 10.1021/bm700520m
   Ganji F, 2008, CARBOHYD POLYM, V74, P435, DOI 10.1016/j.carbpol.2008.03.017
   Hamley IW, 2005, BIOMACROMOLECULES, V6, P1310, DOI 10.1021/bm049286g
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kim JY, 2009, MACROMOLECULES, V42, P3147, DOI 10.1021/ma900341m
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6
   Ngoenkam J, 2010, INT J PHARMACEUT, V391, P115, DOI 10.1016/j.ijpharm.2010.02.028
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Park SY, 2007, MACROMOL RAPID COMM, V28, P1172, DOI 10.1002/marc.200600914
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Radu LC, 2009, MACROMOL BIOSCI, V9, P36, DOI 10.1002/mabi.200800193
   Sa-Lima H, 2010, SOFT MATTER, V6, P5184, DOI 10.1039/c0sm00041h
   Shim WS, 2006, BIOMACROMOLECULES, V7, P1935, DOI 10.1021/bm0600567
   Suh JM, 2005, ADV MATER, V17, P118, DOI 10.1002/adma.200400905
   Yoshikawa HY, 2011, J AM CHEM SOC, V133, P1367, DOI 10.1021/ja1060615
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 42
TC 28
Z9 28
U1 1
U2 42
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 14
BP 5484
EP 5491
DI 10.1039/c0jm03894f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 738RJ
UT WOS:000288659500041
DA 2018-10-19
ER

PT J
AU Beuvier, T
   Calvignac, B
   Delcroix, GEJR
   Tran, MK
   Kodjikian, S
   Delorme, N
   Bardeau, JF
   Gibaud, A
   Boury, F
AF Beuvier, Thomas
   Calvignac, Brice
   Delcroix, Gaetan Jean-Robert
   My Kien Tran
   Kodjikian, Stephanie
   Delorme, Nicolas
   Bardeau, Jean-Francois
   Gibaud, Alain
   Boury, Frank
TI Synthesis of hollow vaterite CaCO3 microspheres in supercritical carbon
   dioxide medium
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID CALCIUM-CARBONATE; CO2; PARTICLES; PHASE; PRECIPITATION; FABRICATION;
   MORPHOLOGY; CRYSTALLIZATION; TRANSFORMATION; AGGREGATION
AB We here describe a rapid method for synthesizing hollow core, porous crystalline calcium carbonate microspheres composed of vaterite using supercritical carbon dioxide in aqueous media, without surfactants. We show that the reaction in alkaline media rapidly conducts to the formation of microspheres with an average diameter of 5 mu m. SEM, TEM and AFM observations reveal that the microspheres have a hollow core of around 0.7 mu m width and are composed of nanograins with an average diameter of 40 nm. These nanograins are responsible for the high specific surface area of 16 m(2) g(-1) deduced from nitrogen absorption/desorption isotherms, which moreover confers an important porosity to the microspheres. We believe this work may pave the way for the elaboration of a biomaterial with a large potential for therapeutic as well as diagnostic applications.
C1 [Calvignac, Brice; Delcroix, Gaetan Jean-Robert; My Kien Tran; Boury, Frank] Lunam Univ Maine, INSERM Ingn Vectorisat Particulaire U646, IBS CHU ANGERS, F-49933 Angers 9, France.
   [Beuvier, Thomas; Delorme, Nicolas; Bardeau, Jean-Francois; Gibaud, Alain] Univ Maine, Lunam Univ Maine, Lab Phys Etat Condense, UMR CNRS 6087, F-72085 Le Mans, France.
   [Kodjikian, Stephanie] Univ Maine, Lunam Univ Maine, Lab Oxydes & Fluorures, UMR CNRS 6010, F-72085 Le Mans, France.
RP Boury, F (reprint author), Lunam Univ Maine, INSERM Ingn Vectorisat Particulaire U646, IBS CHU ANGERS, Batiment IRIS,4 Rue Larrey, F-49933 Angers 9, France.
EM thomas.beuvier@univ-lemans.fr; brice.calvignac@univ-angers.fr;
   delcroix.gaetan@gmail.com; mykiend2002@yahoo.com;
   stephanie.kodjikian@univ-lemans.fr; nicolas.delorme@univ-lemans.fr;
   jean-francois.bardeau@univ-lemans.fr; alain.gibaud@univ-lemans.fr;
   frank.boury@univ-angers.fr
RI Calvignac, Brice/K-4789-2015; Boury, Frank/L-1834-2015
OI Calvignac, Brice/0000-0002-2007-5750; Nicolas,
   Delorme/0000-0003-4195-2000
FU ANR (France) [ANR-09-PIRI-0004-01]; Regional research program (Pays de
   Loire, France-Bioregos program); CNRS (France)
FX The authors thank the financial support of ANR (France-Project
   ANR-09-PIRI-0004-01), Regional research program (Pays de Loire,
   France-Bioregos program) and CNRS (France). The authors thank the
   Institut des Materiaux Jean Rouxel (Nantes, France) for nitrogen
   adsorption/desorption measurements and the SCIAM laboratory (Angers,
   France) for SEM analysis.
CR Bing Z, 2007, EUR POLYM J, V43, P4814, DOI 10.1016/j.eurpolymj.2007.08.014
   BOURY F, 2007, METHOD PREPARING PAR
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   Darr JA, 1999, CHEM REV, V99, P495, DOI 10.1021/cr970036i
   Dickinson SR, 2001, ANALYST, V126, P1118, DOI 10.1039/b103004n
   Domingo C, 2004, J CRYST GROWTH, V271, P268, DOI 10.1016/j.jcrysgro.2004.07.060
   Fenghour A, 1998, J PHYS CHEM REF DATA, V27, P31, DOI 10.1063/1.556013
   Ferrentino G, 2010, J SUPERCRIT FLUID, V52, P142, DOI 10.1016/j.supflu.2009.10.005
   Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1
   Gu W, 2006, J MATER CHEM, V16, P3312, DOI 10.1039/b607184h
   Han YS, 2006, J MATER SCI, V41, P4663, DOI 10.1007/s10853-006-0037-4
   Han YS, 2005, J CRYST GROWTH, V276, P541, DOI 10.1016/j.jcrysgro.2004.11.408
   Hou WT, 2005, J CRYST GROWTH, V282, P214, DOI 10.1016/j.jcrysgro.2005.04.102
   Im SH, 2005, NAT MATER, V4, P671, DOI 10.1038/nmat1448
   Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8
   Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632
   Kitamura M, 2001, J COLLOID INTERF SCI, V236, P318, DOI 10.1006/jcis.2000.7398
   Kontoyannis CG, 2000, ANALYST, V125, P251, DOI 10.1039/a908609i
   Pan Y, 2007, MATER LETT, V61, P2810, DOI 10.1016/j.matlet.2006.10.034
   Pan Y, 2010, LANGMUIR, V26, P4184, DOI 10.1021/la904067q
   Peng CY, 2010, COLLOID SURFACE A, V353, P132, DOI 10.1016/j.colsurfa.2009.11.004
   Qi LM, 2002, ADV MATER, V14, P300
   Shivkumara C, 2006, MATER RES BULL, V41, P1455, DOI 10.1016/j.materresbull.2006.01.026
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Span R, 1996, J PHYS CHEM REF DATA, V25, P1509, DOI 10.1063/1.555991
   Tong H, 2004, BIOMATERIALS, V25, P3923, DOI 10.1016/j.biomaterials.2003.10.038
   Wakayama H, 2005, J MATER CHEM, V15, P1134, DOI 10.1039/b418569b
   WALSH D, 1995, NATURE, V377, P320, DOI 10.1038/377320a0
   Watanabe H, 2009, ADV POWDER TECHNOL, V20, P89, DOI 10.1016/j.apt.2008.10.004
   Wei W, 2008, J AM CHEM SOC, V130, P15808, DOI 10.1021/ja8039585
   Yan GW, 2008, MATER RES BULL, V43, P2069, DOI 10.1016/j.materresbull.2007.09.014
   Yu JG, 2006, ADV FUNCT MATER, V16, P2035, DOI 10.1002/adfm.200600552
NR 32
TC 36
Z9 37
U1 4
U2 73
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 26
BP 9757
EP 9761
DI 10.1039/c1jm10770d
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 780SC
UT WOS:000291878100047
DA 2018-10-19
ER

PT J
AU Cacaina, D
   Areva, S
   Laaksonen, H
   Simon, S
   Ylanen, H
AF Cacaina, D.
   Areva, S.
   Laaksonen, H.
   Simon, S.
   Ylanen, H.
TI Preparation and complex characterization of silica holmium sol-gel
   monoliths
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLY(L-LACTIC ACID) MICROSPHERES; INTERNAL RADIATION-THERAPY; IN-VITRO;
   BIOACTIVE GLASSES; LIVER-TUMORS; STATE; YTTRIUM; SURFACE;
   ACETYLACETONATE; CAO-P2O5-SIO2
AB Amorphous, sol-gel derived SiO(2) are known to biocompatible and bioresorbable materials. Biodegradable and inert materials containing radioactive isotopes have potential application as delivery vehicles of the beta radiation to the cancer tumors inside the body. Incorporation of holmium in the sol-gel derived SiO(2) could lead to the formation of a biodegradable material which could be used as carrier biomaterial for the radiation of radioactive holmium to the various cancer sites. The homogeneity of the prepared sol-gel silica holmium monoliths was investigated by Back Scattered Electron Imaging of Scanning Electron Microscope equipped with Energy Dispersive X-ray Analysis, X-ray Induced Photoelectron Spectroscopy and Nuclear Magnetic Resonance Spectroscopy. The biodegradation of the monoliths was investigated in Simulated Body Fluid and TRIS (Trizma pre-set Crystals) solution. The results show that by suitable tailoring of the sol-gel processing parameters holmium can be homogeneously incorporated in the silica matrix with a controlled biodegradation rate.
C1 [Cacaina, D.; Areva, S.; Laaksonen, H.; Ylanen, H.] Univ Turku, Turku Biomat Ctr, SF-20500 Turku, Finland.
   [Areva, S.; Laaksonen, H.; Ylanen, H.] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Simon, S.] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
RP Cacaina, D (reprint author), Univ Turku, Turku Biomat Ctr, Itainen Pitkakatu 4 B PharmaCity, SF-20500 Turku, Finland.
EM dana.cacaina@yahoo.com
FU The Finnish Funding Agency for Technology and Innovation [40118/06]
FX The Finnish Funding Agency for Technology and Innovation (TEKES-Project
   40118/06) is acknowledged for the financial support of this work. Thanks
   to T. Radu and R.V.F. Turcu from Babes-Bolyai University for the XPS and
   NMR measurements and Department of Physical Chemistry of angstrom bo
   Akademi University for N<INF>2</INF>-sorption measurements.
CR Aparicio M, 2005, CERAM INT, V31, P631, DOI 10.1016/j.ceramint.2004.08.002
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Bult W, 2010, PHARM RES-DORDR, V27, P2205, DOI 10.1007/s11095-010-0226-3
   Cacaina D, 2007, J OPTOELECTRON ADV M, V9, P2566
   Cacaina D, 2006, J MATER SCI-MATER M, V17, P709, DOI 10.1007/s10856-006-9681-0
   CACAINA D, 2007, J MATER SCI, V19, P1225
   CACAINA D, 2005, KEY ENG MATER, V411, P284
   Coelho C, 2006, J SOL-GEL SCI TECHN, V40, P181, DOI 10.1007/s10971-006-7431-x
   Conzone SD, 2002, J BIOMED MATER RES, V60, P260, DOI 10.1002/jbm.10047
   Day DE, 1993, INTRO BIOCERAMICS, V1, P305
   Drake KO, 2005, SOLID STATE NUCL MAG, V27, P28, DOI 10.1016/j.ssnmr.2004.08.008
   Eighmy T. T., 1999, Surface Science Spectra, V6, P193, DOI 10.1116/1.1247925
   Hafeli UO, 2001, APPL RADIAT ISOTOPES, V54, P869, DOI 10.1016/S0969-8043(00)00313-4
   Hench L. L., 1993, INTRO BIOCERAMICS, V1, P1
   Ho S, 1998, CANCER, V83, P1894, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1894::AID-CNCR4>3.3.CO;2-F
   Jokinen M, 1998, J SOL-GEL SCI TECHN, V12, P159, DOI 10.1023/A:1008642117227
   Kawashita M, 2003, BIOMATERIALS, V24, P2955, DOI 10.1016/S0142-9612(03)00094-2
   Kennedy AS, 2006, INT J RADIAT ONCOL, V65, P412, DOI 10.1016/j.ijrobp.2005.12.051
   Kennedy AS, 2004, INT J RADIAT ONCOL, V60, P1552, DOI 10.1016/j.ijrobp.2004.09.004
   Kepinski L, 2003, MATER CHEM PHYS, V81, P396, DOI 10.1016/S0254-0584(03)00031-2
   Khattak GD, 2004, J NON-CRYST SOLIDS, V337, P174, DOI 10.1016/j.jnoncrysol.2003.08.088
   LANG WC, 1975, FARADAY DISCUSS, V60, P37, DOI 10.1039/dc9756000037
   LIN W, 2004, J NUCL MED, V41, P1892
   LIVAGE J, 1988, PROG SOLID STATE CH, V18, P259, DOI 10.1016/0079-6786(88)90005-2
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   Nijsen JFW, 2002, BIOMATERIALS, V23, P1831, DOI 10.1016/S0142-9612(01)00309-X
   Nijsen JFW, 2002, CURR MED CHEM, V9, P73, DOI 10.2174/0929867023371454
   Nijsen JFW, 2001, BIOMATERIALS, V22, P3073, DOI 10.1016/S0142-9612(01)00055-2
   Parmentier J, 2001, SOLID STATE SCI, V3, P495, DOI 10.1016/S1293-2558(01)01151-7
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   PRADO D, 2000, MAT RES, V3, P61
   Ramila A, 2001, BIOMATERIALS, V22, P2301, DOI 10.1016/S0142-9612(00)00419-1
   ROBERTO WS, 2003, ARTIF ORGANS, V27, P420
   Sepulveda P, 2001, J BIOMED MATER RES, V58, P734, DOI 10.1002/jbm.10026
   Simon V, 2007, SOLID STATE COMMUN, V141, P42, DOI 10.1016/j.ssc.2006.09.036
   Smits MLJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-70
   Vente MAD, 2008, EUR J NUCL MED MOL I, V35, P1259, DOI 10.1007/s00259-008-0747-8
   Vente MAD, 2010, EUR RADIOL, V20, P862, DOI 10.1007/s00330-009-1613-1
   Vente MAD, 2010, EXPERT REV MED DEVIC, V7, P581, DOI 10.1586/ERD.10.48
   Viitala R, 2005, J SOL-GEL SCI TECHN, V36, P147, DOI 10.1007/s10971-005-5286-1
   Viitala R, 2002, BIOMATERIALS, V23, P3073, DOI 10.1016/S0142-9612(02)00017-0
   WHITE JE, 1994, KEY ENG MAT, V94-9, P181, DOI 10.4028/www.scientific.net/KEM.94-95.181
   Wickremesekera JK, 2001, INT J RADIAT ONCOL, V49, P1015, DOI 10.1016/S0360-3016(00)01420-6
   Yoshida K, 1999, J BIOMED MATER RES, V46, P221, DOI 10.1002/(SICI)1097-4636(199908)46:2<221::AID-JBM11>3.0.CO;2-T
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
   Zotov N, 1998, AM MINERAL, V83, P823
NR 47
TC 3
Z9 3
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2011
VL 22
IS 1
BP 29
EP 40
DI 10.1007/s10856-010-4186-2
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736TF
UT WOS:000288516300004
PM 21132520
DA 2018-10-19
ER

PT J
AU Thakurta, SG
   Subramanian, A
AF Thakurta, Sanjukta Guha
   Subramanian, Anuradha
TI Evaluation of in situ albumin binding surfaces: a study of protein
   adsorption and platelet adhesion
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ACUTE INFLAMMATORY RESPONSES; OXIDE)
   COUPLING-POLYMER; SERUM-ALBUMIN; PLASMA; BIOMATERIALS; ACTIVATION;
   FIBRINOGEN; BLOOD; VITRO
AB Surface modification strategies that take advantage of the passivation effects of albumin are important in the development of biomaterial surfaces. In this study, linear peptides (LP1, LP2) and a small chemical ligand (SCL) with albumin binding affinities were grafted onto silane functionalized silicon substrates. Surfaces were characterized with contact angle and ellipsometric measurements, and densities of immobilized ligands were assessed spectro-scopically. Ellipsometrically measured thickness correlated with the predicted molecular lengths of grafted moieties. Contact angle analysis indicated that the LP1 and LP2 functionalized surfaces were hydrophilic compared to SCL functionalized and control surfaces. Adsorption of albumin from human serum was evaluated and quantified via specific enzyme-linked immunosorbent assays and 2D gel electrophoresis. The following trend was noted for surface adsorbed albumin: LP1 > LP2 > SCL > C, with LP1 derivatized surfaces having similar to 2.450 mu g/cm(2) of bound albumin. LP1 derivatized surfaces possessed the least number of adsorbed platelets with rounded platelet morphology when compared to control surface.
C1 [Thakurta, Sanjukta Guha; Subramanian, Anuradha] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
EM asubramanian2@unl.edu
FU NSF [CTS-0411632]; Army Research Laboratory [W911NF-04-2-0011]
FX This work was partially supported by NSF Grant CTS-0411632 and Army
   Research Laboratory W911NF-04-2-0011. We are thankful to Gaye Homer,
   University of Nebraska Health Center, Lincoln, NE for letting us use the
   platelet counting instrument; Dr. H. Chen and Dr. Y. Joe. Zhou of
   microscopy facility of Center of Biotechnology; Dr. D. W. Thompson and
   Dr. T. Hofmann of Center for Materials Research and Analysis, University
   of Nebraska, Lincoln, NE for in hand training at SEM and Ellipsometry
   facility, respectively.
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BRASH JL, 1988, MAKROMOL CHEM-M SYMP, V17, P441, DOI 10.1002/masy.19880170133
   Cao L, 2006, J BIOMED MATER RES A, V79A, P788, DOI 10.1002/jbm.a.30908
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHANDY T, 1985, BIOMATERIALS, V6, P416, DOI 10.1016/0142-9612(85)90103-6
   CHANDY T, 1992, ARTIF ORGANS, V16, P568
   Chiumiento A, 2007, BIOMACROMOLECULES, V8, P523, DOI 10.1021/bm060664m
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Demiryas N, 2007, J APPL POLYM SCI, V105, P1808, DOI 10.1002/app.26187
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Frautschi JR, 1995, J BIOMAT SCI-POLYM E, V7, P563
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Guhathakurta S, 2007, J ELECTROCHEM SOC, V154, pP136, DOI 10.1146/1.2779951
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   Keogh James R., 1996, Cells and Materials, V6, P209
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   Lyman D J, 1972, Adv Nephrol Necker Hosp, V2, P97
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1969, J BIOMED MATER RES, V3, P175
   Ma ZY, 2006, REACT FUNCT POLYM, V66, P618, DOI 10.1016/j.reactfunctpolym.2005.10.014
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   Martin MCL, 2003, J MATER SCI-MATER M, V14, P945, DOI 10.1023/A:1026394431100
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   McFarland CD, 1998, J BIOMAT SCI-POLYM E, V9, P1227, DOI 10.1163/156856298X00749
   MUSTARD JF, 1970, PHARMACOL REV, V22, P97
   Odabasi M, 2004, J APPL POLYM SCI, V93, P719, DOI 10.1002/app.20485
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Riccitelli S D, 1985, Trans Am Soc Artif Intern Organs, V31, P250
   Sato AK, 2002, BIOTECHNOL PROGR, V18, P182, DOI 10.1021/bp010181o
   Sharma C P, 1987, J Biomater Appl, V2, P205, DOI 10.1177/088532828700200202
   SIMAL-GANDARA J, 1993, FOOD ADDIT CONTAM A, V10, P555
   Subramanian A, 1997, SO BIOMM ENGN CONF P, P57, DOI 10.1109/SBEC.1997.583213
   SUBRAMANIAN A, 1994, J CHROMATOGR A, V672, P11, DOI 10.1016/0021-9673(94)80590-3
   Subramanian A, 2006, CARBOHYD POLYM, V66, P321, DOI 10.1016/j.carbpol.2006.03.022
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TAOA W, 2008, APPL SURF SCI, V254, P2831
   THAKURTA G, 2009, DESIGN DEV SITU ALBU
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   VANOSS CJ, 1969, INTERFACIAL FORCES A
   VROMAN L, 1972, B NEW YORK ACAD MED, V48, P302
   Wang DA, 2001, J BIOMAT SCI-POLYM E, V12, P1123, DOI 10.1163/15685620152691896
   Wang DA, 2002, BIOCONJUGATE CHEM, V13, P792, DOI 10.1021/bc0255079
   Wu YD, 2007, J BIOMED MATER RES A, V81A, P956, DOI 10.1002/jbm.a.31105
   WU YSF, 2005, J BIOMED MATER RES A, V74, P238
NR 50
TC 11
Z9 11
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2011
VL 22
IS 1
BP 137
EP 149
DI 10.1007/s10856-010-4169-3
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736TF
UT WOS:000288516300014
PM 21120589
DA 2018-10-19
ER

PT J
AU Dupret-Bories, A
   Schultz, P
   Vrana, NE
   Lavalle, P
   Vautier, D
   Debry, C
AF Dupret-Bories, Agnes
   Schultz, Philippe
   Vrana, Nihal Engin
   Lavalle, Philippe
   Vautier, Dominique
   Debry, Christian
TI Development of surgical protocol for implantation of tracheal prostheses
   in sheep
SO JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT
LA English
DT Article
DE artificial larynx; epithelium; function; laryngeal cancer;
   laryngectomees; outcome; porous titanium; prosthetic surgery;
   rehabilitation; sheep; surgical protocol; survival rate
ID CARINAL REPLACEMENT; AORTIC ALLOGRAFTS; SURVIVAL ANALYSIS; POROUS
   TITANIUM; HOMOGRAFT; AUTOGRAFT; SURGERY; TISSUE
AB This article documents experiments performed in ewes to design an artificial larynx. The artificial larynx is composed of a hollow, porous tube that elongates the trachea and is capped with a valve that acts as a laryngeal sphincter. Through an industrial collaboration, our team developed a porous biomaterial that can be colonized by cervical tissues. This biomaterial has been used in animals to replace part of the trachea, but it is meant to eventually substitute for laryngeal cartilage. The tracheal prosthesis is a hollow cylindrical tube composed of titanium microbeads. We performed a study in large animals to establish an optimal surgical protocol for tracheal replacement in humans. The study included 11 sheep (n = 11) and compared 5 methods of implantation. We successfully established an optimal three-step surgical protocol to make the porous-titanium tracheal prosthesis functional: (1) large lumen endoprosthetics, (2) colonization by the peripheral tissues, and (3) endoprosthetic epithelialization. This study is the first step in developing an artificial larynx because it successfully identifies a biomaterial capable of extending the trachea to allow it to open at the junction of the upper aerodigestive tracts.
C1 [Dupret-Bories, Agnes; Schultz, Philippe; Debry, Christian] Hop Hautepierre, Hop Univ Strasbourg, Dept Otorhinolaryngol, Strasbourg, France.
   [Dupret-Bories, Agnes; Schultz, Philippe; Debry, Christian] Hop Hautepierre, Hop Univ Strasbourg, Tech Res Team, Strasbourg, France.
   [Vrana, Nihal Engin; Lavalle, Philippe; Vautier, Dominique] INSERM, Dept Res, Unite 977, Strasbourg, France.
RP Dupret-Bories, A (reprint author), CHU Hautepierre, Dept Otorhinolaryngol, Ave Moliere, F-67098 Strasbourg, France.
EM agnes.dupret@chru-strasbourg.fr
RI Lavalle, Philippe/E-6328-2016; Vrana, Nihal/A-2029-2010
OI Lavalle, Philippe/0000-0001-8798-912X; Vrana, Nihal/0000-0002-5398-6710;
   Dupret-Bories, Agnes/0000-0002-7068-3500
FU Reseau National des Technologies de Sante de l'Agence Nationale de la
   Recherche [French National Research Agency]
FX This material was based on work supported by the Reseau National des
   Technologies de Sante de l'Agence Nationale de la Recherche [French
   National Research Agency], PROTimplant Project.
CR Anoosh F, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-23
   Azorin JF, 2006, EUR J CARDIO-THORAC, V29, P261, DOI 10.1016/j.ejcts.2005.11.026
   Babin E, 2008, J OTOLARYNGOL-HEAD N, V37, P495, DOI 10.2310/7070.2008.0094
   Brian E, 2007, REV PNEUMOL CLIN, V63, P224, DOI 10.1016/S0761-8417(07)90127-3
   Coraux C, 2005, M S-MED SCI, V21, P1063
   Davidson MB, 2009, ANN THORAC SURG, V88, P1006, DOI 10.1016/j.athoracsur.2009.01.044
   Dodge-Khatami Ali, 2003, Asian Cardiovasc Thorac Ann, V11, P245
   Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002
   Grillo HC, 2003, ANN THORAC SURG, V75, P1039, DOI 10.1016/S0003-4975(02)04109-7
   Grillo HC, 2003, ANN THORAC SURG, V75, P610, DOI 10.1016/S0003-4975(02)04108-5
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Guillemot F, 2002, J COLLOID INTERF SCI, V255, P75, DOI 10.1006/jcis.2002.8623
   *I LAB AN RES NAT, 2010, COMM UPD GUID CAR US, P43891
   Ko PJ, 2009, LARYNGOSCOPE, V119, P2331, DOI 10.1002/lary.20615
   Kojima K, 2003, FASEB J, V17, P823, DOI 10.1096/fj.02-0462com
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Makris D, 2007, CURR OPIN PULM MED, V13, P278, DOI 10.1097/MCP.0b013e32816b5c3b
   Makris D, 2010, CHEST, V137, P60, DOI 10.1378/chest.09-1275
   Martinod E, 2000, CR ACAD SCI III-VIE, V323, P455, DOI 10.1016/S0764-4469(00)00150-5
   Martinod E, 2001, REV MAL RESPIR, V18, P639
   NEVILLE WE, 1976, J THORAC CARDIOV SUR, V72, P596
   Schultz P, 2007, EUR ARCH OTO-RHINO-L, V264, P433, DOI 10.1007/s00405-006-0195-7
   Schultz P, 2004, EUR ARCH OTO-RHINO-L, V261, P484, DOI 10.1007/s00405-003-0717-5
   Schultz P, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P201
   Schultz P, 2002, ANN THORAC SURG, V73, P1747, DOI 10.1016/S0003-4975(02)03569-5
   Seguin A, 2006, ANN THORAC SURG, V81, P1068, DOI 10.1016/j.athoracsur.2005.07.079
   Seguin A, 2009, ANN THORAC SURG, V87, P861, DOI 10.1016/j.athoracsur.2008.11.038
   ten Hallers EJO, 2004, BIOMATERIALS, V25, P1533, DOI 10.1016/S0142-9612(03)00500-3
   Tojo T, 1998, ANN THORAC SURG, V66, P209, DOI 10.1016/S0003-4975(98)00270-7
   Wurtz A, 2010, J THORAC CARDIOV SUR, V140, P387, DOI 10.1016/j.jtcvs.2010.01.043
NR 30
TC 6
Z9 8
U1 0
U2 7
PU JOURNAL REHAB RES & DEV
PI BALTIMORE
PA DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET,
   BALTIMORE, MD 21202-4051 USA
SN 0748-7711
J9 J REHABIL RES DEV
JI J. Rehabil. Res. Dev.
PY 2011
VL 48
IS 7
BP 851
EP 863
DI 10.1682/JRRD.2010.10.0194
PG 13
WC Rehabilitation
SC Rehabilitation
GA 828LV
UT WOS:000295503400010
PM 21938669
OA Bronze
DA 2018-10-19
ER

PT J
AU Yamazaki, T
   Ikeda, T
   Lim, B
   Okumura, K
   Ishida, M
   Sawada, K
AF Yamazaki, Tomoyuki
   Ikeda, Takaaki
   Lim, Byounghyun
   Okumura, Koichi
   Ishida, Makoto
   Sawada, Kazuaki
TI Smart Integrated Sensor for Multiple Detections of Glucose and L-Lactate
   Using On-Chip Electrochemical System
SO JOURNAL OF SENSORS
LA English
DT Article
ID CMOS SENSOR; L-LYSINE; OXIDASE; ELECTRODE; FABRICATION; BIOCHIP;
   REACTOR; SAMPLES; DESIGN; LAYER
AB Multiple sensor electrodes, a supplementary electrode, a reference electrode, and signal-processing circuits were integrated on a single chip to develop a chip-shaped electrochemical sensing system. L-lactate and glucose were measured using on-chip working electrodes modified by polyion complex to immobilize lactate oxidase and glucose oxidase, respectively. Cyclic voltammetry measurements were conducted using an on-chip potentiostat. Selective and quantitative detection of glucose and L-lactate and the interference behavior were studied. Hydrogen peroxide generated by enzymatic reactions was detected by an increase in anodic oxidation current. Reaction currents at +0.7 V versus Ag/AgCl were used to obtain calibration plots. The measured dynamic ranges for L-lactate and glucose were 0.2-1.0mM and 2.0-8.0mM, respectively. The sensitivities were 65 nA/mM and 15 nA/mM, respectively, using a working electrode of 0.5mm(2). The 3 sigma detection limit was 0.19mMand 1.1mM, respectively. We have achieved multiple biomaterial detections on a circuit-equipped single chip. This integrated electrochemical sensor chip could be the best candidate for realizing point-of-care testing due to its portability and potential for mass production.
C1 [Yamazaki, Tomoyuki; Ikeda, Takaaki; Lim, Byounghyun; Okumura, Koichi; Ishida, Makoto; Sawada, Kazuaki] Toyohashi Univ Technol, Elect & Informat Engn Dept, Toyohashi, Aichi 4418580, Japan.
   [Yamazaki, Tomoyuki] Hioki EE Corp, New Prod Dev Dept, Ueda, Nagano 3861192, Japan.
   [Ishida, Makoto; Sawada, Kazuaki] JST CREST, Chiyoda Ku, Tokyo 1020075, Japan.
RP Yamazaki, T (reprint author), Toyohashi Univ Technol, Elect & Informat Engn Dept, C3-601,1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM yamazaki-t@int.ee.tut.ac.jp
FU Global COE Program "Frontiers of Intelligent Sensing" from the Ministry
   of Education, Culture, Sports, Science and Technology
FX The authors thank Professor Fumio Mizutani for information on the
   polyion complex method and Mr. Naoto Nakayama for helpful discussions.
   This work was supported in part by the Global COE Program "Frontiers of
   Intelligent Sensing" from the Ministry of Education, Culture, Sports,
   Science and Technology.
CR Avramescu A, 2002, ANAL CHIM ACTA, V458, P203, DOI 10.1016/S0003-2670(01)01580-X
   Baader J., 2010, BIOSENS BIOELECTRON, V26, P1839
   Barbaro M, 2006, SENSOR ACTUAT B-CHEM, V118, P41, DOI 10.1016/j.snb.2006.04.010
   Cheng YT, 2007, SENSOR ACTUAT B-CHEM, V120, P758, DOI 10.1016/j.snb.2006.03.045
   de Oliveira ACA, 2005, ANAL CHIM ACTA, V535, P213, DOI 10.1016/j.aca.2004.11.053
   Fischer LM, 2009, MICROELECTRON ENG, V86, P1282, DOI 10.1016/j.mee.2008.11.045
   Frebel H, 1997, SENSOR ACTUAT B-CHEM, V43, P87, DOI 10.1016/S0925-4005(97)00133-0
   Haccoun J, 2006, BIOELECTROCHEMISTRY, V68, P218, DOI 10.1016/j.bioelechem.2005.09.001
   IIJIMA S, 1993, ANAL CHIM ACTA, V281, P483, DOI 10.1016/0003-2670(93)85006-6
   Jia WZ, 2010, TRAC-TREND ANAL CHEM, V29, P306, DOI 10.1016/j.trac.2010.01.006
   Kurita R, 2002, SENSOR ACTUAT B-CHEM, V87, P296, DOI 10.1016/S0925-4005(02)00249-6
   Levine PM, 2008, IEEE J SOLID-ST CIRC, V43, P1859, DOI 10.1109/JSSC.2008.925407
   Liu SQ, 2007, BIOSENS BIOELECTRON, V22, P905, DOI 10.1016/j.bios.2006.03.019
   MIZUTANI F, 1995, ANAL CHIM ACTA, V314, P233, DOI 10.1016/0003-2670(95)00278-8
   Mizutani F, 1996, DENKI KAGAKU, V64, P1266
   Pan DW, 2005, SENSOR ACTUAT B-CHEM, V104, P68, DOI 10.1016/j.snb.2004.04.100
   Parra A, 2006, ANAL CHIM ACTA, V555, P308, DOI 10.1016/j.aca.2005.09.025
   Patel NG, 2000, SENSOR ACTUAT B-CHEM, V67, P134, DOI 10.1016/S0925-4005(00)00410-X
   Shi Y, 2008, SENSOR ACTUAT B-CHEM, V131, P516, DOI 10.1016/j.snb.2007.12.053
   Tokuda T, 2007, SENSOR ACTUAT A-PHYS, V135, P315, DOI 10.1016/j.sna.2006.08.027
   Yamazaki T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DL11
NR 21
TC 2
Z9 2
U1 0
U2 16
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-725X
EI 1687-7268
J9 J SENSORS
JI J. Sens.
PY 2011
AR 190284
DI 10.1155/2011/190284
PG 7
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA V31DS
UT WOS:000208864900003
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Carnio, S
   Serena, E
   Rossi, CA
   De Coppi, P
   Elvassore, N
   Vitiello, L
AF Carnio, Silvia
   Serena, Elena
   Rossi, Carlo Alberto
   De Coppi, Paolo
   Elvassore, Nicola
   Vitiello, Libero
TI Three-dimensional porous scaffold allows long-term wild-type cell
   delivery in dystrophic muscle
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE collagen scaffold; biomaterials; reservoir; muscle precursor cells;
   dystrophin; mdx
ID DUCHENNE MUSCULAR-DYSTROPHY; HUMAN MYOBLAST TRANSPLANTATION; NORMAL
   MYOGENIC CELLS; SKELETAL-MUSCLE; COLLAGEN SCAFFOLD; PRECURSOR CELLS;
   SATELLITE CELLS; STEM-CELLS; THERAPY; REGENERATION
AB Duchenne muscular dystrophy (DMD) is caused by the lack of dystrophin; affected muscles are characterized by continuous bouts of muscle degeneration, eventually leading to the exhaustion of the endogenous satellite cell pool. At present, only palliative treatments are available, although several gene and cell therapy-based approaches are being studied. In this study we proposed to overcome the limitations hampering intramuscular cell injection by using a biomaterial-based strategy. In particular, we used a three-dimensional (3D) collagen porous scaffold to deliver myogenic precursor cells (MPCs) in vivo in the mdx murine model of DMD. MPCs, derived from single fibres of wild-type donors, were expanded in vitro, seeded onto collagen scaffolds and implanted into the tibialis anterior muscles of normal and mdx mice. As a control, cells were delivered via direct intramuscular cell injection in the contralateral muscles. Scaffold-delivered MPCs displayed lower apoptosis and higher proliferation than injected cells; in terms of dystrophin restoration, collagen scaffolds yielded better results than direct injections. Importantly, time-course experiments indicated that the scaffolds acted as a cell reservoir, although cell migration was mostly contained within 400 mu m from the scaffold-host tissue interface. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Carnio, Silvia; Serena, Elena; Elvassore, Nicola] Univ Padua, Dept Chem Engn, I-35100 Padua, Italy.
   [Carnio, Silvia; Vitiello, Libero] Univ Padua, Dept Biol, I-35121 Padua, Italy.
   [Carnio, Silvia; Rossi, Carlo Alberto; Elvassore, Nicola] Venetian Inst Mol Med, Padua, Italy.
   [Rossi, Carlo Alberto; De Coppi, Paolo] Univ Padua, Stem Cell Proc Lab, I-35100 Padua, Italy.
   [Rossi, Carlo Alberto; De Coppi, Paolo] Univ Padua, Div Paediat Surg, Dept Paediat, I-35100 Padua, Italy.
   [Rossi, Carlo Alberto; De Coppi, Paolo] UCL Inst Child Hlth, Surg Unit, London, England.
   [Rossi, Carlo Alberto; De Coppi, Paolo] Great Ormond St Hosp Sick Children, London, England.
RP Elvassore, N (reprint author), Univ Padua, Dept Chem Engn, Via Marzolo 9, I-35100 Padua, Italy.
EM nicola.elvassore@unipd.it; libero.vitiello@unipd.it
OI De Coppi, Paolo/0000-0002-1659-0207
FU Ministry of Research; University of Padova; Fondazione Telethon
   [GGP07216]; Foundation Il Sangue; Great Ormond Street Hospital Childrens
   Charity [V1230]
FX We thank the Italian Ministry of Research, the University of Padova,
   Fondazione Telethon (Grant No. GGP07216, to P.D.C.) and Foundation Il
   Sangue. No conflict of interest, economic or academic, exists for any of
   the authors.
CR Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113
   Bian WN, 2008, IEEE ENG MED BIOL, V27, P109, DOI 10.1109/MEMB.2008.928460
   Boldrin L, 2007, TISSUE ENG, V13, P253, DOI 10.1089/ten.2006.0093
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Chin CD, 2008, BIOMED MICRODEVICES, V10, P459, DOI 10.1007/s10544-007-9155-2
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Cimetta E, 2007, INT J ARTIF ORGANS, V30, P415
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8
   Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8
   Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970
   GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   HUARD J, 1991, CLIN SCI, V81, P287, DOI 10.1042/cs0810287
   HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504
   HUARD J, 1994, MUSCLE NERVE, V17, P224, DOI 10.1002/mus.880170214
   Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X
   KINOSHITA I, 1994, MUSCLE NERVE, V17, P1407, DOI 10.1002/mus.880171210
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   Price FD, 2007, BBA-MOL BASIS DIS, V1772, P272, DOI 10.1016/j.bbadis.2006.08.011
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Serena E, 2008, NEUROL RES, V30, P207, DOI 10.1179/174313208X281109
   Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023
   Skuk D, 2003, J NEUROPATH EXP NEUR, V62, P951, DOI 10.1093/jnen/62.9.951
   Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81
   Tremblay JP, 2008, MOL THER, V16, P1907, DOI 10.1038/mt.2008.243
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
NR 34
TC 11
Z9 11
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2011
VL 5
IS 1
BP 1
EP 10
DI 10.1002/term.282
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 697AB
UT WOS:000285481400001
PM 20607681
DA 2018-10-19
ER

PT J
AU Branford, OA
   Brown, RA
   McGrouther, DA
   Grobbelaar, AO
   Mudera, V
AF Branford, O. A.
   Brown, R. A.
   McGrouther, D. A.
   Grobbelaar, A. O.
   Mudera, V.
TI Shear-aggregated fibronectin with anti-adhesive properties
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE anti-adhesion; biomaterial; cell attachment; fibronectin; interface;
   tendon
ID HEPARIN-BINDING DOMAIN; FLEXOR TENDON REPAIR; EXTRACELLULAR-MATRIX
   PROTEINS; DAMAGED SPINAL-CORD; PLASMA FIBRONECTIN; CELL ATTACHMENT;
   POSTOPERATIVE ADHESIONS; PERITENDINOUS ADHESIONS; BIOLOGICAL-ACTIVITIES;
   SYNOVIAL FIBROBLASTS
AB Biomaterials based on proteins, such as fibronectin, have the potential to guide cell and tissue behaviour during healing as a function of their unique mechanical and bioactive properties. Fibronectin has been reported as a scaffold for attachment of fibroblasts and subsequent deposition of collagen. We have recently developed a derivative process of shear-aggregated fibronectin that prevents cell attachment without causing cell death. This has potential applications in clinical situations where adhesions form across gliding surfaces and cause loss of function, e. g. peritoneal or flexor tendon adhesions. This in vitro study tested this derivative fibronectin biomaterial and its effects on aggressive adhesion-forming cells, using rabbit flexor tendon synovial fibroblasts. We investigated degradation of the novel biomaterial, and attachment of fibroblasts to glass coated with the biomaterial, relative to fibroblast attachment to uncoated and fibronectin-coated glass. We assessed infiltration of the derivative fibronectin biomaterial by fibroblasts and cytotoxicity of the biomaterial to fibroblasts. The interaction between fibroblasts and the derivative fibronectin biomaterial was visualized using time-lapse photography. The derivative fibronectin biomaterial dissolved by 88% of its mass by 3 weeks. Fibroblast attachment to the novel biomaterial was significantly reduced at 6 h. After 24 h of exposure to the novel biomaterial, fibroblasts did not migrate into it, there was no cell death and no attachment was seen using time-lapse. This novel derivative fibronectin biomaterial combines inhibition of fibroblast attachment with barrier effects and has suitable mechanical properties for surgical use in preventing adhesions in vivo. Copyright. (C) 2010 John Wiley & Sons, Ltd.
C1 [Branford, O. A.; Grobbelaar, A. O.] Mt Vernon Hosp, RAFT, Northwood HA6 2RN, Middx, England.
   [Brown, R. A.; Mudera, V.] Univ Coll London, Div Surg & Intervent Sci, Tissue Repair & Engn Ctr, Inst Orthopaed, Stanmore, Middx, England.
   [McGrouther, D. A.] Univ Manchester Plast & Reconstruct Surg Res, Manchester, Lancs, England.
RP Branford, OA (reprint author), Mt Vernon Hosp, RAFT, Leopold Muller Bldg, Northwood HA6 2RN, Middx, England.
EM olivier.branford@totalise.co.uk
OI Branford, Olivier/0000-0003-3711-3394
FU Big Lottery UK; Biotechnology and Biological Sciences Research Council
FX This project was supported by the Big Lottery UK and the Biotechnology
   and Biological Sciences Research Council. The cold precipitate raw
   material for the mats was donated from Bio Products Laboratory, Elstree,
   UK. We would like to thank Dr James Phillips, and Rebecca Porter,
   University College London Tissue Repair and Engineering Centre, for
   their technical help with this study. There are no financial or personal
   relationships between ourselves and others that might bias this work. No
   potential conflicts of interest exist in this study.
CR AHMED Z, 1999, ADHESION, V42, P331
   ASHLEY F L, 1964, Plast Reconstr Surg, V33, P411, DOI 10.1097/00006534-196405000-00001
   AUSTIN RT, 1979, INJURY, V10, P211, DOI 10.1016/0020-1383(79)90011-1
   Beredjiklian PK, 2003, J BONE JOINT SURG AM, V85A, P539, DOI 10.2106/00004623-200303000-00025
   Branford OA, 2008, PLAST RECONSTR SURG, V121, P781, DOI 10.1097/01.prs.0000299373.25294.65
   BRIGMAN BE, 1994, J ORTHOPAED RES, V12, P253, DOI 10.1002/jor.1100120215
   BROWN RA, 1983, LANCET, V2, P1058
   BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9
   BURT A, 1992, ANIMAL CELL BIOTECHN, P158
   Chung AS, 2009, J BIOMED MATER RES A, V89A, P841, DOI 10.1002/jbm.a.32431
   CLARK RAF, 1988, J BIOL CHEM, V263, P12115
   Clark RAF, 2003, J INVEST DERMATOL, V121, P695, DOI 10.1046/j.1523-1747.2003.12484.x
   COSGRIFF TM, 1983, VOX SANG, V44, P98, DOI 10.1111/j.1423-0410.1983.tb04109.x
   CZOP JK, 1982, J IMMUNOL, V129, P2678
   DARBY I, 1990, LAB INVEST, V63, P21
   DJERKOVIC GS, 2005, INT J ARTIF ORGANS, V28, P284
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   ESKELAND G, 1977, J BONE JOINT SURG BR, V59, P206
   Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416
   FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018
   Fukai F, 2000, CELL MOL BIOL, V46, P145
   Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189
   Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076
   GELBERMAN RH, 1991, J HAND SURG-AM, V16A, P686, DOI 10.1016/0363-5023(91)90195-H
   Golash A, 2003, J HAND SURG-BRIT EUR, V28B, P113, DOI 10.1016/S0266-7681(02)00249-8/jhsb.2003.0851
   GRINNELL F, 1994, J INVEST DERMATOL, V103, P155, DOI 10.1111/1523-1747.ep12392625
   GRINNELL F, 1992, J INVEST DERMATOL, V98, P410, DOI 10.1111/1523-1747.ep12499839
   GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206
   Hanff G, 1998, J HAND SURG-AM, V23A, P658, DOI 10.1016/S0363-5023(98)80052-X
   Harding SI, 2002, BIOPROC BIOSYST ENG, V25, P53, DOI 10.1007/s004490100268
   Harding SI, 2000, BIOPROCESS ENG, V22, P159, DOI 10.1007/s004490050025
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   HIRAIZUMI Y, 1995, SPINE, V20, P2272, DOI 10.1097/00007632-199511000-00002
   HOFER U, 1990, J BIOL CHEM, V265, P14561
   Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2
   HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597
   HOMANDBERG GA, 1987, BIOPOLYMERS, V26, P2087, DOI 10.1002/bip.360261208
   HOMANDBERG GA, 1986, BIOCHIM BIOPHYS ACTA, V874, P61, DOI 10.1016/0167-4838(86)90102-0
   Jeekel H., 1997, EUR J SURG S, V579, P43
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kato R, 2001, EXP CELL RES, V265, P54, DOI 10.1006/excr.2001.5179
   Khan U, 1996, J HAND SURG-BRIT EUR, V21B, P813, DOI 10.1016/S0266-7681(96)80199-9
   Khan U, 2000, J BONE JOINT SURG BR, V82B, P1054, DOI 10.1302/0301-620X.82B7.9892
   Khan U, 1997, PLAST RECONSTR SURG, V99, P465, DOI 10.1097/00006534-199702000-00023
   Khan U, 1998, J HAND SURG-AM, V23A, P266, DOI 10.1016/S0363-5023(98)80125-1
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Kitsis CK, 1998, J HAND SURG-BRIT EUR, V23B, P344, DOI 10.1016/S0266-7681(98)80055-7
   KULICK MI, 1986, J HAND SURG-AM, V11A, P110, DOI 10.1016/S0363-5023(86)80116-2
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777
   Menzies D, 2001, ANN ROY COLL SURG, V83, P40
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   MEREDITH JE, 1997, ANN R COLL SURG ENGL, V7, P146
   MOORADIAN DL, 1992, INVEST OPHTH VIS SCI, V33, P3034
   MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   OBARA M, 1988, FDS, V53, P649
   Oharazawa H, 2005, OPHTHAL RES, V37, P191, DOI 10.1159/000086595
   Peck FH, 1998, J HAND SURG-BRIT EUR, V23B, P41, DOI 10.1016/S0266-7681(98)80216-7
   PETERSON WW, 1990, J HAND SURG-AM, V15A, P48, DOI 10.1016/S0363-5023(09)91105-4
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   POTENZA AD, 1963, J BONE JOINT SURG AM, V45, P1217, DOI 10.2106/00004623-196345060-00009
   POTENZA AD, 1962, J BONE JOINT SURG AM, V44, P49, DOI 10.2106/00004623-196244010-00004
   Priestley JV, 2002, J PHYSIOL-PARIS, V96, P123, DOI 10.1016/S0928-4257(01)00088-2
   Ragoowansi R, 2003, J HAND SURG-BRIT EUR, V28B, P465, DOI 10.1016/S0266-7681(03)00140-2
   RIEDERERHENDERSON MA, 1983, IN VITRO CELL DEV B, V19, P127
   ROCCO M, 1983, J BIOL CHEM, V258, P4545
   RUOSLAHTI E, 1981, J BIOL CHEM, V256, P7277
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   Sakata N, 2000, CONNECT TISSUE RES, V41, P213, DOI 10.3109/03008200009005291
   SCOVILL WA, 1978, ANN SURG, V188, P521, DOI 10.1097/00000658-197810000-00009
   Sethi KK, 2002, CELL MOTIL CYTOSKEL, V52, P231, DOI 10.1002/cm.10047
   SHIMOOKA T, 1988, CELL STRUCT FUNCT, V13, P515, DOI 10.1247/csf.13.515
   SIDDIQI NA, 1995, J APPL BIOMATER, V6, P43, DOI 10.1002/jab.770060107
   SKORSTENGAARD K, 1986, EUR J BIOCHEM, V154, P15, DOI 10.1111/j.1432-1033.1986.tb09353.x
   STACK MS, 1993, J BIOL CHEM, V268, P18924
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   STARK HH, 1977, J BONE JOINT SURG AM, V59, P908, DOI 10.2106/00004623-197759070-00012
   Strickland J W, 1985, Hand Clin, V1, P167
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   THOMAS SC, 1986, CLIN ORTHOP RELAT R, P281
   TSUKADA H, 1995, CIRC RES, V77, P651, DOI 10.1161/01.RES.77.4.651
   Underwood S, 2001, BIOTECHNOL BIOENG, V73, P295, DOI 10.1002/bit.1062
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   WHITBY DJ, 1991, DEVELOPMENT, V112, P651
   WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2
   WILKE MS, 1991, J INVEST DERMATOL, V97, P573, DOI 10.1111/1523-1747.ep12481915
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
   WojciakStothard B, 1997, IN VITRO CELL DEV-AN, V33, P110
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
   YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553
   YAMADA KM, 1987, J CELL PHYSIOL, V130, P21, DOI 10.1002/jcp.1041300105
   Zavahir F, 2001, J MATER SCI-MATER M, V12, P1005, DOI 10.1023/A:1012877504092
   ZLATOPOL'SKII A D, 1989, Biokhimiya, V54, P74
   ZLATOPOLSKY AD, 1992, BIOCHEM BIOPH RES CO, V183, P383, DOI 10.1016/0006-291X(92)90492-4
NR 101
TC 6
Z9 6
U1 0
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2011
VL 5
IS 1
BP 20
EP 31
DI 10.1002/term.284
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 697AB
UT WOS:000285481400003
PM 20652877
DA 2018-10-19
ER

PT J
AU Vavken, P
   Joshi, SM
   Murray, MM
AF Vavken, Patrick
   Joshi, Shilpa M.
   Murray, Martha M.
TI Fibrin concentration affects ACL fibroblast proliferation and collagen
   synthesis
SO KNEE
LA English
DT Article
DE Fibrin; Wound healing; Fibroblast; Tissue engineering
ID ANTERIOR CRUCIATE LIGAMENT; PLATELET-RICH PLASMA; MESENCHYMAL
   STEM-CELLS; REPAIR; SCAFFOLD; KNEE; OSTEOARTHRITIS; DEPENDENCE;
   SEALANTS; THROMBIN
AB Fibrin is a frequently used biomaterial in surgery and tissue engineering. While it has been shown that fibrin supports cellular proliferation and biosynthesis, there is a scarcity of studies focusing on the effects of fibrin concentration. The objective of this study is to assess the effect of fibrin concentrations around the physiological concentration of 3 mg/ml on the behavior of ligament fibroblasts. Fibroblasts were obtained from the anterior cruciate ligaments of four pigs and seeded throughout fibrin gels of either 1, 3, or 6 mg/ml fibrin. The gels were collected at 2, 6, and 10 days for measurement of DNA and collagen content. We found that both DNA and collagen content increased significantly over time in gels made with all concentrations of fibrin. However, the increases were significantly lower in gels made with the higher concentrations of fibrin (3 and 6 mg/ml). Microscopic assessment of FITC-labeled gels showed a decrease in pore size at high fibrin concentrations, which might be a reason for the observed effect on bioactivity. To enhance cell behavior and thus clinical results fibrin applications should build on physiologic or sub-physiologic concentrations, and those with higher concentrations, such as currently available sealants, should be used cautiously. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Vavken, Patrick; Joshi, Shilpa M.; Murray, Martha M.] Harvard Univ, Childrens Hosp Boston, Dept Orthoped Surg, Sch Med, Boston, MA 02115 USA.
RP Vavken, P (reprint author), Harvard Univ, Childrens Hosp Boston, Dept Orthoped Surg, Sch Med, 300 Longwood Ave,Enders 1016, Boston, MA 02115 USA.
EM patrick.vavken@childrens.harvard.edu
FU NIH-NIAMS [R01 AR052772]
FX This study was supported by the NIH-NIAMS grant R01 AR052772.
CR Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   ARNESON D, 1976, THROMB RES, V8, P31, DOI 10.1016/0049-3848(76)90120-1
   ARRUDA V, 2008, HARRISONS PRINCIPLES, pCH110
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Cheras PA, 1997, CLIN ORTHOP RELAT R, P57
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   GIDDINGS JC, 1971, J CLIN PATHOL, V24, P467, DOI 10.1136/jcp.24.5.467
   Gorodetsky R, 1999, J INVEST DERMATOL, V112, P866, DOI 10.1046/j.1523-1747.1999.00600.x
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Kamolz LP, 2005, BURNS, V31, P25, DOI 10.1016/j.burns.2004.06.015
   Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601
   Kratz A, 2008, HARRISONS PRINCIPLES
   MASTRANGELO A, 2009, J ORTHOP RE IN PRESS
   Mastrangelo AN, 2010, J ORTHOP RES, V28, P644, DOI 10.1002/jor.21018
   Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7
   Mohtadi N, 2006, CLIN J SPORT MED, V16, P457, DOI 10.1097/01.jsm.0000248844.39498.1f
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2009, CLIN SPORT MED, V28, P51, DOI 10.1016/j.csm.2008.08.005
   Murray MM, 2009, J ORTHOP RES, V27, P639, DOI 10.1002/jor.20796
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Murray MM, 2006, J ORTHOP RES, V24, P508, DOI 10.1002/jor.20054
   Murray MM, 2004, AM J SPORT MED, V32, P1484, DOI 10.1177/0363546504263700
   Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827
   Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   VAVKEN P, 2009, J ORTHOP RES
   VAVKEN P, 2009, TISSUE ENG PART A, DOI DOI 10.1089/TEN.TEA.2009.0147
   Visna P, 2004, ACTA CHIR BELG, V104, P709, DOI 10.1080/00015458.2004.11679648
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
NR 32
TC 17
Z9 18
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0968-0160
EI 1873-5800
J9 KNEE
JI Knee
PD JAN
PY 2011
VL 18
IS 1
BP 42
EP 46
DI 10.1016/j.knee.2009.12.008
PG 5
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 715FP
UT WOS:000286866300009
PM 20080411
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhao, SW
   Chen, A
   Revzin, A
   Pan, TR
AF Zhao, Siwei
   Chen, Arnold
   Revzin, Alexander
   Pan, Tingrui
TI Stereomask lithography (SML): a universal multi-object micro-patterning
   technique for biological applications
SO LAB ON A CHIP
LA English
DT Article
ID EMBRYONIC STEM-CELLS; ARRAYS; CULTURE; MICROARRAYS; GROWTH;
   PHOTOLITHOGRAPHY; DIFFERENTIATION; ORIENTATION; FABRICATION; TECHNOLOGY
AB The advent of biological micro-patterning techniques has given new impetus to many areas of biological research, including quantitative biochemical analysis, tissue engineering, biosensing, and regenerative medicine. Derived from photolithography or soft lithography, current bio-patterning approaches have yet to completely address the needs of out-of-cleanroom, universal applicability, high feature resolution, as well as multi-object placement, though many have shown great promise to precisely pattern one specific biomaterial. In this paper, we present a novel versatile biological lithography technique to achieve integrated multi-object patterning with high feature resolution and high adaptability to various biomaterials, referred to as stereomask lithography (SML). Successive patterning of multiple objects is enabled by using unique three-dimensional masks (i.e., the stereomasks), which lay out current micropatterns while protecting pre-existing biological features on the substrate. Furthermore, high-precision reversible alignment among multiple bio-objects is achieved by adopting a peg-in-hole design between the substrate and stereomasks. We demonstrate that the SML technique is capable of constructing a complex biological microenvironment with various bio-functional components at the single-cell resolution, which to the best of our knowledge has not been realized before.
C1 [Zhao, Siwei; Chen, Arnold; Pan, Tingrui] Univ Calif Davis, Dept Biomed Engn, MiNI Lab, Davis, CA 95616 USA.
RP Pan, TR (reprint author), Univ Calif Davis, Dept Biomed Engn, MiNI Lab, Davis, CA 95616 USA.
EM tingrui@ucdavis.edu
FU National Science Foundation [ECCS-0846502, EFRI BSBA- 0937997]
FX This work is supported in part by National Science Foundation CAREER
   ECCS-0846502 and EFRI BSBA- 0937997. The authors would like to thank Dr
   Julie Sutcliffe and Dr Laura Marcu for use of the microscopes, and Dr
   Jiyoun Lee and Ms Jun Yan for technical assistance with cell culture and
   fluorescent microscopy. In addition, we would acknowledge DuPont Company
   for generously providing PerMX dry film samples.
CR Blicharz TM, 2009, ANAL CHEM, V81, P2106, DOI 10.1021/ac802181j
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen Y, 2003, CANCER RES, V63, P1927
   Choudhuri S, 2004, J BIOCHEM MOL TOXIC, V18, P171, DOI 10.1002/jbt.20023
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498
   Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Ilic B., 2000, BIOMED MICRODEVICES, V2, P6
   Inoue I, 2001, LAB CHIP, V1, P50, DOI 10.1039/b103931h
   Jinno S, 2008, J BIOMED MATER RES A, V86A, P278, DOI 10.1002/jbm.a.32030
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Lee JY, 2008, LANGMUIR, V24, P2232, DOI 10.1021/la702883d
   Lee JY, 2009, LANGMUIR, V25, P3880, DOI [10.1021/la803635r, 10.1021/1a803635r]
   LIJEON N, 2002, NAT BIOTECHNOL, V20, P826
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Ma HC, 2006, DRUG DISCOV TODAY, V11, P661, DOI 10.1016/j.drudis.2006.05.002
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012
   Naffar-Abu-Amara S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001457
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Orth RN, 2003, BIOPHYS J, V85, P3066, DOI 10.1016/S0006-3495(03)74725-0
   Pan T, 2006, J MICROELECTROMECH S, V15, P267, DOI 10.1109/JMEMS.2005.859200
   Pirone DM, 2004, J MAMMARY GLAND BIOL, V9, P405, DOI 10.1007/s10911-004-1410-z
   Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Shah SS, 2009, ACS APPL MATER INTER, V1, P2592, DOI 10.1021/am900508m
   Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076
   Tan CP, 2010, NANO LETT, V10, P719, DOI 10.1021/nl903968s
   Tan CP, 2009, INTEGR BIOL, V1, P587, DOI 10.1039/b908036h
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786
   Vulto P, 2005, LAB CHIP, V5, P158, DOI [10.1039/b411885e, 10.1039/b411885c]
   Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Zhao SW, 2009, LAB CHIP, V9, P1128, DOI 10.1039/b817925e
   Zhu H, 2008, LAB CHIP, V8, P2197, DOI 10.1039/b810244a
NR 48
TC 21
Z9 21
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2011
VL 11
IS 2
BP 224
EP 230
DI 10.1039/c0lc00275e
PG 7
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 697LI
UT WOS:000285514700005
PM 21113523
DA 2018-10-19
ER

PT J
AU Ghafar-Zadeh, E
   Waldeisen, JR
   Lee, LP
AF Ghafar-Zadeh, Ebrahim
   Waldeisen, John R.
   Lee, Luke P.
TI Engineered approaches to the stem cell microenvironment for cardiac
   tissue regeneration
SO LAB ON A CHIP
LA English
DT Review
ID SMOOTH-MUSCLE-CELLS; FLUID SHEAR-STRESS; ELECTRICAL-STIMULATION;
   IN-VITRO; MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; CARDIOMYOCYTE
   PHENOTYPE; ENDOTHELIAL-CELLS; FIELD STIMULATION; PROGENITOR CELLS
AB Micro- and nanoscale engineering approaches in medicine have the potential to recreate physiologically relevant stem cell microenvironments to enhance our understanding of stem cell behaviour and bring stem cell therapy closer to fruition. The realization of such advancements will impact a number of therapeutic applications, the most immediate of which may be the repair of heart tissue. Despite profound advances in creating physiologically relevant in vivo stem cell niches through the control of biochemical regulatory factors, further synergism of innovative techniques promise to elucidate the impact of a number of physical cues such as stem cell differentiation into cardiac cells, the electromechanical coupling among these cells, and the formation of bioengineered cardiac tissue grafts. This review examines the recent physiologically relevant micro-and nanoengineering efforts that have been made to address these factors. In Sections II and III, we introduce the traditional focuses of stem cell derived cardiac tissue: differentiation directed by transcription factors and structural cues within the stem cell niche. However, the majority of this review, Sections IV-VII, endeavours to highlight innovative and unconventional microscale engineering techniques that have employed topographic, biomaterial, microfluidic, mechanical, electrical, and optical stimulation for stem cell based cardiac tissue engineering.
C1 [Ghafar-Zadeh, Ebrahim; Waldeisen, John R.; Lee, Luke P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Waldeisen, John R.; Lee, Luke P.] Univ Calif Berkeley, UCSF Grad Program Bioengn, Berkeley, CA 94720 USA.
RP Lee, LP (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM lplee@berkeley.edu
FU Natural Sciences and Engineering Research Council (NSERC) of Canada
FX E. G. gratefully acknowledges support from the Natural Sciences and
   Engineering Research Council (NSERC) of Canada for awarding him a
   Post-Doctoral Fellowship.
CR Abilez O, 2006, J SURG RES, V132, P170, DOI 10.1016/j.jss.2006.2.017
   ALLEGRE G, 1994, NEUROSCI LETT, V180, P261, DOI 10.1016/0304-3940(94)90534-7
   [Anonymous], 2010, HEART DIS STROK UPD
   Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001
   Au HTH, 2009, LAB CHIP, V9, P564, DOI 10.1039/b810034a
   BALABAN P, 1992, LASER SURG MED, V12, P329, DOI 10.1002/lsm.1900120315
   Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Belus A, 2003, J PHYSIOL-LONDON, V546, P501, DOI 10.1113/jphysiol.2002.027573
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704
   Bursac Nenad, 2009, IEEE Eng Med Biol Mag, V28, P84, DOI 10.1109/MEMB.2009.931792
   Cantz T, 2010, ADV BIOCHEM ENG BIOT, V123, P107, DOI 10.1007/10_2010_74
   Chen MQ, 2010, BIOTECHNOL PROGR, V26, P1164, DOI 10.1002/btpr.431
   Chen MQ, 2009, CELL MOL BIOENG, V2, P625, DOI 10.1007/s12195-009-0096-0
   Chiu LL, 2008, TISSUE ENG PART A, V14, P1
   Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Chronis N, 2003, OPT EXPRESS, V11, P2370, DOI 10.1364/OE.11.002370
   Clause KC, 2009, TISSUE ENG PT A, V15, P1373, DOI 10.1089/ten.tea.2008.0169
   Cohen-Karni T., 2010, P NATL ACAD SCI USA, V107, P15
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Di Carlo D, 2006, ANAL CHEM, V78, P7918
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dvir T., 2010, NAT REV MOL CELL BIO, V12, P36
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   FORK RL, 1971, SCIENCE, V171, P907, DOI 10.1126/science.171.3974.907
   Genovese JA, 2008, BIOCHEM BIOPH RES CO, V370, P450, DOI 10.1016/j.bbrc.2008.03.115
   GIMENO MA, 1967, NATURE, V214, P1014, DOI 10.1038/2141014a0
   Gottwald E, 2007, LAB CHIP, V7, P777, DOI 10.1039/b618488j
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050
   Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056
   Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282
   Huang NF, 2007, TISSUE ENG, V13, P1809, DOI 10.1089/ten.2006.0096
   Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002
   Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63
   JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305
   Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166
   Jeong KH, 2004, OPT EXPRESS, V12, P2494, DOI 10.1364/OPEX.12.002494
   Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039
   Kamkin AG, 2008, PHYSL MOL BIOL CELL
   Kamkin A, 2010, MECHANOSENS CELLS TI, V3, P239, DOI 10.1007/978-90-481-2850-1_9
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Kawahara Y, 2006, PATHOBIOLOGY, V73, P288, DOI 10.1159/000099123
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khine M, 2005, LAB CHIP, V5, P38, DOI 10.1039/b408352k
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kreysing MK, 2008, OPT EXPRESS, V16, P16984, DOI 10.1364/OE.16.016984
   Kurpinski Kyle, 2006, Molecular & Cellular Biomechanics, V3, P21
   Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038
   Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614
   Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030
   Lii J, 2008, ANAL CHEM, V80, P3640, DOI 10.1021/ac8000034
   Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631
   Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Malleo D, 2010, MICROFLUID NANOFLUID, V9, P191, DOI 10.1007/s10404-009-0534-2
   Maloney JM, 2010, BIOPHYS J, V99, P2479, DOI 10.1016/j.bpj.2010.08.052
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Martherus RSRM, 2010, BIOTECHNIQUES, V48, P65, DOI 10.2144/000113308
   Mayer-Wagner S, 2011, BIOELECTROMAGNETICS, V32, P283, DOI 10.1002/bem.20633
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056
   Min JY, 2002, J APPL PHYSIOL, V92, P288
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Murtuza B, 2009, TISSUE ENG PART B-RE, V15, P443, DOI 10.1089/ten.TEB.2009.0006
   Musunuru K., 2010, ANNU REV MED, V61, P287
   Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562
   NATHAN RD, 1976, J GEN PHYSIOL, V67, P27, DOI 10.1085/jgp.67.1.27
   Neild A, 2007, BIOTECHNOL BIOENG, V97, P1335, DOI 10.1002/bit.21315
   Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Oberti S, 2010, ULTRASONICS, V50, P247, DOI 10.1016/j.ultras.2009.09.004
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Oyamada Y, 1996, EXP CELL RES, V229, P318, DOI 10.1006/excr.1996.0377
   Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551
   Park JY, 2009, LAB CHIP, V9, P2194, DOI 10.1039/b822006a
   Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250
   Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040
   Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M., 2010, P NATL ACAD SCI USA, V107, P3329
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731
   Sachinidis A, 2003, CELL PHYSIOL BIOCHEM, V13, P423, DOI 10.1159/000075130
   Sauer H., 1996, J CELL BIOCHEM, V74, P710
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015
   Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e
   Sheng T, 2005, CIRCULATION, V111, P2438, DOI 10.1161/01.CIR.0000167553.49133.81
   Shi JJ, 2008, LAB CHIP, V8, P221, DOI 10.1039/b716321e
   Shi JJ, 2009, LAB CHIP, V9, P3354, DOI 10.1039/b915113c
   Shi JJ, 2009, LAB CHIP, V9, P2890, DOI 10.1039/b910595f
   Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092
   Sim WY, 2007, LAB CHIP, V7, P1775, DOI 10.1039/b712361m
   Smith NI, 2008, OPT EXPRESS, V16, P8604, DOI 10.1364/OE.16.008604
   Sraj I, 2010, BIOMED OPT EXPRESS, V1, P482, DOI 10.1364/BOE.1.000482
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Stern-Straeter J, 2005, J CELL MOL MED, V9, P883, DOI 10.1111/j.1582-4934.2005.tb00386.x
   Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Suzuki K, 2000, CIRCULATION, V102, P216
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tandon N, 2010, LAB CHIP, V10, P692, DOI 10.1039/b917743d
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Teo S. K., 2010, PHYS REV A, V81, P1
   Timko BP, 2009, NANO LETT, V9, P914, DOI 10.1021/nl900096z
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tsai MT, 2009, J ORTHOP RES, V27, P1169, DOI 10.1002/jor.20862
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Villa M, 2010, BIOMED MICRODEVICES, V12, P253, DOI 10.1007/s10544-009-9380-y
   Villa-Diaz LG, 2009, LAB CHIP, V9, P1749, DOI 10.1039/b820380f
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wang Y., 2006, NATURE, V441, P1097
   Wells J, 2005, OPT LETT, V30, P504, DOI 10.1364/OL.30.000504
   Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Wu X. S., 1995, ENCYCLO HDB BIOMATE
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Xu WR, 2004, EXP BIOL MED, V229, P623
   Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004
   Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568
   Yeh ETH, 2003, CIRCULATION, V108, P2070, DOI 10.1161/01.CIR.0000099501.52718.70
   Yi FF, 2009, ARCH MED RES, V40, P339, DOI 10.1016/j.arcmed.2009.06.005
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/S0008-6363(96)00089-2
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann Wolfram-Hubertus, 2007, Trends Cardiovasc Med, V17, P134, DOI 10.1016/j.tcm.2007.02.007
   Zimmermann WH, 2009, PEDIATR CARDIOL, V30, P716, DOI 10.1007/s00246-009-9405-6
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 160
TC 45
Z9 47
U1 3
U2 63
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2011
VL 11
IS 18
BP 3031
EP 3048
DI 10.1039/c1lc20284g
PG 18
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 812BT
UT WOS:000294263400001
PM 21785806
DA 2018-10-19
ER

PT J
AU Luecha, J
   Hsiao, A
   Brodsky, S
   Liu, GL
   Kokini, JL
AF Luecha, Jarupat
   Hsiao, Austin
   Brodsky, Serena
   Liu, Gang Logan
   Kokini, Jozef L.
TI Green microfluidic devices made of corn proteins
SO LAB ON A CHIP
LA English
DT Article
ID ALPHA-ZEIN PROTEINS; SOFT LITHOGRAPHY; SURFACE-MORPHOLOGY; TENSILE
   PROPERTIES; CROSS-LINKING; WATER-VAPOR; MAIZE; FILMS; CYTOCOMPATIBILITY;
   BIOMATERIAL
AB An alternative green microfluidic device made of zein, a prolamin of corn, can be utilized as a disposable environmentally friendly microchip especially in agriculture applications. Using standard soft lithography and stereo lithography techniques, we fabricated thin zein films with microfluidic chambers and channels. These were bonded to both a glass slide and another zein film. The zein film with microfluidic features bonds irreversibly with other surfaces by vapor-deposition of ethanol to create an adhesive layer resulting in very little or no trapped air and small shape distortion. Zein-zein and zein-glass microfluidic devices demonstrated sufficient strength to facilitate fluid flow in a complex microfluidic design that showed no leakage under high hydraulic pressure. Zein-glass microfluidic devices with serpentine mixing design showed successful fluid manipulation as a concentration gradient of Rhodamine B solution was generated. The ease of fabrication and bonding and the flexibility and moldability of zein offer attractive possibilities for microfluidic device design and manufacturing. These devices can include several unit operations with mixing being one of the most commonly used. The zein-based microfluidic devices, made entirely from a biopolymer from agricultural origin, offer alternative environmentally friendly material choices that are less dependent on limited petroleum based polymer resources.
C1 [Hsiao, Austin; Liu, Gang Logan] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Luecha, Jarupat; Kokini, Jozef L.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Hsiao, Austin; Liu, Gang Logan] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.
   [Brodsky, Serena] Univ Illinois, Dept Agr & Biol Engn, Urbana, IL 61801 USA.
   [Liu, Gang Logan] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
RP Liu, GL (reprint author), Univ Illinois, Dept Bioengn, 1304 W Springfield Ave, Urbana, IL 61801 USA.
EM loganliu@illinois.edu; kokini@illinois.edu
FU Thai government; USDA [2007-35603-17744]
FX The authors thank to Scott Robinson, Catherine Wallace and Leilei Yin
   from Beckman Institute, University of Illinois Urbana-Champaign for
   their help in SEM imaging and fluorescence spectroscopy. Ms. Luecha
   thanks the Thai government for the financial support through the Royal
   Thai Government Scholarship. This work was partly supported by USDA
   grant 2007-35603-17744.
CR Altunakar B., 2010, P 13 NAN C EXP, V2
   ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   Core J., 2002, AGR RES, V50, P20
   Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   ESEN A, 1986, PLANT PHYSIOL, V80, P623, DOI 10.1104/pp.80.3.623
   ESEN A, 1987, J CEREAL SCI, V5, P117, DOI 10.1016/S0733-5210(87)80015-2
   Hernandez-Izquierdo VM, 2008, J FOOD SCI, V73, pR30, DOI 10.1111/j.1750-3841.2007.00636.x
   Kim S, 2004, IND CROP PROD, V20, P291, DOI 10.1016/j.indcrop.2003.10.013
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Lafleur JP, 2010, TALANTA, V81, P722, DOI 10.1016/j.talanta.2009.12.001
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lawton JW, 2004, CEREAL CHEM, V81, P1, DOI 10.1094/CCHEM.2004.81.1.1
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   Lazstity R., 1996, CEREAL PROTEINS, P185
   LEHMAN RL, 2004, ADHESIVE CRC HDB MEC, P30
   Liu CM, 2010, J MATER SCI, V45, P6775, DOI 10.1007/s10853-010-4774-z
   Madeka H, 1996, CEREAL CHEM, V73, P433
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Neethirajan S, 2011, LAB CHIP, V11, P1574, DOI [10.1039/c0lc00230e, 10.1039/c01c00230e]
   Okos J.R., 2007, FOOD DEHYDRATION HDB, P601
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Powell DE, 1999, ENVIRON SCI TECHNOL, V33, P3706, DOI 10.1021/es9903476
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Shi K, 2009, J AGR FOOD CHEM, V57, P2186, DOI 10.1021/jf803559v
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54
   Skottrup PD, 2008, BIOSENS BIOELECTRON, V24, P339, DOI 10.1016/j.bios.2008.06.045
   Sun QS, 2005, BIOPOLYMERS, V78, P268, DOI 10.1002/bip.20298
   TATHAM AS, 1993, J BIOL CHEM, V268, P26253
   Tsao CW, 2009, MICROFLUID NANOFLUID, V6, P1, DOI 10.1007/s10404-008-0361-x
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Wang HJ, 2009, COLLOID SURFACE B, V69, P109, DOI 10.1016/j.colsurfb.2008.11.015
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Xi YQ, 2010, TALANTA, V82, P1072, DOI 10.1016/j.talanta.2010.06.007
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
NR 39
TC 15
Z9 15
U1 3
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2011
VL 11
IS 20
BP 3419
EP 3425
DI 10.1039/c1lc20726a
PG 7
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 825JT
UT WOS:000295270100008
PM 21918783
DA 2018-10-19
ER

PT S
AU Peng, WX
   Xue, Q
   Wu, FJ
   Zhang, X
   Zhang, ZF
AF Peng Wan-xi
   Xue Qiu
   Wu Feng-juan
   Zhang Xu
   Zhang Zhong-feng
BE Zeng, D
TI Analysis on Health Risk of Volatile Organic Compounds of Smoked Bamboo
   Biomaterial by TD-GC-MS
SO MATERIALS, MECHATRONICS AND AUTOMATION, PTS 1-3
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT International Conference on Materials, Mechatronics and Automation
   (ICMMA 2011)
CY JAN 15-16, 2011
CL Melbourne, AUSTRALIA
SP Natl Univ Singapore, Int Sci & Engn Ctr
DE Health risk; Smoked bamboo; Volatile organic compounds; Biomaterial;
   TD-GC-MS
AB Smoked bamboo, which was made by bamboo in high temperature smoke, is a new indoors materials. In order to evaluate its potential health risk to human settlements, the volatile organic compounds of smoked bamboo biomaterial were adsorbed and determined by TD-GC-MS. And the main constituents of volatiles at 60 degrees C were cyclononasiloxane, octadecamethyl-(35.14%), acetic acid(23.27%), cyclotrisiloxane, hexamethyl- (9.53%), bicyclo[4.4.0]dec-1-ene,2-isoprop yl-5-methyl-9-methylene-(7.56%), silane, 1,4-phenylenebis[trimethyl(4.32%), 1,3-benzodioxole, 5-(2-propenyl)- (3.47%), cedrol(2.75%), etc. (2) The main constituents of volatiles at 130 degrees C were acetic acid(43.78%), 2,5-furandione, dihydro-3- methylene-(16.57%), 1,3-benzodioxole, 5-(1-propenyl)-,(z)-(6.75%), octasiloxane, 1,1,3,3,5,5,7,7,9,9, 11,11,13, 13,15,15- hexadecamethyl -(4.09%), bicyclo[2.2.1]heptan-2-one, 1,7,7- trimethyl-, (1s)- (3.21%), etc. Generally, the smoked bamboo biomaterial was safe under 60-130 degrees C.
C1 [Peng Wan-xi; Xue Qiu; Wu Feng-juan; Zhang Xu; Zhang Zhong-feng] Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China.
RP Peng, WX (reprint author), Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China.
EM pengwanxi@163.com
CR DU Chungui, 2004, J AGR SCI YANBIAN U, V26, P50
   Flander K. D, 2008, CONSTR BUILD MATER, V38, P323
   Lugt PVD, 2006, CONSTR BUILD MATER, V20, P648
   Qisheng ZH, 2007, CHINA FORESTRY IND A, VA3, P22
   Wanxi P., 2010, ADV MAT RES, V129-131, P60
   ZHIYONG H, 2005, FOOD SCI TECHNOLOGY, P98
NR 6
TC 0
Z9 0
U1 3
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 467-469
BP 1697
EP 1701
DI 10.4028/www.scientific.net/KEM.467-469.1697
PG 5
WC Automation & Control Systems; Engineering, Manufacturing; Materials
   Science, Multidisciplinary
SC Automation & Control Systems; Engineering; Materials Science
GA BZY38
UT WOS:000303364701050
DA 2018-10-19
ER

PT J
AU Szot, CS
   Buchanan, CF
   Gatenholm, P
   Rylander, MN
   Freeman, JW
AF Szot, Christopher S.
   Buchanan, Cara F.
   Gatenholm, Paul
   Rylander, Marissa Nichole
   Freeman, Joseph W.
TI Investigation of cancer cell behavior on nanofibrous scaffolds
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanofibrous scaffold; Electrospinning; Polycaprolactone; Collagen I;
   Bacterial cellulose; Cancer
ID MESENCHYMAL STEM-CELLS; BACTERIAL CELLULOSE; IN-VITRO; TISSUE;
   DIFFERENTIATION; PROLIFERATION; EXPRESSION; CARTILAGE; POROSITY; FIBERS
AB Tissue engineering and the use of nanofibrous biomaterial scaffolds offer a unique perspective for studying cancer development in vitro. Current in vitro models of tumorigenesis are limited by the use of static, two-dimensional (2D) cell culture monolayers that lack the structural architecture necessary for cell-cell interaction and three-dimensional (3D) scaffolds that are too simplistic for studying basic pathological mechanisms. In this study, two nanofibrous biomaterials that mimic the structure of the extracellular matrix, bacterial cellulose and electrospun polycaprolactone (PCL)/collagen I, were investigated as potential 3D scaffolds for an in vitro cancer model. Multiple cancer cell lines were cultured on each scaffold material and monitored for cell viability, proliferation, adhesion, infiltration, and morphology. Both bacterial cellulose and electrospun PCL/collagen I, which have nanoscale structures on the order of 100-500 nm, have been used in many diverse tissue engineering applications. Cancer cell adhesion and growth were limited on bacterial cellulose, while all cellular processes were enhanced on the electrospun scaffolds. This initial analysis has demonstrated the potential of electrospun PCL/collagen I scaffolds toward the development of an improved 3D in vitro cancer model. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Szot, Christopher S.; Buchanan, Cara F.; Gatenholm, Paul; Rylander, Marissa Nichole; Freeman, Joseph W.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
   [Gatenholm, Paul] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
RP Freeman, JW (reprint author), Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM jwfreeman@vt.edu
RI Rylander, Marissa Nichole/F-2455-2014
FU Institute for Critical Technology and Applied Sciences at Virginia Tech
FX We would like to thank Dr. Sang Jin Lee for his assistance with
   electrospinning the PCL/collagen scaffolds and Dr. Aase Bodin for her
   contribution of bacterial cellulose. This work was funded by the
   Institute for Critical Technology and Applied Sciences at Virginia Tech.
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Esguerra M., 2009, J BIOMED MAT RES A
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li SM, 2005, BIOMACROMOLECULES, V6, P489, DOI 10.1021/bm049458+
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Rhodes NP, 2004, J MATER SCI-MATER M, V15, P391, DOI 10.1023/B:JMSM.0000021108.74004.7e
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang XL, 2005, BIOTECHNOL PROGR, V21, P1289, DOI 10.1021/bp050003l
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 33
TC 25
Z9 25
U1 2
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2011
VL 31
IS 1
SI SI
BP 37
EP 42
DI 10.1016/j.msec.2009.12.005
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 704HG
UT WOS:000286041100007
DA 2018-10-19
ER

PT S
AU Pinheiro, ALB
   Aciole, GTS
   Soares, LGP
   Correia, NA
   dos Santos, JN
AF Pinheiro, Antonio Luiz B.
   Aciole, Gilberth T. S.
   Soares, Luiz G. P.
   Correia, Neandder A.
   dos Santos, Jean N.
BE Hamblin, MR
   Waynant, RW
   Anders, J
TI Effects of LED Phototherapy on Bone Defects Grafted with MTA, Bone
   Morphogenetic Proteins and Guided Bone Regeneration in a Rodent Model: A
   Description of the Bone Repair by Light Microscopy
SO MECHANISMS FOR LOW-LIGHT THERAPY VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms for Low-Light Therapy VI
CY JAN 22-23, 2011
CL San Francisco, CA
SP SPIE
DE Biomaterial; Light Emitting Diode; Mineral trioxide aggregate
ID MINERAL TRIOXIDE AGGREGATE; END FILLING MATERIALS; INFRARED-LASER LIGHT;
   IN-VIVO; RAMAN-SPECTROSCOPY; DENTAL IMPLANTS; DIABETIC-RATS; BOVINE
   BONE; PHOTOBIOMODULATION; TISSUE
AB We carried out a histological analysis on surgical bone defects grafted or not with MTA, treated or not with LED, BMPs and GBR. We have used several models to assess the effects of laser on bone. Benefits of the isolated or combined use them on bone healing has been suggested. There is no previous report on their association with LED light. 90 rats were divided into 10 groups. On Groups II and I the defect were filled with the clot. On Group II, were further irradiated. On groups III-VI, defect was filled with MTA + Collagen gel (III); animals of group IV were further irradiated. On groups V and VI, the defects filled with the MTA were covered with a membrane. Animals of Group VI were further irradiated. On Groups VII and VIII a pool of BMPs was added to the MTA and was further irradiated. On groups IX and X, the MTA + BMP graft was covered with a membrane. On group X, the defect was further irradiated. LED (lambda 850 +/- 10nm, 150mW, A=0.5cm(2), 54s, 0.3W/cm(2), 16 J/cm(2)) was applied at 48 h intervals during 15 days. Specimens were taken, processed, cut and stained with H&E and Sirius red and underwent histological analysis. The results showed that MTA seemed not being affected by LED light. However, its use positively affected healing around the graft. It is concluded that MTA is not affected by the LED light due to it characteristics, but beneficial results with LED usage was found.
C1 [Pinheiro, Antonio Luiz B.; Aciole, Gilberth T. S.; Soares, Luiz G. P.; Correia, Neandder A.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio Luiz B.] Univ Camilo Castelo Branco, BR-12245230 Sao Jose, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq for providing financial support for this
   project.
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Al-Watban FAH, 2003, J CLIN LASER MED SUR, V21, P249, DOI 10.1089/104454703322564451
   BIBIKOVA A, 1995, ANAT REC, V241, P123, DOI 10.1002/ar.1092410116
   BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170
   Camilleri J, 2006, INT ENDOD J, V39, P747, DOI 10.1111/j.1365-2591.2006.01135.x
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121
   Economides N, 2003, INT ENDOD J, V36, P44, DOI 10.1046/j.0143-2885.2003.00611.x
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Lanzafame RJQ, 2004, J CLIN LASER MED SUR, V22, P1, DOI 10.1089/104454704773660895
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Oviir T, 2006, J ENDODONT, V32, P210, DOI 10.1016/j.joen.2006.10.036
   Perez AL, 2003, INT ENDOD J, V36, P564, DOI 10.1046/j.1365-2591.2003.00691.x
   Perinpanayagam H, 2009, J CAN DENT ASSOC, V75, P369
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Regan JD, 2002, INT ENDOD J, V35, P840, DOI 10.1046/j.1365-2591.2002.00582.x
   Rox Anderson R, 2002, LASER SURG MED, V30
   Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20
   Silva AN, 2002, J CLIN LASER MED SUR, V20, P83, DOI 10.1089/104454702753768061
   Sommer AP, 2001, J CLIN LASER MED SUR, V19, P29, DOI 10.1089/104454701750066910
   STAHL SS, 1990, J CLIN PERIODONTOL, V17, P191, DOI 10.1111/j.1600-051X.1990.tb01085.x
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
   Vo-Dinh T, 2003, BIOMEDICAL PHOTONICS, P4821
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Whelan H. T, 2002, LASERS SURG MED S14, V30, P14
   Whelan HT, 2002, J CLIN LASER MED SUR, V20, P319, DOI 10.1089/104454702320901107
   Whelan HT, 2001, AIP CONF PROC, V552, P35
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
NR 46
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8424-6
J9 PROC SPIE
PY 2011
VL 7887
AR 78870F
DI 10.1117/12.875836
PG 7
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BXY13
UT WOS:000297594100008
DA 2018-10-19
ER

PT J
AU Reinis, A
   Pilmane, M
   Stunda, A
   Vetra, J
   Kroica, J
   Rostoka, D
   Salms, G
   Vostroilovs, A
   Dons, A
   Berzina-Cimdina, L
AF Reinis, Aigars
   Pilmane, Mara
   Stunda, Agnese
   Vetra, Janis
   Kroica, Juta
   Rostoka, Dagnija
   Salms, Girts
   Vostroilovs, Antons
   Dons, Aleksejs
   Berzina-Cimdina, Liga
TI An In Vitro and In Vivo Study on the Intensity of Adhesion and
   Colonization by Staphylococcus epidermidis and Pseudomonas aeruginosa on
   Originally Synthesized Biomaterials With Different Chemical Composition
   and Modified Surfaces and Their Effect on Expression of TNF-alpha,
   beta-Defensin 2 and IL-10 in Tissues
SO MEDICINA-LITHUANIA
LA English
DT Article
DE biomaterials; Staphylococcus epidermidis; Pseudomonas aeruginosa;
   interleukin 10; tumor necrosis factor alpha; beta-defensin 2
ID DIAGNOSIS
AB The aim of this study was to determine adhesion and colonization of bacteria on the surface of originally synthesized glass-ceramic biomaterials and their effect on inflammation reactions in tissues surrounding the implant.
   Materials and Methods. Biomaterial discs were contaminated with bacterial suspensions of 10, 10(2), and 10(3) colony forming units (CFU)/mL (P aeruginosa ATCC 27853 and S. epidermidis ATCC 12228), and after 2 hours of cultivation, the intensity of bacterial adhesion was determined. For in vivo tests, the samples were contaminated with 10(2) and 10(3) CFU/mL cultivated at 37 degrees C for 2 h to ensure bacterial adhesion. Contaminated biomaterial samples were implanted in the interscapular area of chinchilla rabbits for 2 and 4 weeks. The biomaterials were removed, and using plate count and sonification methods, bacterial colonization on the surface of biomaterials was determined. Moreover, the expression of TNF-alpha, beta-defensin 2, and IL-10 in the surrounding tissues was assessed by using immunohistochemistry methods.
   Results. P aeruginosa more intensively colonized biomaterials in the in vivo study as compared with S. epidermidis. 11-10 is a regulatory cytokine, which reduces the intensity of inflammatory cell activity, thus reducing nonspecific resistance of the organism.
   Conclusions. The expression of TNF-alpha and IL-10 was not affected by short (2 and 4 weeks) biomaterial implantation. Pronounced cytokine expression in tissues around implanted biomaterials contaminated with P aeruginosa was observed.
C1 [Reinis, Aigars; Kroica, Juta; Rostoka, Dagnija] Riga Stradins Univ, Dept Biol & Microbiol, LV-1007 Riga, Latvia.
   [Pilmane, Mara; Vetra, Janis] Riga Stradins Univ, Inst Anat & Anthropol, LV-1007 Riga, Latvia.
   [Stunda, Agnese; Berzina-Cimdina, Liga] Riga Tech Univ, Ctr Dev & Innovat Biomat, Riga, Latvia.
   [Salms, Girts; Vostroilovs, Antons] Riga Stradins Univ, Inst Stomatol, LV-1007 Riga, Latvia.
   [Dons, Aleksejs] Riga Stradins Univ, Fac Med, LV-1007 Riga, Latvia.
RP Reinis, A (reprint author), Riga Stradins Univ, Dept Biol & Microbiol, Dzirciema 16, LV-1007 Riga, Latvia.
EM areinis@apollo.lv
OI Stunda-Zujeva, Agnese/0000-0003-4970-5186
FU European Social Fund within the project "Multidisciplinary Research in
   Biomaterials Technology of New Scientist Group"
   [2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090, PVS ID1380]
FX This work was partly supported by the European Social Fund within the
   project "Multidisciplinary Research in Biomaterials Technology of New
   Scientist Group," No. 2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090, (PVS
   ID1380)
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Jones LC, 2001, J BONE JOINT SURG BR, V83B, P448, DOI 10.1302/0301-620X.83B3.10734
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Pavlova A, 2011, ADV MATER RES-SWITZ, V222, P301, DOI 10.4028/www.scientific.net/AMR.222.301
   Reinis A, 2010, IFMBE PROC, V31, P1204, DOI 10.1007/978-3-642-14515-5_305
   Sampedro MF, 2010, SPINE, V35, P1218, DOI 10.1097/BRS.0b013e3181c3b2f3
   Schneider JJ, 2005, J MOL MED-JMM, V83, P587, DOI 10.1007/s00109-005-0657-1
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   SLUTSKY L, 2001, BIOL ASPECTS BIOMATE, P25
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Yuehuei H.A, 2000, HDB BACTERIAL ADHESI, P11
NR 15
TC 4
Z9 4
U1 0
U2 3
PU KAUNAS UNIV MEDICINE & VILNIUS UNIV
PI KAUNAS
PA KAUNAS UNIV MEDICINE, A MICKEVICIAUS 9, KAUNAS, LT-44307, LITHUANIA
SN 1010-660X
J9 MED LITH
JI Med. Lith.
PY 2011
VL 47
IS 10
BP 560
EP 565
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 878FG
UT WOS:000299240300006
PM 22186120
OA DOAJ Gold
DA 2018-10-19
ER

PT S
AU Menchaca-Campos, C
   Hernandez-del Fabbro, S
   Sarmiento-Bustos, E
   Cruz-Silva, R
   Garcia-Sanchez, MA
   Bahena, D
   Uruchurtu, J
AF Menchaca-Campos, C.
   Hernandez-del Fabbro, S.
   Sarmiento-Bustos, E.
   Cruz-Silva, R.
   Garcia-Sanchez, M. A.
   Bahena, D.
   Uruchurtu, J.
BE PalomarPardave, M
   Rodriguez, FJ
   Uruchurtu, J
   RomeroRomo, MA
   Casillas, N
TI Electrochemical Noise Analysis for Nylon/Titanium Hybrid Materials
SO MES 26: ELECTROCHEMISTRY AS A TOOL FOR SUSTAINABLE DEVELOPMENT
SE ECS Transactions
LA English
DT Proceedings Paper
CT 26th National Meeting of the Mexican-Electrochemical-Society (MES) / 4th
   Meeting of the Mexican Section of the Electrochemical-Society (ECS)
CY MAY 29-JUN 03, 2011
CL Mexico City, MEXICO
SP Mexican Electrochem Soc (MES), Electrochem Soc (ECS), Mexican Sect
ID BEHAVIOR
AB Development of hybrid materials is a necessity. Polymeric materials are widely used in industry because their superior properties. In this work, synthesis, characterization and electrochemical noise evaluation of hybrid materials casted from nylon 6-6 and titanium are involved. Synthesis was carried out with 30, 40 and 50% wt of titanium functionalized with APTES. The materials obtained were characterized through scanning electron microscopy (SEM), thermal analysis (TA), infrared spectroscopy (IR) and electrochemical noise technique in Hank solution to simulate the internal fluids of the human body, in terms of biomaterial application, amongst others. SEM shows a homogenous material. Concentration of titanium was verified with TA. IR spectra show differences between Ny-Ti at different concentrations. Hybrid material made with 50% wt titanium present the lower resistance and the 30% wt the highest, as electrochemical noise resistance confirms. All samples show high resistivity in atmospheric conditions, while in Hank solution electrochemical characteristics were observed.
C1 [Menchaca-Campos, C.; Hernandez-del Fabbro, S.; Cruz-Silva, R.; Bahena, D.; Uruchurtu, J.] UAEM, Ctr Invest Ingn & Ciencias Aplicadas, Av Univ 1001, Cuernavaca 62209, Morelos, Mexico.
   [Menchaca-Campos, C.; Garcia-Sanchez, M. A.] Univ Autonoma Metropolitana Iztapalapa, Depto Quim, Mexico City 09340, DF, Mexico.
   [Menchaca-Campos, C.; Bahena, D.] Univ Tecnol Emiliano Zapata Estado Morelos, Zapata 62790, Mexico.
RP Menchaca-Campos, C (reprint author), UAEM, Ctr Invest Ingn & Ciencias Aplicadas, Av Univ 1001, Cuernavaca 62209, Morelos, Mexico.
CR Botana J., 2006, RUIDO ELECTROQUIMICO, P51
   Castano-Marras C.Ma., 2002, DYNA INGENIERA IND, V77, P1
   Cottis R., 1999, ELECTROCHEMICAL IMPE, P71
   Gonzalez-Nunez M. A., 2003, J CORROSION SCI ENG, V6, pC117
   Kearns J.R., 1996, STP ASTM, V1277, P446
   MAGILL JH, 1981, POLYMER, V22, P43, DOI 10.1016/0032-3861(81)90075-6
   Marcellan A, 2006, POLYMER, V47, P367, DOI 10.1016/j.polymer.2005.10.093
   Neirinck B, 2009, ADV ENG MATER, V11, P633, DOI 10.1002/adem.200900074
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 S MAIN ST, PENNINGTON, NJ 08534-2839 USA
SN 1938-5862
BN 978-1-56677-940-1
J9 ECS TRANSACTIONS
PY 2011
VL 36
IS 1
BP 83
EP 92
DI 10.1149/1.3660601
PG 10
WC Electrochemistry
SC Electrochemistry
GA BDM07
UT WOS:000313723300009
DA 2018-10-19
ER

PT J
AU Winn, B
   Quarles, CD
   Marcus, RK
   LaBerge, M
AF Winn, Brad
   Quarles, C. Derrick, Jr.
   Marcus, R. Kenneth
   LaBerge, Martine
TI Nickel ions inhibit alpha-actin expression and decrease aspect ratio of
   rat vascular smooth muscle cells in vitro
SO METALLOMICS
LA English
DT Article
ID SHAPE-MEMORY METAL; TECHNIQUE ICP-AES; NI-TI ALLOYS; MECHANICAL STRAIN;
   STAINLESS-STEEL; MULTIELEMENT ANALYSIS; INDUCED GENOTOXICITY; CORROSION
   PRODUCTS; CALCIUM-CHANNELS; BODY-FLUIDS
AB Traditionally, in vitro material biocompatibility studies involved evaluating cell response when cultured in the presence of a sample of the material. In this study, we present a different approach to evaluate the biocompatibility of a metallic biomaterial. Our study is based on estimating what local concentrations of metallic ions are present at the site of implantation of an endovascular stent based on other studies in the literature. We then quantify the concentrations of metallic ions present in our conditioned media in which Nitinol wires were allowed to corrode, and compare cell response to ion concentrations in order to provide better experimental reproducibility. This is important to eliminate the variability of ion release rates from metals (even from the same lot) under similar conditions. Cell culture experiments using vascular smooth muscle cells exposed to clinically significant concentrations of nickel ions released from Nitinol showed two important responses. A decrease in cell aspect ratios showing a morphological change possibly indicating a shift towards a more synthetic phenotype was observed. Secondly, a decrease in alpha-actin expression was characterized by immunostaining with a fluorescent tag. At the highest concentration tested, average fluorescence decreased by approximately 26%, indicating a loss of the cellular contractile mechanism. However, the ion concentrations utilized in this study did not significantly affect cellular proliferation.
C1 [Winn, Brad; Quarles, C. Derrick, Jr.; Marcus, R. Kenneth; LaBerge, Martine] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Winn, B (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
CR Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Butcher JT, 2006, BIOMATERIALS, V27, P5252, DOI 10.1016/j.biomaterials.2006.05.040
   Castro J, 2009, ANAL METHODS-UK, V1, P188, DOI 10.1039/b9ay00080a
   CONWAY K, 1987, CARCINOGENESIS, V8, P1115, DOI 10.1093/carcin/8.8.1115
   Costa M, 2001, MOL CELL BIOCHEM, V222, P205, DOI 10.1023/A:1017978500031
   DalleDonne I, 1999, BBA-GEN SUBJECTS, V1426, P32, DOI 10.1016/S0304-4165(98)00120-2
   Faxon D., 2001, RESTENOSIS GUIDE THE
   Gunaratnam M, 2004, TOXICOL IN VITRO, V18, P245, DOI 10.1016/j.tiv.2003.08.014
   Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje
   HEATH JC, 1967, BRIT J CANCER, V21, P768, DOI 10.1038/bjc.1967.90
   HENNIG FF, 1992, J TRACE ELEM ELECT H, V6, P239
   Hillen U, 2002, CONTACT DERMATITIS, V47, P353, DOI 10.1034/j.1600-0536.2002.470607.x
   Hong YC, 1997, ENVIRON HEALTH PERSP, V105, P744, DOI 10.1289/ehp.97105744
   Hu YH, 1998, FASEB J, V12, P1135
   Ke QD, 2007, TOXICOL APPL PHARM, V219, P18, DOI 10.1016/j.taap.2006.08.013
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1
   Li Q, 2009, TOXICOL APPL PHARM, V235, P191, DOI 10.1016/j.taap.2008.12.005
   Li WD, 1996, TOXICOL APPL PHARM, V136, P101, DOI 10.1006/taap.1996.0012
   Liu DL, 2002, CLIN EXP PHARMACOL P, V29, P395, DOI 10.1046/j.1440-1681.2002.03674.x
   Lynn S, 1997, BIOL TRACE ELEM RES, V59, P1, DOI 10.1007/BF02783224
   Mills I, 1997, J CELL PHYSIOL, V170, P228, DOI 10.1002/(SICI)1097-4652(199703)170:3<228::AID-JCP2>3.0.CO;2-Q
   MLINAR B, 1993, J PHYSIOL-LONDON, V469, P639, DOI 10.1113/jphysiol.1993.sp019835
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okazaki Y, 2008, CORROS SCI, V50, P3429, DOI 10.1016/j.corsci.2008.09.002
   PAZZAGLIA UE, 1983, ACTA ORTHOP SCAND, V54, P574, DOI 10.3109/17453678308992891
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Rahil-Khazen R, 2002, J TRACE ELEM MED BIO, V16, P15, DOI 10.1016/S0946-672X(02)80004-9
   Rahil-Khazen R, 2000, SCAND J CLIN LAB INV, V60, P677, DOI 10.1080/00365510050216402
   Rose E C, 1998, J Orofac Orthop, V59, P253, DOI 10.1007/BF01321792
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   RZUCIDLO E, 2007, J VASC SURG, V45
   SAFAR ME, 1981, CIRCULATION, V63, P393, DOI 10.1161/01.CIR.63.2.393
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Shih CC, 2001, J BIOMED MATER RES, V57, P200, DOI 10.1002/1097-4636(200111)57:2<200::AID-JBM1159>3.0.CO;2-5
   SUDHIR K, 1993, J CLIN INVEST, V92, P3003, DOI 10.1172/JCI116923
   SUNDERMAN FW, 1989, J ORTHOPAED RES, V7, P307, DOI 10.1002/jor.1100070302
   Wataha JC, 2001, J BIOMED MATER RES, V58, P537, DOI 10.1002/jbm.1052.abs
   WEBB M, 1972, BRIT J CANCER, V26, P292, DOI 10.1038/bjc.1972.39
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741
NR 43
TC 4
Z9 4
U1 0
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1756-5901
J9 METALLOMICS
JI Metallomics
PY 2011
VL 3
IS 9
BP 934
EP 940
DI 10.1039/c1mt00035g
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 814KF
UT WOS:000294449100006
PM 21766118
DA 2018-10-19
ER

PT J
AU Pandis, L
   Zavan, B
   Bassetto, F
   Ferroni, L
   Iacobellis, L
   Abatangelo, G
   Lepidi, S
   Cortivo, R
   Vindigni, V
AF Pandis, Laura
   Zavan, Barbara
   Bassetto, Franco
   Ferroni, Letizia
   Iacobellis, Laura
   Abatangelo, Giovanni
   Lepidi, Sandro
   Cortivo, Roberta
   Vindigni, Vincenzo
TI HYALURONIC ACID BIODEGRADABLE MATERIAL FOR RECONSTRUCTION OF VASCULAR
   WALL: A PRELIMINARY STUDY IN RATS
SO MICROSURGERY
LA English
DT Article
ID CAROTID-ARTERY ENDARTERECTOMY; ENDOTHELIAL PROGENITOR CELLS;
   SMOOTH-MUSCLE-CELLS; IN-VIVO; PULMONARY-ARTERY; ANIMAL-MODEL; TISSUE;
   SCAFFOLD; PATCHES; ELASTIN
AB The objective of this preliminary study was to develop a reabsorbable vascular patch that did not require in vitro cell or biochemical preconditioning for vascular wall repair. Patches were composed only of hyaluronic acid (HA). Twenty male Wistar rats weighing 250-350 g were used. The abdominal aorta was exposed and isolated. A rectangular breach (1 mm x 5 mm) was made on vessel wall and arterial defect was repaired with HA made patch. Performance was assessed at 1, 2, 4, 8, and 16 weeks after surgery by histology and immunohistochemistry. Extracellular matrix components were evaluated by molecular biological methods. After 16 weeks, the biomaterial was almost completely degraded and replaced by a neoartery wall composed of endothelial cells, smooth muscle cells, collagen, and elastin fibers organized in layers. In conclusion, HA patches provide a provisional three-dimensional support to interact with cells for the control of their function, guiding the spatially and temporally multicellular processes of artery regeneration. (C) 2011 Wiley-Liss, Inc. Microsurgery 31:138-145, 2011.
C1 [Pandis, Laura; Bassetto, Franco; Vindigni, Vincenzo] Univ Padua, Clin Plast & Reconstruct Surg, I-35100 Padua, Italy.
   [Zavan, Barbara; Ferroni, Letizia; Iacobellis, Laura; Abatangelo, Giovanni; Cortivo, Roberta] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
   [Lepidi, Sandro] Univ Padua, Clin Vasc Surg, I-35100 Padua, Italy.
RP Vindigni, V (reprint author), Univ Padua, Clin Plast & Reconstruct Surg, Via Giustiniani 2, I-35100 Padua, Italy.
EM vincenzo.vindigni@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Aburahma Ali F, 2004, Semin Vasc Surg, V17, P243, DOI 10.1016/S0895-7967(04)00044-4
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BOND R, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000071
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301
   Cho SW, 2005, BIOMATERIALS, V26, P1915, DOI 10.1016/j.biomaterials.2004.06.018
   DallaLibera L, 1997, J MUSCLE RES CELL M, V18, P295
   Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010
   Genasetti A, 2008, CONNECT TISSUE RES, V49, P120, DOI 10.1080/03008200802148462
   Hertzer NR, 2006, J VASC SURG, V43, P959, DOI 10.1016/j.jvs.2005.12.060
   Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Jacobowitz GR, 2001, ANN VASC SURG, V15, P281, DOI 10.1007/s100160010086
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P103, DOI 10.1089/ten.tea.2007.0390
   Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   LEPIDI S, 2006, FASEB J, V20, P103, DOI DOI 10.1096/FJ.05-4802FJE
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Mendelson K, 2007, CARDIOVASC PATHOL, V16, P277, DOI 10.1016/j.carpath.2007.03.008
   Mettler BA, 2008, ANN THORAC SURG, V86, P132, DOI 10.1016/j.athoracsur.2008.02.074
   Milella E, 2002, BIOMATERIALS, V23, P1053, DOI 10.1016/S0142-9612(01)00217-4
   MITCHELL JD, 1994, J THORAC CARDIOV SUR, V107, P1481
   MONCHAUX E, 2010, FRONT BIOSCI SCHOL E, V1, P239
   Muto A, 2009, J VASC SURG, V50, P206, DOI 10.1016/j.jvs.2009.01.062
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Pandis L, 2010, J BIOMED MATER RES A, V93A, P1289, DOI 10.1002/jbm.a.32626
   Pasquinelli G, 2009, TISSUE ENG PT A, V15, P2751, DOI 10.1089/ten.tea.2008.0232
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Sales VL, 2007, TISSUE ENG, V13, P525, DOI 10.1089/ten.2006.0128
   Schmidt D, 2005, EUR J CARDIO-THORAC, V27, P795, DOI 10.1016/j.ejcts.2005.01.064
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Smaill BH, 2000, J THORAC CARDIOV SUR, V120, P1053, DOI 10.1067/mtc.2000.110187
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Tremblay D, 2009, ANN THORAC SURG, V88, P1484, DOI 10.1016/j.athoracsur.2009.07.023
   Tsai JW, 2009, ANN VASC SURG, V23, P374, DOI 10.1016/j.avsg.2008.10.004
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   VESCOVO G, 1996, BASIC APPL MYOL, V6, P183
   Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972
   Wong P, 2002, ANN VASC SURG, V16, P407, DOI 10.1007/s10016-001-0163-z
   Yang C, 2006, ANN THORAC SURG, V81, P57, DOI 10.1016/j.athoracsur.2005.07.013
   Zavan B, 2008, FASEB J, V22, P2853, DOI 10.1096/fj.08-107284
NR 50
TC 2
Z9 2
U1 2
U2 15
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0738-1085
J9 MICROSURG
JI Microsurgery
PY 2011
VL 31
IS 2
BP 138
EP 145
DI 10.1002/micr.20856
PG 8
WC Surgery
SC Surgery
GA 725KJ
UT WOS:000287643300009
PM 21268111
DA 2018-10-19
ER

PT J
AU Rodriguez-Cabello, JC
   Martin, L
   Girotti, A
   Garcia-Arevalo, C
   Arias, FJ
   Alonso, M
AF Carlos Rodriguez-Cabello, J.
   Martin, Laura
   Girotti, Alessandra
   Garcia-Arevalo, Carmen
   Javier Arias, F.
   Alonso, Matilde
TI Emerging applications of multifunctional elastin-like recombinamers
SO NANOMEDICINE
LA English
DT Review
DE drug delivery; elastin-like recombinamers; nanodevices; protein
   purification; surface engineering; tissue engineering
ID EXTRACELLULAR-MATRIX PROTEINS; POLYPEPTIDE-DOXORUBICIN CONJUGATE;
   INVERSE TEMPERATURE TRANSITION; CELL-ADHESION; DRUG-DELIVERY;
   CROSS-LINKING; BIOMEDICAL APPLICATIONS; SOLID TUMORS; POLYMERS; DESIGN
AB Elastin-like recombinamers have grown in popularity in the field of protein-inspired biomimetic materials and have found widespread use in biomedical applications. Modern genetic-engineering techniques have allowed the design of multifunctional materials with an extraordinary control over their architecture and physicochemical properties, such as stimuli-responsiveness, monodispersity, biocompatibility or self-assembly, amongst others. Indeed, these materials are playing an increasingly important role in a diverse range of applications, such as drug delivery, tissue engineering and 'smart' systems. Herein, we review some of the most interesting examples of recent advances, and progressive applications of elastin-like recombinamers in biomaterial and nano-engineering sciences in recent years.
C1 [Carlos Rodriguez-Cabello, J.; Martin, Laura; Girotti, Alessandra; Garcia-Arevalo, Carmen; Javier Arias, F.; Alonso, Matilde] Univ Valladolid, CIBER BBN, Bioforge Grp, E-47011 Valladolid, Spain.
RP Rodriguez-Cabello, JC (reprint author), Univ Valladolid, CIBER BBN, Bioforge Grp, Edificio I D,Paseo de Belen 11, E-47011 Valladolid, Spain.
EM cabello@bioforge.uva.es
RI Arias, Francisco Javier/A-2640-2012; Rodriguez-Cabello, Jose
   Carlos/G-6555-2017; Girotti, Alessandra/D-4325-2012; ALONSO,
   MATILDE/G-6719-2017; Martin, Laura/J-9291-2017; Garcia-Arevalo,
   Carmen/N-6120-2018
OI Arias, Francisco Javier/0000-0001-8584-3768; Rodriguez-Cabello, Jose
   Carlos/0000-0002-3438-858X; Girotti, Alessandra/0000-0003-4754-7022;
   ALONSO, MATILDE/0000-0002-6853-8427; Martin, Laura/0000-0002-6583-8731; 
FU EU; Ministerio de Ciencia e Innovacion - Inoicio (MICINN) [MAT
   2007-66275-C02-01, MAT 2007-61604, MAT 2009-14195-C03-03,
   PSE-300100-2006-2001]; Junta de Castilla y Leon (JCyL) [VA034A09,
   VA030A08]; El Centro de Investigacion Biomedica en Red en Bioingenieria,
   Biomateriales y Nanomedicina [CB06-01-0003]; Instituto de Salud Carlos
   III under the 'Network Center of Regenerative Medicine and Cellular
   Therapy of Castilla and Leon'
FX The authors acknowledge financial support through the European Regional
   Development Fund from the EU, from the Ministerio de Ciencia e
   Innovacion - Inoicio (MICINN; projects MAT 2007-66275-C02-01, MAT
   2007-61604, MAT 2009-14195-C03-03 and PSE-300100-2006-2001), the Junta
   de Castilla y Leon (JCyL; projects VA034A09 and VA030A08), the El Centro
   de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y
   Nanomedicina (project CB06-01-0003), the JCyL and the Instituto de Salud
   Carlos III under the 'Network Center of Regenerative Medicine and
   Cellular Therapy of Castilla and Leon'. The authors have no other
   relevant affiliations or financial involvement with any organization or
   entity with a financial interest in or financial conflict with the
   subject matter or materials discussed in the manuscript apart from those
   disclosed.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Alonso M, 2001, MACROMOLECULES, V34, P8072, DOI 10.1021/ma010455o
   Alvarez-Rodriguez R, 2010, EUR POLYM J, V46, P643, DOI 10.1016/j.eurpolymj.2009.12.022
   Alvarez-Rodriguez R, 2010, MACROMOL RAPID COMM, V31, P568, DOI 10.1002/marc.200900727
   Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Aparicio C, 2009, Journal of Medical Devices, V3, DOI 10.1115/1.3190476
   Araujo R, 2009, BIOMACROMOLECULES, V10, P1655, DOI 10.1021/bm9002943
   Barbosa JS, 2010, ADV ENG MATER, V12, pB37, DOI 10.1002/adem.200980152
   Bessa PC, 2010, J CONTROL RELEASE, V142, P312, DOI 10.1016/j.jconrel.2009.11.003
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015
   Rodriguez-Cabello JC, 2009, POLYMER, V50, P5159, DOI 10.1016/j.polymer.2009.08.032
   Rodrikuez-Cabello JC, 2006, NANOMEDICINE-UK, V1, P267, DOI 10.2217/17435889.1.3.267
   Carlsen A, 2009, CURR OPIN COLLOID IN, V14, P329, DOI 10.1016/j.cocis.2009.04.007
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Costa RR, 2009, ADV FUNCT MATER, V19, P3210, DOI 10.1002/adfm.200900568
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Elloumi I, 2006, BIOMATERIALS, V27, P3451, DOI 10.1016/j.biomaterials.2006.02.003
   Fahmi A, 2010, ADV FUNCT MATER, V20, P1011, DOI 10.1002/adfm.200902013
   Floquet N, 2004, BIOPOLYMERS, V76, P266, DOI 10.1002/bip.20029
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Furgeson DY, 2006, J CONTROL RELEASE, V110, P362, DOI 10.1016/j.jconrel.2005.10.006
   Garcia Y, 2009, TISSUE ENG PT A, V15, P887, DOI 10.1089/ten.tea.2008.0104
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Kim W, 2010, ANGEW CHEM INT EDIT, V49, P4257, DOI 10.1002/anie.201001356
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee J, 2001, MACROMOLECULES, V34, P4114, DOI 10.1021/ma0015673
   Li B, 2001, J MOL BIOL, V305, P581, DOI 10.1006/jmbi.2000.4306
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Liu JC, 2008, BIOMACROMOLECULES, V9, P2984, DOI 10.1021/bm800469j
   MacEwan SR, 2010, NANOMEDICINE-UK, V5, P793, DOI 10.2217/NNM.10.50
   Machado R, 2009, J NANO RES, V6, P133, DOI 10.4028/www.scientific.net/JNanoR.6.133
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]
   Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007
   Martin L, 2010, SOFT MATTER, V6, P1121, DOI 10.1039/b923684h
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   Martin L, 2009, SOFT MATTER, V5, P1591, DOI 10.1039/b823488d
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Martinez-Osorio H, 2009, CURR EYE RES, V34, P48, DOI 10.1080/02713680802542053
   Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jcornel.2005.08.007
   Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/o09-161, 10.1139/O09-161]
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Nath N, 2002, ADV MATER, V14, P1243, DOI 10.1002/1521-4095(20020903)14:17<1243::AID-ADMA1243>3.0.CO;2-M
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   NICOL A, 1993, J BIOMED MATER RES, V27, P801, DOI 10.1002/jbm.820270613
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Ozturk N, 2009, BIOMATERIALS, V30, P5417, DOI 10.1016/j.biomaterials.2009.06.044
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220
   Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200
   Ribeiro A, 2009, BIOPHYS J, V97, P312, DOI 10.1016/j.bpj.2009.03.030
   Rodriguez-Cabello JC, 2006, ADV POLYM SCI, V200, P119, DOI 10.1007/12_047
   Rodriguez-Cabello JC, 2005, PROG POLYM SCI, V30, P1119, DOI 10.1016/j.progpolymsci.2005.07.004
   Sallach RE, 2006, J AM CHEM SOC, V128, P12014, DOI 10.1021/ja0638509
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   Sallach RE, 2009, BIOMATERIALS, V30, P409, DOI 10.1016/j.biomaterials.2008.09.040
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Straley Karin S, 2009, Front Neuroeng, V2, P9, DOI 10.3389/neuro.16.009.2009
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Urry D.W., 2006, WHAT SUSTAINS LIFE C
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   Wada A, 2003, J AM CHEM SOC, V125, P16228, DOI 10.1021/ja036459l
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Wu YQ, 2009, BIOMACROMOLECULES, V10, P19, DOI 10.1021/bm801033f
NR 77
TC 34
Z9 34
U1 2
U2 22
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD JAN
PY 2011
VL 6
IS 1
BP 111
EP 122
DI 10.2217/NNM.10.141
PG 12
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 733SZ
UT WOS:000288284500020
PM 21182423
DA 2018-10-19
ER

PT J
AU Brown, CP
   Rosei, F
   Traversa, E
   Licoccia, S
AF Brown, Cameron P.
   Rosei, Federico
   Traversa, Enrico
   Licoccia, Silvia
TI Spider silk as a load bearing biomaterial: tailoring mechanical
   properties via structural modifications
SO NANOSCALE
LA English
DT Article
ID DRAGLINE SILK; FTIR SPECTROSCOPY; GLASSY POLYMERS; BETA-SHEET;
   TOUGHNESS; DESIGN; MATRIX; SUPERCONTRACTION; MICROSTRUCTURE;
   NANOSTRUCTURE
AB Spider silk shows great potential as a biomaterial: in addition to biocompatibility and biodegradability, its strength and toughness are greater than native biological fibres (e. g. collagen), with toughness exceeding that of synthetic fibres (e. g. nylon). Although the ultimate tensile strength and toughness at failure are unlikely to be limiting factors, its yield strain of 2% is insufficient, particularly for biomedical application because of the inability to mimic the complex ultrastructure of natural tissues with current tissue engineering approaches. To harness the full potential of spider silk as a biomaterial, it is therefore necessary to increase its yield strain. In this paper, we discuss the means by which the mechanical properties of spider silk, particularly the yield strain, can be optimized through structural modifications.
C1 [Brown, Cameron P.; Licoccia, Silvia] Univ Roma Tor Vergata, Ctr NAST, Dipartimento Sci & Tecnol Chim, I-000133 Rome, Italy.
   [Brown, Cameron P.; Rosei, Federico] Univ Quebec, Inst Natl Rech Sci, Varennes, PQ, Canada.
   [Traversa, Enrico] Natl Inst Mat Sci, Int Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.
RP Brown, CP (reprint author), Univ Roma Tor Vergata, Ctr NAST, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-000133 Rome, Italy.
EM brown@emt.inrs.ca; rosei@emt.inrs.ca
RI Brown, Cameron/G-5594-2011; Traversa, Enrico/E-4547-2011
OI Brown, Cameron/0000-0003-2520-9030; Traversa, Enrico/0000-0001-6336-941X
FU Ministry for Foreign Affairs of Italy (Direzione Generale per la
   Promozione e la Cooperazione Culturale); Ministere pour le Developpement
   Economique, de l'Innovation et l'Exportation (Province of Quebec); FRSQ;
   Canada Research Chairs program; NSERC
FX This work was supported by the The Ministry for Foreign Affairs of Italy
   (Direzione Generale per la Promozione e la Cooperazione Culturale) and
   the Ministere pour le Developpement Economique, de l'Innovation et
   l'Exportation (Province of Quebec) under the framework of the
   Italy-Quebec Joint Laboratory in Nanostructured Materials for Energy,
   Catalysis and Biomedical Applications. C. P. B acknowledges partial
   salary support from the FRSQ Post-Doctoral Fellowship programme. F. R.
   acknowledges partial salary support from the Canada Research Chairs
   program and funding from NSERC (Discovery Grant).
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   ALTMAN DG, 2003, BIOMATERIALS, V24, P401
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ARGON AS, 1973, PHILOS MAG, V28, P839, DOI 10.1080/14786437308220987
   Ball P, 2001, NATURE, V409, P413, DOI 10.1038/35053198
   Benninghof A, 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   Broom N.D, 1988, COLLAGEN FRAMEWORK A, V2, P244
   Carmichael S, 1999, INT J BIOL MACROMOL, V24, P219, DOI 10.1016/S0141-8130(99)00008-2
   CRIST B, 1997, YIELD PROCESSES GLAS
   DENNY M, 1976, J EXP BIOL, V65, P483
   Dicko C, 2008, BIOMACROMOLECULES, V9, P216, DOI 10.1021/bm701069y
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   GLIOVI A, 2008, MACROMOLECULES, V41, P390
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland GP, 2008, CHEM COMMUN, P5568, DOI 10.1039/b812928b
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Keten S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061913
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   LIU XY, 2008, BIOMACROMOLECULES, V9, P116
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0
   MARTINEZ G, 1995, J STRUCT BIOL, V114, P23, DOI 10.1006/jsbi.1995.1002
   MASDEN B, 1999, INT J BIOL MACROMOL, V24, P301
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   OLOYEDE A, 1994, CLIN BIOMECH, V9, P149, DOI 10.1016/0268-0033(94)90014-0
   Papadopoulos P, 2007, EUR PHYS J E, V24, P193, DOI 10.1140/epje/i2007-10229-9
   Papadopoulos P, 2008, COLLOID POLYM SCI, V287, P231
   Peng XN, 2005, BIOMACROMOLECULES, V6, P302, DOI 10.1021/bm049598j
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   PORTER D, 2009, ADV MATER, V21, P1
   Porter D, 2007, NANO TODAY, V2, P6, DOI 10.1016/S1748-0132(07)70071-3
   ROBERTSON RE, 1966, J CHEM PHYS, V44, P3950, DOI 10.1063/1.1726558
   Rong WZ, 2004, NANO LETT, V4, P2287, DOI 10.1021/nl0487368
   Rousseau ME, 2007, J AM CHEM SOC, V129, P3897, DOI 10.1021/ja067471r
   Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217
   Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   WORK RW, 1985, J EXP BIOL, V118, P379
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang Y, 2005, ADV MATER, V17, P84, DOI 10.1002/adma.200400344
   Yang Z, 1997, MACROMOLECULES, V30, P8254, DOI 10.1021/ma970548z
NR 58
TC 16
Z9 19
U1 0
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2011
VL 3
IS 3
BP 870
EP 876
DI 10.1039/c0nr00752h
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 732VR
UT WOS:000288218300007
PM 21212901
DA 2018-10-19
ER

PT B
AU Daud, N
   Shanks, RA
AF Daud, Norlinda
   Shanks, Robert A.
BE Laudon, M
   Romanowicz, B
TI Biomimetic High Filler Content Composites using Bisphenol-A Ethoxy
   Diacrylate
SO NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND
   ENERGY, NSTI-NANOTECH 2011, VOL 3
LA English
DT Proceedings Paper
CT NSTI Nanotechnology Conference and Expo
CY JUN 13-16, 2011
CL Boston, MA
SP Clean Technol & Sustainable Ind Org, European Patent Off, Greenberg Traurig, Innovat & Mat Sci Inst, Jackson Walker LLP, Linde Nanomaterials, Lockheed Martin, Nano Sci & Technol Inst, Nano Tech Japan, NanoEurope Fair & Conf, Nanpolis Suzhou, Suzhou Nanotech Co Ltd, Natl Inst Standards & Technol, Ctr Nanoscale Sci & Technol, Fraunhofer, Res Germany, TechConnect, Technol Innovat Program, Canadian Trade Commiss Serv, Italian Trade Commiss
DE composite; biomimetic; thermomechanical property; biomaterial;
   viscoelasticity; thermal stability
ID SURFACE-TREATED FILLERS; POLYPROPYLENE COMPOSITES
AB Biomimetic composites of Bisphenol-A ethoxy diacrylate with 77-86 % fillers content were prepared by in situ polymerization using two compacting techniques. Centrifugating produced more compacted composites compared with a compression moulding method. Either method was much different from natural formation from layer-by-layer construction, however the composites formed were of high filler content, without achieving the 95 %.w/w level in nature. The filler space was efficiently filled by using a combination of nano and microsize fillers. The composites were effectively compacted so that wetting and adhesion at the resin-filler interface would provide optimum cohesion.
C1 [Daud, Norlinda; Shanks, Robert A.] RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
RP Daud, N (reprint author), RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
OI Shanks, Robert/0000-0003-3790-5148
CR Genovese A, 2008, COMPOS PART A-APPL S, V39, P398, DOI 10.1016/j.compositesa.2007.09.009
   Luz GM, 2010, COMPOS SCI TECHNOL, V70, P1777, DOI 10.1016/j.compscitech.2010.05.013
   Ren Z, 2003, POLYM POLYM COMPOS, V11, P541, DOI 10.1177/096739110301100703
   Ren Z, 2002, POLYM POLYM COMPOS, V10, P173, DOI 10.1177/096739110201000203
   Ren Z, 2001, J APPL POLYM SCI, V79, P1942, DOI 10.1002/1097-4628(20010314)79:11<1942::AID-APP1001>3.0.CO;2-P
   Reynaud E, 2001, POLYMER, V42, P8759, DOI 10.1016/S0032-3861(01)00446-3
   Shanks RA, 1997, POLYM NETWORK BLEND, V7, P87
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Zhu AP, 2008, APPL SURF SCI, V254, P3745, DOI 10.1016/j.apsusc.2007.11.042
NR 9
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-7138-6
PY 2011
BP 159
EP 162
PG 4
WC Energy & Fuels; Engineering, Environmental; Nanoscience &
   Nanotechnology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Energy & Fuels; Engineering; Science & Technology - Other Topics;
   Research & Experimental Medicine; Materials Science
GA BG9XC
UT WOS:000394061000043
DA 2018-10-19
ER

PT B
AU Ansari, MNM
   Shanks, RA
AF Ansari, M. N. M.
   Shanks, Robert A.
BE Laudon, M
   Romanowicz, B
TI Cellulose Fiber and Nano-Fiber Composites based on Castor
   Oil-Polyurethane Matrix
SO NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND
   ENERGY, NSTI-NANOTECH 2011, VOL 3
LA English
DT Proceedings Paper
CT NSTI Nanotechnology Conference and Expo
CY JUN 13-16, 2011
CL Boston, MA
SP Clean Technol & Sustainable Ind Org, European Patent Off, Greenberg Traurig, Innovat & Mat Sci Inst, Jackson Walker LLP, Linde Nanomaterials, Lockheed Martin, Nano Sci & Technol Inst, Nano Tech Japan, NanoEurope Fair & Conf, Nanpolis Suzhou, Suzhou Nanotech Co Ltd, Natl Inst Standards & Technol, Ctr Nanoscale Sci & Technol, Fraunhofer, Res Germany, TechConnect, Technol Innovat Program, Canadian Trade Commiss Serv, Italian Trade Commiss
DE bio-composite; biomaterial; natural resource; natural fiber; cellulose;
   urethane
ID MECHANICAL-PROPERTIES; NANOCOMPOSITES; DEGRADATION; RESISTANCE; BEHAVIOR
AB Hybrid cellulose composites comprising woven hemp fabric interspersed with microcrystalline cellulose in a matrix of castor oil based polyurethane. The compsoites were derived from natural resources except for the diisocyanate required for chain extension and crosslinking, together with likely interfacial bonding with the cellulose components. The composites were characterised using scanning electron and optical microscopy, thermogravimetry and infrared spectroscopy. Mechanical properties measured were creep, recovery and modulated force thermomechanical analysis. Multiplexed frequency was used to obtain activation energy for the glass transition. The composites were semi -flexible, with hiigh tensile strength and toughness, the main damping peak was centred on ambient temperature making the composites suitable for vibration damping application.
C1 [Ansari, M. N. M.] RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
   Univ Tenaga Nas, Coll Engn, Mech Engn, Kajang, Malaysia.
RP Ansari, MNM (reprint author), RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
EM ansari@uniten.edu.my
OI Shanks, Robert/0000-0003-3790-5148
CR Cao X, 2008, EXPRESS POLYM LETT, V2, P502, DOI 10.3144/expresspolymlett.2008.60
   Kechaou B, 2010, EXPRESS POLYM LETT, V4, P171, DOI 10.3144/expresspolymlett.2010.22
   Kumar MNS, 2007, J APPL POLYM SCI, V105, P3153, DOI 10.1002/app.24481
   Madbouly SA, 2009, PROG POLYM SCI, V34, P1283, DOI 10.1016/j.progpolymsci.2009.08.002
   Marklund E, 2008, COMPOS SCI TECHNOL, V68, P2156, DOI 10.1016/j.compscitech.2008.03.011
   Ouajai S, 2005, POLYM DEGRAD STABIL, V89, P327, DOI 10.1016/j.polymdegradstab.2005.01.016
   Ouajai S, 2009, COMPOS SCI TECHNOL, V69, P2119, DOI 10.1016/j.compscitech.2009.05.005
   Spoljaric S, 2009, COMPOS PART A-APPL S, V40, P791, DOI 10.1016/j.compositesa.2009.03.011
   Wielage B, 2003, J MATER PROCESS TECH, V139, P140, DOI 10.1016/S0924-0136(03)00195-X
   Wong S, 2008, COMPOS INTERFACE, V15, P131, DOI 10.1163/156855408783810894
   Wu JH, 2010, COMPOS SCI TECHNOL, V70, P1258, DOI 10.1016/j.compscitech.2010.03.014
   Zhang QL, 2008, J POLYM SCI POL PHYS, V46, P1243, DOI 10.1002/polb.21458
NR 12
TC 0
Z9 0
U1 1
U2 2
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-7138-6
PY 2011
BP 179
EP 182
PG 4
WC Energy & Fuels; Engineering, Environmental; Nanoscience &
   Nanotechnology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Energy & Fuels; Engineering; Science & Technology - Other Topics;
   Research & Experimental Medicine; Materials Science
GA BG9XC
UT WOS:000394061000048
DA 2018-10-19
ER

PT B
AU Olyveira, GM
   Costa, LMM
   Basmaji, P
AF Olyveira, G. M.
   Costa, L. M. M.
   Basmaji, Pierre
BE Laudon, M
   Romanowicz, B
TI Nanoskin Bacterial cellulose structured- Towards the Development of
   regenerative medicine
SO NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND
   ENERGY, NSTI-NANOTECH 2011, VOL 3
LA English
DT Proceedings Paper
CT NSTI Nanotechnology Conference and Expo
CY JUN 13-16, 2011
CL Boston, MA
SP Clean Technol & Sustainable Ind Org, European Patent Off, Greenberg Traurig, Innovat & Mat Sci Inst, Jackson Walker LLP, Linde Nanomaterials, Lockheed Martin, Nano Sci & Technol Inst, Nano Tech Japan, NanoEurope Fair & Conf, Nanpolis Suzhou, Suzhou Nanotech Co Ltd, Natl Inst Standards & Technol, Ctr Nanoscale Sci & Technol, Fraunhofer, Res Germany, TechConnect, Technol Innovat Program, Canadian Trade Commiss Serv, Italian Trade Commiss
DE Nanoskin (R); bacterial cellulose; artificial blood vessels
ID BIOMEDICAL APPLICATIONS; MICROBIAL CELLULOSE; CELL-ADHESION; SURFACE;
   MICROFIBRILS; ADSORPTION; CULTURE; PROTEIN; FILMS
AB Bacterial cellulose (BC) has established to be a remarkably versatile biomaterial and can be used in wide variety of applied scientific endeavors, especially for medical devices. In fact, biomedical devices recently have gained a significant amount of attention because of increased interesting tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. The architecture of BC materials can be engineered over length scales ranging from nano to macro by controlling the biofabrication process. It has unique properties that make it an exciting candidate as a vascular graft material: strength, good integration into host tissue, and flexibility of production in various shapes and sizes. In this article, the structural features of microbial cellulose and its properties are discussed with AFM and SEM and novel bionanocomposites from BC/collagen and BC/chitosan are presented for artificial blood vessels by modifying culture medium of bacterial cellulose.
C1 [Olyveira, G. M.; Costa, L. M. M.] Univ Fed Abc, CCNH, Rua Santa Adelia 166, Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, Sao Carlos, SP, Brazil.
RP Olyveira, GM (reprint author), Univ Fed Abc, CCNH, Rua Santa Adelia 166, Santo Andre, SP, Brazil.
EM gmolyveira@yahoo.com.br; pierre@innovatecsco.com
CR Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Basmaji P., 2010, NMEE 2010 SEM WHICH
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Borges JP, 2001, MECH COMPOS MATER, V37, P257, DOI 10.1023/A:1010650803273
   Cienchanska D., 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   HAIGLER CH, 1982, J CELL BIOL, V94, P64, DOI 10.1083/jcb.94.1.64
   HAIGLER CH, 1980, SCIENCE, V210, P903, DOI 10.1126/science.7434003
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Hult EL, 2003, CARBOHYD POLYM, V53, P9, DOI 10.1016/S0144-8617(02)00297-7
   Olyveira G. M., 2010, 3 SEM INT NAN NAN HA
   Orts WJ, 2005, J POLYM ENVIRON, V13, P301, DOI 10.1007/s10924-005-5514-3
   Schrecker ST, 2005, BIOTECHNOL LETT, V27, P1435, DOI 10.1007/s10529-005-1465-y
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   WATANABE K, 1995, BIOSCI BIOTECH BIOCH, V59, P65, DOI 10.1271/bbb.59.65
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
NR 22
TC 0
Z9 1
U1 0
U2 1
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-7138-6
PY 2011
BP 267
EP 270
PG 4
WC Energy & Fuels; Engineering, Environmental; Nanoscience &
   Nanotechnology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Energy & Fuels; Engineering; Science & Technology - Other Topics;
   Research & Experimental Medicine; Materials Science
GA BG9XC
UT WOS:000394061000071
DA 2018-10-19
ER

PT B
AU Xing, ZC
   Yuan, J
   Chae, WP
   Kang, IK
   Kim, SY
AF Xing, Zhi-Cai
   Yuan, Jiang
   Chae, Won-Pyo
   Kang, Inn-Kyu
   Kim, Suk-Young
BE Ying, F
TI Keratin Nanofibers as a Biomaterial
SO NANOTECHNOLOGY AND BIOSENSORS
LA English
DT Proceedings Paper
CT International Conference on Nanotechnology and Biosensors
CY DEC 28-30, 2010
CL Hong Kong, PEOPLES R CHINA
SP Asia Pacific Chem Biol Environm Engn Soc
DE biodegradability; NIH3T3 cells; keratin; nanofiber; poly(ethylene oxide)
ID KERATEINE BLEND FILMS; SILK; WATER; JETS
AB Keratin is one of the most abundant proteins which can be used in a variety of biomedical applications due to its biocompatibility and biodegradability. However, keratin is insoluble in solvents and soluble in few solvent systems, which lead to a limitation in its processability for further utilization. In this study, keratin was extracted and chemically modified by reacting sulfide side group with iodoacetic acid to enhance its solubility in organic solvent. The modified keratin (m-keratin) was then blended with poly (ethylene oxide) (PEO) in different proportions, dissolved in 2,2,2,-trifluoroethanol (TFE), and electrospun to produce nanofibrous mats. The m-keratin nanofibers were obtained by crosslinking the m-keratin/PEO nanofibrous mats with glutaraldehyde vapor (25%) and washed with distilled water for 3 times to remove PEO. The morphology, diameter distribution, biodegradation, and interaction of NIH 3T3 cells with nanofibrous mats were investigated. The results showed that the crosslinked m-keratin nanofibrous mats have a potential to be used in tissue engineering and wound dressing.
C1 [Xing, Zhi-Cai; Yuan, Jiang; Chae, Won-Pyo; Kang, Inn-Kyu] Kyungpook Natl Univ, Dept Polymer Sci & Engn, Daegu 702701, South Korea.
   [Kim, Suk-Young] Yeungnam Univ, Sch Mat Sci & Engn, Gyongbuk 712749, South Korea.
RP Kang, IK (reprint author), Kyungpook Natl Univ, Dept Polymer Sci & Engn, Daegu 702701, South Korea.
EM ikkang@knu.ac.kr
FU Biotechnology development project [2009-0090907]; Ministry of Education,
   Science and Technology of Korea [2010-0011125]
FX This research was supported by the research grants of the Biotechnology
   development project (2009-0090907) and by the grant of 2010-0011125 from
   Ministry of Education, Science and Technology of Korea.
CR Alessio V., 2008, J POLYM SCI B, V46, P1193, DOI [10.1002/polb.21452, DOI 10.1002/POLB.21452]
   Aluigi A, 2007, J APPL POLYM SCI, V104, P863, DOI 10.1002/app.25623
   Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Andreia V., 2008, BIOMACROMOLECULES, V9, P1299, DOI [10.1021/bm7012789, DOI 10.1021/BM7012789]
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Fu ZL, 1998, LANGMUIR, V14, P4300, DOI 10.1021/la971382y
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Larrondo L, 1981, POLYM SCI SER B, V19, P909, DOI DOI 10.1002/P0L.1981.180190601
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Wnek G., 2003, NANO LETT, V3, P231
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yuan J, 2009, MACROMOL RES, V17, P850, DOI 10.1007/BF03218625
NR 21
TC 1
Z9 1
U1 0
U2 1
PU INT ASSOC COMPUTER SCIENCE & INFORMATION TECHNOLOGY PRESS-IACSIT PRESS
PI SINGAPORE
PA SINGAPORE OFFICE, NO. 07-42, BLK 708, JURONG WEST STREET 81, SINGAPORE,
   00000, SINGAPORE
BN 978-981-08-8643-1
PY 2011
BP 120
EP 124
PG 5
WC Engineering, Environmental; Engineering, Chemical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BG9RL
UT WOS:000393717700028
DA 2018-10-19
ER

PT J
AU Dvir, T
   Timko, BP
   Kohane, DS
   Langer, R
AF Dvir, Tal
   Timko, Brian P.
   Kohane, Daniel S.
   Langer, Robert
TI Nanotechnological strategies for engineering complex tissues
SO NATURE NANOTECHNOLOGY
LA English
DT Review
ID NANOWIRE TRANSISTOR ARRAYS; MESENCHYMAL STEM-CELLS; CARBON NANOTUBES;
   EXTRACELLULAR-MATRIX; DELIVERY-SYSTEM; ALGINATE SCAFFOLDS; NEURONAL
   GROWTH; DEVICE ARRAYS; RGD PEPTIDE; IN-VITRO
AB Tissue engineering aims at developing functional substitutes for damaged tissues and organs. Before transplantation, cells are generally seeded on biomaterial scaffolds that recapitulate the extracellular matrix and provide cells with information that is important for tissue development. Here we review the nanocomposite nature of the extracellular matrix, describe the design considerations for different tissues and discuss the impact of nanostructures on the properties of scaffolds and their uses in monitoring the behaviour of engineered tissues. We also examine the different nanodevices used to trigger certain processes for tissue development, and offer our view on the principal challenges and prospects of applying nanotechnology in tissue engineering.
C1 [Dvir, Tal; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Dvir, Tal; Timko, Brian P.; Kohane, Daniel S.] Harvard Univ, Lab Biomat & Drug Delivery, Childrens Hosp Boston, Div Crit Care Med,Sch Med,Dept Anesthesiol, Boston, MA 02115 USA.
   [Timko, Brian P.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Dvir, T (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
OI Timko, Brian/0000-0002-7958-8980
FU National Institutes of Health [DE13023, DE016516, EB006365,
   R01GM073626]; NSF [BES-0609182]; American Heart Association; NIH
   National Institute of General Medical Sciences
FX This work was supported by the National Institutes of Health grants
   DE13023, DE016516, EB006365 and R01GM073626, and NSF grant BES-0609182.
   T.D. acknowledges a Postdoctoral Fellowship from the American Heart
   Association. B.P.T. acknowledges a Ruth L. Kirschstein National Research
   Service Award from the NIH National Institute of General Medical
   Sciences. We thank S. Cohen, S. McAllister and B. Tian for their
   comments.
CR Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247
   Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Barone PW, 2009, ACS NANO, V3, P3869, DOI 10.1021/nn901025x
   Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bettinger CJ, 2009, TISSUE ENG PT A, V15, P1321, DOI 10.1089/ten.tea.2008.0134
   Bhattacharyya S, 2009, J BIOMED NANOTECHNOL, V5, P69, DOI 10.1166/jbn.2009.032
   Bianco A, 2010, INT J ARTIF ORGANS, V33, P271
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Cao HQ, 2010, J CONTROL RELEASE, V144, P203, DOI 10.1016/j.jconrel.2010.02.003
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/nnano.2008.374, 10.1038/NNANO.2008.374]
   Chan CK, 2006, NANOMEDICINE-UK, V1, P177, DOI 10.2217/17435889.1.2.177
   Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079
   Cohen-Karni T, 2010, NANO LETT, V10, P1098, DOI 10.1021/nl1002608
   Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dong B, 2009, SMALL, V5, P1508, DOI 10.1002/smll.200801750
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Eschermann JF, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194138
   Evans N. D., 2009, EUR CELLS MATER, V18, P13
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fan DL, 2010, NAT NANOTECHNOL, V5, P545, DOI [10.1038/NNANO.2010.104, 10.1038/nnano.2010.104]
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Gui XC, 2010, ACS NANO, V4, P2320, DOI 10.1021/nn100114d
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Heino J, 2009, CURR PHARM DESIGN, V15, P1309, DOI 10.2174/138161209787846720
   Heller DA, 2009, NAT NANOTECHNOL, V4, P114, DOI [10.1038/nnano.2008.369, 10.1038/NNANO.2008.369]
   Heo SJ, 2009, TISSUE ENG PT A, V15, P977, DOI 10.1089/ten.tea.2008.0190
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Ito A, 2005, TISSUE ENG, V11, P1553, DOI 10.1089/ten.2005.11.1553
   Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/44/445702
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Lim DK, 2010, NAT MATER, V9, P60, DOI [10.1038/NMAT2596, 10.1038/nmat2596]
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Mallouk TE, 2009, SCI AM, V300, P72, DOI 10.1038/scientificamerican0509-72
   Massobrio G, 2008, NANO LETT, V8, P4433, DOI 10.1021/nl802341r
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pappas TC, 2007, NANO LETT, V7, P513, DOI 10.1021/nl062513v
   Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114
   Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   PETERSEN TH, SCIENCE, V329, P538
   Pislaru SV, 2006, CIRCULATION, V114, pI314, DOI 10.1161/CIRCULATIONAHA.105.001446
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Rexeisen EL, 2009, LANGMUIR, V26, P1953
   Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842
   Schofer MD, 2009, J MATER SCI-MATER M, V20, P1535, DOI 10.1007/s10856-009-3719-z
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suhr J, 2007, NAT NANOTECHNOL, V2, P417, DOI 10.1038/nnano.2007.186
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033
   Tian BZ, 2009, NAT NANOTECHNOL, V4, P824, DOI [10.1038/NNANO.2009.304, 10.1038/nnano.2009.304]
   Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807
   Timko BP, 2009, NANO LETT, V9, P914, DOI 10.1021/nl900096z
   Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Wu SL, 2008, NANO LETT, V8, P3803, DOI 10.1021/nl802145n
   Xu J, 2008, J BIOMED MATER RES A, V87A, P819, DOI 10.1002/jbm.a.31826
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhou HJ, 2009, BIOMATERIALS, V30, P1715, DOI 10.1016/j.biomaterials.2008.12.016
   Zhou XJ, 2007, NAT NANOTECHNOL, V2, P185, DOI 10.1038/nnano.2007.34
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 108
TC 672
Z9 687
U1 28
U2 554
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD JAN
PY 2011
VL 6
IS 1
BP 13
EP 22
DI 10.1038/NNANO.2010.246
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 698EB
UT WOS:000285574000007
PM 21151110
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Aboushwareb, T
   Mckenzie, P
   Wezel, F
   Southgate, J
   Badlani, G
AF Aboushwareb, Tamer
   Mckenzie, Patrick
   Wezel, Felix
   Southgate, Jennifer
   Badlani, Gopal
TI Is Tissue Engineering and Biomaterials the Future for Lower Urinary
   Tract Dysfunction (LUTD)/Pelvic Organ Prolapse (POP)?
SO NEUROUROLOGY AND URODYNAMICS
LA English
DT Article
DE biomaterials; pelvic floor; regenerative medicine
ID SMALL-INTESTINAL SUBMUCOSA; RANDOMIZED CONTROLLED-TRIAL; ACELLULAR
   MATRIX GRAFT; SMOOTH-MUSCLE-CELLS; FREE VAGINAL TAPE;
   STRESS-INCONTINENCE; BLADDER AUGMENTATION; STEM-CELLS; IN-VITRO;
   UROTHELIAL CELLS
AB The fields of tissue engineering and regenerative medicine have seen major advances over the span of the past two decades, with biomaterials playing a central role. Although the term "regenerative medicine" has been applied to encompass most fields of medicine, in fact urology has been one of the most progressive. Many urological applications have been investigated over the past decades, with the culmination of these technologies in the introduction of the first laboratory-produced organ to be placed in a human body. 1 With the quality of life issues associated with urinary incontinence, there is a strong driver to identify and introduce new technologies and the potential exists for further major advancements from regenerative medicine approaches using biomaterials, cells or a combination of both. A central question is why use biomaterials? The answer rests on the need to make up for inadequate or lack of autologous tissue, to decrease morbidity and to improve long-term efficacy. Thus, the ideal biomaterial needs to meet the following criteria: (1) Provide mechanical and structural support, (2) Maintain compliance and be biocompatible with surrounding tissues, and (3) Be "fit for purpose" by meeting specific application needs ranging from static support to bioactive cell signaling. In essence, this represents a wide range of biomaterials with a spectrum of potential applications, from use as a supportive or bulking implant alone, to implanted biomaterials that promote integration and eventual replacement by infiltrating host cells, or scaffolds pre-seeded with cells prior to implant. In this review we shall discuss the structural versus the integrative uses of biomaterials by referring to two key areas in urology of (1) pelvic organ support for prolapse and stress urinary incontinence, and (2) bladder replacement/augmentation. Neurourol. Urodynam. 30:775-782, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Aboushwareb, Tamer; Mckenzie, Patrick; Badlani, Gopal] Wake Forest Univ, Dept Urol, Winston Salem, NC 27109 USA.
   [Aboushwareb, Tamer] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA.
   [Wezel, Felix; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.
   [Wezel, Felix] Univ Med Ctr, Dept Urol, Mannheim, Germany.
RP Badlani, G (reprint author), Wake Forest Univ, Dept Urol, Winston Salem, NC 27109 USA.
EM gbadlani@wfubmc.edu
OI Southgate, Jennifer/0000-0002-0135-480X
CR Abrams P, 2007, BJU INT, V100, P987, DOI 10.1111/j.1464-410X.2007.07205.x
   Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202
   Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Amrute KV, 2009, THESCIENTIFICWORLDJO, V9, P23, DOI 10.1100/tsw.2009.7
   ANDUS T, 1993, DIGEST DIS SCI, V38, P1638, DOI 10.1007/BF01303172
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Baker SC, 2008, BIOMATERIALS, V29, P3357, DOI 10.1016/j.biomaterials.2008.04.033
   Benassi L, 2002, Minerva Ginecol, V54, P317
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Buchsbaum GM, 2002, OBSTET GYNECOL, V100, P226, DOI 10.1016/S0029-7844(02)02076-8
   Cain MP, 2010, J UROLOGY, V183, P2124, DOI 10.1016/j.juro.2010.03.067
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Chen B, 2004, NEUROUROL URODYNAM, V23, P119, DOI 10.1002/nau.20012
   Chen B, 2003, AM J OBSTET GYNECOL, V189, P89, DOI 10.1067/mob.2003.373
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   Chen BH, 2002, INT UROGYNECOL J PEL, V13, P80, DOI 10.1007/s001920200020
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen Y, 2004, NEUROUROL URODYNAM, V23, P367, DOI 10.1002/nau.20006
   Chopra B, 2008, TOXICOL PATHOL, V36, P485, DOI 10.1177/0192623308315672
   COHEN JR, 1987, SURG GYNECOL OBSTET, V164, P355
   Culligan P, 2005, OBSTET GYNECOL, V106, P29, DOI 10.1097/01.AOG.0000165824.62167.c1
   Curti P, 2010, PELVIC FLOOR DISORDERS: IMAGING AND MULTIDISCIPLINARY APPROACH TO MANAGEMENT, P235, DOI 10.1007/978-88-470-1542-5_28
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Del Popolo G, 2008, EUR UROL, V53, P1013, DOI 10.1016/j.eururo.2007.09.034
   Delancey JOL, 2004, GASTROENTEROLOGY, V126, pS23, DOI 10.1053/j.gastro.2003.10.080
   Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2
   Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   Drewa T, 2009, TRANSPL P, V41, P4345, DOI 10.1016/j.transproceed.2009.08.059
   Dwyer PL, 2006, INT UROGYNECOL J, V17, pS10, DOI 10.1007/s00192-006-0103-0
   Eberli D, 2009, BJU INT, V103, P248, DOI 10.1111/j.1464-410X.2008.08001.x
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   Fraser M, 2004, BJU INT, V93, P609, DOI 10.1111/j.1464-410X.2004.04675.x
   Fu Q, 2010, UROLOGY, V75, P718, DOI 10.1016/j.urology.2009.10.003
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   GADEK JE, 1992, AM J MED, V92, pS27, DOI 10.1016/0002-9343(92)90604-A
   GANROT PO, 1967, SCAND J CLIN LAB INV, V19, P205, DOI 10.3109/00365516709090627
   Gomez DE, 1997, EUR J CELL BIOL, V74, P111
   Hafez AT, 2003, J UROLOGY, V170, P1639, DOI 10.1097/01.ju.0000083887.58315.7e
   Hafez AT, 2003, J UROLOGY, V169, P2316, DOI 10.1097/01.ju.0000067485.51252.f5
   HAFEZ AT, 2003, J UROLOGY, V170, P41
   HARRIS ED, 1984, COLLAGEN REL RES, V4, P493
   Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002
   Hautmann RE, 2006, WORLD J UROL, V24, P305, DOI 10.1007/s00345-006-0105-z
   HORWITZ AL, 1977, P NATL ACAD SCI USA, V74, P897, DOI 10.1073/pnas.74.3.897
   Hoshi A, 2008, TRANSPLANTATION, V85, P1617, DOI 10.1097/TP.0b013e318170572b
   Hosper NA, 2010, BIOMATERIALS, V31, P3910, DOI 10.1016/j.biomaterials.2010.01.129
   HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Karlovsky Matthew E, 2005, Curr Urol Rep, V6, P376, DOI 10.1007/s11934-005-0057-7
   Karsenty G, 2008, EUR UROL, V53, P275, DOI 10.1016/j.eururo.2007.10.013
   Keane DP, 1997, BRIT J OBSTET GYNAEC, V104, P994, DOI 10.1111/j.1471-0528.1997.tb12055.x
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Kleinert S, 2008, LANCET, V372, P789, DOI 10.1016/S0140-6736(08)61320-3
   KONDO A, 1994, NEUROUROL URODYNAM, V13, P507, DOI 10.1002/nau.1930130502
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kushner L, 2006, J UROLOGY, V175, P108
   Kushner L, 2004, NEUROUROL URODYNAM, V23, P198, DOI 10.1002/nau.10174
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Liapis A, 2002, EUR UROL, V41, P469, DOI 10.1016/S0302-2838(02)00033-7
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Maher C, 2008, NEUROUROL URODYNAM, V27, P3, DOI 10.1002/nau.20542
   MALLYA SK, 1990, BIOCHEMISTRY-US, V29, P10628, DOI 10.1021/bi00499a008
   McAteer H, 2007, J TISSUE ENG REGEN M, V1, P343, DOI 10.1002/term.36
   McKenzie P, 2010, CURR OPIN UROL, V20, P291, DOI 10.1097/MOU.0b013e32833a4436
   Mushkat Y, 1996, AM J OBSTET GYNECOL, V174, P617, DOI 10.1016/S0002-9378(96)70437-4
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Paraiso MFR, 2004, OBSTET GYNECOL, V104, P1249, DOI 10.1097/AOG.0000146290.10472.b3
   PARKS WC, 1990, AM J RESP CELL MOL, V2, P399, DOI 10.1165/ajrcmb/2.5.399
   Patel PD, 2007, INDIAN J UROL, V23, P135, DOI 10.4103/0970-1591.32064
   Petros P E, 1993, Scand J Urol Nephrol Suppl, V153, P1
   Peyrat L, 2002, BJU INT, V89, P61, DOI 10.1046/j.1464-4096.2001.01813.x
   Praud C, 2007, CELL TRANSPLANT, V16, P741, DOI 10.3727/000000007783465118
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   RECHBERGER T, 1993, EUR J OBSTET GYN R B, V49, P187, DOI 10.1016/0028-2243(93)90268-H
   Rechberger T, 1998, AM J OBSTET GYNECOL, V179, P1511, DOI 10.1016/S0002-9378(98)70017-1
   Rizk DEE, 2006, INT UROGYNECOL J, V17, P436, DOI 10.1007/s00192-005-0055-9
   SAULNIER JM, 1991, CLIN CHIM ACTA, V200, P129, DOI 10.1016/0009-8981(91)90084-P
   SMITH ARB, 1989, BRIT J OBSTET GYNAEC, V96, P24, DOI 10.1111/j.1471-0528.1989.tb01571.x
   Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56
   Soergel TM, 2004, J UROLOGY, V172, P51
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   Southgate J, 2002, CULTURE EPITHELIAL C, P381, DOI DOI 10.1002/0471221201.CH12
   Stein J, 1996, CLIN CHEM, V42, P222
   STEWART M, 1982, BRIT J SURG, V69, P414, DOI 10.1002/bjs.1800690720
   Stohrer M, 2009, EUR UROL, V56, P81, DOI 10.1016/j.eururo.2009.04.028
   Tanaka ST, 2010, TISSUE ENG PT A, V16, P2121, DOI 10.1089/ten.TEA.2009.0557
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   TURNER A, 2010, EUR UROL IN PRESS
   Turner AM, 2007, WOODHEAD PUBL MATER, P445, DOI 10.1533/9781845693817.2.445
   ULMSTEN U, 1987, ACTA OBSTET GYN SCAN, V66, P455, DOI 10.3109/00016348709022054
   VERSI E, 1988, BRIT J OBSTET GYNAEC, V95, P147, DOI 10.1111/j.1471-0528.1988.tb06844.x
   Visco AG, 2003, AM J OBSTET GYNECOL, V189, P102, DOI 10.1067/mob.2003.372
   Vishwajit S, 2009, CURR BLADDER DYSFUNC, V4, P13, DOI 10.1007/s11884-009-0003-5
   Wiesmann HP, 2009, FUNDAMENTALS TISSUE, P457
   Wood D, 2008, CURR OPIN UROL, V18, P564, DOI 10.1097/MOU.0b013e32830f9402
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 104
TC 20
Z9 24
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0733-2467
J9 NEUROUROL URODYNAM
JI Neurourol. Urodyn.
PY 2011
VL 30
IS 5
BP 775
EP 782
DI 10.1002/nau.21101
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 777DO
UT WOS:000291595700026
PM 21661029
DA 2018-10-19
ER

PT S
AU Zhou, YL
   Luo, DM
   Hu, WY
   Li, YC
   Hodgson, P
   Wen, C
AF Zhou, Ying-Long
   Luo, Dong-Mei
   Hu, Wang-Yu
   Li, Yuncang
   Hodgson, Peter
   Wen, Cui'e
BE Zhou, HY
   Gu, TL
   Yang, DG
   Jiang, ZY
   Zeng, JM
TI Compressive Properties of Hot-rolled Mg-Zr-Ca Alloys for Biomedical
   Applications
SO NEW AND ADVANCED MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Manufacturing Science and Engineering
CY APR 09-11, 2011
CL Guilin, PEOPLES R CHINA
SP Guangxi Univ, Guilin Univ Elect Technol, Univ Wollongong, Korea Maritime Univ, Hong Kong Ind Technol Res Ctr
DE Compressive Property; Mg-Zr-Ca alloy; Hot-rolling; Biomaterial;
   Microstructure
ID MAGNESIUM ALLOYS; CORROSION; BIOMATERIALS; BONE
AB This paper investigated the microstructures and compressive properties of hot-rolled Mg-Zr-Ca alloys for biomedical applications. The microstructures of the Mg-Zr-Ca alloys were examined by X-ray diffraction analysis and optical microscopy, and the compressive properties were determined from compressive tests. The experimental results indicate that the hot-rolled Mg-Zr-Ca alloys with 1% Ca are composed of one single alpha phase and those alloys with 2% Ca consist of both Mg2Ca and alpha phase. The hot-rolled Mg-Zr-Ca alloys exhibit typical elongated microstructures with obvious fibrous stripe, and have much higher compressive strength and lower compressive modulus than pure Mg. All the studied alloys have much higher compressive yield strength than the human bone (90 similar to 140 MPa) and comparable modulus with the human bone, suggesting that they have a great potential to be good candidates for biomedical applications.
C1 [Zhou, Ying-Long; Luo, Dong-Mei] Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
   [Hu, Wang-Yu] Hunan Univ, Dept Appl Phys, Changsha 410082, Hunan, Peoples R China.
   [Li, Yuncang; Hodgson, Peter; Wen, Cui'e] Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
EM ylzhou@fosu.edu.cn; dmluo@fosu.edu.cn; wangyuhu2001cn@yahoo.com.cn;
   yuncang.li@deakin.edu.au; peter.hodgson@deakin.edu.au;
   cuie.wen@deakin.edu.au
RI Hu, Wangyu/B-5762-2009; Wen, Cuie/I-2872-2012; Li, Yuncang/I-5832-2012
OI Hu, Wangyu/0000-0001-7416-3994; Wen, Cuie/0000-0001-8008-3536; Li,
   Yuncang/0000-0003-4290-4772
FU Key Scientific and Technological Projects of Guangdong Province, PR
   China [2008B010600003];  [AISRF-BF030031]
FX This work was supported by the Key Scientific and Technological Projects
   of Guangdong Province, PR China (Project No. 2008B010600003) and
   AISRF-BF030031, Australia.
CR [艾延龄 AI Yanling], 2005, [机械工程材料, Materials for Mechanical Engineering], V29, P3
   ASM International, 1992, ASM HDB, V3
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu H, 2007, MAGNESIUM ALLOYS FAB
   Zhou Y.-L., ADV SCI LET IN PRESS
NR 11
TC 9
Z9 10
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-035-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 197-198
BP 56
EP +
DI 10.4028/www.scientific.net/AMR.197-198.56
PN 1,2
PG 2
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BVM03
UT WOS:000291849700012
DA 2018-10-19
ER

PT S
AU Wilson, D
   Florido, A
   Valderrama, C
   de Labastida, MF
   Alegret, S
   del Valle, M
AF Wilson, D.
   Florido, A.
   Valderrama, C.
   Fernandez de Labastida, M.
   Alegret, S.
   del Valle, M.
BE Gouma, P
TI Electronic Tongue-FIA system for the Monitoring of Heavy Metal
   Biosorption Processes
SO OLFACTION AND ELECTRONIC NOSE: PROCEEDINGS OF THE 14TH INTERNATIONAL
   SYMPOSIUM ON OLFACTION AND ELECTRONIC NOSE
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 14th International Symposium on Olfaction and Electronic Nose
CY MAY 02-05, 2011
CL Rockefeller Univ, New York, NY
SP SUNY Stoney Brook, Engn Conf Int (ECI), Alpha MOS, Int Soc Olfact & Chem Sensors, Amer Ceramic Soc, Infratec, Synkera
HO Rockefeller Univ
DE grape stalk wastes; copper sorption; ion-selective electrode;
   flow-injection; electronic tongue; on-line monitoring
AB An automated flow injection potentiometric (PIP) system with electronic tongue detection (ET) was used for the monitoring of biosorption processes of heavy metals on waste biomaterial. Grape stalk wastes were used as biosorbent to remove Cu2+ ions in a fixed-bed column setup. For the monitoring, the used ET employed a sensor array formed by Cu2+ and Ca2+ selective electrodes and two generic heavy-metal electrodes. The subsequent cross-response obtained was processed by a multilayer artificial neural network (ANN) model in order to resolve the concentrations of the monitored species. The coupling of the electronic tongue with the automation features of the flow-injection system (ET-FIP) allowed us to accurately characterize the biosorption process, through obtaining its breakthrough curves. In parallel, fractions of the extract solution were analyzed by atomic absorption spectroscopy in order to validate the results obtained with the reported methodology.
C1 [Wilson, D.; Alegret, S.; del Valle, M.] Univ Autonoma Barcelona, Dept Chem, Sensors & Biosensors Grp, Edifici Cn, E-08193 Barcelona, Spain.
   [Florido, A.; Valderrama, C.; Fernandez de Labastida, M.] Univ Politecn Cataluna, Dept Chem Engn, Barcelona 08028, Spain.
RP Wilson, D (reprint author), Univ Autonoma Barcelona, Dept Chem, Sensors & Biosensors Grp, Edifici Cn, E-08193 Barcelona, Spain.
EM manel.delvalle@uab.es
RI Valderrama, Cesar/D-1092-2011; del Valle, Manuel/D-8171-2011
OI Valderrama, Cesar/0000-0001-6711-8183; del Valle,
   Manuel/0000-0002-1032-8611; Florido, Antonio/0000-0003-4266-7236;
   Wilson, Deivy/0000-0001-9509-5273
FU MICINN (Spanish Ministry of Science and Innovation)
   [CTM2008-06776-C02-02/TECNO, TEC2007-68012-C03-02/MIC]
FX This work was supported by MICINN (Spanish Ministry of Science and
   Innovation) projects CTM2008-06776-C02-02/TECNO and
   TEC2007-68012-C03-02/MIC.
CR Florido A, 2010, ANAL CHIM ACTA, V668, P26, DOI 10.1016/j.aca.2010.01.019
NR 1
TC 0
Z9 0
U1 0
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0920-0
J9 AIP CONF PROC
PY 2011
VL 1362
BP 98
EP +
DI 10.1063/1.3626320
PG 2
WC Engineering, Biomedical; Physics, Applied
SC Engineering; Physics
GA BXE77
UT WOS:000295913500035
DA 2018-10-19
ER

PT J
AU Ronkko, S
   Kaarniranta, K
   Kalesnykas, G
   Uusitalo, H
AF Ronkko, Seppo
   Kaarniranta, Kai
   Kalesnykas, Giedrius
   Uusitalo, Hannu
TI Biocompatibility of Different Poly(Lactide-Coglycolide) Polymers
   Implanted into the Subconjunctival Space in Rats
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Biocompatibility; Biodegradable; Fibronectin; Polymers
ID BIODEGRADABLE SCLERAL PLUGS; FIBRONECTIN MATRIX; CELL-ADHESION; IN-VIVO;
   PLASMA FIBRONECTIN; CONTROLLED-RELEASE; EIIIA SEGMENT; MICROSPHERES;
   COLLAGEN; SURGERY
AB Aims: Biomaterials are widely used in ophthalmology, and biodegradable polymers have been evaluated for use in surgery, tissue engineering and targeted drug delivery. We examined the tissue reactions attributable to 3 biodegradable polymers in the rat eye. Methods: Inion GTR (TM) membrane [a blend of 85:15 poly(L-lactide-coglycolide) and 70:30 poly(L-lactide-co-1,3-trimethylene carbonate) copolymers in a molar ratio of 70:30], a 50:50 molar ratio of poly(DL-lactide-coglycolide) (PDLGA 50:50), and a 85:15 molar ratio of poly(DL-lactide-coglycolide) (PDLGA 85:15) were surgically implanted into the subconjuctival space of rat eyes. Biocompatibility was evaluated by following the eyes clinically and with histo-and immunohistochemical techniques. Results: No clinical signs of inflammation were observed around the implants during follow-up. However, immunohistochemical sections revealed increased accumulation of magrophages around PDLGA 85:15 at 2 weeks and of myofibroblasts around GTR membrane material at 1 month. The order of the degradation time of the material was GTR membrane material > PDLGA 85:15 > PDLGA 50:50; Fourier transform infrared microscopy revealed some differences in the degradation behavior of the polymers. Immunohistochemical staining for plasma or cellular fibronectin was observed around all implants. Conclusions: Despite the different decay times and influences on the expression levels of fibronectins, all polymers evoked rather similar tissue reactions during the observation period. This study provides new data on the biocompatibility of biomaterials in rat eyes. Our findings of the tissue decay of the implant and biomaterial-induced tissue reaction may help in the development of better biomaterials for eye surgery with optimal drug delivery properties. Copyright (C) 2011 S. Karger AG, Basel
C1 [Ronkko, Seppo; Kaarniranta, Kai; Kalesnykas, Giedrius] Univ Eastern Finland, Dept Ophthalmol, Sch Med, Inst Clin Med, FI-70211 Kuopio, Finland.
   [Kaarniranta, Kai] Kuopio Univ Hosp, Dept Ophthalmol, SF-70210 Kuopio, Finland.
   [Uusitalo, Hannu] Univ Tampere, FIN-33101 Tampere, Finland.
   [Uusitalo, Hannu] Tampere Univ Hosp, Tampere, Finland.
RP Ronkko, S (reprint author), Univ Eastern Finland, Dept Ophthalmol, Sch Med, Inst Clin Med, POB 1627, FI-70211 Kuopio, Finland.
EM Seppo.Ronkko@uef.fi
OI Kaarniranta, Kai/0000-0003-2600-8679
FU Finnish Academy; Finnish Eye Foundation; Finnish Eye and Tissue Bank
   Foundation; Finnish Medical Foundation; Finnish Funding Agency for
   Technology and Innovation; Finnish Cultural Foundation; Kuopio
   University Foundation
FX This work was supported by the Finnish Academy, the Finnish Eye
   Foundation, the Finnish Eye and Tissue Bank Foundation, the Finnish
   Medical Foundation, Finnish Funding Agency for Technology and
   Innovation, the Finnish Cultural Foundation and Kuopio University
   Foundation. We thank Paivi Perttula, Anne-Mari Haapaniemi, Erika Oksala
   and Tiina Sistonen for their technical assistance and Ewen MacDonald,
   DPharm, for revising the English language of the manuscript.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Bertram JP, 2009, J MICROENCAPSUL, V26, P18, DOI 10.1080/02652040802095250
   Cai J, 1998, POLYMER, V39, P4409, DOI 10.1016/S0032-3861(97)10346-9
   Cai J., 1997, POLYM INT, V42, P373
   Cardillo JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P81, DOI 10.1001/archophthalmol.2009.352
   Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823
   Clark K, 2005, J CELL SCI, V118, P291, DOI 10.1242/jcs.01623
   Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GINDE RM, 1987, J APPL POLYM SCI, V33, P2411, DOI 10.1002/app.1987.070330712
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Kivalo M, 1999, J MATER SCI-MATER M, V10, P53, DOI 10.1023/A:1008896211886
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x
   Lu DW, 2000, J OCUL PHARMACOL TH, V16, P529, DOI 10.1089/jop.2000.16.529
   Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   MIAN M, 1992, INT J TISSUE REACT, V14, P1
   Mosher DF, 2001, NAT MED, V7, P290, DOI 10.1038/85426
   Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100
   Nuss Katja M R, 2008, Open Orthop J, V2, P66, DOI 10.2174/1874325000802010066
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Peng YJ, 2010, J BIOMED MATER RES A, V94A, P426, DOI 10.1002/jbm.a.32697
   Rabowsky JH, 1996, OPHTHALMOLOGY, V103, P800
   Ronkko S, 2009, J BIOMED MATER RES A, V88A, P717, DOI 10.1002/jbm.a.31932
   RUOSLAHTI E, 1973, BIOCHIM BIOPHYS ACTA, V322, P352, DOI 10.1016/0005-2795(73)90310-3
   Sakurai E, 2001, INVEST OPHTH VIS SCI, V42, P2043
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P4845, DOI 10.1167/iovs.02-1228
   Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x
   Steffensen B, 2002, MATRIX BIOL, V21, P399, DOI 10.1016/S0945-053X(02)00032-X
   TAMKUN JW, 1983, J BIOL CHEM, V258, P4641
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200
   Wang Y, 2004, BIOMATERIALS, V25, P4279, DOI 10.1016/j.biomaterials.2003.10.075
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1
   Xie LX, 2001, CORNEA, V20, P748, DOI 10.1097/00003226-200110000-00015
   Yasukawa T, 2001, ADV DRUG DELIVER REV, V52, P25, DOI 10.1016/S0169-409X(01)00192-2
   Zhu KJ, 2003, J MICROENCAPSUL, V20, P731, DOI 10.1080/02652040310001600785
NR 46
TC 4
Z9 4
U1 1
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
EI 1423-0259
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PY 2011
VL 46
IS 2
BP 55
EP 65
DI 10.1159/000322996
PG 11
WC Ophthalmology
SC Ophthalmology
GA 799EI
UT WOS:000293266200001
PM 21228610
DA 2018-10-19
ER

PT S
AU Rossi, F
   Matteini, P
   Ratto, F
   Menabuoni, L
   Lenzetti, I
   Pini, R
AF Rossi, Francesca
   Matteini, Paolo
   Ratto, Fulvio
   Menabuoni, Luca
   Lenzetti, Ivo
   Pini, Roberto
BE Manns, F
   Soderberg, PG
   Ho, A
TI Laser welding of chitosan-GNRs films for the closure of a capsulorhexis
SO OPHTHALMIC TECHNOLOGIES XXI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Ophthalmic Technologies XXI
CY JAN 22-24, 2011
CL San Francisco, CA
SP SPIE, Topcon Adv Biomed Imaging Lab, Swedish Ophthalmol Soc, Resident Opt Course
DE gold nanorods; chitosan patch; laser welding; capsulorhexis
ID GOLD NANORODS
AB In this work we present the first attempt to close the anterior lens capsule bag by the use of chitosan patches, where Gold Nanorods (GNRs) are embedded. GNRs exhibit intense localized plasmon resonances at optical frequencies in the near infrared (NIR): upon excitation with a NIR laser, a strong photothermal effect is produced, which can be exploited to develop minimally invasive therapies. Here we use the chitosan-GNRs films as a novel NIR sensitive nanocomposite for the photothermal conversion of NIR laser light during surgical interventions of tissue welding. Chitosan is an attractive biomaterial due to its biodegradability, biocompatibility, antimicrobial and wound healing-promoting activity. Colloidal GNRs were embedded in chitosan based, highly stabilized, flexible and easy-to-handle films, which were stored in water until the time of surgery. In these preliminary tests, a capsulorhexis was performed in freshly enucleated porcine eyes. The lens was aspired, then the patch was put onto the capsule bag and welded: a diode laser (810 nm) was used to deliver single spots (200 mu m core diameter optical fiber) of local capsule/patch adhesion. Then the bag was refilled with silicon oil. The result is an immediate closure of the capsular tissue, with high mechanical strength. The laser welded chitosan-GNRs films are an innovative and highly stable solution to be exploited for the treatment of capsular breaks and for the implementation of a lens refilling procedure.
C1 [Rossi, Francesca; Matteini, Paolo; Ratto, Fulvio; Pini, Roberto] CNR, Inst Appl Pys Nello Carrara, Via Madonna del Piano 10, I-50019 Florence, Italy.
   [Menabuoni, Luca; Lenzetti, Ivo] U O Oculist Osped Misericordia & Dolce, Prato, Italy.
RP Rossi, F (reprint author), CNR, Inst Appl Pys Nello Carrara, Via Madonna del Piano 10, I-50019 Florence, Italy.
RI Matteini, Paolo/N-3725-2015; Rossi, Francesca/A-5105-2010
OI Rossi, Francesca/0000-0002-1199-8019; Menabuoni,
   Luca/0000-0002-7741-9964
CR Matteini P, 2010, PROC SPIE, V7574, DOI 10.1117/12.840923
   Matteini P, 2010, ADV MATER, V22, P4313, DOI 10.1002/adma.201002228
   PINI R, 2008, BIOL MED PHYS BIOMED, V15, P275
   Pini R, 2008, OPHTHAL SURG LAS IM, V39, P260, DOI 10.3928/15428877-20080501-12
   Ratto F., 2008, OPHTHALMIC TECHNOLOG, V6844
   Ratto F, 2010, J NANOPART RES, V12, P2029, DOI 10.1007/s11051-009-9712-0
   Ratto F, 2009, NANOMED-NANOTECHNOL, V5, P143, DOI 10.1016/j.nano.2008.10.002
NR 7
TC 1
Z9 1
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8422-2
J9 PROC SPIE
PY 2011
VL 7885
AR 78851O
DI 10.1117/12.876476
PG 4
WC Optics
SC Optics
GA BXY08
UT WOS:000297590500035
DA 2018-10-19
ER

PT J
AU Verma, S
   Jain, SL
   Sain, B
AF Verma, Sanny
   Jain, Suman L.
   Sain, Bir
TI An efficient biomaterial supported bifunctional organocatalyst (ES-SO3-
   C5H5NH+) for the synthesis of beta-amino carbonyls
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Article
ID AZA-MICHAEL REACTIONS; CATALYZED CONJUGATE ADDITION; ASYMMETRIC
   ORGANOCATALYSIS; ALPHA,BETA-ETHYLENIC COMPOUNDS; ENANTIOSELECTIVE
   SYNTHESIS; ORGANIC CATALYSTS; IONIC LIQUIDS; WATER; ACID; ALKENES
AB A biomaterial supported organocatalyst, readily synthesized by the reaction of chemically modified sulfonic group containing expanded corn starch with pyridine exhibited excellent catalytic activity for the synthesis of beta-amino carbonyls in excellent yields via aza-Michael addition of amines to electron deficient alkenes. A remarkable enhancement in the reaction rates was observed with the prepared bifunctional organocatalyst in comparison to the either starch grafted sulfonic acid or the corresponding homogeneous pyridinium p-toluenesulfonate.
C1 [Verma, Sanny; Jain, Suman L.; Sain, Bir] Indian Inst Petr, Div Chem Sci, Mohkampur 248005, Dehradun, India.
RP Jain, SL (reprint author), Indian Inst Petr, Div Chem Sci, Mohkampur 248005, Dehradun, India.
EM suman@iip.res.in; birsain@iip.res.in
RI Sain, Bir/F-8603-2010
FU CSIR, New Delhi
FX We are thankful to the Director, IIP for his kind permission to publish
   these results. SV acknowledges CSIR, New Delhi, for his Research
   Fellowship. We kindly acknowledge Dr J. K. Gupta for TGA analysis,
   Analytical Division, for IR, elemental analysis and GCMS analysis and Dr
   A. K. Sinha for providing surface area analysis.
CR ASLAM UM, 2010, RENEWABLE ENERGY RES
   BARTOLI G, 1994, J ORG CHEM, V59, P5328, DOI 10.1021/jo00097a039
   BARTOLI G, 2001, J ORG CHEM, V66, P9055
   Benaglia M, 2003, CHEM REV, V103, P3401, DOI 10.1021/cr010440o
   Benaglia M., 2009, RECOVERABLE RECYCLAB
   Biermann U, 2000, ANGEW CHEM INT EDIT, V39, P2206, DOI 10.1002/1521-3773(20000703)39:13<2206::AID-ANIE2206>3.0.CO;2-P
   Biermann U, 2000, ANGEW CHEM, V112, P2292
   Cardillo G, 1996, CHEM SOC REV, V25, P117, DOI 10.1039/cs9962500117
   Chaudhuri MK, 2005, TETRAHEDRON LETT, V46, P8329, DOI 10.1016/j.tetlet.2005.09.167
   Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d
   Cozzi F, 2006, ADV SYNTH CATAL, V348, P1367, DOI 10.1002/adsc.200606096
   Dalko PI, 2004, ANGEW CHEM INT EDIT, V43, P5138, DOI 10.1002/anie.200400650
   Ding K., 2008, HDB ASYMMETRIC HETER
   Dondoni A, 2008, ANGEW CHEM INT EDIT, V47, P4638, DOI 10.1002/anie.200704684
   GIMBERT C, 2007, TETRAHEDRON, V63, P8035
   Guidotti M., 2007, CATALYSIS RENEWABLES, P257
   Guillena G, 2006, TETRAHEDRON-ASYMMETR, V17, P1465, DOI 10.1016/j.tetasy.2006.05.020
   Hayashi Y, 1996, J AM CHEM SOC, V118, P5502, DOI 10.1021/ja960766s
   Hegedus LS, 2009, J AM CHEM SOC, V131, P17995, DOI 10.1021/ja908581u
   JENNER G, 1995, TETRAHEDRON LETT, V36, P233, DOI 10.1016/0040-4039(94)02215-W
   Kantam ML, 2005, ADV SYNTH CATAL, V347, P763, DOI 10.1002/adsc.200404361
   Kumar R, 2006, GREEN CHEM, V8, P356, DOI 10.1039/b517397c
   Lee DH, 2009, ADV SYNTH CATAL, V351, P2912, DOI 10.1002/adsc.200900495
   Li L, 2009, J AM CHEM SOC, V131, P11648, DOI 10.1021/ja9034494
   Loh TP, 1998, SYNLETT, P975
   Maiti SK, 2008, J MOL CATAL A-CHEM, V287, P135, DOI 10.1016/j.molcata.2008.03.008
   Maruoka K, 2008, ORG PROCESS RES DEV, V12, P679, DOI 10.1021/op7002979
   MATSUBARA S, 1994, CHEM LETT, P827, DOI 10.1246/cl.1994.827
   Melchiorre P, 2008, ANGEW CHEM INT EDIT, V47, P6138, DOI 10.1002/anie.200705523
   Palomo C, 2009, CHEM SOC REV, V38, P632, DOI 10.1039/b708453f
   Pettersen D, 2007, TETRAHEDRON LETT, V48, P7805, DOI 10.1016/j.tetlet.2007.09.012
   Polshettiwar V, 2010, TETRAHEDRON, V66, P1091, DOI 10.1016/j.tet.2009.11.015
   Ranu BC, 2007, TETRAHEDRON LETT, V48, P141, DOI 10.1016/j.tetlet.2006.10.142
   Reboule I., 2005, TETRAHEDRON LETT, V46, P7761
   Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m
   ROSSITER BE, 1992, CHEM REV, V92, P771, DOI 10.1021/cr00013a002
   Sakthivel A, 2006, CATAL COMMUN, V7, P302, DOI 10.1016/j.catcom.2005.11.017
   Seayad J, 2005, ORG BIOMOL CHEM, V3, P719, DOI 10.1039/b415217b
   Shaabani A, 2008, CATAL COMMUN, V9, P13, DOI 10.1016/j.catcom.2007.05.021
   Surendra K, 2006, TETRAHEDRON LETT, V47, P2125, DOI 10.1016/j.tetlet.2006.01.124
   Xu LW, 2004, NEW J CHEM, V28, P183, DOI 10.1039/b312047c
   Xu LW, 2003, CHEM COMMUN, P2570, DOI 10.1039/b307733k
   Yadav JS, 2003, CHEM LETT, V32, P988, DOI 10.1246/cl.2003.988
NR 43
TC 24
Z9 24
U1 1
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PY 2011
VL 9
IS 7
BP 2314
EP 2318
DI 10.1039/c0ob00965b
PG 5
WC Chemistry, Organic
SC Chemistry
GA 735YM
UT WOS:000288456700037
PM 21321768
DA 2018-10-19
ER

PT J
AU Reynolds, MM
   Annich, GM
AF Reynolds, Melissa M.
   Annich, Gail M.
TI The artificial endothelium
SO ORGANOGENESIS
LA English
DT Article
DE extracorporeal circulation; nitric oxide; platelet; biomaterial
   interface; artificial endothelium; rabbit; activation
ID NITRIC-OXIDE RELEASE; EXTRACORPOREAL-CIRCULATION; CATALYTIC GENERATION;
   POLYMERIC COATINGS; S-NITROSOTHIOLS; CARDIOPULMONARY BYPASS; PLATELET
   ACTIVATION; BLOOD COMPATIBILITY; IN-SITU; HEPARIN
C1 [Annich, Gail M.] Univ Michigan, Div Pediat Crit Care Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.
   [Reynolds, Melissa M.] Colorado State Univ, Dept Chem, Coll Nat Sci, Sch Biomed Engn,Coll Engn, Ft Collins, CO 80523 USA.
RP Annich, GM (reprint author), Univ Michigan, Div Pediat Crit Care Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.
EM gannich@med.umich.edu
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Edmunds L H Jr, 1995, ASAIO J, V41, P824, DOI 10.1097/00002480-199510000-00002
   Edmunds LH, 2002, PERFUSION-UK, V17, P243, DOI 10.1191/0267659102pf585oa
   *ELSO, 2009, ECMO REG EXTR LIF SU
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   Eynden FV, 2008, J CARDIAC SURG, V23, P288, DOI 10.1111/j.1540-8191.2008.00682.x
   Gorman RC, 1996, J THORAC CARDIOV SUR, V112, P557, DOI 10.1016/S0022-5223(96)70295-7
   HAYASHI Y, 1998, ASAIO, V44, P456
   Hwang S, 2006, ANGEW CHEM INT EDIT, V45, P2745, DOI 10.1002/anie.200503588
   Hwang S, 2008, BIOMATERIALS, V29, P2443, DOI 10.1016/j.biomaterials.2008.02.004
   Keh D, 1999, EUR J CLIN INVEST, V29, P344
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Mangoush O, 2007, EUR J CARDIO-THORAC, V31, P1058, DOI 10.1016/j.ejcts.2007.01.029
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   Mellgren K, 1996, ANN THORAC SURG, V61, P1194, DOI 10.1016/0003-4975(96)00017-3
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Murray DWG, 1937, SURGERY, V2, P163
   Oh BK, 2004, BIOMATERIALS, V25, P283, DOI 10.1016/S0142-9612(03)00530-1
   Oh BK, 2003, J AM CHEM SOC, V125, P9552, DOI 10.1021/ja035775x
   PLOTZ F B, 1992, Perfusion (London), V7, P27, DOI 10.1177/026765919200700106
   RADOMSKI MW, 1993, ADV EXP MED BIOL, V344, P251
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Ranucci M, 2009, ANN THORAC SURG, V87, P1311, DOI 10.1016/j.athoracsur.2008.09.076
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   VAUGHN M, 1998, AM J PHYSIOL, V274, P2163
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Wu B, 2007, BIOMATERIALS, V28, P4047, DOI 10.1016/j.biomaterials.2007.06.002
   Wu YD, 2007, SENSOR ACTUAT B-CHEM, V121, P36, DOI 10.1016/j.snb.2006.09.025
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhou ZR, 2005, BIOMATERIALS, V26, P6506, DOI 10.1016/j.biomaterials.2005.04.046
NR 34
TC 24
Z9 25
U1 2
U2 12
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1547-6278
J9 ORGANOGENESIS
JI Organogenesis
PD JAN-MAR
PY 2011
VL 7
IS 1
BP 42
EP 49
DI 10.4161/org.7.1.14029
PG 8
WC Biochemistry & Molecular Biology; Developmental Biology; Engineering,
   Biomedical
SC Biochemistry & Molecular Biology; Developmental Biology; Engineering
GA 759RS
UT WOS:000290266700007
PM 21289481
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Chen, Q
   Chan, KC
   Liu, L
AF Chen, Q.
   Chan, K. C.
   Liu, L.
TI Tribological characterisation of Zr-based bulk metallic glass in
   simulated physiological media
SO PHILOSOPHICAL MAGAZINE
LA English
DT Article
DE metallic glass; biomaterial; friction; tribology; wear
ID SUPERCOOLED LIQUID; RESISTANCE
AB Due to their excellent wear resistant properties and high strength, as well as a low Young's modulus, Zr-based bulk metallic glasses (BMGs) are potentially suitable biomaterials for low-friction arthroplasty. The wear characteristics of the Zr(60.14)Cu(22.31)Fe(4.85)Al(9.7)Ag(3) bulk amorphous alloy against ultra-high-molecular-weight polyethylene (UHMWPE) compared to a CoCrMo/UHMWPE combination were investigated in two different wear screening test devices, reciprocating and unidirectional. Hank's solution and sterile calf bovine serum were selected as the lubricant fluid media. It was found that different fluid media had insignificant effect on polyethylene wear against BMG counterfaces. The wear behaviour obtained on both test devices demonstrated that Zr-based BMG achieved UHMWPE counterface wear rates superior to conventional cast CoCrMo alloy, where the wear rate of UHMWPE is decreased by over 20 times. The tribological performance of these joints is superior to that of conventional metal-on-polymer designs. Contact angle measurements suggested that the advantage of BMG over a CoCrMo alloy counterface is attributed to its highly hydrophilic surfaces.
C1 [Chen, Q.; Chan, K. C.] Hong Kong Polytech Univ, Adv Mfg Technol Res Ctr, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
   [Liu, L.] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Chen, Q (reprint author), Hong Kong Polytech Univ, Adv Mfg Technol Res Ctr, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
EM hustcq@gmail.com
RI Chan, K.C./A-2311-2014; Chen, Qi/A-6167-2010; BAI, JIE/D-7448-2016
OI Chan, K.C./0000-0002-6173-5532; 
FU Research Grants Council of The Hong Kong Special Administration Region
   [PolyU5112/07 E]
FX This work was financially supported by the Research Grants Council of
   The Hong Kong Special Administration Region (Project No. PolyU5112/07
   E). The authors would like to thank Mr. S.Y.Lau at the Materials
   Engineering Laboratory of The Hong Kong Polytechnic University for
   assistance in the wear tests.
CR Black J., 1998, HDB BIOMATERIAL PROP
   Borruto A, 2005, TRIBOL LETT, V20, P1, DOI 10.1007/s11249-005-7787-z
   El-Domiaty A, 2002, J MATER ENG PERFORM, V11, P577, DOI 10.1361/105994902770343845
   Greer AL, 2002, INT MATER REV, V47, P87, DOI 10.1179/095066001225001067
   Inoue A, 1999, MAT SCI ENG A-STRUCT, V267, P171, DOI 10.1016/S0921-5093(99)00089-1
   Inoue A, 2010, INT J APPL GLASS SCI, V1, P273, DOI 10.1111/j.2041-1294.2010.00019.x
   Kawamura Y, 1998, ACTA MATER, V46, P253, DOI 10.1016/S1359-6454(97)00235-8
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   Liu L, 2010, INTERMETALLICS, V18, P1978, DOI 10.1016/j.intermet.2010.02.039
   Liu Z, 2009, J ALLOY COMPD, V487, P152, DOI 10.1016/j.jallcom.2009.08.030
   Morrison ML, 2005, J BIOMED MATER RES A, V74A, P430, DOI 10.1002/jbm.a.30361
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   OVERHOLSER R, 2006, P MAT PROC MED DEV C, P37
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Wataha JC, 2000, J BIOMED MATER RES, V52, P360, DOI 10.1002/1097-4636(200011)52:2<360::AID-JBM16>3.0.CO;2-B
   Zhang QS, 2009, SCRIPTA MATER, V61, P241, DOI 10.1016/j.scriptamat.2009.03.056
NR 16
TC 18
Z9 18
U1 2
U2 34
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1478-6435
J9 PHILOS MAG
JI Philos. Mag.
PY 2011
VL 91
IS 28
BP 3705
EP 3715
DI 10.1080/14786435.2011.589867
PG 11
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Metallurgy & Metallurgical Engineering; Physics
GA 869FQ
UT WOS:000298583100004
DA 2018-10-19
ER

PT S
AU Xiong, Y
   Ye, WN
AF Xiong, Yule
   Ye, Winnie N.
BE Kashyap, R
   Tetu, M
   Kleiman, RN
TI Vertically Coupled Si-based Athermal Double-Ring Biosensor
SO PHOTONICS NORTH 2011
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Photonics North
CY MAY 16-18, 2011
CL Ottawa, CANADA
SP Ontario Photon Ind Network (OPIN), Quebec Photon Network, Institut Nat dOptique (INO), Canadian Photon Consortium (CPC), Universite Laval, photonique et Laser, Centre doptique
DE double-ring; ring resonator; biosensor; temperature;
   silicon-on-insulator; waveguide
ID RESONATORS; SILICON
AB A silicon-based athermal double-ring resonator biosensor with a vertically coupled configuration is developed. We present an optimal design of the sensor structure by specifying the radii of the reference and the sensing rings, the vertical coupling offset, d, between the two rings and the bus waveguide, and the lateral offset, l, between the edges of the rings and the bus waveguide. By using Lumerical software package, we demonstrate that the optimal vertical and lateral offsets are d=325 nm and l=-80 nm, respectively. One major challenge faced by ring based biosensors is their temperature dependent characteristics. In this study, the sensing ring is exposed to the biomaterial under test, while the reference ring provides a temperature-insensitive reference to the sensing measurements. By assuming the biomaterial medium has small variations in temperature, we conclude that the proposed biosensor device offers temperature insensitive measurement, where the temperature effects are fully corrected by the reference ring response. The doublering sensors are proposed to be fabricated with the local oxidation of silicon process, without the need for advanced lithography methods such as e-beam or deep UV lithography. In addition, the vertically coupled double-ring configuration allows precise control of the critical coupling separation between the rings and the bus waveguide. The proposed silicon double-ring biosensor can be used for highly sensitive and stable sensing for both biomedical and environmental applications.
C1 [Xiong, Yule; Ye, Winnie N.] Carleton Univ, Dept Elect, Ottawa, ON K1S 5B6, Canada.
RP Xiong, Y (reprint author), Carleton Univ, Dept Elect, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.
EM winnie_ye@doe.carleton.ca
RI Ye, Winnie/E-1651-2011
OI Ye, Winnie/0000-0003-2817-4531
CR Bienstman P., 2007, OPT EXPRESS, V15, P7610
   Chamanzar M, 2010, APPL PHYS B-LASERS O, V101, P263, DOI 10.1007/s00340-010-4034-6
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Kusko M, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/6/064012
   Little BE, 1999, IEEE PHOTONIC TECH L, V11, P215, DOI 10.1109/68.740708
   Rowe LK, 2007, ELECTRON LETT, V43, P392, DOI 10.1049/el:20073680
   Vos K. D., 2009, IEEE PHOTONICS J, V1, P225
   Washburn AL, 2009, ANAL CHEM, V81, P9499, DOI 10.1021/ac902006p
   Xu DX, 2010, OPT LETT, V35, P2771, DOI 10.1364/OL.35.002771
   Xu D.-X, 2008, GROUP 4 PHOT 5 IEEE, P398
   Xu DX, 2010, OPT EXPRESS, V18, P22867, DOI 10.1364/OE.18.022867
   Yalcin A, 2006, IEEE J SEL TOP QUANT, V12, P148, DOI 10.1109/JSTQE.2005.863003
   Ye WN, 2008, IEEE PHOTONIC TECH L, V20, P885, DOI 10.1109/LPT.2008.922338
NR 13
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-81948-581-6
J9 PROC SPIE
PY 2011
VL 8007
AR 80070V
DI 10.1117/12.905392
PG 8
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BXX89
UT WOS:000297560400031
DA 2018-10-19
ER

PT J
AU Xu, PF
   Noh, H
   Lee, JH
   Cha, JN
AF Xu, Phyllis F.
   Noh, Hyunwoo
   Lee, Ju Hun
   Cha, Jennifer N.
TI DNA mediated assembly of single walled carbon nanotubes: role of DNA
   linkers and annealing
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID SEPARATION; DISPERSION; ARRAYS; ROUTE; FILMS
AB With the high demand for nanoelectronic devices, extensive research has focused on the use of single walled carbon nanotubes (CNTs) due to their high electron carrier mobility, large tensile strength, and single nanometer dimensions. Despite their promise, however, their applicability has been greatly hindered by the inherent difficulties of both separating nanotubes of different chiralities and diameters and positioning them from metallic tubes and positioning them in a precise location on a surface. In recent years, single stranded DNA (ssDNA) has been identified as a potential solution for both of these problems since DNA can be used to both separate the different types of CNTs as well as direct their organization. We demonstrate here the first principles on how to guide CNT assembly directly on surfaces from solution by specific DNA hybridization. It was found that the specific DNA sequence used to disperse the carbon nanotubes greatly influences the adsorption and specificity of nanotube binding to the surface. Furthermore, we demonstrate here that thermal annealing can correct misaligned tubes or incorrect binding. These studies provide an excellent foundation for employing two-dimensional DNA templates for CNT organization for nanoelectronic logic and memory based applications. Furthermore, using a single biomaterial to both sort and place CNTs in minimal steps would greatly help the throughput, manufacturability, and cost of such devices.
C1 [Cha, Jennifer N.] Univ CA, Dept Nanoengn & Mat Sci, La Jolla, CA 92093 USA.
   Univ CA, Engn Program, La Jolla, CA 92093 USA.
RP Cha, JN (reprint author), Univ CA, Dept Nanoengn & Mat Sci, 9500 Gilman Dr,M-C 0448, La Jolla, CA 92093 USA.
EM jencha@ucsd.edu
RI Lee, Ju Hun/H-3851-2013
FU Office of Naval Research [N00014-09-01-0250]; National Science
   Foundation [CMMI-7045043]; DARPA [N66001-09-1-2093]
FX The authors thank Dr Andrew Goodwin for manuscript editing, Mr Matt
   Nakatsuka for help with the zeta potential measurements and Prof. Shyni
   Varghese for use of a UV-vis spectrophotometer. This work is financially
   supported by the Office of Naval Research (Award Number:
   N00014-09-01-0250), the National Science Foundation (CMMI-7045043) and
   the DARPA YFA Program (N66001-09-1-2093).
CR Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52
   Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l
   Gao JB, 2004, J AM CHEM SOC, V126, P16698, DOI 10.1021/ja044499z
   Hazani M, 2004, CHEM PHYS LETT, V391, P389, DOI 10.1016/j.cplett.2004.05.042
   Keren K, 2003, SCIENCE, V302, P1380, DOI 10.1126/science.1091022
   Ko H, 2004, J PHYS CHEM B, V108, P4385, DOI 10.1021/jp031229e
   Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534
   Lay MD, 2004, NANO LETT, V4, P603, DOI 10.1021/nl035233d
   Li XL, 2007, J AM CHEM SOC, V129, P4890, DOI 10.1021/ja071114e
   Maeda Y, 2005, J AM CHEM SOC, V127, P10287, DOI 10.1021/ja051774o
   Maeda Y, 2006, J AM CHEM SOC, V128, P12239, DOI 10.1021/ja063776u
   Martel R, 2008, ACS NANO, V2, P2195, DOI 10.1021/nn800723u
   Maune H. T., 2009, NAT NANOTECHNOL, V5, P61
   Meitl MA, 2004, NANO LETT, V4, P1643, DOI 10.1021/nl0491935
   Noh H, 2010, ACS NANO, V4, P5076, DOI 10.1021/nn101593d
   Noh H, 2009, ACS NANO, V3, P2376, DOI 10.1021/nn900559m
   Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797
   Qiu HX, 2009, J AM CHEM SOC, V131, P16529, DOI 10.1021/ja906932p
   Ramesh S, 2007, J PHYS CHEM C, V111, P17827, DOI 10.1021/jp071322t
   Rao SG, 2003, NATURE, V425, P36, DOI 10.1038/425036a
   Tu XM, 2008, NANO RES, V1, P185, DOI 10.1007/s12274-008-8022-7
   Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116
   Valentin E, 2002, MICROELECTRON ENG, V61-2, P491, DOI 10.1016/S0167-9317(02)00580-4
   Voggu R, 2010, J AM CHEM SOC, V132, P5560, DOI 10.1021/ja100190p
   Wang YH, 2006, P NATL ACAD SCI USA, V103, P2026, DOI 10.1073/pnas.0511022103
   Xin HJ, 2003, J AM CHEM SOC, V125, P8710, DOI 10.1021/ja035902p
   Yan YH, 2007, SMALL, V3, P24, DOI 10.1002/smll.200600354
   Zhang L, 2008, J AM CHEM SOC, V130, P2686, DOI 10.1021/ja7106492
   Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877
   Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911
NR 30
TC 11
Z9 11
U1 0
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2011
VL 13
IS 21
BP 10004
EP 10008
DI 10.1039/c0cp02815k
PG 5
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 765TR
UT WOS:000290732000011
PM 21336403
DA 2018-10-19
ER

PT J
AU Budzynska, A
   Wieckowska-Szakiel, M
   Sadowska, B
   Kalemba, D
   Rozalska, B
AF Budzynska, Aleksandra
   Wieckowska-Szakiel, Marzena
   Sadowska, Beata
   Kalemba, Danuta
   Rozalska, Barbara
TI Antibiofilm Activity of Selected Plant Essential Oils and their Major
   Components
SO POLISH JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE biofilm eradication; biomaterial-associated infections; essential oils
ID TEA-TREE OIL; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITY; BIOFILMS;
   ANTIBACTERIAL; RESISTANT; ANTIFUNGAL; MRSA
AB The aim of the study was to examine the antibiofilm activity of selected essential oils (EO): Lavandula angustifolia (LEO), Melaleuca alternifolia (TTO), Melissa officinalis (MEO) and some of their major constituents: linalool, linalyl acetate, a-terpineol, terpinen-4-ol. Biofilms were formed by Staphylococcus aureus ATCC 29213 and Escherichia coli NCTC 8196 on the surface of medical biomaterials (urinary catheter, infusion tube and surgical mesh). TTC reduction assay was used for the evaluation of mature biofilm eradication from these surfaces. Moreover, time-dependent eradication of biofilms preformed in polystyrene 96-well culture microplates was examined and expressed as minimal biofilm eradication concentration (evaluated by MTT reduction assay). TTO, alpha-terpineol and terpinen-4-ol as well as MEO, showed stronger anti-biofilm activity than LEO and linalool or linalyl acetate. Among the biomaterials tested, surgical mesh was the surface most prone to persistent colonization since biofilms formed on it, both by S. mucus and E. coli, were difficult to destroy. The killing rate studies of S. aureus biofilm treated with TTO, LEO, MEO and some of their constituents revealed that partial (50%) destruction of 24-h-old biofilms (MBEC50) was achieved by the concentration 4-8 x MIC after 1 h, whereas 2-4 x MIC was enough to obtain 90% reduction in biomass metabolic activity (MBEC90) after just 4 h of treatment. A similar dose-dependent effect was observed for E. coli biofilm which, however, was more susceptible to the action of phytochemicals than the biofilms of S. aureus. It is noteworthy that an evident decrease in biofilm cells metabolic activity does not always lead to their total destruction and eradication.
C1 [Rozalska, Barbara] Univ Lodz, Dept Immunol & Infect Biol, Inst Microbiol Biotechnol & Immunol, PL-90237 Lodz, Poland.
   [Kalemba, Danuta] Tech Univ Lodz, Inst Gen Food Chem, PL-90924 Lodz, Poland.
RP Rozalska, B (reprint author), Univ Lodz, Dept Immunol & Infect Biol, Inst Microbiol Biotechnol & Immunol, Banacha 12-16, PL-90237 Lodz, Poland.
EM rozab@biol.uni.lodz.pl
RI Kalemba, Danuta/P-4183-2018
OI Kalemba, Danuta/0000-0002-4018-5260
CR Amalaradjou MAR, 2010, J UROLOGY, V184, P358, DOI 10.1016/j.juro.2010.03.006
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Brady A, 2006, J MED MICROBIOL, V55, P1375, DOI 10.1099/jmm.0.46558-0
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Budzynska Aleksandra, 2009, Medycyna Doswiadczalna i Mikrobiologia, V61, P281
   Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006
   Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103
   Chao S, 2008, FLAVOUR FRAG J, V23, P444, DOI 10.1002/ffj.1904
   Dai T, 2010, Recent Pat Antiinfect Drug Discov, V5, P124
   Durig A, 2010, APPL MICROBIOL BIOT, V87, P309, DOI 10.1007/s00253-010-2471-0
   Fabian D, 2006, TOXICOL IN VITRO, V20, P1435, DOI 10.1016/j.tiv.2006.06.012
   Flemming K, 2009, J ANTIMICROB CHEMOTH, V63, P136, DOI 10.1093/jac/dkn464
   Gibbons S, 2008, PLANTA MED, V74, P594, DOI 10.1055/s-2008-1074518
   Gursoy UK, 2009, ANAEROBE, V15, P164, DOI 10.1016/j.anaerobe.2009.02.004
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   HOSSAINZADEGAN H, 2009, ACTA MED IRANICA, V47, P35
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Kalemba D, 2003, CURR MED CHEM, V10, P813, DOI 10.2174/0929867033457719
   Karpanen TJ, 2008, J ANTIMICROB CHEMOTH, V62, P1031, DOI 10.1093/jac/dkn325
   Kwiecinski J, 2009, INT J ANTIMICROB AG, V33, P343, DOI 10.1016/j.ijantimicag.2008.08.028
   Mimica-Dukic N, 2004, J AGR FOOD CHEM, V52, P2485, DOI 10.1021/jf030698a
   Reichling J, 2009, FORSCH KOMPLEMENTMED, V16, P79, DOI 10.1159/000207196
   Roller S, 2009, J ALTERN COMPLEM MED, V15, P275, DOI 10.1089/acm.2008.0268
   Rozalska Barbara, 1998, Medycyna Doswiadczalna i Mikrobiologia, V50, P115
   Walencka E, 2007, PLANTA MED, V73, P545, DOI 10.1055/s-2007-967179
   Walencka Elzbieta, 2005, Polish Journal of Microbiology, V54, P191
   Warnke PH, 2006, PHYTOMEDICINE, V13, P463, DOI 10.1016/j.phymed.2005.09.012
NR 27
TC 31
Z9 35
U1 1
U2 28
PU POLSKIE TOWARZYSTWO MIKROBIOLOGOW-POLISH SOCIETY OF MICROBIOLOGISTS
PI WARSAW
PA CHELMSKA STR 30-34, WARSAW, 00-725, POLAND
SN 1733-1331
J9 POL J MICROBIOL
JI Pol. J. Microbiol.
PY 2011
VL 60
IS 1
BP 35
EP 41
PG 7
WC Microbiology
SC Microbiology
GA 742FY
UT WOS:000288927900005
PM 21630572
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Peng, ZY
   Peng, ZP
   Shen, YQ
AF Peng, Zhiyuan
   Peng, Zhiping
   Shen, Yongqiang
TI Fabrication and Properties of Gelatin/Chitosan Composite Hydrogel
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Chitosan; Composite hydrogel; Fabrication; Gelatin; Properties
ID BIOCOMPATIBILITY; SCAFFOLDS; ADHESION; RELEASE; DESIGN
AB Gelatin/chitosan hydrogels were prepared by using glutaraldehyde as crosslinker. The porous structure was confirmed by scanning electron microscope (SEM). Swelling ratios of the hydrogels with various ratio of gelatin to chitosan and crosslinker reagent dosage were studied in phosphate-buffered saline (PBS). In addition, in-vitro cytotoxicity was assessed via MTT assay with fibroblastic cell cultured in hydrogel extractions. It was found that by increasing glutaraldehyde dosage and chitosan content, the swelling ratio of the hydrogels decreased in buffer solutions. The MTT test showed that the gelatin/chitosan hydrogel clearly presented adequate cell viability, non-toxicity, and suitable properties. Therefore, these developed blends, based on gelatin and chitosan has broadened the number of choices of biomaterials to be potentially used in biomedical applications such as biomaterial, drug delivery vehicles and skin tissue engineering.
C1 [Peng, Zhiyuan; Peng, Zhiping; Shen, Yongqiang] Jishou Univ, Coll Chem & Chem Engn, Jishou 416000, Peoples R China.
RP Peng, ZY (reprint author), Jishou Univ, Coll Chem & Chem Engn, Jishou 416000, Peoples R China.
EM z_ypeng@126.com
CR [Anonymous], 2006, 10993 ISO 11
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lim YM, 2010, MACROMOL RES, V18, P29, DOI 10.1007/s13233-009-0068-1
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Peng ZY, 2011, POLYM-PLAST TECHNOL, V50, P245, DOI 10.1080/03602559.2010.531438
   Peng ZY, 2010, INT J POLYM MATER, V59, P450, DOI 10.1080/00914030903538637
   Rathna GVN, 2008, J MATER SCI-MATER M, V19, P2351, DOI 10.1007/s10856-007-3334-9
   Yang ZY, 2010, SCI CHINA LIFE SCI, V53, P215, DOI 10.1007/s11427-010-0036-1
   Zhang WF, 2009, J MATER SCI-MATER M, V20, P1321, DOI 10.1007/s10856-008-3680-2
   Zhou HY, 2008, CARBOHYD POLYM, V73, P265, DOI 10.1016/j.carbpol.2007.11.026
NR 19
TC 31
Z9 32
U1 8
U2 35
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2011
VL 50
IS 11
BP 1160
EP 1164
DI 10.1080/03602559.2011.574670
PG 5
WC Polymer Science
SC Polymer Science
GA 885JO
UT WOS:000299775400012
DA 2018-10-19
ER

PT J
AU Cui, J
   Kratz, K
   Hiebl, B
   Jung, F
   Lendlein, A
AF Cui, J.
   Kratz, K.
   Hiebl, B.
   Jung, F.
   Lendlein, A.
TI Soft poly(n-butyl acrylate) networks with tailored mechanical properties
   designed as substrates for in vitro models
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Polymers for Advanced Technologies (PAT
   2009)
CY OCT 11-14, 2009
CL Jerusalem, ISRAEL
DE biomaterial; hydrophobic polymer; poly(n-butyl acrylate); soft polymer
   networks; adjustable mechanical properties
ID SHAPE-MEMORY PROPERTIES; MESENCHYMAL STEM-CELLS; POLYMER NETWORKS;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; STERILIZATION; MOTILITY; ADHESION;
   BEHAVIOR; CYTOTOXICITY; STIMULATION
AB Mechanical conditioning can serve as a potent tool to influence mechano-responsive cells, which plays a prominent role during formation and regeneration of functional tissue. Recently, the differentiation of mesenchymal stem cells could be influenced by the local stiffness of hydrogels used as 2D substrates. However, the mechanical properties and the swellability of hydrogels in physiological liquids are difficult to control precisely as their properties strongly depend on physical parameters like ionic strength or pH value. Here, we explored amorphous, hydrophobic poly(n-butyl acrylate) networks (cPnBA) as soft substrates for cell culture system with adjustable mechanical properties. cPnBAs were synthesized via bulk radical polymerization from n-butyl acrylate (nBA) and poly(propylene glycol) dimethacrylate (PPGDMA) as crosslinker. The Young's modulus for cPnBAs determined by tensile tests could be systematically adjusted from 100 kPa to 10 MPa by increasing the PPGDMA-content at ambient temperature, while the glass transition temperature (T-g) was found to increase from -46 to -22 degrees C. All cPnBAs exhibited similar surface properties with a surface roughness (R-q) in the range from 1.4 to 0.4 mu m and advancing contact angles from 115 degrees to 100 degrees, which remained constant after ethylene oxide sterilization. The extracts of sterilized materials were tested for cytotoxic effects with L929 cells. All tested samples were non-cytotoxic. The functional integrity of cell membranes and mitochondrial activity stayed unaffected. The investigated polymer networks are promising candidates as soft substrates for passive mechanical stimulation of cells in vitro in cell culture devices or in vivo as implant coatings. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Cui, J.; Kratz, K.; Hiebl, B.; Jung, F.; Lendlein, A.] Geesthacht GmbH, GKSS Res Ctr, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Cui, J.; Kratz, K.; Hiebl, B.; Jung, F.; Lendlein, A.] Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Geesthacht GmbH, GKSS Res Ctr, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013; Jung,
   Friedrich/L-1301-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670;
   Jung, Friedrich/0000-0001-8098-7180; Hiebl, Bernhard/0000-0002-6450-0675
CR Bartzoka V, 1999, ADV MATER, V11, P257, DOI 10.1002/(SICI)1521-4095(199903)11:3<257::AID-ADMA257>3.0.CO;2-S
   Briganti E, 2006, J MATER SCI-MATER M, V17, P259, DOI 10.1007/s10856-006-7312-4
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Chen CC, 2009, MATER LETT, V63, P1872, DOI 10.1016/j.matlet.2009.05.073
   Cortese B, 2009, ADV FUNCT MATER, V19, P2961, DOI 10.1002/adfm.200900918
   Cranfield C, 2006, INT J BIOMED IMAGING, DOI 10.1155/IJBI/2006/21304
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P180, DOI 10.1002/pat.1733
   Cui J, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/6/065019
   Cui J, 2009, MATER RES SOC SYMP P, V1190, P93
   Disher D. E., 2005, SCIENCE, V310, P1139
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FDA, 2002, STER REV GUID K90 1
   Frias C, 2010, J BIOMECH, V43, P1061, DOI 10.1016/j.jbiomech.2009.12.010
   Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004
   Goveia VR, 2007, REV LAT-AM ENFERM, V15, P373, DOI 10.1590/S0104-11692007000300002
   Ha-Anh T, 2005, POLYM TEST, V24, P775, DOI 10.1016/j.polymertesting.2005.03.016
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   Jaasma MJ, 2008, TISSUE ENG PT A, V14, P1213, DOI [10.1089/ten.tea.2007.0321, 10.1089/tea.2007.0321]
   Kadow-Romacker A, 2009, CELLS TISSUES ORGANS, V190, P61, DOI 10.1159/000178022
   Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   Kommareddy KP, 2010, BIOINTERPHASES, V5, P45, DOI 10.1116/1.3431524
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836
   Nair PD, 1995, J BIOMATER APPL, V10, P121, DOI 10.1177/088532829501000203
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Ogura K, 2003, J SOC RHEOL JPN, V31, P85
   Perry MJ, 2009, MED ENG PHYS, V31, P42, DOI 10.1016/j.medengphy.2008.04.003
   Pompe T, 2009, BIOPHYS J, V97, P2154, DOI 10.1016/j.bpj.2009.07.047
   Prasitsilp M, 2003, J MATER SCI-MATER M, V14, P595, DOI 10.1023/A:1024066806347
   Rickert D, 2007, LARYNGO RHINO OTOL, V86, P507, DOI 10.1055/s-2007-966091
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Spiller D, 2009, J MATER SCI-MATER M, V20, P2511, DOI 10.1007/s10856-009-3823-0
   Ueki Y, 2010, BIOCHEM BIOPH RES CO, V394, P94, DOI 10.1016/j.bbrc.2010.02.115
NR 41
TC 21
Z9 21
U1 3
U2 32
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD JAN
PY 2011
VL 22
IS 1
SI SI
BP 126
EP 132
DI 10.1002/pat.1816
PG 7
WC Polymer Science
SC Polymer Science
GA 702GE
UT WOS:000285881800019
DA 2018-10-19
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI CUTTING MECHANICS OF HIGH SPEED DRY MACHINING OF MAGNESIUM-CALCIUM
   BIOMEDICAL ALLOY USING INTERNAL STATE VARIABLE PLASTICITY MODEL
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE 2011, VOL 1
LA English
DT Proceedings Paper
CT 6th ASME International Manufacturing Science and Engineering Conference
   / 4th JSME/ASME International Conference on Materials and Processing
CY JUN 13-17, 2011
CL Oregon State Univ, Corvallis, OR
HO Oregon State Univ
DE High speed machining; dry cutting; cutting mechanics; FEA; biomaterial;
   magnesium alloy
ID SURFACE
AB Magnesium-Calcium (MgCa) alloys have become attractive orthopedic biomaterials due to their biodegradability, biocompatibility, and congruent mechanical properties with bone tissues. However, process mechanics of machining biomedical Mg Ca alloys is poorly understood. Mechanical properties of the biomedical magnesium alloy at high strain rates and large strains are determined by using the split-Hopkinson pressure bar testing method. Internal state variable (ISV) plasticity model is implemented to understand the dynamic material behavior under cutting conditions. A finite element simulation model has been developed to study the chip formation during high speed dry cutting of MgCa0.8 (wt %) alloy. Continuous chip formation predicted by the FE simulation is verified by high speed dry face milling of MgCa0.8 using polycrystalline diamond (PCD) inserts. Chip ignition is known as the most hazardous aspect of machining Mg alloys. The predicted temperature distributions may well explain the reason for machining safety of high-speed dry cutting of MgCa0.8 alloy.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Byrne G, 2003, CIRP ANN-MANUF TECHN, V52, P483, DOI 10.1016/S0007-8506(07)60200-5
   Danilenko B.D., 2009, RUSS ENG RES, V29, P316
   DAVIES EDH, 1963, J MECH PHYS SOLIDS, V11, P155, DOI 10.1016/0022-5096(63)90050-4
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2007, P 7 INT C MG ALL THE, P895
   Denkena B, 2005, P 5 EUSP INT C MONTP
   Fang FZ, 2005, J MATER PROCESS TECH, V167, P119, DOI 10.1016/j.jmatprotec.2004.10.002
   Friemuth T, 1999, ADV ENG MATER, V1, P183, DOI 10.1002/(SICI)1527-2648(199912)1:3/4<183::AID-ADEM183>3.3.CO;2-M
   Gama B, 2004, APPL MECH REV, V57, P223, DOI DOI 10.1115/1.1704626
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Gray III G. T., 2000, ASM HDB, V8
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Guo YB, 2002, J MANUF SCI E-T ASME, V124, P189, DOI 10.1115/1.1430678
   Hallum D, 1995, AM MACH, V139, P48
   Lathrop J. F., 1996, SAND978218 SANDIA LA
   Massalski T.B., 1990, 927928 ASM INT
   Pedersen W, 2006, J MATER PROCESS TECH, V172, P417, DOI 10.1016/j.jmatprotec.2005.07.016
   Salahshoor M, 2009, INT J MACH TOOL MANU, V49, P1136, DOI 10.1016/j.ijmachtools.2009.07.016
   Salahshoor M., 2010, P ASME INT MAN SCI E
   Salahshoor M., 2009, P ASM MPMD C EXP MIN
   Sanz C, 2007, P 7 INT C MG ALL THE, P916
   Schmidt J., 1998, ALUMINIUM, V74, P412
   Schwerin R, 2007, P 7 INT C MG ALL THE, P922
   Tomac N., 1991, ANN CIRP, V40, P79
   Tonshoff HK, 1997, SURF COAT TECH, V94-5, P610, DOI 10.1016/S0257-8972(97)00505-7
   Tonshoff HK, 1999, MATERIALWISS WERKST, V30, P401
   Tonshoff HK, 2000, MG ALLOYS THEIR APP, P406
   Videm M, 1994, SAE T, V103, P213
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
NR 31
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4430-4
PY 2011
BP 85
EP 92
PG 8
WC Engineering, Mechanical
SC Engineering
GA BFJ30
UT WOS:000320096800012
DA 2018-10-19
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI PROCESS MECHANICS IN DEEP ROLLING OF MAGNESIUM-CALCIUM (MgCa)
   BIOMATERIAL
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE 2011, VOL 1
LA English
DT Proceedings Paper
CT 6th ASME International Manufacturing Science and Engineering Conference
   / 4th JSME/ASME International Conference on Materials and Processing
CY JUN 13-17, 2011
CL Oregon State Univ, Corvallis, OR
HO Oregon State Univ
DE Deep rolling; magnesium alloy; orthopedic biomaterial; contact
   mechanics; FEA
ID RESIDUAL-STRESS STABILITY; STAINLESS-STEEL AISI-304; TI-6AL-4V ALLOY;
   BONE-RESORPTION; SURFACE; FATIGUE; PERFORMANCE; PROPERTY; BEHAVIOR
AB Magnesium-Calcium (MgCa) alloys have received considerable attention recently in medical device manufacturing industry specially in making biodegradable bone implants. Deep rolling (DR) is as a promising manufacturing technique to adjust surface characteristics of implants with the ultimate goal of being able to adjust corrosion rates of MgCa implants. Contact mechanics between rolling ball and the workpiece is essential to understand the DR process. Contact mechanics is further complicated by the normal force reduction due to hydraulic pressure loss at the tip of DR tool, and the penetration depth reduction due to elastic recovery. The measured normal force, in this study, shows maximum 23% reduction compared to theoretical value. The normal force drop is not uniform and increases with increasing applied pressure. A 2D axisymmetric, semi-infinite FEM model is developed and validated to predict the amount of elastic recovery after deep rolling. The dynamic mechanical behavior of the material is simulated using the internal state variable (ISV) plasticity model and implemented in FEM code using a user material subroutine. The simulated dent geometry agrees with the measured ones in terms of profile and depth. Simulation results suggest 8% elastic recovery on average.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR [Anonymous], 2008, ABAQUS US MAN
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Bozdana AT, 2008, MATER SCI TECH-LOND, V24, P1378, DOI 10.1179/174328408X302431
   Brinksmeier E, 2008, CIRP ANN-MANUF TECHN, V57, P541, DOI 10.1016/j.cirp.2008.03.100
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2007, ADV MATER RES-SWITZ, V22, P67, DOI 10.4028/www.scientific.net/AMR.22.67
   Denkena B., 2005, P 5 EUSP INT C MONT
   Disegi J. A., 2009, P ASM MPMD C EXP MIN
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Gill CM, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/17/174005
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Isaksson H., 2003, BIOENG C, P1041
   Jayaraman N., 2007, P ASIP PALM SPER CA
   Juijerm P, 2007, SCRIPTA MATER, V56, P745, DOI 10.1016/j.scriptamat.2007.01.021
   Lathrop J. F., 1996, SAND978218 SANDIA LA
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Majzoobi GH, 2009, MAT SCI ENG A-STRUCT, V516, P235, DOI 10.1016/j.msea.2009.03.020
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Nikitin I, 2008, MAT SCI ENG A-STRUCT, V491, P297, DOI 10.1016/j.msea.2008.03.034
   Nikitin I, 2007, MAT SCI ENG A-STRUCT, V465, P176, DOI 10.1016/j.msea.2007.02.004
   Prevey P., 2009, P ASM MPMD C EXP MIN
   Prevey PS, 2007, MATER SCI FORUM, V539-543, P3807, DOI 10.4028/www.scientific.net/MSF.539-543.3807
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   Prevey PS, 2004, INT J FATIGUE, V26, P975, DOI 10.1016/j.ijfatigue.2004.01.010
   Salahshoor M., 2009, P ASM MPMD C EXP MIN
   Scheel J. E., 2009, SAFE LIFE CONVERSION
   Schuh A., 2006, J BIOMED MATER RES B, DOI [10.1002/jbmb, DOI 10.1002/JBMB]
   Seemikeri CY, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896121
   SEILER HG, 1987, HDB TOXICITY INORGAN
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Tsuji N, 2008, MAT SCI ENG A-STRUCT, V488, P139, DOI 10.1016/j.msea.2007.11.079
   Tsuji N, 2009, MAT SCI ENG A-STRUCT, V499, P482, DOI 10.1016/j.msea.2008.09.008
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
NR 35
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4430-4
PY 2011
BP 303
EP 311
PG 9
WC Engineering, Mechanical
SC Engineering
GA BFJ30
UT WOS:000320096800038
DA 2018-10-19
ER

PT J
AU Mohammadi, H
AF Mohammadi, H.
TI Nanocomposite biomaterial mimicking aortic heart valve leaflet
   mechanical behaviour
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE material characterization; uniaxial tensile test; anisotropy; heart
   valve leaflet; hyperelasticity
ID POLY(VINYL ALCOHOL) HYDROGELS; BIOMEDICAL APPLICATIONS; CELLULOSE;
   FIBERS
AB The main problem with polymeric heart valves (which are already biocompatible) is that they usually fail in the long term owing to tearing and calcification of the leaflets under high dynamic tensile bending stress and oxidative reactions with blood. To overcome this shortcoming, it is hypothesized that synthetic valve leaflets which mimic native valve leaflet structure fabricated from fibre-reinforced composite material will optimize leaflet stresses and decrease tears and perforations. The objective of this study is to develop a PVA-BC (polyvinyl alcohol-bacterial cellulose)-based hydrogel that mimics not only the non-linear mechanical properties displayed by porcine heart valves, but also their anisotropic behaviour. By applying a controlled strain to the PVA samples, while undergoing low-temperature thermal cycling, it was possible to create oriented mechanical properties in PVA hydrogels. The oriented stress-strain properties of porcine aortic valves were matched simultaneously by a PVA hydrogel (15 per cent PVA, 0.5 BC cycle 4, 75 per cent initial tensile strain). This novel technique allows the control of anisotropy to PVA hydrogel, and gives a broad range of control of its mechanical properties, for specific medical device applications.
C1 Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.
RP Mohammadi, H (reprint author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.
EM hadim74@gmail.com
FU Canadian Institutes of Health Research (CIHR)
FX The author would like to thank the Canadian Institutes of Health
   Research (CIHR) for a Vascular Research Training Award.
CR CASCONE MG, 1995, J MATER SCI-MATER M, V6, P71, DOI 10.1007/BF00120410
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   FUNG YC, 1996, BIOMECHANICS MECH PR, P75
   GALLOCHER LS, 2006, J BIOMED MATER RES B, V79, P325
   Gordon M, 1999, THESIS U W ONTARIO
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Joseph G, 2003, J CHEM TECHNOL BIOT, V78, P964, DOI 10.1002/jctb.869
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 2001, Patent No. [WO 2001061026 (A1), 2001061026]
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Mohammadi H, 2009, P I MECH ENG H, V223, P697, DOI 10.1243/09544119JEIM493
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   SURESH S, 1998, FATIGUE MAT, P21
NR 18
TC 15
Z9 16
U1 3
U2 30
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2011
VL 225
IS H7
BP 718
EP 722
DI 10.1177/0954411911399826
PG 5
WC Engineering, Biomedical
SC Engineering
GA 808SY
UT WOS:000293999900010
PM 21870379
DA 2018-10-19
ER

PT J
AU Kurniawan, D
   Nor, FM
   Lee, HY
   Lim, JY
AF Kurniawan, D.
   Nor, F. M.
   Lee, H. Y.
   Lim, J. Y.
TI Elastic properties of polycaprolactone at small strains are
   significantly affected by strain rate and temperature
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE polycaprolactone; mechanical properties; strain rate; temperature
ID POLYMERS; DEFORMATION; SCAFFOLD; BEHAVIOR; STRESS; DESIGN; BONE
AB Tensile tests were conducted on polycaprolactone at various strain rates and temperatures. Focusing on the mechanical properties within only the small-strain elastic region, i.e. up to the inflection point in the stress-strain diagram, it was found that strain rate and temperature had significant effects on the polymer. This finding implies that the effects of strain rate and temperature on the elastic properties of polycaprolactone should be considered in the design and manufacture of rigidity-sensitive, load-bearing applications, including use as biomaterial for scaffolds in tissue engineering applications.
C1 [Kurniawan, D.; Nor, F. M.; Lee, H. Y.; Lim, J. Y.] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul 100715, South Korea.
RP Lim, JY (reprint author), Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul 100715, South Korea.
EM jylim@dongguk.edu
RI Kurniawan, Denni/C-2703-2008
OI Kurniawan, Denni/0000-0002-4179-0454; Nor, Fethma M./0000-0001-5430-7866
FU Ministry of Education, Science, and Technology, Korea [S2009A000400056]
FX This work was supported by the Ministry of Education, Science, and
   Technology, Korea (grant number S2009A000400056).
CR [Anonymous], D638 ASTM
   Arnoult M, 2007, POLYMER, V48, P1012, DOI 10.1016/j.polymer.2006.12.053
   ARRUDA EM, 1995, MECH MATER, V19, P193, DOI 10.1016/0167-6636(94)00034-E
   Baas E, 2010, J BIOMECH, V43, P733, DOI 10.1016/j.jbiomech.2009.10.016
   Boyce MC, 2000, POLYMER, V41, P2183, DOI 10.1016/S0032-3861(99)00406-1
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   FLORY PJ, 1962, J AM CHEM SOC, V84, P2857, DOI 10.1021/ja00874a004
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Guarino V, 2010, P I MECH ENG H, V224, P1389, DOI 10.1243/09544119JEIM744
   Gueguen O, 2010, MECH MATER, V42, P1, DOI 10.1016/j.mechmat.2009.04.012
   Hobeika S, 2000, MACROMOLECULES, V33, P1827, DOI 10.1021/ma9910484
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   LU Z, 2002, P IUTAM S THEOR NUM, P41
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ohashi F, 2002, POLYM ENG SCI, V42, P1046, DOI 10.1002/pen.11011
   Rajagopalan S, 2006, MED IMAGE ANAL, V10, P693, DOI 10.1016/j.media.2006.06.001
   Richeton J, 2006, INT J SOLIDS STRUCT, V43, P2318, DOI 10.1016/j.ijsolstr.2005.06.040
   Sanz-Herrera JA, 2010, J BIOMECH, V43, P2480, DOI 10.1016/j.jbiomech.2010.05.027
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
NR 23
TC 6
Z9 6
U1 1
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2011
VL 225
IS H10
BP 1015
EP 1020
DI 10.1177/0954411911413059
PG 6
WC Engineering, Biomedical
SC Engineering
GA 824DS
UT WOS:000295182900008
PM 22204123
DA 2018-10-19
ER

PT J
AU Goncalves, PP
   Singh, MK
   Silva, VS
   Marques, F
   Marques, A
   Leduc, PR
   Gracio, J
   Marques, PAAP
   Goncalves, G
   Sousa, ACM
AF Goncalves, Paula P.
   Singh, Manoj K.
   Silva, Virgilia S.
   Marques, Filipa
   Marques, Ana
   LeDuc, Philip R.
   Gracio, Jose
   Marques, Paula A. A. P.
   Goncalves, Gil
   Sousa, Antonio C. M.
TI Automated high-throughput screening of carbon nanotube-based
   bio-nanocomposites for bone cement applications
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Conference on Nanomaterials and Nanotechnology (NANO)
CY DEC 13-16, 2010
CL Tiruchengode, INDIA
DE bone cement; carbon nanotubes; high-throughput methodology;
   nanocomposites; nanotechnology; orthopedic materials
ID BIOMEDICAL APPLICATIONS; COMPOSITES; BIOCOMPATIBILITY; CERAMICS
AB In this work we demonstrate the potential of using an automated cell viability analyzer for developing high-throughput screening of orthopedic bioactive materials. We used a biomaterial of carbon nanotubes (CNTs)-based composite integrated with hydroxyapatite/ polymethyl methacrylate (HA/PMMA) with controlled physical and chemical properties to evaluate the usefulness of morphometric analysis in conjunction with trypan blue dye exclusion assays in MG63 cell cultures. The MG63 cell line, derived from human bone osteo sarcoma, is often used as a model for studying osteoblast-like cellular response to bioactive materials for orthopedic surgery. The viability analyzer, Vi-CELLTM XR, Beckman Coulter, was used with trypan blue dye exclusion method in cell suspensions obtained after trypsinization along with determining the distribution plots of cell diameter and circularity, which are critical cellular characteristics. In addition, the activity of alkaline phosphatase (ALP), a typical representation of osteogenic activity of osteoblasts, was also measured spectrophotometrically using p-nitrophenol phosphate as the substrate. Comparative analysis of the frequency histogram of average cell diameter and circularity allowed for the analyses of significant alterations in cell morphology not only over time in control cultures (spherical vs. a flat morphology) but also with respect to PMMA and HA nanocomposites. After cell exposure to HA/PMMA/CNTs, a shift toward loss of cell circularity was observed. The appearances of more differentiated morphologic features were well correlated with the increase of secreted ALP activity. In conclusion, the evaluation of material-induced changes of cell morphology could represent a valuable prescreening test for bioactive properties.
C1 [LeDuc, Philip R.; Gracio, Jose; Marques, Paula A. A. P.; Goncalves, Gil; Sousa, Antonio C. M.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.
   [Goncalves, Paula P.; Silva, Virgilia S.; Marques, Filipa; Marques, Ana] Univ Aveiro, Dept Biol & CESAM, P-3810193 Aveiro, Portugal.
   [Singh, Manoj K.] Univ Aveiro, Nanotechnol Res Div, Ctr Mech Technol & Automat, P-3810193 Aveiro, Portugal.
RP Gracio, J (reprint author), Carnegie Mellon Univ, Dept Mech Engn, 415 Scaife Hall,5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM pgoncalves@ua.pt; mksingh@ua.pt
RI LeDuc, Philip/M-1103-2014; Silva, Virgilia/D-9914-2011; FMUP,
   CINTESIS/C-6631-2014; Division, Nanotechnology/O-2342-2013; Singh,
   Manoj/D-1366-2012; Grupo, AE/B-3302-2014; Marques, Paula/A-7371-2008;
   Research Unit, TEMA/H-9264-2012; Goncalves, Gil/M-7640-2013; Sousa,
   Antonio/D-2348-2013; Polonia Goncalves, Maria Paula/B-1056-2011
OI LeDuc, Philip/0000-0001-6397-2905; Silva, Virgilia/0000-0002-1962-6543;
   FMUP, CINTESIS/0000-0001-7248-2086; Singh, Manoj/0000-0003-3044-1010;
   Grupo, AE/0000-0002-0913-4772; Marques, Paula/0000-0002-7498-452X;
   Goncalves, Gil/0000-0002-2302-9661; Sousa, Antonio/0000-0001-6046-1368;
   Polonia Goncalves, Maria Paula/0000-0001-6891-3963; Gracio,
   Jose/0000-0002-0343-4387; Marques, Filipa Daniela/0000-0002-6387-1917
FU International Iberian Laboratory of Nanotechnology
   [NANO/NMed-AT/0115/2007]; Portuguese Foundation of Science and
   Technology; University of Aveiro; Carnegie Mellon University; 
   [SFRH/BPD/14677/2003]
FX This work was supported by the International Iberian Laboratory of
   Nanotechnology (NANO/NMed-AT/0115/2007), the Portuguese Foundation of
   Science and Technology (Program Compromise with Science (to M. K. S. and
   P. M.) and SFRH/BPD/14677/2003 (to V. S. S.)) and the research and
   development agreement between the University of Aveiro and Carnegie
   Mellon University.
CR Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11
   Chlopek J, 2006, CARBON, V44, P1106, DOI 10.1016/j.carbon.2005.11.022
   Curtin WA, 2004, MATER TODAY, V7, P44, DOI 10.1016/S1369-7021(04)00508-5
   Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Haque S, 2007, LANGMUIR, V23, P6671, DOI 10.1021/la063517i
   Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kis A, 2004, NAT MATER, V3, P153, DOI 10.1038/nmat1076
   LIDEN E, 1995, J AM CERAM SOC, V78, P1761, DOI 10.1111/j.1151-2916.1995.tb08886.x
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Peigney A, 2003, NAT MATER, V2, P15, DOI 10.1038/nmat794
   Pelletier MH, 2010, ACTA BIOMATER, V6, P886, DOI 10.1016/j.actbio.2009.09.016
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Singh MK, 2008, ADV FUNCT MATER, V18, P694, DOI 10.1002/adfm.200700888
   Singh MK, 2010, NANOSCALE, V2, P2855, DOI 10.1039/c0nr00237b
   Szabo S E, 2004, Lab Hematol, V10, P109, DOI 10.1532/LH96.04020
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   White AA, 2007, INT J APPL CERAM TEC, V4, P1, DOI 10.1111/j.1744-7402.2007.02113.x
NR 21
TC 1
Z9 1
U1 1
U2 19
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0033-4545
EI 1365-3075
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PY 2011
VL 83
IS 11
BP 2063
EP 2069
DI 10.1351/PAC-CON-11-04-06
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 871MO
UT WOS:000298742400009
DA 2018-10-19
ER

PT J
AU Lainka, E
   Bielak, M
   Hilger, V
   Basu, O
   Neudorf, U
   Wittkowski, H
   Holzinger, D
   Roth, J
   Niehues, T
   Foell, D
AF Lainka, Elke
   Bielak, Maria
   Hilger, Volker
   Basu, Oliver
   Neudorf, Ulrich
   Wittkowski, Helmut
   Holzinger, Dirk
   Roth, Johannes
   Niehues, Tim
   Foell, Dirk
TI Translational research network and patient registry for
   auto-inflammatory diseases
SO RHEUMATOLOGY
LA English
DT Article
DE Registry for auto-inflammatory diseases; Biomaterial bank; Hereditary
   periodic fever; FMF; TNF receptor 1-associated periodic syndrome;
   Hyperimmunoglobulinaemia D and periodic fever syndrome;
   Cryopyrin-associated periodic syndrome; Pharyngitis and adenopathy
   syndrome; Systemic-onset JIA
ID HEREDITARY AUTOINFLAMMATORY SYNDROMES; JUVENILE IDIOPATHIC ARTHRITIS;
   FAMILIAL MEDITERRANEAN FEVER; NEUTROPHIL-DERIVED S100A12; PERIODIC
   FEVERS; PROTEIN; DISORDERS; MUTATIONS; MRP14; PHAGOCYTES
AB Methods. In 2009, a federally funded clinical and research consortium (AID-Net) was established, including an online registry for AIDs (http://www.aid-register.uk-essen.de). Inclusion criteria are disease-associated mutations for hereditary periodic fever syndromes [FMF, hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS), TNF receptor 1-associated periodic syndrome (TRAPS) and cryopyrin-associated periodic syndrome (CAPS)], or, alternatively, clinically confirmed AID, systemic-onset JIA (SoJIA) and periodic fever, aphthous stomatitis, pharyngitis and adenopathy (PFAPA) syndrome with unknown genetic background. Patients were recruited to the registry and patient material was deposited in biomaterial banks (DNA/serum). In addition, basic research projects were initiated that focus on molecular mechanisms of AID.
   Results. During the first 9 months, 117 patients (65 males, 52 females; age 1-21 years) have been recorded and classified as FMF (n = 84), HIDS (n = 1), TRAPS (n = 3) and CAPS (n = 1); clinically confirmed AID (n = 5); SoJIA (n = 22); and PFAPA (n = 1). One hundred and fifty blood samples of 18 patients were included in biomaterial banks.
   Conclusion. Recruitment and follow-up of patients with AID will enable us to comprehensively address the correlation between clinical and epidemiological data, genetics and biomarkers. The translational approach may help to identify genetic or inflammatory markers relevant for the course and outcome of diseases.
C1 [Lainka, Elke; Bielak, Maria; Neudorf, Ulrich] Univ Duisburg Essen, Childrens Hosp, Dept Paediat Rheumatol, Essen, Germany.
   [Wittkowski, Helmut; Foell, Dirk] Univ Childrens Hosp Munster, Dept Gen Paediat, Munster, Germany.
   [Wittkowski, Helmut; Holzinger, Dirk; Roth, Johannes] Univ Hosp Munster, Inst Immunol, Munster, Germany.
   [Niehues, Tim] HELIOS Klinikum Krefeld, Dept Paediat, Krefeld, Germany.
RP Lainka, E (reprint author), Univ Duisburg Essen, Childrens Hosp, Dept Paediat Rheumatol, Essen, Germany.
EM elke.lainka@uni-due.de
OI Holzinger, Dirk/0000-0002-8062-8820
FU Federal Ministry of Education and Research (BMBF) [01GM08104]
FX The AID-Net consortium is supported by the Federal Ministry of Education
   and Research (BMBF project 01GM08104).
CR Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976
   Church LD, 2006, SPRINGER SEMIN IMMUN, V27, P494, DOI 10.1007/s00281-006-0015-6
   Cooper David N, 2006, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s12
   de Menthiere CS, 2003, NUCLEIC ACIDS RES, V31, P282, DOI 10.1093/nar/gkg031
   DEPELCH M, 2001, CURR OPIN IMMUNOL, V13, P539
   Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938
   Drenth JPH, 2001, NEW ENGL J MED, V345, P1748, DOI 10.1056/NEJMra010200
   Farasat S, 2008, ARCH DERMATOL, V144, P392, DOI 10.1001/archderm.144.3.392
   Fietta Pieranna, 2004, Acta Biomed, V75, P92
   Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531
   Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170
   Gattorno M, 2008, ARTHRITIS RHEUM-US, V58, P1823, DOI 10.1002/art.23474
   Gattorno M, 2009, PEDIATRICS, V124, pE721, DOI 10.1542/peds.2009-0088
   Glock J., 2006, GMS MED INFORM BIOM, V2, pDoc06
   Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137
   Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523
   Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6
   Kallinich T, 2010, ANN RHEUM DIS, V69, P677, DOI 10.1136/ard.2009.114363
   Kastner Daniel L, 2005, Hematology Am Soc Hematol Educ Program, P74
   Lainka E, 2009, RHEUMATOLOGY, V48, P987, DOI 10.1093/rheumatology/kep140
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851
   Milhavet F, 2008, HUM MUTAT, V29, P803, DOI 10.1002/humu.20720
   Naik E, 2010, J CLIN IMMUNOL, V30, P485, DOI 10.1007/s10875-010-9383-8
   Rammes A, 1997, J BIOL CHEM, V272, P9496
   RENG CM, 2006, SCHRIFTREIHE TMF
   Schneider R, 1998, BAILLIERE CLIN RHEUM, V12, P245, DOI 10.1016/S0950-3579(98)80018-6
   Simon A, 2006, RHEUMATOLOGY, V45, P269, DOI 10.1093/rheumatology/kei138
   Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b
   Touitou I, 2009, RHEUMATOLOGY, V48, P665, DOI 10.1093/rheumatology/kep056
   Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019
   Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446
   Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638
   Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29
   Wittkowski H, 2008, ARTHRITIS RHEUM, V58, P3924, DOI 10.1002/art.24137
   Woo P, 2006, NAT CLIN PRACT RHEUM, V2, P28, DOI 10.1038/ncprheum0084
   Yao Q, 2008, RHEUMATOLOGY, V47, P946, DOI 10.1093/rheumatology/ken118
NR 37
TC 21
Z9 21
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1462-0324
J9 RHEUMATOLOGY
JI RHEUMATOLOGY
PD JAN
PY 2011
VL 50
IS 1
BP 237
EP 242
DI 10.1093/rheumatology/keq270
PG 6
WC Rheumatology
SC Rheumatology
GA 692ZD
UT WOS:000285193500032
PM 21148158
OA Bronze
DA 2018-10-19
ER

PT J
AU Tsai, IY
   Kuo, CC
   Tomczyk, N
   Stachelek, SJ
   Composto, RJ
   Eckmann, DM
AF Tsai, Irene Y.
   Kuo, Chin-Chen
   Tomczyk, Nancy
   Stachelek, Stanley J.
   Composto, Russell J.
   Eckmann, David M.
TI Human macrophage adhesion on polysaccharide patterned surfaces
SO SOFT MATTER
LA English
DT Article
ID GIANT-CELL FORMATION; ENDOTHELIAL GLYCOCALYX; MICROPATTERNED SURFACES;
   TERTIARY STRUCTURES; EPITHELIAL-CELLS; AQUEOUS-SOLUTION;
   HYALURONIC-ACID; DEXTRAN; TOPOGRAPHY; PROTEINS
AB Despite many advances in designing biocompatible materials, inflammation remains a problem in medical devices and implants. We report two methods, microcontact printing and photodegradation by UV exposure, to pattern dextran and hyaluronic acid on glass, as well as demonstrate their utility for use as an anti-inflammatory biomaterial. The dextran/glass patterned surface can be further modified by grafting hyaluronic acid to glass, creating a binary polysaccharide patterned surface. We used two geometries, 90 mu m squares and 22 mu m stripes, to study the human macrophage (THP-1) adhesion on the patterned surfaces containing dextran, hyaluronic acid and the binary pattern. The results indicate that a majority of the macrophages are non-adherent on hyaluronic acid for three day culture. The ranking of surfaces according to macrophage adhesion is 3-aminopropyltriethoxysilane-modified glass culture dish, dextranized surfaces, glass, and hyaluronic acid-modified surfaces. On the binary pattern of dextran and hyaluronic acid, macrophages preferentially attach and adhere to the dextranized area. Patterned surfaces provide an excellent platform for mimicking the complexity of the glycocalyx and investigating the interface between this surface and cells. This binary polysaccharide pattern also offers a new route to address anti-inflammatory potential of surface coatings on biomaterials in a high through-put fashion.
C1 [Tomczyk, Nancy; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Tsai, Irene Y.; Kuo, Chin-Chen; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Stachelek, Stanley J.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.
RP Eckmann, DM (reprint author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
EM eckmanndm@uphs.upenn.edu
FU NIH [R01-HL060230, T32-GM007612]; NSF/NSEC [DMR08-32802]; NSF/Polymer
   Program [DMR0907493]
FX This work was supported by NIH grants R01-HL060230 and T32-GM007612. RJC
   acknowledges partial support from NSF/NSEC (DMR08-32802) and NSF/Polymer
   Program (DMR0907493). Use of University of Pennsylvania Nano/Bio
   Interface Center AFM/TIRF instrument is acknowledged.
CR Ahmad SA, 2010, LANGMUIR, V26, P9937, DOI 10.1021/la100438d
   Andersson AS, 2003, IEEE T NANOBIOSCI, V2, P49, DOI 10.1109/TNB.2003.813934
   Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.0.CO;2-M
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chacko BK, 2005, FASEB J, V19, pA776
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeMond AL, 2007, CURR OPIN IMMUNOL, V19, P722, DOI 10.1016/j.coi.2007.07.008
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Goto M, 2008, ANAL BIOANAL CHEM, V390, P817, DOI 10.1007/s00216-007-1496-4
   Gray DS, 2004, BIOSENS BIOELECTRON, V19, P1765, DOI 10.1016/j.bios.2004.03.016
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   LAURENT TC, 1992, FASEB J, V6, P2397
   Lei YG, 2011, BIOMATERIALS, V32, P39, DOI 10.1016/j.biomaterials.2010.08.103
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Lu YX, 2008, LANGMUIR, V24, P8050, DOI 10.1021/la800998n
   Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b
   Miksa D, 2006, BIOMACROMOLECULES, V7, P557, DOI 10.1021/bm050601o
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Okochi N, 2009, LANGMUIR, V25, P6947, DOI 10.1021/la9006668
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Peramo A, 2006, LANGMUIR, V22, P3228, DOI 10.1021/la051166m
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   SABATIE J, 1988, CARBOHYD POLYM, V9, P287, DOI 10.1016/0144-8617(88)90047-1
   Sahlin H, 2006, J BIOMED MATER RES A, V77A, P43, DOI 10.1002/jbm.a.30642
   Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850
   Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j
   Squire JM, 2001, J STRUCT BIOL, V136, P239, DOI 10.1006/jsbi.2002.4441
   Tsai IY, 2007, METHOD CELL BIOL, V83, P67, DOI 10.1016/S0091-679X(07)83004-4
   Tsai IY, 2011, COLLOID SURFACE B, V84, P241, DOI 10.1016/j.colsurfb.2011.01.006
   Tsai IY, 2004, J BIOMED MATER RES A, V71A, P462, DOI 10.1002/jbm.a.30183
   Veiseh M, 2007, LANGMUIR, V23, P4472, DOI 10.1021/la062849k
   Wang B, 2005, MACROMOL BIOSCI, V5, P767, DOI 10.1002/mabi.200500037
   Wang DY, 2007, J BIOMED MATER RES B, V80B, P447, DOI 10.1002/jbm.b.30616
   WARD BJ, 1993, CARDIOVASC RES, V27, P384, DOI 10.1093/cvr/27.3.384
   Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Zhang G, 2003, LANGMUIR, V19, P9850, DOI 10.1021/la035084e
   Zheng N, 2010, SCI CHINA TECHNOL SC, V53, P257, DOI 10.1007/s11431-009-0288-9
   Zhou Y, 2004, MICROCHIM ACTA, V147, P21, DOI 10.1007/s00604-004-0223-5
NR 49
TC 12
Z9 12
U1 0
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 7
BP 3599
EP 3606
DI 10.1039/c0sm01353f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 738XZ
UT WOS:000288677200069
PM 21479122
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gomes, S
   Leonor, IB
   Mano, JF
   Reis, RL
   Kaplan, DL
AF Gomes, Silvia
   Leonor, Isabel B.
   Mano, Joao F.
   Reis, Rui L.
   Kaplan, David L.
TI Spider silk-bone sialoprotein fusion proteins for bone tissue
   engineering
SO SOFT MATTER
LA English
DT Article
ID HYDROXYAPATITE NUCLEATION; ESCHERICHIA-COLI; BLOCK-COPOLYMERS; CELL
   ATTACHMENT; DRAGLINE SILK; STEM-CELLS; COLLAGEN; MINERALIZATION;
   BIOMATERIALS; OSTEOPONTIN
AB The remarkable mechanical characteristics of the spider silk protein major ampullate spidroin protein suggest this polymer as a promising biomaterial to consider for the fabrication of scaffolds for bone regeneration. Herein, a new functionalized spider silk-bone sialoprotein fusion protein was designed, cloned, expressed, purified and the osteogenic activity studied. Bone sialoprotein (BSP) is a multidomain protein with the ability to induce cell attachment and differentiation and the deposition of calcium phosphates (CaP). Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) was used to assess the secondary structure of the fusion protein. In vitro mineralization studies demonstrated that this new fusion protein with BSP retained the ability to induce the deposition of CaP. Studies in vitro indicated that human mesenchymal stem cells had significant improvement towards osteogenic outcomes when cultivated in the presence of the new fusion protein vs. silk alone. The present work demonstrates the potential of this new fusion protein for future applications in bone regeneration.
C1 [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Res Group Biomat Biodegradables & Biomimet 3BS, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, Taipas, Guimaraes, Portugal.
   [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] IBB Inst Biotechnol & Bioengn, PT Associated Lab, Guimaraes, Portugal.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Phys, Medford, MA 02155 USA.
RP Reis, RL (reprint author), Univ Minho, Res Group Biomat Biodegradables & Biomimet 3BS, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, AvePk, Taipas, Guimaraes, Portugal.
EM rgreis@dep.uminho.pt; David.Kaplan@tufts.edu
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Reis, Rui
   L./A-8938-2008; Gomes, Silvia/J-6099-2013; Leonor, Isabel/B-5260-2011
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Reis,
   Rui L./0000-0002-4295-6129; Leonor, Isabel/0000-0002-4319-4883; Gomes,
   Silvia/0000-0002-4881-7808
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/28603/2006]; European NoE EXPERTISSUES [NMP3-CT-2004-500283];
   agency EU-EC; FCT agency [PTDC/FIS/68517/2006,
   PTDC/EBB-EBI/109093/2008]; NIH, Tissue Engineering Resource Center [P41
   EB002520]; NIH [EB003210, DE017207]
FX The authors acknowledge Olena Rabotyagova for advice in protein sequence
   design. Silvia Gomes thanks Portuguese Foundation for Science and
   Technology (FCT) for providing her PhD grant SFRH/BD/28603/2006. This
   work was carried out under the scope of European NoE EXPERTISSUES
   (NMP3-CT-2004-500283), the FIND & BIND project funded by the agency
   EU-EC (FP7 program), the FCT R&D project Proteo-Light
   (PTDC/FIS/68517/2006) funded by the FCT agency, the Chimera project
   (PTDC/EBB-EBI/109093/2008) funded by the FCT agency, and the NIH (P41
   EB002520) Tissue Engineering Resource Center and the NIH (EB003210 and
   DE017207).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004
   Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019
   Bellahcene A, 2000, CIRC RES, V86, P885, DOI 10.1161/01.RES.86.8.885
   Bernards MT, 2008, COLLOID SURFACE B, V64, P236, DOI 10.1016/j.colsurfb.2008.01.025
   BERNARDS MT, 2007, J BIOMED MATER RES A, P779
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CHOONG PFM, 1993, J ORTHOPAED RES, V11, P638, DOI 10.1002/jor.1100110505
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Fedarko NS, 2000, J BIOL CHEM, V275, P16666, DOI 10.1074/jbc.M001123200
   Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146
   FLEISH H, 1961, AM J PHYSIOL, V200, P1296
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   FUJISAWA R, 1995, CALCIFIED TISSUE INT, V56, P140, DOI 10.1007/BF00296346
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246
   Graf HL, 2008, INT J ORAL MAX SURG, V37, P634, DOI 10.1016/j.ijom.2008.01.021
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Higuchi A, 2003, J BIOMED MATER RES A, V65A, P369, DOI 10.1002/jbm.a.10428
   HIRSCHLER A, 1990, FEMS MICROBIOL ECOL, V73, P211, DOI 10.1016/0378-1097(90)90732-6
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   JACKSON SF, 1957, PROC R SOC SER B-BIO, V146, P270, DOI 10.1098/rspb.1957.0010
   Jeon WB, 2011, BMB REP, V44, P22, DOI 10.5483/BMBRep.2011.44.1.22
   Karadag A, 2004, J NATL CANCER I, V96, P956, DOI 10.1093/jnci/djh169
   Karadag A, 2006, J BONE MINER RES, V21, P1627, DOI 10.1359/JBMR.060710
   Kruyt MC, 2009, J ORTHOP RES, V27, P1055, DOI 10.1002/jor.20830
   Lancaster M. V., 1996, [No title captured], Patent No. [US 5501959, 5501959]
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lian J B, 1995, Iowa Orthop J, V15, P118
   LIU Q, 1996, 5 WORLD BIOM C TOR
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078
   Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Rabotyagova OS, 2010, MACROMOL BIOSCI, V10, P49, DOI 10.1002/mabi.200900203
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Schmidt C, 2002, J BIOMED MATER RES, V63, P252, DOI 10.1002/jbm.10185
   Smeenk JM, 2006, MACROMOLECULES, V39, P2989, DOI 10.1021/ma0521654
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Werten MWT, 2008, BIOMACROMOLECULES, V9, P1705, DOI 10.1021/bm701111z
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Xu L, 2007, BIOMATERIALS, V28, P750, DOI 10.1016/j.biomaterials.2006.09.022
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yan SZ, 2001, J BIOL CHEM, V276, P8500, DOI 10.1074/jbc.M010361200
   Yang M, 2008, J BIOMED MATER RES A, V84A, P353, DOI 10.1002/jbm.a.31348
NR 62
TC 23
Z9 23
U1 2
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 10
BP 4964
EP 4973
DI 10.1039/c1sm05024a
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 759FZ
UT WOS:000290227400052
DA 2018-10-19
ER

PT J
AU Yue, TT
   Zhang, XR
AF Yue, Tongtao
   Zhang, Xianren
TI Molecular understanding of receptor-mediated membrane responses to
   ligand-coated nanoparticles
SO SOFT MATTER
LA English
DT Article
ID DISSIPATIVE PARTICLE DYNAMICS; GOLD NANOPARTICLES; MESOSCOPIC
   SIMULATION; BIOLOGICAL-MEMBRANES; COMPUTER-SIMULATION;
   BILAYER-MEMBRANES; LIPID-MEMBRANES; CELLULAR UPTAKE; ENDOCYTOSIS;
   MECHANISM
AB The cytotoxicity of nanoparticles (NPs) and their potential applications in drug delivery and intracellular imaging have been extensively investigated, and a thorough molecular understanding of how cellular membrane responds to the introduction of NPs is essential for biomaterial design. In this work, N-varied dissipative particle dynamics (DPD) simulation is applied to investigate how a membrane responds to adsorption of ligand-coated NP. Depending on the membrane surface tension, ligand area density and NP size, four kinds of membrane responses are observed: membrane rupture, NP adhesion, NP penetration, and receptor-mediated endocytosis. While endocytosis provides an effective pathway for cellular uptake of NPs, the NP penetration and NP-induced membrane rupture are related to cytotoxicity. These results support the recent experimental reports that NPs have a Janus face for their biomedical applications: serving as carriers for the transmembrane transport of drug and causing cytotoxicity.
C1 [Yue, Tongtao; Zhang, Xianren] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Div Mol & Mat Simulat, Beijing, Peoples R China.
RP Zhang, XR (reprint author), Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Div Mol & Mat Simulat, Beijing, Peoples R China.
EM zhangxr@mail.buct.edu.cn
RI Yue, Tongtao/H-3348-2014; Zhang, Xianren/P-6595-2015
OI Zhang, Xianren/0000-0002-8026-9012
FU National Natural Science Foundation of China [20736005, 20876004]
FX The authors thank "Chemical Grid Project" of BUCT for the generous
   allocations of computer time and excellent technical assistance. This
   work was financially supported by National Natural Science Foundation of
   China (No. 20736005 and No. 20876004).
CR Alexeev A, 2008, ACS NANO, V2, P1117, DOI 10.1021/nn8000998
   Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003
   Ba HJ, 2010, NANO LETT, V10, P3006, DOI 10.1021/nl101454a
   Bechet D, 2008, TRENDS BIOTECHNOL, V26, P612, DOI 10.1016/j.tibtech.2008.07.007
   Chen HM, 1997, J COLLOID INTERF SCI, V190, P118, DOI 10.1006/jcis.1997.4865
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   Chithrani BD, 2009, NANOMED-NANOTECHNOL, V5, P118, DOI 10.1016/j.nano.2009.01.008
   Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r
   Decuzzi P, 2007, BIOMATERIALS, V28, P2915, DOI 10.1016/j.biomaterials.2007.02.013
   Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290
   Deserno M, 2002, J PHYS CHEM B, V106, P5543, DOI 10.1021/jp0138476
   ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001
   Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006
   Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102
   Ginzburg VV, 2007, NANO LETT, V7, P3716, DOI 10.1021/nl072053l
   Grafmuller A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218101
   Grafmuller A, 2009, BIOPHYS J, V96, P2658, DOI 10.1016/j.bpj.2008.11.073
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Groot RD, 2001, BIOPHYS J, V81, P725, DOI 10.1016/S0006-3495(01)75737-2
   Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784
   Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851
   HONG B, 2006, J PHYS CHEM B, V111, P5837
   HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001
   Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009
   Jeng RL, 2001, CURR BIOL, V11, pR691, DOI 10.1016/S0960-9822(01)00410-9
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940
   Kranenburg M, 2005, J PHYS CHEM B, V109, P6553, DOI 10.1021/jp0457646
   LERNER DM, 1993, BIOPHYS J, V65, P73, DOI 10.1016/S0006-3495(93)81071-3
   Leroueil PR, 2007, ACCOUNTS CHEM RES, V40, P335, DOI 10.1021/ar600012y
   Li SY, 2010, BIOPHYS J, V98, P2554, DOI 10.1016/j.bpj.2010.02.032
   Li SY, 2009, J PHYS CHEM B, V113, P14431, DOI 10.1021/jp9053567
   Lin JQ, 2010, ACS NANO, V4, P5421, DOI 10.1021/nn1010792
   Lipowsky R, 1998, EUROPHYS LETT, V43, P219, DOI 10.1209/epl/i1998-00343-4
   Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101
   McNerny DQ, 2010, WIRES NANOMED NANOBI, V2, P249, DOI 10.1002/wnan.79
   MEYER FJ, 2008, BIOPHYS J, V95, P1851
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Noguchi H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.021903
   Peetla C, 2009, LANGMUIR, V25, P2369, DOI 10.1021/la803361y
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840
   Roiter Y, 2008, NANO LETT, V8, P941, DOI 10.1021/nl080080l
   Shillcock JC, 2005, NAT MATER, V4, P225, DOI 10.1038/nmat1333
   Smith KA, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766953
   Venturoli M, 2005, BIOPHYS J, V88, P1778, DOI 10.1529/biophysj.104.050849
   Venturoli M, 2006, PHYS REP, V437, P1, DOI 10.1016/j.physrep.2006.07.006
   Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Wallace EJ, 2008, NANO LETT, V8, P2751, DOI 10.1021/nl801217f
   Wang ZJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2060666
   Wong-Ekkabut J, 2008, NAT NANOTECHNOL, V3, P363, DOI 10.1038/nnano.2008.130
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yan LT, 2009, ACS NANO, V3, P2171, DOI 10.1021/nn9004236
   Yang K, 2010, NAT NANOTECHNOL, V5, P579, DOI [10.1038/nnano.2010.141, 10.1038/NNANO.2010.141]
   Yue TT, 2010, SOFT MATTER, V6, P6109, DOI 10.1039/c0sm00418a
   Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393
   Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619
NR 60
TC 73
Z9 75
U1 3
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 19
BP 9104
EP 9112
DI 10.1039/c1sm05398a
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 822YE
UT WOS:000295085700053
DA 2018-10-19
ER

PT J
AU Liu, RX
   Milani, AH
   Saunders, JM
   Freemont, TJ
   Saunders, BR
AF Liu, Ruixue
   Milani, Amir H.
   Saunders, Jennifer. M.
   Freemont, Tony J.
   Saunders, Brian R.
TI Tuning the swelling and mechanical properties of pH-responsive doubly
   crosslinked microgels using particle composition
SO SOFT MATTER
LA English
DT Article
ID HYDROGEL SCAFFOLDS; HYBRID MICROGELS; LINKING POLYMER; GEL POINT;
   TRANSITIONS; BEHAVIOR; ACID; NANOPARTICLES; DISPERSIONS; SUSPENSIONS
AB pH-Responsive microgel particles are crosslinked polymer colloid particles that swell when the pH approaches the pK(a). They have attracted a great deal of interest because of the ability to prepare stimulus responsive dispersions. Microgels that have only one form of crosslinking are termed singly crosslinked microgels (SX microgels). SX microgels are defined here as microgel particles that contain intra-particle linkages as the only source of covalent crosslinks. Recently, we introduced the first examples of a new family of pH-responsive doubly crosslinked microgel (DX microgels) [Liu et al., Soft Matter, 2011, 7, 4696]. DX microgels are hydrogels composed of covalently-linked functionalised SX microgel particles. DX microgels contain inter-particle crosslinking as well as intra-particle crosslinking. Here, we investigate pH-responsive DX microgels prepared using a new, more versatile, microgel functionalisation strategy. Carbodiimide chemistry is used to vinyl-functionalise poly(MMA/MAA/EGDMA) (methyl methacrylate, methacrylic acid and ethyleneglycol dimethacrylate) microgels (abbreviated as M-EGD). The DX microgels were prepared using pH-triggered inter-penetration of 2-aminoethylmethacrylate (AEM) functionalised SX microgels and free-radical crosslinking. The DX microgels based on M-EGD had built-in microporosity. Furthermore, dynamic rheology data show for the first time that the elastic modulus of DX microgels is proportional to the extent of vinyl group functionalisation. The generality of this approach was demonstrated by the preparation of DX microgels based on poly(EA/MAA/BDD) (ethylacrylate and 1, 4-butanediol diacrylate), which is abbreviated as E-BDD. The pH-responsive DX microgels have high elastic modulus values, swell strongly and have low sol fractions. They are injectable and the DX microgels have improved swelling at low pH which should increase the pH range for potential biomaterial applications. The data are compared with those reported by Liu et al. and the differences discussed.
C1 [Liu, Ruixue; Milani, Amir H.; Saunders, Jennifer. M.; Saunders, Brian R.] Univ Manchester, Manchester Mat Sci Ctr, Sch Mat, Biomat Res Grp, Manchester M1 7HS, Lancs, England.
   [Liu, Ruixue] Zhengzhou Univ Light Ind, Sch Mat & Chem Engn, Zhengzhou 450002, Peoples R China.
   [Freemont, Tony J.] Univ Manchester, Sch Med, Div Regenerat Med, Manchester M13 9PT, Lancs, England.
RP Saunders, BR (reprint author), Univ Manchester, Manchester Mat Sci Ctr, Sch Mat, Biomat Res Grp, Grosvenor St, Manchester M1 7HS, Lancs, England.
RI Freemont, Tony/A-9000-2015
OI Freemont, Tony/0000-0002-9780-208X; Saunders, Brian/0000-0003-1410-2967
FU EPSRC; UMIP; Engineering and Physical Sciences Research Council
   [EP/G026610/1]
FX BRS and AJF would like to thank the EPSRC for funding RL for this work.
   We also acknowledge funding from UMIP for AHM. Robert Bird is thanked
   for assistance with SEM.
CR Agrawal M, 2008, J MATER CHEM, V18, P2581, DOI 10.1039/b802102c
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bradley M, 2005, LANGMUIR, V21, P2750, DOI 10.1021/la047322r
   Cai T, 2008, MACROMOLECULES, V41, P9508, DOI 10.1021/ma802035d
   Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e
   Cho EC, 2010, LANGMUIR, V26, P3854, DOI 10.1021/la903350j
   Chougnet A, 2007, RHEOL ACTA, V46, P793, DOI 10.1007/s00397-006-0126-y
   CORNELIUS VJ, 2007, P SPIE INT SOC OPTIC, V6417
   Dai JH, 2006, LANGMUIR, V22, P4274, DOI 10.1021/la0600550
   Debord SB, 2003, J PHYS CHEM B, V107, P2927, DOI 10.1021/jp026783n
   Dupin D, 2007, LANGMUIR, V23, P4035, DOI 10.1021/la063278z
   Fernandez-Nieves A, 2000, MACROMOLECULES, V33, P2114, DOI 10.1021/ma991520l
   FERNANDEZBARBER.A, 2009, INTERFACE SCI, V147, P88
   FitzGerald PA, 2008, LANGMUIR, V24, P10228, DOI 10.1021/la8017425
   Friedrich T, 2011, LANGMUIR, V27, P2997, DOI 10.1021/la104585k
   Gan TT, 2009, BIOMACROMOLECULES, V10, P1410, DOI 10.1021/bm900022m
   Hoare T, 2008, CURR OPIN COLLOID IN, V13, P413, DOI 10.1016/j.cocis.2008.03.004
   Hoare T, 2006, LANGMUIR, V22, P7342, DOI 10.1021/la0608718
   Jha AK, 2010, SOFT MATTER, V6, P5045, DOI 10.1039/c0sm00101e
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Lally S, 2007, J COLLOID INTERF SCI, V316, P367, DOI 10.1016/j.jcis.2007.08.030
   Lally S, 2011, COLLOID POLYM SCI, V289, P647, DOI 10.1007/s00396-010-2366-8
   Lally S, 2009, COLLOID POLYM SCI, V287, P335, DOI 10.1007/s00396-008-1994-8
   Lapeyre V, 2009, LANGMUIR, V25, P4659, DOI 10.1021/la9003438
   Lemmers M, 2011, SOFT MATTER, V7, P1378, DOI 10.1039/c0sm00767f
   Liu RX, 2011, SOFT MATTER, V7, P4696, DOI 10.1039/c1sm05216k
   Longo GS, 2011, MACROMOLECULES, V44, P147, DOI 10.1021/ma102312y
   Lyon LA, 2009, CHEM SOC REV, V38, P865, DOI 10.1039/b715522k
   Maeda Y, 2000, LANGMUIR, V16, P7503, DOI 10.1021/la0001575
   PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8
   Pinprayoon O, 2008, J COLLOID INTERF SCI, V321, P315, DOI 10.1016/j.jcis.2008.02.037
   Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3
   RODRIGUEZ BE, 1994, MACROMOLECULES, V27, P6642, DOI 10.1021/ma00100a058
   Sahiner N, 2006, COLLOID POLYM SCI, V284, P1121, DOI 10.1007/s00396-006-1489-4
   Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2
   Saunders BR, 1997, MACROMOLECULES, V30, P482, DOI 10.1021/ma961277f
   SAUNDERS BR, 2009, INTERFACE SCI, V147, P147
   Saunders JM, 2007, SOFT MATTER, V3, P486, DOI 10.1039/b613943d
   Senff H, 2000, COLLOID POLYM SCI, V278, P830, DOI 10.1007/s003960000329
   Thompson KL, 2008, POLYM DEGRAD STABIL, V93, P1460, DOI 10.1016/j.polymdegradstab.2008.05.013
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209
   Yang M, 2010, MACROMOLECULES, V43, P10645, DOI 10.1021/ma1022555
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P27, DOI 10.1021/bm050832v
   Zhou B, 2007, POLYMER, V48, P2874, DOI 10.1016/j.polymer.2007.03.025
   2011, SCIFINDER SCHOLAR
NR 46
TC 18
Z9 18
U1 3
U2 61
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 19
BP 9297
EP 9306
DI 10.1039/c1sm05922j
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 822YE
UT WOS:000295085700075
DA 2018-10-19
ER

PT J
AU Stasiak, J
   Zaffora, A
   Costantino, ML
   Moggridge, GD
AF Stasiak, Joanna
   Zaffora, Adriano
   Costantino, Maria Laura
   Moggridge, Geoff D.
TI A real time SAXS study of oriented block copolymers during fast cyclical
   deformation, with potential application for prosthetic heart valves
SO SOFT MATTER
LA English
DT Article
ID ESTER) THERMOPLASTIC ELASTOMERS; STYRENE TRIBLOCK COPOLYMER;
   X-RAY-SCATTERING; CYLINDRICAL MORPHOLOGY; MECHANICAL-PROPERTIES;
   BUTADIENE; BEHAVIOR; POLYSTYRENE; BIOMATERIAL; DEGRADATION
AB Simultaneous small angle X-ray scattering (SAXS) and force measurements have been recorded during tensile loading/unloading deformation cycles of three oriented thermoplastic elastomers. SAXS patterns were obtained in only 10 ms, during deformation. Over this timescale, the microstructure of the materials reacted instantly to the applied deformation. Microstructural changes were followed over 10 000 cycles, each cycle period being less than 1 s. Morphological evolution from the initial state as the deformation proceeded has been linked to mechanical properties. The direction of orientation was the most significant parameter determining the mechanical strength of tested materials, followed by styrene weight fraction. Samples oriented parallel to the deformation direction showed greater resistance to applied force and also better microstructural reversibility over the 10 000 cycles.
C1 [Stasiak, Joanna; Moggridge, Geoff D.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.
   [Zaffora, Adriano; Costantino, Maria Laura] Politecn Milan, Dept Struct Engn, I-20133 Milan, Italy.
RP Stasiak, J (reprint author), Univ Cambridge, Dept Chem Engn & Biotechnol, Pembroke St, Cambridge CB2 3RA, England.
EM js744@cam.ac.uk; gdm14@cam.ac.uk
RI COSTANTINO, MARIA LAURA/A-8700-2012; Stasiak, Joanna/C-6612-2015
OI COSTANTINO, MARIA LAURA/0000-0001-6974-2692; Stasiak,
   Joanna/0000-0002-8132-8694
FU EPSRC [EP/E035299/1]; Engineering and Physical Sciences Research Council
   [EP/F007663/1]
FX The authors thank the EPSRC for financial support for this work under
   Grant EP/E035299/1 and Diamond Light Source, Harwell, U.K. for the
   provision of beamtime on I22 and in particular for scientific support
   from Marc Malfois and Nick Terrill. In additions the authors thank Dr
   Adam Squires (University of Reading) and Amanda Talhat (University of
   Cambridge) for help with the experiments.
CR Allen NS, 2004, POLYM DEGRAD STABIL, V86, P11, DOI 10.1016/j.polymdegradstab.2003.10.010
   *DIAM LIGHT SOURC, 122 NONCR DIFFR
   El Fray M, 2006, BIOMACROMOLECULES, V7, P844, DOI 10.1021/bm050971c
   FAKIROV S, 1992, POLYMER, V33, P3818, DOI 10.1016/0032-3861(92)90368-7
   FAKIROV S, 1991, POLYMER, V32, P1173, DOI 10.1016/0032-3861(91)90218-8
   Gallocher SL, 2006, J BIOMED MATER RES B, V79B, P325, DOI 10.1002/jbm.b.30546
   Hess K, 1944, Z PHYS CHEM-LEIPZIG, V193, P196
   Honeker CC, 2000, MACROMOLECULES, V33, P9395, DOI 10.1021/ma000593y
   Jiang DD, 2000, POLYM DEGRAD STABIL, V68, P75, DOI 10.1016/S0141-3910(99)00167-6
   Kennedy JE, 2009, J MATER SCI, V44, P889, DOI 10.1007/s10853-008-3156-2
   Kwee T, 2005, POLYMER, V46, P4480, DOI 10.1016/j.polymer.2005.02.031
   Meng S, 2005, POLYMER, V46, P5580, DOI 10.1016/j.polymer.2005.05.030
   Nagura M, 2009, J APPL POLYM SCI, V113, P2462, DOI 10.1002/app.30027
   PAKULA T, 1985, MACROMOLECULES, V18, P1294, DOI 10.1021/ma00148a044
   Pinchuk L, 2008, BIOMATERIALS, V29, P448, DOI 10.1016/j.biomaterials.2007.09.041
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Puskas JE, 2003, EUR POLYM J, V39, P2041, DOI 10.1016/S0014-3057(03)00130-7
   Puskas JE, 2009, POLYMER, V50, P591, DOI 10.1016/j.polymer.2008.10.061
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   SAKOTA K, 1976, J APPL POLYM SCI, V20, P2811, DOI 10.1002/app.1976.070201015
   Stasiak J, 2010, SOFT MATTER, V6, P1941, DOI 10.1039/c000975j
   Stasiak J, 2010, FUNCT MATER LETT, V3, P249, DOI 10.1142/S1793604710001342
   Stasiak J, 2009, MACROMOLECULES, V42, P5256, DOI 10.1021/ma8026639
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Xu JB, 2007, POLYM DEGRAD STABIL, V92, P1682, DOI 10.1016/j.polymdegradstab.2007.06.008
NR 25
TC 7
Z9 7
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 24
BP 11475
EP 11482
DI 10.1039/c1sm06503c
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 853KS
UT WOS:000297425700022
DA 2018-10-19
ER

PT J
AU Ponnusamy, KE
   Iyer, S
   Gupta, G
   Khanna, AJ
AF Ponnusamy, Karthikeyan E.
   Iyer, Sravisht
   Gupta, Gaurav
   Khanna, A. Jay
TI Instrumentation of the osteoporotic spine: biomechanical and clinical
   considerations
SO SPINE JOURNAL
LA English
DT Review
DE Osteoporosis; Vertebral compression fractures; Pedicle screws; Anterior
   approaches; Instrumentation; Vertebral augmentation
ID PEDICLE SCREW FIXATION; CALCIUM-PHOSPHATE CEMENT; BONE-MINERAL DENSITY;
   PULLOUT STRENGTH; END-PLATE; IN-VIVO; VERTEBROPLASTY AUGMENTATION;
   KYPHOPLASTY AUGMENTATION; COMPRESSION FRACTURES; VERTEBRAL COLLAPSE
AB BACKGROUND CONTEXT: Osteoporosis is a major health-care problem that is increasing in magnitude with the aging population. Such patients are more prone to develop painful and debilitating spinal deformities but are difficult to treat. Currently, no definitive treatment algorithm has been established.
   PURPOSE: To review the failure modes of instrumentation and novel surgical treatments of spinal deformities in patients with osteoporosis with the goal of improving surgical care.
   STUDY DESIGN/SETTING: Review article.
   METHODS: We systematically searched PubMed for articles regarding instrumentation failure modes and surgical treatments of spinal deformities in patients with osteoporosis and summarized current treatment options.
   RESULTS: The surgical treatment options are severely limited because of the tendency for instrument failure secondary to pullout and subsidence, leading to revision procedures; multiple levels and multiple fixation points are recommended to minimize the risk. The literature supports the use of vertebroplasty in conjunction with pedicle screw-based instrumentation for treating more severe spinal deformities. Other techniques and modifications with evidence of reduced failure risk are bicortical screws, hydroxyapatite coatings, double screws, and expandable screws. Anterior approaches may provide another avenue of treatment, but only a few studies have been conducted on these implants in patients with osteoporosis.
   CONCLUSIONS: Spinal deformities in patients with osteoporosis are difficult to treat because of their debilitating and progressive nature. Novel surgical approaches and instruments have been designed to decrease construct failures in this patient population by reducing implant pullout, subsidence, and incidence of revision surgery. The success of these techniques depends on integrating biomaterial, biologic, and biomechanical aspects with clinical considerations. Synthesizing this myriad of aspects will lead to improved treatment options for patients with osteoporosis who are suffering from spinal deformities. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Ponnusamy, Karthikeyan E.; Gupta, Gaurav] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   [Iyer, Sravisht] Harvard Univ, Harvard Med Sch, Div Hlth Sci & Technol, Cambridge, MA 02138 USA.
   [Khanna, A. Jay] Johns Hopkins Univ Hosp, Dept Orthopaed Surg, Baltimore, MD 21287 USA.
   [Khanna, A. Jay] Johns Hopkins Univ Hosp, Dept Biomed Engn, Baltimore, MD 21287 USA.
RP Khanna, AJ (reprint author), Care of Henze EP, Johns Hopkins Bayview Med Ctr, Dept Orthopaed Surg, 4940 Eastern Ave,A665, Baltimore, MD 21224 USA.
EM ehenze1@jhmi.edu
CR Aldini NN, 2002, J ORTHOPAED RES, V20, P1217
   Andreassen GS, 2004, ARCH ORTHOP TRAUM SU, V124, P161, DOI 10.1007/s00402-004-0642-0
   Aydogan M, 2009, J SPINAL DISORD TECH, V22, P444, DOI 10.1097/BSD.0b013e31818e0945
   BABA H, 1995, PARAPLEGIA, V33, P281, DOI 10.1038/sc.1995.64
   Babat L Brett, 2005, Spine J, V5, P542, DOI 10.1016/j.spinee.2005.01.008
   Bai B, 2001, SPINE, V26, P2679, DOI 10.1097/00007632-200112150-00009
   Bonnick Sydney L, 2006, Clin Cornerstone, V8, P28, DOI 10.1016/S1098-3597(06)80063-3
   Bostrom MPG, 1997, SPINE, V22, p38S, DOI 10.1097/00007632-199712151-00007
   Bransford R, 2007, EUR SPINE J, V16, P557, DOI 10.1007/s00586-006-0212-y
   Breeze SW, 1998, SPINE, V23, P1829, DOI 10.1097/00007632-199809010-00004
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Burval DJ, 2007, SPINE, V32, P1077, DOI 10.1097/01.brs.0000261566.38422.40
   Chapman JR, 1996, J BIOMECH ENG-T ASME, V118, P391, DOI 10.1115/1.2796022
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P354
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   Chen CS, 2005, MED ENG PHYS, V27, P487, DOI 10.1016/j.medengphy.2004.12.007
   Chen SI, 2003, MED ENG PHYS, V25, P275, DOI 10.1016/S1350-4533(02)00219-9
   Clausen JD, 1996, J NEUROSURG, V84, P1039, DOI 10.3171/jns.1996.84.6.1039
   COE JD, 1990, SPINE, V15, P902, DOI 10.1097/00007632-199009000-00012
   Cook S D, 2001, Spine J, V1, P109, DOI 10.1016/S1529-9430(01)00020-1
   Cook S D, 2001, Am J Orthop (Belle Mead NJ), V30, P387
   Cook Stephen D, 2004, Spine J, V4, P402, DOI 10.1016/j.spinee.2003.11.010
   Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109
   Das K, 2001, J NEUROSURG, V94, P174, DOI 10.3171/spi.2001.94.1.0174
   DAWSON EG, 2003, SPINAL DEFORMITIES C, P195
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Delmas PD, 2005, J BONE MINER RES, V20, P557, DOI 10.1359/JBMR.041214
   DeWald CJ, 2006, SPINE, V31, pS144, DOI 10.1097/01.brs.0000236893.65878.39
   Erbe EM, 2001, EUR SPINE J, V10, pS147, DOI 10.1007/s005860100288
   Ergur I, 2007, EUR SPINE J, V16, P1519, DOI 10.1007/s00586-007-0326-x
   ESSES SI, 1991, SPINE, V16, pS283, DOI 10.1097/00007632-199106001-00021
   Ferguson SJ, 2002, EUR SPINE J, V11, P527, DOI 10.1007/s00586-002-0449-z
   Fini M, 2003, J BIOMED MATER RES A, V66A, P176, DOI 10.1002/jbm.a.10605
   Frankel BM, 2007, J NEUROSURG-SPINE, V7, P47, DOI 10.3171/SPI-07/07/047
   Gaines RW, 2000, J BONE JOINT SURG AM, V82A, P1458, DOI 10.2106/00004623-200010000-00013
   Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017
   Gezici AR, 2009, J KOREAN NEUROSURG S, V46, P45, DOI 10.3340/jkns.2009.46.1.45
   GILBERT SG, 1993, J SPINAL DISORD, V6, P513, DOI 10.1097/00002517-199306060-00007
   Goldhahn J, 2006, ARCH ORTHOP TRAUM SU, V126, P554, DOI 10.1007/s00402-006-0185-7
   Goldhahn J, 2006, J ORTHOP RES, V24, P917, DOI 10.1002/jor.20133
   Grant JP, 2002, J ORTHOP RES, V20, P1115, DOI 10.1016/S0736-0266(02)00039-6
   HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008
   Hasegawa K, 1997, SPINE, V22, P958, DOI 10.1097/00007632-199705010-00004
   Hasegawa Toru, 2005, Spine J, V5, P239, DOI 10.1016/j.spinee.2004.11.010
   Heini PF, 2005, OSTEOPOROSIS INT, V16, pS85, DOI 10.1007/s00198-004-1723-1
   Heller JG, 1996, J BONE JOINT SURG AM, V78A, P1315, DOI 10.2106/00004623-199609000-00004
   Hitchon PW, 2003, SPINE, V28, P9, DOI 10.1097/00007632-200301010-00004
   Hoshikawa A, 2003, BIOMATERIALS, V24, P4967, DOI 10.1016/S0142-9612(03)00422-8
   Hu SS, 1997, SPINE, V22, p43S, DOI 10.1097/00007632-199712151-00008
   Huang TJ, 2003, CLIN BIOMECH, V18, pS40, DOI 10.1016/S0268-0033(03)00083-4
   Jiang L, 2007, J SPINAL DISORD TECH, V20, P430, DOI 10.1097/BSD.0b013e318030e945
   Jost B, 1998, EUR SPINE J, V7, P132
   Keller TS, 2003, SPINE, V28, P455, DOI 10.1097/00007632-200303010-00009
   Kettler A, 2006, CLIN BIOMECH, V21, P676, DOI 10.1016/j.clinbiomech.2006.02.005
   Kim WJ, 2006, CLIN ORTHOP RELAT R, P75, DOI 10.1097/01.blo.0000200237.22308.93
   Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
   Kobayashi H, 2010, J BIOMED MATER RES A, V92A, P596, DOI 10.1002/jbm.a.32397
   KOSTUIK JP, 1993, SPINE, V18, P1273, DOI 10.1097/00007632-199308000-00005
   Kwon BK, 2006, SPINE, V31, P1943, DOI 10.1097/01.brs.0000229258.83071.db
   Larsson S, 2006, SCAND J SURG, V95, P111, DOI 10.1177/145749690609500206
   Lehman RA, 2002, SPINE, V27, P806, DOI 10.1097/00007632-200204150-00006
   Lehman Ronald A Jr, 2004, Spine J, V4, P36, DOI 10.1016/S1529-9430(03)00427-3
   Lehman RA, 2010, SPINE, V35, P146, DOI 10.1097/BRS.0b013e3181b71a96
   LICHT NJ, 1992, SPINE, V17, P892, DOI 10.1097/00007632-199208000-00006
   Lieberman IH, 1998, SPINE, V23, P908, DOI 10.1097/00007632-199804150-00012
   Lieberman Isador H, 2005, Spine J, V5, p305S, DOI 10.1016/j.spinee.2005.02.020
   Lim TH, 2001, SPINE, V26, P951, DOI 10.1097/00007632-200104150-00021
   Linhardt O, 2006, INT ORTHOP, V30, P366, DOI 10.1007/s00264-006-0100-4
   Linhardt O, 2006, J SPINAL DISORD TECH, V19, P87, DOI 10.1097/01.bsd.0000177212.52583.bd
   Lippuner K, 2003, EUR SPINE J, V12, pS132, DOI 10.1007/s00586-003-0608-x
   Luk KDK, 2005, SPINE, V30, P525, DOI 10.1097/01.brs.0000154649.55589.bf
   Margulies J Y, 1997, Eur Spine J, V6, P245, DOI 10.1007/BF01322446
   MATHEWS HH, 1995, SPINE, V20, P1797, DOI 10.1097/00007632-199508150-00009
   MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271
   Moore DC, 1997, SPINE, V22, P1696, DOI 10.1097/00007632-199708010-00003
   Mutsuzaki H, 2007, J MATER SCI-MATER M, V18, P1799, DOI 10.1007/s10856-007-3051-4
   *NAT OST FDN, 2005, FAST FACTS OST
   Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904
   Ngu BB, 2006, SPINE, V31, pE166, DOI 10.1097/01.brs.0000202747.90508.0d
   Pateder DB, 2007, ORTHOP CLIN N AM, V38, P409, DOI 10.1016/j.ocl.2007.03.010
   Ponnusamy K, 2009, SPINE, V34, P2104, DOI 10.1097/BRS.0b013e3181b20212
   Ragel BT, 2007, NEUROSURGERY, V61, P317, DOI 10.1227/01.neu.0000303988.57493.b6
   Reinhold M, 2006, SPINE, V31, P406, DOI 10.1097/01.brs.0000199894.63450.70
   Renner SM, 2004, SPINE, V29, pE212, DOI 10.1097/00007632-200406010-00020
   Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801
   Sanden B, 2002, J BONE JOINT SURG BR, V84B, P387, DOI 10.1302/0301-620X.84B3.12388
   Sanden B, 2000, EUR SPINE J, V9, P534, DOI 10.1007/s005860000180
   Sarzier JS, 2002, J NEUROSURG, V96, P309, DOI 10.3171/spi.2002.96.3.0309
   Smit RS, 2008, ARCH ORTHOP TRAUM SU, V128, P989, DOI 10.1007/s00402-008-0680-0
   Spivak JM, 1999, SPINE, V24, P334, DOI 10.1097/00007632-199902150-00005
   Steffen T, 2000, SPINE, V25, P1077, DOI 10.1097/00007632-200005010-00007
   Tan JS, 2004, SPINE, V29, P1723, DOI 10.1097/01.BRS.0000134569.63542.49
   Tomita S, 2004, SPINE, V29, P1203, DOI 10.1097/00007632-200406010-00009
   Tsai CH, 2008, BIOMATERIALS, V29, P984, DOI 10.1016/j.biomaterials.2007.10.014
   Tsuchiya K, 2006, SPINE, V31, P303, DOI 10.1097/01.brs.0000197193.81296.f1
   Uchida K, 2006, J NEUROSURG-SPINE, V4, P454, DOI 10.3171/spi.2006.4.6.454
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Wheeler DL, 2007, SPINE J, V7, P308, DOI 10.1016/j.spinee.2006.01.005
   Yazu N, 2005, J ORTHOP SCI, V10, P56, DOI 10.1007/s00776-004-0862-8
   Yildirim OS, 2006, SPINE, V31, pE215, DOI 10.1097/01.brs.0000210221.00778.c7
   Yilmaz C, 2006, J SPINAL DISORD TECH, V19, P373, DOI 10.1097/01.bsd.0000210115.94273.76
   ZINDRICK MR, 1986, CLIN ORTHOP RELAT R, P99
   ZUCHERMAN JF, 1995, SPINE, V20, P2029, DOI 10.1097/00007632-199509150-00015
NR 105
TC 56
Z9 67
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
EI 1878-1632
J9 SPINE J
JI Spine Journal
PD JAN
PY 2011
VL 11
IS 1
BP 54
EP 63
DI 10.1016/j.spinee.2010.09.024
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 696AP
UT WOS:000285414600013
PM 21168099
DA 2018-10-19
ER

PT J
AU Walsh, WR
   Oliver, RA
   Gage, G
   Yu, Y
   Bell, D
   Bellemore, J
   Adkisson, HD
AF Walsh, William R.
   Oliver, Rema A.
   Gage, Gary
   Yu, Yan
   Bell, David
   Bellemore, Jeremy
   Adkisson, Huston Davis
TI Application of Resorbable Poly(Lactide-co-Glycolide) with Entangled
   Hyaluronic Acid as an Autograft Extender for Posterolateral
   Intertransverse Lumbar Fusion in Rabbits
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID DEMINERALIZED BONE-MATRIX; SPINAL-FUSION; IN-VITRO; CELL-PROLIFERATION;
   GROWTH-FACTOR; REPAIR; CD44; SCAFFOLDS; DIFFERENTIATION; ARTHRODESIS
AB Facilitating fusion between bony segments in a reliable and reproducible manner using a synthetic bone graft material has a number of benefits for the surgeon as well as the patient. Although autograft remains the gold standard, associated comorbidities continue to drive the development of new biomaterials for use in spinal fusion. The ability of autograft alone and autograft combined with a radiolucent biomaterial composed of resorbable osteoconductive poly(lactide-co-glycolide) with entangled hyaluronic acid to facilitate fusion was examined in a single-level noninstrumented posterolateral intertransverse lumbar fusion model in New Zealand White rabbits. Progressive bone formation was demonstrated radiographically for the extender group (synthetic biomaterial plus autograft) between 3 and 6 months. Computed tomography revealed a new cortical shell in the fusion mass at 3 and 6 months for both study groups. Tensile testing at 6 months demonstrated that the quality of bone formed between the intertransverse space was equivalent for both study groups. Histologic evaluation of the fusion mass revealed new bone on and adjacent to the transverse processes with the synthetic biomaterial group that extended laterally, supporting the osteoconductive nature of the material. Histological evidence of endochondral bone growth in the intertransverse space was observed for the autograft plus synthetic biomaterial group. Bone remodeling, new marrow spaces, and peripheral cortices were observed for each study group at 3 months that matured by 6 months. These findings support the use of a radiolucent biosynthetic material comprising poly(lactide-co-glycolide) with integrated hyaluronic acid as an autograft extender for lumbar intertransverse fusion.
C1 [Walsh, William R.; Oliver, Rema A.; Yu, Yan; Bell, David; Bellemore, Jeremy] Univ New S Wales, Prince Wales Hosp, Surg & Orthopaed Res Labs, Randwick, NSW 2031, Australia.
   [Gage, Gary; Adkisson, Huston Davis] ISTO Technol Inc, St Louis, MO USA.
RP Walsh, WR (reprint author), Univ New S Wales, Prince Wales Hosp, Surg & Orthopaed Res Labs, Randwick, NSW 2031, Australia.
EM w.walsh@unsw.edu.au
OI Walsh, William/0000-0002-5023-6148
FU ISTO Technologies
FX This study was performed by financial support provided by ISTO
   Technologies. Gary Gage and H. Davis Adkisson are paid employees of ISTO
   Technologies.
CR Adkisson H.D., 2007, 53 ANN M ORTH RES SO
   Ariyoshi W, 2005, J BIOL CHEM, V280, P18967, DOI 10.1074/jbc.M412740200
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1997, J SPINAL DISORD, V10, P1
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Cao JJ, 2005, J BONE MINER RES, V20, P30, DOI 10.1359/JBMR.041014
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37
   Damien CJ, 2002, SPINE, V27, pS50, DOI 10.1097/01.BRS.0000020736.40268.AO
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   KNUDSON CB, 1993, FASEB J, V7, P1233
   Lee CT, 2006, J MATER SCI-MATER M, V17, P1411, DOI 10.1007/s10856-006-0617-5
   Lesley J, 2000, J BIOL CHEM, V275, P26967
   Lilli C, 2002, J BIOMED MATER RES, V63, P577, DOI 10.1002/jbm.10301
   LOCCI P, 1995, CELL TISSUE RES, V281, P317
   Macri C., 2007, ADV DRUG DELIV REV, V59, P1366
   Morone MA, 1998, SPINE, V23, P159, DOI 10.1097/00007632-199801150-00003
   Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.04-1376fje
   Noonan KJ, 1996, J ORTHOP RES, V14, P573, DOI 10.1002/jor.1100140411
   NUGENT PJ, 1993, CLIN ORTHOP RELAT R, P107
   Palumbo Mark, 2004, Spine J, V4, P287
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   SASAKI T, 1995, BONE, V16, P9, DOI 10.1016/S8756-3282(94)00001-8
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Valdes M, 2007, SPINE J, V7, P318, DOI 10.1016/j.spinee.2006.02.005
   Valdes Mauricio, 2004, Spine J, V4, P293
   Walsh WR, 2009, EUR SPINE J, V18, P1610, DOI 10.1007/s00586-009-1034-5
   WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   Yee AJM, 2004, SPINE, V29, P1308, DOI 10.1097/01.BRS.0000127184.43765.61
   Yee AJM, 2003, SPINE, V28, P2435
   Zou LJ, 2008, J ORTHOP RES, V26, P713, DOI 10.1002/jor.20539
NR 35
TC 7
Z9 7
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2011
VL 17
IS 1-2
BP 213
EP 220
DI 10.1089/ten.tea.2010.0008
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 703QQ
UT WOS:000285995800021
PM 20712417
OA Green Published
DA 2018-10-19
ER

PT J
AU Lee, JH
   Wang, HJ
   Kaplan, JB
   Lee, WY
AF Lee, Joung-Hyun
   Wang, Hongjun
   Kaplan, Jeffrey B.
   Lee, Woo Y.
TI Microfluidic Approach to Create Three-Dimensional Tissue Models for
   Biofilm-Related Infection of Orthopaedic Implants
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; MINERALIZED MATRIX DEPOSITION; 3D
   PERFUSION CULTURE; DEVICES; GROWTH; MICROFABRICATION; COLONIZATION;
   INTEGRATION; DETACHMENT; INCREASES
AB With conventional in vitro culture methods, it is difficult to study complex interactions of host cells with pathogens and drugs in physiologically relevant microenvironments. To simulate orthopaedic implant-associated infection, a multi-channel microfluidic device was used to (1) observe in real-time the development of osteoblasts into three-dimensional (3D) tissue-like structures and (2) study how this development was influenced by phenotypes of Staphylococcus epidermidis. In the absence of bacteria, osteoblasts formed a confluent layer on the bottom channel surface, gradually migrated to the side and top surfaces, and formed calcified 3D nodular structures in 8 days. The delivery timing and concentration of an antibiotic were controlled to produce small colony variants, sessile biofilms, or dead cells of S. epidermidis. In the presence of the small colony variants, osteoblasts initially adhered, and spread, but were killed within 2 days. In contrast, the sessile biofilms and dead bacteria cells did not significantly interfere with the formation of tissue-like structures. The results suggest the possibility of creating in vitro tissue-biofilm-biomaterial interfaces and therefore 3D tissue models, as an entirely new method of studying biofilm-related infection of orthopaedic implants with physiological relevance.
C1 [Lee, Joung-Hyun; Lee, Woo Y.] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
   [Wang, Hongjun] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.
   [Kaplan, Jeffrey B.] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA.
RP Lee, WY (reprint author), Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
EM wlee@stevens.edu
FU National Science Foundation [NIRT-CBET 0708379]
FX This study was supported by the National Science Foundation (NIRT-CBET
   0708379). We thank Prof. Matthew Libera at Stevens Institute of
   Technology for support and discussion.
CR Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1993, INT J ARTIF ORGANS, V16, P765
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Frommelt L, 2006, INJURY, V37, P87, DOI 10.1016/j.injury.2006.04.014
   Futai N, 2006, LAB CHIP, V6, P149, DOI 10.1039/b510901a
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Griffith L., 2002, 3 SMITH NEPH INT S T, P72
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Jang K, 2008, ANAL BIOANAL CHEM, V390, P825, DOI 10.1007/s00216-007-1752-7
   Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Khare MD, 2007, J INFECTION, V54, P146, DOI 10.1016/j.jinf.2006.03.002
   Kuijer R, 2007, BIOMATERIALS, V28, P5148, DOI 10.1016/j.biomaterials.2007.06.003
   Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002
   Lee J. H., 2010, ACTA BIOMATER
   Lee JH, 2008, BIOMED MICRODEVICES, V10, P489, DOI 10.1007/s10544-007-9157-0
   Long M., 2009, PRIV SEM STEV I TECH
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Matl FD, 2008, ANTIMICROB AGENTS CH, V52, P1957, DOI 10.1128/AAC.01438-07
   Monzon M, 2001, J ANTIMICROB CHEMOTH, V48, P793, DOI 10.1093/jac/48.6.793
   Multi-Agency Tissue Engineering Science Interagency Working Group, 2007, ADV TISS SCI ENG
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   RICHARDS RG, 2006, INJURY, V37, pS113
   Rusu-Balaita L, 2003, POLYM BULL, V50, P91, DOI 10.1007/s00289-003-0144-1
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182
   Tang HY, 2007, J BIOMED MATER RES A, V80A, P885, DOI 10.1002/jbm.a.30952
   van Gennip M., 2009, ASM C BIOF 2009 CANC
   Vaudaux P, 2006, INJURY, V37, P15, DOI 10.1016/j.injury.2006.04.004
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Widmer AF, 1997, NUTRITION, V13, pS18, DOI 10.1016/S0899-9007(97)00218-9
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   ZEILER HJ, 1987, AM J MED, V82, P87
   Zimmerli W., 2004, NEW ENGL J MED, V351, P1701
NR 43
TC 24
Z9 25
U1 1
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JAN
PY 2011
VL 17
IS 1
BP 39
EP 48
DI 10.1089/ten.tec.2010.0285
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 702DL
UT WOS:000285874700005
PM 20618080
DA 2018-10-19
ER

PT J
AU Li, B
   Li, J
   Xia, J
   Kennedy, JF
   Yie, X
   Liu, TG
AF Li, B.
   Li, J.
   Xia, J.
   Kennedy, J. F.
   Yie, X.
   Liu, T. G.
TI Effect of gamma irradiation on the condensed state structure and
   mechanical properties of konjac glucomannan/chitosan blend films
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Konjac glucomannan; Chitosan; Blend film; Gamma irradiation;
   Biomaterial; Condensed state structure; Mechanical properties;
   Miscibility
ID PHYSICAL-PROPERTIES; CHITOSAN SCAFFOLDS; SODIUM ALGINATE; BEAN FLOURS;
   STARCH; RADIATION; DEGRADATION; RICE; BIOCOMPATIBILITY; MAIZE
AB Konjac glucomannan and chitosan blend films with different blend ratio were gamma irradiated up to 80 kGy, The mechanical properties achieved their maximum under 25 kGy dose, the tensile strength and breaking elongation of KC2 were enhanced about 40% and 30%, respectively. No change occurred in the primary group such as hydroxyl and acetyl of the blend films during irradiation. The effect of irradiation decreased with the increase of konjac glucomannan content, and the blend film KC2 irradiated by 25 kGy had the highest cystallinity. The miscibility of KGM and CHI in the blend film also played an important role in keeping its morphology, in addition to the content of chitosan when the films were irradiated. 25 kGy gamma irradiation was not only a useful sterilization method for the film biomaterial but also an efficient modification method for enhancing the properties of KC2. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Li, B.; Li, J.; Xia, J.; Yie, X.; Liu, T. G.] Huazhong Agr Univ, Coll Food Sci, Wuhan 430070, Peoples R China.
   [Kennedy, J. F.] Inst Adv Sci, Chembiotech Labs, Bromsgrove B60 4JE, Worcs, England.
RP Li, B (reprint author), Huazhong Agr Univ, Coll Food Sci, Wuhan 430070, Peoples R China.
EM libinfood@mail.hzau.edu.cn
FU National 863 plans projects; Program for New Century Excellent Talents
   in University, China; Program for Excellent Young Talents in Hubei,
   China
FX Contract grant sponsors: National 863 plans projects, Program for New
   Century Excellent Talents in University, China: and Program for
   Excellent Young Talents in Hubei, China.
CR Abu JO, 2006, FOOD CHEM, V95, P386, DOI 10.1016/j.foodchem.2005.01.008
   Bao JS, 2005, STARCH-STARKE, V57, P480, DOI 10.1002/star.200500422
   Bao JS, 2002, J AGR FOOD CHEM, V50, P336, DOI 10.1021/jf010230c
   Bao JS, 2001, J FOOD QUALITY, V24, P327, DOI 10.1111/j.1745-4557.2001.tb00612.x
   Cao Wenling, 2005, Nuclear Techniques, V28, P187
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Choi WS, 2002, POLYM DEGRAD STABIL, V78, P533, DOI 10.1016/S0141-3910(02)00226-4
   Fang YE, 1997, NUCL TECHNIQUES, V20, P226
   *GB, 44561996 GBT
   Huang MF, 2005, INT J BIOL MACROMOL, V36, P98, DOI 10.1016/j.ijbiomac.2005.04.002
   JIANG TD, 2002, CHITOSAN, P38
   Kang B, 2007, POLYM DEGRAD STABIL, V92, P359, DOI 10.1016/j.polymdegradstab.2006.12.006
   Kume T, 2002, RADIAT PHYS CHEM, V63, P625, DOI 10.1016/S0969-806X(01)00558-8
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Li B, 2006, CARBOHYD POLYM, V65, P488, DOI 10.1016/j.carbpol.2006.02.006
   Li B, 2006, CARBOHYD POLYM, V64, P510, DOI 10.1016/j.carbpol.2005.11.001
   Li B, 2004, J APPL POLYM SCI, V93, P2775, DOI 10.1002/app.20769
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MAJETI NN, 2002, REACTIVE FUNCT POLYM, V46, P1
   Nagasawa N, 2004, CARBOHYD POLYM, V58, P109, DOI 10.1016/j.carbpol.2004.04.021
   Nagasawa N, 2000, POLYM DEGRAD STABIL, V69, P279, DOI 10.1016/S0141-3910(00)00070-7
   Oungbho K, 1997, INT J PHARM, V156, P229, DOI 10.1016/S0378-5173(97)00201-9
   Pathak C. P., 2003, United States Patent, Patent No. [6,639,014, 6639014]
   Prawitwong P, 2007, FOOD HYDROCOLLOID, V21, P1362, DOI 10.1016/j.foodhyd.2006.10.015
   RAYASDUARTE P, 1993, J FOOD SCI, V58, P389, DOI 10.1111/j.1365-2621.1993.tb04282.x
   Rombo GO, 2004, J SCI FOOD AGR, V84, P350, DOI 10.1002/jsfa.1663
   Rombo GO, 2001, J SCI FOOD AGR, V81, P497, DOI 10.1002/jsfa.838
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   SOKHEY AS, 1993, FOOD STRUCT, V12, P397
   Wang K, 2002, INT J PHARM, V244, P117, DOI 10.1016/S0378-5173(02)00324-1
   Wasikiewicz JM, 2005, RADIAT PHYS CHEM, V73, P287, DOI 10.1016/j.radphyschem.2004.09.021
   Xiao CB, 2000, J APPL POLYM SCI, V76, P509, DOI 10.1002/(SICI)1097-4628(20000425)76:4<509::AID-APP8>3.0.CO;2-2
   YANG F, 2003, J DIALYSIS ARTIFICIA, V14, P13
   Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005
   Zhai ML, 2004, CARBOHYD POLYM, V57, P83, DOI 10.1016/j.carbpol.2004.04.003
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhang Y, 2001, J NON-CRYST SOLIDS, V282, P159, DOI 10.1016/S0022-3093(01)00345-3
NR 37
TC 29
Z9 36
U1 2
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 1
PY 2011
VL 83
IS 1
BP 44
EP 51
DI 10.1016/j.carbpol.2010.07.017
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 675DH
UT WOS:000283805600007
DA 2018-10-19
ER

PT J
AU Jeong, SI
   Lee, SE
   Yang, H
   Jin, YH
   Park, CS
   Park, YS
AF Jeong, Seong Ii
   Lee, Seung Eun
   Yang, Hana
   Jin, Young-Ho
   Park, Cheung-Seog
   Park, Yong Seek
TI Toxicologic evaluation of bacterial synthesized cellulose in endothelial
   cells and animals
SO MOLECULAR & CELLULAR TOXICOLOGY
LA English
DT Article
DE Bacterial cellulose; Gluconacetobacter xylinus; Endothelial cells;
   Tissue engineering; Biocompatibility
ID APOPTOSIS; EXPRESSION; PROTEIN; RNA
AB Compared to plant cellulose, bacterial cellulose synthesized by Gluconacetobacter xylinus has features such as high crystallinity, tensile strength and water absorption capacity; biocompatibility; resistance to degradation and low solubility that may be advantageous for engineered tissue. However, little information is available concerning the potential toxicity of bacterial cellulose-based biomaterials. The present study investigated the toxicity of bacterial cellulose nanofibers in vitro in human umbilical vein endothelial cells (HUVECs) using viability and flow cytometric assays and in vivo using C57/B16 mice. The absence of toxicity in vitro and in vivo supports the view that bacterial cellulose may be amenable for use as a tissue engineering biomaterial.
C1 [Jeong, Seong Ii; Lee, Seung Eun; Yang, Hana; Park, Cheung-Seog; Park, Yong Seek] Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul, South Korea.
   [Jin, Young-Ho] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea.
RP Park, YS (reprint author), Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul, South Korea.
EM yongseek@khu.ac.kr
FU Korea government (MEST) [2010002 8329]
FX This work was supported by the Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korea government (MEST) (No. 2010002 8329).
CR ANDERSON RL, 1992, CANCER LETT, V63, P83, DOI 10.1016/0304-3835(92)90057-3
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dimmeler S, 2000, CIRC RES, V87, P434
   El-Saied H, 2008, BIORESOURCES, V3, P1196
   ESGUERRA M, J BIOMED MAT RES A, V93, P140
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hioki N., 1995, JAPAN TAPPI J, V49, P718, DOI DOI 10.2524/JTAPPIJ.49.718
   Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   LEE HC, 1996, KOREAN J BIOTECHNOL, V11, P550
   Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028
   Moreira S, 2009, TOXICOL LETT, V189, P235, DOI 10.1016/j.toxlet.2009.06.849
   Park YS, 2007, ARTERIOSCL THROM VAS, V27, P1319, DOI 10.1161/ATVBAHA.106.132837
   Rambo CR, 2008, MAT SCI ENG C-BIO S, V28, P549, DOI 10.1016/j.msec.2007.11.011
   Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Sanchavanakit N, 2006, BIOTECHNOL PROGR, V22, P1194, DOI 10.1021/bp060035o
   Sgonc R, 1998, EXP GERONTOL, V33, P525, DOI 10.1016/S0531-5565(98)00031-X
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   ULICH TR, 1991, AM J PATHOL, V138, P1485
   UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Yamada Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1244, DOI 10.1271/bbb.61.1244
   Zhao HP, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2450666
NR 30
TC 42
Z9 43
U1 0
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1738-642X
J9 MOL CELL TOXICOL
JI Mol. Cell. Toxicol.
PD DEC 31
PY 2010
VL 6
IS 4
BP 373
EP 380
DI 10.1007/s13273-010-0049-7
PG 8
WC Biochemistry & Molecular Biology; Toxicology
SC Biochemistry & Molecular Biology; Toxicology
GA 700JS
UT WOS:000285735500006
DA 2018-10-19
ER

PT J
AU Numata, K
   Kaplan, DL
AF Numata, Keiji
   Kaplan, David L.
TI Silk-based delivery systems of bioactive molecules
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Silk; Recombinant protein; Gene delivery; Drug delivery; Biomaterials;
   Bioengineering
ID CELL-PENETRATING PEPTIDES; SPIDER DRAGLINE SILK; GENETICALLY-ENGINEERED
   SILK; MEDIATED GENE DELIVERY; BOMBYX-MORI SILK; IN-VITRO;
   CONTROLLED-RELEASE; NUCLEIC-ACIDS; BIOMATERIAL COATINGS; ADENOSINE
   RELEASE
AB Silks are biodegradable, biocompatible, self-assembling proteins that can also be tailored via genetic engineering to contain specific chemical features, offering utility for drug and gene delivery. Silkworm silk has been used in biomedical sutures for decades and has recently achieved Food and Drug Administration approval for expanded biomaterials device utility. With the diversity and control of size, structure and chemistry, modified or recombinant silk proteins can be designed and utilized in various biomedical application, such as for the delivery of bioactive molecules. This review focuses on the biosynthesis and applications of silk-based multi-block copolymer systems and related silk protein drug delivery systems. The utility of these systems for the delivery of small molecule drugs, proteins and genes is reviewed. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Numata, Keiji; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Numata, Keiji/H-9751-2012
OI Numata, Keiji/0000-0003-2199-7420
FU NIH (Tissue Engineering Resource Center); NSF; AFOSR; Japan Society for
   the Promotion of Science
FX The authors thank Carmen Preda (M.Sc.), Dean L Glettig, Dr. Michael
   Lovett, Eleanor Pritchard, and Dr. Aneta J. Mieszawska for providing the
   images in Fig. 5. This work has been supported by grants from the NIH
   (Tissue Engineering Resource Center), the NSF and the AFOSR (D.K.). K.N.
   was supported by a Japan Society for the Promotion of Science
   Postdoctoral Fellowship for Research Abroad.
CR Abes S, 2007, BIOCHEM SOC T, V35, P53, DOI 10.1042/BST0350053
   Akai Hiromu, 1999, International Journal of Wild Silkmoth & Silk, V4, P7
   Akai Hiromu, 1999, International Journal of Wild Silkmoth & Silk, V4, P13
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Bessa P.C., J TISSUE ENG REGEN M
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Contreras JL, 2004, ILAR J, V45, P334, DOI 10.1093/ilar.45.3.334
   COTTEN M, 1992, P NATL ACAD SCI USA, V89, P6094, DOI 10.1073/pnas.89.13.6094
   CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905
   CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376
   CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850
   DENNY M, 1976, J EXP BIOL, V65, P483
   Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0
   Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s
   Deshayes S, 2004, BBA-BIOMEMBRANES, V1667, P141, DOI 10.1016/j.bbamem.2004.09.010
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x
   El-Andaloussi S, 2006, J GENE MED, V8, P1262, DOI 10.1002/jgm.950
   Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316
   Endoh T, 2009, ADV DRUG DELIVER REV, V61, P704, DOI 10.1016/j.addr.2009.04.005
   Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Gottschalk S, 1996, GENE THER, V3, P448
   Greish K, 2009, BIOMACROMOLECULES, V10, P2183, DOI 10.1021/bm900356j
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Gupta V, 2009, INT J NANOMED, V4, P115
   Gustafson J, 2009, J CONTROL RELEASE, V140, P256, DOI 10.1016/j.jconrel.2009.05.022
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3
   HOLLANDER DH, 1994, MED HYPOTHESES, V43, P155, DOI 10.1016/0306-9877(94)90142-2
   Holm T, 2006, NAT PROTOC, V1, P1001, DOI 10.1038/nprot.2006.174
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Jarvert P, 2007, BIOCHEM SOC T, V35, P770
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kaplan D. L., 1994, ACS S SER, V544
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kim WJ, 2005, J CONTROL RELEASE, V106, P224, DOI 10.1016/j.jconrel.2005.04.016
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kurosaki S, 1999, Nihon Ika Daigaku Zasshi, V66, P41, DOI 10.1272/jnms.66.41
   Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101
   Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LEAR JD, 1987, J BIOL CHEM, V262, P6500
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   LUCAS F, 1960, J MOL BIOL, V2, P339, DOI 10.1016/S0022-2836(60)80045-9
   Lundberg P, 2006, INT J PEPT RES THER, V12, P105, DOI 10.1007/s10989-005-9007-y
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Makela AR, 2006, J VIROL, V80, P6603, DOI 10.1128/JVI.00528-06
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Mandal BB, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355101
   Mandal BB, 2009, BIOMED MICRODEVICES, V11, P467, DOI 10.1007/s10544-008-9252-x
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Medina-Kauwe LK, 2003, ADV DRUG DELIVER REV, V55, P1485, DOI 10.1016/j.addr.2003.07.010
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MICHAEL SI, 1994, GENE THER, V1, P223
   Nagarsekar A, 2002, J BIOMED MATER RES, V62, P195, DOI 10.1002/jbm.10272
   NARA M, 1994, FEBS LETT, V349, P84, DOI 10.1016/0014-5793(94)00645-8
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Numata K., SILK BASED GEN UNPUB
   Numata K, 2010, J CONTROL RELEASE, V146, P136, DOI 10.1016/j.jconrel.2010.05.006
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Oba M, 2007, BIOCONJUGATE CHEM, V18, P1415, DOI 10.1021/bc0700133
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Oupicky D, 1999, BIOCONJUGATE CHEM, V10, P764, DOI 10.1021/bc990007+
   Pasqualini R, 1996, MOL PSYCHIATR, V1, P423
   Pilch J, 2006, P NATL ACAD SCI USA, V103, P2800, DOI 10.1073/pnas.0511219103
   PLANK C, 1994, J BIOL CHEM, V269, P12918
   Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Pritchard E.M., J CONTROL RELEASE ON
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Renigunta A, 2006, BIOCONJUGATE CHEM, V17, P327, DOI 10.1021/bc050263o
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Ruoslahti E, 2002, DRUG DISCOV TODAY, V7, P1138, DOI 10.1016/S1359-6446(02)02501-1
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Shewry P.R., 2004, ELASTOMERIC PROTEINS, P136
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tanaka C, 2009, BIOMACROMOLECULES, V10, P923, DOI 10.1021/bm801439t
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vives E, 2008, BBA-REV CANCER, V1786, P126, DOI 10.1016/j.bbcan.2008.03.001
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P6099, DOI 10.1073/pnas.89.13.6099
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Wyman TB, 1997, BIOCHEMISTRY-US, V36, P3008, DOI 10.1021/bi9618474
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zauner W, 1998, ADV DRUG DELIVER REV, V30, P97, DOI 10.1016/S0169-409X(97)00110-5
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
NR 143
TC 170
Z9 176
U1 9
U2 334
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 30
PY 2010
VL 62
IS 15
BP 1497
EP 1508
DI 10.1016/j.addr.2010.03.009
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 707MP
UT WOS:000286291000007
PM 20298729
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Antunes, RA
   Rodas, ACD
   Lima, NB
   Higa, OZ
   Costa, I
AF Antunes, R. A.
   Rodas, A. C. D.
   Lima, N. B.
   Higa, O. Z.
   Costa, I.
TI Study of the corrosion resistance and in vitro biocompatibility of PVD
   TiCN-coated AISI 316 L austenitic stainless steel for orthopedic
   applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE TiCN coating; PVD; 316 L; Corrosion; Biomaterial
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; MECHANICAL-PROPERTIES;
   ELECTRONIC-STRUCTURE; PASSIVE FILMS; COATINGS; TIN; BEHAVIOR; TITANIUM;
   MULTILAYER; ALLOY
AB The aim of the present work was to study the corrosion resistance in Hanks' solution and the in vitro biocompatibility of a TiCN-coated AISI 316 L stainless steel. The electrochemical behavior was assessed using potentiodynamic polarization and electrochemical impedance spectroscopy. Cytotoxicity and genotoxicity tests were performed to evaluate the potential biocompatibility of the specimens. TiCN morphology was investigated using scanning electron microscopy (SEM). Bare 316 L specimens were also evaluated for comparison. The results showed that the film morphology strongly influences the electrochemical behavior of the coated underlying metal. TiCN-coated specimens presented neither cytotoxicity nor genotoxicity. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Antunes, R. A.] Fed Univ ABC UFABC, Engn Modeling & Appl Social Sci Ctr CECS, BR-09210170 Santo Andre, SP, Brazil.
   [Rodas, A. C. D.; Lima, N. B.; Higa, O. Z.; Costa, I.] IPEN CNEN SP, BR-05508900 Sao Paulo, Brazil.
RP Antunes, RA (reprint author), Fed Univ ABC UFABC, Engn Modeling & Appl Social Sci Ctr CECS, BR-09210170 Santo Andre, SP, Brazil.
EM renato.antunes@ufabc.edu.br
RI Antunes, Renato/K-4738-2015; Costa, Isolda/E-8506-2012; Rodas,
   Andrea/E-1130-2012; Biofabris, Inct/I-2418-2013
OI Antunes, Renato/0000-0003-1540-6495; Costa, Isolda/0000-0002-4987-3334;
   Batista de Lima, Nelson/0000-0002-6444-9224
FU CNPq (National Council of Scientific and Technological Development)
FX The authors are thankful to Bodycote Brasimet S. A., especially to Dr.
   Ronaldo Ruas for the deposition of TiCN films and to CNPq (National
   Council of Scientific and Technological Development) for the financial
   support to this work.
CR ANTUNES RA, 2006, THESIS U SAO PAULO
   Bayon R, 2009, TRIBOL INT, V42, P591, DOI 10.1016/j.triboint.2008.06.015
   Belo MD, 1998, CORROS SCI, V40, P447, DOI 10.1016/S0010-938X(97)00158-3
   Belo MD, 1998, CORROS SCI, V40, P481, DOI 10.1016/S0010-938X(98)00016-X
   Carmezim MJ, 2005, CORROS SCI, V47, P581, DOI 10.1016/j.corsci.2004.07.002
   Cheng Y, 2007, SURF COAT TECH, V201, P4909, DOI 10.1016/j.surfcoat.2006.07.216
   Donnelly N, 2000, MATER SCI FORUM, V325-3, P141, DOI 10.4028/www.scientific.net/MSF.325-326.141
   Fang TH, 2004, APPL SURF SCI, V228, P365, DOI 10.1016/j.apsusc.2004.01.053
   Feng HP, 2003, MAT SCI ENG A-STRUCT, V347, P123, DOI 10.1016/S0921-5093(02)00578-6
   Garriott ML, 2002, MUTAT RES-GEN TOX EN, V517, P123, DOI 10.1016/S1383-5718(02)00059-1
   Ge HH, 2003, APPL SURF SCI, V211, P321, DOI 10.1016/S0169-4332(03)00355-6
   Gispert MP, 2007, WEAR, V263, P1060, DOI 10.1016/j.wear.2006.11.036
   GRONING P, 1992, APPL SURF SCI, V62, P209, DOI 10.1016/0169-4332(92)90361-Z
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   HAKIKI NE, 1995, CORROS SCI, V37, P1809, DOI 10.1016/0010-938X(95)00084-W
   Hollstein F, 1999, SURF COAT TECH, V120, P672, DOI 10.1016/S0257-8972(99)00357-6
   *INT ORG STAND, 1992, 109933 ISO
   International Organization for Standardization, 1992, 109935 ISO
   *JCPDS, 1993, POWD DIFFR FIL
   Jeffery J. M., 1971, METHODS XRAY CRYSTAL
   Kannan S, 2003, MATER LETT, V57, P2382, DOI 10.1016/S0167-577X(02)01239-9
   KORHONEN AS, 1994, VACUUM, V45, P1031, DOI 10.1016/0042-207X(94)90015-9
   Li Y, 2003, CORROS SCI, V45, P1367, DOI 10.1016/S0010-938X(02)00223-8
   Liskiewicz T, 2005, WEAR, V259, P835, DOI 10.1016/j.wear.2005.02.071
   Liu C, 2003, CORROS SCI, V45, P1243, DOI 10.1016/S0010-938X(02)00213-5
   Liu C, 1995, SURF COAT TECH, V76-77, P615, DOI 10.1016/0257-8972(95)02545-6
   Liu CL, 2007, CORROS SCI, V49, P3783, DOI 10.1016/j.corsci.2007.03.041
   Marin E, 2009, ELECTROCHEM COMMUN, V11, P2060, DOI 10.1016/j.elecom.2009.08.052
   MATTOX D, 2002, MET FINISH, V100, P396
   Merl DK, 2004, ELECTROCHIM ACTA, V49, P1527, DOI 10.1016/j.electacta.2003.11.012
   Montemor MF, 2000, CORROS SCI, V42, P1635, DOI 10.1016/S0010-938X(00)00012-3
   NOYAN IC, 1987, RESIDUAL STRESS MEAS
   *ORG EC COOP DEV, IECD GUID TEST CHEM, V487
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Perez FJ, 2002, SURF COAT TECH, V155, P250
   Polcar T, 2006, WEAR, V260, P40, DOI 10.1016/j.wear.2004.12.031
   Precht W, 1996, VACUUM, V47, P867, DOI 10.1016/0042-207X(96)00084-X
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   SCHNEIDER JM, 1995, SURF COAT TECH, V74-5, P312, DOI 10.1016/0257-8972(95)08238-7
   Senna LF, 1997, SURF COAT TECH, V94-5, P390, DOI 10.1016/S0257-8972(97)00447-7
   Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010
   Souto RM, 2000, CORROS SCI, V42, P2201, DOI 10.1016/S0010-938X(00)00057-3
   Surviliene S, 2004, SURF COAT TECH, V176, P193, DOI 10.1016/S0257-8972(03)00716-3
   Vacandio F, 2000, THIN SOLID FILMS, V359, P221, DOI 10.1016/S0040-6090(99)00763-4
   Xulin Sun, 1997, Journal of Biomedical Materials Research, V34, P9, DOI 10.1002/(SICI)1097-4636(199701)34:1<9::AID-JBM2>3.0.CO;2-V
   Yang DZ, 2005, CURR APPL PHYS, V5, P417, DOI 10.1016/j.cap.2004.11.002
   YILBAS BS, 1995, CORROS SCI, V37, P1627, DOI 10.1016/0010-938X(95)00065-R
NR 47
TC 53
Z9 56
U1 2
U2 31
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 25
PY 2010
VL 205
IS 7
BP 2074
EP 2081
DI 10.1016/j.surfcoat.2010.08.101
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 708DY
UT WOS:000286343100039
DA 2018-10-19
ER

PT J
AU Park, BJ
   Seo, HJ
   Kim, J
   Kim, HL
   Kim, JK
   Choi, JB
   Han, I
   Hyun, SO
   Chung, KH
   Park, JC
AF Park, Bong Joo
   Seo, Hyok Jin
   Kim, Jungsung
   Kim, Hye-Lee
   Kim, Jeong Koo
   Choi, Jae Bong
   Han, Inho
   Hyun, Soon O.
   Chung, Kie-Hyung
   Park, Jong-Chul
TI Cellular responses of vascular endothelial cells on surface modified
   polyurethane films grafted electrospun PLGA fiber with microwave-induced
   plasma at atmospheric pressure
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th Asian-European International Conference on Plasma Surface
   Engineering
CY SEP 20-25, 2009
CL Busan, SOUTH KOREA
DE Polyurethane; Poly (D,L-lactic-co-glycolic acid); Human umbilical vein
   endothelial cells; Microwave-induced argon plasma
ID INDUCED ARGON PLASMA; SCAFFOLDS; ADHESION; POLY(LACTIDE-CO-GLYCOLIDE);
   FABRICATION; NANOFIBERS; BEHAVIORS; GELATIN; GROWTH
AB To improve cell-material interaction, the surface modification of materials in tissue engineering is carried out by change in chemical structure or by ion-beam irradiation and plasma treatment. The modifications of biological surface, such as coating or peptide grafting, may also enhance endothelialization of biomaterial surfaces.
   In this study, the surface of polyurethane (PU) grafted with electrospun poly (D,L-lactic-co-glycolic acid) (PLGA) fibers (PU/PLGA) was modified with microwave-induced argon plasma and the PU/PLGA films with plasma modified surface were examined to investigate their effects on the attachment and growth of human umbilical vein endothelial cells (HUVECs) for applications in vascular tissue engineering.
   In comparison with the control, PU film with microwave plasma modified surface was more hydrophilic and the roughness of the surface was enhanced. Furthermore, the plasma treatment on PU/PLGA has significantly increased the attachment of HUVECs and proliferation of the cells was slightly enhanced as well. These results suggested that the surface of PU/PLGA films modified with plasma treatment can be effectively used as a biocompatible material for vascular tissue engineering application, although more in-depth studies are needed. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Park, Jong-Chul] Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
   [Park, Bong Joo; Seo, Hyok Jin; Kim, Jeong Koo] Inje Univ, Coll Biomed Sci & Engn, Bioogran Tissue Regenerat Project Team BK21, Gimhae 621749, South Korea.
   [Park, Bong Joo; Seo, Hyok Jin; Kim, Jeong Koo] Inje Univ, Coll Biomed Sci & Engn, Dept Biomed Engn, Gimhae 621749, South Korea.
   [Kim, Jungsung; Kim, Hye-Lee; Park, Jong-Chul] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
   [Choi, Jae Bong] Hansung Univ, Div Ind & Syst Engn, Seoul 136792, South Korea.
   [Han, Inho] Korea Univ, Inst Clin Dent Res, Seoul 152703, South Korea.
   [Hyun, Soon O.; Chung, Kie-Hyung] Korea Accelerator & Plasma Res Assoc, Physicotechnol Lab, Cheorwon Gun, Gangwon Do, South Korea.
RP Park, JC (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
EM parkjc@yuhs.ac
CR Bini TB, 2006, J MATER SCI, V41, P6453, DOI 10.1007/s10853-006-0714-3
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   DEJUN L, 1994, APPL SURF SCI, V78, P195
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lim HR, 2008, SURF COAT TECH, V202, P5768, DOI 10.1016/j.surfcoat.2008.06.115
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Nakao A, 1996, SURF INTERFACE ANAL, V24, P252, DOI 10.1002/(SICI)1096-9918(199604)24:4<252::AID-SIA113>3.0.CO;2-R
   NICHOLS NK, 1981, T AM SOC ART INT ORG, V27, P208
   Ozeki E, 1990, ASAIO Trans, V36, pM294
   Park BJ, 2003, PHYS PLASMAS, V10, P4539, DOI 10.1063/1.1613655
   PATTERSON RB, 1995, ASAIO J, V41, pM625, DOI 10.1097/00002480-199507000-00086
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Rowlands AS, 2007, BIOMATERIALS, V28, P2109, DOI 10.1016/j.biomaterials.2006.12.032
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   VACANTI CA, 1996, BIOMATERIALS FORUM, V18, P17
   VENUGOPAL J, 2005, J NANOENG NANOSYST, V218, P36
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
NR 25
TC 10
Z9 11
U1 1
U2 34
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 25
PY 2010
VL 205
SU 1
SI SI
BP S222
EP S226
DI 10.1016/j.surfcoat.2010.07.087
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 708DZ
UT WOS:000286343200045
DA 2018-10-19
ER

PT J
AU Lee, JS
   Johnson, AJW
   Murphy, WL
AF Lee, Jae Sung
   Johnson, Amy J. Wagoner
   Murphy, William L.
TI A Modular, Hydroxyapatite-Binding Version of Vascular Endothelial Growth
   Factor
SO ADVANCED MATERIALS
LA English
DT Article
ID STEM-CELL DIFFERENTIATION; BONE REGENERATION; ANGIOGENESIS; VEGF;
   SURFACES; ENHANCEMENT; DELIVERY; PROTEIN; MODEL; BIOCERAMICS
AB We report a modular peptide that mimics the pro-angiogenic properties of vascular endothelial growth factor and the hydroxyapatite-binding ability of bone protein osteocalcin. It binds rapidly and efficiently to hydroxyapatite, and locally induces early pro-angiogenic activities, including endothelial cell proliferation and migration both when it exists in a soluble form and when it is immobilized on a hydroxyapatite biomaterial.
C1 [Lee, Jae Sung; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53792 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA.
   [Johnson, Amy J. Wagoner] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.
RP Murphy, WL (reprint author), Univ Wisconsin, Dept Biomed Engn, 1550 Engn Dr, Madison, WI 53706 USA.
EM wlmurphy@wisc.edu
RI Wagoner Johnson, Amy/C-3472-2008; Murphy, William/I-4096-2014; Yang,
   Zengchao/H-3884-2011
OI Wagoner Johnson, Amy/0000-0001-8396-3803; 
FU AO Research Foundation [F-07-65M]; Wallace H. Coulter Foundation
FX The authors gratefully acknowledge funding from the AO Research
   Foundation (Grant No. F-07-65M) and the Wallace H. Coulter Foundation
   (Translational Research Partnership Grant).
CR Alt V, 2004, J CONTROL RELEASE, V99, P103, DOI 10.1016/j.jconrel.2004.06.017
   Anderson SM, 2009, BIOMATERIALS, V30, P4618, DOI 10.1016/j.biomaterials.2009.05.030
   BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chiang CK, 2010, ACTA BIOMATER, V6, P1904, DOI 10.1016/j.actbio.2009.12.005
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Dowd TL, 2001, BBA-MOL BASIS DIS, V1535, P153, DOI 10.1016/S0925-4439(00)00094-6
   Eckardt H, 2005, J BONE JOINT SURG BR, V87B, P1434, DOI 10.1302/0301-620X.87B10
   Gerber HP, 1999, NAT MED, V5, P623
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hossain M, 2005, BIOMATERIALS, V26, P2595, DOI 10.1016/j.biomaterials.2004.07.051
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JS, 2009, ANGEW CHEM INT EDIT, V48, P6266, DOI 10.1002/anie.200901618
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Lowenstam HA, 1989, BIOMINERALIZATION
   Lu Y, 2009, ARTHROSCOPY, V25, P1427, DOI 10.1016/j.arthro.2009.06.008
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   POSER JW, 1979, J BIOL CHEM, V254, P431
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   RIPAMONTI U, 1993, BIOCHEM BIOPH RES CO, V193, P509, DOI 10.1006/bbrc.1993.1653
   Santulli G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-41
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Sumner DR, 2006, J BONE JOINT SURG AM, V88A, P806, DOI 10.2106/JBJS.E.00846
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Zambonin G, 1999, ACTA ORTHOP SCAND, V70, P217, DOI 10.3109/17453679909011266
NR 37
TC 46
Z9 46
U1 0
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD DEC 21
PY 2010
VL 22
IS 48
BP 5494
EP 5498
DI 10.1002/adma.201002970
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 695UF
UT WOS:000285397400009
PM 20941802
DA 2018-10-19
ER

PT J
AU Kim, MK
   Kim, JJ
   Shin, US
   Kim, HW
AF Kim, Mi-Kyung
   Kim, Jung-Ju
   Shin, Ueon Sang
   Kim, Hae-Won
TI Production of a biomimetic apatite nanotube mesh via biotemplating a
   polymer nanofiber mesh
SO MATERIALS LETTERS
LA English
DT Article
DE Hydroxyapatite; Nanotube; Bone substitutes; Bioceramics
ID TISSUE REGENERATION; BONE
AB Here, we report the preparation of hydroxyapatite nanotubes for specific use as bone regeneration material. The nanofiber mesh of a polymer (polycaprolactone) used as a template was mineralized within solutions via a biomimetic process. A subsequent heat-treatment (over 500 degrees C) completely eliminated the inner polymer, resulting in preserving the surface mineral phase in the form of nanotubes. The nanotubes had diameters of hundreds of nanometers with nonwoven mesh, replicating the initial nanofiber template. Furthermore, the nanotubes revealed a phase of poorly crystallized apatite, mimicking biological bone mineral. The developed biomimetic apatite nanotubes may be useful for bone regeneration as a new type of biomaterial. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kim, Hae-Won] Dankook Univ, Grad Sch, Biomat & Tissue Engn Lab, Dept Nanobiomed Sci, Seoul, South Korea.
   [Kim, Mi-Kyung; Kim, Jung-Ju; Shin, Ueon Sang; Kim, Hae-Won] Dankook Univ, Grad Sch, WCU Res Ctr, Seoul, South Korea.
   [Kim, Mi-Kyung; Kim, Jung-Ju; Shin, Ueon Sang; Kim, Hae-Won] Dankook Univ, ITREN, Seoul, South Korea.
   [Kim, Hae-Won] Dankook Univ, Sch Dent, Dept Biomat Sci, Seoul, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Grad Sch, Biomat & Tissue Engn Lab, Dept Nanobiomed Sci, Seoul, South Korea.
EM kimhw@dku.edu
FU Dankook University
FX This work was supported by the research fund of Dankook University in
   2009.
CR Hench L.L., 1998, AM CERAM SOC BULL, V81
   HENGST V, 2007, STORM G INTER PHARM, V331, P224
   KIM H, 2006, KNOWLES JC J BLAMED, V79, P643
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee HH, 2008, J MATER SCI-MATER M, V19, P3029, DOI 10.1007/s10856-008-3435-0
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   SHIN KS, 2007, KOHN DH J BLAMED MAT, V83, P1076
   YU HS, 2009, KIM HW MAT CHEM THY, V113, P873
   Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709
NR 10
TC 4
Z9 4
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD DEC 15
PY 2010
VL 64
IS 23
BP 2655
EP 2658
DI 10.1016/j.matlet.2010.05.021
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 677DI
UT WOS:000283968900027
DA 2018-10-19
ER

PT J
AU Qiu, DL
   Wang, AP
   Yin, YS
AF Qiu, Deliang
   Wang, Aiping
   Yin, Yansheng
TI Characterization and corrosion behavior of hydroxyapatite/zirconia
   composite coating on NiTi fabricated by electrochemical deposition
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE NiTi; Hydroxyapatite; Zirconia; Coating; Corrosion
ID BIOMATERIAL APPLICATIONS; TITANIUM; ELECTRODEPOSITION; METALS; ALLOY
AB NiTi alloy is used as biomaterial due to its unique properties, but the high content of Ni (about 50 at.%) in biomedical NiTi is concerned. Hydroxyapatite and hydroxyapatite/zirconia composite coatings were directly electrodeposited on NiTi alloy surface. The coated samples were characterized using X-ray diffraction, scanning electron microscopy, infrared spectroscopy, bonding strength test, polarization and EIS. Results showed that when ZrO(2) was added into the electrolyte, morphology of HAP was changed from thin flake-flower-like crystals to needle-flower-like crystals, and coating was denser. Besides, HAP crystal grains in the coating were preferentially arranged in the [001] direction. Addition of ZrO(2) could improve the bonding strength between the coating and the substrate. Corrosion resistance of NiTi in the simulated body fluid at 37 degrees C was significantly improved by almost 60 times by electrodeposition of the hydroxyapatite/zirconia composite coating. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Qiu, Deliang; Wang, Aiping] Ocean Univ China, Inst Mat Sci & Engn, Qingdao 266100, Peoples R China.
   [Yin, Yansheng] Shanghai Maritime Univ, Inst Marine Mat Sci & Engn, Shanghai 200135, Peoples R China.
RP Yin, YS (reprint author), Ocean Univ China, Inst Mat Sci & Engn, Qingdao 266100, Peoples R China.
EM yys2006@ouc.edu.cn
FU Innovative Foundation of Shandong Province [200703104]; Key Foundation
   of Qingdao [09-1-3-38-jch]
FX This work was supported by Innovative Foundation of Shandong Province
   (200703104) and Key Foundation of Qingdao (09-1-3-38-jch).
CR Blackwood DJ, 2009, MAT SCI ENG C-BIO S, V29, P1233, DOI 10.1016/j.msec.2008.10.015
   Bonora PL, 1996, ELECTROCHIM ACTA, V41, P1073, DOI 10.1016/0013-4686(95)00440-8
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Fu L, 2000, SURF COAT TECH, V127, P66, DOI 10.1016/S0257-8972(00)00559-4
   Hu R, 2007, J BIOMED MATER RES A, V80A, P687, DOI 10.1002/jbm.a.30891
   Jiao MJ, 2009, MATER LETT, V63, P2286, DOI 10.1016/j.matlet.2009.07.048
   Kasano Fujihiko, 1997, Auris Nasus Larynx, V24, P137, DOI 10.1016/S0385-8146(96)00026-0
   Kwok CT, 2009, APPL SURF SCI, V255, P6736, DOI 10.1016/j.apsusc.2009.02.086
   MacDonald J. R., 1986, IMPEDANCE SPECTROSCO
   MANSFELD F, 1993, 26 SOL SCHL
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   Miyazaki S, 1998, SHAPE MEMORY MAT, P267
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Ng KW, 2008, APPL SURF SCI, V254, P6725, DOI 10.1016/j.apsusc.2008.04.076
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wang J, 2010, SURF COAT TECH, V204, P2576, DOI 10.1016/j.surfcoat.2010.01.042
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Yahia L., 2000, SHAPE MEMORY IMPLANT
NR 24
TC 38
Z9 41
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 15
PY 2010
VL 257
IS 5
BP 1774
EP 1778
DI 10.1016/j.apsusc.2010.09.014
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 669KW
UT WOS:000283349200069
DA 2018-10-19
ER

PT J
AU Kowalczuk, D
   Ginalska, G
   Golus, J
AF Kowalczuk, Dorota
   Ginalska, Grazyna
   Golus, Joanna
TI Characterization of the developed antimicrobial urological catheters
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Antimicrobial protection; Surface characterization; Catheters;
   Sparfloxacin
ID URINARY-TRACT-INFECTION; BACTERIAL ADHESION; HEPARIN; IMMOBILIZATION;
   BIOMATERIALS; PREVENTION; HYDROGEL; FILMS
AB Antimicrobial urological catheters were developed by the mixed, covalent and non-covalent binding of sparfloxacin (SPA) to heparin (HP) film which was first deposited on the latex surface of biomaterial. The SPA-HP modified surface was characterized by SEM analysis and ATR-Fourier transform infrared spectroscopy. For the antimicrobial prevention, SPA as an antibiotic with a broad antimicrobial spectrum was chosen. Antimicrobial activity of antibiotic-modified catheter against Staphylococcus aureus, Staphylococcus epidermidis and Escherichia coli strains was assessed using various procedures. On the basis of the inhibition zone and diffusion assays the efficacy around the modified catheters was demonstrated. The test samples clearly showed an antibacterial activity against all tested bacterial stains for a least one month. Inhibition of the bacterial colonization on the modified catheter surface was proved by the biofilm test. Antimicrobial activity of SPA-treated catheter surface was also quantitatively evaluated according to standard method of ISO based on JIS. The R-values were found to be higher than 3.8. The performed research indicated that the immobilization of SPA on the catheter surface by means of the mixed-type bonds resulted in stable antibacterial protection of the urological catheters for a long time. (c) 2010 Elsevier B.V. All rights reserved.
C1 [Kowalczuk, Dorota] Med Univ Lublin, Chair Med Chem, PL-20090 Lublin, Poland.
   [Ginalska, Grazyna; Golus, Joanna] Med Univ Lublin, Chair Biochem & Biotechnol, PL-20093 Lublin, Poland.
   [Ginalska, Grazyna; Golus, Joanna] Med Univ Lublin, Dept Biochem & Biotechnol, PL-20093 Lublin, Poland.
   [Kowalczuk, Dorota] Med Univ Lublin, Dept Med Chem, PL-20090 Lublin, Poland.
RP Kowalczuk, D (reprint author), Med Univ Lublin, Chair Med Chem, Jaczewskiego St 4, PL-20090 Lublin, Poland.
EM dorota.kowalczuk@am.lublin.pl
OI Ginalska, Grazyna/0000-0002-9961-4226; Kowalczuk,
   Dorota/0000-0001-7458-5054
FU Polish Ministry of Scientific Research and Information Technology, State
   Committee for Scientific Research [N N405 385037]
FX This research was supported by a grant from the Polish Ministry of
   Scientific Research and Information Technology, State Committee for
   Scientific Research KBN No N N405 385037.
CR Aksoy AE, 2008, MACROMOL SYMP, V269, P145, DOI 10.1002/masy.200850918
   [Anonymous], 2007, 221962007E ISO
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Bhupathiraju VK, 1999, J MICROBIOL METH, V37, P231, DOI 10.1016/S0167-7012(99)00069-X
   CHENOWETH CE, 2005, CATHETER RELATED INF, P551
   Choong S, 2001, INT J ANTIMICROB AG, V17, P305, DOI 10.1016/S0924-8579(00)00348-4
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Dorofeev V.L., 2004, PHARM CHEM J, V38, P693, DOI DOI 10.1007/S11094-005-0063-6
   Eydelnant IA, 2008, LANGMUIR, V24, P10273, DOI 10.1021/la801525d
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   GINALSKA G, 2010, B URZEDU PATENTOWEGO, V9, P5
   *JIS, 2001, Z28012000E JIS JAP S
   *JIS, 2005, Z28012000V10 JIS IND
   JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145
   Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009
   LOPEZLOPEZ G, 1991, DIAGN MICR INFEC DIS, V14, P1, DOI 10.1016/0732-8893(91)90078-T
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Nicolle LE, 2005, DRUG AGING, V22, P627, DOI 10.2165/00002512-200522080-00001
   Pascual A, 2002, CLIN MICROBIOL INFEC, V8, P256, DOI 10.1046/j.1469-0691.2002.00418.x
   Raad I, 1996, J INFECT DIS, V173, P418, DOI 10.1093/infdis/173.2.418
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   Rose SF, 2005, J MATER SCI-MATER M, V16, P1003, DOI 10.1007/s10856-005-4755-y
   Sekiguchi Y, 2007, INT J UROL, V14, P426, DOI 10.1111/j.1442-2042.2007.01743.x
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   Sushko N. I., 1994, Journal of Applied Spectroscopy, V61, P704, DOI 10.1007/BF02606421
   Tenke P, 2006, WORLD J UROL, V24, P13, DOI 10.1007/s00345-005-0050-2
   VISSER MR, 1991, ANTIMICROB AGENTS CH, V35, P858, DOI 10.1128/AAC.35.5.858
   Warren JW, 2001, INT J ANTIMICROB AG, V17, P299, DOI 10.1016/S0924-8579(00)00359-9
   Yang SH, 2007, J BIOMED MATER RES B, V83B, P304, DOI 10.1002/jbm.b.30796
   Yao Y, 2008, J BIOMED MATER RES B, V85B, P453, DOI 10.1002/jbm.b.30965
NR 30
TC 32
Z9 32
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD DEC 15
PY 2010
VL 402
IS 1-2
BP 175
EP 183
DI 10.1016/j.ijpharm.2010.10.014
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 721GI
UT WOS:000287341200023
PM 20951780
DA 2018-10-19
ER

PT J
AU Pinheiro, ALB
   Aciole, GTS
   Cangussu, MCT
   Pacheco, MTT
   Silveira, L
AF Pinheiro, Antonio L. B.
   Aciole, Gilberth T. S.
   Cangussu, Maria Cristina T.
   Pacheco, Marcos T. T.
   Silveira, Landulfo, Jr.
TI Effects of laser photherapy on bone defects grafted with mineral
   trioxide aggregate, bone morphogenetic proteins, and guided bone
   regeneration: A Raman spectroscopic study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; laser; LLLT; MTA
ID END FILLING MATERIALS; RODENT MODEL; IN-VIVO; TISSUE REGENERATION;
   PERIAPICAL LESIONS; DENTAL IMPLANTS; BOVINE BONE; GUINEA-PIGS; REPAIR;
   LIGHT
AB We have used Raman analysis to assess bone healing on different models. Benefits on the isolated or combined use of mineral trioxide aggregate, bone morphogenetic proteins, guided bone regeneration and laser on bone repair have been reported, but not their combination. We studied peaks of hydroxyapatite and CH groups on defects grafted with MTA, treated or not with laser, BMPs, and GBR. Ninety rats were divided in 10 groups each, subdivided into three subgroups. Laser (lambda 850 nm) was applied at every other day for 2 weeks. Raman readings were taken at the surface of the defect. Statistical analysis (CHA) showed significant differences between all groups (p = 0.001) and between Group II and all other (p < 0.001), but not with Group X (p = 0.09). At day 21 differences were seen between all groups (p = 0.031) and between Groups VIII and X when compared with Groups VI (p = 0.03), V (p < 0.001), IV (p < 0.001), and IX (p = 0.04). At the end of the experimental period no significant differences were seen. On regards CH, significant differences were seen at the 15(th) day (p = 0.002) and between Group II and all other groups (p < 0.0001) but not with control. Advanced maturation on irradiated bone is because of increased secretion of calcium hydroxyapatite (CHA) that is indicative of greater calcification and resistance of the bone. We conclude that the association of the MTA with laser phototherapy (LPT) and/or not with GBR resulted in a better bone repair. The use of the MTA associated to IR LPT resulted in a more advanced and quality bone repair. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 10411047, 2010.
C1 [Pinheiro, Antonio L. B.; Aciole, Gilberth T. S.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.; Pacheco, Marcos T. T.; Silveira, Landulfo, Jr.] Univ Camilo Castelo Branco, Nucleo Parque Tecnol Sao Jose dos Campos, BR-12245230 Sao Jose Dos Campos, SP, Brazil.
   [Pinheiro, Antonio L. B.] Inst Nacl Ciancia & Tecnol Opt & Foton, BR-13560970 Sao Carlos, SP, Brazil.
   [Cangussu, Maria Cristina T.] Univ Fed Bahia, Sch Dent, BR-40110150 Salvador, BA, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Optica e fotonica, Inct/I-2419-2013; Pacheco, Marcos/B-7991-2012;
   Pinheiro, Antonio Luiz/A-1962-2008
OI Pacheco, Marcos/0000-0002-1725-4803; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321; Silveira, Jr., Landulfo/0000-0002-6616-3334
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170
   CORTELLINI P, 1993, J PERIODONTOL, V64, P387, DOI 10.1902/jop.1993.64.5.387
   De Moor RJG, 2002, INT ENDOD J, V35, P946, DOI 10.1046/j.1365-2591.2002.00597.x
   De Rossi A, 2005, ORAL SURG ORAL MED O, V99, P628, DOI 10.1016/j.tripleo.2004.07.018
   Economides N, 2003, INT ENDOD J, V36, P44, DOI 10.1046/j.0143-2885.2003.00611.x
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x
   Holland R, 1999, J ENDODONT, V25, P728, DOI 10.1016/S0099-2399(99)80118-6
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Oviir T, 2006, J ENDODONT, V32, P210, DOI 10.1016/j.joen.2006.10.036
   Park YJ, 2000, J BIOMED MATER RES, V51, P391, DOI 10.1002/1097-4636(20000905)51:3<391::AID-JBM13>3.0.CO;2-9
   PASTORI CM, 1996, REV BRAS CIENC ESTOM, V1, P51
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66
   Regan JD, 2002, INT ENDOD J, V35, P840, DOI 10.1046/j.1365-2591.2002.00582.x
   RESTREPO LL, 2001, AVALIACAO IMPLANTES
   Schwartz RS, 1999, J AM DENT ASSOC, V130, P967, DOI 10.14219/jada.archive.1999.0337
   Segundo T., 2000, RGO, V48, P217
   Silva AN, 2002, J CLIN LASER MED SUR, V20, P83, DOI 10.1089/104454702753768061
   STAHL SS, 1990, J CLIN PERIODONTOL, V17, P191, DOI 10.1111/j.1600-051X.1990.tb01085.x
   TAGA EM, 2001, BIOMATERIAIS USO CLI
   Torabinejad M, 1998, J ENDODONT, V24, P468, DOI 10.1016/S0099-2399(98)80048-4
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P569, DOI 10.1016/S0099-2399(06)80987-8
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
   TRONSTAD L, 1988, ENDOD DENT TRAUMATOL, V4, P241
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Zhu Q, 2000, J ENDODONT, V26, P404, DOI 10.1097/00004770-200007000-00006
NR 46
TC 29
Z9 30
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2010
VL 95A
IS 4
BP 1041
EP 1047
DI 10.1002/jbm.a.32930
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 677VX
UT WOS:000284023200008
PM 20872755
DA 2018-10-19
ER

PT J
AU Dias, GJ
   Mahoney, P
   Swain, M
   Kelly, RJ
   Smith, RA
   Ali, MA
AF Dias, George J.
   Mahoney, Patricia
   Swain, Michael
   Kelly, Robert J.
   Smith, Robert A.
   Ali, Mohammad A.
TI Keratin-hydroxyapatite composites: Biocompatibility, osseointegration,
   and physical properties in an ovine model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE keratin; bone graft substitute; osteoconduction; keratin-hydroxyapatite;
   soft tissue fixation
ID PLATES
AB Reconstituted keratin has shown promise as an orthopaedic biomaterial. This in vivo study investigates the biological response of composite materials prepared from reconstituted keratin containing a high content of hydroxyapatite (HA) (40 wt % HA), implanted for up to 18 weeks in the long bones of sheep. Keratin-HA composites were compared with a commercially available polylactic acid (PLA) HA composite (BIO RCI HA (R), Smith and Nephew). Porous keratin-HA materials displayed excellent biocompatibility and osseointegration, with full integration into bone by 12 weeks. Dense keratin-HA materials also showed excellent biocompatibility, with a more limited osseointegration, involving the penetration of new bone into the periphery of the implant after eight weeks. In contrast, the PLA-HA implant did not integrate with surrounding tissue. Microindentation showed that porous keratin-HA implants were initially soft, but became stiffer as new bone penetrated the implant from four weeks onwards. In contrast, although the initial rigidity of dense keratin-HA composites was maintained for at least two weeks, the implant material weakened after four weeks. The PLA-HA implant maintained its physical properties throughout the course of the trial. This study demonstrates the increased osseointegration/osteoconduction capacity of keratin-HA composites and provides further evidence supporting the suitability of keratin-based materials, such as bone graft substitutes and soft tissue fixation devices. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 1084-1095, 2010.
C1 [Dias, George J.; Mahoney, Patricia] Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand.
   [Swain, Michael] Univ Otago, Dept Dent, Dunedin, New Zealand.
   [Kelly, Robert J.; Smith, Robert A.] Keraplast Technol Ltd, San Antonio, TX 78258 USA.
   [Ali, Mohammad A.] AgRes, Biobased Mat Sci, Christchurch, New Zealand.
RP Dias, GJ (reprint author), Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand.
EM george.dias@anatomy.otago.ac.nz
RI Swain, Michael/J-7266-2017
OI Ali, Dr Azam/0000-0002-0136-6800
FU Keratec Ltd (New Zealand)
FX Contract grant sponsor: Keratec Ltd (New Zealand)
CR BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Dias GJ, 2003, J MATER SCI-MATER M, V14, P739, DOI 10.1023/A:1025076002948
   LIN Y, 2004, J BIOMECH, V37, P623
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   ROSEN A, 1981, BIOTECH HISTOCHEM, V56, P48
   Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X
   SUURONEN R, 1998, J ORAL MAXILLOFAC SU, V56, P614
NR 7
TC 26
Z9 27
U1 1
U2 29
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2010
VL 95A
IS 4
BP 1084
EP 1095
DI 10.1002/jbm.a.32908
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 677VX
UT WOS:000284023200013
PM 20878901
DA 2018-10-19
ER

PT J
AU Ode, A
   Duda, GN
   Glaeser, JD
   Matziolis, G
   Frauenschuh, S
   Perka, C
   Wilson, CJ
   Kasper, G
AF Ode, Andrea
   Duda, Georg N.
   Glaeser, Juliane D.
   Matziolis, Georg
   Frauenschuh, Simone
   Perka, Carsten
   Wilson, Cameron J.
   Kasper, Grit
TI Toward biomimetic materials in bone regeneration: Functional behavior of
   mesenchymal stem cells on a broad spectrum of extracellular matrix
   components
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stem cells; MSC functional behavior; extracellular; matrix;
   biomimetic materials; bone regeneration
ID INTEGRIN-MEDIATED INTERACTIONS; ENDOTHELIAL-CELLS; GENE-EXPRESSION;
   OSTEOGENIC DIFFERENTIATION; EPITHELIAL-CELLS; COLLAGEN-IV; IN-VITRO;
   ADHESION; FIBRONECTIN; SPECIFICITY
AB Bone defect treatments can be augmented by mesenchymal stem cell (MSC) based therapies. MSC interaction with the extracellular matrix (ECM) of the surrounding tissue regulates their functional behavior. Understanding of these specific regulatory mechanisms is essential for the therapeutic stimulation of MSC in vivo. However, these interactions are presently only partially understood. This study examined in parallel, for the first time, the effects on the functional behavior of MSCs of 13 ECM components from bone, cartilage and hematoma compared to a control protein, and hence draws conclusions for rational biomaterial design. ECM components specifically modulated MSC adhesion, migration, proliferation, and osteogenic differentiation, for example, fibronectin facilitated migration, adhesion, and proliferation, but not osteogenic differentiation, whereas fibrinogen enhanced adhesion and proliferation, but not migration. Subsequently, the integrin expression pattern of MSCs was determined and related to the cell behavior on specific ECM components. Finally, on this basis, peptide sequences are reported for the potential stimulation of MSC functions. Based on the results of this study, ECM component coatings could be designed to specifically guide cell functions. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 1114-1124,2010.
C1 [Ode, Andrea; Duda, Georg N.; Glaeser, Juliane D.; Matziolis, Georg; Perka, Carsten; Wilson, Cameron J.; Kasper, Grit] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Ode, Andrea; Duda, Georg N.; Glaeser, Juliane D.; Matziolis, Georg; Perka, Carsten; Wilson, Cameron J.; Kasper, Grit] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
   [Ode, Andrea; Duda, Georg N.; Perka, Carsten; Kasper, Grit] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
   [Frauenschuh, Simone] Tech Univ Berlin, Inst Biotechnol, Dept Bioproc Engn, D-1000 Berlin, Germany.
RP Duda, GN (reprint author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
EM georg.duda@charite.de
RI Wilson, Cameron/F-8713-2010; Duda, Georg/H-2085-2016; Ode,
   Andrea/B-6805-2015
OI Wilson, Cameron/0000-0002-5954-6820; Duda, Georg/0000-0001-7605-3908; 
FU Federal Ministry of Education and Research (BMBF) Excellence Cluster;
   Berlin-Brandenburg Center for Regenerative Therapies; AO Foundation
FX Contract grant sponsors: Federal Ministry of Education and Research
   (BMBF) Excellence Cluster, Berlin-Brandenburg Center for Regenerative
   Therapies, AO Foundation
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chernousov MA, 2003, EXP CELL RES, V291, P514, DOI 10.1016/S0014-4827(03)00409-9
   Coles CP, 2000, CAN J SURG, V43, P256
   Da Silva MS, 2003, CELL COMMUN ADHES, V10, P59, DOI 10.1080/15419060390260905
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   Flick MJ, 2004, EXP BIOL MED, V229, P1105
   FORSBERG E, 1994, EXP CELL RES, V213, P183, DOI 10.1006/excr.1994.1189
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hantgan RR, 2006, PROTEIN SCI, V15, P1893, DOI 10.1110/ps.052049506
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Hong H, 2008, J BIOMAT SCI-POLYM E, V19, P1279, DOI 10.1163/156856208786052380
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   JUNQZUEIRA LC, 2004, HISTOLOGIE
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   Klees RF, 2005, MOL BIOL CELL, V16, P881
   Klees RF, 2007, MATRIX BIOL, V26, P106, DOI 10.1016/j.matbio.2006.10.001
   KOISTINEN P, INTEGRINS CANC CELL
   Krishnamurti U, 1996, LAB INVEST, V74, P650
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015
   LIDA J, 1998, J BIOL CHEM, V273, P5955
   LODISH H, 2000, CELL MATRIX ADHESION
   Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470
   Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   ROBEY PG, 2002, PRINCIPLES BONE BIOL, P225
   Rubin K, 1996, EXTRACELLULAR MATRIX, P262
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Ruster B, 2005, STEM CELLS DEV, V14, P231, DOI 10.1089/scd.2005.14.231
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413
   Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100
   UNDERWOOD PA, 1995, BIOCHEM J, V309, P765, DOI 10.1042/bj3090765
   VENSTROM K, 1995, MOL BIOL CELL, V6, P419
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zeng ZZ, 2009, TRANSL ONCOL, V2, P8, DOI 10.1593/tlo.08187
   Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186
   Zou LJ, 2008, J ORTHOP RES, V26, P713, DOI 10.1002/jor.20539
NR 56
TC 40
Z9 39
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2010
VL 95A
IS 4
BP 1114
EP 1124
DI 10.1002/jbm.a.32909
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 677VX
UT WOS:000284023200016
PM 20878902
DA 2018-10-19
ER

PT J
AU Yang, XY
   Gan, YL
   Gao, X
   Zhao, L
   Gao, CY
   Zhang, XL
   Feng, YB
   Ting, K
   Gou, ZR
AF Yang, Xianyan
   Gan, Yilai
   Gao, Xin
   Zhao, Li
   Gao, Changyou
   Zhang, Xinli
   Feng, Yanbo
   Ting, Kang
   Gou, Zhongru
TI Preparation and characterization of trace elements-multidoped injectable
   biomimetic materials for minimally invasive treatment of osteoporotic
   bone trauma
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteoporotic trauma; trace elements; injectable biomaterials;
   multidoping; minimally invasive therapy
ID MARROW STROMAL CELLS; BIOACTIVE GLASS 45S5; IN-VITRO OSTEOBLAST;
   OF-THE-ART; CALCIUM-PHOSPHATE; OCTACALCIUM PHOSPHATE; OVARIECTOMIZED
   RATS; FEMALE RATS; STEM-CELLS; DISSOLUTION
AB It has always been a clinical challenge to use the proper implants or biomaterials to restore function to traumatized bone defects in patients with osteoporosis. In this study, we prepared the alginate chitosan/trace elements-multidoped octacalcium phosphate-bioglass (AT-CS/teOCP-BG) hydrogel composite as an injectable biomaterial and evaluated its physicochemical properties and biological performance. Trace amount of silicon, strontium, and zinc was first doped into the structure of OCP porous microspheres via a wet chemical reaction. The AT-CS complex was mechanically mixed with teOCP and then neutralized by the ionic products of bioglass 58S particles dissolution. Formulations of this novel composite presented in wet state have teOCP-BG contents ranging from 7.8 to 25.4% and AT-CS content of below 3.2%. The composite retained gel in culture medium at 37 degrees C, and the ratio of storage modulus and loss modulus (G'/G '') exhibited a marked increase with decreasing the amount of BG, signifying a pH-dependent enhancement of rheological properties and gel stability. After injection into rat femoral bone marrow cavity with minimal tissue invasion, new bone ingrowth was observed from radiologic images in the ovariectomized (OVXed) rats, which was significantly greater than that found in sham-operated animals within 8 weeks postoperatively. The fast bone regeneration phenomenon was observed in the OVXed rats by radiographic and microcomputerized tomography examination and histological analysis. These findings suggest that the AT-CS/teOCP-BG system might be used as an injectable biomaterial for minimally invasive treatment of osteoporosis-related (micro-)trauma. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 1170 1181, 2010.
C1 [Yang, Xianyan; Gan, Yilai; Gao, Xin; Gao, Changyou; Zhang, Xinli; Gou, Zhongru] Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou 310029, Zhejiang, Peoples R China.
   [Zhao, Li] Natl Tissue Engn Ctr China NTEDC, Shanghai 200235, Peoples R China.
   [Zhang, Xinli; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90095 USA.
   [Feng, Yanbo] Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou 325035, Peoples R China.
RP Gou, ZR (reprint author), Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou 310029, Zhejiang, Peoples R China.
EM zhrgou@zju.edu.n
OI Gao, Changyou/0000-0001-5084-7208
FU Science and Technology Department of Zhejiang Province Foundation
   [2008C21058]; National Science Foundation of China [20934003, 50902121];
   Fundamental Research Funds for the Central Universities [KYJD09027];
   Zhejiang University-Wenzhou Science and Technology Bureau Co-foundation
   [H20080039]
FX Contract grant sponsor: Science and Technology Department of Zhejiang
   Province Foundation;contract grant number: 2008C21058; Contract grant
   sponsor: National Science Foundation of China; contract grant numbers:
   20934003, 50902121; Contract grant sponsor: Fundamental Research Funds
   for the Central Universities; contract grant number: KYJD09027; Contract
   grant sponsor: Zhejiang University-Wenzhou Science and Technology Bureau
   Co-foundation; contract grant number: H20080039
CR Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906
   Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI [10.1089/ten.tea.2007.0339, 10.1089/tea.2007.0339]
   [Anonymous], 2000, NIH CONSENSUS STATE, V17, P1
   AXEN N, 2004, ADV BIOCERAMICS BIOC, P71
   Bielby RC, 2005, TISSUE ENG, V11, P479, DOI 10.1089/ten.2005.11.479
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 2007, J MATER CHEM, V17, P3980, DOI 10.1039/b706411j
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   Calomme M, 2006, CALCIFIED TISSUE INT, V78, P227, DOI 10.1007/s00223-005-0288-0
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014
   Goldhahn J, 2008, OSTEOPOROSIS INT, V19, P761, DOI 10.1007/s00198-007-0515-9
   Goldhahn J, 2008, BONE, V43, P343, DOI 10.1016/j.bone.2008.04.017
   Gou ZR, 2009, CRYSTENGCOMM, V11, P1585, DOI 10.1039/b823210p
   Gur A, 2002, J BONE MINER METAB, V20, P39, DOI 10.1007/s774-002-8445-y
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Hao H, 2004, BIOMATERIALS, V25, P431, DOI 10.1016/S0142-9612(03)00550-7
   HENCH LL, 2002, SCIENCE, V295, P2014
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   HOTT M, 1993, CALCIFIED TISSUE INT, V53, P174, DOI 10.1007/BF01321834
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P783
   Kobayashi K, 2005, EUR RADIOL, V15, P360, DOI 10.1007/s00330-004-2549-0
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   LIU C, 2008, BIOMED MATER
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   Maki K, 2002, AM J ORTHOD DENTOFAC, V122, P410, DOI 10.1067/mod.2002.126152
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Ohsawa K, 2004, J MATER SCI-MATER M, V15, P859, DOI 10.1023/B:JMSM.0000036273.37843.0c
   Ostuka M, 2008, J PHARM SCI, V97, P421
   Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Stefanidou M, 2006, ARCH TOXICOL, V80, P1, DOI 10.1007/s00204-005-0009-5
   Sun JS, 2004, BIOMATERIALS, V25, P607, DOI 10.1016/S0142-9612(03)00567-2
   Suzuki O, 2008, CURR MED CHEM, V15, P305, DOI 10.2174/092986708783497283
   Takada K, 2006, STEM CELLS, V24, P399, DOI 10.1634/stemcells.2005-0068
   TAN WH, 2007, ADV MATER, V19, P2697
   Teofilo JM, 2004, ARCH ORAL BIOL, V49, P755, DOI 10.1016/j.archoralbio.2004.02.013
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   Wang ML, 2007, SPINE J, V7, P466, DOI 10.1016/j.spinee.2006.06.400
   Yao J, 2005, J BIOMED MATER RES A, V75A, P794, DOI 10.1002/jbm.a.30494
   ZHAO Q, 2010, BIOMED MATER
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 54
TC 13
Z9 14
U1 3
U2 38
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2010
VL 95A
IS 4
BP 1170
EP 1181
DI 10.1002/jbm.a.32936
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 677VX
UT WOS:000284023200022
PM 20878988
DA 2018-10-19
ER

PT J
AU Cruz, DMG
   Gomes, M
   Reis, RL
   Moratal, D
   Salmeron-Sanchez, M
   Ribelles, JLG
   Mano, JF
AF Garcia Cruz, Dunia M.
   Gomes, M.
   Reis, Rui. L.
   Moratal, David
   Salmeron-Sanchez, Manuel
   Gomez Ribelles, Jose L.
   Mano, Joao F.
TI Differentiation of mesenchymal stem cells in chitosan scaffolds with
   double micro and macroporosity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; macroporous scaffolds; mesenchymal stem cells; tissue
   engineering
ID MARROW STROMAL CELLS; TISSUE ENGINEERING SCAFFOLDS; IN-VITRO
   DEGRADATION; OF-THE-ART; BONE-MARROW; OSTEOGENIC DIFFERENTIATION;
   COMPOSITE SCAFFOLDS; BIOABSORBABLE SCAFFOLDS; OSTEOBLAST CULTURES;
   ENZYME-IMMUNOASSAY
AB Bone Marrow mesenchymal stem cells can be induced to differentiate into osteoblasts to regenerate damaged bone tissue using tissue engineering techniques. In this study, we examine the use of chitosan scaffolds with double pore structure prepared by an innovative method that combines freeze gelation (that produces micropores) and particle leaching out technique (that produces interconnected spherical macropores) seeking to enhance the osteogenic differentiation of goat bone marrow stromal cells (GBMSCs). The double pore architecture of the scaffold was characterized by scanning electron microscopy (SEM), microcomputed tomography and confocal laser scanning microscopy. The obtained hierarchical pore structure allowed very efficient seeding of GBMSCs that are able to occupy the whole volume of the scaffold, showing good adhesion and proliferation. GBMSCs were differentiated into osteoblasts as indicated by alkaline phosphatase activity and osteocalcin expression. The results of this study demonstrate that chitosan scaffold may be promising biomaterial for bone regeneration. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 1182-1193,2010.
C1 [Garcia Cruz, Dunia M.; Salmeron-Sanchez, Manuel; Gomez Ribelles, Jose L.] Ctr Invest Principe Felipe, Valencia 46013, Spain.
   [Garcia Cruz, Dunia M.; Moratal, David; Salmeron-Sanchez, Manuel; Gomez Ribelles, Jose L.] Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, Valencia 46022, Spain.
   [Gomes, M.; Reis, Rui. L.; Mano, Joao F.] Univ Minho, Dept Polymer Engn, Res Grp 3Bs, P-4710057 Braga, Portugal.
   [Gomes, M.; Reis, Rui. L.; Mano, Joao F.] IBB, PT Govt Associated Lab, Braga, Portugal.
   [Salmeron-Sanchez, Manuel; Gomez Ribelles, Jose L.] CIBER BBN, Valencia, Spain.
RP Cruz, DMG (reprint author), Ctr Invest Principe Felipe, Autopista Saler 16, Valencia 46013, Spain.
EM dugarcru@ter.upv.es
RI Moratal, David/D-1853-2010; Reis, Rui L./A-8938-2008; Salmeron-Sanchez,
   Manuel/E-4680-2010; Gomes, Manuela/B-6282-2009; Group, 3Bs/E-4374-2012;
   Gomez Ribelles, Jose Luis/L-5629-2014; Mano, Joao/A-4418-2009
OI Moratal, David/0000-0002-2825-3646; Reis, Rui L./0000-0002-4295-6129;
   Salmeron-Sanchez, Manuel/0000-0002-8112-2100; Gomes,
   Manuela/0000-0002-2036-6291; Group, 3Bs/0000-0002-5195-3456; Gomez
   Ribelles, Jose Luis/0000-0001-9099-0885; Mano, Joao/0000-0002-2342-3765
FU Spanish Ministry of Education [MAT2007-66759-C03-01]; Science and
   Innovation Ministry [PTA2008-0943-P]; Generalitat Valenciana (Grups
   d'investigacio Emergents) [GV/2009/126]; VI National RDi Plan;
   Iniciativa Ingenio; Consolider Program; CIBER Actions; Instituto de
   Salud Carlos III; FCT [PTDC/QUI/68804/2006]
FX Contract grant sponsor: Spanish Ministry of Education (including the
   FEDER financial support); contract grant number: MAT2007-66759-C03-01;
   Contract grant sponsor: Science and Innovation Ministry; contract grant
   number: PTA2008-0943-P; Contract grant sponsor: Generalitat Valenciana
   (Grups d'investigacio Emergents); contract grant number: GV/2009/126;
   Contract grant sponsors: VI National R&D&D&i Plan 2008-2011, Iniciativa
   Ingenio 2010, Consolider Program, CIBER Actions, Instituto de Salud
   Carlos III (European Regional Development Fund); Contract grant sponsor:
   FCT project; contract grant number: PTDC/QUI/68804/2006
CR da Silva MLA, 2010, ACTA BIOMATER, V6, P1149, DOI 10.1016/j.actbio.2009.09.006
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Aubin Jane E., 1993, P1
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   BROUWER J, 1984, CLIN CHIM ACTA, V142, P21, DOI 10.1016/0009-8981(84)90097-4
   CHARQUES LN, 2006, ESTRA COMPUTER AIDED
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   da Silva RMP, 2008, MACROMOL CHEM PHYSIC, V209, P1463, DOI 10.1002/macp.200800191
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Fischer EM, 2003, TISSUE ENG, V9, P1179, DOI 10.1089/10763270360728080
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Cruz DMG, 2008, J BIOMED MATER RES B, V87B, P544, DOI 10.1002/jbm.b.31142
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Jiang T, 2010, J BIOMED MATER RES A, V93A, P1193, DOI 10.1002/jbm.a.32615
   JIANZHUANG L, 1991, INT C CIRC SYST CHIN, V1, P325
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kassem M, 2006, ANN NY ACAD SCI, V1067, P436, DOI 10.1196/annals.1354.062
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Krajewska B, 2005, SEP PURIF TECHNOL, V41, P305, DOI 10.1016/j.seppur.2004.03.019
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MARINO AD, 2005, BIOMATERIALS, V26, P5983
   MARKOSE ER, 1990, P NATL ACAD SCI USA, V87, P1701, DOI 10.1073/pnas.87.5.1701
   Marques AP, 2003, J MATER SCI-MATER M, V14, P167, DOI 10.1023/A:1022028114896
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Miyake T, 1997, J ANAT, V190, P239, DOI 10.1046/j.1469-7580.1997.19020239.x
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496, DOI 10.1210/endo-128-3-1496
   Peter M, 2010, CHEM ENG J, V158, P353, DOI 10.1016/j.cej.2010.02.003
   POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315
   PORSTMANN B, 1989, CLIN BIOCHEM, V22, P349, DOI 10.1016/S0009-9120(89)80031-1
   Qi X, 2004, CHINESE MED J-PEKING, V117, P576
   Reis RL, 1997, POLYM INT, V43, P347
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006
   Shin M, 2008, J BIOMED MATER RES A, V84A, P702, DOI 10.1002/jbm.a.31392
   Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Thein-Han WW, 2008, MATER SCI TECH-LOND, V24, P1062, DOI 10.1179/174328408X341753
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Yang F, 2006, POLYM DEGRAD STABIL, V91, P3065, DOI 10.1016/j.polymdegradstab.2006.08.008
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 61
TC 19
Z9 20
U1 1
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2010
VL 95A
IS 4
BP 1182
EP 1193
DI 10.1002/jbm.a.32906
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 677VX
UT WOS:000284023200023
PM 20925083
DA 2018-10-19
ER

PT J
AU Qin, Z
   Buehler, MJ
AF Qin, Zhao
   Buehler, Markus J.
TI Cooperative deformation of hydrogen bonds in beta-strands and beta-sheet
   nanocrystals
SO PHYSICAL REVIEW E
LA English
DT Article
ID SPIDER DRAGLINE SILK; TOUGHNESS; STRENGTH; ENERGY; SIMULATIONS;
   ORIENTATION; DESIGN
AB Beta-sheet protein domains are stabilized by weak hydrogen bonds, yet materials such as silk-whose ultimate tensile strength is controlled primarily by this secondary structure-can exceed the ultimate tensile strength of steel. Earlier work has suggested that this is because hydrogen bonds deform cooperatively within small protein domains to reach the maximum strength. Here we study the atomistic mechanism of this concerted deformation mechanism by applying an elastic structural model, used to solve the deformation field of the chemical bonds in beta-sheet nanostructures under stretching and thereby identify the number of hydrogen bonds that deform cooperatively. Through this analysis, we predict the optimal beta-strand and beta-sheet nanocrystal size associated with reaching the maximum usage of hydrogen bonds under loading applied per unit material volume. Our results, albeit based on a simple model and analytical equations, quantitatively agree with results based on experimental and molecular-dynamics studies and provide physical insight into the underlying molecular mechanisms of weak bond cooperativity. A comparison with the size of hydrogen bond clusters in biology reveals excellent agreement with the cluster sizes predicted by our analysis, suggesting that perhaps the confinement of hydrogen bonds into nanoscale elements is a universal biological design paradigm that turns weakness to strength. The parameters used in this study could be modified and applied to other protein and polymer structures, which imply potential applications of our model in understanding the physics of deformation and failure in a broader range of biological and polymer materials, as well as in de novo biomaterial design.
C1 [Qin, Zhao; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, Cambridge, MA 02139 USA.
RP Buehler, MJ (reprint author), MIT, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, 77 Massachusetts Ave,Room 1-253A&B, Cambridge, MA 02139 USA.
EM mbuehler@mit.edu
RI Qin, Zhao/B-4667-2010; Qin, Zhao/J-5338-2015; Buehler,
   Markus/C-4580-2008
OI Qin, Zhao/0000-0001-5696-8553; Buehler, Markus/0000-0002-4173-9659
FU AFOSR [FA9550081-0321]; ARO [W911NF-10-0127]; ONR [N000141010562,
   N000140810844]
FX Support from AFOSR (Grant No. FA9550081-0321), ARO (Grant No.
   W911NF-10-0127), and ONR (Grants No. N000141010562 and No.
   N000140810844) is acknowledged.
CR Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104
   [Anonymous], 2005, STEEL CONSTR MAN, V1
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Buehler M. J., 2009, NAT MATER, V8, P175
   DENNY M, 1976, J EXP BIOL, V65, P483
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   FOSSEY SA, 1991, BIOPOLYMERS, V31, P1529, DOI 10.1002/bip.360311309
   GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   LOMBARDI SJ, 1990, J ARACHNOL, V18, P297
   MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499
   Penel S, 2003, PROTEIN ENG, V16, P957, DOI 10.1093/protein/gzg147
   Qin Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198304
   Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591
   Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905
   Tooze J., 1999, INTRO PROTEIN STRUCT, P410
   Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
NR 31
TC 24
Z9 24
U1 0
U2 19
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2470-0045
EI 2470-0053
J9 PHYS REV E
JI Phys. Rev. E
PD DEC 14
PY 2010
VL 82
IS 6
AR 061906
DI 10.1103/PhysRevE.82.061906
PN 1
PG 9
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 713OE
UT WOS:000286746500010
PM 21230689
DA 2018-10-19
ER

PT J
AU Schexnailder, PJ
   Gaharwar, AK
   Bartlett, RL
   Seal, BL
   Schmidt, G
AF Schexnailder, Patrick J.
   Gaharwar, Akhilesh K.
   Bartlett, Rush L., II
   Seal, Brandon L.
   Schmidt, Gudrun
TI Tuning Cell Adhesion by Incorporation of Charged Silicate Nanoparticles
   as Cross-Linkers to Polyethylene Oxide
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adhesion; biocompatibility; layered silicates; nanocomposites;
   nanoparticles
ID NANOCOMPOSITE POLYMER HYDROGELS; POLY(ETHYLENE OXIDE); TISSUE;
   BIOMATERIALS; SURFACES; LAPONITE; PROTEIN; CLAY; MONTMORILLONITE;
   DISSOLUTION
AB Controlling cell adhesion on a biomaterial surface is associated with the long-term efficacy of an implanted material. Here we connect the material properties of nanocomposite films made from PEO physically cross-linked with layered silicate nanoparticles (Laponite) to cellular adhesion. Fibroblast cells do not adhere to pure PEO, but they attach to silicate containing nanocomposites. Under aqueous conditions, the films swell and the degree of swelling depends on the nanocomposite composition and film structure. Higher PEO compositions do not support cell proliferation due to little exposed silicate surfaces. Higher silicate compositions do allow significant cell proliferation and spreading. These bio-nanocomposites have potential for the development of biomedical materials that can control cellular adhesion.
C1 [Schexnailder, Patrick J.; Gaharwar, Akhilesh K.; Bartlett, Rush L., II; Seal, Brandon L.; Schmidt, Gudrun] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Schmidt, G (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
EM gudrun@purdue.edu
RI Gaharwar, Akhilesh/A-2002-2014; Gaharwar, Akhilesh/C-5856-2009
OI Gaharwar, Akhilesh/0000-0002-0284-0201; Gaharwar,
   Akhilesh/0000-0002-0284-0201
FU NSF [0711783]; Purdue Lynn Doctoral fellowship
FX The authors thank Prof. O. Akkus of the Weldon School of Biomedical
   Engineering, Purdue University, for use of his polarized microscope and
   Ms. Christine Gustafson for sample preparation. Work by the authors was
   supported by an NSF-CAREER award 0711783, to GS and by a Purdue Lynn
   Doctoral fellowship to PS. The authors declare that they have no
   conflict of interest.
CR Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Castelletto V, 2003, MACROMOLECULES, V36, P1694, DOI 10.1021/ma021396x
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Dundigalla A, 2005, MACROMOL RAPID COMM, V26, P143, DOI 10.1002/marc.200400489
   GAHARWAR AK, 2009, ADV FUNCT MATER, V20, P429
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Harris JM, 1992, POLY ETHYLENE GLYCOL
   HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003
   Helen W, 2007, BIOMATERIALS, V28, P2010, DOI 10.1016/j.biomaterials.2007.01.011
   Heyes CD, 2007, MOL BIOSYST, V3, P419, DOI 10.1039/b700055n
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Lai W, 2002, BIOMATERIALS, V23, P213, DOI 10.1016/S0142-9612(01)00097-7
   Lee WF, 2003, J APPL POLYM SCI, V89, P3652, DOI 10.1002/app.12624
   Lewkowitz-Shpuntoff HM, 2009, BIOMATERIALS, V30, P8, DOI 10.1016/j.biomaterials.2008.09.015
   Loizou E, 2006, MACROMOLECULES, V39, P1614, DOI 10.1021/ma0517547
   Loizou E, 2005, MACROMOLECULES, V38, P2047, DOI 10.1021/ma047411a
   Loizou E, 2010, MACROMOLECULES, V43, P1041, DOI 10.1021/ma9019448
   Loyens W, 2005, POLYMER, V46, P915, DOI 10.1016/j.polymer.2004.11.076
   Nelson A, 2004, LANGMUIR, V20, P10382, DOI 10.1021/la049323p
   Nelson A, 2004, LANGMUIR, V20, P2298, DOI 10.1021/la035268t
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ratna D, 2006, POLYMER, V47, P4068, DOI 10.1016/j.polymer.2006.02.040
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Stefanescu EA, 2006, POLYMER, V47, P7339, DOI 10.1016/j.polymer.2006.08.051
   Strawhecker KE, 2003, CHEM MATER, V15, P844, DOI 10.1021/cm0212865
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096
   THOMPSON DW, 1992, J COLLOID INTERF SCI, V151, P236, DOI 10.1016/0021-9797(92)90254-J
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu CJ, 2009, MACROMOL RAPID COMM, V30, P1492, DOI 10.1002/marc.200900163
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 41
TC 48
Z9 49
U1 2
U2 29
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 8
PY 2010
VL 10
IS 12
BP 1416
EP 1423
DI 10.1002/mabi.201000053
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 694QP
UT WOS:000285313000004
PM 20602416
DA 2018-10-19
ER

PT J
AU Desmet, T
   Billiet, T
   Berneel, E
   Cornelissen, R
   Schaubroeck, D
   Schacht, E
   Dubruel, P
AF Desmet, Tim
   Billiet, T.
   Berneel, Elke
   Cornelissen, Ria
   Schaubroeck, David
   Schacht, Etienne
   Dubruel, Peter
TI Post-Plasma Grafting of AEMA as a Versatile Tool to Biofunctionalise
   Polyesters for Tissue Engineering
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; films; gelatine; poly(epsilon-caprolactone); surface
   characterisation; surface modification
ID POLY-EPSILON-CAPROLACTONE; SYNTHETIC BIODEGRADABLE POLYMERS; AMINOLYZED
   POLY(L-LACTIC ACID); OF-THE-ART; SURFACE MODIFICATION; ACRYLIC-ACID;
   CELL-ADHESION; POLY(ETHYLENE-TEREPHTHALATE) FILMS; ENDOTHELIUM
   REGENERATION; MECHANICAL-PROPERTIES
AB In the last decade, substantial research in the field of post-plasma grafting surface modification has focussed on the introduction of carboxylic acids on surfaces by grafting acrylic acid (AAc). In the present work, we report on an alternative approach for biomaterial surface functionalisation. Thin poly-epsilon-caprolactone (PCL) films were subjected to a dielectric barrier discharge Ar-plasma followed by the grafting of 2-aminoethyl methacrylate (AEMA) under UV-irradiation. X-ray photoelectron spectroscopy (XPS) confirmed the presence of nitrogen. The ninhydrin assay demonstrated, both quantitatively and qualitatively, the presence of free amines on the surface. Confocal fluorescence microscopy (CFM), atomic force microscopy (AFM) and scanning electron microscopy (SEM) were used to visualise the grafted surfaces, indicating the presence of pAEMA. Static contact angle (SCA) measurements indicated a permanent increase in hydrophilicity. Furthermore, the AEMA grafted surfaces were applied for comparing the physisorption and covalent immobilisation of gelatin. CFM demonstrated that only the covalent immobilisation lead to a complete coverage of the surface. Those gelatin-coated surfaces obtained were further coated using fibronectin. Osteosarcoma cells demonstrated better cell-adhesion and cell-viability on the modified surfaces, compared to the pure PCL films.
C1 [Desmet, Tim; Billiet, T.; Schacht, Etienne; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   [Berneel, Elke; Cornelissen, Ria] Univ Ghent, Dept Anat Embryol Histol & Med Phys, B-9000 Ghent, Belgium.
   [Schaubroeck, David] Univ Ghent, ELIS, Ctr Microsyst Technol CMST, BE-9052 Ghent, Belgium.
RP Dubruel, P (reprint author), Univ Ghent, Polymer Chem & Biomat Res Grp, Krijgslaan 281 S4 Bis, B-9000 Ghent, Belgium.
EM peter.dubruel@ugent.be
OI Schaubroeck, David/0000-0001-9576-3091
FU Ghent University
FX For the fluorescence work, the authors would like to acknowledge the
   invaluable and charming help of Christopher J. Guerin, leader of the
   microscopy core facility, of the Flemish Institute of Biotechnology,
   Department of Molecular Biomedical Research. For XPS training the
   authors would like to thank Nico De Roo. A special thanks to Dr. Sandra
   Van Vlierberghe, Monica Rymaczek-Machal, Els Vanderleyden, Nele De Smet
   and many others, for the nice discussions, technical advice and
   suggestions. This research was funded by Ghent University.
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Amato I, 2007, BIOMATERIALS, V28, P3668, DOI 10.1016/j.biomaterials.2007.04.038
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chim H, 2006, INT J ORAL MAX SURG, V35, P928, DOI 10.1016/j.ijom.2006.03.024
   Choi HS, 2004, SURF COAT TECH, V182, P55, DOI 10.1016/S0257-8972(02)00880-6
   Chong MSK, 2007, MAT SCI ENG C-BIO S, V27, P309, DOI 10.1016/j.msec.2006.03.008
   DESMET T, 2008, TISSUE ENG ROLES MAT
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Detrait E, 1999, J BIOMED MATER RES, V45, P404, DOI 10.1002/(SICI)1097-4636(19990615)45:4<404::AID-JBM16>3.3.CO;2-W
   Duan Y, 2007, J BIOMAT SCI-POLYM E, V18, P1153, DOI 10.1163/156856207781554019
   FALLY F, 1995, J APPL POLYM SCI, V56, P597, DOI 10.1002/app.1995.070560509
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   Gupta B, 2002, J APPL POLYM SCI, V85, P1874, DOI 10.1002/app.10739
   Gupta B, 2001, J APPL POLYM SCI, V81, P2993, DOI 10.1002/app.1749
   Gupta B, 2008, J APPL POLYM SCI, V107, P324, DOI 10.1002/app.26745
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hsu SH, 2007, J BIOMED MATER RES B, V80B, P519, DOI 10.1002/jbm.b.30626
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Iwasaki Y, 2002, J BIOMAT SCI-POLYM E, V13, P323, DOI 10.1163/156856202320176556
   Kim HJ, 2005, CLIN ORAL IMPLAN RES, V16, P557, DOI 10.1111/j.1600-0501.2005.01164.x
   Luetzow K, 2007, J BIOMECH, V40, pS80, DOI 10.1016/j.jbiomech.2007.02.022
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027
   Marletta G, 2005, BIOMATERIALS, V26, P4793, DOI 10.1016/j.biomaterials.2004.11.047
   Olah L, 2006, POLYM ADVAN TECHNOL, V17, P889, DOI 10.1002/pat.768
   Perale G, 2008, J APPL POLYM SCI, V108, P1591, DOI 10.1002/app.27875
   POKHARNA HK, 1990, J BIOACT COMPAT POLY, V5, P42
   Ren JR, 2008, APPL SURF SCI, V255, P263, DOI 10.1016/j.apsusc.2008.06.181
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011
   Shin YM, 2008, BIOMACROMOLECULES, V9, P1772, DOI 10.1021/bm701410g
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Sun JJ, 2007, J MATER SCI-MATER M, V18, P1017, DOI 10.1007/s10856-007-0155-9
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   Thompson KL, 2008, POLYM DEGRAD STABIL, V93, P1460, DOI 10.1016/j.polymdegradstab.2008.05.013
   Tiaw KS, 2005, BIOMATERIALS, V26, P763, DOI 10.1016/j.biomaterials.2004.03.010
   Tsujii Y, 2006, ADV POLYM SCI, V197, P1, DOI 10.1007/12_063
   Turmanova S, 2008, J POLYM RES, V15, P309, DOI 10.1007/s10965-007-9172-0
   Ulubayram K, 2002, J BIOMATER APPL, V16, P227, DOI 10.1106/088532802021178
   VACANTI CA, 1994, ACS SYM SER, V540, P16
   Vacanti CA, 2008, J AM COLL SURGEONS, V206, P1095, DOI 10.1016/j.jamcollsurg.2007.12.046
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Vlierberghe S. V., 2009, MACROMOL BIOSCI, V9, P1105
   VLIERBERGHE SV, 2009, MACROMOL BIOSCI, V9999, P1105
   Vogel V, 1995, PROTEINS INTERFACES
   Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wirsen A, 2005, BIOMACROMOLECULES, V6, P2281, DOI 10.1021/bm050170+
   Yang Q, 2005, LANGMUIR, V21, P10717, DOI 10.1016/la051797g
   Yang Q, 2005, CHEM J CHINESE U, V26, P189
   Yu HY, 2007, J MEMBRANE SCI, V302, P235, DOI 10.1016/j.memsci.2007.06.061
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 67
TC 30
Z9 30
U1 1
U2 56
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 8
PY 2010
VL 10
IS 12
BP 1484
EP 1494
DI 10.1002/mabi.201000147
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 694QP
UT WOS:000285313000011
PM 20857390
DA 2018-10-19
ER

PT J
AU Buehler, MJ
AF Buehler, Markus J.
TI MULTISCALE MECHANICS OF BIOLOGICAL AND BIOLOGICALLY INSPIRED MATERIALS
   AND STRUCTURES
SO ACTA MECHANICA SOLIDA SINICA
LA English
DT Article
DE biological materials; materiomics; mechanics; mechanical properties;
   mutability; tunability; deformation; failure
ID OSTEOGENESIS-IMPERFECTA; SPIDER SILK; PROTEIN MATERIALS; COLLAGEN
   FIBRILS; BETA-SHEET; STRENGTH; DISEASE; NANOSTRUCTURE; DEFORMATION;
   ASSEMBLIES
AB The world of natural materials and structures provides an abundance of applications in which mechanics is a critical issue for our understanding of functional material properties. In particular, the mechanical properties of biological materials and structures play an important role in virtually all physiological processes and at all scales, from the molecular, and nanoscale to the macroscale, linking research fields as diverse as genetics to structural mechanics in an approach referred to as materiomics. Example cases that illustrate the importance of mechanics in biology include mechanical support provided by materials like bone, the facilitation of locomotion capabilities by muscle and tendon, or the protection against environmental impact by materials as the skin or armors. In this article we review recent progress and case studies, relevant for a variety of applications that range from medicine to civil engineering. We demonstrate the importance of fundamental mechanistic insight at multiple time- and length-scales to arrive at a systematic understanding of materials and structures in biology, in the context of both physiological and disease states and for the development of de novo biomaterials. Three particularly intriguing issues that will be discussed here include: First, the capacity of biological systems to turn weakness to strength through the utilization of multiple structural levels within the universality-diversity paradigm. Second, material breakdown in extreme and disease conditions. And third, we review an example where the hierarchical design paradigm found in natural protein materials has been applied in the development of a novel biomaterial based on amyloid protein.
C1 [Buehler, Markus J.] MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.
RP Buehler, MJ (reprint author), MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, 77 Massachusetts Ave,Room 1-235A&B, Cambridge, MA 02139 USA.
EM mbuehler@MIT.EDU
RI Buehler, Markus/C-4580-2008
OI Buehler, Markus/0000-0002-4173-9659
FU NSF; ARO; AFOSR; ONR
FX Project supported by NSF, ARO, AFOSR and ONR. Additional support from
   DARPA and the MITEI is acknowledged.
CR Ackbarow T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006015
   Alberts B, 2002, MOL BIOL CELL
   Buehler M. J., 2008, ATOMISTIC MODELING M
   Buehler MJ, 2008, NANO RES, V1, P63, DOI 10.1007/s12274-008-8006-7
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2010, NANO TODAY, V5, P379, DOI 10.1016/j.nantod.2010.08.001
   Buehler MJ, 2010, REV MOD PHYS, V82, P1459, DOI 10.1103/RevModPhys.82.1459
   Buehler MJ, 2010, NAT NANOTECHNOL, V5, P172, DOI 10.1038/nnano.2010.28
   Buehler MJ, 2010, HFSP J, V4, P26, DOI 10.2976/1.3267779
   Buehler MJ, 2009, NAT MATER, V8, P175, DOI 10.1038/nmat2387
   BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Cranford Steven, 2009, International Journal of Materials and Structural Integrity, V3, P161, DOI 10.1504/IJMSI.2009.028611
   CRANFORD S, 2010, J NANOTECHNOLOGY SCI, V3, P127
   Cranford SW, 2010, SOFT MATTER, V6, P4175, DOI 10.1039/c0sm00095g
   Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357
   Dietz H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.098101
   Dodge C., 1997, COMPUTER MUSIC SYNTH
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Garcia AP, 2011, METALL MATER TRANS A, V42A, P3889, DOI 10.1007/s11661-010-0477-y
   Garcia AP, 2010, COMP MATER SCI, V48, P303, DOI 10.1016/j.commatsci.2010.01.011
   Gautieri A, 2009, BIOPHYS J, V97, P857, DOI 10.1016/j.bpj.2009.04.059
   Gautieri A, 2009, PROTEIN SCI, V18, P161, DOI 10.1002/pro.21
   Godsel LM, 2008, TRENDS CELL BIOL, V18, P28, DOI 10.1016/j.tcb.2007.11.004
   Gumbsch P, 1998, SCIENCE, V282, P1293, DOI 10.1126/science.282.5392.1293
   Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416
   Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296
   Kamien R, 2007, MUSIC APPRECIATION
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/NNANO.2010.26, 10.1038/nnano.2010.26]
   LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Miller E, 2007, CALCIFIED TISSUE INT, V81, P206, DOI 10.1007/s00223-007-9045-x
   Mostaert AS, 2009, J ADHESION, V85, P465, DOI 10.1080/00218460902996366
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   PAPARCONE R, SELF FOLDING A UNPUB
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0
   Schmidt DJ, 2009, ACS NANO, V3, P2207, DOI 10.1021/nn900526c
   Trotter JA, 2000, BIOCHEM SOC T, V28, P357, DOI 10.1042/0300-5127:0280357
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   Xu ZP, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061910
NR 46
TC 15
Z9 16
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0894-9166
J9 ACTA MECH SOLIDA SIN
JI Acta Mech. Solida Sin.
PD DEC
PY 2010
VL 23
IS 6
SI 1
BP 471
EP 483
PG 13
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA 760ZJ
UT WOS:000290363700001
DA 2018-10-19
ER

PT J
AU El-Shenawy, NS
AF El-Shenawy, Nahla S.
TI Effect of Streptomyces 23-2B metabolites on hepatic lipid peroxidation
   and some antioxidant parameters in Wister rats
SO WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
LA English
DT Article
DE Glutathione; Lipid peroxidation; Cholesterol; Triglyceride; TNF-alpha;
   Nitric oxide
ID NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; KUPFFER CELLS; URIC-ACID;
   ANTITUMOR; SERUM; POLYSACCHARIDES; CHOLESTEROL; INHIBITION; SECRETION
AB Streptomyces 23-2B is one of actinomycetes associated with marine clam Donax trunculus and has potential source of bioactive metabolites, which possesses a broad spectrum antibiotic and anticancer activities. This study aims to evaluate the effect of Streptomyces 23-2B metabolites on hepatic lipid peroxidation (LPO), reduced glutathione (GSH) levels, as well as serum uric acid, total cholesterol (TC), triglyceride (TG), nitric oxide (NO) and tumor necrosis factor-alpha (TNF-alpha) levels of rat. Animals were divided into four groups: the control group, which received 0.1 ml of 10% Tween-80 by intraperitoneally injection, and the other three experimental groups, which received 10% Tween 80 solution of Streptomyces 23-2B metabolites in doses of 0.5, 5 and 50 mg/kg body weight at an interval 2 days for 2 weeks. LPO levels showed significant decrease with the lowest doses. The effect at a dose of 50 mg/kg of Streptomyces 23-2B metabolites on TG was more pronounced than the other two doses (0.5 and 5 mg/kg body weight). Hypocholesterolemia was recorded in the treated rats with 0.5 and 5 mg/kg of Streptomyces 23-2B. However, the highest dose enhanced the elevation of serum TNF-alpha and NO levels. Thus, the present study reveals that Streptomyces 23-2B metabolite is a newly discovered biomaterial from microorganisms. The novel substance showed inhibitory activity against LPO in rat liver homogenate and improving the immune response by releasing TNF-alpha and NO in serum.
C1 Suez Canal Univ, Dept Zool, Fac Sci, Ismailia 41522, Egypt.
RP El-Shenawy, NS (reprint author), Suez Canal Univ, Dept Zool, Fac Sci, El Daaeri Kilo 4, Ismailia 41522, Egypt.
EM elshenawy_nahla@hotmail.com
CR ALLAIN CC, 1974, CLIN CHEM, V20, P470
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329
   BUCCOLO G, 1973, CLIN CHEM, V19, P475
   Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003
   DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x
   DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162
   Demain A.L., 1999, MANUAL IND MICROBIOL
   DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
   Dunger A, 1996, DIABETES, V45, P183, DOI 10.2337/diabetes.45.2.183
   El-Shatoury SA, 2009, WORLD J MICROB BIOT, V25, P1547, DOI 10.1007/s11274-009-0040-4
   Forstermann U, 2000, HANDB EXP PHARMACOL, V143, P71
   FOSSATI P, 1980, CLIN CHEM, V26, P227
   GOLDBERG IJ, 1982, J CLIN INVEST, V70, P1184, DOI 10.1172/JCI110717
   Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0
   Holt J. G., 1994, BERGEYS MANUAL DETER
   Jing YW, 2008, BBA-GEN SUBJECTS, V1780, P34, DOI 10.1016/j.bbagen.2007.09.015
   KATO S, 1993, J ANTIBIOT, V46, P892, DOI 10.7164/antibiotics.46.892
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   MOSHAGE H, 1995, CLIN CHEM, V41, P892
   Mukherjee AK, 2001, CURR MED CHEM, V8, P1467, DOI 10.2174/0929867013372094
   SANFORD H. S., 1954, SCIENCE, V119, P100
   Schepetkin IA, 2005, INT IMMUNOPHARMACOL, V5, P1783, DOI 10.1016/j.intimp.2005.05.009
   Tanigawa K, 2000, J IMMUNOTHER, V23, P528, DOI 10.1097/00002371-200009000-00003
   Villinger Francois, 2003, Expert Rev Vaccines, V2, P317, DOI 10.1586/14760584.2.2.317
   Wach MJ, 2005, NITRIC OXIDE-BIOL CH, V12, P46, DOI 10.1016/j.niox.2004.11.004
   Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7
   Wink DA, 1995, TOXICOL LETT, V82-3, P221, DOI 10.1016/0378-4274(95)03557-5
   Yoon TJ, 2008, INT IMMUNOPHARMACOL, V8, P36, DOI 10.1016/j.intimp.2007.10.005
NR 30
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0959-3993
J9 WORLD J MICROB BIOT
JI World J. Microbiol. Biotechnol.
PD DEC
PY 2010
VL 26
IS 12
BP 2185
EP 2191
DI 10.1007/s11274-010-0403-x
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 756WN
UT WOS:000290045600009
DA 2018-10-19
ER

PT J
AU Honsawek, S
   Bumrungpanichthaworn, P
   Thanakit, V
   Kunrangseesomboon, V
   Muchmee, S
   Ratprasert, S
   Tangchainavaphum, P
   Dechprapatsorn, S
   Prajuabtanyachat, S
   Suksamran, A
   Rojchanawatsirivech, A
AF Honsawek, Sittisak
   Bumrungpanichthaworn, Piyanuch
   Thanakit, Voranuch
   Kunrangseesomboon, Vachiraporn
   Muchmee, Supamongkon
   Ratprasert, Siriwimon
   Tangchainavaphum, Pruksapon
   Dechprapatsorn, Saran
   Prajuabtanyachat, Sittichok
   Suksamran, Apasri
   Rojchanawatsirivech, Apimit
TI Osteoinductive potential of small intestinal submucosa/demineralized
   bone matrix as composite scaffolds for bone tissue engineering
SO ASIAN BIOMEDICINE
LA English
DT Article
DE Demineralized bone matrix; human periosteal cells; small intestinal
   submucosa; osteoblast differentiation
ID DEMINERALIZED BONE; BLADDER AUGMENTATION; EXTRACELLULAR-MATRIX;
   GROWTH-FACTORS; STEM-CELLS; IN-VIVO; SUBMUCOSA; REGENERATION;
   DIFFERENTIATION; GRAFTS
AB Background: Demineralized bone matrix (DBM) is extensively used in orthopedic, periodontal, and maxillofacial application and investigated as a material to induce new bone formation. Small intestinal submucosa (SIS) derived from the submucosa layer of porcine intestine has widely utilized as biomaterial with minimum immune response.
   Objectives: Determine the osteoinductive potential of SIS, DBM, SIS/DBM composites in the in vitro cell culture and in vivo animal bioassays for bone tissue engineering.
   Materials and methods: Human periosteal (HPO) cells were treated in the absence or presence SIS, DBM, and SIS/DBM. Cell proliferation was examined by direct cell counting. Osteoblast differentiation of the HPO cells was analyzed with alkaline phosphatase activity assay. The Wistar rat muscle implant model was used to evaluate the osteoinductive potential of SIS, DBM, and SIS/DBM composites.
   Results: HPO cells could differentiate along osteogenic lineage when treated with either DBM or SIS/DBM. SIS/DEM had a tendency to promote more cellular proliferation and osteoblast differentiation than the other treatments. In Wistar rat bioassay, SIS showed no new bone formation and the implants were surrounded by fibrous tissues. DBM demonstrated new bone formation along the edge of old DBM particles. SIS/DBM composite exhibited high osteoinductivity, and the residual SIS/DBM was surrounded by osteoid-like matrix and newly formed bone.
   Conclusion: DBM and SIS/DBM composites could retain their osteoinductive capability. SIS/DBM scaffolds may provide an alternative approach for bone tissue engineering.
C1 [Honsawek, Sittisak] Chulalongkorn Univ, Dept Biochem, Fac Med, Bangkok 10330, Thailand.
   [Thanakit, Voranuch] Chulalongkorn Univ, Dept Pathol, Bangkok 10330, Thailand.
   [Kunrangseesomboon, Vachiraporn; Muchmee, Supamongkon; Ratprasert, Siriwimon; Tangchainavaphum, Pruksapon; Dechprapatsorn, Saran; Prajuabtanyachat, Sittichok; Suksamran, Apasri; Rojchanawatsirivech, Apimit] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand.
RP Honsawek, S (reprint author), Chulalongkorn Univ, Dept Biochem, Fac Med, Rama 4, Bangkok 10330, Thailand.
EM Sittisak.H@chula.ac.th
FU National Science and Technology Development Agency (NSTDA), Thailand;
   Thailand Research Fund; National Research Council of Thailand.
FX The authors would like to acknowledge the financial support from the
   Research, Development and Engineering (RD&E) Fund through National
   Nanotechnology Center (NANOTEC), National Science and Technology
   Development Agency (NSTDA), Thailand. This investigation was also
   supported in part by the Thailand Research Fund and the National
   Research Council of Thailand. The authors would also like to thank
   Chulalongkorn Medical Research Center (Chula MRC) for kindly
   contributing the facilities.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8
   Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Honsawek S, 2007, ASIAN BIOMED, V1, P383
   Honsawek Sittisak, 2005, J Med Assoc Thai, V88 Suppl 4, pS260
   Honsawek Sittisak, 2006, J Med Assoc Thai, V89 Suppl 3, pS189
   Honsawek S, 2007, ASIAN BIOMED, V1, P229
   Honsawek Sittisak, 2005, Cell and Tissue Banking, V6, P13, DOI 10.1007/s10561-005-1445-4
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kim MS, 2006, ADV EXP MED BIOL, V585, P209
   Kokich VG, 2004, J ORAL MAXIL SURG, V62, P48, DOI 10.1016/j.joms.2004.05.210
   KROPP BP, 1995, ADV EXP MED BIOL, V385, P229
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Moore DC, 2004, J BIOMED MATER RES A, V69A, P259, DOI 10.1002/jbm.a.20123
   Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VERT M, 2007, PROG POLYM SCI, V32, P762
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   VOYTIKHARBIN SL, 1996, T 1 SIS S, P31
   Wada Y, 1998, BONE, V22, P479, DOI 10.1016/S8756-3282(98)00039-8
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   WOLFINBARGER L, 1993, IN VITRO CELL DEV-AN, V29A, P914
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 32
TC 3
Z9 4
U1 0
U2 8
PU CHULALONGKORN UNIV, FAC MED
PI BANGKOK
PA CHULALONGKORN UNIV, FAC MED, 1873, RAMA 4, BANGKOK, 10330, THAILAND
SN 1905-7415
J9 ASIAN BIOMED
JI Asian Biomed.
PD DEC
PY 2010
VL 4
IS 6
BP 913
EP 922
DI 10.2478/abm-2010-0119
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 700JW
UT WOS:000285736000010
OA Other Gold
DA 2018-10-19
ER

PT J
AU Barragan, F
   Guardian, R
   Menchaca, C
   Rosales, I
   Uruchurtu, J
AF Barragan, F.
   Guardian, R.
   Menchaca, C.
   Rosales, I.
   Uruchurtu, J.
TI Electrochemical Corrosion of Hot Pressing Titanium Coated Steels for
   Biomaterial Applications
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Corrosion; titanium; steels; hot pressing; biomaterials
AB Titanium diffusion process was applied to three selected steels, namely series AISI 1045, 4140 and stainless steel 304 using the hot pressing technique for a possible biomaterial use. Chemical analyses indicate that Ti diffuses into the steel matrix sample according to time of exposure, obtaining several microns in coating width and producing simultaneously a TiO(2) oxidized layer. Electrochemical evaluation namely linear polarization and electrochemical noise as a function of time, was performed for these different samples under Hank solution immersion conditions. The comparison of test results obtained after electrochemical experiments in Hank solution, indicate that treatment increased the corrosion resistance of steels, specially the AISI-304 stainless steel, presenting the formation and growth of a biofilm.
C1 [Barragan, F.; Guardian, R.; Menchaca, C.; Rosales, I.; Uruchurtu, J.] Univ Autonoma Estado de Morelos, Cuernavaca, Morelos, Mexico.
RP Barragan, F (reprint author), Univ Autonoma Estado de Morelos, CIICAp Av Univ 1001,Colonia Chamilpa, Cuernavaca, Morelos, Mexico.
EM juch25@uaem.mx
FU PROMEP [UAEM-PTC-074, CONACYT-S53120-Y]
FX The authors are grateful with PROMEP for financial support under grant
   UAEM-PTC-074 and CONACYT-S53120-Y. Technical support from M. A.
   Ramon-Garcia and J. Soto-Tapia is recognized.
CR BARDOS DI, 1977, HDB STAINLESS STEELS
   Bhola R, 2010, INT J ELECTROCHEM SC, V5, P917
   BRENEMARK PI, 1977, SCAND J PLAST RECONS, V11, P1
   BRENEMARK PI, 1983, J PROSTHET DENT, V50, P399
   CANO U, 1994, CORROSAO PROTECCAO M, V13, P11
   CONZALEZ A, 1989, CONTROL CORROSION ES
   GENESCALLONGERA.J, 2001, TECNICAS ELECTROQUIM
   Gunzel R, 1999, SURF COAT TECH, V112, P307, DOI 10.1016/S0257-8972(98)00776-2
   Huicochea C., 2007, PORT ELECTROCHIM ACT, V23, P195
   Jonagova I., 2004, BIOMATERIALS, V25, P1187
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kearns J. R., 1996, ELECTROCHEMICAL NOIS
   LEAKE ES, 1982, J CLIN MICROBIOL, V15, P320
   LLEWELLYN DT, 1992, STEELS METALLURGY AP
   MARLISKA A, 1997, J MATER SCI, V23, P6375
   RAVAGLIOLI A, 1992, MAT PROPERTIES APPL, V5, P261
   Ruiz JA, 2010, INT J ELECTROCHEM SC, V5, P593
   Sarmiento E, 2009, INT J ELECTROCHEM SC, V4, P144
   SENNERBY L, 1992, J MATER SCI-MATER M, V3, P262, DOI 10.1007/BF00705291
   URUCHURTU J, 1997, TECNICAS MONITOREO C
   Urzua R, 2009, PORT ELECTROCHIM ACT, V27, P127, DOI 10.4152/pea.200902127
NR 21
TC 14
Z9 15
U1 0
U2 9
PU ELECTROCHEMICAL SCIENCE GROUP
PI BELGRADE
PA A SPOMENICE 7/12 , 19210 BOR, BELGRADE, VJ 12, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD DEC
PY 2010
VL 5
IS 12
BP 1799
EP 1809
PG 11
WC Electrochemistry
SC Electrochemistry
GA 684ZL
UT WOS:000284593700007
DA 2018-10-19
ER

PT J
AU Levine, BR
   Fabi, DW
AF Levine, B. R.
   Fabi, D. W.
TI Porous metals in orthopedic applications - A review
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article; Proceedings Paper
CT 12th International and Interdisciplinary NRW Symposium on Biomaterials
   and Biomechanics Fundamentals and Clinical Applications
CY MAR 17-19, 2010
CL Essen, GERMANY
DE Porous metal; orthopedic applications; coating; osseointegration
ID TOTAL HIP-ARTHROPLASTY; 10-YEAR FOLLOW-UP; HISTOLOGIC ANALYSIS; TIBIAL
   COMPONENTS; TANTALUM IMPLANT; TISSUE INGROWTH; BONE INGROWTH; TOTAL
   KNEE; REPLACEMENT; FIXATION
AB The development of porous metals and coatings for osseointegration has revolutionized the specialty of orthopedics, particularly total joint reconstruction. However, until recently most implants are fabricated utilizing traditional materials (i.e. sintered beads, fiber metal, plasma spray), which have several inherent limitations. Several new highly porous metals have been recently introduced to improve upon the biomaterial properties of traditional coatings, namely porosity, surface coefficient and modulus of elasticity. These new biomaterials have a similar microscopic appearance that is much like cancellous bone, The open-cell structure of these metals affords several intriguing properties, including; high volumetric porosity (60-80%), low moduli of elasticity and high surface frictional characteristics. The self-passivating nature of these metals and complex nanostructures allow for rapid bone ingrowth in multiple applications of orthopedic surgery. The following represents a review of contemporary implants and biomaterial properties in orthopedic surgery for this class of highly porous metals.
C1 [Levine, B. R.] Rush Univ, Med Ctr, Chicago, IL 60612 USA.
   [Fabi, D. W.] San Diego Orthopaed Associates Med Grp, San Diego, CA USA.
RP Levine, BR (reprint author), Rush Univ, Med Ctr, 1611 W Harrison St,Suite 300, Chicago, IL 60612 USA.
EM Blevine@rushortho.com
CR Bloebaum RD, 1997, J ARTHROPLASTY, V12, P920, DOI 10.1016/S0883-5403(97)90162-5
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P179
   BOBYN JD, 1981, ACTA ORTHOP SCAND, V52, P145, DOI 10.3109/17453678108991775
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, V149, P291
   BOBYN JD, 1999, J BONE JOINT SURG BR, pB81
   Bobyn JD, 1980, CLIN ORTHOPAEDICS, V150, P263
   BOURNE RB, 1994, CLINORTHOP, P298
   BRYAN RS, 1958, P STAFF M MAYO CLIN, V33, P453
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Cook S D, 1988, J Arthroplasty, V3, P249
   DELLAVALLE CJ, 2006, CLIN ORTHOPRELAT RES, V452, P285
   ENGH CA, 1985, BIOL FIXATION TOTAL
   Frenkel SR, 2004, J BIOMED MATER RES B, V71B, P387, DOI 10.1002/jbm.b.30104
   FRIEDENBERG AB, 1963, SURG GYNECOL OBSTET, V116, P588
   GALANTE JO, 1984, UNCEMENTED TOTAL REP, P79
   GILMER WS, 1961, SURG GYNECOL OBSTET, V113, P143
   GREENFIELD EJ, 1909, Patent No. 478360
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   HEINER AD, 2007, ORTH RES SOC ANN M F
   Hennessy DW, 2009, CLIN ORTHOP RELAT R, V467, P2290, DOI 10.1007/s11999-009-0831-9
   Hirschhorn J.S., 1969, RES DENTAL MED MATER, P137
   Hofmann AA, 2000, J ARTHROPLASTY, V15, P833, DOI 10.1054/arth.2000.9318
   Hofmann AA, 2001, CLIN ORTHOP RELAT R, P85
   HULBERT SF, 1973, J BIOMED MATER RES, V7, P1, DOI 10.1002/jbm.820070303
   HUNGERFORD DS, 1982, ORTHOP CLIN N AM, V13, P103
   HUNGERFORD DS, 1984, TOTAL HIP ARTHROPLAS
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   KIM YH, 1993, J BONE JOINT SURG BR, V75, P6
   KYLE RF, 1984, UNCEMENTED TOTAL JOI, P60
   LACHIEWICZ PF, 2007, CLINORTHOPRELAT RES, V465, P117
   LANDON GC, 1986, CLIN ORTHOP RELAT R, V205, P49
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Lombardi AV, 2007, J ARTHROPLASTY, V22, P25, DOI 10.1016/j.arth.2007.02.006
   LUECK R A, 1969, Surgical Forum (Chicago), V20, P456
   MALCHAU H, 1995, IMPORTANCE STEPWISE, P3
   MANDARINO M P, 1958, Surg Forum, V9, P762
   MENEGHINI MR, 2008, J BONE JOINT SURG AM, V90, P78
   MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757
   MURRAY P, 1996, 63 ANN AC ORTH SURG
   *NC, S03001 NC
   OWEN TD, 1994, J BONE JOINT SURG BR, V76B, P258
   PETERSEN CD, 1969, J BONE JOINT SURG AM, VA 51, P805
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   POPOVICI A F, 1954, Bull Georgetown Univ Med Cent, V7, P177
   Radnay CS, 2006, CLIN ORTHOP RELAT R, V446, P83
   Ramappa M, 2009, HIP INT, V19, P239
   RONNIGEN H, 1980, T 26 ANN M ORTH RES
   SADR B, 1977, INJURY, V8, P234, DOI 10.1016/0020-1383(77)90137-1
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   SMITH L, 1963, ARCH SURG-CHICAGO, V87, P137
   Smith SE, 1998, J ARTHROPLASTY, V13, P50, DOI 10.1016/S0883-5403(98)90075-4
   SPECTOR M, 1987, J ARTHROPLASTY, V2
   STRUTHERS A M, 1955, Plast Reconstr Surg (1946), V15, P274, DOI 10.1097/00006534-195504000-00003
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   TURNER TM, 1986, J BONE JOINT SURG AM, V68A, P1396, DOI 10.2106/00004623-198668090-00013
   Udomkiat P, 2002, J BONE JOINT SURG AM, V84A, P1195, DOI 10.2106/00004623-200207000-00016
   VIGORITA VJ, 1993, CLIN ORTHOP RELAT R, P211
   Weeden SH, 2007, J ARTHROPLASTY, V22, P151, DOI 10.1016/j.arth.2007.04.024
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   XENOS JS, 1996, 63 ANN AC ORTH SURG, P489
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zou XN, 2005, SPINE, V30, pE392, DOI 10.1097/01.brs.0000170588.80377.3f
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
   BIOFOAMTM POROUS MET
NR 70
TC 14
Z9 14
U1 1
U2 31
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2010
VL 41
IS 12
BP 1002
EP 1010
DI 10.1002/mawe.201000701
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 712UH
UT WOS:000286691200002
DA 2018-10-19
ER

PT J
AU Vienken, J
AF Vienken, J.
TI Biomaterials for medical devices: Are current hemo- or biocompatibility
   tests adequate?
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article; Proceedings Paper
CT 12th International and Interdisciplinary NRW Symposium on Biomaterials
   and Biomechanics Fundamentals and Clinical Applications
CY MAR 17-19, 2010
CL Essen, GERMANY
DE biomaterials; biocompatibility tests; medical devices
ID DIALYSIS PATIENTS; HEMODIALYSIS; INFLAMMATION; PLATELETS; UREMIA
AB Many factors can affect the characterisation of biomaterials during testing. Among them is the type of the testing solution, such as human, animal blood or saline solutions of even different composition. Further influencing factors are drugs that have been administered to the blood donor prior to testing. Experimental details affecting the quality of testing refer to the guidance of blood across the biomaterial leading to different shear stress on blood cells and specific blood donor conditions, such as the age, race and gender. Some of the misconceptions in testing are described here and serve to indicate that a systems approach, and not only individual test parameters, is best when reliably testing for the biocompatibility of biomaterials for further use in medical devices.
C1 BioSci Fresenius Med Care, D-61352 Bad Homburg, Germany.
RP Vienken, J (reprint author), BioSci Fresenius Med Care, Else Kroener Str 1, D-61352 Bad Homburg, Germany.
EM joerg.vienken@fmc-ag.com
CR ALEXIEWICZ JM, 1991, AM J NEPHROL, V11, P102, DOI 10.1159/000168284
   [Anonymous], 2007, ASAIO J, V53, P159, DOI 10.1097/MAT.0b013e318031121f
   Averbukh Z, 2001, ARTIF ORGANS, V25, P437, DOI 10.1046/j.1525-1594.2001.025006437.x
   BOHLER J, 1993, NEPHROL DIAL TRANSPL, V8, P1359
   Canaud B, 2005, J AM SOC NEPHROL, V16, P1819, DOI 10.1681/ASN.2004050361
   Check E, 2007, NATURE, V446, P485, DOI 10.1038/446485a
   Erlenkotter A, 2008, ARTIF ORGANS, V32, P962, DOI 10.1111/j.1525-1594.2008.00657.x
   Fujii T, 1999, AM J KIDNEY DIS, V33, P29, DOI 10.1016/S0272-6386(99)70254-4
   Himmelfarb J, 1997, KIDNEY INT, V51, P834, DOI 10.1038/ki.1997.117
   Hutter JC, 2000, JAMA-J AM MED ASSOC, V283, P2128, DOI 10.1001/jama.283.16.2128
   ISO, 2002, 109934 ISO
   *ISO, 2003, 1099312 ISO
   Krieter DH, 1998, KIDNEY INT, V53, P1026, DOI 10.1111/j.1523-1755.1998.00837.x
   Lee SS, 2007, ARTIF ORGANS, V31, P80, DOI 10.1111/j.1525-1594.2007.00344.x
   LEVI FA, 1988, CLIN EXP IMMUNOL, V71, P329
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   MATTANA J, 1995, AM J NEPHROL, V15, P208, DOI 10.1159/000168834
   Mimic-Oka J, 1999, CLIN NEPHROL, V51, P233
   Mueller XM, 2001, INT J ARTIF ORGANS, V24, P89
   Omijie D, 2008, CLIN NEPHROL, V70, P312
   PAUL JL, 1991, NEPHRON, V57, P428, DOI 10.1159/000186308
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Vecino A, 1998, NEPHRON, V78, P271, DOI 10.1159/000044934
   VIENKEN J, 1995, NIEREN HOCHDRUCK, V24, P480
   Watanabe J, 2003, J BIOL CHEM, V278, P42361, DOI 10.1074/jbc.M307752200
NR 25
TC 2
Z9 2
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0933-5137
EI 1521-4052
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2010
VL 41
IS 12
BP 1081
EP 1085
DI 10.1002/mawe.201000712
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 712UH
UT WOS:000286691200012
DA 2018-10-19
ER

PT J
AU Kashiwazaki, H
   Yamaguchi, K
   Harada, N
   Akazawa, T
   Murata, M
   Iizuka, T
   Ikoma, T
   Tanaka, J
   Inoue, N
AF Kashiwazaki, Haruhiko
   Yamaguchi, Keisuke
   Harada, Naoki
   Akazawa, Toshiyuki
   Murata, Masaru
   Iizuka, Tadashi
   Ikoma, Toshiyuki
   Tanaka, Junzo
   Inoue, Nobuo
TI In vivo Evaluation of a Novel Chitosan/HAp Composite Biomaterial as a
   Carrier of rhBMP-2
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Chitosan; Hydroxyapatite (HAp); Osteoinduction; Bioabsorption;
   Recombinant human bone morphogenetic protein-2 (rhBMP-2)
ID BONE MORPHOGENETIC PROTEIN-2; CHITOSAN/HYDROXYAPATITE NANOCOMPOSITES;
   BIODEGRADATION; MORPHOLOGY; PHOSPHATE; SURGERY; CANINE
AB We developed a porous chitosan/hydroxyapatite (HAp) composite, in which the HAp nanocrystals align along the chitosan molecules, and examined the biocompatibility, osteoinductive activity, and the ability to act as a carrier of recombinant human bone morphogenetic protein-2 (rhBMP-2) of this novel biomaterial. The composite was subcutaneously implanted into the backs of 11-week-old SD rats, with or without rhBMP-2 (5 mu g). At 2 and 8 weeks after the implantation, the composite was explanted for morphohistological evaluation. In the presence of rhBMP-2, ectopic bone formation was found at 2 weeks and maturation of the newly formed bone around the composite at 8 weeks. Chitosan/HAp composite alone caused little inflammation, and new blood vessel growth and multinucleated giant cells were found around the composite, accompanied with roughening of the surface due to degradation at 2 weeks; however, neither cartilage nor bone formation was found around the composite. With rhBMP-2, the bioabsorption of the composite was accelerated as the rhBMP-2-induced bone matured. Histomorphometrical analysis showed that the mean value of the composite areas with rhBMP-2 was significantly smaller than that without rhBMT-2 at 2 and 8 weeks after the implantation. These results suggested that the novel chitosan/HAp composite was an effective bioabsorbable material as a carrier of rhBMP-2.
C1 [Kashiwazaki, Haruhiko] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Kita Ku, Sapporo, Hokkaido 0608586, Japan.
   [Akazawa, Toshiyuki] Hokkaido Res Org, Ind Technol Res Dev, Ind Res Inst, Sapporo, Hokkaido, Japan.
   [Murata, Masaru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral & Maxillofacial Surg, Tobetsu, Japan.
   [Iizuka, Tadashi] Hokkaido Univ, Grad Sch Dent Med, Support Sect Educ & Res, Sapporo, Hokkaido 0608586, Japan.
   [Ikoma, Toshiyuki; Tanaka, Junzo] Tokyo Inst Technol, Dept Inorgan Mat, Tokyo 152, Japan.
RP Kashiwazaki, H (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Kita Ku, Kita 13,Nishi 7, Sapporo, Hokkaido 0608586, Japan.
EM kashi@den.hokudai.ac.jp
RI Ikoma, Toshiyuki/E-4288-2012; Iizuka, Tadashi/D-5445-2012
OI Ikoma, Toshiyuki/0000-0003-3154-1777; 
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
FX This work was supported in part by Grant-in-Aid for Scientific Research
   (C) from the Ministry of Education, Culture, Sports, Science, and
   Technology of Japan. We thank Ms Masako Yanome for her help in
   preparation of the manuscript.
CR Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   COOK SD, 1986, SPINE, V11, P305, DOI 10.1097/00007632-198605000-00002
   Cooke F W, 1992, Clin Orthop Relat Res, P135
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   ISAKSSON B, 1992, SWED DENT J S, V84, P1
   Ito M, 1994, J JPN SOC DENT MAT D, V3, P351
   Kashiwazaki H, 2009, BIO-MED MATER ENG, V19, P133, DOI 10.3233/BME-2009-0572
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Lee Y. L., 1999, J BIOMED MATER RES B, V48, P111
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Murata M, 2007, J BIOMED MATER RES B, V81B, P469, DOI 10.1002/jbm.b.30686
   MURATA M, 1997, J HARD TISSUE BIOL, V6, P105
   MURATA M, 2002, J HARD TISSUE BIOL, V10, P19
   ODA S, 2002, J MED DENT SCI, V44, P53
   OGAWA K, 1984, MACROMOLECULES, V17, P973, DOI 10.1021/ma00134a076
   Okuyama K, 1999, INT J BIOL MACROMOL, V26, P285, DOI 10.1016/S0141-8130(99)00095-1
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P331, DOI 10.1163/156856299X00397
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WEIBEL ER, 1975, BEITR PATHOL, V155, P1
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Wu C., 2004, CHIN J CLIN REHABIL, V8, P929
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
   ZDEBLICK TA, 1994, SPINE, V19, P2348, DOI 10.1097/00007632-199410150-00017
NR 28
TC 1
Z9 1
U1 0
U2 9
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD DEC
PY 2010
VL 19
IS 3
BP 181
EP 186
DI 10.2485/jhtb.19.181
PG 6
WC Engineering, Biomedical
SC Engineering
GA 706JF
UT WOS:000286213700007
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Kalita, SJ
   Somani, V
AF Kalita, Samar Jyoti
   Somani, Vikas
TI Al2TiO5-Al2O3-TiO2 nanocomposite: Structure, mechanical property and
   bioactivity studies
SO MATERIALS RESEARCH BULLETIN
LA English
DT Article
DE Composites; Sol-gel chemistry; X-ray diffraction; Crystal structure;
   Mechanical properties
ID BIAXIAL FLEXURAL STRENGTH; ALUMINUM TITANATE; THERMAL-STABILITY; CERAMIC
   MATERIALS; TEMPERATURE; DIFFRACTION; IMPLANTS; AL2TIO5
AB Novel biomaterials are of prime importance in tissue engineering. Here, we developed novel nanostructured Al2TiO5-Al2O3-TiO2 composite as a biomaterial for bone repair. Initially, nanocrystalline Al2O3-TiO2 composite powder was synthesized by a sol-gel process. The powder was cold compacted and sintered at 1300-1500 degrees C to develop nanostructured Al2TiO5-Al2O3-TiO2 composite. Nano features were retained in the sintered structures while the grains showed irregular morphology. The grain-growth and microcracking were prominent at higher sintering temperatures. X-ray diffraction peak intensity of beta-Al2TiO5 increased with increasing temperature. beta-Al2TiO5 content increased from 91.67% at 1300 degrees C to 98.83% at 1500 degrees C, according to Rietveld refinement. The density of beta-Al2TiO5 sintered at 1300 degrees C, 1400 degrees C and 1500 degrees C were computed to be 3.668 g cm(-3), 3.685 g cm(-3) and 3.664 g cm(-3), respectively.
   Nanocrystalline grains enhanced the flexural strength. The highest flexural strength of 43.2 MPa was achieved. Bioactivity and biomechanical properties were assessed in simulated body fluid. Electron microscopy confirmed the formation of apatite crystals on the surface of the nanocomposite. Spectroscopic analysis established the presence of Ca and P ions in the crystals. Results throw light on biocompatibility and bioactivity of beta-Al2TiO5 phase, which has not been reported previously. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Kalita, Samar Jyoti] Univ N Dakota, Engineered Surfaces Ctr, Sch Engn & Mines, Grand Forks, ND 58203 USA.
   [Somani, Vikas] Univ Cent Florida, Dept Mech Mat & Aerosp Engn, Orlando, FL 32816 USA.
RP Kalita, SJ (reprint author), Univ N Dakota, Engineered Surfaces Ctr, Sch Engn & Mines, 4201 James Ray Dr,Suite 1100,Stop 8391, Grand Forks, ND 58202 USA.
EM Samar.Kalita@und.nodak.edu
RI Somani, Vikas/G-9063-2016
OI Somani, Vikas/0000-0003-1412-4111
CR Albakry M, 2003, J PROSTHET DENT, V89, P374, DOI 10.1067/mpr.2003.42
   BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201
   Black JT, 1999, J MANUF SYST, pU1
   Cattell MJ, 1997, J DENT, V25, P409, DOI 10.1016/S0300-5712(96)00059-0
   Duan RG, 2004, SCRIPTA MATER, V51, P1135, DOI 10.1016/j.scriptamat.2004.08.022
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   Fischer H, 2001, DENT MATER, V17, P289, DOI 10.1016/S0109-5641(00)00086-5
   FREUDENBERG B, 1987, J AM CERAM SOC, V70, P33, DOI 10.1111/j.1151-2916.1987.tb04849.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HILL RJ, 1986, LHPM RIETVELD REFINE
   HOFFMANN S, 2006, J ELECTROCERAM, V16
   Hunter B, 1998, INT UNION CRYSTALLOG, V20
   Kalita SJ, 2008, MATER CHEM PHYS, V109, P392, DOI 10.1016/j.matchemphys.2007.12.031
   Kalita SJ, 2002, J MATER RES, V17, P3042, DOI 10.1557/JMR.2002.0442
   KANEKO H, 2002, BIOCERAMICS, V14, P649
   KATO E, 1980, J AM CERAM SOC, V63, P355, DOI 10.1111/j.1151-2916.1980.tb10745.x
   Kingery WD, 1976, INTRO CERAMICS
   Koch C. C., 2002, NANOSTRUCTURED MAT P
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Lee HL, 1997, J MATER SCI, V32, P5687, DOI 10.1023/A:1018605431120
   Liu TS, 1998, J MATER SCI, V33, P995, DOI 10.1023/A:1004368029554
   MOROSIN B, 1972, ACTA CRYSTALLOGR A, V28, pS250
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Skala RD, 2009, J EUR CERAM SOC, V29, P67, DOI 10.1016/j.jeurceramsoc.2008.05.037
   Somani V, 2007, J AM CERAM SOC, V90, P2372, DOI 10.1111/j.1551-2916.2007.01797.x
   Stanciu L, 2004, SCRIPTA MATER, V50, P1259, DOI 10.1016/j.scriptamat.2004.01.034
   SUGIYAMA K, 1991, Z KRISTALLOGR, V194, P305, DOI 10.1524/zkri.1991.194.3-4.305
   Suryanarayana C, 2000, HYPERFINE INTERACT, V130, P5, DOI 10.1023/A:1011026900989
   Takahashi M, 2002, J AM CERAM SOC, V85, P3025
   Thomas H.A.J., 1989, BR CERAM T J, V88, P44
   THOMAS HAJ, 1989, BRIT CERAM TRANS J, V88, P184
   Toebbens D.M., 2001, MATER SCI FORUM, V378, P288
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
NR 35
TC 5
Z9 5
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-5408
J9 MATER RES BULL
JI Mater. Res. Bull.
PD DEC
PY 2010
VL 45
IS 12
BP 1803
EP 1810
DI 10.1016/j.materresbull.2010.09.017
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 699QV
UT WOS:000285678800005
DA 2018-10-19
ER

PT J
AU Ghanaati, S
   Barbeck, M
   Orth, C
   Willershausen, I
   Thimm, BW
   Hoffmann, C
   Rasic, A
   Sader, RA
   Unger, RE
   Peters, F
   Kirkpatrick, CJ
AF Ghanaati, Shahram
   Barbeck, Mike
   Orth, Carina
   Willershausen, Ines
   Thimm, Benjamin W.
   Hoffmann, Christiane
   Rasic, Angela
   Sader, Robert A.
   Unger, Ronald E.
   Peters, Fabian
   Kirkpatrick, C. James
TI Influence of beta-tricalcium phosphate granule size and morphology on
   tissue reaction in vivo
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cerasorb; beta-TCP; Bioactivity; Vascularization; Osteoclast-like cells
ID FOREIGN-BODY RESPONSE; OSTEOCLAST-LIKE CELLS; BONE DEFECTS; ILIAC CREST;
   POROUS HYDROXYAPATITE; MONONUCLEAR-CELLS; BIOMATERIALS; REGENERATION;
   PARTICLES; GRAFTS
AB In this study the tissue reaction to five different beta-tricalcium phosphate (beta-TCP)-based bone substitute materials differing only in size, shape and porosity was analyzed over 60 days, at 3, 10, 15, 30 and 60 days after implantation. Using the subcutaneous implantation model in Wistar rats both the inflammatory response within the implantation bed and the resulting vascularization of the biomaterials were qualitatively and quantitatively assessed by means of standard and special histological staining methods. The data from this study showed that all investigated beta-TCP bone substitutes induced the formation of multinucleated giant cells. Changes in size, shape and porosity influenced the integration of the biomaterials within the implantation bed and the formation of tartrate-resistant acid phosphatase (TRAP)-positive and TRAP-negative multinucleated giant cells, as well as the rate of vascularization. While a high porosity generally allowed cell and fiber in-growth within the center of the bone substitute, a lower porosity resulted in a mosaic-like integration of the materials, with the granules serving as place holders. The number of multinucleated giant cells located in the implantation bed positively correlated with the vascularization rate. These data emphasize that all biomaterials investigated were capable of inducing the formation of TRAP-positive multinucleated giant cells as a sign of biomaterial stability. Furthermore, these cells directly influenced vascularization by secretion of vascular endothelial growth factor (VEGF), as well as other chemokines. Based on these findings, the role of multinucleated giant cells in the foreign body reaction to biomaterials might need to be reconsidered. This study demonstrates that variations in the physical properties of a bone substitute material clearly influence the (extent of the) inflammatory reaction and its consequences. (C) 2010 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Ghanaati, Shahram; Barbeck, Mike; Orth, Carina; Rasic, Angela; Unger, Ronald E.; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, D-55101 Mainz, Germany.
   [Willershausen, Ines] Johannes Gutenberg Univ Mainz, Inst Dent Mat Sci & Technol, Univ Med Ctr, D-55101 Mainz, Germany.
   [Thimm, Benjamin W.] ETH, Inst Biomech, CH-8093 Zurich, Switzerland.
   [Hoffmann, Christiane; Peters, Fabian] Curasan AG, Frankfurt Plant, D-65933 Frankfurt, Germany.
   [Sader, Robert A.] Goethe Univ Frankfurt, Dept Oral Craniomaxillofacial & Facial Plast Surg, Med Ctr, Frankfurt, Germany.
RP Ghanaati, S (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Langenbeckstr 1, D-55101 Mainz, Germany.
EM ghanaati@uni-mainz.de
RI Thimm, Benjamin/G-7410-2012
FU German Federation of Industrial Research Associations (AiF)
   [KA2061701UL8]
FX The authors thank Mrs. U. Hilbig for her excellent technical assistance.
   This research was supported by the Central Innovation Programme for
   Small and Medium-sized Enterprises (project no. KA2061701UL8) of the
   German Federation of Industrial Research Associations (AiF).
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   Abshagen K, 2009, J BIOMED MATER RES A, V91A, P557, DOI 10.1002/jbm.a.32237
   AlSaffar N, 1997, J MATER SCI-MATER M, V8, P641, DOI 10.1023/A:1018575504518
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231
   ATHANASOU NA, 1990, J CLIN PATHOL, V43, P997, DOI 10.1136/jcp.43.12.997
   BRANTIGAN JW, 1993, SPINE, V18, P1213, DOI 10.1097/00007632-199307000-00015
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   DOUSSIS IA, 1992, J CLIN PATHOL, V45, P398, DOI 10.1136/jcp.45.5.398
   DREXLER HG, 1994, LEUKEMIA, V8, P359
   Eggli PS, 1987, BIOMATERIALS CLIN AP, P53
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005
   Ghanaati SM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025004
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601
   Henkel KO, 2005, KEY ENG MAT, V284-286, P885, DOI 10.4028/www.scientific.net/KEM.284-286.885
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   IBBOTSON KJ, 1984, J CELL BIOL, V99, P471, DOI 10.1083/jcb.99.2.471
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   KADOYA Y, 1994, BONE MINER, V27, P85, DOI 10.1016/S0169-6009(08)80211-5
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kessler P, 2005, BRIT J ORAL MAX SURG, V43, P51, DOI 10.1016/j.bjoms.2004.08.026
   Kirkpatrick CJ, 2003, J MATER SCI-MATER M, V14, P677, DOI 10.1023/A:1024903514335
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Lane JM, 1999, CLIN ORTHOP RELAT R, pS107
   Lange T, 2009, BIOMATERIALS, V30, P5312, DOI 10.1016/j.biomaterials.2009.06.023
   LLDAMIEN CJ, 1991, J Appl Biomater, V2, P187
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mazock JB, 2003, J ORAL MAXIL SURG, V61, P1497, DOI 10.1016/j.joms.2003.03.001
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465
   Nolff MC, 2010, J CRANIO MAXILL SURG, V38, P38, DOI 10.1016/j.jcms.2009.07.010
   OKLUND SA, 1986, CLIN ORTHOP RELAT R, P269
   Peters F, 2004, MATERIALWISS WERKST, V35, P203, DOI 10.1022/mawe.200400735
   Stavropoulos A, 2010, J PERIODONTOL, V81, P325, DOI 10.1902/jop.2009.090386
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
   Zerbo IR, 2004, CLIN ORAL IMPLAN RES, V15, P724, DOI 10.1111/j.1600-0501.2004.01055.x
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
NR 56
TC 65
Z9 69
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2010
VL 6
IS 12
BP 4476
EP 4487
DI 10.1016/j.actbio.2010.07.006
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682EX
UT WOS:000284385300002
PM 20624495
DA 2018-10-19
ER

PT J
AU Koens, MJW
   Faraj, KA
   Wismans, RG
   van der Vliet, JA
   Krasznai, AG
   Cuijpers, VMIJ
   Jansen, JA
   Daamen, WF
   van Kuppevelt, TH
AF Koens, M. J. W.
   Faraj, K. A.
   Wismans, R. G.
   van der Vliet, J. A.
   Krasznai, A. G.
   Cuijpers, V. M. I. J.
   Jansen, J. A.
   Daamen, W. F.
   van Kuppevelt, T. H.
TI Controlled fabrication of triple layered and molecularly defined
   collagen/elastin vascular grafts resembling the native blood vessel
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Type I collagen; Elastin; Heparin; Acellular; Vascular graft; Molecular
   tissue engineering
ID COLLAGENOUS MATRICES; CROSS-LINKING; DECELLULARIZED VEIN; ELASTIN
   SCAFFOLDS; SHEEP MODEL; VIVO; BIOMATRIX; HEPARIN; REPAIR;
   POLYCAPROLACTONE
AB There is a consistent need for a suitable natural biomaterial to function as an arterial prosthesis in achieving arterial regeneration. Natural grafts are generally obtained by decellularization of native blood vessels, but batch to batch variations may occur and the nature/content of remaining contaminants is generally unknown. In this study we fabricated a molecularly defined natural arterial graft from scratch resembling the native three layered architecture from the fibrillar extracellular matrix components collagen and elastin. Using casting, moulding, freezing and lyophilization techniques, a triple layered construct was prepared consisting of an inner layer of elastin fibres, a middle (porous) film layer of collagen fibrils and an outer scaffold layer of collagen fibrils. The construct was carbodiimide cross-linked and heparinized. Characterization included biochemical/biophysical analyses, scanning electron microscopy, micro-computed tomography, (immuno)histology and haemocompatibility. Burst pressures were up to 400 mm Hg and largely conferred by the intermediate porous collagen film layer. The highly purified type I collagen fibrils and elastin fibres used did not evoke platelet aggregation in vitro. Suturability of the graft in end to side anastomosis was successful and considered adequate for in vivo application, (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Koens, M. J. W.; Faraj, K. A.; Wismans, R. G.; Daamen, W. F.; van Kuppevelt, T. H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem 280, NCMLS, NL-6500 HB Nijmegen, Netherlands.
   [Faraj, K. A.] AAP Bioimplants EMCM BV, NL-6545 CH Nijmegen, Netherlands.
   [van der Vliet, J. A.; Krasznai, A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Surg 690, NL-6500 HB Nijmegen, Netherlands.
   [Cuijpers, V. M. I. J.; Jansen, J. A.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat 309, NL-6500 HB Nijmegen, Netherlands.
RP van Kuppevelt, TH (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biochem 280, NCMLS, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM a.vankuppevelt@ncmls.ru.nl
RI Vliet, J.A./L-4721-2015; Cuijpers, Vincent/H-7735-2016; Daamen,
   Willeke/D-5854-2015; Jansen, John/H-8055-2014; Kuppevelt,
   A.H.M.S.M./L-4463-2015
OI Daamen, Willeke/0000-0003-3155-3030; 
FU Dutch Program for Tissue Engineering [DPTE 6735]
FX Carel Eckmann and Liesbeth Marks from Sanquin (Amsterdam, The
   Netherlands) are gratefully acknowledged for supplying machinery and
   assistance in platelet aggregation tests. Roger Lomme from the
   Department of Surgery (RUNMC) is acknowledged for his assistance in
   analysis of the biomechanical data. The Microscopical Imaging Centre
   (NCMLS) is acknowledged for facilitating electron microscopical
   services. This study was financially supported by the Dutch Program for
   Tissue Engineering (DPTE 6735).
CR Bancroft J, 1996, THEORY PRACTICE HIST
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/ten.2004.10.1526
   Buijtenhuijs P, 2004, BIOTECHNOL APPL BIOC, V39, P141, DOI 10.1042/BA20030105
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Buttafoco L, 2006, J BIOMED MATER RES B, V77B, P357, DOI 10.1002/jbm.b.30444
   Buttafoco L, 2006, BIOMATERIALS, V27, P2380, DOI 10.1016/j.biomaterials.2005.10.017
   Daamen WF, 2005, TISSUE ENG, V11, P1168, DOI 10.1089/ten.2005.11.1168
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DEWAARD JWD, 1995, BRIT J CANCER, V72, P456, DOI 10.1038/bjc.1995.355
   Engbers-Buijtenhuijs P, 2006, BIOMATERIALS, V27, P2390, DOI 10.1016/j.biomaterials.2005.10.016
   Faraj KA, 2009, TISSUE ENG PART C-ME, V15, P493, DOI 10.1089/ten.tec.2008.0436
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goblieb AI, 2005, CARDIOVASC PATHOL, V14, P181, DOI 10.1016/j.carpath.2005.03.007
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Heise RL, 2009, TISSUE ENG PT A, V15, P3951, DOI [10.1089/ten.tea.2009.0044, 10.1089/ten.TEA.2009.0044]
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   Hinds MT, 2006, J BIOMED MATER RES A, V77A, P458, DOI 10.1002/jbm.a.30571
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Keuren JFW, 2004, ARTERIOSCL THROM VAS, V24, P613, DOI 10.1161/01.ATV.0000116026.18945.66
   Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031
   Lammers G, 2009, BIOMATERIALS, V30, P6213, DOI 10.1016/j.biomaterials.2009.07.050
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046
   Martin ND, 2005, J SURG RES, V129, P17, DOI 10.1016/j.jss.2005.06.037
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nuininga JE, 2003, EUR UROL, V44, P266, DOI 10.1016/S0302-2838(03)00249-5
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Roelofs LAJ, 2008, FETAL DIAGN THER, V24, P7, DOI 10.1159/000132399
   Roelofs LAJ, 2008, TISSUE ENG PT A, V14, P2033, DOI 10.1089/ten.tea.2007.0191
   Santana Daniel Bia, 2007, Cell and Tissue Banking, V8, P43, DOI 10.1007/s10561-006-9000-5
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960
   VEITH FJ, 1979, SURGERY, V85, P253
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 48
TC 18
Z9 19
U1 2
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2010
VL 6
IS 12
BP 4666
EP 4674
DI 10.1016/j.actbio.2010.06.038
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682EX
UT WOS:000284385300024
PM 20619367
DA 2018-10-19
ER

PT J
AU Sun, LT
   Bencherif, SA
   Gilbert, TW
   Lotze, MT
   Washburn, NR
AF Sun, Liang Tso
   Bencherif, Sidi A.
   Gilbert, Thomas W.
   Lotze, Michael T.
   Washburn, Newell R.
TI Design principles for cytokine-neutralizing gels: Cross-linking effects
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Antibody; Biomimetic material; Pro-inflammatory cytokines; Hyaluronic
   acid; Inflammation
ID GROWTH-FACTORS; BIOMATERIALS; HYDROGELS; ALPHA
AB Constructs composed of cytokine-neutralizing antibodies conjugated to high-molecular-weight hyaluronic acid have been shown to be effective at controlling inflammatory responses in vivo. A critical question in the development of this new class of biomaterial is whether crosslinked conjugates have similar anti-inflammatory effects, which would open up a broad range of tissue engineering applications in which the material would have intrinsic inflammation-controlling function. To test this, high-molecular-weight hyaluronic acid was conjugated with monoclonal antibodies to the pro-inflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha in two forms of the material: viscous, non-crosslinked polymer-antibody conjugates and crosslinked, elastomeric polymer-antibody conjugates. The cytokine affinities of both constructs were validated using molecular characterization methods, and the biological activities were tested through subcutaneous implantation in Sprague-Dawley rats. In vitro, both forms of these constructs are capable of binding cytokines, but in vivo only the non-crosslinked polymer significantly reduces markers of acute inflammation compared to controls that lack the antibodies. We propose that these materials function by retarding cytokine diffusion, with the non-crosslinked polymers being capable of retarding the diffusion of cytokines in the extracellular matrix and preventing engagement with receptors. In contrast, crosslinked materials have long diffusion lengths into the gel compared with those between cells on the surface of the material, which may make them ineffective at sequestering pro-inflammatory cytokines on biologically relevant timescales. These results suggest an important design principle for preparing cytokine-regulating materials based on consideration of transport phenomena. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Sun, Liang Tso; Washburn, Newell R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
   [Bencherif, Sidi A.; Washburn, Newell R.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA.
   [Gilbert, Thomas W.; Lotze, Michael T.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
   [Gilbert, Thomas W.; Lotze, Michael T.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA.
   [Gilbert, Thomas W.; Lotze, Michael T.; Washburn, Newell R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA.
RP Washburn, NR (reprint author), Carnegie Mellon Univ, Dept Biomed Engn, 4400 5th Ave, Pittsburgh, PA 15213 USA.
EM washburn@andrew.cmu.edu
OI BENCHERIF, SIDI/0000-0002-7704-5608
FU U.S. Army DAMD [17-02-1-0717]; Armed Forces Institute for Regenerative
   Medicine [W81 x WH-08-2-0032]; NIH [1R43GM085897]; 3 M Non-Tenured
   Faculty; The Sanford C. Bernstein and Company, LLC [P01 CA
   101,944-01A2]; The Clinical and Translational Research Program (Reis,
   Steven) [1U54RR023506-01]
FX The authors gratefully acknowledge Dr. Stephen F. Badylak for helpful
   discussions and for providing access to the animal facilities at the
   McGowan Institute for Regenerative Medicine. Financial support was
   provided from U.S. Army DAMD 17-02-1-0717, the Armed Forces Institute
   for Regenerative Medicine W81 x WH-08-2-0032 (N.R.W.) and NIH
   1R43GM085897 (N.R.W.). N.R.W. also acknowledges support from a 3 M
   Non-Tenured Faculty Grant. This report was funded, in part, by 1 P01 CA
   101,944-01A2 (MTL) Integrating NK and DC into Cancer Therapy and under a
   special grant initiative on behalf of Jonathan Gray from The Sanford C.
   Bernstein and Company, LLC. The Clinical and Translational Research
   Program (Reis, Steven: 1U54RR023506-01) Catalyst Program is also
   gratefully acknowledged for supporting L.T.S. N.R.W. has formed a
   company to commercialize aspects of this research and acknowledges a
   potential conflict of interest.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BADYLAK SF, 2007, IMMUNE RESPONSE BIOL
   Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047
   Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200
   Crank J., 1980, MATH DIFFUSION
   DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501
   HAY ED, 1991, CELL BIOL EXTRACELLU, P488
   Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074
   Krause WE, 2001, BIOMACROMOLECULES, V2, P65, DOI 10.1021/bm0055798
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Sun LT, 2010, WOUND REPAIR REGEN, V18, P302, DOI 10.1111/j.1524-475X.2010.00591.x
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   THOMSON AW, 2003, CYTOKINE HDB, P1536
   WASHBURN N, 2008, INFLAMMATION REGULAT
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3
NR 22
TC 6
Z9 6
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2010
VL 6
IS 12
BP 4708
EP 4715
DI 10.1016/j.actbio.2010.06.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682EX
UT WOS:000284385300028
PM 20601239
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Holloway, JL
   Lowman, AM
   Palmese, GR
AF Holloway, Julianne L.
   Lowman, Anthony M.
   Palmese, Giuseppe R.
TI Mechanical evaluation of poly(vinyl alcohol)-based fibrous composites as
   biomaterials for meniscal tissue replacement
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyvinylalcohol; Mechanical properties; Cross-linking; Microstructure;
   Fibrous tissue
ID ARTICULAR-CARTILAGE; HYDROGELS; MORPHOLOGY
AB In this study, poly(vinyl alcohol) (PVA) hydrogels were reinforced with ultrahigh molecular weight polyethylene (UHMWPE) and PP fibers and evaluated as potential nondegradable meniscal replacements. An investigation of hydrogel and composite mechanical properties indicates that fiber-reinforced PVA hydrogels could replicate the unique anisotropic modulus distribution present in the native meniscus; the most commonly damaged orthopedic tissue. More specifically, fibrous reinforcement successfully increased the tensile modulus of the biomaterial from 0.23 +/- 0.02 MPa without any reinforcement to 258.1 +/- 40.1 MPa at 29 vol.% UHMWPE. Additionally, the molecular weight between cross-links, bound water and the microstructure of the PVA hydrogels were evaluated as a function of freeze-thaw cycles and polymer concentration to lend insight into the processes occurring during synthesis. These results suggest the presence of multiple mechanisms as causes for increasing hydrogel modulus with freeze-thaw cycling, including hydrogen bonding between amorphous and/or crystalline regions, and the formation of highly concentrated regions of mostly amorphous PVA chains. It is possible that the formation of regions with highly concentrated amounts of PVA increases the load-bearing ability of the hydrogels. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Holloway, Julianne L.; Lowman, Anthony M.; Palmese, Giuseppe R.] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA.
RP Palmese, GR (reprint author), Drexel Univ, Dept Chem & Biol Engn, 3141 Chestnut St, Philadelphia, PA 19104 USA.
EM jlh572@drexel.edu; alowman@coe.drexel.edu; palmese@coe.drexel.edu
FU Department of Defense through the National Defense Science and
   Engineering Graduate Fellowship; US Army Research Laboratory through the
   Army Materials Center of Excellence [W911NF-06-2-0013]
FX We acknowledge Lauren Santi and Drexel University College of Medicine
   for use of the cryostat and optical microscope. Additionally, Mark
   Vanlandingham from the Army Research Labs in Aberdeen, MD and Suzanne
   Maher from the Hospital for Special Surgery in New York, NY provided
   valuable insight over the course of this research. Funding for this
   project was provided by the Department of Defense through the National
   Defense Science and Engineering Graduate Fellowship, in addition to the
   US Army Research Laboratory through the Army Materials Center of
   Excellence Program, contract W911NF-06-2-0013.
CR Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Arnoczky SP, 1992, KNEE MENISCUS BASIC, P1
   BRAY JC, 1973, J APPL POLYM SCI, V17, P3779, DOI 10.1002/app.1973.070171219
   Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   Gharpuray V, 1998, HDB BIOMATERIAL PROP, P48
   Grant C, 2006, BIOTECHNOL PROGR, V22, P1400, DOI 10.1021/bp060181u
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hatakeyema T, 2005, THERMOCHIM ACTA, V431, P144, DOI 10.1016/j.tca.2005.01.062
   Katta JK, 2007, J BIOMED MATER RES A, V83A, P471, DOI 10.1002/jbm.a.31238
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG, P397
   Lozinsky VI, 2008, COLLOID J+, V70, P189, DOI 10.1007/s10595-008-2011-0
   Maher SA, 2007, J BIOMED MATER RES A, V83A, P145, DOI 10.1002/jbm.a.31255
   Ping ZH, 2001, POLYMER, V42, P8461, DOI 10.1016/S0032-3861(01)00358-5
   Ricciardi R, 2004, MACROMOLECULES, V37, P9510, DOI 10.1021/ma048418v
   Roos H, 1998, ARTHRITIS RHEUM, V41, P687, DOI 10.1002/1529-0131(199804)41:4<687::AID-ART16>3.0.CO;2-2
   Spiller K. L., 2009, J BIOMED MATER RES B, V20, P752
   Thomas J, 2003, J BIOMED MATER RES A, V67A, P1329, DOI 10.1002/jbm.a.10119
   VANTIENEN TG, 2009, CLIN SPORTS MED
   YOKOYAMA F, 1986, COLLOID POLYM SCI, V264, P595, DOI 10.1007/BF01412597
NR 22
TC 49
Z9 51
U1 1
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2010
VL 6
IS 12
BP 4716
EP 4724
DI 10.1016/j.actbio.2010.06.025
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682EX
UT WOS:000284385300029
PM 20601243
DA 2018-10-19
ER

PT J
AU Jin, KL
   Mao, XO
   Xie, L
   Greenberg, RB
   Peng, BT
   Moore, A
   Greenberg, MB
   Greenberg, DA
AF Jin, Kunlin
   Mao, XiaoOu
   Xie, Lin
   Greenberg, Rose B.
   Peng, Botao
   Moore, Alexander
   Greenberg, Maeve B.
   Greenberg, David A.
TI Delayed transplantation of human neural precursor cells improves outcome
   from focal cerebral ischemia in aged rats
SO AGING CELL
LA English
DT Article
DE brain; ischemia; neural precursor; stroke; transplant
ID PROMOTES FUNCTIONAL RECOVERY; ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS;
   DENTATE GYRUS; STROKE MODEL; ADULT-RAT; BRAIN; NEUROGENESIS;
   PROLIFERATION; INFARCTION
AB P>Neural precursor cell (NPC) transplantation may have a role in restoring brain function after stroke, but how aging might affect the brain's receptivity to such transplants is unknown. We reported previously that transplantation of human embryonic stem cell (hESC)-derived NPCs together with biomaterial (Matrigel) scaffolding into the brains of young adult Sprague-Dawley rats 3 weeks after distal middle cerebral artery occlusion (MCAO) reduced infarct volume and improved neurobehavioral performance. In this study, we compared the effect of NPC and Matrigel transplants in young adult (3-month-old) and aged (24-month-old) Fisher 344 rats from the National Institute on Aging's aged rodent colony. Distal MCAO was induced by electrocoagulation, and hESC-derived NPCs were transplanted into the infarct cavity 3 weeks later. Aged rats developed larger infarcts, but infarct volume and performance on the cylinder and elevated body swing tests, measured 6-8 weeks post-transplant, were improved by transplantation. We conclude that advanced age does not preclude a beneficial response to NPC transplantation following experimental stroke.
C1 [Jin, Kunlin; Mao, XiaoOu; Xie, Lin; Greenberg, Rose B.; Peng, Botao; Moore, Alexander; Greenberg, Maeve B.; Greenberg, David A.] Buck Inst Age Res, Novato, CA 94945 USA.
RP Greenberg, DA (reprint author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.
EM dgreenberg@buckinstitute.org
FU NIH [NS44921, AG21980, NS057186]
FX This work was supported by NIH grants NS44921 (to D. A. G) and AG21980
   and NS057186 (to K.J.).
CR Aliabadi AZ, 2007, DRUG AGING, V24, P913, DOI 10.2165/00002512-200724110-00004
   Ay H, 2005, STROKE, V36, P2632, DOI 10.1161/01.STR.0000189991.23918.01
   Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003
   BORLONGAN CV, 1995, J NEUROSCI, V15, P5372
   Brevig T, 2000, TRENDS NEUROSCI, V23, P337, DOI 10.1016/S0166-2236(00)01605-2
   Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100
   Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010
   Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038
   Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691
   Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829
   Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104
   Duan WM, 1998, EUR J NEUROSCI, V10, P2595, DOI 10.1046/j.1460-9568.1998.00279.x
   Greenberg David A, 2006, NeuroRx, V3, P458, DOI 10.1016/j.nurx.2006.08.003
   Guerra-Crespo M, 2009, NEUROSCIENCE, V160, P470, DOI 10.1016/j.neuroscience.2009.02.029
   Harms KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009767
   Hayashi J, 2006, J CEREBR BLOOD F MET, V26, P906, DOI 10.1038/sj.jcbfm.9600247
   Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246
   Jantunen E, 2006, BONE MARROW TRANSPL, V38, P715, DOI 10.1038/sj.bmt.1705514
   Jenny B, 2009, STEM CELLS, V27, P1309, DOI 10.1002/stem.46
   Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251
   Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808
   Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Popa-Wagner A, 2007, CURR NEUROVASC RES, V4, P216
   Saxena R, 2009, INT UROL NEPHROL, V41, P195, DOI 10.1007/s11255-008-9489-6
   Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8
   SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5
   Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187
   Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150
   SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47
   Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016
   Won SJ, 2006, BRAIN RES, V1123, P237, DOI 10.1016/j.brainres.2006.09.055
   Zhang ZH, 2008, NEUROSCI LETT, V444, P227, DOI 10.1016/j.neulet.2008.08.049
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
   Zhu W, 2005, NEUROSURGERY, V57, P325, DOI 10.1227/01.NEU.0000166682.50272.BC
NR 42
TC 39
Z9 43
U1 1
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2010
VL 9
IS 6
BP 1076
EP 1083
DI 10.1111/j.1474-9726.2010.00638.x
PG 8
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 678KB
UT WOS:000284071400014
PM 20883527
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Hattori, H
   Amano, Y
   Nogami, Y
   Takase, B
   Ishihara, M
AF Hattori, H.
   Amano, Y.
   Nogami, Y.
   Takase, B.
   Ishihara, M.
TI Hemostasis for Severe Hemorrhage with Photocrosslinkable Chitosan
   Hydrogel and Calcium Alginate
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Hemostasis; Chitosan; Hydrogel; Calcium alginate; Biodegradation
ID EXTREMITY ARTERIAL HEMORRHAGE; CYTOKINE PRODUCTION; CHITIN; AGENTS;
   SWINE; MODEL; EPIDEMIOLOGY; BIOMATERIAL; ADHESIVE
AB In patients with severe hemorrhage, complications such as shock or death may occur if the patient is not treated appropriately and expeditiously. To create a hemostat kit for severe hemorrhage, ultraviolet light irradiation was applied to photocrosslinkable chitosan hydrogel and calcium alginate. As a hemorrhage model, the femoral arteries and veins of anesthetized rats were cut. Hemodynamics and hematological parameters including red blood cell (RBC) count, hemoglobin concentration, hematocrit, white blood cell (WBC) count, and platelet count, and serum parameters including aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured as a marker of hemostasis. In rats for which no procedure was used, death occurred within 30 min. By using the hydrogel hemostat, the survival rate rose to 75% or more. RBC count, hemoglobin, hematocrit, and platelet levels were not significantly changed for 3 days. WBC count increased 1 day after hemostasis. AST and ALT increased 1 day after hemostasis, but it decreased 3 days later. The photocrosslinkable chitosan hydrogel and calcium alginate were biodegraded at 3 and 28 days, respectively, by neutrophils and keratinocyte chemoattractant.
C1 [Hattori, H.; Amano, Y.; Ishihara, M.] Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   [Nogami, Y.] Japan Air Self Def Force, Aero Med Evacuat Squadron, Aichi, Japan.
   [Takase, B.] Natl Def Med Coll, Dept Intens Care Med, Saitama, Japan.
RP Hattori, H (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
EM h2@ndmc.ac.jp
CR Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9
   Alam HB, 2005, MIL MED, V170, P63, DOI 10.7205/MILMED.170.1.63
   Austin S.K., 2009, MEDICINE, V37, P133
   Benesch J, 2002, BIOMATERIALS, V23, P2561, DOI 10.1016/S0142-9612(01)00391-X
   Champion HR, 2003, J TRAUMA, V54, pS7, DOI 10.1097/01.TA.0000056154.34788.C6
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chou TC, 2003, BIOCHEM BIOPH RES CO, V302, P480, DOI 10.1016/S0006-291X(03)00173-6
   Duerbeck N B, 1997, Obstet Gynecol Surv, V52, P575, DOI 10.1097/00006254-199709000-00023
   Gardner RL, 2004, METH MOL B, V254, P383
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Ishihara M, 2001, WOUND REPAIR REGEN, V9, P513, DOI 10.1046/j.1524-475x.2001.00513.x
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19
   Kheirabadi BS, 2009, J TRAUMA, V67, P450, DOI 10.1097/TA.0b013e3181ac0c99
   Kheirabadi BS, 2009, J TRAUMA, V66, P316, DOI [10.1097/TA.0b013e31819634a1, 10.1097/TA.0b0l3e31819634a1]
   Kozen BG, 2008, ACAD EMERG MED, V15, P74, DOI 10.1111/j.1553-2712.2007.00009.x
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   Park CJ, 2009, BIOMATERIALS, V30, P436, DOI 10.1016/j.biomaterials.2008.09.060
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Thatte HS, 2004, J TRAUMA, V57, pS7, DOI 10.1097/01.TA.0000136742.04816.38
   Thomas S, 2000, J Wound Care, V9, P56
   Thomas S, 2000, J Wound Care, V9, P115
   van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328
   Ward KR, 2007, J TRAUMA, V63, P276, DOI 10.1097/%A.0b013e3180eea8a5
   Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44
   Whang HS, 2005, J MACROMOL SCI-POL R, VC45, P309, DOI 10.1080/15321790500304122
NR 32
TC 29
Z9 30
U1 4
U2 60
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2010
VL 38
IS 12
BP 3724
EP 3732
DI 10.1007/s10439-010-0121-4
PG 9
WC Engineering, Biomedical
SC Engineering
GA 678GN
UT WOS:000284062200014
PM 20617383
DA 2018-10-19
ER

PT J
AU Previtera, ML
   Langhammer, CG
   Langrana, NA
   Firestein, BL
AF Previtera, Michelle L.
   Langhammer, Christopher G.
   Langrana, Noshir A.
   Firestein, Bonnie L.
TI Regulation of Dendrite Arborization by Substrate Stiffness is Mediated
   by Glutamate Receptors
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Glutamate receptors; Rigidity; Dendrite branching; Astrocytes; AMPA;
   NMDA; Hydrogels; Polyacrylamide
ID IN-VIVO; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; NMDA; CELLS; GROWTH;
   DIFFERENTIATION; INTEGRINS; RIGIDITY; TRANSCRIPTION
AB Brain injury or disease can initiate changes in local or global stiffness of brain tissue. While stiffness of the extracellular environment is known to affect the morphology and function of many cell types, little is known about how the dendrites of neurons respond to changes in brain stiffness. To assess how extracellular stiffness affects dendrite morphology, we took biomaterial and biomedical engineering approaches. We cultured mixed and pure hippocampal neurons on hydrogels composed of polyacrylamide (PA) of varying stiffnesses to mimic the effects of extracellular matrix stiffness on dendrite morphology. The majority of investigations of cortical and spinal cord neurons on soft hydrogels examined branching at early time points (days in vitro (DIV) 2-7), an important distinction from our study, where we include later time points that encompass the peak of branching (DIV 10-12). At DIV 12, dendrite branching was altered by stiffness for both pure and mixed neuronal cultures. Furthermore, we treated hippocampal cultures with glutamate receptor antagonists and with astrocyte-conditioned media. Blocking AMPA and NMDA receptors affected the changes in dendrite branching seen at varying rigidities. Moreover, extracellular factors secreted by astrocytes also change dendrite branching seen at varying rigidities. Thus, astrocytes and ionotropic glutamate receptors contribute to mechanosensing.
C1 [Previtera, Michelle L.; Langhammer, Christopher G.; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.
   [Previtera, Michelle L.] Rutgers State Univ, Grad Program Mol Biosci, Piscataway, NJ 08854 USA.
   [Langhammer, Christopher G.] Rutgers State Univ, Grad Program Biomed Engn, Piscataway, NJ 08854 USA.
   [Langrana, Noshir A.; Firestein, Bonnie L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
RP Firestein, BL (reprint author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.
EM firestein@biology.rutgers.edu
OI Firestein, Bonnie/0000-0002-1679-3565
FU National Science Foundation [IBN-0548543, IBN-0919747]; March of Dimes
   [1-FY08-464]; New Jersey Commission on Brain Injury Research
   [09-3209-BIR-E-2]; American Heart Association [0555801T]; IGERT; NSF
   [DGE-0333196]; Louis Bevier Dissertation Fellowship; National Institute
   of General Medical Sciences [5T32GM008339]
FX This work was funded by grants from National Science Foundation
   IBN-0548543 and IBN-0919747; March of Dimes 1-FY08-464; New Jersey
   Commission on Brain Injury Research, #09-3209-BIR-E-2; American Heart
   Association 0555801T. MLP was supported by the IGERT Program on
   Biointerfaces, NSF Grant DGE-0333196 and Louis Bevier Dissertation
   Fellowship. CGL was supported by Biotechnology Fellowship, Grant
   5T32GM008339 from National Institute of General Medical Sciences. We
   would like to thank Dr. Penelope Georges for her scientific guidance and
   support.
CR Akum BF, 2004, NAT NEUROSCI, V7, P145, DOI 10.1038/nn1179
   Bernard-Trifilo JA, 2005, J NEUROCHEM, V93, P834, DOI 10.1111/j.1471-4159.2005.03062.x
   BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015
   Carrel D, 2009, J NEUROSCI, V29, P8248, DOI 10.1523/JNEUROSCI.5287-08.2009
   Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595
   Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006
   Chen M, 2005, MOL BIOL CELL, V16, P5103, DOI 10.1091/mbc.E05-02-0165
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Cline H T, 1990, Adv Exp Med Biol, V268, P197
   CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8
   CLINE HT, 1990, J NEUROSCI, V10, P1197
   Dijkstra S, 1999, NEUROSCIENCE, V92, P1331, DOI 10.1016/S0306-4522(99)00060-3
   Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472
   Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661
   Earnshaw BA, 2006, J NEUROSCI, V26, P12362, DOI 10.1523/JNEUROSCI.3601-06.2006
   Firestein BL, 1999, J BIOL CHEM, V274, P10545, DOI 10.1074/jbc.274.15.10545
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Heng JE, 1999, DEV BRAIN RES, V113, P67, DOI 10.1016/S0165-3806(98)00191-6
   Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000
   Hof PR, 1996, BRAIN RES, V723, P77, DOI 10.1016/0006-8993(96)00218-1
   Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795
   Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z
   Jiang FX, 2010, TISSUE ENG PT A, V16, P1873, DOI [10.1089/ten.tea.2009.0574, 10.1089/ten.TEA.2009.0574]
   JIANG X, 2007, OPEN NEUROSCI J, V1, P7
   Johansson S, 2002, J COMP NEUROL, V443, P237, DOI 10.1002/cne.10119
   Juhasz G, 2008, BRAIN RES, V1233, P20, DOI 10.1016/j.brainres.2008.05.032
   Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852
   Kramar EA, 2003, J BIOL CHEM, V278, P10722, DOI 10.1074/jbc.M210225200
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Li Z, 2000, NAT NEUROSCI, V3, P217
   Lin B, 2003, J NEUROPHYSIOL, V89, P2874, DOI 10.1152/jn.00783.2002
   Matsutani S, 1998, J NEUROBIOL, V37, P251, DOI 10.1002/(SICI)1097-4695(19981105)37:2<251::AID-NEU5>3.0.CO;2-S
   Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Piccini A, 2002, J NEUROSCI, V22, P5387
   PREVITERA ML, 2010, J BIOSCI BIOMED 0510
   Rajan I, 1998, J NEUROSCI, V18, P7836
   Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#
   Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Xia ZG, 1996, J NEUROSCI, V16, P5425
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 44
TC 23
Z9 23
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2010
VL 38
IS 12
BP 3733
EP 3743
DI 10.1007/s10439-010-0112-5
PG 11
WC Engineering, Biomedical
SC Engineering
GA 678GN
UT WOS:000284062200015
PM 20614247
DA 2018-10-19
ER

PT J
AU Kon'kov, AS
   Pustovalova, OL
   Agapov, II
AF Kon'kov, A. S.
   Pustovalova, O. L.
   Agapov, I. I.
TI Biocompatible Materials from Regenerated Silk for Tissue Engineering and
   Medicinal Therapy
SO APPLIED BIOCHEMISTRY AND MICROBIOLOGY
LA English
DT Article
DE artificial matrix; medicinal therapy; spider net; regenerated silk;
   creation of hybrid tissues and organs; transplantology; fibroin
ID MESENCHYMAL STEM-CELLS; SPIDER SILK; CONTROLLED-RELEASE; BIOMATERIAL
   COATINGS; FIBROIN SCAFFOLDS; ATOPIC-DERMATITIS; VASCULAR GRAFTS;
   BOMBYX-MORI; PROTEIN; DELIVERY
AB The present review is devoted to the application of biomaterials from regenerated silk for designing tissue-engineered constructs-the basis for hybrid organs and tissues. Fibroin, the main structural protein of silkworm silk, can be used to design artificial cartilages, bone tissue fragments, blood vessels, as well as to regenerate nervous tissue. Fibroin capsules containing bioactive compounds are successfully applicable in medicinal therapy, such as controlled drug delivery in cancer treatment. Apart from fibroin, tissue engineering can successfully be based on biopolymer spidroin, a spider net protein, which is also a biocompatible material with valuable mechanical properties.
C1 [Kon'kov, A. S.; Pustovalova, O. L.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia.
   [Agapov, I. I.] Russian Minist Hlth & Social Dev, Federal State Inst, Shumakov Fed Res Ctr Transplantol & Artificial Or, Moscow 113182, Russia.
RP Kon'kov, AS (reprint author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia.
EM igor_agapov@mail.ru
RI Agapov, Igor/D-9450-2014
OI Agapov, Igor/0000-0002-0273-4601
FU Russian Foundation for Basic Research [09-02-00173]
FX The work has been supported by the Russian Foundation for Basic Research
   (grant No. 09-02-00173).
CR Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Boison D, 2009, BIOCHEM PHARMACOL, V78, P1428, DOI 10.1016/j.bcp.2009.08.005
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gupta V, 2009, INT J NANOMED, V4, P115
   Hermanson KD, 2007, PHYS CHEM CHEM PHYS, V9, P6442, DOI 10.1039/b709808a
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Koller DY, 2007, PEDIATR ALLERGY IMMU, V18, P335, DOI 10.1111/j.1399-3038.2006.00511.x
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002
   Liebmann B, 2008, COLLOID SURFACE A, V331, P126, DOI 10.1016/j.colsurfa.2008.04.005
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Mason Rupert, 2008, J Fam Health Care, V18, P63
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ni Y, 2008, OTOLARYNG HEAD NECK, V139, P256, DOI 10.1016/j.otohns.2008.03.028
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   RAMMENSEE SS, 2005, APPL PHYS A, V82, P261
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Seo YK, 2009, J ORTHOP RES, V27, P495, DOI 10.1002/jor.20752
   Shangkai C, 2007, TISSUE ENG, V13, P483, DOI 10.0189/ten.2006.0181
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Spelzini F, 2007, GYNECOL OBSTET INVES, V63, P155, DOI 10.1159/000096893
   Stinco G, 2008, DERMATOLOGY, V217, P191, DOI 10.1159/000141648
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   VEPARI C, 2009, J BIOMED MAT RES A
   WANG S, 2008, BIOMED MATER, V3, pNIL49
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
NR 54
TC 4
Z9 5
U1 6
U2 27
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0003-6838
J9 APPL BIOCHEM MICRO+
JI Appl. Biochem. Microbiol.
PD DEC
PY 2010
VL 46
IS 8
BP 739
EP 744
DI 10.1134/S0003683810080028
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 679NB
UT WOS:000284167000002
DA 2018-10-19
ER

PT J
AU Zander, NE
   Orlicki, JA
   Rawlett, AM
   Beebe, TP
AF Zander, Nicole E.
   Orlicki, Joshua A.
   Rawlett, Adam M.
   Beebe, Thomas P., Jr.
TI Surface-modified nanofibrous biomaterial bridge for the enhancement and
   control of neurite outgrowth
SO BIOINTERPHASES
LA English
DT Article
ID PERIPHERAL-NERVE REGENERATION; NEURAL STEM-CELLS; ELECTROSPUN
   NANOFIBERS; FIBROUS SCAFFOLDS; IN-VITRO; IMMOBILIZATION; GROWTH;
   GUIDANCE; FABRICATION; ALIGNMENT
AB Biomaterial bridges constructed from electrospun fibers offer a promising alternative to traditional nerve tissue regeneration substrates. Aligned and unaligned polycaprolactone (PCL) electrospun fibers were prepared and functionalized with the extracellular matrix proteins collagen and laminin using covalent and physical adsorption attachment chemistries. The effect of the protein modified and native PCL nanofiber scaffolds on cell proliferation, neurite outgrowth rate, and orientation was examined with neuronlike PC12 cells. All protein modified scaffolds showed enhanced cellular adhesion and neurite outgrowth compared to unmodified PCL scaffolds. Neurite orientation was found to be in near perfect alignment with the fiber axis for cells grown on aligned fibers, with difference angles of less than 7 degrees from the fiber axis, regardless of the surface chemistry. The bioavailability of PCL fibers with covalently attached laminin was found to be identical to that of PCL fibers with physically adsorbed laminin, indicating that the covalent chemistry did not change the protein conformation into a less active form and the covalent attachment of protein is a suitable method for enhancing the biocompatibility of tissue engineering scaffolds. (c) 2010 American Vacuum Society. [DOI: 10.1116/1.3526140]
C1 [Zander, Nicole E.; Orlicki, Joshua A.; Rawlett, Adam M.] USA, Res Lab, Weap & Mat Res Directorate, Aberdeen Proving Ground, MD 21005 USA.
   [Zander, Nicole E.; Beebe, Thomas P., Jr.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
RP Zander, NE (reprint author), USA, Res Lab, Weap & Mat Res Directorate, Aberdeen Proving Ground, MD 21005 USA.
EM nicole.zander@arl.army.mil
CR Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Corey JM, 2005, ANN NEUROL, V58, pS65
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JW, 2010, J BIOMED MATER RES A, V92A, P378, DOI 10.1002/jbm.a.32377
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Ma HW, 2005, ADV FUNCT MATER, V15, P529, DOI 10.1002/adfm.200400088
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102
   Sangsanoh P, 2007, BIOMACROMOLECULES, V8, P1587, DOI 10.1021/bm061152a
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shriver-Lake LC, 1997, BIOSENS BIOELECTRON, V12, P1101, DOI 10.1016/S0956-5663(97)00070-5
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Waddell RL, 2003, BIOTECHNOL PROGR, V19, P1767, DOI 10.1021/bp034086m
   WANG B, 2010, ACTA BIOMATER, V6, P2970
   Wang ZH, 2004, J IMMUNOL METHODS, V285, P237, DOI 10.1016/j.jim.2003.12.002
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Yildirim ED, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014109
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 42
TC 29
Z9 31
U1 0
U2 40
PU AVS
PI RESEARCH TRIANGLE PARK
PA EDITORIAL OFFICE, 100 PARK DR, STE 105, CALLER BOX 13994, RESEARCH
   TRIANGLE PARK, NC 27709 USA
SN 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD DEC
PY 2010
VL 5
IS 4
BP 149
EP 158
DI 10.1116/1.3526140
PG 10
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 703JO
UT WOS:000285974400008
PM 21219036
OA Bronze
DA 2018-10-19
ER

PT J
AU Serban, MA
   Kaplan, DL
AF Serban, Monica A.
   Kaplan, David L.
TI pH-Sensitive Ionomeric Particles Obtained via Chemical Conjugation of
   Silk with Poly(amino acid)s
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTROLLED DRUG-DELIVERY; FIBROIN; BIOMATERIALS; SCAFFOLDS; RELEASE;
   POLYMER; MORI
AB Silk-fibroin-based biomaterials have been widely utilized for a range of biomaterial-related systems. For all these previously reported systems, the beta-sheet forming feature of the silk was the key stabilizing element of the final material structure. Herein, we describe a different strategy, based on the engineering of silk-based ionomers that can yield stable colloidal composites or particle suspensions through electrostatic interactions. These silk-based ionomers were obtained by carbodiimide-mediated coupling of silk fibroin with polylysine hydrobromide and polyglutamic acid sodium salts, respectively. Colloidal composites could be obtained by mixing the ionomeric pair at high concentration (i.e., 25% w/v), while combining them at lower concentrations (i.e., 5% w/v) yielded particle suspensions. The assembly of the ionomers was driven by electrostatic interactions, pH-dependent, and reversible. The network assembly appeared to be polarized, with the interacting poly(amino acid) chains clustered to the core of the particles and the silk backbone oriented outward. In agreement with this assembly mode, doxorubicin, a hydrophilic antitumor drug, could be released at a slow rate, in a pH-dependent manner, indicating that the inside of the ionomeric particles was mainly hydrophilic in nature.
C1 [Serban, Monica A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [P41 EB002520]
FX We thank Dr. Bill Rice for his help with confocal microscopy data
   acquisition and Dr. Aneta Mieszawska for her assistance with SEM image
   acquisition. Funding for this project was provided by the NIH (P41
   EB002520).
CR Asakura T, 2004, MAGN RESON CHEM, V42, P258, DOI 10.1002/mrc.1337
   Bidros DS, 2009, NEUROTHERAPEUTICS, V6, P539, DOI 10.1016/j.nurt.2009.04.004
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Gupta V, 2009, INT J NANOMED, V4, P115
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee ES, 2008, J CONTROL RELEASE, V132, P164, DOI 10.1016/j.jconrel.2008.05.003
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Shi LJ, 2006, ADV MATER, V18, P2315, DOI 10.1002/adma.200600610
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sohn S, 2004, BIOMACROMOLECULES, V5, P751, DOI 10.1021/bm034393
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   van Sluis R, 1999, MAGN RESON MED, V41, P743
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 25
TC 21
Z9 21
U1 2
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2010
VL 11
IS 12
BP 3406
EP 3412
DI 10.1021/bm100925s
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 694AP
UT WOS:000285267500023
PM 21028849
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Foster, LJR
   Thomson, K
   Marcal, H
   Butt, J
   Watson, SL
   Wakefield, D
AF Foster, L. John R.
   Thomson, Kyle
   Marcal, Helder
   Butt, Julian
   Watson, Stephanie L.
   Wakefield, Denis
TI Chitosan-Vancomysin Composite Biomaterial as a Laser Activated Surgical
   Adhesive with Regional Antimicrobial Activity
SO BIOMACROMOLECULES
LA English
DT Article
ID RESISTANT STAPHYLOCOCCUS-AUREUS; IN-VITRO; TISSUE-REPAIR; FILMS; VIVO;
   POLYHYDROXYALKANOATES; MICROSPHERES; DELIVERY; AGENT
AB We have used laser irradiation to enhance the natural adhesiveness of chitosan to form a thin film surgical adhesive. Prevention of infection at surgical sites often utilizes systemic provision of antibiotics with reduced local efficacy and potential side effects. In the work reported here, we investigate the bactericidal properties of laser-irradiated chitosan films and their impregnation with the antibiotic vancomycin. Despite strong efficacy in solution, chitosan films showed no antimicrobial activity against representatives of common pathogens Escherichia coli, Staphylococcus aureus, and S. epidermidis. In contrast, a composite of chitosan adhesive and the antibiotic vancomycin showed therapeutically significant release profiles greater that the Minimum Bactericidal Concentrations (MBCs) for the Staphylococci over a 28 day period. These composite films had greater crystallinity, up to 28 +/- 3 compared to 8.9 +/- 2%, for its unblended counterpart. Despite a significant increase in material strength from 31.4 +/- 4 to 77.5 +/- 5 MPa, flexibility was still maintained with an elongation to break around 5 +/- 2% and fold endurance of approximately 30 +/- 3-folds. Laser irradiation had no apparent effect on the release or activity of the antibiotic which survived transient temperatures at the film tissue interface during infrared irradiation of around 54 degrees C. Furthermore, significant adhesive strength was still apparent, 15.6 +/- 2 KPa. Thus, we have developed a laser-activated bioadhesive with the potential to close wounds while facilitating the prevention of microbial infection through local release of antibiotic targeted to the site of potential infection.
C1 [Foster, L. John R.; Thomson, Kyle; Marcal, Helder; Butt, Julian] Univ New S Wales, Bio Polymer Res Grp, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci,Fac Sci, Sydney, NSW, Australia.
   [Watson, Stephanie L.; Wakefield, Denis] Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia.
   [Watson, Stephanie L.] Univ New S Wales, Prince Wales Hosp, Sydney, NSW, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Bio Polymer Res Grp, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci,Fac Sci, Sydney, NSW, Australia.
EM j.foster@unsw.edu.au
OI Watson, Stephanie/0000-0001-6699-1765; Thomson, Kyle/0000-0002-0846-7428
FU ARC [DP077253]; ORIA
FX The authors gratefully acknowledge sponsorship of this research through
   an ARC Discovery Award (DP077253) to L.J.R.F. and an ORIA Project Award
   to S.L.W. and L.J.R.F.
CR Appendini P., 2002, Innovative Food Science and Emerging Technologies, V3, P113, DOI 10.1016/S1466-8564(02)00012-7
   Atkins TW, 1998, DRUG DELIV, V5, P63, DOI 10.3109/10717549809052029
   Beverlya RL, 2008, FOOD MICROBIOL, V25, P534, DOI 10.1016/j.fm.2007.11.002
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Della Valle AG, 2001, ACTA ORTHOP SCAND, V72, P237
   Enwemeka CS, 2009, PHOTOMED LASER SURG, V27, P221, DOI 10.1089/pho.2008.2413
   Foster LJR, 2008, BIOMACROMOLECULES, V9, P314, DOI 10.1021/bm7006289
   Foster LJR, 2001, BIOTECHNOL LETT, V23, P893, DOI 10.1023/A:1010528229685
   Fung LC, 1999, LASER SURG MED, V25, P285, DOI 10.1002/(SICI)1096-9101(1999)25:4<285::AID-LSM3>3.0.CO;2-S
   Gershlick AH, 2002, ATHEROSCLEROSIS, V160, P259, DOI 10.1016/S0021-9150(01)00618-9
   GUIQING W, 2006, J CLIN MICROBIOL, V44, P3883
   Harris L. G., 2002, European Cells & Materials, V4, P39
   HUA X, 2001, PROG BIOMED OPTICS I, V2, P189
   KHOR L, 2003, BIOMATERIALS, V24, P2339
   Kjaergard HK, 2001, AM J SURG, V182, p15S, DOI 10.1016/S0002-9610(01)00772-3
   Kramer K, 2002, ARCH SURG-CHICAGO, V137, P278, DOI 10.1001/archsurg.137.3.278
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 2005, LASER SURG MED, V36, P193, DOI 10.1002/lsm.20145
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   Lee SH, 2004, J CONTROL RELEASE, V96, P1, DOI 10.1016/j.jconrel.2003.12.029
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   LIU SJ, 2008, INT J PHARMACEUT, V370, P75
   MILLESI H, 1982, SCAND J PLAST RECONS, V19, P25
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   Pecha RE, 1998, GASTROINTEST ENDOSC, V48, P299, DOI 10.1016/S0016-5107(98)70196-8
   *PIR LTD, 2005, GLUES SEAL IND BACKG
   Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   WALSH CT, 1996, CHEM BIOL        JAN, P321
   Wan Y, 2003, POLYMER, V44, P1057, DOI 10.1016/S0032-3861(02)00881-9
   Wilson M, 2002, BACTERIAL DIS MECH I
   Wong ACY, 1997, J VINYL ADDIT TECHN, V3, P64, DOI 10.1002/vnl.10167
   Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444
   Wright NT, 2002, ANNU REV BIOMED ENG, V4, P109, DOI 10.1146/annurev.bioeng.4.101001.131546
NR 37
TC 15
Z9 15
U1 1
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2010
VL 11
IS 12
BP 3563
EP 3570
DI 10.1021/bm101028g
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 694AP
UT WOS:000285267500042
PM 21080623
DA 2018-10-19
ER

PT J
AU Sengupta, S
   Park, SH
   Seok, GE
   Patel, A
   Numata, K
   Lu, CL
   Kaplan, DL
AF Sengupta, Sejuti
   Park, Sang-Hyug
   Seok, Gil Eun
   Patel, Atur
   Numata, Keiji
   Lu, Chia-Li
   Kaplan, David L.
TI Quantifying Osteogenic Cell Degradation of Silk Biomaterials
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOBLASTIC DIFFERENTIATION; MATRIX
   METALLOPROTEINASES; BONE-FORMATION; ACID-SEQUENCE; IDENTIFICATION;
   FIBRONECTIN; SCAFFOLDS; CHEMISTRY; FIBROIN
AB The degradation of silk protein films by human mesenchymal stem cells (hMSCs), osteoblasts and osteoclasts, cells involved in osteogenic functions in normal and diseased bone, was assessed in vitro. The involvement of specific matrix metalloproteinases (MMPs) and integrin signaling in the degradation process was determined. Scanning electron microscopy (SEM) and atomic force microscopy (AFM) were used to quantitatively compare degradation by the different cell types using surface patterned silk films. Osteoblasts and osteoclasts demonstrated significant degradation of the silk films in vitro in comparison to the hMSCs and the film controls without cells. The osteoclasts degraded the silk films the most and also generated the highest level of MMPs 1 and 2. The osteoblasts upregulated integrins alpha 5 and beta 1, while the osteoclast upregulated integrins alpha 2 and beta 1. There was significant contrast in responses on the silk matrices between osteogenic cells versus undifferentiated hMSCs to illustrate in vitro the role of cell type on matrix remodeling. These are important issues in matching biomaterial matrix features and studies in vitro to remodeling in vivo, in both normal and disease tissue systems. Cell populations and niche factors impact tissue regeneration, wound healing, physiological state, and the ability to better understand the role of different cell types is critical to overall regenerative outcomes.
C1 [Sengupta, Sejuti; Park, Sang-Hyug; Seok, Gil Eun; Patel, Atur; Numata, Keiji; Lu, Chia-Li; Kaplan, David L.] Tufts Univ, Sch Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Sch Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Numata, Keiji/H-9751-2012
OI Numata, Keiji/0000-0003-2199-7420; Sengupta, Sejuti/0000-0002-1019-2785
FU NIH P41 Tissue Engineering Resource Center [EB002520]; NIH [EB003210,
   DE017207]
FX The authors thank Carmen Preda for her technical contributions. This
   work was supported by NIH P41 Tissue Engineering Resource Center
   (EB002520) and the NIH (EB003210 and DE017207).
CR Abraham LC, 2007, BIOMATERIALS, V28, P151, DOI 10.1016/j.biomaterials.2006.07.001
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   AOTA S, 1991, J BIOL CHEM, V266, P15938
   Bode W, 1999, APMIS, V107, P3, DOI 10.1111/j.1699-0463.1999.tb01520.x
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cao ZJ, 1998, J BIOL CHEM, V273, P31670, DOI 10.1074/jbc.273.48.31670
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323
   Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1
   Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200
   Jones GL, 2009, BIOMATERIALS, V30, P5376, DOI 10.1016/j.biomaterials.2009.07.028
   Kang CD, 1996, BIOCHEM BIOPH RES CO, V221, P95, DOI 10.1006/bbrc.1996.0551
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344
   MEIKLE MC, 1992, J CELL SCI, V103, P1093
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nicolin V, 2006, J MOL HISTOL, V37, P171, DOI 10.1007/s10735-006-9058-1
   Numata K, 2006, MACROMOL BIOSCI, V6, P41, DOI 10.1002/mabi.200500160
   Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   PARK SH, 2001, BIOMATERIALS, V31, P6162
   Phillips JA, 2005, EXP CELL RES, V310, P79, DOI 10.1016/j.yexcr.2005.03.039
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Seifter SEH, 1971, ENZYMES, V3, P649
   Shimo T, 2007, J CELL COMMUN SIGNAL, V1, P103, DOI 10.1007/s12079-007-0010-2
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Srivastava AK, 2005, CURR MED RES OPIN, V21, P1015, DOI 10.1185/030079905X49635
   SUBRAMANIAN B, 2010, TISSUE ENG A
   Wang YD, 2009, MEDIAT INFLAMM, DOI 10.1155/2009/275072
   WOESSNER JF, 2000, MATRIX METALLOPROTEI, P101
   Wozney JM, 2003, NAT BIOTECHNOL, V21, P506, DOI 10.1038/nbt0503-506
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 42
TC 30
Z9 31
U1 1
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2010
VL 11
IS 12
BP 3592
EP 3599
DI 10.1021/bm101054q
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 694AP
UT WOS:000285267500046
PM 21105641
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gil, ES
   Mandal, BB
   Park, SH
   Marchant, JK
   Omenetto, FG
   Kaplan, DL
AF Gil, Eun Seok
   Mandal, Biman B.
   Park, Sang-Hyug
   Marchant, Jeffrey K.
   Omenetto, Fiorenzo G.
   Kaplan, David L.
TI Helicoidal multi-lamellar features of RGD-functionalized silk
   biomaterials for corneal tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Cornea; RGD; Silk; Surface patterns; Tissue engineering
ID CROSS-LINKED COLLAGEN; FIBROIN FILMS; IN-VIVO; CELL; STROMA; SCAFFOLDS;
   SURFACE; FIBROBLASTS; RESPONSES; ADHESION
AB RGD-coupled silk protein-biomaterial lamellar systems were prepared and studied with human cornea fibroblasts (hCFs) to match functional requirements. A strategy for corneal tissue engineering was pursued to replicate the structural hierarchy of human corneal stroma within thin stacks of lamellae-like tissues, in this case constructed from scaffolds constructed with RGD-coupled, patterned, porous, mechanically robust and transparent silk films. The influence of RGD-coupling on the orientation, proliferation, ECM organization, and gene expression of hCFs was assessed. RGD surface modification enhanced cell attachment, proliferation, alignment and expression of both collagens (type land V) and proteoglycans (decorin and biglycan). Confocal and histological images of the lamellar systems revealed that the bio-functionalized silk human cornea 3D constructs exhibited integrated corneal stroma tissue with helicoidal multi-lamellar alignment of collagen-rich and proteoglycan-rich extracellular matrix, with transparency of the construct. This biomimetic approach to replicate corneal stromal tissue structural hierarchy and architecture demonstrates a useful strategy for engineering human cornea. Further, this approach can be exploited for other tissue systems due to the pervasive nature of such helicoids in most human tissues. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Gil, Eun Seok; Mandal, Biman B.; Park, Sang-Hyug; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Sch Engn, Medford, MA 02155 USA.
   [Marchant, Jeffrey K.; Kaplan, David L.] Tufts Univ, Sackler Sch Biomed Sci, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Sch Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [EY01819]; NIH P41 Tissue Engineering Resource Center [EB002520]
FX The authors are grateful to May Griffith at the LinkopingUniversity for
   contributing the human corneal fibroblasts. This work was supported by
   the NIH R21 (EY01819) and the NIH P41 Tissue Engineering Resource Center
   (EB002520).
CR Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999
   BIRK DE, 1990, J CELL SCI, V95, P649
   Boateng SY, 2005, AM J PHYSIOL-CELL PH, V288, pC30, DOI 10.1152/ajpcell.00199.2004
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543
   Crabb RAB, 2006, TISSUE ENG, V12, P1565, DOI 10.1089/ten.2006.12.1565
   DOANE KJ, 1992, EXP CELL RES, V200, P490, DOI 10.1016/0014-4827(92)90200-R
   DONOHUE DJ, 1995, J OPT SOC AM A, V12, P1425, DOI 10.1364/JOSAA.12.001425
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055
   *EYE BANK ASS AM, 2005, ANN REP EYE BANK ASS
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Hogan M. J., 1971, HISTOLOGY HUMAN EYE
   Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jun HW, 2004, J BIOMAT SCI-POLYM E, V15, P73, DOI 10.1163/156856204322752246
   Jung HJ, 2005, MACROMOL RES, V13, P446, DOI 10.1007/BF03218479
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Mannis MJ, 1997, CORNEA, V16, P683
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mimura T, 2008, MOL VIS, V14, P1819
   Morishige N, 2006, J CATARACT REFR SURG, V32, P1784, DOI 10.1016/j.jcrs.2006.08.027
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Myung D, 2007, BIOMED MICRODEVICES, V9, P911, DOI 10.1007/s10544-006-9040-4
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   STEELE C, 1999, OPTOM TODAY, V9, P28
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
   Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200
NR 48
TC 83
Z9 86
U1 5
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 34
BP 8953
EP 8963
DI 10.1016/j.biomaterials.2010.08.017
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 675GJ
UT WOS:000283814600015
PM 20801503
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Chan, AW
   Neufeld, RJ
AF Chan, Ariel W.
   Neufeld, Ronald J.
TI Tuneable semi-synthetic network alginate for absorptive encapsulation
   and controlled release of protein therapeutics
SO BIOMATERIALS
LA English
DT Article
DE Alginate; Absorption; Controlled drug release; Hydrogel; Peptide;
   Swelling
ID LIGHT-SCATTERING; DRUG-DELIVERY; PORE-SIZE; BEADS; HYDROGELS; CHITOSAN;
   INSULIN; BIOMATERIALS; TRANSITION; DIFFUSION
AB Stimuli-responsive hydrogels swell or contract in response to external pH, ionic strength or temperature, and are of considerable interest as pharmaceutical controlled release devices. Alginate, a mucoadhesive biopolymer, was used as building block in the semi-synthesis of a tetra-functional acetal-linked networked polymer (SNAP) with carboxylate moieties preserved as stimuli-responsive sensors and tuneable pore sizes larger than the hydrodynamic radius of model molecules ranging between 1 and 540 kDa. Based on the diffusion coefficients calculated from protein uptake experiments, the networked polymer with pre-designed pore size of 80 nm can allow vitamin B(12), lysozyme, subtilisin, insulin, albumin, and urease to diffuse freely into the hydrogel with diffusivity ratio of D(gel)/D(water) (diffusion coefficients in hydrogel to water) between 0.60 and 0.95. Drying was applied as post-fabrication modification to alter/control the diffusional properties of the gel matrix. Together with the pH-responsive swelling properties, SNAP granules containing acid-labile protein therapeutics such as insulin showed protective characteristics by retaining collapsed/compact state in gastric environment (pH1.2) while swelling in neutral pH to release the bioactives at near zero-order kinetics. SNAP, a new class of tuneable biomaterial, can be semi-synthesized with desired pore properties, which when applied with the absorptive encapsulation technique, can serve as a technology platform for oral delivery of biomolecules with wide range of molecular sizes. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Chan, Ariel W.; Neufeld, Ronald J.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Neufeld, RJ (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM ron.neufeld@chee.queensu.ca
FU Natural Sciences and Engineering Research Council of Canada
FX The authors thank the Natural Sciences and Engineering Research Council
   of Canada for financial support.
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Baumann A, 2009, DRUG DISCOV TODAY, V14, P1112, DOI 10.1016/j.drudis.2009.09.013
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g
   BRODE PF, 1992, LANGMUIR, V8, P1325, DOI 10.1021/la00041a014
   Chan AW, 2008, BIOMACROMOLECULES, V9, P2536, DOI 10.1021/bm800594f
   Chan AW, 2009, BIOMATERIALS, V30, P6119, DOI 10.1016/j.biomaterials.2009.07.034
   Chan AW, 2009, BIOMACROMOLECULES, V10, P609, DOI 10.1021/bm801316z
   Chan AWJ, 2005, PROCESS BIOCHEM, V40, P1903, DOI 10.1016/j.procbio.2004.07.006
   CRANK J, 1998, MATH DIFFUSION, P89
   DeGroot AR, 2001, ENZYME MICROB TECH, V29, P321, DOI 10.1016/S0141-0229(01)00393-3
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Elzatahry AA, 2009, J APPL POLYM SCI, V111, P2452, DOI 10.1002/app.29221
   Follmer C, 2004, BIOPHYS CHEM, V111, P79, DOI 10.1016/j.bpc.2004.03.009
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Grigsby JJ, 2000, J PHYS CHEM B, V104, P3645, DOI 10.1021/jp993177s
   Halle B, 2003, P NATL ACAD SCI USA, V100, P12135, DOI 10.1073/pnas.2033320100
   Hovgaard L, 1996, INT J PHARM, V132, P107, DOI 10.1016/0378-5173(95)04371-3
   Jorgensen TE, 2007, BIOMACROMOLECULES, V8, P2388, DOI 10.1021/bm070208d
   Kim S, 2009, EUR J PHARM BIOPHARM, V71, P420, DOI 10.1016/j.ejpb.2008.09.021
   KLEIN J, 1983, EUR J APPL MICROBIOL, V18, P86, DOI 10.1007/BF00500829
   Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J
   Lin SY, 1999, POLYMER, V40, P6307, DOI 10.1016/S0032-3861(98)00872-6
   Lindstrom T, 2002, DIABETES CARE, V25, P1049, DOI 10.2337/diacare.25.6.1049
   Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b
   Patil SB, 2009, J MICROENCAPSUL, V26, P432, DOI 10.1080/02652040802456726
   Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P698, DOI 10.1016/j.tibtech.2009.09.004
   Reis CP, 2008, J PHARM SCI-US, V97, P5290, DOI 10.1002/jps.21347
   Shin HS, 1998, J APPL POLYM SCI, V69, P479, DOI 10.1002/(SICI)1097-4628(19980718)69:3<479::AID-APP7>3.0.CO;2-D
   Srinivasan C, 2005, J MICROENCAPSUL, V22, P127, DOI 10.1080/02652040400026400
   TANAKA H, 1984, BIOTECHNOL BIOENG, V26, P53, DOI 10.1002/bit.260260111
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Vehring R, 2008, PHARM RES-DORDR, V25, P999, DOI 10.1007/s11095-007-9475-1
   WANG ZY, 1995, BIOPOLYMERS, V35, P227, DOI 10.1002/bip.360350211
   Woitiski CB, 2009, ACTA BIOMATER, V5, P2475, DOI 10.1016/j.actbio.2009.03.007
   Yin YH, 2008, CARBOHYD POLYM, V71, P682, DOI 10.1016/j.carbpol.2007.07.012
   Zhang Y, 2006, MACROMOLECULES, V39, P1073, DOI 10.1021/ma0522357
NR 37
TC 46
Z9 48
U1 5
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 34
BP 9040
EP 9047
DI 10.1016/j.biomaterials.2010.07.111
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 675GJ
UT WOS:000283814600025
PM 20739057
DA 2018-10-19
ER

PT J
AU Kolind, K
   Dolatshahi-Pirouz, A
   Lovmand, J
   Pedersen, FS
   Foss, M
   Besenbacher, F
AF Kolind, Kristian
   Dolatshahi-Pirouz, Alireza
   Lovmand, Jette
   Pedersen, Finn Skou
   Foss, Morten
   Besenbacher, Flemming
TI A combinatorial screening of human fibroblast responses on
   micro-structured surfaces
SO BIOMATERIALS
LA English
DT Article
DE Fibroblast; Cell proliferation; Surface topography; Microstructure;
   Combinatorial screening
ID MESENCHYMAL STEM-CELLS; FOCAL ADHESIONS; EXTRACELLULAR-MATRIX; IN-VITRO;
   TOPOGRAPHY; NANOTOPOGRAPHY; PROLIFERATION; MORPHOLOGY; EXPRESSION;
   MIGRATION
AB Biomaterial surfaces structured with topographical features have been predicted to play an important role in the next generation of biomedical implants. Specific trends with regard to the influence of the topographical effect on cellular behavior are however challenging to establish due to differences in the topographical features and geometries in the various studies. Here, we demonstrate the use of a highly versatile combinatorial screening approach to identify the effect of 169 distinct surface topographies, consisting of pillars, on fibroblast proliferation and mechanical response. Altering the inter-pillar gap size of the structures revealed a significant change in fibroblast proliferation and identified obvious stress-induced changes in the cytoskeleton and focal adhesion morphology. Larger (4-6 mu m) inter-pillar gap sizes reduced fibroblast proliferation and elicited a strong elongation leading to a disruption of the actin cytoskeleton anchored primarily to focal adhesions located between the pillars. Smaller (1-2 mu m) interpillar gap sizes, on the contrary, caused the fibroblasts to proliferate comparable to cells on a non-structured surface with cells having a clear actin cytoskeleton attached to focal adhesions located mostly on top of the pillars. The approach reveals a strong correlation between the exact topographical periodicities and cellular responses such as cell proliferation, cell morphology and focal adhesion. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Foss, Morten] Aarhus Univ, Interdisciplinary Nanosci Ctr, Dept Mol Biol, DK-8000 Aarhus C, Denmark.
   [Kolind, Kristian; Dolatshahi-Pirouz, Alireza; Lovmand, Jette; Foss, Morten; Besenbacher, Flemming] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.
   [Besenbacher, Flemming] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark.
RP Foss, M (reprint author), Aarhus Univ, Interdisciplinary Nanosci Ctr, Dept Mol Biol, DK-8000 Aarhus C, Denmark.
EM foss@inano.au.dk
RI Dolatshahi-Pirouz, Alireza/P-8179-2014
OI Dolatshahi-Pirouz, Alireza/0000-0001-6326-0836
FU Coloplast A/S; Interdisciplinary Nanoscience Center, Aarhus University,
   Denmark
FX We gratefully thank Coloplast A/S for financial support, for providing
   the cells for this study and for lab facilities during seeding and
   culturing of cells, and we thank the Interdisciplinary Nanoscience
   Center, Aarhus University, Denmark, for financial support.
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   Alvarez B, 2008, J CELL PHYSIOL, V214, P474, DOI 10.1002/jcp.21215
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   BERSHADSKY AD, 1985, EXP CELL RES, V158, P433, DOI 10.1016/0014-4827(85)90467-7
   BETTINGER Z, 2008, ADV MATER, V20, P99
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Bohmer RM, 1996, MOL BIOL CELL, V7, P101
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Buckley CD, 1998, MOL MEMBR BIOL, V15, P167, DOI 10.3109/09687689709044318
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Dolatshahi-Pirouz A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/9/095101
   DOLATSHAHIPIROU.A, 2008, PHYS REV B, V77
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Fu J, 2008, APPL SURF SCI, V255, P286, DOI 10.1016/j.apsusc.2008.06.064
   Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100
   JAIN P, 2002, MATER RES SOC S P, V749, P107
   JAMES B, 1994, CLIN MAT, V16, P167
   Langevin HM, 2005, AM J PHYSIOL-CELL PH, V288, pC747, DOI 10.1152/ajpcell.00420.2004
   Lee IC, 2009, J BIOMED MATER RES A, V91A, P929, DOI 10.1002/jbm.a.32309
   Li P, 2003, IEEE T NANOBIOSCI, V2, P138, DOI 10.1109/TNB.2003.816228
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lovmand J, 2009, BIOMATERIALS, V30, P2015, DOI 10.1016/j.biomaterials.2008.12.081
   Markert LD, 2009, STEM CELLS DEV, V18, P1331, DOI 10.1089/scd.2009.0114
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Pennisi CP, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385103
   RECHENDORFF K, 2005, APPL PHYS LETT, V87
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang XF, 2008, BIOMATERIALS, V29, P2049, DOI 10.1016/j.biomaterials.2007.12.047
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yuan QA, 2010, J BIOMED MATER RES A, V93A, P381, DOI 10.1002/jbm.a.32548
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
NR 56
TC 44
Z9 44
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 35
BP 9182
EP 9191
DI 10.1016/j.biomaterials.2010.08.048
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682HZ
UT WOS:000284393300005
PM 20832853
DA 2018-10-19
ER

PT J
AU Han, QQ
   Jin, W
   Xiao, ZF
   Ni, HB
   Wang, JH
   Kong, J
   Wu, J
   Liang, WB
   Chen, L
   Zhao, YN
   Chen, B
   Dai, JW
AF Han, Qianqian
   Jin, Wei
   Xiao, Zhifeng
   Ni, Hongbin
   Wang, Jinhuan
   Kong, Jie
   Wu, Jun
   Liang, Weibang
   Chen, Lei
   Zhao, Yannan
   Chen, Bing
   Dai, Jianwu
TI The promotion of neural regeneration in an extreme rat spinal cord
   injury model using a collagen scaffold containing a collagen binding
   neuroprotective protein and an EGFR neutralizing antibody
SO BIOMATERIALS
LA English
DT Article
DE Collagen; EGFR neutralizing antibody; Spinal cord injury; Nerve
   regeneration
ID MYELIN-ASSOCIATED GLYCOPROTEIN; EPIDERMAL-GROWTH-FACTOR;
   CENTRAL-NERVOUS-SYSTEM; AXON REGENERATION; FUNCTIONAL RECOVERY; NEURITE
   OUTGROWTH; ADULT-RAT; MONOCLONAL-ANTIBODY; WHITE-MATTER; RECEPTOR
AB In the treatment of spinal cord injury, implantation of scaffolding biomaterials and the addition of neuroprotective factors will promote neural regeneration. It has been demonstrated in our previous work that linear ordered collagen scaffold (LOCS) will bridge neural regeneration after the injury of spinal cord hemisection, and BDNF fused with a collagen binding domain (CBD-BDNF) can bind to collagen specifically to exert the neuroprotective effect. Besides neuroprotective factors, the lack of axon regeneration of the injured spinal cord has been attributed partially to regeneration inhibitors such as myelin associated proteins and chondroitin sulfate proteoglycans (CSPGs). Epidermal growth factor receptor (EGFR) activation is downstream of the signaling pathways of these inhibitors. Here, the monoclonal antibody, 151IgG that inhibits signaling of EGFR was used to neutralize EGFR. 151IgG was cross-linked to LOCS and CBD-BDNF bound to LOCS to make a triple-functional biomaterial for neural regeneration (bridging, prompting growth and neutralizing growth inhibitors). This triple-functional device was tested in a 6 mm transected SCI model. Results showed that this collagen scaffold with the addition of 151IgG and CBD-BDNF provided effective bridging and stimulation effects for neural regeneration, recovery of electrical transmission of synapses and preventing the formation of glial scars in the extreme transected rat SCI model. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Jin, Wei; Ni, Hongbin; Kong, Jie; Wu, Jun; Liang, Weibang] Nanjing Univ, Dept Neurosurg, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Peoples R China.
   [Han, Qianqian; Xiao, Zhifeng; Chen, Lei; Zhao, Yannan; Chen, Bing; Dai, Jianwu] Chinese Acad Sci, Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100080, Peoples R China.
   [Han, Qianqian] Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China.
   [Wang, Jinhuan] Tianjing Huanhu Hosp, Inst Neurosurg, Tianjin 300060, Peoples R China.
RP Liang, WB (reprint author), Nanjing Univ, Dept Neurosurg, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Peoples R China.
EM lwbnj@yahoo.com.cn; jwdai@genetics.ac.cn
FU National Natural Science Foundation of China [30930032, 30688002];
   Chinese Academy of Sciences [KSCX2-YW-R-133]; Ministry of Science and
   Technology of China [2006CB943601]; K.C. Wang Education Foundation
FX This work was supported by grants from National Natural Science
   Foundation of China (30930032 and 30688002), Chinese Academy of Sciences
   (KSCX2-YW-R-133), and the Ministry of Science and Technology of China
   (2006CB943601). The authors also gratefully acknowledge the support of
   K.C. Wang Education Foundation.
CR Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166
   Bandtlow CE, 2003, EXP GERONTOL, V38, P79, DOI 10.1016/S0531-5565(02)00165-1
   Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003
   Cao Y, 2008, NEUROREHAB NEURAL RE, V22, P262, DOI 10.1177/1545968307308550
   CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7
   CHANDLER LP, 1985, J BIOL CHEM, V260, P3360
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5
   Erschbamer M, 2007, J NEUROSCI, V27, P6428, DOI 10.1523/JNEUROSCI.1037-07.2007
   Gauvreau V, 2004, BIOCONJUGATE CHEM, V15, P1146, DOI 10.1021/bc049858u
   Giger RJ, 2008, RESTOR NEUROL NEUROS, V26, P97
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009
   Hasegawa Y, 2004, J NEUROSCI, V24, P6826, DOI 10.1523/JNEUROSCI.1856-04.2004
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab
   Kastin AJ, 2005, CURR PHARM DESIGN, V11, P1247, DOI 10.2174/1381612053507440
   Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015
   KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210
   Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462
   Lee RJ, 2007, STEM CELLS, V25, P712, DOI 10.1634/stemcells.2005-0602
   Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004
   Li WW, 2004, J BIOL CHEM, V279, P43780, DOI 10.1074/jbc.M401803200
   Li X, 2009, NEUROREPORT, V20, P708, DOI 10.1097/WNR.0b013e32832aa942
   Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Liu S, 1998, J NEUROSCI RES, V51, P723, DOI 10.1002/(SICI)1097-4547(19980315)51:6<723::AID-JNR6>3.0.CO;2-D
   MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nishio T, 2009, J NEUROL, V256, pS306, DOI 10.1007/s00415-009-5244-x
   NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020
   Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856
NR 37
TC 65
Z9 75
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 35
BP 9212
EP 9220
DI 10.1016/j.biomaterials.2010.08.040
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682HZ
UT WOS:000284393300008
PM 20869112
DA 2018-10-19
ER

PT J
AU Khoo, X
   O'Toole, GA
   Nair, SA
   Snyder, BD
   Kenan, DJ
   Grinstaff, MW
AF Khoo, Xiaojuan
   O'Toole, George A.
   Nair, Shrikumar A.
   Snyder, Brian D.
   Kenan, Daniel J.
   Grinstaff, Mark W.
TI Staphylococcus aureus resistance on titanium coated with multivalent
   PEGylated-peptides
SO BIOMATERIALS
LA English
DT Article
DE Peptide; Surface modification; Bacteria; Biofilm; Implant; Biomaterial
ID SELF-ASSEMBLED MONOLAYERS; PHAGE DISPLAY; BIOFILM FORMATION; PROTEIN
   ADSORPTION; REPEATING POLYPEPTIDES; POLY(ETHYLENE GLYCOL);
   SURFACE-CHEMISTRY; POLYMER-COATINGS; CELL-ADHESION; BACTERIAL
AB Bacterial infections can have adverse effects on the efficacy, lifetime and safety of an implanted device and are the second most commonly attributed cause of orthopedic implant failure. We have previously shown the assembly of PEGylated titanium-binding peptides (TBPs) on Ti to obtain a bacteriophobic surface coating that can effectively resist protein adsorption and Staphylococcus aureus (S. aureus) adhesion. In the present study, we examine the effect of multiple TBP repeats on coating performance in vitro. Mono, di, and tetravalent peptides were synthesized and assessed for binding affinity and serum stability. PEGylated analogs were prepared and evaluated for their effect on S. aureus attachment and biofilm formation. Coating performance improved with the number of TBP repeats, with the tetravalent coating, TBP(4)-PEG, showing the best performance in all assays. In particular, TBP(4)-PEG forms a serum-resistant surface coating capable of preventing S. aureus colonization and subsequent biofilm formation. These results further support the role that multivalency can play in the development of improved surface coatings with enhanced stabilities and efficacy for in vivo clinical use. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Khoo, Xiaojuan; Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Khoo, Xiaojuan; Grinstaff, Mark W.] Boston Univ, Dept Chem, Boston, MA 02215 USA.
   [O'Toole, George A.] Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA.
   [Nair, Shrikumar A.] Affinergy Inc, Durham, NC 27713 USA.
   [Snyder, Brian D.] Harvard Univ, Sch Med, Dept Orthoped Surg, Childrens Hosp, Boston, MA 02215 USA.
   [Kenan, Daniel J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
RP Grinstaff, MW (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM mgrin@bu.edu
RI Grinstaff, Mark/U-2829-2017
OI Grinstaff, Mark/0000-0002-5453-3668
FU National Institutes of Health [AR054872-01]
FX The authors thank the team at Affinergy Inc including Drs. Wayne Beyer,
   Sathya Ganesan Paul Hamilton, Bruce Lamb, and Guy Orgambide as well as
   Mr. Michael Doligalski for their contributions to the isolation, design
   of the Ti-binding peptides, peptide synthesis, purification, and
   discussion of interfacial biomaterials. This work was financially
   supported by the National Institutes of Health (Grant No. AR054872-01).
CR ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E
   Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85
   Arciola Carla Renata, 2002, Expert Rev Mol Diagn, V2, P478, DOI 10.1586/14737159.2.5.478
   Barber TA, 2006, J ORTHOP RES, V24, P1366, DOI 10.1002/jor.20165
   Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269
   Brown S, 2000, J MOL BIOL, V299, P725, DOI 10.1006/jmbi.2000.3682
   Burritt JB, 1996, ANAL BIOCHEM, V238, P1, DOI 10.1006/abio.1996.0241
   Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003
   CLIFFORD R, 2000, AO PRINCIPLES FRACTU, P617
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Darouiche R, 2007, INT J ARTIF ORGANS, V30, P820
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dwyer MA, 2000, CHEM BIOL, V7, P263, DOI 10.1016/S1074-5521(00)00102-2
   Fernandez ICS, 2007, BIOMATERIALS, V28, P4105, DOI 10.1016/j.biomaterials.2007.05.023
   Gebhardt K, 1996, PEPTIDE RES, V9, P269
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Hart E, 2010, J ANTIMICROB CHEMOTH, V65, P974, DOI 10.1093/jac/dkq057
   HEALY JM, 1995, BIOCHEMISTRY-US, V34, P3948, DOI 10.1021/bi00012a012
   Hou SY, 2007, APPL ENVIRON MICROB, V73, P4300, DOI 10.1128/AEM.02633-06
   Huang X, 2010, ANN BIOMED ENG, V38, P1965, DOI 10.1007/s10439-010-9986-5
   KAY BK, 1996, PHAGE DISPLAY PEPTID
   Kenan DJ, 2006, CHEM BIOL, V13, P695, DOI 10.1016/j.chembiol.2006.06.013
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Meyers SR, 2007, ADV MATER, V19, P2492, DOI 10.1002/adma.200700029
   Meyers SR, 2008, CHEMMEDCHEM, V3, P1645, DOI 10.1002/cmdc.200800205
   Meyers SR, 2009, BIOMATERIALS, V30, P277, DOI 10.1016/j.biomaterials.2008.08.042
   Murase K, 2003, CHEM BIOL, V10, P161, DOI 10.1016/S1074-5521(03)00025-5
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0
   RATNER BD, 2000, BIOMATERIALS SCI INT
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Scott EA, 2008, BIOMATERIALS, V29, P4481, DOI 10.1016/j.biomaterials.2008.08.003
   Seker UOS, 2009, BIOMACROMOLECULES, V10, P250, DOI 10.1021/bm8009895
   Shanks RMQ, 2006, NEPHROL DIAL TRANSPL, V21, P2247, DOI 10.1093/ndt/gfl170
   Sparks Andrew B., 1996, P227, DOI 10.1016/B978-012402380-2/50015-0
   STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X
   Subbiahdoss G, 2010, EUR CELLS MATER, V19, P205, DOI 10.22203/eCM.v019a20
   Tamerler C, 2009, PHILOS T R SOC A, V367, P1705, DOI 10.1098/rsta.2009.0018
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Vinh Donald C, 2005, J Long Term Eff Med Implants, V15, P467, DOI 10.1615/JLongTermEffMedImplants.v15.i5.20
   Wach JY, 2008, CHEM-EUR J, V14, P10579, DOI 10.1002/chem.200801134
   Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033
   Williams D F, 1996, Injury, V27 Suppl 3, pSC1
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   XIA N, 2002, LANGMUIR, V18, P3225
NR 53
TC 32
Z9 33
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 35
BP 9285
EP 9292
DI 10.1016/j.biomaterials.2010.08.031
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682HZ
UT WOS:000284393300015
PM 20863561
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Pidhatika, B
   Moller, J
   Benetti, EM
   Konradi, R
   Rakhmatullina, E
   Muhlebach, A
   Zimmermann, R
   Werner, C
   Vogel, V
   Textor, M
AF Pidhatika, Bidhari
   Moller, Jens
   Benetti, Edmondo M.
   Konradi, Rupert
   Rakhmatullina, Ekaterma
   Muhlebach, Andreas
   Zimmermann, Ralf
   Werner, Carsten
   Vogel, Viola
   Textor, Marcus
TI The role of the interplay between polymer architecture and bacterial
   surface properties on the microbial adhesion to polyoxazoline-based
   ultrathin films
SO BIOMATERIALS
LA English
DT Article
DE Poly(2-methyl-2-oxazoline); Nonfouling surfaces; Bacteria adhesion;
   Escherichia coli (E coli); Fimbriae; Polymer brush; Ionic strength;
   Surface charge; Streaming current; Non-specific adhesion
ID GLYCOL) ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI;
   PROTEIN ADSORPTION; OXIDE SURFACES; CONFORMATIONAL-CHANGES; BIOMATERIAL
   SURFACES; CHARGED SURFACES; GRAFTED POLYMERS; TYPE-1 FIMBRIAE
AB Surface platforms were engineered from poly(L-lysine)-graft-poly(2-methyl-2-oxazoline) (PLL-g-PMOXA) copolymers to study the mechanisms involved in the non-specific adhesion of Escherichia coli (E coli) bacteria Copolymers with three different grafting densities alpha (PMOXA chains/Lysine residue of 009 033 and 0 56) were synthesized and assembled on niobia (Nb(2)O(5)) surfaces PLL-modified and bare niobia surfaces served as controls To evaluate the impact of fimbriae expression on the bacterial adhesion the surfaces were exposed to genetically engineered E coli strains either lacking or constitutively expressing type 1 fimbriae The bacterial adhesion was strongly influenced by the presence of bacterial fimbriae Non-fimbriated bacteria behaved like hard charged particles whose adhesion was dependent on surface charge and ionic strength of the media In contrast bacteria expressing type 1 fimbriae adhered to the substrates independent of surface charge and ionic strength and adhesion was mediated by non-specific van der Waals and hydrophobic interactions of the proteins at the fimbrial tip Adsorbed polymer mass average surface density of the PMOXA chains and thickness of the copolymer films were quantified by optical waveguide lightmode spectroscopy (OWLS) and variable-angle spectroscopic ellipsometry (VASE) whereas the lateral homogeneity was probed by time-of-flight secondary ion mass spectrometry (ToF-SIMS) Streaming current measurements provided information on the charge formation of the polymer-coated and the bare niobia surfaces The adhesion of both bacterial strains could be efficiently inhibited by the copolymer film only with a grafting density of 033 characterized by the highest PMOXA chain surface density and a surface potential close to zero (C) 2010 Elsevier Ltd All rights reserved
C1 [Pidhatika, Bidhari; Benetti, Edmondo M.; Konradi, Rupert; Rakhmatullina, Ekaterma; Textor, Marcus] ETH, BioInterfaceGrp, Lab Surface Sci & Technol, Dept Mat, CH-8093 Zurich, Switzerland.
   [Moller, Jens; Vogel, Viola] ETH, Lab Biologically Oriented Mat, Dept Mat, CH-8093 Zurich, Switzerland.
   [Muhlebach, Andreas] BASF Switzerland, CH-4002 Basel, Switzerland.
   [Zimmermann, Ralf; Werner, Carsten] Max Bergmann Ctr Biomat, Leibniz Inst Polymer Res Dresden, D-01069 Dresden, Germany.
   [Zimmermann, Ralf; Werner, Carsten] Ctr Regenerat Therapies Dresden, D-01069 Dresden, Germany.
RP Textor, M (reprint author), ETH, BioInterfaceGrp, Lab Surface Sci & Technol, Dept Mat, CH-8093 Zurich, Switzerland.
RI Umlauf, Ursula/D-3356-2014; Werner, Carsten/F-8127-2010; Moeller,
   Jens/F-5110-2011; Vogel, Viola/O-8025-2015; Benetti, Edmondo
   Maria/N-5969-2015; Textor, Marcus/A-6200-2012
OI Werner, Carsten/0000-0003-0189-3448; Moeller, Jens/0000-0002-7226-0675;
   Vogel, Viola/0000-0003-2898-7671; Benetti, Edmondo
   Maria/0000-0002-5657-5714; Textor, Marcus/0000-0002-0178-1801
FU Swiss National Science Foundation (SNSF) [200021-116163]; BASF
   Switzerland/Germany; EU [NMP4-SL-2008-214666 ASMENA]
FX This research was financially supported by the Swiss National Science
   Foundation (SNSF Project 200021-116163) BASF Switzerland/Germany and EU
   FP7 (Grant NMP4-SL-2008-214666 ASMENA) The authors also gratefully
   acknowledge Dr Karl-Emanuel Mayerhofer and Dr Beat Keller EMPA,
   Switzerland, for their support with ToF-SIMS measurements Louis
   Bertschi, Mass Spectrometry service center at the Laboratory for Organic
   Chemistry, ETH Zurich for fruitful discussions on MALDI-ToF analysis and
   Esther Amstad for her help with zeta potential measurements of the
   bacteria
CR Abd El-Mohdy H. L., 2009, J POLYM RES, V16, P1, DOI DOI 10.1007/S10965-008-9196-0
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bansal B, 2006, COMPR REV FOOD SCI F, V5, P27, DOI 10.1111/j.1541-4337.2006.tb00080.x
   Barth KA, 2008, ADV FUNCT MATER, V18, P1459, DOI 10.1002/adfm.200701246
   Benetti EM, 2009, MACROMOL RAPID COMM, V30, P411, DOI 10.1002/marc.200800628
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1016/0378-1097(87)90062-0
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Carignano MA, 2002, MOL PHYS, V100, P2993, DOI 10.1080/00268970210121650
   Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129
   CHEN CH, 1994, POLYMER, V35, P3587, DOI 10.1016/0032-3861(94)90532-0
   Cringus-Fundeanu I, 2007, LANGMUIR, V23, P5120, DOI 10.1021/la063531v
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Ducker R, 2008, SOFT MATTER, V4, P1774, DOI 10.1039/b804861b
   ESHDAT Y, 1981, J BACTERIOL, V148, P308
   Feuz L, 2008, LANGMUIR, V24, P7232, DOI 10.1021/la800272v
   Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298
   Frirdich E, 2005, J ENDOTOXIN RES, V11, P133, DOI 10.1179/096805105X46592
   Granville A.M., 2004, POLYM BRUSHES SYNTHE, P35
   Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Lussi JW, 2006, BIOMATERIALS, V27, P2534, DOI 10.1016/j.biomaterials.2005.11.027
   LYKLEMA J, 1995, FUNDAMENTALS INTERFA, V2, P25
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001
   Norde W, 1999, MACROMOL SYMP, V145, P125, DOI 10.1002/masy.19991450114
   Norde W., 1995, PROTEINS INTERFACES, P26
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto K, 1999, J BACTERIOL, V181, P5210
   Otto K, 1999, COLLOID SURFACE B, V15, P99, DOI 10.1016/S0927-7765(99)00050-8
   Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   Pasche S, 2005, LANGMUIR, V21, P6508, DOI 10.1021/la050386x
   Patra M, 2006, NANO LETT, V6, P133, DOI 10.1021/nl051611y
   PIDHATIKA B, RELATING MOL A UNPUB
   Pidhatika B, 2008, CHIMIA, V62, P264, DOI 10.2533/chimia.2008.264
   Prado AGS, 2008, APPL CATAL B-ENVIRON, V82, P219, DOI 10.1016/j.apcatb.2008.01.024
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rehfeldt F, 2002, LANGMUIR, V18, P4908, DOI 10.1021/la0112559
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443
   Schneider OD, 2008, J MATER CHEM, V18, P2679, DOI 10.1039/b800522b
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   SOKURENKO EV, 1994, J BACTERIOL, V176, P748, DOI 10.1128/jb.176.3.748-755.1994
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Terada A, 2006, MICROBIOL-SGM, V152, P3575, DOI 10.1099/mic.0.28881-0
   Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548
   Trong I.L., 2010, CELL, V141, P645
   Ubbink J, 2007, CURR OPIN COLLOID IN, V12, P263, DOI 10.1016/j.cocis.2007.08.004
   Vacheethasanee K., 2000, HDB BACTERIAL ADHESI, P73
   van Oss CJ, 2003, J MOL RECOGNIT, V16, P177, DOI 10.1002/jmr.618
   VANOSS CJ, 1989, CELL BIOPHYS, V14, P1
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Voros J, 2002, BIOMATERIALS, V23, P3699, DOI 10.1016/S0142-9612(02)00103-5
   Wagner MS, 2004, ANAL CHEM, V76, P1483, DOI 10.1021/ac034873y
   Werner C, 1998, J COLLOID INTERF SCI, V208, P329, DOI 10.1006/jcis.1998.5787
   Zapotoczny S, 2007, J MATER CHEM, V17, P3293, DOI 10.1039/b707379h
   Zimmermann R, 2006, MICROFLUID NANOFLUID, V2, P367, DOI 10.1007/s10404-006-0087-6
   Zurcher S, 2006, J AM CHEM SOC, V128, P1064, DOI 10.1021/ja056256
NR 66
TC 74
Z9 74
U1 4
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 36
BP 9462
EP 9472
DI 10.1016/j.biomaterials.2010.08.033
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 691ZH
UT WOS:000285120800010
PM 21059465
DA 2018-10-19
ER

PT J
AU Widhe, M
   Bysell, H
   Nystedt, S
   Schenning, I
   Malmsten, M
   Johansson, J
   Rising, A
   Hedhammar, M
AF Widhe, Mona
   Bysell, Helena
   Nystedt, Sara
   Schenning, Ingrid
   Malmsten, Martin
   Johansson, Jan
   Rising, Anna
   Hedhammar, My
TI Recombinant spider silk as matrices for cell culture
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Cytocompatibility; Collagen production; Fibroblasts; Serum
   free; Tissue engineering
ID EMBRYONIC STEM-CELLS; TERM SELF-RENEWAL; WETTABILITY GRADIENT; 3
   DIMENSIONS; POLYMER; FIBERS; FIBROBLASTS; SCAFFOLDS; RESPONSES; SURFACES
AB The recombinant miniature spider silk protein 4RepCT was used to fabricate film foam fiber and mesh matrices of different dimensionality microstructure and nanotopography These matrices were evaluated regarding their suitability for cell culturing Human primary fibroblasts attached to and grew well on all matrix types also in the absence of serum proteins or other animal-derived additives The highest cell counts were obtained on matrices combining film and fiber/mesh The cells showed an elongated shape that followed the structure of the matrices and exhibited prominent actin filaments Moreover the fibroblasts produced secreted and deposited collagen type I onto the matrices These results together with findings of the matrices being mechanically robust hold promise not only for in vitro cell culturing but also for tissue engineering applications (C) 2010 Elsevier Ltd All rights reserved
C1 [Widhe, Mona; Johansson, Jan; Rising, Anna; Hedhammar, My] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, S-75123 Uppsala, Sweden.
   [Bysell, Helena; Malmsten, Martin] Uppsala Univ, Dept Pharm, Biomed Ctr, S-75123 Uppsala, Sweden.
   [Nystedt, Sara; Schenning, Ingrid] Spiber Technol AB, Uppsala, Sweden.
RP Widhe, M (reprint author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, S-75123 Uppsala, Sweden.
OI Rising, Anna/0000-0002-1872-1207
FU Swedish Research Council; FORMAS; Vinnova; Magnus Bergvall s foundation
FX This work was supported by The Swedish Research Council, FORMAS, Vinnova
   and Magnus Bergvall s foundation
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Dal Pra I, 2003, TISSUE ENG, V9, P1113, DOI 10.1089/10763270360728026
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Foroughi F, 2008, J TISSUE ENG REGEN M, V2, P507, DOI 10.1002/term.126
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Gjorevski N, 2009, CYTOKINE GROWTH F R, V20, P459, DOI 10.1016/j.cytogfr.2009.10.013
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001
   Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924
   Malmsten M, 2003, BIOPOLYMERS INTERFAC
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473
   Petroll WM, 2003, CELL MOTIL CYTOSKEL, V55, P254, DOI 10.1002/cm.10126
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Ruardy TG, 1997, J COLLOID INTERF SCI, V188, P209, DOI 10.1006/jcis.1997.4769
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yamada KM, 2002, NATURE, V419, P790, DOI 10.1038/419790a
   Yang LA, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045002
NR 44
TC 53
Z9 54
U1 2
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 36
BP 9575
EP 9585
DI 10.1016/j.biomaterials.2010.08.061
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 691ZH
UT WOS:000285120800022
PM 20875917
DA 2018-10-19
ER

PT J
AU Culpepper, BK
   Phipps, MC
   Bonvallet, PP
   Bellis, SL
AF Culpepper, Bonnie K.
   Phipps, Matthew C.
   Bonvallet, Paul P.
   Bellis, Susan L.
TI Enhancement of peptide coupling to hydroxyapatite and implant
   osseointegration through collagen mimetic peptide modified with a
   polyglutamate domain
SO BIOMATERIALS
LA English
DT Article
DE Bone repair; Hydroxyapatite; Collagen; Peptide; Mesenchymal stem cell
ID MESENCHYMAL STEM-CELLS; BONE-MARROW-CELLS; OSTEOBLASTIC CELLS;
   GENE-EXPRESSION; IN-VITRO; OSTEOGENIC DIFFERENTIATION; BIOMATERIAL
   SURFACES; SERUM-PROTEINS; RGD PEPTIDES; ADHESION
AB Hydroxyapatite (HA) is a widely-used biomaterial for bone repair due to its high degree of osteoconductivity However strategies for improving HA performance by functionalizing surfaces with bioactive factors are limited In this study we explored the use of a HA-binding domain (heptaglutamate E7) to facilitate coupling of the collagen mimetic peptide DGEA to two types of HA-containing materials solid HA disks and electrospun polycaprolactone matrices incorporating nanoparticulate HA We found that the E7 domain directed significantly more peptide to the surface of HA and enhanced peptide retention on both materials in vitro Moreover E7-modified peptides were retained in vivo for at least two months highlighting the potential of this mechanism as a sustained delivery system for bioactive peptides Most importantly E7-DGEA-coupled HA as compared with DGEA-HA enhanced the adhesion and osteoblastic differentiation of mesenchymal stem cells and also Increased new bone formation and direct bone-implant contact on HA disks implanted into rat tibiae Collectively these results support the use of E7-DGEA peptides to promote osteogenesis on HA substrates and further suggest that the E7 domain can serve as a universal tool for anchoring a wide variety of bone regenerative molecules to any type of HA-containing material (C) 2010 Elsevier Ltd All rights reserved
C1 [Phipps, Matthew C.; Bonvallet, Paul P.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA.
   [Culpepper, Bonnie K.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Bellis, SL (reprint author), Univ Alabama Birmingham, Dept Physiol & Biophys, 982A MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.
FU NIH/NIAMS [R01AR51539]
FX This research was supported by NIH/NIAMS grant R01AR51539 (SLB) The
   authors gratefully acknowledge Dr Jack Lemons (University of Alabama
   Birmingham) for providing the stainless steel and titanium alloy disks,
   and the Bone Histomorphometry Core Facility for their assistance with
   tissue processing and staining
CR Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200
   Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6
   Castel S, 2001, LAB INVEST, V81, P1615, DOI 10.1038/labinvest.3780375
   Catledge SA, 2007, BIOMED MATER, V2, P142, DOI 10.1088/1748-6041/2/2/013
   Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.3.CO;2-3
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   Gomar F, 2007, INT ORTHOP, V31, P93, DOI 10.1007/s00264-006-0087-x
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho JE, 2007, J BIOMED MATER RES A, V81A, P720, DOI 10.1002/jbm.a.31008
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leupold JA, 2006, J BIOMED MATER RES B, V79B, P292, DOI 10.1002/jbm.b.30541
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Memmo LM, 1998, J CELL SCI, V111, P425
   Mineur P, 2005, BBA-MOL CELL RES, V1746, P28, DOI 10.1016/j.bbamcr.2005.07.004
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021
   Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   Rammelt S, 2004, CELLS TISSUES ORGANS, V178, P146, DOI 10.1159/000082245
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Ripamonti U, 2009, BIOMATERIALS, V30, P1428, DOI 10.1016/j.biomaterials.2008.10.065
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   Stayton PS, 2003, CRIT REV ORAL BIOL M, V14, P370, DOI 10.1177/154411130301400507
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Valentin Andreas H., 2004, Keio Journal of Medicine, V53, P166, DOI 10.2302/kjm.53.166
   WEATHERSBY PK, 1976, T AM SOC ART INT ORG, V22, P242
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
NR 64
TC 30
Z9 32
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 36
BP 9586
EP 9594
DI 10.1016/j.biomaterials.2010.08.020
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 691ZH
UT WOS:000285120800023
PM 21035181
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wolchok, JC
   Tresco, PA
AF Wolchok, Jeffrey C.
   Tresco, Patrick A.
TI The isolation of cell derived extracellular matrix constructs using
   sacrificial open-cell foams
SO BIOMATERIALS
LA English
DT Article
DE ECM (extracellular matrix); Fibrous tissue; Fibroblast; Mesenchymal stem
   cell; Polyurethane; Scaffold
ID DECELLULARIZED VEIN; GENE-EXPRESSION; IN-VITRO; SCAFFOLDS; COLLAGEN;
   REGENERATION; XENOGRAFTS; CARTILAGE; POLYMERS; SHEETS
AB Extracellular matrix derived from human and animal tissues is being used to repair and reconstruct a variety of tissues clinically The utility of such constructs is limited by the geometry composition and constitutive properties of the tissue or organ from which the ECM is harvested To address this limitation we have developed an approach to Isolate extracellular matrix in bulk from populations of living cells grown in culture on three-dimensional substrates Human biopsy derived fibroblasts were seeded within open-cell foams and cultured in-vitro for periods up to three weeks after which the synthetic component was removed by incubation in a water miscible solvent After several wash steps and lyophilization a white lacy multi-molecular construct was isolated Tandem mass spectroscopy showed that it contained 22 extracellular matrix constituents including such proteins and proteoglycans as collagen type I and type Ill fibronectin transforming growth factor beta decorin and biglycan among others On average 47 mg of construct was isolated for each gram of synthetic substrate initially seeded with cells The biomaterial harvested from human tracheal fibroblasts had an elastic modulus (250 kPa) and a composition similar to that of human vocal fold tissue and supported reseeding with human tracheal derived fibroblasts An Important finding was that the approach was useful in isolating ECM from a variety of cell lineages and developmental stages including skin fibroblasts brain derived astrocytes and mesenchymal stem cells The results together with the archival literature suggest that the approach can be used to produce a range of cell derived constructs with unique physical and chemical attributes for a variety of research and medical applications (C) 2010 Elsevier Ltd All rights reserved
C1 [Wolchok, Jeffrey C.; Tresco, Patrick A.] Univ Utah, Keck Ctr Tissue Engn, Dept Bioengn, Coll Engn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Keck Ctr Tissue Engn, Dept Bioengn, Coll Engn, 20 S 2030 E Bldg,570 BPRB,Room 108D, Salt Lake City, UT 84112 USA.
CR Aframian DJ, 2002, TISSUE ENG, V8, P649, DOI 10.1089/107632702760240562
   ALLAIRE E, 1994, J VASC SURG, V19, P446, DOI 10.1016/S0741-5214(94)70071-0
   Allaire E, 1997, SURGERY, V122, P73, DOI 10.1016/S0039-6060(97)90267-1
   Allaire E, 1996, TRANSPLANTATION, V62, P794, DOI 10.1097/00007890-199609270-00017
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Broadhead KW, 2002, BIOMATERIALS, V23, P4689, DOI 10.1016/S0142-9612(02)00212-0
   David-Vaudey E, 2005, Eur Cell Mater, V10, P51
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Fujihara Y, 2010, BIOMATERIALS, V31, P1227, DOI 10.1016/j.biomaterials.2009.10.053
   Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   Hoganson DM, 2010, BIOMATERIALS, V31, P6934, DOI 10.1016/j.biomaterials.2010.05.026
   Ishihara K, 2002, ARTIF ORGANS, V26, P1014, DOI 10.1046/j.1525-1594.2002.07039.x
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Kim M, 2007, ENVIRON TECHNOL, V28
   Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020
   Lareu RR, 2007, TISSUE ENG, V13, P385, DOI 10.1089/ten.2006.0224
   Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365
   Martin ND, 2005, J SURG RES, V129, P17, DOI 10.1016/j.jss.2005.06.037
   McCarthy JB, 1997, J IMMUNOL, V159, P2424
   Meyer SR, 2006, J BIOMED MATER RES A, V79A, P254, DOI 10.1002/jbm.a.30777
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   Montjovent MO, 2007, J BIOMED MATER RES A, V83A, P41, DOI 10.1002/jbm.a.31208
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9
   Romano N, 2010, BIOCH BIOPHYS ACTA
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   SHEKARAN A, 2010, BIOCH BIOPHYS A 0508
   Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026
   Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5
   Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036
   West PA, 2004, APPL SPECTROSC, V58, P376, DOI 10.1366/000370204773580194
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
NR 48
TC 30
Z9 30
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2010
VL 31
IS 36
BP 9595
EP 9603
DI 10.1016/j.biomaterials.2010.08.072
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 691ZH
UT WOS:000285120800024
PM 20950855
DA 2018-10-19
ER

PT J
AU Wang, XY
   Zuo, Y
   Huang, D
   Hou, XD
   Li, YB
AF Wang, Xiao-Yan
   Zuo, Yi
   Huang, Di
   Hou, Xian-Deng
   Li, Yu-Bao
TI Comparative Study on Inorganic Composition and Crystallographic
   Properties of Cortical and Cancellous Bone
SO BIOMEDICAL AND ENVIRONMENTAL SCIENCES
LA English
DT Article
DE Cortical bone; Cancellous bone; Bone mineral; Composition;
   Crystallographic property
ID X-RAY-DIFFRACTION; NUCLEAR-MAGNETIC-RESONANCE; HEAT-TREATMENT; WATER;
   APATITE; HYDROXYAPATITE; SPECTROSCOPY; SCATTERING; BEHAVIOR
AB Objective To comparatively investigate the inorganic composition and crystallographic properties of cortical and cancellous bone via thermal treatment under 700 degrees C. Methods Thermogravimetric measurement, infrared spectrometer, X-ray diffraction, chemical analysis and X-ray photo-electron spectrometer were used to test the physical and chemical properties of cortical and cancellous bone at room temperature 250 degrees C, 450 degrees C, and 650 degrees C, respectively. Results The process of heat treatment induced an extension in the a-lattice parameter and changes of the c-lattice parameter, and an increase in the crystallinity reflecting lattice rearrangement after release of lattice carbonate and possible lattice water. The mineral content in cortical and cancellous bone was 73.2wt% and 71.5wt%, respectively. For cortical bone, the weight loss was 6.7% at the temperature from 60 degrees C to 250 degrees C, 17.4% from 250 degrees C to 450 degrees C, and 2.7% from 450 degrees C to 700 degrees C. While the weight loss for the cancellous bone was 5.8%, 19.9%, and 2.8% at each temperature range, the Ca/P ratio of cortical bone was 1.69 which is higher than the 1.67 of stoichiometric HA due to the B-type CO(3)(2-) substitution in apatite lattice. The Ca/P ratio of cancellous bone was lower than 1.67, suggesting the presence of more calcium deficient apatite. Conclusion The collagen fibers of cortical bone were arrayed more orderly than those of cancellous bone, while their mineralized fibers ollkded similar. The minerals in both cortical and cancellous bone are composed of poorly crystallized nano-size apatite crystals with lattice carbonate and possible lattice water. The process of heat treatment induces a change of the lattice parameter, resulting in lattice rearrangement after the release of lattice carbonate and lattice water and causing an increase in crystal size and crystallinity. This finding is helpful for future biomaterial design, preparation and application.
C1 [Wang, Xiao-Yan; Zuo, Yi; Huang, Di; Hou, Xian-Deng; Li, Yu-Bao] Sichuan Univ, Res Ctr Nanobiomat Anal & Testing, Chengdu 610064, Sichuan, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Res Ctr Nanobiomat Anal & Testing, Chengdu 610064, Sichuan, Peoples R China.
EM nic7504@scu.edu.cn
RI Hou, Xiandeng/B-4159-2011
FU China 973 Fund [2007CB936102]; National Natural Science Foundation of
   China [50972096]
FX This work is supported by China 973 Fund (No.2007CB936102) and the
   National Natural Science Foundation of China (No. 50972096).
CR Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Benmarouane A, 2004, PHYSICA B, V350, pE611, DOI 10.1016/j.physb.2004.03.163
   Dalconi MC, 2003, NUCL INSTRUM METH B, V200, P406, DOI 10.1016/S0168-583X(02)01730-5
   Danilchenko SN, 2006, CRYST RES TECHNOL, V41, P268, DOI 10.1002/crat.200510572
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   Enzo S, 2007, J ARCHAEOL SCI, V34, P1731, DOI 10.1016/j.jas.2006.12.011
   Fleet ME, 2003, J SOLID STATE CHEM, V174, P412, DOI 10.1016/S0022-4596(03)00281-0
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   HENCH LL, 1993, INTRO BIOECERAMICS, P145
   Hiller JC, 2006, J ARCHAEOL SCI, V33, P560, DOI 10.1016/j.jas.2005.09.012
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Kaelble EF., 1967, HDB XRAYS
   LEBON M, 2010, J ARCHAEOL SCI, P1
   LEGEROS RZ, 1978, CALC TISS RES, V26, P111, DOI 10.1007/BF02013245
   Ni QW, 2007, MEAS SCI TECHNOL, V18, P715, DOI 10.1088/0957-0233/18/3/022
   NOMURA S, 1977, BIOPOLYMERS, V16, P231, DOI 10.1002/bip.1977.360160202
   Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049
   Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3
   Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2
   Piga G, 2008, J ARCHAEOL SCI, V35, P2171, DOI 10.1016/j.jas.2008.02.003
   Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7
   Thompson TJU, 2009, J ARCHAEOL SCI, V36, P910, DOI 10.1016/j.jas.2008.11.013
   TIMMINS PA, 1977, CALC TISS RES, V23, P1, DOI 10.1007/BF02012759
   Utku FS, 2008, J STRUCT BIOL, V162, P361, DOI 10.1016/j.jsb.2008.01.004
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243
   Wilson EE, 2005, J BONE MINER RES, V20, P625, DOI 10.1359/JBMR.041217
NR 29
TC 23
Z9 24
U1 1
U2 19
PU CHINESE ACAD PREVENTIVE MEDICINE
PI ORLANDO
PA C/O ACADEMIC PRESS INC, 6277 SEA HARBOR DR, ORLANDO, FL 32887-4900 USA
SN 0895-3988
J9 BIOMED ENVIRON SCI
JI Biomed. Environ. Sci.
PD DEC
PY 2010
VL 23
IS 6
BP 473
EP 480
DI 10.1016/S0895-3988(11)60010-X
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 710UM
UT WOS:000286542500009
PM 21315246
DA 2018-10-19
ER

PT J
AU Nie, FL
   Zheng, YF
   Wei, SC
   Hu, C
   Yang, G
AF Nie, F. L.
   Zheng, Y. F.
   Wei, S. C.
   Hu, C.
   Yang, G.
TI In vitro corrosion, cytotoxicity and hemocompatibility of bulk
   nanocrystalline pure iron
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID PORCINE CORONARY-ARTERIES; MAGNESIUM ALLOYS; STENTS; BIOCOMPATIBILITY;
   METAL; IMPLANTATION; BIOMATERIAL; DEGRADATION; TITANIUM; CELLS
AB Bulk nanocrystalline pure iron rods were fabricated by the equal channel angular pressure (ECAP) technique up to eight passes. The microstructure and grain size distribution, natural immersion and electrochemical corrosion in simulated body fluid, cellular responses and hemocompatibility were investigated in this study. The results indicate that nanocrystalline pure iron after severe plastic deformation (SPD) would sustain durable span duration and exhibit much stronger corrosion resistance than that of the microcrystalline pure iron. The interaction of different cell lines reveals that the nanocrystalline pure iron stimulates better proliferation of fibroblast cells and preferable promotion of endothelialization, while inhibits effectively the viability of vascular smooth muscle cells (VSMCs). The burst of red cells and adhesion of the platelets were also substantially suppressed on contact with the nanocrystalline pure iron in blood circulation. A clear size-dependent behavior from the grain nature deduced by the gradual refinement microstructures was given and well-behaved in vitro biocompatibility of nanocrystalline pure iron was concluded.
C1 [Nie, F. L.; Zheng, Y. F.] Peking Univ, State Key Lab Turbulence & Complex Syst, Dept Adv Mat & Nanotechnol, Coll Engn, Beijing 100871, Peoples R China.
   [Nie, F. L.; Zheng, Y. F.; Wei, S. C.] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100083, Peoples R China.
   [Wei, S. C.] Peking Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100081, Peoples R China.
   [Hu, C.; Yang, G.] Cent Iron & Steel Res Inst, Inst Struct Mat, Beijing 100081, Peoples R China.
RP Nie, FL (reprint author), Peking Univ, State Key Lab Turbulence & Complex Syst, Dept Adv Mat & Nanotechnol, Coll Engn, Beijing 100871, Peoples R China.
EM niefeilong@pku.edu.cn; yfzheng@pku.edu.cn; weishicheng99@163.com;
   huchao511@gmail.com; yanggang@nercast.com
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU Ministry of Science and Technology of China [2007CB936103]; NSFC-RFBR
   [31011120091]; National Natural Science Foundation of China [30670560,
   30770580]; Research Funds for the Central Universities [PKUJC2009001];
   Program for New Century Excellent Talents in University [NCET-07-0033]
FX This work was financially supported by the Ministry of Science and
   Technology of China (project no 2007CB936103), NSFC-RFBR joint project
   (31011120091), National Natural Science Foundation of China (nos
   30670560 and 30770580), Research Funds for the Central Universities
   (PKUJC2009001) and Program for New Century Excellent Talents in
   University (NCET-07-0033).
CR ASTM, 2004, ANN BOOK ASTM STAND
   BOTHWELL T, 1962, IRON METABOLISM
   Chen CZ, 2008, SOLID STATE IONICS, V179, P971, DOI 10.1016/j.ssi.2008.03.019
   Colombo A, 2000, CIRCULATION, V102, P371
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Heitz E., 1996, MICROBIALLY INFLUENC
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P107, DOI 10.4028/www.scientific.net/AMR.15-17.107
   Herting G, 2008, J ENVIRON MONITOR, V10, P1092, DOI 10.1039/b805075a
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hietala EM, 2001, J VASC RES, V38, P361, DOI 10.1159/000051067
   Kim TN, 2007, BIOMED MATER, V2, pS117, DOI 10.1088/1748-6041/2/3/S06
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Pereira MC, 1999, BIOMATERIALS, V20, P2193, DOI 10.1016/S0142-9612(99)00124-6
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   REINHOLD JG, 1975, CLIN CHEM, V21, P476
   SHEN Y, 2009, ACTA BIOMATER, V9, P3593, DOI DOI 10.1016/J.ACTBIO.2009.05.021
   Stolyarov VV, 1999, NANOSTRUCT MATER, V11, P947, DOI 10.1016/S0965-9773(99)00384-0
   Tao NR, 1999, NANOSTRUCT MATER, V11, P433, DOI 10.1016/S0965-9773(99)00324-4
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yang G, 2009, MAT SCI ENG A-STRUCT, V515, P199, DOI 10.1016/j.msea.2009.03.031
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 31
TC 23
Z9 23
U1 3
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2010
VL 5
IS 6
AR 065015
DI 10.1088/1748-6041/5/6/065015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 703ZO
UT WOS:000286020800018
PM 21079282
DA 2018-10-19
ER

PT J
AU Bhatia, SK
AF Bhatia, Sujata K.
TI Tissue engineering for clinical applications
SO BIOTECHNOLOGY JOURNAL
LA English
DT Review
DE Chronic obstructive pulmonary disease; Coronary artery disease; Stroke;
   Tissue engineering; Tissue regeneration
ID II EPITHELIAL-CELLS; CARBON NANOTUBES; STEM-CELLS; IN-VIVO;
   ENDOTHELIAL-CELLS; NEURONAL GROWTH; POLYELECTROLYTE MULTILAYER;
   MYOCARDIAL-INFARCTION; BONE-FORMATION; LUNG-TISSUE
AB Tissue engineering is increasingly being recognized as a beneficial means for lessening the global disease burden. One strategy of tissue engineering is to replace lost tissues or organs with polymeric scaffolds that contain specialized populations of living cells, with the goal of regenerating tissues to restore normal function. Typical constructs for tissue engineering employ biocompatible and degradable polymers, along with organ-specific and tissue-specific cells. Once implanted, the construct guides the growth and development of new tissues; the polymer scaffold degrades away to be replaced by healthy functioning tissue. The ideal biomaterial for tissue engineering not only defends against disease and supports weakened tissues or organs, it also provides the elements required for healing and repair, stimulates the body's intrinsic immunological and regenerative capacities, and seamlessly interacts with the living body. Tissue engineering has been investigated for virtually every organ system in the human body. This review describes the potential of tissue engineering to alleviate disease, as well as the latest advances in tissue regeneration. The discussion focuses on three specific clinical applications of tissue engineering: cardiac tissue regeneration for treatment of heart failure; nerve regeneration for treatment of stroke; and lung regeneration for treatment of chronic obstructive pulmonary disease.
C1 DuPont Appl BioSci, Expt Stn, Wilmington, DE 19880 USA.
RP Bhatia, SK (reprint author), DuPont Appl BioSci, Expt Stn, Wilmington, DE 19880 USA.
EM sujata.k.bhatia@usa.dupont.com
CR Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006
   Baxendale M, 2003, J MATER SCI-MATER EL, V14, P657, DOI 10.1023/A:1026158432563
   BLAU H, 1988, J CELL PHYSIOL, V136, P203, DOI 10.1002/jcp.1041360202
   Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC
   Cortiella J, 2006, TISSUE ENG, V12, P1213, DOI 10.1089/ten.2006.12.1213
   Daubine F, 2009, BIOMATERIALS, V30, P6367, DOI 10.1016/j.biomaterials.2009.08.002
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Facca S, 2010, P NATL ACAD SCI USA, V107, P3406, DOI 10.1073/pnas.0908531107
   Facca S, 2008, BIO-MED MATER ENG, V18, P231, DOI 10.3233/BME-2008-0530
   Fioretti F, 2010, ACS NANO, V4, P3277, DOI 10.1021/nn100713m
   Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7
   Gilmore JL, 2008, J NEUROIMMUNE PHARM, V3, P83, DOI 10.1007/s11481-007-9099-6
   GREENWOOD HL, 2006, PLOS MED, V9, pE381
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grossin L, 2009, ADV MATER, V21, P650, DOI 10.1002/adma.200801541
   Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080
   Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Kellar RS, 2005, TISSUE ENG, V11, P1678, DOI 10.1089/ten.2005.11.1678
   Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032
   Kotov NA, 2004, LANGMUIR, V20, P7887, DOI 10.1021/la049958o
   Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2
   Li RK, 1999, CIRCULATION, V100, P63
   Lote C., 2000, PRINCIPLES RENAL PHY
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   MCGUIGAN AP, 2009, PLOS ONE, V3, pE2258
   McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Mondrinos MJ, 2007, AM J PHYSIOL-LUNG C, V293, pL639, DOI 10.1152/ajplung.00403.2006
   Mondrinos MJ, 2008, TISSUE ENG PT A, V14, P361, DOI 10.1089/tea.2007.0041
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   Nadiri A, 2007, SMALL, V3, P1577, DOI 10.1002/smll.200700115
   Nichols Joan E, 2008, Proc Am Thorac Soc, V5, P723, DOI 10.1513/pats.200802-022AW
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465
   Shanbhag S, 2005, SMALL, V1, P1208, DOI 10.1002/smll.200500191
   SHANNON JM, 1987, BIOCHIM BIOPHYS ACTA, V931, P143, DOI 10.1016/0167-4889(87)90200-X
   Shigemura N, 2006, AM J RESP CRIT CARE, V174, P1199, DOI 10.1164/rccm.200603-406OC
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SUGIHARA H, 1993, AM J PATHOL, V142, P783
   World Health Organization, 2008, GLOB BURD DIS 2004 U
   XIAO P, 2007, J AM CHEM SOC, V129, P4483
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
   Zhang X, 2008, NANO LETT, V8, P2432, DOI 10.1021/nl801379y
   Zhang X, 2010, BIOMATERIALS, V31, P6013, DOI 10.1016/j.biomaterials.2010.04.024
   Zhang X, 2010, BIOMATERIALS, V31, P1699, DOI 10.1016/j.biomaterials.2009.11.032
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 61
TC 30
Z9 32
U1 0
U2 61
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1860-6768
J9 BIOTECHNOL J
JI Biotechnol. J.
PD DEC
PY 2010
VL 5
IS 12
SI SI
BP 1309
EP 1323
DI 10.1002/biot.201000230
PG 15
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 693UZ
UT WOS:000285252200007
PM 21154670
DA 2018-10-19
ER

PT J
AU Svensson, O
   Arnebrant, T
AF Svensson, Olof
   Arnebrant, Thomas
TI Mucin layers and multilayers - Physicochemical properties and
   applications
SO CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
LA English
DT Review
DE Mucin; BSM; PGM; MUC5B; Adsorption; Surface properties; Multilayer; Anti
   adhesion; Immunological response; Lubrication; Biomaterial
ID BOVINE SUBMAXILLARY MUCIN; ATOMIC-FORCE MICROSCOPY; GASTROINTESTINAL
   MUCUS GEL; SOLID-LIQUID INTERFACES; PORCINE STOMACH MUCIN; GASTRIC
   MUCIN; POLYELECTROLYTE MULTILAYERS; MICA SURFACES; IN-VITRO;
   VISCOELASTIC PROPERTIES
AB The present review summarizes recent and important previous findings on properties of mucin layers and multilayers and ways to tailor their properties Specifically progress has been made in understanding the effects of mum type preparations ambient conditions and surface properties on adsorption and on mixed layer assembly including multilayers Apart from structural features the stability lubrication and biological functions of such layers are addressed (C) 2010 Elsevier Ltd All rights reserved
C1 [Svensson, Olof; Arnebrant, Thomas] Malmo Univ, Fac Hlth & Soc, S-20506 Malmo, Sweden.
RP Arnebrant, T (reprint author), Malmo Univ, Fac Hlth & Soc, S-20506 Malmo, Sweden.
FU Gustav Th Ohlsson Foundation
FX Financial support from Gustav Th Ohlsson Foundation is gratefully
   acknowledged
CR Aguirre A, 1989, Dysphagia, V4, P95, DOI 10.1007/BF02407152
   Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922
   BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223
   Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001
   Bastardo L, 2002, LANGMUIR, V18, P3848, DOI 10.1021/la015717u
   BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492
   Bongaerts JHH, 2007, TRIBOL LETT, V27, P277, DOI 10.1007/s11249-007-9232-y
   Bromberg LE, 2000, BIOMACROMOLECULES, V1, P325, DOI 10.1021/bm005532m
   Bushnak IA, 2010, BIOFOULING, V26, P387, DOI 10.1080/08927011003646809
   Cao XX, 1999, BIOPHYS J, V76, P1250, DOI 10.1016/S0006-3495(99)77288-7
   Cardenas M, 2007, BIOMACROMOLECULES, V8, P1149, DOI 10.1021/bm061055h
   CARLSTEDT I, 1983, BIOCHEM J, V213, P427, DOI 10.1042/bj2130427
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Dedinaite A, 2005, LANGMUIR, V21, P9502, DOI 10.1021/la0511844
   Dedinaite A, 2002, LANGMUIR, V18, P9383, DOI 10.1021/la0259813
   Di Cola E, 2008, BIOMACROMOLECULES, V9, P3216, DOI 10.1021/bm800799u
   Dresselhuis DM, 2008, J COLLOID INTERF SCI, V321, P21, DOI 10.1016/j.jcis.2008.01.051
   DURRER C, 1995, J COLLOID INTERF SCI, V170, P555, DOI 10.1006/jcis.1995.1134
   Efremova NV, 2002, LANGMUIR, V18, P836, DOI 10.1021/la011303p
   EMINOVSKI JH, 2010, BIOFOULING, V26, P511
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Exley C, 1998, J INORG BIOCHEM, V70, P195, DOI 10.1016/S0162-0134(98)10017-X
   Feiler AA, 2007, J COLLOID INTERF SCI, V315, P475, DOI 10.1016/j.jcis.2007.07.029
   Feldoto Z, 2008, LANGMUIR, V24, P3348, DOI 10.1021/la703366k
   Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010
   Haberska K, 2008, TALANTA, V76, P1159, DOI 10.1016/j.talanta.2008.05.017
   Hahn Berg IC, 2004, BIOFOULING, V20, P65
   Halthur TJ, 2010, LANGMUIR, V26, P4901, DOI 10.1021/la902267c
   HARDING SE, 1989, ADV CARBOHYD CHEM BI, V47, P345
   Hong ZN, 2005, BIOMACROMOLECULES, V6, P3458, DOI 10.1021/bm0505843
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501
   Iontcheva I, 2000, J DENT RES, V79, P732
   Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013
   Kocevar Nared J., 1997, BIOMATERIALS, V18, P677
   Kovacevic D, 2002, LANGMUIR, V18, P5607, DOI 10.1021/la025639q
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lee S, 2005, LANGMUIR, V21, P8344, DOI 10.1021/la050779w
   LEVINE MJ, 1987, J DENT RES, V66, P436, DOI 10.1177/00220345870660020901
   Lindh L, 2002, COLLOID SURFACE B, V25, P139, DOI 10.1016/S0927-7765(01)00300-9
   Lindh L, 2007, J COLLOID INTERF SCI, V310, P74, DOI 10.1016/j.jcis.2007.01.086
   LUNDIN M, 2009, LANGMUIR, V26, P3242
   LUNDIN M, 2009, THESIS ROYAL I TECHN
   Lundin M, 2009, J COLLOID INTERF SCI, V336, P30, DOI 10.1016/j.jcis.2009.03.061
   MALMSTEN M, 1992, J COLLOID INTERF SCI, V151, P579, DOI 10.1016/0021-9797(92)90506-H
   MALMSTEN M, 1994, COLLOID SURFACE B, V2, P463
   McCullagh CM, 1996, INT J BIOL MACROMOL, V18, P247, DOI 10.1016/0141-8130(95)01086-6
   Mehrotra R, 1998, BIOCHEM J, V334, P415, DOI 10.1042/bj3340415
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   Nylander T, 1998, PROG COLL POL SCI S, V108, P34
   Nylander T, 1997, COLLOID SURFACE A, V129, P339, DOI 10.1016/S0927-7757(97)00051-4
   Offner G D, 2000, Adv Dent Res, V14, P69
   PARK H, 1987, PHARMACEUT RES, V4, P457, DOI 10.1023/A:1016467219657
   Patel MM, 2003, BIOMACROMOLECULES, V4, P1184, DOI 10.1021/bm034028p
   PEREZ E, 1984, COLLOID SURFACE, V9, P297, DOI 10.1016/0166-6622(84)80173-0
   PEREZ E, 1987, J COLLOID INTERF SCI, V118, P182, DOI 10.1016/0021-9797(87)90447-4
   PETTERSSON T, 2008, EFFECT SALT CONCENTR, P1
   Pettersson T, 2008, J COLLOID INTERF SCI, V324, P246, DOI 10.1016/j.jcis.2008.04.055
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   PROUST JE, 1984, COLLOID SURFACE, V10, P43, DOI 10.1016/0166-6622(84)80006-2
   PROUST JE, 1983, J COLLOID INTERF SCI, V94, P421, DOI 10.1016/0021-9797(83)90282-5
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200
   Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/bj3620289
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Rogunova MA, 1997, BIORHEOLOGY, V34, P295, DOI 10.1016/S0006-355X(98)00006-7
   Round AN, 2002, BIOPHYS J, V83, P1661, DOI 10.1016/S0006-3495(02)73934-9
   SANDBERG T, 2008, THESIS UPPSALA U UPP
   Sandberg T, 2007, MICROSC RES TECHNIQ, V70, P864, DOI 10.1002/jemt.20489
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P773, DOI 10.1002/jbm.a.32315
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P762, DOI 10.1002/jbm.a.32266
   Sandberg T, 2009, J MATER SCI-MATER M, V20, P621, DOI 10.1007/s10856-008-3595-y
   SELLERS LA, 1987, BIORHEOLOGY, V24, P615
   SHI I, 1999, THESIS U UTAH UTAH
   Shi L, 1999, COLLOID SURFACE B, V15, P303, DOI 10.1016/S0927-7765(99)00096-X
   Shi L, 2000, J COLLOID INTERF SCI, V224, P372, DOI 10.1006/jcis.2000.6724
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   Shrivastava HY, 2003, J BIOMOL STRUCT DYN, V20, P575, DOI 10.1080/07391102.2003.10506874
   Silletti E., 2008, THESIS WAGENINGEN U
   Sukhishvili SA, 2006, MACROMOLECULES, V39, P8873, DOI 10.1021/ma061617p
   Svendsen IE, 2008, J COLLOID INTERF SCI, V321, P52, DOI 10.1016/j.jcis.2008.01.041
   Svensson O, 2006, J COLLOID INTERF SCI, V299, P608, DOI 10.1016/j.jcis.2006.02.027
   Svensson O, 2008, J COLLOID INTERF SCI, V325, P346, DOI 10.1016/j.jcis.2008.06.013
   Svensson O, 2008, LANGMUIR, V24, P2573, DOI 10.1021/la702680x
   TABAK L A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P229
   TABAK LA, 1985, ARCH ORAL BIOL, V30, P423, DOI 10.1016/0003-9969(85)90070-6
   Tachibana Y, 2002, TETRAHEDRON, V58, P10213, DOI 10.1016/S0040-4020(02)01359-5
   Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x
   Thornton DJ, 1999, GLYCOBIOLOGY, V9, P293, DOI 10.1093/glycob/9.3.293
   Turner BS, 1999, BBA-GENE STRUCT EXPR, V1447, P77, DOI 10.1016/S0167-4781(99)00099-8
   VILAR JP, 1999, J BIOL CHEM, V274, P31751
   Wickstrom C, 2000, BIOCHEM J, V351, P421, DOI 10.1042/0264-6021:3510421
   Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685
   Wickstrom C, 2009, MICROBIOL-SGM, V155, P2866, DOI 10.1099/mic.0.030536-0
   Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w
NR 96
TC 48
Z9 49
U1 7
U2 51
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1359-0294
EI 1879-0399
J9 CURR OPIN COLLOID IN
JI Curr. Opin. Colloid Interface Sci.
PD DEC
PY 2010
VL 15
IS 6
BP 395
EP 405
DI 10.1016/j.cocis.2010.05.015
PG 11
WC Chemistry, Physical
SC Chemistry
GA 684AS
UT WOS:000284520000002
DA 2018-10-19
ER

PT J
AU Devos, M
   Schultz, P
   Guillere, F
   Debry, C
AF Devos, M.
   Schultz, P.
   Guillere, F.
   Debry, C.
TI Thyroplasty for unilateral vocal fold paralysis using an adjustable
   implant in porous titanium
SO EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES
LA English
DT Article
DE Vocal fold paralysis; Titanium; Dysphonia
AB Objectives: The aim of this study was to describe a new porous titanium thyroplasty implant that can be adjusted with a screw.
   Material and methods: Retrospective study of 15 patients with unilateral vocal fold paralysis undergoing type I thyroplasty under local anaesthesia. Each patient's dysphonia and swallowing disorders were evaluated both objectively and subjectively before and 3 months after thyroplasty.
   Results: Speech and swallowing disorders were improved in all the cases, except when the patients were suffering from severe associated neurological disorders (n = 3). The postoperative complications were minor including a laryngeal edema treated by corticotherapy per os (n = 1) and a superficial cervical haematoma (n = 1).
   Conclusions: This implant is easy to insert and the results show high tolerance of the biomaterial and above all the improvement of functions comparable to other laryngeal implants. (C) 2010 Elsevier Masson SAS. All rights reserved.
C1 [Devos, M.; Schultz, P.; Guillere, F.; Debry, C.] Hop Hautepierre, Serv ORL & Chirurg Cervicofaciale, F-67098 Strasbourg, France.
RP Devos, M (reprint author), Hop Hautepierre, Serv ORL & Chirurg Cervicofaciale, Ave Moliere, F-67098 Strasbourg, France.
EM marie.devos@chru-strasbourg.fr
OI MAILLY, Marie/0000-0002-5906-8291
CR Abraham MT, 2001, LARYNGOSCOPE, V111, P1322, DOI 10.1097/00005537-200108000-00003
   [Anonymous], 2002, PAR REC AD
   Brentel Aline Scalone, 2006, J. Appl. Oral Sci., V14, P213, DOI 10.1590/S1678-77572006000300013
   CUMMINGS CW, 1993, ANN OTO RHINOL LARYN, V102, P843, DOI 10.1177/000348949310201104
   Dejonckere PH, 2001, EUR ARCH OTO-RHINO-L, V258, P77, DOI 10.1007/s004050000299
   Giovanni A, 2009, Rev Laryngol Otol Rhinol (Bord), V130, P3
   Giovanni A, 1997, Ann Otolaryngol Chir Cervicofac, V114, P158
   Gorham MM, 1998, ARCH OTOLARYNGOL, V124, P739, DOI 10.1001/archotol.124.7.739
   Hartl D M, 2005, Ann Otolaryngol Chir Cervicofac, V122, P163, DOI 10.1016/S0003-438X(05)82344-8
   Hartl D M, 2000, Ann Otolaryngol Chir Cervicofac, V117, P60
   ISSHIKI N, 1974, ACTA OTO-LARYNGOL, V78, P451, DOI 10.3109/00016487409126379
   Laccourreye O, 2005, LARYNGOSCOPE, V115, P1411, DOI 10.1097/01.mlg.0000168059.12949.a6
   McCulloch TM, 2000, LARYNGOSCOPE, V110, P1306, DOI 10.1097/00005537-200008000-00015
   NETTERVILLE JL, 1993, ANN OTO RHINOL LARYN, V102, P413, DOI 10.1177/000348949310200602
   Nouwen J, 2004, ACTA OTO-LARYNGOL, V124, P732, DOI 10.1080/00016480310016875
   Rosen CA, 2004, LARYNGOSCOPE, V114, P159
   Schneider B, 2003, OTOLARYNG HEAD NECK, V128, P815, DOI 10.1016/S0194-5998(03)00359-0
   Schneider B, 2003, LARYNGOSCOPE, V113, P628, DOI 10.1097/00005537-200304000-00008
   Stasney CR, 2001, J VOICE, V15, P151, DOI 10.1016/S0892-1997(01)00015-7
   TUCKER HM, 1993, LARYNGOSCOPE, V103, P525
NR 20
TC 6
Z9 7
U1 0
U2 0
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 1879-7296
EI 1879-730X
J9 EUR ANN OTORHINOLARY
JI Eur. Ann. Otorhinolaryngol.-Head Neck Dis.
PD DEC
PY 2010
VL 127
IS 6
BP 204
EP 212
DI 10.1016/j.anorl.2010.08.001
PG 9
WC Otorhinolaryngology
SC Otorhinolaryngology
GA V35SX
UT WOS:000209169500002
PM 21087907
OA Bronze
DA 2018-10-19
ER

PT J
AU Chang, JM
   Tseng, FG
   Chieng, CC
AF Chang, Joe-Ming
   Tseng, Fan-Gang
   Chieng, Ching-Chang
TI Mixed-SAM Surfaces Monitoring CTX-Protein Part I: Using Atomic Force
   Microscope Measurements
SO IEEE TRANSACTIONS ON NANOBIOSCIENCE
LA English
DT Article
DE Adhesion force; atomic force microscope; mixed SAM surfaces; protein
   molecule
ID SELF-ASSEMBLED MONOLAYERS; ADHESION FORCES; 3-MERCAPTOPROPIONIC ACID;
   COBRA CARDIOTOXIN; FUNCTIONAL-GROUPS; PHASE-SEPARATION; COATED SURFACES;
   CHAIN-LENGTH; GOLD; ADSORPTION
AB Fast and efficient detection of Cobra cardiotoxin (CTX) protein molecules on biochip surfaces is an example of application in biotechnology. One potential application of mixed self assembled monolayers (SAMs) as chip surfaces yield different binding affinities of the CTX proteins, a series of studies on the interaction force between CTX proteins and the mixed SAMs surfaces formed from mixtures of two thiols with the same/different chain lengths and/or with the same/different terminal groups will be investigated. In these dual papers, the mixed SAMs of n-alkinethiol SAMs of different chain lengths are chosen as the first examples of this series due to the simple functions of the mixed SAMs surface structure. Thus, the adhesion force measurements of CTX protein molecules on mixed SAMs of n-alkinethiol SAMs of different chain lengths: 1-decanethiol (C9) and 1-hexanethiol (C5) with different mixing ratios are developed and conducted using atomic force microscope (AFM). There are two major tasks in Part I of the dual papers: the development of the AFM measurements providing reliable information, and selection of the surface with highest binding affinity among this mixed SAMs group. Results indicate that the adhesion forces for CTX protein molecules on mixed SAMs with mixing ratio (chi(C9)) of 0.25, 0.5, 0.75 and 1, are 1.26, 1.8, 1.38, and 1.25 folds respectively, compared with the adhesion force of CTX protein molecules on the C5 surface only. Therefore, the SAM surfaces of chi(C9) = 0.5 is the best choice as a biomaterial sensor of this group of mixed SAMs because the strongest binding force and highest efficiency. Effects of the loading force of the AFM operation, the radius of curvature of the AFM tip, and the AFM tip endurance as well as control experiments were examined to ensure the quantitative determination of adhesion force for AFM measurement. The physical mechanism of protein adsorption on SAM surfaces will be studied and analyzed by molecular dynamics (MD) simulations and will be reported in Part II of the dual papers to compensate the limited information on the interaction taking place at atomic level that experiments cannot provide.
C1 [Tseng, Fan-Gang; Chieng, Ching-Chang] Natl Tsing Hua Univ, Fac Inst NanoEngn & Microsyst, Hsinchu 30034, Taiwan.
   [Tseng, Fan-Gang; Chieng, Ching-Chang] Natl Tsing Hua Univ, Fac Dept Engn & Syst Sci, Hsinchu 30034, Taiwan.
   [Chang, Joe-Ming] Natl Tsing Hua Univ, Inst NanoEngn & Microsyst, Hsinchu 30034, Taiwan.
RP Chieng, CC (reprint author), Natl Tsing Hua Univ, Fac Inst NanoEngn & Microsyst, Hsinchu 30034, Taiwan.
EM d949207@oz.nthu.edu.tw; Fangang@ess.nthu.edu.tw; cchieng@mx.nthu.edu.tw
RI Chieng, Ching-Chang/A-8614-2012
OI Tseng, Fan-Gang/0000-0001-7654-6905
FU National Science Council, Taiwan, Republic of China
   [NSC95-2323-B-007-00]
FX This work was supported in part by the National Science Council, Taiwan,
   Republic of China, under Contract NSC95-2323-B-007-00. Asterisk
   indicates corresponding author.
CR Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   BAIN CD, 1988, J AM CHEM SOC, V110, P6560, DOI 10.1021/ja00227a044
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1988, J AM CHEM SOC, V110, P3665, DOI 10.1021/ja00219a055
   BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040
   BAIN CD, 1988, SCIENCE, V240, P62, DOI 10.1126/science.240.4848.62
   Barrias CC, 2005, BIOMATERIALS, V26, P2695, DOI 10.1016/j.biomaterials.2004.07.033
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bumm LA, 1999, J AM CHEM SOC, V121, P8017, DOI 10.1021/ja982157l
   Chen SF, 2000, LANGMUIR, V16, P9287, DOI 10.1021/la000417i
   DAUPLAIS M, 1995, EUR J BIOCHEM, V230, P213, DOI 10.1111/j.1432-1033.1995.tb20553.x
   Dubovskii PV, 2001, J MOL BIOL, V305, P137, DOI 10.1006/jmbi.2000.4283
   Dupont-Gillain CC, 2003, J BIOMED MATER RES A, V67A, P548, DOI 10.1002/jbm.a.10092
   FOLKERS JP, 1992, LANGMUIR, V8, P1330, DOI 10.1021/la00041a015
   Frederix F, 2003, LANGMUIR, V19, P4351, DOI 10.1021/la026908f
   Hardy M. A., 1993, REGRESSION DUMMY VAR, P1
   Hobara D, 1998, J ELECTROANAL CHEM, V444, P113, DOI 10.1016/S0022-0728(97)00553-6
   Huang WN, 2003, BIOCHEMISTRY-US, V42, P7457, DOI 10.1021/bi0344477
   Hung SW, 2006, NANOTECHNOLOGY, V17, pS8, DOI 10.1088/0957-4484/17/4/002
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kidoaki S, 2002, COLLOID SURFACE B, V23, P153, DOI 10.1016/S0927-7765(01)00232-6
   Kidoaki S, 2001, LANGMUIR, V17, P1080, DOI 10.1021/la000003p
   Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014
   Lee DH, 2005, J PHYS CHEM B, V109, P11301, DOI 10.1021/jp051232t
   Lee JW, 2005, BIOSENS BIOELECTRON, V20, P1422, DOI 10.1016/j.bios.2004.04.017
   Lee W, 2003, BIOSENS BIOELECTRON, V19, P185, DOI 10.1016/S0956-5663(03)00195-7
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Lin SM, 2007, BIOSENS BIOELECTRON, V22, P1013, DOI 10.1016/j.bios.2006.04.018
   MARTINS MCL, 2003, BIOMATERIALS, V24, P3497
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Munakata H, 2001, J ELECTROANAL CHEM, V496, P29, DOI 10.1016/S0022-0728(00)00363-6
   PATEL N, APPL PHYS A, V66, pS569
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Sawaguchi T, 2001, J ELECTROANAL CHEM, V496, P50, DOI 10.1016/S0022-0728(00)00430-7
   Seber GAF, 2003, LINEAR REGRESSION AN, P35
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Skulason H, 2000, LANGMUIR, V16, P6294, DOI 10.1021/la000208y
   Smith RK, 2004, PROG SURF SCI, V75, P1, DOI 10.1016/j.progsurf.2003.12.001
   Stranick SJ, 1996, NANOTECHNOLOGY, V7, P438, DOI 10.1088/0957-4484/7/4/025
   Tang Q, 2004, SYNTHETIC MET, V147, P247, DOI 10.1016/j.synthmet.2004.06.049
   van der Vegte EW, 2000, LANGMUIR, V16, P3249, DOI 10.1021/la990911q
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Wang ZH, 2006, BIOELECTROCHEMISTRY, V69, P180, DOI 10.1016/j.bioelechem.2006.02.001
   Xu LC, 2006, COLLOID SURFACE B, V48, P84, DOI 10.1016/j.colsurfb.2006.01.012
   Xu LC, 2005, LANGMUIR, V21, P7491, DOI 10.1021/la0509091
   Zhang Q, 2005, LANGMUIR, V21, P5405, DOI 10.1021/la046863d
   Zhang Q, 2003, J PHYS CHEM B, V107, P13123, DOI 10.1021/jp035592x
NR 51
TC 2
Z9 2
U1 0
U2 16
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1536-1241
J9 IEEE T NANOBIOSCI
JI IEEE Trans. Nanobiosci.
PD DEC
PY 2010
VL 9
IS 4
BP 289
EP 296
DI 10.1109/TNB.2010.2070516
PG 8
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA 713ON
UT WOS:000286747400009
PM 20840906
DA 2018-10-19
ER

PT J
AU Bryan, N
   Bayon, Y
   Hunt, J
AF Bryan, N.
   Bayon, Y.
   Hunt, J.
TI Quantification of leukocyte activation in response to biomaterial
   textiles that have applications in abdominal wall repair
SO IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Congress of the British-Society-for-Immunology
CY DEC 06-10, 2010
CL Liverpool, ENGLAND
SP British Soc Immunol
C1 [Bryan, N.; Hunt, J.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
   [Bayon, Y.] Covidien Sofradim Prod, Trevoux, France.
RI Hunt, John/G-6366-2012
OI Hunt, John/0000-0002-5168-4778
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0019-2805
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2010
VL 131
SU 1
BP 186
EP 187
PG 2
WC Immunology
SC Immunology
GA 689XL
UT WOS:000284964100634
DA 2018-10-19
ER

PT J
AU Yang, SH
   Wu, XH
   Xu, WH
   Ye, SN
   Liu, XZ
   Liu, XY
AF Yang, Shuhua
   Wu, Xinghuo
   Xu, Weihua
   Ye, Shunan
   Liu, Xianzhe
   Liu, Xiaoyun
TI Structural Augmentation with Biomaterial-Loaded Allograft Threaded Cage
   for the Treatment of Femoral Head Osteonecrosis
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE osteonecrosis of the femoral head; allograft threaded cage; core
   decompression; decalcified bone matrix; autogenous bone graft
ID DEMINERALIZED BONE-MATRIX; NONTRAUMATIC AVASCULAR NECROSIS; CORE
   DECOMPRESSION; SURVIVORSHIP ANALYSIS; HIP; ARTHROPLASTY; SUBSTITUTES;
   MANAGEMENT; FRACTURES; OSTEOTOMY
AB Seventy-six patients with femoral head necrosis were allocated to a program of either core decompression (control group) or core decompression and implantation of a biomaterial-loaded allograft threaded cage (treatment group) All patients were followed up prospectively clinically and radiographically In the control group no significant improvement in Harris hip score was found and 13 of the 22 hips had deteriorated to stage III In the treatment group the mean Harris hip score was improved from 62 8 to 81 6 the clinical success rate at 36 months postoperatively was 91% Collapse was seen in 1 hip, and another 3 hips exhibited progressive collapse The procedure is attractive as a minimally invasive and salvage procedure, which shows encouraging success rates and early clinical results in patients with Steinberg stage I-II osteonecrosis
C1 [Yang, Shuhua; Wu, Xinghuo; Xu, Weihua; Ye, Shunan; Liu, Xianzhe; Liu, Xiaoyun] Huazhong Univ Sci & Technol, Dept Orthoped, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
RP Wu, XH (reprint author), Huazhong Univ Sci & Technol, Dept Orthoped, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
FU National Natural Science Foundation of China [30170945, 30471753]
FX If benefits or funds were received in partial or total support of the
   research material described in this article please list the sources from
   which these benefits or funds were received National Natural Science
   Foundation of China (no 30170945 30471753)
CR AMSTUTZ HC, 1994, J BONE JOINT SURG BR, V76B, P423
   Babbush Charles A, 2003, Implant Dent, V12, P325, DOI 10.1097/01.ID.0000095466.18042.31
   Beaule PE, 2004, J AM ACAD ORTHOP SUR, V12, P96, DOI 10.5435/00124635-200403000-00005
   Berend KR, 2003, J BONE JOINT SURG AM, V85A, P987, DOI 10.2106/00004623-200306000-00001
   Beris AE, 2004, ORTHOP CLIN N AM, V35, P335, DOI 10.1016/j.ocl.2004.02.008
   Canter HI, 2007, J CRANIOFAC SURG, V18, P95, DOI 10.1097/01.scs.0000244921.07383.cc
   Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778
   Ciombor DM, 2001, TECH ORTHOP, V16, P32
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   Garberina MJ, 2004, ORTHOP CLIN N AM, V35, P353, DOI 10.1016/j.ocl.2004.04.002
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GORE DR, 1987, CLIN ORTHOP RELAT R, P206
   Han B, 2003, J ORTHOPAED RES, V21, P648, DOI 10.1016/S0736-0266(03)00005-6
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Hasegawa Y, 1997, ARCH ORTHOP TRAUM SU, V116, P251
   Hungerford MW, 2006, J BONE JOINT SURG AM, V88A, P126, DOI 10.2106/JBJS.F.00777
   Kang PD, 2007, CONNECT TISSUE RES, V48, P171, DOI 10.1080/01926230701221295
   Lafforgue Pierre, 2006, Rev Prat, V56, P817
   Lavernia CJ, 2000, J ARTHROPLASTY, V15, P171, DOI 10.1016/S0883-5403(00)90132-3
   Leali Alex, 2002, J South Orthop Assoc, V11, P167
   Ludwig SC, 2000, EUR SPINE J, V9, pS119, DOI 10.1007/PL00008317
   MATSUI M, 1992, CLIN ORTHOP RELAT R, P61
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Mont MA, 2004, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000150128.57777.8e
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Piattelli A, 1996, BIOMATERIALS, V17, P1127, DOI 10.1016/0142-9612(96)85915-1
   Plakseychuk AY, 2003, J BONE JOINT SURG AM, V85A, P589, DOI 10.2106/00004623-200304000-00001
   Ranly DM, 2005, J BONE JOINT SURG AM, V87A, P2052, DOI 10.2106/JBJS.D.02752
   Russell JL, 2000, TISSUE ENG, V6, P435, DOI 10.1089/107632700418137
   Simank HG, 1999, INT ORTHOP, V23, P154, DOI 10.1007/s002640050335
   Simank HG, 2001, J ARTHROPLASTY, V16, P790, DOI 10.1054/arth.2001.23580
   Soderman P, 2001, CLIN ORTHOP RELAT R, P189
   Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71
   Urbaniak J R, 1998, J Am Acad Orthop Surg, V6, P44
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
   Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x
   Yang SH, 2008, BIOTECHNOL BIOENG, V100, P560, DOI 10.1002/bit.21792
NR 37
TC 8
Z9 13
U1 0
U2 4
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD DEC
PY 2010
VL 25
IS 8
BP 1223
EP 1230
DI 10.1016/j.arth.2009.08.019
PG 8
WC Orthopedics
SC Orthopedics
GA 687BT
UT WOS:000284749500008
PM 19837551
DA 2018-10-19
ER

PT J
AU Tse, KH
   Sun, MZ
   Mantovani, C
   Terenghi, G
   Downes, S
   Kingham, PJ
AF Tse, Kai-Hei
   Sun, Mingzhu
   Mantovani, Cristina
   Terenghi, Giorgio
   Downes, Sandra
   Kingham, Paul J.
TI In vitro evaluation of polyester-based scaffolds seeded with adipose
   derived stem cells for peripheral nerve regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; nerve conduit; regeneration; Schwann cell; stem cell
ID STROMAL CELLS; BLENDS; REPAIR; TISSUE; TRANSPLANTATION; MORPHOLOGY;
   THERAPIES; CONDUIT; LINEAGE; FILMS
AB To overcome the disadvantages of autografts for peripheral nerve repair, different methods such as artificial nerve conduits have been investigated for an alternative approach. This study demonstrated that solvent casting is a simple but efficient method to create thin polyester-based scaffolds for stem cell delivery. Using poly (c-caprolactone) and poly (DJ-lactic acid), we produced scaffold films containing heterogenous depressions (pits) on the air surface with a size ranging from 0.5 to 30 mu m(2). These scaffolds were moderately hydrophobic; however, they supported the differentiation of adipose derived stem cells (ADSC) into a Schwann cell-like phenotype. The differentiated ADSC (dADSC) expressed S100 protein and glial fibrillary acidic protein and readily adhered to the films and proliferated at a similar rate to those cultured on tissue culture polystyrene. Cells were also positive for proliferating cell nuclear antigen. Furthermore, dADSC retained functional activity and significantly enhanced neurite outgrowth from dorsal root ganglia neurons. This study suggests polymer scaffolds combined with dADSCs could be a promising therapy for peripheral nerve injuries. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 701-708, 2010.
C1 [Tse, Kai-Hei; Mantovani, Cristina; Terenghi, Giorgio; Kingham, Paul J.] Univ Manchester, Fac Med & Human Sci, Blond McIndoe Res Labs, Manchester M13 9PT, Lancs, England.
   [Tse, Kai-Hei; Kingham, Paul J.] Umea Univ, Sect Anat, Dept Integrat Med Biol, SE-90187 Umea, Sweden.
   [Sun, Mingzhu; Downes, Sandra] Univ Manchester, Fac Engn & Phys Sci, Ctr Mat Sci, Manchester M1 7HS, Lancs, England.
RP Kingham, PJ (reprint author), Univ Manchester, Fac Med & Human Sci, Blond McIndoe Res Labs, Manchester M13 9PT, Lancs, England.
EM paul.kingham@anatomy.umu.se
OI Kingham, Paul/0000-0003-2596-5936; Tse, Kai-Hei/0000-0001-7287-3984
FU UK North West Regional Development Agency; Medical Research Council
   [G0502255]
FX Contract grant sponsor: UK North West Regional Development Agency
CR Aslan S, 2000, J MATER SCI, V35, P1615, DOI 10.1023/A:1004787326273
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421
   Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010
   Cui L, 2005, POLYMER, V46, P5334, DOI 10.1016/j.polymer.2005.04.018
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x
   DISCHER DE, 2009, SCIENCE, V325, P1673
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021
   Keilhoff G, 2006, TISSUE ENG, V12, P1451, DOI 10.1089/ten.2006.12.1451
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Mahay D, 2008, EXP CELL RES, V314, P2692, DOI 10.1016/j.yexcr.2008.05.013
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   Meek MF, 2008, ANN PLAS SURG, V60, P110, DOI 10.1097/SAP.0b013e31804d441c
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905
   REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5
   Sun M, 2010, J BIOMED MATER RES A, V93A, P1470, DOI 10.1002/jbm.a.32681
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Terenghi G, 2009, INT REV NEUROBIOL, V87, P393, DOI 10.1016/S0074-7742(09)87021-9
   Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077
   Tsuji H, 2007, POLYM INT, V56, P258, DOI 10.1002/pi.2150
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 29
TC 25
Z9 30
U1 0
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2010
VL 95A
IS 3
BP 701
EP 708
DI 10.1002/jbm.a.32889
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676ZX
UT WOS:000283959800005
PM 20725987
DA 2018-10-19
ER

PT J
AU Yanoso-Scholl, L
   Jacobson, JA
   Bradica, G
   Lerner, AL
   O'Keefe, RJ
   Schwarz, EM
   Zuscik, MJ
   Awad, HA
AF Yanoso-Scholl, Laura
   Jacobson, Justin A.
   Bradica, Gino
   Lerner, Amy L.
   O'Keefe, Regis J.
   Schwarz, Edward M.
   Zuscik, Michael J.
   Awad, Hani A.
TI Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds
   for bone tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone; polylactic acid; tricalcium phosphate; micro-computed tomography;
   biomechanics
ID MORPHOGENETIC PROTEIN-2; SYNTHETIC-POLYMER; DELIVERY-SYSTEMS;
   SPINAL-FUSION; IN-VITRO; RELEASE; BETA; BIOMATERIALS; REGENERATION;
   COMPOSITES
AB Advances in biomaterial fabrication have introduced numerous innovations in designing scaffolds for bone tissue engineering. Often, the focus has been on fabricating scaffolds with high and interconnected porosity that would allow for cellular seeding and tissue ingrowth. However, such scaffolds typically lack the mechanical strength to sustain in vivo ambulatory stresses in models of load bearing cortical bone reconstruction. In this study, we investigated the microstructural and mechanical properties of dense PLA and PLA/beta-TCP 185:151 scaffolds fabricated using a rapid volume expansion phase separation technique, which embeds uncoated beta-TCP particles within the porous polymer. PLA scaffolds had a volumetric porosity in the range of 30 to 40%. With the embedding of beta-TCP mineral particles, the porosity of the scaffolds was reduced in half, whereas the ultimate compressive and torsional strength were significantly increased. We also investigated the properties of the scaffolds as delivery vehicles for growth factors in vitro and in vivo. The low-surface porosity resulted in sub optimal retention efficiency of the growth factors, and burst release kinetics reflecting surface coating rather than volumetric entrapment, regardless of the scaffold used. When loaded with BMP2 and VEGF and implanted in the quadriceps muscle, PLA/beta-TCP scaffolds did not induce ectopic mineralization but induced a significant 1.8-fold increase in neo vessel formation. In conclusion, dense PLA/beta-TCP scaffolds can be engineered with enhanced mechanical properties and potentially be exploited for localized therapeutic factor delivery. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 717-726, 2010.
C1 [Yanoso-Scholl, Laura; Lerner, Amy L.; Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.
   [Yanoso-Scholl, Laura; Jacobson, Justin A.; Lerner, Amy L.; O'Keefe, Regis J.; Schwarz, Edward M.; Zuscik, Michael J.; Awad, Hani A.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY USA.
   [Jacobson, Justin A.; O'Keefe, Regis J.; Schwarz, Edward M.; Zuscik, Michael J.; Awad, Hani A.] Univ Rochester, Dept Orthopaed, Rochester, NY USA.
   [Bradica, Gino] Kensey Nash Corp, Exton, PA USA.
RP Awad, HA (reprint author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.
EM hani_awad@urmc.rochester.edu
RI Awad, Hani/G-6976-2014; Lerner, Amy/F-8916-2015
OI Awad, Hani/0000-0003-2197-2610; Lerner, Amy/0000-0001-5151-8289
FU Wallace H. Coulter Foundation; The Aircast Foundation; National
   Institutes of Health [AR054041]
FX Contract grant sponsors: Wallace H. Coulter Foundation, The Aircast
   Foundation; Contract grant sponsor: National Institutes of Health;
   contract grant number: AR054041
CR Akkus O, 2001, J ORTHOP RES, V19, P927, DOI 10.1016/S0736-0266(01)00004-3
   Arifin DY, 2006, ADV DRUG DELIVER REV, V58, P1274, DOI 10.1016/j.addr.2006.09.007
   Aspenberg P, 1996, BONE, V19, P499, DOI 10.1016/S8756-3282(96)90257-4
   Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159
   Burdick JA, 2003, BIOMATERIALS, V24, P1613, DOI 10.1016/S0142-9612(02)00538-0
   Charles-Harris M, 2007, BIOMATERIALS, V28, P4429, DOI 10.1016/j.biomaterials.2007.06.029
   Guldberg RE, 2003, IEEE ENG MED BIOL, V22, P77, DOI 10.1109/MEMB.2003.1256276
   Hedberg EL, 2002, J CONTROL RELEASE, V84, P137, DOI 10.1016/S0168-3659(02)00261-4
   Helm GA, 1997, J NEUROSURG, V86, P93, DOI 10.3171/jns.1997.86.1.0093
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6
   Liang G, 2005, BIOMATERIALS, V26, P4265, DOI 10.1016/j.biomaterials.2004.10.035
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Montjovent MO, 2007, J BIOMED MATER RES A, V83A, P41, DOI 10.1002/jbm.a.31208
   Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Patel HJ, 2006, BIOTECHNOL PROGR, V22, P38, DOI 10.1021/bp050135e
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   POLSON A, 1950, J PHYS COLLOID CHEM, V54, P649, DOI 10.1021/j150479a007
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Schliephake H, 2007, J BIOMED MATER RES A, V83A, P455, DOI 10.1002/jbm.a.31227
   Schrier JA, 1999, PHARM DEV TECHNOL, V4, P611, DOI 10.1081/PDT-100101400
   Suuronen R, 2000, J Craniomaxillofac Trauma, V6, P19
   Tarquasy A.C., 1974, CONTROLLED RELEASE B, V47, P15
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 29
TC 27
Z9 28
U1 0
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2010
VL 95A
IS 3
BP 717
EP 726
DI 10.1002/jbm.a.32868
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676ZX
UT WOS:000283959800007
PM 20725979
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Alcaide, M
   Serrano, MC
   Roman, J
   Cabanas, MV
   Pena, J
   Sanchez-Zapardiel, E
   Vallet-Regi, M
   Portoles, MT
AF Alcaide, Maria
   Serrano, Maria-Concepcion
   Roman, Jesus
   Cabanas, Maria-Victoria
   Pena, Juan
   Sanchez-Zapardiel, Elena
   Vallet-Regi, Maria
   Portoles, Maria-Teresa
TI Suppression of anoikis by collagen coating of interconnected macroporous
   nanometric carbonated hydroxyapatite/agarose scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; collagen; cell adhesion; apoptosis; scaffold
ID EXTRACELLULAR-MATRIX COMPONENTS; NITRIC-OXIDE; APOPTOSIS-ANOIKIS;
   CELL-ADHESION; PATHWAY; DIFFERENTIATION; REGENERATION; COMPOSITE;
   KINASE; DEATH
AB Three dimensional interconnected macroporous (pore diameter: 600-800 mu m) hydroxyapatite/agarose disks have been evaluated in this study as potential bone regeneration scaffolds. With this purpose, the adhesion and proliferation of human Saos-2 osteoblasts on this biomaterial were analyzed. As an index of cell function, the following parameters were measured: cell morphology, viability, cell size/complexity, cell cycle, reactive oxygen species (ROS) content, and lactate dehydrogenase (LDH) release. The existence of anoikis induced by inappropriate contacts between the cell and the scaffold has been detected by scanning electron microscopy, confocal microscopy, and flow cytometry. The intracellular nitric oxide content has been also measured as potential inducer of anoikis. The positive effects of previous scaffold coating with type I collagen on osteoblast adhesion as well as the collagen protection against anoikis have been demonstrated in this study. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 793-800, 2010.
C1 [Alcaide, Maria; Serrano, Maria-Concepcion; Sanchez-Zapardiel, Elena; Portoles, Maria-Teresa] Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
   [Roman, Jesus; Cabanas, Maria-Victoria; Pena, Juan; Vallet-Regi, Maria] Univ Complutense, Fac Pharm, Dept Inorgan & Bioinorgan Chem, E-28040 Madrid, Spain.
   [Vallet-Regi, Maria] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; CABANAS, VICTORIA/G-8740-2015; Portoles,
   Maria Teresa/U-1678-2017; Serrano, Maria Concepcion/D-7442-2014; pena,
   juan/E-5913-2018
OI Vallet-Regi, Maria/0000-0002-6104-4889; CABANAS,
   VICTORIA/0000-0002-4753-5665; Portoles, Maria
   Teresa/0000-0002-9681-0184; Serrano, Maria
   Concepcion/0000-0002-5010-644X; pena, juan/0000-0002-5992-908X; ROMAN
   ZARAGOZA, JESUS/0000-0002-9722-0303
FU Comunidad de Madrid [S-0505/MAT/0324, S2009/MAT-1472]; Universidad
   Complutense de Madrid
FX Contract grant sponsor: Comunidad de Madrid; contract grant numbers:
   S-0505/MAT/0324, S2009/MAT-1472; Contract grant sponsor: Universidad
   Complutense de Madrid
CR Alcaide M, 2009, BIOMATERIALS, V30, P45, DOI 10.1016/j.biomaterials.2008.09.012
   Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023
   Facompre Michael, 2000, Molecular Cell Biology Research Communications, V4, P37, DOI 10.1006/mcbr.2000.0251
   Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Goligorsky MS, 1999, AM J PHYSIOL-CELL PH, V276, pC1271, DOI 10.1152/ajpcell.1999.276.6.C1271
   Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147
   Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Ho WP, 2005, ANN NY ACAD SCI, V1042, P460, DOI 10.1196/annals.1338.039
   Ivanova K, 1997, J PATHOL, V183, P469, DOI 10.1002/(SICI)1096-9896(199712)183:4<469::AID-PATH931>3.0.CO;2-T
   Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200
   KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Monteiro HP, 2004, NITRIC OXIDE-BIOL CH, V10, P1, DOI 10.1016/j.niox.2004.02.002
   Monteiro HP, 2000, FREE RADICAL BIO MED, V28, P174, DOI 10.1016/S0891-5849(99)00233-6
   Nishimura D, 2006, INT J ONCOL, V29, P713
   Padilla S, 2008, CHEM MATER, V20, P5942, DOI 10.1021/cm801626k
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Pek YS, 2009, BIOMATERIALS, V30, P822, DOI 10.1016/j.biomaterials.2008.10.053
   Pena J, 2010, ACTA BIOMATER, V6, P1288, DOI 10.1016/j.actbio.2009.10.049
   RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193
   Wu MF, 2008, CELL BIOL INT, V32, P151, DOI 10.1016/j.cellbi.2007.08.006
   Yao J, 1998, KIDNEY INT, V53, P598, DOI 10.1046/j.1523-1755.1998.00793.x
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 26
TC 12
Z9 12
U1 2
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2010
VL 95A
IS 3
BP 793
EP 800
DI 10.1002/jbm.a.32901
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676ZX
UT WOS:000283959800016
PM 20725989
DA 2018-10-19
ER

PT J
AU Gruionu, G
   Stone, AL
   Schwartz, MA
   Hoying, JB
   Williams, SK
AF Gruionu, Gabriel
   Stone, Alice L.
   Schwartz, Mark A.
   Hoying, James B.
   Williams, Stuart K.
TI Encapsulation of ePTFE in prevascularized collagen leads to peri-implant
   vascularization with reduced inflammation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE granulation tissue; fibrous capsule; microvascular networks
ID ENDOTHELIAL GROWTH-FACTOR; SUBCUTANEOUS IMPLANTS; NEOVASCULARIZATION;
   TISSUE; ANGIOGENESIS; MEMBRANES; FIBROSIS; MOUSE
AB During the typical healing response to an implanted biomaterial, vascular-rich granulation tissue forms around the implant and later resolves into a relatively avascular, fibrous capsule. We have previously shown that a microvascular construct (MVC) consisting of isolated microvessel fragments suspended in a collagen I gel forms a persistent microcirculation in lieu of avascular scar when implanted. The current study evaluated the potential for microvascular constructs to maintain a vascularized tissue environment around an implanted biomaterial. An analysis of the peri-implant tissue around bare expanded polytetrafluoroethylene (ePTFE), ePTFE embedded within a microvascular construct, or ePTFE embedded within collagen alone revealed that the presence of the MVC, but not collagen alone, promoted vascular densities comparable to that of the granulation tissue formed around bare ePTFE. The vessels within the microvascular construct surrounding the ePTFE were perfusion competent, as determined by India ink perfusion casting, and extended into the interstices of the polymer. In contrast to bare ePTFE, the presence of the MVC or collagen alone significantly reduced the number of activated macrophages in association with ePTFE. Similar results were observed for ePTFE modified to increase cellularity and prevent the formation of an avascular scar. The microvascular construct may prove effective in forming vascularized tissue environments and limiting the number of activated macrophages around implanted polymers thereby leading to effective implant incorporation. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 811-818, 2010.
C1 [Hoying, James B.; Williams, Stuart K.] Cardiovasc Innovat Inst, Div Cardiovasc Therapeut, Louisville, KY 40202 USA.
   [Gruionu, Gabriel; Stone, Alice L.; Schwartz, Mark A.; Hoying, James B.; Williams, Stuart K.] Univ Arizona, Arizona Res Labs, Tucson, AZ USA.
RP Williams, SK (reprint author), Cardiovasc Innovat Inst, Div Cardiovasc Therapeut, 302 E Muhammad Ali Blvd, Louisville, KY 40202 USA.
EM stu.williams@louisville.edu
FU NIH [EB007556, DK078175]
FX Contract grant sponsor: NIH; contract grant numbers: EB007556, DK078175
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   BRAUKER J, 1992, TRANSPLANT P, V24, P2924
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Emmez H, 2008, NEUROSURGERY, V62, P1351, DOI [10.1227/01.neu.0000333307.02802.04, 10.1227/01.NEU.0000317272.86593.E3]
   Gerritsen M, 2000, DIABETES CARE, V23, P143, DOI 10.2337/diacare.23.2.143
   Gruionu G, 2005, AM J PHYSIOL-HEART C, V288, pH2047, DOI 10.1152/ajpheart.00496.2004
   HERING TM, 1986, CONNECT TISSUE RES, V15, P141, DOI 10.3109/03008208609167139
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Kidd KR, 2005, TISSUE ENG, V11, P1379, DOI 10.1089/ten.2005.11.1379
   Kidd KR, 2004, J BIOMED MATER RES A, V69A, P294, DOI 10.1002/jbm.a.20133
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Ono M, 1999, CANCER CHEMOTH PHARM, V43, pS69, DOI 10.1007/s002800051101
   Ruiz-de-Erenchun R, 2005, PLAST RECONSTR SURG, V116, P1370, DOI 10.1097/01.prs.0000181694.07661.0d
   Salzmann DL, 1999, CARDIOVASC PATHOL, V8, P63, DOI 10.1016/S1054-8807(98)00003-9
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E
   Shepherd BR, 2007, TISSUE ENG, V13, P2871, DOI 10.1089/ten.2007.0025
   Shepherd BR, 2004, ARTERIOSCL THROM VAS, V24, P898, DOI 10.1161/01.ATV.0000124103.86943.1e
   Updike SJ, 2000, DIABETES CARE, V23, P208, DOI 10.2337/diacare.23.2.208
   Wilgus TA, 2008, LAB INVEST, V88, P579, DOI 10.1038/labinvest.2008.36
   Williams SK, 1997, J BIOMED MATER RES, V35, P473
   Zhou M, 2009, ARTIF ORGANS, V33, P230, DOI 10.1111/j.1525-1594.2009.00713.x
NR 23
TC 7
Z9 8
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2010
VL 95A
IS 3
BP 811
EP 818
DI 10.1002/jbm.a.32925
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676ZX
UT WOS:000283959800018
PM 20734331
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Sando, L
   Kim, M
   Colgrave, ML
   Ramshaw, JAM
   Werkmeister, JA
   Elvin, CM
AF Sando, Lillian
   Kim, Misook
   Colgrave, Michelle L.
   Ramshaw, John A. M.
   Werkmeister, Jerome A.
   Elvin, Christopher M.
TI Photochemical crosslinking of soluble wool keratins produces a
   mechanically stable biomaterial that supports cell adhesion and
   proliferation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE keratin; photo-crosslinking; di-tyrosine; adhesive; fibroblasts
ID HUMAN HAIR; RECONSTITUTED KERATIN; SILK FIBROIN; FABRICATION;
   DITYROSINE; PROTEINS; SCAFFOLDS; COLLAGEN; MODEL; FILMS
AB Keratins extracted from various "hard tissues" such as wool, hair, and nails are increasingly being investigated as a source of abundant, biocompatible materials. In this study we explored a recent photochemical method to crosslink solubilized wool keratoses, with the aim of producing a mechanically favorable biomaterial. Wool proteins were isolated by oxidizing the disulfides and extracting the resulting soluble keratoses. The alpha- and gamma-keratose fractions were analyzed by liquid chromatography-mass spectrometry to identify their constituent proteins. Hydrogels were produced by covalent crosslinking of the alpha-keratoses via a photo-oxidative process catalyzed by blue light, a ruthenium complex, and persulfate. The presence of dityrosine crosslinks was demonstrated by high performance liquid chromatography and mass spectrometry analyses. The crosslinked alpha-keratose material had moderate tensile strength and elasticity, and high adhesive strength. The material displayed modest shrinking after crosslinking, however the shrinking could be prevented by crosslinking in the presence of 2.5% glycerol, resulting in gels that did not shrink or swell. Small solutes such as Tris and glycerol influenced the crosslink density and elastic modulus of the crosslinked material. The alpha-keratose was able to support adhesion and growth of NIH/3T3 fibroblasts in vitro. The fabrication of mechanically stable keratin biomaterials by this facile photo-crosslinking method may be useful for various tissue engineering applications. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 901-911, 2010.
C1 [Sando, Lillian; Kim, Misook; Colgrave, Michelle L.; Elvin, Christopher M.] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.
   [Ramshaw, John A. M.; Werkmeister, Jerome A.] CSIRO Mol & Hlth Technol, Clayton, Vic 3169, Australia.
RP Sando, L (reprint author), CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.
EM lillian.sando@csiro.au
RI elvin, chris/H-2333-2013; Colgrave, Michelle/A-5710-2012
OI Colgrave, Michelle/0000-0001-8463-805X
FU CSIRO Office of Chief Executive
FX The authors thank Dr. M. Huson at CSIRO Materials Science and
   Engineering, Geelong, Australia, for supplying wool and for calculating
   crosslink densities; Dr. D. Merritt at the University of Queensland,
   Australia, for assisting with microscopy; the Australian Proteome
   Analysis Facility, Sydney, established under the Australian Government's
   Major National Research Facilities program, for amino acid analysis; the
   Molecular and Cellular Proteomics Mass Spectrometry Facility within the
   Institute for Molecular Bioscience at the University of Queensland,
   Australia, for LC-MS/MS analysis; Ms. Y. Peng at CSIRO Molecular and
   Health Technologies, Melbourne, Australia, and Dr. L. Grondahl at the
   University of Queensland, Australia, for assistance with contact angle
   analysis; and Dr. M. Evans at CSIRO Molecular and Health Technologies,
   North Ryde, Australia, for helpful comments on the manuscript. Lillian
   Sando is the recipient of a Postdoctoral Fellowship from the CSIRO
   Office of Chief Executive.
CR AARON BB, 1981, BIOPOLYMERS, V20, P1247, DOI 10.1002/bip.1981.360200611
   Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Aluigi A, 2007, J APPL POLYM SCI, V104, P863, DOI 10.1002/app.25623
   ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   CORFIELD MC, 1958, BIOCHEM J, V68, P348, DOI 10.1042/bj0680348
   CREWTHER WG, 1965, CHEM KERATINS
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   FRASER RDB, 1988, INT J BIOL MACROMOL, V10, P106, DOI 10.1016/0141-8130(88)90017-7
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Fujii T, 2009, J BIOMED MATER RES B, V91B, P528, DOI 10.1002/jbm.b.31426
   GILLESPIE JM, 1974, AUST J BIOL SCI, V27, P617
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Kongsuwan K, 2010, INT J PARASITOL, V40, P499, DOI 10.1016/j.ijpara.2009.10.013
   Kuznetsova N, 1998, BIOCHEMISTRY-US, V37, P11888, DOI 10.1021/bi980089+
   LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205
   Liu BS, 2008, J BIOMED MATER RES A, V87A, P1092, DOI 10.1002/jbm.a.31916
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MARSHALL RC, 1977, AUST J BIOL SCI, V30, P389
   MIES HH, 1987, J CHROMATOGR, V405, P365, DOI 10.1016/S0021-9673(01)81778-7
   Peplow PV, 2009, J BIOMED MATER RES A, V89A, P255, DOI 10.1002/jbm.a.32038
   RAVEN DJ, 1971, BIOCHIM BIOPHYS ACTA, V251, P96, DOI 10.1016/0005-2795(71)90065-1
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Stewart K, 1997, J APPL POLYM SCI, V66, P2365, DOI 10.1002/(SICI)1097-4628(19971226)66:13<2365::AID-APP2>3.0.CO;2-G
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tanabe T, 2004, MAT SCI ENG C-BIO S, V24, P441, DOI 10.1016/j.msec.2003.11.004
   Treloar L. R. G, 1975, PHYS RUBBER ELASTICI
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yuan J, 2008, POLYM INT, V57, P1188, DOI 10.1002/pi.2463
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
NR 42
TC 30
Z9 31
U1 2
U2 51
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2010
VL 95A
IS 3
BP 901
EP 911
DI 10.1002/jbm.a.32913
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676ZX
UT WOS:000283959800027
PM 20845488
DA 2018-10-19
ER

PT J
AU Ereno, C
   Guimaraes, SAC
   Pasetto, S
   Herculano, RD
   Silva, CP
   Graeff, CFO
   Tavano, O
   Baffa, O
   Kinoshita, A
AF Ereno, Cibele
   Catanzaro Guimaraes, Sergio A.
   Pasetto, Silvana
   Herculano, Rondinelli Donizetti
   Silva, Cecilia Pereira
   Graeff, Carlos F. O.
   Tavano, Orivaldo
   Baffa, Oswaldo
   Kinoshita, Angela
TI Latex use as an occlusive membrane for guided bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE guided bone regeneration; biomaterial; latex; electron spin resonance
ID CRANIAL DEFECTS; NATURAL-RUBBER; RATS; OSTEOPROMOTION; SPECTRUM
AB Latex extracted from Hevea brasiliensis was used as an occlusive membrane for guided bone regeneration. Twenty-four rabbits were divided in two groups: treated and control group. Critical size bone defects (2 cm x 1 cm) were surgically made in the rabbit calvarium. Two latex membranes were implanted in each animal of the treated group, whereas the control defect was filled only with autogenous blood clot. After 15, 30, 60, and 120 days, animals from each group were euthanized, and the samples with regenerated bone were removed. No signs of allergy or rejection were noticed around the calvarial bone defect of the treated group. In the histological analysis, no foreign body inflammatory reaction was observed in the adjacent tissues in contact with the membranes demonstrating that latex can be used at injured sites as an aid in the healing process. Histological analysis, digital radiography, and electron spin resonance were used to evaluate the progress of bone repair. The results show significant differences between groups (p < 0.05) suggesting that latex membranes accelerates healing in critical bone defects. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 932-939, 2010.
C1 [Ereno, Cibele; Catanzaro Guimaraes, Sergio A.; Pasetto, Silvana; Kinoshita, Angela] Univ Sagrado Coracao, Programa Pos Grad Biol Oral, PRPPG, Sao Paulo, Brazil.
   [Herculano, Rondinelli Donizetti; Silva, Cecilia Pereira; Baffa, Oswaldo] Univ Sao Paulo, Dept Fis & Matemat FFCLRP, Sao Paulo, Brazil.
   [Graeff, Carlos F. O.] Univ Estadual Paulista, Fac Ciencias, Sao Paulo, Brazil.
   [Tavano, Orivaldo] Ctr Pesquisas Odontol Sao Leopoldo Mandic, Curso Pos Grad Odontol, Radiol Sect, Sao Paulo, Brazil.
RP Kinoshita, A (reprint author), Univ Sagrado Coracao, Programa Pos Grad Biol Oral, PRPPG, Sao Paulo, Brazil.
EM angelak@flash.tv.br
RI Baffa, Oswaldo/E-3251-2012; Nanotecnologias, Inct/I-2407-2013;
   Herculano, Rondinelli Donizetti/D-2249-2012; Kinoshita,
   Angela/C-6946-2012; Graeff, Carlos/C-6703-2012
OI Baffa, Oswaldo/0000-0002-0622-2814; Herculano, Rondinelli
   Donizetti/0000-0001-7236-0847; Kinoshita, Angela/0000-0002-5057-1667;
   Graeff, Carlos/0000-0003-0162-8273
FU FAPESP; CNPq; CAPES
FX Contract grant sponsors: FAPESP, CNPq, CAPES
CR Arias JI, 2008, J TISSUE ENG REGEN M, V2, P228, DOI 10.1002/term.87
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   BARBER D, 2007, J ORAL MAXILLOFAC SU, V65, P748
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   CALLENS FJ, 1991, CALCIFIED TISSUE INT, V48, P249, DOI 10.1007/BF02556376
   CIAPETTI G, 1994, J MATER SCI-MATER M, V5, P647, DOI 10.1007/BF00120348
   DAHLIN C, 1991, J NEUROSURG, V74, P487, DOI 10.3171/jns.1991.74.3.0487
   DAHLIN C, 1994, INT J ORAL MAX SURG, V23, P237, DOI 10.1016/S0901-5027(05)80378-9
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Taga MLD, 2008, INT J ORAL MAX IMPL, V23, P427
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Durmus E, 2003, J INT MED RES, V31, P223, DOI 10.1177/147323000303100309
   Frade M. A. C., 2001, INT J DERMATOL, V40, P237
   Healey AM, 1996, POLYMER, V37, P4009, DOI 10.1016/0032-3861(96)00257-1
   HEESE A, 1991, J AM ACAD DERMATOL, V25, P831, DOI 10.1016/S0190-9622(08)80977-2
   Herculano RD, 2009, MATER RES-IBERO-AM J, V12, P253, DOI 10.1590/S1516-14392009000200023
   Hunt JA, 2008, NAT MATER, V7, P617, DOI 10.1038/nmat2242
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   LINDE A, 1993, J PERIODONTOL, V64, P1116, DOI 10.1902/jop.1993.64.11s.1116
   Lundgren A, 1998, CLIN ORAL IMPLAN RES, V9, P251, DOI 10.1034/j.1600-0501.1998.090406.x
   Marinucci L, 2001, J PERIODONTOL, V72, P753, DOI 10.1902/jop.2001.72.6.753
   MELCHER AH, 1962, J BONE JOINT SURG BR, V44, P424
   Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010
   OLIVEIRA LCS, 2006, THERMOCHIM ACTA, V445, P27
   Paulo N. M., 2005, Acta Scientiae Veterinariae, V33, P79
   Pinho Erika Christina Canarim M. de, 2004, Arq. Bras. Oftalmol., V67, P27, DOI 10.1590/S0004-27492004000100005
   SCHENK RK, 1994, GUIDED BONE REGENERA, P49
   Schliephake H, 2004, CLIN ORAL IMPLAN RES, V15, P112, DOI 10.1111/j.1600-0501.2004.00992.x
   Strietzel FP, 2006, J BIOMED MATER RES B, V78B, P35, DOI 10.1002/jbm.b.30452
   von Arx T, 2005, INT J ORAL MAX IMPL, V20, P843
NR 30
TC 30
Z9 32
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2010
VL 95A
IS 3
BP 932
EP 939
DI 10.1002/jbm.a.32919
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676ZX
UT WOS:000283959800030
PM 20845492
DA 2018-10-19
ER

PT J
AU Karunakaran, C
   Abiramasundari, G
   Gomathisankar, P
   Manikandan, G
   Anandi, V
AF Karunakaran, C.
   Abiramasundari, G.
   Gomathisankar, P.
   Manikandan, G.
   Anandi, V.
TI Cu-doped TiO2 nanoparticles for photocatalytic disinfection of bacteria
   under visible light
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE CuO/TiO2; Solar photodisinfection; E. coli; Photocatalysis
ID FERRITE COMPOSITE NANOPARTICLES; ESCHERICHIA-COLI INACTIVATION;
   BIOMATERIAL SYSTEM; TITANIUM-DIOXIDE; ANTIMICROBIAL PROPERTIES;
   THIN-FILMS; WATER; DEGRADATION; ANATASE; ABATEMENT
AB Two percent Cu-doped TiO2 nanoparticles were prepared by a modified ammonia-evaporation-induced synthetic method, calcined at 450 degrees C, and characterized by powder X-ray diffraction, energy dispersive X-ray analysis, ESR spectroscopy, scanning electron microscopy, UV-visible diffuse reflectance spectrum, photoluminescence spectroscopy, and electrochemical impedance spectroscopy. Doping shifts the optical absorption edge to the visible region but increases the charge-transfer resistance and decreases the capacitance. Under visible light, the composite nanoparticles very efficiently catalyze the disinfection of Escherichia coli. The prepared oxide is selective in photocatalysis; under UV light, its photocatalytic activity to degrade sunset yellow, rhodamine B. and methylene blue dyes is less than that of the undoped one. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Karunakaran, C.; Abiramasundari, G.; Gomathisankar, P.; Manikandan, G.] Annamalai Univ, Dept Chem, Annamalainagar 608002, Tamil Nadu, India.
   [Anandi, V.] Annamalai Univ, Rajah Muthiah Med Coll, Div Microbiol, Annamalainagar 608002, Tamil Nadu, India.
RP Karunakaran, C (reprint author), Annamalai Univ, Dept Chem, Annamalainagar 608002, Tamil Nadu, India.
EM karunakaranc@rediffmail.com
RI Dom, Rekha/B-7113-2012
FU Council of Scientific and Industrial Research (CSIR), New Delhi
   [01(2031)/06/EMR-II]
FX The authors thank the Council of Scientific and Industrial Research
   (CSIR), New Delhi, for the financial support through Research Grant
   01(2031)/06/EMR-II and Degussa for gifting TiO<INF>2</INF> P25 sample.
   P.G. is grateful to CSIR for JRF. The authors also thank Dr. J.
   Jayabharathi, Annamalai University, for the PL facility.
CR Alrousan DMA, 2009, WATER RES, V43, P47, DOI 10.1016/j.watres.2008.10.015
   Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII
   Cho M, 2004, WATER RES, V38, P1069, DOI 10.1016/j.watres.2003.10.029
   Erkan A, 2006, J PHOTOCH PHOTOBIO A, V184, P313, DOI 10.1016/j.jphotochem.2006.05.001
   Gaya UI, 2008, J PHOTOCH PHOTOBIO C, V9, P1, DOI 10.1016/j.jphotochemrev.2007.12.003
   Guillard C, 2008, CR CHIM, V11, P107, DOI 10.1016/j.crci.2007.06.007
   Gumy D, 2006, APPL CATAL B-ENVIRON, V63, P76, DOI 10.1016/j.apcatb.2005.09.013
   Han F, 2009, APPL CATAL A-GEN, V359, P25, DOI 10.1016/j.apcata.2009.02.043
   Hu XL, 2010, LANGMUIR, V26, P3031, DOI 10.1021/la902142b
   Hurum DC, 2003, J PHYS CHEM B, V107, P4545, DOI 10.1021/jp0273934
   Jung H, 2010, APPL CATAL B-ENVIRON, V93, P212, DOI 10.1016/j.apcatb.2009.09.031
   Kubacka A, 2008, APPL CATAL B-ENVIRON, V84, P87, DOI 10.1016/j.apcatb.2008.02.020
   Li YG, 2008, CHEM MATER, V20, P567, DOI 10.1021/cm070784g
   Liu Y, 2008, MICROPOR MESOPOR MAT, V114, P431, DOI 10.1016/j.micromeso.2008.01.032
   Liu Y, 2007, J PHOTOCH PHOTOBIO A, V190, P94, DOI 10.1016/j.jphotochem.2007.03.017
   Nadtochenko VA, 2005, J PHOTOCH PHOTOBIO A, V169, P131, DOI 10.1016/j.photochem.2004.06.011
   Page K, 2007, J MATER CHEM, V17, P95, DOI 10.1039/b611740f
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Reddy MP, 2007, WATER RES, V41, P379, DOI 10.1016/j.watres.2006.09.018
   Rengifo-Herrera JA, 2009, APPL CATAL B-ENVIRON, V88, P398, DOI 10.1016/j.apcatb.2008.10.025
   Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030
   Rengifo-Herrera JA, 2010, J PHYS CHEM C, V114, P2717, DOI 10.1021/jp910486f
   Sclafani A, 1996, J PHYS CHEM-US, V100, P13655, DOI 10.1021/jp9533584
   Sreenivasu D, 2000, B MATER SCI, V23, P281, DOI 10.1007/BF02720083
   Sun DD, 2003, WATER RES, V37, P3452, DOI 10.1016/S0043-1354(03)00228-8
   Sun SQ, 2008, B MATER SCI, V31, P61, DOI 10.1007/s12034-008-0011-7
   Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3
   Sunada K, 2003, ENVIRON SCI TECHNOL, V37, P4785, DOI 10.1021/es034106g
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Trapalis CC, 2003, THIN SOLID FILMS, V433, P186, DOI 10.1016/S0040-6090(03)00331-6
   van Grieken R, 2009, CATAL TODAY, V144, P48, DOI 10.1016/j.cattod.2008.11.017
   Xu Y, 2000, AM MINERAL, V85, P543, DOI 10.2138/am-2000-0416
   Yan MC, 2005, J PHYS CHEM B, V109, P8673, DOI 10.1021/jp046087i
   Yeung KL, 2009, CATAL TODAY, V143, P218, DOI 10.1016/j.cattod.2008.09.036
   Yuranova T, 2006, J PHOTOCH PHOTOBIO A, V181, P363, DOI 10.1016/j.jphotochem.2005.12.020
NR 36
TC 112
Z9 117
U1 7
U2 133
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD DEC 1
PY 2010
VL 352
IS 1
BP 68
EP 74
DI 10.1016/j.jcis.2010.08.012
PG 7
WC Chemistry, Physical
SC Chemistry
GA 661KF
UT WOS:000282726500009
PM 20832079
DA 2018-10-19
ER

PT J
AU Davies, MC
   Alexander, MR
   Hook, AL
   Yang, J
   Mei, Y
   Taylor, M
   Urquhart, AJ
   Langer, R
   Anderson, DG
AF Davies, Martyn C.
   Alexander, Morgan R.
   Hook, Andrew L.
   Yang, Jing
   Mei, Ying
   Taylor, Michael
   Urquhart, Andrew J.
   Langer, Robert
   Anderson, Daniel G.
TI High throughput surface characterization: A review of a new tool for
   screening prospective biomedical material arrays
SO JOURNAL OF DRUG TARGETING
LA English
DT Review
DE Polymer; copolymer; high throughput drug screening; mathematical model;
   stem cell; secondary ion mass spectrometry; water contact angle;
   multivariate statistics
ID EMBRYONIC STEM-CELLS; MICROARRAYS; COMBINATORIAL; BIOMATERIALS;
   FABRICATION; POLYMERS; GROWTH; CHEMISTRY; ADHESION
AB The application of high throughput surface characterization (HTSC) to the analysis of polymeric biomaterial libraries is an important advancement for the discovery and development of new biomedical materials and is the focus of this review. The potential for HTSC to identify structure/activity relationships for large libraries of materials can be utilized to accelerate materials discovery as well as providing insight into the underlying biological-material interactions. Furthermore, the correlations identified between surface chemical structure and cellular behavior could not have been predicted by a rational design approach based simply on review of bulk structure, which demonstrates the importance of HTSC in the assessment of cell-material and cell-biomolecular interactions that are dependent on surface properties.
C1 [Davies, Martyn C.; Alexander, Morgan R.; Hook, Andrew L.; Yang, Jing] Univ Nottingham, Lab Biophys & Surface Anal, Sch Pharm, Nottingham NG7 2RD, England.
   [Mei, Ying; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Mei, Ying; Langer, Robert; Anderson, Daniel G.] MIT, Harvard MIT, Div Hlth Sci Technol, Cambridge, MA 02139 USA.
   [Taylor, Michael] Univ Cent Lancashire, Sch Pharm & Biomed Sci, Preston PR1 2HE, Lancs, England.
   [Urquhart, Andrew J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.
RP Davies, MC (reprint author), Univ Nottingham, Lab Biophys & Surface Anal, Sch Pharm, Nottingham NG7 2RD, England.
EM Martyn.Davies@nottingham.ac.uk
RI yang, jing/E-6850-2012; Taylor, Michael/A-3654-2009; Hook,
   Andrew/K-6924-2012; Urquhart, Andrew/B-8194-2014; Alexander,
   Morgan/C-2506-2009; yang, jing/L-6313-2015
OI Hook, Andrew/0000-0001-7756-8444; Urquhart, Andrew/0000-0002-5322-0002;
   Alexander, Morgan/0000-0001-5182-493X; yang, jing/0000-0002-8822-7124;
   Davies, Martyn/0000-0001-7695-0596
FU Engineering and Physical Sciences Research Council [EP/E036244/1]
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Barbulovic-Nad I, 2006, CRIT REV BIOTECHNOL, V26, P237, DOI 10.1080/07388550600978358
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   Dufva M, 2005, BIOMOL ENG, V22, P173, DOI 10.1016/j.bioeng.2005.09.003
   Gao XL, 2003, PROTEOMICS, V3, P2135, DOI 10.1002/pmic.200300597
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Hook AL, 2009, ACTA BIOMATER, V5, P2350, DOI 10.1016/j.actbio.2009.03.040
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kurkuri MD, 2009, BIOMACROMOLECULES, V10, P1163, DOI 10.1021/bm801417s
   Lausted C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r58
   Lee BH, 2004, BIOTECHNOL BIOPROC E, V9, P69, DOI 10.1007/BF02932987
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Pardo L, 2003, LANGMUIR, V19, P1462, DOI 10.1021/la026171u
   Tare RS, 2009, BIOMATERIALS, V30, P1045, DOI 10.1016/j.biomaterials.2008.10.038
   Taylor M, 2008, MACROMOL RAPID COMM, V29, P1298, DOI 10.1002/marc.200800171
   Taylor M, 2007, LANGMUIR, V23, P6875, DOI 10.1021/la070100j
   Tekin E, 2004, J MATER CHEM, V14, P2627, DOI 10.1039/b407478e
   Tourniaire G, 2006, CHEM COMMUN, P2118, DOI 10.1039/b602009g
   Urquhart AJ, 2008, ANAL CHEM, V80, P135, DOI 10.1021/ac071560k
   Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949
   Webster DC, 2008, MACROMOL CHEM PHYS, V209, P237, DOI 10.1002/macp.200700558
   Zhang R, 2008, CHEM COMMUN, P1317, DOI 10.1039/b717932d
NR 26
TC 24
Z9 24
U1 1
U2 56
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1061-186X
J9 J DRUG TARGET
JI J. Drug Target.
PD DEC
PY 2010
VL 18
IS 10
SI SI
BP 741
EP 751
DI 10.3109/1061186X.2010.521941
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 675VQ
UT WOS:000283868600005
PM 20945971
DA 2018-10-19
ER

PT J
AU Moore, AM
   Wood, MD
   Chenard, K
   Hunter, DA
   Mackinnon, SE
   Sakiyama-Elbert, SE
   Borschel, GH
AF Moore, Amy M.
   Wood, Matthew D.
   Chenard, Kristopher
   Hunter, Daniel A.
   Mackinnon, Susan E.
   Sakiyama-Elbert, Shelly E.
   Borschel, Gregory H.
TI Controlled Delivery of Glial Cell Line-Derived Neurotrophic Factor
   Enhances Motor Nerve Regeneration
SO JOURNAL OF HAND SURGERY-AMERICAN VOLUME
LA English
DT Article
DE Biomaterial; drug delivery; fibrin; peripheral nerve injury; tissue
   engineering
ID PERIPHERAL-NERVE; FIBRIN MATRICES; PLASMINOGEN-ACTIVATOR; FUNCTIONAL
   RECOVERY; CONTROLLED-RELEASE; NEURITE EXTENSION; REPAIR; CONDUITS;
   NEURONS; GROWTH
AB Purpose To determine the effect of a motor-specific neurotrophic factor, glial-derived neurotrophic factor (GDNF) on motor nerve regeneration
   Methods We used a nerve conduit filled with a fibrin-based delivery system that provided controlled release of GDNF during nerve regeneration The motor branch of the rat femoral nerve was used to assess motor nerve regeneration across a 5-mm gap Four experimental groups (n=4 to n=8) were evaluated These included GDNF with the fibrin-based delivery system (GDNF-DS), fibrin alone, empty conduit (negative control), and nerve isograft (positive control) Nerves were harvested at 5 weeks for analysis by histomorphometry and electron microscopy
   Results At 5 mm distal to the conduit or isografts, the GDNF-DS group was not significantly different from the nerve isograft group in the following histomorphometric measures total nerve fibers, percentage of neural tissue, and nerve density Both the GDNF-DS and isograft groups had significantly more fibers and a higher percentage of neural tissue than fibrin alone and empty conduit groups There were no differences in fiber width among all groups By electron microscopy, the GDNF-DS and isograft groups also demonstrated more organized nerve architecture than the fibrin alone and empty conduit groups
   Conclusions The delivery of GDNF from the fibrin-based delivery system promotes motor nerve regeneration at a level similar to an isograft in the femoral motor nerve model This study gives insight into the potential beneficial role of GDNF in the treatment of motor nerve injuries (J Hand Surg 2010,35A 2008-2017 (C) 2010 Published by Elsevier Inc on behalf of the American Society for Surgery of the Hand)
C1 [Borschel, Gregory H.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada.
   Univ Toronto, Toronto, ON M5G 1X8, Canada.
   Washington Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA.
   Washington Univ, Dept Biomed Engn, St Louis, MO USA.
   Washington Univ, Ctr Mat Innovat, St Louis, MO USA.
RP Borschel, GH (reprint author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851; Borschel,
   Gregory/0000-0001-7691-5264; Wood, Matthew/0000-0001-8132-6827
FU American Association of Plastic Surgery; American Foundation for Surgery
   of the Hand; American Society for Peripheral Nerve
FX Funding was provided by the American Association of Plastic Surgery the
   American Foundation for Surgery of the Hand and the American Society for
   Peripheral Nerve SES E may receive income based on a license for related
   technology by the University of Zurich/ETH Zurich to Kuros Therapeutics
   Kuros Therapeutics did not support this research
CR Barras FM, 2002, J NEUROSCI RES, V70, P746, DOI 10.1002/jnr.10434
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277
   BRUSHART TME, 1988, J NEUROSCI, V8, P1026
   BUYLLA AA, 1985, P NATL ACAD SCI USA, V82, P3519
   CROSS RT, 1994, PROTEIN SCI, V3, P620
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664
   Herbert CB, 1996, J COMP NEUROL, V365, P380, DOI 10.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-0
   Hoke A, 2000, NEUROREPORT, V11, P1651
   Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262
   Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018
   KALDERON N, 1984, P NATL ACAD SCI-BIOL, V81, P7216, DOI 10.1073/pnas.81.22.7216
   Kobayashi J, 1997, MUSCLE NERVE, V20, P858, DOI 10.1002/(SICI)1097-4598(199707)20:7<858::AID-MUS10>3.0.CO;2-O
   KRYSTOSEK A, 1984, J CELL BIOL, V98, P773, DOI 10.1083/jcb.98.2.773
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lloyd BM, 2007, MICROSURG, V27, P138, DOI 10.1002/micr.20318
   Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x
   MACKINNON S E, 1990, Journal of Reconstructive Microsurgery, V6, P117, DOI 10.1055/s-2007-1006810
   MACKINNON SE, 1989, CLIN PLAST SURG, V16, P587
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   MILLESI H, 1985, Journal of Reconstructive Microsurgery, V2, P21, DOI 10.1055/s-2007-1007042
   OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0
   Oppenheim RW, 2000, J NEUROSCI, V20, P5001
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Piquilloud G, 2007, EUR J NEUROSCI, V26, P1109, DOI 10.1111/j.1460-9568.2007.05748.x
   PITTMAN RN, 1989, DEV NEUROSCI-BASEL, V11, P361, DOI 10.1159/000111912
   Robinson GA, 2005, EXP NEUROL, V192, P39, DOI 10.1016/j.expneurol.2004.10.013
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SUEMATSU N, 1989, MICROSURG, V10, P71, DOI 10.1002/micr.1920100112
   Taras John S, 2005, J Hand Ther, V18, P191, DOI 10.1197/j.jht.2005.02.012
   Walsh S, 2009, NEUROSURGERY, V65, pA80, DOI 10.1227/01.NEU.0000335651.93926.2F
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wood MD, 2009, J BIOMED MATER RES A, V89A, P909, DOI 10.1002/jbm.a.32043
   YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0
NR 42
TC 33
Z9 33
U1 0
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0363-5023
J9 J HAND SURG-AM
JI J. Hand Surg.-Am. Vol.
PD DEC
PY 2010
VL 35A
IS 12
BP 2008
EP 2017
DI 10.1016/j.jhsa.2010.08.016
PG 10
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 695LJ
UT WOS:000285371300015
PM 21035963
DA 2018-10-19
ER

PT J
AU Tungtasana, H
   Shuangshoti, S
   Shuangshoti, S
   Kanokpanont, S
   Kaplan, DL
   Bunaprasert, T
   Damrongsakkul, S
AF Tungtasana, Hathairat
   Shuangshoti, Somruetai
   Shuangshoti, Shanop
   Kanokpanont, Sorada
   Kaplan, David L.
   Bunaprasert, Tanom
   Damrongsakkul, Siriporn
TI Tissue response and biodegradation of composite scaffolds prepared from
   Thai silk fibroin, gelatin and hydroxyapatite
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CROSS-LINKED COLLAGEN; IN-VIVO; BIOMATERIAL; DEGRADATION; VITRO
AB This work aimed to investigate tissue responses and biodegradation, both in vitro and in vivo, of four types of Bombyx mori Thai silk fibroin based-scaffolds. Thai silk fibroin (SF), conjugated gelatin/Thai silk fibroin (CGSF), hydroxyapatite/Thai silk fibroin (SF4), and hydroxyapatite/conjugated gelatin/Thai silk fibroin (CGSF4) scaffolds were fabricated using salt-porogen leaching, dehydrothermal/chemical crosslinking and an alternate soaking technique for mineralization. In vitro biodegradation in collagenase showed that CGSF scaffolds had the slowest biodegradability, due to the double crosslinking by dehydrothermal and chemical treatments. The hydroxyapatite deposited from alternate soaking separated from the surface of the protein scaffolds when immersed in collagenase. From in vivo biodegradation studies, all scaffolds could still be observed after 12 weeks of implantation in subcutaneous tissue of Wistar rats and also following ISO10993-6: Biological evaluation of medical devices. At 2 and 4 weeks of implantation the four types of Thai silk fibroin based-scaffolds were classified as "non-irritant" to "slight-irritant", compared to Gelfoam(A (R)) (control samples). These natural Thai silk fibroin-based scaffolds may provide suitable biomaterials for clinical applications.
C1 [Tungtasana, Hathairat; Damrongsakkul, Siriporn] Chulalongkorn Univ, Grad Sch, Biomed Program, Bangkok 10330, Thailand.
   [Shuangshoti, Somruetai] Minist Publ Hlth, Inst Pathol, Dept Med Serv, Bangkok 10400, Thailand.
   [Shuangshoti, Somruetai] Chulalongkorn Univ, Fac Med, Dept Pathol, Bangkok 10330, Thailand.
   [Shuangshoti, Somruetai] Chulalongkorn Univ, Fac Med, Chulalongkorn GenePRO Ctr, Bangkok 10330, Thailand.
   [Kanokpanont, Sorada; Damrongsakkul, Siriporn] Chulalongkorn Univ, Fac Engn, Dept Chem Engn, Bangkok 10330, Thailand.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Bunaprasert, Tanom] Chulalongkorn Univ, Fac Med, Dept Otolaryngol, Bangkok 10330, Thailand.
RP Damrongsakkul, S (reprint author), Chulalongkorn Univ, Grad Sch, Biomed Program, Phayathai Rd, Bangkok 10330, Thailand.
EM siriporn.d@chula.ac.th
FU Chulalongkorn University; National Research Council of Thailand
FX The financial supports from the 90th Anniversary of Chulalongkorn
   University Fund (Ratchadaphiseksomphot Endowment Fund), Chulalongkorn
   University Centenary Academic Development Project and National Research
   Council of Thailand are highly acknowledged. H. T. also thanks Polymer
   Engineering Laboratory, Biomedical Engineering Laboratory (Faculty of
   Engineering), and i-Tissue Laboratory (Faculty of Medicine),
   Chulalongkorn University for the support of laboratory facilities.
CR [Anonymous], ISO109936
   BARBANI N, 1994, J MATER SCI-MATER M, V5, P882, DOI 10.1007/BF01172030
   Chamchongkaset J, 2008, ADV MATER RES-SWITZ, V55-57, P685, DOI 10.4028/www.scientific.net/AMR.55-57.685
   Du CL, 2009, MAT SCI ENG C-BIO S, V29, P62, DOI 10.1016/j.msec.2008.05.010
   DYKSTRA JM, 1993, MANUAL APPL TECHNIQU, P109
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lehle K, 2004, BIOMATERIALS, V25, P5457, DOI 10.1016/j.biomaterials.2003.12.055
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Ozeki M, 2005, J BIOMAT SCI-POLYM E, V16, P549, DOI 10.1163/1568562053783731
   Pek YS, 2004, BIOMATERIALS, V25, P473, DOI 10.1016/S0142-9612(03)00541-6
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   TAGCHI T, 1998, CHEM LETT, P711
   Vachiraroj N, 2009, INT J BIOL MACROMOL, V45, P470, DOI 10.1016/j.ijbiomac.2009.07.010
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2002, J NANOPART RES, V4, P535, DOI 10.1023/A:1022841507932
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Zhuang H, 2007, J MATER SCI-MATER M, V18, P951, DOI 10.1007/s10856-006-0093-y
NR 23
TC 12
Z9 13
U1 1
U2 28
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2010
VL 21
IS 12
BP 3151
EP 3162
DI 10.1007/s10856-010-4159-5
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 685BW
UT WOS:000284600400011
PM 20976530
DA 2018-10-19
ER

PT J
AU Huan, ZG
   Zhou, J
   Duszczyk, J
AF Huan, Zhiguang
   Zhou, Jie
   Duszczyk, Jurek
TI Magnesium-based composites with improved in vitro surface
   biocompatibility
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE FORMATION; PURE MAGNESIUM; HYDROXYAPATITE;
   BIOACTIVITY; DEGRADATION; ALLOYS; GLASS; BIOMATERIALS; BEHAVIOR
AB In this study, bioactive glass (BG, 45S5) particles were added to a biodegradable magnesium alloy (ZK30) through a semi-solid high-pressure casting process in order to improve the surface biocompatibility of the biomaterial and potentially its bioactivity. The observation of the as-cast microstructures of ZK30-BG composites indicated homogeneous dispersion of BG particles in the matrix. SEM, EDX and EPMA showed the retention of the morphological characteristics and composition of BG particles in the as-cast composite materials. In vitro tests in a cell culture medium confirmed that the composites indeed possessed an enhanced ability to induce the deposition of a bone-like apatite layer on the surface, indicating an improved surface biocompatibility as compared with the matrix alloy.
C1 [Huan, Zhiguang; Zhou, Jie; Duszczyk, Jurek] Delft Univ Technol, Dept Mat Sci & Engn, NL-2628 CD Delft, Netherlands.
RP Zhou, J (reprint author), Delft Univ Technol, Dept Mat Sci & Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
EM j.zhou@tudelft.nl
RI Zhou, Jie/J-3019-2012
OI Zhou, Jie/0000-0002-6484-9156
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Cortes DA, 2007, MATER SCI FORUM, V539-543, P589, DOI 10.4028/www.scientific.net/MSF.539-543.589
   Gray-Munro JE, 2009, J BIOMED MATER RES A, V91A, P221, DOI 10.1002/jbm.a.32205
   Hashmi J, 1999, J MATER PROCESS TECH, V92-93, P1, DOI DOI 10.1016/S0924-0136(99)00118-1
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   PENG M, 2010, BIOMATERIALS, V31, P398
   Santos JD, 1996, J MATER SCI-MATER M, V7, P181, DOI 10.1007/BF00121258
   So K, 2006, BIOMATERIALS, V27, P4738, DOI 10.1016/j.biomaterials.2006.05.020
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Ye XY, 2010, J MATER SCI-MATER M, V21, P1321, DOI 10.1007/s10856-009-3954-3
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   ZHANG E, 2006, P 2006 BEIJ INT MAT, P317
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 21
TC 10
Z9 10
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2010
VL 21
IS 12
BP 3163
EP 3169
DI 10.1007/s10856-010-4165-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 685BW
UT WOS:000284600400012
PM 20922559
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Wu, HJ
   Fan, JT
   Chu, CC
   Wu, J
AF Wu, Huijun
   Fan, Jintu
   Chu, Chih-Chang
   Wu, Jun
TI Electrospinning of small diameter 3-D nanofibrous tubular scaffolds with
   controllable nanofiber orientations for vascular grafts
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TISSUE-ENGINEERING SCAFFOLDS; BIOMIMETIC EXTRACELLULAR-MATRIX; IN-VITRO;
   ALIGNMENT; FABRICATION; POLYTETRAFLUOROETHYLENE; PROLIFERATION;
   DEGRADATION; ANISOTROPY; COLLAGEN
AB The control of nanofiber orientation in nanofibrous tubular scaffolds can benefit the cell responses along specific directions. For small diameter tubular scaffolds, however, it becomes difficult to engineer nanofiber orientation. This paper reports a novel electrospinning technique for the fabrication of 3-D nanofibrous tubular scaffolds with controllable nanofiber orientations. Synthetic absorbable poly-epsilon-caprolactone (PCL) was used as the model biomaterial to demonstrate this new electrospinning technique. Electrospun 3-D PCL nanofibrous tubular scaffolds of 4.5 mm in diameter with different nanofiber orientations (viz. circumferential, axial, and combinations of circumferential and axial directions) were successfully fabricated. The degree of nanofiber alignment in the electrospun 3-D tubular scaffolds was quantified by using the fast Fourier transform (FFT) analysis. The results indicated that excellent circumferential nanofiber alignment could be achieved in the 3-D nanofibrous PCL tubular scaffolds. The nanofibrous tubular scaffolds with oriented nanofibers had not only directional mechanical property but also could facilitate the orientation of the endothelial cell attachment on the fibers. Multiple layers of aligned nanofibers in different orientations can produce 3-D nanofibrous tubular scaffolds of different macroscopic properties.
C1 [Wu, Huijun; Fan, Jintu] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
   [Chu, Chih-Chang] Cornell Univ, Dept Fiber Sci & Apparel Design, Ithaca, NY 14853 USA.
   [Wu, Jun] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
RP Fan, JT (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcfanjt@inet.polyu.edu.hk
RI Wu, Huijun/E-9755-2012
OI Fan, Jintu/0000-0002-7130-0081
FU Hong Kong Polytechnic University [1-BB82]; Cornell University
FX Professor JT Fan and Dr HJ Wu would like to acknowledge the funding
   support of the Hong Kong Polytechnic University in the form of a Niche
   Area Project (1-BB82). This project is also partially supported by the
   Morgan seed grant program of Cornell University awarded to Professor CC
   Chu for the tissue engineering of vascular tissues.
CR Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X
   Ashammakhi N, 2006, J NANOSCI NANOTECHNO, V6, P2693, DOI 10.1166/jnn.2006.485
   Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chen F, 2008, J BIOMAT SCI-POLYM E, V19, P677, DOI 10.1163/156856208784089661
   Chen Ming, 2006, Biophysical Reviews and Letters, V1, P153, DOI 10.1142/S1793048006000148
   Dalton PD, 2005, POLYMER, V46, P611, DOI 10.1016/j.polymer.2004.11.075
   Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Hass F., 1985, MICROSURG, V6, P59
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li D, 2005, NANO LETT, V5, P913, DOI 10.1021/nl0504235
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Martins A, 2008, INT MATER REV, V53, P257, DOI 10.1179/174328008X353547
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Wu HJ, 2008, J APPL POLYM SCI, V110, P2525, DOI 10.1002/app.28795
   Wu HJ, 2008, MATER LETT, V62, P828, DOI 10.1016/j.matlet.2007.06.080
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang DM, 2008, NANO LETT, V8, P3283, DOI 10.1021/nl801667s
   Zhang DM, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/42/425216
NR 42
TC 91
Z9 93
U1 2
U2 110
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2010
VL 21
IS 12
BP 3207
EP 3215
DI 10.1007/s10856-010-4164-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 685BW
UT WOS:000284600400016
PM 20890639
DA 2018-10-19
ER

PT J
AU Cynthia, W
   Shital, P
   Rui, C
   Owida, A
   Morsi, Y
AF Cynthia, Wong
   Shital, Patel
   Rui, Chen
   Owida, Amal
   Morsi, Yos
TI BIOMIMETIC ELECTROSPUN GELATIN-CHITOSAN POLYURETHANE FOR HEART VALVE
   LEAFLETS
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Polyurethane; gelatin-chitosan; cell retention; endothelial cells;
   electrospinning
ID IN-VITRO CHARACTERIZATION; ENDOTHELIAL-CELLS; TISSUE; SCAFFOLDS; FLOW;
   NANOFIBERS
AB Native heart valve leaflets are subjected to continuous pulsatile and homodynamic forces and can be as thin as 300 mu m. For a proper function of the valve the materials selected for the leaflets need to be biocompatible, robust, flexible, and have comparable mechanical properties to the natural ones.
   In this paper, biocompatibility and cell retention ability for gelatin-chitosan polyurethane (PU), polyglycolide (PGA)/PLA and collagen-coated bovine pericardium were examined and their mechanical properties were tested. Endothelial cells, isolated from ovine carotid arteries were seeded onto these materials and exposed to a range of shear-stresses for a period of 1-3 h.
   The findings indicated that throughout the exposure time and the shear-stress range tested, a mean cell retention rate of 80% was obtained in the gelatin-chitosan PU group. However, for PGA/PLA and pericardium groups it was found that as the exposure time of shear-stress increased, a significant cell reduction was observed. Noticeably for all the range of physiological flow conditions tested, the electrospun gelatin-chitosan PU demonstrated good biocompatibility and cell retention properties and could be potentially used as a biomaterial for tissue engineering of heart valves.
C1 [Shital, Patel; Rui, Chen; Owida, Amal] Swinburne Univ Technol, FEIS, Biomech & Tissue Engn Grp, Hawthorn, Vic 3122, Australia.
   [Cynthia, Wong] Deakin Univ, Inst Biotechnol, Geelong, Vic 3217, Australia.
   [Morsi, Yos] Swinburne Univ Technol, Hawthorn, Vic 3131, Australia.
RP Shital, P (reprint author), Swinburne Univ Technol, FEIS, Biomech & Tissue Engn Grp, Hawthorn, Vic 3122, Australia.
EM ymorsi@swin.edu.au
FU Australian Research Council (ARC) [DP0343652]
FX This research was conducted while Dr. Wong was working with the
   biomechanics and tissue engineering at Swinburne University of
   Technology. The authors would like to acknowledge the Australian
   Research Council for their financial support (ARC Grant (DP0343652)
   tissue engineering of human heart valve grown in vitro).
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   Bernacca GM, 2002, BIOMATERIALS, V23, P45, DOI 10.1016/S0142-9612(01)00077-1
   BIRCHALL IE, 2004, INT J ARTIF ORGANS, V27, P444
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hayashida K, 2007, J THORAC CARDIOV SUR, V134, P152, DOI 10.1016/j.jtcvs.2007.01.087
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   McKinney VZ, 2006, J BIOMECH, V39, P806, DOI 10.1016/j.jbiomech.2005.02.002
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Morsi YS, 2000, ARTIF ORGANS, V24, P564, DOI 10.1046/j.1525-1594.2000.06505.x
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   Tan HP, 2007, J MATER SCI-MATER M, V18, P1961, DOI 10.1007/s10856-007-3095-5
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Van Lieshout MI, 2006, J BIOMAT SCI-POLYM E, V17, P77, DOI 10.1163/156856206774879153
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Wong Cynthia S, 2006, Heart Lung Circ, V15, P371, DOI 10.1016/j.hlc.2006.08.002
   Yin W, 2005, ARTIF ORGANS, V29, P826, DOI 10.1111/j.1525-1594.2005.29109.x
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 27
TC 5
Z9 6
U1 2
U2 40
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD DEC
PY 2010
VL 10
IS 4
BP 563
EP 576
DI 10.1142/S0219519410003551
PG 14
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 732WW
UT WOS:000288221400002
DA 2018-10-19
ER

PT J
AU Ozbolat, IT
   Koc, B
AF Ozbolat, Ibrahim T.
   Koc, Bahattin
TI Modeling of Spatially Controlled Biomolecules in Three-Dimensional
   Porous Alginate Structures
SO JOURNAL OF MEDICAL DEVICES-TRANSACTIONS OF THE ASME
LA English
DT Article
DE tissue engineered structures; stochastic modeling; computer-aided
   design; multichamber single nozzle freeform dispensing systems
ID IN-VITRO; CALCIUM-ALGINATE; RELEASE FORMULATIONS; FREEFORM FABRICATION;
   WOUND DRESSINGS; GROWTH-FACTOR; DELIVERY; MICROSPHERES; HYDROGELS; DRUG
AB This paper presents a computer-aided design (CAD) of 3D porous tissue scaffolds with spatial control of encapsulated biomolecule distributions. A localized control of encapsulated biomolecule distribution over 3D structures is proposed to control release kinetics spatially for tissue engineering and drug release. Imaging techniques are applied to explore distribution of microspheres over porous structures. Using microspheres in this study represents a framework for modeling the distribution characteristics of encapsulated proteins, growth factors, cells, and drugs. A quantification study is then performed to assure microsphere variation over various structures under imaging analysis. The obtained distribution characteristics are mimicked by the developed stochastic modeling study of microsphere distribution over 3D engineered freeform structures. Based on the stochastic approach, 3D porous structures are modeled and designed in CAD. Modeling of microsphere and encapsulating biomaterial distribution in this work helps develop comprehensive modeling of biomolecule release kinetics for further research. A novel multichamber single nozzle solid freeform fabrication technique is utilized to fabricate sample structures. The presented methods are implemented and illustrative examples are presented in this paper. [DOI: 10.1115/1.4002612]
C1 [Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
   [Ozbolat, Ibrahim T.; Koc, Bahattin] SUNY Buffalo, Dept Ind & Syst Engn, Buffalo, NY 14260 USA.
RP Koc, B (reprint author), Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
EM bahattinkoc@sabanciuniv.edu
RI Koc, Bahattin/D-7277-2012
OI Koc, Bahattin/0000-0001-9073-8516
FU U.S. Army Medical Research [W81XWH-05-1-0401]
FX This work is funded by U.S. Army Medical Research Grant No.
   W81XWH-05-1-0401. The authors would like to thank Dr. Robert Hard from
   the School of Medicine and Biomedical Sciences at University at Buffalo
   for dark field images.
CR Agren MS, 1996, BRIT J PLAST SURG, V49, P129, DOI 10.1016/S0007-1226(96)90088-0
   Aludaat K., 2008, APPL MATH SCI, V2, P425
   ANDERSON J, 2008, TOPICS MULTIFUNCTION
   BLAIR SD, 1990, BRIT J SURG, V77, P568, DOI 10.1002/bjs.1800770534
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Cappai A., 1995, INT J ARTIF ORGANS, V18, P95
   CHANG R, 2008, J COMPUT AIDED DES A, V5, P21
   Chang R, 2008, TISSUE ENG PT C-METH, V14, P157, DOI 10.1089/ten.tec.2007.0392
   CHIMATE C, 2010, THESIS U BUFFALO BUF
   Diaz RV, 1997, J CONTROL RELEASE, V43, P59, DOI 10.1016/S0168-3659(96)01470-8
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   Khalil S., 2005, THESIS DREXEL U PHIL
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   Knill CJ, 2004, CARBOHYD POLYM, V55, P65, DOI 10.1016/j.carbpol.2003.08.004
   Lemoine D, 1998, INT J PHARMACEUT, V176, P9, DOI 10.1016/S0378-5173(98)00303-2
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Minitab Inc, 2010, MINITAB 15
   MUMPER RJ, 1994, J CONTROL RELEASE, V30, P241, DOI 10.1016/0168-3659(94)90030-2
   MURATA Y, 1993, J CONTROL RELEASE, V23, P21, DOI 10.1016/0168-3659(93)90067-F
   Ozbolat I., 2009, IND ENG RES C MIAM F
   Ozbolat I.T., 2010, IND ENG RES C CANC M
   Ozbolat I. T., 2009, J COMPUTER AIDED DES, V6, P661
   Palsson B.O., 2004, TISSUE ENG
   Pan H, 2005, J MATER PROCESS TECH, V168, P230, DOI 10.1016/j.jmatprotec.2004.11.017
   Pasparakis G, 2006, INT J PHARM, V323, P34, DOI 10.1016/j.ijpharm.2006.05.054
   Perkins J., 2009, ASME INT MECH ENG C
   Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153
   *R MCNEEL ASS, 2007, RHINOCEROS 4 0
   Ravi N, 2006, POLYMER, V47, P4203, DOI 10.1016/j.polymer.2006.02.029
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   Six K, 2004, J PHARM SCI-US, V93, P124, DOI 10.1002/jps.10522
   Starly B, 2006, COMPUT AIDED DESIGN, V38, P115, DOI [10.1016/j.cad.2005.08.001, 10.1016/J.CAD.2005.08.001]
   WILLIAMS DF, 1994, INT BIODETER BIODEGR, V34, P95, DOI 10.1016/0964-8305(94)90002-7
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Zhang LJ, 2006, CAN J CHEM ENG, V84, P558
   Zheng Y, 2007, ARTERIOSCL THROM VAS, V27, P503, DOI 10.1161/01.ATV.0000256459.06671.3c
NR 43
TC 16
Z9 16
U1 0
U2 16
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1932-6181
J9 J MED DEVICES
JI J. Med. Devices
PD DEC
PY 2010
VL 4
IS 4
AR 041003
DI 10.1115/1.4002612
PG 11
WC Engineering, Biomedical
SC Engineering
GA 692NZ
UT WOS:000285160800003
DA 2018-10-19
ER

PT J
AU Palacio, M
   Schricker, S
   Bhushan, B
AF Palacio, M.
   Schricker, S.
   Bhushan, B.
TI Morphology and protein adsorption characteristics of block copolymer
   surfaces
SO JOURNAL OF MICROSCOPY
LA English
DT Article
DE Atomic force microscopy; block copolymers; protein adsorption
ID ATOMIC-FORCE MICROSCOPY; LIVING RADICAL POLYMERIZATION; THICK LUBRICANT
   FILMS; BOVINE SERUM-ALBUMIN; CLICK CHEMISTRY; RAFT POLYMERIZATION;
   HIGHLY EFFICIENT; ADHESION; POLYMERS; COMBINATION
AB Biocompatible polymers are known to act as scaffolds for the regeneration and growth of bone. Block copolymers are of interest as scaffold materials because novel, structurally diverse polymers can be synthesized from biocompatible blocks. Block copolymer nanostructure and surface morphology is easily tunable with synthetic techniques and the diverse nanostructures can be used to affect cell and tissue behaviour. In this paper, we present atomic force microscopy studies on the morphology and corresponding protein adsorption behaviour of a novel class of methyl methacrylate and acrylic acid diblock and triblock copolymers. The topography, phase angle and adhesion maps were obtained to study the morphology. Atomic force microscopy imaging reveals that the diblock and triblock copolymers present distinct nanomorphologies, although their chemical composition is the same. This has implications on the role of nanomorphology in cell-polymer interactions independent of chemical composition. Protein adsorption on a biomaterial surface is critical to understanding its biocompatibility and bovine serum albumin was used to model that behaviour on the block copolymer surfaces. An increase in the adhesive force of the surface was observed to correlate with the adsorption of bovine serum albumin on the block copolymer surfaces investigated.
C1 [Palacio, M.; Bhushan, B.] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Coll Dent, Columbus, OH 43210 USA.
   [Schricker, S.] Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
RP Bhushan, B (reprint author), Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Coll Dent, Columbus, OH 43210 USA.
EM Bhushan.2@osu.edu
RI Bhushan, Bharat/A-9684-2013; Schricker, Scott/A-3957-2008; Luong-Van,
   Emma/A-8685-2012
OI Bhushan, Bharat/0000-0001-7161-6601; Schricker,
   Scott/0000-0003-1982-1282; 
CR Bhushan B, 2005, ACTA BIOMATER, V1, P327, DOI 10.1016/j.actbio.2005.01.002
   Bhushan B, 2003, NANOTECHNOLOGY, V14, P886, DOI 10.1088/0957-4484/14/8/309
   Bhushan B., 2007, SPRINGER HDB NANOTEC
   Bhushan B., 2008, NANOTRIBOLOGY NANOME
   Bhushan B, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/22/225010
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1631, DOI 10.1098/rsta.2009.0014
   Bhushan B, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/48/485004
   Burton Z, 2005, NANO LETT, V5, P1607, DOI 10.1021/nl050861b
   Candelon N, 2008, CHEM COMMUN, P741, DOI 10.1039/b716306a
   Cheng CX, 2005, LANGMUIR, V21, P6576, DOI 10.1021/la050187d
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   De P, 2008, BIOMACROMOLECULES, V9, P1064, DOI 10.1021/bm701255v
   Ding HX, 2008, NUCLEOS NUCLEOT NUCL, V27, P368, DOI 10.1080/15257770801944055
   Ess DH, 2008, ORG LETT, V10, P1633, DOI 10.1021/ol8003657
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   Goldmann AS, 2008, POLYMER, V49, P2274, DOI 10.1016/j.polymer.2008.03.017
   Gondi SR, 2007, MACROMOLECULES, V40, P474, DOI 10.1021/ma061959v
   Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u
   Hollinger JO, 2005, BONE TISSUE ENG
   Kamal A, 2008, BIOORG MED CHEM LETT, V18, P1468, DOI 10.1016/j.bmcl.2007.12.063
   Kamigaito M, 2001, CHEM REV, V101, P3689, DOI 10.1021/cr9901182
   Karthaus O, 2000, LANGMUIR, V16, P6071, DOI 10.1021/la0001732
   Katagiri D, 2002, J PHYS CHEM B, V106, P9151, DOI 10.1021/jp025757m
   Koutsopoulos S, 2007, LANGMUIR, V23, P2000, DOI 10.1021/la062238s
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Lai CC, 2008, INT J NANOSCI, V7, P299, DOI 10.1142/S0219581X08005468
   LaTorre C, 2005, ULTRAMICROSCOPY, V105, P155, DOI 10.1016/j.ultramic.2005.06.032
   Lau KHA, 2008, ADV FUNCT MATER, V18, P3148, DOI 10.1002/adfm.200800487
   Li Q, 2008, SYNTHETIC COMMUN, V38, P1470, DOI 10.1080/00397910801914020
   Liu D, 2009, LANGMUIR, V25, P4526, DOI 10.1021/la8038957
   Liu HW, 2004, ULTRAMICROSCOPY, V100, P391, DOI 10.1016/j.ultramic.2003.11.016
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   McClellan SJ, 2003, COLLOID SURFACE B, V28, P63, DOI 10.1016/S0927-7765(02)00131-5
   Meudtner RM, 2008, MACROMOL RAPID COMM, V29, P347, DOI 10.1002/marc.200700817
   Moad G, 2008, POLYMER, V49, P1079, DOI 10.1016/j.polymer.2007.11.020
   Nosonovsky M, 2008, NANOSCI TECHNOL, P3
   O'Reilly RK, 2005, POLYM PREPR AM CHEM, V46, P183
   Pitois O, 1999, COLLOID POLYM SCI, V277, P574, DOI 10.1007/s003960050427
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Ranjan R, 2007, MACROMOL RAPID COMM, V28, P2084, DOI 10.1002/marc.200700428
   Ranjan R, 2007, MACROMOLECULES, V40, P6217, DOI 10.1021/ma0705873
   Ren TB, 2008, J BIOMED MATER RES A, V86A, P209, DOI 10.1002/jbm.a.31508
   Riva R, 2008, POLYMER, V49, P2023, DOI 10.1016/j.polymer.2008.03.008
   ROSE L.F., 2004, PERIODONTICS MED SUR
   Ruardy TG, 1997, J COLLOID INTERF SCI, V188, P209, DOI 10.1006/jcis.1997.4769
   Ruzette AV, 2005, NAT MATER, V4, P19, DOI 10.1038/nmat1295
   Sagawa J, 2005, APPL SURF SCI, V244, P611, DOI 10.1016/j.apsusc.2004.09.162
   Sakai K, 2006, LANGMUIR, V22, P5328, DOI 10.1021/la060662n
   Schricker S, 2010, ULTRAMICROSCOPY, V110, P639, DOI 10.1016/j.ultramic.2010.02.025
   Scott WW, 2003, ULTRAMICROSCOPY, V97, P151, DOI 10.1016/S0304-3991(03)00040-8
   Servoli E, 2008, MACROMOL BIOSCI, V8, P1126, DOI 10.1002/mabi.200800110
   Sperling L.H., 2001, INTRO PHYS POLYM SCI
   VROMAN L, 1962, NATURE, V196, P476, DOI 10.1038/196476a0
   Wang CY, 2008, J MATER CHEM, V18, P683, DOI 10.1039/b715520d
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yang YL, 2010, APPL SURF SCI, V256, P3683, DOI 10.1016/j.apsusc.2010.01.006
   Zhu J, 2007, POLYMER, V48, P6992, DOI 10.1016/j.polymer.2007.10.004
NR 60
TC 14
Z9 14
U1 2
U2 25
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc..
PD DEC
PY 2010
VL 240
IS 3
BP 239
EP 248
DI 10.1111/j.1365-2818.2010.03420.x
PG 10
WC Microscopy
SC Microscopy
GA 681AK
UT WOS:000284278400007
PM 21077884
DA 2018-10-19
ER

PT J
AU Aukkanit, N
   Garnjanagoonchorn, W
AF Aukkanit, Nuntaporn
   Garnjanagoonchorn, Wunwiboon
TI Temperature effects on type I pepsin-solubilised collagen extraction
   from silver-line grunt skin and its in vitro fibril self-assembly
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE type I collagen; extraction; temperature; fibril self-assembly
ID ACID-SOLUBLE COLLAGEN; CLEAVAGE; FISH
AB BACKGROUND: Fish skin is a potential source of collagen. Increasing the extraction temperature increases the yield of collagen. However, it may also result in degradation of the peptide chains, thus damaging the 3D structure of collagen that is vital for its application as a biomaterial. This work investigated the effects of extraction temperature on the yield and characteristics, including fibril self-assembly, of type I pepsin-solubilised fish skin collagen.
   RESULTS: Pepsin-solubilised collagens were extracted from fresh skin of silver-line grunt at 4, 10, 20 and 8 degrees C for 6 h. Extraction at 10 degrees C gave the highest yield of collagens (439.32 +/- 96.43 mg g(-1) fresh skin, dry basis), which were identified as type I and comprised beta, alpha 1 and alpha 2 subunits. Extraction at higher temperatures (20 and 28 degrees C) resulted in the formation of low-molecular-weight peptide fragments, thus reducing the yield of the resultant type I collagen. The denaturation temperatures of collagens extracted at 4 and 10 degrees C, as determined by thermal analysis using differential scanning calorimetry, were 39.5 and 37.5 degrees C respectively. In vitro fibril self-assembly of 1 mg mL(-1) collagen solution (pH 6) incubated at 25 degrees C was only observed with collagens extracted at 4 and 10 degrees C. The 10 degrees C collagen not only showed a higher rate of self-assembly, but its matrix also had a larger fibril diameter of 0.50 +/- 0.07 mu m (compared with 0.41 +/- 0.07 mu m for the 4 degrees C collagen) after 4 h of incubation.
   CONCLUSION: The results indicated strong effects of extraction temperature on the yield and characteristics of the collagen obtained. Extraction of pepsin-solubilised collagen from silver-line grunt skin at 4-10 degrees C gave a high yield of type I collagen with molecular integrity suitable for tissue-engineering applications. (C) 2010 Society of Chemical Industry
C1 [Aukkanit, Nuntaporn; Garnjanagoonchorn, Wunwiboon] Kasetsart Univ, Dept Food Sci & Technol, Fac Agroind, Bangkok 10900, Thailand.
RP Garnjanagoonchorn, W (reprint author), Kasetsart Univ, Dept Food Sci & Technol, Fac Agroind, Bangkok 10900, Thailand.
EM fagiwwg@ku.ac.th
FU Graduate School, Kasetsart University
FX The authors thank The Graduate School, Kasetsart University for
   financial support and Union Frozen Product Co., Ltd, Samutsakorn,
   Thailand for the generous supply of fish skins.
CR BAILEY AJ, 1989, CONNECTIVE TISSUE ME, P33
   ENGEL J, 1994, EXTRACELLULAR MATRIX, P1
   Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49
   IKADA Y, 2001, INTEGRATED BIOMATERI, P1
   KIMURA S, 1988, J FOOD SCI, V53, P1315, DOI 10.1111/j.1365-2621.1988.tb09266.x
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   Komsa-Penkova R, 1999, BIOPHYS CHEM, V83, P185
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CS, 2001, ABSTR PAP AM CHEM S, V221, pU399
   LINYKANDLIU DC, 2006, FOOD CHEM, V94, P621
   MIYAHARA M, 1982, J BIOL CHEM, V257, P8442
   Noitup P., 2005, Journal of Aquatic Food Product Technology, V14, P17, DOI 10.1300/J030v14n01_03
   Noitup P, 2006, J FOOD BIOCHEM, V30, P547, DOI 10.1111/j.1745-4514.2006.00081.x
   PURSLOW PP, 1987, ADV MEAT RES, P187
   Rochdi A, 2000, FOOD CHEM, V69, P295, DOI 10.1016/S0308-8146(99)00267-8
   SATO K, 1989, COMP BIOCHEM PHYS B, V92, P87, DOI 10.1016/0305-0491(89)90317-9
   Senaratne LS, 2006, BIORESOURCE TECHNOL, V97, P191, DOI 10.1016/j.biortech.2005.02.024
   Veis A., 1994, EXTRACELLULAR MATRIX, P15
   Wong D.W.S., 1989, MECH THEORY FOOD CHE, P48
   Wong Liong J. W., 1997, Journal of Food Protection, V60, P1022
   Zhang JJ, 2009, FOOD CHEM, V116, P318, DOI 10.1016/j.foodchem.2009.02.053
NR 21
TC 15
Z9 17
U1 4
U2 23
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-5142
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD DEC
PY 2010
VL 90
IS 15
BP 2627
EP 2632
DI 10.1002/jsfa.4131
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 680KX
UT WOS:000284231900013
PM 20718032
DA 2018-10-19
ER

PT J
AU Kwon, H
   Kim, HJ
   Rice, WL
   Subramanian, B
   Park, SH
   Georgakoudi, I
   Kaplan, DL
AF Kwon, Heenam
   Kim, Hyeon Joo
   Rice, William L.
   Subramanian, Balajikarthick
   Park, Sang-Hyug
   Georgakoudi, Irene
   Kaplan, David L.
TI Development of an in vitro model to study the impact of BMP-2 on
   metastasis to bone
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE prostate; cancer; metastasis; BMP-2; silk; PC3
ID PROSTATE-CANCER METASTASIS; SILK-BASED BIOMATERIALS; MARROW STROMAL
   CELLS; MORPHOGENETIC PROTEIN-2; BREAST-CANCER; 3-D SCAFFOLDS;
   STEM-CELLS; EXPRESSION; GROWTH; TUMOR
AB Prostate cancer cases and deaths have increased for years, yet the mechanisms involved in prostate cancer metastasis to bone remain poorly understood. To address this need, an effective and relevant in vitro model for the study of prostate cancer bone metastases would be useful. Therefore, a 3D in vitro tissue system was established using prostate cancer cells (PC3), suitable culture conditions and a 3D silk scaffold biomaterial to provide mechanically robust and slow degrading matrices to support the tissues for extended time frames. The role of BMP-2 on the progression of prostate cancer was investigated using this 3D tissue system. The results suggest that BMP-2 stimulates the migration of PC3 cells, suggesting insight into mechanisms involved in this critical step in the disease. The data support the conclusion that this in vitro system mimics aspects of prostate cancer metastasis in the presence of BMP-2, thus the system can be utilized as a starting point as an in vitro model for further studies of prostate cancer development and metastasis, as well as in the screening of new therapeutic treatments. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Kwon, Heenam; Kim, Hyeon Joo; Rice, William L.; Subramanian, Balajikarthick; Park, Sang-Hyug; Georgakoudi, Irene; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH Tissue Engineering Resource Center [P41 EB002520]
FX We thank the NIH Tissue Engineering Resource Center (Grant No. P41
   EB002520) for support of these studies.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678
   Bobinac D, 2005, CROAT MED J, V46, P389
   BONKHOFF H, 1995, HUM PATHOL, V26, P824, DOI 10.1016/0046-8177(95)90002-0
   Brubaker KD, 2004, J CELL BIOCHEM, V91, P151, DOI 10.1002/jcb.10679
   Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421
   Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015
   Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802
   Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245
   Hall CL, 2006, CANCER METAST REV, V25, P551, DOI 10.1007/s10555-006-9022-2
   Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735
   Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317
   Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5
   Ide H, 1997, CANCER RES, V57, P5022
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim Jong Bin, 2004, Breast Cancer Research and Treatment, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Koeneman KS, 1999, PROSTATE, V39, P246
   Li ZG, 2008, ONCOGENE, V27, P596, DOI 10.1038/sj.onc.210694
   Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528
   Madigan MC, 2008, CANCER IMMUNOL IMMUN, V57, P1367, DOI 10.1007/s00262-008-0473-x
   Mastro AM, 2009, CANCER RES, V69, P4097, DOI 10.1158/0008-5472.CAN-08-4437
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Mori K, 2007, BONE, V40, P981, DOI 10.1016/j.bone.2006.11.006
   Moro L, 2008, CANCER SCI, V99, P553, DOI 10.1111/j.1349-7006.2007.00719.x
   Morrissey C, 2007, J CELL BIOCHEM, V101, P873, DOI 10.1002/jcb.21214
   Nabha SM, 2008, INT J CANCER, V122, P2482, DOI 10.1002/ijc.23431
   Nemeth JA, 1999, CANCER RES, V59, P1987
   Nemeth JA, 2002, J NATL CANCER I, V94, P17
   Sato S, 2008, CANCER SCI, V99, P316, DOI 10.1111/j.1349-7006.2007.00690.x
   Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276
   Singh AS, 2006, ONCOL REP, V15, P519
   Singh AS, 2005, J UROLOGY, V174, P820, DOI 10.1097/01.ju.0000169133.82167.aa
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yoneda T, 2005, BIOCHEM BIOPH RES CO, V328, P679, DOI 10.1016/j.bbrc.2004.11.070
   Yonou H, 2001, CANCER RES, V61, P2177
   Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685
   Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704
NR 47
TC 27
Z9 27
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD DEC
PY 2010
VL 4
IS 8
BP 590
EP 599
DI 10.1002/term.268
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 694BV
UT WOS:000285270900002
PM 20865693
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Webber, MJ
   Han, XQ
   Murthy, SNP
   Rajangam, K
   Stupp, SI
   Lomasney, JW
AF Webber, Matthew J.
   Han, Xiaoqiang
   Murthy, S. N. Prasanna
   Rajangam, Kanya
   Stupp, Samuel I.
   Lomasney, Jon W.
TI Capturing the stem cell paracrine effect using heparin-presenting
   nanofibres to treat cardiovascular diseases
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE regenerative medicine; myocardial infarction; paracrine effect;
   biomaterials; bionanotechnology; stem cells; peptide amphiphiles
ID PEPTIDE-AMPHIPHILE NANOFIBERS; IMPROVES CARDIAC-FUNCTION; MARROW-DERIVED
   CELLS; MYOCARDIAL-INFARCTION; ISCHEMIC-HEART; DILATED CARDIOMYOPATHY;
   FAILING HEART; RAT MODEL; IN-VIVO; TRANSPLANTATION
AB The mechanism for stem cell-mediated improvement following acute myocardial infarction has been actively debated. We support hypotheses that the stem cell effect is primarily paracrine factor-linked. We used a heparin-presenting injectable nanofibre network to bind and deliver paracrine factors derived from hypoxic conditioned stem cell media to mimic this stem cell paracrine effect. Our self-assembling peptide nanofibres presenting heparin were capable of binding paracrine factors from a medium phase. When these factor-loaded materials were injected into the heart following coronary artery ligation in a mouse ischaemia-reperfusion model of acute myocardial infarction, we found significant preservation of haemodynamic function. Through media manipulation, we were able to determine that crucial factors are primarily <30 kDa and primarily heparin-binding. Using recombinant VEGF- and bEGF-loaded nanofibre networks, the effect observed with conditioned media was recapitulated. When evaluated in another disease model, a chronic rat ischaemic hind limb, our factor-loaded materials contributed to extensive limb revascularization. These experiments demonstrate the potency of the paracrine effect associated with stem cell therapies and the potential of a biomaterial to bind and deliver these factors, pointing to a potential therapy based on synthetic materials and recombinant factors as an acellular therapy. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Han, Xiaoqiang; Murthy, S. N. Prasanna; Stupp, Samuel I.; Lomasney, Jon W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Han, Xiaoqiang; Murthy, S. N. Prasanna; Lomasney, Jon W.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.
   [Webber, Matthew J.; Rajangam, Kanya] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL USA.
RP Lomasney, JW (reprint author), Northwestern Univ, Feinberg Sch Med, Ward 3-210,303 E Chicago Ave, Chicago, IL 60611 USA.
EM j-lomasney@northwestern.edu
RI Stupp, Samuel/B-6737-2009; Webber, Matthew/D-4847-2011
OI Webber, Matthew/0000-0003-3111-6228
FU US Army Telemedicine and Advanced Technology Research Center (TATRC)
   [W81XWH-05-1-0381]; Northwestern University; NIH [5T90-DA022881]
FX The authors gratefully acknowledge funding support from the US Army
   Telemedicine and Advanced Technology Research Center (TATRC; Grant No.
   W81XWH-05-1-0381), awarded to S.I.S. Additionally, J.W.L. and S.I.S.
   acknowledge assistance provided through the Northwestern University
   Senyei Translational Research Award. M.J.W. is supported by the
   Northwestern Regenerative Medicine Training Program (RMTP), NIH Award
   No. 5T90-DA022881. We thank Mark Seniw for his assistance with molecular
   graphics. Antibodies for Western blotting were provided by Dr Susan
   Crawford of the Department of Pathology, Northwestern University.
   Mesenchymal stem cells were provided by Dr Christoff Westenfelder,
   University of Utah.
CR Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen SF, 2004, CHINESE MED J-PEKING, V117, P1443
   Dilsizian V, 2005, CIRCULATION, V112, P2169, DOI 10.1061/CIRCULATIONHA.104.530428
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Field LJ, 2006, MOL THER, V14, P755, DOI 10.1016/j.ymthe.2006.10.001
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gong GR, 2003, AM J PHYSIOL-HEART C, V285, pH541, DOI 10.1152/ajpheart.01142.2002
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Herr AB, 1997, J BIOL CHEM, V272, P16382, DOI 10.1074/jbc.272.26.16382
   Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Jaquet K, 2005, STEM CELLS DEV, V14, P299, DOI 10.1089/scd.2005.14.299
   Jiang ZS, 2004, CARDIOVASC RES, V62, P154, DOI 10.1016/j.cardiores.2004.01.009
   KLAGSBRUN M, 1992, CANC BIOL, V3, P81
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800
   Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546
   Mazhari Ramesh, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS21, DOI 10.1038/ncpcardio0770
   Murakami Y, 1999, CIRCULATION, V99, P942, DOI 10.1161/01.CIR.99.7.942
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD
   Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721
   Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040
   Orlic D, 2001, ANN NY ACAD SCI, V938, P221
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104
   Scherschel JA, 2008, MOL THER, V16, P1129, DOI 10.1038/mt.2008.64
   Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   Sussman MA, 2008, J MOL CELL CARDIOL, V44, P950, DOI 10.1016/j.yjmcc.2008.03.007
   Taegtmeyer H, 2004, CIRCULATION, V110, P894, DOI 10.1161/01.CIR.0000139340.88769.D5
   Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072
   Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005
   Togel F, 2008, AM J PHYSIOL-RENAL, V295, pF315, DOI 10.1152/ajprenal.00098.2008
   Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005
   Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Wang XJ, 2007, BIOCHEM BIOPH RES CO, V359, P189, DOI 10.1016/j.bbrc.2007.05.112
   Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JC1200522326
   Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com
NR 53
TC 58
Z9 58
U1 3
U2 14
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD DEC
PY 2010
VL 4
IS 8
BP 600
EP 610
DI 10.1002/term.273
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 694BV
UT WOS:000285270900003
PM 20222010
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Ferraz, N
   Ott, MK
   Hong, J
AF Ferraz, Natalia
   Ott, Marjam Karlsson
   Hong, Jaan
TI Time Sequence of Blood Activation by Nanoporous Alumina: Studies on
   Platelets and Complement System
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE nanotopography; biomaterial; whole blood; thrombospondin-1; platelet
   microparticles
ID VON-WILLEBRAND-FACTOR; ADSORBED PLASMA-PROTEINS; NANO-POROUS ALUMINA;
   WHOLE-BLOOD; IN-VITRO; SURFACES; ADHESION; COAGULATION; ADSORPTION;
   CHEMISTRY
AB In the present work, the time sequence of blood activation by alumina membranes with different porosities (20 and 200 nm in diameter) was studied. The membranes were incubated with whole blood from 2 min to 4 h. Platelet adhesion and activation in addition to complement activation was monitored at different time points. Evaluation of platelet adhesion and activation was done by determining the change in platelet number and the levels of thrombospondin-1 (TSP-1) in the fluid phase. Scanning electron microscopy studies were done to further evaluate platelet adhesion and morphology. Immunocytochemical staining was used to evaluate the presence of CD41 and CD62P antigens on the material surface. Complement activation was monitored by measuring C3a and sC5b-9 in plasma samples by means of enzyme immunoassays. Both alumina membranes displayed similar complement activation time profiles, with levels of C3a and sC5b-9 increasing with incubation time. A statistically significant difference between the membranes was found after 60 min of incubation. Platelet activation characteristics and time profile were different between the two membranes. Platelet adhesion increased over time for the 20 nm surface, while the clusters of microparticles on the 200 nm surface did not appreciably change during the course of the experiment. The release of TSP-1 increased with time for both membranes; however, much later for the 200 nm alumina (240 min) as compared to the 20 nm membrane (60 min). The surface topography of the alumina most probably influence protein transition rate, which in turn affects material platelet activation kinetics. Microsc. Res. Tech. 73:1101-1109, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Ferraz, Natalia; Ott, Marjam Karlsson] Uppsala Univ, Div Surface Biotechnol, Dept Phys & Analyt Chem, BMC, SE-75123 Uppsala, Sweden.
   [Hong, Jaan] Uppsala Univ, Univ Hosp, Rudbeck Lab, Dept Oncol Radiol & Clin Immunol,Div Clin Immunol, Uppsala, Sweden.
RP Ferraz, N (reprint author), Uppsala Univ, Div Surface Biotechnol, Dept Phys & Analyt Chem, BMC, Box 577, SE-75123 Uppsala, Sweden.
EM natalia.ferraz@ytbioteknik.uu.se
CR Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   ANDERSSON J, 2003, THESIS UPPSALA U UPP
   Attaluri AC, 2009, ASAIO J, V55, P217, DOI 10.1097/MAT.0b013e3181949924
   Bergseth G, 2000, THROMB RES, V99, P41, DOI 10.1016/S0049-3848(00)00226-7
   BOUCHARD BA, 2002, PLATELETS, P229
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Broberg M, 1998, COLLOID SURFACE B, V11, P123, DOI 10.1016/S0927-7765(98)00024-1
   Broberg M, 2001, BIOMATERIALS, V22, P2403, DOI 10.1016/S0142-9612(00)00427-0
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Ferraz N, 2008, J BIOMED MATER RES A, V87A, P575, DOI 10.1002/jbm.a.31818
   Ferraz N, 2008, J MATER SCI-MATER M, V19, P3115, DOI 10.1007/s10856-008-3449-7
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   Gong DW, 2003, BIOMED MICRODEVICES, V5, P75, DOI 10.1023/A:1024471618380
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Horbett TA, 2004, BIOMATERIALS SCI INT, P237
   Karlsson M, 2004, MICROSC RES TECHNIQ, V63, P259, DOI 10.1002/jemt.20040
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   La Flamme KE, 2007, BIOMATERIALS, V28, P2638, DOI 10.1016/j.biomaterials.2007.02.010
   Marcus AJ, 1999, INFLAMMATION BASIC P, P77
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Minelli Caterina, 2008, Journal of Nanobiotechnology, V6, P3, DOI 10.1186/1477-3155-6-3
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Sutherland DS, 2001, MACROMOL BIOSCI, V1, P270, DOI 10.1002/1616-5195(20010801)1:6<270::AID-MABI270>3.3.CO;2-V
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   WETTERO J, 2002, THESIS LINKOPING U L
   Wieneke H, 2003, CATHETER CARDIO INTE, V60, P399, DOI 10.1002/ccd.10664
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOLFF R, 1986, J BIOL CHEM, V261, P6840
NR 36
TC 10
Z9 10
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD DEC
PY 2010
VL 73
IS 12
BP 1101
EP 1109
DI 10.1002/jemt.20854
PG 9
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 678HD
UT WOS:000284063800005
PM 20232464
DA 2018-10-19
ER

PT J
AU Hamzah, IH
   Yu, CY
   Abd Manaf, A
   Sidek, O
   Chan, YY
AF Hamzah, I. H.
   Yu, C. Y.
   Abd Manaf, Asrulnizam
   Sidek, O.
   Chan, Y. Y.
TI The effect of photoresist thin film on cyclic voltammetry measurement
   for DNA immobilization and hybridization of indicator-free DNA sensor
SO OPTOELECTRONICS AND ADVANCED MATERIALS-RAPID COMMUNICATIONS
LA English
DT Article
DE Photoresist thin film; Biomaterial; Biosensor; Electrochemical; PDMS
ID GOLD ELECTRODE; MICROARRAY
AB The effect of positive photoresist thin film fabricated between electrodes on the glass slide is the focus in the present study. A 1.04 mm(2) electrode size is used and the cyclic voltammetry (CV) of 0.02M K(3)Fe(CN)(6) in 0.1M KCl has been analyzed throughout the work for Au bare electrodes, DNA probe immobilization and DNA target hybridization. An adhesive bonding method of polydimethylsiloxane (PDMS) is implemented. The atomic force microscope (AFM) analysis on the root mean square (RMS) value is then carried out to prove that the surface roughness and electrode thickness do not influence the analysis.
C1 [Hamzah, I. H.; Abd Manaf, Asrulnizam; Sidek, O.] Univ Sains Malaysia, Collaborat MicroElect Design Excellence Ctr CEDEC, George Town 14300, Malaysia.
   [Hamzah, I. H.; Abd Manaf, Asrulnizam; Sidek, O.] Univ Sains Malaysia, Sch Elect & Elect Engn, George Town 14300, Malaysia.
   [Hamzah, I. H.] Univ Teknol MARA, Fac Elect Engn, Shah Alam 40450, Malaysia.
   [Yu, C. Y.] Univ Sains Malaysia, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia.
RP Hamzah, IH (reprint author), Univ Sains Malaysia, Collaborat MicroElect Design Excellence Ctr CEDEC, Engn Campus, George Town 14300, Malaysia.
EM irnihami@ppinang.uitm.edu.my
RI sidek, othman/E-3392-2012; YU, CHOO YEE/G-2033-2015
OI YU, CHOO YEE/0000-0002-8453-5023
FU Collaborative microElectronic Design Excellence Centre (CEDEC),
   Universiti Sains Malaysia, Penang, Malaysia; Institute for Postgraduate
   Studies (IPS) of Universiti Sains Malaysia
FX This work is sponsored by the internal grant from the Collaborative
   microElectronic Design Excellence Centre (CEDEC), Universiti Sains
   Malaysia, Penang, Malaysia and supported by the Institute for
   Postgraduate Studies (IPS) of Universiti Sains Malaysia through the USM
   Fellowship Scheme awarded to the second author. The financial support is
   gratefully appreciated.
CR Armstrong FA, 2000, ELECTROCHIM ACTA, V45, P2623, DOI 10.1016/S0013-4686(00)00342-X
   Bakker E, 2002, ANAL CHEM, V74, P2781, DOI 10.1021/ac0202278
   CHEN Y, 2006, J PHYS C SER, V34, P204
   Cho S, 2002, J KOREAN PHYS SOC, V41, P1054
   Choi YS, 2005, B KOR CHEM SOC, V26, P379
   CHOI YS, 2001, KIEE INT T EA C, V11, P23
   Escamilla-Gomez V, 2009, BIOSENS BIOELECTRON, V24, P3365, DOI 10.1016/j.bios.2009.04.047
   Hu KC, 2008, ANAL CHEM, V80, P9124, DOI 10.1021/ac8017197
   Kim DJ, 2004, B KOR CHEM SOC, V25, P1430
   KIM DK, 2001, KIEE INT T EA C, V11, P85
   Lee BS, 2004, B KOREAN CHEM SOC, V25, P1531
   Liu SF, 2005, BIOSENS BIOELECTRON, V21, P789, DOI 10.1016/j.bios.2005.02.001
   Loaiza OA, 2008, ELECTROANAL, V20, P1397, DOI 10.1002/elan.200804227
   Pan D, 2007, SENSORS-BASEL, V7, P2671, DOI 10.3390/s7112671
   Park N, 2004, ANAL CHEM, V76, P900, DOI 10.1021/ac026368r
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614
   Steel AB, 1998, ANAL CHEM, V70, P4670, DOI 10.1021/ac980037q
   VANHELDEN PD, 1998, DNA SEQUENCING PROTO, P81
   Weetall HH, 1996, BIOSENS BIOELECTRON, V11, pR1, DOI 10.1016/0956-5663(96)83729-8
   Yao W, 2009, MICROCHIM ACTA, V165, P407, DOI 10.1007/s00604-009-0152-4
NR 21
TC 0
Z9 0
U1 0
U2 3
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1842-6573
J9 OPTOELECTRON ADV MAT
JI Optoelectron. Adv. Mater.-Rapid Commun.
PD DEC
PY 2010
VL 4
IS 12
BP 2103
EP 2107
PG 5
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 704IA
UT WOS:000286043400042
DA 2018-10-19
ER

PT J
AU Albano, C
   Gonzalez, G
   Parra, C
AF Albano, C.
   Gonzalez, G.
   Parra, C.
TI Sonochemical synthesis of polymethylmethacrylate to be used as
   biomaterial
SO POLYMER BULLETIN
LA English
DT Article
DE Synthesis of PMMA; Redox initiation and ultrasonic radiation; In vitro
   biocompatibility; Anionic surfactant; Monomer concentration
ID POLY(METHYL METHACRYLATE); METHYL-METHACRYLATE; EMULSION POLYMERIZATION;
   LATEX-PARTICLES; ULTRASOUND; INITIATION; BONE
AB In the present study, the synthesis of PMMA was carried out by emulsion polymerization under ultrasonic radiation, varying the concentration of the anionic surfactant and monomer concentration. Redox process was introduced in order to observe if an increment in conversion was obtained. Characterization was performed by FTIR, DSC, SEM, and H-1-NMR of protons. The synthesis with redox initiation produced PMMA with majorly syndiotatic triads. The synthesis carried out under redox initiation resulted in a large increased in conversion, showing that there is an optimum surfactant/monomer ratio. Scanning Electron Microscopy showed that for low concentrations of surfactant (0.5% p/v) the latex particles presented a rough surface but high surfactant concentration showed nanometric spherical particles with a smooth surface. The study of in vitro biocompatibility by adhesion of osteoblasts on the materials resulted in higher cell adhesion in materials synthesized without redox initiation.
C1 [Albano, C.] IVIC, Ctr Quim, Lab Polimeros, Caracas, Venezuela.
   [Albano, C.] UCV, Fac Ingn, Escuela Ingn Quim, Caracas, Venezuela.
   [Gonzalez, G.] UCV, Ctr Ingn Mat & Nanotecnol, Mat Lab, Caracas, Venezuela.
   [Gonzalez, G.] UCV, Fac Ciencias, Escuela Fis, Caracas, Venezuela.
   [Parra, C.] Inst Univ Tecnol Dr Federico Rivero Palacio, Caracas, Venezuela.
RP Albano, C (reprint author), IVIC, Ctr Quim, Lab Polimeros, Caracas, Venezuela.
EM carmen.albano@ucv.ve
FU IVIC; FONACIT; CDCH (UCV)
FX The authors want to thank the IVIC, FONACIT and CDCH (UCV) for their
   financial support.
CR Allen NS, 1997, J PHOTOCH PHOTOBIO A, V102, P253, DOI 10.1016/S1010-6030(96)04459-0
   Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/biomaterials.2006.03.004
   BILLINGHAM NC, 1977, MOLAR MASS MEASUREME
   Chou HCJ, 1999, J APPL POLYM SCI, V72, P797, DOI 10.1002/(SICI)1097-4628(19990509)72:6<797::AID-APP7>3.0.CO;2-Z
   COLLIS DK, 1991, J BONE JOINT SURG AM, V73A, P593, DOI 10.2106/00004623-199173040-00017
   GREENE BW, 1970, J COLLOID INTERF SCI, V33, P393, DOI 10.1016/0021-9797(70)90232-8
   HATADA K, 1988, PROG POLYM SCI, V13, P189, DOI 10.1016/0079-6700(88)90004-4
   He YH, 2005, J POLYM SCI POL PHYS, V43, P2617, DOI 10.1002/polb.20544
   Isobe Y, 2001, J POLYM SCI POL CHEM, V39, P1463, DOI 10.1002/pola.1123
   Jiang W, 2004, J POLYM SCI POL CHEM, V42, P733, DOI 10.1002/pola.10864
   Kirsch S, 2001, COLLOID SURFACE A, V183, P725, DOI 10.1016/S0927-7757(01)00499-X
   KUSY RP, 1978, J BIOMED MATER RES, V12, P271, DOI 10.1002/jbm.820120304
   Liao YQ, 2001, J POLYM SCI POL CHEM, V39, P3356, DOI 10.1002/pola.1318
   Moreau MF, 1998, J BIOMED MATER RES, V40, P124, DOI 10.1002/(SICI)1097-4636(199804)40:1<124::AID-JBM14>3.0.CO;2-O
   Ohsawa K, 2001, J BIOMED MATER RES, V54, P501, DOI 10.1002/1097-4636(20010315)54:4<501::AID-JBM50>3.3.CO;2-3
   Pande M, 1996, J CATARACT REFR SURG, V22, P89, DOI 10.1016/S0886-3350(96)80276-8
   PARRA C, 2005, E POLYM, V25
   Parra C, 2008, POLYM ENG SCI, V48, P2066, DOI 10.1002/pen.21101
   Pestaner JP, 1999, BIOL TRACE ELEM RES, V69, P191, DOI 10.1007/BF02783871
   Pilcher SC, 1998, MACROMOLECULES, V31, P3454, DOI 10.1021/ma971722m
   PRICE GJ, 1994, ULTRASON SONOCHEM, V1, pS51, DOI 10.1016/1350-4177(94)90028-0
   PRICE GJ, 1992, MACROMOLECULES, V25, P6447, DOI 10.1021/ma00050a010
   Sarac AS, 1999, PROG POLYM SCI, V24, P1149, DOI 10.1016/S0079-6700(99)00026-X
   SMITH WV, 1948, J CHEM PHYS, V16, P592, DOI 10.1063/1.1746951
   Stevens M. P., 1990, POLYM CHEM INTRO
   STRAKA J, 1995, POLYMER, V36, P1147, DOI 10.1016/0032-3861(95)93916-A
   YEONG S, 2003, POLYMER, V44, P8147
   Zhang ZB, 2006, POLYMER, V47, P6970, DOI 10.1016/j.polymer.2006.08.008
NR 28
TC 4
Z9 4
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD DEC
PY 2010
VL 65
IS 9
BP 893
EP 903
DI 10.1007/s00289-010-0300-3
PG 11
WC Polymer Science
SC Polymer Science
GA 690SA
UT WOS:000285025400004
DA 2018-10-19
ER

PT J
AU Rashidi, H
   Ellis, MJ
   Cartmell, SH
   Chaudhuri, JB
AF Rashidi, Hassan
   Ellis, Marianne J.
   Cartmell, Sarah H.
   Chaudhuri, Julian B.
TI Simvastatin Release from Poly(lactide-co-glycolide) Membrane Scaffolds
SO POLYMERS
LA English
DT Article
DE PLGA; membrane; scaffold; statin; controlled release; bone tissue
   engineering
ID BIOMATERIAL OG-PLG; FORMATION IN-VITRO; HMG-COA REDUCTASE;
   BONE-FORMATION; STATINS; CELLS; COMPACTIN; RATS; DIFFERENTIATION;
   CERIVASTATIN
AB Statins, a group of potent inhibitors of 3-hydroxy-3-methylglutaryl Coenzyme A reductase in cholesterol biosynthesis pathway, have been widely used as a cholesterol lowering drug. The plieotrophic effect of statins on bone metabolism in long-term usage has been begun to be studied during recent years and several in vitro and in vivo studies have demonstrated the ability of statins to promote expression of bone morphogenetic protein-2 (BMP-2), inhibition of osteoclast differentiation and reduction of osteoporotic fractures risk. The high liver specificity and low oral bioavailability of statins, leading to poor peripheral distribution, are the main obstacles to benefit anabolic effects of hydrophobic statins on bone formation. Therefore, developing new administration roots for direct delivery to achieve optimum concentration in the bone microenvironment is of interest. Here we present and compare two approaches of combining statins with bone tissue engineering scaffolds. Simvastatin was combined with a poly(lactide-co- glycolide) (PLGA) membrane scaffold for diffusion-controlled release by dissolving simvastatin (dis-sim) in the membrane casting dope, and for degradation-controlled release by covalently bonding saponifiedsimvastatin (sap-sim) to the PLGA in the spinning dope. Rheological and concentration-dependent membrane morphology changes were observed with saponifiedsimvastatin, suggesting ester bond cleavage and covalent bonding of the statin to the PLGA, but not with dissolved simvastatin. Dissolved simvastatin membranes showed a logarithmic decay release profile while the saponifiedsimvastatin membranes showed constant release. It can be concluded that the covalent bonding of simvastatinto PLGA scaffolds is showing potential for use as a controlled releasescaffold for bone tissue engineering.
C1 [Rashidi, Hassan; Ellis, Marianne J.; Chaudhuri, Julian B.] Univ Bath, Dept Chem Engn, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.
   [Cartmell, Sarah H.] Univ Manchester, Ctr Mat Sci, Sch Mat, Manchester M13 9PL, Lancs, England.
RP Chaudhuri, JB (reprint author), Univ Bath, Dept Chem Engn, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.
EM mgxhr@nottingham.ac.uk; M.J.Ellis@bath.ac.uk;
   sarah.cartmell@manchester.ac.uk; J.B.Chaudhuri@bath.ac.uk
RI Rashidi, Hassan/N-9313-2014; Cartmell, Sarah/J-8506-2012; Rashidi,
   Hassan/D-2572-2009
OI Rashidi, Hassan/0000-0001-8078-6688; Cartmell,
   Sarah/0000-0001-6864-0846; Rashidi, Hassan/0000-0002-9682-8288; Ellis,
   Marianne/0000-0003-4155-0853
FU Marie Curie
FX We would like to thank Fernando Acosta in the Department of Chemical
   Engineering and Ursula Potter in the Centre for Electron Optical Studies
   for their technical assistance, and Marie Curie for funding.
CR Bauer DC, 2003, OSTEOPOROSIS INT, V14, P273, DOI 10.1007/s00198-002-1323-x
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Crawford DT, 2001, J BONE MINER RES, V16, pS295
   Ellis MJ, 2007, BIOTECHNOL BIOENG, V96, P177, DOI 10.1002/bit.21093
   Garrett IR, 2000, J BONE MINER RES, V15, pS225
   Garrett IR, 2002, ARTHRITIS RES, V4, P237, DOI 10.1186/ar413
   Garrett IR, 1999, J BONE MINER RES, V14, pS180
   Gasser JA, 2001, J BONE MINER RES, V16, pS295
   Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002
   Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002.220682
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Maritz FJ, 2001, ARTERIOSCL THROM VAS, V21, P1636, DOI 10.1161/hq1001.097781
   Mulder M., 1992, BASIC PRINCIPLES MEM
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987
   Piskin E, 2009, J BIOMED MATER RES A, V90A, P1137, DOI 10.1002/jbm.a.32157
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   von Stechow D, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-8
   Whang K, 2000, J BONE MINER RES, V15, pS225
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P237, DOI 10.1002/jbm.a.30309
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P247, DOI 10.1002/jbm.a.30370
   Woo JT, 2000, J BONE MINER RES, V15, P650, DOI 10.1359/jbmr.2000.15.4.650
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yao W, 2001, J BONE MINER RES, V16, pS294
NR 27
TC 4
Z9 5
U1 0
U2 17
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD DEC
PY 2010
VL 2
IS 4
BP 709
EP 718
DI 10.3390/polym2040709
PG 10
WC Polymer Science
SC Polymer Science
GA V27GH
UT WOS:000208601200020
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kini, AY
   Byakod, PP
   Angadi, GS
   Pai, U
   Bhandari, AJ
AF Kini, Ashwini Y.
   Byakod, Preeti P.
   Angadi, Gangadhar S.
   Pai, Umesh
   Bhandari, Aruna J.
TI Comprehensive prosthetic rehabilitation of a patient with partial finger
   amputations using silicone biomaterial: A technical note
SO PROSTHETICS AND ORTHOTICS INTERNATIONAL
LA English
DT Article
AB Finger and partial finger amputations are some of the most frequently encountered forms of partial hand loss. A high quality aesthetic prosthesis with passive function can be helpful to the patient since loss or congenital absence or malformation have both a social and psychological impact on the patient. Prosthetics is an art and science which provides a lifelike appearance to the lost structures of the patient. This case report presents the fabrication of a silicone finger prosthesis which had good suspension, adequate function, was comfortable to use and aesthetically acceptable to the patient.</.
C1 [Kini, Ashwini Y.; Byakod, Preeti P.; Angadi, Gangadhar S.; Pai, Umesh; Bhandari, Aruna J.] Rural Dent Coll, Dept Prosthodont, Loni, Maharashtra, India.
RP Kini, AY (reprint author), Loni BK, Dept Prosthodont, Ahmednagar 413736, Maharashtra, India.
EM kini77@gmail.com
CR Aydin C, 2007, J PROSTHET DENT, V97, P191, DOI 10.1016/j.prosdent.2007.02.008
   Aziz T, 2003, J DENT, V31, P213, DOI 10.1016/S0300-5712(02)00131-8
   BEUMER J, 1979, MAXILLOFACIAL REHABI, P528
   KULKARNI GS, 2008, TXB ORTHOPAEDICS TRA, V3, P2401
   Leow MEL, 2001, J REHABIL RES DEV, V38, P273
   MACKIN EJ, 2005, REHABILITATION HAND, V2, P1469
   Michel J, 1994, JPO, V6, P10, DOI DOI 10.1097/00008526-199400610-00003
   MICROSLAN V, 1986, AMPUTATIONS PROSTHES, P33
   Nazir S, 2006, J INDIAN PROSTHODONT, V16, P4
   OFarrell DA, 1996, J HAND SURG-BRIT EUR, V21B, P696, DOI 10.1016/S0266-7681(96)80166-5
   PARRY CBW, 1986, REHABILITATION HAND, P345
   SEALS RR, 1989, J PROSTHET DENT, V62, P327, DOI 10.1016/0022-3913(89)90343-0
   Shweta D, 2008, J INDIAN PROSTHODONT, V8, P165
   TAYLOR T, 2000, FACIAL PROSTHESIS FA, P245
   TAYLOR TD, 2000, FACIAL PROSTHESIS FA, P233
NR 15
TC 6
Z9 6
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0309-3646
J9 PROSTHET ORTHOT INT
JI Prosthet. Orthot. Int.
PD DEC
PY 2010
VL 34
IS 4
BP 488
EP 494
DI 10.3109/03093646.2010.486391
PG 7
WC Orthopedics; Rehabilitation
SC Orthopedics; Rehabilitation
GA 681YK
UT WOS:000284360400011
PM 20528685
DA 2018-10-19
ER

PT J
AU Bahadur, G
   Morrison, M
   Machin, L
AF Bahadur, G.
   Morrison, M.
   Machin, L.
TI Beyond the 'embryo question': human embryonic stem cell ethics in the
   context of biomaterial donation in the UK
SO REPRODUCTIVE BIOMEDICINE ONLINE
LA English
DT Article
DE embryo; embryonic stem cells; ethics; legislation; regulation
ID INFORMED-CONSENT; ATTITUDES; POLITICS; WOMEN
AB Discussion about the ethics of human embryonic stem cell (ESC) research in the UK tends to be dominated by the divisive and potentially intractable issue of the moral status of the embryo. This can have the effect of silencing or marginalizing other concerns, especially in the context of public engagement with science in this field. One such area of potential public concern is the donation of oocytes and embryos to stem cell research. Contemporary research on the views of donors and potential donors about a wide range of biomaterials, from solid organs to gametes and bone marrow, is reviewed and used to illustrate the range and types of ethical concerns articulated by this important group of stakeholders. Attitudes to donation are found to vary according to the type of tissue being donated or collected, the purpose for which donation is being sought and the nature of the recipient of the donation. Pertinently, attitudes towards donating oocytes are found to differ in some respects from donation of embryos or fetal tissue. The implications of these findings for ensuring ethically robust informed consent and publicly acceptable sourcing of human biomaterials for stem cell research are then considered. (C) 2010, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
C1 [Bahadur, G.] N Middlesex Hosp NHS Trust, Fertil Unit, London N18 1QX, England.
   [Morrison, M.; Machin, L.] Univ York, Dept Sociol, SATSU, York YO10 5DD, N Yorkshire, England.
RP Bahadur, G (reprint author), N Middlesex Hosp NHS Trust, Fertil Unit, Stirling Way, London N18 1QX, England.
EM bahadur.g@gmail.com; mm608@york.ac.uk; lm603@york.ac.uk
OI Morrison, Michael/0000-0001-6870-6673; Machin, Laura/0000-0002-6717-959X
FU European Commission [217180]; Economic and Social Research Council
   [RES-062-23-1386]
FX The work of M Morrison contributing to this paper was supported by the
   European Commission FP7 Regenerative Medicine in Europe (REMEDiE)
   project (proposal no. 217180) 2008-2011. The contribution of L Machin
   was supported by the Economic and Social Research Council-funded project
   The political and moral economy of umbilical cord blood banking
   (RES-062-23-1386) 2009-2011.
CR ALENCAR LC, 2009, REV SAUDE PUBL, P70
   ANDERSEN F, 1994, J MED ETHICS, P36
   AXLER RE, 2008, PATHOBIOLOGY, P323
   BAHADUR G, 2008, REPROD BIOMED ONLINE, P25
   BARR M, 2006, BIOSOCIETIES, P12
   Bosk CL, 1999, DAEDALUS, V128, P47
   BUSBY H, 2006, SOCIOL HLTH ILLN, P850
   BUSBY H, 2010, CLIN ETHICS, P1
   CALLAHAN D, 1995, HASTINGS CENT REP, V25, P39, DOI 10.2307/3562493
   Corrigan O, 2003, SOCIOL HEALTH ILL, V25, P768, DOI 10.1046/j.1467-9566.2003.00369.x
   DARLINGTON N, 1994, HUM REPROD, P2343
   Davies G, 2006, ENVIRON PLANN A, V38, P423, DOI 10.1068/a37387
   DECKER O, 2008, J GENDER STUD, P251
   Fernandez CV, 2003, CAN MED ASSOC J, V168, P695
   Fertilisation Human, 2007, HYBR CHIM CONS ETH S
   FRANKLIN S, 2008, REGEN MED, P105
   Franklin Sarah, 1999, TECHNOLOGIES PROCREA
   Fuscaldo G, 2007, HUM REPROD, V22, P3129, DOI 10.1093/humrep/dem325
   GOODSON MI, 2004, J CLIN PATHOL, P4
   HAIMES E, 2009, HUM REPROD, P2142
   HARMON SHE, 2009, LIMITS GOVERNANCE CH, P79
   Hedgecoe AM, 2004, BIOETHICS, V18, P120, DOI 10.1111/j.1467-8519.2004.00385.x
   HUDSON N, 2009, PUBLIC UNDERST SCI, P61
   *HUM FERT EMBR AUT, 2006, DON EGGS RES SAF DON
   HYDE MK, 2010, DEATH STUD, P172
   Irwin A, 2006, SOC STUD SCI, V36, P299, DOI 10.1177/0306312706053350
   Johnson MH, 1999, HUM REPROD, V14, P1912
   JOSEPH JW, 2008, AM J MED GENET A, P305
   KENT J, 2006, BRIT MED J, P866
   Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198
   KIRKMAN M, 2003, WOMEN HLTH, P1
   Laurie G, 2009, LIMITS GOVERNANCE CH, P51
   LEVIDOW L, 1997, OUTLOOK AGR, P145
   McHale J, 2000, HEALTH CARE ANAL, V8, P123, DOI 10.1023/A:1009494327013
   MCMAHON CA, 2001, REPROD TECHNOL, P131
   MOCAN N, 2007, SOC SCI MED, P2527
   MULKAY M, 1997, EMBRYO RES DEBATE SC
   *OFF PUBL MAN, 2007, STEM CELL PUBL DIAL
   Parry S, 2006, SOC SCI MED, V62, P2349, DOI 10.1016/j.socscimed.2005.10.024
   Parry S, 2003, NEW GENET SOC, V22, P145, DOI 10.1080/1463677032000102594
   PARRY S, 2009, SCI CULT, P89
   PEDDIE VL, 2009, HUM REPROD, P1106
   PFEFFER N, 2009, SOCIOL HLTH ILLN, P98
   PFEFFER N, 2006, SOC SCI MED, P3011
   Pfeffer N, 2008, SOC SCI MED, V66, P2544, DOI 10.1016/j.socscimed.2008.01.050
   PROVOOST V, 2010, REPROD BIOMED ONLINE, P880
   Sanner MA, 2001, SOC SCI MED, V52, P1491, DOI 10.1016/S0277-9536(00)00258-6
   Scheper-Hughes N, 2007, AM J TRANSPLANT, V7, P507, DOI 10.1111/j.1600-6143.2006.01679.x
   SCHWEDA M, 2009, SOC SCI MED, P1129
   Streiffer R, 2008, HASTINGS CENT REP, V38, P40
   TAYLOR PL, 2009, CELL STEM CELL, P479
   Titmuss R., 1970, GIFT RELATIONSHIP FR
   WARWICK RM, 2009, TISSUE BLOOD DONATIO
   WEED M, 2005, J LAW MED ETHICS, P802
   Wynne B., 2002, CURR SOCIOL, V50, P459, DOI DOI 10.1177/0011392102050003010
NR 55
TC 12
Z9 12
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1472-6483
J9 REPROD BIOMED ONLINE
JI Reprod. Biomed. Online
PD DEC
PY 2010
VL 21
IS 7
SU S
BP 868
EP 874
DI 10.1016/j.rbmo.2010.10.001
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 705TS
UT WOS:000286161400008
PM 21112540
DA 2018-10-19
ER

PT J
AU Zannettino, ACW
   Paton, S
   Itescu, S
   Gronthos, S
AF Zannettino, Andrew C. W.
   Paton, Sharon
   Itescu, Silviu
   Gronthos, Stan
TI Comparative Assessment of the Osteoconductive Properties of Different
   Biomaterials In Vivo Seeded with Human or Ovine Mesenchymal Stem/Stromal
   Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELLS; HUMAN BONE-MARROW; ARTICULAR-CARTILAGE DEFECTS;
   BETA-TRICALCIUM PHOSPHATE; CERAMIC-COATED HYDROXYAPATITE; CRITICAL-SIZE
   DEFECTS; STEM-CELLS; CALCIUM-PHOSPHATE; GRAFT SUBSTITUTE; SPINAL-FUSION
AB Mesenchymal stromal/stem cells (MSC), when used in combination with biomaterial scaffolds, have been shown to contribute at varying efficiencies to bone and cartilage regeneration in preclinical large animal models and human clinical trials. In an orthopedic context, identification of the optimal scaffold, which is capable of inducing tissue regeneration, has been the subject of numerous studies. In the present study, we show that ex vivo-expanded MSC from human and ovine bone marrow display similar phenotypic properties, but exhibit differences in their ability to form bone in vivo when transplanted with different biocompatible scaffold composites. We found that the ovine MSC formed ectopic bone on all scaffolds tested with the exception of collagen-based demineralized bone matrix. In contrast, human MSC in general formed less bone and only on those biomaterials composed of ceramic particles containing at least 15% hydroxyapatite. This study demonstrates the differences in bone formation potential between human and ovine MSC in vivo based on the osteoconductive properties of different bioscaffolds currently being used for orthopedic clinical applications.
C1 [Zannettino, Andrew C. W.] Inst Med & Vet Sci, Dept Haematol, Myeloma Res Lab, Adelaide, SA 5000, Australia.
   [Zannettino, Andrew C. W.] Ctr Canc Biol SA Pathol, Adelaide, SA, Australia.
   [Zannettino, Andrew C. W.; Paton, Sharon; Gronthos, Stan] Univ Adelaide, Ctr Stem Cell Res, Adelaide, SA, Australia.
   [Paton, Sharon; Gronthos, Stan] Inst Med & Vet Sci, Dept Haematol, Mesenchymal Stem Cell Grp, Adelaide, SA 5000, Australia.
   [Paton, Sharon; Gronthos, Stan] Hanson Inst, Adelaide, SA, Australia.
   [Itescu, Silviu] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Itescu, Silviu] Mesoblast Ltd, Melbourne, Vic, Australia.
RP Gronthos, S (reprint author), Hanson Inst SA Pathol, Inst Med & Vet Sci, Div Haematol, Bone & Canc Labs, Frome Rd, Adelaide, SA 5000, Australia.
EM stan.gronthos@health.sa.gov.au
OI Paton, Sharon/0000-0001-7031-3510
FU National Health and Medical Research Council (NHMRC) [453497]; Mesoblast
   Ltd., Melbourne, Victoria, Australia
FX This work was partly funded by the National Health and Medical Research
   Council (NHMRC) project grant no. 453497 and Mesoblast Ltd., Melbourne,
   Victoria, Australia.
CR Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x
   Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592
   Bajada S, 2007, J BONE JOINT SURG BR, V89B, P1382, DOI 10.1302/0301-620X.89B10.19103
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, P53
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Chang F, 2008, J ORTHOP RES, V26, P18, DOI 10.1002/jor.20470
   Chang SCN, 2003, GENE THER, V10, P2013, DOI 10.1038/sj.gt.3302106
   Clarke SA, 2007, J MATER SCI-MATER M, V18, P2283, DOI 10.1007/s10856-007-3099-1
   Cornell C N, 1991, J Orthop Trauma, V5, P1
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026
   Giannoni P, 2008, J TISSUE ENG REGEN M, V2, P253, DOI 10.1002/term.90
   Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   GRONTHOS S, 2006, J STEM CELLS, V1, P35
   Gronthos S, 2009, STEM CELLS DEV, V18, P1253, DOI 10.1089/scd.2008.0400
   Gunzburg R, 2002, ORTHOPEDICS, V25, pS591
   Guo XM, 2004, TISSUE ENG, V10, P1818, DOI 10.1089/ten.2004.10.1818
   Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32
   Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107
   He DM, 2010, J NEUROSURG, V112, P319, DOI 10.3171/2009.1.JNS08976
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Jeong WK, 2008, BIOTECHNOL APPL BIOC, V49, P155, DOI 10.1042/BA20070149
   Jiang Ying, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P560
   Martinez-Lorenzo MJ, 2009, J ORTHOP RES, V27, P1499, DOI 10.1002/jor.20898
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Khan SN, 2000, ORTHOP CLIN N AM, V31, P389, DOI 10.1016/S0030-5898(05)70158-9
   Kim CW, 2008, J BIOMED MATER RES A, V85A, P1114, DOI 10.1002/jbm.a.31633
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Liu GP, 2008, J MATER SCI-MATER M, V19, P2367, DOI 10.1007/s10856-007-3348-3
   Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   McAndrew M P, 1988, J Orthop Trauma, V2, P333, DOI 10.1097/00005131-198802040-00011
   McCarty RC, 2009, J CELL PHYSIOL, V219, P324, DOI 10.1002/jcp.21670
   Mrugala D, 2008, ANN RHEUM DIS, V67, P288, DOI 10.1136/ard.2007.076620
   Muschler GF, 1996, CLIN ORTHOP RELAT R, P250
   Nair MB, 2009, J BIOMED MATER RES A, V91A, P855, DOI 10.1002/jbm.a.32239
   Nair MB, 2009, ACTA BIOMATER, V5, P1742, DOI 10.1016/j.actbio.2009.01.009
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Shang QX, 2001, J CRANIOFAC SURG, V12, P586, DOI 10.1097/00001665-200111000-00017
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Swieszkowski W, 2007, BIOMOL ENG, V24, P489, DOI 10.1016/j.bioeng.2007.07.014
   Szpalski M, 2002, ORTHOPEDICS, V25, pS601
   Tan K K, 2005, Med J Malaysia, V60 Suppl C, P53
   Tonomura A, 2007, CONNECT TISSUE RES, V48, P229, DOI 10.1080/03008200701507909
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   Watson JT, 2004, ORTHOPEDICS, V27, pS103
   Yan H, 2007, ARTHROSCOPY, V23, P178, DOI 10.1016/j.arthro.2006.09.005
   ZERWEKH JE, 1992, J ORTHOPAED RES, V10, P562, DOI 10.1002/jor.1100100411
   Zhou Shuanhu, 2005, Cell and Tissue Banking, V6, P33, DOI 10.1007/s10561-005-4253-y
NR 67
TC 26
Z9 27
U1 1
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2010
VL 16
IS 12
BP 3579
EP 3587
DI 10.1089/ten.tea.2010.0153
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 692HG
UT WOS:000285143300003
PM 20666614
DA 2018-10-19
ER

PT J
AU Stabenfeldt, SE
   Munglani, G
   Garcia, AJ
   LaPlaca, MC
AF Stabenfeldt, Sarah E.
   Munglani, Gautam
   Garcia, Andres J.
   LaPlaca, Michelle C.
TI Biomimetic Microenvironment Modulates Neural Stem Cell Survival,
   Migration, and Differentiation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID INJURED RAT-BRAIN; EXTRACELLULAR-MATRIX; IN-VITRO; PROGENITOR CELLS;
   SPINAL-CORD; LAMININ; METHYLCELLULOSE; COLLAGEN; NEURONS;
   BETA-1-INTEGRINS
AB Biomaterial matrices presenting extracellular matrix (ECM) components in a controlled three-dimensional configuration provide a unique system to study neural stem cell (NSC)-ECM interactions. We cultured primary murine neurospheres in a methylcellulose (MC) scaffold functionalized with laminin-1 (MC-x-LN1) and monitored NSC survival, apoptosis, migration, differentiation, and matrix production. Overall, MC-x-LN1 enhanced both NSC survival and maturation compared with MC controls. Significantly lower levels of apoptotic activity were observed in MC-x-LN1 than in MC controls, as measured by bcl-2/bax gene expression and tetramethylrhodamine-dUTP nick end labeling. A higher percentage of NSCs extended neurites in a beta(1)-integrin-mediated fashion in MC-x-LN1 than in MC controls. Further, the differentiation profiles of NSCs in MC-x-LN1 exhibited higher levels of neuronal and oligodendrocyte precursor markers than in MC controls. LN1 production and co-localization with alpha(6)beta(1) integrins was markedly increased within MC-x-LN1, whereas the production of fibronectin was more pronounced in MC controls. These findings demonstrate that NSC microenvironments modulate cellular activity throughout the neurosphere, contributing to our understanding of ECM-mediated NSC behavior and provide new avenues for developing rationally designed couriers for neurotransplantation.
C1 [Stabenfeldt, Sarah E.; Munglani, Gautam; LaPlaca, Michelle C.] Emory Univ, Georgia Inst Technol, Petit Inst Bioengn & Biosci, Lab Neuroengn,Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Garcia, Andres J.] Woodruff Sch Mech Engn, Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA USA.
RP LaPlaca, MC (reprint author), Emory Univ, Georgia Inst Technol, Petit Inst Bioengn & Biosci, Lab Neuroengn,Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM michelle.laplaca@bme.gatech.edu
FU NIH NRSA [F31 NS054527]; NSF [EEC-9731643]; NIH [EB001014, EB004496]
FX The project was partially funded by an NIH NRSA award (SES; F31
   NS054527), NSF EEC-9731643 (M. C. L.), NIH EB001014 (M. C. L.), and NIH
   EB004496 (A.J.G.). The authors thank Tim Petrie for technical assistance
   with the antibody blocking studies. We also thank M. Okabe at Osaka
   University for the generous gift of the GFP mice. We acknowledge Scott
   Medway and Vishnu Ambur for assisting with the image quantification.
CR Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Boley SE, 2002, TOXICOL SCI, V66, P209, DOI 10.1093/toxsci/66.2.209
   Boockvar J, 2005, NEUROSURGERY, V56, pN6
   Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Campos LS, 2004, J NEUROSCI RES, V78, P761, DOI 10.1002/jnr.20333
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434
   DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595
   Hiraoka M, 2009, BIOCONJUGATE CHEM, V20, P976, DOI 10.1021/bc9000068
   Hynes SR, 2009, J BIOMED MATER RES A, V89A, P499, DOI 10.1002/jbm.a.31987
   Jacques TS, 1998, DEVELOPMENT, V125, P3167
   Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082
   Kobayashi K, 1999, MACROMOLECULES, V32, P7070, DOI 10.1021/ma990242n
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396
   Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073
   Liesi P, 2001, J NEUROSCI RES, V64, P144, DOI 10.1002/jnr.1061
   Mahoney MJ, 2007, J BIOMED MATER RES A, V81A, P269, DOI 10.1002/jbm.a.30970
   Marchionini DM, 2003, J COMP NEUROL, V464, P172, DOI 10.1002/cne.10785
   Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112
   Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180
   NAKAJIMA M, 2007, BIOMATERIALS, V28, P1040
   Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2
   Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195
   Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x
   REYNOLDS BA, 1992, J NEUROSCI, V12, P4565
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stabenfeldt SE, 2006, J BIOMED MATER RES A, V77A, P718, DOI 10.1002/jbm.a.30638
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.men.2004.05.001
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Watanabe K, 2007, RESTOR NEUROL NEUROS, V25, P109
   Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543
   Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673
NR 46
TC 39
Z9 41
U1 1
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2010
VL 16
IS 12
BP 3747
EP 3758
DI 10.1089/ten.tea.2009.0837
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 692HG
UT WOS:000285143300019
PM 20666608
OA Green Published
DA 2018-10-19
ER

PT J
AU Willie, BM
   Yang, X
   Kelly, NH
   Han, J
   Nair, T
   Wright, TM
   van der Meulen, MCH
   Bostrom, MPG
AF Willie, Bettina M.
   Yang, Xu
   Kelly, Natalie H.
   Han, Jane
   Nair, Turya
   Wright, Timothy M.
   van der Meulen, Marjolein C. H.
   Bostrom, Mathias P. G.
TI Cancellous Bone Osseointegration Is Enhanced by In Vivo Loading
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID COATED ACETABULAR COMPONENTS; POROUS TANTALUM BIOMATERIAL; MECHANICAL
   CONDITIONS; TITANIUM IMPLANTS; TISSUE FORMATION; METAL IMPLANTS;
   ANIMAL-MODEL; INGROWTH; RABBIT; INTERFACE
AB Biophysical stimuli may be an effective therapy to counteract age-related changes in bone structure that affect the primary stability of implants used in joint replacement or fracture fixation. The influence of controlled mechanical loading on osseointegration was investigated using an in vivo device implanted in the distal lateral femur of 12 male rabbits. Compressive loads (1MPa, 1 Hz, 50 cycles/day, 4 weeks) were applied to a porous titanium foam implant and the underlying cancellous bone. The contralateral limbs served as nonloaded controls. Backscattered electron imaging indicated that the amount of bone ingrowth was significantly greater in the loaded limb than in the nonloaded control limb, whereas the amount of underlying cancellous periprosthetic bone was similar. No significant difference in the mineral apposition rate of the bone ingrowth or periprosthetic bone was measured in the loaded compared to the control limb. Histological analysis demonstrated newly formed woven bone in direct apposition to the implant coating, with a lack of fibrous tissue at the implant-periprosthetic bone interface in both loaded and nonloaded implants. The lack of fibrous tissue demonstrates that mechanical stimulation using this model significantly enhanced cancellous bone ingrowth without the detrimental effects of micromotion. These results suggest that biophysical therapy should be further investigated to augment current treatments to enhance long-term fixation of orthopedic devices. Additionally, this novel in vivo loading model can be used to further investigate the influence of biophysical stimulation on other tissue engineering approaches requiring bone ingrowth into both metallic and nonmetallic cell-seeded scaffolds.
C1 [Willie, Bettina M.; Yang, Xu; Kelly, Natalie H.; Han, Jane; Nair, Turya; Wright, Timothy M.; van der Meulen, Marjolein C. H.; Bostrom, Mathias P. G.] Hosp Special Surg, New York, NY 10021 USA.
   [van der Meulen, Marjolein C. H.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
RP Willie, BM (reprint author), Charite Univ Med Berlin, Julius Wolff Inst, Campus Virchow Klinkum, Forum 4,Postfach 24,Augustenburger Pl 1, D-13353 Berlin, Germany.
EM bettina.willie@charite.de
RI van der Meulen, Marjolein/D-1549-2010; Willie, Bettina/G-2397-2014
OI van der Meulen, Marjolein/0000-0001-6637-9808; Willie,
   Bettina/0000-0003-2907-3580; Kelly, Natalie/0000-0002-2022-5800
FU Clark and Kirby Foundations [NIH P30-AR046121]
FX This study was partially supported by the Clark and Kirby Foundations
   and utilized the facilities of the Musculoskeletal Repair and
   Regeneration Core Center (NIH P30-AR046121). The porous titanium foam
   implants were kindly provided by Smith and Nephew, Inc.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Bloebaum RD, 1997, J BONE JOINT SURG AM, V79A, P1013, DOI 10.2106/00004623-199707000-00007
   Bloebaum RD, 1998, J BONE JOINT SURG AM, V80A, P518, DOI 10.2106/00004623-199804000-00008
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, ORTHOPEDICS, V22, P810
   Bragdon CR, 1996, J ARTHROPLASTY, V11, P945, DOI 10.1016/S0883-5403(96)80136-7
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, P173
   COOK SD, 1988, CLIN ORTHOP RELAT R, P90
   Deglurkar M, 2007, J BIOMED MATER RES B, V80B, P528, DOI 10.1002/jbm.b.30627
   DUCHEYNE P, 1977, J BIOMED MATER RES, V11, P811, DOI 10.1002/jbm.820110603
   Duyck J, 2004, J BIOMECH, V37, P1819, DOI 10.1016/j.jbiomech.2004.02.044
   Duyck J, 2007, J CLIN PERIODONTOL, V34, P998, DOI 10.1111/j.1600-051X.2007.01135.x
   Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215
   FROST HM, 1986, INTERMEDIARY ORG SKE
   Galante J, 1971, Orthop Clin North Am, V2, P139
   Geris L, 2008, J BIOMECH, V41, P145, DOI 10.1016/j.jbiomech.2007.07.008
   GOODMAN S, 1993, BIOMATERIALS, V14, P563, DOI 10.1016/0142-9612(93)90171-W
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   HULBERT SF, 1974, J BIOMED MATER RES, V8, pR3
   JONES LC, 1987, CLIN ORTHOP RELAT R, P192
   Lamerigts NMP, 2000, BIOMATERIALS, V21, P741, DOI 10.1016/S0142-9612(99)00247-1
   LANDON GC, 1986, CLIN ORTHOP RELAT R, P49
   Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027
   Meyer U, 2004, BIOMATERIALS, V25, P1959, DOI 10.1016/j.biomaterials.2003.08.070
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   ROSTLUND T, 1989, SCAND J PLAST RECONS, V23, P43
   RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P270
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SUMNER DR, 1995, J ARTHROPLASTY, V10, P157, DOI 10.1016/S0883-5403(05)80122-6
   Uhthoff H K, 1973, J Bone Joint Surg Br, V55, P633
   van der Meulen MCH, 2009, CLIN ORTHOP RELAT R, V467, P2000, DOI 10.1007/s11999-009-0897-4
   van der Meulen MCH, 2006, BONE, V38, P871, DOI 10.1016/j.bone.2005.11.026
   van Gaalen SM, 2010, TISSUE ENG PART B-RE, V16, P209, DOI [10.1089/ten.teb.2009.0503, 10.1089/ten.TEB.2009.0503]
   Vandamme K, 2007, CLIN ORAL IMPLAN RES, V18, P471, DOI 10.1111/j.1600-0501.2007.01339.x
   Vandamme K, 2007, J CLIN PERIODONTOL, V34, P172, DOI 10.1111/j.1600-051X.2006.01014.x
   Waldorff EI, 2007, BONE, V40, P425, DOI 10.1016/j.bone.2006.08.011
   Whiteside LA, 2001, CLIN ORTHOP RELAT R, P77
   Willie BM, 2010, J BIOMED MATER RES B, V92B, P479, DOI 10.1002/jbm.b.31541
NR 44
TC 19
Z9 19
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD DEC
PY 2010
VL 16
IS 6
BP 1399
EP 1406
DI 10.1089/ten.tec.2009.0776
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 685KG
UT WOS:000284627000018
PM 20367497
OA Green Published
DA 2018-10-19
ER

PT J
AU Ota, T
   Kamada, K
   Saito, N
AF Ota, Takahiro
   Kamada, Kyousuke
   Saito, Nobuhito
TI Repair of Cerebrospinal Fluid Leak via Petrous Bone Using Multilayer
   Technique with Hydroxyapatite Paste
SO WORLD NEUROSURGERY
LA English
DT Article
DE CSF leakage; Hydroxyapatite cement; Petrous bone
ID ACOUSTIC NEUROMA SURGERY; CEMENT; RECONSTRUCTION; PNEUMATIZATION
AB OBJECTIVE: Repairing bone defects after drilling in skull base surgery is difficult in deeper locations, the posterior wall of the internal auditory canal, and the petrous apex. These defects traditionally have been repaired by soft tissue, such as fascia, muscle, or adipose tissue, coupled with lumbar drainage for several days postoperatively.
   METHODS: To repair cerebrospinal fluid (CSF) leakage through air cells in the petrous bone, we applied a multilayer technique using hydroxyapatite cement (HAC) in three patients with postoperative CSF leakage. The opening of air cells was drilled widely to visualize the whole site of the opening and then packed with HAC covered with dura mater, fat, and fibrin glue.
   RESULTS: In all patients, CSF leak did not recur after repair with HAC, and there was no postoperative would infection, local inflammation, or cranial nerve damage.
   CONCLUSION: HAC is an effective biomaterial for the repair of refractory CSF leakage due to the opening of air cells in deeper surgical fields such as the petrous bone.
C1 [Ota, Takahiro; Kamada, Kyousuke; Saito, Nobuhito] Univ Tokyo, Dept Neurosurg, Tokyo 113, Japan.
RP Saito, N (reprint author), Univ Tokyo, Dept Neurosurg, Tokyo 113, Japan.
EM nsaito-tky@umin.ac.jp
CR Arriaga MA, 2002, OTOLARYNG HEAD NECK, V126, P512, DOI 10.1067/mhn.2002.124436
   Baird CJ, 2007, J NEUROSURG, V107, P347, DOI 10.3171/JNS-07/08/0347
   Brennan JW, 2001, J NEUROSURG, V94, P217, DOI 10.3171/jns.2001.94.2.0217
   Burstein FD, 1999, PLAST RECONSTR SURG, V104, P1270, DOI 10.1097/00006534-199910000-00005
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   HUGHES GB, 1982, OTOLARYNG HEAD NECK, V90, P117, DOI 10.1177/019459988209000120
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   Jen A, 2004, LARYNGOSCOPE, V114, P656, DOI 10.1097/00005537-200404000-00011
   Kaylie DM, 2001, OTOL NEUROTOL, V22, P686, DOI 10.1097/00129492-200109000-00022
   Kerr RG, 2009, NEUROSURGERY, V64, P527, DOI 10.1227/01.NEU.0000338070.85190.3B
   Kitano M, 2007, NEUROSURGERY, V61, P299, DOI 10.1227/01.neu.0000303984.26999.a9
   Kveton JF, 2004, LARYNGOSCOPE, V114, P33, DOI 10.1097/00005537-200401000-00005
   LANG J, 1989, CLIN OTOLARYNGOL, V14, P425, DOI 10.1111/j.1365-2273.1989.tb00398.x
   Samii M, 1997, NEUROSURGERY, V40, P11, DOI 10.1097/00006123-199701000-00002
   Samii M, 1997, NEUROSURGERY, V40, P29
NR 16
TC 8
Z9 8
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2010
VL 74
IS 6
BP 650
EP 653
DI 10.1016/j.wneu.2010.05.035
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 793IP
UT WOS:000292814100024
PM 21492635
DA 2018-10-19
ER

PT J
AU Wang, L
   Su, JF
   Nie, X
AF Wang, L.
   Su, J. F.
   Nie, X.
TI Corrosion and tribological properties and impact fatigue behaviors of
   TiN- and DLC-coated stainless steels in a simulated body fluid
   environment
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 37th International Conference on Metallurgical Coatings and Thin Films
CY APR 26-30, 2010
CL San Diego, CA
SP Amer Vacuum Soc, Adv Surface Engn Div
DE Coatings; Corrosion; Tribological property; Impact fatigue test;
   Biomedical application
ID CARBON COATINGS; BIOMEDICAL APPLICATIONS; THIN-FILMS; SURGICAL IMPLANTS;
   NITRIDE FILMS; WEAR; BIOCOMPATIBILITY; DEPOSITION; BIOMATERIALS;
   PROTECTION
AB In this study, the corrosion and tribological properties of TIN and DLC coatings were investigated in a simulated body fluid (SBF) environment. The ball-on-plate impact tests were conducted on the coatings under a combined force of a 700 N static load and a 700 N dynamic impact load for 10,000 impacting cycles. The results indicated that the TIN and DLC coatings could achieve a higher corrosion polarization resistance and a more stable corrosion potential in the SBF environment than the uncoated stainless steel substrate SS316L. The good corrosion protection performance of TIN could be due to the formation of a Ti-O passive layer on the coating surface, which protected the coating from further corrosion. The superior corrosion property of the DLC coating was likely attributed to its chemical inertness under the SBF condition. The TIN and DLC coatings also exhibited an excellent wear resistance and chemical stability during the sliding tests against a high density polyethylene (HDPE) biomaterial. Compared to the DLC coating, the TiN coating has a better compatibility with the HDPE. However, the impact tests showed that the fatigue cracks and the coating chipping occurred on the TiN coating but not on the DLC coating. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wang, L.; Su, J. F.; Nie, X.] Univ Windsor, Dept Mech Automot & Mat Engn, Windsor, ON N9B 3P4, Canada.
   [Wang, L.] Zhejiang Normal Univ, Coll Engn, Jinhua 321004, Zhejiang, Peoples R China.
RP Nie, X (reprint author), Univ Windsor, Dept Mech Automot & Mat Engn, Windsor, ON N9B 3P4, Canada.
EM xnie@uwindsor.ca
CR Agrawal CM, 1998, JOM-J MIN MET MAT S, V50, P31, DOI 10.1007/s11837-998-0064-5
   Avelar-Batista JC, 2006, SURF COAT TECH, V201, P4335, DOI 10.1016/j.surfcoat.2006.08.070
   BEHRNDT H, 1991, MAT SCI ENG A-STRUCT, V139, P58, DOI 10.1016/0921-5093(91)90596-F
   Bombac D, 2007, RMZ MAT GEOENVIRON, V54, P471
   Braic M, 2005, SURF COAT TECH, V200, P1014, DOI 10.1016/j.surfcoat.2005.02.140
   Cachet H, 2006, SURF INTERFACE ANAL, V38, P719, DOI 10.1002/sia.2146
   Cui FZ, 2000, SURF COAT TECH, V131, pXV
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hoseini M, 2008, WEAR, V264, P958, DOI 10.1016/j.wear.2007.07.003
   Hubler R, 2001, SURF COAT TECH, V142, P1078, DOI 10.1016/S0257-8972(01)01321-4
   Hubler R, 1999, SURF COAT TECH, V116, P1111, DOI 10.1016/S0257-8972(99)00221-2
   Kamali A, 2005, P I MECH ENG J-J ENG, V219, P41, DOI 10.1243/135065005X9736
   Khatak H. S., 2002, CORROSION AUSTENITIC, P43
   KNOTEK O, 1992, SURF COAT TECH, V55, P536
   Kola PV, 1996, J MATER PROCESS TECH, V56, P422, DOI 10.1016/0924-0136(95)01856-5
   Kotz J. C., 2006, CHEM CHEM REACTIVITY, P975
   Lawes SDA, 2007, J PHYS D APPL PHYS, V40, P5427, DOI 10.1088/0022-3727/40/18/S03
   Leng YX, 2001, THIN SOLID FILMS, V398, P471, DOI 10.1016/S0040-6090(01)01448-1
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Park J, 2003, THIN SOLID FILMS, V435, P102, DOI 10.1016/S0040-6090(03)00412-7
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   Sheeja D, 2001, DIAM RELAT MATER, V10, P1043, DOI 10.1016/S0925-9635(00)00413-1
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Vojs M, 2009, MICROELECTRON J, V40, P650, DOI 10.1016/j.mejo.2008.06.083
   Wang L, 2010, J POWER SOURCES, V195, P3814, DOI 10.1016/j.jpowsour.2009.12.127
   Wang L, 2008, SURF COAT TECH, V203, P816, DOI 10.1016/j.surfcoat.2008.05.045
   WISBEY A, 1987, BIOMATERIALS, V8, P477, DOI 10.1016/0142-9612(87)90085-8
   Zhao J, 2004, J ADHES SCI TECHNOL, V18, P1003, DOI 10.1163/1568561041257522
NR 32
TC 34
Z9 36
U1 5
U2 42
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD NOV 25
PY 2010
VL 205
IS 5
BP 1599
EP 1605
DI 10.1016/j.surfcoat.2010.07.111
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 697BN
UT WOS:000285487700074
DA 2018-10-19
ER

PT J
AU Szili, EJ
   Kumar, S
   DeNichilo, M
   Smart, RS
   Voelcker, NH
AF Szili, Endre J.
   Kumar, Sunil
   DeNichilo, Mark
   Smart, Roger St C.
   Voelcker, Nicolas H.
TI Development of surface modification techniques for the covalent
   attachment of insulin-like growth factor-1 (IGF-1) on PECVD
   silica-coated titanium
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 37th International Conference on Metallurgical Coatings and Thin Films
CY APR 26-30, 2010
CL San Diego, CA
SP Amer Vacuum Soc, Adv Surface Engn Div
DE PECVD silica; Titanium; Covalent attachment; IGF-1; XPS
ID CHEMICAL-VAPOR-DEPOSITION; SIMULATED BODY-FLUID; PLASMA; XPS
AB Osseointegration is a complex process governed by the interaction of many cell types including blood cells (erythrocytes, platelets and leukocytes), phagocytic cells (macrophages) and bone cells (osteoblasts and osteoclasts) on or near the implant surface. The implant surface can be modified through a variety of methods in order to achieve control of some of these cellular interactions and consequently increase the degree of implant fixation with the surrounding bone tissue. In this investigation, titanium was coated with hydroxylated silica by plasma enhanced chemical vapour deposition (PECVD) to increase the surface hydrophilicity and generate reactive surface silanol groups. Subsequently, the silica-coated titanium surface was further modified through silanisation to generate surfaces bearing different reactive chemical functionalities consisting of aldehydes, epoxides and isocyanates, which can react with the amino groups of proteins and growth factors. 2,2,2-trifluoroethylamine (FEAM) was reacted on these surfaces to determine the coupling efficiency of the different surface chemical functionalities. The amino group of FEAM can react with an amino-reactive surface functional group to form a surface terminated with 3 fluorine atoms per FEAM molecule that can be detected by X-ray photoelectron spectroscopy. By analysing the techniques used for protein attachment with the FEAM model molecule, a successful method for isocyanate/amine coupling was found and later adapted for tethering IGF-1 molecules to the functionalised PECVD silica-coated titanium surface. Therefore, this simple method of preliminary testing protein reactivity may prove to be a cost effective strategy in the development of new biomaterial surfaces modified using protein bioconjugation methods. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.
C1 [Kumar, Sunil] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Szili, Endre J.; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem & Phys Sci, Bedford Pk, SA 5042, Australia.
   [Szili, Endre J.] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [DeNichilo, Mark] TGR Biosci, Theharton, SA 5031, Australia.
   [Smart, Roger St C.] Univ S Australia, Appl Ctr Struct & Synchrotron Studies, Mawson Lakes, SA 5095, Australia.
RP Kumar, S (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM sunil.kumar@unisa.edu.au; nico.voelcker@flinders.edu.au
RI Voelcker, Nicolas/D-6199-2012; Smart, Roger/D-1786-2009
OI Voelcker, Nicolas/0000-0002-1536-7804; 
CR ABBOTT JR, 2001, J CRANIOFAC SURG, V8, P17
   Arora PS, 1996, SURF INTERFACE ANAL, V24, P539, DOI 10.1002/(SICI)1096-9918(19960916)24:9<539::AID-SIA162>3.0.CO;2-5
   Brunette D. M., 2001, TITANIUM MED, P827
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   Hozumi A, 2006, SURF SCI, V600, P4044, DOI 10.1016/j.susc.2006.01.120
   JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
   Kokubo T, 2000, BONE ENG, P190
   LeRoith D, 2000, ENDOCRINOLOGY, V141, P1287, DOI 10.1210/en.141.4.1287
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MOSES PR, 1978, ANAL CHEM, V50, P576, DOI 10.1021/ac50026a010
   PENG L, 1987, APPL BIOCHEM BIOTECH, V14, P91, DOI 10.1007/BF02798427
   Perruchot C, 2002, SURF INTERFACE ANAL, V33, P869, DOI 10.1002/sia.1465
   Raspoet G, 1998, J ORG CHEM, V63, P6867, DOI 10.1021/jo980639+
   SODEK J, 2000, BONE ENG, P31
   Steveson M, 1998, SURF INTERFACE ANAL, V26, P1027, DOI 10.1002/(SICI)1096-9918(199812)26:13<1027::AID-SIA452>3.0.CO;2-9
   Szili EJ, 2008, SURF SCI, V602, P2402, DOI 10.1016/j.susc.2008.05.027
   Szili EJ, 2009, APPL SURF SCI, V255, P6846, DOI 10.1016/j.apsusc.2009.02.092
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   TANGVALL P, 2001, TITANIUM MED MAT SCI, P457
   WERGEDAL JE, 1990, J BONE MINER RES, V5, P179, DOI 10.1002/jbmr.5650050212
   WIELAND M, 2000, BONE ENG EM SQUARED
   Windler M. Klabunde, 2001, TITANIUM MED, P703
   Zhang HL, 2006, COLLOID SURFACE A, V291, P128, DOI 10.1016/j.colsurfa.2006.07.057
NR 26
TC 4
Z9 4
U1 0
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD NOV 25
PY 2010
VL 205
IS 5
BP 1630
EP 1635
DI 10.1016/j.surfcoat.2010.05.049
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 697BN
UT WOS:000285487700079
DA 2018-10-19
ER

PT J
AU Ghanaati, S
   Willershausen, I
   Barbeck, M
   Unger, RE
   Joergens, M
   Sader, RA
   Kirkpatrick, CJ
   Willershausen, B
AF Ghanaati, S.
   Willershausen, I.
   Barbeck, M.
   Unger, R. E.
   Joergens, M.
   Sader, R. A.
   Kirkpatrick, C. J.
   Willershausen, B.
TI TISSUE REACTION TO SEALING MATERIALS DIFFERENT VIEW AT BIOCOMPATIBILITY
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE AHPlus; Guttaflow; sealing material; biocompatibility; biomaterial
ID ROOT-CANAL SEALERS; INTRAOSSEOUS BIOCOMPATIBILITY; CONNECTIVE TISSUE;
   FILLING MATERIALS; MAXILLARY SINUS; CELL-LINES; IN-VIVO; CYTOTOXICITY;
   GENOTOXICITY; SCAFFOLDS
AB The biodegradability of root canal sealers in areas other than the root canal system is crucial to the overall success rate of endodontic treatment The aim of the present study was to investigate, the cell and tissue reaction to GuttaFlow and AHPlus, both in vitro and in vivo For the in vitro experiments the materials were incubated with Human Periodontal Ligament Fibroblasts and cell proliferation and cytotoxicity analyses were performed Additional fluorescence-microscope stainings were carried out in order to visualize cell growth and morphology For assessment of the tissue reaction to the materials a subcutaneous implantation model in Wistar rats was employed and the Inflammatory response to the materials was visualized by means of general and specific histology after 6 weeks Human gingival fibroblasts proliferation seemed to be dependent upon dental material and cultivation time After an incubation period of 96 hrs AHPlus proved to be significantly (p <0 002) more cytotoxic than GuttaFlow, as only a small number of fibroblasts survived on AHPlus In vivo, GuttaFlow was surrounded by a fibrous capsule and no degradation took place while AHPlus induced a well-vascularized granulation tissue in which the material was phagocyted by macrophages The results of this study demonstrate that potential cytotoxic effect of sealing material may beneficial in order to have antibacterial properties and induce self degradation when accidentally extruded over the apical foramen
C1 [Ghanaati, S.; Barbeck, M.; Unger, R. E.; Joergens, M.; Kirkpatrick, C. J.] Johannes Gutenberg Univ Mainz, REPAIR Lab, Inst Pathol, D-55101 Mainz, Germany.
   [Ghanaati, S.; Sader, R. A.] Goethe Univ Frankfurt, Med Ctr, Dept Oral Cranio Maxillofacial & Facial Plast Sur, Frankfurt, Germany.
   [Willershausen, I.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Dent Mat Sci & Technol, D-55101 Mainz, Germany.
   [Willershausen, B.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Operat Dent, D-55101 Mainz, Germany.
RP Ghanaati, S (reprint author), Johannes Gutenberg Univ Mainz, REPAIR Lab, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
RI Barbeck, Mike/D-9726-2015
CR Ashraf H, 2010, AUST ENDOD J, V36, P24, DOI 10.1111/j.1747-4477.2009.00173.x
   Batur YB, 2008, ORAL SURG ORAL MED O, V106, pE46, DOI 10.1016/j.tripleo.2008.06.008
   Bouillaguet S, 2006, J ENDODONT, V32, P989, DOI 10.1016/j.joen.2006.05.006
   Brackett MG, 2006, J ENDODONT, V32, P1188, DOI 10.1016/j.joen.2006.07.009
   Brzovic V, 2009, INT ENDOD J, V42, P253, DOI 10.1111/j.1365-2591.2008.01510.x
   Cohen BI, 2000, J ENDODONT, V26, P4
   Dawson Anthony S, 2006, Aust Endod J, V32, P57, DOI 10.1111/j.1747-4477.2006.00019.x
   Eldeniz AU, 2007, INT ENDOD J, V40, P329, DOI 10.1111/j.1365-2591.2007.01211.x
   Friedman S, 2003, J ENDODONT, V29, P787, DOI 10.1097/00004770-200312000-00001
   FRIEDMAN S, 2004, CDA J, V6, P493
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   GENCOGLU N, 2009, ACTA HISTOCHEM  0921
   Ghanaati S, 2008, TISSUE ENG PT A, V14, P917
   GHANAATI S, 2008, BIOMATERIALIEN, V9, P169
   GHANAATI S, 2008, BIOMATERIALIEN, V9, P90
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Giardino L, 2006, J ENDODONT, V32, P692, DOI 10.1016/j.joen.2005.12.001
   Gomes JE, 2007, J APPL ORAL SCI, V15, P186, DOI 10.1590/S1678-77572007000300007
   Grossman LI, 1940, ROOT CANAL THERAPY
   MOVAT HZ, 1955, ARCH PATHOL, V60, P289
   Pertot WJ, 1997, J ENDODONT, V23, P315, DOI 10.1016/S0099-2399(97)80413-X
   Camargo CHR, 2009, ORAL SURG ORAL MED O, V108, P952, DOI 10.1016/j.tripleo.2009.07.015
   Salehrabi R, 2004, J ENDODONT, V30, P846, DOI 10.1097/01.don.0000145031.04236.ca
   SAUNDERS WP, 1994, ENDOD DENT TRAUMATOL, V10, P105
   Sousa CJA, 2006, J ENDODONT, V32, P656, DOI 10.1016/j.joen.2005.12.003
   SWEAT F, 1964, ARCH PATHOL, V78, P69
   Willershausen B, 2000, J ENDODONT, V26, P703, DOI 10.1097/00004770-200012000-00007
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
NR 30
TC 10
Z9 14
U1 1
U2 5
PU I HOLZAPFEL VERLAG GMBH
PI MUNICH
PA HARTHAUSER STR 105, 81545 MUNICH, GERMANY
SN 0949-2321
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD NOV 25
PY 2010
VL 15
IS 11
BP 483
EP 492
DI 10.1186/2047-783X-15-11-483
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 695MC
UT WOS:000285373600004
PM 21159573
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Sadykov, MR
   Zhang, B
   Halouska, S
   Nelson, JL
   Kreimer, LW
   Zhu, YF
   Powers, R
   Somerville, GA
AF Sadykov, Marat R.
   Zhang, Bo
   Halouska, Steven
   Nelson, Jennifer L.
   Kreimer, Lauren W.
   Zhu, Yefei
   Powers, Robert
   Somerville, Greg A.
TI Using NMR Metabolomics to Investigate Tricarboxylic Acid Cycle-dependent
   Signal Transduction in Staphylococcus epidermidis
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID INTERCELLULAR ADHESIN PRODUCTION; CARBON CATABOLITE REPRESSION;
   VIRULENCE GENE-EXPRESSION; BIOFILM FORMATION; BACILLUS-SUBTILIS;
   SIGMA(B) REGULON; IRON LIMITATION; SIGB OPERON; AUREUS; GROWTH
AB Staphylococcus epidermidis is a skin-resident bacterium and a major cause of biomaterial-associated infections. The transition from residing on the skin to residing on an implanted biomaterial is accompanied by regulatory changes that facilitate bacterial survival in the new environment. These regulatory changes are dependent upon the ability of bacteria to "sense" environmental changes. In S. epidermidis, disparate environmental signals can affect synthesis of the biofilm matrix polysaccharide intercellular adhesin (PIA). Previously, we demonstrated that PIA biosynthesis is regulated by tricarboxylic acid (TCA) cycle activity. The observations that very different environmental signals result in a common phenotype (i.e. increased PIA synthesis) and that TCA cycle activity regulates PIA biosynthesis led us to hypothesize that S. epidermidis is "sensing" disparate environmental signals through the modulation of TCA cycle activity. In this study, we used NMR metabolomics to demonstrate that divergent environmental signals are transduced into common metabolomic changes that are "sensed" by metabolite-responsive regulators, such as CcpA, to affect PIA biosynthesis. These data clarify one mechanism by which very different environmental signals cause common phenotypic changes. In addition, due to the frequency of the TCA cycle in diverse genera of bacteria and the intrinsic properties of TCA cycle enzymes, it is likely the TCA cycle acts as a signal transduction pathway in many bacteria.
C1 [Sadykov, Marat R.; Nelson, Jennifer L.; Zhu, Yefei; Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.
   [Zhang, Bo; Halouska, Steven; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.
   [Kreimer, Lauren W.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.
RP Powers, R (reprint author), 722 Hamilton Hall, Lincoln, NE 68588 USA.
EM rpowers3@unl.edu; gsomerville3@unl.edu
RI Somerville, Greg/B-1326-2013; Zhu, Yefei/F-8940-2013; Sadykov,
   Marat/H-3147-2011
OI Somerville, Greg/0000-0002-0991-8737; Zhang, Bo/0000-0001-8858-1425
FU Hatch Act; National Institutes of Health [AI087668]; American Heart
   Association [0860033Z]
FX This manuscript is a contribution of the University of Nebraska
   Agricultural Research Division, supported in part by funds provided
   through the Hatch Act and from National Institutes of Health Grant
   AI087668 (to G. A. S.) and the American Heart Association Grant 0860033Z
   (to R. P.).
CR Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101
   Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005
   Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004
   Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001
   Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141
   Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1
   COLLINS FM, 1962, J GEN MICROBIOL, V29, P531, DOI 10.1099/00221287-29-3-531
   Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x
   Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312
   Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790
   Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Forgue P, 2006, J PROTEOME RES, V5, P1916, DOI 10.1021/pr060114v
   Goddard T. D., SPARKY 3
   Halouska S, 2006, J MAGN RESON, V178, P88, DOI 10.1016/j.jmr.2005.08.016
   Halouska S, 2007, J PROTEOME RES, V6, P4608, DOI 10.1021/pr0704332
   Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108
   HORTON RM, 1990, BIOTECHNIQUES, V8, P528
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892
   KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088
   KENNEDY MC, 1983, J BIOL CHEM, V258, P1098
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Korem M, 2007, FEMS MICROBIOL LETT, V269, P153, DOI 10.1111/j.1574-6968.2006.00625.x
   LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07
   Matinaho S, 2001, FEMS MICROBIOL LETT, V196, P177, DOI 10.1016/S0378-1097(01)00065-9
   Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x
   Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07
   MEKALANOS JJ, 1992, J BACTERIOL, V174, P1
   Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x
   Nguyen BD, 2007, J MAGN RESON, V184, P263, DOI 10.1016/j.jmr.2006.10.014
   Otzen DE, 2007, BIOCHEMISTRY-US, V46, P4348, DOI 10.1021/bi700091r
   PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S
   Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011
   PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Presterl E, 2007, J ANTIMICROB CHEMOTH, V60, P417, DOI 10.1093/jac/dkm221
   Retief J D, 2000, Methods Mol Biol, V132, P243
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   RUPP ME, 1997, STAPHYLOCOCCI HUMAN, P379
   Sadykov MR, 2008, J BACTERIOL, V190, P7621, DOI 10.1128/JB.00806-08
   Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08
   Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x
   Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x
   Somerville G, 1999, J BACTERIOL, V181, P1072
   Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003
   Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003
   Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002
   Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09
   Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772
   Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09
   Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957
   Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003
   Werth MT, 2010, ANAL BIOCHEM, V399, P58, DOI 10.1016/j.ab.2009.12.022
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996
   Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09
NR 71
TC 27
Z9 27
U1 0
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 19
PY 2010
VL 285
IS 47
BP 36616
EP 36624
DI 10.1074/jbc.M110.152843
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 679FE
UT WOS:000284146100050
PM 20861019
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Weiss, MS
   Bernabe, BP
   Bellis, AD
   Broadbelt, LJ
   Jeruss, JS
   Shea, LD
AF Weiss, Michael S.
   Bernabe, Beatriz Penalver
   Bellis, Abigail D.
   Broadbelt, Linda J.
   Jeruss, Jacqueline S.
   Shea, Lonnie D.
TI Dynamic, Large-Scale Profiling of Transcription Factor Activity from
   Live Cells in 3D Culture
SO PLOS ONE
LA English
DT Article
ID BREAST-CANCER CELLS; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; SIGNALING
   PATHWAY; EXTRACELLULAR-MATRIX; AP-1 TRANSCRIPTION; GROWTH-INHIBITION;
   ESTROGEN-RECEPTOR; EPITHELIAL-CELLS; MICROARRAY DATA
AB Background: Extracellular activation of signal transduction pathways and their downstream target transcription factors (TFs) are critical regulators of cellular processes and tissue development. The intracellular signaling network is complex, and techniques that quantify the activities of numerous pathways and connect their activities to the resulting phenotype would identify the signals and mechanisms regulating tissue development. The ability to investigate tissue development should capture the dynamic pathway activity and requires an environment that supports cellular organization into structures that mimic in vivo phenotypes. Taken together, our objective was to develop cellular arrays for dynamic, large-scale quantification of TF activity as cells organized into spherical structures within 3D culture.
   Methodology/Principal Findings: TF-specific and normalization reporter constructs were delivered in parallel to a cellular array containing a well-established breast cancer cell line cultured in Matrigel. Bioluminescence imaging provided a rapid, non-invasive, and sensitive method to quantify luciferase levels, and was applied repeatedly on each sample to monitor dynamic activity. Arrays measuring 28 TFs identified up to 19 active, with 13 factors changing significantly over time. Stimulation of cells with beta-estradiol or activin A resulted in differential TF activity profiles evolving from initial stimulation of the ligand. Many TFs changed as expected based on previous reports, yet arrays were able to replicate these results in a single experiment. Additionally, arrays identified TFs that had not previously been linked with activin A.
   Conclusions/Significance: This system provides a method for large-scale, non-invasive, and dynamic quantification of signaling pathway activity as cells organize into structures. The arrays may find utility for investigating mechanisms regulating normal and abnormal tissue growth, biomaterial design, or as a platform for screening therapeutics.
C1 [Weiss, Michael S.; Bernabe, Beatriz Penalver; Bellis, Abigail D.; Broadbelt, Linda J.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Jeruss, Jacqueline S.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Evanston, IL USA.
   [Jeruss, Jacqueline S.; Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst Bionanotechnol Med IBNAM, Evanston, IL USA.
RP Weiss, MS (reprint author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
EM j-jeruss@md.northwestern.edu; l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009; Broadbelt, Linda/B-7640-2009
FU National Institutes of Health [R21CA125285, UL1DE019587, T32GM008449];
   Chicago Biomedical Consortium
FX National Institutes of Health - R21CA125285, UL1DE019587, T32GM008449
   (www.nih.gov). Chicago Biomedical Consortium
   (http://www.chicagobiomedicalconsortium.org/). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930
   Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381
   Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553
   Chang JH, 1998, MOL CELL BIOL, V18, P4986, DOI 10.1128/MCB.18.9.4986
   Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116
   Cocolakis E, 2001, J BIOL CHEM, V276, P18430, DOI 10.1074/jbc.M010768200
   Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365
   Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939
   Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906
   de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008
   Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695
   Dedieu S, 2006, CELL SIGNAL, V18, P889, DOI 10.1016/j.cellsig.2005.08.001
   Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729
   Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035
   Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580
   Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8
   Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187
   Ho J, 2004, CELL SIGNAL, V16, P693, DOI 10.1016/j.cellsig.2003.11.002
   Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059
   Ikeda K, 2004, ARCH HISTOL CYTOL, V67, P435, DOI 10.1679/aohc.67.435
   Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816
   JIANG SY, 1992, MOL CELL ENDOCRINOL, V90, P77, DOI 10.1016/0303-7207(92)90104-E
   Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4
   Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703
   Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004
   Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838
   King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255
   Liu JW, 1999, CELL GROWTH DIFFER, V10, P677
   Lonnstedt I, 2002, STAT SINICA, V12, P31
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001
   Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707
   Molinari AM, 2000, CANCER RES, V60, P2594
   Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x
   Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822
   Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   PHILIPS A, 1993, J BIOL CHEM, V268, P14103
   R Team:, 2008, R LANG ENV STAT COMP
   Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002
   Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186
   Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217
   Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187
   Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Smyth GK, 2005, STAT BIOL HEALTH, P397
   Souchelnytskyi S, 2002, J MAMMARY GLAND BIOL, V7, P359, DOI 10.1023/A:1024029930563
   Streuli CH, 1999, J MAMMARY GLAND BIOL, V4, P183, DOI 10.1023/A:1018729308878
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Woodward TL, 2000, ENDOCRINOLOGY, V141, P2814, DOI 10.1210/en.141.8.2814
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Yun CH, 2007, DEVELOPMENT, V134, P769, DOI 10.1242/dev.02778
   Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042
   Zhang YY, 2009, MOL CANCER RES, V7, P498, DOI 10.1158/1541-7786.MCR-08-0415
NR 66
TC 21
Z9 21
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2010
VL 5
IS 11
AR e14026
DI 10.1371/journal.pone.0014026
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 681OY
UT WOS:000284327800012
PM 21103341
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Park, JK
   Kim, YJ
   Yeom, J
   Jeon, JH
   Yi, GC
   Je, JH
   Hahn, SK
AF Park, Jung Kyu
   Kim, Yong-Jin
   Yeom, Junseok
   Jeon, Ju Hyeong
   Yi, Gyu-Chul
   Je, Jung Ho
   Hahn, Sei Kwang
TI The Topographic Effect of Zinc Oxide Nanoflowers on Osteoblast Growth
   and Osseointegration
SO ADVANCED MATERIALS
LA English
DT Article
ID CELL-ADHESION; REGENERATION; TITANIUM; BIOCOMPATIBILITY; NANOTOPOGRAPHY;
   NANOWIRES; NANORODS; BEHAVIOR
AB ZnO nanoflowers prepared by a solution-based hydrothermal growth method result in effective osteoblast growth with higher DNA content, ALP activity, and adhesion strength than those on ZnO film. Furthermore, ZnO nanoflowers are tightly osseointegrated into the regenerated bones. The approach for fabricating nanoflower structures on biomaterial surfaces can be successfully exploited for various bone tissue engineering applications.
C1 [Park, Jung Kyu; Yeom, Junseok; Jeon, Ju Hyeong; Je, Jung Ho; Hahn, Sei Kwang] Pohang Univ Sci & Technol POSTECH, Dept Mat Sci & Engn, Pohang 790784, Kyungbuk, South Korea.
   [Kim, Yong-Jin; Yi, Gyu-Chul] Seoul Natl Univ, Dept Phys & Astron, Natl CRI Ctr Semicond Nanorods, Seoul 151742, South Korea.
RP Hahn, SK (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Mat Sci & Engn, San 31, Pohang 790784, Kyungbuk, South Korea.
EM skhanb@postech.ac.kr
RI Kim, Yong-Jin/D-2550-2009; Yi, Gyu-Chul/F-1326-2011
OI Yeom, Junseok/0000-0003-3556-2911
FU Ministry of Health & Welfare, Republic of Korea [A084132]; Ministry of
   Education, Science and Technology [2009-0081871]; KOSEF
   [R16-2004-004-01001-0]
FX This study was supported by a grant of the Korea Health 21 R&D Project,
   Ministry of Health & Welfare, Republic of Korea (A084132). This research
   was also supported by the Converging Research Center Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education, Science and Technology (2009-0081871). This work was also
   financially supported by the National Creative Research Initiative
   Project (R16-2004-004-01001-0) of KOSEF.
CR Alberts B, 2002, MOL BIOL CELL
   Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3
   CHEN ALJ, 2008, NANOTECHNOLOGY, V19
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912
   Zhou J, 2006, ADV MATER, V18, P2432, DOI 10.1002/adma.200600200
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim YJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/31/315202
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Lieber CM, 2007, MRS BULL, V32, P99, DOI 10.1557/mrs2007.41
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293
   Oh EJ, 2009, BIOMATERIALS, V30, P6026, DOI 10.1016/j.biomaterials.2009.07.024
   Park JK, 2009, ACTA BIOMATER, V5, P3394, DOI 10.1016/j.actbio.2009.05.019
   Qi SJ, 2009, ACS APPL MATER INTER, V1, P30, DOI 10.1021/am800027d
   Wang ZL, 2008, SCI AM, V298, P82, DOI 10.1038/scientificamerican0108-82
   Yeom J, 2010, BIOCONJUGATE CHEM, V21, P240, DOI 10.1021/bc9002647
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
NR 22
TC 52
Z9 54
U1 5
U2 75
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD NOV 16
PY 2010
VL 22
IS 43
BP 4857
EP +
DI 10.1002/adma.201002255
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 685HJ
UT WOS:000284619500012
PM 20830716
DA 2018-10-19
ER

PT J
AU Ding, MH
   Wang, BL
   Li, L
   Zheng, YF
AF Ding, M. H.
   Wang, B. L.
   Li, L.
   Zheng, Y. F.
TI A study of TaxC1-x coatings deposited on biomedical 316L stainless steel
   by radio-frequency magnetron sputtering
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE TaxC1-x coating; 316L stainless steel; Microstructure; Mechanical
   property; Corrosion; Hemocompatibility
ID AMORPHOUS-CARBON FILMS; TITANIUM-OXIDE FILMS; BLOOD COMPATIBILITY;
   CORROSION BEHAVIOR; PLATELET-ADHESION; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY; BIOMATERIAL; TEMPERATURE; NICKEL
AB In this paper, TaxC1-x coatings were deposited on 316L stainless steel (316L SS) by radio-frequency (RF) magnetron sputtering at various substrate temperatures (T-s) in order to improve its corrosion resistance and hemocompatibility. XRD results indicated that T-s could significantly change the microstructure of TaxC1-x coatings. When T-s was < 150 degrees C, the TaxC1-x coatings were in amorphous condition, whereas when T-s was >= 150 degrees C, TaC phase was formed, exhibiting in the form of particulates with the crystallite sizes of about 15-25nm (T-s = 300 degrees C). Atomic force microscope (AFM) results showed that with the increase of T-s, the root-mean-square (RMS) values of the TaxC1-x coatings decreased. The nano-indentation experiments indicated that the TaxC1-x coating deposited at 300 degrees C had a higher hardness and modulus. The scratch test results demonstrated that TaxC1-x coatings deposited above 150 degrees C exhibited good adhesion performance. Tribology tests results demonstrated that TaxC1-x coatings exhibited excellent wear resistance. The results of potentiodynamic polarization showed that the corrosion resistance of the 316L SS was improved significantly because of the deposited TaxC1-x coatings. The platelet adhesion test results indicated that the TaxC1-x coatings deposited at T-s of 150 degrees C and 300 degrees C possessed better hemocompatibility than the coating deposited at T-s of 25 degrees C. Additionally, the hemocompatibility of the TaxC1-x coating on the 316L SS was found to be influenced by its surface roughness, hydrophilicity and the surface energy. (C) 2010 Elsevier B. V. All rights reserved.
C1 [Zheng, Y. F.] Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
   [Ding, M. H.; Wang, B. L.; Li, L.; Zheng, Y. F.] Harbin Engn Univ, Ctr Biomed Mat & Engn, Harbin 150001, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, 5 Yi He Yuan Rd, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Wang, B.L./B-5317-2008
OI Zheng, Yufeng/0000-0002-7402-9979; 
FU Fundamental Research Funds for the Central Universities [HEUCFZ1017];
   Outstanding Youth Funding of Heilongjiang Province [JC200608]
FX This work was supported by the Fundamental Research Funds for the
   Central Universities (No. HEUCFZ1017) and the Outstanding Youth Funding
   of Heilongjiang Province (JC200608).
CR Alm SH, 2004, SURF COAT TECH, V177, P638, DOI 10.1016/S0257-8972(03)00939-3
   Barshilia HC, 2006, SURF COAT TECH, V201, P2193, DOI 10.1016/j.surfcoat.2006.03.037
   Brunski J. B., 2004, BIOMATERIALS SCI INT, P137
   Chen JY, 2000, MATER CHEM PHYS, V65, P310, DOI 10.1016/S0254-0584(00)00255-8
   COHEN JB, 1990, ULTRAMICROSCOPY, V34, P41, DOI 10.1016/0304-3991(90)90055-Q
   GEORGIEV G, 1986, VACUUM, V36, P595, DOI 10.1016/0042-207X(86)90327-1
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   HAUDRECHY P, 1993, CORROS SCI, V35, P329, DOI 10.1016/0010-938X(93)90164-C
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   HOSHINO S, 1986, J ELECTROCHEM SOC, V133, P681, DOI 10.1149/1.2108653
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang Y, 2008, APPL SURF SCI, V255, P257, DOI 10.1016/j.apsusc.2008.06.192
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Kwok SCH, 2006, DIAM RELAT MATER, V15, P893, DOI 10.1016/j.diamond.2005.10.062
   Leng YX, 2001, THIN SOLID FILMS, V398, P471, DOI 10.1016/S0040-6090(01)01448-1
   Liu CL, 2006, SURF COAT TECH, V201, P2802, DOI 10.1016/j.surfcoat.2006.05.028
   Macionczyk F, 2001, SURF COAT TECH, V142, P1084, DOI 10.1016/S0257-8972(01)01096-9
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   PalDey S, 2003, MAT SCI ENG A-STRUCT, V342, P58, DOI 10.1016/S0921-5093(02)00259-9
   Pan CJ, 2007, J MATER SCI-MATER M, V18, P2193, DOI 10.1007/s10856-007-3075-9
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   TSAI RY, 1989, J ELECTROCHEM SOC, V136, P1341, DOI 10.1149/1.2096918
   Wang LP, 2002, MAT SCI ENG A-STRUCT, V336, P75, DOI 10.1016/S0921-5093(01)01923-2
   Yang WM, 2007, SURF COAT TECH, V201, P8062, DOI 10.1016/j.surfcoat.2006.02.058
   Yoon SG, 2005, THIN SOLID FILMS, V475, P239, DOI 10.1016/j.tsf.2004.07.043
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
   Zhang L, 2008, DIAM RELAT MATER, V17, P1922, DOI 10.1016/j.diamond.2008.04.011
   Zheng YF, 2006, MAT SCI ENG A-STRUCT, V438, P891, DOI 10.1016/j.msea.2006.01.131
NR 34
TC 11
Z9 13
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2010
VL 257
IS 3
BP 696
EP 703
DI 10.1016/j.apsusc.2010.07.026
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 651QJ
UT WOS:000281941900007
DA 2018-10-19
ER

PT J
AU Chiu, LLY
   Radisic, M
   Vunjak-Novakovic, G
AF Chiu, Loraine L. Y.
   Radisic, Milica
   Vunjak-Novakovic, Gordana
TI Bioactive Scaffolds for Engineering Vascularized Cardiac Tissues
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterial; scaffold; growth factors; angipoietin-1; VEGF;
   immobilization; vasculogenesis; tissue engineering; cardiac muscle
ID ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC STEM-CELLS; INFARCTED RAT HEARTS;
   MYOCARDIAL-INFARCTION; IN-VITRO; COVALENT INCORPORATION;
   ISCHEMIC-MYOCARDIUM; SUSTAINED DELIVERY; ALGINATE HYDROGELS; COLLAGEN
   MATRICES
AB Functional vascularization is a key requirement for the development and function of most tissues, and most critically cardiac muscle. Rapid and irreversible loss of cardiomyocytes during cardiac infarction directly results from the lack of blood supply. Contractile cardiac grafts, engineered using cardiovascular cells in conjunction with biomaterial scaffolds, are an actively studied method for cardiac repair. In this article, we focus on biomaterial scaffolds designed to mediate the development and maturation of vascular networks, by immobilized growth factors. The interactive effects of multiple vasculogenic factors are discussed in the context of cardiac tissue engineering.
C1 [Chiu, Loraine L. Y.; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
RP Radisic, M (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 164 Coll St,Room 407, Toronto, ON M5S 3G9, Canada.
EM m.radisic@utoronto.ca; gv2131@columbia.edu
RI vunjak-novakovic, gordana/J-9279-2012
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Radisic,
   Milica/0000-0003-1249-4135
FU Canadian Institutes of Health Research; Natural Sciences and Engineering
   Research Council of Canada; Heart and Stroke Foundation [NA6077]; NSERC;
   National Institutes of Health [HL076485, EB002520, HL088913]
FX The authors gratefully acknowledge funding support by the Canadian
   Institutes of Health Research and Natural Sciences and Engineering
   Research Council of Canada (CARE project and CHRP grant to MR), the
   Heart and Stroke Foundation Grant-in-Aid (NA6077 to MR), NSERC Alexander
   Graham Bell Canada Graduate Scholarship (to L.L.Y.C.), and National
   Institutes of Health (HL076485, EB002520 and HL088913 to GVN). We also
   thank Dr. Nebojsa Mirkovic for his expert help with the preparation of
   figures.
CR Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077
   Boublik J, 2005, TISSUE ENG, V11, P1122, DOI 10.1089/ten.2005.11.1122
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Cheng M, 2007, TISSUE ENG, V13, P2709, DOI 10.1089/ten.2006.0414
   Chiang CK, 2010, ACTA BIOMATER, V6, P1904, DOI 10.1016/j.actbio.2009.12.005
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007
   Freytes DO, 2009, J CELL BIOCHEM, V108, P1047, DOI 10.1002/jcb.22355
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603
   Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Hoshiba T, 2007, BIOCHEM BIOPH RES CO, V359, P151, DOI 10.1016/j.bbrc.2007.05.079
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   JAY SM, 2009, CONTROLLED RELEASE, V134, P26
   Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03
   Jones N, 2003, MOL CELL BIOL, V23, P2658, DOI 10.1128/MCB.23.8.2658-2668.2003
   Kim SH, 2007, PEPTIDES, V28, P2125, DOI 10.1016/j.peptides.2007.08.010
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kwak HJ, 2000, CIRCULATION, V101, P2317, DOI 10.1161/01.CIR.101.19.2317
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee H, 2007, J BIOACT COMPAT POL, V22, P89, DOI 10.1177/0883911506073363
   Lee KW, 2004, TRANSPLANT P, V36, P2464, DOI 10.1016/j.transproceed.2004.08.078
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Metheny-Barlow LJ, 2004, MICROVASC RES, V68, P221, DOI 10.1016/j.mvr.2004.08.005
   Morisada T, 2006, ENDOTHELIUM-J ENDOTH, V13, P71, DOI 10.1080/10623320600697989
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   Oates M, 2007, BIOMATERIALS, V28, P3679, DOI 10.1016/j.biomaterials.2007.04.042
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Radisic M, 2009, TISSUE ENG PT A, V15, P851, DOI 10.1089/ten.tea.2008.0223
   RAKUSAN K, 1982, GROWTH, V46, P275
   RASK F, 2010, J BIOMED MAT RES A
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   RISAU W, 1991, PHARMACOL THERAPEUT, V51, P371, DOI 10.1016/0163-7258(91)90066-U
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105
   Saito M, 2003, CANCER SCI, V94, P782, DOI 10.1111/j.1349-7006.2003.tb01519.x
   SCHROEDER JW, 2007, HEAD NECK-J SCI SPEC, V137, P465
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Taguchi T, 2000, J BIOACT COMPAT POL, V15, P309, DOI 10.1106/U857-BGYG-UP8G-C6T3
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang DF, 2002, AM J PHYSIOL-GASTR L, V282, pG1088, DOI 10.1152/ajpgi.00250.2001
   Wang YH, 2004, J CELL PHYSIOL, V198, P53, DOI 10.1002/jcp.10386
   Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Zacchigna S, 2007, HUM GENE THER, V18, P515, DOI 10.1089/hum.2006.162
   Zhou L, 2005, GENE THER, V12, P196, DOI 10.1038/sj.gt.3302416
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 92
TC 27
Z9 27
U1 2
U2 23
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD NOV 10
PY 2010
VL 10
IS 11
SI SI
BP 1286
EP 1301
DI 10.1002/mabi.201000202
PG 16
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 675MG
UT WOS:000283834200002
PM 20857391
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Moutos, FT
   Estes, BT
   Guilak, F
AF Moutos, Franklin T.
   Estes, Bradley T.
   Guilak, Farshid
TI Multifunctional Hybrid Three-dimensionally Woven Scaffolds for Cartilage
   Tissue Engineering
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; biological applications of polymers; fibers;
   mechanical properties; modulus
ID MESENCHYMAL STEM-CELLS; INTRINSIC MECHANICAL-PROPERTIES;
   SMALL-INTESTINAL SUBMUCOSA; ARTICULAR-CARTILAGE; CHONDROGENIC
   DIFFERENTIATION; IN-VITRO; MATRIX; AGAROSE; GRAFT; IDENTIFICATION
AB The successful replacement of large-scale cartilage defects or osteoarthritic lesions using tissue-engineering approaches will likely require composite biomaterial scaffolds that have biomimetic mechanical properties and can provide cell-instructive cues to control the growth and differentiation of embedded stem or progenitor cells. This study describes a novel method of constructing multifunctional scaffolds for cartilage tissue engineering that can provide both mechanical support and biological stimulation to seeded progenitor cells. 3-D woven PCL scaffolds were infiltrated with a slurry of homogenized CDM of porcine origin, seeded with human ASCs, and cultured for up to 42 d under standard growth conditions. These constructs were compared to scaffolds derived solely from CDM as well as 3-D woven PCL fabric without CDM. While all scaffolds promoted a chondrogenic phenotype of the ASCs, CDM scaffolds showed low compressive and shear moduli and contracted significantly during culture. Fiber-reinforced CDM scaffolds and 3-D woven PCL scaffolds maintained their mechanical properties throughout the culture period, while supporting the accumulation of a cartilaginous extracellular matrix. These findings show that fiber-reinforced hybrid scaffolds can be produced with biomimetic mechanical properties as well as the ability to promote ASC differentiation and chondrogenesis in vitro.
C1 [Moutos, Franklin T.; Estes, Bradley T.; Guilak, Farshid] Duke Univ, Dept Orthopaed Surg, Med Ctr, Durham, NC 27710 USA.
   [Moutos, Franklin T.; Estes, Bradley T.; Guilak, Farshid] Duke Univ, Dept Biomed Engn, Med Ctr, Durham, NC 27710 USA.
RP Guilak, F (reprint author), Duke Univ, Dept Orthopaed Surg, Med Ctr, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
OI Guilak, Farshid/0000-0001-7380-0330
FU NIH [AR57600, AR55042, AR50245, AG15768, AR48182, AR48852]; Osteotech
   Inc.; Wallace H. Coulter Foundation; Duke Translational Research
   Institute [RR024128]; Kauffman Foundation
FX This work was supported in part by NIH grants AR57600, AR55042, AR50245,
   AG15768, AR48182, and AR48852, Osteotech Inc., the Wallace H. Coulter
   Foundation, the Duke Translational Research Institute RR024128, and the
   Kauffman Foundation. We also thank Simon Sutter of EMS-Griltech for
   generously donating PCL fiber and Dr. Lisa Freed for many helpful
   discussions.
CR ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Basile P, 2008, MOL THER, V16, P466, DOI 10.1038/sj.mt.6300395
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Chung S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015019
   Diekman B O, 2009, TISSUE ENG PART A, V16, P523
   DIEKMAN BO, 2009, J BIOMED MATER RES A, V93, P994
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Estes BT, 2008, BIOTECHNOL BIOENG, V99, P986, DOI 10.1002/bit.21662
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Janjanin S, 2008, J SURG RES, V149, P47, DOI 10.1016/j.jss.2007.12.788
   Jurvelin JS, 1997, J BIOMECH, V30, P235, DOI 10.1016/S0021-9290(96)00133-9
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Krishnan R, 2005, J BIOMECH, V38, P1665, DOI 10.1016/j.jbiomech.2004.07.025
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Leach JK, 2006, REGEN MED, V1, P447, DOI 10.2217/17460751.1.4.447
   Luo Y, 2004, BIOMACROMOLECULES, V5, P2315, DOI 10.1021/bm0495811
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Moutos F.T., 2009, TISSUE ENG PART A, V16, P1291
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Serrano MC, 2005, MACROMOL BIOSCI, V5, P415, DOI 10.1002/mabi.200400214
   SETTON LA, 1993, J BIOMECH, V26, P581, DOI 10.1016/0021-9290(93)90019-B
   Soltz MA, 2000, J BIOMECH ENG-T ASME, V122, P576, DOI 10.1115/1.1324669
   Toolan BC, 1998, J BIOMED MATER RES, V41, P244, DOI 10.1002/(SICI)1097-4636(199808)41:2<244::AID-JBM9>3.0.CO;2-I
   Tsuji H, 2003, POLYM INT, V52, P843, DOI 10.1002/pi.1199
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang HQ, 1997, J BIOMECH, V30, P771, DOI 10.1016/S0021-9290(97)00031-6
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Xu CC, 2007, TISSUE ENG, V13, P551, DOI 10.1089/ten.2006.0169
   Yim EKF, 2006, BIOMATERIALS, V27, P6111, DOI 10.1016/j.biomaterials.2006.07.037
NR 50
TC 54
Z9 55
U1 1
U2 28
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD NOV 10
PY 2010
VL 10
IS 11
SI SI
BP 1355
EP 1364
DI 10.1002/mabi.201000124
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 675MG
UT WOS:000283834200008
PM 20857388
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mehrhof, F
   Loffler, M
   Gelbrich, G
   Ozcelik, C
   Posch, M
   Hense, HW
   Keil, U
   Scheffold, T
   Schunkert, H
   Angermann, C
   Ertl, G
   Jahns, R
   Pieske, B
   Wachter, R
   Edelmann, F
   Wollert, KC
   Maisch, B
   Pankuweit, S
   Erbel, R
   Neumann, T
   Herzog, W
   Katus, H
   Muller-Tasch, T
   Zugck, C
   Dungen, HD
   Regitz-Zagrosek, V
   Lehmkuhl, E
   Stork, S
   Siebert, U
   Wasem, J
   Neumann, A
   Gohler, A
   Anker, SD
   Kohler, F
   Mockel, M
   Osterziel, KJ
   Dietz, R
   Rauchhaus, M
AF Mehrhof, Felix
   Loeffler, Markus
   Gelbrich, Goetz
   Oezcelik, Cemil
   Posch, Maximilian
   Hense, Hans-Werner
   Keil, Ulrich
   Scheffold, Thomas
   Schunkert, Heribert
   Angermann, Christiane
   Ertl, Georg
   Jahns, Roland
   Pieske, Burkert
   Wachter, Rolf
   Edelmann, Frank
   Wollert, Kai C.
   Maisch, Bernhard
   Pankuweit, Sabine
   Erbel, Raimund
   Neumann, Till
   Herzog, Wolfgang
   Katus, Hugo
   Mueller-Tasch, Thomas
   Zugck, Christian
   Duengen, Hans-Dirk
   Regitz-Zagrosek, Vera
   Lehmkuhl, Elke
   Stoerk, Stefan
   Siebert, Uwe
   Wasem, Juergen
   Neumann, Anja
   Goehler, Alexander
   Anker, Stefan D.
   Koehler, Friedrich
   Moeckel, Martin
   Osterziel, Karl-Josef
   Dietz, Rainer
   Rauchhaus, Mathias
CA Competence Network Heart Failure
TI A network against failing hearts-Introducing the German "Competence
   Network Heart Failure"
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Letter
DE Heart failure; Epidemiology of heart failure; Molecular mechanisms of
   heart failure; Pharmacological therapy of heart failure; Management of
   heart failure; Biomaterial banking
ID RATIONALE; DESIGN; MORTALITY; TRIAL
C1 [Mehrhof, Felix; Oezcelik, Cemil; Posch, Maximilian; Duengen, Hans-Dirk; Anker, Stefan D.; Koehler, Friedrich; Moeckel, Martin; Dietz, Rainer; Rauchhaus, Mathias] Charite, Dept Cardiol, D-13353 Berlin, Germany.
   [Loeffler, Markus; Gelbrich, Goetz] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.
   [Hense, Hans-Werner; Keil, Ulrich] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany.
   [Scheffold, Thomas] Univ Witten Herdecke, Inst Heart & Circulat Res, Dortmund, Germany.
   [Schunkert, Heribert] Univ Klinikum Schleswig Holstein, Cardiovasc & Pulm Med Ctr, D-23538 Lubeck, Germany.
   [Angermann, Christiane; Ertl, Georg; Jahns, Roland; Stoerk, Stefan] Univ Wurzburg, Dept Internal Med, Wurzburg, Germany.
   [Pieske, Burkert] Graz Univ, Dept Cardiol, Graz, Austria.
   [Wachter, Rolf; Edelmann, Frank] Univ Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany.
   [Wollert, Kai C.] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.
   [Maisch, Bernhard; Pankuweit, Sabine] Univ Hosp Giessen & Marburg, Dept Cardiol, Marburg, Germany.
   [Erbel, Raimund; Neumann, Till] Univ Essen Gesamthsch, W German Heart Ctr, Essen, Germany.
   [Katus, Hugo; Zugck, Christian] Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany.
   [Regitz-Zagrosek, Vera; Lehmkuhl, Elke] Charite, Cardiovasc Res Ctr, D-13353 Berlin, Germany.
   [Osterziel, Karl-Josef] Cardiopraxis Amberg, Amberg, Germany.
   [Wasem, Juergen; Neumann, Anja] Univ Duisburg Essen, Inst Hlth Care Management, Essen, Germany.
   [Siebert, Uwe; Goehler, Alexander] Harvard Univ, Sch Med, Cardiovasc Res Program, Inst Technol Assessment, Boston, MA USA.
   [Siebert, Uwe; Goehler, Alexander] Massachsetts Gen Hosp, Dept Radiol, Boston, MA USA.
   [Siebert, Uwe; Goehler, Alexander] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA.
   [Siebert, Uwe; Goehler, Alexander] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Informat Syst & Hlth Technol Asses, Hall In Tirol, Austria.
RP Mehrhof, F (reprint author), Charite, Dept Cardiol, Campus Virchow Klinikum, D-13353 Berlin, Germany.
EM felix.mehrhof@charite.de
RI Katus, Hugo/P-1712-2016
OI Wachter, Rolf/0000-0003-2231-2200; Wasem, Juergen/0000-0001-9653-168X
CR Angermann CE, 2007, EUR J HEART FAIL, V9, P1212, DOI 10.1016/j.ejheart.2007.10.005
   Coats AJS, 2009, INT J CARDIOL, V131, P149, DOI 10.1016/j.ijcard.2008.11.048
   Dungen HD, 2008, CLIN RES CARDIOL, V97, P578, DOI 10.1007/s00392-008-0681-6
   Gohler A, 2008, EUR J HEART FAIL, V10, P1026, DOI 10.1016/j.ejheart.2008.07.018
   Jahns R, 2006, INT J CARDIOL, V112, P7, DOI 10.1016/j.ijcard.2006.05.008
   Kohler F, 2007, DEUT MED WOCHENSCHR, V132, P458, DOI 10.1055/s-2007-970358
   Markus MRP, 2008, J HYPERTENS, V26, P2040, DOI 10.1097/HJH.0b013e328308da55
   Muller-Tasch T, 2007, J CARD FAIL, V13, P818, DOI 10.1016/j.cardfail.2007.07.008
   Neumann T, 2007, EUR J MED RES, V12, P243
   Posch MG, 2009, INT J CARDIOL, V136, P108, DOI 10.1016/j.ijcard.2008.03.089
   Pullicino P, 2006, J CARD FAIL, V12, P39, DOI 10.1016/j.cardfail.2005.07.007
   Stork S, 2008, EUR J HEART FAIL, V10, P1236, DOI 10.1016/j.ejheart.2008.09.008
NR 12
TC 23
Z9 23
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD NOV 5
PY 2010
VL 145
IS 1
BP 135
EP 138
DI 10.1016/j.ijcard.2009.06.061
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 674HA
UT WOS:000283727000076
PM 19679361
DA 2018-10-19
ER

PT J
AU Kim, DH
   Lee, H
   Lee, YK
   Nam, JM
   Levchenko, A
AF Kim, Deok-Ho
   Lee, Hyojin
   Lee, Young Kwang
   Nam, Jwa-Min
   Levchenko, Andre
TI Biomimetic Nanopatterns as Enabling Tools for Analysis and Control of
   Live Cells
SO ADVANCED MATERIALS
LA English
DT Article
ID DIP-PEN NANOLITHOGRAPHY; ELECTRON-BEAM LITHOGRAPHY; TISSUE ENGINEERING
   APPLICATIONS; SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   STEM-CELLS; SIGNAL-TRANSDUCTION; COLLAGEN NANOFIBERS; PROTEIN
   NANOARRAYS; FIBROUS SCAFFOLDS
AB It is becoming increasingly evident that cell biology research can be considerably advanced through the use of bioengineered tools enabled by nanoscale technologies. Recent advances in nanopatterning techniques pave the way for engineering biomaterial surfaces that control cellular interactions from the nano-to the microscale, allowing more precise quantitative experimentation capturing multi-scale aspects of complex tissue physiology in vitro. The spatially and temporally controlled display of extracellular signaling cues on nanopatterned surfaces (e. g., cues in the form of chemical ligands, controlled stiffness, texture, etc.) that can now be achieved on biologically relevant length scales is particularly attractive enabling experimental platform for investigating fundamental mechanisms of adhesion-mediated cell signaling. Here, we present an overview of bio-nanopatterning methods, with the particular focus on the recent advances on the use of nanofabrication techniques as enabling tools for studying the effects of cell adhesion and signaling on cell function. We also highlight the impact of nanoscale engineering in controlling cell-material interfaces, which can have profound implications for future development of tissue engineering and regenerative medicine.
C1 [Lee, Hyojin; Lee, Young Kwang; Nam, Jwa-Min] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea.
   [Kim, Deok-Ho; Levchenko, Andre] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
RP Nam, JM (reprint author), Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea.
EM jmnam@snu.ac.kr; alev@hju.edu
OI Kim, Deok-Ho/0000-0002-6989-6074
FU National Institutes of Health [1R21EB008562-01A1]; American Heart
   Association [0815104E]; National Research Foundation of Korea
   [20090077361]; 21C Frontier Functional Proteomics Project
   [FPR08-A2-150]; Korea Science and Engineering Foundation from Ministry
   of Education, Science and Technology; Seoul Science Fellowship
FX Authors D.-H. K. and H. Lee. and contribute equally to this work. This
   work was supported by the National Institutes of Health
   (1R21EB008562-01A1) and the American Heart Association (0815104E). This
   work was also supported by the National Research Foundation of Korea
   (20090077361), the 21C Frontier Functional Proteomics Project
   (FPR08-A2-150) and the Nano R&D Program (2008-02890) through the Korea
   Science and Engineering Foundation from Ministry of Education, Science
   and Technology. H. Lee and Y. K. Lee were partially supported from the
   Seoul Science Fellowship. We also acknowledge K.-J. Jang for helpful
   discussions.
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Bazilevsky AV, 2007, LANGMUIR, V23, P2311, DOI 10.1021/la063194q
   Ben-Haim N, 2008, NANO LETT, V8, P1368, DOI 10.1021/nl080105g
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Bhushan B, 2007, MICROELECTRON ENG, V84, P387, DOI 10.1016/j.mee.2006.10.059
   Boddapati SV, 2008, NANO LETT, V8, P2559, DOI 10.1021/nl801908y
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Burgin T, 2000, LANGMUIR, V16, P5371, DOI 10.1021/la000038p
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen Y, 2001, ELECTROPHORESIS, V22, P187, DOI 10.1002/1522-2683(200101)22:2<187::AID-ELPS187>3.0.CO;2-0
   Cheung CL, 2003, J AM CHEM SOC, V125, P6848, DOI 10.1021/ja034479h
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Christman KL, 2009, J AM CHEM SOC, V131, P521, DOI 10.1021/ja804767j
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040
   Coffey DC, 2005, J AM CHEM SOC, V127, P4564, DOI 10.1021/ja0428917
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   DALBY MJ, 2007, NAT MAT
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Gadegaard N, 2004, ADV MATER, V16, P1857, DOI 10.1002/adma.200400408
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651
   Groves JT, 2005, SCI STKE, V2005, ppe45
   Gu J, 2008, J VAC SCI TECHNOL B, V26, P1860, DOI 10.1116/1.2998754
   Hirschfeld-Warneken VC, 2008, EUR J CELL BIOL, V87, P743, DOI 10.1016/j.ejcb.2008.03.011
   Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298
   Hong JM, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/1/015003
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9
   Huo FW, 2008, SCIENCE, V321, P1658, DOI 10.1126/science.1162193
   Hyun J, 2004, J AM CHEM SOC, V126, P4770, DOI 10.1021/ja049956q
   Jan JS, 2005, CHEM MATER, V17, P4310, DOI 10.1021/cm0504440
   Jang KJ, 2008, SMALL, V4, P1930, DOI 10.1002/smll.200800270
   Jeoung E, 2001, LANGMUIR, V17, P6396, DOI 10.1021/la010531g
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Jiang HL, 2006, J BIOMED MATER RES B, V79B, P50, DOI 10.1002/jbm.b.30510
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim D H, 2009, P NATL ACAD SCI USA, V107, P565
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Krsko P, 2009, BIOMATERIALS, V30, P721, DOI 10.1016/j.biomaterials.2008.10.011
   Kukula H, 2002, J AM CHEM SOC, V124, P1658, DOI 10.1021/ja012091l
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee KB, 2003, J AM CHEM SOC, V125, P5588, DOI 10.1021/ja034236p
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee M, 2006, PROTEOMICS, V6, P1094, DOI 10.1002/pmic.200500392
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Lenhert S, 2007, SMALL, V3, P71, DOI 10.1002/smll.200600431
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li D, 2005, NANO LETT, V5, P913, DOI 10.1021/nl0504235
   Li HW, 2003, LANGMUIR, V19, P1963, DOI 10.1021/la0269098
   Li Nianzhen, 2003, Crit Rev Biomed Eng, V31, P423, DOI 10.1615/CritRevBiomedEng.v31.i56.20
   Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Lim JH, 2003, ANGEW CHEM INT EDIT, V42, P2309, DOI 10.1002/anie.200351256
   Liu GY, 2000, ACCOUNTS CHEM RES, V33, P457, DOI 10.1021/ar980081s
   Liu JF, 2004, APPL PHYS LETT, V84, P1359, DOI 10.1063/1.1647281
   Liu MZ, 2002, NANO LETT, V2, P863, DOI 10.1021/nl025626x
   Liu XH, 2009, BIOMATERIALS, V30, P4094, DOI 10.1016/j.biomaterials.2009.04.024
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Lussi JW, 2005, NANOTECHNOLOGY, V16, P1781, DOI 10.1088/0957-4484/16/9/062
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mannix RJ, 2008, NAT NANOTECHNOL, V3, P36, DOI 10.1038/nnano.2007.418
   Marchi-Artzner V, 2003, LANGMUIR, V19, P835, DOI 10.1021/la026227k
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McManus MC, 2007, J BIOMED MATER RES A, V81A, P299, DOI 10.1002/jbm.a.30989
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238
   Myung S, 2005, ADV MATER, V17, P2361, DOI 10.1002/adma.200500682
   Nakarnatsu K, 2006, J VAC SCI TECHNOL B, V24, P195, DOI 10.1116/1.2151913
   Nam JM, 2006, CHEMBIOCHEM, V7, P436, DOI 10.1002/cbic.200500479
   Nam JM, 2004, ANGEW CHEM INT EDIT, V43, P1246, DOI 10.1002/anie.200353203
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Odom TW, 2002, LANGMUIR, V18, P5314, DOI 10.1021/la020169l
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Pautot S, 2005, NAT CHEM BIOL, V1, P283, DOI 10.1038/nchembio737
   Pesen D, 2007, SOFT MATTER, V3, P1280, DOI 10.1039/b710659a
   PLAROCA M, 2007, LANGMUIR
   Rabuka D, 2007, J AM CHEM SOC, V129, P5462, DOI 10.1021/ja067819i
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e
   Rundqvist J, 2007, J AM CHEM SOC, V129, P59, DOI 10.1021/ja063698a
   Rundqvist J, 2006, LANGMUIR, V22, P5100, DOI 10.1021/la052306v
   Salaita K, 2005, SMALL, V1, P940, DOI 10.1002/smll.200500202
   Salaita K, 2006, ANGEW CHEM INT EDIT, V45, P7220, DOI 10.1002/anie.200603142
   Salaita KS, 2006, NANO LETT, V6, P2493, DOI 10.1021/nl061719t
   Schmid H, 2000, MACROMOLECULES, V33, P3042, DOI 10.1021/ma982034l
   Sekula S, 2008, SMALL, V4, P1785, DOI 10.1002/smll.200800949
   Seo J, 2009, BIOMACROMOLECULES, V10, P2254, DOI 10.1021/bm900439r
   Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191
   Smith JC, 2003, NANO LETT, V3, P883, DOI 10.1021/nl025956h
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771
   Torres AJ, 2008, ANNU REV BIOPHYS, V37, P265, DOI 10.1146/annurev.biophys.36.040306.132651
   Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h
   Vega RA, 2005, ANGEW CHEM INT EDIT, V44, P6013, DOI 10.1002/anie.200501978
   Vega RA, 2007, SMALL, V3, P1482, DOI 10.1002/smll.200700244
   Vieu C, 2000, APPL SURF SCI, V164, P111, DOI 10.1016/S0169-4332(00)00352-4
   Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9
   Wang XF, 2004, J VAC SCI TECHNOL B, V22, P2563, DOI 10.1116/1.1805544
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571
   XIA Y, 1996, SCIENCE, V273, P345
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   YAO L, 2009, J BIOMED MAT RES B
   Yoo PJ, 2004, CHEM MATER, V16, P5000, DOI 10.1021/cm049068u
   Zhang DM, 2008, NANO LETT, V8, P3283, DOI 10.1021/nl801667s
   Zhang DM, 2007, ADV MATER, V19, P3664, DOI 10.1002/adma.200700896
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhang YZ, 2004, CHEM MATER, V16, P3406, DOI 10.1021/cm049580f
   ZHAO YM, 1996, ADV MATER, V98, P837
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
NR 137
TC 105
Z9 106
U1 5
U2 112
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD NOV 2
PY 2010
VL 22
IS 41
BP 4551
EP 4566
DI 10.1002/adma.201000468
PG 16
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 677OV
UT WOS:000284002600002
PM 20803528
DA 2018-10-19
ER

PT J
AU D'Angelo, D
   Armentano, I
   Tiribuzi, R
   Mattioli, S
   Reale, U
   Montesano, S
   Crispoltoni, L
   Cerulli, GG
   Kenny, JM
   Palmerini, CA
   Martino, S
   Orlacchio, A
AF D'Angelo, D.
   Armentano, I.
   Tiribuzi, R.
   Mattioli, S.
   Reale, U.
   Montesano, S.
   Crispoltoni, L.
   Cerulli, G. G.
   Kenny, J. M.
   Palmerini, C. A.
   Martino, S.
   Orlacchio, A.
TI Stem cells and biomaterial interactions for neural tissue engineering
   models: A matter of mechanotransduction
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Meeting Abstract
CT 14th International Biotechnology Symposium and Exhibition (IBS-2008)
CY SEP 14-18, 2010
CL Rimini, ITALY
C1 [D'Angelo, D.; Tiribuzi, R.; Montesano, S.; Crispoltoni, L.; Martino, S.; Orlacchio, A.] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06100 Perugia, Italy.
   [Armentano, I.; Mattioli, S.; Kenny, J. M.] Univ Perugia, Mat Engn Ctr, I-06100 Perugia, Italy.
   [Reale, U.; Cerulli, G. G.] Univ Perugia, Dept Orthoped & Traumatol, I-06100 Perugia, Italy.
   [Palmerini, C. A.] Univ Perugia, Dipartimento Med Interna, I-06100 Perugia, Italy.
RI Kenny, Jose/F-9372-2010; Martino, Sabata/F-2309-2014
OI Kenny, Jose/0000-0001-6329-3048; Martino, Sabata/0000-0002-3942-237X
NR 0
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD NOV
PY 2010
VL 150
SU 1
BP S469
EP S470
DI 10.1016/j.jbiotec.2010.09.700
PG 2
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 741OQ
UT WOS:000288873402018
DA 2018-10-19
ER

PT J
AU Reslinski, A
   Mikucka, A
   Szmytkowski, J
   Glowacka, K
   Szczesny, W
   Gospodarek, E
   Dabrowiecki, S
AF Reslinski, Adrian
   Mikucka, Agnieszka
   Szmytkowski, Jakub
   Glowacka, Katarzyna
   Szczesny, Wojciech
   Gospodarek, Eugenia
   Dabrowiecki, Stanislaw
TI Biofilm Detection on the Surface of Hernia Mesh Implants
SO ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE hernia; surgical mesh; biofilm; TTC
ID INCISIONAL HERNIAS; SURGICAL MESHES; REPAIR; INFECTION; EXTRAPERITONEAL;
   EXPERIENCE; MODEL
AB Background. One serious complication of tension-free mesh hernioplasty is deep surgical site infection (SSI) involving the implant (mesh infection). As evidenced by in vitro studies, bacterial colonization of a synthetic implant may lead to the development of a biofilm on its surface, which is a serious therapeutic problem.
   Objectives. The goal of this study was to evaluate the usefulness of a biofilm detection method based on 2,3,5-triphenyltetrazolium chloride (TTC) for screening for the presence of bacterial biofilm on the surface of biomaterials utilized in hernia surgery.
   Material and Methods. The study group included samples of 12 synthetic implants harvested from 12 patients treated for deep SSIs after abdominal and inguinal hernia repair. The presence of biofilm was evaluated using the TTC reduction method, scanning electron microscopy and a quantitative method.
   Results.. Bacterial biofilm was found on the surfaces of all of the implants. The presence of a biofilm detected by TTC reduction was confirmed in each case by scanning electron microscopy and a quantitative method. The quantitative analysis yielded between 3.25 x 10(5) and 2.50 x 10(8) CFU/ml in the biofilm present on individual biomaterial samples.
   Conclusion. The TTC reduction method is useful for initial screening for the presence of a bacterial biofilm on the surface of implants utilized in hernia surgery (Adv Clin :Exp Med 2010, 19, 6, 685-690).
C1 [Reslinski, Adrian; Szmytkowski, Jakub; Szczesny, Wojciech; Dabrowiecki, Stanislaw] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Dept Gen & Endocrine Surg, PL-85094 Bydgoszcz, Poland.
   [Mikucka, Agnieszka; Gospodarek, Eugenia] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Dept Microbiol, PL-85094 Bydgoszcz, Poland.
   [Glowacka, Katarzyna] Warmia Mazury Univ, Dept Plant Physiol & Biotechnol, Olsztyn, Poland.
RP Reslinski, A (reprint author), Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Dept Gen & Endocrine Surg, M Sklodowskiej Curie 9, PL-85094 Bydgoszcz, Poland.
EM bigar@wp.pl
RI Szmytkowski, Jakub/F-6110-2014; Szczesny, Wojciech/F-6117-2014;
   Gospodarek, Eugenia/H-2511-2014; Reslinski, Adrian/E-9809-2014
OI Glowacka, Katarzyna/0000-0002-3649-4669
CR Andersson B, 2003, SURGERY, V133, P464, DOI 10.1067/msy.2003.98
   Bellon JM, 2001, BIOMATERIALS, V22, P2021, DOI 10.1016/S0142-9612(00)00390-2
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Lledo JB, 2009, CIR ESPAN, V85, P158, DOI 10.1016/j.ciresp.2008.09.008
   Engelsman AF, 2008, BRIT J SURG, V95, P1051, DOI 10.1002/bjs.6154
   Engelsman AF, 2010, ANN SURG, V251, P133, DOI 10.1097/SLA.0b013e3181b61d9a
   GALLIMORE B, 1991, J INFECT DIS, V164, P1220, DOI 10.1093/infdis/164.6.1220
   Hamy A, 2003, J AM COLL SURGEONS, V196, P531, DOI 10.1016/S1072-7515(03)00009-7
   Heniford BT, 2000, J AM COLL SURGEONS, V190, P645, DOI 10.1016/S1072-7515(00)00280-5
   HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606
   Jaloza D., 2009, SEPSIS, V2, P143
   Jezupors A, 2006, WORLD J SURG, V30, P2270, DOI 10.1007/s00268-006-0130-5
   Lal P, 2003, SURG ENDOSC, V17, P850, DOI 10.1007/s00464-002-8575-6
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Morrison JE, 2008, SURG LAPARO ENDO PER, V18, P33, DOI 10.1097/SLE.0b013e318157b155
   Nolla-Salas J, 2000, SCAND J INFECT DIS, V32, P560, DOI 10.1080/003655400458893
   Petersen S, 2001, EUR J SURG, V167, P453
   Praveen-Kumar, 2003, BIOL FERT SOILS, V38, P186, DOI 10.1007/s00374-003-0600-y
   Rasnake Mark S, 2006, Surg Infect (Larchmt), V7, P555, DOI 10.1089/sur.2006.7.555
   RESLINSKI A, 2008, CHIR POL, V3, P181
   Rios A, 2001, Hernia, V5, P148
   Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y
   Rosen MJ, 2009, AM J SURG, V197, P353, DOI 10.1016/j.amjsurg.2008.11.003
   Saygun O, 2006, J SURG RES, V131, P73, DOI 10.1016/j.jss.2005.06.020
   Sohail MR, 2004, J CLIN MICROBIOL, V42, P2858, DOI 10.1128/JCM.42.6.2858-2860.2004
   Taylor SG, 1999, BRIT J SURG, V86, P562
   UMEMOTO K, 1985, B CHEM SOC JPN, V58, P2051, DOI 10.1246/bcsj.58.2051
   Varghese TK, 2002, J SURG RES, V105, P115, DOI 10.1006/jsre.2002.6383
NR 28
TC 2
Z9 2
U1 0
U2 10
PU WROCLAW MEDICAL UNIV
PI WROCLAW
PA T CHALUBINSKIEGO 6A, WROCLAW, 50-368, POLAND
SN 1230-025X
J9 ADV CLIN EXP MED
JI Adv. Clin. Exp. Med.
PD NOV-DEC
PY 2010
VL 19
IS 6
BP 685
EP 690
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 727XN
UT WOS:000287836600004
DA 2018-10-19
ER

PT J
AU Adzet, JM
   Sorolla, RSS
   Castell, JC
AF Adzet, Jose M.
   Silvia Sorolla, Rosa Sabe
   Carles Castell, Joan
TI DRY BIOMATERIAL PRODUCTION FROM FRESH HIDES AND SKINS
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article; Proceedings Paper
CT 105th Annual Meeting of the American-Leather-Chemists-Association
CY JUN 18-21, 2009
CL Wheeling, WV
SP Amer Leather Chem Assoc
AB Fresh hides and skins were processed directly from the slaughterhouse. New unhairing and dewooling operations based on bath temperature control were applied, without affecting the quality and properties of the not yet stabilized collagen fibbers. The objective was the activation of the enzymes already present in raw hides and skins, resulting in an ecological process that avoids chemicals. Only small additions of auxiliaries to control pH were added to the unhairing or dewooling bath. Once hair and wool were removed from the grain side, the pelts were subjected to a solvent dehydration-degreasing operation, where the putrescible collagen material was converted into a stable dry collagen material able to be commercialized and easily stabilized by immersion procedures. It included the design of a new machine to obtain a collagen-dehydrated biomaterial (BCD) in a non-emission cycle using a polar solvent. The results are; curing and soaking are not necessary, salts and sulphides can be avoided. For this reason, this is projected to be a new non-pollutant beamhouse procedure followed by the production of dry collagenic material that is stable, spongy and with no special requirements for their storage and commercialization.
C1 [Adzet, Jose M.; Silvia Sorolla, Rosa Sabe; Carles Castell, Joan] AIICA, Igualada 08700, Spain.
RP Adzet, JM (reprint author), AIICA, Pla Massa S-N, Igualada 08700, Spain.
EM info@aiica.com
CR Adzet J. M., 1985, QUIMICA TECNICA TENE
   BARLETT PL, 1978, Patent No. 4147511
   Bienkiewicz K., 1983, PHYS CHEM LEATHER MA
   DIETER H, 1976, Patent No. 4039281
   Draeger A., 1972, LEDER, V23, P220
   HEIDEMANN E, 1963, LEDER, V14, P87
   KOLLAGEN RG, 1967, DEHYDRATION ORGANIC
   MAIRE MS, 1976, JALCA, V71, P438
   OFLAHERTY F, 1962, CHEM TECHNOLOGY LEAT
   SOLUNTO G, 1990, CPMC, V66, P76
   1980, JALCA, V75, P138
NR 11
TC 0
Z9 0
U1 0
U2 2
PU AMER LEATHER CHEMISTS ASSOC
PI LUBBOCK
PA TEXAS TECH UNIV, BOX 45300, LUBBOCK, TX 79409-5300 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD NOV
PY 2010
VL 105
IS 11
BP 376
EP 382
PG 7
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 676GC
UT WOS:000283898000004
DA 2018-10-19
ER

PT J
AU Neira, IS
   Kolen'ko, YV
   Kommareddy, KP
   Manjubala, I
   Yoshimura, M
   Guitian, F
AF Neira, Ines S.
   Kolen'ko, Yury V.
   Kommareddy, Krishna P.
   Manjubala, Inderchand
   Yoshimura, Masahiro
   Guitian, Francisco
TI Reinforcing of a Calcium Phosphate Cement with Hydroxyapatite Crystals
   of Various Morphologies
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Biocomposite; calcium phosphate cement; reinforcement; mechanical
   properties; micromechanical properties; compression strength;
   nanoindentation; stiff interface
ID MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; BONE; COMPOSITE; BIOCERAMICS;
   CERAMICS; WHISKERS; FRACTURE; MODULUS; FIBERS
AB A series of biocomposite materials was successfully prepared by reinforcing advanced calcium phosphate cement with hydroxyapatite fibrous and elongated plate like particles. Powder X-ray diffraction showed that ball milled biocomposite precursors (dicalcium and ditetracalcium phosphates) entirely transform to a single phase hydroxyapatite end product within 7 h at 37 degrees C. Electron microscopy showed that, the resultant biocomposites are constituted of nanosclaed cement particles intimately associated with the reinforcement crystals. The influence of shape, size, and concentration of the hydroxyapatite filler on the compression strength of reinforced cements is discussed. The best compression strength of 37 +/- 3 MPa (enhancement of similar to 50 % compared to pure cement) was achieved using submicrometer-sized hydroxyapatite crystals with complementary shapes. Nanoindentation revealed that averaged elastic modulus and hardness values of the cements are consistent with those reported for trabecular and cortical human bones, indicating a good match of the micromechanical properties for their potential use for bone repair. The stiffness of the biocomposites was confirmed to gradate-compliant cement matrix, cement filler interface, and stiff filler-as a result of the structuring at the nanometer-micrometer level. This architecture is critical in conditioning the final mechanical properties of the functional composite biomaterial. In vitro cell culture experiments showed that the developed biomaterial system is noncytotoxic.
C1 [Neira, Ines S.; Guitian, Francisco] Univ Santiago de Compostela, Galician Inst Ceram, E-15782 Santiago De Compostela, Spain.
   [Neira, Ines S.; Kolen'ko, Yury V.; Yoshimura, Masahiro] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
   [Neira, Ines S.; Kommareddy, Krishna P.; Manjubala, Inderchand] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.
RP Neira, IS (reprint author), Univ Santiago de Compostela, Galician Inst Ceram, E-15782 Santiago De Compostela, Spain.
EM ines.sanchez@usc.es
RI INL, Citations/K-3436-2015; Kolen'ko, Yury/P-5890-2015; Yoshimura,
   Masahiro/H-5938-2011; Inderchand, Manjubala/B-9020-2012
OI INL, Citations/0000-0002-3745-5100; Kolen'ko, Yury/0000-0001-7493-1762;
   Yoshimura, Masahiro/0000-0003-1810-0301; Manjubala,
   I/0000-0003-4873-2377
FU Spanish Ministry of Education and Science [MAT2002-03857]; European
   Union [MEST-CT-2004-504465]
FX The authors thank Dr. T. Taniguchi for assistance with TEM work; C.
   Pilz-Allen for help with the cells experiment; and Dr. H. S. Gupta, Dr.
   A. V. Olenev, and T. P. B. Cotter for helpful discussions. This work was
   partially supported by the Spanish Ministry of Education and Science
   (MAT2002-03857) and the European Union Marie Curie EST Fellowship on
   Biomimetic Systems (MEST-CT-2004-504465).
CR BEHIRI JC, 1984, J BIOMECH, V17, P25, DOI 10.1016/0021-9290(84)90076-9
   BHATTACHARYA AK, 1988, INT J SOLIDS STRUCT, V24, P1287, DOI 10.1016/0020-7683(88)90091-1
   Bohner M, 2007, J MATER CHEM, V17, P3980, DOI 10.1039/b706411j
   BROWN WE, 1983, J DENT RES, V62, P672
   BROWN WE, 1985, Patent No. 4518430
   Burguera EF, 2005, J BIOMED MATER RES A, V75A, P966, DOI 10.1002/jbm.a.30497
   Dorner-Reisel A, 2004, ADV ENG MATER, V6, P572, DOI 10.1002/adem.200400401
   Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   GRENOBLE DE, 1972, J BIOMED MATER RES, V6, P221, DOI 10.1002/jbm.820060311
   GUO XE, 2001, BONE MECH HDB, P9
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kasuga T, 1996, J AM CERAM SOC, V79, P1821, DOI 10.1111/j.1151-2916.1996.tb08001.x
   Knepper M, 1998, J MATER SCI-MATER M, V9, P589, DOI 10.1023/A:1008965626695
   Kumar R, 2005, ACTA MATER, V53, P2327, DOI 10.1016/j.actamat.2005.01.039
   Lakes RS., 2003, BIOMATERIALS PRINCIP, P79
   Larbi ABC, 2006, J MATER ENG PERFORM, V15, P575, DOI 10.1361/105994906X124569
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6
   Muller FA, 2007, J AM CERAM SOC, V90, P3694, DOI 10.1111/J.1551-2916.2007.01967.x
   Neira IS, 2009, MAT SCI ENG C-MATER, V29, P2124, DOI 10.1016/j.msec.2009.04.011
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PARK K, 1994, J MATER RES, V9, P2476
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Roeder RK, 2003, J BIOMED MATER RES A, V67A, P801, DOI 10.1002/jbm.a.10140
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Turner C. H., 2001, BONE MECH HDB, P7
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Xu HHK, 2004, J BIOMED MATER RES A, V69A, P267, DOI 10.1002/jbm.a.20124
   Xu HHK, 2003, DENT MATER, V19, P359, DOI 10.1016/S0109-5641(02)00078-7
NR 33
TC 22
Z9 22
U1 2
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD NOV
PY 2010
VL 2
IS 11
BP 3276
EP 3284
DI 10.1021/am100710b
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 683EL
UT WOS:000284454400044
PM 21038864
DA 2018-10-19
ER

PT J
AU Ren, KF
   Fourel, L
   Rouviere, CG
   Albiges-Rizo, C
   Picart, C
AF Ren, Kefeng
   Fourel, Laure
   Rouviere, Cecile Gauthier
   Albiges-Rizo, Corinne
   Picart, Catherine
TI Manipulation of the adhesive behaviour of skeletal muscle cells on soft
   and stiff polyelectrolyte multilayers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell adhesion; Myoblasts or skeletal muscle cells; Layer-by-layer
   assembly; Mechanical properties; Muscle tissue engineering
ID EXTRACELLULAR-MATRIX; BIOMEDICAL APPLICATIONS; SUBSTRATE STIFFNESS;
   INTEGRIN ACTIVATION; FOCAL ADHESIONS; IN-VITRO; FILMS; DIFFERENTIATION;
   ELASTICITY; TISSUE
AB Polyelectrolyte multilayer coatings have emerged as substrates to control a variety of cell behaviour, including adhesion, proliferation and differentiation. In particular, it is possible to modulate film stiffness by physical or chemical cross-linking. In this study, we evaluate the adhesive behaviour of skeletal muscle cells (C2C12 myoblasts) during the initial steps of spreading on layer-by-layer films of controlled stiffness made of poly(L-lysine) and hyaluronan as model biomaterial surfaces for muscle tissue engineering. We show that integrin clustering, integrin actin cytoskeleton connection and focal adhesion formation for cell spreading can be decoupled by controlling film stiffness. This made it possible to switch the cells morphologically between round and spreading shapes depending on the stiffness of the microenvironment. Although hyaluronan is one of the main components of cross-linked multilayer films, the HA receptor CD44 did not appear to mediate early adhesion as suggested by the use of blocking antibodies. In contrast, integrins were found to play a pivotal role in early adhesion: their activation significantly enhanced C2C12 myoblast spreading on soft films, where they were otherwise round. Integrin clustering was also induced by the softer films and enhanced on the stiffest films. Conversely, the use of soluble inhibitors or blocking antibodies directed against integrins induced a round phenotype on stiff films, where cells were well spread out in control conditions. We show that specific integrins were involved in the adhesion process as blocking beta(3), but not beta(1) integrins inhibited cell adhesion. These soft, stiff films can thus be used to tune the adhesion of C2C12 myoblasts, an early key event in myogenesis, via integrin clustering and subsequent signalling. They may be further used to decorticate the signalling pathways associated with beta(3) integrins. (C) 2010 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Ren, Kefeng; Fourel, Laure; Picart, Catherine] Minatec, Grenoble Inst Technol, F-38016 Grenoble, France.
   [Ren, Kefeng; Fourel, Laure; Picart, Catherine] Minatec, LMGP, F-38016 Grenoble, France.
   [Rouviere, Cecile Gauthier] CNRS, CRBM, UMR 5237, IFR 122, F-34293 Montpellier, France.
   [Fourel, Laure; Albiges-Rizo, Corinne] Univ Grenoble 1, ERL CNRS3148, INSERM, Inst Albert Bonniot,U823, F-38042 Grenoble 9, France.
RP Picart, C (reprint author), Minatec, Grenoble Inst Technol, 3 Parvis Louis Neel, F-38016 Grenoble, France.
EM catherine.picart@minatec.grenoble-inp.fr
RI Ren, Ke-feng/I-3593-2012; Fourel, Laure/M-3061-2013; Albiges-Rizo,
   Corinne/M-2568-2013
OI PICART, Catherine/0000-0002-4854-6366; PICART,
   Catherine/0000-0003-0130-1000
FU Association Francaise contre les Myopathies (AFM) [12671]; Association
   pour la Recherche sur le Cancer (ARC) [7918]; Fondation Recherche
   Medicale [INE20061108297]; Agence Nationale pour la Recherche
   [ANR-06-NANO-006]; Institut Universitaire de France; ARC
FX This work was supported by the Association Francaise contre les
   Myopathies (AFM, Grant No. 12671), the Association pour la Recherche sur
   le Cancer (ARC, Grant No. 7918), the Fondation Recherche Medicale (Grant
   No. INE20061108297), and the Agence Nationale pour la Recherche (Grant
   ANR-06-NANO-006). C.P. is indebted to the Institut Universitaire de
   France for financial support and K.R. to the ARC for a post-doctoral
   fellowship. The groups of C.P. and C.A.B. come from the CNRS consortium
   CellTiss. We thank Dr. Marc Morgan (Matrix Research Centre, Manchester,
   UK) for fruitful discussions.
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076
   Bellin RM, 2009, P NATL ACAD SCI USA, V106, P22102, DOI 10.1073/pnas.0902639106
   Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Chen AA, 2009, BIOMATERIALS, V30, P1113, DOI 10.1016/j.biomaterials.2008.10.055
   Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017
   Cohen M, 2006, EMBO J, V25, P302, DOI 10.1038/sj.emboj.7600960
   Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004
   Crouzier T, 2009, BIOMACROMOLECULES, V10, P433, DOI 10.1021/bm8012378
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Kidambi S, 2004, J AM CHEM SOC, V126, P4697, DOI 10.1021/ja039359o
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827
   Meredith JE, 1997, TRENDS CELL BIOL, V7, P146, DOI 10.1016/S0962-8924(97)01002-7
   Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200
   Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724
   Neumann T, 2003, TISSUE ENG, V9, P995, DOI 10.1089/107632703322495637
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4
   Semenov OV, 2009, TISSUE ENG PT A, V15, P2977, DOI [10.1089/ten.tea.2008.0602, 10.1089/ten.TEA.2008.0602]
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 55
TC 39
Z9 40
U1 0
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2010
VL 6
IS 11
BP 4238
EP 4248
DI 10.1016/j.actbio.2010.06.014
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 663WS
UT WOS:000282921500007
PM 20601233
DA 2018-10-19
ER

PT J
AU Fundeanu, I
   Klee, D
   Schouten, AJ
   Busscher, HJ
   van der Mei, HC
AF Fundeanu, Irina
   Klee, Doris
   Schouten, Arend J.
   Busscher, Henk J.
   van der Mei, Henny C.
TI Solvent-free functionalization of silicone rubber and efficacy of PAAm
   brushes grafted from an amino-PPX layer against bacterial adhesion
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Solvent-free functionalization of silicone rubber;
   Poly(o-amino-p-xylylene-co-p-xylylene);
   gamma-Aminopropyltriethoxysilane; Polyacrylamide brushes; Bacterial
   adhesion
ID VAPOR-DEPOSITION POLYMERIZATION; MICROBIAL ADHESION; SURFACE
   MODIFICATION; CHEMICAL-STRUCTURE; IMPLANT DEVICES; POLYACRYLAMIDE;
   PROTEIN; ADSORPTION; POLYMERS; BIOFILMS
AB Silicone rubber is a frequently employed biomaterial that is prone to bacterial adhesion and biofilm formation. In this study, the surface of silicone rubber was solvent-free functionalized by chemical vapor deposition (CVD) of poly(o-amino-p-xylylene-co-p-xylylene (amino-PPX). Subsequently, the amino groups of the amino-PPX layer were used to introduce the initiator from a vapor phase for atom transfer radical polymerization of acrylamide to form polyacrylamide (PAAm) brushes. The modification steps were verified by means of X-ray photoelectron spectroscopy and attenuated total reflection-Fourier transform infrared spectroscopy. Adhesion of Staphylococcus aureus ATCC 12600 and Escherichia coli 3.14 to an amino-PPX-PAAm brush coating in a parallel plate flow chamber was strongly reduced with respect to non-coated silicone rubber - by 93% and 99%, respectively. For E. coli 3.14, this reduction is larger than that obtained for solvent functionalization of gamma-aminopropyltriethoxysilane-PAAm brushes due to the higher density of amino groups introduced by the CVD of amino-PPX. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Busscher, Henk J.; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Fundeanu, Irina; Schouten, Arend J.] Univ Groningen, Dept Polymer Chem, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
   [Klee, Doris] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52074 Aachen, Germany.
   [Klee, Doris] Rhein Westfal TH Aachen, DWI, D-52074 Aachen, Germany.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR ALEXANDER S, 1977, J PHYS-PARIS, V38, P977, DOI 10.1051/jphys:01977003808097700
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   Coates J., 2000, ENCY ANAL CHEM, V12, P10815, DOI DOI 10.1002/9780470027318.A5606
   Cringus-Fundeanu I, 2007, LANGMUIR, V23, P5120, DOI 10.1021/la063531v
   DEGENNES PG, 1976, J PHYS-PARIS, V37, P1445, DOI 10.1051/jphys:0197600370120144500
   Dijk F, 2000, J BIOMED MATER RES, V51, P408, DOI 10.1002/1097-4636(20000905)51:3<408::AID-JBM15>3.0.CO;2-M
   EldamerRinaudo M, 1997, J MATER CHEM, V7, P1549, DOI 10.1039/a702559i
   Elving GJ, 2001, J BIOMED MATER RES, V58, P421
   Esteves CLC, 2005, INFECT IMMUN, V73, P5198, DOI 10.1128/IAI.73.8.5198-5203.2005
   Fundeanu I, 2008, COLLOID SURFACE B, V64, P297, DOI 10.1016/j.colsurfb.2008.02.005
   George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012
   Husein IF, 2000, J MATER SCI LETT, V19, P1883, DOI 10.1023/A:1006774308291
   Jin ZL, 2009, COLLOID SURFACE B, V70, P53, DOI 10.1016/j.colsurfb.2008.12.005
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Kusakabe M, 1999, POLYM ADVAN TECHNOL, V10, P713, DOI 10.1002/(SICI)1099-1581(199912)10:12<713::AID-PAT932>3.0.CO;2-J
   Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1
   Lahann J, 1999, J MATER SCI-MATER M, V10, P443, DOI 10.1023/A:1008939400812
   Lahann J, 1998, MACROMOL RAPID COMM, V19, P441, DOI 10.1002/(SICI)1521-3927(19980901)19:9<441::AID-MARC441>3.0.CO;2-G
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Mirzadeh H, 1998, IRAN POLYM J, V7, P5
   Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339
   Nakanishi K., 1962, INFRARED ABSORPTION
   Rodrigues L, 2004, APPL MICROBIOL BIOT, V66, P306, DOI 10.1007/s00253-004-1674-7
   Roos A, 2003, BIOMATERIALS, V24, P4417, DOI 10.1016/S0142-9612(03)00342-9
   Schinkinger B, 2001, APPL SURF SCI, V179, P79, DOI 10.1016/S0169-4332(01)00267-7
   Silverstein R. M., 1998, SPECTROMETRIC IDENTI
   Suh KY, 2003, APPL PHYS LETT, V83, P4250, DOI 10.1063/1.1628392
   Volcker N, 2001, J MATER SCI-MATER M, V12, P111, DOI 10.1023/A:1008938525489
   WEISS N, 2005, THESIS RWTH AACHEN
   Wu T, 2002, J AM CHEM SOC, V124, P9394, DOI 10.1021/ja027412n
NR 31
TC 18
Z9 20
U1 3
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2010
VL 6
IS 11
BP 4271
EP 4276
DI 10.1016/j.actbio.2010.06.010
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 663WS
UT WOS:000282921500010
PM 20558329
DA 2018-10-19
ER

PT J
AU Chen, QZ
   Quinn, JMW
   Thouas, GA
   Zhou, XA
   Komesaroff, PA
AF Chen, Qi-Zhi
   Quinn, Julian M. W.
   Thouas, George A.
   Zhou, Xian
   Komesaroff, Paul A.
TI Bone-Like Elastomer-Toughened Scaffolds with Degradability Kinetics
   Matching Healing Rates of Injured Bone
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID POLY(GLYCEROL SEBACATE); BIODEGRADABLE ELASTOMER; MECHANICAL-PROPERTIES;
   IN-VIVO; TISSUE; BIOMATERIALS; BIOGLASS; BIOMECHANICS; BIOCERAMICS;
   PERSPECTIVE
AB Biomaterial scaffolds provide a potentially powerful means of creating precisely engineered bone tissue substitutes with appropriate architecture and mechanical properties. Despite many efforts, there are few satisfactory products available for clinical use, and significant challenges remain in the design of smart constructs, especially for mechanically functional scaffolds. For successful long-term repair of bone, a scaffold must be strong yet have degradation kinetics matching the healing rate of remodeling bone. Here we report a new family of elastomer-toughened composite scaffolds fabricated from poly(glycerol sebacate) and Bioglass (R). These synthetic scaffolds have very similar mechanical properties to that of cancellous bone of the same porosity, and exhibit a mechanically steady state over an extended period in a physiologic environment. The second feature is of great importance to bone tissue engineering, where a lag phase of degradation following implantation is highly desirable in order to provide support to the damaged or fragmented bone tissue. This work shows that a mechanically smart construct with the three-stage profile (lag, log, and plateau phases) of ideal degradation kinetics in mechanical function is achievable with synthetic biomaterials.
C1 [Chen, Qi-Zhi; Thouas, George A.; Zhou, Xian] Monash Univ, Dept Mat Engn, Div Biol Engn, Clayton, Vic 3800, Australia.
   [Quinn, Julian M. W.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia.
   [Quinn, Julian M. W.] Prince Henrys Inst, Clayton, Vic 3168, Australia.
   [Komesaroff, Paul A.] Monash Univ, Dept Med, Alfred Hosp, Melbourne, Vic 3181, Australia.
RP Chen, QZ (reprint author), Monash Univ, Dept Mat Engn, Div Biol Engn, Clayton, Vic 3800, Australia.
EM qizhi.chen@eng.monash.edu.au
CR AMLER MH, 1981, J PERIODONTAL RES, V16, P617, DOI 10.1111/j.1600-0765.1981.tb01000.x
   Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Beaupied H, 2007, JOINT BONE SPINE, V74, P233, DOI 10.1016/j.jbspin.2007.01.019
   Bettinger CJ, 2005, MATER RES SOC SYMP P, V845, P25
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen QZ, 2007, ACTA BIOMATER, V3, P551, DOI 10.1016/j.actbio.2007.01.008
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2006, ADV ENG MATER, V8, P285, DOI 10.1002/adem.200500259
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   Cukjati D, 2001, MED BIOL ENG COMPUT, V39, P263, DOI 10.1007/BF02344811
   Dekker RJ, 2005, BIOMATERIALS, V26, P5231, DOI 10.1016/j.biomaterials.2005.01.057
   Donnet J.B., 2005, SCI TECHNOLOGY RUBBE, P367
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   FRANZEN L, 1983, ACTA PATH MICRO IM A, V91, P281
   Gibson LJ, 1999, CELLULAR SOLIDS STRU, P429
   GRISS P, 1976, J BIOMED MATER RES, V10, P511, DOI 10.1002/jbm.820100406
   Hench L.L., 1999, INTRO BIOCERAMICS
   Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001
   Holand W, 2009, ADV APPL CERAM, V108, P373, DOI 10.1179/174367609X414099
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Juhasz JA, 2004, BIOMATERIALS, V25, P949, DOI 10.1016/j.biomaterials.2003.07.005
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   Lao J, 2008, J PHYS CHEM C, V112, P9418, DOI 10.1021/jp800583m
   Liu QY, 2009, POLYM DEGRAD STABIL, V94, P1427, DOI 10.1016/j.polymdegradstab.2009.05.023
   Ma LJ, 2007, ANAL SCI, V23, P799, DOI 10.2116/analsci.23.799
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Oliveira SM, 2009, TISSUE ENG PT A, V15, P635, DOI 10.1089/ten.tea.2008.0052
   Piegat A, 2008, ADV APPL CERAM, V107, P287, DOI 10.1179/174367508X297777
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Seal S, 2004, MRS BULL, V29, P9, DOI 10.1557/mrs2004.10
   Shah J, 2009, MAT SCI ENG A-STRUCT, V523, P199, DOI 10.1016/j.msea.2009.05.059
   Silva MJ, 2007, INJURY, V38, P69, DOI 10.1016/j.injury.2007.08.014
   Soffa WA, 2004, PROG MATER SCI, V49, P347, DOI 10.1016/S0079-6425(03)00029-X
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P2668, DOI 10.1016/j.actbio.2009.04.029
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wang YD, 2002, MATER RES SOC SYMP P, V724, P223
   Witte F, 2008, ORTHOPADE, V37, P125, DOI 10.1007/s00132-008-1193-9
NR 45
TC 13
Z9 13
U1 1
U2 13
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD NOV
PY 2010
VL 12
IS 11
BP B642
EP B648
DI 10.1002/adem.201080002
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 693FR
UT WOS:000285210500007
DA 2018-10-19
ER

PT J
AU Song, SJ
   Choi, J
   Park, YD
   Lee, JJ
   Hong, SY
   Sun, K
AF Song, Seung-Joon
   Choi, Jaesoon
   Park, Yong-Doo
   Lee, Jung-Joo
   Hong, So Young
   Sun, Kyung
TI A Three-Dimensional Bioprinting System for Use With a Hydrogel-Based
   Biomaterial and Printing Parameter Characterization
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Pediatric Mechanical Circulatory Support
   Systems and Pediatric Cardiopulmonary Perfusion
CY MAY 06-08, 2010
CL Boston, MA
DE Bioprinting; Regenerative medicine; Tissue engineering; 3D printing;
   Bioartificial organ
ID MAMMALIAN-CELLS
AB Bioprinting is an emerging technology for constructing tissue or bioartificial organs with complex three-dimensional (3D) structures. It provides high-precision spatial shape forming ability on a larger scale than conventional tissue engineering methods, and simultaneous multiple components composition ability. Bioprinting utilizes a computer-controlled 3D printer mechanism for 3D biological structure construction. To implement minimal pattern width in a hydrogel-based bioprinting system, a study on printing characteristics was performed by varying printer control parameters. The experimental results showed that printing pattern width depends on associated printer control parameters such as printing flow rate, nozzle diameter, and nozzle velocity. The system under development showed acceptable feasibility of potential use for accurate printing pattern implementation in tissue engineering applications and is another example of novel techniques for regenerative medicine based on computer-aided biofabrication system.
C1 [Song, Seung-Joon; Choi, Jaesoon; Park, Yong-Doo; Lee, Jung-Joo; Hong, So Young; Sun, Kyung] Korea Univ, Korea Artificial Organ Ctr, Seoul, South Korea.
   [Song, Seung-Joon; Choi, Jaesoon; Park, Yong-Doo; Hong, So Young] Korea Univ, Brain Korea Project Biomed Sci 21, Dept Biomed Engn, Seoul, South Korea.
   [Sun, Kyung] Korea Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 136705, South Korea.
RP Sun, K (reprint author), Univ Korea Hosp, Korea Artificial Organ Ctr, 126-1,Anam 5 Ga, Seoul 136705, South Korea.
EM ksunmd@kumc.or.kr
RI Jansen, Reza/M-8460-2018
FU Basic Research Program for the Korea Science & Engineering Foundation,
   Korea [2009-0076151, R01-2006-000-11368-0]; Ministry of Education and
   Human Resources Development, Republic of Korea
FX This work was supported in part by grants (No. 2009-0076151 and No.
   R01-2006-000-11368-0) from the Basic Research Program for the Korea
   Science & Engineering Foundation, Korea and by the Brain Korea 21
   Project of the Ministry of Education and Human Resources Development,
   Republic of Korea.
CR Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161
   BASTIEN R, 2009, FABRICATION 3D POROU
   Buyukhatipoglu K, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035003
   Jakab K, 2004, BIORHEOLOGY, V41, P371
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Sun W, 2002, COMPUT METH PROG BIO, V67, P85, DOI 10.1016/S0169-2607(01)00116-X
   Wilson WC, 2003, ANAT REC PART A, V272A, P491, DOI 10.1002/ar.a.10057
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
NR 8
TC 29
Z9 29
U1 4
U2 94
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD NOV
PY 2010
VL 34
IS 11
BP 1044
EP 1048
DI 10.1111/j.1525-1594.2010.01143.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 684XJ
UT WOS:000284588300030
PM 21092048
DA 2018-10-19
ER

PT J
AU Ajiro, H
   Akashi, M
AF Ajiro, Hiroharu
   Akashi, Mitsuru
TI Cell Proliferation on Stereoregular isotactic-Poly(propylene oxide) as a
   Bulk Substrate
SO BIOMACROMOLECULES
LA English
DT Article
DE m
ID WATER-STRUCTURE; BLOOD COMPATIBILITY; PLATELET COMPATIBILITY;
   POLY(PROPYLENE OXIDE); TRIBLOCK COPOLYMERS; BACTERIAL ADHESION;
   BLOCK-COPOLYMERS; POLYMER; SURFACES; METHACRYLATE)
AB Stereoregular isotactic-poly(propylene oxide) (it-PPO) was investigated for use as a biomaterial surface. The conventional characteristic of nonstereoregular atactic PPO was altered to a hydrophobic solid nature (contact angle: 95.6 +/- 3.8 degrees), which resulted in the potential solid surface applications. The high crystallinity of it-PPO created both smooth and rnicrosized, random crater-shaped surfaces using the spin coating and dip coating approaches, respectively. The results of protein adsorption with bovine serum albumin (BSA), bovine gamma globulin (B gamma G), and bovine plasma fibrinogen (BPF) showed multilayered adsorption onto it-PPO. Mouse fibroblast L929 cells adhered onto the it-PPO surfaces, and cultured well as compared with commercially available Cell Desk LFI as a control surface. These unique physical characteristics of it-PPO were due to the configuration of the polymer chain backbone structure, which maintained the polyether chemical structure.
C1 [Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.
   Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan.
RP Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.
EM akashi@chem.eng.osaka-u.ac.jp
FU Tokuyama Science Foundation;  [B; 21750220]
FX The authors are grateful to Dr. M. Matsusaki for the measurement of
   three-dimensional images with a laser scanning microscope. This study
   was partially supported by a Grant-in-Aid for Young Scientists (B;
   21750220) and Tokuyama Science Foundation. We thank Drs. T. Kida, M.
   Matsusaki. J. Watanabe, T. Akagi, and Prof. Geoffrey W. Coates for their
   helpful discussions.
CR Ajiro H, 2009, DALTON T, P8828, DOI 10.1039/b914573g
   ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Baugh L. S., 2007, STEREOSELECTIVE POLY
   Bromberg L, 2005, BIOCONJUGATE CHEM, V16, P626, DOI 10.1021/bc049749f
   Cakmakli B, 2005, BIOMACROMOLECULES, V6, P1750, DOI 10.1021/bm050063f
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Costa L, 1996, POLYM DEGRAD STABIL, V53, P301, DOI 10.1016/0141-3910(96)00094-8
   Doh J, 2010, BIOMATERIALS, V31, P3422, DOI 10.1016/j.biomaterials.2010.01.018
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   HATADA K, 1985, POLYM J, V17, P977, DOI 10.1295/polymj.17.977
   HAZER B, 1995, MACROMOL CHEM PHYSIC, V196, P1945, DOI 10.1002/macp.1995.021960614
   Hirahata W, 2008, J AM CHEM SOC, V130, P17658, DOI 10.1021/ja807709j
   Hirota E, 2006, J BIOMED MATER RES A, V76A, P540, DOI 10.1002/jbm.a.30563
   Hirota E, 2007, J BIOMED MATER RES A, V81A, P710, DOI 10.1002/jbm.a.31113
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA N, 1986, MACROMOLECULES, V19, P2464, DOI 10.1021/ma00163a027
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Kalayci OA, 2010, POLYM BULL, V65, P215, DOI 10.1007/s00289-009-0196-y
   KITAYAMA T, 1995, POLYM J, V27, P314, DOI 10.1295/polymj.27.314
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Kyomoto M, 2010, BIOMATERIALS, V31, P1017, DOI 10.1016/j.biomaterials.2009.10.055
   Kyomoto M, 2010, BIOMATERIALS, V31, P658, DOI 10.1016/j.biomaterials.2009.09.083
   Liaw J, 2000, J CONTROL RELEASE, V68, P273, DOI 10.1016/S0168-3659(00)00268-6
   Miyamoto D, 2008, LANGMUIR, V24, P5010, DOI 10.1021/la703813f
   NATTA G, 1955, J AM CHEM SOC, V77, P1708, DOI 10.1021/ja01611a109
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Nishikawa T, 2000, LANGMUIR, V16, P1337, DOI 10.1021/la9809170
   Niu GG, 2008, BIOMACROMOLECULES, V9, P2621, DOI 10.1021/bm800573e
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Peretti KL, 2005, J AM CHEM SOC, V127, P11566, DOI 10.1021/ja053451y
   PRICE CC, 1966, J AM CHEM SOC, V88, P4039, DOI 10.1021/ja00969a026
   Serizawa T, 2003, MACROMOLECULES, V36, P1762, DOI 10.1021/ma021611+
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   Watanabe J, 2003, SCI TECHNOL ADV MAT, V4, P539, DOI 10.1016/j.stam.2003.09.018
   Yasuda H, 2004, REACT FUNCT POLYM, V61, P277, DOI 10.1016/j.reactfunctpolym.2004.06.007
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
NR 40
TC 6
Z9 6
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2010
VL 11
IS 11
BP 2840
EP 2844
DI 10.1021/bm100926p
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 675FD
UT WOS:000283810900003
PM 20923199
DA 2018-10-19
ER

PT J
AU Luo, XG
   Zhang, LN
AF Luo, Xiaogang
   Zhang, Lina
TI Immobilization of Penicillin G Acylase in Epoxy-Activated Magnetic
   Cellulose Microspheres for Improvement of Biocatalytic Stability and
   Activities
SO BIOMACROMOLECULES
LA English
DT Article
ID MULTIPOINT COVALENT ATTACHMENT; SALT-INDUCED IMMOBILIZATION; ENZYME
   IMMOBILIZATION; OPTIMUM PERFORMANCE; SUPPORTS; DISSOLUTION;
   STABILIZATION; PROTEINS; LIGANDS; LIQUIDS
AB We prepared magnetic cellulose porous microspheres (MCM) with mean diameter of similar to 200 mu m by employing the sol-gel transition (SGT) method from a mixture of magnemite ferrofluid and cellulose dissolved in 7 wt % NaOH/12% urea aqueous solvent precooled to -12 degrees C. Subsequently, the cellulose microspheres were activated with epoxy chloropropane to enhance loading efficiency of biomacromolecules. Their morphology, structure, and properties were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray diffraction, and vibrating-sample magnetometer. The results indicated that the spherical magnetic gamma-Fe(2)O(3) nanoparticles with mean size of 10 nm were uniformly dispersed and embedded in the cellulose substrate of MCM, and the structure and nature of gamma-Fe(2)O(3) were conserved perfectly. Penicillin G acylase (PGA) as a biocatalyst was immobilized successfully in the porous microspheres, as a result of the existence of the cavity and affinity forces in the activated cellulose matrix. The immobilized PGA exhibited highly effective catalytic activity, thermal stability, and enhanced tolerance to pH variations. Furthermore, the cellulose microspheres loaded with the enzymes could be removed and recovered easily by introducing a magnetic field, leading to an acceptable reusability. Therefore, we have provided a simple and biocompatible support for the enzyme immobilization, which will be promising for the applications in the biomaterial fields.
C1 [Luo, Xiaogang; Zhang, Lina] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
RP Zhang, LN (reprint author), Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
EM lnzhang@public.wh.hb.cn
OI Zhang, Lina/0000-0003-3890-8690
FU National Basic Research Program of China [2010CB732203]; National
   Supporting Project for Science and Technology [2006BAF02A09]; National
   High Technology Research and Development Program of China [2003AA333040,
   2006AA02Z102]; National Natural Science Foundation of China [30530850,
   59933070, 20474048, 20874079]
FX This work was supported by National Basic Research Program of China (973
   Program, 2010CB732203), National Supporting Project for Science and
   Technology (2006BAF02A09), the National High Technology Research and
   Development Program of China (863 Program, 2003AA333040 and
   2006AA02Z102), major grants of the National Natural Science Foundation
   of China (30530850 and 59933070), and the National Natural Science
   Foundation of China (20474048 and 20874079).
CR Bagheri M, 2008, BIOMACROMOLECULES, V9, P381, DOI 10.1021/bm701023w
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Bornscheuer UT, 2003, ANGEW CHEM INT EDIT, V42, P3336, DOI 10.1002/anie.200301554
   Cai J, 2007, ADV MATER, V19, P821, DOI 10.1002/adma.200601521
   Cai J, 2006, J POLYM SCI POL PHYS, V44, P3093, DOI 10.1002/polb.20938
   Cai J, 2008, MACROMOLECULES, V41, P9345, DOI 10.1021/ma801110g
   Cao L. Q., 2005, CARRIER BOUND IMMOBI, P169
   Chen CI, 2007, J MEMBRANE SCI, V298, P24, DOI 10.1016/j.memsci.2007.03.054
   Cho SJ, 2002, B KOR CHEM SOC, V23, P929
   Corma A, 2001, CHEM COMMUN, P419, DOI 10.1039/b009232k
   Dradford MM, 1976, ANAL BIOCHEM, V72, P248
   Fernandez-Lafuente R, 1999, ENZYME MICROB TECH, V24, P96, DOI 10.1016/S0141-0229(98)00102-1
   GUISAN JM, 2006, IMMOBILIZATION ENZYM, P47
   Heinze T, 2001, PROG POLYM SCI, V26, P1689, DOI 10.1016/S0079-6700(01)00022-3
   Kallenberg AI, 2005, ADV SYNTH CATAL, V347, P905, DOI 10.1002/adsc.200505042
   Kaplan DL, 1998, BIOPOLYMERS RENEWABL, P1, DOI DOI 10.1007/978-3-662-03680-8_
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   KLEMM D, 2002, BIOPOLYMERS POLYSACC
   Lei L, 2009, J MAGN MAGN MATER, V321, P252, DOI 10.1016/j.jmmm.2008.08.047
   LUO X, 2008, Patent No. 2008100473141
   Luo XG, 2009, J HAZARD MATER, V171, P340, DOI 10.1016/j.jhazmat.2009.06.009
   Luo XG, 2009, J MATER CHEM, V19, P3538, DOI 10.1039/b900103d
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   Mateo C, 2002, BIOTECHNOL PROGR, V18, P629, DOI 10.1021/bp010171n
   Mateo C, 2000, BIOMACROMOLECULES, V1, P739, DOI 10.1021/bm000071q
   Mateo C, 2000, ENZYME MICROB TECH, V26, P509, DOI 10.1016/S0141-0229(99)00188-X
   Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018
   Mislovicova D, 2004, J BIOTECHNOL, V110, P11, DOI 10.1016/j.jbiotec.2004.01.006
   NELSON M. L., 1964, J APPL POLYM SCI, V8, P1311, DOI DOI 10.1002/APP.1964.070080322
   Norouzian D, 2002, ENZYME MICROB TECH, V30, P26, DOI 10.1016/S0141-0229(01)00445-8
   Pernemalm P.A., 1985, European Patent, Patent No. 0132244
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Schwertmann U, 2000, IRON OXIDES LAB PREP
   Sheldon R.A., 2007, BIOCATALYSIS PHARM B, P351
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   SHEWALE J G, 1987, Biotechnology Techniques, V1, P69, DOI 10.1007/BF00156291
   SUNDBERG L, 1974, J CHROMATOGR, V90, P87, DOI 10.1016/S0021-9673(01)94777-6
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Taqieddin E, 2004, BIOMATERIALS, V25, P1937, DOI 10.1016/j.biomaterials.2003.08.034
   Tominaga J, 2005, BIOMACROMOLECULES, V6, P2299, DOI 10.1021/bm050193o
   TURKOVA J, 1978, BIOCHIM BIOPHYS ACTA, V524, P162, DOI 10.1016/0005-2744(78)90114-6
   van Roon JL, 2005, BIOTECHNOL BIOENG, V89, P660, DOI 10.1002/bit.20345
   Wang W, 2007, ENZYME MICROB TECH, V40, P255, DOI 10.1016/j.enzmictec.2006.04.020
   WHEATLEY JB, 1993, J CHROMATOGR, V644, P11, DOI 10.1016/0021-9673(93)80114-N
   Wheatley JB, 1999, J CHROMATOGR A, V849, P1, DOI 10.1016/S0021-9673(99)00484-7
NR 45
TC 81
Z9 83
U1 2
U2 96
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2010
VL 11
IS 11
BP 2896
EP 2903
DI 10.1021/bm100642y
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 675FD
UT WOS:000283810900010
PM 20919701
DA 2018-10-19
ER

PT J
AU Zhang, Z
   Lai, YX
   Yu, L
   Ding, JD
AF Zhang, Zheng
   Lai, Yuxiao
   Yu, Lin
   Ding, Jiandong
TI Effects of immobilizing sites of RGD peptides in amphiphilic block
   copolymers on efficacy of cell adhesion
SO BIOMATERIALS
LA English
DT Article
DE Surface modification; Cell adhesion; RGD peptide; Block copolymer;
   Hydrogel
ID MESENCHYMAL STEM-CELLS; DIBLOCK COPOLYMERS; IN-VITRO; THERMOREVERSIBLE
   GELATION; TRIBLOCK COPOLYMER; AQUEOUS-SOLUTIONS; DRUG-DELIVERY;
   POLY(ETHYLENE GLYCOL); OSTEOBLAST ADHESION; INJECTABLE HYDROGEL
AB This paper examines the effects of immobilizing sites of a bioactive ligand on its biological efficacy in a self assembly biomaterial. We synthesized an amphiphilic block copolymer PCLA-PEG-PCLA (PCLA: poly(epsilon-caprolactone-co-lactide), PEG: poly(ethylene glycol)), and then achieved immobilization of arginine-glycine-aspartate (RGD) peptides into either hydrophobic PCLA blocks or hydrophilic PEG blocks. The block copolymers could self assemble into hydrogels composed of percolated micelle network in water, and the sal-gel transition temperature was adjusted between room and body temperatures. In vitro examinations of chondrocyte viability were performed. We found that immobilization of RGD in hydrophilic blocks enhanced cell adhesion on the corresponding hydrogel surface much more significantly than that in hydrophobic blocks. The difference might come from that RGD ligands in hydrophilic blocks are exposed on the micellar surface in water more than those in hydrophobic blocks. The present research highlights the importance of the immobilizing sites of RGD peptides in amphiphilic polymers on the eventual cell-binding efficacy, and is thus meaningful for guiding the molecular design of bioactive materials. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Zhang, Zheng; Lai, Yuxiao; Yu, Lin; Ding, Jiandong] Fudan Univ, Key Lab Mol Engn Polymers, Dept Macromol Sci, Minist Educ,Lab Adv Mat, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Key Lab Mol Engn Polymers, Dept Macromol Sci, Minist Educ,Lab Adv Mat, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
FU Chinese Ministry of Science and Technology [2009CB930000, 2005CB522700];
   NSF of China [20774020, 50903021]; Science and Technology Developing
   Foundation of Shanghai [074319117, 09ZR1403700]; Specialized Research
   Fund for the Doctoral Program of Higher Education of China
   [20090071120014]; Shanghai Education Committee [B112]
FX The authors are grateful for the financial supports from Chinese
   Ministry of Science and Technology (973 Program Nos. 2009CB930000 and
   2005CB522700), NSF of China (grant Nos. 20774020 and 50903021), Science
   and Technology Developing Foundation of Shanghai (grant Nos. 074319117
   and 09ZR1403700), the Specialized Research Fund for the Doctoral Program
   of Higher Education of China (grant No. 20090071120014), and Shanghai
   Education Committee (project No. B112).
CR Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Buwalda SJ, 2010, BIOMACROMOLECULES, V11, P224, DOI 10.1021/bm901080d
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chen K, 2009, BIOMATERIALS, V30, P6912, DOI 10.1016/j.biomaterials.2009.08.045
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Chun C, 2009, BIOMATERIALS, V30, P6295, DOI 10.1016/j.biomaterials.2009.08.011
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Danhier F, 2009, J CONTROL RELEASE, V140, P166, DOI 10.1016/j.jconrel.2009.08.011
   Deng C, 2006, BIOMACROMOLECULES, V7, P590, DOI 10.1021/bm050678c
   Devouge S, 2005, BIOORG MED CHEM LETT, V15, P3252, DOI 10.1016/j.bmcl.2005.04.071
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V68A, P615, DOI 10.1002/jbm.a.20051
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039
   Guo X, 2009, BIOMATERIALS, V30, P2741, DOI 10.1016/j.biomaterials.2009.01.048
   Hannachi IE, 2009, BIOMATERIALS, V30, P5427, DOI 10.1016/j.biomaterials.2009.06.033
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hiemstra C, 2007, J CONTROL RELEASE, V119, P320, DOI 10.1016/j.jconrel.2007.03.014
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jiang ZQ, 2007, J POLYM SCI POL CHEM, V45, P4091, DOI 10.1002/pola.22222
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   Kim EH, 2009, BIOMACROMOLECULES, V10, P2476, DOI 10.1021/bm9004436
   Kim HK, 2009, TISSUE ENG PT A, V15, P923, DOI 10.1089/ten.tea.2007.0407
   Kim MS, 2006, TISSUE ENG, V12, P2863, DOI 10.1089/ten.2006.12.2863
   Kim MS, 2006, J POLYM SCI POL CHEM, V44, P5413, DOI 10.1002/pola.21659
   Kuhlman W, 2007, BIOMACROMOLECULES, V8, P3206, DOI 10.1021/bm070237o
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Li F, 2005, BIOMATERIALS, V26, P3093, DOI 10.1016/j.biomaterials.2004.07.063
   Lieb E, 2005, BIOMATERIALS, V26, P2333, DOI 10.1016/j.biomaterials.2004.07.010
   Liu SQ, 2009, BIOMATERIALS, V30, P1453, DOI 10.1016/j.biomaterials.2008.11.023
   Liu XH, 2010, BIOMATERIALS, V31, P259, DOI 10.1016/j.biomaterials.2009.09.046
   Lo CL, 2009, BIOMATERIALS, V30, P3961, DOI 10.1016/j.biomaterials.2009.04.002
   Loh XJ, 2009, J PHYS CHEM B, V113, P11822, DOI 10.1021/jp903984r
   Lynn AD, 2009, J BIOMED MATER RES A, V93A, P941
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   NOZAKI H, 1967, TETRAHEDRON, V23, P45, DOI 10.1016/S0040-4020(01)83285-3
   Oba M, 2007, BIOCONJUGATE CHEM, V18, P1415, DOI 10.1021/bc0700133
   Park KH, 2005, J BIOSCI BIOENG, V99, P598, DOI 10.1263/jbb.99.598
   Park KH, 2005, BIOTECHNOL LETT, V27, P227, DOI 10.1007/s10529-004-8297-z
   Perlin L, 2008, SOFT MATTER, V4, P2331, DOI 10.1039/b801646a
   Pourcelle V, 2007, BIOMACROMOLECULES, V8, P3977, DOI 10.1021/bm700841y
   Pourcelle V, 2009, BIOMACROMOLECULES, V10, P966, DOI 10.1021/bm900027r
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Rerat V, 2010, J POLYM SCI POL CHEM, V48, P195, DOI 10.1002/pola.23778
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Weber CJ, 1930, J BIOL CHEM, V86, P217
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Xiong XB, 2007, BIOMACROMOLECULES, V8, P874, DOI 10.1021/bm060967g
   Xiong XB, 2009, BIOMATERIALS, V30, P242, DOI 10.1016/j.biomaterials.2008.09.025
   Xun W, 2009, MACROMOL BIOSCI, V9, P1219, DOI 10.1002/mabi.200900298
   Yamazaki CM, 2010, BIOMATERIALS, V31, P1925, DOI 10.1016/j.biomaterials.2009.10.014
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yasuda A, 2006, TISSUE ENG, V12, P1237, DOI 10.1089/ten.2006.12.1237
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v
NR 84
TC 112
Z9 117
U1 7
U2 146
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 31
BP 7873
EP 7882
DI 10.1016/j.biomaterials.2010.07.014
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 653PM
UT WOS:000282109100004
PM 20674012
DA 2018-10-19
ER

PT J
AU Benfenati, V
   Toffanin, S
   Capelli, R
   Camassa, LMA
   Ferroni, S
   Kaplan, DL
   Omenetto, FG
   Muccini, M
   Zamboni, R
AF Benfenati, Valentina
   Toffanin, Stefano
   Capelli, Raffaella
   Camassa, Laura M. A.
   Ferroni, Stefano
   Kaplan, David L.
   Omenetto, Fiorenzo G.
   Muccini, Michele
   Zamboni, Roberto
TI A silk platform that enables electrophysiology and targeted drug
   delivery in brain astroglial cells
SO BIOMATERIALS
LA English
DT Article
DE Silk platform; Astrocytes; Biocompatibility; Patch clamp; Potassium
   channels; Guanosine
ID RECTIFYING K+ CURRENTS; CENTRAL-NERVOUS-SYSTEM; GLIAL-CELLS;
   HIPPOCAMPAL-NEURONS; CORTICAL ASTROCYTES; ADENOSINE RELEASE; KIR4.1
   CHANNELS; ION CHANNELS; IN-VITRO; POTASSIUM
AB Astroglial cell survival and ion channel activity are relevant molecular targets for the mechanistic study of neural cell interactions with biomaterials and/or electronic interfaces. Astrogliosis is the most typical reaction to in vivo brain implants and needs to be avoided by developing biomaterials that preserve astroglial cell physiological function. This cellular phenomenon is characterized by a proliferative state and altered expression of astroglial potassium (K(+)) channels. Silk is a natural polymer with potential for new biomedical applications due to its ability to support in vitro growth and differentiation of many cell types. We report on silk interactions with cultured neocortical astroglial cells. Astrocytes survival is similar when plated on silk-coated glass and on poly-D-lysine (PDL), a well known polyionic substrate used to promote astroglial cell adhesion to glass surfaces. Comparative analyses of whole-cell patch-clamp experiments reveal that silk- and PDL-coated cells display depolarized resting membrane potentials (-40 mV), very high input resistance, and low specific conductance, with values similar to those of undifferentiated glial cells. Analysis of K(+) channel conductance reveals that silk-astrocytes express large outwardly delayed rectifying K(+) current (K(DR)). The magnitude of KDR in PDL- and silk-coated astrocytes is similar, indicating that silk does not alter the resting K(+) current. We also demonstrate that guanosine- (GUO) embedded silk enables the direct modulation of astroglial K(+) conductance in vitro. Astrocytes plated on GUO-embedded silk are more hyperpolarized and express inward rectifying K(+) conductance (K(ir)). The K(+) inward current increases and this is paralleled by upregulation and membrane polarization of K(ir)4.1 protein signal. Collectively these results indicate that silk is a suitable biomaterial platform for the in vitro studies of astroglial ion channel responses and related physiology. (c) 2010 Elsevier Ltd. Al! rights reserved.
C1 [Benfenati, Valentina; Toffanin, Stefano; Capelli, Raffaella; Muccini, Michele; Zamboni, Roberto] CNR, ISMN, I-40129 Bologna, Italy.
   [Camassa, Laura M. A.] Univ Oslo, Ctr Mol Biol & Neurosci, NO-0317 Oslo, Norway.
   [Ferroni, Stefano] Univ Bologna, Dept Human & Gen Physiol, I-40127 Bologna, Italy.
   [Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Benfenati, V (reprint author), CNR, ISMN, Via Gobetti 101, I-40129 Bologna, Italy.
EM v.benfenati@bo.ismn.cnr.it
RI Muccini, Michele/D-6935-2018; Zamboni, Roberto/P-3610-2015; Capelli,
   Raffaella/N-5625-2015; Benfenati, Valentina/D-4579-2016; Toffanin,
   Stefano/N-7651-2015
OI Muccini, Michele/0000-0003-0489-8316; Zamboni,
   Roberto/0000-0003-3739-2207; Capelli, Raffaella/0000-0001-8442-0202;
   Benfenati, Valentina/0000-0002-2858-8497; Toffanin,
   Stefano/0000-0003-4099-8664
FU EU [PF6 035859-2, FP7-ICT-248052]; NIH [P41 EB002520]
FX This work has been supported by EU projects PF6 035859-2 (BIMORE) and
   FP7-ICT-248052 (PHOTO-FET). We also would like to thank the NIH P41
   Tissue Engineering Resource Center (P41 EB002520) for partial financial
   support.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Benfenati V, 2006, J NEUROCHEM, V98, P430, DOI 10.1111/j.1471-4159.2006.03877.x
   Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017
   Boison D, 2009, BIOCHEM PHARMACOL, V78, P1428, DOI 10.1016/j.bcp.2009.08.005
   Bordey A, 1999, J NEUROPHYSIOL, V82, P3476
   Bordey A, 2000, NEUROREPORT, V11, P3151, DOI 10.1097/00001756-200009280-00022
   CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L
   Chvatal A, 2008, PHYSIOL RES, V57, pS101
   D'Ambrosio R, 1999, J NEUROSCI, V19, P8152
   FERRONI S, 1995, FEBS LETT, V367, P319, DOI 10.1016/0014-5793(95)00588-Z
   Habela CW, 2008, J NEUROSCI, V28, P9205, DOI 10.1523/JNEUROSCI.1897-08.2008
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574
   Hinterkeuser S, 2000, EUR J NEUROSCI, V12, P2087, DOI 10.1046/j.1460-9568.2000.00104.x
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008
   Kofuji P, 2000, J NEUROSCI, V20, P5733
   KRESSIN K, 1995, GLIA, V15, P173, DOI 10.1002/glia.440150210
   Lascola CD, 1996, J NEUROSCI, V16, P2532
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5
   Neary JT, 1996, TRENDS NEUROSCI, V19, P13, DOI 10.1016/0166-2236(96)81861-3
   Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171
   Noel G, 2005, J NEUROCHEM, V94, P691, DOI 10.1111/j.1471-4159.2005.03191.x
   Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x
   Olsen ML, 2004, GLIA, V46, P63, DOI 10.1002/glia.10346
   ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   RANSOM CB, 1995, J NEUROPHYSIOL, V73, P333
   Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9
   Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870
   Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neurosicence.2004.09.053
   Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011
   Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308
   Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Verkhratsky A, 2000, BRAIN RES REV, V32, P380, DOI 10.1016/S0165-0173(99)00093-4
   Vinade ER, 2003, BRAIN RES, V977, P97, DOI 10.1016/S0006-8993(03)02769-0
   Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Xu T, 2009, BIOMATERIALS, V30, P4377, DOI 10.1016/j.biomaterials.2009.04.047
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 45
TC 37
Z9 40
U1 3
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 31
BP 7883
EP 7891
DI 10.1016/j.biomaterials.2010.07.013
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 653PM
UT WOS:000282109100005
PM 20688390
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hudson, JE
   Frith, JE
   Donose, BC
   Rondeau, E
   Mills, RJ
   Wolvetang, EJ
   Brooke, GP
   Cooper-White, JJ
AF Hudson, James E.
   Frith, Jessica E.
   Donose, Bogdan C.
   Rondeau, Elisabeth
   Mills, Richard J.
   Wolvetang, Ernst J.
   Brooke, Gary P.
   Cooper-White, Justin J.
TI A synthetic elastomer based on acrylated polypropylene glycol triol with
   tunable modulus for tissue engineering applications
SO BIOMATERIALS
LA English
DT Article
DE Tissue engineering; Mesenchymal stem cells; Substrate elasticity;
   Osteogenisis; Adipogeniesis
ID MESENCHYMAL STEM-CELLS; CROSS-LINKING; HYDROGELS; GROWTH;
   DIFFERENTIATION; CYTOSKELETON; DEGRADATION; FIBROBLASTS; ACTIVATION;
   SCAFFOLDS
AB As strategies for manipulating cellular behaviour in vitro and in vivo become more sophisticated, synthetic biomaterial substrates capable of reproducing critical biochemical and biophysical properties (or cues) of tissue micro-environments will be required. Cytoskeletal tension has been shown to be highly deterministic of cell fate decisions, yet few synthetic biomaterials are capable of modulating cytoskeletal tension of adhered cells through variations in stiffness, at least in the ranges applicable to tissue properties (e.g., 1-100 kPa), whilst also possessing other required properties, such as biodegradability, biocompatibility and processability. In this paper we describe a non-cytotoxic polymer system based on acrylated polypropylene glycol triol (aPPGT). This new elastomer system has tunable elastic moduli, is degradable, can be easily surface modified and can be manufactured into porous three dimensional scaffolds or micropatterned substrates. We demonstrate that the PPGT substrates can modulate hMSC morphology, growth, and differentiation, and that they can produce similar outcomes as observed for a non-degradable polyacrylamide substrate, confirming their utility as a degradable elastomer for tissue engineering and other biomedical applications. Crown Copyright (c) 2010 Published by Elsevier Ltd. All rights reserved.
C1 [Hudson, James E.; Frith, Jessica E.; Rondeau, Elisabeth; Mills, Richard J.; Cooper-White, Justin J.] Univ Queensland, Tissue Engn & Microfluid Lab, AIBN, St Lucia, Qld 4072, Australia.
   [Donose, Bogdan C.] Univ Queensland, Australian Natl Fabricat Facil, AIBN, St Lucia, Qld 4072, Australia.
   [Wolvetang, Ernst J.] Univ Queensland, Stem Cell Engn Grp, AIBN, St Lucia, Qld 4072, Australia.
   [Brooke, Gary P.] MMRI, Adult Stem Cell Grp, Brisbane, Qld 4101, Australia.
   [Brooke, Gary P.] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Tissue Engn & Microfluid Lab, AIBN, Cnr Cooper & Coll Rd, St Lucia, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Donose, Bogdan/C-5657-2009; Wolvetang, Ernst/J-7602-2013; Wolvetang,
   Ernst/D-6644-2017; Hudson, James/O-1775-2013; Frith, Jessica/J-6873-2017
OI Donose, Bogdan/0000-0003-1935-9489; Wolvetang,
   Ernst/0000-0002-2146-6614; Hudson, James/0000-0003-0832-9356; Frith,
   Jessica/0000-0002-6558-5412; Cooper-White, Justin/0000-0002-1920-8229
FU Australian Research Council
FX The authors would like to acknowledge the Australian Research Council
   Discovery Grants Scheme for funding this work. We would also like to
   acknowledge Dr Tristan Croll and Dr Andrew Rowlands for their
   contributions to discussions associated with this investigation.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   ARNOLD IC, 2007, J CELL PHYSL, V213, P341
   Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Cao Yang, 2004, Methods Mol Biol, V238, P87
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Center for the Evaluation of Risks to Human Reproduction, 2004, REPROD TOXICOL, V18, P533, DOI DOI 10.1016/J.REPR0T0X.2004.01.004
   Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jorgensen C, 2004, CURR OPIN BIOTECH, V15, P406, DOI 10.1016/j.copbio.2004.08.003
   Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Nivasu VM, 2004, POLYM ADVAN TECHNOL, V15, P128, DOI 10.1002/pat.415
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ravi N, 2002, J POLYM SCI POL PHYS, V40, P2677, DOI 10.1002/polb.10306
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   Schoenmakers RG, 2004, J CONTROL RELEASE, V95, P291, DOI 10.1016/j.jconrel.2003.12.009
   SHINTANI Y, 1988, APPL MICROBIOL BIOT, V27, P533, DOI 10.1007/BF00451627
   Studenovska H, 2008, J MATER SCI-MATER M, V19, P615, DOI 10.1007/s10856-007-3217-0
   Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5
   Zannettino ACW, 2007, HAEMATOL-HEMATOL J, V92, P1707, DOI 10.3324/haematol.11691
   Zimmermann J, 2002, BIOMATERIALS, V23, P2127, DOI 10.1016/S0142-9612(01)00343-X
NR 41
TC 11
Z9 12
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 31
BP 7937
EP 7947
DI 10.1016/j.biomaterials.2010.07.007
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 653PM
UT WOS:000282109100008
PM 20688386
DA 2018-10-19
ER

PT J
AU Schneider, RK
   Anraths, J
   Kramann, R
   Bornemann, J
   Bovi, M
   Knuchel, R
   Neuss, S
AF Schneider, Rebekka K.
   Anraths, Julia
   Kramann, Rafael
   Bornemann, Joerg
   Bovi, Manfred
   Knuechel, Ruth
   Neuss, Sabine
TI The role of biomaterials in the direction of mesenchymal stem cell
   properties and extracellular matrix remodelling in dermal tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE Dermal tissue engineering; Mesenchymal stem cells; Organotypic skin
   culture; Matrix remodelling; Paracrine activity
ID EPIDERMAL MORPHOGENESIS; ORGANOTYPIC CULTURES; HACAT KERATINOCYTES;
   SKIN; FIBROBLASTS; EXPRESSION; DIFFERENTIATION; ORGANIZATION;
   EQUIVALENTS; MECHANISMS
AB Recently, a new generation of dermal equivalents (DE) was presented which are solely generated on a human fibroblast-derived dermal matrix. Since human mesenchymal stem cells from bone marrow (BM-MSC) and Wharton's Jelly of the umbilical cord (UC-MSC) are characterised by a distinct biosynthetic and paracrine activity, they are an appealing alternative approach for generating cell-based DE. This study compares the epithelial-mesenchymal interaction and extracellular matrix (ECM) remodelling of cell-based and collagen-based DE using fibroblasts, BM-MSC or UC-MSC, respectively, in co-culture with the keratinocyte cell line HaCaT. While fibroblast-based DE exhibit normal matrix synthesis, proliferation and differentiation of keratinocytes, mesenchymal stem cell-based DE resulted in excessive production of inhomogenous matrix aggregates, loss of polarisation of the epidermal cell layer and an inconstant paracrine activity. In contrast, collagen-embedded MSC revealed a homogenous growth pattern as well as a constant expression of growth factors and ECM proteins without a negative influence on the epidermal layer as shown by histology, electron microscopy, immunohistochemistry and realtime-RT-PCR. These results indicate the necessity of an instructive biomaterial-based scaffold to direct stem cell differentiation, proliferation, paracrine activity as well as regulation of ECM deposition. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Schneider, Rebekka K.; Anraths, Julia; Knuechel, Ruth; Neuss, Sabine] Rhein Westfal TH Aachen, Fac Med, Inst Pathol, D-52074 Aachen, Germany.
   [Kramann, Rafael] Rhein Westfal TH Aachen, Fac Med, Div Nephrol & Clin Immunol, D-52074 Aachen, Germany.
   [Bornemann, Joerg; Bovi, Manfred] Rhein Westfal TH Aachen, Fac Med, Elect Microscop Facil, D-52074 Aachen, Germany.
RP Schneider, RK (reprint author), Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM reschneider@ukaachen.de
OI Kramann, Rafael/0000-0003-4048-6351
CR ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6
   Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412
   BREITKREUTZ D, 1991, CANCER RES, V51, P4402
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Diaz-Flores L, 2009, FRONT BIOSCI-LANDMRK, V14, P1433, DOI 10.2741/3317
   ELGHALBZOUR, 2009, BIOMATERIALS, V30, P71
   FUSENIG NE, 1983, J INVEST DERMATOL, V81, pS168, DOI 10.1111/1523-1747.ep12541032
   Green JA, 2009, J BIOL CHEM, V284, P8148, DOI 10.1074/jbc.M805934200
   Hoeller D, 2001, EXP DERMATOL, V10, P264, DOI 10.1034/j.1600-0625.2001.100406.x
   Kamamoto F, 2003, ARTIF ORGANS, V27, P701, DOI 10.1046/j.1525-1594.2003.07277.x
   Kondo S, 1997, J CELL PHYSIOL, V171, P190, DOI 10.1002/(SICI)1097-4652(199705)171:2<190::AID-JCP9>3.0.CO;2-J
   Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044
   Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815
   LEBLAN, 2003, SCAND J IMMUNOL, V57, P11
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Muffler S, 2008, STEM CELLS, V26, P2506, DOI 10.1634/stemcells.2007-0991
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Rasmusson I, 2007, SCAND J IMMUNOL, V65, P336, DOI 10.1111/j.1365-3083.2007.01905.x
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Schneider RK, 2010, DIFFERENTIATION, V79, P182, DOI 10.1016/j.diff.2010.01.005
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Schneider RKM, 2008, DIFFERENTIATION, V76, P156, DOI 10.1111/j.1432-0436.2007.00204.x
   Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254
   Stark HJ, 2004, BIOL PROCED ONLINE, V6, P55, DOI DOI 10.1251/BP072
   Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620
   Zinn M, 2006, EUR J CELL BIOL, V85, P333, DOI 10.1016/j.ejcb.2005.12.002
NR 35
TC 48
Z9 55
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 31
BP 7948
EP 7959
DI 10.1016/j.biomaterials.2010.07.003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 653PM
UT WOS:000282109100009
PM 20688387
DA 2018-10-19
ER

PT J
AU Rai, B
   Lin, JL
   Lim, ZXH
   Guldberg, RE
   Hutmacher, DW
   Cool, SM
AF Rai, Bina
   Lin, Jane L.
   Lim, Zophia X. H.
   Guldberg, Robert E.
   Hutmacher, Dietmar W.
   Cool, Simon M.
TI Differences between in vitro viability and differentiation and in vivo
   bone-forming efficacy of human mesenchymal stem cells cultured on
   PCL-TCP scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Bone repair; Stem cell; Scaffold; In vitro test; In vivo test;
   Polycaprolactone
ID MARROW STROMAL CELLS; TRICALCIUM PHOSPHATE SCAFFOLDS; PLATELET-RICH
   PLASMA; OSTEOGENIC DIFFERENTIATION; POLYCAPROLACTONE SCAFFOLDS;
   IMMUNOLOGICAL-PROPERTIES; TISSUE REGENERATION; GROWTH-FACTOR; FIBRIN;
   PROLIFERATION
AB Human mesenchymal stem cells (hMSCs) possess great therapeutic potential for the treatment of bone disease and fracture non-union. Too often however, in vitro evidence alone of the interaction between hMSCs and the biomaterial of choice is used as justification for continued development of the material into the clinic. Clearly for hMSC-based regenerative medicine to be successful for the treatment of orthopaedic trauma, it is crucial to transplant hMSCs with a suitable carrier that facilitates their survival, optimal proliferation and osteogenic differentiation in vitro and in vivo. This motivated us to evaluate the use of polycaprolactone-20% tricalcium phosphate (PCL-TCP) scaffolds produced by fused deposition modeling for the delivery of hMSCs. When hMSCs were cultured on the PCL-TCP scaffolds and imaged by a combination of phase contrast, scanning electron and confocal laser microscopy, we observed five distinct stages of colonization over a 21-day period that were characterized by cell attachment, spreading, cellular bridging, the formation of a dense cellular mass and the accumulation of a mineralized extracellular matrix when induced with osteogenic stimulants. Having established that PCL-TCP scaffolds are able to support hMSC proliferation and osteogenic differentiation, we next tested the in vivo efficacy of hMSC-loaded PCL-TCP scaffolds in nude rat critical-sized femoral defects. We found that fluorescently labeled hMSCs survived in the defect site for up to 3 weeks post-transplantation. However, only 50% of the femoral defects treated with hMSCs responded favorably as determined by new bone volume. As such, we show that verification of hMSC viability and differentiation in vitro is not sufficient to predict the efficacy of transplanted stem cells to consistently promote bone formation in orthotopic defects in vivo. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Rai, Bina; Lin, Jane L.; Lim, Zophia X. H.; Cool, Simon M.] ASTAR, Inst Med Biol, Singapore, Singapore.
   [Guldberg, Robert E.; Hutmacher, Dietmar W.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Hutmacher, Dietmar W.] Queensland Inst Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.
   [Cool, Simon M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthoped Surg, Singapore 117595, Singapore.
RP Cool, SM (reprint author), ASTAR, Inst Med Biol, Singapore, Singapore.
EM simon.cool@imb.a-star.edu.sg
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134
FU Singapore's Agency of Science, Technology and Research (A*STAR);
   Institute of Medical Biology (IMB), Singapore
FX The authors would like to acknowledge the grant support from Singapore's
   Agency of Science, Technology and Research (A*STAR) and the Institute of
   Medical Biology (IMB), Singapore. The authors are grateful to Dr Amber
   A. Sawyer for her efforts in establishing the preliminary work for this
   study, as well as Susan and Keith Rogers from the Histology Department,
   A*STAR.
CR Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   BURWELL RG, 1985, CLIN ORTHOP RELAT R, P125
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Elbert S., 2000, J CONTROL RELEASE, V65, P389
   FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Horwitz EM, 2009, ISR MED ASSOC J, V11, P209
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   IZQUIERDO HC, 2007, J BIOMED MATER RES A, V82, P129
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kruyt MC, 2004, J ORTHOPAED RES, V22, P697, DOI 10.1016/j.orthres.2003.10.021
   Kruyt MC, 2007, BIOMATERIALS, V28, P1798, DOI 10.1016/j.biomaterials.2006.11.038
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Leong Natalie L, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2651
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Meijer G.J., 2007, PLOS MED, V4, pe9, DOI DOI 10.1371/JOURNAL.PMED.0040009
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Morgan SM, 2007, BIOMATERIALS, V28, P5332, DOI 10.1016/j.biomaterials.2007.08.029
   Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019
   Niyibizi C, 2004, MOL THER, V9, P955, DOI 10.1016/j.ymthe.2004.02.022
   Peister A, 2009, TISSUE ENG PT A, V15, P3129, DOI [10.1089/ten.tea.2008.0536, 10.1089/ten.TEA.2008.0536]
   Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024
   Rai B, 2004, BIOMATERIALS, V25, P5499, DOI 10.1016/j.biomaterials.2004.01.007
   Rai B, 2007, J ORAL MAXIL SURG, V65, P2195, DOI 10.1016/j.jams.2006.11.026
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3
   Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   STARK GB, 1995, EUR J PLAST SURG, V18, P267
   Themistocleous GS, 2003, IN VIVO, V17, P489
   Trombi L, 2008, TRANSFUSION, V48, P2246, DOI 10.1111/j.1537-2995.2008.01829.x
   Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9
   Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006
   Vacanti CA, 2006, J CELL MOL MED, V10, P569, DOI 10.2755/jcmm010.003.20
   Woodruff MA, 2007, J MOL HISTOL, V38, P491, DOI 10.1007/s10735-007-9142-1
   YANG L, 2006, J MAT SCI ENG C, V27, P293
   Yeo A, 2008, J BIOMED MATER RES A, V84A, P208, DOI 10.1002/jbm.a.31454
   Zanetta M, 2009, ACTA BIOMATER, V5, P1126, DOI 10.1016/j.actbio.2008.12.003
   Zhang XL, 2009, IMMUNOBIOLOGY, V214, P179, DOI 10.1016/j.imbio.2008.07.030
   Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456
NR 56
TC 82
Z9 82
U1 2
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 31
BP 7960
EP 7970
DI 10.1016/j.biomaterials.2010.07.001
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 653PM
UT WOS:000282109100010
PM 20688388
DA 2018-10-19
ER

PT J
AU Pritchard, CD
   Arner, KM
   Langer, RS
   Ghosh, FK
AF Pritchard, Christopher D.
   Arner, Karin M.
   Langer, Robert S.
   Ghosh, Fredrik K.
TI Retinal transplantation using surface modified poly(glycerol-co-sebacic
   acid) membranes
SO BIOMATERIALS
LA English
DT Article
DE Cell adhesion; Elastomer; Nanotopography; Polycaprolactone; Retina;
   Transplantation
ID FULL-THICKNESS RETINA; CELL; LAMININ
AB In retinal transplantation experiments it is hypothesized that remaining diseased photoreceptor cells in the host retina and inner retinal cells in transplants physically obstruct the development of graft-host neuronal contacts which are required for vision. Recently, we developed methods for the isolation of donor photoreceptor layers in vitro, and the selective removal of host photoreceptors in vivo using biodegradable elastomeric membranes composed of poly(glycerol-co-sebacic acid) (PGS). We also coated PGS membranes with electrospun nanofibers, composed of laminin and poly(epsilon-caprolactone) (PCL), to promote attachment of embryonic retinal explants, allowing the resulting composites to be handled surgically as a single entity. Here, we report subretinal transplantation of these composites into adult porcine eyes. In hematoxylin and eosin stained sections of composite explants after 5-7 days in vitro, excellent fusion of retinas and biomaterial membranes was noted, with the immature retinal components showing laminated as well as folded and rosetted areas. The composite grafts could be transplanted in all cases and, 3 months after surgery, eyes displayed clear media, attached retinas and the grafts located subretinally. Histological examination revealed that the biomaterial membrane had degraded without any signs of inflammation. Transplanted retinas displayed areas of rosettes as well as normal lamination. In most cases inner retinal layers were present in the grafts. Laminated areas displayed well-developed photoreceptors adjacent to an intact host retinal pigment epithelium and degeneration of the host outer nuclear layer (ONL) was often observed together with occasional fusion of graft and host inner layers. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Pritchard, Christopher D.; Langer, Robert S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Arner, Karin M.; Ghosh, Fredrik K.] Univ Lund Hosp, Dept Ophthalmol, S-22185 Lund, Sweden.
RP Pritchard, CD (reprint author), MIT, Dept Chem Engn, Room E25-342,45 Carleton St, Cambridge, MA 02142 USA.
EM cpritcha@mit.edu
OI Ghosh, Fredrik/0000-0002-3302-1233
FU Faculty of Medicine, University of Lund; Swedish Research Council;
   Princess Margaretas Foundation for Blind Children; Torsten and Ragnar
   Soderberg Foundation; National Institutes of Health [DE013023,
   HL060435]; Richard and Gail Siegal Gift Fund; MIT/CIMIT; InVivo
   Therapeutics Corporation
FX We thank Kurt Broderick for assistance with clean room operation (MTL,
   MIT, Cambridge, MA), Nikki Watson assistance with cryosectioning
   (Whitehead Institute, Cambridge, MA), Rebekah Neal for electrospinning
   (University of Virginia, Charlottesville, VA), and Kerry Mahon for
   providing lab space and materials for electrospinning (Stemgent, Inc.,
   Cambridge, MA). We thank Elizabeth Pritchard for writing assistance
   (Starnberg, Germany). This work was supported by The Faculty of
   Medicine, University of Lund, The Swedish Research Council, The Princess
   Margaretas Foundation for Blind Children, the Torsten and Ragnar
   Soderberg Foundation, the National Institutes of Health (Grants DE013023
   and HL060435), and the Richard and Gail Siegal Gift Fund. C.D.P. was
   supported by a MIT/CIMIT Medical Engineering Fellowship and a gift to
   MIT by InVivo Therapeutics Corporation.
CR Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190
   Engelsberg K, 2007, CELL TRANSPLANT, V16, P31, DOI 10.3727/000000007783464506
   Ghosh F, 2008, NEUROSCIENCE, V152, P526, DOI 10.1016/j.neuroscience.2007.12.035
   Ghosh F, 2002, RETINA-J RET VIT DIS, V22, P478, DOI 10.1097/00006982-200208000-00013
   Ghosh F, 1999, INVEST OPHTH VIS SCI, V40, P133
   Ghosh F, 1999, EXP EYE RES, V68, P67, DOI 10.1006/exer.1998.0582
   Ghosh F, 1998, RETINA-J RET VIT DIS, V18, P136, DOI 10.1097/00006982-199818020-00007
   Ghosh F, 1999, INVEST OPHTH VIS SCI, V40, P126
   Ghosh F, 2009, INVEST OPHTH VIS SCI, V50, P826, DOI 10.1167/iovs.08-2389
   Ghosh F, 2011, TISSUE ENG PT A, V17, P1675, DOI [10.1089/ten.tea.2008.0450, 10.1089/ten.TEA.2008.0450]
   Ghosh F, 2010, DEV NEUROSCI-BASEL, V32, P47, DOI 10.1159/000261704
   JULIUSSON B, 1993, CELL TRANSPLANT, V2, P411, DOI 10.1177/096368979300200509
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Pritchard CD, 2010, BIOMATERIALS, V31, P2153, DOI 10.1016/j.biomaterials.2009.11.074
   SCHUSCHEREBA ST, 1992, EXP NEUROL, V115, P95, DOI 10.1016/0014-4886(92)90228-I
   Seiler MJ, 2009, VET OPHTHALMOL, V12, P158, DOI 10.1111/j.1463-5224.2009.00693.x
   Seiler MJ, 1998, INVEST OPHTH VIS SCI, V39, P2121
   TURNER JE, 1986, BRAIN RES, V391, P91
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wasselius J, 2001, INVEST OPHTH VIS SCI, V42, P2632
NR 25
TC 30
Z9 30
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 31
BP 7978
EP 7984
DI 10.1016/j.biomaterials.2010.07.026
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 653PM
UT WOS:000282109100012
PM 20656341
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Tokatlian, T
   Shrum, CT
   Kadoya, WM
   Segura, T
AF Tokatlian, Talar
   Shrum, Chadwick T.
   Kadoya, Warren M.
   Segura, Tatiana
TI Protease degradable tethers for controlled and cell-mediated release of
   nanoparticles in 2-and 3-dimensions
SO BIOMATERIALS
LA English
DT Article
DE Controlled release; Nanoparticle; Matrix metalloproteinase; Hydrogel;
   Cell-mediated release
ID POLY(ETHYLENE GLYCOL) HYDROGELS; GROWTH-FACTOR DELIVERY;
   MATRIX-METALLOPROTEINASES; EXTRACELLULAR-MATRIX; BIOACTIVE HYDROGELS;
   EXPRESSION; SCAFFOLDS; INHIBITORS; SUBSTRATE; SYSTEM
AB Strategies to control the release rate of bioactive signals from tissue engineering scaffolds are essential for tissue regeneration and tissue engineering applications. Here we report on a strategy to achieve temporal control over nanoparticle release from biomaterials using cell-secreted proteases. This cell-triggered release approach utilizes peptides that are degraded by matrix metalloproteinases (MMPs) at different rates to immobilize nanoparticles directly to the biomaterial surface. Thus, the peptide-immobilized nanoparticles are released with temporal control through the action of cell-released MMPs. We found that release rates of peptide-immobilized nanoparticles were a function of peptide sensitivity to proteases, the number of tethers between the nanoparticle and the surface and the concentration of proteases used to induce release. Cellular internalization of the peptide-immobilized nanoparticles was also a function of the peptide sensitivity to proteases, the number of tethers between the nanoparticle and the surface and MMP expression profile of the cells. Similar trends were observed for peptide-immobilized nanoparticles inside micro-porous hydrogels, indicating protease sensitive tethers are effective in controlling release rate and internalization of nanoparticles. Such a temporal delivery strategy of nanoparticles loaded with therapeutic payloads (e.g. protein, DNA, siRNA) can be an ideal means to guide tissue formation. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Tokatlian, Talar; Shrum, Chadwick T.; Kadoya, Warren M.; Segura, Tatiana] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.
RP Segura, T (reprint author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, 5531 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.
EM tsegura@ucla.edu
FU NIH [1R21EB007730-01, T32GM067555]; NSF [0747539]; CRCC
FX The authors would like to thank Dr. Armando Durazo at the UCLA Molecular
   Instrumentation Center for running all elemental analysis samples and
   Dr. Jianjun Zhang and Zheng Chen for their help with SEM imaging. T.
   Tokatlian would especially like to thank Yuguo Lei, Dr. Quinn Ng, Sean
   Anderson, and Anandika Dhaliwal for their helpful discussions and advice
   and Robert Hanusa, Dashel Thompson, and Jonah Schwartz for their time
   and effort towards this project. The authors acknowledge the NIH
   (1R21EB007730-01), NSF (CAREER 0747539), and CRCC for funding this work.
   T. Tokatlian acknowledges the NIH Biotech Training Grant (T32GM067555)
   for funding. Supporting Information is available online from Wiley
   InterScience or from the author.
CR Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Kaiser K, 1997, BIOCONJUGATE CHEM, V8, P545, DOI 10.1021/bc970086u
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Lei YG, 2009, BIOMATERIALS, V30, P254, DOI 10.1016/j.biomaterials.2008.09.027
   Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Pirila E, 2007, WOUND REPAIR REGEN, V15, P47, DOI 10.1111/j.1524-475X.2006.00184.x
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Saul JM, 2007, BIOMATERIALS, V28, P4705, DOI 10.1016/j.biomaterials.2007.07.026
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201
   Tauro JR, 2008, PEPTIDES, V29, P1965, DOI 10.1016/j.peptides.2008.06.021
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
NR 22
TC 24
Z9 24
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 31
BP 8072
EP 8080
DI 10.1016/j.biomaterials.2010.07.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 653PM
UT WOS:000282109100022
PM 20688389
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hu, XA
   Wang, XL
   Rnjak, J
   Weiss, AS
   Kaplan, DL
AF Hu, Xiao
   Wang, Xiuli
   Rnjak, Jelena
   Weiss, Anthony S.
   Kaplan, David L.
TI Biomaterials derived from silk-tropoelastin protein systems
SO BIOMATERIALS
LA English
DT Article
DE Miscibility; Silk; Tropoelastin; Elastin; Polymer blends; DSC
ID ATOMIC-FORCE MICROSCOPY; CRYSTALLIZATION KINETICS; THERMAL-PROPERTIES;
   ELASTIC PROPERTIES; FIBROUS PROTEINS; BLENDS; POLYMER; WATER;
   COACERVATION; RELEASE
AB A structural protein blend system based on silkworm silk fibroin and recombinant human tropoelastin is described. Silk fibroin, a semicrystalline fibrous protein with beta-sheet crystals provides mechanical strength and controllable biodegradation, while tropoelastin, a noncrystallizable elastic protein provides elasticity. Differential scanning calorimetry (DSC) and temperature modulated DSC (TMDSC) indicated that silk becomes miscible with tropoelastin at different blend ratios, without macrophase separation. Fourier transform infrared spectroscopy (FTIR) revealed secondary structural changes of the blend system (beta-sheet content) before and after methanol treatment. Atomic Force Microscopy (AFM) nano-indentation demonstrated that blending silk and tropoelastin at different ratios resulted in modification of mechanical features, with resilience from similar to 68%-similar to 97%, and elastic modulus between 2 and 9 Mpa, depending on the ratio of the two polymers. Some of these values are close to those of native aortic elastin or elastin-like polypeptides. Significantly, during blending and drying silk tropoelastin form micro- and nano-scale porous morphologies which promote human mesenchymal stem cell attachment and proliferation. These blends offer a new protein biomaterial system for cell support and tailored biomaterial properties to match mechanical needs. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Hu, Xiao; Wang, Xiuli; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Rnjak, Jelena; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Hu, Xiao/F-2403-2012; Rnjak-Kovacina, Jelena/B-8928-2014
OI Hu, Xiao/0000-0002-2579-2820; WEISS, ANTHONY/0000-0002-8106-4836
FU NIH P41 Tissue Engineering Resource Center [P41 EB002520]; Australian
   Research Council; National Heart Foundation; National Health and Medical
   Research Council
FX The authors thank the NIH P41 Tissue Engineering Resource Center (P41
   EB002520), the Australian Research Council, the National Heart
   Foundation and the National Health and Medical Research Council for
   supporting this work.
CR Altman Greg, 2002, FASEB Journal, V16, P270
   Annabi N, 2010, BIOMATERIALS, V31, P1655, DOI 10.1016/j.biomaterials.2009.11.051
   Chen H, 2008, J THERM ANAL CALORIM, V93, P201, DOI 10.1007/s10973-007-8885-y
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   del Mercato LL, 2008, BIOMACROMOLECULES, V9, P796, DOI 10.1021/bm7010104
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Domke J, 2000, COLLOID SURFACE B, V19, P367, DOI 10.1016/S0927-7765(00)00145-4
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Feldstein MM, 2003, POLYMER, V44, P1819, DOI 10.1016/S0032-3861(03)00046-6
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2009, J THERM ANAL CALORIM, V96, P827, DOI 10.1007/s10973-009-0049-9
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Huson MG, 2006, POLYM TEST, V25, P2, DOI 10.1016/j.polymertesting.2005.09.014
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Miwa Y, 2005, MACROMOLECULES, V38, P2355, DOI 10.1021/ma0480401
   Motta A, 2009, J BIOMAT SCI-POLYM E, V20, P1875, DOI 10.1163/156856208X399936
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Penning JP, 1996, MACROMOLECULES, V29, P77, DOI 10.1021/ma950651t
   Pepe A, 2009, SOFT MATTER, V5, P104, DOI 10.1039/b811286j
   PIZZOLI M, 1994, MACROMOLECULES, V27, P4755, DOI 10.1021/ma00095a016
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   Reguera J, 2004, J AM CHEM SOC, V126, P13212, DOI 10.1021/ja047417f
   Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921
   Schafer A, 2008, EUR BIOPHYS J BIOPHY, V37, P197, DOI [10.1007/s00249-007-0216-5, 10.1007/S00249-007-0216-5]
   Taddese S, 2009, MATRIX BIOL, V28, P84, DOI 10.1016/j.matbio.2008.12.002
   Teng WB, 2009, BIOMACROMOLECULES, V10, P3028, DOI 10.1021/bm900651g
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Yamada K, 2003, THIN SOLID FILMS, V440, P208, DOI 10.1016/S0040-6090(03)00460-7
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
NR 50
TC 93
Z9 95
U1 5
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 32
BP 8121
EP 8131
DI 10.1016/j.biomaterials.2010.07.044
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 666KA
UT WOS:000283112700002
PM 20674969
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Elvin, CM
   Vuocolo, T
   Brownlee, AG
   Sando, L
   Huson, MG
   Liyou, NE
   Stockwell, PR
   Lyons, RE
   Kim, M
   Edwards, GA
   Johnson, G
   McFarland, GA
   Ramshaw, JAM
   Werkmeister, JA
AF Elvin, Christopher M.
   Vuocolo, Tony
   Brownlee, Alan G.
   Sando, Lillian
   Huson, Mickey G.
   Liyou, Nancy E.
   Stockwell, Peter R.
   Lyons, Russell E.
   Kim, Misook
   Edwards, Glenn A.
   Johnson, Graham
   McFarland, Gail A.
   Ramshaw, John A. M.
   Werkmeister, Jerome A.
TI A highly elastic tissue sealant based on photopolymerised gelatin
SO BIOMATERIALS
LA English
DT Article
DE Gelatin; Crosslinking; Tissue sealant; Elasticity; Photopolymerisation
ID CROSS-LINKING AGENTS; IN-VITRO; MECHANICAL-PROPERTIES;
   THERMAL-PROPERTIES; HYDROGEL; ADHESIVE; FILMS; GLUTARALDEHYDE;
   FIBRINOGEN; PROTEINS
AB Gelatin is widely used as a medical biomaterial because it is readily available, cheap, biodegradable and demonstrates favourable biocompatibility. Many applications require stabilisation of the biomaterial by chemical crosslinking, and this often involves derivatisation of the protein or treatment with cytotoxic crosslinking agents. We have previously shown that a facile photochemical method, using blue light, a ruthenium catalyst and a persulphate oxidant, produces covalent di-tyrosine crosslinks in resilin and fibrinogen to form stable hydrogel biomaterials. Here we show that various gelatins can also be rapidly crosslinked to form highly elastic (extension to break >650%) and adhesive (stress at break >100 kPa) biomaterials. Although the method does not require derivatisation of the protein, we show that when the phenolic (tyrosine-like) content of gelatin is increased, the crosslinked material becomes resistant to swelling, yet retains considerable elasticity and high adhesive strength. The reagents are not cytotoxic at the concentration used in the photopolymerisation reaction. When tested in vivo in sheep lung, the photopolymerised gelatin effectively sealed a wound in lung tissue from blood and air leakage, was not cytotoxic and did not produce an inflammatory response. The elastic properties, thermal stability, speed of curing and high tissue adhesive strength of this photopolymerised gelatin, offer considerable improvement over current surgical tissue sealants. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
C1 [Elvin, Christopher M.; Vuocolo, Tony; Brownlee, Alan G.; Sando, Lillian; Liyou, Nancy E.; Stockwell, Peter R.; Lyons, Russell E.; Kim, Misook] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.
   [Huson, Mickey G.] CSIRO Mat Sci & Engn, Geelong, Vic 3216, Australia.
   [Ramshaw, John A. M.; Werkmeister, Jerome A.] CSIRO Mol & Hlth Technol, Clayton, Vic 3169, Australia.
   [Edwards, Glenn A.] Univ Melbourne, Dept Vet Sci, Werribee, Vic 3030, Australia.
   [Johnson, Graham; McFarland, Gail A.] CSIRO Mol & Hlth Technol, N Ryde, NSW 2113, Australia.
RP Elvin, CM (reprint author), CSIRO Livestock Ind, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4067, Australia.
EM chris.elvin@csiro.au
RI Lyons, Russell/A-7051-2011; Huson, Mickey/K-2474-2012; elvin,
   chris/H-2333-2013; Russell, Lyons/H-7942-2013; Vuocolo,
   Tony/H-7533-2013; Ramshaw, John/A-9411-2011
OI Huson, Mickey/0000-0003-1859-7805; Russell, Lyons/0000-0002-0795-7994; 
CR ALBES JM, 1993, ANN THORAC SURG, V56, P910, DOI 10.1016/0003-4975(93)90354-K
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Bertoni F, 2006, BIOTECHNOL LETT, V28, P697, DOI 10.1007/s10529-006-9046-2
   BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529
   Chen TH, 2006, J BIOMED MATER RES B, V77B, P416, DOI 10.1002/jbm.b.30439
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Elvin CM, 2010, J BIOMED MATER RES A, V93A, P687, DOI 10.1002/jbm.a.32572
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gattas-Asfura KM, 2005, BIOMACROMOLECULES, V6, P1503, DOI 10.1021/bm049238w
   Ghavamzadeh R, 2004, J BIOMAT SCI-POLYM E, V15, P1019, DOI 10.1163/1568562041526478
   Hsu SH, 2007, BIORHEOLOGY, V44, P17
   KALEEM K, 1987, NATURE, V325, P328, DOI 10.1038/325328a0
   Kojima T., 2004, RADIAT PHYS CHEM, V71, P233
   Kommareddy S, 2007, NANOMED-NANOTECHNOL, V3, P32, DOI 10.1016/j.nano.2006.11.005
   Koob TJ, 2003, BIOMATERIALS, V24, P1285, DOI 10.1016/S0142-9612(02)00465-9
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laib S, 2009, BIOMATERIALS, V30, P1568, DOI 10.1016/j.biomaterials.2008.11.031
   Liu BS, 2008, J BIOMED MATER RES A, V87A, P1092, DOI 10.1002/jbm.a.31916
   Matsuda S, 2002, BIOMATERIALS, V23, P2901, DOI 10.1016/S0142-9612(01)00418-5
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   Miller BT, 1996, BIOCHEM BIOPH RES CO, V218, P377, DOI 10.1006/bbrc.1996.0066
   NOFRE C, 1963, CR HEBD ACAD SCI, V257, P791
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   Peng HT, 2007, J MATER SCI-MATER M, V18, P975, DOI 10.1007/s10856-006-0088-8
   Quinn JV, 2005, TISSUE ADHESIVES CLI, P1
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   Singh RP, 2008, INT SURG, V93, P25
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Syedain ZH, 2009, BIOMATERIALS, V30, P6695, DOI 10.1016/j.biomaterials.2009.08.039
   Tomihata K, 1996, Tissue Eng, V2, P307, DOI 10.1089/ten.1996.2.307
   Ulubayram K, 2002, J BIOMAT SCI-POLYM E, V13, P1203, DOI 10.1163/156856202320892966
   van den Bosch E, 2003, CHROMATOGRAPHIA, V58, P507, DOI 10.1365/s10337-003-0024-8
NR 42
TC 61
Z9 63
U1 6
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 32
BP 8323
EP 8331
DI 10.1016/j.biomaterials.2010.07.032
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 666KA
UT WOS:000283112700023
PM 20674967
DA 2018-10-19
ER

PT J
AU Bott, K
   Upton, Z
   Schrobback, K
   Ehrbar, M
   Hubbell, JA
   Lutolf, MP
   Rizzi, SC
AF Bott, Katrin
   Upton, Zee
   Schrobback, Karsten
   Ehrbar, Martin
   Hubbell, Jeffrey A.
   Lutolf, Matthias P.
   Rizzi, Simone C.
TI The effect of matrix characteristics on fibroblast proliferation in 3D
   gels
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Biomimetic material; Cell encapsulation; Cell proliferation;
   Matrix metalloproteinase; Mechanical properties
ID POLY(ETHYLENE GLYCOL) HYDROGELS; 3-DIMENSIONAL EXTRACELLULAR-MATRIX;
   CO-PEG NETWORKS; MECHANICAL-PROPERTIES; CELL-ADHESIVE; 3-D MIGRATION;
   IN-VITRO; TISSUE; DIFFERENTIATION; INTEGRIN
AB Engineering synthetic hydrogels on a molecular basis to introduce natural features that are important in instructing cell behavior is becoming increasingly crucial in biomaterial-based approaches for regenerative medicine and in cell biology to study cell matrix interactions in three-dimensions (3D). Here, we used collagen gels and exploited the design flexibility of the biological, biochemical and physical characteristics offered by a PEG-based hydrogel system to systematically study the effect of specific extracellular microenvironments on the behavior of primary human fibroblasts in 3D. We firstly found that the proliferation profiles of fibroblasts from different patients cultured within collagen gels (3D) differed significantly from their behavior observed on tissue culture plastic (2D). Furthermore, using the biomimetic PEG-based matrix we showed that cell proliferation in 3D could be selectively manipulated via alteration of the gel characteristics. In particular, this study revealed that, in spite of matrix sensitivity to proteases (e.g. MMP) and the presence of cell-integrin binding sites, at high stiffness (elastic modulus, G' > 1200 Pa) the matrix acts as a barrier for cells cultured in 3D. Finally, a comparison between the biomimetic PEG-based and collagen gels indicated that differences in their viscoelastic behaviours, determined by the nature of network structures and cross-links, may influence the mechanism(s) cells employ to remodel their 3D extracellular microenvironment. In conclusion, these studies highlight that for proliferation in 3D, compared to 2D, cells require strategies to overcome the physical impediment posed by the matrix. We also demonstrate that by exploiting the design flexibility of the characteristics offered by these biomimetic hydrogels, it is possible to separately investigate complex aspects characterizing the cell matrix interactions in 3D; this has the potential to have great impact in regenerative medicine, as well as in cell biology and cancer research. (C) 2010 Elsevier Ltd. Ail rights reserved.
C1 [Bott, Katrin; Upton, Zee; Schrobback, Karsten; Rizzi, Simone C.] Queensland Univ Technol, IHBI, Tissue Repair & Regenerat Program, Brisbane, Qld 4001, Australia.
   [Ehrbar, Martin] Univ Zurich Hosp, Dept Craniomaxillofacial Surg, CH-8091 Zurich, Switzerland.
   [Hubbell, Jeffrey A.; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.
RP Rizzi, SC (reprint author), PSE C EPFL, QGel SA, CH-1015 Lausanne, Switzerland.
EM rizzi.sc@gmail.com
RI Ehrbar, Martin/F-4578-2012; Upton, Zee/I-9777-2012; Hubbell,
   Jeffrey/A-9266-2008; Lutolf, Matthias/E-5914-2010; Schrobback,
   Karsten/J-1110-2012
OI Ehrbar, Martin/0000-0003-2707-4870; Hubbell,
   Jeffrey/0000-0003-0276-5456; Schrobback, Karsten/0000-0002-9312-7275
FU Government of Queensland; Tissue Therapies Ltd.; Queensland University
   of Technology (Brisbane, Australia); Australian Research Council (ARC);
   Institute of Health and Biomedical Innovation (Queensland University of
   Technology, Brisbane, Australia)
FX The authors thank Dr Thomas P. Kraehenbuehl and Dr Andre J. van der
   Vlies (EPF Lausanne, Switzerland) for technical support and advice on
   the chemical functionalization of PEG. We also thank Dr Christina
   Theodoropoulos (now at Leica, Brisbane, Australia) for assistance in
   confocal scanning microscopy; Ms Rebecca Dawson (Queensland University
   of Technology, Brisbane, Australia) for support in cell culture; Dr
   Timothy Nicholson, Dr Elisabeth Rondeau and Prof Justin Cooper-White
   (University of Queensland, Brisbane, Australia) for assistance in
   rheology. We are also thankful to Prof. Dietmar Hutmacher (Queensland
   University of Technology, Brisbane Australia) for helpful discussions
   and inputs. Z.U. and S.C.R gratefully acknowledge the Government of
   Queensland, Tissue Therapies Ltd. and the Queensland University of
   Technology (Brisbane, Australia) for financial support through the Smart
   State Fellowship Scheme. This work was supported by the Australian
   Research Council (ARC) and by an Early Career Grant Scheme from the
   Institute of Health and Biomedical Innovation (Queensland University of
   Technology, Brisbane, Australia).
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998
   BERRY CC, 2008, J TISSUE ENG REGEN M, V3, P43
   Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0
   Bullard KM, 1999, J SURG RES, V84, P31, DOI 10.1006/jsre.1999.5599
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498
   Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Han YP, 2001, J CELL SCI, V114, P131
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x
   Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054
   Liao HM, 2008, ACTA BIOMATER, V4, P1161, DOI 10.1016/j.actbio.2008.04.013
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   PARKER AJ, 2007, THESIS QUEENSLAND U
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Raeber GP, 2007, ACTA BIOMATER, V3, P615, DOI 10.1016/j.actbio.2007.03.013
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sperinde JJ, 2000, MACROMOLECULES, V33, P5476, DOI 10.1021/ma000459d
   Sperinde JJ, 1997, MACROMOLECULES, V30, P5255, DOI 10.1021/ma970345a
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Wu CC, 2005, J BIOMAT SCI-POLYM E, V16, P1261, DOI 10.1163/156856205774269494
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 71
TC 145
Z9 149
U1 8
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 32
BP 8454
EP 8464
DI 10.1016/j.biomaterials.2010.07.046
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 666KA
UT WOS:000283112700037
PM 20684983
DA 2018-10-19
ER

PT J
AU Schulte, VA
   Hu, YB
   Diez, M
   Bunger, D
   Moller, M
   Lensen, MC
AF Schulte, Vera A.
   Hu, Yibing
   Diez, Mar
   Buenger, Daniel
   Moeller, Martin
   Lensen, Marga C.
TI A hydrophobic perfluoropolyether elastomer as a patternable biomaterial
   for cell culture and tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Fluoropolymers; Hydrophobicity; Micro-patterning; Cell adhesion;
   Fibroblasts; Integrin
ID INDUCED CONFORMATIONAL-CHANGES; SYNTHETIC CORNEAL ONLAY;
   HUMAN-ENDOTHELIAL-CELLS; SURFACE-CHEMISTRY; INTEGRIN BINDING;
   TOPOGRAPHICAL CONTROL; FIBROBLAST ADHESION; PROTEIN ADSORPTION; SOFT
   LITHOGRAPHY; FIBRONECTIN
AB We present a systematic study of a perfluoropolyether (PFPE)-based elastomer as a new biomaterial. Besides its excellent long-term stability and inertness, PFPE can be decorated with topographical surface structures by replica molding. Micrometer-sized pillar structures led to considerably different cell morphology of fibroblasts. Although PFPE is a very hydrophobic material we could show that PFPE substrates allow cell adhesion and spreading of primary human fibroblasts (HDF) very similar to that observed on standard cell culture substrates. Less advanced cell spreading was observed for L929 (murine fibroblast cell line) cells during the first 5 h in culture which was accompanied by retarded recruitment of alpha(v)beta(3)-integrin into focal adhesions (FAs). After 24 h distinct FAs were evident also in L929 cells on PFPE. Furthermore, organization of soluble FN into a fibrillar ECM network was shown for hdF and L929 cells.
   Based on these results PFPE is believed to be a suitable substrate for several biological applications. On the one hand it is an ideal cell culture substrate for fundamental research of substrate-independent adhesion signaling due to its different characteristics (e.g. wettability, elasticity) compared to glass or TCPS. On the other hand it could be a promising implant material, especially due to its straightforward patternability, which is a tool to direct cell growth and differentiation. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lensen, Marga C.] Tech Univ Berlin, D-10623 Berlin, Germany.
   [Schulte, Vera A.; Hu, Yibing; Diez, Mar; Buenger, Daniel; Moeller, Martin; Lensen, Marga C.] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52056 Aachen, Germany.
   [Schulte, Vera A.; Hu, Yibing; Diez, Mar; Buenger, Daniel; Moeller, Martin; Lensen, Marga C.] Rhein Westfal TH Aachen, DWI eV, D-52056 Aachen, Germany.
RP Lensen, MC (reprint author), Tech Univ Berlin, Sekr TC 1,Str 17 Juni 124, D-10623 Berlin, Germany.
EM Lensen@chem.tu-berlin.de
RI Moller, Martin/F-7860-2015
OI Moller, Martin/0000-0002-5955-4185
FU Alexander von Humboldt Foundation; Federal Ministry for Education and
   Research (BMBF); DFG Graduate School [GRK 1035]
FX This work was funded by the Alexander von Humboldt Foundation and the
   Federal Ministry for Education and Research (BMBF) in the form of a
   Sofia Kovalevskaja Award (MCL) and by the DFG Graduate School
   "Biointerface" (GRK 1035). The authors thank Dr. B. Wehrle-Haller for
   providing the GFP-integrin fibroblasts and Dr. W. Tillmann for
   assistance with Raman spectroscopy.
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   BALE MD, 1989, BLOOD, V74, P2698
   Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Bartneck M, 2010, ACTA BIOMATER, V6, P3864, DOI 10.1016/j.actbio.2010.04.025
   Bongiovanni R, 1998, MACROMOL CHEM PHYS, V199, P1099
   Chan GYN, 2006, BIOMATERIALS, V27, P1287, DOI 10.1016/j.biomaterials.2005.08.005
   Chaouk H, 2001, J APPL POLYM SCI, V80, P1756, DOI 10.1002/app.1270
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Diez M, 2009, SMALL, V5, P2756, DOI 10.1002/smll.200901313
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans MDM, 2002, INVEST OPHTH VIS SCI, V43, P3196
   Evans MDM, 2001, BIOMATERIALS, V22, P3319, DOI 10.1016/S0142-9612(01)00169-7
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Giacomelli CE, 2001, J COLLOID INTERF SCI, V233, P234, DOI 10.1006/jcis.2000.7219
   GILLES S, 2010, NANOTECHNOLOGY, V21, pNIL96
   Gratton SEA, 2008, ACCOUNTS CHEM RES, V41, P1685, DOI 10.1021/ar8000348
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Harrison RG, 1912, ANAT REC, V6, P181, DOI 10.1002/ar.1090060404
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Latour RA, 2005, ENCY BIOMATERIALS BI
   Lensen MC, 2008, PURE APPL CHEM, V80, P2479, DOI 10.1351/pac200880112479
   Lensen MC, 2007, LANGMUIR, V23, P7841, DOI 10.1021/la7007683
   Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Norde W, 1999, MACROMOL SYMP, V145, P125, DOI 10.1002/masy.19991450114
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Rolland JP, 2004, ANGEW CHEM INT EDIT, V43, P5796, DOI 10.1002/anie.200461122
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   Sweeney DF, 2008, CLIN EXP OPTOM, V91, P56, DOI 10.1111/j.1444-0938.2007.00198.x
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Toselli M, 2001, POLYMER, V42, P1771, DOI 10.1016/S0032-3861(00)00568-1
   Truong TT, 2007, LANGMUIR, V23, P2898, DOI 10.1021/la062981k
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Volger EA, 1993, WETTABILITY, P184
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 64
TC 16
Z9 16
U1 0
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 33
BP 8583
EP 8595
DI 10.1016/j.biomaterials.2010.07.070
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676LK
UT WOS:000283912700009
PM 20708794
DA 2018-10-19
ER

PT J
AU Reing, JE
   Brown, BN
   Daly, KA
   Freund, JM
   Gilbert, TW
   Hsiong, SX
   Huber, A
   Kullas, KE
   Tottey, S
   Wolf, MT
   Badylak, SF
AF Reing, Janet E.
   Brown, Bryan N.
   Daly, Kerry A.
   Freund, John M.
   Gilbert, Thomas W.
   Hsiong, Susan X.
   Huber, Alexander
   Kullas, Karen E.
   Tottey, Stephen
   Wolf, Matthew T.
   Badylak, Stephen F.
TI The effects of processing methods upon mechanical and biologic
   properties of porcine dermal extracellular matrix scaffolds
SO BIOMATERIALS
LA English
DT Article
DE ECM (extracellular matrix); Porcine dermis; Glycosaminoglycans; Growth
   factors; Cell viability; Mechanical properties
ID SMALL-INTESTINAL SUBMUCOSA; URINARY-BLADDER MATRIX; HEART-VALVES;
   MACROPHAGE PHENOTYPE; GROWTH-FACTOR; IN-VITRO; TISSUE; BIOMATERIAL;
   REPAIR; DECELLULARIZATION
AB Biologic materials from various species and tissues are commonly used as surgical meshes or scaffolds for tissue reconstruction. Extracellular matrix (ECM) represents the secreted product of the cells comprising each tissue and organ, and therefore provides a unique biologic material for selected regenerative medicine applications. Minimal disruption of ECM ultrastructure and content during tissue processing is typically desirable. The objective of this study was to systematically evaluate effects of commonly used tissue processing steps upon porcine dermal ECM scaffold composition, mechanical properties, and cytocompatibility. Processing steps evaluated included liming and hot water sanitation, trypsin/SDS/TritonX-100 decellularization, and trypsin/TritonX-100 decellularization. Liming decreased the growth factor and glycosaminoglycan content, the mechanical strength, and the ability of the ECM to support in vitro cell growth (p <= 0.05 for all). Hot water sanitation treatment decreased only the growth factor content of the ECM (p <= 0.05). Trypsin/SDS/TritonX-100 decellularization decreased the growth factor content and the ability of the ECM to support in vitro cell growth (p <= 0.05 for both). Trypsin/Triton X-100 decellularization also decreased the growth factor content of the ECM but increased the ability of the ECM to support in vitro cell growth (p <= 0.05 for both). We conclude that processing steps evaluated in the present study affect content, mechanical strength, and/or cytocompatibility of the resultant porcine dermal ECM, and therefore care must be taken in choosing appropriate processing steps to maintain the beneficial effects of ECM in biologic scaffolds. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Reing, Janet E.; Brown, Bryan N.; Daly, Kerry A.; Freund, John M.; Gilbert, Thomas W.; Huber, Alexander; Tottey, Stephen; Wolf, Matthew T.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Brown, Bryan N.; Wolf, Matthew T.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA.
   [Gilbert, Thomas W.; Tottey, Stephen; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
   [Hsiong, Susan X.; Kullas, Karen E.] CR Bard Inc, Murray Hill, NJ 07974 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr Suite 300, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689; Reing, Janet/0000-0003-0048-8563
FU National Institutes of Health [NIH 5R01 AR054940-03]; C. R. Bard, Inc.
FX Funding for this study was provided through a grant from the National
   Institutes of Health (NIH 5R01 AR054940-03) and by C. R. Bard, Inc.
CR Akkus O, 2005, J ORTHOP RES, V23, P838, DOI 10.1016/j.orthres.2005.01.007
   Armour AD, 2006, PLAST RECONSTR SURG, V117, P845, DOI 10.1097/01.prs.0000204567.28952.9d
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cebotari S, 2006, CIRCULATION, V114, pI132, DOI 10.1161/CIRCULATIONAHA.105.001065
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Curtil A, 1997, CRYOBIOLOGY, V34, P13, DOI 10.1006/cryo.1996.1982
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI [10.1089/ten.tea.2009.0089, 10.1089/ten.TEA.2009.0089]
   Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x
   EWALT DH, 1992, J UROLOGY, V148, P544, DOI 10.1016/S0022-5347(17)36650-8
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2005, BIOMATERIALS, V26, P5518, DOI 10.1016/j.biomaterials.2005.01.070
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   Grabow N, 2004, ARTIF ORGANS, V28, P971, DOI 10.1111/j.1525-1594.2004.00007.x
   Hafeez Y. M., 2005, Cell and Tissue Banking, V6, P85, DOI 10.1007/s10561-004-1888-z
   HARDINGHAM TE, 1992, FASEB J, V6, P861
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Lichtenberg A, 2006, CIRCULATION, V114, pI559, DOI 10.1161/CIRCULATIONAHA.105.001206
   Lovekamp JJ, 2006, BIOMATERIALS, V27, P1507, DOI 10.1016/j.biomaterials.2005.08.003
   Marra KG, 2008, PLAST RECONSTR SURG, V121, P1153, DOI 10.1097/01.prs.0000305517.93747.72
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Ota T, 2008, J THORAC CARDIOV SUR, V136, P1309, DOI 10.1016/j.jtcvs.2008.07.008
   OTT HC, 2010, NAT MED
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437
   SOUZAFERNANDES AB, 2006, CRIT CARE, V10, pNI271
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Walles T, 2003, BIOMATERIALS, V24, P1233, DOI 10.1016/S0142-9612(02)00490-8
NR 49
TC 153
Z9 157
U1 3
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 33
BP 8626
EP 8633
DI 10.1016/j.biomaterials.2010.07.083
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676LK
UT WOS:000283912700013
PM 20728934
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lindenmair, A
   Wolbank, S
   Stadler, G
   Meinl, A
   Peterbauer-Scherb, A
   Eibl, J
   Polin, H
   Gabriel, C
   van Griensven, M
   Redl, H
AF Lindenmair, Andrea
   Wolbank, Susanne
   Stadler, Guido
   Meinl, Alexandra
   Peterbauer-Scherb, Anja
   Eibl, Johann
   Polin, Helene
   Gabriel, Christian
   van Griensven, Martijn
   Redl, Heinz
TI Osteogenic differentiation of intact human amniotic membrane
SO BIOMATERIALS
LA English
DT Article
DE Human amniotic membrane; Sessile stem cells; Biomineralization; Bone
   tissue engineering; Osteogenesis
ID MESENCHYMAL STEM-CELLS; LYSOSOMAL STORAGE DISEASES; BONE MORPHOGENETIC
   PROTEIN-2; EPITHELIAL-CELLS; VITAMIN-C; IN-VITRO; POSTOPERATIVE
   ADHESIONS; TISSUE-TRANSPLANTATION; PROGENITOR CELLS; STROMAL CELLS
AB Tissue engineering strategies usually require cell isolation and combination with a suitable biomaterial. Human amniotic membrane (AM) represents a natural two-layered sheet comprising cells with proven stem cell characteristics. In our approach, we evaluated the differentiation potential of AM in tow with its sessile stem cells as alternative to conventional approaches requiring cell isolation and combination with biomaterials. For this, AM-biopsies were differentiated in vitro using two osteogenic media compared with control medium (CM) for 28 days. Mineralization and osteocalcin expression was demonstrated by (immuno)histochemistry. Alkaline phosphatase (AP) activity, calcium contents and mRNA expression of RUNX2, AP, osteopontin, osteocalcin, BMP-2 (bone morphogenetic protein), and BMP-4 were quantified and AM viability was evaluated. Under osteogenic conditions, AM-biopsies mineralized successfully and by day 28 the majority of cells expressed osteocalcin. This was confirmed by a significant rise in calcium contents (up to 27.4 +/- 6.8 mg/dl d28), increased AP activity, and induction of RUNX2, AP, BMP-2 and BMP-4 mRNA expression. Relatively high levels of viability were retained, especially in osteogenic media (up to 78.3 +/- 19.0% d14; 62.9 +/- 22.3% d28) compared to CM (42.2 +/- 15.2% d14; 35.1 +/- 8.6% d28). By this strategy, stem cells within human AM can successfully be driven along the osteogenic pathways while residing within their natural environment. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lindenmair, Andrea; Wolbank, Susanne; Stadler, Guido; Meinl, Alexandra; van Griensven, Martijn; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, A-1200 Vienna, Austria.
   [Peterbauer-Scherb, Anja; Polin, Helene; Gabriel, Christian] Red Cross Blood Transfus Serv Upper Austria, A-4020 Linz, Austria.
   [Meinl, Alexandra] Bernhard Gottlieb Univ, Sch Dent, A-1090 Vienna, Austria.
   [Eibl, Johann] Bioprod & Bioengn AG, A-1010 Vienna, Austria.
RP Wolbank, S (reprint author), Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM susanne.wolbank@trauma.lbg.ac.at
RI Gabriel, Christian/A-1689-2014; van Griensven, Martijn/F-5808-2012
OI Gabriel, Christian/0000-0003-2043-9320; van Griensven,
   Martijn/0000-0001-5104-9881
FU Fondation Jerome LeJeune
FX This work has been supported by the European scientific grant
   NovusSanguis of the Fondation Jerome LeJeune. We thank Krystyna Labuda
   for assistance during manuscript preparation.
CR ADINOLFI M, 1982, NATURE, V295, P325, DOI 10.1038/295325a0
   AKLE CA, 1981, LANCET, V2, P1003
   ARORA M, 1994, EUR J OBSTET GYN R B, V55, P179, DOI 10.1016/0028-2243(94)90035-3
   BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9
   Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507
   DHALL K, 1984, BRIT J OBSTET GYNAEC, V91, P279, DOI 10.1111/j.1471-0528.1984.tb04768.x
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001
   FAULK WP, 1980, LANCET, V1, P1156
   Gajiwala Kalpesh, 2004, Cell and Tissue Banking, V5, P73, DOI 10.1023/B:CATB.0000034076.16744.4b
   Ganatra M A, 2003, J Pak Med Assoc, V53, P29
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   GRUSS JS, 1978, CAN MED ASSOC J, V118, P1237
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He Qingyi, 2002, Chin J Traumatol, V5, P200
   Hennerbichler Simone, 2007, Cell and Tissue Banking, V8, P1, DOI 10.1007/s10561-006-9002-3
   Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/bioreprod.103.020651
   Kim GJ, 2005, AM J OBSTET GYNECOL, V193, P1137, DOI 10.1016/j.ajog.2005.06.032
   KIM JC, 1995, CORNEA, V14, P473
   Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491
   Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   NISOLLE M, 1992, J GYNECOL SURG, V8, P25, DOI 10.1089/gyn.1992.8.25
   Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101
   Raida M, 2006, INT J MOL MED, V18, P735
   RENNEKAMPFF HO, 1994, INVEST SURG, V7, P187
   Rossig L, 2001, CIRCULATION, V104, P2182, DOI 10.1161/hc4301.098284
   SAKURAGAWA N, 1992, BRAIN DEV-JPN, V14, P7, DOI 10.1016/S0387-7604(12)80272-5
   Sakuragawa N, 2004, J NEUROSCI RES, V78, P208, DOI 10.1002/jnr.20257
   SCAGGIANTE B, 1987, TRANSPLANTATION, V44, P59, DOI 10.1097/00007890-198707000-00014
   Smith AR, 2002, FASEB J, V16, P1102, DOI 10.1096/fj.01-0825fje
   Speer MY, 2005, CARDIOVASC RES, V66, P324, DOI 10.1016/j.cardiores.2005.01.023
   Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804
   SUBRAHMANYAM M, 1995, BRIT J PLAST SURG, V48, P477, DOI 10.1016/0007-1226(95)90123-X
   Sugimoto M, 2006, FREE RADICAL RES, V40, P213, DOI 10.1080/10715760500417005
   Tosi GM, 2005, J CELL PHYSIOL, V202, P849, DOI 10.1002/jcp.20181
   TYLKISZYMANSKA A, 1985, J INHERIT METAB DIS, V8, P101, DOI 10.1007/BF01819289
   WARD DJ, 1989, BRIT J PLAST SURG, V42, P463, DOI 10.1016/0007-1226(89)90015-5
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313
   Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022
   YEAGER AM, 1985, AM J MED GENET, V22, P347, DOI 10.1002/ajmg.1320220219
   YOUNG RL, 1991, FERTIL STERIL, V55, P624
   Zhao P, 2005, TRANSPLANTATION, V79, P528, DOI 10.1097/01.TP.0000149503.92433.39
   ZOHAR Y, 1987, LARYNGOSCOPE, V97, P978
NR 49
TC 25
Z9 26
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2010
VL 31
IS 33
BP 8659
EP 8665
DI 10.1016/j.biomaterials.2010.07.090
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 676LK
UT WOS:000283912700017
PM 20719379
DA 2018-10-19
ER

PT J
AU Pinto, S
   Alves, P
   Matos, CM
   Santos, AC
   Rodrigues, LR
   Teixeira, JA
   Gil, MH
AF Pinto, S.
   Alves, P.
   Matos, C. M.
   Santos, A. C.
   Rodrigues, L. R.
   Teixeira, J. A.
   Gil, M. H.
TI Poly(dimethyl siloxane) surface modification by low pressure plasma to
   improve its characteristics towards biomedical applications
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Poly(dimethyl siloxane); Pluronic (R) F-68; Poly(ethylene glycol) methyl
   methacrylate; Plasma; Surface modification; Biomaterials
ID INDUCED GRAFT-POLYMERIZATION; PROTEIN ADSORPTION; PLATELET-ADHESION;
   POLY(ETHYLENE GLYCOL); OXYGEN PLASMA; CELL-ADHESION;
   POLYDIMETHYLSILOXANE; COPOLYMERIZATION; METHACRYLATE; TOXICITY
AB Poly(dimethyl siloxane) elastomer, (PDMS) is widely used as a biomaterial. However, PDMS is very hydrophobic and easily colonized by several bacteria and yeasts. Consequently, surface modification has been used to improve its wettability and reduce bacterial adhesion.
   The aim of this work was to modify the PDMS surface in order to improve its hydrophilicity and bacterial cell repulsion to be used as a biomaterial. Plasma was used to activate the PDMS surface and sequentially promote the attachment of a synthetic surfactant, Pluronic F-68, or a polymer, Poly(ethylene glycol) methyl methacrylate, PEGMA. Bare PDMS, PDMS argon plasma activated, PDMS coated with Pluronice F-68 and PEGMA-grafted PDMS were characterized by contact angle measurements, X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM). The influence of the surface modifications on blood compatibility of the materials was evaluated by thrombosis and haemolysis assays. The cytotoxicity of these materials was tested for mouse macrophages.
   After modification, AFM results suggest the presence of a distinct layer at the surface and by the contact angle measures it was observed an increase of hydrophilicity. XPS analysis indicates an increase of the oxygen content at the surface as a result of the modification. All the studied materials revealed no toxicity and were found to be non-haemolytic or in some cases slightly haemolytic.
   Therefore, plasma was found to be an effective technique for the PDMS surface modification. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Pinto, S.; Alves, P.; Gil, M. H.] Univ Coimbra, Dept Chem Engn, P-3030790 Coimbra, Portugal.
   [Matos, C. M.; Santos, A. C.] Univ Coimbra, Sch Med, Biophys Biomath Inst, Biomed Inst Res Light & Image, P-3000548 Coimbra, Portugal.
   [Rodrigues, L. R.; Teixeira, J. A.] Univ Minho, Ctr Biol Engn, IBB, P-4710057 Braga, Portugal.
RP Pinto, S (reprint author), Univ Coimbra, Dept Chem Engn, Polo 2,Rua Silvio Lima, P-3030790 Coimbra, Portugal.
EM susanacspinto@gmail.com
RI Teixeira, Jose Antonio/A-6268-2012; Alves, Patricia/I-1004-2013
OI Teixeira, Jose Antonio/0000-0002-4918-3704; Alves,
   Patricia/0000-0002-8943-8329; Pinto, Susana/0000-0003-2658-1045;
   Rodrigues, Ligia/0000-0001-9265-0630; Gil, Maria
   Helena/0000-0003-0657-7751
FU Portuguese Science and Technology Foundation (Fundacao para a Ciencia e
   Tecnologia - FCT) [BIOSURFA - PTDC/SAU-BEB/73498/2006]
FX The present study was developed under the scope of the BIOSURFA -
   PTDC/SAU-BEB/73498/2006 project funded by the Portuguese Science and
   Technology Foundation (Fundacao para a Ciencia e Tecnologia - FCT).
CR Abbasi F, 2004, INT J ADHES ADHES, V24, P247, DOI 10.1016/j.ijadhadh.2003.10.006
   [Anonymous], 10993 ISO 4
   [Anonymous], F75600 ASTM
   BARILE FA, 1994, CELL BIOL TOXICOL, V10, P155, DOI 10.1007/BF00757558
   BESTEIRO MC, 2009, J BIOMED MATER RES A, DOI DOI 10.1002/JBM.A.32594
   BODAS D, 2006, MICROELECTRON ENG, V83, P1227
   Bodas D, 2008, EUR POLYM J, V44, P2130, DOI 10.1016/j.eurpolymj.2008.04.012
   Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037
   Boxshall K, 2006, SURF INTERFACE ANAL, V38, P198, DOI 10.1002/sia.2274
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   Chen J, 1999, J RADIOANAL NUCL CH, V240, P943, DOI 10.1007/BF02349879
   Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3
   Correia NT, 1997, J COLLOID INTERF SCI, V189, P361, DOI 10.1006/jcis.1997.4857
   *DAT PHYS INSTR GM, 2002, DAT INT CHEM OP MAN
   Ferreira P, 2007, INT J BIOL MACROMOL, V40, P144, DOI 10.1016/j.ijbiomac.2006.06.023
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   MAUEL J, 1971, J EXP MED, V134, P335, DOI 10.1084/jem.134.2.335
   Molinari BL, 2005, MICRON, V36, P177, DOI 10.1016/j.micron.2004.08.002
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NHOA YC, 2003, RADIAT PHYS CHEM, V66, P299
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Owens D., 1969, J APPL POLYM SCI, V13, P1711
   QINGXIA N, 2001, J IMMUNOL METHODS, V251, P11
   Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024
   SANTOS AC, 2002, AGUA TROCAVEL PULMAO, P305
   Sharma V, 2007, VACUUM, V81, P1094, DOI 10.1016/j.vacuum.2007.02.004
   SHNYDER B, 2003, SURF SCI, V532, P1067
   Sugiura S, 2008, COLLOID SURFACE B, V63, P301, DOI 10.1016/j.colsurfb.2007.12.013
   Wang P, 2000, EUR POLYM J, V36, P1323, DOI 10.1016/S0014-3057(99)00193-7
   WEIR DM, 1973, HDB EXPT IMMUNOLOGY, V2
   Wenzhong Shen, 2008, Recent Patents on Chemical Engineering, V1, P27
   Williams RL, 2004, BIOMATERIALS, V25, P4659, DOI 10.1016/j.biomaterials.2003.12.010
   Wu MH, 2009, SURF INTERFACE ANAL, V41, P11, DOI 10.1002/sia.2964
   Zanini S, 2009, EUR PHYS J D, V54, P159, DOI 10.1140/epjd/e2008-00217-9
   Zhao CS, 2003, BIOMATERIALS, V24, P3747, DOI 10.1016/S0142-9612(03)00250-3
   Zou XP, 2002, PLASMAS POLYM, V7, P151, DOI 10.1023/A:1016243403102
NR 39
TC 89
Z9 91
U1 4
U2 86
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD NOV 1
PY 2010
VL 81
IS 1
BP 20
EP 26
DI 10.1016/j.colsurfb.2010.06.014
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 652JA
UT WOS:000281999000003
PM 20638249
DA 2018-10-19
ER

PT J
AU Sionkowska, A
   Kozlowska, J
AF Sionkowska, Alina
   Kozlowska, Justyna
TI Characterization of collagen/hydroxyapatite composite sponges as a
   potential bone substitute
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Collagen; Hydroxyapatite; Biomaterial
ID SELF-ORGANIZATION MECHANISM; IN-VIVO; HYDROXYAPATITE/COLLAGEN COMPOSITE;
   RECONSTITUTED COLLAGEN; POROUS HYDROXYAPATITE; NANOCOMPOSITES;
   GLUTARALDEHYDE; NANOFIBERS; SCAFFOLDS
AB Hydroxyapatite and collagen composites (HAp/Col) have the potential in mimicking and replacing skeletal bones. Their combination should prove beneficial for bone tissue engineering due to their natural biological resemblance and properties. In this study, hydroxyapatite and collagen isolated from animal tendons were used in different proportions as composites. Sponges were prepared by freezing and lyophylization of corresponding composite solutions. The properties of composite sponges, such as microstructure, chemical and physical properties were studied. In the present investigation, a collagen sponge and a composite sponge made of composite of HAp/Col were prepared in our lab and characterized by attenuated total reflection Fourier transform infra-red spectroscopy, thermogravimetric analysis and scanning electron microscopy (SEM). Infrared spectroscopy (IR) in combination with attenuated total reflection (ATR) spectroscopy is one of the most widely used technique for surface infrared analysis. The ATR-IR analysis did not indicate shift of the band corresponding to -COO- for none of the used HAp/Col ratios. Thermogravimetric results suggested that collagen chains had been embedded with HAP to several complexes with different thermal stabilities. SEM was used to observe the morphology and pore size of the sponges. SEM observations showed the sponges of HAp/Col with fully interconective macroporosity. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Sionkowska, Alina; Kozlowska, Justyna] N Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
RP Sionkowska, A (reprint author), N Copernicus Univ, Fac Chem, Gagarin 7, PL-87100 Torun, Poland.
EM as@chem.uni.torun.pl
RI Kozlowska, Justyna/O-6446-2015; Sionkowska, Alina/I-5599-2014
OI Kozlowska, Justyna/0000-0002-2482-339X
FU Ministry of Science (MNiSW, Poland) [N N507 349535]; European Social
   Fund (EFS, Poland); State Budget
FX Financial support from the Ministry of Science (MNiSW, Poland) Grant No
   N N507 349535 and PhD Students Grant of the European Social Fund (EFS,
   Poland) and State Budget is gratefully acknowledged.
CR Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Bigi A, 1998, BIOMATERIALS, V19, P739, DOI 10.1016/S0142-9612(97)00194-4
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Chang MC, 2002, J MATER SCI-MATER M, V13, P993, DOI 10.1023/A:1019825132610
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Drewa T, 2007, TISSUE ENG, V13, P1762
   Drewa Tomasz, 2008, Polim Med, V38, P33
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Hsu FY, 2005, J MATER SCI-MATER M, V16, P341, DOI 10.1007/s10856-005-0633-x
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Ko HF, 2007, MAT SCI ENG C-BIO S, V27, P479, DOI 10.1016/j.msec.2006.05.045
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Teng SH, 2008, MATER LETT, V62, P3055, DOI 10.1016/j.matlet.2008.01.104
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang Y, 2009, CERAM INT, V35, P2151, DOI 10.1016/j.ceramint.2008.11.022
NR 29
TC 50
Z9 52
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD NOV 1
PY 2010
VL 47
IS 4
BP 483
EP 487
DI 10.1016/j.ijbiomac.2010.07.002
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 665AT
UT WOS:000283007000009
PM 20637799
DA 2018-10-19
ER

PT J
AU Chen, JL
   Chen, C
   Chen, ZY
   Chen, JY
   Li, QL
   Huang, N
AF Chen, Jialong
   Chen, Cheng
   Chen, Zhuoyue
   Chen, Junying
   Li, Quanli
   Huang, Nan
TI Collagen/heparin coating on titanium surface improves the
   biocompatibility of titanium applied as a blood-contacting biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE layer-by-layer self-assembly; cytocompatibility; hemocompatibility;
   heparin; collagen
ID CROSS-LINKED COLLAGEN; ENDOTHELIAL-CELL; EXTRACELLULAR-MATRIX;
   HEPARAN-SULFATE; VASCULAR TISSUE; NITRIC-OXIDE; ADHESION; GROWTH; STENT;
   PHYSIOLOGY
AB Thrombosis and restenosis are the main causes leading to failure of cardiovascular and other blood-contacting biomedical devices. It is recognized that rapid re-endothelialization is a promising method for preventing these complications. This article deals with improving the endothelial progenitor cell (EPC) compatibility and hemocompatibility of titanium by coating an extracellular matrix-like film with heparin(hep) and collagen(col) by a layer-by-layer (LBL) self-assembly technique. In the work described here, LBL-produced col/hep coating growth is initialized by deposition of a layer of poly-L-lysine on a titanium surface, which is negatively charged after treatment with NaOH, followed by formation of a multilayer film formed by alternating deposition of negatively charged heparin and positively charged collagen using electrostatic interaction. The X-ray photoelectron spectroscopy results and fluorescence staining of collagen show that collagen is predominant on the surface and that collagen interpenetrates the heparin layer. In vitro EPC attachment and proliferation increase greatly on the col/hep coating. Immunofluorescent staining of cytoskeleton actin reveals that cells on the col/hep coating form a compact confluent cell layer after culture for 3 days. After culture for 5 days, cell viability on the col/hep increases persistently and on titanium the cell viability begins to decrease, showing that the coating possesses the ability to maintain cell viability. Platelet adhesion under dynamic conditions in vitro implies that the hemocompatibility of the col/hep coating is superior to that of titanium. The col/hep coating improves the biocompatibility of titanium and has good potential for application in blood-contacting biomaterials. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 341-349, 2010.
C1 [Li, Quanli] Anhui Med Univ, Coll Stomatol, Hefei 230032, Peoples R China.
   [Chen, Jialong; Chen, Cheng; Chen, Zhuoyue; Chen, Junying; Huang, Nan] SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Li, QL (reprint author), Anhui Med Univ, Coll Stomatol, Hefei 230032, Peoples R China.
EM ql-li@126.com; nhuang@263.com
RI Chen, Jialong/E-4388-2015
OI Chen, Jialong/0000-0002-5323-1801
FU National Basic Research Program of China [2005CB623904]; National
   High-Tech Research Program of China [2006AA02A139]; National Natural
   Science Foundation of China [30670564]
FX Contract grant sponsor: National Basic Research Program of China;
   contract grant number: 2005CB623904; Contract grant sponsor: National
   High-Tech Research Program of China; contract grant number:
   2006AA02A139; Contract grant sponsor: National Natural Science
   Foundation of China; contract grant number: 30670564
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen JL, 2009, APPL SURF SCI, V255, P6894, DOI 10.1016/j.apsusc.2009.03.011
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   Cines DB, 1998, BLOOD, V91, P3527
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   EBERT CD, 1982, ACS ADV CHEM SERIES, V199, P161
   ESMON CT, 1989, J BIOL CHEM, V264, P4743
   GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081
   Ge SN, 2007, KEY ENG MATER, V342-343, P305, DOI 10.4028/www.scientific.net/KEM.342-343.305
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   INGBER DE, 1987, IN VITRO CELL DEV B, V23, P387
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Li Q. L., 2008, J BIOMED MATER RES A, V89A, P575, DOI [10.1002/jbm.a.31999, DOI 10.1002/JBM.A.31999]
   Li QL, 2009, J BIOACT COMPAT POL, V24, P129, DOI 10.1177/0883911508101553
   Losordo DW, 2003, CIRCULATION, V107, P2635, DOI 10.1161/01.CIR.0000071083.31270.C3
   Mackay J, 2004, ATLAS HEART DIS STRO
   MADRI JA, 1988, AM J PATHOL, V132, P18
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   NICHOLAS K, 2004, J AM COLLE CARDI, V44, P733
   OLSEN BR, 1999, GUIDEBOOK EXTRACELLU, P380
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   ROSENBERG RD, 1989, AM J MED, V87, pS2, DOI 10.1016/0002-9343(89)80523-6
   Ruoslahti E, 1997, SCIENCE, V276, P1345, DOI 10.1126/science.276.5317.1345
   SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Sousa JE, 2003, CIRCULATION, V107, P2274, DOI 10.1161/01.CIR.0000069330.41022.90
   Stephan S, 2006, J ANAT, V209, P495, DOI 10.1111/j.1469-7580.2006.00633.x
   Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987
   VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4
   Weng YJ, 2007, KEY ENG MATER, V330-332, P865, DOI 10.4028/www.scientific.net/KEM.330-332.865
   WESSEL GM, 1987, DEV BIOL, V121, P149, DOI 10.1016/0012-1606(87)90148-5
   Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Yu JL, 1997, BIOMATERIALS, V18, P421, DOI 10.1016/S0142-9612(96)00154-8
NR 49
TC 48
Z9 54
U1 2
U2 44
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2010
VL 95A
IS 2
BP 341
EP 349
DI 10.1002/jbm.a.32847
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 660TF
UT WOS:000282666600002
PM 20623672
DA 2018-10-19
ER

PT J
AU Smith, BS
   Yoriya, S
   Grissom, L
   Grimes, CA
   Popat, KC
AF Smith, Barbara S.
   Yoriya, Sorachon
   Grissom, Laura
   Grimes, Craig A.
   Popat, Ketul C.
TI Hemocompatibility of titania nanotube arrays
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hemocompatibility; titania nanotube arrays; platelet adhesion and
   activation; whole blood clotting kinetics
ID NANOPOROUS ALUMINA MEMBRANES; IN-VITRO; NANOSTRUCTURED SURFACES;
   MICROSCALE TOPOGRAPHY; TIO2 NANOTUBES; CELL-ADHESION; BONE;
   BIOMATERIALS; FABRICATION; OXIDE
AB Hemocompatibility is a key consideration for the long-term success of blood contacting biomaterials; hence, there is a critical need to understand the physiological response elicited from blood/nano-biomaterial interactions. In this study, we have investigated the adsorption of key blood serum proteins, in vitro adhesion and activation of platelets, and clotting kinetics of whole blood on titania nanotube arrays. Previous studies have demonstrated improved mesenchymal stem cell functionality, osteoblast phenotypic behavior, localized drug delivery, and the production of endothelial cell ECM on titania nanotube arrays. Furthermore, these titania nanotube arrays have elicited minimal levels of monocyte activation and cytokine secretion, thus exhibiting a very low degree of immunogenicity. Titania nanotube arrays were fabricated using anodization technique and the surface morphology was examined through scanning electron microscopy (SEM). The crystalline phases were identified using glancing angled X-ray diffraction (GAXRD). Nanoindentation and scratch tests were used to characterize the mechanical properties of titania nanotube arrays. The adsorption of key blood proteins (albumin, fibrinogen, and immunoglobulin-g) was evaluated using a micro-BCA assay and X-ray photoelectron spectroscopy (XPS). The adhesion and activation of platelets was investigated using live-cell staining, MTT assay, and SEM. Whole blood clotting kinetics was evaluated by measuring the free hemoglobin concentration, and SEM was used to visualize the clot formation. Our results indicate increased blood serum protein adsorption, platelet adhesion and activation, and whole blood clotting kinetics on titania nanotube arrays. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 350-360, 2010.
C1 [Smith, Barbara S.; Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Yoriya, Sorachon; Grimes, Craig A.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   [Grissom, Laura] Chappelow Arts & Literacy Magnet Sch K 8, Evans, CO 80620 USA.
   [Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
RP Popat, KC (reprint author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
EM ketul.popat@colostate.edu
RI Yoriya, Sorachon/H-5823-2011
OI Popat, Ketul C./0000-0002-2417-7789
FU National Science Foundation (NSF) [CBET-0827827, 0827845]; Colorado
   Office of Economic Development and International Trade
FX Contract grant sponsor: National Science Foundation (NSF); contract
   grant numbers: CBET-0827827 and 0827845; Contract grant sponsor:
   Colorado Office of Economic Development and International Trade
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Beamish JA, 2009, BIOMATERIALS, V30, P6286, DOI 10.1016/j.biomaterials.2009.08.004
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   BHAT SV, 2005, BIOMATERIALS
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   BLAKE GB, 1990, BRIT J PLAST SURG, V43, P528, DOI 10.1016/0007-1226(90)90115-G
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 1996, J DENT RES, V75, P1426, DOI 10.1177/00220345960750061501
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Fine E, 2009, INT J NANOMED, V4, P91
   Fiore VF, 2010, BIOMATERIALS, V31, P810, DOI 10.1016/j.biomaterials.2009.09.100
   Gao L, 2009, J BIOMED MATER RES B, V89B, P335, DOI 10.1002/jbm.b.31221
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Heissler E, 1998, INT J ORAL MAX SURG, V27, P334, DOI 10.1016/S0901-5027(98)80060-X
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Klouda L, 2009, BIOMATERIALS, V30, P4558, DOI 10.1016/j.biomaterials.2009.05.029
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee J, 2009, BIOMATERIALS, V30, P4488, DOI 10.1016/j.biomaterials.2009.05.028
   Lopez CA, 2006, BIOMATERIALS, V27, P3075, DOI 10.1016/j.biomaterials.2005.12.017
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Meyers SR, 2009, BIOMATERIALS, V30, P277, DOI 10.1016/j.biomaterials.2008.08.042
   Miller R, 2006, BIOMATERIALS, V27, P208, DOI 10.1016/j.biomaterials.2005.05.087
   Mor GK, 2005, ADV FUNCT MATER, V15, P1291, DOI 10.1002/adfm.200500096
   Mor GK, 2004, J MATER RES, V19, P628, DOI 10.1557/jmr.2004.19.2.628
   Mor GK, 2003, J MATER RES, V18, P2588, DOI 10.1557/JMR.2003.0362
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Naidu SH, 2006, J HAND SURG-AM, V31A, P760, DOI 10.1016/j.jhsa.2005.12.022
   Oezyuerek Z, 2009, BIOMATERIALS, V30, P1026, DOI 10.1016/j.biomaterials.2008.11.005
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Popat KC, 2006, J ORTHOP RES, V24, P619, DOI 10.1002/jor.20105
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Porter JR, 2009, TISSUE ENG PT A, V15, P2547, DOI 10.1089/ten.tea.2008.0476
   Ratner BD, 1999, CURR OPIN SOLID ST M, V4, P379, DOI 10.1016/S1359-0286(99)00051-0
   Roy SC, 2007, BIOMATERIALS, V28, P4667, DOI 10.1016/j.biomaterials.2007.07.045
   Ruan CM, 2005, J PHYS CHEM B, V109, P15754, DOI 10.1021/jp052736u
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Swan EEL, 2005, BIOMATERIALS, V26, P1969, DOI 10.1016/j.biomaterials.2004.07.001
   Tang CJ, 2010, SURF COAT TECH, V204, P1487, DOI 10.1016/j.surfcoat.2009.09.084
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
NR 64
TC 64
Z9 66
U1 2
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2010
VL 95A
IS 2
BP 350
EP 360
DI 10.1002/jbm.a.32853
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 660TF
UT WOS:000282666600003
PM 20629021
DA 2018-10-19
ER

PT J
AU Horwitz, JA
   Shum, KM
   Bodle, JC
   Deng, MX
   Chu, CC
   Reinhart-King, CA
AF Horwitz, Joshua A.
   Shum, Katrina M.
   Bodle, Josephine C.
   Deng, MingXiao
   Chu, Chih-Chang
   Reinhart-King, Cynthia A.
TI Biological performance of biodegradable amino acid-based poly(ester
   amide)s: Endothelial cell adhesion and inflammation in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(ester-amide); vascular graft; endothelial cell monolayer; cell
   adhesion; inflammatory response
ID GLYCOL) DIACRYLATE HYDROGELS; POLY(ETHER ESTER AMIDE)S;
   PLATELET-ADHESION; FUNCTIONAL-GROUPS; L-PHENYLALANINE; L-ALANINE;
   COPOLYMERS; SURFACES; BLOOD; DEGRADABILITY
AB Functionalized amino-acid-based poly(ester-amide)s (PEA) are a new family of synthetic biodegradable polymers consisting of three naturally occurring building blocks (amino acids, diols, and dicarboxylic acids) that have been suggested to be promising biomaterials for therapeutic use. However, little is known about their cytotoxicity, ability to support cell growth, inflammatory properties, or mechanical properties, key aspects to most biomaterials designed for in vivo implantation and tissue engineering applications. In this study, we investigated the ability of two functionalized PEA materials (amino-functionalized and carboxylic acid functionalized) and a neutral PEA control to support endothelial cell viability, proliferation, and adhesion. Additionally, we investigated the inflammatory response elicited by these functionalized PEA materials using a macrophage cell model. Our results indicate that all forms of PEA were noncytotoxic and noninflammatory in vitro. The amino-functionalized PEA bests supports endothelial cell adhesion, growth, and monolayer formation. Mechanical testing indicates that the elastic moduli of these materials are strongly dependent on the charge formulation, but do exhibit linearly elastic behavior at small strains (<10%). Our data suggest that PEA may be a viable biomaterial for use in tissue engineering applications, particularly for use as a vascular graft. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 371-380, 2010.
C1 [Horwitz, Joshua A.; Shum, Katrina M.; Bodle, Josephine C.; Chu, Chih-Chang; Reinhart-King, Cynthia A.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   [Deng, MingXiao] Cornell Univ, Fiber & Polymer Sci Program, Dept Text & Apparel, Ithaca, NY 14853 USA.
RP Reinhart-King, CA (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
EM cak57@cornell.edu
RI Reinhart-King, Cynthia/A-9264-2016
OI Reinhart-King, Cynthia/0000-0001-6959-3914
FU Morgan Family Tissue Engineering Initiative
FX We acknowledge funding from the Morgan Family Tissue Engineering
   Initiative.
CR Armelin E, 2001, POLYMER, V42, P7923, DOI 10.1016/S0032-3861(01)00315-9
   Berglund JD, 2003, BRIT J PHARMACOL, V140, P627, DOI 10.1038/sj.bjp.0705457
   Bet MR, 2003, BIOMATERIALS, V24, P131, DOI 10.1016/S0142-9612(02)00270-3
   Brewster LP, 2007, BIOMATERIALS, V28, P5028, DOI 10.1016/j.biomaterials.2007.07.048
   Califano JP, 2010, J BIOMECH, V43, P79, DOI 10.1016/j.jbiomech.2009.09.012
   Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x
   Chu C. C., 2003, US Patent, Patent No. [6,503,538, 6503538]
   Chu CC, 1997, WOUND CLOSURE BIOMAT
   De Wit MA, 2008, J POLYM SCI POL CHEM, V46, P6376, DOI 10.1002/pola.22915
   DeFife KM, 2009, J BIOMAT SCI-POLYM E, V20, P1495, DOI 10.1163/092050609X12464344572881
   Deng MX, 2009, BIOMACROMOLECULES, V10, P3037, DOI 10.1021/bm9006437
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Fan YJ, 2002, J POLYM SCI POL CHEM, V40, P385, DOI 10.1002/pola.10126
   Guo K, 2005, J POLYM SCI POL CHEM, V43, P3932, DOI 10.1002/pola.20781
   Guo K, 2005, J POLYM SCI POL CHEM, V43, P1463, DOI 10.1002/pola.20463
   Guo K, 2008, J APPL POLYM SCI, V110, P1858, DOI 10.1002/app.28826
   Guo K, 2007, BIOMACROMOLECULES, V8, P2851, DOI 10.1021/bm070158c
   Guo K, 2007, J BIOMAT SCI-POLYM E, V18, P489, DOI 10.1163/156856207780852569
   Guo K, 2007, BIOMATERIALS, V28, P3284, DOI 10.1016/j.biomaterials.2007.03.031
   Guo K, 2007, J POLYM SCI POL CHEM, V45, P1595, DOI 10.1002/pola.21926
   Jirouskova M, 1997, J MATER SCI-MATER M, V8, P19, DOI 10.1023/A:1018534111419
   Jokhadze G, 2007, J BIOMAT SCI-POLYM E, V18, P411, DOI 10.1163/156856207780425031
   Katsarava R, 1999, J POLYM SCI POL CHEM, V37, P391, DOI 10.1002/(SICI)1099-0518(19990215)37:4<391::AID-POLA3>3.0.CO;2-E
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Lee YJ, 2002, CELL GROWTH DIFFER, V13, P237
   Montane J, 2002, J APPL POLYM SCI, V85, P1815, DOI 10.1002/app.10379
   Paredes N, 1998, J POLYM SCI POL CHEM, V36, P1271
   Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P45, DOI 10.1016/S0076-6879(08)02003-X
   Rodriguez-Galan A, 2000, POLYMER, V41, P5967, DOI 10.1016/S0032-3861(99)00756-9
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   SONG H, 2007, L ARGININE BASED BIO
   Tsitlanadze G, 2004, J BIOMAT SCI-POLYM E, V15, P1, DOI 10.1163/156856204322752200
   Tsitlanadze G, 2004, J MATER SCI-MATER M, V15, P185, DOI 10.1023/B:JMSM.0000011821.46166.1e
NR 35
TC 40
Z9 40
U1 1
U2 26
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2010
VL 95A
IS 2
BP 371
EP 380
DI 10.1002/jbm.a.32858
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 660TF
UT WOS:000282666600005
PM 20629024
DA 2018-10-19
ER

PT J
AU Mi, SL
   Chen, B
   Wright, B
   Connon, CJ
AF Mi, Shengli
   Chen, Bo
   Wright, Bernice
   Connon, Che John
TI Plastic compression of a collagen gel forms a much improved scaffold for
   ocular surface tissue engineering over conventional collagen gels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE artificial corneal epithelium; limbal epithelial cells; collagen gel;
   plastic compression; scaffold
ID LIMBAL STEM-CELLS; CORNEAL EPITHELIUM; CROSS-LINKING; CRYOPROTECTIVE
   AGENTS; MECHANICAL-PROPERTIES; RECONSTRUCTION; CONSTRUCTS; MODEL;
   CRYOPRESERVATION; STRATIFICATION
AB We compare the use of plastically compressed collagen gels to conventional collagen gels as scaffolds onto which corneal limbal epithelial cells (LECs) are seeded to construct an artificial corneal epithelium. LECs were isolated from bovine corneas (limbus) and seeded onto either conventional uncompressed or novel compressed collagen gels and grown in culture. Scanning electron microscopy (SEM) results showed that fibers within the uncompressed gel were loose and irregularly ordered, whereas the fibers within the compressed gel were densely packed and more evenly arranged. Quantitative analysis of LECs expansion across the surface of the two gels showed similar growth rates (p > 0.05). Under SEM, the LECs, expanded on uncompressed gels, showed a rough and heterogeneous morphology, whereas on the compressed gel, the cells displayed a smooth and homogeneous morphology. Transmission electron microscopy (TEM) results showed the compressed scaffold to contain collagen fibers of regular diameter and similar orientation resembling collagen fibers within the normal cornea. TEM and light microscopy also showed that cell-cell and cell-matrix attachment, stratification, and cell density were superior in LECs expanded upon compressed collagen gels. This study demonstrated that the compressed collagen gel was an excellent biomaterial scaffold highly suited to the construction of an artificial corneal epithelium and a significant improvement upon conventional collagen gels. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 447-453, 2010.
C1 [Mi, Shengli; Chen, Bo; Wright, Bernice; Connon, Che John] Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
RP Connon, CJ (reprint author), Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
EM c.j.connon@reading.ac.uk
RI Connon, Che/B-3128-2012; Chen, Bo/A-3351-2015; Liu, Yifei/L-7828-2014
OI Connon, Che/0000-0001-8264-6531; Liu, Yifei/0000-0002-1087-9827
FU Biotechnology and Biological Sciences Research Council of United Kingdom
   [BB/F019742/1]; Biotechnology and Biological Sciences Research Council
   [BB/F019742/1]
FX Contract grant sponsor: Biotechnology and Biological Sciences Research
   Council of United Kingdom; contract grant number: BB/F019742/1
CR Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   Bentley E, 2002, INVEST OPHTH VIS SCI, V43, P2136
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/ten.2004.10.1526
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064
   Connon CJ, 2006, CELL TISSUE RES, V323, P177, DOI 10.1007/s00441-005-0059-2
   CONNON CJ, 2007, PLOS ONE, V2
   Devireddy RV, 2003, TISSUE ENG, V9, P1089, DOI 10.1089/10763270360728008
   Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742
   Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021
   Ensanya AAN, 2006, SOFT MATTER, V2, P986
   Feng Z, 2003, ARTIF ORGANS, V27, P84, DOI 10.1046/j.1525-1594.2003.07187.x
   Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415
   Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002
   Koob TJ, 2002, BIOMATERIALS, V23, P203, DOI 10.1016/S0142-9612(01)00096-5
   Li F, 2005, BIOMATERIALS, V26, P3093, DOI 10.1016/j.biomaterials.2004.07.063
   Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Mi SL, 2008, MOL REPROD DEV, V75, P1607, DOI 10.1002/mrd.20900
   Neidert MR, 2004, TISSUE ENG, V10, P23, DOI 10.1089/107632704322791664
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   Notara M, 2007, J MATER SCI-MATER M, V18, P329, DOI 10.1007/s10856-006-0697-2
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Qu L, 2009, VET J, V179, P392, DOI 10.1016/j.tvjl.2007.10.009
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Shi Y, 2006, TISSUE ENG, V12, P2601, DOI 10.1089/ten.2006.12.2601
   Taliana L, 2001, INVEST OPHTH VIS SCI, V42, P81
   XIAODONG D, 2007, BIOMATERIALS, V28, P78
   Yang XY, 2008, MOL VIS, V14, P1064
   YUWEN L, 2006, INVEST OPHTH VIS SCI, V47, P1869
NR 34
TC 52
Z9 52
U1 2
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2010
VL 95A
IS 2
BP 447
EP 453
DI 10.1002/jbm.a.32861
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 660TF
UT WOS:000282666600013
PM 20648540
DA 2018-10-19
ER

PT J
AU Bota, PCS
   Collie, AMB
   Puolakkainen, P
   Vernon, RB
   Sage, EH
   Ratner, BD
   Stayton, PS
AF Bota, Paige C. S.
   Collie, Angela M. B.
   Puolakkainen, Pauli
   Vernon, Robert B.
   Sage, E. Helene
   Ratner, Buddy D.
   Stayton, Patrick S.
TI Biomaterial topography alters healing in vivo and monocyte/macrophage
   activation in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE human monocytes/macrophages; topography; surface dependent behavior;
   foreign body reaction; microarray
ID ENCAPSULATES SUBCUTANEOUS IMPLANTS; CYTOKINE MESSENGER-RNAS; MONOCYTES
   MACROPHAGES; BIOMEDICAL POLYMERS; SURFACE; TISSUE; GENERATION;
   CHEMOKINES; CELLS; QUANTIFICATION
AB The effect of biomaterial topography on healing in vivo and monocyte/macrophage stimulation in vitro was assessed. A series of expanded polytetrafluoroethylene (ePTFE) materials were characterized by increasing average intranodal distance of 1.2 mu m (1.2-ePTFE), 3.0 mu m (3.0-ePTFE), and 4.4 mu m (4.4-ePTFE), but presented consistent surface chemistry with nonporous PTFE (np-PTFE). Subcutaneous implantation of 4.4-ePTFE into mice resulted in a statistically thinner capsule that appeared less organized and less dense than the np-PTFE response. In vitro, isolated monocytes/macrophages cultured on np-PTFE produced low levels of interleukin 1-beta (IL-1 beta), 1.2-ePTFE and 3.0-ePTFE stimulated intermediate levels, and 4.4-ePTFE stimulated a 15-fold increase over np-PTFE. Analysis of cDNA microarrays demonstrated that additional proinflammatory cytokines and chemokines, including IL-1 beta, interleukin 6, tumor necrosis factor alpha, monocyte chemotactic protein 1, and macrophage inflammatory protein 1-beta, were expressed at higher levels by monocytes/macrophages cultured on 4.4-ePTFE at 4 and 24 h, respectively. Expression ratios for several genes were quantified by RT-PCR and were consistent with those from the cDNA array results. These results demonstrate the effect of biomaterial topography on early proinflammatory cytokine production and gene transcription by monocytes/macrophages in vitro and decreased fibrous capsule thickness in vivo. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 649-657, 2010.
C1 [Bota, Paige C. S.; Collie, Angela M. B.; Ratner, Buddy D.; Stayton, Patrick S.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Puolakkainen, Pauli; Vernon, Robert B.; Sage, E. Helene] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA.
RP Collie, AMB (reprint author), Cleveland Clin, Pathol & Lab Med Inst, Mail Code L25,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM bookwaam@hotmail.com
RI Luong-Van, Emma/A-8685-2012
FU National Science Foundation [NSF EEC-9529161]; NIH [GM045873]; Whitaker
   Foundation; Medical Scientist Training Program [GM07266]; Engineered
   Biomaterials Training Program [GM065098]
FX Contract grant sponsor: National Science Foundation; contract grant
   number: NSF EEC-9529161; Contract grant sponsor: NIH; contract grant
   number: GM045873; ESCA was conducted at the NIH NESAC/BIO Center
   (RR-01296), and SEMs were prepared by Stephanie Lara and Thomas Wight.
   P. C. S. B. was supported by a fellowship from the Whitaker Foundation.
   A. M. B. C. was supported by fellowships from the Medical Scientist
   Training Program (GM07266) and the Engineered Biomaterials Training
   Program (GM065098).
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bauer GJ, 2000, SHOCK, V14, P435, DOI 10.1097/00024382-200014040-00003
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Broberg EK, 2003, J VIROL METHODS, V112, P53, DOI 10.1016/S0166-0934(03)00191-5
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478
   Dinnes DLM, 2007, J BIOMED MATER RES A, V80A, P895, DOI 10.1002/jbm.a.30967
   Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001
   Frangogiannis NG, 2004, INFLAMM RES, V53, P585, DOI 10.1007/s00011-004-1298-5
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   MIDDLETON E, 1998, ALLERGY PRINCIPLES P
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   Rozen S, 2000, Methods Mol Biol, V132, P365
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E
   Teo IA, 2002, J IMMUNOL METHODS, V270, P119, DOI 10.1016/S0022-1759(02)00218-1
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 31
TC 83
Z9 86
U1 3
U2 44
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2010
VL 95A
IS 2
BP 649
EP 657
DI 10.1002/jbm.a.32893
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 660TF
UT WOS:000282666600034
PM 20725970
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bras, LED
   Proffitt, JL
   Bloor, S
   Sibbons, PD
AF Bras, Lisandra E. de Castro
   Proffitt, Joanne L.
   Bloor, Steve
   Sibbons, Paul D.
TI Effect of crosslinking on the performance of a collagen-derived
   biomaterial as an implant for soft tissue repair: A rodent model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE crosslinking; collagen; permacol; biocompatibility; animal model
ID PORCINE DERMAL COLLAGEN; EXTRACELLULAR-MATRIX; HERNIA REPAIR;
   RECONSTRUCTION; GRAFT; ANGIOGENESIS; PERMACOL(TM); INFILTRATION; TENDON;
   CELLS
AB One of the main problems in healthcare is the loss of tissues resulting from diseases, post-surgery complications or trauma. As a result there is a need for biomaterials designed to promote tissue regeneration and improve wound healing. This study assessed the effect of crosslinking of a porcine dermal collagen matrix with regard to strength of implant/host tissue integration, implant biocompatibility and general healing in a rodent model. Permacol (TM), a crosslinked acellular collagenous biomaterial was compared with its noncrosslinked equivalent at 3, 6, and 12 months postsubcutaneous implantation. Both matrices were well tolerated and showed no evidence of inflammation or adverse responses either in the host tissue or implants. Progressive integration of the implants with the surrounding tissue was observed. Cellular response was similar for both collagenous matrices although, at 3 and 6 months, noncrosslinked implants showed a significantly higher level of cellular penetration than crosslinked implants. However, at 12 months crosslinked implants showed significantly higher levels of cellular density, neo-vascularisation and integration with host tissue. Additionally, at long term, noncrosslinked implants lost volume suggesting some absorption. The crosslinking process does not seem to be detrimental to cellular response and biocompatibility. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 95B: 239-249, 2010.
C1 [Bras, Lisandra E. de Castro; Sibbons, Paul D.] Northwick Pk Inst Med Res, Dept Surg Res, Harrow HA1 1UJ, Middx, England.
RP Bras, LED (reprint author), Northwick Pk Inst Med Res, Dept Surg Res, Harrow HA1 1UJ, Middx, England.
EM lisandra.bras@iit.it
OI de Castro Bras, Lisandra E./0000-0001-9014-8858
FU Tissue Science Laboratories plc
FX Contract grant sponsor: Tissue Science Laboratories plc
CR ABHINAV K, 2008, EUR J SURG ONCOL, V35, P439
   Alaedeen D I, 2007, Hernia, V11, P41, DOI 10.1007/s10029-006-0164-5
   Albo Daniel, 2006, Am J Surg, V192, pe12, DOI 10.1016/j.amjsurg.2006.08.029
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Benito-Ruiz J, 2006, PLAST RECONSTR SURG, V117, P2517, DOI 10.1097/01.prs.0000220001.83772.36
   Carbonell AM, 2005, SURG ENDOSC, V19, P430, DOI 10.1007/s00464-004-8810-4
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   CHAUDHRY A, 2008, INT SEMINARS SURG ON, V5, P1
   Cillo JE, 2007, J ORAL MAXIL SURG, V65, P1017, DOI 10.1016/j.joms.2005.08.024
   Coons DA, 2006, SPORTS MED ARTHROSC, V14, P185, DOI 10.1097/00132585-200609000-00011
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   DENCH JE, 2006, DIS COLON RECTUM, V49, P1992
   Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Hammond TM, 2008, BRIT J SURG, V95, P438, DOI 10.1002/bjs.5883
   HARPER C, 2001, HOSP MED, V62, P2
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hwang K, 2007, J CRANIOFAC SURG, V18, P551, DOI 10.1097/scs.0b013e3180534421
   Inan I, 2007, DIS COLON RECTUM, V50, P1465, DOI 10.1007/s10350-007-0275-9
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kelley P, 2005, PLAST RECONSTR SURG, V116, P1780, DOI 10.1097/01.prs.0000186529.60982.60982.0a
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Leek RD, 1996, CANCER RES, V56, P4625
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   MacLeod TM, 2004, BURNS, V30, P704, DOI 10.1016/j,.burns.2004.03.008
   MacLeod TM, 2004, BURNS, V30, P431, DOI 10.1016/j.burns.2004.01.018
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Metcalfe DD, 1997, PHYSIOL REV, V77, P1033
   MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1
   OLDEDAMINK LHH, 1995, J MATER SCI-MATER M, V6, P429
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Pentlow A, 2008, PEDIATR TRANSPLANT, V12, P20, DOI 10.1111/j.1399-3046.2007.00824.x
   Prussin Calman, 2003, Journal of Allergy and Clinical Immunology, V111, pS486
   RAMSHAW B, GEN SURG NEWS 2007
   Richards SK, 2005, PEDIATR TRANSPLANT, V9, P627, DOI 10.1111/j.1399-3046.2005.00312.x
   Saettele T M, 2007, Hernia, V11, P279, DOI 10.1007/s10029-006-0186-z
   Skipworth R J E, 2007, Hernia, V11, P541, DOI 10.1007/s10029-007-0234-3
   Smart NJ, 2007, DIS COLON RECTUM, V50, P1422, DOI 10.1007/s10350-007-0219-4
   Smith GHM, 2007, DIS COLON RECTUM, V50, P1719, DOI 10.1007/s10350-007-9052-z
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Wang JW, 2003, J BIOMED MATER RES A, V64A, P262, DOI 10.1002/jbm.a.10358
   YAO C, 2007, BIOMATERIALS, V29, P66
NR 44
TC 16
Z9 16
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2010
VL 95B
IS 2
BP 239
EP 249
DI 10.1002/jbm.b.31704
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 666GU
UT WOS:000283103400001
PM 20878916
DA 2018-10-19
ER

PT J
AU Rojo, FJ
   Paez, JMG
   Jorge-Herrero, E
   Atienza, JM
   Millan, I
   Rocha, A
   de Cordova, AHF
   Guinea, GV
AF Rojo, Francisco J.
   Garcia Paez, Jose M.
   Jorge-Herrero, Eduardo
   Atienza, Jose M.
   Millan, Isabel
   Rocha, Aurora
   Fernandez de Cordova, Alfonso Hoyos
   Guinea, Gustavo V.
TI Optimal selection of biological tissue using the energy dissipated in
   the first loading cycle
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE fatigue; energy dissipation; selection; biological tissue
ID BIOPROSTHETIC HEART-VALVES; BOVINE PERICARDIUM; CALF PERICARDIUM;
   CARDIAC BIOPROSTHESES; FIBER ARCHITECTURE; DURABILITY; CALCIFICATION;
   BIOMATERIAL; LEAFLETS; DETERIORATION
AB Calf pericardium, similar to that used in the manufacturing of prosthetic valve cusps, was fatigue tested. After six batches of 100 cycles of 1 MPa of loading pressure, half of the samples broke. The mean energy dissipated in the first cycle by the surviving samples was 0.16 J, which is lower than the 0.28 J dissipated by the specimens that broke (p = 0.005). The hysteresis of the first cycle was characteristic and different from the following ones and correlated superbly with fatigue resistance. Setting a threshold value for the energy of the first cycle of 0.20 J, the performance index (the percentage of true predictions) was almost 80%, and the area under the ROC curve was 0.823 (maximum value is 1). When including the mean thickness in the selection parameters, as an indirect measure of the specimen mass, the performance index grew over 95%, meaning that the error of the predictions was less than 5%. Combining both parameters in one, a high performance index is maintained at 87.5% and the area under the ROC curve increases to 0.917. This non-destructive method should help optical methods in the process of selecting the most appropriate and homogenous biological material. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 95B: 414-420, 2010.
C1 [Rojo, Francisco J.; Atienza, Jose M.; Guinea, Gustavo V.] Univ Politecn Madrid, Dept Ciencia Mat, Escuela Ingenieros Caminos Canales & Puertos, Madrid, Spain.
   [Garcia Paez, Jose M.; Jorge-Herrero, Eduardo; Rocha, Aurora; Fernandez de Cordova, Alfonso Hoyos] Hosp Univ Puerta da Hierro Majadahonda, Unidad Biomat, Madrid, Spain.
   [Millan, Isabel] Hosp Univ Puerta da Hierro Majadahonda, Serv Bioestadist, Madrid, Spain.
RP Rojo, FJ (reprint author), Univ Politecn Madrid, Dept Ciencia Mat, Escuela Ingenieros Caminos Canales & Puertos, Madrid, Spain.
EM fjrojo@mater.upm.es
RI GUINEA TORTUERO, GUSTAVO VICTOR/N-1241-2014; Rojo Perez, Francisco
   Javier/F-7710-2016
OI GUINEA TORTUERO, GUSTAVO VICTOR/0000-0002-4326-3746; Rojo Perez,
   Francisco Javier/0000-0001-9517-0050; ATIENZA RIERA, JOSE
   MIGUEL/0000-0002-1444-8979
FU Comunidad de Madrid [MADR.IB-CM/S-SAL/0312/2006]
FX This research was financed by the Comunidad de Madrid through the
   MADR.IB-CM/S-SAL/0312/2006 program.
CR Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Butany J, 2001, J Long Term Eff Med Implants, V11, P115
   Butterfield M, 2001, J HEART VALVE DIS, V10, P105
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7
   Fann JI, 1996, ANN THORAC SURG, V62, P1301, DOI 10.1016/0003-4975(96)00629-7
   Flecher EM, 2008, J CARDIAC SURG, V23, P234, DOI 10.1111/j.1540-8191.2008.00593.x
   Paez JMG, 2007, J MATER SCI-MATER M, V18, P715, DOI 10.1007/s10856-006-0009-x
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GUERRA F, 1990, J THORAC CARDIOV SUR, V99, P838
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   HERRERO EJ, 1991, RES SURG, V3, P62
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Igual A, 2006, CIR CARDIOVASC, V13, P171
   Jorge-Herrero E, 2005, J Appl Biomater Biomech, V3, P67
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   KRAMER S, 1985, MAUSNER BAHN EPIDEMI, P214
   Lau L, 2006, ANN THORAC SURG, V82, P2123, DOI 10.1016/j.athoracsur.2006.07.027
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   Paez JMG, 2006, J BIOMED MATER RES A, V77A, P839, DOI 10.1002/jbm.a.30650
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 2002, J MATER SCI-MATER M, V13, P381
   PAEZ JMG, 1994, BIOMATERIALS, V15, P172, DOI 10.1016/0142-9612(94)90063-9
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   PURINYA B, 1994, J BIOMECH, V27, P1, DOI 10.1016/0021-9290(94)90027-2
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
NR 38
TC 3
Z9 3
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2010
VL 95B
IS 2
BP 414
EP 420
DI 10.1002/jbm.b.31732
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 666GU
UT WOS:000283103400021
PM 20878926
DA 2018-10-19
ER

PT J
AU Jannetty, J
   Kolb, E
   Boxberger, J
   Deslauriers, R
   Ganey, T
AF Jannetty, Joseph
   Kolb, Eric
   Boxberger, John
   Deslauriers, Richard
   Ganey, Timothy
TI Guiding Bone Formation in a Critical-Sized Defect and Assessments
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Synthetic graft; biomaterial; bone surrogate; bioabsorbable;
   biologically transparent
ID NITRIC-OXIDE; FRACTURE REPAIR; ORTHOPEDIC TRAUMA; GRAFT SUBSTITUTES;
   CEMENT; RATS
AB Purpose: Development of alternatives to autologous bone has been served by many hypotheses and developments. Favorable properties of synthetic materials used currently in bone grafting support tissue differentiation without shielding capacity for integrated modeling. Ideally, new materials provide tissue compatibility and minimize patient morbidity and are attractive because of potential for in situ delivery, isothermal polymerization, porous structure, and nontoxic chemistry. For application in cranial bone, ability for materials to be laid adjacent to brain and offer postsurgical protection without neural risk is a critical asset.
   Methods: Kryptonite Bone Cement (KBC) meets the property criteria for cranial bone repair with regard to adhesive, conductive, and biologic transparency and US Food and Drug Administration approval for cranial bone void repair. To better delineate the morphology effective in cranial bone repair, a comparison was made between KBC and BoneSource, another material approved for the same indication. After Institutional Animal Care and Use Committee approval, the study assessed 24 rabbits, each with 2 separate cranial implants, to evaluate integration and absorption of the biomaterial at defined time points of 12, 18, 24, and 36 weeks.
   Results: The 36-week assessment demonstrated near-complete resorption/integration of the BoneSource graft material. Bone was present within the biomaterial as well as independent of contact. The KBC was similarly integrated throughout the mass of the material, and new bone was in contact with the grafting material and also seen as separate islands of new bone. The bone demonstrated lamellar bone architecture with clear trabecular morphology. At higher magnification, the bone architecture can be clearly delineated, and comparison between the graft fillers is not obvious relative to the bone that has formed. Despite microscopic similarities, the most striking difference was maintenance of scaffold anatomy during bone regeneration.
   Conclusions: Kryptonite Bone Cement meets the criteria described in the introduction; properties of biologic transparency, osteoconductivity, and ergonomic utility offer other potential uses in bone repair. Key tenets of bone tissue regeneration observed in this analysis included adequate cell differentiation and tissue support. Bone that formed demonstrated lamellar rather than woven bone to suggest response to loading strain rather than merely biochemical precipitation. Over the 36-week study, the graft showed progressive bioabsorbable potential with calibrated replacement.
C1 [Ganey, Timothy] Atlanta Med Ctr, Dept Orthoped Surg, Atlanta, GA 30312 USA.
   Doctors Res Grp, Southbury, CT USA.
RP Ganey, T (reprint author), Atlanta Med Ctr, Dept Orthoped Surg, 303 Pkwy Dr NE,Box 227, Atlanta, GA 30312 USA.
EM timothy.ganey@tenethealth.com
CR Baldik Y, 2002, CLIN ORTHOP RELAT R, P343, DOI 10.1097/01.blo.0000022182.66847.8b
   CHAKKALAKAL DA, 2004, J BIOMED MATER RES, V28, P1439
   Corbett SA, 1999, CLIN ORTHOP RELAT R, P247
   Corbett SA, 1999, J BONE JOINT SURG BR, V81B, P531, DOI 10.1302/0301-620X.81B3.8852
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Desai Bharat M, 2007, Am J Orthop (Belle Mead NJ), V36, P8
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Diwan AD, 2000, J BONE MINER RES, V15, P342, DOI 10.1359/jbmr.2000.15.2.342
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2
   Filho J.R.L., 2009, J ORAL SCI, V51, P451
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Gay C, 2002, INTEGR COMP BIOL, V42, P1123, DOI 10.1093/icb/42.6.1123
   Habal MB, 2008, J CRANIOFAC SURG, V19, P1435, DOI 10.1097/SCS.0b013e31818a2235
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   HAO YJ, 2005, CLIN ORTHOP RELAT R, V435, P226
   HILLAM RA, 1995, J BONE MINER RES, V10, P683
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   LEBLANC AD, 1990, J BONE MINER RES, V5, P843
   Mancini L, 2000, BIOCHEM BIOPH RES CO, V274, P477, DOI 10.1006/bbrc.2000.3164
   Miller L, 2005, ANN PLAS SURG, V55, P87, DOI 10.1097/01.sap.0000162510.05196.c6
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Pinheiro CR, 2009, ORAL SURG ORAL MED O, V108, pE56, DOI 10.1016/j.tripleo.2009.08.008
   Rawlinson SCF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008358
   Ribeiro MFP, 2004, INT DENT J, V54, P47, DOI 10.1111/j.1875-595X.2004.tb00252.x
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Toolan BC, 2006, FOOT ANKLE INT, V27, P561, DOI 10.1177/107110070602700715
   Wimalawansa SJ, 2000, CALCIFIED TISSUE INT, V66, P56, DOI 10.1007/s002230050011
   WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8
   Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014
NR 31
TC 9
Z9 11
U1 1
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD NOV
PY 2010
VL 21
IS 6
BP 1848
EP 1854
DI 10.1097/SCS.0b013e3181f43ee8
PG 7
WC Surgery
SC Surgery
GA 688DK
UT WOS:000284829800045
PM 21119438
DA 2018-10-19
ER

PT J
AU Garcia-Rosales, G
   Colin-Cruz, A
AF Garcia-Rosales, G.
   Colin-Cruz, A.
TI Biosorption of lead by maize (Zea mays) stalk sponge
SO JOURNAL OF ENVIRONMENTAL MANAGEMENT
LA English
DT Review
DE Biosorption; Lead; Zea mays; Site density; Surface properties
ID AQUEOUS-SOLUTIONS; HEAVY-METALS; ZERO CHARGE; WASTE-WATER; REMOVAL;
   CELLULOSE; BIOMASS; PB(II); IONS; ADSORPTION
AB This study investigated the removal of Pb(II) from aqueous solutions by a maize (Zea mays) stalk sponge. Equilibrium and kinetic models for Pb(II) sorption were developed by considering the effect of the contact time and concentration at the optimum pH of 6 +/- 0.2. The Freundlich model was found to describe the sorption energetics of Pb(II) by Z. mays stalk sponge, and a maximum Pb(II) loading capacity of 80 mg g(-1) was determined. The kinetic parameters were obtained by fitting data from experiments measuring the effect of contact time on adsorption capacity into pseudo-first and second-order equations. The kinetics of Pb(II) sorption onto Z. mays biosorbent were well defined using linearity coefficients (R-2) by the pseudo-second-order equation (0.9998). The results obtained showed that Zea may stalk sponge was a useful biomaterial for Pb(II) sorption and that pH has an important effect on metal biosorption capacity. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Garcia-Rosales, G.; Colin-Cruz, A.] Univ Autonoma Estado Mexico, Fac Quim, Toluca 50120, Mexico.
   [Garcia-Rosales, G.] Inst Nacl Invest Nucl, Dept Quim, Mexico City 11801, DF, Mexico.
RP Garcia-Rosales, G (reprint author), Inst Tecnol Toluca, Av Inst Tecnol S-N, Ex Rancho Virgen Metepec 52140, Estado Mexico, Mexico.
EM gegaromx@yahoo.com.mx
RI Colin-Cruz, Arturo/D-2238-2016
OI Colin-Cruz, Arturo/0000-0001-7612-8391
CR Adebajo MO, 2004, SPECTROCHIM ACTA A, V60, P2315, DOI 10.1016/j.saa.2003.12.005
   AMDUR MO, 1991, TOXICOLOGY BASIC SCI, P639
   Barros AJM, 2006, BRAZ J CHEM ENG, V23, P153, DOI 10.1590/S0104-66322006000200001
   BELL LC, 1973, J COLLOID INTERF SCI, V42, P250, DOI 10.1016/0021-9797(73)90288-9
   Bonet M, 2004, CAN J ANAL SCI SPECT, V49, P234
   Cernansky S., 2007, African Journal of Biotechnology, V6, P1932
   Chen Hong, 2005, J Zhejiang Univ Sci B, V6, P171, DOI 10.1631/jzus.2005.B0171
   Cossich ES, 2002, ELECTRON J BIOTECHN, V5, P133
   Doyurum S, 2006, J HAZARD MATER, V138, P22, DOI 10.1016/j.jhazmat.2006.03.071
   DZOMBAK DA, 1990, SURFACE COMPLEXATION
   Emongor V., 2007, J AGR FOOD ENV SCI, V1, P1
   Garg U, 2008, J HAZARD MATER, V154, P1149, DOI 10.1016/j.jhazmat.2007.11.040
   Goksungur Yekta, 2003, Turkish Journal of Biology, V27, P23
   GREY P, 1969, CAN J CHEM, V47, P4343
   Guo SS, 2000, AM J HUM BIOL, V12, P64
   Hinterstoisser B, 1999, CELLULOSE, V6, P251, DOI 10.1023/A:1009225815913
   HOWSMON JA, 1963, CELLULOSE CELLULOS 1, V5, P231
   Igwe JC, 2005, AFR J BIOTECHNOL, V4, P1109
   Iqbal M, 2007, PAK J BOT, V39, P231
   Jankiewicz B, 2001, POL J ENVIRON STUD, V10, P123
   JORGENSEN SE, 1981, PRINCIPLES ENV SCI T, P306
   Kang SY, 2008, INT J ENVIRON POLLUT, V34, P195, DOI 10.1504/IJEP.2008.020791
   KIM SH, 2007, GEOPHYS RES ABS, V9, P3141
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Kumar U, 2006, SCI RES ESSAYS, V1, P33
   LIANG CY, 1959, J POLYM SCI, V37, P385, DOI 10.1002/pol.1959.1203713209
   Liu YW, 2006, J HAZARD MATER, V135, P389, DOI 10.1016/j.jhazment.2005.11.078
   Mudipalli A, 2007, INDIAN J MED RES, V126, P518
   Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319
   NOH JS, 1989, J COLLOID INTERF SCI, V130, P157, DOI 10.1016/0021-9797(89)90086-6
   Oh SY, 2005, CARBOHYD RES, V340, P417, DOI 10.1016/j.carres.2004.11.027
   Pavan FA, 2008, BIOCHEM ENG J, V40, P357, DOI 10.1016/j.bej.2008.01.004
   Pehlivan E, 2009, J HAZARD MATER, V164, P982, DOI 10.1016/j.jhazmat.2008.08.115
   Qi BC, 2008, BIORESOURCE TECHNOL, V99, P5595, DOI 10.1016/j.biortech.2007.10.042
   REGAZZONI AE, 1983, J COLLOID INTERF SCI, V91, P560, DOI 10.1016/0021-9797(83)90370-3
   Schiewer S, 2009, CHEM ENG J, V146, P211, DOI 10.1016/j.cej.2008.05.034
   Sun Y, 2008, BIORESOURCES, V3, P297
   SVOBODA L, 1994, COLLECT CZECH CHEM C, V59, P558, DOI 10.1135/cccc19940558
   TAVARES T, 1998, 2 EUR S BIOCH ENG SC, P16
   Uluozlu OD, 2008, BIORESOURCE TECHNOL, V99, P2972, DOI 10.1016/j.biortech.2007.06.052
   Unlu N, 2006, J HAZARD MATER, V136, P272, DOI 10.1016/j.jhazmat.2005.12.013
   VALLEJOPUERTA V, 2008, AFINIDAD, V65, P224
   Wang L. K., 2004, PHYSICOCHEMICAL TREA, V3, P141
   WANNER H, 1994, RADIOCHIM ACTA, V66-7, P157
   Yu B, 2001, J HAZARD MATER, V84, P83, DOI 10.1016/S0304-3894(01)00198-4
   ZVINOWANDA CM, 2008, J HAZARD MATER, DOI DOI 10.1016/J.HAZMAT.2008.08.110
NR 46
TC 54
Z9 58
U1 0
U2 24
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0301-4797
EI 1095-8630
J9 J ENVIRON MANAGE
JI J. Environ. Manage.
PD NOV
PY 2010
VL 91
IS 11
BP 2079
EP 2086
DI 10.1016/j.jenvman.2010.06.004
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 645LN
UT WOS:000281459400001
PM 20615602
DA 2018-10-19
ER

PT J
AU Neethling, WML
   Glancy, R
   Hodges, AJ
AF Neethling, William M. L.
   Glancy, Ross
   Hodges, Andrew J.
TI Mitigation of Calcification and Cytotoxicity of a
   Glutaraldehyde-Preserved Bovine Pericardial Matrix: Improved
   Biocompatibility After Extended Implantation in the Subcutaneous Rat
   Model
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article
ID PORCINE HEART-VALVES; IMMUNE-RESPONSE; TISSUE; BIOPROSTHESES; CELLS;
   DECELLULARIZATION; FAILURE; RECELLULARIZATION; PROSTHESES; SCAFFOLDS
AB Background and aims of the study: Implanted non-crosslinked tissues suffer rapid degeneration, shrinkage and absorption, whereas standard crosslinked tissues cause local cytotoxicity and calcification. Both approaches diminish implant capacity for long-term function. The study aim was to examine the tissue-engineered characteristics (cytotoxicity, calcification potential, biocompatibility) of bovine pericardium, crosslinked with a low concentration of glutaraldehyde (GA) followed by ADAPT (R) anti-mineralization, following prolonged implantation in a subcutaneous rat model.
   Methods: Bovine pericardium was decellularized with Triton X-100, deoxycholate, IgePal CA-630 (R), and nucleases. The resulting matrices were allocated to: group I (control, n = 10), crosslinked in 0.2% polymeric GA; and group II (treatment, n = 10), crosslinked in 0.05% monomeric GA + ADAPT. Cytotoxicity was determined by in vitro cell seeding with human fibroblasts, and quantified using an Alamar Blue assay. The matrices were then implanted in a subcutaneous rat model and retrieved after extended implantation times (26 and 52 weeks). This was followed by further histology, immunohistochemical staining, and measurement of calcium deposition.
   Results: Complete acellularity and biostability were significantly (p <0.01) achieved in group II. Inflammatory responses were reduced and beneficial host cell infiltration with neocapillary formation was limited to group II. Fibroblast infiltration was significantly increased from six to 12 months' implantation time. Only group II tested positive for Factor VIII and vimentin. After 52 weeks, extractable calcium levels were significantly (p <0.001) reduced in group 11 (2.56 +/- 0.22 mu g Ca/mg tissue) compared to group I (136.02 +/- 0.39 mu g Ca/mg tissue).
   Conclusion: Acellular bovine pericardium, when crosslinked with a low concentration of GA and treated with ADAPT, retains and improves its integrity with a low immunoreactivity over a prolonged period. Host cell infiltration is also optimized over time. The maintenance of reduced calcification levels in group II suggests that such a biomaterial might have an advanced long-term in vivo potential.
C1 [Neethling, William M. L.] Univ Western Australia, Fremantle Heart Inst, Nedlands, WA 6009, Australia.
   [Neethling, William M. L.] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia.
   [Glancy, Ross] Fremantle Hosp, Dept Histopathol, Fremantle, WA 6160, Australia.
   [Neethling, William M. L.] Fremantle Hosp, Fremantle Heart Inst, Cell Biol Res Unit, Dept Cardiothorac Surg, Fremantle, WA 6160, Australia.
RP Neethling, WML (reprint author), Fremantle Hosp, Fremantle Heart Inst, Cell Biol Res Unit, Dept Cardiothorac Surg, Z Block,Alma St, Fremantle, WA 6160, Australia.
EM Leon.Neethling@health.wa.gov.au
CR Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   da Costa FDA, 2004, ARTIF ORGANS, V28, P366, DOI 10.1111/j.1525-1594.2004.47357.x
   DIAZJOUANEN E, 1975, AM J MED, V58, P620, DOI 10.1016/0002-9343(75)90497-0
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   HARKEN R, 1962, AM J CARDIOL, V9, P202
   HILBERT S J, 1988, Medical Progress Through Technology, V14, P115
   Hopkins RA, 2005, CIRCULATION, V111, P2712, DOI 10.1161/CIRCULATIONAHA.104.527820
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   Jamieson WRE, 2005, J THORAC CARDIOV SUR, V129, P1301, DOI 10.1016/j.jtcvs.2004.09.042
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athorascur.2004.09.033
   Kim KM, 2002, J BIOMED MATER RES, V59, P639, DOI 10.1002/jbm.10038
   Konakci KZ, 2005, EUR J CLIN INVEST, V35, P17
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Mirzaie M, 2000, SCAND CARDIOVASC J, V34, P589
   NEETHLIN WML, 1992, J CARDIOVASC SURG, V3, P285
   NEETHLING VVM, 2008, J HEART VALVE DIS, V17, P456
   Neethling WML, 2006, J CARDIOVASC SURG, V47, P711
   Neethling WML, 2004, J HEART VALVE DIS, V13, P689
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   ROCCHINI AP, 1981, CIRCULATION, V64, P162
   ROSSI MA, 1990, J EXP PATHOL, V71, P187
   Seifalian AM, 2001, J BIOMED MATER RES, V55, P637, DOI 10.1002/1097-4636(20010615)55:4<637::AID-JBM1058>3.0.CO;2-Z
   SHIN M, 1995, J CLIN LAB ANAL, V9, P424, DOI 10.1002/jcla.1860090615
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   SIMONESCU DT, 2004, EXPERT OPIN BIOL TH, V4, P1971
   Valente M, 1998, J HEART VALVE DIS, V7, P180
   Walles T, 2003, INT J ARTIF ORGANS, V26, P225
NR 33
TC 19
Z9 20
U1 1
U2 14
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD NOV
PY 2010
VL 19
IS 6
BP 778
EP 785
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 694FT
UT WOS:000285281100017
PM 21214104
DA 2018-10-19
ER

PT J
AU Banerjee, KK
   Kumar, S
   Bremmell, KE
   Griesser, HJ
AF Banerjee, K. K.
   Kumar, S.
   Bremmell, K. E.
   Griesser, H. J.
TI Molecular-level removal of proteinaceous contamination from model
   surfaces and biomedical device materials by air plasma treatment
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Article
DE Contact angle; Dental burs; Plasma cleaning; Proteinaceous
   contamination; Surgical stainless steel; X-ray photoelectron
   spectroscopy
ID INDUCTIVELY-COUPLED PLASMA; STAINLESS-STEEL WIRES; PRION PROTEIN;
   SURGICAL-INSTRUMENTS; STERILIZATION; INACTIVATION; DECONTAMINATION;
   INFECTIVITY; XPS; TRANSMISSION
AB Established methods for cleaning and sterilising biomedical devices may achieve removal of bioburden only at the macroscopic level while leaving behind molecular levels of contamination (mainly proteinaceous). This is of particular concern if the residue might contain prions. We investigated at the molecular level the removal of model and real-life proteinaceous contamination from model and practical surfaces by air plasma (ionised air) treatment. The surface-sensitive technique of X-ray photoelectron spectroscopy (XPS) was used to assess the removal of proteinaceous contamination, with the nitrogen (N1s) photoelectron signal as its marker. Model proteinaceous contamination (bovine serum albumin) adsorbed on to a model surface (silicon wafer) and the residual proteinaceous contamination resulting from incubating surgical stainless steel (a practical biomaterial) in whole human blood exhibited strong N1s signals [16.8 and 18.5 atomic percent (at.%), respectively] after thorough washing. After 5 min air plasma treatment, XPS detected no nitrogen on the sample surfaces, indicating complete removal of proteinaceous contamination, down to the estimated XPS detection limit 10 ng/cm(2). Applying the same plasma treatment, the 7.7 at.% nitrogen observed on a clinically cleaned dental bur was reduced to a level reflective of new, as-received burs. Contact angle measurements and atomic force microscopy also indicated complete molecular-level removal of the proteinaceous contamination upon air plasma treatment. This study demonstrates the effectiveness of air plasma treatment for removing proteinaceous contamination from both model and practical surfaces and offers a method for ensuring that no molecular residual contamination such as prions is transferred upon re-use of surgical and dental instruments. Crown Copyright (C) 2010 Published by Elsevier Ltd on behalf of The Hospital Infection Society. All rights reserved.
C1 [Banerjee, K. K.; Kumar, S.; Bremmell, K. E.; Griesser, H. J.] Univ S Australia, IanWark Res Inst, Adelaide, SA 5095, Australia.
RP Kumar, S (reprint author), Univ S Australia, IanWark Res Inst, Mawson Lakes Campus, Adelaide, SA 5095, Australia.
EM sunil.kumar@unisa.edu.au
RI Bremmell, Kristen/B-7725-2011; Griesser, Hans/E-5628-2011
OI Bremmell, Kristen/0000-0002-7633-0562; Griesser,
   Hans/0000-0003-1072-7863
FU University of South Australia; Australian Research Council through SRC
FX K.K.B. acknowledges the postgraduate scholarship from University of
   South Australia.; This work was supported by the Australian Research
   Council through SRC for Particle and Material Interfaces.
CR Baxter HC, 2005, J GEN VIROL, V86, P2393, DOI 10.1099/vir.0.81016-0
   Brevig T, 2005, BIOMATERIALS, V26, P3039, DOI 10.1016/j.biomaterials.2004.09.006
   Brown P, 2000, P NATL ACAD SCI USA, V97, P3418, DOI 10.1073/pnas.050566797
   Cvelbar U, 2006, J PHYS D APPL PHYS, V39, P3487, DOI 10.1088/0022-3727/39/16/S06
   Davis J.R., 1998, METALS HDB DESK EDIT
   Fichet G, 2007, J HOSP INFECT, V67, P278, DOI 10.1016/j.jhin.2007.08.020
   Halfmann H, 2007, J PHYS D APPL PHYS, V40, P4145, DOI 10.1088/0022-3727/40/14/008
   Hayashi N, 2006, JPN J APPL PHYS 1, V45, P8358, DOI 10.1143/JJAP.45.8358
   Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   JELLINEK HHG, 1984, J PHYS CHEM-US, V88, P3048, DOI 10.1021/j150658a024
   Kumar S, 2006, J ASTM INT JAI ONLIN, V3, P5
   Kunze S, 2008, J MICROSC-OXFORD, V230, P224, DOI 10.1111/j.1365-2818.2008.01979.x
   Kylian O, 2006, EUR PHYS J-APPL PHYS, V34, P139, DOI 10.1051/epjap:2006034
   Kylian O, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/9/095201
   Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078
   Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0
   Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791
   Lipscomb IP, 2007, J GEN VIROL, V88, P2619, DOI 10.1099/vir.0.82228-0
   Lipscomb IP, 2006, J HOSP INFECT, V64, P339, DOI 10.1016/j.jhin.2006.08.007
   McLeod K, 2006, APPL SURF SCI, V253, P2644, DOI 10.1016/j.apsusc.2006.05.031
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299
   Rauscher H, 2009, VACUUM, V84, P75, DOI 10.1016/j.vacuum.2009.05.012
   Richard A, 2005, APPL SURF SCI, V240, P204, DOI 10.1016/j.apsusc.2004.06.090
   ROWLAND SA, 1995, J APPL BIOMATER, V6, P1, DOI 10.1002/jab.770060102
   Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989
   Stapelmann K, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/192005
   Sutton JM, 2006, CLIN INFECT DIS, V43, P757, DOI 10.1086/507030
   Taylor DM, 1999, J HOSP INFECT, V43, pS69, DOI 10.1016/S0195-6701(99)90067-1
   Tencer M, 2007, APPL SURF SCI, V253, P9209, DOI 10.1016/j.apsusc.2007.05.079
   Vicoveanu D, 2008, PLASMA PROCESS POLYM, V5, P350, DOI 10.1002/ppap.200700146
   Wagner MS, 2002, J BIOMAT SCI-POLYM E, V13, P407, DOI 10.1163/156856202320253938
   WEISSLER GL, 1979, VACUUM PHYS TECHNOLO, P13
   Whittaker AG, 2004, J HOSP INFECT, V56, P37, DOI 10.1016/j.jhin.2003.09.019
   Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392
   Yip J, 2004, POLYM INT, V53, P634, DOI 10.1002/pi.1278
NR 39
TC 7
Z9 7
U1 1
U2 8
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0195-6701
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD NOV
PY 2010
VL 76
IS 3
BP 234
EP 242
DI 10.1016/j.jhin.2010.07.001
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 660ZD
UT WOS:000282688700009
PM 20850199
DA 2018-10-19
ER

PT J
AU Tarnita, D
   Bolcu, D
   Berceanu, C
   Cismaru, FL
AF Tarnita, D.
   Bolcu, D.
   Berceanu, C.
   Cismaru, F. L.
TI Theoretical and experimental studies for an orthopedic staple made up
   Nitinol
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Nitinol; crystallographic phases; spectral decomposition; experimental
   studies; orthopedic staple
ID ANISOTROPIC ELASTIC-MATERIALS; MEMORY ALLOY FIXATOR; NI-TI; MARTENSITE;
   DIFFRACTION; FORCE; WIRES
AB Super-elastic NiTi has become a very important biomaterial, successfully used for technical and design issues relating to the miniaturization of medical devices and the increasing trend for less invasive and less traumatic procedures. In this paper, we present the elasticity matrix, the decomposition of the elasticity matrix, the eigenvalues and the eigenvectors for the crystallographic phases of Nitinol: trigonal, cubic, monoclinic and orthorhombic. In order to determine the variation law for the compression force developed by the Nitinol orthopaedic staple as function of temperature and, also, to validate the compression potential of the staple through constant pressure at the temperature of the human body, we made an experimental study, using an experimental stand. Using the video capture SIMI Motion software, the kinematical parameters of the both extremities of the staple were obtained. The analytical variation in time of the compression force exerted by the Nitinol staple is also obtained. The data acquired through this methods can be used to corroborate the experimental kinematical parameters with kinematical parameters obtained using various analytical or computer aided simulations in order to confirm a certain mechanical model.
EM dtarnita@yahoo.com
RI Tarnita, Daniela/O-6968-2016
OI Tarnita, Daniela/0000-0002-6935-6641
FU CNCSIS-UEFISCSU [86/2007, Idei_92]
FX This research Work was supported by CNCSIS-UEFISCSU, grant 86/2007,
   Idei_92
CR BIHLMAYER, 1996, PHILOS MAG B, V73, P51
   BIHLMAYER G, 1993, J PHYS-CONDENS MAT, V5, P5083, DOI 10.1088/0953-8984/5/29/006
   BRUINSMA R, 1982, PHYS REV B, V25, P2951, DOI 10.1103/PhysRevB.25.2951
   BUHRER W, 1983, J PHYS F MET PHYS, V13, pL77, DOI 10.1088/0305-4608/13/5/002
   COWIN SC, 1987, Q J MECH APPL MATH, V40, P451, DOI 10.1093/qjmam/40.4.451
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Duerig TW, 1996, METALL, V50, P569
   HEHEMANN RF, 1971, SCRIPTA METALL MATER, V5, P801, DOI 10.1016/0036-9748(71)90167-0
   Kelvin Lord, 1856, PHILOS T ROY SOC LON, V166, P481
   KUDOH Y, 1985, ACTA METALL MATER, V33, P2049, DOI 10.1016/0001-6160(85)90128-2
   KULKOVA SE, 1991, SOLID STATE COMMUN, V77, P667, DOI 10.1016/0038-1098(91)90766-O
   KULKOVA SE, 1995, J PHYS IV, V5, pC8
   Lagoudas DC, 1999, P 4 INT WORKSH MATH
   MANTOVANI D, 2000, METALS MAT SOC, V52, P36
   MEHRABADI MM, 1990, Q J MECH APPL MATH, V43, P15, DOI 10.1093/qjmam/43.1.15
   MICHAL GM, 1981, ACTA CRYSTALLOGR B, V37, P1803, DOI 10.1107/S0567740881007292
   Morawiec HZ, 2007, J MATER SCI-MATER M, V18, P1791, DOI 10.1007/s10856-007-3029-2
   Ng Y, 2006, SURG ENDOSC, V20, P311, DOI 10.1007/s00464-004-001-9
   Parlinski K, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064307
   Patoor E, 2006, MECH MATER, V38, P391, DOI 10.1016/j.mechmat.2005.05.027
   Pelton AR, 2000, MATER SCI FORUM, V327-3, P63, DOI 10.4028/www.scientific.net/MSF.327-328.63
   Petoumeno E, 2008, J OROFAC ORTHOP, V69, P411, DOI 10.1007/s00056-008-0808-4
   Rychlewski J., 1989, ARCH MECH, V47, P697
   Ryhanen J, 2006, ARCH ORTHOP TRAUM SU, V126, P22, DOI 10.1007/s00402-005-0074-5
   Sevilla P, 2008, J MATER SCI-MATER M, V19, P525, DOI 10.1007/s10856-007-0164-8
   SHABALOVSKAYA SA, 1995, J PHYS 4
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   Smith G. F., 1958, T AM MATH SOC, V88, P175, DOI DOI 10.1090/S0002-9947-1958-0095618-2
   Sutcliffe S., 1992, J APPL MECH, V59, P761
   Tarnita D, 2010, ROM J MORPHOL EMBRYO, V51, P315
   THEOCARIS PS, 1989, ARCH MECH, V41
   TING TCT, 1987, Q J MECH APPL MATH, V40, P431, DOI 10.1093/qjmam/40.3.431
   Wever DJ, 2002, EUR SPINE J, V11, P100, DOI 10.1007/s005860100347
   Xu W, 1999, ANN BIOMED ENG, V27, P663, DOI 10.1114/1.216
   Yanaru K, 2003, DENT MATER J, V22, P146, DOI 10.4012/dmj.22.146
   Yeung KWK, 2007, J BIOMED MATER RES A, V82A, P403, DOI 10.1002/jbm.a.31154
   ZHAO GL, 1993, PHYS REV B, V48, P2031, DOI 10.1103/PhysRevB.48.2031
NR 37
TC 2
Z9 2
U1 0
U2 10
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD NOV
PY 2010
VL 12
IS 11
BP 2323
EP 2332
PG 10
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 695UV
UT WOS:000285399000023
DA 2018-10-19
ER

PT J
AU Sterodimas, A
   de Faria, J
   Nicaretta, B
   Pitanguy, I
AF Sterodimas, Aris
   de Faria, Jose
   Nicaretta, Beatriz
   Pitanguy, Ivo
TI Tissue engineering with adipose-derived stem cells (ADSCs): Current and
   future applications
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Review
DE Adipose; Tissue engineering; Stem cells; Fat grafting; Biomolecules;
   Biomaterial
ID ASSISTED LIPOTRANSFER; ADIPOGENIC DIFFERENTIATION; SUPPORTIVE USE;
   SCAFFOLDS; PROLIFERATION; AUGMENTATION; EXPERIENCE; THERAPIES;
   EXPANSION; SURGERY
AB Soft-tissue loss presents an ongoing challenge in plastic and reconstructive surgery. Standard approaches to soft-tissue reconstruction include autologous tissue flaps, autologous fat transplantation and alloplastic implants. All of these approaches have disadvantages, including donor-site morbidity, implant migration and absorption and foreign body reaction. Stem cell application has recently been suggested as a possible novel therapy. Adipose-derived stem cells (ADSCs) are an abundant, readily available population of multipotent progenitor cells that reside in adipose tissue, which is an easily accessible and abundant source of putative stem cells for translational clinical research. Their therapeutic use in preclinical studies and experimental clinical trials has been well documented.
   We present the current strategies of tissue engineering with ADSC and we discuss the possible future applications of this new method in the field of plastic and reconstructive surgery. Complete understanding of the mechanisms of interactions among adipose stem cells, growth factors and biomaterials in tissue engineering is still lacking. Adipose tissue stem cell-based regenerative strategies hold tremendous promise, although this potential must be balanced against stringent standards of scientific and clinical investigation, before developing 'off-the-shelf' tissue engineering products. (c) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Sterodimas, Aris; de Faria, Jose; Pitanguy, Ivo] Pontificia Univ Catolica Rio de Janeiro, Dept Plast Surg, BR-22280020 Rio De Janeiro, Brazil.
   [Sterodimas, Aris; de Faria, Jose; Pitanguy, Ivo] Carlos Chagas Postgrad Med Inst, BR-22280020 Rio De Janeiro, Brazil.
   [Nicaretta, Beatriz] Policlin Geral, Dept Plast Surg, BR-22020100 Rio De Janeiro, Brazil.
RP Sterodimas, A (reprint author), Pontificia Univ Catolica Rio de Janeiro, Dept Plast Surg, Rua Dona Mariana 65, BR-22280020 Rio De Janeiro, Brazil.
EM pitanguy@pitanguy.com.br
CR ALTMAN AM, 2008, STEM CELLS      0925
   Choi YS, 2006, BIOCHEM BIOPH RES CO, V345, P631, DOI 10.1016/j.bbrc.2006.04.128
   CONDEGREEN A, 2009, J PLAST RECONST 0811
   DEROSA A, 2009, TISSUE ENG C    0302
   Estes BT, 2008, BIOTECHNOL BIOENG, V99, P986, DOI 10.1002/bit.21662
   Flynn L, 2007, BIOMATERIALS, V28, P3834, DOI 10.1016/j.biomaterials.2007.05.002
   Flynn LE, 2008, BIOMATERIALS, V29, P1862, DOI 10.1016/j.biomaterials.2007.12.028
   Gonda K, 2008, PLAST RECONSTR SURG, V121, P401, DOI 10.1097/01.prs.0000298322.70032.bc
   Hemmrich K, 2006, EXPERT REV MED DEVIC, V3, P635, DOI 10.1586/17434440.3.5.635
   ILLOUZ Y-G, 1992, Facial Plastic Surgery, V8, P59, DOI 10.1055/s-2008-1064631
   ILLOUZ YG, 1983, PLAST RECONSTR SURG, V72, P591, DOI 10.1097/00006534-198311000-00001
   ILLOUZ YG, 2009, AESTHETIC PLAST 0604
   ITOI Y, 2009, J PLAST RECONST 0413
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7
   Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070
   Kakudo N, 2008, PLAST RECONSTR SURG, V122, P1352, DOI 10.1097/PRS.0b013e3181882046
   Kaufman MR, 2007, PLAST RECONSTR SURG, V119, P2287, DOI 10.1097/01.prs.0000260712.44089.e7
   Kurita M, 2008, PLAST RECONSTR SURG, V122, P438, DOI 10.1097/PRS.0b013e31817d618d
   LIU ZJ, 2009, J CELL BIOCH    0219
   Lu F, 2008, PLAST RECONSTR SURG, V121, P50, DOI 10.1097/01.prs.0000293876.10700.b8
   Lu Feng, 2006, Chin J Traumatol, V9, P359
   LUND P, 2009, CYTOTHERAPY     0225, P1
   Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e
   Ogawa Rei, 2006, Curr Stem Cell Res Ther, V1, P13, DOI 10.2174/157488806775269043
   Parker AM, 2007, CYTOTHERAPY, V9, P637, DOI 10.1080/14653240701508452
   PEREIRA LH, 2009, AESTHETIC PLAST 0604
   PEREIRA LH, AESTH PLAST SURG, V32, P393
   PEREIRA LH, 2009, J PLAST RECONST 0310
   Pereira LH, 2008, J PLAST RECONSTR AES, V61, P231, DOI 10.1016/j.bjps.2007.10.015
   Pereira LH, 2009, PLAST RECONSTR SURG, V123, p162E, DOI 10.1097/PRS.0b013e31819e5d59
   Prichard HL, 2008, STEM CELLS, V26, P2691, DOI 10.1634/stemcells.2008-0140
   Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71
   RODBELL M, 1964, J BIOL CHEM, V239, P753
   Rubin JP, 2007, PLAST RECONSTR SURG, V120, P414, DOI 10.1097/01.prs.0000267699.99369.a8
   SANTANA KP, 2009, J PLAST RECONST 0401
   Schipper BM, 2008, ANN PLAS SURG, V60, P538, DOI 10.1097/SAP.0b013e3181723bbe
   STERODIMAS A, 2008, J PLAST RECONST 0815
   Sterodimas A, 2009, ANN PLAS SURG, V62, P97, DOI 10.1097/SAP.0b013e3181788ec9
   Stillaert FB, 2008, BIOMATERIALS, V29, P3953, DOI 10.1016/j.biomaterials.2008.06.005
   SUGA H, 2008, STEM CELLS      0904
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   VANROBIN LR, 1977, CELL TISSUE RES, V181, P197, DOI 10.1007/BF00219980
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
   Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4
   Zhang J, 2007, J HUAZHONG U SCI-MED, V27, P5, DOI 10.1007/s11596-007-0102-5
   Zocchi ML, 2008, AESTHET PLAST SURG, V32, P313, DOI 10.1007/s00266-007-9089-3
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 50
TC 127
Z9 142
U1 5
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
EI 1878-0539
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PD NOV
PY 2010
VL 63
IS 11
BP 1886
EP 1892
DI 10.1016/j.bjps.2009.10.028
PG 7
WC Surgery
SC Surgery
GA 664FA
UT WOS:000282944600033
PM 19969517
DA 2018-10-19
ER

PT J
AU Ramos-Saenz, CR
   Sundaram, PA
   Diffoot-Carlo, N
AF Ramos-Saenz, C. R.
   Sundaram, P. A.
   Diffoot-Carlo, N.
TI Tribological properties of Ti-based alloys in a simulated bone-implant
   interface with Ringer's solution at fretting contacts
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Titanium alloy; Titanium oxide; Tribology; Fretting; Bone-implant
ID TOTAL HIP REPLACEMENTS; TITANIUM; WEAR; ARTHROPLASTY; FAILURE
AB The wear properties of oxidized and non-oxidized gamma-TiAl (a potential biomaterial) as well as Ti-6Al-4V and CP-Ti disks were studied and characterized by means of standard wear tests using a custom made bone pin arrangement. The Ti-based disks were oxidized in air at 500 and 800 degrees C for one hour. The tribological properties of the oxides formed over the disks were studied using a linear reciprocating wear testing machine under both dry and simulated biological conditions using Ringer's solution. Loss of metal oxide and coefficient of friction values were determined from wear testing. From the results, abrasion and adhesion were the primary wear mechanisms in each of the three alloy-bone pairs. Specifically, the oxide formed on gamma-TiAl possessed the highest COF and wear resistance of the three materials which were studied. Also, as expected, bone wears down faster than the Ti-based metal oxide. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Ramos-Saenz, C. R.; Sundaram, P. A.] Univ Puerto Rico, Dept Mech Engn, Mayaguez, PR 00680 USA.
   [Diffoot-Carlo, N.] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00680 USA.
RP Sundaram, PA (reprint author), Univ Puerto Rico, Dept Mech Engn, Call Box 9000, Mayaguez, PR 00680 USA.
EM psundaram@me.uprm.edu
RI Rinaldi2, Carlos/D-4479-2011
FU National Institutes of Health (NIH), National Institute of General
   Medical Sciences (NIGMS)/MBRS-SCORE, University of Puerto Rico, Mayaguez
   Campus [SO6GM-08103]
FX This project was supported by the grant SO6GM-08103 from the National
   Institutes of Health (NIH), National Institute of General Medical
   Sciences (NIGMS)/MBRS-SCORE, University of Puerto Rico, Mayaguez Campus.
   Most of the sample characterizations were carried out at HP Puerto Rico
   in Aguadilla, Puerto Rico.
CR Bohler M, 2002, J BONE JOINT SURG BR, V84B, P128, DOI 10.1302/0301-620X.84B1.11324
   Choubey A, 2004, MAT SCI ENG A-STRUCT, V379, P234, DOI 10.1016/j.msea.2004.02.027
   CHU P, 2008, BIOMATERIAL FABRICAT
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Harman MK, 1997, J ARTHROPLASTY, V12, P938, DOI 10.1016/S0883-5403(97)90164-9
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   KIM YH, 1993, J BONE JOINT SURG BR, V75, P6
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   NORTHMOREBALL MD, 1993, J BONE JOINT SURG BR, V75, P22
   SCOTT IR, 1993, J BONE JOINT SURG BR, V75, P28
   Shimmin A, 2008, J BONE JOINT SURG AM, V90A, P637, DOI 10.2106/JBJS.G.01012
   Sieber HP, 1999, J BONE JOINT SURG BR, V81B, P46, DOI 10.1302/0301-620X.81B1.9047
   Taljanovic MS, 2003, RADIOGRAPHICS, V23, P1295, DOI 10.1148/rg.235035059
   Wimhurst JA, 2001, J BONE JOINT SURG BR, V83B, P588, DOI 10.1302/0301-620X.83B4.10513
   WITT JD, 1991, J BONE JOINT SURG BR, V73, P559
NR 16
TC 17
Z9 17
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD NOV
PY 2010
VL 3
IS 8
BP 549
EP 558
DI 10.1016/j.jmbbm.2010.06.006
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 665AZ
UT WOS:000283007800001
PM 20826360
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Sanchez-Arevalo, FM
   Farfan, M
   Covarrubias, D
   Zenit, R
   Pulos, G
AF Sanchez-Arevalo, F. M.
   Farfan, M.
   Covarrubias, D.
   Zenit, R.
   Pulos, G.
TI The micromechanical behavior of lyophilized glutaraldehyde-treated
   bovine pericardium under uniaxial tension
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterial; Bovine pericardium; Cardiac valves; Micromechanical
   behavior; Lyophilization; Digital image correlation
ID MECHANICAL-PROPERTIES; CALCIFICATION; DEFECTS; REPAIR
AB The micromechanical behavior of lyophilized glutaraldehyde bovine pericardium undergoing uniaxial tension was studied by digital image correlation. The experiments were conducted simultaneously at macromechanical and micromechanical levels, to correlate the mechanical response of this biomaterial at different scales. From the experiments, displacement and force data were acquired; in addition, an image sequence of each sample surface was registered with a high-definition camera. With the images, it was possible to obtain the vector displacement field between pairs of images and then the in-plane strain was calculated. The secant and final moduli of this material were obtained at macromechanical and micromechanical levels. A good agreement between the micro and macro moduli was observed. This analysis is a useful alternative technique for studying this biomaterial when local properties are needed for medical applications. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Sanchez-Arevalo, F. M.] Univ Iberoamer, Lomas De Santa Fe 01219, Mexico.
   [Farfan, M.] Univ Politecn Pachuca, Zempoala 43830, Hidalgo, Mexico.
   [Covarrubias, D.] Univ Nacl Autonoma Mexico, Fac Vet, Dept Med Cirugia & Zootecn Especias Pequenas, Mexico City 04510, DF, Mexico.
   [Zenit, R.; Pulos, G.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
RP Sanchez-Arevalo, FM (reprint author), Univ Iberoamer, Prol Paseo Reforma 880, Lomas De Santa Fe 01219, Mexico.
EM francisco.sanchez@uia.mx
OI Sanchez-Arevalo, Francisco M/0000-0003-4369-1262; Zenit,
   Roberto/0000-0002-2717-4954
FU PAPIIT DGAPA-UNAM program [IN1106005]; CONACyT [IX121504,
   Salud-2002-001-8175]
FX This work was financially supported by the PAPIIT DGAPA-UNAM program
   through grant IN1106005 and CONACyT through grants IX121504 and
   Salud-2002-001-8175.
CR ADJA R, 1985, JPN J PHYSL, V35, P831
   Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Arcidiacono G, 2005, J BIOMECH, V38, P1483, DOI 10.1016/j.jbiomech.2004.07.007
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   ELIAS HERBERT, 1960, JOUR NEW YORK MED COLL, V2, P50
   Fung YC, 1993, BIOMECHANICS MECH PR
   GALLO JI, 1982, J THORAC CARDIOV SUR, V83, P905
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   HOLT JP, 1970, AM J CARDIOL, V26, P455, DOI 10.1016/0002-9149(70)90702-2
   ISHIHARA T, 1980, AM J CARDIOL, V46, P744, DOI 10.1016/0002-9149(80)90424-5
   JASSOVICTORIA R, 1995, REV I NAL ENF RESP, V8, P189
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   LIM KO, 1975, CAN J PHYSIOL PHARM, V53, P330, DOI 10.1139/y75-048
   Maizato MJS, 2008, ARTIF ORGANS, V32, P268, DOI 10.1111/j.1525-1594.2008.00541.x
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   MANSBERGER AR, 1973, J TRAUMA, V13, P766, DOI 10.1097/00005373-197309000-00002
   Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   SANCHEZ FM, 2007, THESIS U NACL AUTONO, P116
   Sanchez-Arevalo FM, 2008, MATER CHARACT, V59, P1572, DOI 10.1016/j.matchar.2008.02.002
   Sanchez-Arevalo FM, 2009, MATER CHARACT, V60, P775, DOI 10.1016/j.matchar.2009.01.006
   WILLERT CE, 1991, EXP FLUIDS, V10, P181
   Zhang DS, 2002, EXP MECH, V42, P409, DOI 10.1007/BF02412146
   ZIOUPOS P, 1994, BIOMATERIALS, V15, P366, DOI 10.1016/0142-9612(94)90249-6
   ZIOUPOS P, 1992, MED BIOL ENG COMPUT, V30, P76, DOI 10.1007/BF02446197
NR 26
TC 7
Z9 8
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD NOV
PY 2010
VL 3
IS 8
BP 640
EP 646
DI 10.1016/j.jmbbm.2010.06.010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 665AZ
UT WOS:000283007800013
PM 20826372
DA 2018-10-19
ER

PT J
AU Sadjadi, MS
   Meskinfam, M
   Sadeghi, B
   Jazdarreh, H
   Zare, K
AF Sadjadi, M. S.
   Meskinfam, M.
   Sadeghi, B.
   Jazdarreh, H.
   Zare, K.
TI In situ biomimetic synthesis, characterization and in vitro
   investigation of bone-like nanohydroxyapatite in starch matrix
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Nanostructures; Biomaterial; Organic templating; Bioactivity
ID MECHANICAL-PROPERTIES; HYDROXYAPATITE; COMPOSITE; POLYMERS; GROWTH
AB In this work, we report the synthesis of bone-like hydroxyapatite (HAp) nanorods in wheat starch matrix via a biomimetic process. Characterization of the samples was performed by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FT-IR). Scanning and transmission electron microscopy (SEM and TEM) were used to determine the size, shape and morphology of nano-HAp. The results indicate that, the shape and morphology of nHAp is influenced by the presence of starch as a template agent and rod-like nHAp similar to the inorganic component in the human body is obtained at room temperature. In vitro bioactivity of the synthesized HAp nanocomposites was finally verified by comparison of the HAp's structures and morphology before and after immersion in simulated body fluid (SBF) solution for 3, 7, and 14 days. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Sadjadi, M. S.; Meskinfam, M.] Islamic Azad Univ, Dept Chem, Sci & Res Branch, Tehran, Iran.
   [Sadeghi, B.] Islamic Azad Univ, Tonekabon Branch, Dept Chem, Tonekabon, Iran.
   [Jazdarreh, H.] Iran Univ Sci & Technol, Dept Mech Engn, Tehran, Iran.
   [Zare, K.] Shahid Beheshti Univ, Fac Sci, Dept Chem, Tehran, Iran.
RP Sadjadi, MS (reprint author), Islamic Azad Univ, Dept Chem, Sci & Res Branch, Tehran, Iran.
EM msadjad@gmail.com
FU Research vice Presidency of Science and Research branch, Islamic Azad
   University; Iranian Nanotechnology Initiative (Govt. of Iran)
FX We thanks Research vice Presidency of Science and Research branch,
   Islamic Azad University and Iranian Nanotechnology Initiative (Govt. of
   Iran) for their financial and encouragement supports.
CR Alexeev VL, 2000, POLYM ENG SCI, V40, P1211, DOI 10.1002/pen.11248
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   CIFTCIOGLU N, 2005, LUNAR PLANET SCI, V36, P1205
   Clavaguera N, 1997, THERMOCHIM ACTA, V290, P173, DOI 10.1016/S0040-6031(96)03077-8
   Dalas E, 2003, J CRYST GROWTH, V255, P163, DOI 10.1016/S0022-0248(03)01209-0
   Dragunski D.C., 2001, MAT RES, V4, P77, DOI DOI 10.1590/S1516-14392001000200006
   DRIESSENS FC, 1983, BIOCERAMICS CALCIUM, P7
   Estroff LA, 2004, ORG BIOMOL CHEM, V2, P137, DOI 10.1039/b309731e
   Galliard T., 1987, STARCH PROPERTIES PO, P1
   JING YW, 2006, MATER LETT, V60, P3227
   Katti K., 2002, P 15 ASCE ENG MECH C
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Mollazadeh S, 2007, CERAM INT, V33, P1579, DOI 10.1016/j.ceramint.2006.06.006
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Pena J, 2006, J EUR CERAM SOC, V26, P3631, DOI 10.1016/j.jeurceramsoc.2005.12.028
   Qiu CF, 2008, CERAM INT, V34, P1747, DOI 10.1016/j.ceramint.2007.06.001
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Shi R, 2006, POLYM DEGRAD STABIL, V91, P3289, DOI 10.1016/j.polymdegradstab.2006.06.007
   Sinha A, 2009, MAT SCI ENG C-BIO S, V29, P1330, DOI 10.1016/j.msec.2008.10.024
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Weeraphat P., 2008, MATER CHEM PHYS, V112, P453
   Wu G, 2008, MATER CHEM PHYS, V107, P364, DOI 10.1016/j.matchemphys.2007.07.028
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
NR 30
TC 26
Z9 26
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD NOV 1
PY 2010
VL 124
IS 1
BP 217
EP 222
DI 10.1016/j.matchemphys.2010.06.022
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 660AB
UT WOS:000282607900046
DA 2018-10-19
ER

PT J
AU Yamada, M
   Shikano, J
   Harada, Y
AF Yamada, Masanori
   Shikano, Jun
   Harada, Yoshimi
TI Accumulation of harmful compounds by the composite of DNA and
   cyclodextrin: Effect on intramolecular cavity of cyclodextrin
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Polymers; Composite material; Organic compounds
ID BISPHENOL-A; POLY(ALLYLAMINE); DERIVATIVES; CHEMISTRY
AB Alpha-cyclodextrin (alpha-CD), beta-CD, and gamma-CD are composed of six, seven, and eight D-glucopyranose residues, respectively, and have a hydrophobic cavity in their molecules. In this study, the water-soluble cyclodextrin-immobilized poly(allylamine) (PCD) with various cavity sizes was synthesized. These alpha-PCD, beta-PCD, and gamma-PCD showed stability constants of 9.9 x 10(2) M(-1), 4.5 x 10(3) M(-1), and 6.2 x 10(3) M(-1) to the 1,8-ANS molecule, respectively. Additionally, these PCD polymers formed water-insoluble composite materials by mixing with the double-stranded DNA, which can accumulate planar structure-containing harmful compounds, such as dioxin and polychlorobiphenyl (PCB). Therefore, we demonstrated the accumulation of various harmful compounds by the DNA-PCD composite materials having various cavity sizes. As a result, although the DNA-beta-PCD composite material could encapsulate the non-planar structure-containing harmful compounds, such as bisphenol A and diethylstilbestrol, the DNA-alpha-PCD composite material did not interact with these molecules. These phenomena were due to the effect on the intramolecular cavity of the CD in the polymer. In contrast, all of the DNA-PCDs could accumulate the planar structure-containing compounds by an intercalation mechanism regardless of the cavity size in the CD. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Yamada, Masanori; Shikano, Jun; Harada, Yoshimi] Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, Okayama 7000005, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
FU MEXT (Ministry of Education, Culture, Sports, Science and Technology of
   Japan); Wesco Scientific Promotion Foundation
FX This work was supported by matching fund subsidy for private
   universities from MEXT (Ministry of Education, Culture, Sports, Science
   and Technology of Japan). Additionally, the part of this work was
   supported by Wesco Scientific Promotion Foundation.
CR Aoki N, 2003, CARBOHYD POLYM, V52, P219, DOI 10.1016/S0144-8617(02)00308-9
   Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   Bender M.L., 1978, CYCLODEXTRIN CHEM
   Ehsan S, 2007, CHEMOSPHERE, V68, P150, DOI 10.1016/j.chemosphere.2006.12.018
   Hollas M, 1998, J PHYS CHEM B, V102, P2947, DOI 10.1021/jp9800719
   Ito N, 1996, J CHEM SOC PERK T 2, P965, DOI 10.1039/p29960000965
   Khan AR, 1998, CHEM REV, V98, P1977, DOI 10.1021/cr970012b
   Lehn J.-M., 1995, SUPRAMOLECULAR CHEM
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   Liu XD, 2008, CHEM SOC REV, V37, P2745, DOI 10.1039/b801433g
   Nishiki M, 2000, Carbohydr Lett, V4, P61
   Palin R, 2001, TETRAHEDRON LETT, V42, P8897, DOI 10.1016/S0040-4039(01)01934-7
   Saenger W., 1987, PRINCIPLES NUCL ACID
   Sainz-Rozas PR, 2005, J PHOTOCH PHOTOBIO A, V173, P248, DOI 10.1016/j.j.photochem.2005.04.022
   SEO T, 1987, MAKROMOL CHEM, V188, P2071
   Silverstein R. M., 1998, SPECTROMETRIC IDENTI
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   TAKAHASHI K, 1984, TETRAHEDRON LETT, V25, P3331, DOI 10.1016/S0040-4039(01)81377-0
   Wang X, 2006, SENSOR ACTUAT B-CHEM, V114, P565, DOI 10.1016/j.snb.2005.06.020
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2008, POLYMER, V49, P4658, DOI 10.1016/j.polymer.2008.08.027
   Yamada M, 2008, BIOMACROMOLECULES, V9, P3341, DOI 10.1021/bm800984p
NR 24
TC 3
Z9 3
U1 1
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD NOV 1
PY 2010
VL 124
IS 1
BP 623
EP 627
DI 10.1016/j.matchemphys.2010.07.024
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 660AB
UT WOS:000282607900113
DA 2018-10-19
ER

PT J
AU Bruning, M
   Kreplak, L
   Leopoldseder, S
   Muller, SA
   Ringler, P
   Duchesne, L
   Fernig, DG
   Engel, A
   Ucurum-Fotiadis, Z
   Mayans, O
AF Bruning, Marc
   Kreplak, Laurent
   Leopoldseder, Sonja
   Mueller, Shirley A.
   Ringler, Philippe
   Duchesne, Laurence
   Fernig, David G.
   Engel, Andreas
   Ucurum-Fotiadis, Zoehre
   Mayans, Olga
TI Bipartite Design of a Self-Fibrillating Protein Copolymer with
   Nanopatterned Peptide Display Capabilities
SO NANO LETTERS
LA English
DT Article
DE Nanofiber; protein polymer; protein engineering; self-assembly;
   biomaterial; peptide display system; gold nanoparticles; 1D array
ID CELL-ADHESION; FIBRILS; TITIN; NANOPARTICLES; BIOMATERIALS; MODEL; Z1Z2
AB The development of biomatrices for technological and biomedical applications employs self-assembled scaffolds built from short peptidic motifs. However, biopolymers composed of protein domains would offer more varied molecular frames to introduce finer and more complex functionalities in bioreactive scaffolds using bottom-up approaches. Yet, the rules governing the three-dimensional organization of protein architectures in nature are complex and poorly understood. As a result, the synthetic fabrication of ordered protein association into polymers poses major challenges to bioengineering. We have now fabricated a self-assembling protein nanofiber with predictable morphologies and amenable to bottom-up customization, where features supporting function and assembly are spatially segregated. The design was inspired by the cross-linking of titin filaments by telethonin in the muscle sarcomere. The resulting fiber is a two-protein system that has nanopatterned peptide display capabilities as shown by the recruitment of functionalized gold nanoparticles at regular intervals of similar to 5 nm, yielding a semiregular linear array over micrometers. This polymer promises the uncomplicated display of biologically active motifs to selectively bind and organize matter in the fine nanoscale. Further, its conceptual design has high potential for controlled plurifunctionalization.
C1 [Bruning, Marc; Leopoldseder, Sonja; Ucurum-Fotiadis, Zoehre; Mayans, Olga] Univ Basel, Div Struct Biol, CH-4056 Basel, Switzerland.
   [Kreplak, Laurent; Mueller, Shirley A.; Ringler, Philippe; Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
   [Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
   [Bruning, Marc; Duchesne, Laurence; Fernig, David G.; Mayans, Olga] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.
   [Bruning, Marc; Duchesne, Laurence; Fernig, David G.; Mayans, Olga] Univ Liverpool, Liverpool Inst Nanoscale Sci Engn & Technol, Liverpool L69 7ZB, Merseyside, England.
RP Mayans, O (reprint author), Univ Basel, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Olga.Mayans@liv.ac.uk
RI Fernig, David/A-3590-2008
OI Fernig, David/0000-0003-4875-4293; Mayans, Olga/0000-0001-6876-8532
FU Swiss National Foundation [3100A0-112595, 3100A0-108299]; Maurice E.
   Muller Foundation; Human Frontiers Science Programme; North West Cancer
   Research Fund
FX This work was supported by the Swiss National Foundation (Grants
   3100A0-112595 to O.M. and I.K. and 3100A0-108299 to All.) and by the
   Maurice E. Muller Foundation. D.G.F. and thank the Human Frontiers
   Science Programme and the North West Cancer Research Fund.
CR BALDWIN AJ, 2006, DJ AM CHEM SOC, V128, P2162
   Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105
   Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   DOMINGO GJ, 2001, R N J MEL, V305, P259
   Duchesne L, 2008, LANGMUIR, V24, P13572, DOI 10.1021/la802876u
   Ghirlanda G, 2002, J MOL BIOL, V319, P243, DOI 10.1016/S0022-2836(02)00233-4
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421
   Kasotakis E, 2009, BIOPOLYMERS, V92, P164, DOI 10.1002/bip.21163
   Kheterpal I, 2006, ACCOUNTS CHEM RES, V39, P584, DOI 10.1021/ar050057w
   Kodama H, 2004, CHEM COMMUN, P2876, DOI 10.1039/b409641j
   Lee EH, 2007, BIOPHYS J, V93, P1719, DOI 10.1529/biophysj.107.105528
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009
   Moll D, 2002, P NATL ACAD SCI USA, V99, P14646, DOI 10.1073/pnas.232299399
   Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404
   Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998
   Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007
   Ryadnov MG, 2004, J AM CHEM SOC, V126, P7454, DOI 10.1021/ja048144r
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   VILLARD V, 2006, PEPTIDE SC, V12, P206
   WILLIAMS AD, 2006, N J BLOT, V357, P1283
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343
NR 26
TC 8
Z9 8
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD NOV
PY 2010
VL 10
IS 11
BP 4533
EP 4537
DI 10.1021/nl1024886
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 676JQ
UT WOS:000283907600040
PM 20954695
DA 2018-10-19
ER

PT J
AU Holladay, C
   Keeney, M
   Newland, B
   Mathew, A
   Wang, W
   Pandit, A
AF Holladay, C.
   Keeney, M.
   Newland, B.
   Mathew, A.
   Wang, W.
   Pandit, A.
TI A reliable method for detecting complexed DNA in vitro
SO NANOSCALE
LA English
DT Article
ID NONVIRAL GENE DELIVERY; PLASMID DNA; POLYAMIDOAMINE DENDRIMERS; CATIONIC
   LIPIDS; STEM-CELLS; TRANSFECTION; VECTORS; SCAFFOLDS; SYSTEMS;
   NANOPARTICLES
AB Quantification of eluted nucleic acids is a critical parameter in characterizing biomaterial based genedelivery systems. The most commonly used method is to assay samples with an intercalating fluorescent dye such as PicoGreen (R). However, this technique was developed for unbound DNA and the current trend in gene delivery is to condense DNA with transfection reagents, which interfere with intercalation. Here, for the first time, the DNA was permanently labeled with the fluorescent dye Cy5 prior to complexation, an alternative technique hypothesized to allow quantification of both bound and unbound DNA. A comparison of the two methods was performed by quantifying the elution of six different varieties of DNA complexes from a model biomaterial (collagen) scaffold. After seven days of elution, the PicoGreen assay only allowed detection of three types of complexes (those formed using Lipofectin (TM) and two synthesised copolymers). However, the Cy5 fluorescent labeling technique enabled detection of all six varieties including those formed via common transfection agents poly(ethylene imine), poly-L-lysine and SuperFect (TM). This allowed reliable quantification of the elution of all these complexes from the collagen scaffold. Thus, while intercalating dyes may be effective and reliable for detecting double-stranded, unbound DNA, the technique described in this work allowed reliable quantification of DNA independent of complexation state.
C1 [Holladay, C.; Keeney, M.; Newland, B.; Mathew, A.; Wang, W.; Pandit, A.] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat, NFB Bldg,IDA Business Pk, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
OI Newland, Ben/0000-0002-5214-2604; Pandit, Abhay/0000-0002-6292-4933;
   Wang, Wenxin/0000-0002-5053-0611
FU Science Foundation Ireland, Strategic Research Cluster [07/SRC/B1163]
FX Funding for this project was provided by Science Foundation Ireland,
   Strategic Research Cluster under Grant No. 07/SRC/B1163.
CR Barteau B, 2008, CURR GENE THER, V8, P313, DOI 10.2174/156652308786070961
   Bielinska AU, 1999, BIOCONJUGATE CHEM, V10, P843, DOI 10.1021/bc990036k
   Boulaiz H, 2005, CELL MOL BIOL, V51, P3, DOI 10.1170/T594
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Dadsetan M, 2009, J BIOMED MATER RES A, V91A, P1170, DOI 10.1002/jbm.a.32291
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Ditto AJ, 2009, MOL PHARMACEUT, V6, P986, DOI 10.1021/mp9000316
   Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017
   Eliyahu H, 2005, MOLECULES, V10, P34, DOI 10.3390/10010034
   Haider HK, 2008, MOL MED, V14, P79, DOI 10.2119/2007-00092.Haider
   Holden MJ, 2009, J AGR FOOD CHEM, V57, P7221, DOI 10.1021/jf901165h
   Holladay C, 2009, J CONTROL RELEASE, V136, P220, DOI 10.1016/j.jconrel.2009.02.006
   Hosseinkhani H, 2005, TISSUE ENG, V11, P1459, DOI 10.1089/ten.2005.11.1459
   Hussain M, 2004, J CONTROL RELEASE, V99, P139, DOI 10.1016/j.jconrel.2004.06.009
   Juan A. S., 2007, J BIOMED MATER RES A, V83A, P819
   Kang HC, 2005, CRIT REV EUKAR GENE, V15, P317, DOI 10.1615/CritRevEukarGeneExpr.v15.i4.30
   Kawakami S, 2008, J PHARM SCI-US, V97, P726, DOI 10.1002/jps.21024
   Ko IK, 2008, BIOMATERIALS, V29, P3872, DOI 10.1016/j.biomaterials.2008.06.003
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Kundu PP, 2008, CURR OPIN SOLID ST M, V12, P89, DOI 10.1016/j.cossms.2009.01.005
   Lampela P, 2004, INT J PHARM, V270, P175, DOI 10.1016/j.ijpharm.2003.10.004
   Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049
   Lin QK, 2009, COLLOID SURFACE B, V74, P298, DOI 10.1016/j.colsurfb.2009.07.036
   Luo D, 1999, PHARMACEUT RES, V16, P1300, DOI 10.1023/A:1014870102295
   Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pitarresi G, 2009, INT J PHARMACEUT, V382, P7, DOI 10.1016/j.ijpharm.2009.07.032
   Pouton CW, 2001, ADV DRUG DELIVER REV, V46, P187, DOI 10.1016/S0169-409X(00)00133-2
   Premaraj S, 2005, Orthod Craniofac Res, V8, P320, DOI 10.1111/j.1601-6343.2005.00355.x
   Ragusa A, 2007, IEEE T NANOBIOSCI, V6, P319, DOI 10.1109/TNB.2007.908996
   Rao NM, 2006, EXPERT OPIN THER PAT, V16, P825, DOI 10.1517/13543776.16.6.825
   Ruponen M, 2003, J CONTROL RELEASE, V93, P213, DOI 10.1016/j.jconrel.2003.08.004
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   Shcharbin DG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1070, DOI 10.1134/S0006297909100022
   Shcharbin D, 2009, J CONTROL RELEASE, V135, P186, DOI 10.1016/j.jconrel.2009.01.015
   Smith DK, 2008, CURR TOP MED CHEM, V8, P1187, DOI 10.2174/156802608785849030
   Son S, 2010, BIOMATERIALS, V31, P133, DOI 10.1016/j.biomaterials.2009.09.024
   Tai HY, 2009, BIOMACROMOLECULES, V10, P822, DOI 10.1021/bm801308q
   Vicennati P, 2008, CURR MED CHEM, V15, P2826, DOI 10.2174/092986708786242778
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   Wangerek LA, 2001, J GENE MED, V3, P72, DOI 10.1002/1521-2254(200101/02)3:1<72::AID-JGM157>3.0.CO;2-M
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Wong SY, 2007, PROG POLYM SCI, V32, P799, DOI 10.1016/j.progpolymsci.2007.05.007
   Xu XM, 2008, J BIOMED MATER RES A, V84A, P73, DOI 10.1002/jbm.a.31372
   Zhou LZ, 2007, J PHARMACEUT BIOMED, V43, P330, DOI 10.1016/j.jpba.2006.06.021
NR 48
TC 9
Z9 9
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
J9 NANOSCALE
JI Nanoscale
PD NOV
PY 2010
VL 2
IS 12
BP 2718
EP 2723
DI 10.1039/c0nr00456a
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 705UY
UT WOS:000286167400033
PM 20835447
DA 2018-10-19
ER

PT J
AU Pradhan, S
   Farach-Carson, MC
AF Pradhan, Swati
   Farach-Carson, Mary C.
TI Mining the extracellular matrix for tissue engineering applications
SO REGENERATIVE MEDICINE
LA English
DT Review
DE basement membrane protein; biomaterial; biomimetic scaffold;
   extracellular matrix-derived peptide; tissue reconstruction
ID HYALURONAN-BINDING DOMAINS; COLLAGEN-MIMETIC PEPTIDE; ASP-CONTAINING
   PEPTIDES; BONE-MARROW-CELLS; BASEMENT-MEMBRANE; DRUG-DELIVERY;
   OSTEOBLASTIC DIFFERENTIATION; NEURITE OUTGROWTH; ADHESION MOLECULES;
   MATRICRYPTIC SITES
AB Tissue engineering is a rapidly evolving interdisciplinary field that aims to regenerate new tissue to replace damaged tissues or organs. The extracellular matrix (ECM) of animal tissues is a complex mixture of macromolecules that play an essential instructional role in the development of tissues and organs. Therefore, tissue engineering approaches rely on the need to present the correct cues to cells, to guide them to maintain tissue-specific functions. Recent research efforts have allowed us to mine various sequences and motifs, which play key roles in these guidance functions, from the ECM. Small conserved peptide sequences mined from ECM molecules can mimic some of the biological functions of their large parent molecules. In addition, these peptide sequences can be linked to various biomaterial scaffolds that can provide the cells with mechanical support to ensure appropriate cell growth and aid the formation of the correct tissue structure. The tissue engineering field will continue to benefit from the advent of these mined ECM sequences which have two major advantages over recombinant ECM molecules: material consistency and scalability.
C1 [Pradhan, Swati; Farach-Carson, Mary C.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.
   [Pradhan, Swati; Farach-Carson, Mary C.] Univ Delaware, CTCR, Newark, DE 19716 USA.
RP Farach-Carson, MC (reprint author), Rice Univ, Houston, TX 77251 USA.
EM farachca@rice.edu
CR Acharya S, 1998, J BIOL CHEM, V273, P31599, DOI 10.1074/jbc.273.47.31599
   Acharya S, 2000, J BIOL CHEM, V275, P6945, DOI 10.1074/jbc.275.10.6945
   Alberts B, 2002, MOL BIOL CELL
   Amemiya K, 2005, BBA-GEN SUBJECTS, V1724, P94, DOI 10.1016/j.bbagen.2005.04.029
   Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   BAJT ML, 1992, J BIOL CHEM, V267, P3789
   BAJT ML, 1994, J BIOL CHEM, V269, P20913
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Baroli B, 2007, J PHARM SCI-US, V96, P2197, DOI 10.1002/jps.20873
   BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x
   BILOZUR ME, 1988, DEV BIOL, V125, P19, DOI 10.1016/0012-1606(88)90055-3
   Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150
   Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925
   Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441
   Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0
   BRONZINO JD, 2006, TISSUE ENG ARTIFICIA
   Bushkin-Harav I, 1998, FEBS LETT, V424, P243, DOI 10.1016/S0014-5793(98)00180-X
   CASTRONOVO V, 1993, INVAS METAST, V13, P1
   Chen L, 2003, BRIT J OPHTHALMOL, V87, P212, DOI 10.1136/bjo.87.2.212
   Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109
   Danen EHJ, 2003, J PATHOL, V200, P471, DOI 10.1002/path.1416
   Das S, 1997, GENE, V190, P223, DOI 10.1016/S0378-1119(97)00035-8
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   Davis GE, 2010, J MOL CELL CARDIOL, V48, P454, DOI 10.1016/j.yjmcc.2009.09.002
   Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104
   Dunehoo AL, 2006, J PHARM SCI-US, V95, P1856, DOI 10.1002/jps.20676
   Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2
   Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001
   Farach-Carson MC, 2008, MATRIX BIOL, V27, P150, DOI 10.1016/j.matbio.2007.09.007
   Farach-Carson MC, 2005, CRIT REV EUKAR GENE, V15, P29, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.30
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   GARDNER JM, 1985, CELL, V42, P439, DOI 10.1016/0092-8674(85)90101-1
   GARTNER TK, 1985, J BIOL CHEM, V260, P1891
   GINSBERG M, 1985, J BIOL CHEM, V260, P3931
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Gomes RR, 2004, CELLS TISSUES ORGANS, V176, P79, DOI 10.1159/000075029
   Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4
   GORDON MY, 1988, BRIT J HAEMATOL, V70, P1, DOI 10.1111/j.1365-2141.1988.tb02425.x
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRAMMATIKAKIS N, 1995, J BIOL CHEM, V270, P16198, DOI 10.1074/jbc.270.27.16198
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Gustafsson E, 2003, ANN NY ACAD SCI, V995, P140, DOI 10.1111/j.1749-6632.2003.tb03217.x
   Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004
   HAMILTON R, 1991, ANAT REC, V231, P218, DOI 10.1002/ar.1092310210
   Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Hofmann M, 1998, J CELL SCI, V111, P1673
   Hopker VH, 1999, NATURE, V401, P69
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001
   Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702
   IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059
   Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101
   Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   Kirn-Safran Catherine B, 2004, Birth Defects Res C Embryo Today, V72, P69, DOI 10.1002/bdrc.20005
   Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   LABATROBERT J, 1990, FEBS LETT, V268, P386, DOI 10.1016/0014-5793(90)81291-U
   Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Ma DHK, 2006, PROG RETIN EYE RES, V25, P563, DOI 10.1016/j.preteyeres.2006.09.001
   Macdonald PR, 2010, J STRUCT BIOL, V170, P398, DOI 10.1016/j.jsb.2010.02.004
   McCann TJ, 1997, MATRIX BIOL, V16, P273, DOI 10.1016/S0945-053X(97)90015-9
   Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200
   Mckee KK, 2009, J BIOL CHEM, V284, P8984, DOI 10.1074/jbc.M809719200
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685
   Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713
   Mineur P, 2005, BBA-MOL CELL RES, V1746, P28, DOI 10.1016/j.bbamcr.2005.07.004
   MINTZ KP, 1993, J BONE MINER RES, V8, P985
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200
   NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689
   Parameswaran K, 2006, CELL BIOCHEM BIOPHYS, V44, P139, DOI 10.1385/CBB:44:1:139
   Pereira Antonio L.A., 2005, Rev. Bras. Otorrinolaringol., V71, P81, DOI 10.1590/S0034-72992005000100014
   PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057
   PLOW EF, 1985, BLOOD, V66, P724
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Pradhan S, 2009, TISSUE ENG PT A, V15, P3309, DOI [10.1089/ten.tea.2008.0669, 10.1089/ten.TEA.2008.0669]
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   PYTELA R, 1994, METHOD ENZYMOL, V245, P420
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   Ratcliffe EM, 2008, DEV NEUROBIOL, V68, P960, DOI 10.1002/dneu.20634
   REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Roelen Bernard A J, 2003, J Orthop Sci, V8, P740, DOI 10.1007/s00776-003-0702-2
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007
   Ruegg C, 2006, BBA-REV CANCER, V1765, P155, DOI 10.1016/j.bbcan.2005.09.003
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033
   Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176
   Schofield KP, 1999, BIOCHEM J, V343, P663, DOI 10.1042/0264-6021:3430663
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X
   SEPHEL GC, 1989, DEV BIOL, V135, P172, DOI 10.1016/0012-1606(89)90167-X
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Sisson K, 2009, BIOMACROMOLECULES
   SMITH JW, 1988, J BIOL CHEM, V263, P18726
   Sugawara K, 2008, EXP DERMATOL, V17, P473, DOI 10.1111/j.1600-0625.2008.00721.x
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015
   UNDERHILL C, 1992, J CELL SCI, V103, P293
   Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057
   WEBER KT, 1995, HERZ, V20, P81
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
   Yamaguchi K, 2000, J EXP CLIN CANC RES, V19, P113
   YANG BH, 1993, J BIOL CHEM, V268, P8617
   Yang WD, 2005, TISSUE ENG, V11, P76, DOI 10.1089/ten.2005.11.76
   Yang WD, 2006, TISSUE ENG, V12, P2009, DOI 10.1089/ten.2006.12.2009
   Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006
   ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x
NR 137
TC 25
Z9 27
U1 0
U2 21
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD NOV
PY 2010
VL 5
IS 6
BP 961
EP 970
DI 10.2217/RME.10.61
PG 10
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 686VP
UT WOS:000284724900017
PM 21082894
DA 2018-10-19
ER

PT J
AU Dolce, CJ
   Stefanidis, D
   Keller, JE
   Walters, KC
   Newcomb, WL
   Heath, JJ
   Norton, HJ
   Lincourt, AE
   Kercher, KW
   Heniford, BT
AF Dolce, Charles J.
   Stefanidis, Dimitrios
   Keller, Jennifer E.
   Walters, K. C.
   Newcomb, William L.
   Heath, Jessica J.
   Norton, H. J.
   Lincourt, Amy E.
   Kercher, Kent W.
   Heniford, B. T.
TI Pushing the envelope in biomaterial research: initial results of
   prosthetic coating with stem cells in a rat model
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Hernia; Stem cell; Adhesions; Prosthetic
ID FIBROBLASTS; MESH
AB Coating prosthetic for hernia repair with a patient's own cells could improve biocompatibility by decreasing inflammation and adhesion formation and by increasing tissue ingrowth and resistance to infection. The objective of this study was to prove the feasibility of prosthetic coating with stem cells and to assess its resistance to adhesion formation when implanted in an animal model.
   Adult Lewis rat bone marrow stem cells were harvested and cultured. Stem cells were then implanted on three different prosthetics. The prosthetic with the best stem cell adherence was implanted intraperitoneally into six adult rats. Untreated prosthetic was implanted in control animals (n = 12). After 2 weeks, intra-abdominal adhesions were graded using an adhesion scoring scale by two surgeons who were blinded to the animal group. Data were analyzed using the Wilcoxon rank-sum test.
   Stem cells demonstrated the best adherence and growth on polyglactin prosthetics. After implantation, the stem cell-coated polyglactin prosthetic had < 25% of its surface area covered with adhesions in five (83%) samples, whereas the control polyglactin group had only one sample (8.3%) with < 25% adhesions, and seven of its samples (58.3%) had > 50% surface area adhesions (p < 0.05).
   The feasibility of hernia prosthetic coating with stem cells was demonstrated. Furthermore, stem-cell coated polyglactin prosthetic exhibited improved biocompatibility by decreasing adhesion formation in an animal model. Further study is needed to determine the factors that promote stem cell adherence to prosthetics and the in vivo prosthetic biomechanics after stem cell coating. This work is underway in our laboratory.
C1 [Dolce, Charles J.; Stefanidis, Dimitrios; Keller, Jennifer E.; Walters, K. C.; Newcomb, William L.; Heath, Jessica J.; Norton, H. J.; Lincourt, Amy E.; Kercher, Kent W.; Heniford, B. T.] Carolinas Med Ctr, Dept Gastrointestinal & Minimally Invas Surg, Dept Surg, Charlotte, NC 28203 USA.
RP Heniford, BT (reprint author), Carolinas Med Ctr, Dept Gastrointestinal & Minimally Invas Surg, Dept Surg, 1000 Blythe Blvd,MEB 601, Charlotte, NC 28203 USA.
EM cjdolce@gmail.com; Todd.heniford@carolinashealthcare.org
FU Society of American Gastrointestinal and Endoscopic Surgeons
FX This study was in part funded by the Society of American
   Gastrointestinal and Endoscopic Surgeons.
CR Cobb William S, 2005, Surg Innov, V12, P63, DOI 10.1177/155335060501200109
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Fraser John K, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS33, DOI 10.1038/ncpcardio0444
   Kapischke M, 2005, SURG ENDOSC, V19, P791, DOI 10.1007/s00464-004-9222-1
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Kyzer S, 1997, EUR SURG RES, V29, P84, DOI 10.1159/000129511
   Liu HW, 2007, TISSUE ENG, V13, P1113, DOI 10.1089/ten.2006.0209
   Olivares EL, 2004, AM J PHYSIOL-HEART C, V287, pH464, DOI 10.1152/ajpheart.01141.2003
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   SHIN M, 2007, J BIOMED MATER RES A, V84, P702
   Wu W, 2007, BRIT J ORAL MAX SURG, V45, P272, DOI 10.1016/j.bjoms.2006.09.004
   Yoon JJ, 2002, BIOTECHNOL BIOENG, V78, P1, DOI 10.1002/bit.10239
NR 13
TC 18
Z9 21
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD NOV
PY 2010
VL 24
IS 11
BP 2687
EP 2693
DI 10.1007/s00464-010-1026-x
PG 7
WC Surgery
SC Surgery
GA 666LP
UT WOS:000283117000005
PM 20349089
DA 2018-10-19
ER

PT J
AU Moioli, EK
   Chen, M
   Yang, RJ
   Shah, B
   Wu, JN
   Mao, JJ
AF Moioli, Eduardo K.
   Chen, Mo
   Yang, Rujing
   Shah, Bhranti
   Wu, June
   Mao, Jeremy J.
TI Hybrid Adipogenic Implants from Adipose Stem Cells for Soft Tissue
   Reconstruction In Vivo
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; BREAST RECONSTRUCTION; CULTURE; GRAFTS;
   REGENERATION; VITRO; SHAPE
AB A critical barrier in tissue regeneration is scale-up. Bioengineered adipose tissue implants have been limited to similar to 10 mm in diameter. Here, we devised a 40-mm hybrid implant with a cellular layer encapsulating an acellular core. Human adipose-derived stem cells (ASCs) were seeded in alginate. Poly(ethylene)glycol-diacrylate (PEGDA) was photopolymerized into 40-mm-diameter dome-shaped gel. Alginate-ASC suspension was painted onto PEGDA surface. Cultivation of hybrid constructs ex vivo in adipogenic medium for 28 days showed no delamination. Upon 4-week in vivo implantation in athymic rats, hybrid implants well integrated with host subcutaneous tissue and could only be surgically separated. Vascularized adipose tissue regenerated in the thin, painted alginate layer only if ASC-derived adipogenic cells were delivered. Contrastingly, abundant fibrous tissue filled ASC-free alginate layer encapsulating the acellular PEGDA core in control implants. Human-specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) was detected in human ASC-seeded implants. Interestingly, rat-specific PPAR-gamma was absent in either human ASC-seeded or ASC-free implants. Glycerol content in ASC-delivered implants was significantly greater than that in ASC-free implants. Remarkably, rat-specific platelet/endothelial cell adhesion molecule (PECAM) was detected in both ASC-seeded and ASC-free implants, suggesting anastomosis of vasculature in bioengineered tissue with host blood vessels. Human nuclear staining revealed that a substantial number of adipocytes were of human origin, whereas endothelial cells of vascular wall were of chemaric human and nonhuman (rat host) origins. Together, hybrid implant appears to be a viable scale-up approach with volumetric retention attributable primarily to the acellular biomaterial core, and yet has a biologically viable cellular interface with the host. The present 40-mm soft tissue implant may serve as a biomaterial tissue expander for reconstruction of lumpectomy defects.
C1 [Moioli, Eduardo K.; Chen, Mo; Yang, Rujing; Shah, Bhranti; Mao, Jeremy J.] Columbia Univ, Med Ctr, TERML, New York, NY 10032 USA.
   [Shah, Bhranti; Mao, Jeremy J.] Dept Biomed Engn, New York, NY USA.
   [Wu, June] Columbia Univ, Med Ctr, Coll Phys & Surg, Div Plast Surg, New York, NY 10032 USA.
RP Mao, JJ (reprint author), Columbia Univ, Med Ctr, TERML, 630 W 168 St PH7E CDM, New York, NY 10032 USA.
EM jmao@columbia.edu
FU Women at Risk (WAR); NIH [R01EB006263]
FX We thank S. Kennedy and F. Guo for technical and administrative support.
   The work ws supported by a grant from Women at Risk (WAR) to E.K.M. and
   NIH Grant R01EB006263 to J.J.M.
CR Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Alhadlaq A, 2003, J DENT RES, V82, P951, DOI 10.1177/154405910308201203
   Arnez ZM, 1999, BRIT J PLAST SURG, V52, P276, DOI 10.1054/bjps.1999.3100
   Arnez ZM, 1999, BRIT J PLAST SURG, V52, P351, DOI 10.1054/bjps.1999.3099
   Boone C, 2000, J ANIM SCI, V78, P885
   Brandl F, 2010, BIOMACROMOLECULES, V11, P496, DOI 10.1021/bm901235g
   CHAJCHIR A, 1986, AESTHET PLAST SURG, V10, P115, DOI 10.1007/BF01575279
   Cho SW, 2007, CELL TRANSPLANT, V16, P421, DOI 10.3727/000000007783464795
   Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006
   DELA FA, 1988, AESTHET PLAST SURG, V12, P39
   Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036
   Flynn L, 2009, J BIOMED MATER RES A, V89A, P929, DOI 10.1002/jbm.a.32044
   Halberstadt C, 2002, TISSUE ENG, V8, P309, DOI 10.1089/107632702753725067
   Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198
   Jenkins ME, 1996, J INVEST SURG, V9, P1, DOI 10.3109/08941939609012455
   Kimura Y, 2010, J TISSUE ENG REGEN M, V4, P55, DOI 10.1002/term.218
   Lin YC, 2009, ACTA BIOMATER, V5, P1416, DOI 10.1016/j.actbio.2008.11.031
   MATSUDO PKR, 1988, AESTHET PLAST SURG, V12, P35, DOI 10.1007/BF01570383
   Mizuno H, 2008, CELLS TISSUES ORGANS, V187, P177, DOI 10.1159/000110805
   Moioli EK, 2008, BONE, V42, P332, DOI 10.1016/j.bone.2007.10.004
   Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x
   Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922
   NIECHAJEV I, 1994, PLAST RECONSTR SURG, V94, P496, DOI 10.1097/00006534-199409000-00012
   Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032
   Shiffman M A, 1994, Med Law, V13, P681
   Stosich MS, 2007, TISSUE ENG, V13, P2881, DOI 10.1089/ten.2007.0078
   Stosich MS, 2009, METHODS, V47, P116, DOI 10.1016/j.ymeth.2008.10.013
   VAN ZD, 2004, ACTA CHIR BELG, V104, P158
   Weiser B, 2008, TISSUE ENG PT A, V14, P275, DOI 10.1089/tea.2007.0130
   Yang R., 2010, PLOS ONE IN PRESS
NR 30
TC 11
Z9 12
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2010
VL 16
IS 11
BP 3299
EP 3307
DI 10.1089/ten.tea.2010.0157
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 676GS
UT WOS:000283899600002
PM 20528671
OA Green Published
DA 2018-10-19
ER

PT J
AU Stuckey, DJ
   Ishii, H
   Chen, QZ
   Boccaccini, AR
   Hansen, U
   Carr, CA
   Roether, JA
   Jawad, H
   Tyler, DJ
   Ali, NN
   Clarke, K
   Harding, SE
AF Stuckey, Daniel J.
   Ishii, Hikaru
   Chen, Qi-Zhi
   Boccaccini, Aldo R.
   Hansen, Ulrich
   Carr, Carolyn A.
   Roether, Judith A.
   Jawad, Hedeer
   Tyler, Damian J.
   Ali, Nadire N.
   Clarke, Kieran
   Harding, Sian E.
TI Magnetic Resonance Imaging Evaluation of Remodeling by Cardiac
   Elastomeric Tissue Scaffold Biomaterials in a Rat Model of Myocardial
   Infarction
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID LEFT-VENTRICULAR FUNCTION; ENGINEERED HEART-TISSUE; MESENCHYMAL
   STEM-CELLS; POLY(GLYCEROL SEBACATE); BONE-FORMATION; STROMAL CELLS;
   CINE-MRI; IMPROVES; ENGRAFTMENT; PATCH
AB Grafting of elastomeric biomaterial scaffolds may offer a radical strategy for the prevention of heart failure after myocardial infarction by increasing efficacy of stem cell delivery as well as acting as mechanical restraint devices to constrain scar expansion. Biomaterials can be partially optimized in vitro, but their in vivo performance is most critical and should ideally be monitored serially and noninvasively. We used magnetic resonance imaging (MRI) to assess three scaffold materials with a range of structural moduli equal to or greater than myocardial tissue: poly(glycerol sebacate) (PGS), poly(ethyleneterephathalate)/dimer fatty acid (PED), and TiO2-reinforced PED (PED-TiO2). Patches, 1 cm in diameter, were grafted onto the hearts of infarcted rats, with biomaterial-free infarcted rat hearts used as controls. MRI was able to determine scaffold size and location on the heart and identified unexpectedly rapid in vivo degradation of the PGS compared with previous in vitro testing. PED patches did not withstand in vivo attachment, but the more rigid PED-TiO2 material was detrimental to heart function, increasing chamber and scar sizes and reducing ejection fractions compared with controls. In contrast, the mechanically compatible PGS scaffold successfully reduced hypertrophy, giving it potential for limiting excessive postinfarct remodeling. PGS was unable to support systolic function, but it would be suitable for strategies to deliver cardiac stem/progenitor cells, to limit remodeling during the period of functional cellular integration, and to degrade after cell assimilation by the heart. This work has also shown for the first time the value of using MRI as a noninvasive tool for evaluating and optimizing therapeutic biomaterials in vivo.
C1 [Stuckey, Daniel J.; Carr, Carolyn A.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Boccaccini, Aldo R.; Roether, Judith A.; Jawad, Hedeer] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
   [Ishii, Hikaru; Chen, Qi-Zhi; Jawad, Hedeer; Ali, Nadire N.; Harding, Sian E.] Natl Heart & Lung Inst, London, England.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Nurnberg, Germany.
   [Hansen, Ulrich] Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, London, England.
RP Stuckey, DJ (reprint author), Hammersmith Hosp, MRC Clin Sci Ctr, A107,1st Floor MRC Annexe Bldg,Cane Rd, London W12 0NN, England.
EM daniel.stuckey1@imperial.ac.uk
RI Boccaccini, Aldo/C-7905-2013; Hansen, Ulrich/K-3255-2014; Tyler,
   Damian/E-6296-2011
OI stuckey, daniel/0000-0001-8888-627X; Tyler, Damian/0000-0002-0780-8905
FU CBS; RBH Campus; Imperial College; Biotechnology and Biological Sciences
   Research Council [BB/D011027/1]; British Heart Foundation
   [PG/07/021/22511]; British Heart Foundation [RG/07/004/22659,
   FS/10/002/28078, PS/02/002/14893]; Medical Research Council [G0601490]
FX The authors thank the staff at CBS, RBH Campus, Imperial College, for
   their support. This study was funded by the Biotechnology and Biological
   Sciences Research Council (BB/D011027/1), British Heart Foundation
   (PG/07/021/22511). The authors also acknowledge Prof. M. El Fray,
   Polymer Institute, West Pomeranian University of Technology, Poland, for
   developing the PED and PED-TiO<INF>2</INF> materials used in this study.
CR Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cwajg JM, 2000, J AM COLL CARDIOL, V35, P1152, DOI 10.1016/S0735-1097(00)00525-8
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Hartman EHM, 2002, TISSUE ENG, V8, P1029, DOI 10.1089/107632702320934128
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hwang DW, 2008, EUR J NUCL MED MOL I, V35, P1887, DOI 10.1007/s00259-008-0751-z
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Mann DL, 1998, CIRCULATION, V98, P2367, DOI 10.1161/01.CIR.98.22.2367
   Nahrendorf M, 2001, J MAGN RESON IMAGING, V14, P547, DOI 10.1002/jmri.1218
   Nitzsche H, 2009, TISSUE ENG PART C-ME, V15, P513, DOI [10.1089/ten.tec.2008.0488, 10.1089/ten.TEC.2008.0488]
   Piegat A, 2008, ADV APPL CERAM, V107, P287, DOI 10.1179/174367508X297777
   Poirier-Quinot M, 2010, TISSUE ENG PART C-ME, V16, P185, DOI [10.1089/ten.tec.2009.0015, 10.1089/ten.TEC.2009.0015]
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502
   Sheikh AY, 2007, STEM CELLS, V25, P2677, DOI 10.1634/stemcells.2007-0041
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423
   Stuckey DJ, 2008, MAGN RESON MED, V60, P582, DOI 10.1002/mrm.21677
   Stuckey DJ, 2008, NMR BIOMED, V21, P765, DOI 10.1002/nbm.1268
   Stuckey DJ, 2006, STEM CELLS, V24, P1968, DOI 10.1634/stemcells.2006-0074
   Terrovitis JV, 2006, TISSUE ENG, V12, P2765, DOI 10.1089/ten.2006.12.2765
   Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wei HJ, 2006, BIOMATERIALS, V27, P5409, DOI 10.1016/j.jbiomaterials.2006.06.022
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 39
TC 50
Z9 50
U1 2
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2010
VL 16
IS 11
BP 3395
EP 3402
DI 10.1089/ten.tea.2010.0213
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 676GS
UT WOS:000283899600011
PM 20528670
DA 2018-10-19
ER

PT J
AU Doroski, DM
   Levenston, ME
   Temenoff, JS
AF Doroski, Derek M.
   Levenston, Marc E.
   Temenoff, Johnna S.
TI Cyclic Tensile Culture Promotes Fibroblastic Differentiation of Marrow
   Stromal Cells Encapsulated in Poly(Ethylene Glycol)-Based Hydrogels
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; COLLAGEN TYPE-I; MECHANICAL STIMULATION;
   FUMARATE) HYDROGELS; TENDON; CONSTRUCTS; EXPRESSION; MATRIX; BONE;
   PROLIFERATION
AB To inform future efforts in tendon/ligament tissue engineering, our laboratory has developed a well-controlled model system with the ability to alter both external tensile loading parameters and local biochemical cues to better understand marrow stromal cell differentiation in response to both stimuli concurrently. In particular, the synthetic, poly(ethylene glycol)-based hydrogel material oligo(poly(ethylene glycol) fumarate) (OPF) has been explored as a cell carrier for this system. This biomaterial can be tailored to present covalently incorporated bioactive moieties and can be loaded in our custom cyclic tensile bioreactor for up to 28 days with no loss of material integrity. Human marrow stromal cells encapsulated in these OPF hydrogels were cultured (21 days) under cyclic tensile strain (10%, 1 Hz, 3 h of strain followed by 3 h without) or at 0% strain. No difference was observed in cell number due to mechanical stimulation or across time (n = 4), with cells remaining viable (n = 4) through 21 days. Cyclic strain significantly upregulated all tendon/ligament fibroblastic genes examined (collagen I, collagen III, and tenascin-C) by day 21 (n >= 6), whereas genes for other pathways (osteogenic, chondrogenic, and adipogenic) did not increase. After 21 days, the presence of collagen I and tenascin-C was observed via immunostaining (n = 2). This study demonstrates the utility of this hydrogel/bioreactor system as a versatile, yet well-controlled, model environment to study marrow stromal cell differentiation toward the tendon/ligament phenotype under a variety of conditions.
C1 [Doroski, Derek M.; Temenoff, Johnna S.] Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Doroski, Derek M.; Temenoff, Johnna S.] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Levenston, Marc E.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.
RP Temenoff, JS (reprint author), Georgia Tech, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr,Room 2112, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
FU NIH [R21EB008918]; Arthritis Foundation
FX We thank Brian Nguyen (Georgia Tech BME undergraduate) for his help in
   collecting tensile degradation data. This research was supported by NIH
   R21EB008918 and an Arthritis Foundation Investigator Award to J.S.T.
CR Abousleiman RI, 2009, TISSUE ENG PT A, V15, P787, DOI 10.1089/ten.tea.2008.0102
   Altman Greg, 2002, FASEB Journal, V16, P270
   Benhardt HA, 2009, TISSUE ENG PART B-RE, V15, P467, DOI 10.1089/ten.TEB.2008.0687
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Butler DL, 2003, FUNCTIONAL TISSUE ENGINEERING, P213, DOI 10.1007/0-387-21547-6_16
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Chen JS, 2006, TISSUE ENG, V12, P3085, DOI 10.1089/ten.2006.12.3085
   Chokalingam K, 2009, TISSUE ENG PT A, V15, P2561, DOI 10.1089/ten.TEA.2008.0451
   Connelly JT, 2010, TISSUE ENG PT A, V16, P1913, DOI 10.1089/ten.TEA.2009.0561
   CONNELLY JT, 2006, ORTH RES SOC M CHIC
   CONNELLY JT, 2005, ORTH RES SOC M WASH
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054
   Ghazanfari S, 2009, BIOCHEM BIOPH RES CO, V388, P601, DOI 10.1016/j.bbrc.2009.08.072
   Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Kearney EM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979870
   Kessler MA, 2008, KNEE SURG SPORT TR A, V16, P442, DOI 10.1007/s00167-008-0498-x
   KHATOD M, 2003, DANIELS KNEE INJURIE, P31
   Kinneberg KRC, 2010, J ORTHOP RES, V28, P1092, DOI 10.1002/jor.21095
   Krych AJ, 2008, ARTHROSCOPY, V24, P292, DOI 10.1016/j.arthro.2007.08.029
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170
   LOUIE L, 1998, FRONTIERS TISSUE ENG, P412
   Mackie EJ, 1996, J ANAT, V188, P157
   MARTIN RB, 1998, SKELETAL TISSUE MECH, P309
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nieponice A, 2007, J BIOMED MATER RES A, V81A, P523, DOI 10.1002/jbm.a.31041
   Noth U, 2005, CYTOTHERAPY, V7, P447, DOI 10.1080/14653240500319093
   Saber S, 2010, TISSUE ENG PT A, V16, P2085, DOI [10.1089/ten.tea.2010.0032, 10.1089/ten.TEA.2010.0032]
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181
   Shin H, 2003, BIOMACROMOLECULES, V4, P552, DOI 10.1021/bm020121m
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775
   VANDERPLOEG EJ, 2006, THESIS GEORGIA I TEC
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026
NR 46
TC 45
Z9 48
U1 1
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2010
VL 16
IS 11
BP 3457
EP 3466
DI 10.1089/ten.tea.2010.0233
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 676GS
UT WOS:000283899600017
PM 20666585
OA Green Published
DA 2018-10-19
ER

PT J
AU Balaguer, T
   Boukhechba, F
   Clave, A
   Bouvet-Gerbettaz, S
   Trojani, C
   Michiels, JF
   Laugier, JP
   Bouler, JM
   Carle, GF
   Scimeca, JC
   Rochet, N
AF Balaguer, Thierry
   Boukhechba, Florian
   Clave, Arnaud
   Bouvet-Gerbettaz, Sebastien
   Trojani, Christophe
   Michiels, Jean-Francois
   Laugier, Jean-Pierre
   Bouler, Jean-Michel
   Carle, Georges F.
   Scimeca, Jean-Claude
   Rochet, Nathalie
TI Biphasic Calcium Phosphate Microparticles for Bone Formation: Benefits
   of Combination with Blood Clot
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PLATELET-RICH PLASMA; MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS;
   HYDROXYPROPYL METHYLCELLULOSE; 3-DIMENSIONAL CULTURE; FIBRIN;
   REGENERATION; SUBSTITUTE; HYDROGEL; DIFFERENTIATION
AB Particulate forms of biphasic calcium phosphate (BCP) biomaterials below 500 mu m are promising bone substitutes that provide with interconnected open porosity allowing free circulation of fluids and cells. Dispersion of the particles in the surrounding tissues at the time of implantation is a major drawback preventing from an easy use. We have asked whether blood clot could be a convenient natural hydrogel for handling BCP microparticles, and we hypothesized that blood clot might also confer osteoinductive properties to these particles. We show here that blood clotted around BCP microparticles constitutes a cohesive, moldable, and adaptable biomaterial that can be easily implanted in subcutaneous sites but also inserted and maintained in segmental bone defects, conversely to BCP microparticles alone. Moreover, implantation in bony and ectopic sites revealed that this composite biomaterial has osteogenic properties. It is able to repair a 6-mm critical femoral defect in rat and induced woven bone formation after subcutaneous implantation. Parameters such as particle size and loading into the clot are critical for its osteogenic properties. In conclusion, this blood/BCP microparticle composite is a moldable and osteoinductive biomaterial that could be used for bone defect filling in dental and orthopedic surgery.
C1 [Balaguer, Thierry; Boukhechba, Florian; Clave, Arnaud; Bouvet-Gerbettaz, Sebastien; Trojani, Christophe; Carle, Georges F.; Scimeca, Jean-Claude; Rochet, Nathalie] Univ Nice Sophia Antipolis, CNRS, UFR Med, GEPITOS, F-06100 Nice, France.
   [Balaguer, Thierry] Hop St Roche, Ctr Hosp Univ Nice, Serv Chirurg Plast Reparatrice & Esthet Chirurg M, Nice, France.
   [Trojani, Christophe] Ctr Hosp Univ Nice, Hop Archet, Serv Chirurg Orthoped, Nice, France.
   [Michiels, Jean-Francois] Ctr Hosp Univ Nice, Hop Pasteur, Serv Anatomopathol, Nice, France.
   [Laugier, Jean-Pierre] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, UFR Sci, F-06100 Nice, France.
   [Bouler, Jean-Michel] Univ Nantes, LIOAD, INSERM, UFR Odontol Nantes,UMR 791, Nantes, France.
RP Rochet, N (reprint author), Univ Nice Sophia Antipolis, CNRS, UFR Med, GEPITOS, 28 Ave Valombrose, F-06100 Nice, France.
EM nathalie.rochet@unice.fr
RI ROCHET, Nathalie/N-1819-2018
OI ROCHET, Nathalie/0000-0002-9995-6699; Scimeca,
   Jean-Claude/0000-0003-3773-6110; Clave, Arnaud/0000-0002-9961-463X;
   BOULER, Jean-Michel/0000-0001-9784-5584
FU P.R.A. fellowship; Fondation pour la Recherche Medicale; Centre National
   de la Recherche Scientifique (CNRS); Fondation de l'Avenir
FX The authors are grateful to Graftys Sarl for supplying BCP particles.
   The authors thank all the staff of the anatomy pathology department for
   excellent technical assistance and Majlinda Topi for animal care. The
   authors are very grateful to Stryker France SAS for lending the Stryker
   TPS device. This work was supported by a P.R.A. fellowship for T.B.
   (Accord cadre CNRS/CHU de Nice), by a fellowship from the Fondation pour
   la Recherche Medicale for A.C., and grants from the Centre National de
   la Recherche Scientifique (CNRS) and the Fondation de l'Avenir.
CR Aulakh TS, 2009, BIOMATERIALS, V30, P1732, DOI 10.1016/j.biomaterials.2008.12.035
   Baroth S, 2009, BIO-MED MATER ENG, V19, P71, DOI 10.3233/BME-2009-0565
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 2010, J MATER SCI-MATER M, V21, P855, DOI 10.1007/s10856-009-3914-y
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   de Oliveira MA, 2010, ACTA CIR BRAS, V25, P28, DOI 10.1590/S0102-86502010000100008
   Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   DVORAK HF, 1987, LAB INVEST, V57, P673
   Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Fellah BH, 2007, J MATER SCI-MATER M, V18, P287, DOI 10.1007/s10856-006-0691-8
   Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Griffin XL, 2009, INJURY, V40, P158, DOI 10.1016/j.injury.2008.06.025
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Kawasumi M, 2008, J BONE JOINT SURG BR, V90B, P966, DOI 10.1302/0301-620X.90B7.20235
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687
   Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054
   Mankani MH, 2008, TISSUE ENG PT A, V14, P1949, DOI 10.1089/ten.tea.2007.0348
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   MIZUNO K, 1990, J BONE JOINT SURG BR, V72, P822
   Nikolidakis D, 2006, TISSUE ENG, V12, P2555, DOI 10.1089/ten.2006.12.2555
   Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515
   Park SH, 2002, J ORTHOPAED RES, V20, P1197, DOI 10.1016/S0736-0266(02)00072-4
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
   Seybold D, 2010, LANGENBECK ARCH SURG, V395, P719, DOI 10.1007/s00423-009-0588-3
   Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Torigoe I, 2009, TISSUE ENG PT A, V15, P1489, DOI 10.1089/ten.tea.2008.0317
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001
   Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
NR 43
TC 25
Z9 25
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2010
VL 16
IS 11
BP 3495
EP 3505
DI 10.1089/ten.tea.2010.0227
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 676GS
UT WOS:000283899600020
PM 20590522
DA 2018-10-19
ER

PT J
AU McGrath, AM
   Novikova, LN
   Novikova, LN
   Wiberg, M
AF McGrath, Aleksandra M.
   Novikova, Liudmila N.
   Novikova, Lev N.
   Wiberg, Mikael
TI BD (TM) PuraMatrix (TM) peptide hydrogel seeded with Schwann cells for
   peripheral nerve regeneration
SO BRAIN RESEARCH BULLETIN
LA English
DT Article
DE Peripheral nerve injury; Tissue engineering; Regeneration; Biomaterial;
   Retrograde labeling; Nerve repair
ID FUNCTIONAL RECOVERY; NANOFIBER SCAFFOLD; SPINAL-CORD; IN-VITRO;
   MYOCARDIAL-INFARCTION; NEUROTROPHIC FACTORS; ALGINATE HYDROGEL;
   STEM-CELLS; TRANSPLANTATION; DIFFERENTIATION
AB This study investigated the effects of a membrane conduit filled with a synthetic matrix BD (TM) PuraMatrix (TM) peptide (BD) hydrogel and cultured Schwann cells on regeneration after peripheral nerve injury in adult rats
   After sciatic axotomy a 10 mm gap between the nerve stumps was bridged using ultrafiltration membrane conduits filled with BD hydrogel or BD hydrogel containing Schwann cells In control experiments the nerve defect was bridged using either membrane conduits with alginate/fibronectin hydrogel or autologous nerve graft Axonal regeneration within the conduit was assessed at 3 weeks and regeneration of spinal motoneurons and recovery of muscle weight evaluated at 16 weeks postoperatively
   Schwann cells survived in the BD hydrogel both in culture and after transplantation into the nerve defect Regenerating axons grew significantly longer distances within the conduits filled with BD hydrogel when compared with the alginate/fibronectin hydrogel and alginate/fibronectin with Schwann cells Addition of Schwann cells to the BD hydrogel considerably Increased regeneration distance with axons crossing the injury gap and entering into the distal nerve stump The conduits with BD hydrogel showed a linear alignment of nerve fibers and Schwann cells
   The number of regenerating motoneurons and recovery of the weight of the gastrocnemius muscle was inferior in BD hydrogel and alginate/fibronectin groups compared with nerve grafting Addition of Schwann cells did not improve regeneration of motoneurons or muscle recovery
   The present results suggest that BD hydrogel with Schwann cells could be used within biosynthetic conduits to Increase the rate of axonal regeneration across a nerve defect (C) 2010 Elsevier Inc All rights reserved.
C1 [McGrath, Aleksandra M.; Novikova, Liudmila N.; Novikova, Lev N.; Wiberg, Mikael] Umea Univ, Sect Anat, Dept Integrat Med Biol, SE-90187 Umea, Sweden.
   [McGrath, Aleksandra M.; Wiberg, Mikael] Umea Univ, Sect Hand & Plast Surg, Dept Surg & Perioperat Sci, SE-90187 Umea, Sweden.
RP McGrath, AM (reprint author), Umea Univ, Sect Anat, Dept Integrat Med Biol, SE-90187 Umea, Sweden.
RI Novikov, Lev/I-1983-2012
OI Novikov, Lev/0000-0001-5520-3890; McGrath,
   Aleksandra/0000-0001-6142-6791
CR Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Ide C, 1996, NEUROSCI RES, V25, P101
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   JUNG JP, 2009, BIOMATERIALS, V12, P2400
   Kingham PJ, 2006, J ANAT, V209, P511, DOI 10.1111/j.1469-7580.2006.00623.x
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Reyes Onix, 2005, P R Health Sci J, V24, P215
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Siemionow M, 2007, J RECONSTR MICROSURG, V23, P511, DOI 10.1055/s-2007-1022694
   Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Wiberg Mikael, 2003, Surg Technol Int, V11, P303
   Yannas IV, 2007, J BIOMAT SCI-POLYM E, V18, P943, DOI 10.1163/156856207781494386
NR 39
TC 34
Z9 35
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD OCT 30
PY 2010
VL 83
IS 5
BP 207
EP 213
DI 10.1016/j.brainresbull.2010.07.001
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 683YN
UT WOS:000284514300005
PM 20633614
DA 2018-10-19
ER

PT J
AU Proulx, S
   Uwamaliya, JD
   Carrier, P
   Deschambeault, A
   Audet, C
   Giasson, CJ
   Guerin, SL
   Auger, FA
   Germain, L
AF Proulx, Stephanie
   Uwamaliya, Jeanne d'Arc
   Carrier, Patrick
   Deschambeault, Alexandre
   Audet, Caroline
   Giasson, Claude J.
   Guerin, Sylvain L.
   Auger, Francois A.
   Germain, Lucie
TI Reconstruction of a human cornea by the self-assembly approach of tissue
   engineering using the three native cell types
SO MOLECULAR VISION
LA English
DT Article
ID IN-VITRO CORNEA; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; DRUG PERMEATION;
   WOUND REEPITHELIALIZATION; AMNIOTIC MEMBRANE; BASEMENT-MEMBRANE; OCULAR
   SURFACE; RABBIT CORNEA; STEM-CELLS
AB Purpose: The purpose of this study was to produce and characterize human tissue-engineered corneas reconstructed using all three corneal cell types (epithelial, stromal, and endothelial cells) by the self-assembly approach.
   Methods: Fibroblasts cultured in medium containing serum and ascorbic acid secreted their own extracellular matrix and formed sheets that were superposed to reconstruct a stromal tissue. Endothelial and epithelial cells were seeded on each side of the reconstructed stroma. After culturing at the air-liquid interface, the engineered corneas were fixed for histology and transmission electron microscopy (TEM). Immunofluorescence labeling of epithelial keratins, basement membrane components, Na+/K+-ATPase alpha 1, and collagen type I was also performed.
   Results: Epithelial and endothelial cells adhered to the reconstructed stroma. After 10 days at the air-liquid interface, the corneal epithelial cells stratified (4 to 5 cell layers) and differentiated into well defined basal and wing cells that also expressed Na+/K+-ATPase alpha 1 protein, keratin 3/12, and basic keratins. Basal epithelial cells from the reconstructed epithelium formed many hemidesmosomes and secreted a well defined basement membrane rich in laminin V and collagen VII. Endothelial cells formed a monolayer of tightly-packed cells and also expressed the function related protein Na+/K+-ATPase alpha 1.
   Conclusions: This study demonstrates the feasibility of producing a complete tissue-engineered human cornea, similar to native corneas, using untransformed fibroblasts, epithelial and endothelial cells, without the need for exogenous biomaterial.
C1 [Proulx, Stephanie; Uwamaliya, Jeanne d'Arc; Carrier, Patrick; Deschambeault, Alexandre; Audet, Caroline; Guerin, Sylvain L.; Auger, Francois A.; Germain, Lucie] Univ Quebec, Ctr Hosp, Ctr LOEX Univ Laval, Genie Tissulaire & Regenerat LOEX Ctr Rech FRSQ, Quebec City, PQ G1J 1Z4, Canada.
   [Proulx, Stephanie; Uwamaliya, Jeanne d'Arc; Carrier, Patrick; Deschambeault, Alexandre; Audet, Caroline; Guerin, Sylvain L.; Auger, Francois A.; Germain, Lucie] Univ Laval, Dept Otorhinolaryngol & Ophtalmol, Quebec City, PQ, Canada.
   [Proulx, Stephanie; Uwamaliya, Jeanne d'Arc; Carrier, Patrick; Deschambeault, Alexandre; Audet, Caroline; Auger, Francois A.; Germain, Lucie] Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ G1K 7P4, Canada.
   [Giasson, Claude J.] Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada.
RP Germain, L (reprint author), Univ Quebec, Ctr Hosp, Ctr LOEX Univ Laval, Genie Tissulaire & Regenerat LOEX Ctr Rech FRSQ, 1401 18E Rue, Quebec City, PQ G1J 1Z4, Canada.
EM lucie.germain@chg.ulaval.ca
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
FU Vision Research Network of the Fonds de la Recherche en Sante du Quebec
   (FRSQ); Canadian Institutes of Health Research (CIHR); CHA Research
   Center of the FRSQ; Natural Sciences and Engineering Research Council of
   Canada (NSERC); Canadian Research Chair from the CIHR in Stem Cells and
   Tissue Engineering
FX The authors thank Dr Christine Corriveau and Louise Mercier from the
   department of Ophthalmology at the Centre Hospitalier de l'Universite de
   Montreal (CHUM) for kindly providing human limbal specimens. This study
   was supported by the Vision Research Network of the Fonds de la
   Recherche en Sante du Quebec (FRSQ), the Canadian Institutes of Health
   Research (CIHR; L.G., S.L. G., F.A.A.), and the CHA Research Center of
   the FRSQ. S.P. held a postdoctoral fellowship from the Natural Sciences
   and Engineering Research Council of Canada (NSERC). L.G. is the
   recipient of a Canadian Research Chair from the CIHR in Stem Cells and
   Tissue Engineering.
CR Ahn JI, 2007, ARTIF ORGANS, V31, P711, DOI 10.1111/j.1525-1594.2007.00441.x
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Amano S, 2005, JPN J OPHTHALMOL, V49, P448, DOI 10.1007/s10384-005-0245-5
   Amano S, 2003, CORNEA, V22, pS66, DOI 10.1097/00003226-200310001-00010
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   Balasubramanian S, 2008, INDIAN J MED RES, V128, P616
   Ban Y, 2003, EXP EYE RES, V76, P735, DOI 10.1016/S0014-4835(03)00033-2
   BROWN STUART I., 1965, INVEST OPHTHALMOL, V4, P216
   Burgalassi S, 2004, J OCUL PHARMACOL TH, V20, P518, DOI 10.1089/1080768042727891
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001
   Chang JE, 2000, PHARMACEUT RES, V17, P670, DOI 10.1023/A:1007569929765
   Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012
   Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764
   DUBE J, 2005, MED SCI PARIS S2, V21, pS23
   Dube J, 2010, TISSUE ENG PT A, V16, P3055, DOI [10.1089/ten.tea.2010.0030, 10.1089/ten.TEA.2010.0030]
   ENGELMANN K, 1995, CORNEA, V14, P62
   FISCHBARG J, 1985, CURR EYE RES, V4, P351, DOI 10.3109/02713688509025148
   Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7
   Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064
   Germain LGC, 2004, ENCY BIOMATERIALS BI, P1534
   Germain Lucie, 1995, P699
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Griffith M, 2002, CORNEA, V21, pS54, DOI 10.1097/01.ICO.0000028326.06702.9C
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Guo NX, 2007, J BIOL CHEM, V282, P12475, DOI 10.1074/jbc.M609280200
   Hitani K, 2008, MOL VIS, V14, P1
   HODSON S, 1971, EXP EYE RES, V11, P20, DOI 10.1016/S0014-4835(71)80060-X
   HOGAN MJ, 1971, HISTOLOGY HUMAN EYE, P55
   HUFF JW, 1981, CURR EYE RES, V1, P113, DOI 10.3109/02713688109001735
   Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654
   KAHN CR, 1993, INVEST OPHTH VIS SCI, V34, P3429
   Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567
   Kruszewski FH, 1997, FUND APPL TOXICOL, V36, P130, DOI 10.1006/faat.1997.2289
   KURPAKUS MA, 1992, DEV BIOL, V150, P243, DOI 10.1016/0012-1606(92)90239-D
   KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   MAURICE DM, 1984, VEGETATIVE PHYSL BIO
   Michel M, 1999, IN VITRO CELL DEV-AN, V35, P318
   MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316
   Miyashita H, 2008, TISSUE ENG PT A, V14, P1275, DOI [10.1089/ten.tea.2007.0212, 10.1089/tea.2007.0212]
   Mohan RR, 2003, EXP EYE RES, V77, P395, DOI 10.1016/S0014-4835(03)00175-1
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769
   Pouliot R, 2002, TRANSPLANTATION, V73, P1751, DOI 10.1097/00007890-200206150-00010
   Proulx S, 2007, MOL VIS, V13, P524
   Proulx S, 2009, TISSUE ENG PT A, V15, P1709, DOI 10.1089/ten.tea.2008.0208
   Proulx S, 2009, INVEST OPHTH VIS SCI, V50, P2686, DOI 10.1167/iovs.08-2793
   Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225
   Reichl S, 2003, INT J PHARM, V250, P191, DOI 10.1016/S0378-5173(02)00541-0
   Ren R, 2008, DEV DYNAM, V237, P2705, DOI 10.1002/dvdy.21606
   Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515
   Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje
   Tegtmeyer S, 2001, EUR J PHARM BIOPHARM, V51, P119, DOI 10.1016/S0939-6411(01)00123-0
   Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599
   Werner A, 2008, VET OPHTHALMOL, V11, P280, DOI 10.1111/j.1463-5224.2008.00646.x
   Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs-030814
   ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300
   Zorn-Kruppa M, 2004, ALTEX-ALTERN TIEREXP, V21, P129
NR 63
TC 59
Z9 60
U1 0
U2 16
PU MOLECULAR VISION
PI ATLANTA
PA C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E,
   ATLANTA, GA 30322 USA
SN 1090-0535
J9 MOL VIS
JI Mol. Vis.
PD OCT 29
PY 2010
VL 16
IS 234-36
BP 2192
EP 2201
PG 10
WC Biochemistry & Molecular Biology; Ophthalmology
SC Biochemistry & Molecular Biology; Ophthalmology
GA 674FD
UT WOS:000283718900002
PM 21139684
DA 2018-10-19
ER

PT J
AU Vazquez-Hernandez, F
   Mendoza-Barrera, C
   Altuzar, V
   Melendez-Lira, M
   Santana-Aranda, MA
   Olvera, MD
AF Vazquez-Hernandez, F.
   Mendoza-Barrera, C.
   Altuzar, V.
   Melendez-Lira, M.
   Santana-Aranda, M. A.
   Olvera, M. de la L.
TI Synthesis and characterization of hydroxyapatite nanoparticles and their
   application in protein adsorption
SO MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE
   MATERIALS
LA English
DT Article; Proceedings Paper
CT Symposium on Advances in Semiconducting Materials held at 18th
   International Materials Research Congress
CY AUG 15-19, 2009
CL Cancun, MEXICO
SP Acad Mexicana Ciencias, Mat Res Soc
DE Hydroxyapatite; Biomaterial; Hydrothermal synthesis; Bioceramic
   materials
ID BOVINE SERUM-ALBUMIN; SURFACE; FIBRINOGEN; PH; CHARGE; SIMS; XPS
AB Hydroxyapatite (HAp) is a bioceramic material used to decrease the operatory time for bone trauma fixing, protein purification, prosthetic covering, and complementing the consolidation and substitution in bone solutions since this material works in favor of the bone neoformation when it is in touch with the physiological tissue. In this work the hydrothermal method, by using a starting solution containing hydrate dipotassium hydrogen phosphate, K2HPO4 center dot 3H(2)O, and cetyltrimethylammonium bromide, CTAB, dissolved in deionized water was employed to synthesize HAp nanoparticles with sizes between 15 and 60 nm, high policrystallinity and Ca/P and Ca/O ratios close to the theoretical. The synthesized HAp particles were characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), and energy dispersive spectroscopy (EDS). Pellets with a diameter of 5 mm and weight of 150 mg were used to support the fibrinogen (FGN) and bovine serum albumin (BSA) adsorption (0.15, 0.7, and 1.5 mg/ml) studies. The protein adsorption studies were carried out via atomic force microscopy (AFM). (C) 2010 Elsevier B.V. All rights reserved.
C1 [Vazquez-Hernandez, F.; Olvera, M. de la L.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ingn Elect, Mexico City 07360, DF, Mexico.
   [Melendez-Lira, M.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis, Mexico City 07360, DF, Mexico.
   [Mendoza-Barrera, C.; Altuzar, V.] Univ Veracruzana, MICRONA, Lab Bionanotecnol, Boca Del Rio 94294, Veracruz, Mexico.
   [Santana-Aranda, M. A.] Univ Guadalajara, CUCEI, Dept Fis, Guadalajara 44430, Jalisco, Mexico.
RP Vazquez-Hernandez, F (reprint author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ingn Elect, Mexico City 07360, DF, Mexico.
EM fvazquez@cinvestav.mx
RI Santana-Aranda, Miguel Angel/D-3947-2014
OI Santana-Aranda, Miguel Angel/0000-0002-6296-4425; Melendez-Lira,
   Miguel/0000-0001-9799-8337
CR BERNABEU P, 1990, BIOMATERIALS, V11, P258, DOI 10.1016/0142-9612(90)90007-D
   Bosma JC, 1998, AICHE J, V44, P2399, DOI 10.1002/aic.690441108
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   Fuss C, 2001, J VASC INTERV RADIOL, V12, P677, DOI 10.1016/S1051-0443(07)61437-7
   Gelamo EL, 2000, SPECTROCHIM ACTA A, V56, P2255, DOI 10.1016/S1386-1425(00)00313-9
   HARRINGTON WF, 1956, BIOCHEM J, V62, P569, DOI 10.1042/bj0620569
   JOHNSSON M, 1991, ARCH ORAL BIOL, V36, P631, DOI 10.1016/0003-9969(91)90014-L
   Kopac T, 2008, COLLOID SURFACE A, V322, P19, DOI 10.1016/j.colsurfa.2008.02.010
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   MENDOZABARRERA C, 2005, REV SUP VACIO, V10, P31
   Menon MK, 1998, ANAL CHEM, V70, P1581, DOI 10.1021/ac970902r
   Monkawa A, 2006, BIOMATERIALS, V27, P5748, DOI 10.1016/j.biomaterials.2006.07.029
   MORENO EC, 1982, J BIOL CHEM, V257, P2981
   Tsapikouni TS, 2007, COLLOID SURFACE B, V57, P89, DOI 10.1016/j.colsurfb.2007.01.011
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   Wang YJ, 2006, MATER LETT, V60, P1484, DOI 10.1016/j.matlet.2005.11.053
   Yanagisawa K, 2005, J CERAM SOC JPN, V113, P565, DOI 10.2109/jcersj.113.565
NR 17
TC 18
Z9 19
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-5107
EI 1873-4944
J9 MATER SCI ENG B-ADV
JI Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.
PD OCT 25
PY 2010
VL 174
IS 1-3
SI SI
BP 290
EP 295
DI 10.1016/j.mseb.2010.03.011
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 664AA
UT WOS:000282930100059
DA 2018-10-19
ER

PT J
AU Alves, NM
   Pashkuleva, I
   Reis, RL
   Mano, JF
AF Alves, Natalia M.
   Pashkuleva, Iva
   Reis, Rui L.
   Mano, Joao F.
TI Controlling Cell Behavior Through the Design of Polymer Surfaces
SO SMALL
LA English
DT Review
ID SELF-ASSEMBLED MONOLAYERS; POLYELECTROLYTE MULTILAYER FILMS;
   POLY(L-LACTIC ACID); IN-VITRO; LASER-ABLATION; BIOMEDICAL APPLICATIONS;
   FIBROBLAST ADHESION; FIBROUS SCAFFOLDS; NEURITE OUTGROWTH;
   FUNCTIONAL-GROUPS
AB Polymers have gained a remarkable place in the biomedical field as materials for the fabrication of various devices and for tissue engineering applications. The initial acceptance or rejection of an implantable device is dictated by the crosstalk of the material surface with the bioentities present in the physiological environment. Advances in microfabrication and nanotechnology offer new tools to investigate the complex signaling cascade induced by the components of the extracellular matrix and consequently allow cellular responses to be tailored through the mimicking of some elements of the signaling paths. Patterning methods and selective chemical modification schemes at different length scales can provide biocompatible surfaces that control cellular interactions on the micrometer and sub-micrometer scales on which cells are organized. In this review, the potential of chemically and topographically structured micro- and nanopolymer surfaces are discussed in hopes of a better understanding of cell biomaterial interactions, including the recent use of biomimetic approaches or stimuli-responsive macromolecules. Additionally, the focus will be on how the knowledge obtained using these surfaces can be incorporated to design biocompatible materials for various biomedical applications, such as tissue engineering, implants, cell-based biosensors, diagnostic systems, and basic cell biology. The review focusses on the research carried out during the last decade.
C1 [Alves, Natalia M.; Pashkuleva, Iva; Reis, Rui L.; Mano, Joao F.] Univ Minho, Res Grp 3B, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Alves, Natalia M.; Pashkuleva, Iva; Reis, Rui L.; Mano, Joao F.] PT Associated Lab, IBB, Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp 3B, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Pashkuleva, Iva/B-5590-2008; Alves,
   Natalia/I-5459-2015; Reis, Rui L./A-8938-2008; Mano, Joao/A-4418-2009
OI Group, 3Bs/0000-0002-5195-3456; Pashkuleva, Iva/0000-0001-6818-3374;
   Reis, Rui L./0000-0002-4295-6129; Mano, Joao/0000-0002-2342-3765; Alves,
   Natalia/0000-0002-8741-4091
FU European Union [NMP4-SL-2009-229292]; FCT [PTDC/FIS/68517/2006,
   PTDC/QUI/69263/2006, PTDC/FIS/68209/2006, PTDC/QUI/68804/2006]
FX The research leading to these results has received partial funding from
   the European Union Seventh Framework Programme (FP7/2007-2013) under
   grant agreement no. NMP4-SL-2009-229292 and by the FCT projects
   PTDC/FIS/68517/2006, PTDC/QUI/69263/2006, PTDC/FIS/68209/2006, and
   PTDC/QUI/68804/2006.
CR Alves NM, 2009, J BIOMED MATER RES A, V91A, P480, DOI 10.1002/jbm.a.32210
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Berry CC, 2006, J BIOMED MATER RES A, V79A, P431, DOI 10.1002/jbm.a.30960
   Berry CC, 2005, BIOMATERIALS, V26, P4985, DOI 10.1016/j.biomaterials.2005.01.046
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b
   Martinez EC, 2008, TISSUE ENG PT A, V14, P1751, DOI 10.1089/ten.tea.2007.0270
   Costa RR, 2009, ADV FUNCT MATER, V19, P3210, DOI 10.1002/adfm.200900568
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   CUSTODIO CA, 2010, J TISSUE EN IN PRESS
   Da Silva RMP, 2007, TRENDS BIOTECHNOL, V25, P577, DOI 10.1016/j.tibtech.2007.08.014
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   Drexler E, 1986, ENGINES CREATION COM
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Eliason MT, 2008, J BIOMED MATER RES A, V86A, P996, DOI 10.1002/jbm.a.31697
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d
   Gleason NJ, 2003, LANGMUIR, V19, P513, DOI 10.1021/la026534q
   Goessl A, 2001, J BIOMAT SCI-POLYM E, V12, P721, DOI 10.1163/156856201750411620
   GOESSL A, 2001, BLAMED MAT RES, V57, P15
   GOESSL A, 2001, POLYMER, V12, P739
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Groll J, 2005, LANGMUIR, V21, P3076, DOI 10.1021/la047438n
   HAMMARBACK JA, 1988, DEV BIOL, V126, P29, DOI 10.1016/0012-1606(88)90235-7
   HAMMARBACK JA, 1985, J NEUROSCI RES, V13, P213, DOI 10.1002/jnr.490130115
   Hannachi IE, 2009, BIOMATERIALS, V30, P5427, DOI 10.1016/j.biomaterials.2009.06.033
   Huo FW, 2008, SCIENCE, V321, P1658, DOI 10.1126/science.1162193
   Hyun J, 2001, LANGMUIR, V17, P6358, DOI 10.1021/la010695x
   Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023
   Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021
   Jungbauer S, 2004, CHEMPHYSCHEM, V5, P85, DOI 10.1002/cphc.200300868
   Kalinina S, 2008, BIOMATERIALS, V29, P3004, DOI 10.1016/j.biomaterials.2008.04.003
   Khor HL, 2007, BIOMACROMOLECULES, V8, P1530, DOI 10.1021/bm0611533
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Lin CC, 2005, BIOMATERIALS, V26, P3655, DOI 10.1016/j.biomaterials.2004.09.051
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nakayama Y, 1999, LANGMUIR, V15, P1667, DOI 10.1021/la981169h
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m
   Ostuni E, 2003, LANGMUIR, V19, P1861, DOI 10.1021/la020649c
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   Pan YV, 2002, PLASMAS POLYM, V7, P171, DOI 10.1023/A:1016295419941
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   PRABAHARAN M, 2007, BLAMED MAT RES B, V81, P427
   RICHARD D, 2006, D LAURENTMAQUIND BLA, V79, P108
   Sanchez FH, 2005, BIOMACROMOLECULES, V6, P3283, DOI 10.1021/bm050323t
   Sanchez MS, 2005, THERMOCHIM ACTA, V430, P201, DOI 10.1016/j.tca.2005.01.066
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Semler EJ, 2006, ADV BIOCHEM ENG BIOT, V102, P1, DOI 10.1007/10012
   Shi J, 2007, ADV FUNCT MATER, V17, P3312, DOI 10.1002/adfm.200601206
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6
   Spatz JP, 2000, MACROMOLECULES, V33, P150, DOI 10.1021/ma990751p
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   TEXTOR M, 2005, Patent No. 20050014151A1
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Torres AJ, 2008, ANNU REV BIOPHYS, V37, P265, DOI 10.1146/annurev.biophys.36.040306.132651
   Tsai IY, 2007, METHOD CELL BIOL, V83, P67, DOI 10.1016/S0091-679X(07)83004-4
   Tsuda Y, 2005, BIOMATERIALS, V26, P1885, DOI 10.1016/j.biomaterials.2004.06.005
   Tsuda Y, 2007, ADV MATER, V19, P3633, DOI 10.1002/adma.200700988
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   Tsuda Y, 2006, BIOCHEM BIOPH RES CO, V348, P937, DOI 10.1016/j.bbrc.2006.07.138
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016
   Vazquez CP, 2009, LANGMUIR, V25, P3556, DOI 10.1021/la803577t
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang Y, 2005, MACROMOLECULES, V38, P4712, DOI 10.1021/ma047934i
   Welle A, 2005, J NEUROSCI METH, V142, P243, DOI 10.1016/j.jneumeth.2004.08.011
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yamato M, 2003, J BIOMED MATER RES A, V67A, P1065, DOI 10.1002/jbm.a.10078
   Yang ZP, 2000, ADV MATER, V12, P413, DOI 10.1002/(SICI)1521-4095(200003)12:6<413::AID-ADMA413>3.0.CO;2-#
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zhang Y, 2008, J APPL PHYS, V104, DOI 10.1063/1.2981070
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 116
TC 188
Z9 189
U1 12
U2 205
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD OCT 18
PY 2010
VL 6
IS 20
BP 2208
EP 2220
DI 10.1002/smll.201000233
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 676DO
UT WOS:000283890500002
PM 20848593
DA 2018-10-19
ER

PT J
AU Ilgin, P
   Avci, G
   Silan, C
   Ekici, S
   Aktas, N
   Ayyala, RS
   John, VT
   Sahiner, N
AF Ilgin, Pinar
   Avci, Gulden
   Silan, Coskun
   Ekici, Sema
   Aktas, Nahit
   Ayyala, Ramesh S.
   John, Vijay T.
   Sahiner, Nurettin
TI Colloidal drug carries from (sub)micron hyaluronic acid hydrogel
   particles with tunable properties for biomedical applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Composites; Magnetic particles; Delivery; Biomaterial; Hyaluronic acid
ID VOCAL FOLD REGENERATION; MAGNETIC NANOPARTICLES; POTENTIAL APPLICATION;
   DELIVERY; NETWORKS
AB Hyaluronic acid (HA) hydrogel particles were synthesized in a single step employing water-in-oil microemulsion system. The HA particles were formed in the micro-environments of aqueous HA solution in oil by chemical crosslinking with divinyl sulfone (DVS). To produce magnetic field responsive HA-composite particles, iron magnetic nanoparticles were introduced into microemulsion system during synthesis to obtain HA-magnetic composites. For this purpose, iron nanoparticles were separately synthesized and mixed with linear HA followed by chemical crosslinking of linear HA with DVS in the micro-environments to envelope magnetic metal nanoparticles in the emulsion system. Scanning electron microscopy (SEM), dynamic light scattering (DLS) studies, and zeta potentials measurement were performed for particle size, charge and morphological characterization. Additionally. HA particles were chemically modified to induce desired functional groups on the particle surface and utilized for potential drug delivery vehicles. Trimethoprim (TMP) a bacteriostatic antibiotic drug were used as a model drug for the release studies in phosphate buffer solution (PBS) at pH 7.4 from bare HA, magnetic HA-composite and modified HA hydrogel particles. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Ilgin, Pinar; Ekici, Sema; Sahiner, Nurettin] Canakkale Onsekiz Mart Univ, Dept Chem, Fac Sci & Arts, TR-17100 Canakkale, Turkey.
   [Avci, Gulden; Silan, Coskun] Canakkale Onsekiz Mart Univ, Sch Med Reconstruct & Plast Surg, TR-17100 Canakkale, Turkey.
   [Avci, Gulden; Ekici, Sema; Sahiner, Nurettin] Canakkale Onsekiz Mart Univ, Nanosci & Technol Res & Applicat Ctr NANORAC, TR-17100 Canakkale, Turkey.
   [Silan, Coskun] Canakkale Onsekiz Mart Univ, Dept Pharm, TR-17100 Canakkale, Turkey.
   [Aktas, Nahit] Yuzuncu Yil Univ, Fac Engn, Dept Chem Engn, TR-65080 Van, Turkey.
   [Ayyala, Ramesh S.] Tulane Univ, Dept Ophthalmol, Tulane Med Ctr, New Orleans, LA 70118 USA.
RP Sahiner, N (reprint author), Canakkale Onsekiz Mart Univ, Dept Chem, Fac Sci & Arts, Terzioglu Campus, TR-17100 Canakkale, Turkey.
EM sahiner71@gmail.com
RI John, Vijay/G-3747-2010; Ilgin, Pinar/Q-4321-2017
OI John, Vijay/0000-0001-5426-7585; Sahiner, Nurettin/0000-0003-0120-530X
FU Scientific and Technical Research Council of Turkey [108T133]; Turkish
   Academy of Science
FX This work is supported by The Scientific and Technical Research Council
   of Turkey (Grant No. 108T133). N. Sahiner is also grateful to Turkish
   Academy of Science for the support under 2008, TUBA-GEBIP program.
CR Bodnar M, 2009, COLLOID POLYM SCI, V287, P991, DOI 10.1007/s00396-009-2061-9
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   ENSTWISTLE J, 1998, J CELL BIOCHEM, V61, P569
   Francis S, 2004, RADIAT PHYS CHEM, V69, P481, DOI 10.1016/j.radphyschem.2003.09.004
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Kumar A, 2007, NANOMED-NANOTECHNOL, V3, P132, DOI 10.1016/j.nano.2007.03.001
   Lin QK, 2009, COLLOID SURFACE B, V74, P298, DOI 10.1016/j.colsurfb.2009.07.036
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 2001, BIOCONJUGATE CHEM, V12, P1085, DOI 10.1021/bc015513p
   Luo Y, 2001, METHODS TISSUE ENG, P539
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Rouse JJ, 2007, INT J PHARMACEUT, V330, P175, DOI 10.1016/j.ijpharm.2006.11.066
   Sahiner N, 2008, TURK J CHEM, V32, P397
   Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Yan F, 2009, J NANOPART RES, V11, P289, DOI 10.1007/s11051-008-9382-3
NR 20
TC 27
Z9 27
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD OCT 15
PY 2010
VL 82
IS 3
BP 997
EP 1003
DI 10.1016/j.carbpol.2010.06.033
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 646FY
UT WOS:000281524900067
DA 2018-10-19
ER

PT J
AU Cao, YR
   Liu, ZA
   Cheng, GL
   Jing, XB
   Xu, H
AF Cao, Yan-ru
   Liu, Zhuan
   Cheng, Guang-lei
   Jing, Xiao-bing
   Xu, Heng
TI Exploring single and multi-metal biosorption by immobilized spent
   Tricholoma lobayense using multi-step response surface methodology
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Tricholoma lobayense; Competitive adsorption; Inhibition; Heavy metals;
   Response surface methodology; Desorption
ID FUNGUS TRAMETES-VERSICOLOR; AQUEOUS-SOLUTION; ALGINATE BEADS;
   HEAVY-METALS; SACCHAROMYCES-CEREVISIAE; PYCNOPORUS-SANGUINEUS; CADMIUM
   BIOSORPTION; EXPERIMENTAL-DESIGN; CA-ALGINATE; WASTE-WATER
AB A multi-step response surface methodology was successfully applied to interpret the adsorption characteristics of lead, cadmium and copper ions onto immobilized spent Tricholoma lobayense (ISTL) in single and ternary systems in this study. Firstly, the most significant medium factors, which were pH, biomass loading and contact time, on biosorption of three metals, were determined by Minimum Run Res V Design. Then central composite design followed by mixture design was utilized to identify the affinity and predict the adsorption capacities of three metals onto the biosorbent. The results showed that the preference of ISTL for three metals was in the order of Pb(II) > Cu(II) > Cd(II) and lead ions could still be effectively removed from aqueous solution in the presence of both cadmium and copper while removal of the cadmium and copper ions would be suppressed by lead. Sorption isotherm data were better represented by Freundlich model. The both adsorption and desorption process of three metals followed the pseudo-second-order kinetics model. Scanning electron microscope (SEM) and energy dispersive spectrometry (EDS) analysis testified the obvious change of the surface morphology and the presence of three metals on the biosorbent after metal binding. The ISTL could be regenerated with 1 M HNO3, which allowed the reuse of the biomass in three biosorption-desorption cycles without considerable loss of adsorption capacity. The present work suggests that ISTL as an abundant low-cost biomaterial was an efficient biosorbent for heavy metals removal from wastewater. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Cao, Yan-ru; Liu, Zhuan; Jing, Xiao-bing; Xu, Heng] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Educ Minist, Coll Life Sci, Chengdu 610064, Peoples R China.
   [Cheng, Guang-lei] Sichuan Univ, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
RP Xu, H (reprint author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Educ Minist, Coll Life Sci, Wangjiang Rd 29, Chengdu 610064, Peoples R China.
EM xuheng64@sina.com
FU National 863 High Technology Research and Development Program of China
   [2006AA06Z361]; Science and Technology Supportive Project of Sichuan
   Province, China [2009SZ0204]; Science and Technology Project of Chengdu
FX This study was financially supported by the National 863 High Technology
   Research and Development Program of China (2006AA06Z361), Science and
   Technology Supportive Project of Sichuan Province, China (2009SZ0204)
   and Science and Technology Project of Chengdu (the first project, 2010).
CR ALLEN SJ, 1995, J CHEM TECHNOL BIOT, V62, P17, DOI 10.1002/jctb.280620103
   ALLEN SJ, 1988, ENVIRON POLLUT, V52, P39, DOI 10.1016/0269-7491(88)90106-6
   Arica MY, 2001, BIORESOURCE TECHNOL, V80, P121, DOI 10.1016/S0960-8524(01)00084-0
   Azila YY, 2008, BIORESOURCE TECHNOL, V99, P8549, DOI 10.1016/j.biortech.2008.03.056
   Bar C, 2007, J BIOTECHNOL, V128, P444, DOI 10.1016/j.jbiotec.2006.11.010
   Bayramoglu G, 2003, J HAZARD MATER, V101, P285, DOI 10.1016/S0304-3894(03)00178-X
   Bayramoglu G, 2006, INT J MINER PROCESS, V81, P35, DOI 10.1016/j.minpro.2006.06.002
   Bayramoglu G, 2009, BIORESOURCE TECHNOL, V100, P186, DOI 10.1016/j.biortech.2008.05.050
   Carmona MER, 2005, PROCESS BIOCHEM, V40, P779, DOI 10.1016/j.procbio.2004.02.024
   Chen GQ, 2008, BIORESOURCE TECHNOL, V99, P7034, DOI 10.1016/j.biortech.2008.01.020
   Ertugay N, 2008, J HAZARD MATER, V154, P432, DOI 10.1016/j.jhazmat.2007.10.070
   Ertugay N, 2010, DESALINATION, V255, P137, DOI 10.1016/j.desal.2010.01.002
   Ghorbani F, 2008, CHEM ENG J, V145, P267, DOI 10.1016/j.cej.2008.04.028
   Goksungur Y, 2005, BIORESOURCE TECHNOL, V96, P103, DOI 10.1016/j.biortech.2003.04.002
   Hammaini A, 2007, J ENVIRON MANAGE, V84, P419, DOI 10.1016/j.jenvman.2006.06.015
   Hasan SH, 2009, J HAZARD MATER, V168, P1155, DOI 10.1016/j.jhazmat.2009.02.142
   Hasan SH, 2009, J ENVIRON MANAGE, V90, P3313, DOI 10.1016/j.jenvman.2009.05.005
   Hawari AH, 2007, PROCESS BIOCHEM, V42, P1546, DOI 10.1016/j.procbio.2007.08.009
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Kumar D, 2008, BIORESOURCE TECHNOL, V99, P8280, DOI 10.1016/j.biortech.2008.03.008
   Kumar R, 2008, CHEM ENG J, V135, P202, DOI 10.1016/j.cej.2007.03.004
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   LOUREIRO VJM, 2008, Hazard MAT, V154, P1173
   Lu WB, 2008, J HAZARD MATER, V153, P372, DOI 10.1016/j.jhazmat.2007.08.059
   Mack C, 2007, BIOTECHNOL ADV, V25, P264, DOI 10.1016/j.biotechadv.2007.01.003
   Mahamadi C, 2010, BIORESOURCE TECHNOL, V101, P859, DOI 10.1016/j.biortech.2009.08.097
   Martinez M, 2006, J HAZARD MATER, V133, P203, DOI 10.1016/j.jhazmat.2005.10.030
   Mashitah MD, 2008, BIORESOURCE TECHNOL, V99, P4742, DOI 10.1016/j.biortech.2007.09.062
   Mata YN, 2009, J HAZARD MATER, V163, P555, DOI 10.1016/j.jhazmat.2008.07.015
   Melgar MJ, 2007, SCI TOTAL ENVIRON, V385, P12, DOI 10.1016/j.scitotenv.2007.07.01
   Montgomery D. C., 2001, DESIGN ANAL EXPT, P427
   Najafpour G, 2004, BIORESOURCE TECHNOL, V92, P251, DOI 10.1016/j.biortech.2003.09.009
   Papageorgiou SK, 2009, J HAZARD MATER, V162, P1347, DOI 10.1016/j.jhazmat.2008.06.022
   Rangsayatorn N, 2004, ENVIRON INT, V30, P57, DOI 10.1016/S0160-4120(03)00146-6
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Sahan T, 2010, BIORESOURCE TECHNOL, V101, P4520, DOI 10.1016/j.biortech.2010.01.105
   SARL A, 2009, J HAZARD MATER, V164, P1004
   Say R, 2001, BIORESOURCE TECHNOL, V76, P67, DOI 10.1016/S0960-8524(00)00071-7
   Sheng PX, 2008, CHEM ENG J, V136, P156, DOI 10.1016/j.cej.2007.03.033
   SHI WB, 2006, J HAZARD MAT */* MAT, V134, P80
   Smith J. M., 1970, CHEM ENG KINETICS
   Uslu G, 2006, J HAZARD MATER, V135, P87, DOI 10.1016/j.jhazmat.2005.11.029
   WHO (World Health Organization), 2006, GUID DRINK WAT QUAL
   Wong KK, 2003, CHEMOSPHERE, V50, P23, DOI 10.1016/S0045-6535(02)00598-2
   Yahaya YA, 2009, J HAZARD MATER, V161, P189, DOI 10.1016/j.jhazmat.2008.03.104
NR 46
TC 29
Z9 29
U1 2
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD OCT 15
PY 2010
VL 164
IS 1
BP 183
EP 195
DI 10.1016/j.cej.2010.08.055
PG 13
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 673BR
UT WOS:000283633700024
DA 2018-10-19
ER

PT J
AU Boutry, C
   Blackledge, TA
AF Boutry, Cecilia
   Blackledge, Todd Alan
TI Evolution of supercontraction in spider silk: structure-function
   relationship from tarantulas to orb-weavers
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE spider silk; supercontraction; biomaterials; biomechanics
ID CLAVIPES DRAGLINE SILK; MECHANICAL-PROPERTIES; NEPHILA-CLAVIPES; TENSILE
   PROPERTIES; CAPTURE-SILK; FIBERS; WEB; ARANEAE; PROTEIN; ORIENTATION
AB Spider silk is a promising biomaterial with impressive performance. However, some spider silks also 'supercontract' when exposed to water, shrinking by up to similar to 50% in length. Supercontraction may provide a critical mechanism to tailor silk properties, both for future synthetic silk production and by the spiders themselves. Several hypotheses are proposed for the mechanism and function of supercontraction, but they remain largely untested. In particular, supercontraction may result from a rearrangement of the GPGXX motif within the silk proteins, where G represents glycine, P proline and X is one of a small subset of amino acids. Supercontraction may prevent sagging in wet orb-webs or allow spiders to tailor silk properties for different ecological functions. Because both the molecular structures of silk proteins and how dragline is used in webs differ among species, we can test these hypotheses by comparing supercontraction of silk across diverse spider taxa. In this study we measured supercontraction in 28 spider taxa, ranging from tarantulas to orb-weaving spiders. We found that silk from all species supercontracted, except that of most tarantulas. This suggests that supercontraction evolved at least with the origin of the Araneomorphae, over 200 million years ago. We found differences in the pattern of evolution for two components of supercontraction. Stress generated during supercontraction of a restrained fiber is not associated with changes in silk structure and web architecture. By contrast, the shrink of unrestrained supercontracting fibers is higher for Orbiculariae spiders, whose silk contains high ratios of GPGXX motifs. These results support the hypothesis that supercontraction is caused by a rearrangement of GPGXX motifs in silk, and that it functions to tailor silk material properties.
C1 [Boutry, Cecilia] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
RP Boutry, C (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
EM cb54@zips.uakron.edu
FU National Science Foundation [DEB-0516038, DBI-0521261, IOS-0745379];
   University of Akron
FX We would like to thank the following people for providing spiders or
   giving advice on species to use: T. C. Jones, D. Ubick, C. Hayashi, J.
   Coddington, M. Kuntner, L. Rayor, J. Bond, A. Sensenig, M. Rezac. Chad
   Rooks and Ingi Agnarsson helped with silk collection. Two anonymous
   reviewers provided helpful comments. This research was funded by
   National Science Foundation awards DEB-0516038, DBI-0521261 and
   IOS-0745379 to T. A. B. and a University of Akron Integrated Bioscience
   award to C. B. This is publication no. 26 of the Bath Nature Preserve.
CR Agnarsson I, 2009, ZOOLOGY, V112, P325, DOI 10.1016/j.zool.2008.11.003
   Agnarsson I, 2009, J EXP BIOL, V212, P1989, DOI 10.1242/jeb.028282
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   AYOUB NA, 2007, PLOS ONE, V2, P154
   Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001
   Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Boutry C, 2009, ZOOLOGY, V112, P451, DOI 10.1016/j.zool.2009.03.003
   Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344
   Coddington J. A., 2005, SPIDERS N AM IDENTIF, P18
   CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025
   Eberhard W.G., 2008, SYST BIODIVERS, V6, P1
   Eles PT, 2004, MACROMOLECULES, V37, P1342, DOI 10.1021/ma035567p
   Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179
   GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gellynck K, 2006, WOODH PUBL TEXT, P350
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Grubb DT, 1999, INT J BIOL MACROMOL, V24, P203, DOI 10.1016/S0141-8130(98)00086-5
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Guinea GV, 2005, J EXP ZOOL PART A, V303A, P37, DOI 10.1002/jez.a.111
   Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344
   Guinea GV, 2003, POLYMER, V44, P5785, DOI 10.1016/S0032-3861(03)00625-6
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Jelinski LW, 1999, INT J BIOL MACROMOL, V24, P197, DOI 10.1016/S0141-8130(98)00085-3
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Madsen B, 2000, NATURWISSENSCHAFTEN, V87, P148, DOI 10.1007/s001140050694
   Ohgo K, 2006, BIOMACROMOLECULES, V7, P1210, DOI 10.1021/bm0600522
   PALMER JM, 1985, J MORPHOL, V186, P195, DOI 10.1002/jmor.1051860205
   PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072
   Pouchkina-Stantcheva NN, 2004, COMP BIOCHEM PHYS B, V138, P371, DOI 10.1016/j.cbpc.2004.04.020
   RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1
   Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x
   Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217
   Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225
   Savage KN, 2004, BIOMACROMOLECULES, V5, P675, DOI 10.1021/bm034270w
   Selden PA, 1999, J ARACHNOL, V27, P401
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Swanson BO, 2006, EVOLUTION, V60, P2539
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Tian MZ, 2004, BIOMACROMOLECULES, V5, P657, DOI 10.1021/bm034391w
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
   WORK RW, 1981, J ARACHNOL, V9, P299
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099
NR 64
TC 41
Z9 41
U1 1
U2 31
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
J9 J EXP BIOL
JI J. Exp. Biol.
PD OCT 15
PY 2010
VL 213
IS 20
BP 3505
EP 3514
DI 10.1242/jeb.046110
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 659BK
UT WOS:000282541800014
PM 20889831
OA Bronze
DA 2018-10-19
ER

PT J
AU Alves, A
   Caridade, SG
   Mano, JF
   Sousa, RA
   Reis, RL
AF Alves, Anabela
   Caridade, Sofia G.
   Mano, Joao F.
   Sousa, Rui A.
   Reis, Rui L.
TI Extraction and physico-chemical characterization of a versatile
   biodegradable polysaccharide obtained from green algae
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE Polysaccharide; Extraction; Ulvan; Green algae; Biomaterial; Tissue
   engineering
ID TISSUE ENGINEERING APPLICATIONS; CELL-WALL POLYSACCHARIDES; FIBER-MESH
   SCAFFOLDS; ULVA-RIGIDA ULVALES; SULFATED POLYSACCHARIDES; ACID
   POLYSACCHARIDE; CHEMICAL-STRUCTURE; NMR-SPECTROSCOPY; SORBED WATER;
   CHLOROPHYTA
AB During the last years, considerable attention has been given to different marine organisms, like algae, as potential sources of valuable materials. The continuous demand for novel materials and technologies is high and research on the underexploited marine green algae, including its polysaccharidic part-ulvan, has increased accordingly. In this research work, a novel method for extraction of ulvan from green algae is proposed and demonstrated successfully. Different characterization techniques were employed to characterize the isolated algal polysaccharide, namely, on what concerns its thermal trace and crystallinity. Upon heating, ulvan behaves as a non-meltable polysaccharide that is thermally stable before degradation at 220 degrees C Ulvan is semi-crystalline in nature and possesses high hygroscopic features, as revealed in this research work. Due to its properties, ulvan can be considered, pure or modified, as a versatile biodegradable polymer for different applications, including tissue engineering and regenerative medicine. (C) 2010 Elsevier Ltd. All rights reserved.
C1 Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   PT Associated Lab, IBB, Guimaraes, Portugal.
RP Alves, A (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM anabela.pinto@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Caridade,
   Sofia/P-1925-2015; Mano, Joao/A-4418-2009; Alves, Anabela/C-2729-2011
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129;
   Caridade, Sofia/0000-0002-0448-1871; Mano, Joao/0000-0002-2342-3765;
   Alves, Anabela/0000-0002-6878-0766; Sousa, Rui/0000-0003-0362-7418
FU POCTEP; Fundacao para a Ciencia e Tecnologia [SFRH/BD/39359/2007]
FX This work was partially supported by the POCTEP project IberoMare.;
   Anabela Alves is grateful for the financial support from Fundacao para a
   Ciencia e Tecnologia through SFRH/BD/39359/2007 grant.
CR Aguilera JM, 1998, CARBOHYD POLYM, V37, P79, DOI 10.1016/S0144-8617(98)00030-7
   Arenas JMC, 2002, J NON-CRYST SOLIDS, V307, P758
   BobinDubigeon C, 1997, J SCI FOOD AGR, V73, P149, DOI 10.1002/(SICI)1097-0010(199702)73:2<149::AID-JSFA685>3.0.CO;2-L
   BRADING JWE, 1954, J CHEM SOC, P319, DOI 10.1039/jr9540000319
   Bubb WA, 2003, CONCEPTS MAGN RESO A, V19A, P1, DOI 10.1002/cmr.a.10080
   Chattopadhyay K, 2007, FOOD CHEM, V104, P928, DOI 10.1016/j.foodchem.2006.12.048
   d'Ayala GG, 2008, MOLECULES, V13, P2069, DOI 10.3390/molecules13092069
   Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n
   Fringant C, 1996, INT J BIOL MACROMOL, V18, P281, DOI 10.1016/0141-8130(95)01087-4
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0
   HEIDELBAUGH ND, 1975, J AGR FOOD CHEM, V23, P611, DOI 10.1021/jf60200a006
   Iijima M, 2000, CARBOHYD POLYM, V41, P101, DOI 10.1016/S0144-8617(99)00116-2
   Kaeffer B, 1999, PLANTA MED, V65, P527, DOI 10.1055/s-1999-14009
   Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X
   LAHAYE M, 1993, CARBOHYD POLYM, V22, P261, DOI 10.1016/0144-8617(93)90129-R
   Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mao WJ, 2006, J APPL PHYCOL, V18, P9, DOI 10.1007/s10811-005-9008-4
   Mazeau K, 2004, FOOD HYDROCOLLOID, V18, P885, DOI 10.1016/j.foodhyd.2004.04.004
   MCKINNELL JP, 1962, J CHEM SOC, P2082
   Morelli A, 2010, MACROMOL CHEM PHYS, V211, P821, DOI 10.1002/macp.200900562
   Paradossi G, 1999, INT J BIOL MACROMOL, V25, P309, DOI 10.1016/S0141-8130(99)00049-5
   Parikh A, 2006, BIORESOURCE TECHNOL, V97, P1822, DOI 10.1016/j.biortech.2005.09.008
   PERCIVAL E, 1963, J CHEM SOC, P5459, DOI 10.1039/jr9630005459
   Perdomo J, 2009, CARBOHYD POLYM, V76, P305, DOI 10.1016/j.carbpol.2008.10.023
   RAY B, 1995, CARBOHYD RES, V274, P313, DOI 10.1016/0008-6215(95)00059-3
   RAY B, 1995, CARBOHYD RES, V274, P251, DOI 10.1016/0008-6215(95)00138-J
   Robic A, 2008, CARBOHYD POLYM, V74, P344, DOI 10.1016/j.carbpol.2008.02.020
   Robic A, 2009, CARBOHYD POLYM, V77, P206, DOI 10.1016/j.carbpol.2008.12.023
   Robic A, 2008, J APPL PHYCOL, V21, P451, DOI DOI 10.1007/S10811-008-9390-9
   Royall PG, 2005, INT J PHARM, V301, P181, DOI 10.1016/j.ijpharm.2005.05.015
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   Tsai C.S, 2007, BIOMACROMOLECULES IN
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Villetti MA, 2002, J THERM ANAL CALORIM, V67, P295, DOI 10.1023/A:1013902510952
NR 37
TC 39
Z9 39
U1 3
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
J9 CARBOHYD RES
JI Carbohydr. Res.
PD OCT 13
PY 2010
VL 345
IS 15
BP 2194
EP 2200
DI 10.1016/j.carres.2010.07.039
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 663XG
UT WOS:000282922900011
PM 20800225
DA 2018-10-19
ER

PT J
AU Yang, JM
   Tsai, SC
AF Yang, Jen Ming
   Tsai, Shih Chang
TI Biocompatibility of epoxidized styrene-butadiene-styrene block copolymer
   membrane
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Styrene-butadiene-styrene block copolymer; Epoxidation;
   Biocompatibility; Fibroblasts
ID SBS-G-VP; WATER-VAPOR TRANSMISSION; OXYGEN PERMEATION; BIOMATERIAL
   USAGE; WOUND DRESSINGS; EPOXIDATION; RADIATION; POLYMERS; NONWOVEN; ACID
AB Styrene-butadiene-styrene block copolymer (SBS) membrane was prepared by solution casting method and then was epoxidized with peroxyformic acid generated in situ to yield the epoxidized styrene-butadiene-styrene block copolymer membrane (ESBS). The structure and properties of ESBS were characterized with infrared spectroscopy, Universal Testing Machine, differential scanning calorimetry (DSC), and thermogravimetry analysis (TGA). The performances of contact angle, water content, protein adsorption, and water vapor transmission rate on ESBS membrane were determined. After epoxidation, the hydrophilicity of the membrane increased. The water vapor transmission rate of ESBS membrane is similar to human skin. The biocompatibility of ESBS membrane was evaluated with the cell culture of fibroblasts on the membrane. It revealed that the cells not only remained viable but also proliferated on the surface of the various ESBS membranes and the population doubling time for fibroblast culture decreased. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Yang, Jen Ming; Tsai, Shih Chang] Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
FU National Science Council of the Republic of China; Chang Gung Memorial
   Hospital
FX This work was supported by the National Science Council of the Republic
   of China and partially financially supported by Chang Gung Memorial
   Hospital.
CR Adamson AW, 1990, PHYS CHEM SURFACES
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   CHEN CC, 2000, Patent No. 6022330
   Fan S, 2001, MACROMOLECULES, V34, P645, DOI 10.1021/ma001201q
   Freshney R. I., 2005, CULTURE ANIMAL CELLS, P322
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3363, DOI 10.1002/pola.1990.080281215
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3761, DOI 10.1002/pola.1990.080281319
   HUANG WK, 1988, J POLYM SCI POL CHEM, V26, P1867, DOI 10.1002/pola.1988.080260714
   Lin FH, 2007, MATER CHEM PHYS, V102, P152, DOI 10.1016/j.matchemphys.2006.11.017
   Lin FH, 2000, MATER CHEM PHYS, V64, P189, DOI 10.1016/S0254-0584(99)00262-X
   LUDA MP, 1992, MAKROMOL CHEM, V193, P113
   Minoura F. N., 1993, BIOMEDICAL APPL POLY, P118
   Serrano E, 2004, POLYM DEGRAD STABIL, V83, P495, DOI 10.1016/j.polymdegradstab.2003.08.009
   UDIPI K, 1979, J APPL POLYM SCI, V23, P3311, DOI 10.1002/app.1979.070231117
   UDIPI K, 1979, J APPL POLYM SCI, V23, P3301, DOI 10.1002/app.1979.070231116
   Wang CC, 2009, MAT SCI ENG C-BIO S, V29, P1715, DOI 10.1016/j.msec.2009.01.020
   Wang SM, 1996, J POLYM SCI POL CHEM, V34, P1483
   WINKLER DE, 1971, Patent No. 3555112
   Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yang JM, 2008, MAT SCI ENG C-BIO S, V28, P150, DOI 10.1016/j.msec.2007.01.011
   YANG JM, 1991, MACROMOLECULES, V24, P4010, DOI 10.1021/ma00014a007
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 31
TC 16
Z9 16
U1 3
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 12
PY 2010
VL 30
IS 8
BP 1151
EP 1156
DI 10.1016/j.msec.2010.06.014
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 663RK
UT WOS:000282905600011
DA 2018-10-19
ER

PT J
AU Wan, P
   Ren, YB
   Zhang, BC
   Yang, K
AF Wan, Peng
   Ren, Yibin
   Zhang, Bingchun
   Yang, Ke
TI Effect of nitrogen on blood compatibility of nickel-free high nitrogen
   stainless steel for biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE High nitrogen stainless steel; Nickel-free; Blood compatibility; Surface
   property
ID PARTIALLY-STABILIZED ZIRCONIA; IN-VITRO; SURFACE; WETTABILITY;
   ADSORPTION; ALLOYS; ENERGY
AB The aim of this paper was to study the effect of nitrogen content on blood compatibility including platelet adhesion and kinetic clotting time of nickel-free high nitrogen stainless steel (HNS), also in comparison with a conventional austenitic stainless steel AISI 317L. X-ray photoelectron spectroscopy (XPS) was used to analyze the surface chemical composition. The surface wettability and surface free energy (SFE) of these materials were characterized by water contact angle (WCA) measurement to analysis the relationship between surface properties and blood compatibility. Kinetic clotting time was used to evaluate the blood coagulation for these materials and platelet adhesion was assessed by scanning electron microscopy (SEM). The results showed that more platelets adhered on the surface of 317L stainless steel than that on HNS, and with the increase of nitrogen content, the amount of adherent platelets was further decreased on the surface of HNS. Kinetic clotting time results also showed the increased nitrogen content extended the initial clotting time of HNS. The results of surface properties also explained the effect of nitrogen on blood compatibility by traditional theory of SFE and interfacial energy. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wan, Peng; Ren, Yibin; Zhang, Bingchun; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   [Wan, Peng] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China.
RP Ren, YB (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
EM ybren@imr.ac.cn
RI ren, yibin/M-5508-2014
OI ren, yibin/0000-0002-5422-761X
FU National Natural Science Foundation of China [50534010]; Chinese Academy
   of Science [KGCX2-YW-207]
FX This work was financially supported by a fund from the National Natural
   Science Foundation of China (No. 50534010) and a fund from the Chinese
   Academy of Science (No. KGCX2-YW-207).
CR Andrade J D, 1973, Med Instrum, V7, P110
   BACHELET GB, 1982, PHYS REV B, V26, P4199, DOI 10.1103/PhysRevB.26.4199
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Di Schino A, 2000, J MATER SCI, V35, P375, DOI 10.1023/A:1004774130483
   Di Schino A., 1999, P 20 SAMPE INT C PAR, P175
   Fini M, 2004, J BIOMED MATER RES B, V71B, P30, DOI 10.1002/jbm.b.30068
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   FORBES CD, 1994, THROMBOSIS ARTIFICIA
   Gavriljuk VG, 2000, ACTA MATER, V48, P3879, DOI 10.1016/S1359-6454(00)00192-0
   Gavriljuk VG, 1999, HIGH NITROGEN STEELS, P1
   GOODMAN SL, 1984, SEM 1984, V1, P279
   Gu H. Q., 1993, BIOMEDICAL MAT
   Hao L, 2004, COLLOID SURFACE B, V34, P87, DOI 10.1016/j.colsurfb.2003.12.008
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   KAEBLE DH, 1977, POLYMER, V18, P475
   Kim S.J., 2006, ICASS 2006, P594
   Montanaro L, 2006, J MATER SCI-MATER M, V17, P267, DOI 10.1007/s10856-006-7313-3
   Montanaro L, 2005, INT J ARTIF ORGANS, V28, P58
   NAKAJIMA H, 1970, T JPN I MET, V19, P400
   NYILAS E, 1977, J BIOMED MATER RES S, V8, P51
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   RATNER BD, 1982, ACS SYM SER, V199, P9
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Ren YB, 2005, MATER LETT, V59, P1785, DOI 10.1016/j.matlet.2005.01.067
   Seith W., 1955, DIFFUSION METALLEN P
   Speidel HJC, 1999, MATER SCI FORUM, V318-3, P241, DOI 10.4028/www.scientific.net/MSF.318-320.241
   Stein G, 1995, INT J MATER PROD TEC, V10, P290
   XI TF, 1988, T 3 WORLD BIOM C JAP, P32
   Yamamoto A, 2004, MAT SCI ENG C-BIO S, V24, P737, DOI 10.1016/j.msec.2004.08.017
   Yuan Y, 2008, J MATER SCI-MATER M, V19, P2187, DOI 10.1007/s10856-007-3319-8
   ZHAO GL, 1986, BIOMATERIAL
NR 32
TC 22
Z9 24
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 12
PY 2010
VL 30
IS 8
BP 1183
EP 1189
DI 10.1016/j.msec.2010.06.015
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 663RK
UT WOS:000282905600016
DA 2018-10-19
ER

PT J
AU Meyer, M
   Baltzer, H
   Schwikal, K
AF Meyer, M.
   Baltzer, H.
   Schwikal, K.
TI Collagen fibres by thermoplastic and wet spinning
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Collagen; Fibre; Melt extrusion; Wet spinning
ID BIOMEDICAL APPLICATIONS; BIOMATERIAL
AB Collagen threads of high yardage were manufactured by two different techniques being wet spinning of collagen dispersions and melt spinning of thermoplastic collagen. The fibres were characterised according to their structural, textile physical and biochemical properties. The wet spun fibres showed higher physical stability than the thermoplastic spun ones. Both fibre types were cross linked with different agents (formaldehyde, glutaraldehyde, and 1-ethy1-3-(3-dimethylaminopropyl)carbodiimid (EDC)) to increase mechanical stability as well as to lower susceptibility against enzymatic attack. Fibres cross linked by 0.1% glutaraldehyde as well as non cross linked fibres showed no cytotoxic effect against mouse fibroblasts. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Meyer, M.; Baltzer, H.] Forschungsinst Leder & Kunststoffbahnen, D-09599 Freiberg, Germany.
   [Schwikal, K.] Thuring Inst Text & Kunststoff Forsch eV, D-07407 Rudolstadt, Germany.
RP Meyer, M (reprint author), Forschungsinst Leder & Kunststoffbahnen, Meissner Ring 1-5, D-09599 Freiberg, Germany.
EM michael.meyer@filkfreiberg.de
RI Meyer, Michael/A-6227-2016
OI Meyer, Michael/0000-0003-2934-9962
FU German Ministry of Economy
FX We thank Oliver Kotlarski for the preparation of thermoplastic collagen
   and his important share in melt extrusion. The German Ministry of
   Economy is gratefully acknowledged for financial support.
CR AALBERSBERG WY, 2003, IND PROTEINS PERSPEC, V23
   AHERN TJ, 1992, CHEM PHYS PATHWAYS A
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   BIENKIEWICZ K, 1984, LEDER SCHUHE LEDERWA, V6, P278
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   CHANUKOV LA, 1976, SOWJETISCHE BEITRAGE, V16, P193
   CHU CC, 1981, ANN SURG, V193, P365, DOI 10.1097/00000658-198103000-00021
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   HEIDEMAN E, 1974, DAS LEDER, V25, P190
   Krochta J. M., 2002, PROTEIN BASED FILMS
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Maxwell CA, 2006, BIOMACROMOLECULES, V7, P2321, DOI 10.1021/bm060250t
   Meyer M, 2005, POLYM DEGRAD STABIL, V87, P137, DOI 10.1016/j.polymdegradstab.2004.07.015
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Purslow PP, 1998, J EXP BIOL, V201, P135
   SCHIMPF WC, 1977, IND ENG CHEM PROD RD, V16, P90, DOI 10.1021/i360061a018
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   VASILEV MP, 1972, KHIMICHESKIE VOLOKNA, V1, P34
   Zeugolis DI, 2008, J APPL POLYM SCI, V108, P2886, DOI 10.1002/app.27208
   Zeugolis DI, 2008, ACTA BIOMATER, V4, P1646, DOI 10.1016/j.actbio.2008.05.015
   Zeugolis D I, 2007, J BIOMED MATER RES B, V85, P343
   Zeugolis DI., 2008, J BIOMED MATER RES A, V89A, P895
NR 23
TC 24
Z9 25
U1 0
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 12
PY 2010
VL 30
IS 8
BP 1266
EP 1271
DI 10.1016/j.msec.2010.07.005
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 663RK
UT WOS:000282905600027
DA 2018-10-19
ER

PT J
AU Li, JF
   Lin, ZY
   Zheng, QX
   Guo, XD
   Lan, SH
   Liu, SA
   Yang, SH
AF Li, Jingfeng
   Lin, Zhenyu
   Zheng, Qixin
   Guo, Xiaodong
   Lan, Shenghui
   Liu, Sunan
   Yang, Shuhua
TI Repair of rabbit radial bone defects using true bone ceramics combined
   with BMP-2-related peptide and type I collagen
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Synthetic peptide; BMP-2; True bone ceramics; Type I collagen;
   Hydroxylapatite crystal; Bone regeneration
ID MARROW STROMAL CELLS; MINERALIZED COLLAGEN; BIOINSPIRED GROWTH; BMP-2;
   HYDROXYAPATITE; MATRIX; PHOSPHATE; MODEL; VITRO; OSTEOINDUCTION
AB An ideal bone graft material is the one characterized with good biocompatibility, biodegradation, osteoconductivity and osteoinductivity. In this study, a novel synthetic BMP-2-related peptide (designated P24) corresponding to residues of the knuckle epitope of BMP-2 was introduced into a biomimetic scaffold based on sintered bovine bone or true bone ceramics (TBC) and type I collagen (TBC/collagen I) using a simulated body fluid (SBF). Hydroxylapatite crystal mineralization with a Ca/P molar ratio of 1.63 was observed on the surface of P24/TBC/collagen I composite by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX) and X-ray diffraction (XRD) techniques. Cell adhesion rate evaluation of bone marrow stromal cells (BMSCs) seeded on materials in vitro showed that the percentage of cells attached to P24/TBC/collagen I composite was significantly higher than that of the TBC/collagen I composite. A 10 mm unilateral segmental bone defect was created in the radius of New Zealand white rabbits and randomly implanted with three groups of biomaterials (Group A: P24/TBC/collagen I composite; Group B: TBC/collagen I composite and Group C: TBC alone). Based on radiographic evaluation and histological examination, the implants of P24/TBC/collagen I composite significantly stimulated bone growth, thereby confirming the enhanced rate of bone healing compared with that of TBC/collagen I composite and TBC alone. It was concluded that BMP-2-related peptide P24 could induce nucleation of calcium phosphate crystals on the surface of TBC/collagen I composite. The TBC/collagen I composite loaded with the synthetic BMP-2-related peptide is a promising scaffold biomaterial for bone tissue engineering. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Li, Jingfeng; Lin, Zhenyu; Zheng, Qixin; Guo, Xiaodong; Lan, Shenghui; Liu, Sunan; Yang, Shuhua] Huazhong Univ Sci & Technol, Dept Orthopaed, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
RP Zheng, QX (reprint author), Huazhong Univ Sci & Technol, Dept Orthopaed, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
EM zheng-qx@163.com; gxdwh@yahoo.com.cn
RI guo, xiaodong/K-2600-2013
FU "863" Key Project of the National High Technology Research and
   Development Program of China [2006AA02A124]; Ministry of Education of
   China [NCET-05-0647]; National Natural Sciences Foundation of China
   [30973027]
FX This work was financially supported by the "863" Key Project of the
   National High Technology Research and Development Program of China
   (Grant No. 2006AA02A124), the Program for New Century Excellent Talents
   in University from the Ministry of Education of China (NCET-05-0647),
   and the National Natural Sciences Foundation of China (No. 30973027).
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Asashina I, 1997, J MED DENT SCI, V44, P63
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CHYUN YY, 1994, CLIN ORTHOP RELAT R, V298, P286
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Duan ZX, 2007, J HUAZHONG UNIV SCI, V27, P179, DOI 10.1007/s11596-007-0219-6
   Duan ZX, 2008, J HUAZHONG U SCI-MED, V28, P426, DOI 10.1007/s11596-008-0411-3
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Herliansyah MK, 2009, MAT SCI ENG C-BIO S, V29, P1674, DOI 10.1016/j.msec.2009.01.007
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Jayasuriya AC, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015003
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   KINGSBURY GH, 1963, J BONE JOINT SURG AM, V45, P1593
   Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   Knaus P, 2001, BIOL CHEM, V382, P1189, DOI 10.1515/BC.2001.149
   Lawson AC, 1998, P I MECH ENG H, V212, P413, DOI 10.1243/0954411981534187
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   Liao SS, 2004, J BIOACT COMPAT POL, V19, P117, DOI 10.1177/0883911504042643
   Lin XH, 2005, J BONE MINER RES, V20, P693, DOI 10.1359/JBMR.041104
   Madurantakam PA, 2009, BIOMATERIALS, V30, P5456, DOI 10.1016/j.biomaterials.2009.06.043
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Ozturk A, 2006, INT ORTHOP, V30, P147, DOI 10.1007/s00264-006-0079-x
   Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REDDI AH, 2001, J BONE JOINT SURG, V83, P51
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Santin M, 1998, J BIOMED MATER RES, V40, P434, DOI 10.1002/(SICI)1097-4636(19980605)40:3<434::AID-JBM14>3.0.CO;2-J
   Schilephake H., 2002, INT J ORAL MAXILLOF, V31, P469, DOI DOI 10.1054/IJOM.2002.0244
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Srouji S, 2006, REGEN MED, V1, P519, DOI 10.2217/17460751.1.4.519
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Villavicencio AT, 2005, J NEUROSURG-SPINE, V3, P436, DOI 10.3171/spi.2005.3.6.0436
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Yuan Q, 2007, KEY ENG MATER, V334-335, P1261, DOI 10.4028/www.scientific.net/KEM.334-335.1261
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
NR 44
TC 24
Z9 26
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 12
PY 2010
VL 30
IS 8
BP 1272
EP 1279
DI 10.1016/j.msec.2010.07.011
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 663RK
UT WOS:000282905600028
DA 2018-10-19
ER

PT J
AU Song, L
   Hu, W
   Wang, GJ
   Niu, GG
   Zhang, HB
   Cao, H
   Wang, KJ
   Yang, HA
   Zhu, SQ
AF Song, Li
   Hu, Wang
   Wang, Guojie
   Niu, Guoguang
   Zhang, Hongbin
   Cao, Hui
   Wang, Kaijie
   Yang, Huai
   Zhu, Siquan
TI Tailored (Meth)Acrylate Shape-Memory Polymer Networks for Ophthalmic
   Applications
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; biological applications of polymers; crosslinking;
   mechanical properties; transparency
ID INTRAOCULAR-LENS MATERIALS; THERMOMECHANICAL PROPERTIES; VOLUME
   RELAXATION; CENTRATION; KINETICS
AB The unique features of shape-memory polymers enables their use in minimally invasive surgical procedures with a compact starting material switching over to a voluminous structure in vivo. In this work, a series of transparent, thermoset (meth)acrylate shape-memory polymer networks with tailored thermomechanics have been synthesized and evaluated. Fundamental trends were established for the effect of the crosslinker content and crosslinker molecular weight on glass transition temperature, rubbery modulus and shape-recovery behavior, and the results are intended to help with future shape-memory device design. The prepared (meth)acrylate networks with high transparency and favorable biocompatibility are presented as a promising shape-memory ophthalmic biomaterial.
C1 [Song, Li; Hu, Wang; Wang, Guojie; Niu, Guoguang; Zhang, Hongbin; Cao, Hui; Yang, Huai] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Wang, Kaijie; Zhu, Siquan] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100730, Peoples R China.
RP Wang, GJ (reprint author), Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
EM guojie.wang@mater.ustb.edu.cn; yanghuai@mater.ustb.edu.cn;
   siquanzhu@sina.com
RI Niu, Guoguang/F-9929-2014; Yang, Huai/H-9802-2014
OI Niu, Guoguang/0000-0002-1686-4116
FU Key Program for Panel Display of 863 Program of China [2008AA03A318];
   National Natural Science Foundation [50973010]; National Key Technology
   Program [2007BAE31B00]; Scientific Plan of Beijing City
   [D090803044209001]; Beijing Natural Science Foundation [2102021]
FX This work was financially supported by the Key Program for Panel Display
   of 863 Program of China (Grant No. 2008AA03A318), the National Natural
   Science Foundation (Grant No. 50973010), the National Key Technology
   Program (Grant No. 2007BAE31B00), the Fund of Scientific Plan of Beijing
   City (Grant No. D090803044209001) and the Beijing Natural Science
   Foundation (Grant No. 2102021).
CR Amon M, 2001, J CATARACT REFR SURG, V27, P178, DOI 10.1016/S0886-3350(01)00742-8
   ANSETH KS, 1995, MACROMOLECULES, V28, P2491, DOI 10.1021/ma00111a050
   ANSETH KS, 1994, J POLYM SCI POL CHEM, V32, P139, DOI 10.1002/pola.1994.080320116
   ANSETH KS, 1994, CHEM ENG SCI, V49, P2207, DOI 10.1016/0009-2509(94)E0055-U
   APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9
   Assia EI, 1999, J CATARACT REFR SURG, V25, P347, DOI 10.1016/S0886-3350(99)80082-0
   Chen MC, 2009, BIOMATERIALS, V30, P79, DOI 10.1016/j.biomaterials.2008.09.006
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   COLVARD DM, 1990, J CATARACT REFR SURG, V16, P312, DOI 10.1016/S0886-3350(13)80700-6
   Cunanan CM, 1998, J CATARACT REFR SURG, V24, P341, DOI 10.1016/S0886-3350(98)80322-2
   CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   HAYASHI S, 1995, PLAST ENG, V51, P29
   Hayashi S., 1993, INT PROGR URETHANES, V6, P90
   Hettlich H J, 1992, Ger J Ophthalmol, V1, P346
   HOSAKA S, 1980, J BIOMED MATER RES, V14, P557, DOI 10.1002/jbm.820140503
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, Med Device Technol, V16, P12
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Lovell LG, 2003, POLYMER, V44, P39, DOI 10.1016/S0032-3861(02)00737-1
   Merline JD, 2007, EUR POLYM J, V43, P3629, DOI 10.1016/j.eurpolymj.2007.05.032
   Neuss S, 2009, BIOMATERIALS, V30, P1697, DOI 10.1016/j.biomaterials.2008.12.027
   Ortega AM, 2008, J APPL POLYM SCI, V110, P1559, DOI 10.1002/app.28732
   Ping P, 2007, J POLYM SCI POL PHYS, V45, P557, DOI 10.1002/polb.20974
   Safranski DL, 2008, POLYMER, V49, P4446, DOI 10.1016/j.polymer.2008.07.060
   Seymour R. B., 1984, STRUCTURE PROPERTY R
   Small W, 2007, IEEE T BIO-MED ENG, V54, P1157, DOI 10.1109/TBME.2006.889771
   Sokolowski W, 2007, BIOMED MATER, V2, pS23, DOI 10.1088/1748-6041/2/1/S04
   Swindle KE, 2008, J BIOMED MATER RES A, V87A, P656, DOI 10.1002/jbm.a.31769
   Tehrani M, 2004, OPHTHALMOLOGICA, V218, P57, DOI 10.1159/000074568
   TUCCI V, 1995, P ANTEC 95, P2102
   VERSURA P, 1992, J CATARACT REFR SURG, V18, P58, DOI 10.1016/S0886-3350(13)80384-7
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wheatley DJ, 2000, EUR J CARDIO-THORAC, V17, P440, DOI 10.1016/S1010-7940(00)00381-X
   Yakacki CM, 2008, ADV FUNCT MATER, V18, P2428, DOI 10.1002/adfm.200701049
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
   Yang TF, 2007, BIOMATERIALS, V28, P725, DOI 10.1016/j.biomaterials.2006.09.035
NR 36
TC 14
Z9 14
U1 1
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD OCT 8
PY 2010
VL 10
IS 10
BP 1194
EP 1202
DI 10.1002/mabi.201000028
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 667OH
UT WOS:000283202900009
PM 20625994
DA 2018-10-19
ER

PT J
AU Ku, SH
   Lee, JS
   Park, CB
AF Ku, Soak Hee
   Lee, Joan Seok
   Park, Chan Beum
TI Spatial Control of Cell Adhesion and Patterning through Mussel-Inspired
   Surface Modification by Polydopamine
SO LANGMUIR
LA English
DT Article
ID THIN-FILMS; GROWTH; CHEMISTRY; DOPAMINE; CULTURE; ASSAYS
AB The spatial control and patterning of mammalian cells were achieved by using the universal adhesive property of mussel-inspired polydopamine (FDA). The self-polymerization of dopamine, a small molecule inspired by the DOPA motif of mussel foot proteins, resulted in the formation of a PDA adlayer when aqueous dopamine solution was continuously injected into poly(dimethylsiloxane) microchannels. We found that various cells (fibrosarcoma mouse preostcoblast MC3T3-EI, and mouse fibroblast NIH-3T3) predominantly adhered to PDA-modified regions, maintaining their normal morphologies. The cells aligned in the direction of striped FDA patterns, and this tendency was not limited by the type of cell line. Because FDA modification does not require complex chemical reactions and is applicable to any type of material, it enables cell patterning in a simple and versatile manner as opposed to conventional methods based on the immobilization of adhesive proteins. The FDA-based method of cell patterning should be useful in many biomaterial research areas such as the fabrication of tissue engineering scaffolds, cell-based devices for drug screening, and the fundamental study of cell material interactions.
C1 [Ku, Soak Hee; Lee, Joan Seok; Park, Chan Beum] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, KAIST Inst BioCentury, Taejon 305701, South Korea.
RP Park, CB (reprint author), Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, KAIST Inst BioCentury, 335 Sci Rd, Taejon 305701, South Korea.
EM parkcb@kaist.ac.kr
RI Lee, Joonseok/E-5695-2013; Park, Chan Beum/C-1651-2011
OI Lee, Joonseok/0000-0001-9551-6402; 
FU National Research Foundation (NRF) via National Research Laboratory
   (NRL) [R0A-2008-000-20041-0]; Converging Research Center [2009-0082276];
   Engineering Research Center [2008-0062205]; Republic of Korea
   [20070301034038]
FX This study was supported by the National Research Foundation (NRF) via
   National Research Laboratory (NRL) (R0A-2008-000-20041-0), Converging
   Research Center (2009-0082276), and Engineering Research Center
   (2008-0062205) programs. This research was also partially supported by
   the BioGreen 21 program (20070301034038), Republic of Korea.
CR ACHYUTA AKH, 2009, LANGMUIR, P4160
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Ceriotti L, 2009, SOFT MATTER, V5, P1406, DOI 10.1039/b814616k
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Chen C, 2009, BIOSENS BIOELECTRON, V24, P2726, DOI 10.1016/j.bios.2008.12.016
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fei B., 2008, CARBON, V46, P1792
   Hatakeyama H, 2007, BIOMATERIALS, V28, P3632, DOI 10.1016/j.biomaterials.2007.04.019
   Jain T, 2007, LAB CHIP, V7, P1004, DOI 10.1039/b707479d
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Johann RM, 2007, BIOMED MICRODEVICES, V9, P475, DOI 10.1007/s10544-007-9054-6
   Kang SM, 2009, J AM CHEM SOC, V131, P13224, DOI 10.1021/ja905183k
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   Lee H, 2008, ADV MATER, V21, P431
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee JS, 2008, LANGMUIR, V24, P7068, DOI 10.1021/la800907c
   Lee JS, 2009, ANAL CHEM, V81, P2751, DOI 10.1021/ac802701z
   Li YL, 2006, THIN SOLID FILMS, V497, P270, DOI 10.1016/j.tsf.2005.10.048
   Liu WF, 2007, ADV DRUG DELIVER REV, V59, P1319, DOI 10.1016/j.addr.2007.08.011
   Matsuda T, 1996, J BIOMED MATER RES, V32, P165
   Nair RR, 2008, MOL PHARMACOL, V73, P919, DOI 10.1124/mol.107.042606
   Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2
   Patrito N, 2007, LANGMUIR, V23, P715, DOI 10.1021/la062007l
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   SMITH AL, 1984, APPL SPECTROSC, V38, P822, DOI 10.1366/0003702844554549
   Takahashi H, 2008, ADV FUNCT MATER, V18, P2079, DOI 10.1002/adfm.200800105
   Tan YM, 2010, J PHYS CHEM B, V114, P5016, DOI 10.1021/jp100922t
   Thompson DM, 2004, ANN BIOMED ENG, V32, P1120
   Thompson DM, 2001, TISSUE ENG, V7, P247, DOI 10.1089/10763270152044125
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yu ZTF, 2009, BIOMED MICRODEVICES, V11, P547, DOI 10.1007/s10544-008-9260-x
NR 36
TC 130
Z9 131
U1 8
U2 142
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 5
PY 2010
VL 26
IS 19
BP 15104
EP 15108
DI 10.1021/la102825p
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 654BI
UT WOS:000282142700009
PM 20806924
DA 2018-10-19
ER

PT J
AU Chandler-Temple, AF
   Wentrup-Byrne, E
   Griesser, HJ
   Jasieniak, M
   Whittaker, AK
   Grondahl, L
AF Chandler-Temple, Adrienne F.
   Wentrup-Byrne, Edeline
   Griesser, Hans J.
   Jasieniak, Marek
   Whittaker, Andrew K.
   Grondahl, Lisbeth
TI Comprehensive Characterization of Grafted Expanded
   Poly(tetrafluoroethylene) for Medical Applications
SO LANGMUIR
LA English
DT Article
ID ACRYLIC-ACID; POLYPROPYLENE MONOFILAMENT; BIOMEDICAL APPLICATIONS;
   BIOMATERIAL INTERFACE; POLYMER SURFACES; MEMBRANES; PHOSPHATE;
   POLYSTYRENE; COPOLYMERS; POLYTETRAFLUOROETHYLENE
AB Successful implantation of any biomaterial depends on its mechanical, architectural, and surface properties. Materials with good bulk properties seldom possess the appropriate surface characteristics required or good biointegration. The present study investigates the results of surface modification of a highly porous, fully fluorinated polymeric substrate, expanded poly(tetrafluoroethylene)(ePTFE), with a view to improving the surface bioactivity and hence ultimately its biointegration. Modification involved gamma irradiation-induced graft copolymerization with the monomers monoacryloxyethyl phosphate (MAEP) and methacryloxyethyl phosphate (MOEP) in various solvent systems (water, methanol, methyl ethyl ketone, and mixtures thereof). In order to determine the penetration depth of the graft copolymer into the pores and/or the bulk of the ePTFE membranes, angle-dependent X-ray photoelectron spectroscopy (XPS) and magnetic resonance imaging (M RI) were used. It was found that the penetration depth was critically affected by the choice of monomer and solvent as well as by the technique used to remove dissolved oxygen from the grafting mixture: nitrogen degassing versus vacuum. Difficulties due to the porous nature of the membranes in establishing the lateral position of the graft copolymers were largely overcome by combining data from microattenuated total reflectance Fourier transfer infrared (mu-ATR-FTIR) mapping and time-of-flight secondary ion mass spectrometry (ToF-SIMS) imaging. Results show that the large variation in graft heterogeneity found between different samples is largely an effect of the underlying substrate and choice of monomer. The results from this study provide the necessary knowledge and experimental data to control both the graft copolymer lateral position and depth of penetration in these porous ePTFE membranes.
C1 [Chandler-Temple, Adrienne F.; Grondahl, Lisbeth] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
   [Wentrup-Byrne, Edeline] Queensland Univ Technol, Tissue Repair & Regenerat Program, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Griesser, Hans J.; Jasieniak, Marek] Univ S Australia, Ian Work Res Inst, Mawson Lakes, SA 5095, Australia.
   [Chandler-Temple, Adrienne F.; Whittaker, Andrew K.] Univ Queensland, Ctr Adv Imaging & Australian, Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
RP Grondahl, L (reprint author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
RI Griesser, Hans/E-5628-2011; Whittaker, Andrew/E-6172-2011
OI Griesser, Hans/0000-0003-1072-7863; Whittaker,
   Andrew/0000-0002-1948-8355; Grondahl, Lisbeth/0000-0001-6012-9808
FU School of Molecular and Microbial Sciences (UQ)
FX Part of this work was funded by a School of Molecular and Microbial
   Sciences (UQ) Chemistry Alumni Fellowship (A.F.C.-T.). The authors thank
   Dr. Llew Rintoul, Coordinator of Vibrational Spectroscopy at Queensland
   University of Technology, and Dr. Barry Wood from the Centre for
   Microscopy and Microanalysis at the University of Queensland for their
   assistance with infrared and X-ray photoelectron spectroscopy,
   respectively.
CR Beamson G., 1992, SCI ESCA300 DATABASE
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   Briggs D., 1998, SURFACE ANAL POLYM X
   Cardona F, 2002, J POLYM SCI POL CHEM, V40, P3191, DOI 10.1002/pola.10409
   Cardona F, 2002, MACROMOLECULES, V35, P355, DOI 10.1021/ma0022295
   Chan KLA, 2003, APPL SPECTROSC, V57, P381, DOI 10.1366/00037020360625907
   Chandler-Temple A, 2010, J APPL POLYM SCI, V117, P3331, DOI 10.1002/app.31242
   COSTELLO CA, 1987, MACROMOLECULES, V20, P2819, DOI 10.1021/ma00177a030
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dargaville TR, 2003, PROG POLYM SCI, V28, P1355, DOI 10.1016/S0079-6700(03)00047-9
   Feng D, 2007, J MACROMOL SCI A, V44, P1141, DOI 10.1080/10601320701561015
   GORE WL, 2002, PRODUCTS HEAD NECK
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Grondahl L, 2003, J MATER SCI-MATER M, V14, P503, DOI 10.1023/A:1023403929496
   Grondahl L, 2002, J APPL POLYM SCI, V86, P2550, DOI 10.1002/app.11177
   Gupta B, 2006, RADIAT PHYS CHEM, V75, P161, DOI 10.1016/j.radphyschem.2005.04.003
   GUPTA B, 1994, POLYM ADVAN TECHNOL, V5, P493
   Gupta B, 2008, J APPL POLYM SCI, V107, P324, DOI 10.1002/app.26745
   HEGAZY ESA, 1992, J POLYM SCI POL CHEM, V30, P1969, DOI 10.1002/pola.1992.080300920
   HEGAZY ESA, 1981, J APPL POLYM SCI, V26, P3871, DOI 10.1002/app.1981.070261132
   Hietala S, 1999, J POLYM SCI POL CHEM, V37, P1741, DOI 10.1002/(SICI)1099-0518(19990615)37:12<1741::AID-POLA3>3.0.CO;2-5
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Irwan GS, 2003, J APPL POLYM SCI, V87, P458, DOI 10.1002/app.11403
   Keen I, 2002, MACROMOL SYMP, V184, P287, DOI 10.1002/1521-3900(200208)184:1<287::AID-MASY287>3.0.CO;2-Y
   Keen I, 2001, APPL SPECTROSC, V55, P984, DOI 10.1366/0003702011953126
   LIANG CY, 1956, J CHEM PHYS, V25, P563, DOI 10.1063/1.1742964
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   MUKHERJEE AK, 1985, J APPL POLYM SCI, V30, P265
   Paynter RW, 2007, SURF INTERFACE ANAL, V39, P445, DOI 10.1002/sia.2538
   Schmidt C, 2007, CHEM MATER, V19, P4277, DOI 10.1021/cm070174g
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Spelt J. K., 2000, APPARENT MICROSCOPIC
   Suzuki S, 2005, BIOMATERIALS, V26, P5303, DOI 10.1016/j.biomaterilas.2005.01.061
   VANOS MT, 1999, PLASMA DEPOSITION TR
   Wentrup-Byrne E, 2005, POLYM INT, V54, P1581, DOI 10.1002/pi.1902
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yang P, 2005, ANAL CHEM, V77, P1068, DOI 10.1021/ac048869d
NR 37
TC 16
Z9 16
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 5
PY 2010
VL 26
IS 19
BP 15409
EP 15417
DI 10.1021/la1010677
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 654BI
UT WOS:000282142700048
PM 20812688
DA 2018-10-19
ER

PT J
AU Gil, ES
   Park, SH
   Tien, LW
   Trimmer, B
   Hudson, SM
   Kaplan, DL
AF Gil, Eun Seok
   Park, Sang-Hyug
   Tien, Lee W.
   Trimmer, Barry
   Hudson, Samuel M.
   Kaplan, David L.
TI Mechanically Robust, Rapidly Actuating, and Biologically Functionalized
   Macroporous Poly(N-isopropylacrylamide)/Silk Hybrid Hydrogels
SO LANGMUIR
LA English
DT Article
ID SILK FIBROIN; POLYMER GELS; SCAFFOLDS; NETWORKS; KINETICS; FILMS;
   EMBOLIZATION; CHONDROCYTES; BIOMATERIAL; MORPHOLOGY
AB A route toward mechanically robust, rapidly actuating, and biologically functionalized polymeric actuators using macroporous soft materials is described. The materials were prepared by combining silk protein and a synthetic polymer (poly(N-isopropylacrylamide) (PNIAPPm)) to form interpenetrating network materials and macroporous structures by freeze-drying, with hundreds of micrometer diameter pores and exploiting the features of both polymers related to dynamic materials and structures. The chemically cross-linked PNIPAAm networks provided stimuli-responsive features, while the silk interpenetrating network formed by inducing protein beta-sheet crystallinity in situ for physical cross-links provided material robustness, improved expansion force, and enzymatic degradability. The macroporous hybrid hydrogels showed enhanced thermal-responsive properties in comparison to pure PNIPAAm hydrogels, nonporous silk/pNIPAAm hybrid hydrogels, and previously reported macroporous PNIPAAm hydrogels. These new systems reach near equilibrium sizes in shrunken/swollen states in less than 1 min, with the structural features providing improved actuation rates and stable oscillatory properties due to the macroporous transport and the mechanically robust silk network. Confocal images of the hydrated hydrogels around the lower critical solution temperature (LCST) revealed macropores that could be used to track changes in the real time morphology upon thermal stimulus. The material system transformed from a microporous to a nonporous structure upon enzymatic degradation. To extend the utility of the system, an affinity platform for a switchable or tunable system was developed by immobilizing biotin and avidin on the macropore surfaces.
C1 [Gil, Eun Seok; Park, Sang-Hyug; Tien, Lee W.; Trimmer, Barry; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Trimmer, Barry] Tufts Univ, Dept Biol, Medford, MA 02155 USA.
   [Hudson, Samuel M.] N Carolina State Univ, Fiber & Polymer Sci Program, Raleigh, NC 27695 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU AFOSR; DARPA
FX We thank the AFOSR and DARPA for support of this work.
CR Antonietti M, 1999, MACROMOLECULES, V32, P1383, DOI 10.1021/ma9812478
   Basheer C, 2005, CHEM COMMUN, P409, DOI 10.1039/b414429e
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   BENNETT DJ, 1995, POLYM INT, V36, P219, DOI 10.1002/pi.1995.210360301
   Dainiak MB, 2006, P NATL ACAD SCI USA, V103, P849, DOI 10.1073/pnas.0508432103
   Diez-Pena E, 2002, POLYMER, V43, P4341, DOI 10.1016/S0032-3861(02)00270-7
   Dogu Y, 2006, J APPL POLYM SCI, V99, P37, DOI 10.1002/app.22140
   Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Gil ES, 2007, BIOMACROMOLECULES, V8, P258, DOI 10.1021/bm060543m
   Gotoh T, 1998, J APPL POLYM SCI, V69, P895, DOI 10.1002/(SICI)1097-4628(19980801)69:5<895::AID-APP8>3.0.CO;2-H
   Huang X, 2007, TISSUE ENG, V13, P2645, DOI 10.1089/ten.2007.0084
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Ju YM, 2008, J BIOMED MATER RES A, V87A, P136, DOI 10.1002/jbm.a.31756
   Kaneko T, 2005, MACROMOL CHEM PHYSIC, V206, P566, DOI 10.1002/macp.200400405
   Kaneko Y, 1998, MACROMOLECULES, V31, P6099, DOI 10.1021/ma971899g
   Kato N, 1997, B CHEM SOC JPN, V70, P1289, DOI 10.1246/bcsj.70.1289
   Kato N, 2000, B CHEM SOC JPN, V73, P1089, DOI 10.1246/bcsj.73.1089
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kishi R, 2004, COLLOID POLYM SCI, V283, P133, DOI 10.1007/s00396-004-1103-6
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   Lee BH, 2006, BIOMACROMOLECULES, V7, P2059, DOI 10.1021/bm060211h
   Lee YJ, 2005, POLYMER, V46, P10056, DOI 10.1016/j.polymer.2005.08.047
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   Liang L, 2000, LANGMUIR, V16, P9895, DOI 10.1021/la000279v
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Okay O, 2000, PROG POLYM SCI, V25, P711, DOI 10.1016/S0079-6700(00)00015-0
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Pandori MW, 2005, GENE THER, V12, P521, DOI 10.1038/sj.gt.3302420
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Spatz JP, 2005, NAT MATER, V4, P115, DOI 10.1038/nmat1315
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Takeoka Y, 2002, LANGMUIR, V18, P5977, DOI 10.1021/la020133t
   Tokuyama H, 2007, LANGMUIR, V23, P11246, DOI 10.1021/la701492u
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vernon B, 2005, J BIOMAT SCI-POLYM E, V16, P1153, DOI 10.1163/1568562054798536
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang DW, 2008, ANGEW CHEM INT EDIT, V47, P373, DOI 10.1002/anie.200702721
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Xue W, 2002, POLYMER, V43, P5181, DOI 10.1016/S0032-3861(02)00396-8
   Yang XY, 2006, ADV MATER, V18, P410, DOI 10.1002/adma.200502003
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Zhang XZ, 2008, SOFT MATTER, V4, P385, DOI 10.1039/b713803m
   Zhang XZ, 2003, CHEM COMMUN, P1446, DOI 10.1039/b301423a
   Zhang XZ, 2001, LANGMUIR, V17, P6094, DOI 10.1021/la010105v
NR 53
TC 22
Z9 23
U1 4
U2 77
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 5
PY 2010
VL 26
IS 19
BP 15614
EP 15624
DI 10.1021/la102509a
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 654BI
UT WOS:000282142700075
PM 20804220
DA 2018-10-19
ER

PT J
AU Hsu, SH
   Fu, KY
   Huang, TB
   Tsai, IJ
   Yen, CY
AF Hsu, Shan-hui
   Fu, Keng-yen
   Huang, Tsung-bin
   Tsai, I-jine
   Yen, Chung-yang
TI The Effect of Laser Preexposure on Seeding Endothelial Cells to a
   Biomaterial Surface
SO PHOTOMEDICINE AND LASER SURGERY
LA English
DT Article
ID IN-VITRO; GENE-EXPRESSION; VASCULAR GRAFTS; IRRADIATION; PROLIFERATION;
   ULTRASOUND; ADHESION; THERAPY; ARTERY
AB Objective: In this study, the possible effect of low-level laser (LLL) on improving the adhesion of endothelial cells (ECs) to a biomaterial substrate was evaluated. Background Data: Despite the numerous studies regarding the effects of LLL on biologic systems, the influence of LLL on the binding between cells and materials was rarely investigated. Materials and Methods: A low-power He-Ne laser apparatus with a continuous wavelength of 632.8 nm (a maximum power output of 50 mW) was used. The average irradiation energy on cells was 1.18 J/cm(2). Cell morphology and the concentrations of nitric oxide and calcium after laser exposure were measured. Biomedical grade poly(carbonate) urethane (PU) was synthesized and used to prepare microporous vascular grafts. ECs exposed to laser were harvested and seeded on the PU grafts. No further exposure was given. Results: LLL could change the morphology and increase the matrix secretion of ECs, and such effects persisted when preexposed cells were harvested and seeded to another substrate. The number of ECs attached on the biomaterial substrate was not affected. Preexposed ECs on the PU graft, however, were, on average, more resistant to flushing (i.e., greater cell retention). Conclusion: ECs were pretreated with LLL before being seeded onto the PU biomaterial vascular grafts. The retention of LLL-preexposed ECs on the graft surface was enhanced, but not as significantly as that of ECs preexposed to low-intensity ultrasound.
C1 [Hsu, Shan-hui; Tsai, I-jine] Natl Chung Hsing Univ, Inst Biomed Engn, Taichung 40227, Taiwan.
   [Hsu, Shan-hui; Fu, Keng-yen] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taichung, Taiwan.
   [Huang, Tsung-bin] Chang Jung Christian Univ, Dept Biosci Technol, Tainan, Taiwan.
   [Yen, Chung-yang] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan.
RP Hsu, SH (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
EM shhsu@ntu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU National Science Council, Taiwan, R.O.C.
FX The work was supported by National Science Council, Taiwan, R.O.C.
CR Bergh N, 2008, ENDOTHELIUM-J ENDOTH, V15, P231, DOI 10.1080/10623320802487536
   BERGMAN M, 1963, ANAL CHEM, V35, P1961
   Boulton M., 1986, Lasers in the Life Sciences, V1, P125
   Bowlin GL, 2001, J BIOMATER APPL, V16, P157, DOI 10.1106/NCQT-JFV9-2EQ1-EBGU
   Chen CH, 2009, J ORTHOP RES, V27, P646, DOI 10.1002/jor.20800
   Chen CH, 2008, LASER SURG MED, V40, P46, DOI 10.1002/lsm.20589
   Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x
   DEJUN L, 1994, APPL SURF SCI, V78, P195
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fields C, 2002, J BIOMATER APPL, V17, P135, DOI 10.1106/088532802030556
   Fields C, 2002, J BIOMATER APPL, V17, P45, DOI 10.1106/088532802027861
   HAGIWARA H, 1984, THROMB RES, V33, P363, DOI 10.1016/0049-3848(84)90075-6
   Hsu SH, 2006, J BIOMED MATER RES B, V76B, P85, DOI 10.1002/jbm.b.30345
   Hsu SH, 2000, ARTIF ORGANS, V24, P119, DOI 10.1046/j.1525-1594.2000.06338.x
   Karu TI, 1996, LASER SURG MED, V18, P171, DOI 10.1002/(SICI)1096-9101(1996)18:2<171::AID-LSM7>3.0.CO;2-P
   Kent K C, 1988, ASAIO Trans, V34, P578
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Ko KS, 2001, J CELL SCI, V114, P1155
   Lilge L, 2000, J CLIN LASER MED SUR, V18, P235, DOI 10.1089/clm.2000.18.235
   LOW J, 1993, ELECTROTHERAPY EXPLA, P299
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Pourreau-Schneider N, 1989, Quintessence Int, V20, P887
   REDDY GK, 1998, LASER SURG MED, V22, P187
   Reher P, 2002, BONE, V31, P236, DOI 10.1016/S8756-3282(02)00789-5
   RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199304000-00002
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sato H, 1999, J BIOMATER APPL, V14, P169, DOI 10.1177/088532829901400203
   Tam G, 1999, J CLIN LASER MED SUR, V17, P29, DOI 10.1089/clm.1999.17.29
   UCHIDA N, 1993, J BIOMED MATER RES, V27, P1269, DOI 10.1002/jbm.820271007
   VANBREUGEL HHFI, 1992, LASER SURG MED, V12, P528, DOI 10.1002/lsm.1900120512
   Yaakobi T, 1996, CALCIFIED TISSUE INT, V59, P297, DOI 10.1007/s002239900126
   Yamamoto Y, 1996, J Clin Laser Med Surg, V14, P129
   Zhang ZJ, 2003, ULTRASOUND MED BIOL, V29, P1645, DOI 10.1016/j.ultrasmedbio.2003.08.011
NR 33
TC 0
Z9 0
U1 0
U2 6
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-5418
J9 PHOTOMED LASER SURG
JI Photomed. Laser Surg.
PD OCT
PY 2010
VL 28
SU 2
DI 10.1089/pho.2009.2613
PG 6
WC Surgery
SC Surgery
GA 798AL
UT WOS:000293172400007
PM 20932129
DA 2018-10-19
ER

PT J
AU Pinheiro, ALB
   Lopes, CB
   Pacheco, MTT
   Brugnera, A
   Zanin, FAA
   Cangussu, MCT
   Silveira, L
AF Pinheiro, Antonio L. B.
   Lopes, Cibelle B.
   Pacheco, Marcos T. T.
   Brugnera Junior, Aldo
   Zanin, Fatima Antonia A.
   Cangussu, Maria Cristina T.
   Silveira Junior, Landulfo
TI Raman Spectroscopy Validation of DIAGNOdent-Assisted Fluorescence
   Readings on Tibial Fractures Treated with Laser Phototherapy, BMPs,
   Guided Bone Regeneration, and Miniplates
SO PHOTOMEDICINE AND LASER SURGERY
LA English
DT Article
ID OCCLUSAL CARIES; IN-VITRO; RODENT MODEL; MORPHOGENETIC PROTEINS; DENTAL
   IMPLANTS; BOVINE BONE; VIVO; PERFORMANCE; REPAIR; LIGHT
AB Objectives: We aimed to assess through Raman spectroscopy and fluorescence the levels of calcium hydroxyapatite (CHA) and lipids and proteins in complete fractures treated with internal rigid fixation (IRF) treated or not with laser phototherapy (LPT) and associated or not with bone morphogenetic proteins (BMPs) and guided bone regeneration (GBR). Background: Fractures have different etiologies and treatments and may be associated with bone losses. LPT has been shown to improve bone healing. Methods: Tibial fractures were created on 15 animals and divided into five groups. LPT started immediately after surgery, repeated at 48-h intervals. Animal death occurred after 30 days. Results: Raman spectroscopy and fluorescence were performed at the surface. Fluorescence data of group IRF + LPT + Biomaterial showed similar readings to those of the group IRF-no bone loss. Significant differences were seen between groups IRF + LPT + Biomaterial and IRF + LPT; IRF + LPT + Biomaterial; and IRF + Biomaterial; and between IRF + LPT + Biomaterial and IRF. CH groups of lipids and proteins readings showed decreased levels of organic components in subjects treated with the association of LPT, biomaterial, and GBR. Pearson correlation showed that fluorescence readings of both CHA and CH groups of lipids and proteins correlated negatively with the Raman data. Conclusions: The use of both methods indicates that the use of the biomaterials associated with infrared LPT resulted in a more-advanced and higher quality of bone repair in fractures treated with miniplates and that the DIAGNOdent may be used to perform optical biopsy on bone.
C1 [Pinheiro, Antonio L. B.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.; Pacheco, Marcos T. T.; Brugnera Junior, Aldo; Silveira Junior, Landulfo] Univ Camilo Castelo Branco, Sao Jose Dos Campos, SP, Brazil.
   [Pinheiro, Antonio L. B.] Inst Nacl Ciencia & Tecnol Opt & Foton, Sao Carlos, SP, Brazil.
   [Lopes, Cibelle B.] UNIVAP, FCS, Sch Dent, Sao Jose Dos Campos, SP, Brazil.
   [Zanin, Fatima Antonia A.] Inst Brugnera & Zanin, Sao Paulo, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, 62 Araujo Pinho Ave, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Silveira, Landulfo/I-2474-2012; Pinheiro, Antonio Luiz/A-1962-2008;
   Optica e fotonica, Inct/I-2419-2013; Pacheco, Marcos/B-7991-2012
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321; Pacheco, Marcos/0000-0002-1725-4803
CR Anttonen V, 2003, CARIES RES, V37, P17, DOI 10.1159/000068227
   Braga MM, 2008, ORAL HLTH PREV DENT, V6, P165
   Cortes DF, 2003, CARIES RES, V37, P8, DOI 10.1159/000068230
   Farah RA, 2008, J DENT, V36, P915, DOI 10.1016/j.jdent.2008.07.012
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Hibst R, 1999, CARIES RES, V33, P295
   Hibst R, 2001, MED LASER APPL, V16, P205
   Hosoya Y, 2008, J DENT, V36, P1041, DOI 10.1016/j.jdent.2008.08.010
   Leblanc L, 2002, FEMS MICROBIOL LETT, V211, P147, DOI 10.1016/S0378-1097(02)00636-5
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Lussi A, 1999, CARIES RES, V33, P261, DOI 10.1159/000016527
   Lussi A, 2001, EUR J ORAL SCI, V109, P14, DOI 10.1034/j.1600-0722.2001.109001014.x
   Lussi A, 2005, EUR J ORAL SCI, V113, P141, DOI 10.1111/j.1600-0722.2004.00195.x
   Lussi A, 2003, CARIES RES, V37, P2, DOI 10.1159/000068286
   Lussi A, 2004, J DENT RES, V83, P80
   Mendes Fausto Medeiros, 2004, Braz. oral res., V18, P141, DOI 10.1590/S1806-83242004000200009
   Morris MD, 2002, PROC SPIE, V4614, P28, DOI 10.1117/12.460796
   Nogueira GV, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1908129
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Pinelli C, 2002, CARIES RES, V36, P19, DOI 10.1159/000057585
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Sailer R, 2001, CARIES RES, V35, P267
   Sheehy EC, 2001, CARIES RES, V35, P421, DOI 10.1159/000047485
   Shi XQ, 2001, ACTA ODONTOL SCAND, V59, P74, DOI 10.1080/000163501750157153
   Silva Junior N, 2002, J CLIN LASER MED SUR, V20, P83
   Silveira L, 2003, J CLIN LASER MED SUR, V21, P203, DOI 10.1089/104454703768247774
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   ZANIN F, 2006, ATLAS LASER THERAPY, P91
   ZANIN F, 2001, LASER DENT, V4249, P145
   ZANIN F, 2001, JADA BRASIL, V4, P245
   Zhang SM, 2009, J PERIODONTOL, V80, P1462, DOI 10.1902/jop.2009.080659
NR 40
TC 4
Z9 5
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-5418
J9 PHOTOMED LASER SURG
JI Photomed. Laser Surg.
PD OCT
PY 2010
VL 28
SU 2
DI 10.1089/pho.2009.2674
PG 9
WC Surgery
SC Surgery
GA 798AL
UT WOS:000293172400016
PM 20929388
DA 2018-10-19
ER

PT J
AU Spreafico, A
   Chellini, F
   Frediani, B
   Niccolini, S
   Bernardini, G
   Rocchi, A
   Marcolongo, R
   Galeazzi, M
   Santucci, A
AF Spreafico, A.
   Chellini, F.
   Frediani, B.
   Niccolini, S.
   Bernardini, G.
   Rocchi, A.
   Marcolongo, R.
   Galeazzi, M.
   Santucci, A.
TI EFFECT OF HUMAN PLATELET RICH PLASMA RELEASATES ON PROLIFERATION AND
   MATRIX SYNTHESIS OF HUMAN ARTICULAR CHONDROCYTES GROWN ON A POLYGLYCOLIC
   ACID-BASED BIOMATERIAL (PGA): MOLECULAR, PROTEOMICAL AND
   IMMUNOFLUORESCENCE ANALYSIS
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Meeting Abstract
CT World Congress of the OsteoArthritis-Research-Society-International
CY SEP 23-26, 2010
CL Brussels, BELGIUM
SP OsteoArthritis Res Soc Int
C1 [Spreafico, A.; Chellini, F.; Frediani, B.; Niccolini, S.; Galeazzi, M.] Univ Siena, Div Rheumatol, Dept Clin Med & Immunol Sci, I-53100 Siena, Italy.
   [Spreafico, A.; Chellini, F.; Frediani, B.; Marcolongo, R.; Santucci, A.] Univ Siena, Ctr Interdipartimentale Studio Biochim & Clin Pat, I-53100 Siena, Italy.
   [Bernardini, G.; Rocchi, A.; Santucci, A.] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD OCT
PY 2010
VL 18
SU 2
BP S85
EP S85
DI 10.1016/S1063-4584(10)60202-6
PG 1
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 670UN
UT WOS:000283452900198
OA Bronze
DA 2018-10-19
ER

PT J
AU Frey, ST
   Guilmet, SL
   Egan, RG
   Bennett, A
   Soltau, SR
   Holz, RC
AF Frey, Steven T.
   Guilmet, Stephanie L.
   Egan, Richard G., III
   Bennett, Alyssa
   Soltau, Sarah R.
   Holz, Richard C.
TI Immobilization of the Aminopeptidase from Aeromonas proteolytica on
   Mg2+/Al3+ Layered Double Hydroxide Particles
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE layered double hydroxide; immobilization; aminopeptidase; biocomposite;
   catalyst
ID PROTEINS; ENZYMES; HYDROLYSIS; ELECTRODES; BIOSENSORS; CARBONATE;
   PHOSPHATE; PROSPECTS; SOLVENTS; DESIGN
AB A novel biomaterial formed by the immobilization of the Aminopeptidase from Aeromonas proteolytica (AAP) on synthetic Mg2+ and Al3+ ion-containing layered double hydroxide (LDH) particles was prepared. Immobilization of AAP on the LDH particles in a buffered, aqueous mixture is rapid such that the maximum loading capacity, 1 x 10(-9) moles of AAP/mg LDH, is achieved in a few minutes. X-ray powder diffraction of LDH samples before and after treatment with AAP indicates that the enzyme does not intercalate between the layers of LDH, but instead binds to the surface. Treatment of AAP/LDH with various amounts of salt in a buffered mixture demonstrates that between 15 and 20% of AAP can be removed from the LDH by washing the composite material in 0.2 M NaCl. However, the residual AAP remains bound to the LDH even at 1 M salt concentrations. A suspension of the AAP/LDH biomaterial in 10 mM Tricine buffered, aqueous solution (pH 8.0 and 25 degrees C) catalyzes the hydrolysis of L-leucine-p-nitroanilide demonstrating that immobilized AAP remains available to substrate and retains its catalytic activity. Recycling experiments reveal that the AAP/LDH particles can be recovered and reused multiple times without appreciable loss of activity. This work provides the foundation for the development of materials that will function in the degradation or detection of peptide hormones or neurotoxins.
C1 [Frey, Steven T.; Guilmet, Stephanie L.; Egan, Richard G., III; Bennett, Alyssa; Soltau, Sarah R.] Skidmore Coll, Dept Chem, Saratoga Springs, NY 12866 USA.
   [Holz, Richard C.] Loyola Univ Chicago, Dept Chem, Chicago, IL 60026 USA.
RP Frey, ST (reprint author), Skidmore Coll, Dept Chem, 815 North Broadway, Saratoga Springs, NY 12866 USA.
EM sfrey@skidmore.edu
FU Petroleum Research Fund; National Science Foundation [CHE-0652981];
   National Institutes of Health [R15 AI085559-01A1]
FX Acknowledgment is made to the donors of The Petroleum Research Fund,
   administered by the ACS, for partial support of this research. This work
   was also supported by the National Science Foundation (CHE-0652981, RCH)
   and the National Institutes of Health (R15 AI085559-01A1, RCH). The
   authors thank Dr. Michael E. Hagerman for recording the powder XRD
   patterns and insightful discussions.
CR An Z, 2009, LANGMUIR, V25, P10704, DOI 10.1021/la901205c
   Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002
   ARNOLD FH, 1988, PROTEIN ENG, V2, P21, DOI 10.1093/protein/2.1.21
   BAKER JO, 1983, BIOCHEMISTRY-US, V22, P2098, DOI 10.1021/bi00278a009
   Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0
   Cordova DIC, 2009, QUIM NOVA, V32, P1495, DOI 10.1590/S0100-40422009000600025
   Chen GJ, 1997, BIOCHEMISTRY-US, V36, P4278, DOI 10.1021/bi9618676
   Chen GJ, 2008, BIOCONJUGATE CHEM, V19, P138, DOI 10.1021/bc700224q
   CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7
   CHIN J, 1991, ACCOUNTS CHEM RES, V24, P145, DOI 10.1021/ar00005a004
   Choy JH, 2000, ANGEW CHEM INT EDIT, V39, P4042
   CONSTANTINO VRL, 1995, INORG CHEM, V34, P883, DOI 10.1021/ic00108a020
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   Dismukes GC, 1996, CHEM REV, V96, P2909, DOI 10.1021/cr950053c
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Frenkel-Mullerad H, 2005, J AM CHEM SOC, V127, P8077, DOI 10.1021/ja0507719
   Griebenow K, 1996, J AM CHEM SOC, V118, P11695, DOI 10.1021/ja961869d
   HAUSINGER RP, 1993, BIOCH NICKEL, V12
   LAI KH, 1994, J BIOL CHEM, V269, P16579
   Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j
   Melo J. V. D., 2002, ANAL CHEM, V74, P4037
   MENGER FM, 1987, J AM CHEM SOC, V109, P2800, DOI 10.1021/ja00243a038
   Millange F, 2000, J MATER CHEM, V10, P1713, DOI 10.1039/b002827o
   Mousty C, 2004, APPL CLAY SCI, V27, P159, DOI 10.1016/j.clay.2004.06.005
   Mylerovd V., 2003, CURR ORG CHEM, V7, P1
   Naik RR, 2004, CHEM COMMUN, P1684, DOI 10.1039/b404586f
   O'Neill H, 2005, CHEM MATER, V17, P2654, DOI 10.1021/cm047763w
   Park SJ, 2004, ANAL SCI, V20, P1635, DOI 10.2116/analsci.20.1635
   Prescott J M, 1976, Methods Enzymol, V45, P530
   Rahman MBA, 2004, APPL BIOCHEM BIOTECH, V118, P313, DOI 10.1385/ABAB:118:1-3:313
   Shan D, 2003, ANAL CHEM, V75, P3872, DOI 10.1021/ac030030v
   Shan D, 2004, ANAL CHEM, V76, P178, DOI 10.1021/ac034713m
   Smith K, 2002, J AM CHEM SOC, V124, P4247, DOI 10.1021/ja012215u
   TAGAYA H, 1993, CHEM MATER, V5, P1431, DOI 10.1021/cm00034a011
   Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b
   Yu AM, 2005, CHEM MATER, V17, P171, DOI 10.1021/cm048659h
   Zen JM, 2004, ANAL CHEM, V76, p205A, DOI 10.1021/ac041566z
NR 37
TC 15
Z9 16
U1 2
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD OCT
PY 2010
VL 2
IS 10
BP 2828
EP 2832
DI 10.1021/am1005095
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 670XP
UT WOS:000283463700025
PM 20825230
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Cosgriff-Hernandez, E
   Hahn, MS
   Russell, B
   Wilems, T
   Munoz-Pinto, D
   Browning, MB
   Rivera, J
   Hook, M
AF Cosgriff-Hernandez, E.
   Hahn, M. S.
   Russell, B.
   Wilems, T.
   Munoz-Pinto, D.
   Browning, M. B.
   Rivera, J.
   Hoeoek, M.
TI Bioactive hydrogels based on Designer Collagens
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Scl proteins; Hydrogel; Endothelial cells; Smooth muscle cells
ID POLY(ETHYLENE GLYCOL) HYDROGELS; DIAMETER VASCULAR GRAFTS; GROUP-A
   STREPTOCOCCUS; INTEGRINS ALPHA(1)BETA(1); POLYETHYLENE-GLYCOL; SCL2
   PROTEINS; BINDING; ALPHA(2)BETA(1); SEQUENCE; SITE
AB Designer Collagens are based on streptococcal collagen-like (Scl) proteins that form a triple helix similar to mammalian collagens but that are non-platelet aggregating. In contrast to the numerous cell-binding sites on collagen, Scl2 from Streptococcus pyogenes serotype M28 does not contain any known cell-binding sites and thus provides a blank slate in terms of cellular interactions In the current study, Scl2 protein was modified to include receptor binding motifs that interact with alpha 1 and/or alpha 2 integrin subunits The modfied Scl2 proteins have been demonstrated to mediate differential endothelial cell (EC) and smooth muscle cell (SMC) adhesion via these integrins and to retain the non-platelet aggregating properties of the "parent" Scl2 Thromboresistant scaffolds which selectively bind ECs vs SMCs would be desirable for vascular repair or replacement
   Despite the potential of these Scl proteins in vascular applications, the utility of this recombinant protein family is currently limited to coatings due to the inability of Scl proteins to assemble into stable three-dimensional networks To address this limitation, the Scl2 proteins were functionalized with photocrosslinking sites to enable incorporation into a hydrogel matrix Characterization studies confirmed that the functionalization of the Scl2 proteins did not disrupt triple helix conformation, integrin binding or cell adhesion Bioactive hydrogels were fabricated by combining the functionalized Scl2 proteins with poly(ethylene glycol) diacrylate (PEGDA) and photocrosslinking. EC and SMC adhesion studies confirmed cell-specific adhesion due to selective integrin binding to the two receptor binding motifs investigated These results serve to highlight the potential of this novel biomaterial platform in the development of improved tissue engineered vascular grafts Published by Elsevier Ltd on behalf of Acta Materialia Inc
C1 [Cosgriff-Hernandez, E.; Wilems, T.; Browning, M. B.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
   [Hahn, M. S.; Munoz-Pinto, D.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.
   [Russell, B.; Rivera, J.; Hoeoek, M.] Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA.
RP Cosgriff-Hernandez, E (reprint author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016; Hahn, Mariah/G-3998-2014
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600; Hahn,
   Mariah/0000-0001-8794-129X
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   BURKEL WE, 1989, MED PROG TECHNOL, V14, P165
   Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x
   Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x
   Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Faries PL, 2000, J VASC SURG, V32, P1080, DOI 10.1067/mva.2000.111279
   Gobin AS, 2003, J BIOMED MATER RES A, V67A, P255, DOI 10.1002/jbm.a.10110
   Grace MJ, 2005, J BIOL CHEM, V280, P6327, DOI 10.1074/jbc.M41234200
   GRIESLER HP, 1990, ANN VASC SURG, V4, P98
   Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x
   Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200
   Kader KN, 2000, TISSUE ENG, V6, P241, DOI 10.1089/10763270050044425
   Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   MONETA GL, 1995, J LONG-TERM EFF MED, V5, P47
   PEDUZZI P, 1992, CIRCULATION, V86, P121
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Sebra RP, 2005, LANGMUIR, V21, P10907, DOI 10.1021/la052101m
   SEO N, COLLAGEN LIKE UNPUB
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   VACANTI JP, 1999, LANCET S1, V354, P132
   VORHEES AB, 1952, ANN SURG, V135, P332
   WHITTEMORE AD, 1989, J VASC SURG, V10, P299, DOI 10.1067/mva.1989.14116
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
NR 34
TC 42
Z9 42
U1 2
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2010
VL 6
IS 10
BP 3969
EP 3977
DI 10.1016/j.actbio.2010.05.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 654YL
UT WOS:000282207100016
PM 20466083
DA 2018-10-19
ER

PT J
AU Raucci, MG
   D'Anto, V
   Guarino, V
   Sardella, E
   Zeppetelli, S
   Favia, P
   Ambrosio, L
AF Raucci, M. G.
   D'Anto, V.
   Guarino, V.
   Sardella, E.
   Zeppetelli, S.
   Favia, P.
   Ambrosio, L.
TI Biomineralized porous composite scaffolds prepared by chemical synthesis
   for bone tissue regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Composite material; Hydroxyapante; Scaffold; Human mesenchymal stem
   cell; Tissue engineering
ID POLY-EPSILON-CAPROLACTONE; MESENCHYMAL STEM-CELLS; SOL-GEL SYNTHESIS;
   IN-VITRO; OSTEOGENIC DIFFERENTIATION; HYDROXYAPATITE; GROWTH;
   BIOMATERIALS; BIOACTIVITY; FABRICATION
AB Scaffold design is a key factor in the clinical success of bone tissue engineering grafts To date, no existing single biomaterial used in bone repair and regeneration fulfils all the requirements for an ideal bone graft In this study hydroxyapatite/polycaprolactone (HA/PCL) composite scaffolds were prepared by a wet chemical method at room temperature The physico-chemical properties of the composite materials were characterized by X-ray diffraction, Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy, while scaffold morphology was investigated by scanning electron microscopy (SEM) with energy-dispersive spectroscopy to validate the process used for synthesis Finally, the response of bone marrow-derived human mesenchymal stem cells (hMSCs) in terms of cell proliferation and differentiation to the osteoblastic phenotype was evaluated using the Alamar blue assay, SEM and alkaline phosphatase activity Microstructural analysis indicated that the HA particles were distributed homogeneously within the PCL matrix The biological results revealed that the HA/PCL composite scaffolds are suitable for the proliferation and differentiation of MSCs in vitro, supporting osteogenesis after 15 days All the results indicate that these scaffolds meet the requirements of materials for bone tissue engineering and could be used for many clinical applications in orthopaedic and maxillofacial surgery (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Raucci, M. G.; D'Anto, V.; Guarino, V.; Zeppetelli, S.; Ambrosio, L.] CNR, IMCB, I-80125 Naples, Italy.
   [Sardella, E.; Favia, P.] Univ Bari, CNR, IMIP, I-70126 Bari, Italy.
   [Favia, P.] Univ Bari, Dept Chem, I-70126 Bari, Italy.
RP Raucci, MG (reprint author), CNR, IMCB, Piazza Tecchio 80, I-80125 Naples, Italy.
RI Guarino, Vincenzo/F-5793-2011
OI Favia, Pietro/0000-0002-5896-895X; Guarino,
   Vincenzo/0000-0003-1546-3721; AMBROSIO, LUIGI/0000-0002-8367-2405;
   SARDELLA, ELOISA/0000-0002-6776-8327
FU Rete Nazionale di Ricerca TISSUENET [RBPRO5RS]; Ministero
   dell'Universita e della Ricerca
FX This study was supported from the Ministero dell'Universita e della
   Ricerca by funds of Rete Nazionale di Ricerca TISSUENET no. RBPRO5RS.
   The authors also thank Dr Manlio Colella for facilitating the SEM
   characterization.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   AHMED K, 1994, CELL MOL BIOL RES, V40, P539
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Catauro M, 2006, J BIOMED MATER RES A, V77A, P340, DOI 10.1002/jbm.a.30617
   Catauro M, 2004, J MATER SCI-MATER M, V15, P991, DOI 10.1023/B:JMSM.0000042684.13247.38
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   DELREAL, 2002, BIOMATERIALS, V23, P3673
   Dong J, 2001, MAT SCI ENG C-BIO S, V17, P37, DOI 10.1016/S0928-4931(01)00333-2
   Elliott J. C., 1994, STRUCTURE CHEM APATI, P389
   GOEGAN P, 1995, TOXICOL IN VITRO, V9, P257, DOI 10.1016/0887-2333(95)00004-R
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guarino V, 2008, J BIOMED MATER RES B, V86B, P548, DOI 10.1002/jbm.b.31055
   Guarino V, 2007, EXPERT REV MED DEVIC, V4, P405, DOI 10.1586/17434440.4.3.405
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Iojoiu C, 2004, J POLYM SCI POL CHEM, V42, P689, DOI 10.1002/pola.10849
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kim HW, 2007, J BIOMED MATER RES A, V83A, P169, DOI 10.1002/jbm.a.31247
   Kim IS, 2004, MAT SCI ENG B-SOLID, V111, P232, DOI 10.1016/j.mseb.2004.04.011
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li Z, 2005, J MATER SCI, V40, P107
   Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Ng AMH, 2008, J BIOMED MATER RES A, V85A, P301, DOI 10.1002/jbm.a.31324
   Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Salerno A, 2009, ACTA BIOMATER, V5, P1082, DOI 10.1016/j.actbio.2008.10.012
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Small DM, 1986, PHYS CHEM LIPIDS ALK
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Ueyama Y, 2002, BIOMATERIALS, V23, P2027, DOI 10.1016/S0142-9612(01)00332-5
   VANDERHOUWEN, 2003, J CRYST GROWTH, V249, P572
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Xu HHK, 2004, J BIOMED MATER RES A, V69A, P267, DOI 10.1002/jbm.a.20124
   XUDONG L, 2006, BIOMATERIALS, V27, P2426
   Yamaguchi T, 2006, NUCL INSTRUM METH B, V249, P723, DOI 10.1016/j.nimb.2006.03.126
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 46
TC 42
Z9 46
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2010
VL 6
IS 10
BP 4090
EP 4099
DI 10.1016/j.actbio.2010.04.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 654YL
UT WOS:000282207100031
PM 20417736
DA 2018-10-19
ER

PT J
AU Wang, K
   Cai, L
   Hao, F
   Xu, XM
   Cui, MZ
   Wang, SF
AF Wang, Kan
   Cai, Lei
   Hao, Feng
   Xu, Xuemin
   Cui, Meizhen
   Wang, Shanfeng
TI Distinct Cell Responses to Substrates Consisting of
   Poly(epsilon-caprolactone) and Poly(propylene fumarate) in the Presence
   or Absence of Cross-Links
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTROLLED-PORE STRUCTURES; BINARY POLYMER MIXTURES;
   SMOOTH-MUSCLE-CELLS; PHYSICAL-PROPERTIES; MECHANICAL-PROPERTIES; FOCAL
   ADHESIONS; IN-VITRO; BLENDS; BONE; PROLIFERATION
AB To investigate the role of chemical cross-links in regulating biomaterial properties and cell behavior, we have prepared and Characterized a series of biodegradable polymer blends in both un-cross-linked and photo-crosslinked forms. In this comparative study, these blends consisted of an oligomeric, cross-linkable. amorphous poly(propylene fumarate) (PPF) and a high-molecular-weight, semicrystalline poly(epsilon-caprolactone) (PCL) After cross-linking; semi-interpenetrating polymer networks (semi-IPNs) were formed by combining PIT chemical network and PCL physical network tint was associated by the crystallites. The material design strategy presented here was different front previously studied semicrystalline polymer networks, in which crystallizable segments participated covalently in the chemical network and were significantly suppressed by the network. For these PPF/PCL blends, thermal-properties such as melting temperature (T-m) and crystallinity have been correlated with their rheological and mechanical properties to demonstrate the effects of cross-linking density and crystallinity.. Surface morphology, hydrophilicity, and the capability of adsorbing proteins from cell culture media have also been determined. For potential applications in bone and vascular tissue engineering and demonstration of regulating cell behavior on polymer substrates with controllable physicochemical characteristics, in vitro cell studies that included cell viability; attachment, spreading, find proliferation have been performed using mouse MC3T3 cells and primary rat aortic smooth-muscle cells (SMCs). In a similar manner, these two cell types have been found to show distinct cell responses to the polymer substrates in the presence or absence of cross-links.
C1 [Wang, Kan; Cai, Lei; Wang, Shanfeng] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [Hao, Feng; Xu, Xuemin; Cui, Meizhen] Univ Tennessee, Dept Pathobiol, Knoxville, TN 37996 USA.
RP Wang, SF (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM swang16@utk.edu
RI Cai, Lei/D-1589-2013
OI xu, xuemin/0000-0002-7426-272X; Cui, Mei-Zhen/0000-0003-4745-6999
FU University of Tennessee
FX This work was supported by the Start-up Research Fund from the
   University of Tennessee. We thank Xueguang Jiang, Xiaoming Jiang, and
   Dr. Bin Zhao in the Department of Chemistry at the University of
   Tennessee for the help with GPC and contact angle measurements.
CR BHATIA QS, 1988, MACROMOLECULES, V21, P2166, DOI 10.1021/ma00185a049
   Brandrup J, 1989, POLYM HDB
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Cai L, 2010, BIOMATERIALS, V31, P7423, DOI 10.1016/j.biomaterials.2010.06.028
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Cai L, 2010, POLYMER, V51, P164, DOI 10.1016/j.polymer.2009.11.042
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   Chan-Park MB, 2009, J BIOMED MATER RES A, V88A, P1104, DOI 10.1002/jbm.a.32318
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Fisher JP, 2001, ANN REV MATER RES, V31, P171, DOI 10.1146/annurev.matsci.31.1.171
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Harbers G.M., 2005, INTRO BIOMATERIALS, P15
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KW, 2006, TISSUE ENG, V12, P2801, DOI 10.1089/ten.2006.12.2801
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003
   Mirzadeh H, 2003, J BIOMED MATER RES A, V67A, P727, DOI 10.1002/jbm.a.10107
   Moussallem MD, 2009, BIOMACROMOLECULES, V10, P3062, DOI 10.1021/bm9007309
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Nishino T, 2000, POLYM ENG SCI, V40, P336, DOI 10.1002/pen.11167
   Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   PERRIN DE, 1997, HDB BIODEGRADABLE PO, P63
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   ROSS JM, 1998, FRONTIERS TISSUE ENG, P15
   Rubinstein M., 2003, POLYM PHYS
   Saltzman WM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P279, DOI 10.1016/B978-012370615-7/50024-X
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   Shi X., 2006, INTRO BIOMATERIALS, P205
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Tang ZG, 2006, BIOMATERIALS, V27, P4409, DOI 10.1016/j.biomaterials.2006.04.009
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   WANG K, 2010, ABSTR PAP AM CHEM S, V238
   WANG K, 2010, ABSTR PAP AM CHEM S, V240
   WANG S, 2006, P AICHE ANN M SAN FR
   Wang SF, 2006, BIOMACROMOLECULES, V7, P1976, DOI 10.1021/bm060096a
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang SF, 2005, MACROMOLECULES, V38, P7358, DOI 10.1021/ma050884c
   Wang SF, 2005, MACROMOLECULES, V38, P125, DOI 10.1021/ma0489669
   Wang SF, 2004, MACROMOLECULES, V37, P1641, DOI 10.1021/ma034835g
   Wang SF, 2003, MACROMOLECULES, V36, P5355, DOI 10.1021/ma0210426
   Wang SF, 2008, BIOMACROMOLECULES, V9, P1229, DOI 10.1021/bm7012313
   Wang SF, 2009, ACTA BIOMATER, V5, P1531, DOI 10.1016/j.actbio.2008.12.015
   Wang SF, 2008, POLYMER, V49, P5692, DOI 10.1016/j.polymer.2008.10.021
   Wang SF, 2009, BIOMATERIALS, V30, P3359, DOI 10.1016/j.biomaterials.2009.03.015
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zhang K, 2005, BIOMACROMOLECULES, V6, P1615, DOI 10.1021/bm0500648
NR 61
TC 35
Z9 35
U1 0
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2010
VL 11
IS 10
BP 2748
EP 2759
DI 10.1021/bm1008102
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 662UU
UT WOS:000282840200027
PM 20822174
DA 2018-10-19
ER

PT J
AU Larkin, AL
   Davis, RM
   Rajagopalan, P
AF Larkin, Adam L.
   Davis, Richey M.
   Rajagopalan, Padmavathy
TI Biocompatible, Detachable, and Free-Standing Polyelectrolyte Multilayer
   Films
SO BIOMACROMOLECULES
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; THIN-FILMS; IN-VITRO; MECHANICAL CHARACTERIZATION;
   EXTRACELLULAR-MATRIX; POLYMER MEMBRANES; HYALURONIC-ACID; CHITOSAN;
   DESIGN; GLUTARALDEHYDE
AB Self-assembled polyelectrolyte multilayers have gained tremendous popularity over, the past decade and have been incorporated in diverse applications. However, the fabrication of detachable and free-standing polyelectrolyte multi layers (PEMs) has proven to-he difficult. We report the design of detachable, free-standing. and biocompatible PEMs comprised of hyaluronic acid (anionic PE) and chitosan (cationic PE). These PEMs can be detached from an underlying inert substrate without any postprocessing steps. Our approach enables the fabrication of detachable PEMs from a wide range of polyelectrolytes. Cross-linked PEMs exhibited greater than 95% weight retention when maintained in phosphate buffered saline at 37 degrees C over a seven day period. The PEM thickness was approximately 3 mu m for dried films and increased 2-fold under hydration. A unique feature of the detachable, free-standing PEMs is their optical transparency in the 400-900 nm range under hydrated conditions. The Young's modulus of the cross-linked films-ranged from 300-400 MPa, rendering these detachable free-standing multilayers ideal for biomaterial applications: BALB/c 3T3 fibroblasts adhered on the PEMs and colonized the entire surface over a six day period. The cellular responses, as well as the physical properties, demonstrate that the detachable PEM films exhibit tremendous potential for applications in biomaterials and tissue engineering.
C1 [Larkin, Adam L.; Davis, Richey M.; Rajagopalan, Padmavathy] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
RP Rajagopalan, P (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
EM padmar@vt.edu
FU National Science Foundation [DMR-090750]; MILES-NSF
FX We gratefully acknowledge financial support from the National Science
   Foundation (DMR-090750, P.R. and R.M.D.), and the MILES-NSF IGERT
   program-at Virginia Polytechnic Institute and State University (P.R. and
   A.L.L.). Parts of this work were carried out using instruments in the
   Nanoscale Characterization and Fabrication Laboratory, a Virginia
   Polytechnic Institute and State University facility operated by the
   Institute for Critical Technology and Applied Science.
CR Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Choi HJ, 2005, NANOTECHNOLOGY, V16, pS143, DOI 10.1088/0957-4484/16/5/002
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1994, THIN SOLID FILMS, V244, P772, DOI 10.1016/0040-6090(94)90569-X
   DeRocher JP, 2010, MACROMOLECULES, V43, P2430, DOI 10.1021/ma902451s
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Endo H, 2008, J MATER CHEM, V18, P1302, DOI 10.1039/b717080g
   Endo H, 2006, MACROMOLECULES, V39, P5559, DOI 10.1021/ma052410j
   Ferri JK, 2006, MACROMOLECULES, V39, P1532, DOI 10.1021/ma0516485
   Fischer-Cripps A. C., 2002, NANOINDENTATION
   Gheith MK, 2005, ADV MATER, V17, P2663, DOI 10.1002/adma.200500366
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Hajicharalambous CS, 2009, BIOMATERIALS, V30, P4029, DOI 10.1016/j.biomaterials.2009.03.020
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   HEIMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   Hua F, 2004, NANO LETT, V4, P823, DOI 10.1021/nl0498031
   Jaber JA, 2006, J AM CHEM SOC, V128, P2940, DOI 10.1021/ja055892n
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Janorkar AV, 2008, BIOMATERIALS, V29, P625, DOI 10.1016/j.biomaterials.2007.10.022
   Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212
   Jiang CY, 2006, ADV MATER, V18, P829, DOI 10.1002/adma.200502444
   Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020
   Kim BS, 2009, LANGMUIR, V25, P14086, DOI 10.1021/la9017618
   Kim Y, 2010, TISSUE ENG PT A, V16, P2731, DOI 10.1089/ten.tea.2009.0695
   Koktysh DS, 2002, ADV FUNCT MATER, V12, P255, DOI 10.1002/1616-3028(20020418)12:4<255::AID-ADFM255>3.0.CO;2-1
   Kujawa P, 2007, BIOMACROMOLECULES, V8, P3169, DOI 10.1021/bm7006339
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   LUBIG R, 1981, MONATSH CHEM, V112, P1313, DOI 10.1007/BF00904683
   Lutkenhaus JL, 2005, J AM CHEM SOC, V127, P17228, DOI 10.1021/ja053472s
   Lutkenhaus JL, 2008, MACROMOLECULES, V41, P6047, DOI 10.1021/ma800003x
   Lvov YM, 1997, BIOL MEMBRANY, V14, P229
   Mallwitz F, 2005, ADV MATER, V17, P1296, DOI 10.1002/adma.200401123
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Nolte AJ, 2005, MACROMOLECULES, V38, P5367, DOI 10.1021/ma0507950
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Ono SS, 2006, NANO LETT, V6, P592, DOI 10.1021/nl0515504
   Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X
   Pavoor PV, 2004, MACROMOLECULES, V37, P4865, DOI 10.1021/ma049777t
   Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimomura H, 2010, ACS APPL MATER INTER, V2, P813, DOI 10.1021/am900883f
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Shutava TG, 2009, ACS NANO, V3, P1877, DOI 10.1021/nn900451a
   Sievers TK, 2007, LANGMUIR, V23, P12179, DOI 10.1021/la702199d
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Swierczewska M, 2008, ACTA BIOMATER, V4, P827, DOI 10.1016/j.actbio.2007.11.004
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   VEITLIB V, 2008, J MATER RES, V23, P1026
   Wong SY, 2010, BIOMATERIALS, V31, P4079, DOI 10.1016/j.biomaterials.2010.01.119
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   Zimnitsky D, 2008, LANGMUIR, V24, P5996, DOI 10.1021/la7038575
NR 65
TC 54
Z9 54
U1 0
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2010
VL 11
IS 10
BP 2788
EP 2796
DI 10.1021/bm100867h
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 662UU
UT WOS:000282840200032
PM 20815399
DA 2018-10-19
ER

PT J
AU Choi, YJ
   Lee, JY
   Park, JH
   Park, JB
   Suh, JS
   Choi, YS
   Lee, SJ
   Chung, CP
   Park, YJ
AF Choi, Yoon Jung
   Lee, Jue Yeon
   Park, Jung Hyun
   Park, Jun Beom
   Suh, Jin Sook
   Choi, Young Suk
   Lee, Seung Jin
   Chung, Chong-Pyoung
   Park, Yoon Jeong
TI The identification of a heparin binding domain peptide from bone
   morphogenetic protein-4 and its role on osteogenesis
SO BIOMATERIALS
LA English
DT Article
DE Heparin binding domain (HBD) peptide; Bone morphogenetic protein-4;
   Osteoblastic differentiation; ERK1/2 pathway; Bioactive material; Bone
   formation
ID FIBROBLAST-GROWTH-FACTOR; OSTEOBLASTIC DIFFERENTIATION;
   CELL-DIFFERENTIATION; IN-VITRO; KINASE; FIBRONECTIN; ACTIVATION;
   RECEPTOR; SULFATE; BMP-2
AB The presence of heparin binding has been become crucial in exerting growth factor related tissue formation. Receptor-mediated osteoblastic differentiation by bone morphogenetic protein (BMP)-4 and supportive function of its heparin binding has been proposed, direct role of the heparin binding site of BMP-4 on osteogenesis has not yet been fully investigated. If the binding site itself plays role on osteogenesis, the site domain can be useful in bone formation in combination with biomaterial. Herein, we synthesized a peptide sequence corresponding to residues 15-24 of BMP-4 (HBD, RKKNPNCRRH), as potential heparin binding sequence. The HBD peptide-induced ostoegenic differentiation by activating extracellular signal-regulated kinase (ERK1/2), one of the key regulators in hMSC. Also, treatment of cultured hMSCs with heparinase blocked both HBD peptide-induced osteogenic differentiation and GAG chain detection while abolishing the increased phospho-ERK level. These results suggest that the identified heparin binding domain peptide (HBD) stimulated osteoblastic differentiation via interaction with heparin and the ERK signaling. In vivo results further demonstrated that HBD, as a form of complex with alginate gel, was able to induce bone formation in the bone defect. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Park, Jung Hyun; Park, Jun Beom; Chung, Chong-Pyoung; Park, Yoon Jeong] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul 110749, South Korea.
   [Choi, Yoon Jung; Lee, Jue Yeon; Park, Jung Hyun; Park, Jun Beom; Suh, Jin Sook; Choi, Young Suk; Chung, Chong-Pyoung; Park, Yoon Jeong] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
   [Lee, Seung Jin] Ewha Womans Univ, Coll Pharm, Dept Ind Pharm, Seoul, South Korea.
   [Lee, Jue Yeon; Chung, Chong-Pyoung; Park, Yoon Jeong] Nano Intelligent Biomed Engn Corp NIBEC, Res Ctr, Seoul, South Korea.
RP Park, YJ (reprint author), Seoul Natl Univ, Sch Dent, Dept Periodontol, 28-22 Yongon Dong, Seoul 110749, South Korea.
EM ccpperio@snu.ac.kr; parkyj@snu.ac.kr
FU Korean Science and Technology Foundation (KOSEF) [2008 - 00889];
   Bioteeth development program [2009 - 0084043]; Korea Research Council of
   Fundamental Science & Technology (KRCF), Korea
FX This study was supported in part by the Korean Science and Technology
   Foundation (KOSEF) Nanobiotechnology development program (# 2008 -
   00889), in part by Bioteeth development program (# 2009 - 0084043) and
   in part by Korea Research Council of Fundamental Science & Technology
   (KRCF), Korea.
CR BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001
   Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530
   Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Kanzaki S, 2008, J CELL PHYSIOL, V216, P844, DOI 10.1002/jcp.21468
   Kozawa O, 2002, J CELL BIOCHEM, V84, P583, DOI 10.1002/jcb.10056
   Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200
   Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351
   Lin X, 2006, BBA-GEN SUBJECTS, V1760, P1403, DOI 10.1016/j.bbagen.2006.05.010
   Lou J, 2000, BIOCHEM BIOPH RES CO, V268, P757, DOI 10.1006/bbrc.2000.2210
   Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200
   Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080
   Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535
   Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4
   Park JB, 2007, J PERIODONTOL, V78, P157, DOI 10.1902/jop.2007.060200
   Park YJ, 2005, FASEB J, V19, P1555, DOI 10.1096/fj.04-2322fje
   Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744
   Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004
   Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Sagnella S, 2005, TISSUE ENG, V11, P226, DOI 10.1089/ten.2005.11.226
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Sammons J, 2004, STEM CELLS DEV, V13, P273, DOI 10.1089/154732804323099208
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3
   Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   Tang CH, 2003, J BONE MINER RES, V18, P502, DOI 10.1359/jbmr.2003.18.3.502
   Van Der Horst G, 2002, BONE, V31, P661, DOI 10.1016/S8756-3282(02)00903-1
   Vinall RL, 2001, J BONE JOINT SURG AM, V83A, pS63
   Wan Mei, 2005, Biochemical and Biophysical Research Communications, V328, P651, DOI 10.1016/j.bbrc.2004.11.067
NR 38
TC 29
Z9 30
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2010
VL 31
IS 28
BP 7226
EP 7238
DI 10.1016/j.biomaterials.2010.05.022
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 642DE
UT WOS:000281183000003
PM 20621352
DA 2018-10-19
ER

PT J
AU Cai, L
   Wang, SF
AF Cai, Lei
   Wang, Shanfeng
TI Parabolic dependence of material properties and cell behavior on the
   composition of polymer networks via simultaneously controlling
   crosslinking density and crystallinity
SO BIOMATERIALS
LA English
DT Article
DE Poly(propylene fumarate) (PPF); Poly(epsilon-caprolactone) diacrylate
   (PCLDA); Photo-crosslinking; Substrate stiffness; Cell-biomaterial
   interaction
ID POLY(EPSILON-CAPROLACTONE FUMARATE) NETWORKS; TISSUE ENGINEERING
   SCAFFOLD; CONTROLLED-PORE STRUCTURES; POLY(PROPYLENE FUMARATE);
   PHYSICAL-PROPERTIES; MECHANICAL-PROPERTIES; POLY(CAPROLACTONE FUMARATE);
   SUBSTRATE STIFFNESS; PERIPHERAL-NERVE; MOLECULAR-WEIGHT
AB A systematic investigation was performed on regulating materials properties and cell behavior using hybrid networks composed of amorphous poly(propylene fumarate) (PPF) and three poly(epsilon-caprolactone) diacrylates (PCLDAs) with variance in crystallinity and melting temperature. Through controlling both crosslinking density and crystallinity in the photo-crosslinked PPF/PCLDA blends, mechanical properties could be tuned efficiently in a wide range. For PCLDA synthesized from a low-molecular weight PCL diol precursor with a low crystallinity and a low melting point, crosslinks could completely suppress crystalline domains over the composition range in the PPF/PCLDA networks. Consequently, tensile, shear, torsional, and compression moduli all increased with the composition of PPF or the crosslinking density continuously for amorphous PPF/PCLDA networks. For PCLDAs synthesized using two PCL diols with higher molecular weights, crystallinity remained for the PCLDA compositions between similar to 80% and 100%. Minimum moduli and tensile stress at break were found at the lowest required composition of PPF for suppressing crystallinity. Surface physicochemical properties and morphology of the crosslinked blend disks have been characterized and their capabilities of adsorbing proteins from cell culture medium have been determined. Using both mouse MC3T3-E1 cells and rat Schwann cell precursor line (SpL201) cells, cell responses to these polymer networks such as cell adhesion, spreading, and proliferation were found to be dramatically distinct on different polymer networks and demonstrated non-monotonic or parabolic dependence on the network composition, coincident with the composition dependence of the mechanical properties. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Cai, Lei; Wang, Shanfeng] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
RP Wang, SF (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM swang16@utk.edu
RI Cai, Lei/D-1589-2013
FU University of Tennessee; Center of Nanophase Materials [CNMS2009-R03]
FX This work was supported by the start-up fund of the University of
   Tennessee. We thank Xiaoming Jiang and Dr. Bin Zhao in the Department of
   Chemistry for the help with contact angle measurements, Dr. Anthony J.
   Windebank and Jarred Nesbitt at Mayo Clinic for supplying rat SpL201
   cells. Supported by the Center of Nanophase Materials Sciences Research
   Proposal of CNMS2009-R03, AFM measurements were performed at Oak Ridge
   National Laboratory with the help from Dr. Stephen Jesse.
CR Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5
   Brandrup J, 1989, POLYM HDB
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Cai L, 2010, POLYMER, V51, P164, DOI 10.1016/j.polymer.2009.11.042
   Cai L, 2010, BIOMACROMOLECULES, V11, P304, DOI 10.1021/bm901237t
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Harbers G.M., 2005, INTRO BIOMATERIALS, P15
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852
   Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KW, 2006, TISSUE ENG, V12, P2801, DOI 10.1089/ten.2006.12.2801
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lobsiger CS, 2001, GLIA, V36, P31, DOI 10.1002/glia.1093
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Nojima S, 1998, POLYMER, V39, P1727, DOI 10.1016/S0032-3861(97)00457-6
   Nojima S, 1997, POLYMER, V38, P2711, DOI 10.1016/S0032-3861(97)85605-4
   Norman LL, 2009, TISSUE ENG PART B-RE, V15, P291, DOI [10.1089/ten.teb.2009.0114, 10.1089/ten.TEB.2009.0114]
   Park A, 1996, J BIOMED MATER RES, V31, P117
   Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salgado AJ, 2006, MATER SCI FORUM, V514-516, P1020, DOI 10.4028/www.scientific.net/MSF.514-516.1020
   Saltzman WM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P279, DOI 10.1016/B978-012370615-7/50024-X
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Shi X., 2006, INTRO BIOMATERIALS, P205
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   SPERLING LH, 2001, INTRO PHYS POLYM SCI, P363
   STRASSMAN RJ, 1973, EXP CELL RES, V81, P482, DOI 10.1016/0014-4827(73)90539-9
   Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363
   SUGGS LJ, 2006, PHYS PROPERTIES POLY, P939
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   WANG S, 2006, P AICHE ANN M SAN FR
   Wang SF, 2006, BIOMACROMOLECULES, V7, P1976, DOI 10.1021/bm060096a
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang SF, 2005, MACROMOLECULES, V38, P7358, DOI 10.1021/ma050884c
   Wang SF, 2008, BIOMACROMOLECULES, V9, P1229, DOI 10.1021/bm7012313
   Wang SF, 2009, ACTA BIOMATER, V5, P1531, DOI 10.1016/j.actbio.2008.12.015
   Wang SF, 2008, POLYMER, V49, P5692, DOI 10.1016/j.polymer.2008.10.021
   Wang SF, 2009, BIOMATERIALS, V30, P3359, DOI 10.1016/j.biomaterials.2009.03.015
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woodhoo A, 2007, BRAIN, V130, P2175, DOI 10.1093/brain/awm125
NR 62
TC 42
Z9 42
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2010
VL 31
IS 29
BP 7423
EP 7434
DI 10.1016/j.biomaterials.2010.06.028
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 642DG
UT WOS:000281183200002
PM 20663551
DA 2018-10-19
ER

PT J
AU Okada, M
   Payne, TR
   Oshima, H
   Momoi, N
   Tobita, K
   Huard, J
AF Okada, Masaho
   Payne, Thomas R.
   Oshima, Hideki
   Momoi, Nobuo
   Tobita, Kimimasa
   Huard, Johnny
TI Differential efficacy of gels derived from small intestinal submucosa as
   an injectable biomaterial for myocardial infarct repair
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; Animal model; Bioactivity; Cardiac tissue engineering;
   Fibroblast growth factor; SIS (small intestine submucosa)
ID ASSEMBLING PEPTIDE NANOFIBERS; EXTRACELLULAR-MATRIX;
   VENTRICULAR-FUNCTION; ENDOTHELIAL-CELLS; CARDIAC-FUNCTION; STEM-CELLS;
   PDGF-BB; HYDROGEL; ALGINATE; TISSUE
AB Injectable biomaterials have been recently investigated as a therapeutic approach for cardiac repair. Porcine-derived small intestinal submucosa (SIS) material is currently used in the clinic to promote accelerated wound healing for a variety of disorders. In this study, we hypothesized that gels derived from SIS extracellular matrix would be advantageous as an injectable material for cardiac repair. We evaluated 2 forms of SIS gel, types B (SIS-B) and C (SIS-C), for their ability to provide a therapeutic effect when injected directly into ischemic myocardium using a murine model of an acute myocardial infarction. Echocardiography analysis at both 2 and 6 weeks after infarction demonstrated preservation of end-systolic left ventricular geometry and improvement of cardiac contractility in the hearts injected with SIS-B when compared with control hearts injected with saline. However, the SIS-C gel provided no functional efficacy in comparison with control. Histological analysis revealed that SIS-B reduced infarct size and induced angiogenesis relative to control, whereas injection of SIS-C had minimal effect on these histological parameters. Characterization of both gels revealed differential growth factor content with SIS-B exhibiting higher levels of basic fibroblast growth factor than SIS-C, which may explain, at least in part, the differential histological and functional results. This study suggests that SIS gel offers therapeutic potential as an injectable material for the repair of ischemic myocardium. Further understanding of SIS gel characteristics, such as biological and physical properties, that are critical determinants of efficacy would be important for optimization of this biomaterial for cardiac repair. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Huard, Johnny] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15219 USA.
   [Okada, Masaho; Payne, Thomas R.; Oshima, Hideki; Huard, Johnny] Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Pittsburgh, PA 15213 USA.
   [Momoi, Nobuo; Tobita, Kimimasa; Huard, Johnny] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA.
   [Huard, Johnny] Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15219 USA.
   [Payne, Thomas R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Payne, Thomas R.] Cook MyoSite, Pittsburgh, PA USA.
RP Huard, J (reprint author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, 450 Technol Dr,2 Bridgeside Point,Suite 206, Pittsburgh, PA 15219 USA.
EM jhuard@pitt.edu
RI Oshima, Hideki/I-7373-2014
FU Donaldson Chair at Children's Hospital of Pittsburgh; Henry J. Mankin
   Chair at the University of Pittsburgh
FX The Donaldson Chair at Children's Hospital of Pittsburgh and the Henry
   J. Mankin Chair at the University of Pittsburgh supported this work. We
   thank James Cummins, Ronald Jankowski, and Michelle Chutka for their
   assistance in the preparation of this manuscript. We also thank Cook
   Biotech Incorporated for providing SIS gel material.
CR Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Cheng EY, 2000, WORLD J UROL, V18, P26, DOI 10.1007/PL00007071
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2005, BIOCHEM BIOPH RES CO, V332, P1146, DOI 10.1016/j.bbrc.2005.04.174
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Janis A. D., 2005, WOUND REPAIR REGEN, V13, pA4
   Jankowski Ron, 2004, Rev Urol, V6, P51
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2
   Okada M, 2008, J AM COLL CARDIOL, V52, P1869, DOI 10.1016/j.jacc.2008.07.064
   Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.04.686
   Pavcnik D, 2002, J VASC SURG, V35, P598, DOI 10.1067/mva.2002.118825
   Rosen Michael, 2005, Surg Innov, V12, P227, DOI 10.1177/155335060501200307
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   ZHAO ZQ, 2008, CIRCULATION, V118
NR 37
TC 51
Z9 54
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2010
VL 31
IS 30
BP 7678
EP 7683
DI 10.1016/j.biomaterials.2010.06.056
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645XD
UT WOS:000281498600009
PM 20674011
DA 2018-10-19
ER

PT J
AU Miyagi, Y
   Zeng, FQ
   Huang, XP
   Foltz, WD
   Wu, J
   Mihic, A
   Yau, TM
   Weisel, RD
   Li, RK
AF Miyagi, Yasuo
   Zeng, Faquan
   Huang, Xi-Ping
   Foltz, Warren D.
   Wu, Jun
   Mihic, Anton
   Yau, Terrence M.
   Weisel, Richard D.
   Li, Ren-Ke
TI Surgical ventricular restoration with a cell- and cytokine-seeded
   biodegradable scaffold
SO BIOMATERIALS
LA English
DT Article
DE Biodegradation; Cardiac tissue engineering; Cytokine; Hydrogel; Stem
   cell; Surgical ventricular restoration (SVR)
ID MYOCARDIAL TISSUE; BONE-MARROW; STEM-CELLS; THERAPY; RAT;
   TRANSPLANTATION; INFARCT; SURGERY; GRAFTS
AB Late after a myocardial infarction (MI), surgical ventricular restoration (SVR) can reduce left ventricular volumes, but an enhanced cardiac patch may be required to restore function. We developed a new, biodegradable patch (modified gelfoam, MGF) consisting of a spongy inner core (gelfoam) to encourage cell engraftment and an outer coating (poly epsilon-caprolactone) to provide sufficient strength to permit ventricular repair. Two weeks after coronary ligation in rats. SVR was performed using one of the following: gelfoam, MGF, MGF patches with hydrogel alone, or with hydrogel and cytokines (stem cell factor, stromal cell-derived factor-1 alpha), bone marrow mesenchymal stem cells, or both. Cardiac function and morphology were evaluated by echocardiography, conduction catheterization, magnetic resonance imaging, and histology. Animals whose hearts were repaired with untreated gelfoam died of ventricular rupture. The MGF groups had significantly improved myocardial systolic function vs. MI controls. Enhancement with cytokines and/or cells promoted more a-smooth muscle actin-positive cells, more capillaries, greater wall thickness, a more ellipsoid shape, greater fractional shortening, and better-preserved systolic elastance than MGF alone. This combination of the new, reinforced, biodegradable biomaterial and cytokine/cell treatment created a viable tissue after SVR and produced better functional outcomes than un-reinforced gelfoam or MGF alone. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Miyagi, Yasuo; Zeng, Faquan; Huang, Xi-Ping; Wu, Jun; Mihic, Anton; Yau, Terrence M.; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Hosp, Div Cardiovasc Surg, Toronto, ON, Canada.
   [Miyagi, Yasuo; Zeng, Faquan; Huang, Xi-Ping; Wu, Jun; Mihic, Anton; Yau, Terrence M.; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Toronto, ON, Canada.
   [Foltz, Warren D.] Univ Hlth Network, Princess Margaret Hosp, Radiat Med Program, Toronto, ON, Canada.
   [Foltz, Warren D.] Univ Toronto, Toronto, ON, Canada.
RP Li, RK (reprint author), MaRS Ctr, Toronto Med Discovery Tower,Room 3-702,101 Coll S, Toronto, ON M5G 1L7, Canada.
EM renkeli@uhnres.utoronto.ca
OI Li, Ren-Ke/0000-0002-2584-060X
FU Heart and Stroke Foundation of Canada [16604]; Canada Research Chair in
   Cardiac Regeneration; Canadian Institutes of Health Research [RMF82498]
FX R-KL is a Career Investigator of the Heart and Stroke Foundation of
   Canada, and holds a Canada Research Chair in Cardiac Regeneration. This
   research was supported by grants to R-KL from the Heart and Stroke
   Foundation of Ontario (16604) and by a team grant from the Canadian
   Institutes of Health Research (RMF82498).
CR Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Behfar A, 2008, J MOL CELL CARDIOL, V45, P523, DOI 10.1016/j.yjmcc.2008.09.122
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471
   DI D, 2001, J THORAC CARDIOVASC, V121, P91
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019
   Feygin J, 2007, AM J PHYSIOL-HEART C, V293, pH1772, DOI 10.1152/ajpheart.00242.2007.
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   GURALNICK WC, 1948, ORAL SURG ORAL MED O, V1, P632, DOI 10.1016/0030-4220(48)90337-5
   Horii B, 2004, EUR J CARDIO-THORAC, V26, P1174, DOI 10.1016/j.ejcts.2004.06.023
   Hu QS, 2006, AM J PHYSIOL-HEART C, V291, pH648, DOI 10.1152/ajpheart.01387.2005
   Huang NF, 2007, TISSUE ENG, V13, P1809, DOI 10.1089/ten.2006.0096
   JENKINS HP, 1946, JAMA-J AM MED ASSOC, V132, P614, DOI 10.1001/jama.1946.02870460004002
   Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559
   Kan CD, 2007, J AM COLL CARDIOL, V50, P1086, DOI 10.1016/j.jacc.2007.06.009
   Krogman KC, 2007, LANGMUIR, V23, P3137, DOI 10.1021/la063085b
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   Ozawa T, 2002, CIRCULATION, V106, pI176, DOI 10.1161/01.cir.0000032901.55215.cc
   Saeed M, 2002, RADIOLOGY, V224, P830, DOI 10.1148/radiol.2243011372
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499
   Tomita S, 1999, CIRCULATION, V100, P247
   Wu J, 2009, CIRCULATION, V120, pS997
   Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005
NR 25
TC 32
Z9 36
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2010
VL 31
IS 30
BP 7684
EP 7694
DI 10.1016/j.biomaterials.2010.06.048
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645XD
UT WOS:000281498600010
PM 20659765
DA 2018-10-19
ER

PT J
AU Verron, E
   Gauthier, O
   Janvier, P
   Pilet, P
   Lesoeur, J
   Bujoli, B
   Guicheux, J
   Bouler, JM
AF Verron, Elise
   Gauthier, Olivier
   Janvier, Pascal
   Pilet, Paul
   Lesoeur, Julie
   Bujoli, Bruno
   Guicheux, Jerome
   Bouler, Jean-Michel
TI In vivo bone augmentation in an osteoporotic environment using
   bisphosphonate-loaded calcium deficient apatite
SO BIOMATERIALS
LA English
DT Article
DE Calcium phosphates; Drug delivery; Osteoporosis; Animal model; Bone
   regeneration
ID IMPLANTS DELIVERING BISPHOSPHONATE; HIP FRACTURE; POSTMENOPAUSAL WOMEN;
   MEVALONATE PATHWAY; PROXIMAL FEMUR; OVARIECTOMIZED RATS; ELDERLY
   PATIENTS; MINERAL DENSITY; PREVENTION; PHOSPHATE
AB Resorbable calcium phosphate (CaP) biomaterials have demonstrated considerable efficacy in bone reconstructive surgery. Furthermore, bisphosphonates (BPs) are well known anti-resorptive agents largely used in clinical treatments for osteoporosis. An injectable BP-combined CaP matrix has been developed in order to biologically reinforce osteoporotic bone by increasing the bone fraction and improving bone micro-architecture. Our previous in vitro studies have shown that CaP is effective for loading and releasing BPs at doses that can inhibit excessive bone resorption without affecting osteoblasts. In vivo studies in relevant animal models are necessary to explore the effect of our injectable BP-combined biomaterial on femur bone structure by performing three-dimensional microtomography analysis, histological studies and SEM observations. Firstly, in rat model, our BP-combined CaP matrix significantly improved the bone micro-architecture as compared to CaP alone. The implantation of the BP-loaded biomaterial within proximal femurs of osteoporotic ewes led to a significant increase in relative bone content and an improvement of its micro-architecture. These modifications were confirmed by histological and SEM observations, which revealed CaP granule resorption and new bone trabeculae formation. This approach could be considered in the future for preventing osteoporotic fractures that are preferentially localized in the proximal femur, vertebral bodies or wrist. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Verron, Elise; Gauthier, Olivier; Pilet, Paul; Lesoeur, Julie; Guicheux, Jerome; Bouler, Jean-Michel] PRES UNAM, INSERM, UMR 791, LIOAD, F-44042 Nantes 1, France.
   [Gauthier, Olivier] ONIRIS, Plateforme Chirurg Expt, F-44307 Nantes 3, France.
   [Janvier, Pascal; Bujoli, Bruno] PRES UNAM, CNRS, UMR 6230, CEISAM, F-44322 Nantes 3, France.
   [Verron, Elise] GRAFTYS SA, F-13854 Aix En Provence, France.
RP Bouler, JM (reprint author), PRES UNAM, INSERM, UMR 791, LIOAD, BP 84215, F-44042 Nantes 1, France.
EM Jean-michel.bouler@univ-nantes.fr
RI guicheux, Jerome/F-7767-2013; Gauthier, Olivier/A-4639-2015; Paul,
   Pilet/A-3755-2015; Verron, Elise/P-2645-2014
OI guicheux, Jerome/0000-0003-2754-3024; Verron, Elise/0000-0003-4276-5127;
   BOULER, Jean-Michel/0000-0001-9784-5584
FU ANR (MIADROS) [RNTS 05-00401]; Graftys SA (Aix en Provence, France)
FX This work was supported by the ANR (MIADROS, RNTS 05-00401) and Graftys
   SA (Aix en Provence, France).
CR Aulakh TS, 2009, BIOMATERIALS, V30, P1732, DOI 10.1016/j.biomaterials.2008.12.035
   Beckmann J, 2007, MED ENG PHYS, V29, P755, DOI 10.1016/j.medengphy.2006.08.006
   Bobyn JD, 2009, J BONE JOINT SURG AM, V91A, P23, DOI 10.2106/JBJS.I.00518
   Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Cesareo R, 2007, Minerva Endocrinol, V32, P275
   Chavassieux P, 2001, J BONE MINER RES, V16, P89, DOI 10.1359/jbmr.2001.16.1.89
   Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8
   Cranney A, 2007, CAN MED ASSOC J, V177, P575, DOI 10.1503/cmaj.070234
   Dinah AF, 2002, INJURY, V33, P393, DOI 10.1016/S0020-1383(02)00015-3
   Emkey RD, 2006, AM J MED, V119, p18S, DOI 10.1016/j.amjmed.2005.12.019
   Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x
   Erben RG, 2002, J BONE MINER RES, V17, P1498, DOI 10.1359/jbmr.2002.17.8.1498
   FAUCHEUX C, 2008, J BIOMED MATER RES A, P46
   Fisher JE, 2000, ENDOCRINOLOGY, V141, P4793, DOI 10.1210/en.141.12.4793
   FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R
   Fulfaro F, 1998, PAIN, V78, P157, DOI 10.1016/S0304-3959(98)00135-3
   Gallagher AM, 2008, J BONE MINER RES, V23, P1569, DOI [10.1359/jbmr.080510, 10.1359/JBMR.080510]
   Heini PF, 2004, CLIN BIOMECH, V19, P506, DOI 10.1016/j.clinbiomech.2004.01.014
   Huybrechts KF, 2006, BONE, V38, P922, DOI 10.1016/j.bone.2005.10.022
   ISHIKAWA K, 1993, J MATER SCI-MATER M, V4, P165, DOI 10.1007/BF00120386
   Ito M, 2003, BONE, V33, P90, DOI 10.1016/S8756-3282(03)00170-4
   Jiang Guizhen, 2004, J Oral Sci, V46, P75, DOI 10.2334/josnusd.46.75
   JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352
   Josse S, 2005, BIOMATERIALS, V26, P2073, DOI 10.1016/j.biomaterials.2004.05.019
   Josse S, 2004, ADV MATER, V16, P1423, DOI 10.1002/adma.200306340
   KALU D, 1999, BONE MINER, V15, P175
   Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101
   KHAIROUN I, 2009, 19 GRIBOI INT RES C
   KHAIROUN I, 2008, 8 WORLD BIOM C 2008
   Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721
   Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581
   McClung M R, 2000, Expert Opin Pharmacother, V1, P225, DOI 10.1517/14656566.1.2.225
   McCombs JS, 2004, MATURITAS, V48, P271, DOI 10.1016/j.maturitas.2004.02.005
   MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Newton BI, 2004, J COMP PATHOL, V130, P323, DOI 10.1016/j.jcpa.2003.12.007
   Obadia L, 2007, J BIOMED MATER RES B, V80B, P32, DOI 10.1002/jbm.b.30565
   Orcel P, 2005, JOINT BONE SPINE, V72, P461, DOI 10.1016/j.jbspin.2005.09.002
   Owens G, 2007, AM J MANAG CARE S, V13, pS290
   Owens G, 2007, AM J MANAG CARE, V13, pS290
   Papapoulos SE, 2005, OSTEOPOROSIS INT, V16, P468, DOI 10.1007/s00198-004-1725-z
   PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096
   PECK WA, 1993, AM J MED, V94, P646
   Peter B, 2005, BONE, V36, P52, DOI 10.1016/j.bone.2004.10.004
   Peter B, 2006, J BIOMED MATER RES A, V76A, P133, DOI 10.1002/jbm.a.30456
   Quigley PA, 2007, REHABIL NURS, V32, P120, DOI 10.1002/j.2048-7940.2007.tb00163.x
   Rabenda V, 2008, OSTEOPOROSIS INT, V19, P811, DOI 10.1007/s00198-007-0506-x
   Rabenda V, 2008, J BONE JOINT SURG AM, V90A, P2142, DOI 10.2106/JBJS.G.00864
   RANSOM S, 1998, TEXAS J AGING, V1, P8
   Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967
   Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C
   Roussiere H, 2005, J MATER CHEM, V15, P3869, DOI 10.1039/b503680a
   Roussiere H, 2008, CHEM MATER, V20, P182, DOI 10.1021/cm702584d
   Russell RGG, 2006, BONE, V38, pS7, DOI 10.1016/j.bone.2006.01.151
   Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013
   Stadelmann VA, 2008, EUR CELLS MATER, V16, P10, DOI 10.22203/eCM.v016a02
   STADELMANN VA, 2009, J BIOMECH, V42, P1219
   Stadelmann VA, 2009, J BIOMECH, V42, P1206, DOI 10.1016/j.jbiomech.2009.03.024
   Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7
   TURNER AS, 1995, BONE, V17, pS395, DOI 10.1016/8756-3282(95)00317-7
   TURNER AS, 1995, BONE, V17, P421
   van Balen R, 2001, CLIN ORTHOP RELAT R, P232
   van der Steenhoven TJ, 2009, CLIN BIOMECH, V24, P286, DOI 10.1016/j.clinbiomech.2008.11.009
NR 64
TC 54
Z9 55
U1 3
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2010
VL 31
IS 30
BP 7776
EP 7784
DI 10.1016/j.biomaterials.2010.06.047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645XD
UT WOS:000281498600019
PM 20643480
DA 2018-10-19
ER

PT J
AU He, Q
   Ao, Q
   Gong, K
   Zhang, LH
   Hu, M
   Gong, YD
   Zhang, XF
AF He, Qing
   Ao, Qiang
   Gong, Kai
   Zhang, Lihai
   Hu, Min
   Gong, Yandao
   Zhang, Xiufang
TI Preparation and characterization of chitosan-heparin composite matrices
   for blood contacting tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID CELL HEMOSTATIC PROPERTIES; BY-LAYER DEPOSITION; IN-VITRO;
   ENDOTHELIAL-CELLS; MOLECULAR-WEIGHT; THROMBOMODULIN EXPRESSION;
   POLYELECTROLYTE COMPLEXES; COVALENT IMMOBILIZATION; BIOMEDICAL
   APPLICATIONS; POLY(ETHYLENE OXIDE)
AB Chitosan has been widely used for biomaterial scaffolds in tissue engineering because of its good mechanical properties and cytocompatibility. However, the poor blood compatibility of chitosan has greatly limited its biomedical utilization, especially for blood contacting tissue engineering. In this study, we exploited a polymer blending procedure to heparinize the chitosan material under simple and mild conditions to improve its antithrombogenic property. By an optimized procedure, a macroscopically homogeneous chitosan-heparin (Chi-Hep) blended suspension was obtained, with which Chi-Hep composite films and porous scaffolds were fabricated. X-ray photoelectron spectroscopy and sulfur elemental analysis confirmed the successful immobilization of heparin in the composite matrices (i.e. films and porous scaffolds). Toluidine blue staining indicated that heparin was distributed homogeneously in the composite matrices. Only a small amount of heparin was released from the matrices during incubation in normal saline for 10 days. The composite matrices showed improved blood compatibility, as well as good mechanical properties and endothelial cell compatibility. These results suggest that the Chi-Hep composite matrices are promising candidates for blood contacting tissue engineering.
C1 [He, Qing; Gong, Kai; Gong, Yandao; Zhang, Xiufang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.
   [Ao, Qiang] Tsinghua Univ, Yuquan Hosp, Beijing 100049, Peoples R China.
   [Zhang, Lihai; Hu, Min] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China.
RP Zhang, XF (reprint author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.
EM zxf-dbs@mail.tsinghua.edu.cn
FU National Natural Science Foundation of China [30700848, 30772443];
   National Basic Research Program of China ('973 Program') [2005CB623905];
   National Natural Science Foundation of Beijing [7082090]
FX This work was supported by the National Natural Science Foundation of
   China (nos 30700848, 30772443), the National Basic Research Program of
   China ('973 Program', no 2005CB623905) and the National Natural Science
   Foundation of Beijing (no 7082090).
CR Amaral IF, 2009, BIOMATERIALS, V30, P5465, DOI 10.1016/j.biomaterials.2009.06.056
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Ao Q, 2006, J BIOMED MATER RES A, V77A, P11, DOI 10.1002/jbm.a.30593
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Cerri PS, 2003, MICRON, V34, P365, DOI 10.1016/S0968-4328(03)00098-2
   Chandy T, 2002, DRUG DELIV, V9, P87, DOI 10.1080/1042650020095584
   CHAVASIT V, 1990, BIOTECHNOL PROGR, V6, P2, DOI 10.1021/bp00001a001
   Chen LC, 2009, J INFECTION, V58, P368, DOI 10.1016/j.jinf.2009.02.018
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chou TC, 2003, BIOCHEM BIOPH RES CO, V302, P480, DOI 10.1016/S0006-291X(03)00173-6
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Conklin BS, 2004, ARTIF ORGANS, V28, P668, DOI 10.1111/j.1525-1594.2004.00062.x
   Cox M. C., 2004, LEHNINGER PRINCIPLES, P254
   Dautzenberg H, 2000, MACROMOL SYMP, V162, P1, DOI 10.1002/1521-3900(200012)162:1<1::AID-MASY1>3.0.CO;2-0
   de Vasconcelos CL, 2006, BIOMACROMOLECULES, V7, P1245, DOI 10.1021/bm050963w
   Di Stefano R, 2009, THROMB RES, V123, P925, DOI 10.1016/j.thromres.2008.10.013
   DING S, 2006, CHIN J CLIN REHABIL, V10, P161
   DION I, 1992, INT J ARTIF ORGANS, V15, P617
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Gattas-Asfura KM, 2006, COLLOID SURFACE A, V282, P471, DOI 10.1016/j.colsurfa.2005.10.068
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   Hoffmann B, 2009, J MATER SCI-MATER M, V20, P1495, DOI 10.1007/s10856-009-3707-3
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Hu W, 2009, J MATER SCI-MATER M, V20, P2275, DOI 10.1007/s10856-009-3797-y
   Jao WC, 2010, POLYM ADVAN TECHNOL, V21, P543, DOI 10.1002/pat.1459
   Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x
   KLEIN NJ, 1992, J CELL SCI, V102, P821
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Lee JW, 1999, J APPL POLYM SCI, V73, P113
   Letourneur D, 2002, J BIOMED MATER RES, V60, P94, DOI 10.1002/jbm.10072
   Lin WC, 2005, MACROMOL BIOSCI, V5, P1013, DOI 10.1002/mabi.200500077
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   Liu L, 2008, J BIOMED MATER RES B, V87B, P244, DOI 10.1002/jbm.b.31103
   Liu YC, 2004, J BIOL CHEM, V279, P36142, DOI 10.1074/jbc.M405039200
   Liu ZG, 2007, J BIOMED MATER RES A, V83A, P806, DOI 10.1002/jbm.a.31407
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P104, DOI 10.1016/0021-9797(83)90317-X
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Luangtana-anan M, 2005, PHARM DEV TECHNOL, V10, P189, DOI 10.1081/PDT-200054388
   Macleod GS, 1999, J CONTROL RELEASE, V58, P303, DOI 10.1016/S0168-3659(98)00168-0
   Marchetti M, 2003, HAEMATOLOGICA, V88, P895
   May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3
   Mende M, 2002, COLLOID POLYM SCI, V280, P342, DOI 10.1007/s00396-001-0614-7
   Miralem T, 1996, J BIOL CHEM, V271, P17100, DOI 10.1074/jbc.271.29.17100
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Neto CGD, 2005, POLYM INT, V54, P659, DOI 10.1002/pi.1738
   Ogwu AA, 2008, J BIOMED MATER RES B, V85B, P105, DOI 10.1002/jbm.b.30922
   Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Salmivirta M, 1996, FASEB J, V10, P1270
   Saraswathi V, 2004, J LIPID RES, V45, P794, DOI 10.1194/jlr.M300497-JLR200
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   SCHNEIDER PA, 1990, J VASC SURG, V11, P365, DOI 10.1067/mva.1990.16373
   She MY, 2007, J BIOMED MATER RES A, V80A, P497, DOI 10.1002/jbm.a.31083
   Sogias IA, 2008, BIOMACROMOLECULES, V9, P1837, DOI 10.1021/bm800276d
   Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928
   Tan QG, 2003, BIOMATERIALS, V24, P4699, DOI 10.1016/S0142-9612(03)00363-6
   Thornber K, 2006, FEBS J, V273, P5032, DOI 10.1111/j.1742-4658.2006.05500.x
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Vignoli A, 2006, HAEMATOL-HEMATOL J, V91, P207
   Wang AJ, 2006, J BIOMED MATER RES A, V79A, P36, DOI 10.1002/jbm.a.30683
   Wang DA, 2001, BIOMATERIALS, V22, P1549, DOI 10.1016/S0142-9612(00)00311-2
   Wang M, 2008, ACAD EMERG MED, V15, P656, DOI 10.1111/j.1553-2712.2008.00146.x
   Wang XH, 2005, J BIOMAT SCI-POLYM E, V16, P1063, DOI 10.1163/1568562054798554
   Wang XH, 2003, J BIOACT COMPAT POL, V18, P453, DOI 10.1177/0883911503040434
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Weecharangsan W, 2008, INT J PHARMACEUT, V348, P161, DOI 10.1016/j.ijpharm.2007.07.011
   WINTERTON LC, 1986, J COLLOID INTERF SCI, V111, P314, DOI 10.1016/0021-9797(86)90038-X
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   XU YL, 1994, J INVEST DERMATOL, V102, P833, DOI 10.1111/1523-1747.ep12382086
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Yang J, 2008, J BIOMED MATER RES B, V84B, P131, DOI 10.1002/jbm.b.30853
   Yin M, 2009, BIOMATERIALS, V30, P2764, DOI 10.1016/j.biomaterials.2009.01.039
   Zhang C, 2006, BRIT J PHARMACOL, V148, P741, DOI 10.1038/sj.bjp.0706741
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
   Zhu AP, 2005, APPL SURF SCI, V241, P485, DOI 10.1016/j.apsusc.2004.07.055
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
NR 80
TC 12
Z9 13
U1 0
U2 33
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD OCT
PY 2010
VL 5
IS 5
AR 055001
DI 10.1088/1748-6041/5/5/055001
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 655UR
UT WOS:000282277300019
PM 20826908
DA 2018-10-19
ER

PT J
AU Huang, ZY
   Chen, M
   Pan, SR
   Chen, DH
AF Huang, Zhan-Yun
   Chen, Min
   Pan, Shi-Rong
   Chen, Di-Hu
TI Effect of surface microstructure and wettability on plasma protein
   adsorption to ZnO thin films prepared at different RF powers
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID VITRO BLOOD COMPATIBILITY; ELECTRICAL-PROPERTIES; FIBRINOGEN;
   HEMOCOMPATIBILITY; IMMOBILIZATION; BIOMATERIAL; ELISA
AB In this paper, the adsorption behavior of plasma proteins on the surface of ZnO thin films prepared by radio frequency (RF) sputtering under different sputtering powers was studied. The microstructures and surface properties of the ZnO thin films were investigated by x-ray diffraction (XRD), scanning electron microscopy (SEM), UV-visible optical absorption spectroscopy and contact angle techniques. The results show that the ZnO thin films have better orientation of the (0 0 2) peak with increasing RF power, especially at around 160 W, and the optical band gap of the ZnO films varies from 3.2 to 3.4 eV. The contact angle test carried out by the sessile drop technique denoted a hydrophobic surface of the ZnO films, and the surface energy and adhesive work of the ZnO thin films decreased with increasing sputtering power. The amounts of human fibrinogen (HFG) and human serum albumin (HSA) adsorbing on the ZnO films and reference samples were determined by using enzyme-linked immunosorbent assay (ELISA). The results show that fewer plasma proteins and a smaller HFG/HSA ratio adsorb on the ZnO thin films' surface.
C1 [Huang, Zhan-Yun; Chen, Min; Chen, Di-Hu] Sun Yat Sen Univ, State Key Lab Optoelect Mat & Technol, Guangzhou 510275, Guangdong, Peoples R China.
   [Pan, Shi-Rong] Sun Yat Sen Univ, Affiliated Hosp 1, Artificial Heart Lab, Guangzhou 510080, Guangdong, Peoples R China.
RP Chen, DH (reprint author), Sun Yat Sen Univ, State Key Lab Optoelect Mat & Technol, Guangzhou 510275, Guangdong, Peoples R China.
EM stscdh@mail.sysu.edu.cn
FU National Science Foundation of China [NSFC 30770588, 30370410]
FX This work was supported by the National Science Foundation of China
   under grant nos. NSFC 30770588 and 30370410.
CR Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4
   CASPARY EA, 1957, BIOCHEM J, V67, P41, DOI 10.1042/bj0670041
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hwang DK, 2003, J CRYST GROWTH, V254, P449, DOI 10.1016/S0022-0248(03)01205-3
   Li BS, 2003, J CRYST GROWTH, V249, P179, DOI 10.1016/S0022-0248(02)02069-9
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   Lousinian S, 2007, MICROELECTRON ENG, V84, P479, DOI 10.1016/j.mee.2006.10.082
   Lu YM, 2001, MATER CHEM PHYS, V72, P269, DOI 10.1016/S0254-0584(01)00450-3
   Mansur H, 2002, SPECTROSC-INT J, V16, P351, DOI 10.1155/2002/183053
   Mansur HS, 2005, J MATER SCI-MATER M, V16, P333, DOI 10.1007/s10856-005-0632-y
   Mitsakakis K, 2007, BIOMOL ENG, V24, P119, DOI 10.1016/j.bioeng.2006.05.013
   Okpalugo TIT, 2004, DIAM RELAT MATER, V13, P1088, DOI 10.1016/j.diamond.2003.10.064
   Pineiro M, 2009, VET IMMUNOL IMMUNOP, V127, P228, DOI 10.1016/j.vetimm.2008.10.318
   ROOHK HV, 1976, T AM SOC ART INT ORG, V22, P1
   SAWYER PN, 1953, SURGERY, V34, P491
   SLACK S M, 1991, Journal of Biomaterials Science Polymer Edition, V2, P227
   Spijker HT, 2003, BIOMATERIALS, V24, P4717, DOI 10.1016/S0142-9612(03)00380-6
   VANOSS CJ, 1990, J PROTEIN CHEM, V9, P487, DOI 10.1007/BF01024625
   Vossen J., 1977, PHYS THIN FILMS, V9, P1
   Ye JY, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055004
NR 21
TC 15
Z9 15
U1 1
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD OCT
PY 2010
VL 5
IS 5
AR 054116
DI 10.1088/1748-6041/5/5/054116
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 655UR
UT WOS:000282277300017
PM 20876960
DA 2018-10-19
ER

PT J
AU Kohane, DS
   Langer, R
AF Kohane, Daniel S.
   Langer, Robert
TI Biocompatibility and drug delivery systems
SO CHEMICAL SCIENCE
LA English
DT Review
ID DURATION LOCAL-ANESTHESIA; PROTEIN-SUGAR PARTICLES; SCIATIC-NERVE
   BLOCKADE; HYALURONIC-ACID; IN-VIVO; POSTSURGICAL ADHESIONS;
   PLASMINOGEN-ACTIVATOR; RABBIT MODEL; BUPIVACAINE; BIOMATERIALS
AB Drug delivery technology has emerged as an important focus of biotechnological research and commercial enterprise. While much attention is justifiably focused on the design and effectiveness of drug delivery devices, the nature of their interaction with surrounding tissues their biocompatibility is crucial. Here we discuss biocompatibility, specifically as it relates to drug delivery systems, which differ from other biomaterial-based devices by possibly containing large quantities of drugs with their own effects on tissues.
C1 [Kohane, Daniel S.] Harvard Univ, Sch Med, Lab Biomat & Drug Delivery, Dept Anesthesiol,Div Crit Care Med,Childrens Hosp, Boston, MA 02115 USA.
   [Langer, Robert] MIT, Koch Inst Integrat Canc Technol, Cambridge, MA 02139 USA.
RP Kohane, DS (reprint author), Harvard Univ, Sch Med, Lab Biomat & Drug Delivery, Dept Anesthesiol,Div Crit Care Med,Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.
EM Daniel.Kohane@childrens.harvard.edu
FU NIGMS (National Institute of General Medical Sciences) [GM073626]; NIBIB
   (National Institute of Biomedical Imaging and Bioengineering) [EB006365]
FX This work was supported by GM073626 (to DSK) from NIGMS (National
   Institute of General Medical Sciences) and EB006365 (to RL) from NIBIB
   (National Institute of Biomedical Imaging and Bioengineering).
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   ANDERSON JM, 1994, EUR J PHARM BIOPHARM, V40, P1
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Castillo J, 1996, ANESTHESIOLOGY, V85, P1157, DOI 10.1097/00000542-199611000-00025
   Ciolino JB, 2009, INVEST OPHTH VIS SCI, V50, P3346, DOI 10.1167/iovs.08-2826
   Colombo G, 2005, J BIOMED MATER RES A, V75A, P458, DOI 10.1002/jbm.a.30443
   Colombo G, 2004, J BIOMED MATER RES A, V68A, P651, DOI 10.1002/jbm.a.20074
   Epstein-Barash H, 2009, P NATL ACAD SCI USA, V106, P7125, DOI 10.1073/pnas.0900598106
   Fielden MR, 2006, CURR OPIN DRUG DISC, V9, P84
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Haining WN, 2004, J IMMUNOL, V173, P2578, DOI 10.4049/jimmunol.173.4.2578
   Hoare T, 2010, J BIOMED MATER RES A, V92A, P586, DOI 10.1002/jbm.a.32420
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Hudson SP, 2010, BIOMATERIALS, V31, P1444, DOI 10.1016/j.biomaterials.2009.11.016
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301
   Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654
   Kohane DS, 2003, PAIN, V104, P415, DOI 10.1016/S0304-3959(03)00049-6
   Kohane DS, 1998, ANESTHESIOLOGY, V89, P119, DOI 10.1097/00000542-199807000-00019
   Kohane DS, 2002, BRAIN RES, V946, P206, DOI 10.1016/S0006-8993(02)02878-0
   Kohane DS, 2002, J BIOMED MATER RES, V59, P450, DOI 10.1002/jbm.1261
   Kohane DS, 2000, PHARMACEUT RES, V17, P1243, DOI 10.1023/A:1026470831256
   Little SR, 2008, J MATER CHEM, V18, P832, DOI 10.1039/b712930k
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   ORITA H, 1991, INT J FERTIL, V36, P172
   Padera R, 2008, ANESTHESIOLOGY, V108, P921, DOI 10.1097/ALN.0b013e31816c8a48
   Padera RF, 2006, MUSCLE NERVE, V34, P747, DOI 10.1002/mus.20618
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simons EJ, 2009, MOL PHARMACEUT, V6, P265, DOI 10.1021/mp800167a
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Yea Y, 2007, J CONTROL RELEASE, V120, P178, DOI 10.1016/j.jconrel.2007.04.016
   Yeo Y, 2008, EUR J PHARM BIOPHARM, V68, P57, DOI 10.1016/j.ejpb.2007.03.027
   Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033
   Yeo Y, 2007, ANN SURG, V245, P819, DOI 10.1097/01.sla.0000251519.49405.55
   Yeo Y, 2006, J BIOMED MATER RES A, V78A, P668, DOI 10.1002/jbm.a.30740
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zumbuehl A, 2007, P NATL ACAD SCI USA, V104, P12994, DOI 10.1073/pnas.0705250104
NR 45
TC 116
Z9 118
U1 2
U2 65
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2041-6520
EI 2041-6539
J9 CHEM SCI
JI Chem. Sci.
PD OCT 1
PY 2010
VL 1
IS 4
BP 441
EP 446
DI 10.1039/c0sc00203h
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 671DQ
UT WOS:000283480900002
DA 2018-10-19
ER

PT J
AU Brullmann, DD
   Klein, MO
   Al-Nawas, B
   Horn, S
   Busser, V
   Jung, B
   Wagner, W
   d'Hoedt, B
AF Bruellmann, Dan Dominik
   Klein, Marc O.
   Al-Nawas, Bilal
   Horn, Sigrid
   Buesser, Verena
   Jung, Barbara
   Wagner, Wilfried
   d'Hoedt, Bernd
TI Implementation of new software for fast screening of cell compatibility
   on surface modifications using low-contrast time-lapsed microscopy
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Live cell imaging; Automatic segmentation; Cell-adhesion dynamics;
   Biocompatibility
ID OSTEOBLAST-LIKE CELLS; EXTRACELLULAR-MATRIX; ADHESION MOLECULES; IMPLANT
   SURFACES; SEGMENTATION; COATINGS
AB Assessment of cell adhesion and cell size provides valuable information on surface biocornpatibility. However, most investigations on cell morphology dynamics are time and resource consuming, of rather descriptive character and lack procedures for appropriate quantification. The aim of the study was to develop a software programme which allows automated cell segmentation and identification as well as calculation and further processing of cell size in low-contrast images. The software utilises modified edge detection and morphologic operations for automatic cell analysis in light microscopy images. In an application study, osteogenic cell-adhesion dynamics were quantified for the ECM proteins collagen type I (COL) and fibronectin (FIB) over a period of 12 hrs. Untreated tissue culture polystyrene (TCPS) served as control. The software programme proofed full function in automatic cell tracking and quantification of cell size. After 11 h, cell sizes were highest for COL (6391 +/- 1167 mu m(2)) and FIB (6036 +/- 411 mu m(2)) compared with TCPS (3261 +/- 693 mu m(2)). The developed software allows quantification of initial cell size changes on translucent surface modifications and is suitable as a reliable tool for fast biocompatibility screening. Osteogenic cell adhesion was significantly promoted by COL and FIB indicating the potential of respective functionalized biomaterial surfaces.
C1 [Bruellmann, Dan Dominik; d'Hoedt, Bernd] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Oral Surg, D-55131 Mainz, Germany.
   [Klein, Marc O.; Al-Nawas, Bilal; Buesser, Verena; Wagner, Wilfried] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Oral & Maxillofacial Surg, D-55131 Mainz, Germany.
   [Horn, Sigrid] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, D-55131 Mainz, Germany.
   [Jung, Barbara] Johannes Gutenberg Univ Mainz, Dept Phys Math & Comp Sci, D-55099 Mainz, Germany.
RP Brullmann, DD (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Oral Surg, Augustuspl 2, D-55131 Mainz, Germany.
EM bruellmd@mail.uni-mainz.de; klein@mkg.klinik.uni-mainz.de;
   al-nawas@mkg.klinik.uni-mainz.de; shorn@uni-mainz.de;
   VerenaBuesser@gmx.de; beijung@web.de; wagner@mkg.klinik.uni-mainz.de
RI Al-Nawas, Bilal/C-8885-2013
OI Al-Nawas, Bilal/0000-0002-8665-5803
FU German Association of Implantology (Deutsche Gesellschaft fur
   Implantologie, DGI)
FX This project is supported by a grant from the German Association of
   Implantology (Deutsche Gesellschaft fur Implantologie, DGI).
CR Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   CANNY J, 1986, IEEE T PATTERN ANAL, V8, P697
   Cooke MJ, 2008, CYTOTECHNOLOGY, V56, P71, DOI 10.1007/s10616-007-9119-7
   Dallas SL, 2009, CELLS TISSUES ORGANS, V189, P6, DOI 10.1159/000151745
   Davies E. R., 2005, MACHINE VISION THEOR
   Debeir O, 2004, CYTOM PART A, V60A, P29, DOI 10.1002/cyto.a.20040
   Driemel O, 2007, CYTOPATHOLOGY, V18, P348, DOI 10.1111/j.1365-2303.2006.00401.x
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Ersoy I, 2008, C P IEEE ENG MED BIO, V1, P371
   GLASSNER A, 1990, GRAPHIC GEMS
   Gonzalez RC, 1992, DIGITAL IMAGE PROCES
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Kim HJ, 2005, J BIOMED MATER RES A, V74A, P366, DOI 10.1002/jbm.a.30327
   KIRCHHOF K, 2008, J MATER SCI-MATER M, V20, P897
   Klein MO, 2007, CLIN ORAL IMPLAN RES, V18, P40, DOI 10.1111/j.1600-0501.2006.01279.x
   KLEIN MO, 2006, Z ZAHNARZTL IMPLANTO, V21, P145
   Liu Gang, 2004, Chin J Traumatol, V7, P358
   Myler Harley R., 1993, POCKET HDB IMAGE PRO
   Park BS, 2005, J BIOMED MATER RES A, V74A, P640, DOI 10.1002/jbm.a.30326
   PARKER JR, 1999, ALGORITHMS IMAGE PRO
   PIENTA KJ, 1992, J CELL BIOCHEM, V49, P357, DOI 10.1002/jcb.240490406
   Polesel A, 2000, IEEE T IMAGE PROCESS, V9, P505, DOI 10.1109/83.826787
   Schliephake H, 2005, J BIOMED MATER RES B, V73B, P88, DOI 10.1002/jbm.b.30183
   Schliephake H, 2009, CLIN ORAL IMPLAN RES, V20, P31, DOI 10.1111/j.1600-0501.2008.01603.x
   SEUL M, 2005, PRACTICAL ALGORITHMS
   SHI H, 1995, J MATH IMAGING VIS, V5, P159
   Stadlinger B, 2007, J BIOMED MATER RES B, V83B, P222, DOI 10.1002/jbm.b.30787
   Tsai WB, 2009, J MATER SCI-MATER M, V20, P1367, DOI 10.1007/s10856-008-3687-8
   WALTER C, 2009, CLIN ORAL INVES 0318
   Wang M, 2008, BIOINFORMATICS, V24, P94, DOI 10.1093/bioinformatics/btm530
   Yu D, 2007, J NEUROSCI METH, V166, P125, DOI 10.1016/j.jneumeth.2007.06.028
   ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454
   Zhang K, 2008, J MICROSC-OXFORD, V231, P395, DOI 10.1111/j.1365-2818.2008.02050.x
NR 33
TC 4
Z9 4
U1 1
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD OCT
PY 2010
VL 14
IS 5
BP 499
EP 506
DI 10.1007/s00784-009-0339-4
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 666HT
UT WOS:000283106100003
PM 19697066
DA 2018-10-19
ER

PT J
AU Liu, Y
   Kemmer, A
   Keim, K
   Curdy, C
   Petersen, H
   Kissel, T
AF Liu, Yu
   Kemmer, Annette
   Keim, Klaus
   Curdy, Catherine
   Petersen, Holger
   Kissel, Thomas
TI Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ
   forming parenteral drug delivery systems: A feasibility study
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE Poly(ethylene carbonate); Solubility; Solvent release rate; Rheological
   properties; Morphology of depots
ID INJECTABLE POLY(LACTIDE-CO-GLYCOLIDE) DEPOTS; PHASE INVERSION DYNAMICS;
   DIMETHYL-SULFOXIDE; MEMBRANE FORMATION; PART II; RELEASE;
   BIODEGRADATION; MICROSPHERES; STABILITY; GEL
AB To evaluate the technical feasibility of poly(ethylene carbonate), PEC, for injectable in situ forming drug delivery systems, the physical properties of PEC solutions were characterized. The solubility of PEC was investigated in different solvents, and the Hildebrand solubility parameters and Flory-Huggins interaction parameters of PEC were determined. By turbidity titration, the experimental ternary phase diagram of water-NMP/DMSO-PEC was constructed. NMP solution required more water to precipitate PEC compared to DMSO solution. The dynamic viscosity of PEC solution increased at lower temperature, higher polymer concentration and longer aging time. Differential scanning calorimetric (DSC) measurements confirmed only weak physical interactions in the system after aging, and the physical aging effect was thermo-reversible. Release of NMP from PEC formulations was twofold slower than that of DMSO at similar concentrations. The morphology of PEC depots after injection into aqueous solution was studied using scanning electron microscopy (SEM). A DMSO formulation of bovine serum albumin displayed less burst release than a NMP formulation. In summary, our investigations demonstrate that in situ depot forming systems can be obtained from PEC solutions. Moreover, a solution of PEC in DMSO would be preferred over NMP due to the reduced burst release. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Liu, Yu; Kemmer, Annette; Keim, Klaus; Kissel, Thomas] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany.
   [Curdy, Catherine; Petersen, Holger] Novartis Pharma AG, Basel, Switzerland.
RP Kissel, T (reprint author), Univ Marburg, Dept Pharmaceut & Biopharm, Ketzerbach 63, D-35032 Marburg, Germany.
EM kissel@staff.uni-marburg.de
CR Acemoglu M, 1997, J CONTROL RELEASE, V49, P263, DOI 10.1016/S0168-3659(97)00097-7
   Acemoglu M, 2004, INT J PHARM, V277, P133, DOI 10.1016/j.ijpharm.2003.06.002
   BARTON AFM, 1975, CHEM REV, V75, P731, DOI 10.1021/cr60298a003
   Barton BF, 1997, J POLYM SCI POL PHYS, V35, P569, DOI 10.1002/(SICI)1099-0488(199703)35:4<569::AID-POLB5>3.0.CO;2-L
   BOOM RM, 1992, J MEMBRANE SCI, V73, P277, DOI 10.1016/0376-7388(92)80135-7
   BRISTOW GM, 1958, T FARADAY SOC, V54, P1731, DOI 10.1039/tf9585401731
   Brodbeck KJ, 1999, J CONTROL RELEASE, V62, P333, DOI 10.1016/S0168-3659(99)00159-5
   Chen L, 1997, J CONTROL RELEASE, V43, P261, DOI 10.1016/S0168-3659(96)01496-4
   COLLINS-GOLD L C, 1990, Advanced Drug Delivery Reviews, V5, P189, DOI 10.1016/0169-409X(90)90016-L
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   DAVIS SS, 1986, SITE SPECIFIC DRUG D, P210
   DesNoyer JR, 2003, J CONTROL RELEASE, V86, P15, DOI 10.1016/S0168-3659(02)00293-6
   Dong WY, 2006, J CONTROL RELEASE, V115, P158, DOI 10.1016/j.jconrel.2006.07.013
   Dunn R. L., 1990, US Patent, Patent No. 4938763
   DUNN RL, 1993, Patent No. 539751
   DUNN RL, 1996, Patent No. 9621427
   Espuelas MS, 1997, INT J PHARMACEUT, V158, P19, DOI 10.1016/S0378-5173(97)00194-4
   FLORENCE AT, 1982, INT J PHARM, V11, P277, DOI 10.1016/0378-5173(82)90080-1
   Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8
   Haglund BO, 1996, J CONTROL RELEASE, V41, P229, DOI 10.1016/0168-3659(96)01333-8
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Houen G, 1996, ACTA CHEM SCAND, V50, P68, DOI 10.3891/acta.chem.scand.50-0068
   Huang WY, 2001, MACROMOLECULES, V34, P7166, DOI 10.1021/ma010374s
   Ismail FA, 2000, PHARM DEV TECHNOL, V5, P391, DOI 10.1081/PDT-100100555
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Kim JH, 1998, J MEMBRANE SCI, V138, P153, DOI 10.1016/S0376-7388(97)00224-X
   Korber M, 2008, EUR J PHARM SCI, V35, P283, DOI 10.1016/j.ejps.2008.07.007
   Kranz H, 2008, EUR J PHARM SCI, V34, P164, DOI 10.1016/j.ejps.2008.03.004
   Kranz H, 2001, INT J PHARM, V212, P11, DOI 10.1016/S0378-5173(00)00568-8
   Lambert O, 2000, J CONTROL RELEASE, V67, P89, DOI 10.1016/S0168-3659(00)00198-X
   LAMBERT WJ, 1995, J CONTROL RELEASE, V33, P189, DOI 10.1016/0168-3659(94)00083-7
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   MCHUGH AJ, 1995, J MEMBRANE SCI, V105, P121, DOI 10.1016/0376-7388(95)00046-F
   Moghimi SM, 1998, INT J PHARMACEUT, V162, P11, DOI 10.1016/S0378-5173(97)00407-9
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Park TG, 1998, J CONTROL RELEASE, V55, P181, DOI 10.1016/S0168-3659(98)00050-9
   Saiani A, 1998, MACROMOLECULES, V31, P703, DOI 10.1021/ma9710693
   Sharma A, 1997, INT J PHARM, V154, P123, DOI 10.1016/S0378-5173(97)00135-X
   Shea JA, 1998, J CHROMATOGR SCI, V36, P187, DOI 10.1093/chromsci/36.4.187
   SHIVELY ML, 1995, J CONTROL RELEASE, V33, P237, DOI 10.1016/0168-3659(94)00097-E
   Stevenson CL, 1999, INT J PHARM, V191, P115, DOI 10.1016/S0378-5173(99)00289-6
   Stoll GH, 2001, J CONTROL RELEASE, V76, P209, DOI 10.1016/S0168-3659(01)00417-5
   Strickley RG, 2004, PHARM RES, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23
   THUMM W, 1991, CHROMATOGRAPHIA, V32, P461, DOI 10.1007/BF02327979
   Wang LW, 2005, J BIOMED MATER RES B, V72B, P215, DOI 10.1002/jbm.b.30147
   Wang LW, 2004, J CONTROL RELEASE, V99, P207, DOI 10.1016/j.jconrel.2004.06.021
   Wang LW, 2003, J CONTROL RELEASE, V90, P345, DOI 10.1016/S0168-3659(03)00198-6
   Yang S, 2003, J MEMBRANE SCI, V222, P87, DOI 10.1016/S0376-7388(03)00220-5
   YILMAZ L, 1986, J APPL POLYM SCI, V31, P997, DOI 10.1002/app.1986.070310404
   ZHANG QZ, 2006, J MEMBRANE SCI, V279, P230
   Zhang XC, 1996, INT J PHARM, V132, P195, DOI 10.1016/0378-5173(95)04386-1
NR 51
TC 11
Z9 11
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD OCT
PY 2010
VL 76
IS 2
BP 222
EP 229
DI 10.1016/j.ejpb.2010.07.009
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 674OM
UT WOS:000283756700009
PM 20650316
DA 2018-10-19
ER

PT J
AU Ganguli, R
   Gorb, S
   Lehmann, FO
   Mukherjee, S
AF Ganguli, R.
   Gorb, S.
   Lehmann, F. -O.
   Mukherjee, S.
TI An Experimental and Numerical Study of Calliphora Wing Structure
SO EXPERIMENTAL MECHANICS
LA English
DT Article
DE Micro air vehicle; Calliphora; Mass per unit length; Flexural rigidity;
   Torsional rigidity; Natural frequency; Finite element method
ID MICRO-AIR VEHICLES; BIOMIMETIC ROBOTIC INSECTS; FLAPPING FLIGHT;
   MECHANICAL-PROPERTIES; FLEXURAL STIFFNESS; DESIGN; AERODYNAMICS;
   DEFORMATION; ROTATION; CUTICLE
AB Experiments are performed to determine the mass and stiffness variations along the wing of the blowfly Calliphora. The results are obtained for a pairs of wings of 10 male flies and fresh wings are used. The wing is divided into nine locations along the span and seven locations along the chord based on venation patterns. The length and mass of the sections is measured and the mass per unit length is calculated. The bending stiffness measurements are taken at three locations, basal (near root), medial and distal (near tip) of the fly wing. Torsional stiffness measurements are also made and the elastic axis of the wing is approximately located. The experimental data is then used for structural modeling of the wing as a stepped cantilever beam with nine spanwise sections of varying mass per unit lengths, flexural rigidity (EI) and torsional rigidity (GJ) values. Inertial values of nine sections are found to approximately vary according to an exponentially decreasing law over the nine sections from root to tip and it is used to calculate an approximate value of Young's modulus of the wing biomaterial. Shear modulus is obtained assuming the wing biomaterial to be isotropic. Natural frequencies, both in bending and torsion, are obtained by solving the homogeneous part of the respective governing differential equations using the finite element method. The results provide a complete analysis of Calliphora wing structure and also provide guidelines for the biomimetic structural design of insect-scale flapping wings.
C1 [Ganguli, R.] Indian Inst Sci, Dept Aerosp Engn, Bangalore, Karnataka, India.
   [Gorb, S.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany.
   [Lehmann, F. -O.] Univ Ulm, Inst Neurobiol, Biofuture Res Grp, Ulm, Germany.
   [Mukherjee, S.] Natl Inst Technol, Dept Civil Engn, Tiruchchirappalli, Tamil Nadu, India.
RP Ganguli, R (reprint author), Indian Inst Sci, Dept Aerosp Engn, Bangalore, Karnataka, India.
EM ganguli@aero.iisc.ernet.in
RI Ganguli, Ranjan/B-2592-2010
OI Ganguli, Ranjan/0000-0002-5315-2070
FU Alexander von Humboldt foundation
FX The first author thanks the Alexander von Humboldt foundation for
   providing a fellowship for conducting part of this work.
CR Ansari SA, 2006, PROG AEROSP SCI, V42, P129, DOI 10.1016/j.paerosci.2006.07.001
   Bao L, 2006, APPL MATH MECH-ENGL, V27, P741, DOI 10.1007/s10483-006-0604-1
   Barbakadze N, 2006, J EXP BIOL, V209, P722, DOI 10.1242/jeb.02065
   Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523
   Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524
   Cook R. D., 2005, CONCEPTS APPL FINITE
   DELAURIER JD, 1982, J AIRCRAFT, V19, P368, DOI 10.2514/3.44760
   Deng XY, 2006, IEEE T ROBOT, V22, P789, DOI 10.1109/TRO.2006.875483
   Deng XY, 2006, IEEE T ROBOT, V22, P776, DOI 10.1109/TRO.2006.875480
   Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954
   Ellington CP, 1999, J EXP BIOL, V202, P3439
   ENNOS AR, 1988, J EXP BIOL, V140, P137
   ENNOS AR, 1988, J EXP BIOL, V140, P161
   ENNOS AR, 1995, P ROY SOC LOND B BIO, V140, P161
   Gere JM, 1999, MECH MAT
   Gorb SN, 2002, PHILOS T ROY SOC A, V360, P211, DOI 10.1098/rsta.2001.0926
   Hall KC, 1996, J FLUID MECH, V323, P285, DOI 10.1017/S0022112096000924
   Langer MG, 2004, P ROY SOC B-BIOL SCI, V271, P2209, DOI 10.1098/rspb.2004.2850
   Machida K, 2007, KEY ENG MATER, V345-346, P1237, DOI 10.4028/www.scientific.net/KEM.345-346.1237
   Matushkina N, 2007, ZOOLOGY, V110, P167, DOI 10.1016/j.zool.2006.11.003
   Maybury WJ, 2004, J EXP BIOL, V207, P4707, DOI 10.1242/jeb.01319
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Okamoto M, 1996, J EXP BIOL, V199, P281
   Rao S. S., 2004, MECH VIBRATIONS
   Rosenfeld NC, 2009, J AIRCRAFT, V46, P450, DOI 10.2514/1.34938
   Shyy W, 1999, PROG AEROSP SCI, V35, P455, DOI 10.1016/S0376-0421(98)00016-5
   Smith MJC, 1996, AIAA J, V34, P1348, DOI 10.2514/3.13239
   Sunada S, 1998, J THEOR BIOL, V193, P39, DOI 10.1006/jtbi.1998.0678
   Szmelter J, 2002, INT J NUMER METH FL, V40, P497, DOI 10.1002/fld.314
   Templin RJ, 2000, PROG AEROSP SCI, V36, P393, DOI 10.1016/S0376-0421(00)00007-5
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Wang XS, 2008, COMPOS SCI TECHNOL, V68, P186, DOI 10.1016/j.compscitech.2007.05.023
   Wang ZJ, 2000, J FLUID MECH, V410, P323, DOI 10.1017/S0022112099008071
   Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940
   Watson GS, 2004, APPL SURF SCI, V235, P139, DOI 10.1016/j.apsusc.2004.05.129
   Wootton RJ, 2003, PHILOS T ROY SOC B, V358, P1577, DOI 10.1098/rstb.2003.1351
NR 36
TC 16
Z9 16
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0014-4851
J9 EXP MECH
JI Exp. Mech.
PD OCT
PY 2010
VL 50
IS 8
BP 1183
EP 1197
DI 10.1007/s11340-009-9316-8
PG 15
WC Materials Science, Multidisciplinary; Mechanics; Materials Science,
   Characterization & Testing
SC Materials Science; Mechanics
GA 661CL
UT WOS:000282700500006
DA 2018-10-19
ER

PT J
AU Orenstein, SB
   Saberski, ER
   Klueh, U
   Kreutzer, DL
   Novitsky, YW
AF Orenstein, S. B.
   Saberski, E. R.
   Klueh, U.
   Kreutzer, D. L.
   Novitsky, Y. W.
TI Effects of mast cell modulation on early host response to implanted
   synthetic meshes
SO HERNIA
LA English
DT Article
DE Mast cell; Mesh; Synthetic; Biomaterial; Cromolyn; Hernia; Mouse; In
   vivo; Inflammation; Wound healing; Foreign body reaction
ID ACUTE INFLAMMATORY RESPONSES; HERNIA REPAIR; ABDOMINAL-WALL; MDX MICE;
   RAT; HERNIOPLASTY; MUSCLE; MODEL
AB Mast cells (MCs) and their products (e.g., histamine, serotonin, heparin, prostaglandins, cytokines, etc.) play key roles in controlling local inflammation, wound healing, and foreign body reactions in vivo. Investigation of the role of MCs in mediating local tissue responses to synthetic hernia meshes has been very limited to date. We aimed to determine the effects of MCs/MC products in mice undergoing synthetic mesh implantation.
   Circular samples (5 mm) of heavyweight microporous polypropylene (Trelex(A (R))), midweight microporous polypropylene (ProLite (TM)), lightweight macroporous polypropylene with poliglecaprone (Ultrapro (TM)), and 3-dimensional macroporous polyester (Parietex (TM)) meshes were implanted subcutaneously in C57BL/6 J mice with and without cromolyn (MC stabilizer/suppressant) treatment (50 mg/kg, daily IP). Two weeks post-implantation, all meshes were explanted and evaluated histologically using H&E and trichrome stains.
   Chronic inflammation was focused around individual mesh fibers; inter-fiber inflammation and fibrosis diminished as mesh porosity increased. MC accumulation was seen at the periphery of inflammatory reactions, and in association with mesh-induced fibrosis and neovascularization. Cromolyn treatment resulted in significantly decreased fibrotic responses to all four meshes and reduced inflammation induced by Trelex(A (R)), ProLite (TM), and Parietex (TM) meshes but not Ultrapro (TM).
   We demonstrated that MCs play important roles in mesh-induced host tissue reactions. Blocking MC degranulation decreased early inflammation and fibrosis induced by most synthetic meshes in this study. Further evaluation and understanding of the role of MCs in mesh-induced tissue reactions will provide new therapeutic approaches to enhance the biocompatibility of surgical meshes and ultimately improve clinical outcomes in patients undergoing hernia repair with synthetic biomaterials.
C1 [Orenstein, S. B.; Novitsky, Y. W.] Univ Connecticut, Ctr Hlth, Connecticut Comprehens Ctr Hernia Repair, Dept Surg, Farmington, CT 06030 USA.
   [Klueh, U.; Kreutzer, D. L.] Univ Connecticut, Sch Med, Dept Surg, Ctr Mol Tissue Engn, Farmington, CT 06030 USA.
RP Novitsky, YW (reprint author), Univ Connecticut, Ctr Hlth, Connecticut Comprehens Ctr Hernia Repair, Dept Surg, 263 Farmington Ave,MC 3955, Farmington, CT 06030 USA.
EM ynovit@gmail.com
FU Hartford Hospital, Hartford, CT
FX This study was funded by a Pyrtek Grant award from Hartford Hospital,
   Hartford, CT.
CR Ayubi FS, 2008, HERNIA, V12, P373, DOI 10.1007/s10029-008-0359-z
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Bazi TM, 2007, EUR UROL, V51, P1373
   Bazi TM, 2007, EUR UROL, V51, P1364, DOI 10.1016/j.eururo.2006.10.002
   Cobb William S, 2005, Surg Innov, V12, P63, DOI 10.1177/155335060501200109
   Demirer S, 2006, J SURG RES, V131, P175, DOI 10.1016/j.jss.2005.10.024
   Granchelli JA, 1996, RES COMMUN MOL PATH, V91, P287
   Gray SH, 2008, SURG CLIN N AM, V88, P17, DOI 10.1016/j.suc.2007.11.007
   Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0
   Klinge U, 1998, EUR J SURG, V164, P951
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   Marques MJ, 2008, MUSCLE NERVE, V37, P61, DOI 10.1002/mus.20892
   Metcalfe DD, 1997, PHYSIOL REV, V77, P1033
   Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x
   MINER NA, 1969, APPL MICROBIOL, V17, P250
   Nilsson E, 1998, BRIT J SURG, V85, P1686
   Radley HG, 2006, NEUROBIOL DIS, V23, P387, DOI 10.1016/j.nbd.2006.03.016
   Rosch R, 2003, EUR SURG RES, V35, P161, DOI 10.1159/000070045
   Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4
   Saettele T M, 2007, Hernia, V11, P279, DOI 10.1007/s10029-006-0186-z
   Singh AP, 2008, J CARDIOVASC PHARM, V51, P596, DOI 10.1097/FJC.0b013e31817ae60f
   SNIPES RL, 1981, ANAT EMBRYOL, V162, P455, DOI 10.1007/BF00301871
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   USHER F C, 1958, Am Surg, V24, P969
   USHER FC, 1959, SURGERY, V46, P718
   Vidovic D, 2006, Hernia, V10, P322, DOI 10.1007/s10029-006-0097-z
   WANTZ GE, 1991, SURG GYNECOL OBSTET, V172, P129
   Xu X, 2002, ANN SURG, V236, P593, DOI 10.1097/01.SLA.0000033037.13104.C4
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 30
TC 18
Z9 23
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
J9 HERNIA
JI Hernia
PD OCT
PY 2010
VL 14
IS 5
BP 511
EP 516
DI 10.1007/s10029-010-0680-1
PG 6
WC Surgery
SC Surgery
GA 642VP
UT WOS:000281249400012
PM 20526725
DA 2018-10-19
ER

PT J
AU Oh, KJ
   Pandher, DS
AF Oh, Kwang-Jun
   Pandher, Dilbans Singh
TI A new mode of clinical failure of porous tantalum rod
SO INDIAN JOURNAL OF ORTHOPAEDICS
LA English
DT Article
DE Tantalum rod; osteonecrosis; femur head
ID DONOR-SITE MORBIDITY; FEMORAL-HEAD; AVASCULAR NECROSIS; OSTEONECROSIS;
   BIOMATERIAL; SURVIVAL; IMPLANT; HIPS
AB The area of osteonecrosis of the head of femur affected by the disease process varies from a small localized lesion to a global lesion. Without specific treatment 80% of the clinically diagnosed cases will progress, and most will eventually require arthroplasty. Therefore the goal is to diagnose and treat the condition in the earliest stage. A number of surgical procedures have been described to retard or prevent progression of the disease and to preserve the femoral head. An implant made of porous tantalum has been developed to function as a structural graft to provide mechanical support to the subchondral plate of the necrotic femoral head, and possibly allow bone growth into the avascular region. Porous tantalum implant failure with associated radiological progression of the disease is reported in the literature; however, there is no report of clinical failure of the implant without radiological progression of the disease. We report a case of clinical failure of porous tantalum implant, seven months after surgery without any radiological progression of the disease, and with histopathological evidence of new bone formation around the porous tantalum implant. The patient was succesfully treated by total hip arthroplasty.
C1 [Pandher, Dilbans Singh] Oxford Super Specialty & Trauma Hosp, Jalandhar 144001, Punjab, India.
   [Oh, Kwang-Jun] Konkuk Univ Hosp, Dept Orthopaed, Seoul, South Korea.
   [Pandher, Dilbans Singh] SGL Charitable Hosp, Kapurthala, Punjab, India.
RP Pandher, DS (reprint author), Oxford Super Specialty & Trauma Hosp, Bhagwan Mahanvir Marg, Jalandhar 144001, Punjab, India.
EM dilbans@yahoo.com
CR Aldegheri R, 2007, STRATEG TRAUMA LIMB, V2, P63, DOI 10.1007/s11751-007-0021-9
   Aluisio FV, 1998, CLIN ORTHOP RELAT R, P192
   Berend KR, 2003, J BONE JOINT SURG AM, V85A, P987, DOI 10.2106/00004623-200306000-00001
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Heiner A. D., 1998, Journal of Musculoskeletal Research, V2, P267, DOI 10.1142/S0218957798000263
   Louie BE, 1999, CAN J SURG, V42, P274
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Nadeau Melissa, 2007, Mcgill J Med, V10, P4
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   Tang CL, 1998, MICROSURG, V18, P383, DOI 10.1002/(SICI)1098-2752(1998)18:6<383::AID-MICR8>3.0.CO;2-5
   Tanzer M, 2008, J BONE JOINT SURG AM, V90A, P1282, DOI 10.2106/JBJS.F.00847
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Urbaniak J R, 1998, J Am Acad Orthop Surg, V6, P44
   URBANIAK JR, 1995, J BONE JOINT SURG AM, V77A, P681, DOI 10.2106/00004623-199505000-00004
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
   ZIMMER, 2005, SURG TECHNIQUES BROC
NR 21
TC 4
Z9 7
U1 0
U2 5
PU MEDKNOW PUBLICATIONS
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0019-5413
J9 INDIAN J ORTHOP
JI Indian J. Orthop.
PD OCT-DEC
PY 2010
VL 44
IS 4
BP 464
EP 467
DI 10.4103/0019-5413.69322
PG 4
WC Orthopedics
SC Orthopedics
GA 662LM
UT WOS:000282808800021
PM 20924493
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Yamauchi, K
   Takahashi, T
   Funaki, K
   Hamada, Y
   Yamashita, Y
AF Yamauchi, K.
   Takahashi, T.
   Funaki, K.
   Hamada, Y.
   Yamashita, Y.
TI Histological and histomorphometrical comparative study of
   beta-tricalcium phosphate block grafts and periosteal expansion
   osteogenesis for alveolar bone augmentation
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE bone augmentation; beta-TCP; periosteum; implant; osteogenesis;
   biomaterial
ID DISTRACTION OSTEOGENESIS; IMPLANT PLACEMENT; JAW BONE; RECONSTRUCTION;
   RIDGE
AB This study evaluated local tissue reaction around the beta-tricalcium phosphate (beta-TCP) block and compared results with beta-TCP block grafting and periosteal expansion osteogenesis (PEO). The mandibular premolars were extracted from five dogs and buccal corticotomy was performed. Narrow alveolar ridge models were created at 4 weeks. The beta-TCP block graft, such as veneer graft, was used on the right side and PEO using beta-TCP block on the left side. Changes of alveolar width, histological findings and histomorphometrical analysis were evaluated. There were no problems with materials at any of the sites at any time. In both groups, the width increased after surgery and results were stable 8 weeks after surgery. Newly formed bone tissue was observed inside the beta-TCP block in both sides. Histological findings differed especially at the division between mandibular bone and beta-TCP block. Histomorphometric analyses revealed that beta-TCP had been absorbed (mean decrease 28%) and new bone had formed (mean increase 43%) at 8 weeks postoperatively on both sides. The beta-TCP block worked as a space-maker under the soft tissue, including the periosteum, and acted as a substitute for original bone. This bone substitute was effective material for bone augmentation in both methods.
C1 [Yamauchi, K.; Takahashi, T.; Funaki, K.; Hamada, Y.; Yamashita, Y.] Kyushu Dent Coll, Div Oral & Maxillofacial Reconstruct Surg, Dept Oral & Maxillofacial Surg, Kitakyushu, Fukuoka 803, Japan.
RP Yamauchi, K (reprint author), 2-6-1 Manazuru Kokurakita ku, Fukuoka 8038580, Japan.
EM k-yama@kyu-dent.ac.jp
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P394, DOI 10.1111/j.1600-0501.2005.01247.x
   Chin M, 1996, J ORAL MAXIL SURG, V54, P45, DOI 10.1016/S0278-2391(96)90303-1
   DELLOYE C, 1990, CLIN ORTHOP RELAT R, V250, P34
   Funaki K, 2009, ORAL SURG ORAL MED O, V107, P350, DOI 10.1016/j.tripleo.2008.10.005
   HIDDING J, 1998, J CRANIOMAXILLOFAC S, V26, P72
   Hikiji H, 2000, J ORAL MAXIL SURG, V58, P1270, DOI 10.1053/joms.2000.16628
   HOLBEIN O, 1995, J ORTHOP RES, V13, P629, DOI 10.1002/jor.1100130420
   Ilizarov G A, 1989, Clin Orthop Relat Res, P263
   Jensen OT, 2002, INT J ORAL MAX IMPL, V17, P52
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P499, DOI 10.1016/j.joms.2004.07.023
   Kessler P, 2007, BRIT J ORAL MAX SURG, V45, P284, DOI 10.1016/j.bjoms.2006.09.010
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   KOSTOPOULOS L, 1995, J CLIN PERIODONTOL, V22, P247
   Laster Z, 2005, J ORAL MAXIL SURG, V63, P1724, DOI 10.1016/j.joms.2005.09.001
   MARX RE, 1994, CLIN PLAST SURG, V21, P377
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Ozerdem OR, 1998, ANN PLAS SURG, V41, P148
   Schmidt BL, 2002, J ORAL MAXIL SURG, V60, P1170, DOI 10.1053/joms.2002.34993
   Sencimen M, 2007, INT J ORAL MAX SURG, V36, P235, DOI 10.1016/j.ijom.2006.08.016
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Takahashi T, 2004, INT J ORAL MAX IMPL, V19, P291
   Verhoeven JW, 2006, CLIN ORAL IMPLAN RES, V17, P58, DOI 10.1111/j.1600-0501.2005.01165.x
   Watzak G, 2006, CLIN ORAL IMPLAN RES, V17, P723, DOI 10.1111/j.1600-0501.2006.01267.x
   Yamatuchi K, 2006, INT J ORAL MAX SURG, V35, P493, DOI 10.1016/j.ijom.2006.01.008
   Yamauchi K, 2008, J PERIODONTOL, V79, P999, DOI [10.1902/jop.2008.070536, 10.1902/jop.2008.070536 ]
NR 29
TC 20
Z9 22
U1 0
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD OCT
PY 2010
VL 39
IS 10
BP 1000
EP 1006
DI 10.1016/j.ijom.2010.05.008
PG 7
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 672UO
UT WOS:000283612600009
PM 20615666
DA 2018-10-19
ER

PT J
AU Olson, ME
   Slater, SR
   Rupp, ME
   Fey, PD
AF Olson, Michael E.
   Slater, Shawn R.
   Rupp, Mark E.
   Fey, Paul D.
TI Rifampicin enhances activity of daptomycin and vancomycin against both a
   polysaccharide intercellular adhesin (PIA)-dependent and -independent
   Staphylococcus epidermidis biofilm
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE biomaterial infections; guinea pig model; tissue cage; icaADBC operon
ID CATHETER-ASSOCIATED INFECTION; FOREIGN-BODY INFECTION; ANTIBIOTIC
   COMBINATIONS; BACTERICIDAL ACTIVITY; PROSTHESIS INFECTION; ANTIMICROBIAL
   AGENTS; GENE-CLUSTER; DNA RELEASE; RAT MODEL; AUREUS
AB This study addressed the efficacy of daptomycin, vancomycin, rifampicin, daptomycin/rifampicin and vancomycin/rifampicin against a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm using flow cell and guinea pig tissue cage models.
   The flow cell model of both PIA-dependent and -independent biofilms demonstrated that the viable cell count after treatment with daptomycin/rifampicin was significantly lower (P < 0.05) than after treatment with vancomycin, vancomycin/rifampicin, daptomycin or rifampicin alone. To validate these observations, a guinea pig tissue cage model was used. The results demonstrated that the addition of rifampicin to daptomycin or vancomycin sterilized 5/6 tissues cages colonized with S. epidermidis 1457 (PIA producing). Similar results were noted with S. epidermidis 1457 icaADBC::dhfr (non-PIA producing), where daptomycin/rifampicin and vancomycin/rifampicin sterilized 5/6 and 6/6 tissue cages, respectively. There was no statistical difference in comparison with the no-treatment control when both 1457 and 1457 icaADBC::dhfr were treated with vancomycin and daptomycin alone. Furthermore, treatment with rifampicin alone sterilized 5/6 and 3/6 1457 and 1457 icaADBC::dhfr tissue cages, respectively.
   Interpretation of these data suggests that rifampicin is highly active against S. epidermidis biofilms and both vancomycin and daptomycin are effective at reducing the subpopulation of bacteria that develop rifampicin resistance.
C1 [Olson, Michael E.; Slater, Shawn R.; Fey, Paul D.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Rupp, Mark E.; Fey, Paul D.] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.
RP Fey, PD (reprint author), Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
EM pfey@unmc.edu
FU Cubist Pharmaceuticals
FX This study was funded in part by an investigator-initiated grant by
   Cubist Pharmaceuticals to P. D. F. and M. E. R.
CR ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282
   ARCHER GL, 1983, REV INFECT DIS, V5, pS538
   Aslam S, 2007, ANTIMICROB AGENTS CH, V51, P1556, DOI 10.1128/AAC.00893-06
   Aubry-Damon H, 1998, ANTIMICROB AGENTS CH, V42, P2590, DOI 10.1128/AAC.42.10.2590
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   Cho SH, 2002, INT J ANTIMICROB AG, V19, P570, DOI 10.1016/S0924-8579(02)00101-2
   Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x
   Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002
   DAROUICHE RO, 1994, J INFECT DIS, V170, P720, DOI 10.1093/infdis/170.3.720
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1118/AAC.49.6.2467-2473.2005
   LaPlante KL, 2007, NEPHROL DIAL TRANSPL, V22, P2239, DOI 10.1093/ndt/gfm141
   LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P3880, DOI 10.1128/AAC.00134-09
   Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003
   Lemmen SW, 2003, CHEMOTHERAPY, V49, P33, DOI 10.1159/000069779
   Lewis K, 2008, CURR TOP MICROBIOL, V322, P107
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mogenet I, 2004, ANN PHARMACOTHER, V38, P986, DOI 10.1345/aph.1D354
   Monzon M, 2001, J ANTIMICROB CHEMOTH, V48, P793, DOI 10.1093/jac/48.6.793
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Raad I, 1998, CLIN INFECT DIS, V26, P1182, DOI 10.1086/520285
   Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005
   Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07
   Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   Saleh-Mghir A, 2002, ANTIMICROB AGENTS CH, V46, P1122, DOI 10.1128/AAC.46.4.1122-1124.2002
   Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003
   Stevens NT, 2009, CELL MICROBIOL, V11, P421, DOI 10.1111/j.1462-5822.2008.01264.x
   Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838
   Stewart PS, 2009, ANTIMICROB AGENTS CH, V53, P3505, DOI 10.1128/AAC.01728-08
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   WIDMER AF, 1992, CLIN INFECT DIS, V14, P1251, DOI 10.1093/clinids/14.6.1251
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537
NR 49
TC 24
Z9 24
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD OCT
PY 2010
VL 65
IS 10
BP 2164
EP 2171
DI 10.1093/jac/dkq314
PG 8
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 654NK
UT WOS:000282174800018
PM 20719763
OA Bronze
DA 2018-10-19
ER

PT J
AU Yung, CW
   Bentley, WE
   Barbari, TA
AF Yung, Chong Wing
   Bentley, William E.
   Barbari, Timothy A.
TI Diffusion of interleukin-2 from cells overlaid with cytocompatible
   enzyme-crosslinked gelatin hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE continuous drug delivery; diffusion coefficient; human interleukin 2;
   crosslinked gelatin hydrogel; microbial transglutaminase
ID CONTAINING ARTIFICIAL SKIN; 13-CIS RETINOIC ACID; EXTRACELLULAR-MATRIX;
   MAINTENANCE THERAPY; ESCHERICHIA-COLI; ADVANCED CANCER; IN-VITRO;
   TRANSGLUTAMINASE; APOPTOSIS; CULTURE
AB In designing an implantable cell encapsulation construct to continuously deliver therapeutic proteins to a patient, it is critical that the biomaterial be compatible with the encapsulated cells, as well as conducive to the diffusion of desired molecules. As a continuation of our previous work, which demonstrated the cytocompatibility of gelatin hydrogels enzymatically crosslinked by microbial transglutaminase (mTG-gels), this work seeks to elucidate the diffusion properties that are needed for sustained release of therapeutic proteins produced by the engineered cells. HEK293 cells genetically engineered to secrete an anticancer drug, interleukin-2 (hIL2), through 4% mTG-gels used as a 1D diffusion model. Under steady-state conditions, cells secrete hIL2 at a therapeutic rate of 5.0-5.7 ng/cm(2)/h/10(6) cells. The diffusion coefficient of hIL2 through the hydrogels is D(m) = 4.0 x 10(-7) cm(2)/s. This value is comparable with similarly sized proteins through hydrogels and is further verified by modeling nonsteady-state diffusion through various thicknesses of the hydrogels, as well as by acellular diffusion chamber experiments. These findings demonstrate that the enzymatically crosslinked hydrogels are not only cytocompatible but also have suitable transport properties that will facilitate the design of sustained drug release devices. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 25-32, 2010.
C1 [Yung, Chong Wing; Bentley, William E.; Barbari, Timothy A.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Yung, Chong Wing; Bentley, William E.] Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA.
   [Bentley, William E.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Barbari, TA (reprint author), Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
EM tab53@georgetown.edu
FU University of Maryland
FX Contract grant sponsor: University of Maryland
CR Alberts B, 2002, MOL BIOL CELL
   BARKER H, 1980, BIOCHIM BIOPHYS ACTA, V632, P589, DOI 10.1016/0304-4165(80)90335-9
   Buck KKS, 2001, J COLLOID INTERF SCI, V234, P400, DOI 10.1006/jcis.2000.7302
   Chen TH, 2003, BIOMACROMOLECULES, V4, P1558, DOI 10.1021/bm034145k
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   DEJACO C, 2006, J CLIN ONCOL, V24, pE35
   Dejaco Christian, 2006, J Clin Oncol, V24, pe35, DOI 10.1200/JCO.2006.06.5201
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Farag SS, 2002, CLIN CANCER RES, V8, P2812
   Figueroa B, 2001, BIOTECHNOL BIOENG, V73, P211, DOI 10.1002/bit.1053
   Figueroa B, 2003, METAB ENG, V5, P230, DOI 10.1016/S1096-7176(03)00044-2
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   Hong SR, 2001, BIOMATERIALS, V22, P2777, DOI 10.1016/S0142-9612(01)00021-7
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   JAIN RK, 1990, CANCER RES, V50, pS814
   Kobayashi K, 1998, BIOSCI BIOTECH BIOCH, V62, P1109, DOI 10.1271/bbb.62.1109
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Mastrangelo AJ, 2000, BIOTECHNOL BIOENG, V67, P544, DOI 10.1002/(SICI)1097-0290(20000305)67:5<544::AID-BIT5>3.3.CO;2-R
   Oktem O, 2007, REPROD SCI, V14, P358, DOI 10.1177/1933719107303397
   Otter W D, 1999, Cancer Immunol Immunother, V48, P419, DOI 10.1007/s002620050595
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Paguirigan AL, 2007, NAT PROTOC, V2, P1782, DOI 10.1038/nprot.2007.256
   Recchia F, 2005, ANTICANCER RES, V25, P3149
   Recchia F, 2001, CLIN CANCER RES, V7, P1251
   SHAW J, 1978, J IMMUNOL, V120, P1967
   TRUSKEY GA, 2004, TRANSPORT PHENOMENA, P816
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Yokoyama K, 1998, BIOSCI BIOTECH BIOCH, V62, P1205, DOI 10.1271/bbb.62.1205
   Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5
   Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431
   Yung CW, 2006, BIOTECHNOL BIOENG, V95, P938, DOI 10.1002/bit.21064
   Yung CW, 2006, METAB ENG, V8, P483, DOI 10.1016/j.ymben.2006.04.005
NR 36
TC 16
Z9 16
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2010
VL 95A
IS 1
BP 25
EP 32
DI 10.1002/jbm.a.32740
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645IU
UT WOS:000281448700003
PM 20740597
DA 2018-10-19
ER

PT J
AU Bruggeman, JP
   Bettinger, CJ
   Langer, R
AF Bruggeman, Joost P.
   Bettinger, Christopher J.
   Langer, Robert
TI Biodegradable xylitol-based elastomers: In vivo behavior and
   biocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; elastomer; biocompatibility; degradation; poly(xylitol
   sebacate); xylitol
ID GLASS-TRANSITION TEMPERATURE; THIN POLYMER-FILMS; DRUG-DELIVERY;
   DEGRADATION; SEBACATE)
AB Biodegradable elastomers based on polycondensation reactions of xylitol with sebacic acid, referred to as poly(xylitol sebacate) (PXS) elastomers have recently been developed. We describe the in vivo behavior of PXS elastomers. Four PXS elastomers were synthesized, characterized, and compared with poly(L-lactic-co-glycolic acid) (PLGA). PXS elastomers displayed a high level of structural integrity and form stability during degradation. The in vivo half-life ranged from approximately 3 to 52 weeks. PXS elastomers exhibited increased biocompatibility compared with PLGA implants. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 92-104, 2010.
C1 [Bruggeman, Joost P.; Bettinger, Christopher J.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Bruggeman, Joost P.] Erasmus Univ, Erasmus Med Ctr, Dept Plast & Reconstruct Surg, NL-3015 GE Rotterdam, Netherlands.
   [Bettinger, Christopher J.] Charles Stark Draper Lab, Ctr Biomed Engn, Cambridge, MA 02139 USA.
RP Langer, R (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
RI Bettinger, Christopher/A-3895-2009
FU Charles Stark Draper Laboratory; NIH [HL060435]
FX Contract grant sponsor: Charles Stark Draper Laboratory Fellowship (to
   C.J.B.); Contract grant sponsor: NIH; contract grant number: HL060435
CR Amsden BG, 2006, BIOMACROMOLECULES, V7, P365, DOI 10.1021/bm050731x
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2009, J BIOMED MATER RES A, V91A, P1077, DOI 10.1002/jbm.a.32306
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   ELLINGSWORTH LR, 1986, J IMMUNOL, V136, P877
   Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002
   Greaves DR, 2002, INT J HEMATOL, V76, P6, DOI 10.1007/BF02982713
   KEDDIE JL, 1994, FARADAY DISCUSS, V98, P219, DOI 10.1039/fd9949800219
   Langer R, 1998, NATURE, V392, P5
   LANGER R, 1993, SCIENCE, V920, P260
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Meek MF, 2008, ANN PLAS SURG, V60, P110, DOI 10.1097/SAP.0b013e31804d441c
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   PEGO AP, 2002, BIODEGRADABLE POLYM
   Pitt CG, 1984, J CONTROL RELEASE, V1, P3
   Scott M, 1983, NATNEWS, V20, P15
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wang ZX, 2006, J BIOMED MATER RES A, V79A, P6, DOI 10.1002/jbm.a.30739
   WILLIAMS DF, 1977, J BIOENG, V1, P279
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
NR 26
TC 18
Z9 18
U1 0
U2 28
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2010
VL 95A
IS 1
BP 92
EP 104
DI 10.1002/jbm.a.32733
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645IU
UT WOS:000281448700010
PM 20540093
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Alijotas-Reig, J
   Hindie, M
   Kandhaya-Pillai, R
   Miro-Mur, F
AF Alijotas-Reig, Jaume
   Hindie, Mathilde
   Kandhaya-Pillai, Renuka
   Miro-Mur, Francesc
TI Bioengineered hyaluronic acid elicited a nonantigenic T cell activation:
   Implications from cosmetic medicine and surgery to nanomedicine
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyaluronic acid; T cell activation; cytokine production; PBMC;
   inflammation
ID CONSTITUTIVELY REGULATES ACTIVATION; STRESS URINARY-INCONTINENCE;
   NITRIC-OXIDE SYNTHASE; TERM-FOLLOW-UP; DENDRITIC CELLS; CLINICAL
   FINDINGS; DERMAL FILLERS; PLACENTAL MALARIA; BREAST IMPLANTS;
   CARCINOMA-CELLS
AB Hyaluronan is known to act as a filling material of extracellular matrices and as an adhesive substrate for cellular migration. Consequently, it is widely used in aesthetic medicine and surgery, and it would be expected to be used in nanomedicine. Previous clinical case reports associated hyaluronic acid implants to delayed immune-mediated adverse effects. A series of experiments to evaluate immune cell activation supported by this dermal filler and nanomedical biomaterial were performed. The study comprised a total of 12 individuals. Four healthy individuals, none with cosmetically injected dermal filler, were considered as control. Five individuals carried injections of hyaluronic acid dermal filler. Three individuals carried injections of hyaluronic acid dermal filler and presented delayed adverse effects related to the dermal filler. Hyaluronic acid-stimulated peripheral blood mononuclear cells (PBMC) produced low levels of pro-inflammatory cytokines. Phytohemagglutinine (PHA)-stimulated PBMC from patients with hyaluronic implants presenting adverse effects showed a slight increase in the production of interferon (IFN)-gamma and higher expression of CD25, CD69, or CD71. In conclusion, hyaluronic acid administration elicited a laboratory evidence of immune cell activation. Production of low levels of proinflammatory cytokines in vitro could be an observation for low-grade inflammation in vivo resulting in T cell activation. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 180-190, 2010.
C1 [Alijotas-Reig, Jaume; Hindie, Mathilde; Kandhaya-Pillai, Renuka; Miro-Mur, Francesc] Vall dHebron Univ Hosp, CIBBIM Nanomed, Mol Biol & Biochem Res Ctr Nanomed, Aging Basic Res Grp, Barcelona, Spain.
   [Alijotas-Reig, Jaume; Hindie, Mathilde; Kandhaya-Pillai, Renuka; Miro-Mur, Francesc] CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Barcelona, Spain.
   [Alijotas-Reig, Jaume] Vall dHebron Univ Hosp, Syst Autoimmune Dis Unit, Barcelona, Spain.
   [Alijotas-Reig, Jaume] Univ Autonoma Barcelona, Dept Med, Barcelona 08035, Spain.
RP Miro-Mur, F (reprint author), Vall dHebron Univ Hosp, CIBBIM Nanomed, Mol Biol & Biochem Res Ctr Nanomed, Aging Basic Res Grp, Barcelona, Spain.
EM jalijotas@vhebron.net; fmiro@ir.vhebron.net
RI Alijotas-Reig, Jaume/H-9262-2016
OI Alijotas-Reig, Jaume/0000-0002-9212-3619; Miro-Mur, Francesc
   A./0000-0003-3936-2693
FU Sociedad Espanola de Medicina y Cirugia Cosmetica (SEMCC; Spanish
   Society for Cosmetic Medicine and Surgery)
FX Contract grant sponsor: Sociedad Espanola de Medicina y Cirugia
   Cosmetica (SEMCC; Spanish Society for Cosmetic Medicine and Surgery)
CR Adams ME, 1995, OSTEOARTHR CARTILAGE, V3, P213, DOI 10.1016/S1063-4584(05)80013-5
   Alijotas-Reig J, 2008, J EUR ACAD DERMATOL, V22, P150, DOI 10.1111/j.1468-3083.2007.02354.x
   Alijotas-Reig J, 1998, AN MED INTERN, V15, P276
   Alijotas-Reig J, 2008, ARCH DERMATOL, V144, P637, DOI 10.1001/archderm.144.5.637
   Alijotas-Reig J, 2009, DERMATOL SURG, V35, P395, DOI 10.1111/j.1524-4725.2008.01049.x
   Alijotas-Reig J, 2009, DERMATOL SURG, V35, P360, DOI 10.1111/j.1524-4725.2008.01041.x
   Andre P, 2004, J EUR ACAD DERMATOL, V18, P422, DOI 10.1111/j.1468-3083.2004.00934.x
   Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614
   Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582
   Bernauer W, 2006, BRIT J OPHTHALMOL, V90, P285, DOI 10.1136/bjo.2005.082792
   Castillo-Vico MT, 2007, INT UROGYNECOL J, V18, P95, DOI 10.1007/s00192-005-0049-7
   Christensen L, 2005, AESTHET PLAST SURG, V29, P34, DOI 10.1007/s00266-004-0113-6
   Christensen L, 2006, EUR J PLAST SURG, V28, P464, DOI 10.1007/s00238-005-0005-2
   Christensen L, 2007, DERMATOL SURG, V33, pS168, DOI 10.1111/j.1524-4725.2007.33357.x
   Do Y, 2004, J IMMUNOTHER, V27, P1, DOI 10.1097/00002371-200401000-00001
   GALANDRINI R, 1994, J IMMUNOL, V153, P21
   HodgeDufour J, 1997, J IMMUNOL, V159, P2492
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Katzin WE, 1996, CLIN DIAGN LAB IMMUN, V3, P156
   Lupton JR, 2000, DERMATOL SURG, V26, P135, DOI 10.1046/j.1524-4725.2000.99202.x
   Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191
   McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013
   McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054
   Miro-Mur F, 2009, J BIOMED MATER RES B, V90B, P510, DOI 10.1002/jbm.b.31312
   Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200
   Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200
   Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189
   Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322
   Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769
   PATRICK M, 2001, DERMATOL SURG, V27, P185
   Peer D, 2008, SCIENCE, V319, P627, DOI 10.1126/science.1149859
   ROBERT G, 2007, DERMATOL SURG, V33, pS176
   Stern R, 2005, PATHOL BIOL, V53, P372, DOI 10.1016/j.patbio.2004.12.021
   STERN R, 2003, GLYCOBIOLOGY, V13, P105
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x
   van Kerrebroeck P, 2003, UROL RES, V30, P356, DOI 10.1007/s00240-002-0290-1
   Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910
   VOJDANI A, 1992, TOXICOL IND HEALTH, V8, P415
   Wang JY, 2002, P NATL ACAD SCI USA, V99, P14362, DOI 10.1073/pnas.222536599
   Yamada J, 2008, CANCER LETT, V272, P307, DOI 10.1016/j.canlet.2008.07.024
   Yang R, 2002, SCAND J IMMUNOL, V55, P2, DOI 10.1046/j.0300-9475.2001.01033.x
   Yang TB, 2002, CANCER RES, V62, P2583
   Yang ZY, 2007, J IMMUNOL, V178, P1077, DOI 10.4049/jimmunol.178.2.1077
   Zardawi IM, 2001, PATHOLOGY, V33, P519, DOI 10.1080/00313020120083296
   Zardawi IM, 2003, J BONE JOINT SURG AM, V85A, P2484, DOI 10.2106/00004623-200312000-00040
NR 49
TC 13
Z9 13
U1 2
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2010
VL 95A
IS 1
BP 180
EP 190
DI 10.1002/jbm.a.32794
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645IU
UT WOS:000281448700019
PM 20564542
DA 2018-10-19
ER

PT J
AU Mason, MN
   Mahoney, MJ
AF Mason, Mariah N.
   Mahoney, Melissa J.
TI A novel composite construct increases the vascularization potential of
   PEG hydrogels through the incorporation of large fibrin ribbons
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PEG hydrogel; fibrin ribbons; scaffold vascularization; coculture;
   endothelial cells
ID POLYETHYLENE-GLYCOL; ENDOTHELIAL-CELLS; GROWTH-FACTOR; PLGA SCAFFOLDS;
   IN-VIVO; TISSUE; ANGIOGENESIS; IMPLANTATION; MATRICES; VESSELS
AB Developing a mechanism to vascularize tissue-engineered constructs is imperative for transplant function and integration, particularly when delivering hypoxia-sensitive tissues, such as pancreatic islets. Previous efforts have focused on bulk modifications of scaffold materials rendering the entire construct permissive to vessel penetration or the formation of a porous structure where vessels can infiltrate the empty spaces. Here, we describe a novel construct composed of large fibrin ribbons encapsulated within a poly(ethylene glycol) (PEG) hydrogel. The PEG/fibrin ribbon composite scaffold facilitates coculture of adhesive and nonadhesive cell types, thus providing closely neighboring environments with distinct material properties specific to the needs of two clinically relevant cell populations. This advantage is demonstrated here by the successful coculture of pancreatic islets in the PEG component and vessel-forming endothelial cells in entrapped fibrin ribbons. Transplanted endothelial cells can form anastomosies with host vasculature, suggesting that our cocultures may lead to more rapid scaffold vascularization. Additionally, we show that surface-seeded endothelial cells form multicellular projections that migrate into nonadhesive PEG hydrogels along permissive fibrin ribbons, further demonstrating composite construct vascularization potential. Distribution of large fibrin ribbons throughout PEG hydrogels provide a potential mechanism for vascularization of a well-established biomaterial without inherently changing its desirable properties. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 95A: 283-293, 2010.
C1 [Mason, Mariah N.; Mahoney, Melissa J.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
RP Mahoney, MJ (reprint author), Univ Colorado, Dept Chem & Biol Engn, Campus Box 424, Boulder, CO 80309 USA.
EM melissa.mahoney@colorado.edu
FU Beta Cell Biology Consortium [VUMC35144]; National Institute of Diabetes
   and Digestive and Kidney Diseases [F30DK081278]; Department of Education
FX Contract grant sponsor: Beta Cell Biology Consortium; contract grant
   number: VUMC35144; Contract grant sponsor: National Institute of
   Diabetes and Digestive and Kidney Diseases; contract grant number:
   F30DK081278; Contract grant sponsor: Department of Education's Graduate
   Assistantships in Areas of National Need Program
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435
   Black AF, 1998, FASEB J, V12, P1331
   Bouton MC, 2007, CIRC RES, V100, P1174, DOI 10.1161/01.RES.0000265066.92923.ee
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Fournier N, 1996, BIOMATERIALS, V17, P1659, DOI 10.1016/0142-9612(96)87645-9
   Hall H, 2007, CURR PHARM DESIGN, V13, P3597, DOI 10.2174/138161207782794158
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kiran MS, 2006, CELL BIOL INT, V30, P704, DOI 10.1016/j.cellbi.2006.05.001
   LANGER R, 1993, SCIENCE, V920, P260
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Laschke MW, 2008, ANN SURG, V248, P939, DOI 10.1097/SLA.0b013e31818fa52f
   Lee DY, 2004, J BIOMAT SCI-POLYM E, V15, P753, DOI 10.1163/156856204774196144
   Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779
   Mahoney MJ, 2007, J BIOMED MATER RES A, V81A, P269, DOI 10.1002/jbm.a.30970
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mason MN, 2009, TISSUE ENG PT A, V15, P3799, DOI [10.1089/ten.tea.2009.0148, 10.1089/ten.TEA.2009.0148]
   Mason MN, 2009, TISSUE ENG PT A, V15, P1343, DOI 10.1089/ten.tea.2008.0290
   Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Rastellini C, 2001, TRANSPLANT P, V33, P658, DOI 10.1016/S0041-1345(00)02188-6
   Ratel D, 2007, THROMB RES, V121, P203, DOI 10.1016/j.thromres.2007.03.024
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Sun QH, 2005, PHARM RES, V22, P1110, DOI 10.1007/s11095-005-5644-2
   TANNOCK IF, 1972, BRIT J RADIOL, V45, P515, DOI 10.1259/0007-1285-45-535-515
   Torio-Padron N, 2007, MINIM INVASIV THER, V16, P155, DOI 10.1080/13645700701384116
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wu F, 2004, PANCREAS, V29, pE23, DOI 10.1097/00006676-200407000-00064
NR 32
TC 11
Z9 11
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2010
VL 95A
IS 1
BP 283
EP 293
DI 10.1002/jbm.a.32825
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645IU
UT WOS:000281448700029
PM 20607870
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Aggarwal, P
   Sousa, KA
   LoGerfo, FW
   Bide, MJ
   Phaneuf, MD
AF Aggarwal, Puja
   Sousa, Kerry A.
   LoGerfo, Frank W.
   Bide, Martin J.
   Phaneuf, Matthew D.
TI Use of textile dyeing technology to create an infection-resistant
   functionalized polyester biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE polyester; antimicrobial; biomaterial; ciprofloxacin; thermofixation
ID SURGICAL-MANAGEMENT; GRAFT INFECTION; STAPHYLOCOCCUS-EPIDERMIDIS;
   VASCULAR PROSTHESES; DACRON; REPLACEMENT
AB Infection is a major complication when utilizing implantable devices. The purpose of this study was to create a functionalized polyethylene terephthalate (polyester) biomaterial with sustained antimicrobial properties using textile-dyeing technology. Polyester was hydrolyzed via exposure to sodium hydroxide (NaOH) to provide two functional sites within the polymeric backbone. A modified textile dyeing technique known as thermofixation or pad-heating (pad-heat) in conjunction with autoclaving was employed to directly incorporate the fluoroquinolone antibiotic Ciprofloxacin (Cipro) into polyester fibers. Woven polyester segments were placed into various concentrations of boiling NaOH solutions to create carboxylic acid and hydroxyl groups (HYD). The segments were then sprayed (padded) with a 5 mg mL(-1) Cipro solution and dried overnight, followed by exposure to intense heat and autoclaving. Untreated HYD, Cipro-dipped, and pad-heat-treated HYD segments were then washed under stringent conditions. The antimicrobial activity of the each material was determined via zone of inhibition. Untreated HYD controls had no antimicrobial activity at any of the time periods examined. Cipro-dipped HYD segments had no antimicrobial activity after 1 h. In contrast, antimicrobial activity for autoclaved, pad-heat-treated HYD segments persisted for 80 days (length of study). Autoclave usage prior to plating affected antimicrobial activity substantially. Additionally, varying hydrolysis concentrations did not significantly affect overall Cipro release. Thus, Cipro application to HYD polyester via thermofixation resulted in controlled, sustained antibiotic release over an extended period of time. The long-term infection resistance provided by this technique may address major problems of infection from which implantable devices suffer. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 95B: 118-125, 2010.
C1 [Aggarwal, Puja; Phaneuf, Matthew D.] BioSurfaces Inc, Ashland, MA 01721 USA.
   [Aggarwal, Puja; Sousa, Kerry A.; LoGerfo, Frank W.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Bide, Martin J.] Univ Rhode Isl, Dept Text Fash Merchandising & Design, Kingston, RI 02881 USA.
RP Phaneuf, MD (reprint author), BioSurfaces Inc, 200 Hamer Ave Unit IP, Ashland, MA 01721 USA.
EM biosurfaces@verizon.net
FU National Institutes of Health [R41 HL078596]
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: R41 HL078596
CR Aggarwal P, 2005, J BIOMED MATER RES A, V75A, P224, DOI 10.1002/jbm.a.30427
   BAKOWSKY U, 2006, ADHESION, P157
   Bandyk D., 2005, VASCULAR SURG, V1, P875
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   BANDYK DF, 1991, J VASC SURG, V13, P575
   Bandyk DF, 2001, J VASC SURG, V34, P411, DOI 10.1067/mva.2001.117147
   Bergamini TM, 1996, J SURG RES, V60, P3, DOI 10.1006/jsre.1996.0002
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   Bide MJ, 2006, WOODH PUBL TEXT, P136
   BOSE A, 1993, SURFACTANT SCI SERIE, V49, P149
   BUNT TJ, 1983, SURGERY, V93, P733
   Chiesa R, 2002, ACTA CHIR BELG, V102, P238
   DRAUS JM, 2004, COMPLICATIONS VASCUL, P305
   Engin C, 2005, TEX HEART I J, V32, P529
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   Gorbach SL, 2004, INFECT DIS
   Hooper D. C., 1993, QUINOLONE ANTIMICROB
   MANNERS I, 2003, SYNTHETIC METAL CONT
   OHARA PJ, 1986, J VASC SURG, V3, P725, DOI 10.1067/mva.1986.avs0030725
   OZAKI CK, 1993, J SURG RES, V55, P543, DOI 10.1006/jsre.1993.1181
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   PHANEUF MD, 1995, J APPL BIOMATER, V6, P289, DOI 10.1002/jab.770060410
   PHANEUF MD, 1993, J BIOMED MATER RES, V27, P233, DOI 10.1002/jbm.820270213
   PHANEUF MD, 2000, ANTIMICROBIAL ANTIIN
   PRESS OW, 1984, MEDICINE, V63, P189, DOI 10.1097/00005792-198407000-00001
   QUINONESBALDRICH WJ, 1991, ARCH SURG-CHICAGO, V126, P507
   RICOTTA JJ, 2005, VASCULAR SURG, V1, P688
   Risberg B, 2000, Lakartidningen, V97, P4280
   ROSENTHAL D, 1990, J VASC SURG, V12, P326, DOI 10.1067/mva.1990.22760
   VOGLER EA, 1993, SURFACTANT SCI SERIE, V49, P187
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   XUE L, 2005, VASCULAR SURG, V1, P723
   YASHAR JJ, 1978, AM J SURG, V135, P499, DOI 10.1016/0002-9610(78)90027-2
   Yeager RA, 1999, J VASC SURG, V30, P76, DOI 10.1016/S0741-5214(99)70178-3
   ZHONG T, 2003, AATCC REV, V3, P24
NR 35
TC 5
Z9 5
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2010
VL 95B
IS 1
BP 118
EP 125
DI 10.1002/jbm.b.31690
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 647YD
UT WOS:000281655900015
PM 20725956
DA 2018-10-19
ER

PT J
AU Singelyn, JM
   Christman, KL
AF Singelyn, Jennifer M.
   Christman, Karen L.
TI Injectable Materials for the Treatment of Myocardial Infarction and
   Heart Failure: The Promise of Decellularized Matrices
SO JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
LA English
DT Article
DE Injectable; Minimally Invasive; Heart Failure; Therapy; Biomaterials;
   Decellularized
ID ASSEMBLING PEPTIDE NANOFIBERS; SKELETAL MYOBLAST TRANSPLANTATION; FIBRIN
   DEGRADATION-PRODUCTS; LEFT-VENTRICULAR FUNCTION; EMBRYONIC STEM-CELLS;
   EXTRACELLULAR-MATRIX; CARDIAC-FUNCTION; METALLOPROTEINASE ACTIVITY;
   INTRACORONARY INJECTION; AUTOLOGOUS PERICARDIUM
AB Cardiovascular disease continues to be the leading cause of death, suggesting that new therapies are needed to treat the progression of heart failure post-myocardial infarction. As cardiac tissue has a limited ability to regenerate itself, experimental biomaterial therapies have focused on the replacement of necrotic cardiomyocytes and repair of the damaged extracellular matrix. While acellular and cellular cardiac patches are applied surgically to the epicardial surface of the heart, injectable materials offer the prospective advantage of minimally invasive delivery directly into the myocardium to either replace the damaged extracellular matrix or to act as a scaffold for cell delivery. Cardiac-specific decellularized matrices offer the further advantage of being biomimetic of the native biochemical and structural matrix composition, as well as the potential to be autologous therapies. This review will focus on the requirements of an ideal scaffold for catheter-based delivery as well as highlight the promise of decellularized matrices as injectable materials for cardiac repair.
C1 [Singelyn, Jennifer M.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,MC 0412, San Diego, CA 92093 USA.
EM christman@bioeng.ucsd.edu
FU NIH [1-DP2-OD004309-01]
FX Unpublished data from the Christman lab was supported in part by the NIH
   Director's New Innovator Award Program, part of the NIH Roadmap for
   Medical Research, through grant number 1-DP2-OD004309-01.
CR ALBINI A, 1992, INT J CANCER, V52, P234, DOI 10.1002/ijc.2910520214
   Badylak SF, 2002, HEART SURG FORUM, V6, pE20
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023
   Bolognese L, 2004, CIRCULATION, V109, P1121, DOI 10.1161/01.CIR.0000118496.44135.A7
   Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410
   Brown L, 2005, AM J PHYSIOL-HEART C, V289, pH973, DOI 10.1152/ajpheart.00443.2005
   Chekanov V, 2003, PACE, V26, P496, DOI 10.1046/j.1460-9592.2003.00080.x
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   DAVID TE, 1987, J THORAC CARDIOV SUR, V94, P710
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3
   Dib N, 2005, CIRCULATION, V112, P1748, DOI 10.1161/CIRCULATIONAHA.105.547810
   Dib N, 2002, J ENDOVASC THER, V9, P313, DOI 10.1583/1545-1550(2002)009<0313:ETOASM>2.0.CO;2
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V54, P71, DOI 10.1016/j.vascn.2005.12.002
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   DURAN CMG, 1995, J THORAC CARDIOV SUR, V110, P511, DOI 10.1016/S0022-5223(95)70248-2
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   FUSTER V, 2001, HURSTS HEART
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   HUTCHINS GM, 1978, AM J CARDIOL, V41, P1127, DOI 10.1016/0002-9149(78)90869-X
   Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   JEREMY RW, 1987, J AM COLL CARDIOL, V9, P989, DOI 10.1016/S0735-1097(87)80298-X
   Kellar RS, 2005, TISSUE ENG, V11, P1678, DOI 10.1089/ten.2005.11.1678
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   LLOYDJONES D, 2009, CIRCULATION, V119, pE1, DOI DOI 10.1161/CIRCULATIONAHA.108.191261
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Naito M, 2000, THROMB RES, V98, P165, DOI 10.1016/S0049-3848(99)00202-9
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Sakuma T, 1998, J AM COLL CARDIOL, V32, P890, DOI 10.1016/S0735-1097(98)00342-8
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Tyagi SC, 1996, MOL CELL BIOCHEM, V155, P13, DOI 10.1007/BF00714328
   Uriel S., 2008, TISSUE ENG PART C-ME, V15, P309
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.186
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   YUE W, 1993, J STEROID BIOCHEM, V44, P671, DOI 10.1016/0960-0760(93)90278-5
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
NR 85
TC 102
Z9 103
U1 2
U2 40
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1937-5387
J9 J CARDIOVASC TRANSL
JI J. Cardiovasc. Transl. Res.
PD OCT
PY 2010
VL 3
IS 5
SI SI
BP 478
EP 486
DI 10.1007/s12265-010-9202-x
PG 9
WC Cardiac & Cardiovascular Systems; Medicine, Research & Experimental
SC Cardiovascular System & Cardiology; Research & Experimental Medicine
GA 686KH
UT WOS:000284694700008
PM 20632221
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Luca, L
   Rougemont, AL
   Walpoth, BH
   Gurny, R
   Jordan, O
AF Luca, Ludmila
   Rougemont, Anne-Laure
   Walpoth, Beat H.
   Gurny, Robert
   Jordan, Olivier
TI The effects of carrier nature and pH on rhBMP-2-induced ectopic bone
   formation
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE BMP-2; Chitosan hydrogel; Hyaluronan hydrogel; Formulation pH;
   Bioactivity; Ectopic bone formation
ID MORPHOGENETIC PROTEIN-2 RHBMP-2; BIOMATERIAL CARRIERS; CHITOSAN
   HYDROGELS; OSTEOGENIC FACTORS; DELIVERY VEHICLES; COLLAGEN SPONGES;
   HYALURONIC-ACID; IN-VITRO; REGENERATION; RETENTION
AB Carrier nature and pH are important factors for rhBMP-2 osteoinductive activity. As for formulation pH, rhBMP-2 undergoes conformational changes and aggregates when shifting from acidic to neutral pH conditions. The present work investigates, to our knowledge for the first time, the effect of the carrier pH on rhBMP-2 bioactivity in a rat ectopic bone formation model. In addition, the influence of the carrier nature on rhBMP-2 osteoinductive activity was studied by comparing under identical experimental conditions two biopolymers having a very similar chemical structure but opposite charges. Specifically, rhBMP-2 was incorporated into chitosan (CH) and hyaluronan (HY) hydrogels at two different pH values. Hydrogels (0.2 mL) containing rhBMP-2 (150 mu g) were injected into quadriceps muscle of Sprague-Dawley rats. Three weeks after injection, animals were euthanized and explanted specimens were analyzed by microcomputerized tomography (micro-CT) and histology. Bone formation was observed in quadriceps muscle with both rhBMP-2-loaded carriers at both pH values. A trend towards higher mineralized bone formation (1.7-fold for CH, 1.4-fold for HY) was observed for rhBMP-2-loaded hydrogels at low pH (4.8 +/- 0.2) compared to high pH (6.2 +/- 0.2). Significantly higher (two- to three-fold) mineralized bone formation was observed with rhBMP2/HY hydrogel compared to rhBMP-2/CH hydrogel, although bone was more mature with the CH hydrogel. These results indicate that both hydrogels are effective carriers for rhBMP-2 and that the carrier nature influences bone formation in terms of volume and quality. This study also provided evidence that the formulation pH is a very important factor that may be critical to design efficient carriers for BMP-2. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Luca, Ludmila; Gurny, Robert; Jordan, Olivier] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland.
   [Rougemont, Anne-Laure] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland.
   [Walpoth, Beat H.] Univ Geneva, Fac Med, Dept Surg, Geneva, Switzerland.
RP Gurny, R (reprint author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
EM Robert.Gurny@unige.ch
RI Jordan, Olivier/B-5590-2009; Rougemont, Anne-Laure/C-5612-2015
OI Jordan, Olivier/0000-0003-3752-2198; 
CR ANDREW JG, 1994, ACTA ORTHOP SCAND, V65, P462, DOI 10.3109/17453679408995493
   Berger J, 2005, INT J PHARM, V288, P197, DOI 10.1016/j.ijpharm.2004.07.037
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bergman K, 2008, J BIOMED MATER RES A, V91A, P1111
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Carlisle Elliot, 2005, Spine J, V5, p240S, DOI 10.1016/j.spinee.2005.02.014
   Crawford CH, 2009, SPINE, V34, P1390, DOI 10.1097/BRS.0b013e3181a2da08
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Joseph V, 2007, SPINE, V32, P2885, DOI 10.1097/BRS.0b013e31815b7596
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Luca L, 2010, INT J PHARMACEUT, V391, P48, DOI 10.1016/j.ijpharm.2010.02.015
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   Oliveira SM, 2009, TISSUE ENG PT A, V15, P635, DOI 10.1089/ten.tea.2008.0052
   PATOIS E, 2008, J BIOMED MATER RES A, V91, P324
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P579
   Schuetz YB, 2008, EUR J PHARM BIOPHARM, V68, P19, DOI 10.1016/j.ejpb.2007.06.020
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Seeherman H, 2001, J BONE JOINT SURG AM, V83A, pS79
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Silva CT, 2008, COMPUT SCI ENG, V10, P9, DOI 10.1109/MCSE.2008.71
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
NR 36
TC 51
Z9 51
U1 1
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD OCT 1
PY 2010
VL 147
IS 1
BP 38
EP 44
DI 10.1016/j.jconrel.2010.06.011
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 663QV
UT WOS:000282903700006
PM 20600403
DA 2018-10-19
ER

PT J
AU Pan, YS
   Xiong, DS
AF Pan, Yusong
   Xiong, Dangsheng
TI Stress relaxation behavior of nano-hydroxyapatite reinforced poly(vinyl
   alcohol) gel composites as biomaterial
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; PVA HYDROGEL; COMPRESSION
AB Nano-hydroxyapatite reinforced poly(vinyl alcohol) (nano-HA/PVA) gel composites has been proposed as a promising biomaterial to replace diseased or damaged articular cartilage. In this paper, the stress relaxation mechanism of nano-HA/PVA gel composites was investigated. The various influence factors on the stress relaxation behavior of the composites were also evaluated. The results showed that the relaxation mechanism of the composites was mainly determined by the synergistic effect of two stress relaxation mechanisms analogous to those of the natural articular cartilage and the polymer. The relaxation rate of the composites increased with the rise of strain ratio, but it declined with the relaxation time. Under the given strain ratio, the relaxation rate of the composite presented a trend of rising first and then falling with the increasing amount of nano-HA content. Contrarily, the normalized equilibrium relaxation modulus of the composites decreased first and then presented increasing trend with the rise of nano-HA content. Furthermore, the normalized equilibrium relaxation modulus of the composites decreased with the rise of strain.
C1 [Pan, Yusong] Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
   [Xiong, Dangsheng] Nanjing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Peoples R China.
RP Pan, YS (reprint author), Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
EM yusongpan@163.com
RI xiong, dangsheng/B-1823-2015
OI xiong, dangsheng/0000-0003-3210-3728
FU Anhui Provincial Universities [KJ2010A099]
FX Research reported in the paper was funded by the Natural Science
   Research of key projects of Anhui Provincial Universities (Project No.
   KJ2010A099).
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Coleman RM, 2007, BIOMATERIALS, V28, P2077, DOI 10.1016/j.biomaterials.2007.01.010
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Dai M., 1998, CHIN J ORTHOP, V18, P484
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   Huang ZH, 2008, MATER LETT, V62, P3376, DOI 10.1016/j.matlet.2008.03.045
   [冀冰 Ji Bing], 2005, [北京科技大学学报, Journal of University Science and Technology Beijing], V27, P589
   Jiang X. L., 2001, POLYM MAT SCI ENG, V17, P116
   Machida Y, 2000, J MOL STRUCT, V554, P81, DOI 10.1016/S0022-2860(00)00561-5
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Nebahat D., 2006, COLLOID SURFACE B, V48, P42
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Rosa R., 2004, MACROMOLECULES, V37, P1921
   Sinha A, 2007, MAT SCI ENG C-BIO S, V27, P70, DOI 10.1016/j.msec.2006.02.008
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   WANG CB, 2001, BIOMECHANICS, V34, P75
   Wang K.Y., 1995, J APPL BIOMECH, V10, P224
   WAYNE JS, 1992, ADV BIOENG, V22, P585
   Weng X.S., 1999, ACTA ACAD MED SINICA, V21, P53
   ZHANG XL, 2000, SHANGHAI MED, V23, P734
   ZHANG XL, 2000, BONE JOINT INJ, V15, P30
NR 27
TC 11
Z9 12
U1 2
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD OCT
PY 2010
VL 45
IS 20
BP 5495
EP 5501
DI 10.1007/s10853-010-4607-0
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 639FX
UT WOS:000280959200009
DA 2018-10-19
ER

PT J
AU Stojkovska, J
   Bugarski, B
   Obradovic, B
AF Stojkovska, Jasmina
   Bugarski, Branko
   Obradovic, Bojana
TI Evaluation of alginate hydrogels under in vivo-like bioreactor
   conditions for cartilage tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ARTICULAR-CARTILAGE; ELECTROSTATIC EXTRUSION; MECHANICAL STIMULATION;
   CELL SUPPORT; GEL; CHONDROCYTES; CULTURE; BEADS; IMMOBILIZATION;
   MICROSPHERES
AB Alginate hydrogels in forms of discs and packed beds of microbeads (similar to 800 mu m) were tested in a novel bioreactor at 10% strain using two regimes: at a loading rate of 337.5 mu m/s and at sequential increments of 50 mu m displacement every 30 min. Compressive strength increased with the increase in alginate concentration (1.5 vs. 2% w/w) and the content of guluronic residues (38.5 vs. 67%). Packed beds of microbeads exhibited significantly higher (similar to 1.5-3.4 fold) compression moduli than the respective discs indicating the effects of gel form and entrapped water. Short-term cultivation of microbeads with immobilized bovine calf chondrocytes (1.5% w/w, 33 x 10(6) cells/ml) under biomimetic conditions (dynamic compression: 1 h on/1 h off, 0.42 Hz, 10% strain) resulted in cell proliferation and bed compaction, so that the compression modulus slightly increased. Thus, the novel bioreactor demonstrated advantages in evaluation of biomaterial properties and cell-biomaterial interactions under in vivo-like settings.
C1 [Stojkovska, Jasmina; Bugarski, Branko; Obradovic, Bojana] Univ Belgrade, Fac Technol & Met, Dept Chem Engn, Belgrade 11120, Serbia.
RP Obradovic, B (reprint author), Univ Belgrade, Fac Technol & Met, Dept Chem Engn, Karnegijeva 4, Belgrade 11120, Serbia.
EM bojana@tmf.bg.ac.rs
OI Obradovic, Bojana/0000-0002-7276-0442
FU Swiss National Science Foundation (SNSF) [IB73B0-111016/1]; Ministry of
   Science and Technological Development of the Republic of Serbia [142075]
FX This work was supported by the Swiss National Science Foundation (SNSF,
   SCOPES grant IB73B0-111016/1) and the Ministry of Science and
   Technological Development of the Republic of Serbia (Grant 142075).
CR Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barbero A, 2003, ARTHRITIS RHEUM, V48, P1315, DOI 10.1002/art.10950
   BIANCO W, 2004, BIOMATERIAL SCI INTR, P379
   Demarteau O, 2003, BIORHEOLOGY, V40, P331
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Freshney RI, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P155, DOI 10.1016/B978-012370615-7/50016-0
   GILSON CD, 1990, PROCESS BIOCHEM, V25, P104
   Junter GA, 2009, CHEM ENG J, V145, P514, DOI 10.1016/j.cej.2008.09.034
   Lakshimi S.N., 2007, PROG POLYM SCI, V32, P762
   Lawrie G, 2007, BIOMACROMOLECULES, V8, P2533, DOI 10.1021/bm070014y
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Lum L, 2003, TOPICS TISSUE ENG, P1
   Mancini M, 1999, J FOOD ENG, V39, P369, DOI 10.1016/S0260-8774(99)00022-9
   Manojlovic V, 2006, J CHEM TECHNOL BIOT, V81, P505, DOI 10.1002/jctb.1465
   Manojlovic V, 2008, SENSORS-BASEL, V8, P1488, DOI 10.3390/s8031488
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1
   Mauck RL, 2003, J BIOMECH ENG-T ASME, V125, P602, DOI 10.1115/1.1611512
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Melvik JE, 2005, FOCUS BIOTECHNOLOGY, P33
   Nedovic VA, 2001, PROCESS BIOCHEM, V37, P17, DOI 10.1016/S0032-9592(01)00172-8
   Nguyen VB, 2009, CHEM ENG SCI, V64, P821, DOI 10.1016/j.ces.2008.10.050
   Obradovic B, 2007, MATER SCI FORUM, V555, P417, DOI 10.4028/www.scientific.net/MSF.555.417
   Obradovic B, 2004, MATER SCI FORUM, V453-454, P549, DOI 10.4028/www.scientific.net/MSF.453-454.549
   Orr DE, 2008, ANN BIOMED ENG, V36, P1228, DOI 10.1007/s10439-008-9505-0
   Osmokrovic A, 2006, FME TRANS, V34, P65
   Petrovic M, 2009, CHEM IND CHEM ENG Q, V15, P41, DOI 10.2298/CICEQ0901041P
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Seidel JO, 2004, BIORHEOLOGY, V41, P445
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Tigh R.S., 2009, J MATER SCI-MATER M, V20, P699
   Wang C, 2005, CHEM ENG SCI, V60, P6649, DOI 10.1016/j.ces.2005.05.052
   Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5
   Williams GM, 2005, ACTA BIOMATER, V1, P625, DOI 10.1016/j.actbio.2005.07.009
   Xu X, 2010, OSTEOARTHR CARTILAGE, V18, P433, DOI 10.1016/j.joca.2009.10.003
NR 43
TC 23
Z9 26
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2010
VL 21
IS 10
BP 2869
EP 2879
DI 10.1007/s10856-010-4135-0
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 669ST
UT WOS:000283371200017
PM 20717710
DA 2018-10-19
ER

PT J
AU Neovius, E
   Engstrand, T
AF Neovius, Erik
   Engstrand, Thomas
TI Craniofacial reconstruction with bone and biomaterials: Review over the
   last 11 years
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Review
DE Review; Craniofacial; Bone; Reconstruction; Biomaterial; Graft
ID POROUS POLYETHYLENE IMPLANTS; SYNDROME MAXILLONASAL DYSPLASIA; SETTING
   HYDROXYAPATITE CEMENT; HIGH-DENSITY POLYETHYLENE; TERM-FOLLOW-UP; NASAL
   RECONSTRUCTION; CRANIAL BONE; ORBITAL RECONSTRUCTION; FRONTAL-BONE;
   PROFILE ROENTGENOGRAMS
AB This review aims to compare bone grafts and different biomaterials for reconstruction of craniofacial bones in congenital defects, after trauma, and after tumour surgery. A Pubmed search was performed and publications over the last 11 years describing reconstructions of craniofacial bones in non-load-bearing areas were reviewed. Only human studies using bone grafts and biomaterials were included. Studies on skull base reconstruction, distraction osteogenesis, free and pedicled bone flaps and bone-anchored epithesis were excluded. Out of 83 studies, three were prospective, 65 retrospective and 15 studies were case reports. There were seven comparative studies found and some efforts on statistical analysis were made. Except for a few studies, the statistical significant differences in outcomes were found to be related to size and location of bone defects rather than reconstruction method and biomaterial used. An increasing number of alloplastic materials have been available as alternatives to the gold standard autologous bone transplantation for craniofacial bone repair. Comparative studies with statistical analyses on differences in success rates between different biomaterials or bone grafts for specific indications are needed. (C) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Neovius, Erik; Engstrand, Thomas] Karolinska Univ Hosp, Stockholm Craniofacial Ctr, Dept Reconstruct Plast Surg, S-17176 Stockholm, Sweden.
   [Neovius, Erik; Engstrand, Thomas] Karolinska Inst, Stockholm, Sweden.
RP Neovius, E (reprint author), Karolinska Univ Hosp, Stockholm Craniofacial Ctr, Dept Reconstruct Plast Surg, S-17176 Stockholm, Sweden.
EM erik.neovius@karolinska.se
FU Stockholm County Council and the Karolinska Institute and through
   Vinnova/Stiftelsen for Strategisk Forskning [28476-1]
FX Financial support was provided through the regional agreement on medical
   training and clinical research (ALF) between Stockholm County Council
   and the Karolinska Institute and through Vinnova/Stiftelsen for
   Strategisk Forskning (project no 28476-1).
CR Arnander C, 2006, J CRANIOFAC SURG, V17, P275, DOI 10.1097/00001665-200603000-00013
   Arnaud E, 2000, CHILD NERV SYST, V16, P659, DOI 10.1007/s003810000321
   Artico M, 2003, SURG NEUROL, V60, P71, DOI 10.1016/S0090-3019(03)00031-4
   Baek RM, 2005, J CRANIOFAC SURG, V16, P736, DOI 10.1097/01.scs.0000168770.86603.21
   Baker SB, 2002, PLAST RECONSTR SURG, V109, P1789, DOI 10.1097/00006534-200205000-00003
   Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158
   Bonucci E, 1997, EUR J ORAL SCI, V105, P557, DOI 10.1111/j.1600-0722.1997.tb00217.x
   Burstein FD, 1997, PLAST RECONSTR SURG, V100, P869, DOI 10.1097/00006534-199709001-00007
   Burstein FD, 1999, PLAST RECONSTR SURG, V104, P1270, DOI 10.1097/00006534-199910000-00005
   Celik M, 2000, PLAST RECONSTR SURG, V105, P1624
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Chambers PA, 2007, BRIT J ORAL MAX SURG, V45, P77, DOI 10.1016/j.bjoms.2005.04.010
   Chen TM, 2004, ANN PLAS SURG, V52, P303, DOI 10.1097/01.sap.0000105522.32658.2f
   Chen TM, 2002, ANN PLAS SURG, V49, P272, DOI 10.1097/01.SAP.0000015488.91165.B8
   Chen TM, 2002, ANN PLAST SURG, V49, P277
   Choi SH, 1998, PEDIATR NEUROSURG, V29, P324, DOI 10.1159/000028747
   Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679
   David L, 2005, J CRANIOFAC SURG, V16, P129, DOI 10.1097/00001665-200501000-00026
   Demirtas Y, 2006, J CRANIOFAC SURG, V17, P131, DOI 10.1097/01.scs.0000197388.89185.f0
   Dickinson BP, 2008, PLAST RECONSTR SURG, V121, P209, DOI 10.1097/01.prs.0000293870.64781.12
   Donati L, 1997, INT SURG, V82, P325
   Ducic Yadranko, 2002, J Oral Maxillofac Surg, V60, P272, DOI 10.1053/joms.2002.30575
   Duman H, 1999, J CRANIO MAXILL SURG, V27, P298, DOI 10.1054/jcms.1999.0902
   Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01.01290.8E
   Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085
   Eppley BL, 2002, J CRANIOFAC SURG, V13, P650, DOI 10.1097/01.SCS.0000026428.32901.AD
   Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002
   Eufinger H, 2001, AORN J, V74, P648, DOI 10.1016/S0001-2092(06)61763-8
   Eufinger H, 2001, AORN J, V74, P658
   Fortunato G, 1997, J CRANIO MAXILL SURG, V25, P124, DOI 10.1016/S1010-5182(97)80003-0
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   Frodel JL, 1998, ARCH OTOLARYNGOL, V124, P1219, DOI 10.1001/archotol.124.11.1219
   Gear AJ, 2002, ANN PLAST SURG, V48, P7
   Gear AJL, 2002, ANN PLAS SURG, V48, P1, DOI 10.1097/00000637-200201000-00001
   Gomez E, 2005, J ORAL MAXIL SURG, V63, P8, DOI 10.1016/j.jams.2004.09.008
   Gosain AK, 1997, J CRANIOFAC SURG, V8, P506, DOI 10.1097/00001665-199711000-00017
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   Greenberg BM, 2005, ANN PLAS SURG, V55, P43, DOI 10.1097/01.sap.0000168157.10664.9c
   Gurley JM, 2001, PLAST RECONSTR SURG, V108, P1895, DOI 10.1097/00006534-200112000-00007
   Gurley JM, 2001, PLAST RECONSTR SURG, V108, P1906
   Heissler E, 1998, INT J ORAL MAX SURG, V27, P334, DOI 10.1016/S0901-5027(98)80060-X
   Herford AS, 2007, J ORAL MAXIL SURG, V65, P2136, DOI 10.1016/j.jams.2007.06.670
   Herford AS, 2004, J ORAL MAXIL SURG, V62, P1082, DOI 10.1016/j.joms.2004.01.023
   Hirano S, 1997, PLAST RECONSTR SURG, V100, P86, DOI 10.1097/00006534-199707000-00015
   Honig JF, 2005, J CRANIOFAC SURG, V16, P457
   Hubli EH, 1998, ANN PLAS SURG, V41, P81, DOI 10.1097/00000637-199807000-00015
   Jackson IT, 1998, PLAST RECONSTR SURG, V102, P1869, DOI 10.1097/00006534-199811000-00010
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   Joffe J, 1999, BRIT J NEUROSURG, V13, P576, DOI 10.1080/02688699943088
   Kelly CP, 2005, J CRANIOFAC SURG, V16, P181, DOI 10.1097/00001665-200501000-00039
   Koppel DA, 1999, BRIT J ORAL MAX SURG, V37, P70, DOI 10.1054/bjom.1998.0349
   Kuttenberger JJ, 2001, J CRANIO MAXILL SURG, V29, P75, DOI 10.1054/jcms.2001.0197
   Lenz JH, 2003, J CRANIO MAXILL SURG, V31, P154, DOI 10.1016/S1010-5182(03)00024-6
   Liu James K, 2004, Neurosurg Focus, V16, pECP1
   Magee WP, 2004, PLAST RECONSTR SURG, V114, P289, DOI 10.1097/01.PRS.0000131868.67896.83
   Mahr MA, 2000, OPHTHALMIC PLAST REC, V16, P393, DOI 10.1097/00002341-200009000-00014
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Mathur Kevin K, 2003, Arch Facial Plast Surg, V5, P379, DOI 10.1001/archfaci.5.5.379
   Matic D, 2002, PLAST RECONSTR SURG, V110, P1, DOI 10.1097/00006534-200207000-00001
   Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004
   Miyake H, 2000, NEUROSURGERY, V46, P414, DOI 10.1097/00006123-200002000-00028
   Moreira-Gonzalez A, 2003, PLAST RECONSTR SURG, V111, P1808, DOI 10.1097/01.PRS.0000055432.20074.93
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Mottaran R, 2004, J Neurosurg Sci, V48, P143
   Neu BR, 2000, PLAST RECONSTR SURG, V106, P160, DOI 10.1097/00006534-200007000-00032
   Niechajev I, 1999, AESTHET PLAST SURG, V23, P395, DOI 10.1007/s002669900308
   Nunes CR, 1997, J BIOMED MATER RES, V36, P560
   Pang DL, 2005, J NEUROSURG, V102, P36, DOI 10.3171/ped.2005.102.1.0036
   Pompili A, 1998, J NEUROSURG, V89, P236, DOI 10.3171/jns.1998.89.2.0236
   Rapidis AD, 2006, J ORAL MAXIL SURG, V64, P12, DOI 10.1016/j.joms.2005.09.007
   Reddi S P, 1999, J Craniomaxillofac Trauma, V5, P7
   Romo T, 1998, AESTHET PLAST SURG, V22, P211, DOI 10.1007/s002669900193
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   Rune B, 1998, PLAST RECONSTR SURG, V101, P297, DOI 10.1097/00006534-199802000-00005
   Rune B, 1998, PLAST RECONSTR SURG, V101, P305
   Salyer KE, 1997, PLAST RECONSTR SURG, V99, P1721, DOI 10.1097/00006534-199705000-00038
   Scolozzi P, 2007, J CRANIOFAC SURG, V18, P224, DOI 10.1097/01.scs.0000249359.56417.7e
   Sevin K, 2000, BRIT J ORAL MAX SURG, V38, P44, DOI 10.1054/bjom.1998.0038
   Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9
   Tessier P, 2005, PLAST RECONSTR SURG, V116, p6S, DOI 10.1097/01.prs.0000173862.20563.12
   Tessier P, 2005, PLAST RECONSTR SURG, V116, p92S
   Tuncer S, 2004, J CRANIOFAC SURG, V15, P243, DOI 10.1097/00001665-200403000-00015
   Turegun M, 1998, AESTHET PLAST SURG, V22, P38, DOI 10.1007/s002669900163
   Turk J B, 2000, Facial Plast Surg, V16, P7, DOI 10.1055/s-2000-7321
   Valentini V, 2007, J CRANIOFAC SURG, V18, P953, DOI 10.1097/scs.0b013e3180690123
   Vargel I, 2004, PLAST RECONSTR SURG, V114, P298, DOI 10.1097/01.PRS.0000131983.48201.E2
   Verret DJ, 2005, OTOLARYNG HEAD NECK, V133, P897, DOI 10.1016/j.otohns.2005.09.001
   Vories A, 2001, Ear Nose Throat J, V80, P29
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wiltfang J, 2004, J ORAL MAXIL SURG, V62, P29, DOI 10.1016/j.joms.2003.02.002
   Wolff KD, 2004, J CRANIO MAXILL SURG, V32, P71, DOI 10.1016/S1010-5182(03)00134-3
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
   Zins JE, 2007, PLAST RECONSTR SURG, V120, P1332, DOI 10.1097/01.prs.0000279557.29134.cd
   Zins JE, 2006, PLAST RECONSTR SURG, V117, P948, DOI 10.1097/01.prs.0000204768.85643.0c
NR 95
TC 95
Z9 100
U1 0
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PD OCT
PY 2010
VL 63
IS 10
BP 1615
EP 1623
DI 10.1016/j.bjps.2009.06.003
PG 9
WC Surgery
SC Surgery
GA 647YA
UT WOS:000281655500007
PM 19577527
DA 2018-10-19
ER

PT J
AU Sealy, MP
   Guo, YB
AF Sealy, M. P.
   Guo, Y. B.
TI Surface integrity and process mechanics of laser shock peening of novel
   biodegradable magnesium-calcium (Mg-Ca) alloy
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Metallic biomaterial; Surface integrity; Implants; Laser shock peening;
   Corrosion; Finite element simulation
ID STRESS-DISTRIBUTION; CONFINED GEOMETRY; BONE-RESORPTION; WAVE
   GENERATION; SIMULATION; PLASMA; WATER; CORROSION; PROPERTY
AB Current permanent metallic biomaterials of orthopedic implants, such as titanium, stainless steel, and cobalt-chromium alloys, have excellent corrosive properties and superior strengths. However, their strengths are often too high resulting in a stress shielding effect that is detrimental to the bone healing process. Without proper healing, costly and painful revision surgeries may be required. The close Young's modulus between magnesium-based implants and cancellous bones has the potential to minimize stress shielding while providing both biocompatibility and adequate mechanical properties. The problem with Mg implants is how to control corrosion rates so that the degradation of Mg implants matches that of bone growth. Laser shock peening (LSP) is an innovative surface treatment method to impart compressive residual stress to a novel Mg-Ca implant. The high compressive residual stress has great potential to slow corrosion rates. Therefore, LSP was initiated in this study to investigate surface topography and integrity produced by sequential peening a Mg-Ca alloy. Also, a 3D semi-infinite simulation was developed to predict the topography and residual stress fields produced by sequential peening. The dynamic mechanical behavior of the biomaterial was modeled using a user material subroutine from the internal state variable plasticity model. The temporal and spatial peening pressure was modeled using a user load subroutine. The simulated dent agrees with the measured dent topography in terms of profile and depth. Sequential peening was found to increase the tensile pile up region which is critical to orthopedic applications. The predicted residual stress profiles are also presented. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Sealy, M. P.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
RI Sealy, Michael/K-5248-2017
OI Sealy, Michael/0000-0002-9236-5458
FU National Science Foundation [CMMI-0555269]
FX This research is based upon the work supported by the National Science
   Foundation under Grant No. CMMI-0555269. The authors would like to thank
   Dr. P.V. Puzinauskas at the University of Alabama for help in setting up
   the experiments.
CR Abbas G, 2005, APPL SURF SCI, V247, P347, DOI [10.1016/j.apsusc.2005.01.169, 10.1016/J.APSUSC.2005.01.169]
   Aksakal B, 2008, J MATER SCI-MATER M, V19, P2097, DOI 10.1007/s10856-007-3304-2
   Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Benli S, 2008, J BIOMECH, V41, P3229, DOI 10.1016/j.jbiomech.2008.08.003
   Berthe L, 1999, J APPL PHYS, V85, P7552, DOI 10.1063/1.370553
   Berthe L, 1997, J APPL PHYS, V82, P2826, DOI 10.1063/1.366113
   Braisted W, 1999, INT J FATIGUE, V21, P719, DOI 10.1016/S0142-1123(99)00035-3
   CASLARU R, 2006, T NAMRI SME, V37, P159
   Clauer AH, 1996, P SURF PERF TIT, P217
   Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006
   Dane C. B., 1998, ADV AER MAT PROC C T
   DEVAUX D, 1993, J APPL PHYS, V74, P2268, DOI 10.1063/1.354710
   FABBRO R, 1990, J APPL PHYS, V68, P775, DOI 10.1063/1.346783
   FAIRAND BP, 1976, OPT COMMUN, V18, P588, DOI 10.1016/0030-4018(76)90327-8
   FAIRAND BP, 1972, J APPL PHYS, V43, P3893, DOI 10.1063/1.1661837
   FAN Y, 2005, J APPL PHYS, V98
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   GUO YB, 2010, ANN CIRP IN PRESS
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Isaksson H., 2003, BIOENG C, P1041
   Manna S., 1996, U.S. Patent, Patent No. [5,569,018, 5569018]
   Masse J. E., 1995, SURFACE COATINGS TEC, V70, P179
   Mondal AK, 2008, SURF COAT TECH, V202, P3187, DOI 10.1016/j.surfcoat.2007.11.030
   Montross CS, 1999, INT J ROCK MECH MIN, V36, P849, DOI 10.1016/S0148-9062(99)00054-6
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   PEYRE P, 2001, MAT SCI ENG A-STRUCT, P102
   SEALY MP, 2008, INT J COMP METHODS E, V10, P149
   SEILER HG, 1987, HDB TOXICITY INORGAN
   Shi JF, 2007, P I MECH ENG H, V221, P903, DOI 10.1243/09544119JEIM256
   *SIMULIA, 2008, ABAQUS US MAN VER 6
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Warren AW, 2008, INT J FATIGUE, V30, P188, DOI 10.1016/j.ijfatigue.2007.01.033
   WARREN AW, 2005, P ASME INT MECH ENG
   WARREN AW, 2007, T NAMRI SME, V35, P409
   Wu B., 2005, J APPL PHYS, V97, P1
   Zhang WW, 2004, J MANUF SCI E-T ASME, V126, P10, DOI 10.1115/1.1645878
   Zhang WW, 2002, J MANUF SCI E-T ASME, V124, P369, DOI 10.1115/1.1445149
NR 39
TC 43
Z9 44
U1 2
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD OCT
PY 2010
VL 3
IS 7
BP 488
EP 496
DI 10.1016/j.jmbbm.2010.05.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 654VB
UT WOS:000282198000003
PM 20696413
DA 2018-10-19
ER

PT J
AU Bhat, A
   Dreifke, MB
   Kandimalla, Y
   Gomez, C
   Ebraheim, NA
   Jayasuriya, AC
AF Bhat, Archana
   Dreifke, Michael B.
   Kandimalla, Yugandhar
   Gomez, Carlos
   Ebraheim, Nabil A.
   Jayasuriya, A. Champa
TI Evaluation of cross-linked chitosan microparticles for bone regeneration
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE microparticles; injectable; bone regeneration; in vivo; radiography;
   histology; microcomputed tomography; von Kossa
ID MESENCHYMAL STEM-CELLS; CULTURE PERIOD; MARROW-CELLS; TISSUE; SCAFFOLDS;
   DIFFERENTIATION; HYDROXYAPATITE; BIOCOMPATIBILITY; PROLIFERATION;
   MICROSPHERES
AB The objective of this preliminary study was to evaluate the applying of chitosan (CS)-based microparticles (MPs) in bone regeneration in vivo. The CS MPs were fabricated using our scale-up method, as previously described. Mesenchymal stem cells (MSC) were harvested from the femora and tibiae of Dark Agouti (DA) rats and seeded on CS MPs. An in vitro MSCs attachment experiment was conducted by trypsinizing the cells attached to the MPs at 5, 10, 20 and 30 h. Fluorescence images of MSCs attached to the MPs were taken at 24 and 48 h, using a LIVE/DEAD cell assay. The MSC/osteoblasts (OB) seeded on MPs were then cultured in vitro using osteogenic media and implanted into partial thickness bone defects in rat femurs. There were two groups of rats, including experimental animals and controls, for the in vivo studies. The experimental group were implanted with MSC-seeded MPs and observed at 4 and 8 weeks. The control group of rats did not receive any implant material except the stainless steel plate to support the defect. Four rats per group were used for the study. The femurs were extracted at 4 and 8 weeks post-implantation and bone formation at the defect site was analysed using radiography, microcomputed tomography (mu CT) and histology. Among all groups, a significant increase in bone formation was observed in the experimental group at 8 weeks implantation. The results of this study suggested that CS MPs prove to be a successful biomaterial for bone regeneration. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Bhat, Archana; Dreifke, Michael B.; Kandimalla, Yugandhar; Gomez, Carlos; Ebraheim, Nabil A.; Jayasuriya, A. Champa] Univ Toledo, Dept Orthopaed, Toledo, OH 43614 USA.
RP Jayasuriya, AC (reprint author), Univ Toledo, Dept Orthopaed, Hlth Sci Campus,3065 Arlington Ave,Dowling Hall 2, Toledo, OH 43614 USA.
EM a.jayasuriya@utoledo.edu
OI kandimalla, yugandhar/0000-0002-3319-9373
FU National Science Foundation (NSF) [0652024]
FX We would like to thank the National Science Foundation (NSF) for
   providing financial support (Grant No. 0652024) for this study.
CR Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Bran GM, 2008, ARCH MED RES, V39, P467, DOI 10.1016/j.arcmed.2008.02.007
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Conti B, 2000, STP PHARMA SCI, V10, P101
   Costa-Pinto AR, 2008, TISSUE ENG PT A, V14, P1049, DOI 10.1089/tea.2007.0153
   Daniels AU, 1994, J APPL BIOMAT, V17, P2373
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Cruz DMG, 2008, J TISSUE ENG REGEN M, V2, P378, DOI 10.1002/term.106
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Ishikawa K, 1997, J BIOMED MATER RES, V36, P393, DOI 10.1002/(SICI)1097-4636(19970905)36:3<393::AID-JBM14>3.0.CO;2-F
   Jayasuriya AC, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055006
   Jayasuriya AC, 2010, J TISSUE EN IN PRESS
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Lauria EA, 1987, CELL TISSUE RES, V248, P449
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Mercier NR, 2005, BIOMATERIALS, V26, P1945, DOI 10.1016/j.biomaterials.2004.06.030
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Silva GA, 2007, BIOMATERIALS, V28, P326, DOI 10.1016/j.biomaterials.2006.07.009
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
NR 31
TC 14
Z9 16
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD OCT
PY 2010
VL 4
IS 7
BP 532
EP 542
DI 10.1002/term.270
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 662UD
UT WOS:000282837900005
PM 20872740
DA 2018-10-19
ER

PT J
AU Subbiahdoss, G
   Kuijer, R
   Busscher, HJ
   van der Mei, HC
AF Subbiahdoss, Guruprakash
   Kuijer, Roel
   Busscher, Henk J.
   van der Mei, Henny C.
TI Mammalian cell growth versus biofilm formation on biomaterial surfaces
   in an in vitro post-operative contamination model
SO MICROBIOLOGY-SGM
LA English
DT Article
ID HUMAN-ENDOTHELIAL CELLS; SMALL-COLONY VARIANTS;
   STAPHYLOCOCCUS-EPIDERMIDIS; TISSUE INTEGRATION; POLYMER SURFACES;
   INFECTIONS; ADHESION; METHACRYLATE; BACTERIA; AUREUS
AB Biomaterial-associated infections are the major cause of implant failure and can develop many years after implantation. Success or failure of an implant depends on the balance between host tissue integration and bacterial colonization. Here, we describe a new in vitro model for the postoperative bacterial contamination of implant surfaces and investigate the effects of contamination on the balance between mammalian cell growth and bacterial biofilm formation. U2OS osteosarcoma cells were seeded on poly(methyl methacrylate) in different densities and allowed to grow for 24 h in a parallel-plate flow chamber at a low shear rate (0.14 s(-1)), followed by contamination with Staphylococcus epidermidis ATCC 35983 at a shear rate of 11 s(-1). The U2OS cells and staphylococci were allowed to grow simultaneously for another 24 h under low-shear conditions (0.14 s(-1)). Mammalian cell growth was severely impaired when the bacteria were introduced to surfaces with a low initial cell density (2.5x10(4) cells cm(-2)), but in the presence of higher initial cell densities (8.2x10(4) cells cm(-2) and 17x10(4) cells cm(-2)), contaminating staphylococci did not affect cell growth. This study is believed to be the first to show that a critical coverage by mammalian cells is needed to effectively protect a biomaterial implant against contaminating bacteria.
C1 [van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   Univ Groningen, NL-9700 AD Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944; Subbiahdoss,
   Guruprakash/0000-0002-6684-7322
FU University Medical Centre Groningen
FX This work was funded by the University Medical Centre Groningen.
CR CHRISTENSEN GD, 1995, METHOD ENZYMOL, V253, P477
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Gristina A G, 1990, Infect Dis Clin North Am, V4, P391
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551
   Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0
   Okell CC, 1935, LANCET, V2, P869
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Singh R, 2009, J MED MICROBIOL, V58, P1067, DOI 10.1099/jmm.0.009720-0
   SUBBIAHDOSS G, 2010, J BIOMED MATER RES A, V9, P533
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
NR 22
TC 18
Z9 18
U1 1
U2 15
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD OCT
PY 2010
VL 156
BP 3073
EP 3078
DI 10.1099/mic.0.040378-0
PN 10
PG 6
WC Microbiology
SC Microbiology
GA 670UZ
UT WOS:000283454100018
PM 20595259
OA Bronze
DA 2018-10-19
ER

PT J
AU Tong, WY
   Liang, M
   Tam, V
   Yip, HK
   Kao, YT
   Cheung, KMC
   Yeung, KWK
   Lam, YW
AF Tong, W. Y.
   Liang, M.
   Tam, V.
   Yip, H. K.
   Kao, Y. T.
   Cheung, K. M. C.
   Yeung, K. W. K.
   Lam, Y. W.
TI Biochemical Characterization of the Cell-Biomaterial Interface by
   Quantitative Proteomics
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID PLASMA-MEMBRANE; ACTIN CYTOSKELETON; MASS-SPECTROMETRY; COLLOIDAL
   SILICA; FOCAL ADHESIONS; PROTEINS; FIBROBLASTS; EXPRESSION; SURFACES;
   NEBULIN
AB Surface topography and texture of cell culture substrata can affect the differentiation and growth of adherent cells. The biochemical basis of the transduction of the physical and mechanical signals to cellular responses is not well understood. The lack of a systematic characterization of cell-biomaterial interaction is the major bottleneck. This study demonstrated the use of a novel subcellular fractionation method combined with quantitative MS-based proteomics to enable the robust and high-throughput analysis of proteins at the adherence interface of Madin-Darby canine kidney cells. This method revealed the enrichment of extracellular matrix proteins and membrane and stress fibers proteins at the adherence surface, whereas it shows depletion of extracellular matrix belonging to the cytoplasmic, nucleus, and lateral and apical membranes. The asymmetric distribution of proteins between apical and adherence sides was also profiled. Apart from classical proteins with clear involvement in cell-material interactions, proteins previously not known to be involved in cell attachment were also discovered. Molecular & Cellular Proteomics 9:2089-2098, 2010.
C1 [Liang, M.; Yeung, K. W. K.; Lam, Y. W.] City Univ Hong Kong, Dept Biol & Chem, Kowloon Tong, Hong Kong, Peoples R China.
   [Tong, W. Y.; Tam, V.; Cheung, K. M. C.; Yeung, K. W. K.] Univ Hong Kong, Queen Mary Hosp, LKS Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China.
   [Kao, Y. T.] Univ Hong Kong, LKS Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Yip, H. K.] James Cook Univ, Sch Med & Dent, Townsville, Qld, Australia.
RP Yeung, KWK (reprint author), City Univ Hong Kong, Dept Biol & Chem, Room B6708,6-F,Acad Bldg,83 Tat Chee Ave, Kowloon Tong, Hong Kong, Peoples R China.
RI Kao, Richard/C-4289-2009
OI Lam, Yun Wah/0000-0001-8929-5965; Cheung, Kenneth/0000-0001-8304-0419;
   Yeung, Kelvin/0000-0003-0887-088X; Tam, Vivian/0000-0002-1074-8018
CR AGGELER J, 1982, J CELL BIOL, V94, P613, DOI 10.1083/jcb.94.3.613
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Bindschedler LV, 2008, PHYTOCHEMISTRY, V69, P1962, DOI 10.1016/j.phytochem.2008.04.007
   Cattelino A, 1999, MOL BIOL CELL, V10, P373, DOI 10.1091/mbc.10.2.373
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   CHANEY LK, 1983, J BIOL CHEM, V258, P62
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   COHEN CM, 1977, J CELL BIOL, V75, P119, DOI 10.1083/jcb.75.1.119
   de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8
   Drees Frauke, 2005, Methods Mol Biol, V294, P303
   FELTKAMP CA, 1991, J CELL SCI, V100, P579
   GATES RE, 1993, BIOCHEM J, V289, P221, DOI 10.1042/bj2890221
   Goode Robert J. A., 2009, V528, P177, DOI 10.1007/978-1-60327-310-7_13
   INGBER DE, PROG BIOPHYSICS MOL, V97, P163
   JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278
   Jaitovich AA, 2006, SEMIN NEPHROL, V26, P386, DOI 10.1016/j.semnephrol.2006.07.002
   Kantawong F, 2009, ACTA BIOMATER, V5, P1137, DOI 10.1016/j.actbio.2008.11.001
   Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069
   LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1006/jmbi.1995.0223
   Lam MT, 2009, BIOMATERIALS, V30, P1150, DOI 10.1016/j.biomaterials.2008.11.014
   Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200
   Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064
   LANG RDA, 1981, J CELL SCI, V49, P383
   Liao S, 2008, MAT SCI ENG C-BIO S, V28, P1189, DOI 10.1016/j.msec.2008.08.015
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma K, 2002, FEBS LETT, V532, P273, DOI 10.1016/S0014-5793(02)03655-4
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   NERMUT MV, 1989, ELECTRON MICROSC REV, V2, P171, DOI 10.1016/0892-0354(89)90015-4
   NICOL A, 1987, J HISTOCHEM CYTOCHEM, V35, P499, DOI 10.1177/35.4.2880891
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736
   Rudnick PA, 2005, J PROTEOME RES, V4, P1353, DOI 10.1021/pr0500509
   Saito T, 2010, MAT SCI ENG C-MATER, V30, P1, DOI 10.1016/j.msec.2009.06.010
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Stamenovic D., 2006, PRINCIPLES CELLULAR, P81
   Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200
   Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092
   Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6
   Vermeulen M, 2009, CURR OPIN CELL BIOL, V21, P761, DOI 10.1016/j.ceb.2009.09.003
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Xu JL, 2009, BIOMATERIALS, V30, P5385, DOI 10.1016/j.biomaterials.2009.07.002
   ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x
NR 43
TC 6
Z9 6
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD OCT
PY 2010
VL 9
IS 10
BP 2089
EP 2098
DI 10.1074/mcp.M110.001966
PG 10
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 656VJ
UT WOS:000282368900001
PM 20562470
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Holst, J
   Watson, S
   Lord, MS
   Eamegdool, SS
   Bax, DV
   Nivison-Smith, LB
   Kondyurin, A
   Ma, LA
   Oberhauser, AF
   Weiss, AS
   Rasko, JEJ
AF Holst, Jeff
   Watson, Sarah
   Lord, Megan S.
   Eamegdool, Steven S.
   Bax, Daniel V.
   Nivison-Smith, Lisa B.
   Kondyurin, Alexey
   Ma, Liang
   Oberhauser, Andres F.
   Weiss, Anthony S.
   Rasko, John E. J.
TI Substrate elasticity provides mechanical signals for the expansion of
   hemopoietic stem and progenitor cells
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID RECEPTOR RETROGENIC MICE; HUMAN TROPOELASTIN; AORTIC ENDOTHELIUM;
   ESCHERICHIA-COLI; PROTEIN; FORCES; MECHANOTRANSDUCTION; EXPRESSION;
   REVEALS; NICHES
AB Surprisingly little is known about the effects of the physical microenvironment on hemopoietic stem and progenitor cells. To explore the physical effects of matrix elasticity on well-characterized primitive hemopoietic cells, we made use of a uniquely elastic biomaterial, tropoelastin. Culturing mouse or human hemopoietic cells on a tropoelastin substrate led to a two- to threefold expansion of undifferentiated cells, including progenitors and mouse stem cells. Treatment with cytokines in the presence of tropoelastin had an additive effect on this expansion. These biological effects required substrate elasticity, as neither truncated nor cross-linked tropoelastin reproduced the phenomenon, and inhibition of mechanotransduction abrogated the effects. Our data suggest that substrate elasticity and tensegrity are important mechanisms influencing hemopoietic stem and progenitor cell subsets and could be exploited to facilitate cell culture.
C1 [Holst, Jeff; Watson, Sarah; Rasko, John E. J.] Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia.
   [Holst, Jeff; Rasko, John E. J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Lord, Megan S.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.
   [Eamegdool, Steven S.; Bax, Daniel V.; Nivison-Smith, Lisa B.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Kondyurin, Alexey] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.
   [Ma, Liang; Oberhauser, Andres F.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA.
   [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia.
RP Rasko, JEJ (reprint author), Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia.
EM j.rasko@centenary.org.au
RI Rasko, John/F-5754-2013; Kondyurin, Alexey/B-9580-2011; Holst,
   Jeff/H-7634-2012; Lord, Megan/D-4673-2013
OI Kondyurin, Alexey/0000-0002-8837-9734; Holst, Jeff/0000-0002-0377-9318;
   Lord, Megan/0000-0002-0506-9811; Nivison-Smith,
   Lisa/0000-0001-6677-1949; WEISS, ANTHONY/0000-0002-8106-4836
FU Cancer Institute of New South Wales; US National Institutes of Health
FX We thank D. Vignali for scientific discussion. J.H. received grant
   support from the Cancer Institute of New South Wales, A. S. W. from the
   Australian Research Council and National Health and Medical Research
   Council, A.F.O. received support from the US National Institutes of
   Health and J.E.J.R. from the National Health and Medical Research
   Council and the Cell and Gene Trust, Cure The Future.
CR Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073
   Ainsworth C, 2008, NATURE, V456, P696, DOI 10.1038/456696a
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738
   Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   CARTER WG, 1988, J BIOL CHEM, V263, P4193
   Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619
   Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517
   Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904
   Gan BK, 2007, LANGMUIR, V23, P2741, DOI 10.1021/la062722v
   GHAFFARI S, 1995, BLOOD, V86, P2976
   Greene DN, 2008, BIOPHYS J, V95, P1360, DOI 10.1529/biophysj.108.130237
   Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858
   Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611
   Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61
   Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797
   Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Mecham R. P, 1991, CELL BIOL EXTRACELLU, P79
   MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014
   Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Ostuni A, 2002, INT J BIOCHEM CELL B, V34, P130, DOI 10.1016/S1357-2725(01)00115-7
   Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967
   Puttini S, 2009, MOL THER, V17, P19, DOI 10.1038/mt.2008.239
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   Spofford CM, 2003, J BIOMECH, V36, P645, DOI 10.1016/S0021-9290(02)00442-6
   Spofford CM, 2001, AM J PHYSIOL-HEART C, V280, pH1354
   Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Wu WJ, 1999, EUR J BIOCHEM, V266, P308, DOI 10.1046/j.1432-1327.1999.00891.x
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
   Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018
NR 54
TC 127
Z9 127
U1 1
U2 36
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD OCT
PY 2010
VL 28
IS 10
BP 1123
EP U168
DI 10.1038/nbt.1687
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 663GF
UT WOS:000282870500035
PM 20890282
DA 2018-10-19
ER

PT J
AU Arbeitman, CR
   del Grosso, MF
   Ibanez, I
   Bermudez, GG
   Duran, H
   Chappa, VC
   Mazzei, R
   Behar, M
AF Arbeitman, C. R.
   del Grosso, M. F.
   Ibanez, I.
   Garcia Bermudez, G.
   Duran, H.
   Chappa, V. C.
   Mazzei, R.
   Behar, M.
TI Irradiation of Polystyrene and Polypropylene to study NIH 3T3
   fibroblasts adhesion
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 15th International Conference of the Radiation Effects in Insulators
CY AUG 30-SEP 04, 2009
CL ITALY
SP Cent Surg Assoc
DE Irradiated polymers; Biocompatibility; Cell adhesion
ID CELLS; POLYETHYLENE; ORGANIZATION; ALIGNMENT
AB When polymers are irradiated with heavy ions new chemical groups are created in a few microns of the material. The irradiation changed the polarity and wettability on the surface so that could enhance the biocompatibility of the modified polymer. The study of chemistry and nanoscale topography of the biomaterial is important in determining its potential applications in medicine and biotechnology, because their strong influence on cell function, adhesion and proliferation. In this study, thin films of Polystyrene and Polypropylene samples were modified by irradiation with low energy ion beams (30-150 keV) and swift heavy ions both with various fluences and energies. The changes were evaluated with different methods. Adhesion of NIH 313 fibroblasts onto unirradiated and irradiated surfaces has been studied by in vitro techniques. The correlations between physicochemical properties as a function of different irradiations parameters were compared with cell adhesion on the modified polymer surface. (c) 2010 Elsevier B.V. All rights reserved.
C1 [del Grosso, M. F.; Ibanez, I.; Garcia Bermudez, G.; Duran, H.; Chappa, V. C.] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
   [Mazzei, R.] UTN FRBA, Dpto Ing Quim, CNEA, UA Tecnol & Agropecuarias, Buenos Aires, DF, Argentina.
   [Behar, M.] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil.
RP del Grosso, MF (reprint author), Av Gral Paz 1499, RA-1650 Buenos Aires, DF, Argentina.
EM delgrosso@tandar.cnea.gov.ar
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Clark P, 2002, INT J BIOCHEM CELL B, V34, P816, DOI 10.1016/S1357-2725(01)00180-7
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Kim KH, 2001, NUCL INSTRUM METH B, V175, P542, DOI 10.1016/S0168-583X(00)00650-9
   Rockova-Hlavackova K, 2004, NUCL INSTRUM METH B, V225, P275, DOI 10.1016/j.nimb.2004.05.004
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Svorcik V, 2004, NUCL INSTRUM METH B, V215, P366, DOI 10.1016/j.nimb.2003.08.030
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
NR 9
TC 6
Z9 6
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD OCT 1
PY 2010
VL 268
IS 19
BP 3059
EP 3062
DI 10.1016/j.nimb.2010.05.041
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 656BP
UT WOS:000282301100047
DA 2018-10-19
ER

PT J
AU Abadi, MBH
   Ghasemi, I
   Khavandi, A
   Shokrgozar, MA
   Farokhi, M
   Homaeigohar, SS
   Eslamifar, A
AF Abadi, M. Bagheri Hossein
   Ghasemi, I.
   Khavandi, A.
   Shokrgozar, M. A.
   Farokhi, M.
   Homaeigohar, S. Sh.
   Eslamifar, A.
TI Synthesis of Nano beta-TCP and the Effects on the Mechanical and
   Biological Properties of beta-TCP/HDPE/UHMWPE Nanocomposites
SO POLYMER COMPOSITES
LA English
DT Article
ID HYDROXYAPATITE-POLYETHYLENE COMPOSITES; MOLECULAR-WEIGHT POLYETHYLENE;
   BIOMEDICAL APPLICATIONS; BIOCERAMICS; BEHAVIOR; BONE; MORPHOLOGY;
   ADHESION; HA
AB High density polyethylene/tricalcium phosphate/ultra high molecular weight polyethylene (TCP/HDPE/UHMWPE) Nanocomposite as an orthopedic biomaterial (with better properties toward TCP/HDPE composite) was obtained. To evaluate the capability of this nanocomposite as a material for bone tissue replacement, mechanical and biological assessments were performed. In this study, nanosize beta-TCP powders with average grain size of 100 nm were synthesized by chemical precipitation method and characterized by means of X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). To evaluate the mechanical properties of this biomaterial, tensile properties were obtained for the material. Results showed that by increasing the weight percentage of beta-TCP, the elastic modulus increases, elongation at yield decreases and with no significant change in tensile strength. SEM micrographs of cryogenic fracture surface of samples indicated that distribution of nano powders in matrix is homogeneous. In vitro biological evaluations on the samples were done by performing cytotoxicity (MTT assay), alkaline phosphatase enzyme, and cell attachment tests. In all of the tests, osteoblast cells were used. Results of biological tests showed that the samples are biocompatible and they have no toxicity. Also, SEM observations demonstrated that the cells can attach to surface of nanocomposite samples, which reveals osteoconductivity of the surface. POLYM. COMPOS., 31:1745-1753, 2010. (C) 2010 Society of Plastics Engineers
C1 [Ghasemi, I.] Iran Polymer & Petrochem Inst, Proc Dept, Tehran, Iran.
   [Abadi, M. Bagheri Hossein; Shokrgozar, M. A.; Farokhi, M.] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.
   [Abadi, M. Bagheri Hossein; Khavandi, A.; Homaeigohar, S. Sh.] Iran Univ Sci & Technol, Dept Mat Sci & Engn, Tehran, Iran.
RP Ghasemi, I (reprint author), Iran Polymer & Petrochem Inst, Proc Dept, Tehran, Iran.
EM ighasemi@ippi.ac.ir
RI shokrgozar, mohammad ali/L-4149-2017; Homaeigohar, Shahin/E-1796-2015;
   Khavandi, Alireza/S-3732-2018; Farokhi, Mehdi/P-9672-2017; khavandi,
   alireza/S-6562-2018
OI shokrgozar, mohammad ali/0000-0001-5123-4155; Homaeigohar,
   Shahin/0000-0003-2426-6690; Farokhi, Mehdi/0000-0001-7023-2905; 
CR AHMED S, 1990, J MATER SCI, V25, P4933, DOI 10.1007/BF00580110
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Cheang P, 2003, MAT SCI ENG A-STRUCT, V345, P47, DOI 10.1016/S0921-5093(02)00284-8
   CHUNGUI Z, 2005, POLYM DEGRAD STABIL, V87, P183
   Ergun C, 2007, J BIOMED MATER RES A, V80A, P990, DOI 10.1002/jbm.a.30923
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Fang LM, 2005, BIOMATERIALS, V26, P3471, DOI 10.1016/j.biomaterials.2004.09.022
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   Gurpinar OA, 2005, J BIOACT COMPAT POL, V20, P183, DOI 10.1177/0883911505051660
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOMAEIGOHAR SSH, 2004, J EUR CERAM SOC, V26, P273
   Jacobs O, 2002, WEAR, V253, P618, DOI 10.1016/S0043-1648(02)00110-2
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   KLEIN CPA, 1993, BIOCERAMICS, V11, P199
   Kurtz S. M., 2004, UHMWPE HDB ULTRA HIG
   Liu Yong, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P1123
   LOZA J, 1995, BONE, V16, pS341
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   PLAZEK DJ, 1991, MACROMOLECULES, V24, P1222, DOI 10.1021/ma00005a044
   Ramachandra R. R., 1997, J MATER SCI-MATER M, V8, P511
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ramakrishna S, 2004, INTRO BIOCOMPOSITES
   RAVAGLIOLI A, 1992, BIOCERAMIC MAT PROPE
   RAVIGAVITAL N, 2000, J BIOMED MATER RES, V51, P660
   SAMAR JK, 2007, J MAT SCI ENG, V27, P441
   SH S, 2005, J BIOMED MATER RES, V75, P14
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Wang M, 1998, J BIOMED MATER RES, V42, P577, DOI 10.1002/(SICI)1097-4636(19981215)42:4<577::AID-JBM14>3.0.CO;2-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   YANG X, 2006, POLYM TEST, V25, P221
   Yu XZ, 2008, MAT SCI ENG C-BIO S, V28, P1138, DOI 10.1016/j.msec.2007.08.001
   2000, BIOMEDICAL ENG HDB
NR 37
TC 13
Z9 13
U1 0
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-8397
EI 1548-0569
J9 POLYM COMPOSITE
JI Polym. Compos.
PD OCT
PY 2010
VL 31
IS 10
BP 1745
EP 1753
DI 10.1002/pc.20965
PG 9
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 656EW
UT WOS:000282310000009
DA 2018-10-19
ER

PT J
AU Chanprateep, S
   Buasri, K
   Muangwong, A
   Utiswannakul, P
AF Chanprateep, Suchada
   Buasri, Ketsunee
   Muangwong, Aumtiga
   Utiswannakul, Phonpisit
TI Biosynthesis and biocompatibility of biodegradable
   poly(3-hydroxybutyrate-co-4-hydroxybutyrate)
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Polyhydroxyalkanoates; Biopolymer; Bioprocess; Biocompatibility
ID ALCALIGENES-EUTROPHUS; GAMMA-HYDROXYBUTYRATE; POLYHYDROXYALKANOATES;
   TISSUE; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); 4-HYDROXYBUTYRATE;
   COPOLYESTERS; DEGRADATION; SYSTEM; ACID
AB Poly(3-hydroxybutyrate), PHB, and poly(3-hydroxybutyrate-co-4-hydroxybutyrate), P(3HB-co-4HB), consisting of 0-94% mole fraction of 4HB content, were produced in high content by Cupriavidus necator strain A-04. The carbon sources used for PHB production included sugars made locally in Thailand: refined sugarcane, brown sugarcane, rock sugar, toddy palm sugar and coconut palm sugar. The switching of the ratios of carbon to nitrogen, together with the ratios of fructose to 1,4-butanediol, were applied to P(3HB-co-4HB) production in fed-batch cultures. Optimal P(3HB-co-4HB) production was achieved with 112 g biomass and 73 g P(3HB-co-4HB) with 38% mole fraction of 4HB content. Next, P(3HB-co-4HB) with a 0, 5, 24,38 and 64% mole fraction of 4HB content were purified and prepared as plastic films. The mechanical properties and biocompatibility of these films were tested and compared with commercial PHB, polystyrene (PS) and polyvinylchloride (PVC) prepared without additives. The results demonstrated that PHB had thermal and mechanical properties similar to those of commercial PHB. The P(3HB-co-4HB) polymers possessed melting temperature and glass transition temperature values higher than those reported previously. The mechanical properties were compared with those of PS and PVC. The in vitro biocompatibility was assessed using L929, human dermal fibroblast and Saos-2 human osteosarcoma cells. The cytotoxicity results and scanning electron micrographs showed that P(3HB-co-4HB) films have good surface characteristics and can promote cell attachment, proliferation and differentiation. Combined with their good mechanical properties, P(3HB-co-4HB) polymers possess potential usefulness for biomaterial applications in artificial skin tissue support and orthopedic support. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Chanprateep, Suchada; Buasri, Ketsunee; Muangwong, Aumtiga; Utiswannakul, Phonpisit] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok 10330, Thailand.
RP Chanprateep, S (reprint author), Chulalongkorn Univ, Fac Sci, Dept Microbiol, Phayathai Rd, Bangkok 10330, Thailand.
EM suchada.cha@chula.ac.th
RI Napathorn, Suchada/Q-1361-2016
OI Napathorn, Suchada/0000-0002-3598-9344
FU National Research Council of Thailand; National Science and Technology
   Development Agency of Thailand; Japan Science and Technology Agency
FX This work was supported in part by the "Joint Program in the field of
   Biotechnology" under National Research Council of Thailand, National
   Science and Technology Development Agency of Thailand, and Japan Science
   and Technology Agency. The authors are grateful to Miss Sukitaya
   Veeranondha at National Science and Technology Development Agency of
   Thailand for her expert assistance and contribution on animal cell
   culture.
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   *ASTM, 1993, ANN BOOK ASTM STAND, pD256
   Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854
   Chanprateep S, 2006, J BIOSCI BIOENG, V101, P51, DOI 10.1263/jbb.101.51
   Chanprateep S, 2008, J IND MICROBIOL BIOT, V35, P1205, DOI 10.1007/s10295-008-0427-5
   Chanprateep S, 2006, POLYM DEGRAD STABIL, V91, P2941, DOI 10.1016/j.polymdegradstab.2006.08.024
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   DOI Y, 1988, MACROMOLECULES, V21, P2722, DOI 10.1021/ma00187a012
   DOI Y, 1990, INT J BIOL MACROMOL, V12, P106, DOI 10.1016/0141-8130(90)90061-E
   Hollaway L. C., 2001, ADV POLYM COMPOSITES
   KEMPERS AJ, 1974, GEODERMA, V12, P201, DOI 10.1016/0016-7061(74)90068-8
   KUNIOKA M, 1990, MACROMOLECULES, V23, P1933, DOI 10.1021/ma00209a009
   KUNIOKA M, 1988, POLYM COMMUN, V61, P3113
   Maitre M, 1997, PROG NEUROBIOL, V51, P337, DOI 10.1016/S0301-0082(96)00064-0
   Martin D, 2003, BIOCH ENG J, V3738, P1
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MARTIN DP, 1999, Patent No. 199932536
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   NELSON T, 1981, J NEUROCHEM, V37, P1345, DOI 10.1111/j.1471-4159.1981.tb04689.x
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Opitz F, 2004, ANN BIOMED ENG, V32, P212, DOI 10.1023/B:ABME.0000012741.85600.f1
   REUSCH RN, 1992, BIOCHIM BIOPHYS ACTA, V1123, P33, DOI 10.1016/0005-2760(92)90168-U
   Shimizu H, 1999, BIOTECHNOL BIOENG, V62, P518
   SHIOYA S, 1992, ADV BIOCHEM ENG BIOT, V46, P111
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sombatmankhong K, 2006, J POLYM SCI POL PHYS, V44, P2923, DOI 10.1002/polb.20915
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   *USDA, 2010, TH9152 GAIN USDA FOR
   VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   WANG YW, 2003, BIOMATERIALS, V24, P1041
   WILLIAMS SF, 2000, Patent No. 2000661948
   Williams SF, 2002, BIOPOLYMERS, P91
NR 38
TC 45
Z9 46
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD OCT
PY 2010
VL 95
IS 10
BP 2003
EP 2012
DI 10.1016/j.polymdegradstab.2010.07.014
PG 10
WC Polymer Science
SC Polymer Science
GA 657CB
UT WOS:000282387900006
DA 2018-10-19
ER

PT J
AU Zeugolis, DI
   Raghunath, M
AF Zeugolis, Dimitrios I.
   Raghunath, Michael
TI The physiological relevance of wet versus dry differential scanning
   calorimetry for biomaterial evaluation: a technical note
SO POLYMER INTERNATIONAL
LA English
DT Article
DE differential scanning calorimetry; hydrophilic and hydrophobic polymers;
   biomaterials
ID TISSUE ENGINEERING APPLICATIONS; X-RAY-DIFFRACTION; COLLAGEN TYPE-I;
   CROSS-LINKING; THERMAL-DENATURATION; GELATIN FILMS; ISOTHERMAL
   CRYSTALLIZATION; MOLECULAR PACKING; ACRYLIC-ACID; FIBERS
AB Collagen and its denatured form, gelatin, have been extensively used as scaffolds for tissue engineering and tissue repair applications. Denaturation temperature, commonly measured using differential scanning calorimetry (DSC), for biomaterial applications is a significant physical property that will determine the stability of a potential implant at body temperature. In order to imitate a clinical setting, DSC should be run under fully hydrated conditions. We show here that for hydrophobic polymers such as poly(e-caprolactone) and chitosan there is no significant difference between dry and wet DSC operation (p > 0.05). In contrast, for hydrophilic polymers such as collagen, gelatin, poly(ethylene glycol) (40 kDa) and poly(ethylene oxide) (900 kDa) significant differences occur between measurements in the dry and the wet state (p < 0.0011). Moreover, we demonstrate that only when wet DSC is carried out are we able to separate the unique crystalline structure of collagen from its randomly coiled heat-denatured by-product gelatin (p < 0.0005). We therefore recommend running DSC under fully hydrated conditions when the function and properties of a biomaterial are under investigation. (C) 2010 Society of Chemical Industry
C1 [Zeugolis, Dimitrios I.; Raghunath, Michael] Natl Univ Singapore, Tissue Modulat Lab, Singapore 117510, Singapore.
   [Zeugolis, Dimitrios I.; Raghunath, Michael] Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
   [Zeugolis, Dimitrios I.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Immunol Programme, Singapore 117456, Singapore.
   [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.
RP Zeugolis, DI (reprint author), NUIG, Network Excellence Funct Biomat NFB, IDA Business Pk, Galway, Ireland.
EM dimitrios.zeugolis@nuigalway.ie
RI Raghunath, Michael/E-6483-2010
OI Raghunath, Michael/0000-0002-2138-6614; zeugolis,
   dimitrios/0000-0002-7599-5191
FU Faculty Research Committee of the Faculty of Engineering, NUS
   [397-000-025-112]; National University of Ireland Galway
FX The authors express their gratitude to Prof. Wolfgang Friess (Munchen
   University, Germany), Dr Li Suming (Max Mousseron Institute of
   Biomolecules, France), Prof. Dietmar Hutmacher (Queensland University of
   Technology, Brisbane, Australia) and Dr Maria Ann Woodruff (National
   University of Singapore) for helpful discussions. This work was
   supported by grants of the Faculty Research Committee of the Faculty of
   Engineering, NUS (no. 397-000-025-112) to MR and of the National
   University of Ireland Galway's Millennium Research Fund to DIZ.
CR Aktas N, 2003, THERMOCHIM ACTA, V407, P105, DOI 10.1016/S0040-6031(03)00306-X
   Badii F, 2006, FOOD HYDROCOLLOID, V20, P879, DOI 10.1016/j.foodhyd.2005.08.010
   BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104
   Bailey AJ, 1989, CONNECTIVE TISSUE ME
   BERLIN E, 1970, J COLLOID INTERF SCI, V34, P488, DOI 10.1016/0021-9797(70)90210-9
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Cameron GJ, 2002, J STRUCT BIOL, V137, P15, DOI 10.1006/jsbi.2002.4459
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   Chen EC, 2007, POLYM DEGRAD STABIL, V92, P1009, DOI 10.1016/j.polymdegradstab.2007.02.019
   Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   Cox EJ, 2003, BOT J LINN SOC, V141, P53, DOI 10.1046/j.1095-8339.2003.00115.x
   DANIELSEN CC, 1981, MECH AGEING DEV, V15, P269, DOI 10.1016/0047-6374(81)90135-4
   Di Maio E, 2004, POLYMER, V45, P8893, DOI 10.1016/j.polymer.2004.10.037
   DJABOUROV M, 1988, CONTEMP PHYS, V29, P273, DOI 10.1080/00107518808224377
   DJABOUROV M, 1983, POLYMER, V24, P537, DOI 10.1016/0032-3861(83)90101-5
   DOYLE BB, 1978, BIOCHIM BIOPHYS ACTA, V535, P25
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   Figueiro SD, 2004, CARBOHYD POLYM, V56, P313, DOI 10.1016/j.carbpol.2004.01.011
   FINCH A, 1974, BIOCHIM BIOPHYS ACTA, V365, P400, DOI 10.1016/0005-2795(74)90012-9
   FINCH A, 1972, BIOCHIM BIOPHYS ACTA, V278, P433, DOI 10.1016/0005-2795(72)90003-7
   FRAGA AN, 1985, POLYMER, V26, P113, DOI 10.1016/0032-3861(85)90066-7
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   HARRINGTON WF, 1961, ADV PROTEIN CHEM, V16, P1
   HORMANN H, 1971, BIOCHEMISTRY-US, V10, P932
   HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0
   HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7
   HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1
   Kim BM, 2000, LASER SURG MED, V27, P329, DOI 10.1002/1096-9101(2000)27:4<329::AID-LSM5>3.0.CO;2-C
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   KOPP J, 1989, Matrix, V9, P443
   KOZLOV PV, 1983, POLYMER, V24, P651, DOI 10.1016/0032-3861(83)90001-0
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Liu XH, 1999, THERMOCHIM ACTA, V342, P67, DOI 10.1016/S0040-6031(99)00131-8
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Mentink CJAL, 2002, CLIN CHIM ACTA, V321, P69, DOI 10.1016/S0009-8981(02)00097-9
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   Miles CA, 2001, BIOPHYS J, V80, P1480, DOI 10.1016/S0006-3495(01)76120-6
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Salom C, 2006, EUR POLYM J, V42, P1798, DOI 10.1016/j.eurpolymj.2006.02.004
   Sharma J, 2000, EUR POLYM J, V36, P1409, DOI 10.1016/S0014-3057(99)00206-2
   Sionkowska A, 2006, POLYM DEGRAD STABIL, V91, P305, DOI 10.1016/j.polymdegradstab.2005.05.012
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Theodossiou TA, 2006, BIOPHYS J, V91, P4665, DOI 10.1529/biophysj.106.093740
   VANDERPLAATS GN, 1993, STRUCT OPTIMIZATION, V6, P1, DOI 10.1007/BF01743168
   VEIS A, 1961, ARCH BIOCHEM BIOPHYS, V94, P20, DOI 10.1016/0003-9861(61)90005-4
   VERZAR F, 1965, BIOCH PHYSL TISSU CO, P381
   WALLACE DG, 1992, J BIOMED MATER RES, V26, P1517, DOI 10.1002/jbm.820261110
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wu CS, 2005, POLYMER, V46, P147, DOI 10.1016/j.polymer.2004.11.013
   YANNAS IV, 1972, J MACROMOL SCI R M C, VC  7, P49, DOI 10.1080/15321797208068160
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
NR 65
TC 20
Z9 20
U1 0
U2 10
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD OCT
PY 2010
VL 59
IS 10
BP 1403
EP 1407
DI 10.1002/pi.2882
PG 5
WC Polymer Science
SC Polymer Science
GA 666GT
UT WOS:000283103300013
DA 2018-10-19
ER

PT J
AU Woodruff, MA
   Hutmacher, DW
AF Woodruff, Maria Ann
   Hutmacher, Dietmar Werner
TI The return of a forgotten polymer-Polycaprolactone in the 21st century
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Polymer; Scaffold; Polycaprolactone; Tissue engineering; Bone;
   Resorbable
ID TISSUE ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS;
   POLY(DL-LACTIDE-EPSILON-CAPROLACTONE) NERVE GUIDES; EPSILON-CAPROLACTONE
   MICROSPHERES; SUPERCRITICAL CARBON-DIOXIDE; CRANIOFACIAL BONE REPAIR;
   CYCLIC MECHANICAL STRAIN; CONTROLLED DRUG-DELIVERY; LONG-TERM
   DEGRADATION; PLATELET-RICH PLASMA
AB During the resorbable-polymer-boom of the 1970s and 1980s, polycaprolactone (PCL) was used extensively in the biomaterials field and a number of drug-delivery devices. Its popularity was soon superseded by faster resorbable polymers which had fewer perceived disadvantages associated with long-term degradation (up to 3-4 years) and intracellular resorption pathways; consequently, PCL was almost forgotten for most of two decades. Recently, a resurgence of interest has propelled PCL back into the biomaterials-arena. The superior rheological and viscoelastic properties over many of its aliphatic polyester counterparts renders PCL easy to manufacture and manipulate into a large range of implants and devices. Coupled with relatively inexpensive production routes and FDA approval, this provides a promising platform for the design and fabrication of longer term degradable implants which may be manipulated physically, chemically and biologically to possess tailorable degradation kinetics to suit a specific anatomical site. This review will discuss the application of PCL as a biomaterial over the last two decades focusing on the advantages which have propagated its return into the spotlight with a particular focus on medical devices, drug delivery and tissue engineering. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Woodruff, Maria Ann; Hutmacher, Dietmar Werner] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
RP Hutmacher, DW (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM Dietmar.Hutmacher@qut.edu.au
RI Woodruff, Maria/J-1247-2012
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134; Woodruff,
   Maria/0000-0002-4909-5288
FU ARC [DP0989000]
FX This work was supported by an ARC Discovery Grant, DP0989000. Thanks to
   Dr. Tim Dargaville for proof-reading and Rachel Engelberg for
   contributing to Fig. 3.
CR Abbah SA, 2009, BIOMATERIALS, V30, P5086, DOI 10.1016/j.biomaterials.2009.05.067
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Ahmed I, 2008, ACTA BIOMATER, V4, P1307, DOI 10.1016/j.actbio.2008.03.018
   Ajili SH, 2009, ACTA BIOMATER, V5, P1519, DOI 10.1016/j.actbio.2008.12.014
   Alani A, 2009, DENT MATER, V25, P400, DOI 10.1016/j.dental.2008.10.010
   Albertsson AC, 1997, MACROMOLECULAR DESIG, P739
   ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   Alonso M J, 2000, Boll Chim Farm, V139, P114
   Ananta M, 2009, TISSUE ENG PT A, V15, P1667, DOI 10.1089/ten.tea.2008.0194
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bai XL, 2001, J APPL POLYM SCI, V80, P1630, DOI 10.1002/app.1257
   Balguid A, 2009, TISSUE ENG PT A, V15, P437, DOI 10.1089/ten.tea.2007.0294
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   BIRRENBACH G, 1976, J PHARM SCI, V65, P1763, DOI 10.1002/jps.2600651217
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Bregy A, 2008, LASER SURG MED, V40, P716, DOI 10.1002/lsm.20710
   Brennan MP, 2008, ANN SURG, V248, P370, DOI 10.1097/SLA.0b013e318184dcbd
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Calvo P, 1996, J PHARM SCI, V85, P530, DOI 10.1021/js950474+
   Calvo P, 1996, PHARMACEUT RES, V13, P311, DOI 10.1023/A:1016015803611
   Campbell PG, 2007, EXPERT OPIN BIOL TH, V7, P1123, DOI 10.1517/14712598.7.8.1123
   CANDAU F, 1985, ENCY POLYM SCI ENG, P719
   CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   CHA Y, 1988, J CONTROL RELEASE, V7, P69, DOI 10.1016/0168-3659(88)90082-X
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   Chen M, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3173283
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chong MSK, 2009, BIOMATERIALS, V30, P2241, DOI 10.1016/j.biomaterials.2008.12.056
   Cohn D, 2004, BIOMATERIALS, V25, P5875, DOI 10.1016/j.biomateriasl.2004.01.040
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005
   COULEMBIER D, 2006, PROGR POLYM SCI, V31, P723
   CUTRIGHT DE, 1972, ORAL SURG ORAL MED O, V33, P28, DOI 10.1016/0030-4220(72)90204-6
   CUTRIGHT DE, 1971, ORAL SURG ORAL MED O, V32, P165, DOI 10.1016/0030-4220(71)90265-9
   Dai NT, 2009, BIOCHEM BIOPH RES CO, V386, P21, DOI 10.1016/j.bbrc.2009.05.123
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Dalton PD, 2009, BIOMATERIALS, V30, P2420, DOI 10.1016/j.biomaterials.2009.01.049
   Davies OR, 2008, ADV DRUG DELIVER REV, V60, P373, DOI 10.1016/j.addr.2006.12.001
   DENDUNNEN WFA, 1993, J MATER SCI-MATER M, V4, P521, DOI 10.1007/BF00120133
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   Dhanaraju MD, 2006, J BIOMED MATER RES A, V76A, P63, DOI 10.1002/jbm.a.30458
   Dhanaraju MD, 2004, CHEM PHARM BULL, V52, P976, DOI 10.1248/cpb.52.976
   Dhanaraju MD, 2003, INT J PHARM, V268, P23, DOI 10.1016/j.ijpharm.2003.08.011
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Gamisans F, 1999, INT J PHARMACEUT, V179, P37, DOI 10.1016/S0378-5173(98)00381-0
   Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034
   GINDE RM, 1987, J APPL POLYM SCI, V33, P2411, DOI 10.1002/app.1987.070330712
   Ginty PJ, 2008, J SUPERCRIT FLUID, V43, P535, DOI 10.1016/j.supflu.2007.07.023
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   GOPFERICH A, 1995, EUR J PHARM BIOPHARM, V41, P81
   Gough JE, 2004, J BIOMED MATER RES A, V69A, P17, DOI 10.1002/jbm.a.20072
   Gough JE, 2002, J BIOMED MATER RES, V59, P481, DOI 10.1002/jbm.10020
   Gratson GM, 2004, NATURE, V428, P386, DOI 10.1038/428386a
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Grignard B, 2008, BIOMACROMOLECULES, V9, P3141, DOI 10.1021/bm800730m
   Guarino V, 2008, BIOMATERIALS, V29, P3662, DOI 10.1016/j.biomaterials.2008.05.024
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   GUTWALD R, 1994, J MATER SCI-MATER M, V5, P485, DOI 10.1007/BF00058988
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   HOLLAND SJ, 1992, ADV PHARM SCI, V6, P101
   Houtchens GR, 2008, J BIOMECH, V41, P762, DOI 10.1016/j.jbiomech.2007.11.027
   Hu WW, 2009, BIOMATERIALS, V30, P5785, DOI 10.1016/j.biomaterials.2009.06.041
   Huang H, 2007, BIOMATERIALS, V28, P3815, DOI 10.1016/j.biomaterials.2007.05.004
   Huang MH, 2006, J APPL POLYM SCI, V102, P1681, DOI 10.1002/app.24196
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   HUANG S, 1985, ENCY POLYM SCI ENG, P220
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hutmacher DW, 2008, HDB FABRICATION PROC, P45
   Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369
   JACKSON J, 2002, INT J PHARMACEUT, V243, P1731
   Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719
   Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jung Y, 2008, J BIOMAT SCI-POLYM E, V19, P1073, DOI 10.1163/156856208784909336
   Jung Y, 2008, J BIOMAT SCI-POLYM E, V19, P61, DOI 10.1163/156856208783227712
   Kazimoglu C, 2003, INT J ARTIF ORGANS, V26, P804
   Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 2003, J MICROBIOL BIOTECHN, V13, P841
   KIM E, 2009, NANOTECHNOLOGY, V20, pNIL38
   Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244
   Kim SY, 2007, MACROMOL RES, V15, P646, DOI 10.1007/BF03218945
   Kim SY, 2001, BIOMATERIALS, V22, P2049, DOI 10.1016/S0142-9612(00)00393-8
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   KIMINTA DMO, 1996, POLYM MAT ENCY, V1, P1298
   Klopp LS, 2008, SPINE, V33, P1518, DOI 10.1097/BRS.0b013e31817886e0
   Koleske JV, 1978, POLYM BLENDS, P369, DOI [10.1016/B978-0-12-546802-2.50018-X, DOI 10.1016/B978-0-12-546802-2.50018-X]
   Kon E, 2008, TISSUE ENG PT A, V14, P1067, DOI 10.1089/ten.tea.2007.0193
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Kwon S, 2008, COLLOID POLYM SCI, V286, P1181, DOI 10.1007/s00396-008-1888-9
   Lacoulonche F, 1999, DRUG DEV IND PHARM, V25, P983, DOI 10.1081/DDC-100102261
   Lam C.X.F., 2008, J BIOMED MATER RES A, V90, P906
   Lam CXF, 2007, POLYM INT, V56, P718, DOI 10.1002/pi.2195
   LAM CXF, 2008, BIOMED MATER, V3, pNI189
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lemmouchi Y, 1998, BIOMATERIALS, V19, P1827, DOI 10.1016/S0142-9612(98)00074-X
   Leroueil-Le Verger M, 1998, EUR J PHARM BIOPHARM, V46, P137, DOI 10.1016/S0939-6411(98)00015-0
   Li WJ, 2009, J TISSUE ENG REGEN M, V3, P1, DOI 10.1002/term.127
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lin CH, 2008, TISSUE ENG PART C-ME, V14, P69, DOI 10.1089/tec.2007.0336
   LOSA C, 1992, J OCUL PHARMACOL, V8, P191, DOI 10.1089/jop.1992.8.191
   LOSA C, 1993, PHARMACEUT RES, V10, P80, DOI 10.1023/A:1018977130559
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   Lu XL, 2008, J MATER SCI-MATER M, V19, P395, DOI 10.1007/s10856-006-0100-3
   Lu Y, 2009, ACTA BIOMATER, V5, P1562, DOI 10.1016/j.actbio.2009.01.044
   Luciani A, 2008, BIOMATERIALS, V29, P4800, DOI 10.1016/j.biomaterials.2008.09.007
   Ma GL, 2006, CONTRACEPTION, V74, P141, DOI 10.1016/j.contraception.2006.02.013
   MARCHALHEUSSLER L, 1993, PHARMACEUT RES, V10, P386, DOI 10.1023/A:1018936205485
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Marrazzo C, 2008, POLYM ENG SCI, V48, P336, DOI 10.1002/pen.20937
   MARTY JJ, 1978, PHARM ACTA HELV, V53, P17
   MEDLICOTT NJ, 1992, INT J PHARM, V84, P85, DOI 10.1016/0378-5173(92)90218-Q
   Meek MF, 2009, J BIOMED MATER RES A, V89A, P734, DOI 10.1002/jbm.a.32024
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Melchels FPW, 2009, BIOMATERIALS, V30, P3801, DOI 10.1016/j.biomaterials.2009.03.055
   Menci P, 1994, J BIOMED MATER RES, V28, P1079
   Merkli A, 1998, PROG POLYM SCI, V23, P563, DOI 10.1016/S0079-6700(97)00048-8
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MINER MR, 2006, J ENDODONT, V31, P723
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Muller CR, 2001, PHARMAZIE, V56, P864
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ng KW, 2007, J BIOMAT SCI-POLYM E, V18, P925, DOI 10.1163/156856207781367693
   Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Onal L, 2008, J APPL POLYM SCI, V107, P3750, DOI 10.1002/app.27518
   Oyane A, 2005, BIOMATERIALS, V26, P2407, DOI 10.1016/j.biomaterials.2004.07.048
   Park SH, 2008, ACTA BIOMATER, V4, P1198, DOI 10.1016/j.actbio.2008.03.019
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   PERSENAIRE A, 2001, BIOMACROMOLECULES, V2, P288
   Piirma I., 1985, ENCY POLYM SCI ENG, P125
   PISTNER H, 1993, BIOMATERIALS, V14, P671, DOI 10.1016/0142-9612(93)90066-B
   PISTNER H, 1993, BIOMATERIALS, V14, P291, DOI 10.1016/0142-9612(93)90121-H
   PITT C G, 1987, Journal of Controlled Release, V4, P283, DOI 10.1016/0168-3659(87)90020-4
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   PITT CG, 1984, LONG ACTING CONTRACE, P63
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   Pulkkinen M, 2009, EUR J PHARM SCI, V37, P183, DOI 10.1016/j.ejps.2009.02.001
   Qu MJ, 2007, J VASC RES, V44, P345, DOI 10.1159/000102278
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Rai B, 2004, BIOMATERIALS, V25, P5499, DOI 10.1016/j.biomaterials.2004.01.007
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Reed CR, 2009, ANN PLAS SURG, V62, P505, DOI 10.1097/SAP.0b013e31818e48bf
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Saez A, 2000, EUR J PHARM BIOPHARM, V50, P379, DOI 10.1016/S0939-6411(00)00125-9
   SANGHEON K, 2007, BIOMATERIALS ASIA, P98
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Schantz JT, 2003, TISSUE ENG, V9, pS113, DOI 10.1089/10763270360697021
   Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   SCHANTZ JT, 2006, NEUROSURGERY S1, V58, pSE176
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Serrano MC, 2009, ACTA BIOMATER, V5, P2045, DOI 10.1016/j.actbio.2009.02.034
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Shenoy DB, 2005, INT J PHARM, V293, P261, DOI 10.1016/j.ijpharm.2004.12.010
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Sivalingam G, 2004, IND ENG CHEM RES, V43, P7702, DOI 10.1021/ie049589r
   Sivalingam G, 2003, POLYM DEGRAD STABIL, V80, P11, DOI 10.1016/S0141-3910(02)00376-2
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Storey RF, 1996, ABSTR PAP AM CHEM S, V211, P114
   STROVER HDH, 1996, POLYM MAT ENCY, V1, P1900
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Van Lieshout M, 2006, TISSUE ENG, V12, P481, DOI 10.1089/ten.2006.12.481
   Van Lieshout MI, 2006, J BIOMAT SCI-POLYM E, V17, P77, DOI 10.1163/156856206774879153
   Van Natta FJ, 1934, J AM CHEM SOC, V56, P455, DOI 10.1021/ja01317a053
   VANLIESHOUT MI, 2005, THESIS TU EINDHOVEN, P1
   Vasir JK, 2003, INT J PHARM, V255, P13, DOI 10.1016/S0378-5173(03)00087-5
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Vert M, 2007, PROG POLYM SCI, V32, P755, DOI 10.1016/j.progpolymsci.2007.05.006
   Vert M, 2009, J MATER SCI-MATER M, V20, P437, DOI 10.1007/s10856-008-3581-4
   Wagner M, 2007, J BIOMED MATER RES A, V83A, P1154, DOI 10.1002/jbm.a.31416
   Wang ZR, 2004, PEPTIDES, V25, P1259, DOI 10.1016/j.peptides.2004.05.014
   Weissman JM, 1996, SCIENCE, V274, P959, DOI 10.1126/science.274.5289.959
   White LJ, 2008, TISSUE ENG PT A, V14, P831
   Williams David, 2003, Med Device Technol, V14, P10
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Xie J, 2006, TISSUE ENG, V12, P449, DOI 10.1089/ten.2006.12.449
   Xie J, 2007, TISSUE ENG, V13, P29, DOI 10.1089/ten.2006.0060
   Yang YY, 2000, CHEM ENG SCI, V55, P2223, DOI 10.1016/S0009-2509(99)00503-5
   Ye WP, 1997, REACT FUNCT POLYM, V32, P161, DOI 10.1016/S1381-5148(96)00081-8
   Yenice I, 2008, EXP EYE RES, V87, P162, DOI 10.1016/j.exer.2008.04.002
   Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709
   Zalfen AM, 2008, ACTA BIOMATER, V4, P1788, DOI 10.1016/j.actbio.2008.05.021
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhou YF, 2007, POLYM INT, V56, P333, DOI 10.1002/pi.2138
   2009, ARTELON CMC SPACER A
NR 217
TC 1325
Z9 1350
U1 51
U2 895
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD OCT
PY 2010
VL 35
IS 10
BP 1217
EP 1256
DI 10.1016/j.progpolymsci.2010.04.002
PG 40
WC Polymer Science
SC Polymer Science
GA 676KJ
UT WOS:000283909500002
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Abubakar, T
   Rahman, M
   Dowling, DP
   Stokes, J
   Hashmi, MSJ
AF Abubakar, T.
   Rahman, M.
   Dowling, D. P.
   Stokes, J.
   Hashmi, M. S. J.
TI Adhesion performance of TiN coating with amorphous NiTi alloy interlayer
   onto 316L stainless biosteel deposited by sputtering process
SO SURFACE ENGINEERING
LA English
DT Article
DE Adhesion; TiN; Amorphous NiTi alloy interlayer; Magnetron sputtering;
   Biomaterial
ID SHAPE-MEMORY ALLOYS; THIN-FILMS; HARD COATINGS; BEHAVIOR
AB In the present study, TiN coatings were deposited with and without NiTi interlayer onto 316L stainless steel substrates to observe the effect of amorphous NiTi layer on the adhesion properties of TiN coatings. The deposition technique was carried out at a temperature (100-150 degrees C) without any substrate heating to form the amorphous NiTi coating, using the closed field unbalanced magnetron sputtering system. The qualitative and quantitative adhesion properties of TiN coatings with and without amorphous NiTi interlayer were measured using the Rockwell C test, the scratch test and the pull-off test. This research demonstrates how the amorphous NiTi interlayer improved the adhesion of TiN coating when a thickness of the NiTi interlayer applied was equal to 0.5 mu m. A thin layer of amorphous NiTi coating was shown to exert a significant influence over the adhesion performance of the TiN coatings and demonstrating its suitability for the tribological applications.
C1 [Abubakar, T.; Stokes, J.; Hashmi, M. S. J.] Dublin City Univ, NCPST, Dublin 9, Ireland.
   [Abubakar, T.; Stokes, J.; Hashmi, M. S. J.] Dublin City Univ, MPRC, Dublin 9, Ireland.
   [Rahman, M.; Dowling, D. P.] Natl Univ Ireland Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland.
RP Abubakar, T (reprint author), Dublin City Univ, NCPST, Dublin 9, Ireland.
EM tuty.abubakar2@mail.dcu.ie
RI Rahman, Mahfujur/G-9974-2011
OI Rahman, Mahfujur/0000-0002-6495-4407
FU Malaysian Government; University Technology of Malaysia
FX The authors would like to thank the Malaysian Government and University
   Technology of Malaysia for providing the funding to do this research and
   Dublin City University and Teer Coatings for equipment and assistance.
CR Botterill NW, 2004, MAT SCI ENG A-STRUCT, V378, P424, DOI 10.1016/j.msea.2003.10.337
   Cao XH, 2008, J ALLOY COMPD, V465, P491, DOI 10.1016/j.jallcom.2007.10.118
   Fu YQ, 2001, SURF COAT TECH, V145, P107, DOI 10.1016/S0257-8972(01)01324-X
   Hu SB, 2001, SURF COAT TECH, V141, P174, DOI 10.1016/S0257-8972(01)01041-6
   Huang JH, 2006, SURF COAT TECH, V201, P3199, DOI 10.1016/j.surfcoat.2006.06.038
   Ni WY, 2006, SURF COAT TECH, V201, P1053, DOI 10.1016/j.surfcoat.2006.01.067
   Ni WY, 2005, WEAR, V259, P842, DOI 10.1016/j.wear.2005.01.015
   Rahman M, 2005, SURF COAT TECH, V200, P1071, DOI 10.1016/j.surfort.2005.02.096
   Rahman M, 2007, SURF COAT TECH, V201, P5310, DOI 10.1016/j.surfcoat.2006.07.179
   Recco AAC, 2007, SURF COAT TECH, V202, P1078, DOI 10.1016/j.surfcoat.2007.07.073
   Sergueeva AV, 2003, MAT SCI ENG A-STRUCT, V339, P159, DOI 10.1016/S0921-5093(02)00122-3
   Shevchenko N, 2004, APPL SURF SCI, V235, P126, DOI 10.1016/j.apsusc.2004.05.273
   SPIES HJ, 1995, SURF COAT TECH, V74-5, P178, DOI 10.1016/0257-8972(95)08366-9
   Zhang YJ, 2007, SURF COAT TECH, V202, P998, DOI 10.1016/j.surfcoat.2007.07.099
   Zhang YJ, 2006, MAT SCI ENG A-STRUCT, V438, P710, DOI 10.1016/j.msea.2006.03.112
NR 15
TC 8
Z9 9
U1 3
U2 10
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0844
J9 SURF ENG
JI Surf. Eng.
PD OCT
PY 2010
VL 26
IS 7
BP 499
EP 505
DI 10.1179/174329409X433885
PG 7
WC Materials Science, Coatings & Films
SC Materials Science
GA 652KY
UT WOS:000282006500001
DA 2018-10-19
ER

PT J
AU Chiu, YC
   Larson, JC
   Isom, A
   Brey, EM
AF Chiu, Yu-Chieh
   Larson, Jeffery C.
   Isom, Anthony, Jr.
   Brey, Eric M.
TI Generation of Porous Poly(Ethylene Glycol) Hydrogels by Salt Leaching
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; DIACRYLATE HYDROGELS; BONE REGENERATION;
   CROSS-LINKING; TISSUE; SCAFFOLDS; DELIVERY; RELEASE; VEGF;
   MICROSTRUCTURES
AB Poly(ethylene glycol) (PEG) hydrogels have been investigated for a number of applications in tissue engineering. The hydrogels can be designed to mimic tissues that have desired chemical and mechanical properties, but their physical structure can hinder cell migration, tissue invasion, and molecular transport. Synthesis of porous PEG hydrogels could improve transport, enhance cell behavior, and increase the surface area available for cell adhesion. Salt leaching methods have been used extensively to generate porous biomaterial scaffolds but have not previously been applied to hydrogels. In this article we describe a modification of traditional salt leaching techniques for application to hydrogels. Salt-saturated polymer precursor solutions are prepared, and salt crystals of a defined size are added before polymerization. The salt crystals are then leached out, resulting in porous hydrogels. Examples are provided for application of this technique to PEG hydrogels. Porous PEG hydrogels were generated with pore sizes ranging from 15 to 86 mu m and porosities from 30% to 75%. Porous hydrogels that were incorporated with a cell adhesion peptide supported cell adhesion with morphology varying with pore size. The simple, reproducible technique described here could be used to generate porous hydrogels with controlled pore sizes for applications in tissue engineering.
C1 [Chiu, Yu-Chieh; Larson, Jeffery C.; Isom, Anthony, Jr.; Brey, Eric M.] IIT, Pritzker Inst Biomed Sci, Chicago, IL 60616 USA.
   [Chiu, Yu-Chieh; Larson, Jeffery C.; Isom, Anthony, Jr.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Brey, Eric M.] Edward Hines Jr VA Hosp, Hines, IL 60141 USA.
RP Brey, EM (reprint author), IIT, Pritzker Inst, Chicago, IL 60616 USA.
EM brey@iit.edu
FU National Science Foundation [0852048, 0731201, 0854430]; U.S. Department
   of Veterans Affairs
FX This research was supported by funding from the National Science
   Foundation (Grant Nos. 0852048, 0731201, and 0854430) and the U.S.
   Department of Veterans Affairs. We thank Monica Lizet Moya, Ph.D., Megan
   Francis-Sedlak, Ph.D., and Bin Jiang for help with cell culture,
   staining, and statistical analysis.
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Francis-Sedlak ME, 2009, BIOMATERIALS, V30, P1851, DOI 10.1016/j.biomaterials.2008.12.014
   GRAHAM NB, 1990, POLYMER, V31, P909, DOI 10.1016/0032-3861(90)90055-4
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238
   Koh WG, 2002, LANGMUIR, V18, P2459, DOI 10.1021/la0115740
   KYU LW, 2003, J BIOMED MATER RES A, V67, P1087
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   SHEN WX, 1992, J POLYM SCI A, V30, P2121
   SIXUE C, 2003, J BIOMED MATER RES A, V67, P96
   SUNG NY, 1999, J BIOMED MATER RES, V47, P8
   Thote AJ, 2005, DRUG DEV IND PHARM, V31, P43, DOI 10.1081/DDC-200043985
   Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028
   Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024
   White JA, 2002, BIOPHYS J, V82, P2081, DOI 10.1016/S0006-3495(02)75555-0
   Williams SR, 2009, BIOMACROMOLECULES, V10, P155, DOI 10.1021/bm801058j
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
   Zhang XZ, 2001, LANGMUIR, V17, P6094, DOI 10.1021/la010105v
   Zhao X, 1998, J PHARM SCI, V87, P1450, DOI 10.1021/js980065o
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 42
TC 44
Z9 44
U1 3
U2 26
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD OCT
PY 2010
VL 16
IS 5
BP 905
EP 912
DI 10.1089/ten.tec.2009.0646
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 655DN
UT WOS:000282223800010
PM 19905877
DA 2018-10-19
ER

PT J
AU Bessa, PC
   Balmayor, ER
   Hartinger, J
   Zanoni, G
   Dopler, D
   Meinl, A
   Banerjee, A
   Casal, M
   Redl, H
   Reis, RL
   van Griensven, M
AF Bessa, Paulo Cesar
   Balmayor, Elizabeth R.
   Hartinger, Joachim
   Zanoni, Gerald
   Dopler, Daniela
   Meinl, Alexandra
   Banerjee, Asmita
   Casal, Margarida
   Redl, Heinz
   Reis, Rui L.
   van Griensven, Martijn
TI Silk Fibroin Microparticles as Carriers for Delivery of Human
   Recombinant Bone Morphogenetic Protein-2: In Vitro and In Vivo
   Bioactivity
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID RAT ECTOPIC MODEL; ESCHERICHIA-COLI; BIOMATERIAL CARRIERS;
   CONTROLLED-RELEASE; INCLUSION-BODIES; SCAFFOLDS; PURIFICATION;
   EXPRESSION; MICROSPHERES; REGENERATION
AB The in vitro and in vivo efficiency of fibroin microparticles as a delivery carrier for bone morphogenetic protein-2 (BMP-2) was evaluated. BMP-2 was encapsulated in silk fibroin particles that were produced by a simple and very mild processing method. The dose-response of BMP-2-loaded fibroin particles was examined in C2C12 cells, after 5 days of culture. The BMP-2 retained most of its activity as observed by the increase in alkaline phosphatase activity, which was much higher when BMP-2 was encapsulated into the particles rather than just surface-adsorbed. After 2 weeks of culture, increased mineralization was observed with BMP-2-loaded particles in comparison to soluble added growth factor. No significant cytotoxicity was detected. When implanted in a rat ectopic model, bone formation was observed by in vivo micro-computed tomography after 2 and 4 weeks post-implantation, with particles loaded with 5 or 12.5 mu g BMP-2. An increase in bone density was observed over time. Histology revealed further evidence of ectopic bone formation, observed by strong alizarin red staining and osteocalcin immunostaining. Our findings show that fibroin microparticles may present an interesting option for future clinical applications in the bone tissue engineering field, and therefore, further studies have been planned.
C1 [Bessa, Paulo Cesar; Hartinger, Joachim; Zanoni, Gerald; Dopler, Daniela; Meinl, Alexandra; Banerjee, Asmita; Redl, Heinz; van Griensven, Martijn] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Bessa, Paulo Cesar; Balmayor, Elizabeth R.; Reis, Rui L.] Univ Minho, Headquarters,European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal.
   [Bessa, Paulo Cesar; Balmayor, Elizabeth R.; Reis, Rui L.] IBB, PT Associated Lab, Guimaraes, Portugal.
   [Bessa, Paulo Cesar; Casal, Margarida] Univ Minho, CBMA, Braga, Portugal.
   [Meinl, Alexandra] Bernhard Gottlieb Univ, Sch Dent, Vienna, Austria.
RP Bessa, PC (reprint author), AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM paulo.bessa@dep.uminho.pt
RI Casal, Margarida/B-6386-2009; Rosado Balmayor, Elizabeth/N-9283-2015;
   CBMA, CBMA/J-1937-2016; Reis, Rui L./A-8938-2008; van Griensven,
   Martijn/F-5808-2012; Group, 3Bs/E-4374-2012
OI Casal, Margarida/0000-0002-0143-9758; Rosado Balmayor,
   Elizabeth/0000-0002-0484-4847; CBMA, CBMA/0000-0002-2841-2678; Reis, Rui
   L./0000-0002-4295-6129; van Griensven, Martijn/0000-0001-5104-9881;
   Group, 3Bs/0000-0002-5195-3456
FU Fundacao para a Ciencia e Tecnologia [SFRH/BD/17049/2004,
   POCI/CTM/57177/2004]; FEDER [POCI/CTM/57177/2004]; Marie Curie Alea
   Jacta EST [MEST-CT-2004-8104]; European STREP [NMP3-CT-2003-505758]
FX The authors acknowledge Anna Hofmann and Anna Khadem for additional help
   with some experiments, and Karin Brenner for animal maintenance. This
   work was supported by Fundacao para a Ciencia e Tecnologia (Ph.D. grant
   SFRH/BD/17049/2004), project ElastM (POCI/CTM/57177/2004 funded by FEDER
   and the Fundacao para a Ciencia e Tecnologia), Marie Curie Alea Jacta
   EST short-term grant (MEST-CT-2004-8104), and European STREP Project
   HIP-POCRATES (NMP3-CT-2003-505758). This work was carried out under the
   scope of the European NoE EXPERTISSUES (NMP3-CT-2004-500283).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bessa PC, 2009, PROTEIN EXPRES PURIF, V63, P89, DOI 10.1016/j.pep.2008.09.014
   Bessa PC, 2008, BIOTECHNOL LETT, V30, P15, DOI 10.1007/s10529-007-9501-8
   BESSA PC, 2009, J TISSUE EN IN PRESS
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hangartner T. N., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P9
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kato M, 2006, BIOMATERIALS, V27, P3927, DOI 10.1016/j.biomaterials.2006.03.013
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Klosch B, 2005, BIOTECHNOL LETT, V27, P1559, DOI 10.1007/s10529-005-1794-x
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Long SN, 2006, PROTEIN EXPRES PURIF, V46, P374, DOI 10.1016/j.pep.2005.09.025
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Maire M, 2005, BIOMATERIALS, V26, P5085, DOI 10.1016/j.biomaterials.2005.01.020
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   PRICE PA, 1989, CONNECT TISSUE RES, V21, P381
   Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Vallejo LF, 2002, J BIOTECHNOL, V94, P185, DOI 10.1016/S0168-1656(01)00425-4
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Zhang Chao, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P100
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
NR 47
TC 44
Z9 46
U1 2
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD OCT
PY 2010
VL 16
IS 5
BP 937
EP 945
DI 10.1089/ten.tec.2009.0486
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 655DN
UT WOS:000282223800014
PM 19958078
DA 2018-10-19
ER

PT J
AU Romero, NP
   Romo, MIG
   Vegas, AG
   Izquierdo, JB
   Varela, JC
   Arteche, AH
   Moyano, AS
AF Romero, N. P.
   Romo, M. I. G.
   Vegas, A. G.
   Izquierdo, J. B.
   Varela, J. C.
   Arteche, A. H.
   Moyano, A. S.
TI Deflux Injections for Vesicoureteral Reflux in Transplanted Kidneys
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article; Proceedings Paper
CT 1st Congress of the Spanish-Society-of-Transplantation (SET)
CY JUN 02-05, 2010
CL Seville, SPAIN
SP Spanish Soc Transplantation (SET)
ID ENDOSCOPIC TREATMENT; RECIPIENTS
AB Introduction. Vesicoureteral reflux (VUR), a complication after kidney transplantation, may be caused by recurrent urinary tract infections evaluating in life-threatening pyelonephritis and urosepsis. Open surgical correction is the standard treatment despite its morbidity. However, minimally invasive approaches are available.
   Materials and methods. Our study group describes seven patients with functioning kidney grafts and a diagnosis of VUR associated with recurrent urinary tract infections. The procedure was performed under antibiotic prophylaxis and spinal anesthesia. An endoscopic injection of 1 mL of biomaterial (copolymer of dextranomer and hyalurunic acid) was administered into the ureteral neo-orifice following the Sting technique. The catheter was removed within 24 hours in all cases.
   Results. Between June 2009 and January 2010, nine procedures were performed in seven patients. Two patients experienced self-limiting post-surgical episodes of hematuria that did not need urologic manipulation. There were no episodes of retention, ureteral obstruction, or urinary infections. One patient required a reinjection 5 months later as a result of clinical failure. Apart from this one case, the other patients showed improvements with no infectious complications.
   Conclusions. Endoscopic correction with VUR seems to be a reliable and safe option as a first treatment for the transplant patient. More cases are required in order to improve the learning curve and, therefore, the success rate. Closer monitoring is needed to evaluate the efficiency of the copolymer, the evolution of the reflux, and the possible long-term complications in this sort of patients.
C1 [Romero, N. P.; Romo, M. I. G.; Vegas, A. G.; Izquierdo, J. B.; Varela, J. C.; Arteche, A. H.; Moyano, A. S.] Hosp Clin San Carlos, Dept Urol, Madrid, Spain.
RP Romero, NP (reprint author), C Goya 141, Madrid 28009, Spain.
EM natape@hotmail.com
CR Escala Aguirre Jose Manuel, 2008, Archivos Espanoles de Urologia, V61, P297
   Favi E, 2009, TRANSPL P, V41, P1218, DOI 10.1016/j.transproceed.2009.03.052
   HANEVOLD CD, 1987, AM J DIS CHILD, V141, P982, DOI 10.1001/archpedi.1987.04460090059024
   Kmetec A, 2001, TRANSPLANT P, V33, P3383, DOI 10.1016/S0041-1345(01)02457-5
   Latchamsetty KC, 2003, TRANSPLANT P, V35, P1378, DOI 10.1016/S0041-1345(03)00448-2
   Ostrowski M, 1999, Ann Transplant, V4, P54
   Perez-Brayfield M, 2004, J UROLOGY, V172, P1614, DOI 10.1097/01.ju.0000139012.00908.1c
   REINBERG Y, 1990, J UROLOGY, V143, P1087, DOI 10.1016/S0022-5347(17)40194-7
   STENBERG A, 1995, J UROLOGY, V154, P800, DOI 10.1016/S0022-5347(01)67168-4
NR 9
TC 7
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPL P
JI Transplant. Proc.
PD OCT
PY 2010
VL 42
IS 8
BP 2892
EP 2895
DI 10.1016/j.transproceed.2010.07.074
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 677XL
UT WOS:000284028900020
PM 20970562
DA 2018-10-19
ER

PT J
AU Morks, MF
AF Morks, M. F.
TI Plasma spraying of zirconia-titania-silica bio-ceramic composite coating
   for implant application
SO MATERIALS LETTERS
LA English
DT Article
DE Plasma spraying; Zirconia-titania-silica; Biomaterial; Microstructure;
   Phase structure; FT-IR
ID HYDROXYAPATITE COATINGS; BONE; MICROSTRUCTURE
AB Zirconia-titania-silica (ZTS) bio-ceramic composite coating was deposited on titanium surface via plasma spray process. The original feedstock was prepared by mixing equal amounts (wt.%) of each powder in ceramic pot followed by stirring with ceramic ball. The resulting composite powder was sprayed at two different stand-off distances (SOD: 45 and 50 mm). Silica particles are distributed uniformly in the coating matrix. Amorphous silica was detected by energy-dispersive X-ray spectroscopy (EDXS) and FT-IR analysis which showed the spectra of Si-O and Ti-O stretching bonds. Anatase phase, the main phase of titania in feedstock, was transformed into rutile phase in the coating structure. The spraying efficiency was increased as the stand-off distance decreased. High intensity of tetrahedral zirconia phase was detected in the composite coating sprayed at 50 mm SOD. (C) 2010 Elsevier B.V. All rights reserved.
C1 Swinburne Univ Technol, Ind Res Inst Swinburne, Hawthorn, Vic 3122, Australia.
RP Morks, MF (reprint author), Swinburne Univ Technol, Ind Res Inst Swinburne, 543-545 Burwood Rd, Hawthorn, Vic 3122, Australia.
EM magdimorks@hotmail.com
RI Hanna, Magdi/F-3720-2011
CR CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Davis RJ, 1997, CHEM MATER, V9, P2311, DOI 10.1021/cm970314u
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   JOHAN F, 2007, ACTA BIOMATER, V3, P980
   LIU ZF, 1994, J PHYS CHEM-US, V98, P1253, DOI 10.1021/j100055a035
   Morks MF, 2007, APPL SURF SCI, V253, P7136, DOI 10.1016/j.apsusc.2007.02.183
   Morks MF, 2007, MAT SCI ENG B-SOLID, V139, P209, DOI 10.1016/j.mseb.2007.02.008
   Morks MF, 2008, APPL SURF SCI, V255, P3426, DOI 10.1016/j.apsusc.2008.09.088
   Morks M. F., 2008, J MANUF PROCESSES, V10, P1
   Morks MR, 2008, J MECH BEHAV BIOMED, V1, P165, DOI 10.1016/j.jmbbm.2007.09.002
   MORKS MF, 2007, J MECH BEHAV BIOMED, V1, P105
   YAMAHARA K, 2004, J NONCRYST SOLIDS, V249, P341
NR 13
TC 12
Z9 12
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP 30
PY 2010
VL 64
IS 18
BP 1968
EP 1971
DI 10.1016/j.matlet.2010.06.016
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 640AR
UT WOS:000281019800010
DA 2018-10-19
ER

PT J
AU Aguirre, A
   Planell, JA
   Engel, E
AF Aguirre, A.
   Planell, J. A.
   Engel, E.
TI Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal
   stem cell interaction in co-culture and its implications in angiogenesis
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Bone marrow; Endothelial progenitor cell; Co-culture; Mesenchymal stem
   cell; Angiogenesis
ID GROWTH-FACTOR; IN-VITRO; TISSUE; DIFFERENTIATION; ANGIOPOIETINS;
   COMMUNICATION; RECEPTOR; BLOOD; VEGF
AB Tissue engineering aims to regenerate tissues and organs by using cell and biomaterial-based approaches. One of the current challenges in the field is to promote proper vascularization in the implant to prevent cell death and promote host integration. Bone marrow endothelial progenitor cells (BM-EPCs) and mesenchymal stem cells (MSCs) are bone marrow resident stem cells widely employed for proangiogenic applications. In vivo, they are likely to interact frequently both in the bone marrow and at sites of injury. In this study, the physical and biochemical interactions between BM-EPCs and MSCs in an in vitro co-culture system were investigated to further clarify their roles in vascularization. BM-EPC/MSC co-cultures established close cell-cell contacts soon after seeding and self-assembled to form elongated structures at 3 days. Besides direct contact, cells also exhibited vesicle transport phenomena. When co-cultured in Matrigel, tube formation was greatly enhanced even in serum-starved, growth factor free medium. Both MSCs and BM-EPCs contributed to these tubes. However, cell proliferation was greatly reduced in co-culture and morphological differences were observed. Gene expression and cluster analysis for wide panel of angiogenesis-related transcripts demonstrated up-regulation of angiogenic markers but down-regulation of many other cytokines. These data suggest that cross-talk occurs in between BM-EPCs and MSCs through paracrine and direct cell contact mechanisms leading to modulation of the angiogenic response. (C) 2010 Elsevier Inc. All rights reserved.
C1 Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain.
   Tech Univ Catalonia UPC, ETSEIB, Dept Mat Sci & Met Engn, Barcelona 08028, Spain.
   CIBER BBN, Zaragoza 50118, Spain.
RP Engel, E (reprint author), Inst Bioengn Catalonia IBEC Lab, Ed Helix,Baldiri Reixac 15-21, Barcelona 08028, Spain.
EM elisabeth.engel@upc.edu
RI Engel, Elisabeth/D-4365-2014; Aguirre, Aitor/A-3294-2013
OI Engel, Elisabeth/0000-0003-4855-8874; Aguirre, Aitor/0000-0002-1383-2792
FU European Commission [NMP3-LA-2008-214402]; CIBER-BBN; Spanish Ministry
   of Science and Innovation [MAT2008-06887-C03-01]; Generalitat of
   Catalunya
FX We thank the European Commission (European project NMP3-LA-2008-214402,
   ANGIOSCAFF), the CIBER-BBN and the Spanish Ministry of Science and
   Innovation for funding (Project MAT2008-06887-C03-01). A.A. was
   supported with an FI-B predoctoral grant from the Generalitat of
   Catalunya. We also thank Prof. Joelle Amedee for suggestions and
   constructive criticism on the manuscript.
CR Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Aguirre A, 2010, BIOCHEM BIOPH RES CO, V393, P156, DOI 10.1016/j.bbrc.2010.01.109
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1
   Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002
   Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004
   Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annutev.med.57.121304.131306
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011
   Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018
   Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896
   Herr F, 2003, J CLIN ENDOCR METAB, V88, P4811, DOI 10.1210/jc.2003-030243
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kovacic JC, 2008, TRENDS CARDIOVAS MED, V18, P45, DOI 10.1016/j.tcm.2007.12.002
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Larrivee B., 2007, V180, P89
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liu ZJ, 2009, J CELL BIOCHEM, V106, P984, DOI 10.1002/jcb.22091
   Nesselmann C, 2008, J CELL MOL MED, V12, P1795, DOI 10.1111/j.1582-4934.2008.00457.x
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Rouwkema J, 2009, TISSUE ENG PT A, V15, P2015, DOI 10.1089/ten.tea.2008.0318
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Schrepfer S, 2007, STEM CELLS DEV, V16, P105, DOI 10.1089/scd.2006.0041
   Sepulveda P, 2007, TRANSPL P, V39, P2089, DOI 10.1016/j.transproceed.2007.07.009
   Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3
   Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
NR 35
TC 85
Z9 94
U1 3
U2 38
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 17
PY 2010
VL 400
IS 2
BP 284
EP 291
DI 10.1016/j.bbrc.2010.08.073
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 654WB
UT WOS:000282200600017
PM 20732306
DA 2018-10-19
ER

PT J
AU Agnarsson, I
   Kuntner, M
   Blackledge, TA
AF Agnarsson, Ingi
   Kuntner, Matjaz
   Blackledge, Todd A.
TI Bioprospecting Finds the Toughest Biological Material: Extraordinary
   Silk from a Giant Riverine Orb Spider
SO PLOS ONE
LA English
DT Article
ID WEAVING SPIDERS; MECHANICAL-PROPERTIES; DRAGLINE SILK; CAPTURE THREADS;
   FORCED SILKING; EVOLUTION; WEB; PERFORMANCE; BIOMATERIAL; PREY
AB Background: Combining high strength and elasticity, spider silks are exceptionally tough, i.e., able to absorb massive kinetic energy before breaking. Spider silk is therefore a model polymer for development of high performance biomimetic fibers. There are over 41.000 described species of spiders, most spinning multiple types of silk. Thus we have available some 200.000+ unique silks that may cover an amazing breadth of material properties. To date, however, silks from only a few tens of species have been characterized, most chosen haphazardly as model organisms (Nephila) or simply from researchers' backyards. Are we limited to 'blindly fishing' in efforts to discover extraordinary silks? Or, could scientists use ecology to predict which species are likely to spin silks exhibiting exceptional performance properties?
   Methodology: We examined the biomechanical properties of silk produced by the remarkable Malagasy 'Darwin's bark spider' (Caerostris darwini), which we predicted would produce exceptional silk based upon its amazing web. The spider constructs its giant orb web (up to 2.8 m(2)) suspended above streams, rivers, and lakes. It attaches the web to substrates on each riverbank by anchor threads as long as 25 meters. Dragline silk from both Caerostris webs and forcibly pulled silk, exhibits an extraordinary combination of high tensile strength and elasticity previously unknown for spider silk. The toughness of forcibly silked fibers averages 350 MJ/m(3), with some samples reaching 520 MJ/m3. Thus, C. darwini silk is more than twice tougher than any previously described silk, and over 10 times better than Kevlar (R). Caerostris capture spiral silk is similarly exceptionally tough.
   Conclusions: Caerostris darwini produces the toughest known biomaterial. We hypothesize that this extraordinary toughness coevolved with the unusual ecology and web architecture of these spiders, decreasing the likelihood of bridgelines breaking and collapsing the web into the river. This hypothesis predicts that rapid change in material properties of silk co-occurred with ecological shifts within the genus, and can thus be tested by combining material science, behavioral observations, and phylogenetics. Our findings highlight the potential benefits of natural history-informed bioprospecting to discover silks, as well as other materials, with novel and exceptional properties to serve as models in biomimicry.
C1 [Agnarsson, Ingi] Univ Puerto Rico, Dept Biol, Fac Nat Sci, San Juan, PR 00936 USA.
   [Agnarsson, Ingi; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.
   [Agnarsson, Ingi; Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Agnarsson, Ingi; Blackledge, Todd A.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
RP Agnarsson, I (reprint author), Univ Puerto Rico, Dept Biol, Fac Nat Sci, San Juan, PR 00936 USA.
EM iagnarsson@gmail.com
FU Slovenian Research Agency [Z1-9799-0618-07]; National Geographic Society
   [8655-09]; National Science Foundation [DBI-0521261, DEB-0516038,
   IOS-0745379]; European Community [MIRG-CT-2005 036536]; Sallee
   Charitable Trust; United States National Science Foundation
   [DEB-9712353]
FX Primary funding for this work came from the Slovenian Research Agency
   (grant Z1-9799-0618-07 to I. Agnarsson), the National Geographic Society
   (grant 8655-09 to the authors), and the National Science Foundation
   (grants DBI-0521261, DEB-0516038 and IOS-0745379 to T. Blackledge).
   Additional funding came from the European Community 6th Framework
   Programme (a Marie Curie International Reintegration Grant MIRG-CT-2005
   036536 to M. Kuntner). The 2001 field work was supported by the Sallee
   Charitable Trust grant to I. Agnarsson and M. Kuntner and by a United
   States National Science Foundation grant (DEB-9712353) to G. Hormiga and
   J. A. Coddington. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x
   Agnarsson I, 2008, J EXP ZOOL PART A, V309A, P494, DOI 10.1002/jez.480
   Agnarsson I, 2009, J EXP BIOL, V212, P1989, DOI 10.1242/jeb.028282
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Booth C., 1989, COMPREHENSIVE POLYM
   Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487
   Boutry C, 2009, ZOOLOGY, V112, P451, DOI 10.1016/j.zool.2009.03.003
   EBERHARD WG, 1990, ANNU REV ECOL SYST, V21, P341, DOI 10.1146/annurev.es.21.110190.002013
   Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c
   Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guan ZB, 2007, POLYM INT, V56, P467, DOI 10.1002/pi.2245
   Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x
   Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x
   Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Opell BD, 2000, BIOL J LINN SOC, V70, P107, DOI 10.1006/bijl.1999.0390
   OPELL BD, 1994, FUNCT ECOL, V8, P85, DOI 10.2307/2390115
   Opell BD, 2001, EVOL ECOL RES, V3, P567
   Opell BD, 2006, ZOOLOGY, V109, P339, DOI 10.1016/j.zool.2006.04.002
   Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Perez-Rigueiro J, 2001, J APPL POLYM SCI, V82, P1928, DOI 10.1002/app.2038
   SENSENIG A, 2010, J EVOLUTION IN PRESS, V23
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068
NR 39
TC 90
Z9 94
U1 4
U2 62
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 16
PY 2010
VL 5
IS 9
AR e11234
DI 10.1371/journal.pone.0011234
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 650QH
UT WOS:000281864100001
PM 20856804
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Shi, SX
   Su, ZQ
   Wei, H
   Chen, XN
AF Shi, Shuxian
   Su, Zhiqiang
   Wei, Hao
   Chen, Xiaonong
TI Fabrication of Aragonite Rosette Superstructure Through the Weak
   Interaction Between Nonionic Polymers and Ca2+
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; nucleation; poly(N-vinyl pyrrolidone); crystal morphology;
   calcium compounds
ID CALCIUM-CARBONATE; CRYSTAL NUCLEATION; CACO3; BIOMINERALIZATION;
   CRYSTALLIZATION; TRANSFORMATION; VATERITE; POLYMORPHISM; ADDITIVES;
   MECHANISM
AB The controlled formation of aragonite by simple method under ambient condition is a big challenge for biomaterial scientists. In this article, we took poly (N-vinyl pyrrolidone) (PVP) as an example to investigate the influence of water-soluble nonionic polymers on the polymorphs of CaCO3 via CO2 diffusion method under ambient pressure and temperature, and found that the existence of PVP molecules favors the formation of aragonite with rosette superstructure. A possible mechanism is proposed that nonionic polymers can be doped into amorphous calcium carbonate (ACC) particles and further participate in the transformation process from ACC to aragonite and then promotes the formation of rosette superstructure through parallel aggregation by cross-linking the aragonite nuclei. The experiments of CaCO3 crystallization in presence of poly(ethylene oxide) (PEO) and poly(vinyl alcohol) (PVA) confirmed the mechanism. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 117: 3308-3314, 2010
C1 [Shi, Shuxian; Su, Zhiqiang; Wei, Hao] Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
   [Chen, Xiaonong] Beijing Univ Chem Technol, Coll Mat Sci & Engn, Dept Biomat, Beijing 100029, Peoples R China.
RP Su, ZQ (reprint author), Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
EM suzq@mail.buct.edu.cn; chenxn@mail.buct.edu.cn
RI Su, Zhiqiang/B-1781-2015
FU National Natural Science Foundation of China (NSFC) [20674003, 20874004]
FX Contract grant sponsor: National Natural Science Foundation of China
   (NSFC); contract grant numbers: 20674003, 20874004.
CR ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732
   Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924
   Barton A. F. M., 1990, CRC HDB POLYM LIQUID
   BELCHER AM, 1996, NATURE, V7, P689
   Bommel K. J. C., 2003, ANGEW CHEM INT EDIT, V42, P980
   BUNN CW, 1948, NATURE, V161, P929, DOI 10.1038/161929a0
   CALVERT P, 1997, NATURE, V386, P12
   Cardarelli F., 2000, MAT HDB CONCISE DESK
   Chen SF, 2006, CHEM MATER, V18, P115, DOI 10.1021/cm0519028
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   COLFEN H, 2005, ANGEW CHEM INT EDIT, V44, P2
   DIDYMUS JM, 1993, J CHEM SOC FARADAY T, V89, P2891, DOI 10.1039/ft9938902891
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   FLEER GJ, 1988, COLLOID SURFACE, V31, P1, DOI 10.1016/0166-6622(88)80178-1
   Gehrke N, 2005, CRYST GROWTH DES, V5, P1317, DOI 10.1021/cg050051d
   Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6
   Hosoda N, 2003, MACROMOLECULES, V36, P6449, DOI 10.1021/ma025869b
   Kim IW, 2005, CRYST GROWTH DES, V5, P513, DOI 10.1021/cg049721q
   KITANO Y, 1962, B CHEM SOC JPN, V35, P1973, DOI 10.1246/bcsj.35.1973
   KUTHER J, 1997, CHEM COMMUN, V37, P1593
   Levi Y, 1998, CHEM-EUR J, V4, P389, DOI 10.1002/(SICI)1521-3765(19980310)4:3<389::AID-CHEM389>3.0.CO;2-X
   Liu CJ, 2005, J PHYS CHEM B, V109, P14807, DOI 10.1021/jp050227m
   MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Naka K, 2001, CHEM MATER, V13, P3245, DOI 10.1021/cm011035g
   OGINO T, 1987, GEOCHIM COSMOCHIM AC, V51, P2757, DOI 10.1016/0016-7037(87)90155-4
   Privman V, 1999, J COLLOID INTERF SCI, V213, P36, DOI 10.1006/jcis.1999.6106
   Rivas L. B., 2003, PROG POLYM SCI, V28, P173
   Tai CY, 1998, AICHE J, V44, P1790, DOI 10.1002/aic.690440810
   WATABE N, 1981, PROGR CRYSTAL GROWTH, V4
   Wei H, 2003, J CRYST GROWTH, V250, P516, DOI 10.1016/S0022-0248(02)02484-3
   WEI H, 2004, J CRYST GROWTH, V260, P511
   WILBUR KM, 1984, BIOL BULL, V166, P251, DOI 10.2307/1541446
   Yang H, 1997, NATURE, V386, P692, DOI 10.1038/386692a0
   Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g
   Zhou GT, 2009, AM MINERAL, V94, P293, DOI 10.2138/am.2009.2957
NR 36
TC 10
Z9 10
U1 3
U2 12
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 15
PY 2010
VL 117
IS 6
BP 3308
EP 3314
DI 10.1002/app.30748
PG 7
WC Polymer Science
SC Polymer Science
GA 626HY
UT WOS:000279958200026
DA 2018-10-19
ER

PT J
AU Liang, WH
   Kienitz, BL
   Penick, KJ
   Welter, JF
   Zawodzinski, TA
   Baskaran, H
AF Liang, Wan-Hsiang
   Kienitz, Brian L.
   Penick, Kitsie J.
   Welter, Jean F.
   Zawodzinski, Thomas A.
   Baskaran, Harihara
TI Concentrated collagen-chondroitin sulfate scaffolds for tissue
   engineering applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biodegradable biomaterials; porous scaffolds; tensile strength;
   centrifugation; compressive strength; cartilage tissue engineering;
   cultured skin equivalents
ID MESENCHYMAL STEM-CELLS; CROSS-LINKED COLLAGEN; ARTIFICIAL SKIN;
   MECHANICAL CHARACTERIZATION; AGGREGATE CULTURE; POROUS SCAFFOLDS;
   PROGENITOR CELLS; GAG SCAFFOLDS; LINKING; MARROW
AB Collagen-chondroitin sulfate biomaterial scaffolds have been used in a number of tissue-engineered products under development or in the clinics. In this article, we describe a new approach based on centrifugation for obtaining highly concentrated yet porous collagen scaffolds. Water uptake, chondroitin sulfate retention, morphology, mechanical properties, and tissue-engineering potential of the concentrated scaffolds were investigated. Our results show that the new approach can lead to scaffolds containing four times as much collagen as that in conventional unconcentrated scaffolds. Further, water uptake in the concentrated scaffolds was significantly greater while chondroitin sulfate retention in the concentrated scaffolds was unaffected. The value of mean pore diameter in the concentrated scaffolds was smaller than that in the unconcentrated scaffolds and the walls of the pores in the former comprised of a continuous sheet of collagen. The mechanical properties measured as moduli of elasticity in compression and tension were improved by as much as 30 times in the concentrated scaffolds. In addition, our tissue culture results with human mesenchymal stem cells and foreskin keratinocytes show that the new scaffolds can be used for cartilage and skin tissue-engineering applications. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1050-1060, 2010.
C1 [Liang, Wan-Hsiang; Kienitz, Brian L.; Zawodzinski, Thomas A.; Baskaran, Harihara] Case Western Reserve Univ, Dept Chem Engn, Cleveland, OH 44106 USA.
   [Penick, Kitsie J.; Welter, Jean F.] Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA.
RP Baskaran, H (reprint author), Case Western Reserve Univ, Dept Chem Engn, Cleveland, OH 44106 USA.
EM hari@case.edu
OI Kienitz, Brian/0000-0002-0648-0303
FU Whitaker Foundation; National Institutes of Health [EB006203, AR050208]
FX Contract grant sponsor: Whitaker Foundation; Contract grant sponsor:
   National Institutes of Health; contract grant numbers: EB006203 (H.B.),
   AR050208 (J.F.W.)
CR BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732
   Buijtenhuijs P, 2004, BIOTECHNOL APPL BIOC, V39, P141, DOI 10.1042/BA20030105
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   CARRINO DA, 1991, BIOCHEM INT, V24, P485
   Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Edwards C, 1995, CLIN DERMATOL, V13, P375, DOI 10.1016/0738-081X(95)00078-T
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   El-Kassaby AW, 2003, J UROLOGY, V169, P31
   GARG AK, 1989, BIOMATERIALS, V10, P413, DOI 10.1016/0142-9612(89)90133-6
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Han B, 2003, J BIOMED MATER RES A, V65A, P118, DOI 10.1002/jbm.a.10460
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kuberka M, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P485, DOI 10.1515/bmte.2002.47.s1a.485
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Medalie DA, 1996, J INVEST DERMATOL, V107, P121, DOI 10.1111/1523-1747.ep12298363
   NOMURA S, 1977, BIOPOLYMERS, V16, P231, DOI 10.1002/bip.1977.360160202
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Papini Sandra, 2003, Stem Cells (Miamisburg), V21, P481, DOI 10.1634/stemcells.21-4-481
   Penick KJ, 2005, BIOTECHNIQUES, V39, P687, DOI 10.2144/000112009
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Saito H, 2007, ACTA BIOMATER, V3, P89, DOI 10.1016/j.actbio.2006.08.003
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124
   Shi HF, 2008, TISSUE ENG PT A, V14, P1775, DOI 10.1089/ten.tea.2007.0007
   Solchaga L., 2004, P ROYAL MICROSC SOC, V39, P313
   Solchaga L., 2004, T ORTHOP RES SOC, V29, P777
   Solchaga LA, 2004, METH MOLEC MED, V100, P53
   Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851
   Springer IN, 2006, TISSUE ENG, V12, P2649, DOI 10.1089/ten.2006.12.2649
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   VERONDA DR, 1970, J BIOMECH, V3, P111, DOI 10.1016/0021-9290(70)90055-2
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Welter JF, 2007, BIOTECHNIQUES, V42, P732, DOI 10.2144/000112451
   WELTER JF, 2005, T ORTHOP RES SOC, V30, P1771
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Yeong WY, 2007, J BIOMED MATER RES B, V82B, P260, DOI 10.1002/jbm.b.30729
NR 50
TC 24
Z9 24
U1 1
U2 25
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1050
EP 1060
DI 10.1002/jbm.a.32774
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000007
PM 20694972
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gurkan, UA
   Cheng, XG
   Kishore, V
   Uquillas, JA
   Akkus, O
AF Gurkan, Umut Atakan
   Cheng, Xingguo
   Kishore, Vipuil
   Uquillas, Jorge Alfredo
   Akkus, Ozan
TI Comparison of morphology, orientation, and migration of tendon derived
   fibroblasts and bone marrow stromal cells on electrochemically aligned
   collagen constructs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tendon; ligament; biocompatibility; tissue engineering; cell migration
ID MESENCHYMAL STEM-CELLS; IN-VIVO EVALUATION; CROSS-LINKING; PATELLAR
   TENDON; REPAIR; TISSUE; VITRO; BIOCOMPATIBILITY; RECONSTRUCTION; FIBERS
AB There are approximately 33 million injuries involving musculoskeletal tissues (including tendons and ligaments) every year in the United States. In certain cases the tendons and ligaments are damaged irreversibly and require replacements that possess the natural functional properties of these tissues. As a biomaterial, collagen has been a key ingredient in tissue engineering scaffolds. The application range of collagen in tissue engineering would be greatly broadened if the assembly process could be better controlled to facilitate the synthesis of dense, oriented tissue-like constructs. An electrochemical method has recently been developed in our laboratory to form highly oriented and densely packed collagen bundles with mechanical strength approaching that of tendons. However, there is limited information whether this electrochemically aligned collagen bundle (ELAC) presents advantages over randomly oriented bundles in terms of cell response. Therefore, the current study aimed to assess the biocompatibility of the collagen bundles in vitro, and compare tendon-derived fibroblasts (TDFs) and bone marrow stromal cells (MSCs) in terms of their ability to populate and migrate on the single and braided ELAC bundles. The results indicated that the ELAC was not cytotoxic; both cell types were able to populate and migrate on the ELAC bundles more efficiently than that observed for random collagen bundles. The braided ELAC constructs were efficiently populated by both TDFs and MSCs in vitro. Therefore, both TDFs and MSCs can be used with the ELAC bundles for tissue engineering purposes. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1070-1079, 2010.
C1 [Gurkan, Umut Atakan; Kishore, Vipuil; Uquillas, Jorge Alfredo; Akkus, Ozan] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Cheng, Xingguo] Div 01 SW Res Inst, San Antonio, TX 78238 USA.
RP Akkus, O (reprint author), Purdue Univ, Weldon Sch Biomed Engn, 206 S Martin Jischke Dr, W Lafayette, IN 47907 USA.
EM ozan@purdue.edu
RI Kishore, Vipuil/A-4959-2013; Kishore, Vipuil/F-8968-2016
OI Kishore, Vipuil/0000-0002-2559-1789; Akkus, Ozan/0000-0003-3523-3421;
   Gurkan, Umut/0000-0002-0331-9960; Uquillas, Jorge/0000-0003-0731-4312
FU National Institutes of Health [NIH 1R21AR056060]; National Science
   Foundation (CBET division) [0754442]
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: NIH 1R21AR056060; Contract grant sponsor: National Science
   Foundation (CBET division); contract grant number: 0754442
CR AWED HA, 2003, J ORTHOP RES, V21, P420
   Becker H, 1979, J Hand Surg Am, V4, P454
   Beredjiklian PK, 2003, J BONE JOINT SURG AM, V85A, P539, DOI 10.2106/00004623-200303000-00025
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240
   CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Crossett LS, 2002, J BONE JOINT SURG AM, V84A, P1354, DOI 10.2106/00004623-200208000-00011
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Ferretti A, 2002, J BONE JOINT SURG AM, V84A, P2179, DOI 10.2106/00004623-200212000-00009
   Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295
   Ge ZG, 2005, CELL TRANSPLANT, V14, P573, DOI 10.3727/000000005783982819
   Gross CL, 2003, TOXICOL MECH METHOD, V13, P263, DOI 10.1080/713857190
   GUILAK F, 2003, FUNCTIONAL TISSUE EN
   Harris MT, 2004, J ORTHOPAED RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x
   Kartus J, 2001, ARTHROSCOPY, V17, P971, DOI 10.1053/jars.2001.28979
   Kofron MD, 2005, CURR GENE THER, V5, P37
   Koob TJ, 2002, COMP BIOCHEM PHYS A, V133, P1171, DOI 10.1016/S1095-6433(02)00247-7
   Koob TJ, 2001, J BIOMED MATER RES, V56, P31, DOI 10.1002/1097-4636(200107)56:1<31::AID-JBM1065>3.0.CO;2-N
   Koob TJ, 2001, J BIOMED MATER RES, V56, P40, DOI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
   KRACKOW KA, 1988, ORTHOPEDICS, V11, P909
   Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018
   Kuo YR, 2003, ANN PLAS SURG, V50, P149, DOI 10.1097/01.SAP.0000037270.95257.B9
   LI Y, 2009, 55 ANN M ORTH RES SO
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Maccarinelli G, 2005, J ENDOCRINOL, V184, P249, DOI 10.1677/joe.1.05837
   Marder RA, 1999, AM J SPORT MED, V27, P304, DOI 10.1177/03635465990270030601
   Nirmalanandhan VS, 2009, TISSUE ENG PT A, V15, P2103, DOI 10.1089/ten.tea.2008.0335
   Paavola M, 2000, AM J SPORT MED, V28, P634, DOI 10.1177/03635465000280050301
   PRAEMER A, 1999, AM ACAD ORTHOP SURG
   Schoen Delores C, 2005, Orthop Nurs, V24, P304
   SILFVERSKIOLD KL, 1993, J HAND SURG-AM, V18A, P654, DOI 10.1016/0363-5023(93)90312-Q
   Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29
   Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   YOUNG HG, 1998, J ORTHOP RES, V16, P406
NR 42
TC 28
Z9 28
U1 0
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1070
EP 1079
DI 10.1002/jbm.a.32783
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000009
PM 20694974
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Giljean, S
   Ponche, A
   Bigerelle, M
   Anselme, K
AF Giljean, S.
   Ponche, A.
   Bigerelle, M.
   Anselme, K.
TI Statistical approach of chemistry and topography effect on human
   osteoblast adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface chemistry; topography; titanium; stainless steel; adhesion;
   osteoblast
ID BIOCOMPATIBLE METALLIC MATERIALS; LONG-TERM ADHESION; SURFACE-CHEMISTRY;
   IN-VITRO; TITANIUM-ALLOY; BIOMATERIAL SURFACE; CELL-ADHESION;
   CHEMICAL-COMPOSITION; VARYING ROUGHNESS; STAINLESS-STEEL
AB Our objective in this work was to determine statistically the relative influence of surface topography and surface chemistry of metallic substrates on long-term adhesion of human bone cell quantified by the adhesion power (AP). Pure titanium, titanium alloy, and stainless steel substrates were processed with electro-erosion, sandblasting, or polishing giving various morphologies and amplitudes. The surface chemistry was characterized by X-ray photoelectron spectroscopy (XPS) associated with an extensive analysis of surface topography. The statistical analysis demonstrated that the effect on AP of the material composition was not significant. More, no correlation was found between AP and the surface element concentrations determined by XPS demonstrating that the surface chemistry was not an influencing parameter for long-term adhesion. In the same way, the roughness amplitude, independently of the process, had no influence on AP, meaning that roughness amplitude is not an intrinsic parameter of long-term adhesion. On the contrary, the elaboration process alone had a significant effect on AP. For a same surface elaboration process, the number of inflexion points, or G parameter, was the most pertinent roughness parameter for describing the topography influence on long-term adhesion. Thus, more the inflexion points, more the discontinuities, higher the long-term adhesion. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1111-1123,2010.
C1 [Giljean, S.; Ponche, A.; Anselme, K.] Univ Haute Alsace, Inst Sci Mat Mulhouse IS2M, CNRS LRC7228, F-68057 Mulhouse, France.
   [Giljean, S.] Univ Haute Alsace, Equipe MMPF Pole STIC SPI Maths, IUT Mulhouse Dept GMP, F-68093 Mulhouse, France.
   [Bigerelle, M.] CNRS UMR 8517, Lab Met Phys & Genie Mat, Equipe Mat ENSAM Lille, F-59046 Lille, France.
   [Bigerelle, M.] Univ Technol Compiegne, Lab Roberval, Ctr Rech Royallieu, CNRS UMR 6253, F-60205 Compiegne, France.
   [Anselme, K.] Univ Littoral Cote dOpale, Lab Rech Biomat & Biotechnol, F-62608 Berck Sur Mer, France.
RP Anselme, K (reprint author), Univ Haute Alsace, Inst Sci Mat Mulhouse IS2M, CNRS LRC7228, 15 Rue Jean Starcky,BP 2488, F-68057 Mulhouse, France.
EM karine.anselme@uha.fr
OI Ponche, Arnaud/0000-0002-8993-2896; Giljean,
   Sylvain/0000-0002-8262-345X; Anselme, Karine/0000-0002-6669-205X;
   Maxence, Bigerelle/0000-0002-4144-245X
FU CETIM (Centre Technique des Industries Mecaniques) Foundation, Senlis,
   France (Nouvelles Methodes D'analyse des etats de Surfaces : de la
   Caracterisation a la Recherche de Parametres Pertinents)
FX Contract grant sponsor: CETIM (Centre Technique des Industries
   Mecaniques) Foundation, Senlis, France (Nouvelles Methodes D'analyse des
   etats de Surfaces : de la Caracterisation a la Recherche de Parametres
   Pertinents)
CR Anselme K, 2006, SURF COAT TECH, V200, P6325, DOI 10.1016/j.surfcoat.2005.11.001
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Bigerelle M, 2005, ACTA BIOMATER, V1, P499, DOI 10.1016/j.actbio.2005.06.001
   Bigerelle M, 2005, J BIOMED MATER RES A, V75A, P530, DOI 10.1002/jbm.a.30473
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   BOYAN BD, 2001, ANN REV MATER RES, V31, P371
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x
   Hacking SA, 2002, CLIN ORTHOP RELAT R, P24, DOI 10.1097/01.blo.0000038469.05771.3d
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lee TM, 2004, BIOMATERIALS, V25, P23, DOI 10.1016/S0142-9612(03)00465-4
   Links J, 1998, BIOMATERIALS, V19, P2219
   Meredith DO, 2007, J MATER SCI-MATER M, V18, P405, DOI 10.1007/s10856-006-0706-5
   Morais S, 1998, BIOMATERIALS, V19, P999, DOI 10.1016/S0142-9612(97)00234-2
   Morra M, 2003, INT J ORAL MAX IMPL, V18, P40
   Morra M, 1997, SURF INTERFACE ANAL, V25, P983, DOI 10.1002/(SICI)1096-9918(199712)25:13<983::AID-SIA345>3.0.CO;2-X
   Olivares R, 2004, SURF COAT TECH, V177, P758, DOI 10.1016/j.surfcoat.2003.08.018
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010
   Tsukimura N, 2008, J BIOMED MATER RES A, V84A, P108, DOI 10.1002/jbm.a.31422
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wennerberg A, 1997, J MATER SCI-MATER M, V8, P757, DOI 10.1023/A:1018560528625
   Wieland M, 2002, J BIOMED MATER RES, V60, P434, DOI 10.1002/jbm.10059
   Wirth C, 2008, MAT SCI ENG C-BIO S, V28, P990, DOI 10.1016/j.msec.2007.10.085
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 47
TC 7
Z9 7
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1111
EP 1123
DI 10.1002/jbm.a.32793
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000013
PM 20694978
DA 2018-10-19
ER

PT J
AU Andersson, J
   Stenhamre, H
   Backdahl, H
   Gatenholm, P
AF Andersson, Jessica
   Stenhamre, Hanna
   Backdahl, Henrik
   Gatenholm, Paul
TI Behavior of human chondrocytes in engineered porous bacterial cellulose
   scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE porous bacterial cellulose; scaffolds; human chondrocytes; cartilage
   regeneration; tissue engineering
ID ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; TRANSPLANTATION;
   MICROSPHERES; REGENERATION; COLLAGEN; GRAFTS; REPAIR; CELLS
AB Regeneration of articular cartilage damage is an area of great interest due to the limited ability of cartilage to self-repair. The latest cartilage repair strategies are dependent on access to biomaterials to which chondrocytes can attach and in which they can migrate and proliferate, producing their own extracellular matrix. In the present study, engineered porous bacterial cellulose (BC) scaffolds were prepared by fermentation of Acetobacter xylinum (A. xylinum) in the presence of slightly fused wax particles with a diameter of 150-300 mu m, which were then removed by extrusion. This porous material was evaluated as a scaffold for cartilage regeneration. Articular chondrocytes from young adult patients as well as neonatal articular chondrocytes were seeded with various seeding techniques onto the porous BC scaffolds. Scanning electron microscopy (SEM) analysis and confocal microscopy analysis showed that cells entered the pores of the scaffolds and that they increasingly filled out the pores over time. Furthermore, DNA analysis implied that the chondrocytes proliferated within the porous BC. Alcian blue van Gieson staining revealed glycosaminoglycan (GAG) production by chondrocytes in areas where cells were clustered together. With some further development, this novel biomaterial can be a suitable candidate for cartilage regeneration applications. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1124-1132, 2010.
C1 [Andersson, Jessica; Stenhamre, Hanna; Backdahl, Henrik; Gatenholm, Paul] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.
   [Stenhamre, Hanna] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden.
RP Gatenholm, P (reprint author), Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.
EM paul.gatenholm@chalmers.se
FU EC [NMP3-CT-2004-500283]; Swedish Research Council [621-2005-6121]
FX Contract grant sponsor: EC NoE Expertissues; contract grant number:
   NMP3-CT-2004-500283; Contract grant sponsor: Swedish Research Council;
   contract grant number: 621-2005-6121
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bigdeli N, 2008, J BIOTECHNOL, V133, P146, DOI 10.1016/j.jbiotec.2007.08.045
   Bodin A., 2006, MODERN MULTIDISCIPLI, P619
   Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   BRITTBERG M, 2008, INJURY INT J CARE S1, V39, P30
   Brittberg M, 2008, ACAD PR SER BIOM ENG, P533, DOI 10.1016/B978-0-12-370869-4.00018-5
   Brown A. J., 1886, J CHEM SOC, V49, P172, DOI DOI 10.1039/CT8864900172
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   Bueno EM, 2007, J BIOTECHNOL, V129, P516, DOI 10.1016/j.jbiotec.2007.01.005
   Capes JS, 2005, J MATER SCI-MATER M, V16, P1069, DOI 10.1007/s10856-005-4708-5
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Esguerra M, 2010, J BIOMED MATER RES A, V93A, P140, DOI 10.1002/jbm.a.32516
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Jung HJ, 2008, ARTIF ORGANS, V32, P981
   Lao LH, 2008, COLLOID SURFACE B, V66, P218, DOI 10.1016/j.colsurfb.2008.06.014
   Lindahl A, 2008, SKELETAL RADIOL, V37, P273, DOI 10.1007/s00256-008-0447-2
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Mercier NR, 2005, BIOMATERIALS, V26, P1945, DOI 10.1016/j.biomaterials.2004.06.030
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   WAN WK, 1998, Patent No. 5846213
NR 39
TC 48
Z9 50
U1 1
U2 31
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1124
EP 1132
DI 10.1002/jbm.a.32784
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000014
PM 20694979
DA 2018-10-19
ER

PT J
AU Zellner, J
   Mueller, M
   Berner, A
   Dienstknecht, T
   Kujat, R
   Nerlich, M
   Hennemann, B
   Koller, M
   Prantl, L
   Angele, M
   Angele, P
AF Zellner, Johannes
   Mueller, Michael
   Berner, Arne
   Dienstknecht, Thomas
   Kujat, Richard
   Nerlich, Michael
   Hennemann, Burkhard
   Koller, Michael
   Prantl, Lukas
   Angele, Martin
   Angele, Peter
TI Role of mesenchymal stem cells in tissue engineering of meniscus
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tissue engineering; avascular zone of meniscus; mesenchymal stem cells;
   hyaluronan-collagen composite matrix; platelet-rich plasma
ID MEDIAL MENISCUS; KNEE-JOINT; PROGENITOR CELLS; GROWTH-FACTORS; PRESSURE
   DISTRIBUTION; DOGS KNEES; IN-VITRO; CHONDROGENESIS; REGENERATION;
   HYALURONAN
AB Tissue engineering is a promising approach for the treatment of tissue defects. Mesenchymal stem cells are of potential use as a source of repair cells or of important growth factors for tissue engineering. The purpose of this study was to examine the role of mesenchymal stem cells in meniscal tissue repair. This was tested using several cell and biomaterial-based treatment options for repair of defects in the avascular zone of rabbit menisci. Circular meniscal punch defects (2 mm) were created in the avascular zone of rabbit menisci and left empty or filled with hyaluronan-collagen composite matrices without cells, loaded with platelet-rich plasma, autologous bone marrow, or autologous mesenchymal stem cells. In some experiments, matrices with stem cells were precultured in chondrogenic medium for 14 days before implantation. Rabbits were then allowed free cage movement after surgery for up to 12 weeks. Untreated defects and defects treated with cell-free implants had muted fibrous healing responses. Neither bone marrow nor platelet-rich plasma loaded in matrices produced improvement in healing compared with cell-free implants. The implantation of 14 days precultured chondrogenic stem cellmatrix constructs resulted in fibrocartilage-like repair tissue, which was only partially integrated with the native meniscus. Non-precultured mesenchymal stem cells in hyaluronan-collagen composite matrices stimulated the development of completely integrated meniscus-like repair tissue. The study shows the necessity of mesenchymal stem cells for the repair of meniscal defects in the avascular zone. Mesenchymal stem cells seem to fulfill additional repair qualities besides the delivery of growth factors. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1150-1161, 2010.
C1 [Zellner, Johannes; Mueller, Michael; Berner, Arne; Dienstknecht, Thomas; Kujat, Richard; Nerlich, Michael; Prantl, Lukas; Angele, Peter] Univ Hosp Regensburg, Dept Trauma Surg, D-93042 Regensburg, Germany.
   [Hennemann, Burkhard] Univ Hosp Regensburg, Dept Hematol & Oncol, D-93042 Regensburg, Germany.
   [Koller, Michael] Univ Hosp Regensburg, Ctr Clin Studies, D-93042 Regensburg, Germany.
   [Angele, Martin] Univ Munich, Klinikum Grosshadern, Dept Surg, D-81377 Munich, Germany.
RP Zellner, J (reprint author), Univ Hosp Regensburg, Dept Trauma Surg, Franz Josef Strauss Allee 11, D-93042 Regensburg, Germany.
EM johannes.zellner@klinik.uni-regensburg.de
OI Zellner, Johannes/0000-0001-5385-9378
FU Faculty of Medicine of the University of Regensburg
FX The authors thank Daniela Drenkard, Thomas Boettner, and Gunnar Muller
   for their excellent technical assistance. This work was supported by a
   grant of the Faculty of Medicine of the University of Regensburg to P.
   Angele and B. Hennemann.
CR Abatangelo G, 1997, BIOMATERIALS, V18, P1411, DOI 10.1016/S0142-9612(97)00089-6
   AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409
   Anderson D Greg, 2005, Spine J, V5, p297S, DOI 10.1016/j.spinee.2005.02.019
   Angele P, 2004, BIORHEOLOGY, V41, P335
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   ARNOCZKY SP, 1999, CLIN ORTHOP S, V367, pS244
   BARATZ ME, 1986, AM J SPORT MED, V14, P270, DOI 10.1177/036354658601400405
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BOURNE RB, 1984, J BONE JOINT SURG AM, V66A, P1431, DOI 10.2106/00004623-198466090-00017
   CABAUD EH, 1981, AM J SPORTS MED, V9, P129
   CANHAM W, 1986, AM J SPORT MED, V14, P376, DOI 10.1177/036354658601400505
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Centeno CJ, 2008, MED HYPOTHESES, V71, P900, DOI 10.1016/j.mehy.2008.06.042
   COX JS, 1975, CLIN ORTHOP RELAT R, P178
   COX JS, 1977, CLIN ORTHOP RELAT R, P236
   FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887
   GERSHUNI DH, 1989, J BONE JOINT SURG AM, V71A, P1363, DOI 10.2106/00004623-198971090-00013
   Hennemann B, 2000, HUM GENE THER, V11, P43, DOI 10.1089/10430340050016148
   HSIEH HH, 1976, J BONE JOINT SURG AM, V58, P87, DOI 10.2106/00004623-197658010-00016
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P580
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   ISHIMURA M, 1991, Arthroscopy, V7, P177, DOI 10.1016/0749-8063(91)90106-8
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KING D, 1990, CLIN ORTHOP RELAT R, P4
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Leung VYL, 2006, EUR SPINE J, V15, pS406, DOI 10.1007/s00586-006-0183-z
   LEVY IM, 1982, J BONE JOINT SURG AM, V64, P883, DOI 10.2106/00004623-198264060-00011
   Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156
   MAST BA, 1993, MATRIX, V13, P441, DOI 10.1016/S0934-8832(11)80110-1
   MILACHOWSKI KA, 1989, INT ORTHOP, V13, P1
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   NEWMAN AP, 1989, AM J SPORT MED, V17, P164, DOI 10.1177/036354658901700205
   OCONNOR BL, 1984, J ANAT, V138, P15
   Ohnishi S, 2007, INT J HEMATOL, V86, P17, DOI 10.1532/IJH97.07041
   Pangborn CA, 2005, TISSUE ENG, V11, P1141, DOI 10.1089/ten.2005.11.1141
   Pangborn CA, 2005, J ORTHOP RES, V23, P1184, DOI 10.1016/j.orthres.2005.01.019
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   Petersen W, 2007, ARCH ORTHOP TRAUM SU, V127, P235, DOI 10.1007/s00402-005-0024-2
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   RADIN EL, 1984, CLIN ORTHOP RELAT R, P290
   ROONEY P, 1993, DIFFERENTIATION, V54, P1
   Schafer R, 2008, PANMINERVA MED, V50, P31
   SOMMERLATH K, 1992, AM J SPORT MED, V20, P73, DOI 10.1177/036354659202000117
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   VETH RPH, 1983, CLIN ORTHOP RELAT R, P258
   WALKER PS, 1975, CLIN ORTHOP RELAT R, P184
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   WILSON AS, 1969, ANAT REC, V165, P485, DOI 10.1002/ar.1091650404
   WOOD DJ, 1990, BIOMATERIALS, V11, P13, DOI 10.1016/0142-9612(90)90045-R
   Xian Cory J, 2006, Curr Stem Cell Res Ther, V1, P213, DOI 10.2174/157488806776956904
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
NR 59
TC 88
Z9 92
U1 0
U2 19
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1150
EP 1161
DI 10.1002/jbm.a.32796
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000017
PM 20694982
DA 2018-10-19
ER

PT J
AU Lampe, KJ
   Mooney, RG
   Bjugstad, KB
   Mahoney, MJ
AF Lampe, Kyle J.
   Mooney, Rachael G.
   Bjugstad, Kimberly B.
   Mahoney, Melissa J.
TI Effect of macromer weight percent on neural cell growth in 2D and 3D
   nondegradable PEG hydrogel culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE neural precursor cell; tissue engineering; hydrogel; poly(ethylene
   glycol) (PEG); biomaterial
ID TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; NEURITE EXTENSION;
   REACTIVE ASTROCYTES; POLY(ETHYLENE GLYCOL); MECHANICAL-PROPERTIES;
   PARKINSONIAN RATS; GEL STIFFNESS; GLIAL GROWTH; SPINAL-CORD
AB Neural precursor cells (NPCs) are a renewable cell source that may be useful for neural cell transplant therapies. Their expansion and differentiation potential have traditionally been explored by culturing them on stiff tissue culture polystyrene. Here we describe advantages of an alternative culture system: bio-inert poly(ethylene glycol) (PEG) hydrogels. Specifically this work reports the effect that macromer weight percent has on the metabolic and apoptotic activity, proliferation, and cellular composition of a mixed population of neurons and multipotent NPCs grown both on 2D and within 3D PEG hydrogels. In 2D culture, hydrogel properties did not affect metabolic or apoptotic activity but did impact cell proliferation and composition leading to an increase in glial cell reactivity as stiffness increased. In 3D culture, low weight percent hydrogels led to greater metabolic activity and lower apoptotic activity with significant proliferation observed only in hydrogels that closely matched the stiffness of native brain tissue. PEG hydrogels therefore provide a versatile in vitro culture system that can be used to culture and expand a variety of neural and glial cell types simply by altering the material properties of the hydrogel. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1162-1171, 2010.
C1 [Lampe, Kyle J.; Mahoney, Melissa J.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Mooney, Rachael G.] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA.
   [Bjugstad, Kimberly B.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.
RP Mahoney, MJ (reprint author), Univ Colorado, Dept Chem & Biol Engn, 424 UCB, Boulder, CO 80309 USA.
EM melissa.mahoney@colorado.edu
OI Mooney, Rachael/0000-0002-9069-0206; Bjugstad,
   Kimberly/0000-0002-0473-5413
FU NIH [R01 NS052597-02]; U.S. Department of Education
FX Contract grant sponsor: NIH; contract grant number: R01 NS052597-02; The
   authors thank the U.S. Department of Education's Graduate Assistantships
   in Areas of National Need Program for fellowship to KJL. They also thank
   Dr. Linda Watkins for providing the qRT-PCR primer sequences and Kaisa
   Wallace-Moyer for assistance in macromer synthesis and purification.
CR BALER RE, 1982, T ASME, V104, P257
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002
   Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409
   BJUGSTAD KB, 2010, J BIOMED MAT RE 0601, DOI DOI 10.1002/JBM.A.32809
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   BUCKWALTER JA, 1983, COLLAGEN REL RES, V3, P489
   Burdick JA, 2004, J NEUROTRAUM, V21, P1311
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Clark JA, 1996, BURNS, V22, P443, DOI 10.1016/0305-4179(96)00038-1
   Clarkson ED, 1998, BRAIN RES, V806, P60, DOI 10.1016/S0006-8993(98)00717-3
   DEYST KA, 1995, DEV BRAIN RES, V88, P122, DOI 10.1016/0165-3806(95)00086-S
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hall VJ, 2007, SEMIN CELL DEV BIOL, V18, P859, DOI 10.1016/j.semcdb.2007.09.004
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   KUROIWA T, 2006, MEASUREMENT BRAIN TI
   Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560
   Lampe KJ, 2009, BIOTECHNOL BIOENG, V103, P1214, DOI 10.1002/bit.22352
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahoney MJ, 2007, J BIOMED MATER RES A, V81A, P269, DOI 10.1002/jbm.a.30970
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Mooney R, 2010, TISSUE ENG PT A, V16, P1607, DOI [10.1089/ten.tea.2009.0372, 10.1089/ten.TEA.2009.0372]
   Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165
   Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Noble M, 2004, DEV BIOL, V265, P33, DOI 10.1016/j.ydbio.2003.06.002
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X
   Reinoso RF, 1997, J PHARMACOL TOXICOL, V38, P87, DOI 10.1016/S1056-8719(97)00053-1
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Studer L, 1998, NAT NEUROSCI, V1, P290
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   YANG J, 1979, P NATL ACAD SCI USA, V76, P3401, DOI 10.1073/pnas.76.7.3401
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 46
TC 48
Z9 49
U1 3
U2 42
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1162
EP 1171
DI 10.1002/jbm.a.32787
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000018
PM 20694983
DA 2018-10-19
ER

PT J
AU Fukano, Y
   Usui, ML
   Underwood, RA
   Isenhath, S
   Marshall, AJ
   Hauch, KD
   Ratner, BD
   Olerud, JE
   Fleckman, P
AF Fukano, Y.
   Usui, M. L.
   Underwood, R. A.
   Isenhath, S.
   Marshall, A. J.
   Hauch, K. D.
   Ratner, B. D.
   Olerud, J. E.
   Fleckman, P.
TI Epidermal and dermal integration into sphere-templated porous
   poly(2-hydroxyethyl methacrylate) implants in mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE wound healing; biointegration; biomaterial; skin; percutaneous
ID DYSTROPHIC EPIDERMOLYSIS-BULLOSA; BLOOD-STREAM INFECTION; HUMAN WOUND
   REPAIR; VII COLLAGEN; PERCUTANEOUS DEVICES; ELECTRON MICROSCOPY;
   ANCHORING FIBRILS; PORE-SIZE; SKIN; INTERFACE
AB Percutaneous medical devices remain susceptible to infection and failure. We hypothesize that healing of the skin into the percutaneous device will provide a seal, preventing bacterial attachment, biofilm formation, and subsequent device failure. Porous poly(2-hydroxyethyl methacrylate) [poly(HEMA)] with sphere-templated pores (40 mu m) and interconnecting throats 116 mu m) were implanted in normal C57BL/6 mice for 7, 14, and 28 days. Poly(HEMA) was either untreated, keeping the surface nonadhesive for cells and proteins, or modified with carbonyldiimidazole (CDI) or CD reacted with laminin 332 to enhance adhesion. No clinical signs of infection were observed. Epidermal and dermal response within the poly(HEMA) pores was evaluated using light and transmission electron microscopy. Cells (keratinocytes, fibroblasts, endothelial cells, inflammatory cells) and basement membrane proteins (laminin 332, beta 4 integrin, type VII collagen) could be demonstrated within the poly(HEMA) pores of all implants. Blood vessels and dermal collagen bundles were evident in all of the 14- and 28-day implants. Fibrous capsule formation and permigration were not observed. Sphere-templated polymers with 40 mu m pores demonstrate an ability to recapitulate key elements of both the dermal and the epidermal layers of skin. Our morphological findings indicate that the implant model can be used to study the effects of biomaterial pore size, pore interconnect (throat) size, and surface treatments on cutaneous biointegration. Further, this model may be used for bacterial challenge studies. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1172-1186, 2010.
C1 [Fukano, Y.; Usui, M. L.; Underwood, R. A.; Isenhath, S.; Olerud, J. E.; Fleckman, P.] Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA.
   [Marshall, A. J.; Hauch, K. D.; Ratner, B. D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Marshall, A. J.; Hauch, K. D.; Ratner, B. D.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Usui, ML (reprint author), Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA.
EM usui@u.washington.edu
FU NSF [EEC 9529161]; NIH [EB 004422, DK 59221]; George F. Odland Endowed
   Research Fund; Marvin and Judy Young Research Fund
FX Contract grant sponsor: NSF; contract grant number: EEC 9529161;
   Contract grant sponsor: NIH; contract grant numbers: EB 004422, DK
   59221; Contract grant sponsor: George F. Odland Endowed Research Fund;
   Contract grant sponsor: Marvin and Judy Young Research Fund
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ASHMAN A, 1977, J PROSTHET DENT, V37, P657, DOI 10.1016/0022-3913(77)90216-5
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Bryant R, 1987, J Enterostomal Ther, V14, P262
   BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129
   CARTER BZ, 1991, LAB INVEST, V65, P610
   Chin CD, 2008, BIOMED MICRODEVICES, V10, P459, DOI 10.1007/s10544-007-9155-2
   Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1362, DOI 10.1086/340105
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Fleckman P, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034006
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Gerritsen M., 2000, Journal of Biomedical Materials Research, V52, P135, DOI 10.1002/1097-4636(200010)52:1<135::AID-JBM17>3.0.CO;2-I
   Goto M, 2006, J INVEST DERMATOL, V126, P766, DOI 10.1038/sj.jid.5700117
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   ISHIKO A, 1993, J CLIN INVEST, V91, P1608, DOI 10.1172/JCI116368
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   KUNZKER JF, 1995, CHEM IND, V16, P56
   LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409
   Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   MARSHALL AJ, 2004, POLYM PREPRINTS, V45, P100
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6
   Mermel LA, 2000, ANN INTERN MED, V133, P395
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1
   ODLAND G, 1968, J CELL BIOL, V39, P135, DOI 10.1083/jcb.39.1.135
   PEAR R, 2007, NY TIMES        0818
   PETTY HR, 1981, J CELL BIOL, V89, P223, DOI 10.1083/jcb.89.2.223
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598
   Ratner BD, 2008, US Appl, Patent No. 20080075752
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754
   ROSS R, 1968, J CELL BIOL, V39, P152, DOI 10.1083/jcb.39.1.152
   Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511
   Sclafani AP, 1997, PLAST RECONSTR SURG, V99, P41, DOI 10.1097/00006534-199701000-00007
   Shin Y, 1997, ARTIF ORGANS, V21, P995
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sonnenberg A, 1999, J INVEST DERMATOL, V112, P830, DOI 10.1046/j.1523-1747.1999.00576.x
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   Sullivan SR, 2004, PLAST RECONSTR SURG, V113, P953, DOI 10.1097/01.PRS.0000105044.03230.F4
   Susin C, 2008, J CLIN PERIODONTOL, V35, P270, DOI 10.1111/j.1600-051X.2007.01196.x
   Tagusari O, 1998, ARTIF ORGANS, V22, P481, DOI 10.1046/j.1525-1594.1998.06152.x
   Takeda H, 2005, EXP DERMATOL, V14, P289, DOI 10.1111/j.0906-6705.2005.00316.x
   TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Underwood RA, 2009, J HISTOCHEM CYTOCHEM, V57, P123, DOI 10.1369/jhc.2008.952176
   VANMULLEM PJ, 1990, BIOMATERIALS, V11, P299, DOI 10.1016/0142-9612(90)90105-Y
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   Woodley DT, 2003, J INVEST DERMATOL, V121, P1021, DOI 10.1046/j.1523-1747.2003.12571.x
   Yannas IV, 2004, CHEMBIOCHEM, V5, P26, DOI 10.1002/cbic.200300682
NR 65
TC 45
Z9 45
U1 0
U2 38
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1172
EP 1186
DI 10.1002/jbm.a.32798
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000019
PM 20694984
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Blit, PH
   Shen, YH
   Ernsting, MJ
   Woodhouse, KA
   Santerre, JP
AF Blit, Patrick H.
   Shen, Yi Hao
   Ernsting, Mark J.
   Woodhouse, Kimberly A.
   Santerre, J. Paul
TI Bioactivation of porous polyurethane scaffolds using fluorinated RGD
   surface modifiers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethanes; surface modification; surface-modifying additives; RGD
   peptide; porous scaffolds
ID POLYMER SCAFFOLDS; IN-VITRO; EXTRACELLULAR-MATRIX; ADHESION PEPTIDES;
   CELL ATTACHMENT; MIGRATION; PROLIFERATION; MICROSCOPY; ENHANCE;
   DIFFERENTIATION
AB Biomaterial scaffolds for tissue engineering require appropriate cell adhesion, proliferation, and infiltration into their three-dimensional 130) porous structures. Surface modification techniques have the potential to enhance cell infiltration into synthetic scaffolds while retaining bulk material properties intact. The objective of this work was to assess the potential of achieving a uniform surface modification in 3D porous constructs through the blending of surface-modifying additives known as bioactive fluorinated surface modifiers (BFSMs) with a base polyurethane material. By coupling RGD peptides to the fluorinated surface modifiers to form RGD-BFSMs, the BFSMs can act as a vehicle for the delivery of RGD moieties to the surface without direct covalent attachment to the polymer substrate. Fluorescent RGD-BFSMs were shown to migrate to the polymer-air interfaces within the porous scaffolds by two-photon confocal microscopy. A-10 rat aortic smooth muscle cells were cultured for 4 weeks on nonmodified and RGD-BFSM-modified porous scaffolds, and cell adhesion, proliferation, and viability were quantified at different depths. RGD-BFSM-modified scaffolds showed significantly greater cell numbers within deeper regions of the scaffolds, and this difference became more pronounced over time. This study demonstrates an effective approach to promote cell adhesion and infiltration within thick (similar to 0.5 cm) porous synthetic scaffolds by providing a uniform distribution of adhesive peptide throughout the scaffolds without the use of covalent surface reaction chemistry. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 1226-1235, 2010.
C1 [Blit, Patrick H.; Shen, Yi Hao; Ernsting, Mark J.; Woodhouse, Kimberly A.; Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Blit, Patrick H.; Ernsting, Mark J.; Woodhouse, Kimberly A.; Santerre, J. Paul] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Woodhouse, Kimberly A.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   [Santerre, J. Paul] Univ Toronto, Fac Dent, Toronto, ON, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
EM paul.santerre@utoronto.ca
FU Natural Sciences and Engineering Research Council (NSERC); Interface
   Biologics
FX Contract grant sponsors: Natural Sciences and Engineering Research
   Council (NSERC) and Interface Biologics
CR AI-Munajjed AA, 2009, J MECH BEHAV BIOMED, V2, P138, DOI 10.1016/j.jmbbm.2008.05.001
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   Cheng G, 2006, BIOPHYS J, V90, P713, DOI 10.1529/biophysj.105.063701
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Diaspro A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-36
   Ernsting MJ, 2007, J BIOMED MATER RES A, V83A, P759, DOI 10.1002/jbm.a.31370
   Ernsting MJ, 2005, BIOMATERIALS, V26, P6536, DOI 10.1016/j.biomaterials.2005.04.047
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Grenier S, 2009, J BIOMED MATER RES A, V89A, P293, DOI 10.1002/jbm.a.31972
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho MH, 2006, MACROMOL BIOSCI, V6, P90, DOI 10.1002/mabi.200500130
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsu YY, 1997, J BIOMED MATER RES, V35, P107, DOI 10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   Lan PX, 2009, J MATER SCI-MATER M, V20, P271, DOI 10.1007/s10856-008-3567-2
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   McGlohorn JB, 2004, TISSUE ENG, V10, P505, DOI 10.1089/107632704323061861
   Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Park IS, 2009, J BIOMAT SCI-POLYM E, V20, P1645, DOI 10.1163/156856208X386237
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   ROGERS KA, 2009, TISSUE ENG PART A, V15, P3889
   Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041
   Safinia L, 2008, J BIOMED MATER RES A, V87A, P632, DOI 10.1002/jbm.a.31731
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WARD RS, 1989, IEEE ENG MED BIOL, V8, P22
   WILLIAMS RM, 1994, FASEB J, V8, P804
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang J, 2005, TISSUE ENG, V11, P1876, DOI 10.1089/ten.2005.11.1876
   Yang J, 2003, J BIOMED MATER RES A, V67A, P1139, DOI 10.1002/jbm.a.10034
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
NR 51
TC 12
Z9 13
U1 1
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2010
VL 94A
IS 4
BP 1226
EP 1235
DI 10.1002/jbm.a.32804
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637ZW
UT WOS:000280860000024
PM 20694989
DA 2018-10-19
ER

PT J
AU Norton, LW
   Park, J
   Babensee, JE
AF Norton, Lori W.
   Park, Jaehyung
   Babensee, Julia E.
TI Biomaterial adjuvant effect is attenuated by anti-inflammatory drug
   delivery or material selection
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Biomaterial; Adjuvant; Dendritic cell; Dexamethasone
AB Biomaterials have been shown to differentially support dendritic cell (DC) maturation, a prerequisite for an adjuvant effect. Treatment of DCs with poly(D,L-lactic-co-glycolic acid) (PLGA) films resulted in DC maturation but agarose films did not In these studies, the biomaterial adjuvant effect was attenuated by material selection (PLGA or agarose scaffolds) or local delivery of an anti-inflammatory/immunosuppressive glucocorticoid, dexamethasone (DX), from PLGA scaffolds. Porous scaffolds (SCs) of PLGA or agarose were produced to deliver equivalent amounts of model antigen, ovalbumin (OVA). Alternatively, PLGA SCs with incorporated OVA were produced with or without DX. These SCs were implanted individually, subcutaneously, and dorsally in C57BL/6 mice. Blood was collected from mice at specific times over a 12-week duration for measurement of antibody production against OVA. Scaffolds were explanted at 12 weeks for histological examination of foreign body response. Scaffolds of PLGA, but not of agarose, were found to elicit higher antibody production against co-delivered OVA, than negative controls. Short-term delivery of DX from PLGA SCs delivering OVA temporarily delayed onset of anti-OVA antibody production. More sustained release of DX at an effective dose and with an appropriate time course is expected to extend the effect of DX on the biomaterial adjuvant effect The immunomodulatory ability of biomaterials to affect the immune response to co-delivered antigen is demonstrated wherein this immunomodulatory ability correlates with the observed in vitro differential effects of biomaterials on DC maturation. (c) 2010 Elsevier B.V. All rights reserved.
C1 [Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU NSF [BES-0239152]; NIH [RO1EB004633-02]; UNCF-Merck
FX The authors would like to acknowledge funding from NSF CAREER grant
   (BES-0239152), NIH RO1EB004633-02, and UNCF-Merck Postdoctoral
   Fellowship. The authors acknowledge the assistance of Sha'Aqua Asberry
   for histological services in the Parker H. Petit Institute for
   Bioengineering and Bioscience (IBB) Sample Analysis Lab and of Todd
   Rogers in histological analysis.
CR Abe M, 2003, TRANSPL IMMUNOL, V11, P357, DOI 10.1016/S0966-3274(03)00050-9
   Araki M, 1999, J INVEST DERM SYMP P, V4, P164, DOI 10.1038/sj.jidsp.5640202
   Arca HC, 2009, EXPERT REV VACCINES, V8, P937, DOI 10.1586/ERV.09.47
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Babensee JE, 2002, ANN NY ACAD SCI, V961, P360, DOI 10.1111/j.1749-6632.2002.tb03124.x
   Beer H D, 2000, Vitam Horm, V59, P217, DOI 10.1016/S0083-6729(00)59008-6
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013
   Cumberbatch M, 1999, IMMUNOPHARMACOLOGY, V41, P235, DOI 10.1016/S0162-3109(99)00037-5
   Duperrier K, 2005, MOL IMMUNOL, V42, P1531, DOI 10.1016/j.molimm.2005.01.006
   EHRLICH HP, 1968, ANN SURG, V167, P324, DOI 10.1097/00000658-196803000-00004
   EHRLICH HP, 1973, ANN SURG, V177, P222, DOI 10.1097/00000658-197302000-00017
   Emmer PM, 2006, TRANSPLANTATION, V81, P1451, DOI 10.1097/01.tp.0000208801.51222.bd
   Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y
   Holt PG, 1997, IMMUNOLOGY, V91, P145, DOI 10.1046/j.1365-2567.1997.00321.x
   Jones CA, 2001, J ALLERGY CLIN IMMUN, V108, P235, DOI 10.1067/mai.2001.117178
   Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5
   Kanazawa T, 2009, INT J PHARMACEUT, V379, P187, DOI 10.1016/j.ijpharm.2009.06.015
   Kang ML, 2009, BIOTECHNOL ADV, V27, P857, DOI 10.1016/j.biotechadv.2009.06.007
   Kitajima T, 1996, J CLIN INVEST, V98, P142, DOI 10.1172/JCI118759
   Lee J, 2006, J MATER CHEM, V16, P3558, DOI 10.1039/b605797g
   Liu YF, 2005, CHEM MATER, V17, P4918, DOI 10.1021/cm048050g
   Loudovaris T, 1996, TRANSPLANTATION, V61, P1678, DOI 10.1097/00007890-199606270-00003
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Matasic R, 1999, J LEUKOCYTE BIOL, V66, P909
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4
   MOSER M, 1995, EUR J IMMUNOL, V25, P2818, DOI 10.1002/eji.1830251016
   Munn DH, 2002, ANN NY ACAD SCI, V961, P343, DOI 10.1111/j.1749-6632.2002.tb03119.x
   Norton LW, 2005, BIOMATERIALS, V26, P3285, DOI 10.1016/j.biomaterials.2004.07.069
   Oishi Y, 2002, BRIT J DERMATOL, V147, P859, DOI 10.1046/j.1365-2133.2002.04949.x
   Padera RF, 1996, BIOMATERIALS, V17, P277, DOI 10.1016/0142-9612(96)85565-7
   Perretti M, 2000, MICROCIRCULATION, V7, P147, DOI 10.1038/sj.mn.7300108
   Piemonti L, 1999, J IMMUNOL, V162, P6473
   Riccardi C, 2002, PHARMACOL RES, V45, P361, DOI 10.1006/phrs.2002.0969
   RIZZA RA, 1982, J CLIN ENDOCR METAB, V54, P131, DOI 10.1210/jcem-54-1-131
   Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3
   Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Singh R, 2008, J PHARM SCI-US, V97, P2497, DOI 10.1002/jps.21183
   Slutter B, 2010, J CONTROL RELEASE, V143, P207, DOI 10.1016/j.jconrel.2010.01.007
   Slutter B, 2009, J CONTROL RELEASE, V138, P113, DOI 10.1016/j.jconrel.2009.05.011
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Thomas C, 2009, INT J PHARMACEUT, V379, P41, DOI 10.1016/j.ijpharm.2009.06.006
   van Vliet SJ, 2006, IMMUNOBIOLOGY, V211, P577, DOI 10.1016/j.imbio.2006.05.022
   Wicke C, 2000, ARCH SURG-CHICAGO, V135, P1265, DOI 10.1001/archsurg.135.11.1265
   Xia CQ, 2005, SCAND J IMMUNOL, V62, P45, DOI 10.1111/j.1365-3083.2005.01640.x
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
NR 54
TC 25
Z9 26
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 15
PY 2010
VL 146
IS 3
BP 341
EP 348
DI 10.1016/j.jconrel.2010.05.032
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 657FH
UT WOS:000282398100010
PM 20595029
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Xu, JJ
   Peng, R
   Ran, Q
   Xian, YZ
   Tian, YA
   Jin, LT
AF Xu, JingJing
   Peng, Ru
   Ran, Qin
   Xian, Yuezhong
   Tian, Yuan
   Jin, Litong
TI A highly soluble poly(3,4-ethylenedioxythiophene)-poly(styrene sulfonic
   acid)/Au nanocomposite for horseradish peroxidase immobilization and
   biosensing
SO TALANTA
LA English
DT Article
DE PEDOT-PSS conductive polymer; Au nanopartiles; Horseradish peroxidase;
   Direct electrochemistry; Hydrogen peroxide; Biosensor
ID DIRECT ELECTRON-TRANSFER; HYDROGEN-PEROXIDE; GOLD NANOPARTICLES; DIRECT
   ELECTROCHEMISTRY; CELLS; PEDOT; FILMS; BIOCOMPATIBILITY; PERFORMANCE;
   CATALYSIS
AB A highly soluble poly(3,4-ethylenedioxythiophene)-poly(styrene sulfonic acid)/Au (PEDOT-PSS/Au) nanocomposite was prepared via one-step chemical synthesis and the matrix was characterized by UV-vis spectroscopy (UV-vis), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscope (SEM) and transmission electron microscope (TEM). Due to the excellent aqueous compatibility and biocompatibility, the PEDOT/PSS-Au nanocomposite can be used as biomaterial for enzymes immobilization. In this system, redox enzyme, horseradish peroxidase (HRP) was integrated with PEDOT/PSS-Au nanocomposite and the direct electron transfer of HRP was observed. Moreover, we find that the HRP/PEDOT-PSS/Au modified electrode shows excellent electrocatalytic ability for H2O2 and the formal Michaelis-Menten constant (K-m(app)) was 0.78 mmol/L The response currents have good linear relation with the concentrations of H2O2 with a linear range from 2.0 x 10(-7) to 3.8 x 10(-4) mol/L. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Xu, JingJing; Peng, Ru; Ran, Qin; Xian, Yuezhong; Tian, Yuan; Jin, Litong] E China Normal Univ, Dept Chem, Shanghai 200062, Peoples R China.
RP Xian, YZ (reprint author), E China Normal Univ, Dept Chem, 3663 Zhongshan N Rd, Shanghai 200062, Peoples R China.
EM yzxian@chem.ecnu.edu.cn
RI Xian, Yuezhong/H-2445-2015
OI Xian, Yuezhong/0000-0001-9535-3658
FU National Natural Science Foundation of China [20875031]; Shanghai
   Rising-Star Program [09QH1400800]; New Century Excellent Talents in
   University [NCET-09-0357]; Shanghai Municipal Education Commission
   [08ZZ25]
FX This work was supported by the National Natural Science Foundation of
   China (No. 20875031), Shanghai Rising-Star Program (No. 09QH1400800),
   New Century Excellent Talents in University (No. NCET-09-0357) and
   Shanghai Municipal Education Commission (No. 08ZZ25).
CR Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Asplund M, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045009
   Bayer AG, 1988, European Patent, Patent No. 339340
   Calvente JJ, 2003, J PHYS CHEM B, V107, P6629, DOI 10.1021/jp030011p
   Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420
   Chen WC, 2004, MACROMOLECULES, V37, P5959, DOI 10.1021/ma049557f
   Chen X, 2008, TALANTA, V77, P37, DOI 10.1016/j.talanta.2008.03.041
   Cho SI, 2005, CHEM MATER, V17, P4564, DOI 10.1021/cm050729c
   Cutler CA, 2005, MACROMOLECULES, V38, P3068, DOI 10.1021/ma047396+
   Dequaire M, 2002, J AM CHEM SOC, V124, P240, DOI 10.1021/ja0170706
   Ferri T, 1998, BIOELECTROCH BIOENER, V45, P221, DOI 10.1016/S0302-4598(98)00102-0
   Groenendaal BL, 2000, ADV MATER, V12, P481, DOI 10.1002/(SICI)1521-4095(200004)12:7<481::AID-ADMA481>3.0.CO;2-C
   HARE JW, 1976, J AM CHEM SOC, V98, P3205, DOI 10.1021/ja00427a025
   Hernandez-Ruiz J, 2001, BIOCHEM J, V354, P107, DOI 10.1042/0264-6021:3540107
   Isaksson J, 2007, NAT MATER, V6, P673, DOI 10.1038/nmat1963
   Jonas F, 1997, SYNTHETIC MET, V85, P1397, DOI 10.1016/S0379-6779(97)80290-1
   Kang XH, 2009, TALANTA, V78, P120, DOI 10.1016/j.talanta.2008.10.063
   Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   Kumar SS, 2007, LANGMUIR, V23, P3401, DOI 10.1021/la063150h
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Lee JS, 2007, ANGEW CHEM INT EDIT, V46, P4093, DOI 10.1002/anie.200700269
   Li DF, 2008, J PHYS CHEM B, V112, P16290, DOI 10.1021/jp8041704
   Lim JA, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3273862
   Liu SQ, 2002, ANAL BIOCHEM, V307, P110, DOI 10.1016/S0003-2697(02)00014-3
   Lu XB, 2006, ELECTROCHEM COMMUN, V8, P874, DOI 10.1016/j.elecom.2006.03.026
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Manesh KM, 2008, TALANTA, V75, P1307, DOI 10.1016/j.talanta.2008.01.038
   Mathiyarasu J, 2008, MATER LETT, V62, P571, DOI 10.1016/j.matlet.2007.06.004
   Menon M, 1997, PHYS REV LETT, V79, P4453, DOI 10.1103/PhysRevLett.79.4453
   Nath N, 2004, ANAL CHEM, V76, P5370, DOI 10.1021/ac049741z
   Onoda M, 2009, THIN SOLID FILMS, V518, P743, DOI 10.1016/j.tsf.2009.07.126
   Ravirajan P, 2005, ADV FUNCT MATER, V15, P609, DOI 10.1002/adfm.200400165
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Roucoux A, 2002, CHEM REV, V102, P3757, DOI 10.1021/cr010350j
   Shipway AN, 2000, ADV MATER, V12, P993, DOI 10.1002/1521-4095(200006)12:13<993::AID-ADMA993>3.0.CO;2-3
   Tamburri E, 2009, SYNTHETIC MET, V159, P406, DOI 10.1016/j.synthmet.2008.10.014
   Xiao Y, 2000, ANAL BIOCHEM, V278, P22
   Zhang BH, 2009, J PHYS CHEM C, V113, P7898, DOI 10.1021/jp810824m
   Zong SZ, 2006, LANGMUIR, V22, P8915, DOI 10.1021/la060930h
NR 40
TC 20
Z9 23
U1 0
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-9140
J9 TALANTA
JI Talanta
PD SEP 15
PY 2010
VL 82
IS 4
BP 1511
EP 1515
DI 10.1016/j.talanta.2010.07.033
PG 5
WC Chemistry, Analytical
SC Chemistry
GA 658HG
UT WOS:000282480500064
PM 20801365
DA 2018-10-19
ER

PT J
AU Lin, YD
   Yeh, ML
   Yang, YJ
   Tsai, DC
   Chu, TY
   Shih, YY
   Chang, MY
   Liu, YW
   Tang, ACL
   Chen, TY
   Luo, CY
   Chang, KC
   Chen, JH
   Wu, HL
   Hung, TK
   Hsieh, PCH
AF Lin, Yi-Dong
   Yeh, Ming-Long
   Yang, Yu-Jen
   Tsai, Da-Ching
   Chu, Ting-Yu
   Shih, Ya-Yun
   Chang, Min-Yao
   Liu, Yen-Wen
   Tang, Alan C. L.
   Chen, Tsai-Yun
   Luo, Chwan-Yau
   Chang, Kung-Chao
   Chen, Jyh-Hong
   Wu, Hua-Lin
   Hung, Tin-Kan
   Hsieh, Patrick C. H.
TI Intramyocardial Peptide Nanofiber Injection Improves Postinfarction
   Ventricular Remodeling and Efficacy of Bone Marrow Cell Therapy in Pigs
SO CIRCULATION
LA English
DT Article
DE biomaterials; bone marrow mononuclear cells; cardiac tissue engineering;
   myocardial infarction
ID HEMATOPOIETIC STEM-CELLS; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS;
   CARDIAC-FUNCTION; DELIVERY; REPAIR
AB Background-Growing evidence suggests that intramyocardial biomaterial injection improves cardiac functions after myocardial infarction (MI) in rodents. Cell therapy is another promising approach to treat MI, although poor retention of transplanted cells is a major challenge. In this study, we hypothesized that intramyocardial injection of self-assembling peptide nanofibers (NFs) thickens the infarcted myocardium and increases transplanted autologous bone marrow mononuclear cell (MNC) retention to attenuate cardiac remodeling and dysfunction in a pig MI model.
   Methods and Results-A total of 40 mature minipigs were divided into 5 groups: sham, MI+ normal saline, MI+NFs, MI+MNCs, and MI+MNCs/NFs. MI was induced by coronary occlusion followed by intramyocardial injection of 2 mL normal saline or 1% NFs with or without 1 X 10(8) isolated autologous MNCs. NF injection significantly improved diastolic function and reduced ventricular remodeling 28 days after treatment. Injection of MNCs alone ameliorated systolic function only, whereas injection of MNCs with NFs significantly improved both systolic and diastolic functions as indicated by +dP/dt and -dP/dt (1214.5 +/- 91.9 and -1109.7 +/- 91.2 mm Hg/s in MI+NS, 1693.7 +/- 84.7 and -1809.6 +/- 264.3 mm Hg/s in MI+MNCs/NFs, respectively), increased transplanted cell retention (29.3 +/- 4.5 cells/mm(2) in MI+MNCs and 229.4 +/- 41.4 cells/mm(2) in MI+ MNCs/NFs) and promoted capillary density in the pen-infarct area.
   Conclusions-We demonstrated that NF injection alone prevents ventricular remodeling, whereas cell implantation with NFs improves cell retention and cardiac functions after MI in pigs. This unprecedented combined treatment in a large animal model has therapeutic effects, which can be translated to clinical applications in the foreseeable future. (Circulation. 2010; 122[suppl 1]:S132-S141.)
C1 [Lin, Yi-Dong; Tsai, Da-Ching; Chu, Ting-Yu; Shih, Ya-Yun; Chang, Min-Yao; Liu, Yen-Wen; Tang, Alan C. L.; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan 70428, Taiwan.
   [Lin, Yi-Dong; Tsai, Da-Ching; Chu, Ting-Yu; Shih, Ya-Yun; Chang, Min-Yao; Liu, Yen-Wen; Tang, Alan C. L.; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Res Ctr Clin Med, Tainan 70428, Taiwan.
   [Lin, Yi-Dong; Yeh, Ming-Long; Chang, Min-Yao; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Biomed Engn, Tainan 70428, Taiwan.
   [Yang, Yu-Jen; Luo, Chwan-Yau; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Dept Surg, Tainan 70428, Taiwan.
   [Liu, Yen-Wen; Chen, Tsai-Yun; Chen, Jyh-Hong] Natl Cheng Kung Univ & Hosp, Dept Med, Tainan 70428, Taiwan.
   [Chang, Kung-Chao] Natl Cheng Kung Univ & Hosp, Dept Pathol, Tainan 70428, Taiwan.
   [Wu, Hua-Lin] Natl Cheng Kung Univ & Hosp, Dept Biochem & Mol Biol, Tainan 70428, Taiwan.
   [Hsieh, Patrick C. H.] Acad Sin, Inst Biomed Sci, Taipei, Taiwan.
   [Hung, Tin-Kan] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.
RP Hsieh, PCH (reprint author), Natl Cheng Kung Univ & Hosp, Inst Clin Med, 35 Xiao Dong Rd,Room 7063, Tainan 70428, Taiwan.
EM phsieh@mail.ncku.edu.tw
RI Hsieh, Patrick Ching-Ho/H-5108-2015
OI Hsieh, Patrick C.H./0000-0002-8910-3596
FU National Science Council [97IR082, 96-2314-B-006-021,
   97-2314-B-006-015]; National Health Research Institutes [EX97-9722SI];
   National Cheng Kung University [981006]
FX This work was supported by the National Science Council (97IR082,
   96-2314-B-006-021, 97-2314-B-006-015), the National Health Research
   Institutes (EX97-9722SI), and the National Cheng Kung University
   Integrated Landmark Project (981006).
CR Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Karen L. C., 2006, J AM COLL CARDIOL, V48, P907
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Park DW, 2009, CIRCULATION, V120, P1987, DOI 10.1161/CIRCULATIONAHA.109.876763
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
NR 25
TC 85
Z9 89
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 14
PY 2010
VL 122
IS 11
SU 1
BP S132
EP S141
DI 10.1161/CIRCULATIONAHA.110.939512
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 655ZI
UT WOS:000282294800020
PM 20837904
OA Bronze
DA 2018-10-19
ER

PT J
AU Wischke, C
   Neffe, AT
   Steuer, S
   Lendlein, A
AF Wischke, Christian
   Neffe, Axel T.
   Steuer, Susi
   Lendlein, Andreas
TI Comparing techniques for drug loading of shape-memory polymer networks -
   effect on their functionalities
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Shape-memory polymer; Controlled drug release; Biomaterial; Degradable
   polymers; Polymer network
ID BIOMEDICAL APPLICATIONS; HYDROLYTIC DEGRADATION; MULTIBLOCK COPOLYMERS;
   MECHANICAL-PROPERTIES; RELEASE; NANOCOMPOSITES; MICROSPHERES;
   CAPABILITY; DELIVERY; SYSTEMS
AB A family of oligo[(c-caprolactone)-co-glycolide]dimethacrylate (oCG-DMA) derived networks of different glycolide contents as well as precursor molecular weights has been synthesized by crosslinking oCG-DMA, providing matrices of different hydrophilicity, network density, and morphology at body temperature. Such networks were loaded with a hydrophilic model drug, ethacridine lactate, either before crosslinking or afterwards by swelling in drug solution. Disadvantageous alterations of the shape-memory functionality and degradation characteristics were observed only in few loaded materials. Loading by swelling generally resulted in low payloads, which slightly increased for more hydrophilic polymer networks, and a substantial burst and fast subsequent release for all investigated materials. Loading before crosslinking gave almost no burst and higher subsequent release rates over longer periods of time. Overall, depending on the needs of a specific application, a material from this polymer family with the desired mechanical properties, shape-memory functionality, and degradation pattern can be selected and combined with drugs when considering that (i) loading by swelling is best suited for applications that require high initial doses and (ii) loading before crosslinking allows easy variation of payloads and low burst release for therapeutics that are non-sensitive to chemical alterations during crosslinking. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wischke, Christian; Neffe, Axel T.; Lendlein, Andreas] GKSS Res Ctr Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Wischke, Christian; Lendlein, Andreas] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
   [Steuer, Susi] Intervet Innovat GmbH, D-55270 Schwabenheim, Germany.
RP Lendlein, A (reprint author), GKSS Res Ctr Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013; Neffe, Axel/H-6997-2013; Wischke,
   Christian/K-9651-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990;
   Wischke, Christian/0000-0001-5531-9033
FU Bundesministerium fur Bildung und Forschung (BMBF) [0311867]
FX The authors thank the Bundesministerium fur Bildung und Forschung (BMBF)
   for financial support through BioFuture Award 0311867.
CR Baer G. M., 2007, BIOMED ENG ONLINE, V6, P8
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2010, ADV POLYM SCI, V226, P1, DOI 10.1007/12_2009_26
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Corrigan OI, 2009, EUR J PHARM SCI, V37, P477, DOI 10.1016/j.ejps.2009.04.004
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Gall K, 2002, ACTA MATER, V50, P5115, DOI 10.1016/S1359-6454(02)00368-3
   Grablowitz H, 2007, J MATER CHEM, V17, P4050, DOI 10.1039/b707104c
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Hill VL, 1998, J THERM ANAL CALORIM, V54, P673, DOI 10.1023/A:1010167214806
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   LANGER R, 1985, ANN NY ACAD SCI, V446, P1, DOI 10.1111/j.1749-6632.1985.tb18386.x
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 1998, MACROMOL CHEM PHYSIC, V199, P2785, DOI 10.1002/macp.1998.021991222
   Lendlein A, 2001, MACROMOL CHEM PHYSIC, V202, P2702, DOI 10.1002/1521-3935(20010901)202:13<2702::AID-MACP2702>3.0.CO;2-I
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Manias E, 2007, NAT MATER, V6, P9, DOI 10.1038/nmat1812
   Nagahama K, 2009, BIOMACROMOLECULES, V10, P1789, DOI 10.1021/bm9002078
   Neffe AT, 2009, MATER RES SOC SYMP P, V1190, P105
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Neffe AT, 2010, MACROMOL CHEM PHYS, V211, P182, DOI 10.1002/macp.200900441
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Sharp AA, 2006, J NEURAL ENG, V3, pL23, DOI 10.1088/1741-2560/3/4/L02
   WADA R, 1991, PHARMACEUT RES, V8, P1292, DOI 10.1023/A:1015860030772
   Wischke C, 2010, ADV POLYM SCI, V226, P177, DOI 10.1007/12_2009_29
   Wischke C, 2010, PHARM RES-DORDR, V27, P527, DOI 10.1007/s11095-010-0062-5
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
   Wykrzykowska JJ, 2009, EXPERT OPIN DRUG DEL, V6, P113, DOI [10.1517/17425240802668495 , 10.1517/17425240802668495]
NR 36
TC 22
Z9 23
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD SEP 11
PY 2010
VL 41
IS 1
BP 136
EP 147
DI 10.1016/j.ejps.2010.06.003
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 638EN
UT WOS:000280875700016
PM 20542110
DA 2018-10-19
ER

PT J
AU Spanninga, SA
   Martin, DC
   Chen, Z
AF Spanninga, Sarah A.
   Martin, David C.
   Chen, Zhan
TI X-ray Photoelectron Spectroscopy Study of Counterion Incorporation in
   Poly(3,4-ethylenedioxythiophene) (PEDOT) 2: Polyanion Effect,
   Toluenesulfonate, and Small Anions
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID POLYPYRROLE; POLYMERS; SERIES; FILMS; XPS
AB Poly(3,4-ethylenedioxythiophene) (PEDOT) is widely used in organic electronics and biomaterial coatings because of its outstanding electrical properties and chemical stability. In our previous research, X-ray photoelectron spectroscopy (XPS) was used to investigate the incorporation of counterions into PEDOT. In this research, XPS was applied to systematically investigate the chemical composition of electrochemically polymerized PEDOT films to determine counterion affinity. The counterions probed here included polyanions such as poly(sodium 4-styrenesulfonate) (PSSNa) and poly(acrylic acid) (PAA), and small anions including lithium perchlorate, lithium bromide, sodium nitrate, sodium thiosulfate, sodium chloride, sodium phosphate monohydrate, sodium phosphate dibasic hepthydrate, sodium acetate trihydrate, sodium p-toluenesulfonate (TosNa), calcium carbonate, and sodium carbonate. In addition to these counterions, an ion mixture, phosphate-buffered solution (PBS), was also examined. In counterions with ion mixtures containing PSSNa during PEDOT electrochemical polymerization, PSSNa was found to be the dominant counterion incorporated into PEDOT due to its polymeric nature over the monomeric-like version TosNa, though bromide anions were found to act as PEDOT counterions even in the presence of PSSNa (or PAA). The overall qualitative PEDOT counterion affinity for anions with one negative charge observed in the XPS spectra was the following: ClO(4)(-) and Br(-) over smaller contributions of Cl(-), Tos(-), and COO(-) (acetate), with no phosphate or NO(3)(-) contributions. As for the anions with two negative charges, S(2)O(3)(2-) dominated over both carbonate and phosphate anions. The trends found in counterion affinity did follow the general trend for anionic hydration suggested by the Hofmeister series. Systematic investigations on counterion incorporation into PEDOT can greatly improve the basic understanding of the chemical composition of various PEDOT films when different counterions or ion mixtures are used in the electrochemical polymerization process, aiding in the design of optimized PEDOT films with tailored properties.
C1 [Spanninga, Sarah A.; Martin, David C.; Chen, Zhan] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
   [Chen, Zhan] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
RP Chen, Z (reprint author), Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
EM zhanc@umich.edu
RI Martin, David/B-1838-2008; Chen, Zhan/G-8312-2016
OI Martin, David/0000-0003-1195-3838; Chen, Zhan/0000-0001-8687-8348
FU MURI; NSF
FX We thank Dr. Kai Sun and Dr. Haiping Sun at the University of Michigan
   Electron Microbeam Analysis Laboratory (EMAL). Funding was provided by
   the MURI: Bio-Integrated Structural and Neural Prosthetic Materials for
   Dr. David C. Martin and the NSF Career Award for Dr. Zhan Chen.
CR Barisci JN, 1998, ANAL CHIM ACTA, V371, P39, DOI 10.1016/S0003-2670(98)00277-3
   Beamson G., 1992, HIGH RESOLUTION XPS
   BRIGGS D, 1993, ANAL CHEM, V65, P1517, DOI 10.1021/ac00059a006
   Briggs D., 1998, SURFACE ANAL POLYM X
   Campbell TE, 1999, ELECTROANAL, V11, P215, DOI 10.1002/(SICI)1521-4109(199904)11:4<215::AID-ELAN215>3.0.CO;2-#
   DIETRICH D, 1994, J ELECTROANAL CHEM, V369, P87
   GELIUS U, 1971, PHYS SCRIPTA, V3, P237, DOI 10.1088/0031-8949/3/5/008
   Gooding JJ, 2004, BIOSENS BIOELECTRON, V20, P260, DOI 10.1016/j.bios.2004.01.010
   Greczynski G, 1999, THIN SOLID FILMS, V354, P129, DOI 10.1016/S0040-6090(99)00422-8
   Greczynski G, 2001, J ELECTRON SPECTROSC, V121, P1, DOI 10.1016/S0368-2048(01)00323-1
   Groenendaal L., 2000, J R ADV MAT, V12, P481
   Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI DOI 10.1007/BF01918191
   Jonsson SKM, 2003, J PHYS CHEM B, V107, P10793, DOI 10.1021/jp034249p
   KANG ET, 1991, PHYS REV B, V44, P10461, DOI 10.1103/PhysRevB.44.10461
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Kiya Y, 2006, LANGMUIR, V22, P10554, DOI 10.1021/la061213q
   Kunz W, 2004, CURR OPIN COLLOID IN, V9, pVII, DOI 10.1016/j.cocis.2004.06.001
   Lock JP, 2006, MACROMOLECULES, V39, P5326, DOI 10.1021/ma060113o
   Marciniak S, 2004, SYNTHETIC MET, V141, P67, DOI 10.1016/j.synthemet.2003.08.017
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Na SI, 2009, J MATER CHEM, V19, P9045, DOI 10.1039/b915756e
   PEI QB, 1994, POLYMER, V35, P1347, DOI 10.1016/0032-3861(94)90332-8
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   SIEGBAHN K, 1967, ESCA ATOMIC MOL SOLI
   Spanninga SA, 2009, J PHYS CHEM C, V113, P5585, DOI 10.1021/jp811282f
   WINTER I, 1995, CHEM PHYS, V194, P207, DOI 10.1016/0301-0104(95)00026-K
   Yang JY, 2007, J BIOMAT SCI-POLYM E, V18, P1075, DOI 10.1163/156856207781494359
   Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020
   Zotti G, 2003, MACROMOLECULES, V36, P3337, DOI 10.1021/ma021715k
NR 30
TC 33
Z9 34
U1 3
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD SEP 9
PY 2010
VL 114
IS 35
BP 14992
EP 14997
DI 10.1021/jp104591d
PG 6
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 684AT
UT WOS:000284520100047
DA 2018-10-19
ER

PT J
AU Wischke, C
   Neffe, AT
   Steuer, S
   Engelhardt, E
   Lendlein, A
AF Wischke, Christian
   Neffe, Axel T.
   Steuer, Susi
   Engelhardt, Eva
   Lendlein, Andreas
TI AB-polymer Networks with Cooligoester and Poly(n-butyl acrylate)
   Segments as a Multifunctional Matrix for Controlled Drug Release
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biodegradable; biomaterials; copolymerization; drug delivery systems;
   networks
ID SHAPE-MEMORY POLYMERS; MULTIBLOCK COPOLYMERS; TISSUE INTEGRATION;
   DEGRADATION RATE; ANIMAL-MODEL; POLY(EPSILON-CAPROLACTONE);
   IMPLANTATION; BIOMATERIAL; MICE
AB Semi-crystalline AB-copolymer networks from oligo[(epsilon-caprolactone)-co-glycolide]dimethacrylates and n-butylacrylate have recently been shown to exhibit a shape-memory functionality, which may be used for self-deploying and anchoring of implants. In this study, a family of such materials differing in their molar glycolide contents chi(G) was investigated to determine structure property functional relationships of unloaded and drug loaded specimens. Drug loading and release were evaluated, as well as their degradation behavior in vitro and in vivo. Higher chi(G) resulted in higher loading levels by swelling and a faster release of ethacridine lactate, lower melting temperature of polymer crystallites, and a decrease in shape fixity ratio of the programmed temporary shape. For unloaded networks, the material behavior in vivo was independent of the mechanical load associated with different implantation sites and agreed well with data from in vitro degradation studies. Thus, AB networks could be used as novel matrices for biofunctional implants, e.g., for urogenital applications, which can self-anchor in vivo and provide mechanical support, release drugs, and finally degrade in the body to excretable fragments.
C1 [Wischke, Christian; Neffe, Axel T.; Lendlein, Andreas] Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, GKSS Res Ctr, D-14513 Teltow, Germany.
   [Wischke, Christian; Lendlein, Andreas] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
   [Engelhardt, Eva] Univ Ulm, Cent Inst Biomed Engn, Dept Biomat, Ulm, Germany.
RP Lendlein, A (reprint author), Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, GKSS Res Ctr, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI Neffe, Axel/H-6997-2013; Wischke, Christian/K-9651-2013; Lendlein,
   Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Wischke, Christian/0000-0001-5531-9033;
   Lendlein, Andreas/0000-0003-4126-4670
FU Bundesministerium fur Bildung und Forschung (BMBF) BioFuture [0311867]
FX The authors would like to thank the Bundesministerium fur Bildung und
   Forschung (BMBF) BioFuture Award 0311867 for financial support and Prof.
   R. P. Franke for facilitating animal studies.
CR Baer G. M., 2007, BIOMED ENG ONLINE, V6, P8
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Behl M, 2010, ADV POLYM SCI, V226, P1, DOI 10.1007/12_2009_26
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   FROST S, 2008, N39F 54 20 MED DEVIC
   Hiebl B, 2009, MATER RES SOC SYMP P, V1140, P143
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Lendlein A, 1998, MACROMOL CHEM PHYSIC, V199, P2785, DOI 10.1002/macp.1998.021991222
   Lendlein A, 2005, J POLYM SCI POL CHEM, V43, P1369, DOI 10.1002/pola.20598
   Lendlein A, 2005, CLIN HEMORHEOL MICRO, V32, P105
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Nagahama K, 2009, BIOMACROMOLECULES, V10, P1789, DOI 10.1021/bm9002078
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Rickert D, 2006, BIOMED TECH, V51, P116, DOI 10.1515/BMT.2006.020
   Sharp AA, 2006, J NEURAL ENG, V3, pL23, DOI 10.1088/1741-2560/3/4/L02
   Small W, 2007, IEEE T BIO-MED ENG, V54, P1657, DOI 10.1109/TBME.2007.892921
   WADA R, 1991, PHARMACEUT RES, V8, P1292, DOI 10.1023/A:1015860030772
   Wischke C, 2010, ADV POLYM SCI, V226, P177, DOI 10.1007/12_2009_29
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
NR 34
TC 17
Z9 17
U1 2
U2 24
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 9
PY 2010
VL 10
IS 9
SI SI
BP 1063
EP 1072
DI 10.1002/mabi.201000089
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 648JP
UT WOS:000281689900009
PM 20603884
DA 2018-10-19
ER

PT J
AU Menzies, DJ
   Cowie, B
   Fong, C
   Forsythe, JS
   Gengenbach, TR
   McLean, KM
   Puskar, L
   Textor, M
   Thomsen, L
   Tobin, M
   Muir, BW
AF Menzies, Donna J.
   Cowie, Bruce
   Fong, Celesta
   Forsythe, John S.
   Gengenbach, Thomas R.
   McLean, Keith M.
   Puskar, Ljiljana
   Textor, Marcus
   Thomsen, Lars
   Tobin, Mark
   Muir, Benjamin W.
TI One-Step Method for Generating PEG-Like Plasma Polymer Gradients:
   Chemical Characterization and Analysis of Protein Interactions
SO LANGMUIR
LA English
DT Article
ID X-RAY-ABSORPTION; SELF-ASSEMBLED MONOLAYERS; IN-SITU CHARACTERIZATION;
   SURFACE INTERACTIONS; PLATELET-ADHESION; PHOTOELECTRON-SPECTROSCOPY;
   MOLECULAR-ORIENTATION; WETTABILITY GRADIENT; FINE-STRUCTURE; TOF-SIMS
AB In this work we report a one-step method for the fabrication of poly(ethylene glycol) PEG-like chemical gradients, which were deposited via continuous wave radio frequency glow discharge plasma polymerization of diethylene glycol dimethyl ether (DG). A knife edge top electrode was used to produce the gradient coatings at plasma load powers of 5 and 30 W. The chemistry across the gradients was analyzed using a number of complementary techniques including spatially resolved synchrotron source grazing incidence FTIR microspectroscopy, X-ray photoelectron spectroscopy (XPS) and synchrotron source near edge X-ray absorption fine structure (NEXAFS) spectroscopy. Gradients deposited at lower load power retained a higher degree of monomer like functionality as did the central region directly underneath the knife edge electrode of each gradient film. Surface derivatization experiments were employed to investigate the concentration of residual ether units in the films. In addition, surface derivatization was used to investigate the reactivity of the gradient films toward primary amine groups in a graft copolymer of poly (L-lysine) and poly(ethylene glycol) (PLL-g-PEG copolymer) which was correlated to residual aldehyde, ketone and carboxylic acid functionalities within the films. The protein adsorption characteristics of the gradients were analyzed using three proteins of varying size and charge. Protein adsorption varied and was dependent on the chemistry and the physical properties (such as size and charge) of the proteins. A correlation between the concentration of ether functionality and the protein fouling characteristics along the gradient films was observed. The gradient coating technique developed in this work allows for the efficient and high-throughput study of biomaterial gradient coating interactions.
C1 [Menzies, Donna J.; Fong, Celesta; Gengenbach, Thomas R.; McLean, Keith M.; Muir, Benjamin W.] CSIRO, Mol & Hlth Technol, Clayton, Vic 3168, Australia.
   [Menzies, Donna J.; Forsythe, John S.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Textor, Marcus] ETH, Surface Sci & Technol Lab, Dept Mat, CH-8093 Zurich, Switzerland.
   [Cowie, Bruce; Puskar, Ljiljana; Thomsen, Lars; Tobin, Mark] Australian Synchrotron, Clayton, Vic 3168, Australia.
RP Muir, BW (reprint author), CSIRO, Mol & Hlth Technol, Clayton, Vic 3168, Australia.
EM ben.muir@csiro.au
RI Thomsen, Lars/B-3016-2012; McLean, Keith/H-1568-2011; Tobin,
   Mark/B-8208-2015; fong, celesta/E-2268-2011; Muir, Benjamin/D-2206-2013;
   Textor, Marcus/A-6200-2012
OI Tobin, Mark/0000-0003-1862-0649; Textor, Marcus/0000-0002-0178-1801;
   Puskar, Ljiljana/0000-0002-8191-7472; Forsythe, John/0000-0003-2849-229X
FU CSIRO
FX This research was undertaken on the soft X-ray (NEXAFS, BL6) and
   infra-red microscope (giFTIR microspectroscopy, BL8) beamlines at the
   Australian Synchrotron, Victoria, Australia. We thank Kevin Prince for
   his helpful discussions towards interpretation of the NEXAFS data. We
   acknowledge the use of the 'Whooshka' software program to perform the
   curve-fitting of the NEXAFS data. D.J.M. thanks the CSIRO OCE Scheme for
   funding her Ph.D. scholarship stipend. M.T. acknowledges support from
   CSIRO's OCE Distinguished Visiting Scientist Program.
CR Bhat RR, 2006, ADV POLYM SCI, V198, P51, DOI 10.1007/12_060
   Blattler TM, 2006, LANGMUIR, V22, P5760, DOI 10.1021/la0602766
   Blondiaux N, 2008, APPL SURF SCI, V254, P6820, DOI 10.1016/j.apsusc.2008.04.073
   Bretagnol F, 2006, ACTA BIOMATER, V2, P165, DOI 10.1016/j.actbio.2005.11.002
   Buchholz V, 1997, LANGMUIR, V13, P3206, DOI 10.1021/la970085q
   Cheng Q, 2009, J PHYS CHEM C, V113, P213, DOI 10.1021/jp807109n
   CHILKOTI A, 1990, J VAC SCI TECHNOL A, V8, P2274, DOI 10.1116/1.576750
   CORUM LE, 2009, BIOMATERIALS, V31, P3148
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   Ekblad T, 2009, LANGMUIR, V25, P3755, DOI 10.1021/la803443d
   Fischer DA, 2004, MACROMOL RAPID COMM, V25, P141, DOI 10.1002/marc.200300178
   Friedrich J, 1998, SURF COAT TECH, V98, P1132, DOI 10.1016/S0257-8972(97)00157-6
   Friedrich JF, 1995, SURF COAT TECH, V74-75, P664, DOI 10.1016/0257-8972(95)08218-2
   Genzer J, 2003, APPL PHYS LETT, V82, P266, DOI 10.1063/1.1535271
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Jeong BJ, 1996, J COLLOID INTERF SCI, V178, P757, DOI 10.1006/jcis.1996.0174
   Khang G, 2000, KOREA POLYM J, V8, P276
   Kim Y, 2009, SURF COAT TECH, V203, P3129, DOI 10.1016/j.surfcoat.2009.03.039
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Latour RA, 2006, J BIOMED MATER RES A, V78A, P843, DOI 10.1002/jbm.a.30818
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Lee TG, 2006, APPL SURF SCI, V252, P6754, DOI 10.1016/j.apsusc.2006.02.205
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Liedberg B, 1997, LANGMUIR, V13, P5329, DOI 10.1021/la962053t
   Morgenthaler S, 2003, LANGMUIR, V19, P10459, DOI 10.1021/la0347071
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Muir BW, 2008, LANGMUIR, V24, P3828, DOI 10.1021/la702689t
   Ogumi Z, 1999, SOLID STATE IONICS, V121, P289, DOI 10.1016/S0167-2738(99)00027-2
   Oran U, 2006, PLASMA PROCESS POLYM, V3, P288, DOI 10.1002/ppap.200500168
   Parry KL, 2006, SURF INTERFACE ANAL, V38, P1497, DOI 10.1002/sia.2400
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   Shard AG, 2004, J PHYS CHEM B, V108, P12472, DOI 10.1021/jp048250f
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Shin YN, 2008, APPL SURF SCI, V255, P293, DOI 10.1016/j.apsusc.2008.06.173
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Swaraj S, 2005, PLASMA PROCESS POLYM, V2, P310, DOI 10.1002/ppap.200400070
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Vasilev K., 2009, BIOMATERIALS, V31, P392
   Vasilev K, 2010, BIOMATERIALS, V31, P392, DOI 10.1016/j.biomaterials.2009.09.056
   Watts B, 2006, J ELECTRON SPECTROSC, V151, P105, DOI 10.1016/j.elspec.2005.11.006
   Watts J. F., 1993, SURF INTERFACE ANAL, V20, P267, DOI 10.1002/sia.740200310
   Wells N, 2009, BIOMATERIALS, V30, P1066, DOI 10.1016/j.biomaterials.2008.10.027
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zwahlen M, 2003, LANGMUIR, V19, P9305, DOI 10.1021/la0350610
NR 59
TC 32
Z9 32
U1 2
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 7
PY 2010
VL 26
IS 17
BP 13987
EP 13994
DI 10.1021/la102033d
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 644DX
UT WOS:000281354000039
PM 20698710
DA 2018-10-19
ER

PT J
AU Szewciw, LJ
   de Kerckhove, DG
   Grime, GW
   Fudge, DS
AF Szewciw, L. J.
   de Kerckhove, D. G.
   Grime, G. W.
   Fudge, D. S.
TI Calcification provides mechanical reinforcement to whale baleen
   alpha-keratin
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE whale baleen; alpha-keratin; calcification; proton-induced X-ray
   emission; transmission electron microscopy; biomechanics
ID HAGFISH SLIME THREADS; INTERMEDIATE-FILAMENTS; INSIGHTS; MATRIX; FIBERS
AB Hard alpha-keratins such as hair, nail, wool and horn are stiff epidermal appendages used by mammals in a variety of functions including thermoregulation, feeding and intraspecific competition. Hard alpha-keratins are fibre-reinforced structures consisting of cytoskeletal elements known as 'intermediate filaments' embedded in an amorphous protein matrix. Recent research has shown that intermediate filaments are soft and extensible in living keratinocytes but become far stiffer and less extensible in keratinized cells, and this stiffening may be mediated by air-drying. Baleen, the keratinous plates used by baleen whales during filter feeding, is an unusual mammalian keratin in that it never air dries, and in some species, it represents the most heavily calcified of all the hard alpha-keratins. We therefore tested the hypothesis that whale baleen is stiffened by calcification. Here, we provide, to our knowledge, the first comprehensive description of baleen material properties and show that calcification contributes to overcoming the shortcomings of stiffening this hard alpha-keratin without the benefit of air-drying. We also demonstrate striking interspecies differences in the calcification patterns among three species of baleen whales and provide novel insights into the function and evolution of this unusual biomaterial.
C1 [Szewciw, L. J.; Fudge, D. S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.
   [de Kerckhove, D. G.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada.
   [Grime, G. W.] Univ Surrey, Surrey Ion Beam Ctr, Surrey GU2 7XH, England.
RP Fudge, DS (reprint author), Univ Guelph, Dept Integrat Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.
EM dfudge@uoguelph.ca
FU National Sciences and Engineering Research Council of Canada;
   Engineering and Physical Sciences Research Council of the UK;
   Engineering and Physical Sciences Research Council [EP/D032210/1]
FX Special thanks to Tonya Wimmer and Donald F. McAlpine for provision of
   baleen samples. Wool samples were provided by Heather Bailey. Atomic
   absorption spectroscopy tests were performed by Nick Schrier. von Kossa
   stained tissue sections were prepared by David Hilchie. Specimens for
   TEM were prepared by Robert Harris. Thanks to Dr Chris Jeynes at the
   Surrey Ion Beam Centre for assistance with the PIXE experiments. Thanks
   also to Ian Smith for creating the line drawing. We would also like to
   acknowledge the contributions of three anonymous reviewers to improving
   our manuscript. This work was funded by the National Sciences and
   Engineering Research Council of Canada. Access to the Surrey Ion Beam
   Centre was made possible by Pump Priming funding from the Engineering
   and Physical Sciences Research Council of the UK.
CR BENDIT EG, 1968, KERATIN ENCY POLYM S, V8, P1
   Feughelman M, 2002, J APPL POLYM SCI, V83, P489, DOI 10.1002/app.2255
   Fraser RBD, 1972, AM LECT SERIES
   Fudge Douglas S., 2009, Aquatic Mammals, V35, P226, DOI 10.1578/AM.35.2.2009.226
   Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   GRIME GW, 1995, NUCL INSTRUM METH B, V104, P107, DOI 10.1016/0168-583X(95)00401-7
   HALSTEAD LB, 1974, VERTEBRATE HARD TISS
   Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1
   Homberger DG, 2001, VERTEBRATE FUNCTIONA, P317
   Howard J, 2001, MECH MOTOR PROTEINS
   Johannson S., 1988, PIXE NOVEL TECHNIQUE
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   MAXWELL JA, 1989, NUCL INSTRUM METH B, V43, P218, DOI 10.1016/0168-583X(89)90042-6
   Nemoto T., 1959, Scientific Reports of the Whales Research Institute Tokyo, VNo. 14, P149
   PAUTARD F G, 1962, Clin Orthop, V24, P230
   PAUTARD FGE, 1963, NATURE, V199, P531, DOI 10.1038/199531a0
   PAUTARD FGE, 1981, PROG CRYST GROWTH CH, V4, P89, DOI 10.1016/0146-3535(81)90049-6
   PAUTARD FGE, 1965, CALCIFIED TISSUES, P347
   Pilkey W. D., 2002, ANAL DESIGN ELASTIC
   Pivorunas A., 1976, Scientific Rep Whales Res Inst Tokyo, VNo. 28, P37
   PIVORUNAS A, 1979, AM SCI, V67, P432
   Saber-Samandari S, 2009, ACTA BIOMATER, V5, P2206, DOI 10.1016/j.actbio.2009.02.009
   Simon A, 2004, NUCL INSTRUM METH B, V219, P405, DOI 10.1016/j.nimb.2004.01.091
   Spatz HC, 1996, P ROY SOC B-BIOL SCI, V263, P287, DOI 10.1098/rspb.1996.0044
   STAUBIN DJ, 1984, CAN J ZOOL, V62, P193
   Vogel S., 1988, LIFES DEVICES PHYS W
   Wainwright S. A., 1976, MECH DESIGN ORGANISM
   Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4
   Williamson G.R., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P279
NR 30
TC 24
Z9 24
U1 1
U2 16
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD SEP 7
PY 2010
VL 277
IS 1694
BP 2597
EP 2605
DI 10.1098/rspb.2010.0399
PG 9
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA 631BG
UT WOS:000280320900003
PM 20392736
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Schaffer, DV
AF Schaffer, David V.
TI Microarraying for Mechanosensivitity
SO CELL STEM CELL
LA English
DT Editorial Material
AB In a recent issue of Science, Gilbert et al. combine biomaterial microarrays with lineage tracking to demonstrate that muscle stem cell survival is sensitive to the microenvironment's mechanical stiffness (Gilbert et al., 2010). This work enhances the breadth and depth of knowledge in stem cell mechanobiology.
C1 [Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biol Engn, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
RP Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Chem & Biol Engn, Berkeley, CA 94720 USA.
EM schaffer@berkeley.edu
CR Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   KEUNG AJ, 2010, ANN REV CEL IN PRESS, V26, DOI DOI 10.10.1146/ANNUREV-CELLBIO-100109-104042
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Wang H., 2000, AM J PHYSIOL-CELL PH, V279, P1345
NR 10
TC 1
Z9 1
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
J9 CELL STEM CELL
JI Cell Stem Cell
PD SEP 3
PY 2010
VL 7
IS 3
BP 273
EP 274
DI 10.1016/j.stem.2010.08.007
PG 2
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA 652VC
UT WOS:000282037800002
PM 20804961
OA Bronze
DA 2018-10-19
ER

PT J
AU Wang, WD
   Chen, B
   Huang, YM
   Cao, J
AF Wang, Weidong
   Chen, Bo
   Huang, Yuming
   Cao, Jia
TI Evaluation of eggshell membrane-based bio-adsorbent for solid-phase
   extraction of linear alkylbenzene sulfonates coupled with
   high-performance liquid chromatography
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article
DE Eggshell membrane; Solid-phase extraction; Linear alkylbenzene
   sulfonate; High-performance liquid chromatography; Bio-adsorbent
ID ENVIRONMENTAL WATER SAMPLES; MULTIWALLED CARBON NANOTUBES;
   MASS-SPECTROMETRY; DEGRADATION-PRODUCTS; PHENOLIC-COMPOUNDS; TREATMENT
   PLANTS; UV DETECTION; METABOLITES; BIOSENSOR; FATE
AB The potential of eggshell membrane (ESM) as a novel solid-phase extraction bio-adsorbent was investigated in the present study. The ESM with a unique structure of intricate lattice network showed a predominant ability to capture linear alkylbenzene sulfonates (LAS) as a model of organic pollutants by the hydrophobic interactions between ESM and LAS molecular at pH very close to the isoelectric point of ESM, which was similar to the most widely used trapping mechanism for SPE. Under the optimal conditions, the breakthrough capacities of the ESM packed cartridge for C10-C13 LAS homologues were found to be 30, 53, 50, and 43 mu g g(-1), respectively. On the basis of high-performance liquid chromatography separation and UV detection of LAS homologues, the proposed system could respond down to 0.027 ng mL(-1) of LAS with a linear calibration range from 0.2 to 100 ng mL(-1), showing a good LAS enrichment ability of eggshell membrane biomaterial with high sensitivity, and could be successfully used for the detection of residual LAS in environmental water samples. The reproducibility among columns was satisfactory (RSD among columns is less than 10%). A comparison study with ESM. C8 and C18 as adsorbents for LAS demonstrated that ESM-based bio-adsorbent was advantageous over C8 and C18, the widely used traditional adsorbents. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wang, Weidong; Chen, Bo; Huang, Yuming] Southwest Univ, Coll Chem & Chem Engn, Key Lab Ecoenvironm Gorges Reservoir Reg 3, Chongqing 400715, Peoples R China.
   [Wang, Weidong] Southwest Univ, Rongchang Branch, Dept Chem, Chongqing 402460, Peoples R China.
   [Cao, Jia] Third Mil Med Univ, Dept Environm Hlth, Chongqing 400038, Peoples R China.
RP Huang, YM (reprint author), Southwest Univ, Coll Chem & Chem Engn, Key Lab Ecoenvironm Gorges Reservoir Reg 3, Chongqing 400715, Peoples R China.
EM yuminghuang2000@yahoo.com
FU Chongqing Science and Technology Commission [2006AA7003]; Key Laboratory
   of Eco-environments in Three Gorges Reservoir Region (Ministry of
   Education)
FX The authors thank the Key Technologies R&D Programme from Chongqing
   Science and Technology Commission (No. 2006AA7003), and Key Laboratory
   of Eco-environments in Three Gorges Reservoir Region (Ministry of
   Education) for their financial supports.
CR Alvarez-Munoz D, 2004, J CHROMATOGR A, V1052, P33, DOI 10.1016/j.chroma.2004.08.014
   Ariffin MM, 2007, ANAL CHEM, V79, P256, DOI 10.1021/ac061062w
   Bones J, 2006, TALANTA, V70, P1117, DOI 10.1016/j.talanta.2006.02.026
   Cai YQ, 2003, ANAL CHEM, V75, P2517, DOI 10.1021/ac0263566
   Choi MMF, 2005, FOOD CHEM, V92, P575, DOI 10.1016/j.foodchem.2004.10.011
   Choi MMF, 2005, ENZYME MICROB TECH, V36, P91, DOI 10.1016/j.enzmictec.2004.06.009
   Dong Q, 2008, CHEM ENG J, V137, P428, DOI 10.1016/j.cej.2007.05.045
   Dong Q, 2007, MATER LETT, V61, P2714, DOI 10.1016/j.matlet.2006.06.091
   Dong Q, 2007, MICROPOR MESOPOR MAT, V98, P344, DOI 10.1016/j.micromeso.2006.09.041
   Eichhorn P, 2001, SCI TOTAL ENVIRON, V269, P75, DOI 10.1016/S0048-9697(00)00825-1
   Gonzalez S, 2004, J CHROMATOGR A, V1052, P111, DOI 10.1016/j.chroma.2004.08.047
   Guan Z, 2008, ANAL CHIM ACTA, V627, P225, DOI 10.1016/j.aca.2008.08.035
   Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1
   Lara-Martin PA, 2006, J CHROMATOGR A, V1137, P188, DOI 10.1016/j.chroma.2006.10.009
   Merino F, 2003, ANAL CHEM, V75, P6799, DOI 10.1021/ac030224a
   Moral A, 2006, ANAL CHIM ACTA, V569, P132, DOI 10.1016/j.aca.2006.03.069
   Nishigaki A, 2004, ANAL SCI, V20, P143, DOI 10.2116/analsci.20.143
   Niu HY, 2007, J CHROMATOGR A, V1172, P113, DOI 10.1016/j.chroma.2007.10.014
   Niu HY, 2007, ANAL CHIM ACTA, V594, P81, DOI 10.1016/j.aca.2007.05.017
   Riu J, 2001, FRESEN J ANAL CHEM, V371, P448, DOI 10.1007/s002160101052
   Rodriguez-Mozaz S, 2007, J CHROMATOGR A, V1152, P97, DOI 10.1016/j.chroma.2007.01.046
   Sarrazin L, 1997, J CHROMATOGR A, V760, P285, DOI 10.1016/S0021-9673(96)00778-9
   Schellen A, 2003, J CHROMATOGR B, V788, P251, DOI 10.1016/S1570-0232(02)01013-9
   Su HL, 2006, J MEMBRANE SCI, V283, P7, DOI 10.1016/j.memsci.2006.07.010
   Tabor CF, 1996, ENVIRON SCI TECHNOL, V30, P161, DOI 10.1021/es950210p
   Tamayo FG, 2007, J CHROMATOGR A, V1152, P32, DOI 10.1016/j.chroma.2006.08.095
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Wang WD, 2007, J CHROMATOGR A, V1173, P27, DOI 10.1016/j.chroma.2007.10.027
   Wangkarn S, 2005, TALANTA, V67, P686, DOI 10.1016/j.talanta.2005.03.011
   Wen GM, 2007, BIOSENS BIOELECTRON, V23, P121, DOI 10.1016/j.bios.2007.03.024
   Wu BL, 2005, SENSOR ACTUAT B-CHEM, V106, P700, DOI 10.1016/j.snb.2004.09.018
   Wu BL, 2004, TALANTA, V64, P546, DOI 10.1016/j.talanta.2004.03.050
   Yang D, 2003, J MATER CHEM, V13, P1119, DOI 10.1039/b301077e
   Yi F, 2004, BIOMATERIALS, V25, P4591, DOI 10.1016/j.biomaterials.2003.11.052
   Zhang GM, 2006, SENSOR ACTUAT B-CHEM, V114, P936, DOI 10.1016/j.snb.2005.08.011
   Zhang Y, 2007, BIOSENS BIOELECTRON, V22, P1791, DOI 10.1016/j.bios.2006.08.038
   Zhao XL, 2008, ENVIRON SCI TECHNOL, V42, P1201, DOI 10.1021/es071817w
   Zhou QX, 2007, J CHROMATOGR A, V1147, P10, DOI 10.1016/j.chroma.2007.02.081
   Zhou QX, 2006, J CHROMATOGR A, V1125, P152, DOI 10.1016/j.chroma.2006.05.047
NR 39
TC 20
Z9 20
U1 2
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD SEP 3
PY 2010
VL 1217
IS 36
BP 5659
EP 5664
DI 10.1016/j.chroma.2010.07.017
PG 6
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 643CM
UT WOS:000281270800003
PM 20674925
DA 2018-10-19
ER

PT J
AU Sorolla, S
   Jorba, M
   Marginet, X
   Castell, JC
   Olle, LL
   Bacardit, A
AF Sorolla, S.
   Jorba, M.
   Marginet, X.
   Castell, J. C.
   Olle, L. L.
   Bacardit, A.
TI Design of Scaffolds for Biopelt from Tanning Sector By-products
SO JOURNAL OF THE SOCIETY OF LEATHER TECHNOLOGISTS AND CHEMISTS
LA English
DT Article
AB The aim of the present work is to generate by in vitro technology at laboratory scale a biomaterial with similar characteristics to genuine leather. The generation of an in vitro tissue from bovine fibroblasts is carried out on the basis of a scaffold to generate a three-dimensional extra-cellular matrix (3D ECM). Finally, the scaffolds have to be suitable for biomaterial production at lab scale using a bioreactor with specific culturing conditions. In a further step, new methodologies to stabilize the new biomaterial were investigated. The biomaterial generation involves the elimination of the heavy water consumption steps in conventional leather manufacture. Since this biopelt doesn't need to be subjected to the beamhouse steps previous to stabilization, a reduction of 50-60% in water consumption is achieved. Consequently, pollution in wastewaters is minimized.
   In view of the nature of this work and the necessary explanatory work, some of the detail has been placed in appendices at the end of the paper. (M.K.L.)
C1 [Olle, L. L.; Bacardit, A.] Igualada Leather Technol Sch EUETII, Igualada 08700, Spain.
   [Sorolla, S.; Jorba, M.; Marginet, X.; Castell, J. C.] AIICA, Igualada 08700, Spain.
RP Bacardit, A (reprint author), Igualada Leather Technol Sch EUETII, Pl Rei 15, Igualada 08700, Spain.
EM annab@euetii.upc.edu
OI Bacardit Dalmases, Anna/0000-0003-1871-4127
FU EU
FX The contents of this paper are part of the 'Dermagenesis' Project funded
   by the EU, which is concerned with the leather sector as part of the 6th
   Framework Programme, in relation to scaffold design and development for
   specific cell growth requirements. The Consortium was made up by 20
   European partners, emphasizing the IAGs participation, various European
   Universities and Technological Centres, and various SMEs of the tanning
   sector.
CR *IPPC, 2003, INT PREV POLL CONTR
   *IUE, 6 IUE
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ma PX, 2006, SCAFFOLDING TISSUE E
   MIKOS AG, 1999, SCI AM           APR, P60
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   NETTI PA, Patent No. 1589098
   Parenteau N, 1999, SCI AM, V280, P83
   PETER XM, 2004, MATER TODAY, V7, P30
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   THER INC, 960227 BRPR THER INC
   VIELA J, 2003, EMERGENCE TISSUE ENG
   WONG, 1997, SYNTHETIC BIODEGRADA
NR 13
TC 2
Z9 2
U1 0
U2 0
PU SOC LEATHER TECHNOL CHEMISTS
PI MOULTON
PA 8 COPPER LEAF CLOSE, MOULTON NN3 7HS, NORTHAMPTON, ENGLAND
SN 0144-0322
J9 J SOC LEATH TECH CH
JI J. Soc. Leather Technol. Chem.
PD SEP-OCT
PY 2010
VL 94
IS 5
BP 190
EP 199
PG 10
WC Materials Science, Textiles
SC Materials Science
GA 708LE
UT WOS:000286362500002
DA 2018-10-19
ER

PT J
AU Kersey, FR
   Zhang, GQ
   Palmer, GM
   Dewhirst, MW
   Fraser, CL
AF Kersey, Farrell R.
   Zhang, Guoqing
   Palmer, Gregory M.
   Dewhirst, Mark W.
   Fraser, Cassandra L.
TI Stereocomplexed Poly(lactic acid)-Poly(ethylene glycol) Nanoparticles
   with Dual-Emissive Boron Dyes for Tumor Accumulation
SO ACS NANO
LA English
DT Article
DE Boron dye; fluorescence; phosphorescence; nanoparticles; poly(lactic
   acid) (PLA) stereocomplexes; poly(ethylene glycol) (PEG); enhanced
   permeation and retention (EPR) effect
ID DIFLUOROBORON DIBENZOYLMETHANE-POLYLACTIDE; ROOM-TEMPERATURE
   PHOSPHORESCENCE; BLOCK-COPOLYMERS; IN-VITRO; VASCULAR-PERMEABILITY;
   OXYGEN SENSORS; DRUG-DELIVERY; LIVE CELLS; PACLITAXEL; DERIVATIVES
AB Responsive biomaterials play important roles in imaging, diagnostics, and therapeutics. Polymeric nanoparticles (NPs) containing hydrophobic and hydrophilic segments are one class of biomaterial utilized for these purposes. The incorporation of luminescent molecules into NPs adds optical imaging and sensing capability to these vectors. Here we report on the synthesis of dual-emissive, pegylated NPs with "stealth"-like properties, delivered intravenously (IV), for the study of tumor accumulation. The NPs were created by means of stereocomplexation using a methoxy-terminated polyethylene glycol and poly(o-lactide) (mPEG-PDLA) block copolymer combined with iodide-substituted difluoroboron dibenzoylmethane-poly(.-lactide) (BF2dbm(I)PLLA). Boron nanoparticles (BNPs) were fabricated in two different solvent compositions to study the effects on BNP size distribution. The physical and photoluminescent properties of the BNPs were studied in vitro over time to determine stability. Finally, preliminary in vivo results show that stereocomplexed BNPs injected IV are taken up by tumors, an important prerequisite to their use as hypoxia imaging agents in preclinical studies.
C1 [Kersey, Farrell R.; Zhang, Guoqing; Fraser, Cassandra L.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.
   [Palmer, Gregory M.; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA.
RP Fraser, CL (reprint author), Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22904 USA.
EM fraser@virginia.edu
RI Zhang, Guoqing/E-4826-2011; Palmer, Gregory/C-6910-2008
OI Palmer, Gregory/0000-0003-2955-8297
FU National Science Foundation [CHE 0718879]; UVA NanoSTAR Institute; UVA
   Cancer Center through the James and Rebecca Craig Foundation; NCI Cancer
   Center [P30 CA44579]; Department of Defense [W81XWH-07-1-0355]; National
   Institutes of Health [R01CA40355]
FX We thank the following people for experimental assistance and use of
   facilities: Prof. D. L. Green and M. Mc Ewan (DLS). This work was
   supported by the National Science Foundation (C.L.F.: CHE 0718879), the
   UVA NanoSTAR Institute, the UVA Cancer Center through the James and
   Rebecca Craig Foundation and the NCI Cancer Center Support Grant
   (C.L.F.: P30 CA44579), the Department of Defense (G.M.P.: Postdoctoral
   Fellowship W81XWH-07-1-0355), and the National Institutes of Health
   (M.W.D.: R01CA40355). We also gratefully acknowledge Purac for their
   generous gift of o-lactide.
CR Allen C, 1999, HOUS THEORY SOC, V16, P3, DOI 10.1080/14036099950150053
   Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
   Bender JL, 2002, J AM CHEM SOC, V124, P8526, DOI 10.1021/ja0261269
   Brinas RP, 2005, J AM CHEM SOC, V127, P11851, DOI 10.1021/ja052947c
   Burt HM, 1999, COLLOID SURFACE B, V16, P161, DOI 10.1016/S0927-7765(99)00067-3
   CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007
   Chen QJ, 2007, MICROBES INFECT, V9, P777, DOI 10.1016/j.micinf.2007.02.009
   CHOW YL, 1993, CAN J CHEM, V71, P846, DOI 10.1139/v93-113
   Chow YL, 1996, J PHYS ORG CHEM, V9, P7, DOI 10.1002/(SICI)1099-1395(199601)9:1<7::AID-POC747>3.3.CO;2-8
   CHOW YL, 1991, CAN J CHEM, V69, P423, DOI 10.1139/v91-064
   CONTRERAS J, 2010, NANOPARTICLES HELA C, V4, P2735
   De Jaeghere F, 2000, PHARM DEV TECHNOL, V5, P473, DOI 10.1081/PDT-100102031
   De Jaeghere F, 1999, PHARMACEUT RES, V16, P859, DOI 10.1023/A:1018826103261
   Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838
   Dreher MR, 2006, J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070
   Fessi H., 1989, INT J PHARMACEUT, V55, pR1
   Guice KB, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2147419
   Hagan SA, 1996, LANGMUIR, V12, P2153, DOI 10.1021/la950649v
   HAMBURGER R, 1975, PHARM ACTA HELV, V50, P10
   Hu JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/18/185607
   Huang Q, 1999, NAT BIOTECHNOL, V17, P1033, DOI 10.1038/13736
   Jie P, 2005, J CONTROL RELEASE, V110, P20, DOI 10.1016/j.jconrel.2005.09.011
   Kang N, 2005, NANO LETT, V5, P315, DOI 10.1021/nl048037v
   Kim SC, 2001, J CONTROL RELEASE, V72, P191, DOI 10.1016/S0168-3659(01)00275-9
   Kim SH, 2009, MACROMOLECULES, V42, P25, DOI 10.1021/ma801739x
   Kim SY, 1998, J CONTROL RELEASE, V56, P197, DOI 10.1016/S0168-3659(98)00083-2
   Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655
   Koo YEL, 2004, ANAL CHEM, V76, P2498, DOI 10.1021/ac035493f
   Lebedev AY, 2009, ACS APPL MATER INTER, V1, P1292, DOI 10.1021/am9001698
   Lee YEK, 2009, ANNU REV ANAL CHEM, V2, P57, DOI 10.1146/annurev.anchem.1.031207.112823
   Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n
   Ma LL, 2008, ADV FUNCT MATER, V18, P716, DOI 10.1002/adfm.200700634
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   McLaurin EJ, 2009, J AM CHEM SOC, V131, P12994, DOI 10.1021/ja902712b
   Mosqueira VCF, 2001, PHARMACEUT RES, V18, P1411, DOI 10.1023/A:1012248721523
   Olivier JC, 2002, PHARMACEUT RES, V19, P1137, DOI 10.1023/A:1019842024814
   Patil YB, 2009, BIOMATERIALS, V30, P859, DOI 10.1016/j.biomaterials.2008.09.056
   Pfister A, 2008, ACS NANO, V2, P1252, DOI 10.1021/nn7003525
   Pulkkinen M, 2008, EUR J PHARM BIOPHARM, V70, P66, DOI 10.1016/j.ejpb.2008.04.018
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Salem AK, 2001, BIOMACROMOLECULES, V2, P575, DOI 10.1021/bm010030+
   Sanchez-Barragan I, 2006, TRAC-TREND ANAL CHEM, V25, P958, DOI 10.1016/j.trac.2006.07.009
   Snee PT, 2006, J AM CHEM SOC, V128, P13320, DOI 10.1021/ja0618999
   Somers RC, 2007, CHEM SOC REV, V36, P579, DOI 10.1039/b517613c
   Sun H, 2006, CHEM MATER, V18, P3381, DOI 10.1021/cm052750j
   Tan JPK, 2009, SMALL, V5, P1504, DOI 10.1002/smll.200801756
   Wu CF, 2009, ANGEW CHEM INT EDIT, V48, P2741, DOI 10.1002/anie.200805894
   Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718
   Yang L, 2007, J COLLOID INTERF SCI, V314, P470, DOI 10.1016/j.jcis.2007.05.074
   Zhang GQ, 2008, ADV MATER, V20, P2099, DOI 10.1002/adma.200702681
   Zhang G, 2007, J AM CHEM SOC, V129, P8942, DOI 10.1021/ja0720255
   Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/NMAT2509, 10.1038/nmat2509]
NR 52
TC 44
Z9 46
U1 3
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD SEP
PY 2010
VL 4
IS 9
BP 4989
EP 4996
DI 10.1021/nn901873t
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 653TY
UT WOS:000282121000005
PM 20704337
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Suzuki, O
AF Suzuki, O.
TI Octacalcium phosphate: Osteoconductivity and crystal chemistry
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Octacalcium phosphate; Stoichiometry; Hydrolysis; Hydroxyapatite; Bone
   regeneration
ID ALPHA-TRICALCIUM PHOSPHATE; MARROW STROMAL CELLS; CALCIUM-PHOSPHATE;
   IN-VITRO; BONE REGENERATION; INORGANIC-PHOSPHATE; GENE-EXPRESSION;
   ELECTROCHEMICAL DEPOSITION; OSTEOCLAST DIFFERENTIATION; DEFICIENT
   HYDROXYAPATITE
AB Octacalcium phosphate (OCP), which is structurally similar to hydroxyapatite (HA), is a possible precursor of bone apatite crystals. Although disagreement remains as to whether OCP comprises the initial mineral crystals in the early stage of bone mineralization, the results of recent biomaterial studies using synthetic OCP indicate the potential role of OCP as a bone substitute material, owing to its highly osteoconductive and biodegradable characteristics. OCP tends to convert to HA not only in an in vitro environment, but also as an implant in bone defects. Several lines of evidence from both in vivo and in vitro studies suggest that the conversion process could be involved in the stimulatory capacity of OCP for osteoblastic differentiation and osteoclast formation. However, the osteoconductivity of OCP cannot always be secured if an OCP with distinct crystal characteristics is used, because the stoichiometry and microstructure of OCP crystals greatly affect bone-regenerative properties. Osteoconductivity and stimulatory capabilities may be caused by the chemical characteristics of OCP, which allows the release or exchange of calcium and phosphate ions with the surrounding of this salt, and its tendency to grow towards specific crystal faces, which could be a variable of the synthesis condition. This paper reviews the effect of calcium phosphates on osteoblastic activity and bone regeneration, with a special emphasis on OCP, since OCP seems to be performing better than other calcium phosphates in vivo. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan.
RP Suzuki, O (reprint author), Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM suzuki-o@m.tains.tohoku.ac.jp
FU Ministry of Education, Science, Sports and Culture of Japan [17076001,
   19390490, 20659304, 21591910]; Uehara Memorial Foundation
FX The study was supported in part by Grants-in-Aid (17076001, 19390490,
   20659304 and 21591910) from the Ministry of Education, Science, Sports
   and Culture of Japan and by the Uehara Memorial Foundation. The author
   also thanks: Dr. Hideki Imaizumi, Osaki Citizen Hospital; Dr. Naohisa
   Miyatake, Department of Orthopedic Surgery, Sendai Orthopedic Hospital;
   Professor Takenobu Katagiri, Saitama Medical University Research Center
   for Genomic Medicine; Professors Ryutaro Kamijo, Masanori Nakamura and
   Dr. Masamichi Takami, Showa University School of Dentistry; Professors
   Shinji Kamakura and Eiji Itoi and Emeritus Professors Minoru Sakurai and
   Manabu Kagayama, Tohoku University Graduate School; Professor Takaaki
   Aoba, Nippon Dental University; and Drs. Takahisa Anada, Yoshitomo
   Honda, and graduate student Shinji Morimoto, the Division of
   Craniofacial Function Engineering, Tohoku University Graduate School of
   Dentistry.
CR Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI [10.1089/ten.tea.2007.0339, 10.1089/tea.2007.0339]
   Anada T, 2008, KEY ENG MATER, V361-363, P31, DOI 10.4028/www.scientific.net/KEM.361-363.31
   AOKI H, 1973, J STOMATOL SOC JPN, V40, P277
   Arellano-Jimenez MJ, 2009, J PHYS CHEM SOLIDS, V70, P390, DOI 10.1016/j.jpcs.2008.11.001
   Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023
   Ball V, 2006, CRYST GROWTH DES, V6, P327, DOI 10.1021/cg050044p
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Barrere F, 2003, J BIOMED MATER RES A, V64A, P378, DOI 10.1002/jbm.a.10291
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Bigi A, 2004, CRYST GROWTH DES, V4, P141, DOI 10.1021/cg034078d
   BIGI A, 1988, J INORG BIOCHEM, V32, P251, DOI 10.1016/0162-0134(88)85004-9
   Bohner M, 2003, BIOMATERIALS, V24, P3463, DOI 10.1016/S0142-9612(03)00234-5
   Bonfield W, 2006, PHILOS T ROY SOC A, V364, P227, DOI 10.1098/rsta.2005.1692
   BROWN WE, 1957, J AM CHEM SOC, V79, P5318, DOI 10.1021/ja01576a068
   BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   BROWN WE, 1981, PROG CRYST GROWTH CH, V4, P59, DOI 10.1016/0146-3535(81)90048-4
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Chow LC., 2001, OCTACALCIUM PHOSPHAT, P94
   Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Dekker RJ, 2005, BIOMATERIALS, V26, P5231, DOI 10.1016/j.biomaterials.2005.01.057
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   Driessens F C, 1988, Ann N Y Acad Sci, V523, P131, DOI 10.1111/j.1749-6632.1988.tb38507.x
   DRIESSENS FCM, 1978, CALC TISS RES, V26, P127, DOI 10.1007/BF02013247
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   EIDELMAN N, 1987, CALCIFIED TISSUE INT, V40, P71, DOI 10.1007/BF02555708
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   Feng B, 2002, BIOMATERIALS, V23, P173, DOI 10.1016/S0142-9612(01)00093-X
   Fuji T, 2009, TISSUE ENG PT A, V15, P3525, DOI [10.1089/ten.tea.2009.0048, 10.1089/ten.TEA.2009.0048]
   FUREDIMILHOFER H, 1994, CONNECT TISSUE RES, V30, P251, DOI 10.3109/03008209409015041
   Gonda Y, 2009, BIOMATERIALS, V30, P4390, DOI 10.1016/j.biomaterials.2009.05.002
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   HAYEK E, 1967, KLIN WOCHENSCHR, V45, P856
   Honda Y, 2007, J BIOMED MATER RES B, V80B, P281, DOI 10.1002/jbm.b.30595
   Honda Y, 2009, TISSUE ENG PT A, V15, P1965, DOI 10.1089/ten.tea.2008.0300
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Iijima M, 1998, J CRYST GROWTH, V193, P182, DOI 10.1016/S0022-0248(98)00455-2
   IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z
   Iijima M, 1996, CALCIFIED TISSUE INT, V59, P377, DOI 10.1007/s002239900143
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   JANSEN JA, 1985, J DENT RES, V64, P891, DOI 10.1177/00220345850640060601
   JARCHO M, 1977, J BIOENG, V1, P79
   JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Kamakura S, 1997, J ELECTRON MICROSC, V46, P397, DOI 10.1093/oxfordjournals.jmicro.a023535
   Kamakura S, 1999, J DENT RES, V78, P1682, DOI 10.1177/00220345990780110401
   Kamakura S, 2006, J BIOMED MATER RES B, V79B, P210, DOI 10.1002/jbm.b.30531
   Kawai T, 2009, TISSUE ENG PT A, V15, P23, DOI 10.1089/ten.tea.2008.0141
   Kikawa T, 2009, ACTA BIOMATER, V5, P1756, DOI 10.1016/j.actbio.2008.12.008
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Kong YY, 1999, NATURE, V397, P315
   Lai YK, 2010, COLLOID SURFACE B, V76, P117, DOI 10.1016/j.colsurfb.2009.10.023
   Leeuwenburgh S, 2001, J BIOMED MATER RES, V56, P208, DOI 10.1002/1097-4636(200108)56:2<208::AID-JBM1085>3.0.CO;2-R
   LEGEROS RZ, 1989, SCANNING MICROSCOPY, V3, P129
   LeGeros RZ, 1999, AM J DENT, V12, P65
   LEGEROS RZ, 1985, CALCIFIED TISSUE INT, V37, P194, DOI 10.1007/BF02554841
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LEGEROS RZ, 1989, SCANNING MICROSCOPY, V3, P137
   Lin SJ, 2003, J BIOMED MATER RES A, V66A, P819, DOI 10.1002/jbm.a.10072
   Liu HN, 2008, ACTA BIOMATER, V4, P1472, DOI 10.1016/j.actbio.2008.02.025
   Liu Y, 2004, KEY ENG MAT, V254-2, P79, DOI 10.4028/www.scientific.net/KEM.254-256.79
   Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu X, 2005, J CRYST GROWTH, V284, P506, DOI 10.1016/j.jcrysgro.2005.07.032
   Lu X, 2006, J CRYST GROWTH, V297, P396, DOI 10.1016/j.jcrysgro.2006.10.168
   MATHEW M, 1988, J CRYST SPECTROSC, V18, P235, DOI 10.1007/BF01194315
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MIAKE Y, 1993, CALCIFIED TISSUE INT, V53, P249, DOI 10.1007/BF01320910
   Miyatake N, 2009, BIOMATERIALS, V30, P1005, DOI 10.1016/j.biomaterials.2008.10.058
   MONMA H, 1980, J MATER SCI, V15, P2428, DOI 10.1007/BF00550744
   Murakami Y, 2010, ACTA BIOMATER, V6, P1542, DOI 10.1016/j.actbio.2009.10.023
   Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   NANCOLLAS GH, 1976, J DENT RES, V55, P617, DOI 10.1177/00220345760550041201
   Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246
   NEWESELY H, 1960, MONATSH CHEM, V91, P1020
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   Okuda T, 2008, BIOMATERIALS, V29, P2719, DOI 10.1016/j.biomaterials.2008.03.028
   Okuda T, 2007, BIOMATERIALS, V28, P2612, DOI 10.1016/j.biomaterials.2007.01.040
   Orii Y, 2010, J BIOMED MATER RES B, V93B, P476, DOI 10.1002/jbm.b.31605
   Panzavolta S, 2009, ACTA BIOMATER, V5, P636, DOI 10.1016/j.actbio.2008.08.017
   Papangkorn K, 2008, J COLLOID INTERF SCI, V320, P96, DOI 10.1016/j.jcis.2007.07.084
   Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Shelton RM, 2006, BIOMATERIALS, V27, P2874, DOI 10.1016/j.biomaterials.2005.12.031
   SUGIHARA F, 1996, BIOCERAMICS, V9, P399
   SUGIHARA F, 1995, BIOCERAMICS, V8, P89
   Sun JS, 1997, BIOMATERIALS, V18, P683, DOI 10.1016/S0142-9612(96)00183-4
   Suzuki O, 2008, CURR MED CHEM, V15, P305, DOI 10.2174/092986708783497283
   SUZUKI O, 1993, BONE MINER, V20, P151, DOI 10.1016/S0169-6009(08)80024-4
   Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004
   Suzuki O, 1995, J DENT RES, V74, P1764, DOI 10.1177/00220345950740110801
   Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   SUZUKI O, 1995, CELL MATER, V5, P45
   Takami M, 2000, ENDOCRINOLOGY, V141, P4711, DOI 10.1210/en.141.12.4711
   Takami M, 2009, TISSUE ENG PT A, V15, P3991, DOI 10.1089/ten.TEA.2009.0065
   TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tseng YH, 2006, J AM CHEM SOC, V128, P6909, DOI 10.1021/ja060336u
   TUNG MS, 1992, ARCH ORAL BIOL, V37, P585, DOI 10.1016/0003-9969(92)90142-U
   Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus
NR 117
TC 92
Z9 94
U1 7
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3379
EP 3387
DI 10.1016/j.actbio.2010.04.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400003
PM 20371385
DA 2018-10-19
ER

PT J
AU Choi, S
   Murphy, WL
AF Choi, Siyoung
   Murphy, William L.
TI Sustained plasmid DNA release from dissolving mineral coatings
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Calcium phosphate mineral; Hydroxyapatite; Simulated body fluid;
   Dissolution; Gene delivery
ID CALCIUM HYDROXYAPATITE POWDER; SIMULATED BODY-FLUID; SCAFFOLDS IN-VITRO;
   OCTACALCIUM PHOSPHATE; APATITE FORMATION; BIOMIMETIC APATITE;
   DISSOLUTION; BONE; DELIVERY; GROWTH
AB Calcium phosphate (CaP) minerals such as hydroxyapatite are able to bind a diverse range of biological molecules due to the presence of anions and cations in their crystal structure. The well-characterized ability of CaP minerals to bind and release plasmid DNA, coupled with the ability of biodegradable CaP coatings to form on the surface of common biomaterials, provides a potential mechanism for controlled release of plasmid DNA from various biomaterials. In this study we hypothesized that the release of plasmid DNA from CaP coatings formed on poly(lactide-co-glycolide) (PLG) substrates would be dependent on both the intrinsic properties of the CaP mineral coating and the surrounding solution conditions. Experiments were designed to consider two general parameters: (i) the stability of various CaP mineral coatings in solution environments that are relevant to physiological conditions; (ii) the relationship between mineral stability and sustained plasmid DNA release. Our results corroborate previous studies that have demonstrated a direct relationship between intrinsic mineral composition and mineral stability. In addition, we further demonstrate that ion composition and pH of the surrounding solution environment can significantly influence mineral stability. In turn, mineral stability significantly influenced release of plasmid DNA from mineral coatings in vitro, and the DNA release efficiency could be tuned by controlling the mineral properties in various solution environments. These CaP mineral coatings may be a useful platform for plasmid DNA delivery applications using various biomaterial platforms. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA.
   [Choi, Siyoung; Murphy, William L.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Murphy, William L.] AO Res Fdn, Davos, Switzerland.
RP Murphy, WL (reprint author), Univ Wisconsin, Dept Biomed Engn, 1550 Engn Dr, Madison, WI 53706 USA.
EM wlmurphy@wisc.edu
RI Murphy, William/I-4096-2014
OI Choi, Si-Young/0000-0003-1648-142X
FU National Institutes of Health [R21HL084547]; AO Research Foundation
FX The authors acknowledge financial support from the National Institutes
   of Health (R21HL084547) and the AO Research Foundation.
CR Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Barrere F, 2006, INT J NANOMED, V1, P317
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   Chou YF, 2004, BIOMATERIALS, V25, P5323, DOI 10.1016/j.biomaterials.2003.12.037
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   COLMAN A, 1978, EUR J BIOCHEM, V91, P303, DOI 10.1111/j.1432-1033.1978.tb20966.x
   DRIESSENS FCM, 1978, CALC TISS RES, V26, P127, DOI 10.1007/BF02013247
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   Giovannini R, 2000, BIOSEPARATION, V9, P359, DOI 10.1023/A:1011174905511
   Horvathova R, 2008, MAT SCI ENG C-BIO S, V28, P1414, DOI 10.1016/j.msec.2008.03.010
   Iijima M, 1998, J CRYST GROWTH, V193, P182, DOI 10.1016/S0022-0248(98)00455-2
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596
   KANG S, 2007, J BIOMED MATER RES A, V85, P747
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Koutsopoulos S, 2000, J CRYST GROWTH, V216, P450, DOI 10.1016/S0022-0248(00)00455-3
   KOUTSOPOULOS S, 1994, LANGMUIR, V10, P2423, DOI 10.1021/la00019a066
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   MAFE S, 1992, J PHYS CHEM-US, V96, P861, DOI 10.1021/j100181a062
   Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081
   Melville AJ, 2006, BIOMATERIALS, V27, P615, DOI 10.1016/j.biomaterials.2005.06.028
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Murphy WL, 2000, MATER RES SOC SYMP P, V599, P347
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   THOMANN JM, 1993, J COLLOID INTERF SCI, V157, P369, DOI 10.1006/jcis.1993.1198
   THOMANN JM, 1991, COLLOID SURFACE, V54, P145, DOI 10.1016/0166-6622(91)80057-U
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   Xin RL, 2005, BIOMATERIALS, V26, P6477, DOI 10.1016/j.biomaterials.2005.04.028
   Zhang QY, 2003, BIOMATERIALS, V24, P4741, DOI 10.1016/S0142-9612(03)00371-5
NR 40
TC 31
Z9 31
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3426
EP 3435
DI 10.1016/j.actbio.2010.03.020
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400008
PM 20304109
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Choe, SW
   Acharya, AP
   Keselowsky, BG
   Sorg, BS
AF Choe, Se-woon
   Acharya, Abhinav P.
   Keselowsky, Benjamin G.
   Sorg, Brian S.
TI Intravital microscopy imaging of macrophage localization to immunogenic
   particles and co-localized tissue oxygen saturation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Image analysis; Immune response; Inflammation; In vivo test; Oxygen
ID BIODEGRADABLE PLGA MICROSPHERES; NITRIC-OXIDE; INFLAMMATORY RESPONSE;
   IN-VIVO; MURINE MACROPHAGES; IMMUNE-RESPONSE; CELL; BIOMATERIALS;
   DELIVERY; MICE
AB Well-designed biomaterial polymer particle-based vaccines will optimally promote immune cell antigen-presenting behavior while minimizing adverse inflammatory responses to the particles and encapsulated drugs or adjuvants. It is important in the design of particle-based vaccines to consider possible harmful effects of immune response on tissue at the vaccination site. Intravital microscopy with rodent dorsal skin window chambers enables in vivo serial observations in the same animal, and such models which have been used to study angiogenesis and macrophage response to implanted biomaterials may also be useful for the development of particle-based vaccines. To our knowledge there have been no reports where intravital microscopy has documented real-time immune cell localization and potentially harmful co-localized tissue effects. In this proof-of-principle study we used fluorescence and spectral imaging intravital microscopy of mouse window chambers to measure macrophage localization and co-localized tissue microvessel hemoglobin saturation changes in response to an immunogenic stimulus from polymer particles loaded with lipopolysaccharide (LPS) serving as a model vaccine/adjuvant system. We observed greater and faster macrophage localization to stronger inflammatory stimuli from LPS-loaded particle doses, a trend of decreased microvessel oxygenation with increased macrophage accumulation and, in an extreme case, complete microvessel collapse accompanied by tissue necrosis. Our technique may be useful for optimizing design of particle-based vaccines and may give insight into the use of hemoglobin saturation as a biomarker of tissue inflammation for clinical investigations of particle-based vaccines. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Choe, Se-woon; Keselowsky, Benjamin G.; Sorg, Brian S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP Sorg, BS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, JG56 BMS Bldg,POB 116131, Gainesville, FL 32611 USA.
EM brian.sorg@bme.ufl.edu
RI Acharya, Abhinav/J-8384-2013
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2009, BIOMATERIALS, V30, P4168, DOI 10.1016/j.biomaterials.2009.04.032
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035
   Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0
   Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080
   Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005
   Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1
   Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122
   Hopf HW, 2007, ANTIOXID REDOX SIGN, V9, P1183, DOI 10.1089/ars.2007.1641
   Huang KT, 1998, BIOCHEM BIOPH RES CO, V245, P33, DOI 10.1006/bbrc.1998.8384
   Igartua M, 1998, J CONTROL RELEASE, V56, P63, DOI 10.1016/S0168-3659(98)00077-7
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778
   JIANG W, 2005, ADV DRUG DELIV REV, V57, P340
   Johansen P, 2000, EUR J PHARM BIOPHARM, V50, P129, DOI 10.1016/S0939-6411(00)00079-5
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Lanz E., 1997, J FLUORESC, V7, P317, DOI DOI 10.1023/A:1022586127784
   Liu KZ, 2009, J PERIODONTAL RES, V44, P117, DOI 10.1111/j.1600-0765.2008.01112.x
   Luzardo-Alvarez A, 2005, J CONTROL RELEASE, V109, P62, DOI 10.1016/j.jconrel.2005.09.015
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   Mochida S, 2007, J CLIN BIOCHEM NUTR, V41, P115, DOI 10.3164/jcbn.2007016
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Park JB, 2003, EXP MOL MED, V35, P325, DOI 10.1038/emm.2003.44
   Ratner B. D., 1997, BIOMATERIALS SCI INT
   Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006
   Rosas JE, 2001, VACCINE, V19, P4445, DOI 10.1016/S0264-410X(01)00192-X
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   SHANKAR SP, 2009, J BIOMED MATER RES A, V92, P1329
   Sorg BS, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2837439
   Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369
   Stamatas GN, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798704
   Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7
   Tang Y, 2007, CANCER GENE THER, V14, P346, DOI 10.1038/sj.cgt.7701030
   Triantafilou M, 2005, J ENDOTOXIN RES, V11, P5, DOI 10.1179/096805105225006641
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
NR 41
TC 11
Z9 11
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3491
EP 3498
DI 10.1016/j.actbio.2010.03.006
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400014
PM 20226885
DA 2018-10-19
ER

PT J
AU Derkaoui, SM
   Labbe, A
   Purnama, A
   Gueguen, V
   Barbaud, C
   Avramoglou, T
   Letourneur, D
AF Derkaoui, Sidi Mohamed
   Labbe, Amelie
   Purnama, Agung
   Gueguen, Virginie
   Barbaud, Christel
   Avramoglou, Thierry
   Letourneur, Didier
TI Films of dextran-graft-polybutylmethacrylate to enhance
   endothelialization of materials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polybutylmethacrylate; Dextran; Copolymer films; Cell proliferation;
   Endothelial cell migration
ID SELF-ASSEMBLED MONOLAYERS; CELL-ADHESION; BIOMATERIAL SURFACES; PROTEIN
   ADSORPTION; IN-VITRO; HYDROGELS; GROWTH; ACID); RATS; BIOCOMPATIBILITY
AB We have synthesized new structures obtained from amphiphilic copolymers of dextran and polybutylmethacrylate with the aim of endothelialization of biomaterials. Grafting of butylmethacrylate onto dextran has been carried out using ceric ammonium nitrate as initiator. Three copolymers were obtained (11,30 and 37 wt.% dextran) and homogeneous thin films were successfully prepared. In contrast to dextran, the resulting films were stable in water, and copolymers characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry and dynamic mechanical analysis showed evidence of hybrid properties between the parent homopolymers. Surfaces of films were smooth when analyzed by atomic force microscopy (roughness 2 +/- 1 nm) but greatly differed in their hydrophilicity by increasing the dextran content (water contact angle from 99 degrees to 57 degrees). In contrast to polybutylmethacrylate, where the proliferation of vascular smooth muscle cells (VSMCs) was excellent but that of endothelial cells was very low, the copolymer containing 11% of dextran was excellent for endothelial cells but very limited for VSMCs. An in vitro wound assay demonstrated that copolymer with 11% dextran is even more favorable for endothelial cell migration than tissue-culture polystyrene. Increasing the dextran content in the copolymers decreased the proliferation for both vascular cell types. Altogether, these results show that transparent and water-insoluble films made from copolymers of dextran and butylmethacrylate copolymers with an appropriate composition could enhance endothelial cell proliferation and migration. Therefore, a potential benefit of this approach is the availability of surfaces with tunable properties for the endothelialization of materials. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Derkaoui, Sidi Mohamed; Labbe, Amelie; Barbaud, Christel; Avramoglou, Thierry; Letourneur, Didier] Univ Paris Cite Paris Diderot, CHU X Bichat, INSERM, U698, F-75018 Paris, France.
   [Derkaoui, Sidi Mohamed; Labbe, Amelie; Gueguen, Virginie; Barbaud, Christel; Avramoglou, Thierry; Letourneur, Didier] Univ Paris Cite Paris Nord, Inst Galilee, F-93430 Villetaneuse, France.
   [Purnama, Agung] Univ Laval, Lab Biomat & Bioengn, Quebec City, PQ, Canada.
RP Letourneur, D (reprint author), Univ Paris 13, Inst Galilee, INSERM, U698, 99 Av JB Clement, F-93430 Villetaneuse, France.
EM didier.letourneur@inserm.fr
RI Didier, letourneur/H-5268-2012
OI Didier, letourneur/0000-0003-2197-9468; Gueguen,
   Virginie/0000-0003-2500-0747
FU INSERM; University Paris 13; IFR Paris Nord-Plaine de France;
   Franco-quebecois Samuel de Champlain
FX This work was supported by INSERM, University Paris 13 and IFR Paris
   Nord-Plaine de France. A.P. was supported by program Franco-quebecois
   Samuel de Champlain. The authors wish to express their gratitude to Dr.
   Cedric Lorthioir (CNRS Thiais, France) for his excellent technical
   assistance in DMA tests.
CR Abed A, 2008, TISSUE ENG PT A, V14, P519, DOI 10.1089/tea.2007.0134
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Ashraf SM, 2007, J APPL POLYM SCI, V103, P1367, DOI 10.1002/app.25439
   Athawale VD, 2000, CARBOHYD POLYM, V41, P407, DOI 10.1016/S0144-8617(99)00101-0
   Barbani N, 2005, EUR POLYM J, V41, P3004, DOI 10.1016/j.eurpolymj.2005.06.010
   Bertholon I, 2006, MACROMOLECULES, V39, P3559, DOI 10.1021/ma060338z
   Bos GW, 2005, BIOMATERIALS, V26, P3901, DOI 10.1016/j.biomaterials.2004.10.008
   Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032
   Chen YM, 2005, BIOMATERIALS, V26, P4588, DOI [10.1016/j.biomaterials.2004.11.025, 10.1016/j.bomaterials.2004.11.025]
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   De Groot CJ, 2001, BIOMATERIALS, V22, P1197, DOI 10.1016/S0142-9612(00)00266-0
   Derkaoui SM, 2008, BIOMACROMOLECULES, V9, P3033, DOI 10.1021/bm800470z
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Grossin L, 2009, ADV MATER, V21, P650, DOI 10.1002/adma.200801541
   Hlawaty H., 2007, AM J PHYSIOL-HEART C, V293, P3593
   Hsu SH, 2004, MACROMOL BIOSCI, V4, P891, DOI 10.1002/mabi.200400062
   Kim YS, 2005, TISSUE ENG, V11, P30, DOI 10.1089/ten.2005.11.30
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   Lavigne D, 2010, ANALYST, V135, P503, DOI 10.1039/b914539g
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   McCool B, 2006, J COLLOID INTERF SCI, V295, P294, DOI 10.1016/j.jcis.2005.08.010
   Moller S, 2007, BIOMOL ENG, V24, P496, DOI 10.1016/j.bioeng.2007.08.014
   Rimmer S, 2005, BIOMATERIALS, V26, P2219, DOI 10.1016/j.biomaterials.2004.07.013
   Risbud MV, 2002, J BIOMAT SCI-POLYM E, V13, P1067, DOI 10.1163/156856202320813792
   Robert D, 2010, BIOMATERIALS, V31, P1586, DOI 10.1016/j.biomaterials.2009.11.014
   Rosier A., 2001, ADV DRUG DELIVERY RE, V53, P95
   San Juan A, 2007, J BIOMED MATER RES A, V83A, P819, DOI 10.1002/jbm.a.31413
   Scotchford CA, 2003, BIOMATERIALS, V24, P1147, DOI 10.1016/S0142-9612(02)00488-X
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   SHI R, 2004, INT J PHARMACEUT, V27, P167
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Stenekes RJH, 1999, INT J PHARM, V183, P29, DOI 10.1016/S0378-5173(99)00038-1
   Tauer K, 1999, COLLOID SURFACE A, V153, P143, DOI 10.1016/S0927-7757(98)00436-1
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yagci C, 2005, EUR POLYM J, V41, P177, DOI 10.1016/j.eurpolymj.2004.08.008
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
   Zheng CL, 2005, SURF COAT TECH, V193, P361, DOI 10.1016/j.surfcoat.2004.08.152
NR 40
TC 9
Z9 9
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3506
EP 3513
DI 10.1016/j.actbio.2010.03.043
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400016
PM 20371388
DA 2018-10-19
ER

PT J
AU Yoshihara, K
   Yoshida, Y
   Nagaoka, N
   Fukegawa, D
   Hayakawa, S
   Mine, A
   Nakamura, M
   Minagi, S
   Osaka, A
   Suzuki, K
   Van Meerbeek, B
AF Yoshihara, Kumiko
   Yoshida, Yasuhiro
   Nagaoka, Noriyuki
   Fukegawa, Daisuke
   Hayakawa, Satoshi
   Mine, Atsushi
   Nakamura, Mariko
   Minagi, Shogo
   Osaka, Akiyoshi
   Suzuki, Kazuomi
   Van Meerbeek, Bart
TI Nano-controlled molecular interaction at adhesive interfaces for hard
   tissue reconstruction
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Interface; Adhesion; Nano; Hydroxyapatite; Dentin
ID BONE-CEMENT; FUNCTIONAL MONOMERS; DENTIN ADHESIVE; HYDROXYAPATITE;
   PERFORMANCE; SYSTEMS; COLLAGEN; LAYER; VIVO
AB Although decayed/fractured teeth can be reconstructed minimally invasively and nearly invisibly using adhesive technology, the clinical longevity of dental composite restorations is still too short. Water sorption is thought to be the principal cause of destabilization of the biomaterial-tooth bond. However, the actual mechanisms of interfacial degradation are far from understood. Here we report how nano-controlled molecular interaction at the biomaterial-hard tissue interface can improve bond durability. The use of functional monomers with a strong chemical affinity for the calcium in hydroxyapatite is essential for long-term durability. Correlative X-ray diffraction and solid-state nuclear magnetic resonance disclosed a time-dependent molecular interaction at the interface with stable ionic bond formation of the monomer to hydroxyapatite competing in time with the deposition of less stable calcium phosphate salts. The advanced tooth-biomaterial interaction model gives not only an insight into the mechanisms of bond degradation, but also provides a basis to develop functional monomers for more durable tooth reconstruction. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mine, Atsushi; Van Meerbeek, Bart] Catholic Univ Louvain, Dept Conservat Dent, Leuven BIOMAT Res Cluster, B-3000 Louvain, Belgium.
   [Yoshihara, Kumiko; Minagi, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama, Japan.
   [Yoshida, Yasuhiro; Fukegawa, Daisuke; Suzuki, Kazuomi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Okayama, Japan.
   [Yoshida, Yasuhiro; Hayakawa, Satoshi; Osaka, Akiyoshi; Suzuki, Kazuomi] Okayama Univ, Biomed Engn Res Ctr, Okayama, Japan.
   [Nagaoka, Noriyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Electron Microscopy Lab, Okayama, Japan.
   [Hayakawa, Satoshi; Osaka, Akiyoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Biomat Lab, Okayama, Japan.
   [Nakamura, Mariko] Junsei Jr Coll, Dept Hlth & Welf Program Dent Hyg, Okayama, Japan.
RP Van Meerbeek, B (reprint author), Catholic Univ Louvain, Dept Conservat Dent, Leuven BIOMAT Res Cluster, B-3000 Louvain, Belgium.
EM bart.vanmeerbeek@med.kuleuven.be
RI MINE, Atsushi/B-2281-2011; YOSHIDA, Yasuhiro/B-2472-2011; HAYAKAWA,
   Satoshi/B-2104-2011; Minagi, Shogo/B-2473-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614; 
FU Ministry of Education, Science, Sports and Culture of Japan; Fund for
   Scientific Research of Flanders (FWO) [G.0206.07]; KU Leuven [OT/06/55];
   Japan Society for the Promotion of Science [VS.011.07N]; FWO Flanders
   [VS.011.07N]
FX This study was supported in part by Grants-in-Aid for Scientific
   Research from the Ministry of Education, Science, Sports and Culture of
   Japan, by the Fund for Scientific Research of Flanders (FWO) Grant No.
   G.0206.07, by KU Leuven Research Grant OT/06/55 and by a Joint Research
   project in the framework of cooperation between the Japan Society for
   the Promotion of Science and FWO Flanders (VS.011.07N).
CR CHOW LC, 2001, MONOGRAPHS ORAL SCI, V18, P98
   *EUR COMM, 2007, 21 PLEN SESS HLTH CO
   Fukegawa D, 2006, J DENT RES, V85, P941, DOI 10.1177/154405910608501014
   Gandhi DD, 2007, NATURE, V447, P299, DOI 10.1038/nature05826
   INOKOSHI S, 1993, OPER DENT, V18, P8
   Inoue S, 2005, J DENT RES, V84, P1160, DOI 10.1177/154405910508401213
   Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945
   Manhart J, 2004, OPER DENT, V29, P481
   *MIN HLTH SOC AFF, 2009, NAT BOARD HLTH WELF
   Morita S, 1998, BIOMATERIALS, V19, P1601, DOI 10.1016/S0142-9612(97)00120-8
   Mumme T, 2007, ARCH ORTHOP TRAUM SU, V127, P409, DOI 10.1007/s00402-007-0340-9
   NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307
   Nakabayashi N, 1998, HYBRIDIZATION DENT H
   Nishiyama N, 2002, J DENT RES, V81, P469, DOI 10.1177/154405910208100707
   Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003
   Sakai T, 2000, J BIOMED MATER RES, V52, P24, DOI 10.1002/1097-4636(200010)52:1<24::AID-JBM4>3.0.CO;2-R
   SANO H, 1995, OPER DENT, V20, P18
   Saunders Ralph H Jr, 2005, Dent Clin North Am, V49, P293, DOI 10.1016/j.cden.2004.10.004
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Tai K, 2007, NAT MATER, V6, P454, DOI 10.1038/nmat1911
   Tay Franklin R, 2002, J Adhes Dent, V4, P255
   THYLSTRUP A, 1996, TXB CLIN CARIOLOGY
   Van Landuyt KL, 2008, J DENT RES, V87, P757, DOI 10.1177/154405910808700804
   Van Meerbeek B, 2003, OPER DENT, V28, P215
   Van Meerbeek B, 1999, J Adhes Dent, V1, P7
   Van Meerbeek B, 1998, J DENT RES, V77, P50, DOI 10.1177/00220345980770010501
   VANMEERBEEK B, 1992, J DENT RES, V71, P1530, DOI 10.1177/00220345920710081301
   VANMEERBEEK B, 2000, AM J DENT, V13, P3
   VANMEERBEEK B, 2009, T 2009 ANN M AC DENT
   WATSON TF, 1989, J DENT RES, V68, P1124, DOI 10.1177/00220345890680061301
   Xu J, 1997, J DENT RES, V76, P596, DOI 10.1177/00220345970760011101
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
   Yoshida Y, 2001, J DENT RES, V80, P1565, DOI 10.1177/00220345010800061701
   Yoshida Y, 1999, J BIOMED MATER RES, V47, P85, DOI 10.1002/(SICI)1097-4636(199910)47:1<85::AID-JBM12>3.0.CO;2-H
   Yoshioka M, 2002, J BIOMED MATER RES, V59, P56, DOI 10.1002/jbm.1216
NR 35
TC 108
Z9 114
U1 2
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3573
EP 3582
DI 10.1016/j.actbio.2010.03.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400024
PM 20346420
DA 2018-10-19
ER

PT J
AU Fu, RH
   Liu, SP
   Ou, CW
   Huang, CM
   Wang, YC
AF Fu, Ru-Huei
   Liu, Shih-Ping
   Ou, Chen-Wei
   Huang, Chin-Mao
   Wang, Yu-Chi
TI Spatial control of cells, peptide delivery and dynamic monitoring of
   cellular physiology with chitosan-assisted dual color quantum dot FRET
   peptides
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Chitosan; Micropatterning; Peptide delivery; Quantum dots; FRET
ID CHAPERONE-MEDIATED AUTOPHAGY; GENE DELIVERY; IN-VITRO; SURFACE
   MODIFICATION; DNA; NANOPARTICLES; NANOCRYSTALS; CYTOTOXICITY;
   FABRICATION; OLIGOMERS
AB Cell-based assays have become important tools in the pharmaceutical and biotechnology industries. However, observing and monitoring molecules in cells that mimic the physiological environment is often difficult. Dynamic processes not only increase the accuracy of simulations, but also improve our understanding of the function and regulation of molecules within cells. In this study we used chitosan as a multifunctional biomaterial for selective micropatterning of cells, peptide delivery and covalent bonding with quantum dots (QD) to decrease the cytotoxicity of QD. Our results demonstrate the efficacy of chitosan-QD-peptide-Alexa Fluor 488 in controlling the spread and spatial organization of cells. Cationic chitosan also provided an efficient delivery mechanism to live cells. We used the shift from green to red fluorescence of the chitosan dual color QD peptide to detect biological activity. This methodology has potential applications in high throughput screening of inhibitors and activators of biological mechanisms and pathways and for use in the pharmaceutical industry. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Yu-Chi] Biotechplex Corp, San Marcos, CA 92078 USA.
   [Liu, Shih-Ping] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.
   [Fu, Ru-Huei; Ou, Chen-Wei; Huang, Chin-Mao; Wang, Yu-Chi] China Med Univ, Grad Inst Immunol, Taichung 40402, Taiwan.
   [Fu, Ru-Huei; Liu, Shih-Ping] China Med Univ Hosp, Ctr Neuropsychiat, Taichung 40402, Taiwan.
RP Wang, YC (reprint author), Biotechplex Corp, 1205 Linda Vista Dr, San Marcos, CA 92078 USA.
EM ywang@biotechplex.com
RI Zhou, Qinghui/C-8436-2011
FU China Medical University Hospital (Taiwan) [DMR-98-138]; Taiwan
   Department of Health Clinical Trial and Research Center of Excellence
   [DOH99-TD-B-111-004]
FX This work was supported by the China Medical University Hospital
   (Taiwan) (DMR-98-138) and the Taiwan Department of Health Clinical Trial
   and Research Center of Excellence (DOH99-TD-B-111-004).
CR Anderson JR, 2000, ANAL CHEM, V72, P3158, DOI 10.1021/ac9912294
   Bakalova R, 2005, J NANOSCI NANOTECHNO, V5, P887, DOI 10.1166/jnn.2005.117
   Berthold A, 2002, ELECTROPHORESIS, V23, P3511, DOI 10.1002/1522-2683(200210)23:20<3511::AID-ELPS3511>3.0.CO;2-C
   Bhandari RNB, 2001, TISSUE ENG, V7, P345, DOI 10.1089/10763270152044206
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   BRITLAND S, 1992, BIOTECHNOL PROGR, V8, P155, DOI 10.1021/bp00014a010
   Burbaum JJ, 1997, CURR OPIN CHEM BIOL, V1, P72, DOI 10.1016/S1367-5931(97)80111-1
   CarrenoGomez B, 1997, INT J PHARM, V148, P231, DOI 10.1016/S0378-5173(96)04847-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang E, 2005, BIOCHEM BIOPH RES CO, V334, P1317, DOI 10.1016/j.bbrc.2005.07.028
   Chen AA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni188
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Clapp AR, 2006, CHEMPHYSCHEM, V7, P47, DOI 10.1002/cphc.200500217
   Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x
   Cuervo AM, 2000, J CELL SCI, V113, P4441
   Derfus AM, 2004, ADV MATER, V16, P961, DOI 10.1002/adma.200306111
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144
   DICE JF, 1992, ANN NY ACAD SCI, V674, P58, DOI 10.1111/j.1749-6632.1992.tb27477.x
   Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Franch HA, 2001, J BIOL CHEM, V276, P19126, DOI 10.1074/jbc.M101777200
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Ho YP, 2006, J CONTROL RELEASE, V116, P83, DOI 10.1016/j.jconrel.2006.09.005
   HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327
   Kubota M, 2005, APPL ENVIRON MICROB, V71, P8895, DOI 10.1128/AEM.71.12.8895-8902.2005
   Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040
   Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021
   Lee M, 2001, PHARMACEUT RES, V18, P427, DOI 10.1023/A:1011037807261
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NAFEE N, 2009, INT J PHARMACEUT, V38, P130
   Parak WJ, 2005, NANOTECHNOLOGY, V16, pR9, DOI 10.1088/0957-4484/16/2/R01
   Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m
   Pinaud F, 2004, J AM CHEM SOC, V126, P6115, DOI 10.1021/ja031691c
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Schulze C, 2008, NANOTOXICOLOGY, V2, P51, DOI 10.1080/17435390802018378
   Shavel A, 2005, CHEMPHYSCHEM, V6, P449, DOI 10.1002/cphc.200400516
   Shi LF, 2006, J AM CHEM SOC, V128, P10378, DOI 10.1021/ja063509o
   Strand SP, 2008, BIOMACROMOLECULES, V9, P3268, DOI 10.1021/bm800832u
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Tan WB, 2005, J BIOMED MATER RES A, V75A, P56, DOI 10.1002/jbm.a.30410
   Tan WB, 2007, J NANOSCI NANOTECHNO, V7, P2389, DOI 10.1166/jnn.2007.415
   TERLECKY SR, 1993, J BIOL CHEM, V268, P23490
   TERLECKY SR, 1992, J BIOL CHEM, V267, P9202
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   WANG YC, 2004, FASEB J, V18, pU620
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Yang ST, 2008, CURR OPIN DRUG DISC, V11, P111
   Zhao LZ, 2009, SCI TOTAL ENVIRON, V407, P5019, DOI 10.1016/j.scitotenv.2009.05.052
NR 58
TC 4
Z9 4
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3621
EP 3629
DI 10.1016/j.actbio.2010.03.005
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400029
PM 20215055
DA 2018-10-19
ER

PT J
AU Torres, FG
   Troncoso, OP
   Piaggio, F
   Hijar, A
AF Torres, Fernando G.
   Troncoso, Omar P.
   Piaggio, Franco
   Hijar, Alfredo
TI Structure-property relationships of a biopolymer network: The eggshell
   membrane
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Eggshell membrane; Biopolymer; Polymer network; Mooney-Rivlin
ID SOFT BIOLOGICAL TISSUES; MECHANICAL-PROPERTIES; ENTROPIC ELASTICITY;
   TENSILE PROPERTIES; CHICKEN EGGSHELL; DNA-MOLECULES; BRAIN-TISSUE;
   SPIDER SILK; COLLAGEN; AFM
AB The eggshell membrane (ESM) is a biopolymer network that may have potential applications in biomedicine, but it also may reveal important details regarding the behaviour of biopolymer networks. In this paper, we have studied the mechanical and morphological properties of the ESM in order to reveal important structure-property relationships. Light optical microscopy and atomic force microscopy were used to assess the morphology of the ESM. The mechanical properties of membranes and individual fibres were studied by means of tensile tests and nanoindentation tests, respectively. The mechanical behaviour of ESM networks in different environmental conditions showed a non-linear and a linear regime. As for elastomers and other biopolymer systems, the non-linear regime was modelled by the Mooney-Rivlin relation. The Young's modulus in the linear regime of the network was related to the Young's modulus of the individual fibres using Gibson and Ashby analysis for cellular solids. The results of morphological characterization were used to relate the properties of individual fibres to the properties of the whole networks. This enabled us to predict the macroscopical properties of the network based on the properties of the individual fibres. It was found that the ESM networks behaved as both Mooney-Rivlin and Hookean materials in different environmental conditions. This study helps elucidate the properties of the biopolymer networks found in nature and describes important mechanical properties for the use of the ESM as a biomaterial. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Torres, Fernando G.; Troncoso, Omar P.; Piaggio, Franco; Hijar, Alfredo] Catholic Univ Peru, Dept Mech Engn, Lima 32, Peru.
RP Torres, FG (reprint author), Catholic Univ Peru, Dept Mech Engn, Lima 32, Peru.
EM fgtorres@pucp.edu.pe
RI Troncoso, Omar/G-6469-2013
OI Troncoso, Omar/0000-0001-9621-2435; Torres, Fernando
   G./0000-0002-3123-266X
FU Academic Research Direction (DAI-PUCP); International Foundation for
   Science (IFS), Stockholm, Sweden [RGA F/4194-2]; Peruvian Council of
   Science and Technology (CONCYTEC)
FX The authors would like to thank the Academic Research Direction
   (DAI-PUCP), the International Foundation for Science (IFS, Stockholm,
   Sweden, RGA F/4194-2) and the Peruvian Council of Science and Technology
   (CONCYTEC) for financial support. We would also like to thank Mr. R.
   Lujan and the Materials Testing Laboratory at PUCP for their help with
   the SEM (Fig. 3a and b).
CR ABRAHAMS M, 1967, MED BIOL ENG, V5, P433, DOI 10.1007/BF02479137
   Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185
   Buehler MJ, 2007, BIOPHYS J, V93, P37, DOI 10.1529/biophysj.106.102616
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Durmus E, 2003, J INT MED RES, V31, P223, DOI 10.1177/147323000303100309
   Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c
   Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966
   Freed AD, 2005, J BIOMECH ENG-T ASME, V127, P587, DOI 10.1115/1.1934145
   Fung YC, 1993, BIOMECHANICS MECH PR
   Garrido MA, 2002, POLYMER, V43, P4495, DOI 10.1016/S0032-3861(02)00254-9
   Ghasemi-Mobarakeh L, 2007, J APPL POLYM SCI, V106, P2536, DOI 10.1002/app.26949
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1
   Johnson K. L., 1994, CONTACT MECH
   LEACH RM, 1982, POULTRY SCI, V61, P2040, DOI 10.3382/ps.0612040
   Lin DC, 2007, EXPRESS POLYM LETT, V1, P576, DOI 10.3144/expresspolymlett.2007.79
   MAEDA K, 1982, BURNS, V8, P313, DOI 10.1016/0305-4179(82)90029-8
   Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008
   Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004
   Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4
   Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2
   Miller K, 2001, J BIOMECH, V34, P651, DOI 10.1016/S0021-9290(00)00236-0
   Misof K, 1997, BIOPHYS J, V72, P1376, DOI 10.1016/S0006-3495(97)78783-6
   Nakano T, 2003, POULTRY SCI, V82, P510, DOI 10.1093/ps/82.3.510
   Nakano T, 2001, POULTRY SCI, V80, P681, DOI 10.1093/ps/80.5.681
   ODIJK T, 1995, MACROMOLECULES, V28, P7016, DOI 10.1021/ma00124a044
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072
   Radmacher M., 1999, ENG MED BIOL MAG, V16, P47
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213
   Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8
   Schafer A, 2008, EUR BIOPHYS J BIOPHY, V37, P197, DOI [10.1007/s00249-007-0216-5, 10.1007/S00249-007-0216-5]
   Shoji R., 2004, J MATER CYCLES WASTE, V6, P142
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P165
   Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795
   Strasser S, 2007, BIOCHEM BIOPH RES CO, V354, P27, DOI 10.1016/j.bbrc.2006.12.114
   Torres FG, 2008, MAT SCI ENG C-BIO S, V28, P1276, DOI 10.1016/j.msec.2007.12.001
   Torres FG, 2009, SOFT MATTER, V5, P4185, DOI 10.1039/b900441f
   Torres FG, 2004, POLYM POLYM COMPOS, V12, P705, DOI 10.1177/096739110401200807
   Troncoso OP, 2008, ACTA BIOMATER, V4, P1114, DOI 10.1016/j.actbio.2008.01.014
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006
   Yang Jui-Yung, 2003, Chang Gung Med J, V26, P153
NR 45
TC 26
Z9 27
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3687
EP 3693
DI 10.1016/j.actbio.2010.03.014
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400036
PM 20227532
DA 2018-10-19
ER

PT J
AU Clauss, M
   Trampuz, A
   Borens, O
   Bohner, M
   Ilchmann, T
AF Clauss, Martin
   Trampuz, Andrej
   Borens, Olivier
   Bohner, Marc
   Ilchmann, Thomas
TI Biofilm formation on bone grafts and bone graft substitutes: Comparison
   of different materials by a standard in vitro test and microcalorimetry
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biofilm; Bone graft; beta-TCP; Infection; Microcalorimetry
ID BIOMATERIAL SURFACE-CHEMISTRY; STAPHYLOCOCCUS-EPIDERMIDIS; INFECTION;
   BACTERIAL; ADHESION; AUREUS; HYDROXYAPATITE; COLONIZATION; CALORIMETRY;
   PERFORMANCE
AB We analyzed the initial adhesion and biofilm formation of Staphylococcus aureus (ATCC 29213) and S. epidermidis RP62A (ATCC 35984) on various bone grafts and bone graft substitutes under standardized in vitro conditions. In parallel, microcalorimetry was evaluated as a real-time microbiological assay in the investigation of biofilm formation and material science research. The materials beta-tricalcium phosphate (beta-TCP), processed human spongiosa (Tutoplast (TM)) and poly(methyl methacrylate) (PMMA) were investigated and compared with polyethylene (PE). Bacterial counts (log(10) cfu per sample) were highest on beta-TCP (S. aureus 7.67 +/- 0.17; S. epidermidis 8.14 +/- 0.05) while bacterial density (log(10) cfu per surface) was highest on PMMA (S. aureus 6.12 +/- 0.2, S. epidermidis 7.65 +/- 0.13). Detection time for S. aureus biofilms was shorter for the porous materials (beta-TCP and processed human spongiosa, p < 0.001) compared to the smooth materials (PMMA and PE), with no differences between beta-TCP and processed human spongiosa (p > 0.05) or PMMA and PE (p > 0.05). In contrast, for S. epidermidis biofilms the detection time was different (p < 0.001) between all materials except between processed human spongiosa and PE (p > 0.05). The quantitative analysis by quantitative culture after washing and sonication of the material demonstrated the importance of monitoring factors like specific surface or porosity of the test materials. Isothermal microcalorimetry proved to be a suitable tool for an accurate, non-invasive and real-time microbiological assay, allowing the detection of bacterial biomass without removing the biofilm from the surface. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Clauss, Martin; Ilchmann, Thomas] Kantonsspital Liestal, Dept Orthoped Surg, CH-4410 Liestal, Switzerland.
   [Clauss, Martin; Bohner, Marc] RMS Fdn, Bettlach, Switzerland.
   [Clauss, Martin; Trampuz, Andrej] Univ Hosp Lausanne CHUV, Dept Internal Med, Infect Dis Serv, Lausanne, Switzerland.
   [Trampuz, Andrej; Borens, Olivier] Univ Hosp Lausanne CHUV, Dept Surg, Sept Surg Unit, Lausanne, Switzerland.
   [Borens, Olivier] Univ Hosp Lausanne CHUV, Dept Orthoped & Traumatol, Lausanne, Switzerland.
RP Clauss, M (reprint author), Kantonsspital Liestal, Dept Orthoped Surg, Rheinstr 26, CH-4410 Liestal, Switzerland.
EM martin.clauss@ksli.ch
RI Bohner, Marc/F-3828-2011
OI Bohner, Marc/0000-0002-5079-3286
FU RMS Foundation, Bettlach, Switzerland; Swiss Orthopedic Society
   (SGO/SSO); Swiss National Foundation [3200B0-112547]; Gebert Ruf
   Stiftung
FX This study was supported by a research grant (E09_0001) from the RMS
   Foundation, Bettlach, Switzerland and a grant from the Swiss Orthopedic
   Society (SGO/SSO). Additional funding was obtained for the
   microcalorimetric analysis from the Swiss National Foundation
   (#3200B0-112547) and the Gebert Ruf Stiftung. Staphylococcus epidermidis
   RP62A (ATCC 35984) was kindly provided by Prof. P. Vaudaux from the
   Department of Infectious Disease, University Hospital, Geneva,
   Switzerland. We want to thank W. Hirsinger for his help with the SEM
   studies, S. Grunefelder and P. Brotschi for their help producing the
   samples, and Dr. A. Steinhuber and B. Schneider for laboratory
   assistance. We also thank the following companies/organizations for
   providing the test materials: Biomet (Biomet Bone Cement R (TM)),
   Novomedics (Tutoplast (TM)) and RMS Foundation (beta-TCP, PE).
CR Baldoni D, 2010, ANTIMICROB AGENTS CH, V54, P157, DOI 10.1128/AAC.00700-09
   Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Bashoor-Zadeh M, 2010, ACTA BIOMATER, V6, P864, DOI 10.1016/j.actbio.2009.08.007
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Bohner M, 2000, INJURY, V31, pS37
   Buchholz F, 2010, ANTIMICROB AGENTS CH, V54, P312, DOI 10.1128/AAC.00583-09
   Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Crockarell JR, 1998, J BONE JOINT SURG AM, V80A, P1306, DOI 10.2106/00004623-199809000-00009
   Cutter C Suzanne, 2006, J Long Term Eff Med Implants, V16, P249
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARRIS LG, 2006, INJURY S2, V37
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Jakubowski W, 2008, ADV APPL CERAM, V107, P217, DOI 10.1179/174367608X263395
   Lerchner J, 2008, J MICROBIOL METH, V74, P74, DOI 10.1016/j.mimet.2008.04.004
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   OSTERMANN PAW, 1994, ORTHOPEDICS, V17, P397
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   Polonio RE, 2001, ANTIMICROB AGENTS CH, V45, P3262, DOI 10.1128/AAC.45.11.3262-3266.2001
   Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0
   Schlegel Urs, 2006, Injury, V37 Suppl 2, pS67, DOI 10.1016/j.injury.2006.04.011
   Stahli C, 2010, ACTA BIOMATER, V6, P2760, DOI 10.1016/j.actbio.2010.01.018
   Sutherland D, 2005, BONE REGENERATION AND REPAIR: BIOLOGY AND CLINICAL APPLICATIONS, P133, DOI 10.1385/1-59259-863-3:133
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Trampuz Andrej, 2008, Curr Infect Dis Rep, V10, P394, DOI 10.1007/s11908-008-0064-1
   Trampuz A, 2007, TRANSFUSION, V47, P1643, DOI 10.1111/j.1537-2995.2007.01336.x
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Trampuz A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-116
   VANBLITTERSWIJK CA, 1986, J BIOMED MATER RES, V20, P989, DOI 10.1002/jbm.820200713
   Vogely HC, 2000, J ORTHOPAED RES, V18, P485, DOI 10.1002/jor.1100180323
   von Ah U, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-106
   von Doernberg MC, 2006, BIOMATERIALS, V27, P5186, DOI 10.1016/j.biomaterials.2006.05.051
   Weibrich G, 2000, Mund Kiefer Gesichtschir, V4, P148, DOI 10.1007/s100060050187
NR 44
TC 35
Z9 37
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2010
VL 6
IS 9
BP 3791
EP 3797
DI 10.1016/j.actbio.2010.03.011
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 643SG
UT WOS:000281318400048
PM 20226886
DA 2018-10-19
ER

PT J
AU Lopez-Valladares, MJ
   Rodriguez-Ares, MT
   Tourino, R
   Gude, F
   Silva, MT
   Couceiro, J
AF Lopez-Valladares, Maria J.
   Teresa Rodriguez-Ares, M.
   Tourino, Rosario
   Gude, Francisco
   Teresa Silva, M.
   Couceiro, Jose
TI Donor age and gestational age influence on growth factor levels in human
   amniotic membrane
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE amniotic membrane; growth factors; interdonor variations; ocular surface
ID OCULAR SURFACE RECONSTRUCTION; TRANSPLANTATION; CORNEAL; PROTEINS;
   PLACENTA; MAINTENANCE; SUPPRESSION; EXPRESSION; ULCERATION; PREGNANCY
AB Purpose:
   Amniotic membrane (AM) is used as a biomaterial for reconstruction in ocular surface surgery. This study investigated the influence of interdonor variations and processing and preservation procedures applied to the AM on growth factors and protein levels.
   Methods:
   Samples of human AM from thirteen donors were analysed. Collected donor data were age, parity and gestational age. Total protein amount was measured in extracts of intact AM nonpreserved, lyophilized and cryopreserved, at -80 degrees C and in liquid nitrogen. An enzyme-linked immunosorbent assay (ELISA) was used to assay growth factors protein levels for epidermal growth factor, basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), transforming growth factor beta1 (TFG-beta(1)) and nerve growth factor (NGF). Univariate and multivariate statistical analyses were used to study the influence of the preservation method applied and interdonor variations on growth factors levels.
   Results:
   We detected important variations in growth factors and protein concentrations between samples from different donors. Total protein amount, bFGF, HGF, KGF and TGF-beta(1) showed lower levels in samples from donors with higher gestational ages and donor ages, for all groups.
   Conclusion:
   The variability in the biochemical composition of AM from different donors is considerable, and it is related with donor factors as donor age and gestational age. As AM biochemical composition has a role in its therapeutic effects, these variations could affect the clinical results of amniotic membrane transplantation and must be taken into account in donor selection processes.
C1 [Lopez-Valladares, Maria J.; Teresa Rodriguez-Ares, M.; Tourino, Rosario] USC Univ Hosp Complex Santiago de Compostela, Dept Ophthalmol, Hosp Conxo, Santiago De Compostela 15706, Spain.
   [Teresa Rodriguez-Ares, M.] USC Univ Hosp Complex Santiago Compostela, Clin Hosp, Dept Surg, Santiago De Compostela, Spain.
   [Gude, Francisco] USC Univ Hosp Complex Santiago Compostela, Clin Hosp, Clin Epidemiol Unit, Santiago De Compostela 15706, Spain.
   [Gude, Francisco] USC Univ Hosp Complex Santiago Compostela, Clin Hosp, Inst Invest Sanitaria Santiago Compostela, Santiago De Compostela 15706, Spain.
   [Teresa Silva, M.; Couceiro, Jose] Univ Santiago Compostela, Inst Orthopaed, Santiago De Compostela, Spain.
   [Teresa Silva, M.; Couceiro, Jose] Univ Santiago Compostela, Muscleskeletal Tissue Bank, Santiago De Compostela, Spain.
RP Lopez-Valladares, MJ (reprint author), USC Univ Hosp Complex Santiago de Compostela, Dept Ophthalmol, Hosp Conxo, C Ramon Baltar S-N, Santiago De Compostela 15706, Spain.
EM lopez.mariajesus@gmail.com
FU Instituto de Salud Carlos III (Spanish Ministry of Science and
   Technology) [FIS-PI021608, BAE09/90052]
FX Supported by Instituto de Salud Carlos III (Spanish Ministry of Science
   and Technology): FIS-PI021608. F. Gude was supported by a grant
   (BAE09/90052) from the Instituto de Salud Carlos-III (Spanish Ministry
   of Science and Technology).
CR BOURNE GL, 1960, AM J OBSTET GYNECOL, V79, P1070, DOI 10.1016/0002-9378(60)90512-3
   CAUGHEY AB, 2008, AM J OBSTET GYNECOL, V198
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Desrosiers P, 2006, FERTIL STERIL, V85, P1744, DOI 10.1016/j.fertnstert.2005.11.046
   Furugori K, 1997, J CLIN ENDOCR METAB, V82, P2726, DOI 10.1210/jc.82.8.2726
   Gargiulo AR, 1997, J CLIN ENDOCR METAB, V82, P113, DOI 10.1210/jc.82.1.113
   Gicquel JJ, 2009, TISSUE ENG PT A, V15, P1919, DOI 10.1089/ten.tea.2008.0432
   Gunduz K, 2006, EYE, V20, P351, DOI 10.1038/sj.eye.6701890
   Hanada K, 2001, AM J OPHTHALMOL, V131, P324, DOI 10.1016/S0002-9394(00)00825-4
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   HOFMANN GE, 1991, J CLIN ENDOCR METAB, V73, P882, DOI 10.1210/jcem-73-4-882
   Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415
   Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5
   Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P975, DOI 10.1016/j.ajog.2004.06.053
   Kauma S, 1997, J CLIN ENDOCR METAB, V82, P949, DOI 10.1210/jc.82.3.949
   KIM JC, 1995, CORNEA, V14, P473
   Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x
   Nakamura T, 2006, ACTA OPHTHALMOL SCAN, V84, P401, DOI 10.1111/j.1600-0420.2006.00667.x
   Nakamura T, 2008, BIOMATERIALS, V29, P3729, DOI 10.1016/j.biomaterials.2008.05.023
   PAOLO R, 2001, TRANSPLANTATION, V72, P1478
   PRESTRELSKI SJ, 1993, BIOPHYS J, V65, P661, DOI 10.1016/S0006-3495(93)81120-2
   Rama Paolo, 2001, Cell and Tissue Banking, V2, P155, DOI 10.1023/A:1020158206073
   Rodriguez-Ares MT, 2004, CORNEA, V23, P577, DOI 10.1097/01.ico.0000121709.58571.12
   SCOTT J, 1985, J CELL SCI, P19
   Shao CK, 2004, INVEST OPHTH VIS SCI, V45, P1758, DOI 10.1167/iovs.03-0882
   Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8
   Rodriguez-Ares MT, 2009, ACTA OPHTHALMOL, V87, P396, DOI 10.1111/j.1755-3768.2008.01261.x
   Touhami A, 2002, INVEST OPHTH VIS SCI, V43, P987
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   Velez DR, 2008, HUM REPROD, V23, P1902, DOI 10.1093/humrep/den170
   von Versen-Hoeynck Frauke, 2004, Cell and Tissue Banking, V5, P45, DOI 10.1023/B:CATB.0000022276.47180.96
   Xuan YH, 2007, HISTOL HISTOPATHOL, V22, P227, DOI 10.14670/HH-22.227
NR 40
TC 22
Z9 22
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-375X
EI 1755-3768
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD SEP
PY 2010
VL 88
IS 6
BP e211
EP e216
DI 10.1111/j.1755-3768.2010.01908.x
PG 6
WC Ophthalmology
SC Ophthalmology
GA 643PI
UT WOS:000281310000003
PM 20528787
OA Bronze
DA 2018-10-19
ER

PT J
AU Zheng, WF
   Zhang, W
   Jiang, XY
AF Zheng, Wenfu
   Zhang, Wei
   Jiang, Xingyu
TI Biomimetic Collagen Nanofibrous Materials for Bone Tissue Engineering
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Review
ID CROSS-LINKED COLLAGEN; NANO-FIBROUS SCAFFOLDS; MESENCHYMAL STEM-CELLS;
   NEUTRAL SALT EXTRACTS; IN-VITRO; MECHANICAL-PROPERTIES; ELECTROSPUN
   COLLAGEN; OSTEOGENIC DIFFERENTIATION; MINERALIZED COLLAGEN;
   CONNECTIVE-TISSUE
AB Hierarchical assemblies of nanofibres are ubiquitous in nature. Mineralized type I collagen is the basic building block of hierarchically organized, highly complex structures of bone tissue. As a biomaterial, collagen is widely utilized in biomimetic nanofibrous matrix fabrication due to its inherent biocompatibility and widespread occurrence in nature. Nanotechnology has recently gained a new impetus due to the introduction of the concept of biomimetic nanofibres for tissue regeneration. The emergence of electrospinning techniques provides a new opportunity to fabricate nano-collagen fibres for bone tissue engineering. By orchestrating major parameters, collagen fibres with different components (pure or blended), sizes (nanometre to micrometre) and surface properties (mineralized or modified by functional bioactive molecules) have been developed and their effects on bone cell adhesion, proliferation, migration and differentiation evaluated. This review briefly introduces natural mineralized collagen structures in bone, biomimetic mineralization and bone grafts, and in vitro mineralization of collagen nanofibres fabricated by using three major techniques-molecular self-assembly, electrospinning, and phase separation. Their applications in bone tissue engineering are also discussed. We highlight the electrospinning technique in collagen nanofibre fabrication and its great potential for bone tissue regeneration.
C1 [Zheng, Wenfu; Zhang, Wei; Jiang, Xingyu] Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
RP Zheng, WF (reprint author), Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, 11 ZhongGuanCun Beiyitiao, Beijing 100190, Peoples R China.
EM zhangw@nanoctr.cn
OI Jiang, Xingyu/0000-0002-5008-4703
FU National Science Foundation of China [90813032, 20890020, 50902025];
   Ministry of Science and Technology [2006CB705600, 2007CB714502,
   2009CB930001]; Chinese Academy of Sciences [KJCX2-YW-M15]
FX We thank the Human Frontier Science Program, the National Science
   Foundation of China (90813032, 20890020 and 50902025), the Ministry of
   Science and Technology (2006CB705600, 2007CB714502 and 2009CB930001) and
   the Chinese Academy of Sciences (KJCX2-YW-M15) for funding.
CR Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Ayerza MA, 2006, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000229291.21722.b5
   BACHRA BN, 1959, ARCH BIOCHEM BIOPHYS, V84, P79, DOI 10.1016/0003-9861(59)90556-9
   BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bernhardt A, 2009, J BIOMED MATER RES A, V90A, P852, DOI 10.1002/jbm.a.32144
   Bisht S, 2005, INT J PHARMACEUT, V288, P157, DOI 10.1016/j.ijpharm.2004.07.035
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Boudriot U, 2006, ARTIF ORGANS, V30, P785, DOI 10.1111/j.1525-1594.2006.00301.x
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BROWN WE, 1976, ANNU REV MATER SCI, V6, P213, DOI 10.1146/annurev.ms.06.080176.001241
   Butler D, 1998, NATURE, V391, P320
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   CHAN CK, 2009, BIOMED MATER, V4, pNIL77
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012
   Cisneros DA, 2007, SMALL, V3, P956, DOI 10.1002/smll.200600598
   Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Damodaran G, 2009, J BIOMED MATER RES A, V89A, P1001, DOI 10.1002/jbm.a.32045
   Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   ELLIOTT DH, 1965, BIOL REV, V40, P392, DOI 10.1111/j.1469-185X.1965.tb00808.x
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Fan TX, 2009, PROG MATER SCI, V54, P542, DOI 10.1016/j.pmatsci.2009.02.001
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163
   Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349
   Gast K, 2001, EUR BIOPHYS J BIOPHY, V30, P273, DOI 10.1007/s002490100148
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234
   GROSS J, 1954, P NATL ACAD SCI USA, V40, P679, DOI 10.1073/pnas.40.8.679
   GROSS J, 1958, J EXP MED, V107, P265, DOI 10.1084/jem.107.2.265
   GROSS J, 1958, J EXP MED, V107, P247, DOI 10.1084/jem.107.2.247
   GROSS J, 1955, P NATL ACAD SCI USA, V41, P1, DOI 10.1073/pnas.41.1.1
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   HIGHBERGER JH, 1951, P NATL ACAD SCI USA, V37, P286, DOI 10.1073/pnas.37.5.286
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1
   Ishii D, 2009, BIOMACROMOLECULES, V10, P237, DOI 10.1021/bm8009363
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Katta P, 2004, NANO LETT, V4, P2215, DOI 10.1021/nl0486158
   KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1
   Keeney M, 2010, BIOMATERIALS, V31, P2893, DOI 10.1016/j.biomaterials.2009.12.041
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Landis WJ, 2006, J MATER CHEM, V16, P1495, DOI 10.1039/b505706j
   Landis WJ, 2002, COMP BIOCHEM PHYS A, V133, P1135, DOI 10.1016/S1095-6433(02)00248-9
   LANE JM, 1999, CLIN ORTHOP S, V367, pS107
   Lanfer B, 2008, BIOMATERIALS, V29, P3888, DOI 10.1016/j.biomaterials.2008.06.016
   Lanfer B, 2009, BIOMATERIALS, V30, P5950, DOI 10.1016/j.biomaterials.2009.07.039
   Lee J, 2008, BIOMATERIALS, V29, P1872, DOI 10.1016/j.biomaterials.2007.12.029
   Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z
   LEES S, 1988, CONNECT TISSUE RES, V18, P41, DOI 10.3109/03008208809019071
   Lewandrowski K U, 2001, J Orthop Sci, V6, P545, DOI 10.1007/s007760100011
   Li JX, 2006, BIOMACROMOLECULES, V7, P2243, DOI 10.1021/bm0603342
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao S, 2005, J BIOMED MATER RES B, V74B, P817, DOI 10.1002/jbm.b.30315
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Liao S, 2008, J MECH BEHAV BIOMED, V1, P252, DOI 10.1016/j.jmbbm.2008.01.007
   Liao S, 2006, BIOMED MATER, V1, pR45, DOI 10.1088/1748-6041/1/3/R01
   Liu LR, 2003, ARTIF CELL BLOOD SUB, V31, P435, DOI 10.1081/BIO-120025414
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Liu YY, 2009, ELECTROPHORESIS, V30, P3269, DOI 10.1002/elps.200900128
   LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198
   Ma K, 2008, BIOMATERIALS, V29, P2096, DOI 10.1016/j.biomaterials.2008.01.024
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Madurantakam PA, 2009, BIOMATERIALS, V30, P5456, DOI 10.1016/j.biomaterials.2009.06.043
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E
   MARSHALL MJ, 1993, CALCIFIED TISSUE INT, V52, P21, DOI 10.1007/BF00675622
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MECHANIC G, 1971, BIOCHEM BIOPH RES CO, V45, P644, DOI 10.1016/0006-291X(71)90465-7
   MECHANIC GL, 1974, BIOCHEM BIOPH RES CO, V60, P756, DOI 10.1016/0006-291X(74)90305-2
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P635, DOI 10.1016/j.ijom.2004.04.006
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   Muscolo DL, 2005, J BONE JOINT SURG AM, V87A, P2449, DOI 10.1206/JBJS.D.02170
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Newton D, 2009, ACTA BIOMATER, V5, P518, DOI 10.1016/j.actbio.2008.06.016
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4
   Pederson AW, 2003, BIOMATERIALS, V24, P4881, DOI 10.1016/S0142-9162(03)00369-7
   Powell HM, 2008, J BIOMED MATER RES A, V84A, P1078, DOI 10.1002/jbm.a.31498
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Rim NG, 2009, MACROMOL BIOSCI, V9, P795, DOI 10.1002/mabi.200800358
   Schofer MD, 2009, J MATER SCI-MATER M, V20, P767, DOI 10.1007/s10856-008-3634-8
   Sefcik LS, 2008, J TISSUE ENG REGEN M, V2, P210, DOI 10.1002/term.85
   SELL SA, 2008, BIOMED MATER, V3, pNI118
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Shamnugasundaram S, 2004, PROCEEDINGS OF THE IEEE 30TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P140
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silver FH, 2002, J THEOR BIOL, V216, P243, DOI 10.1006/jtbi.2002.2542
   Silver FH, 2001, BIOMACROMOLECULES, V2, P750, DOI 10.1021/bm0100615
   Silver FH, 2000, BIOMACROMOLECULES, V1, P180, DOI 10.1021/bm9900139
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Smith LA, 2008, SOFT MATTER, V4, P2144, DOI 10.1039/b807088c
   STACK MV, 1950, NATURE, V166, P1080, DOI 10.1038/1661080b0
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   STRATES BS, 1969, EXPERIENTIA, V25, P924, DOI 10.1007/BF01898065
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   TORBET J, 1984, BIOCHEM J, V219, P1057, DOI 10.1042/bj2191057
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   Torres-Giner S, 2009, ACS APPL MATER INTER, V1, P218, DOI 10.1021/am800063x
   TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822
   Truong-Le VL, 1999, ARCH BIOCHEM BIOPHYS, V361, P47, DOI 10.1006/abbi.1998.0975
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vaccaro AR, 2002, ORTHOPEDICS, V25, P571
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Vanderby R, 2003, J BIOMECH, V36, P1523, DOI 10.1016/S0021-9290(03)00132-5
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   VEIS A, 1961, ARCH BIOCHEM BIOPHYS, V94, P20, DOI 10.1016/0003-9861(61)90005-4
   Venugopal J, 2005, CELL BIOL INT, V29, P861, DOI 10.1016/j.cellbi.2005.03.026
   Wang M., 2006, APPL PHYS LETT, V88
   Wang Y, 2008, J BIOMED MATER RES A, V86A, P244, DOI 10.1002/jbm.a.31758
   Wang YK, 2005, AUST J CHEM, V58, P704, DOI 10.1071/CH05222
   Wang ZG, 2009, SOFT MATTER, V5, P4161, DOI 10.1039/b902637a
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1992, FASEB J, V6, P879
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yang DY, 2007, ADV MATER, V19, P3702, DOI 10.1002/adma.200700171
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoo JJ, 2006, FASEB J, V20, pA1101
   Zeugois DI, 2010, J BIOMED MATER RES A, V92A, P1310, DOI 10.1002/jbm.a.32383
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 172
TC 35
Z9 35
U1 7
U2 108
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD SEP
PY 2010
VL 12
IS 9
SI SI
BP B451
EP B466
DI 10.1002/adem.200980087
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA 677ML
UT WOS:000283996400008
DA 2018-10-19
ER

PT J
AU Mane, V
   Puri, V
AF Mane, Vaishali
   Puri, Vijaya
TI Miniaturized Ag Thick Film Microstripline as Novel Biomaterial Moisture
   Sensor
SO ADVANCED SCIENCE LETTERS
LA English
DT Article
ID MICROWAVE PERMITTIVITY; DIELECTRIC-PROPERTIES; GRAIN; OVERLAY
AB In this paper use of a nondestructive, miniaturized Ag thick film microstripline 1 in. x 1 in. sensor for the study of moisture in biomaterials (groundnuts) is suggested. The in-touch overlay (sample in contact with microstripline) method provides ease of loading and unloading of sample. The perturbation obtained in the transmittance and reflectance of thick film microstripline due to the groundnut overlay has been used to obtain the permittivity. The changes in the moisture content in the groundnut produces frequency dependent changes in the characteristics of microstripline. As moisture content increases, microwave dielectric constant and dielectric loss of groundnut increases. For prediction of moisture content a relationship between dielectric properties and bulk density is identified, and a density-independent function is proposed. At different frequencies and moisture contents an explicit calibration equations for moisture prediction are provided.
C1 [Mane, Vaishali; Puri, Vijaya] Shivaji Univ, Dept Phys, Thick & Thin Film Device Lab, Kolhapur 416004, Maharashtra, India.
RP Puri, V (reprint author), Shivaji Univ, Dept Phys, Thick & Thin Film Device Lab, Kolhapur 416004, Maharashtra, India.
FU University Grants Commission India
FX The author Vijaya Puri gratefully acknowledges the award of research
   scientist "C" by the University Grants Commission India.
CR Abegaonkar MP, 1999, REV SCI INSTRUM, V70, P3145, DOI 10.1063/1.1149877
   Abegaonkar MP, 2002, MICROW OPT TECHN LET, V33, P128, DOI 10.1002/mop.10252
   Ghorpade R, 2005, INT J ELECTRON, V92, P683, DOI 10.1080/00207210412331334815
   GHORPADE R, 2006, RADIO SCI, V41, P1
   GOUKER MA, 1994, IEEE T MICROW THEORY, V42, P2023, DOI 10.1109/22.330113
   Kamble PD, 2008, MICROELECTRON INT, V25, P37, DOI 10.1108/13565360810889610
   KIM JH, 1997, J ELEC ENG INF SCI, V2, P72
   Kraszewski AW, 2003, J MICROWAVE POWER EE, V38, P13
   NELSON SO, 1992, IEEE T INSTRUM MEAS, V41, P116, DOI 10.1109/19.126644
   Rane S., 2000, Active and Passive Electronic Components, V23, P163, DOI 10.1155/APEC.23.163
   Trabelsi S, 1998, IEEE T INSTRUM MEAS, V47, P613, DOI 10.1109/19.744310
   Trabelsi S, 2003, MEAS SCI TECHNOL, V14, P589, DOI 10.1088/0957-0233/14/5/308
   Trabelsi S, 2001, IEEE T INSTRUM MEAS, V50, P877, DOI 10.1109/19.948292
   Trabelsi S, 1999, T ASAE, V42, P531
   TRABELSI S, 2002, IEEE INSTRU MEAS MAG, V2, P1381
   Yogi RA, 1998, SENSOR ACTUAT B-CHEM, V50, P38, DOI 10.1016/S0925-4005(98)00154-3
NR 16
TC 3
Z9 3
U1 0
U2 1
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1936-6612
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD SEP
PY 2010
VL 3
IS 3
BP 282
EP 287
DI 10.1166/asl.2010.1119
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 631PK
UT WOS:000280359700004
DA 2018-10-19
ER

PT J
AU Sergent, F
   Desilles, N
   Lacoume, Y
   Tuech, JJ
   Marie, JP
   Bunel, C
AF Sergent, Fabrice
   Desilles, Nicolas
   Lacoume, Yann
   Tuech, Jean-Jacques
   Marie, Jean-Paul
   Bunel, Claude
TI Biomechanical analysis of polypropylene prosthetic implants for hernia
   repair: an experimental study
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
DE Abdominal hernia; Elasticity; Linear force; Polypropylene; Prosthesis;
   Retraction
ID RAT MODEL; IN-VIVO; MESH; WEIGHT; IMPACT; LIGHT
AB BACKGROUND: Although polypropylene (PP) is the most common biomaterial used for ventral and inguinal hernia repairs, its mechanical properties remain obscure.
   METHODS: Retraction, solidity, and elasticity of 3 large pore-size monofilament PP prostheses, 1 heavy-weight PP (HWPP), a second low-weight PP, and a third coated with atelocollagen were evaluated in a rabbit incisional hernia model. A small pore-size multifilament PP implant (MPP) also was tested.
   RESULTS: Unlike pore size, the weight of the prosthesis was not an influencing factor for retraction. Atelocollagen coating reduced retraction (P < .05). HWPP and MPP were less likely to rupture (P < .05). HWPP had comparatively better elasticity (P < .05), whereas MPP supported the greatest elastic force (P < .05). Nevertheless, the amount of shrinkage of MPP (30% of the original size) made this prosthesis unusable.
   CONCLUSIONS: In this study, HWPP presented the most advantageous biomechanical compromise for hernia surgery. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Sergent, Fabrice; Lacoume, Yann; Marie, Jean-Paul] Univ Rouen, Expt Surg Lab, Fac Med, UPRES EA GRHV 3830, F-76183 Rouen 1, France.
   [Sergent, Fabrice; Desilles, Nicolas; Bunel, Claude] Rouen Natl Inst Appl Sci, CNRS, FRE 3101, Mont St Aignan, France.
   [Tuech, Jean-Jacques] Rouen Univ Hosp, Dept Digest Surg, Rouen, France.
RP Sergent, F (reprint author), Univ Rouen, Expt Surg Lab, Fac Med, UPRES EA GRHV 3830, 22 Bd Gambetta, F-76183 Rouen 1, France.
EM Fabrice.Sergent@chu-rouen.fr
CR Alponat A, 1997, AM SURGEON, V63, P818
   Altman D, 2006, OBSTET GYNECOL, V107, P59, DOI 10.1097/01.AOG.0000192547.58102.ab
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   Arnaud J P, 2003, Hernia, V7, P85, DOI 10.1007/s10029-003-0116-2
   CLAERHOUT F, 2003, NEUROUROL URODYNAM, V5, P516
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   Cobb WS, 2005, J SURG RES, V129, P231, DOI 10.1016/j.jss.2005.06.015
   de Tayrac R, 2007, INT UROGYNECOL J, V18, P251, DOI 10.1007/s00192-006-0135-5
   Holzheimer RG, 2004, EUR J MED RES, V9, P323
   Klinge U, 1998, EUR J SURG, V164, P965
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Klosterhalfen B, 1998, BIOMATERIALS, V19, P2235, DOI 10.1016/S0142-9612(98)00115-X
   Konstantinovic ML, 2007, INT UROGYNECOL J, V18, P619, DOI 10.1007/s00192-006-0202-y
   LICHTENSTEIN IL, 1986, INT SURG, V71, P1
   Macintyre IMC, 2003, BRIT J SURG, V90, P131, DOI 10.1002/bjs.4064
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Pariente JL, 2005, PROG UROL, V15, P1106
   Scheidbach H, 2004, SURG ENDOSC, V18, P211, DOI 10.1007/s00464-003-8113-1
   Schumpelick V, 2003, BRIT J SURG, V90, P1457, DOI 10.1002/bjs.4385
   USHER F C, 1958, Am Surg, V24, P969
   Welty G, 2001, Hernia, V5, P142
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   Wheeler TL, 2006, AM J OBSTET GYNECOL, V194, P1486, DOI 10.1016/j.ajog.2006.01.075
NR 23
TC 9
Z9 11
U1 0
U2 7
PU EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
PI BRIDGEWATER
PA 685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA
SN 0002-9610
EI 1879-1883
J9 AM J SURG
JI Am. J. Surg.
PD SEP
PY 2010
VL 200
IS 3
BP 406
EP 412
DI 10.1016/j.amjsurg.2009.09.024
PG 7
WC Surgery
SC Surgery
GA 653IT
UT WOS:000282083500016
PM 20800718
DA 2018-10-19
ER

PT J
AU Fozdar, DY
   Lee, JY
   Schmidt, CE
   Chen, SC
AF Fozdar, David Y.
   Lee, Jae Young
   Schmidt, Christine E.
   Chen, Shaochen
TI Hippocampal neurons respond uniquely to topographies of various sizes
   and shapes
SO BIOFABRICATION
LA English
DT Article
ID CONTACT GUIDANCE; CNS NEUROBLASTS; GROWTH CONES; CELLS; FABRICATION;
   SCAFFOLDS; MOTILITY; GROOVES
AB A number of studies have investigated the behavior of neurons on microfabricated topography for the purpose of developing interfaces for use in neural engineering applications. However, there have been few studies simultaneously exploring the effects of topographies having various feature sizes and shapes on axon growth and polarization in the first 24 h. Accordingly, here we investigated the effects of arrays of lines (ridge grooves) and holes of microscale (similar to 2 mu m) and nanoscale (similar to 300 nm) dimensions, patterned in quartz (SiO(2)), on the (1) adhesion, (2) axon establishment (polarization), (3) axon length, (4) axon alignment and (5) cell morphology of rat embryonic hippocampal neurons, to study the response of the neurons to feature dimension and geometry. Neurons were analyzed using optical and scanning electron microscopy. The topographies were found to have a negligible effect on cell attachment but to cause a marked increase in axon polarization, occurring more frequently on sub-microscale features than on microscale features. Neurons were observed to form longer axons on lines than on holes and smooth surfaces; axons were either aligned parallel or perpendicular to the line features. An analysis of cell morphology indicated that the surface features impacted the morphologies of the soma, axon and growth cone. The results suggest that incorporating microscale and sub-microscale topographies on biomaterial surfaces may enhance the biomaterials' ability to modulate nerve development and regeneration.
C1 [Lee, Jae Young; Schmidt, Christine E.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
   [Fozdar, David Y.; Chen, Shaochen] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
   [Schmidt, Christine E.; Chen, Shaochen] Univ Texas Austin, Ctr Nano Mol Sci & Technol, Austin, TX 78712 USA.
   [Schmidt, Christine E.; Chen, Shaochen] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA.
   [Schmidt, Christine E.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA.
   [Chen, Shaochen] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Chen, Shaochen] Univ Texas Austin, Microelect Res Ctr, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas Austin, Dept Chem Engn, 1 Univ Stn,C2200, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu; scchen@mail.utexas.edu
RI Schmidt, Christine/P-1613-2016
FU NIH [R01EB004429]; NSF, University of Texas-Austin
FX This work was supported by NIH grant R01EB004429 (C.E.S.). It was
   performed in part at the Center for Nano and Molecular Science and
   Technology (CNM) and at the Microelectronics Research Center (MRC), a
   part of the National Nanofabrication Infrastructure Network supported by
   the NSF, at the University of Texas-Austin (S.C.).
CR ADAMSON AW, 1982, PHYS CHEM SURFACES, P338
   BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   CHRISTENSEN R, 1996, ANAL VARIANCE DESIGN, P114
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   DOTTI CG, 1988, J NEUROSCI, V8, P1454
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   GOMEZ N, 2010, BIOMATERIAL IN PRESS
   Gomez N, 2007, J R SOC INTERFACE, V4, P223, DOI 10.1098/rsif.2006.0171
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072
   LEE JY, 2010, J BIOMED A IN PRESS
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Liu CY, 2003, J HEMATOTH STEM CELL, V12, P689, DOI 10.1089/15258160360732713
   NAGATA I, 1991, DEVELOPMENT, V112, P581
   NAGATA I, 1993, DEVELOPMENT, V117, P401
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Teixeira AI, 2003, J VAC SCI TECHNOL B, V21, P683, DOI 10.1116/1.1545753
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
NR 27
TC 36
Z9 38
U1 0
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
J9 BIOFABRICATION
JI Biofabrication
PD SEP
PY 2010
VL 2
IS 3
AR 035005
DI 10.1088/1758-5082/2/3/035005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 648EU
UT WOS:000281674000006
PM 20823503
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Serban, MA
   Kluge, JA
   Laha, MM
   Kaplan, DL
AF Serban, Monica A.
   Kluge, Jonathan A.
   Laha, Michael M.
   Kaplan, David L.
TI Modular Elastic Patches: Mechanical and Biological Effects
SO BIOMACROMOLECULES
LA English
DT Article
ID SILK-BASED BIOMATERIALS; HYALURONIC-ACID; TISSUE; STIFFNESS;
   MORPHOGENESIS; TROPOELASTIN; DEGRADATION; SUBSTRATE; HYDROGELS; MOTILITY
AB A modular approach to engineering cross-linked elastic biomaterials is presented for fine-tuning of material mechanical and biological properties. The three components, soluble elastin, hyaluronic acid, and silk fibroin, contribute with different features to the overall properties of the final material system. The elastic biomaterial is chemically cross-linked via interaction between primary amine groups naturally present on the two proteins, silk and elastin, or chemically introduced on hyaluronan and N-succinimide functionalities of the cross-linker. The materials obtained by cross-linking the three components in different ratios have Young's moduli ranging from similar to 100 to 230 kPa, strain to failure between similar to 15-40% and ultimate tensile strengths of similar to 30 kPa. The biological effects and enzymatic degradation rates of the different composites are also different based on material composition. These findings further underline the strength of modular, multicomponent systems in creating a range of biomaterials, targeted tissue engineering, and regenerative medicine applications, with application-tailored mechanical and biological properties.
C1 [Serban, Monica A.; Kluge, Jonathan A.; Laha, Michael M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH Tissue Engineering Resource Center [P41 EB002520]
FX Funding for this project was provided by the NIH P41 EB002520 Tissue
   Engineering Resource Center,
CR Alberts B, 2002, MOL BIOL CELL
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   An SS, 2009, BIOCHEM BIOPH RES CO, V382, P697, DOI 10.1016/j.bbrc.2009.03.118
   AYAD S, 1994, EXTRACELLULAR MATRIX
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Bouchie A, 2002, NAT BIOTECHNOL, V20, P1178, DOI 10.1038/nbt1202-1178
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Collis L, 1998, FEBS LETT, V440, P444, DOI 10.1016/S0014-5793(98)01505-1
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Diridollou S, 2000, SKIN RES TECHNOL, V6, P214, DOI 10.1034/j.1600-0846.2000.006004214.x
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x
   HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343
   Iocono JA, 1998, J SURG RES, V76, P111, DOI 10.1006/jsre.1998.5305
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jung S, 1998, J NEUROPATH EXP NEUR, V57, P439, DOI 10.1097/00005072-199805000-00007
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   LINKER A, 1954, NATURE, V174, P1192, DOI 10.1038/1741192a0
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Martino M, 2001, BIOPOLYMERS, V59, P29, DOI 10.1002/1097-0282(200107)59:1<29::AID-BIP1003>3.0.CO;2-F
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Price RD, 2005, AM J CLIN DERMATOL, V6, P393, DOI 10.2165/00128071-200506060-00006
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006
   Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x
   UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Winkler S, 2000, J Biotechnol, V74, P85
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   WUYTS FL, 1995, PHYS MED BIOL, V40, P1577, DOI 10.1088/0031-9155/40/10/002
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 43
TC 5
Z9 5
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2010
VL 11
IS 9
BP 2230
EP 2237
DI 10.1021/bm1007772
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 647PB
UT WOS:000281629600006
PM 20712340
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Sang-Nadir, O
   Seliktar, D
AF Sang-Nadir, Offra
   Seliktar, Dror
TI The role of matrix metalloproteinases in regulating neuronal and
   nonneuronal cell invasion into PEGylated fibrinogen hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Matrix metalloproteinase inhibitor; Dorsal root ganglion; Neuronal
   outgrowth; Peripheral nerve regeneration; Biodegradable hydrogel
ID NERVE GROWTH-FACTOR; BASAL LAMINAE; IN-VITRO; DEGRADATION; SCAFFOLDS;
   MIGRATION; OUTGROWTH; MOTILITY; MMP-2; GELS
AB Injured peripheral nerve tissue could benefit from biomaterial nerve guidance conduits (NGCs) that are designed to promote neuronal regeneration. Nerve regeneration is a complex multi-step process that involves the remodeling of the ECM surrounding the regenerating neural tissue. Hydrogel biomaterials have been used as provisional matrices to regulate this regeneration process by providing the desired physical properties and controllable degradation characteristics. The purpose of this investigation was to understand the mechanism by which nerve cells penetrate into a hydrogel made from PEGylated fibrinogen. In this context, the dorsal root ganglion (DRG) assay was used as an in vitro model to study the cellular invasion behavior of both neural and nonneuronal cells. Our hypothesis stipulated that DRG cells employ matrix metalloproteinases (MMPs) in order to degrade the dense hydrogel matrix and penetrate the biomaterial. Three dimensional (3D) DRG-hydrogel constructs were cultured with MMP inhibitors (MMPi) and the effect of the inhibitors on DRG cell outgrowth was investigated. We also examined the effect of inhibitors on two dimensional (2D) DRG cell outgrowth on PEGylated fibrinogen hydrogels and on tissue culture polystyrene (TCP). Our results demonstrate that DRG cell outgrowth into and onto PEGylated fibrinogen hydrogels was inhibited by MMPi and that the outgrowth characteristics was dependent on the type of inhibitor and its concentration. MMP-3i and MMP-8i decreased both neuronal and nonneuronal outgrowth, where MMP-3i had a stronger inhibitory effect on nonneuronal cells. MMP-2/9i, on the other hand, affected the neuronal outgrowth much more than the others. We concluded that MMPs play a central role in the process of DRG cell penetration into PEGylated fibrinogen hydrogels and may also regulate the adhesion, migration and elongation of neuronal cells on the surface of these hydrogel biomaterials. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Sang-Nadir, Offra; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
FU Israel Science Foundation [1140]; Technion VPR
FX The authors gratefully acknowledge the financial support of the Israel
   Science Foundation (grant no. 1140) and the Technion VPR research fund.
CR Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3
   Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Barker TH, 2001, J BIOMED MATER RES, V56, P529, DOI 10.1002/1097-4636(20010915)56:4<529::AID-JBM1124>3.0.CO;2-2
   Bini A, 1999, BIOCHEMISTRY-US, V38, P13928, DOI 10.1021/bi991096g
   Bini A, 1996, BIOCHEMISTRY-US, V35, P13056, DOI 10.1021/bi960730c
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Ferguson TA, 2000, MOL CELL NEUROSCI, V16, P157, DOI 10.1006/mcne.2000.0859
   Goetzl EJ, 1996, J IMMUNOL, V156, P1
   Herbert CB, 1996, J COMP NEUROL, V365, P380, DOI 10.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-0
   Hiller O, 2000, J BIOL CHEM, V275, P33008, DOI 10.1074/jbc.M001836200
   Liu SY, 2007, ORAL ONCOL, V43, P1026, DOI 10.1016/j.oraloncology.2006.11.018
   Martinez A, 2001, Med Sci Monit, V7, P646
   MUIR D, 1992, J CELL BIOL, V116, P177, DOI 10.1083/jcb.116.1.177
   MUIR D, 1994, EXP CELL RES, V210, P243, DOI 10.1006/excr.1994.1036
   NORDSTROM LA, 1995, MOL CELL NEUROSCI, V6, P56, DOI 10.1006/mcne.1995.1006
   Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349
   PITTMAN RN, 1989, DEV NEUROSCI-BASEL, V11, P41, DOI 10.1159/000111884
   Sarig-Nadir O, 2008, TISSUE ENG PT A, V14, P401, DOI 10.1089/tea.2007.0029
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shubayev VI, 2004, J NEUROSCI RES, V77, P229, DOI 10.1002/jnr.20160
   YAMADA T, 1995, ACTA NEUROPATHOL, V90, P421
   Yong VW, 1998, TRENDS NEUROSCI, V21, P75
   Zuo J, 1998, J NEUROSCI, V18, P5203
NR 25
TC 13
Z9 14
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 25
BP 6411
EP 6416
DI 10.1016/j.biomaterials.2010.04.052
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 627GZ
UT WOS:000280028800006
PM 20537384
DA 2018-10-19
ER

PT J
AU Aronin, CEP
   Shin, SJ
   Naden, KB
   Rios, PD
   Sefcik, LS
   Zawodny, SR
   Bagayoko, ND
   Cui, QJ
   Khan, Y
   Botchwey, EA
AF Aronin, Caren E. Petrie
   Shin, Soo J.
   Naden, Kimberly B.
   Rios, Peter D., Jr.
   Sefcik, Lauren S.
   Zawodny, Sarah R.
   Bagayoko, Namory D.
   Cui, Quanjun
   Khan, Yusuf
   Botchwey, Edward A.
TI The enhancement of bone allograft incorporation by the local delivery of
   the sphingosine 1-phosphate receptor targeted drug FTY720
SO BIOMATERIALS
LA English
DT Article
DE Bone tissue engineering; Drug delivery; Angiogenesis; Osseointegration
ID PROTEIN-COUPLED RECEPTOR; PLATELET-RICH PLASMA; PROGENITOR CELLS;
   SPHINGOSINE-1-PHOSPHATE; ACTIVATION; FIXATION; IMPLANTS; DEFECTS;
   FUSION; EDG-1
AB Poor vascularization coupled with mechanical instability is the leading cause of post-operative complications and poor functional prognosis of massive bone allografts. To address this limitation, we designed a novel continuous polymer coating system to provide sustained localized delivery of pharmacological agent, FTY720, a selective agonist for sphingosine 1-phosphate receptors, within massive tibial defects. In vitro drug release studies validated 64% loading efficiency with complete release of compound following 14 days. Mechanical evaluation following six weeks of healing suggested significant enhancement of mechanical stability in FTY720 treatment groups compared with unloaded controls. Furthermore, superior osseous integration across the host graft interface, significant enhancement in smooth muscle cell investment, and reduction in leukocyte recruitment was evident in FTY720 treated groups compared with untreated groups. Using this approach, we can capitalize on the existing mechanical and biomaterial properties of devitalized bone, add a controllable delivery system while maintaining overall porous structure, and deliver a small molecule compound to constitutively target vascular remodeling, osseous remodeling, and minimize fibrous encapsulation within the allograft host bone interface. Such results support continued evaluation of drug-eluting allografts as a viable strategy to improve functional outcome and long-term success of massive cortical allograft implants. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Aronin, Caren E. Petrie; Shin, Soo J.; Naden, Kimberly B.; Rios, Peter D., Jr.; Sefcik, Lauren S.; Botchwey, Edward A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.
   [Sefcik, Lauren S.] Univ Virginia, Dept Cardiovasc Med, Charlottesville, VA USA.
   [Zawodny, Sarah R.; Bagayoko, Namory D.; Cui, Quanjun; Botchwey, Edward A.] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA USA.
   [Khan, Yusuf] Univ Connecticut, Dept Orthopaed Surg, Ctr Hlth, Storrs, CT 06269 USA.
RP Botchwey, EA (reprint author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.
EM botchwey@virginia.edu
OI Khan, Yusuf/0000-0003-3792-3477
FU UVA Coulter Translational Research; National Institutes of Health
   [K01AR052352-01A1, R01AR056445-01A2, R01DE019935-01]; Biotechnology
   Training Program [T32 GM-008715-03]; National Science Foundation;
   American Heart Association [0815211E]
FX Sources of support for this study include the UVA Coulter Translational
   Research Partnership Program and National Institutes of Health grants
   K01AR052352-01A1, R01AR056445-01A2, R01DE019935-01 to Dr. Botchwey. Dr.
   Caren Petrie Aronin is supported by the Biotechnology Training Program
   grant T32 GM-008715-03. Dr. Lauren Sefcik is supported by predoctoral
   fellowships from the National Science Foundation and American Heart
   Association Mid-Atlantic Affiliate 0815211E. We would also like to
   acknowledge Dr. Trey Cui for funding support of Drs. Jones-Quaidoo,
   Zawodny and Bagayoko.
CR ARONIN CP, 2010, TISSUE ENG A    0308
   Bondre S, 2000, TISSUE ENG, V6, P217, DOI 10.1089/10763270050044399
   Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   DELLOYE C, 1988, ARCH ORTHOP TRAUM SU, V107, P31
   DRUSHEL RF, 1985, CELL DIFFER DEV, V16, P13, DOI 10.1016/0045-6039(85)90603-7
   Giannotti Giovanna, 2005, Cardiovasc Ultrasound, V3, P7, DOI 10.1186/1476-7120-3-7
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Han B, 2009, J BONE JOINT SURG AM, V91A, P1459, DOI 10.2106/JBJS.H.00246
   Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713
   Kimura T, 2004, BLOOD, V103, P4478, DOI 10.1182/blood-2003-03-0875
   Lamberg A, 2006, ACTA ORTHOP, V77, P799, DOI 10.1080/17453670610013024
   Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0
   Lewandrowski KU, 2002, TISSUE ENG, V8, P1017, DOI 10.1089/107632702320934119
   Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905
   Lucarelli E, 2005, CLIN ORTHOP RELAT R, P62, DOI 10.1097/01.blo.0000165736.87628.12
   Mankin HJ, 2005, CLIN ORTHOP RELAT R, P210, DOI 10.1097/01.blo.0000150371.77314.52
   Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284
   Nevins M, 2007, INT J PERIODONT REST, V27, P421
   Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804
   Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004
   Ramchandani M, 1997, J CONTROL RELEASE, V43, P161, DOI 10.1016/S0168-3659(96)01481-2
   Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   STREETEN EA, 1990, BONE MINER, V10, P85, DOI 10.1016/0169-6009(90)90084-S
   THOMPSON RC, 1993, J BONE JOINT SURG AM, V75A, P1663, DOI 10.2106/00004623-199311000-00011
   VANDERGRIEND RA, 1994, J BONE JOINT SURG AM, V76A, P657, DOI 10.2106/00004623-199405000-00005
   Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70
   Wamhoff BR, 2008, ARTERIOSCL THROM VAS, V28, P1454, DOI 10.1161/ATVBAHA.107.159392
   Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50
   Whetzel AM, 2006, CIRC RES, V99, P731, DOI 10.1161/01.RES.0000244088.33375.52
   Yazici C, 2008, BIOMATERIALS, V29, P3882, DOI 10.1016/j.biomaterials.2008.06.007
   ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155
NR 36
TC 31
Z9 31
U1 2
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 25
BP 6417
EP 6424
DI 10.1016/j.biomaterials.2010.04.061
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 627GZ
UT WOS:000280028800007
PM 20621764
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ma, DHK
   Lai, JY
   Cheng, HY
   Tsai, CC
   Yeh, LK
AF Ma, David Hui-Kang
   Lai, Jui-Yang
   Cheng, Hsiao-Yun
   Tsai, Chen-Chi
   Yeh, Lung-Kun
TI Carbodiimide cross-linked amniotic membranes for cultivation of limbal
   epithelial cells
SO BIOMATERIALS
LA English
DT Article
DE Amniotic membrane; Carbodiimide cross-linking; Limbal epithelial cells;
   Cornea; Tissue engineering/regenerative medicine
ID HYALURONIC-ACID HYDROGELS; EX-VIVO; MATRIX METALLOPROTEINASES;
   EXTRACELLULAR-MATRIX; DELIVERY CARRIERS; STEM-CELLS; TISSUE; COLLAGEN;
   LINKING; TRANSPLANTATION
AB In ophthalmic tissue engineering, amniotic membrane (AM) is one of the most prevalent natural matrices used for limbal epithelial cell (LEC) cultivation and transplantation. However, the application of AM as a scaffold is limited by its low biomechanical strength and rapid biodegradation. The present study reports the development of 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide (NHS) cross-linked AM as an LEC carrier. The collagenous tissue materials were modified with varying cross-linker concentrations (0-0.25 mmol EDC/mg AM) and were characterized by attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR), differential scanning calorimetry (DSC), ninhydrin assays, electron microscopy, light transmission measurements, mechanical and in vitro degradation tests, as well as diffusion permeability and cell culture studies. Our results showed that chemical cross-linking approaches saturation at concentrations of 0.05 mmol EDC/mg AM. The formation of cross-links (i.e., amide bonds) in the samples treated with 0.05 mmol EDC/mg AM may cause significant aggregation of tropocollagen molecules and collagen microfibrils without affecting cell morphology of biological tissues. With the optimum concentration of 0.05 mmol EDC/mg AM, chemical cross-linker could significantly enhance the mechanical and thermal stability, optical transparency, and resistance to collagenase digestion. Continuous permeation of albumin through the cross-linked AM would be helpful to cell growth over the matrix surface. In addition, the EDC cross-linked samples were able to support LEC proliferation and preserve epithelial progenitor cells in vitro and in vivo. It is concluded that the AM cross-linked with 0.05 mmol EDC/mg AM may be a potential biomaterial for regenerative medicine. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Ma, David Hui-Kang; Yeh, Lung-Kun] Chang Gung Mem Hosp, Limbal Stem Cell Lab, Dept Ophthalmol, Tao Yuan 33305, Taiwan.
   [Ma, David Hui-Kang] Chang Gung Univ, Dept Chinese Med, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang; Cheng, Hsiao-Yun] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
   [Tsai, Chen-Chi] Maxigen Biotech Inc, Taipei 24891, Taiwan.
   [Yeh, Lung-Kun] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei 10051, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China [NSC98-2221-E-182-012];
   Chang Gung Memorial Hospital [CMRPG350831, CMRPD160393]
FX This work was supported by grant NSC98-2221-E-182-012 from the National
   Science Council of Republic of China and grant CMRPG350831 (2006-2009)
   and CMRPD160393 from Chang Gung Memorial Hospital. The authors are
   grateful to Miss Ya-Ting Li and Shu-Jung Huang (Institute of Biochemical
   and Biomedical Engineering, Chang Gung University), and to Miss
   Hsiang-Ling Chen (Limbal Stem Cell Laboratory, Department of
   Ophthalmology, Chang Gung Memorial Hospital) for technical assistance.
CR Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Burugapalli K, 2009, J BIOMAT SCI-POLYM E, V20, P1049, DOI [10.1163/156856209X444411, 10.1163/156856209X4444111]
   Chan JCY, 2008, BIOMACROMOLECULES, V9, P528, DOI 10.1021/bm701055k
   Chen HCJ, 2009, INVEST OPHTH VIS SCI, V50, P4660, DOI 10.1167/iovs.09-3377
   Crabb RAB, 2006, TISSUE ENG, V12, P1565, DOI 10.1089/ten.2006.12.1565
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Fatima A, 2008, EYE, V22, P1161, DOI 10.1038/sj.eye.6702895
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Gris O, 2003, TRANSPL P, V35, P2031, DOI 10.1016/S0041-1345(03)00699-7
   Grueterich M, 2002, ARCH OPHTHALMOL-CHIC, V120, P783
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63
   Guldner NW, 2009, CIRCULATION, V119, P1653, DOI 10.1161/CIRCULATIONAHA.108.823948
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kumar TR, 2003, J BIOMAT SCI-POLYM E, V14, P689, DOI 10.1163/156856203322274941
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Liu WG, 2009, BIOMATERIALS, V30, P1551, DOI 10.1016/j.biomaterials.2008.11.022
   Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2007, INVEST OPHTH VIS SCI, V48, P644, DOI 10.1167/iovs.06-0884
   Ma DHK, 2009, OCUL SURF, V7, P128
   Ma DHK, 2002, CORNEA, V21, P275, DOI 10.1097/00003226-200204000-00008
   Ma DHK, 2000, BRIT J OPHTHALMOL, V84, P973, DOI 10.1136/bjo.84.9.973
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   NAKATSUJI N, 1984, NATURE, V307, P453, DOI 10.1038/307453a0
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Singh R, 2007, RADIAT PHYS CHEM, V76, P1026, DOI 10.1016/j.radphyschem.2006.09.010
   Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5
   Slansky H H, 1970, Surv Ophthalmol, V14, P402
   SPIRA M, 1994, J BIOMED MATER RES, V28, P91, DOI 10.1002/jbm.820280112
   Spoerl E, 2004, OPHTHAL RES, V36, P71, DOI 10.1159/000076884
   Sun WQ, 2008, ACTA BIOMATER, V4, P817, DOI 10.1016/j.actbio.2008.02.006
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Ti SE, 2002, INVEST OPHTH VIS SCI, V43, P2584
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Weiss A, 2007, FRONT BIOSCI, V12, P649, DOI 10.2741/2089
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Young JJ, 2004, J BIOMAT SCI-POLYM E, V15, P767, DOI 10.1163/156856204774196153
NR 54
TC 80
Z9 82
U1 0
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 25
BP 6647
EP 6658
DI 10.1016/j.biomaterials.2010.05.034
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 627GZ
UT WOS:000280028800032
PM 20541801
DA 2018-10-19
ER

PT J
AU Power, KA
   Fitzgerald, KT
   Gallagher, WM
AF Power, Karen A.
   Fitzgerald, Kathleen T.
   Gallagher, William M.
TI Examination of cell-host-biomaterial interactions via high-throughput
   technologies: A re-appraisal
SO BIOMATERIALS
LA English
DT Article
DE Biocompatibility; Transcriptomics; DNA microarrays; Proteomics; Mass
   spectrometry; Cell interaction
ID BLADDER SMOOTH-MUSCLE; GENE-EXPRESSION; PROTEIN ADSORPTION; IMPLANTED
   BIOMATERIALS; MICROARRAY TECHNOLOGY; INDUCED INFLAMMATION; GOLD
   NANOPARTICLES; STEM-CELLS; TISSUE; SURFACE
AB Biomaterials are required to act harmoniously when exposed to the body or bodily fluids. Investigating cellular or in vivo phenotypic responses and protein adsorption to the material surface helps to determine the associated biocompatibility. Past limitations on progress in this field include time-consuming cell-based screening tools and a limited understanding of the complex nature of cell biomaterial interactions. While high-throughput technologies by their nature are a rapid tool to derive meaning from multifaceted systems and, in recent years, the biomaterial community is beginning to take advantage of these technologies, the key observation in this Leading Opinion Paper is that the biomaterials community has been slow to accept these methods as an addition to their traditional experimentation workflow. The purpose of this paper is to review the definition and recent usage of high-throughput experiments in order to examine biomaterial interactions at the cellular and wider host level, especially as they become more relevant within the biomaterials arena encapsulating tissue engineering, gene, drug and stem cell delivery systems. The technologies under focus include rapid cell-based screening, transcriptomics and proteomics. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Power, Karen A.; Fitzgerald, Kathleen T.; Gallagher, William M.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland.
RP Gallagher, WM (reprint author), Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland.
EM william.gallagher@ucd.ie
OI Gallagher, William/0000-0002-4307-5999
FU Science Foundation Ireland, Network of Excellence for Functional
   Biomaterials, Strategic Research Cluster (SFI NFB SRC) [07/SRC/B1163];
   Programme for Third Level Institutions (PRTLI)
FX Funding is acknowledged from Science Foundation Ireland, Network of
   Excellence for Functional Biomaterials, Strategic Research Cluster (SFI
   NFB SRC 07/SRC/B1163). The UCD Conway Institute is funded by the
   Programme for Third Level Institutions (PRTLI), as administered by the
   Higher Education Authority (HEA) of Ireland.
CR Adler AF, 2009, COMB CHEM HIGH T SCR, V12, P634, DOI 10.2174/138620709788923764
   Agarwal A, 2008, CURR TOP MED CHEM, V8, P311
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002
   BURSTONE CJ, 1985, AM J ORTHOD DENTOFAC, V87, P445, DOI 10.1016/0002-9416(85)90083-1
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Chow EKH, 2008, ACS NANO, V2, P33, DOI 10.1021/nn7000917
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Courtney JM, 2003, PERFUSION-UK, V18, P33, DOI 10.1191/0267659103pf633oa
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Daub A, 2009, CURR OPIN NEUROBIOL, V19, P537, DOI 10.1016/j.conb.2009.10.002
   Dinnes DLM, 2007, J BIOMED MATER RES A, V80A, P895, DOI 10.1002/jbm.a.30967
   Domingo S, 2005, BIO-MED MATER ENG, V15, P357
   Esposito M, 2007, COCHRANE DATABASE SY
   Etzion Y, 2009, TRENDS CARDIOVAS MED, V19, P207, DOI 10.1016/j.tcm.2009.12.006
   Flanagan Thomas C., 2003, European Cells & Materials, V6, P28
   Fox S, 2009, METHODS MOL BIOL, V553, P79, DOI 10.1007/978-1-60327-563-7_5
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Garty S, 2010, BIOMACROMOLECULES, V11, P1516, DOI 10.1021/bm100157s
   Griffitt RJ, 2009, TOXICOL SCI, V107, P404, DOI 10.1093/toxsci/kfn256
   Gundy S, 2008, ACTA BIOMATER, V4, P1734, DOI 10.1016/j.actbio.2008.05.025
   Guo K, 2007, BIOMATERIALS, V28, P3284, DOI 10.1016/j.biomaterials.2007.03.031
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   Hipp J, 2008, BJU INT, V101, P100, DOI 10.1111/j.1464-410X.2007.07211.x
   Hipp JA, 2008, BJU INT, V102, P741, DOI 10.1111/j.1464-410X.2008.07606.x
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hosoki M, 2009, BIO-MED MATER ENG, V19, P53, DOI 10.3233/BME-2009-0563
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657
   Kao CT, 2007, ANGLE ORTHOD, V77, P349, DOI 10.2319/021406-58
   Kaps C, 2006, BIOMATERIALS, V27, P3617, DOI 10.1016/j.biomaterials.2006.02.017
   Kash JC, 2009, ANTIVIR RES, V83, P10, DOI 10.1016/j.antiviral.2009.04.004
   Kashuk K B, 1984, Clin Podiatry, V1, P131
   Kato S, 2000, J BIOMAT SCI-POLYM E, V11, P333, DOI 10.1163/156856200743733
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Ku CH, 2002, BIOMATERIALS, V23, P4193, DOI 10.1016/S0142-9612(02)00161-8
   LANGER R, 1993, SCIENCE, V920, P260
   Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001
   Lee K, 2008, EXPERT REV MED DEVIC, V5, P383, DOI [10.1586/17434440.5.3.383, 10.1586/17434440-5.3-383]
   Li X, 2000, BBA-GEN SUBJECTS, V1524, P102, DOI 10.1016/S0304-4165(00)00118-5
   Lu SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r240
   Lu XY, 2010, BIOMATERIALS, V31, P1965, DOI 10.1016/j.biomaterials.2009.12.044
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Meyers SR, 2009, BIOMATERIALS, V30, P277, DOI 10.1016/j.biomaterials.2008.08.042
   Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929
   Mol A, 2009, EXPERT REV MED DEVIC, V6, P259, DOI [10.1586/erd.09.12, 10.1586/ERD.09.12]
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Mulrane L, 2008, EXPERT REV MOL DIAGN, V8, P707, DOI 10.1586/14737159.8.6.707
   Neidle S, 2005, NAT REV CANCER, V5, P285, DOI 10.1038/nrc1587
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nishant KT, 2009, BIOESSAYS, V31, P912, DOI 10.1002/bies.200900017
   Ocak S, 2009, EUR RESPIR J, V34, P489, DOI 10.1183/09031936.00042409
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   Ramirez CN, 2010, EXPERT OPIN DRUG DIS, V5, P223, DOI 10.1517/17460441003596685
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rowan K, 2009, J NATL CANCER I, V101, P1438, DOI 10.1093/jnci/djp397
   Scott M, 1983, NATNEWS, V20, P15
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Sims AH, 2009, J CLIN PATHOL, V62, P879, DOI 10.1136/jcp.2008.060376
   Stapleton F, 2006, OCUL SURF, V4, P24, DOI 10.1016/S1542-0124(12)70262-8
   Torrisi L, 1999, BIO-MED MATER ENG, V9, P39
   Truong MY, 2010, BIOMATERIALS, V31, P4434, DOI 10.1016/j.biomaterials.2010.02.019
   Ulici V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008866
   Vasina EN, 2009, LAB CHIP, V9, P891, DOI 10.1039/b813475h
   Vastag B, 2000, J NATL CANCER I, V92, P374, DOI 10.1093/jnci/92.5.374
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xu JL, 2008, PROTEOMICS, V8, P4249, DOI 10.1002/pmic.200800103
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yang F, 2009, COMB CHEM HIGH T SCR, V12, P554, DOI 10.2174/138620709788681916
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Zhang H, 2005, J BIOMED MATER RES A, V75A, P98, DOI 10.1002/jbm.a.30400
   Zhu ZJ, 2008, J AM CHEM SOC, V130, P14139, DOI 10.1021/ja805392f
   Zuckerman ST, 2009, BIOMATERIALS, V30, P3825, DOI 10.1016/j.biomaterials.2009.04.007
NR 85
TC 22
Z9 22
U1 2
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 26
BP 6667
EP 6674
DI 10.1016/j.biomaterials.2010.05.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 635XZ
UT WOS:000280692500001
PM 20557931
OA Green Published
DA 2018-10-19
ER

PT J
AU Lai, BFL
   Creagh, AL
   Janzen, J
   Haynes, CA
   Brooks, DE
   Kizhakkedathu, JN
AF Lai, Benjamin F. L.
   Creagh, A. Louise
   Janzen, Johan
   Haynes, Charles A.
   Brooks, Donald E.
   Kizhakkedathu, Jayachandran N.
TI The induction of thrombus generation on nanostructured neutral polymer
   brush surfaces
SO BIOMATERIALS
LA English
DT Article
DE Polymer brushes; Blood-biomaterial interaction; Isothermal titration
   calorimetry; Proteomics; Blood coagulation; Platelet adhesion
ID PROTEIN ADSORPTION; BLOOD COMPATIBILITY; PLASMA-PROTEINS;
   SERUM-PROTEINS; CHAIN-LENGTH; WHOLE-BLOOD; BIOMATERIALS; COAGULATION;
   ACTIVATION; ADHESION
AB Surface induced thrombus generation is a major clinical concern associated with vascular medical devices and implants. Here, we show that high graft density hydrophilic non-charged poly (N,N-dimethylacrylamide) (PDMA) brushes prevent the initiation of blood coagulation on synthetic surfaces. Using a multi-faceted analysis approach, we have identified that PDMA brushes greater than 0.27 chains/nm(2) graft density showed this highly desired property. Non-specific protein adsorption is greatly reduced on high density brushes compared to bare surface as evident from isothermal titration calorimetry, gel electrophoresis, and proteomic analyses. We have identified approximately 129 proteins of various types on bare and PDMA brush coated surfaces at a range of surface concentrations. Thromboelastography, platelet activation, and aggregation analyses show that only high graft density brushes are neutral to blood coagulation. Since the polymer brush synthesis can be adapted to most currently used biomedical materials, these results have significant impact in the design of highly hemocompatible surfaces. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lai, Benjamin F. L.; Janzen, Johan; Brooks, Donald E.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada.
   [Lai, Benjamin F. L.; Janzen, Johan; Brooks, Donald E.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.
   [Creagh, A. Louise; Haynes, Charles A.] Univ British Columbia, Dept Chem & Biol Engn, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.
   [Brooks, Donald E.] Univ British Columbia, Dept Chem, Vancouver, BC V5Z 1M9, Canada.
RP Kizhakkedathu, JN (reprint author), Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada.
EM jay@pathology.ubc.ca
OI Brooks, Donald/0000-0002-7946-4320
FU Michael Smith Foundation for Health Research Infrastructure; Canada
   Foundation for Innovation; University of British Columbia; Canadian
   Diabetes Association; Canadian Institutes of Health Research; Natural
   Sciences and Engineering Research Council of Canada and Canadian Blood
   Services (CBS)
FX The Laboratory of Molecular Biophysics is supported by grants from the
   Michael Smith Foundation for Health Research Infrastructure and Canada
   Foundation for Innovation. JNK acknowledge the funding from University
   of British Columbia, Canadian Diabetes Association, Canadian Institutes
   of Health Research, Natural Sciences and Engineering Research Council of
   Canada and Canadian Blood Services (CBS). We thank Dr Wei Chen and the
   Centre for Blood Research mass spectrometry core facility for proteomics
   analysis. We thank Akhil Gupta, Tiffany Young Mee Jung and Tong Wu for
   assistance with ITC experiments and Zhe Wang with SDS-PAGE. BFLL is a
   recipient of graduate fellowships from CBS, and Canadian Institutes of
   Health Research/Heart and Stroke Foundation of Canada Strategic Training
   Program in Transfusion Sciences (CIHR/HSF STPTS) at Centre for Blood
   Research. JNK is a recipient of a CIHR/CBS new investigator in
   Transfusion Science.
CR Abdullah NM, 2009, CLIN APPL THROMB-HEM, V15, P201, DOI 10.1177/1076029608326753
   Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   BEUMER S, 1994, BLOOD, V84, P3724
   Bonomini M, 2006, J PROTEOME RES, V5, P2666, DOI 10.1021/pr060150u
   BRASH JL, 1995, ACS S SERIES
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Evans-Nguyen KM, 2005, LANGMUIR, V21, P1691, DOI 10.1021/la047303h
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Fukuda T., 2007, MACROMOL ENG, V2, P1137
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Halperin A, 2007, LANGMUIR, V23, P10603, DOI 10.1021/la701007j
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Holland NB, 1998, NATURE, V392, P799
   Hsu LC, 1996, INT ANESTHESIOL CLIN, V34, P109, DOI 10.1097/00004311-199603420-00010
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   Janzen J, 2004, J BIOMAT SCI-POLYM E, V15, P1121, DOI 10.1163/1568562041753043
   JANZEN J, 1991, SURFACTANT SCI SERIE, V39, P19
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Keogh JR, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P94
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kizhakkedathu JN, 2009, LANGMUIR, V25, P3794, DOI 10.1021/la803690q
   Kizhakkedathu JN, 2003, MACROMOLECULES, V36, P591, DOI 10.1021/ma021337j
   Lindhout T., 2002, THROMB HAEMOSTASIS, V88, P186
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   MOGHIMI SM, 1994, CRIT REV THER DRUG, V11, P31
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2431, DOI 10.1016/S0142-9612(03)00113-3
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Salooja N, 2001, BLOOD COAGUL FIBRIN, V12, P327, DOI 10.1097/00001721-200107000-00001
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Steels BM, 2000, J CHROMATOGR B, V743, P41, DOI 10.1016/S0378-4347(00)00206-1
   Sun JCJ, 2009, LANCET, V374, P565, DOI 10.1016/S0140-6736(09)60780-7
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang J, 2008, TALANTA, V75, P636, DOI 10.1016/j.talanta.2007.10.023
   WERNER C, 2007, J MATER CHEM, V17, P1
NR 50
TC 35
Z9 35
U1 3
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 26
BP 6710
EP 6718
DI 10.1016/j.biomaterials.2010.05.052
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 635XZ
UT WOS:000280692500006
PM 20641167
DA 2018-10-19
ER

PT J
AU Unger, RE
   Ghanaati, S
   Orth, C
   Sartoris, A
   Barbeck, M
   Halstenberg, S
   Motta, A
   Migliaresi, C
   Kirkpatrick, CJ
AF Unger, Ronald E.
   Ghanaati, Shahram
   Orth, Carina
   Sartoris, Anne
   Barbeck, Mike
   Halstenberg, Sven
   Motta, Antonella
   Migliaresi, Claudio
   Kirkpatrick, C. James
TI The rapid anastomosis between prevascularized networks on silk fibroin
   scaffolds generated in vitro with cocultures of human microvascular
   endothelial and osteoblast cells and the host vasculature
SO BIOMATERIALS
LA English
DT Article
DE Neovascularization; Bone tissue engineering; Osteoblast; Endothelial
   cell; Inosculation
ID HUMAN PERIPHERAL-BLOOD; GROWTH-FACTOR; MOLECULAR REGULATION; VESSEL
   FORMATION; ANGIOGENESIS; BONE; VASCULARIZATION; BIOMATERIALS;
   OSTEOGENESIS; PERMEABILITY
AB The survival and functioning of a bone biomaterial upon implantation requires a rapidly forming and stably functioning vascularization that connects the implant to the recipient. We have previously shown that human microcapillary endothelial cells (HDMEC) and primary human osteoblast cells (HOS) in coculture on various 3-D bone biomaterial scaffolds rapidly distribute and self-assemble into a morphological structure resembling bone tissue. Endothelial cells form microcapillary-like structures containing a lumen and these were intertwined between the osteoblast cells and the biomaterial. This tissue-like self-assembly occurred in the absence of exogenously added angiogenic stimuli or artificial matrices. The purpose of this study was to determine whether this in vitro pre-formed microvasculature persists and functions in vivo and to determine how the host responds to the cell-containing scaffolds. The scaffolds with cocultures were implanted into immune-deficient mice and compared to scaffolds without cells or with HDMEC alone. Histological evaluation and immunohistochemical staining with human-specific antibodies of materials removed 14 days after implantation demonstrated that the in vitro pre-formed microcapillary structures were present on the silk fibroin scaffolds and showed a perfused lumen that contained red blood cells. This proved anastomosis with the host vasculature. Chimeric vessels in which HDMEC were integrated with the host's ingrowing (murine) capillaries were also observed. No HDMEC-derived microvessel structures or chimeric vessels were observed on implanted silk fibroin when precultured with HDMEC alone. In addition, there was migration of the host (murine) vasculature into the silk fibroin scaffolds implanted with cocultures, whereas silk fibroin alone or silk fibroin precultured only with HDMEC were nearly devoid of ingrowing host microcapillaries. Therefore, not only do the in vitro pre-formed microcapillaries in a coculture survive and anastomose with the host vasculature to become functioning microcapillaries after implantation, the coculture also stimulates the host capillaries to rapidly grow into the scaffold to vascularize the implanted material. Thus, this coculture-based pre-vascularization of a biomaterial implant may have great potential in the clinical setting to treat large bone defects. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Unger, Ronald E.; Ghanaati, Shahram; Orth, Carina; Sartoris, Anne; Barbeck, Mike; Halstenberg, Sven; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, D-55101 Mainz, Germany.
   [Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38050 Trento, Italy.
RP Unger, RE (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Langenbeckstr 1, D-55101 Mainz, Germany.
EM runger@uni-mainz.de
OI Motta, Antonella/0000-0003-4893-6863; Barbeck, Mike/0000-0002-3001-1347
FU BMBF (German Federal Ministry of Education and Research) [0313405C];
   European Commission [500283-2]
FX Parts of this research was generously supported by the BMBF (German
   Federal Ministry of Education and Research, Grant no. 0313405C) and the
   European Commission (Network of Excellence EXPERTISSUES, Contract no.
   500283-2).
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338
   ARONSON J, 1994, CLIN ORTHOP RELAT R, P124
   Bates DO, 2002, J ANAT, V200, P581, DOI 10.1046/j.1469-7580.2002.00066.x
   Black AF, 1998, FASEB J, V12, P1331
   Calonder C, 2005, J BIOMED MATER RES A, V75A, P316, DOI 10.1002/jbm.a.30417
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Dobrogowska DH, 1998, J NEUROCYTOL, V27, P163, DOI 10.1023/A:1006907608230
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kneser U, 2006, J CELL MOL MED, V10, P695, DOI 10.2755/jcmm010.003.06
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Lee KY, 2000, NATURE, V408, P998
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MAES C, 2009, EMBO J
   Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nillesen STM, 2006, J CONTROL RELEASE, V116, pE88, DOI 10.1016/j.jconrel.2006.09.065
   Nor JE, 2001, LAB INVEST, V81, P453
   Peters K, 2002, MICROVASC RES, V64, P334, DOI 10.1006/mvre.2002.2438
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   PETERS K, 2005, SOFTWARE SUPPORTED Q
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Towler Dwight A, 2008, Curr Osteoporos Rep, V6, P67, DOI 10.1007/s11914-008-0012-x
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
NR 49
TC 105
Z9 108
U1 2
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 27
BP 6959
EP 6967
DI 10.1016/j.biomaterials.2010.05.057
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 634WJ
UT WOS:000280616300008
PM 20619788
DA 2018-10-19
ER

PT J
AU Boucher, C
   Ruiz, JC
   Thibault, M
   Buschmann, MD
   Wertheimer, MR
   Jolicoeur, M
   Durocher, Y
   De Crescenzo, G
AF Boucher, Cyril
   Ruiz, Juan-Carlos
   Thibault, Marc
   Buschmann, Michael D.
   Wertheimer, Michael R.
   Jolicoeur, Mario
   Durocher, Yves
   De Crescenzo, Gregory
TI Human corneal epithelial cell response to epidermal growth factor
   tethered via coiled-coil interactions
SO BIOMATERIALS
LA English
DT Article
DE Surface modification; Human corneal epithelial cells; Epidermal growth
   factor (EGF); Coiled-coil interactions; Cell proliferation; Cell
   adhesion
ID PLASMA SURFACE MODIFICATION; MESENCHYMAL STEM-CELLS; FACTOR RECEPTOR;
   OSTEOGENIC DIFFERENTIATION; SELECTIVE EXPANSION; ARTIFICIAL CORNEAS;
   EGF; PROTEINS; BINDING; IMMOBILIZATION
AB The development of new strategies for protein immobilization to control cell adhesion, growth and differentiation is of prime interest in the field of tissue engineering. Here we propose a versatile approach based on the interaction between two de novo designed peptides, Ecoil and Kcoil, for oriented immobilization of epidermal growth factor (EGF) on polyethylene terephthalate (PET) films. After amination of PET surfaces by ammonia plasma treatment, Kcoil peptides were covalently grafted in an oriented fashion using succinimidyl 6-[30-(2-pyridyldithio)-propionamido] hexanoate (LC-SPDP) linker, and the Kcoil-functionalized films were characterized by X-ray photoelectron spectroscopy (XPS). Bioactivity of Ecoil-EGF captured on Kcoil-functionalized PET via coiled-coil interactions was confirmed by EGF receptor phosphorylation analysis following A-431 cell attachment. We also demonstrated cell biological effects where tethered EGF enhanced adhesion, spreading and proliferation of human corneal epithelial cells compared to EGF that was either physically adsorbed or present in solution. Tethered EGF effects were most likely linked to the prolonged activation of both mitogen-activated protein kinase and phosphoinositidine 3-kinase pathways. Taken together, our results indicate that coiled-coil-based oriented immobilization is a powerful method to specifically tailor biomaterial surfaces for tissue engineering applications. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Boucher, Cyril; Thibault, Marc; Buschmann, Michael D.; Jolicoeur, Mario; De Crescenzo, Gregory] Ecole Polytech, Dept Chem Engn, GRSTB, Res Unit Bio P2, Montreal, PQ H3C 3A7, Canada.
   [Ruiz, Juan-Carlos; Wertheimer, Michael R.] Ecole Polytech, Dept Engn Phys, Grp Rech Phys & Technol Couches Minces, Montreal, PQ H3C 3A7, Canada.
   [Boucher, Cyril; Durocher, Yves] Natl Res Council Canada, Biotechnol Res Inst, Anim Cell Technol Grp, Bioproc Ctr, Montreal, PQ H4P 2R2, Canada.
RP De Crescenzo, G (reprint author), Ecole Polytech, Dept Chem Engn, GRSTB, Res Unit Bio P2, POB 6079,Succ Ctr Ville, Montreal, PQ H3C 3A7, Canada.
EM gregory.decrescenzo@polymtl.ca
OI Buschmann, Michael/0000-0002-2242-6198
FU Canada Research Chair on Protein-enhanced Biomaterials; Natural Sciences
   and Engineering Research Council of Canada; Canada Research Chair in
   Applied Metabolic Engineering
FX This work was supported by the Canada Research Chair on Protein-enhanced
   Biomaterials (G.D.C.), the Canada Research Chair in Applied Metabolic
   Engineering (M.J.), by the Natural Sciences and Engineering Research
   Council of Canada (G.D.C., M.J., M.R.W.).
CR Beamson G., 1992, HIGH RESOLUTION XPS
   Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004
   Boucher C, 2010, ANAL BIOCHEM, V399, P138, DOI 10.1016/j.ab.2009.12.007
   Boucher C, 2009, BIOCONJUGATE CHEM, V20, P1569, DOI 10.1021/bc9001147
   Boucher C, 2008, TISSUE ENG PT A, V14, P2069, DOI 10.1089/ten.tea.2008.0037
   Chirila TV, 2001, BIOMATERIALS, V22, P3311, DOI 10.1016/S0142-9612(01)00168-5
   Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   Curran JM, 2010, J MATER SCI-MATER M, V21, P1021, DOI 10.1007/s10856-009-3976-x
   De Crescenzo G, 2004, J BIOL CHEM, V279, P26013, DOI 10.1074/jbc.M400655200
   De Crescenzo G, 2003, J MOL BIOL, V328, P1173, DOI 10.1016/S0022-2836(03)00360-7
   De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450
   Elloumi I, 2006, BIOMATERIALS, V27, P3451, DOI 10.1016/j.biomaterials.2006.02.003
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   Girardeaux C., 1996, PLASMAS POLYM, V1, P327, DOI DOI 10.1007/BF02532829
   HUNTER T, 1981, CELL, V24, P741, DOI 10.1016/0092-8674(81)90100-8
   Huo YA, 2009, EXP EYE RES, V89, P876, DOI 10.1016/j.exer.2009.07.012
   Ichinose J, 2006, BIOMATERIALS, V27, P3343, DOI 10.1016/j.bomaterials.2006.01.047
   Imen EH, 2009, J BIOTECHNOL, V139, P19, DOI 10.1016/j.jbiotec.2008.09.011
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Kato K, 2005, LANGMUIR, V21, P7071, DOI 10.1021/la050893e
   Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008
   Klenkler BJ, 2008, J BIOMAT SCI-POLYM E, V19, P1411, DOI 10.1163/156856208786140346
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   KLENKLER BJ, 2009, J BIOMED MATER RES A, V93, P1043
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LANGER R, 1993, SCIENCE, V920, P260
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   Lee H, 2002, PHARMACEUT RES, V19, P845, DOI 10.1023/A:1016113117851
   Legeais JM, 1998, BIOMATERIALS, V19, P1517, DOI 10.1016/S0142-9612(98)00069-6
   MALDONADO BA, 1995, INVEST OPHTH VIS SCI, V36, P2120
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Nakaji-Hirabayashi T, 2007, BIOMATERIALS, V28, P3517, DOI 10.1016/j.biomaterials.2007.04.022
   Nakaji-Hirabayashi T, 2009, BIOCONJUGATE CHEM, V20, P102, DOI 10.1021/bc800331t
   NISHIDA T, 1984, JPN J OPHTHALMOL, V28, P196
   OCONNORMCCOURT MD, 1998, QUANTITATIVE ANAL BI, P175
   Ogiwara K, 2005, BIOTECHNOL LETT, V27, P1633, DOI 10.1007/s10529-005-2605-0
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Tripet B, 1996, PROTEIN ENG, V9, P1029, DOI 10.1093/protein/9.11.1029
   Truica-Marasescu F, 2008, PLASMA PROCESS POLYM, V5, P44, DOI 10.1002/ppap.200700077
   Wang Z, 2009, INVEST OPHTH VIS SCI, V50, P4828, DOI 10.1167/iovs.08-2983
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Zeng Y, 2008, J GENE MED, V10, P355, DOI 10.1002/jgm.1155
   Zhou ZH, 2009, PREP BIOCHEM BIOTECH, V39, P81, DOI 10.1080/10826060802589643
   Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346
NR 46
TC 33
Z9 33
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 27
BP 7021
EP 7031
DI 10.1016/j.biomaterials.2010.05.072
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 634WJ
UT WOS:000280616300014
PM 20579729
DA 2018-10-19
ER

PT J
AU Oral, E
   Ghali, BW
   Rowell, SL
   Micheli, BR
   Lozynsky, AJ
   Muratoglu, OK
AF Oral, Ebru
   Ghali, Bassem W.
   Rowell, Shannon L.
   Micheli, Brad R.
   Lozynsky, Andrew J.
   Muratoglu, Orhun K.
TI A surface crosslinked UHMWPE stabilized by vitamin E with low wear and
   high fatigue strength
SO BIOMATERIALS
LA English
DT Article
DE Vitamin E; Arthroplasty; Delamination; Interface; Biomaterial; Implant
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP-ARTHROPLASTY; ALPHA-TOCOPHEROL;
   PROPAGATION RESISTANCE; ACETABULAR COMPONENTS; MECHANICAL-PROPERTIES;
   LINKING; IRRADIATION; OXIDATION; REPLACEMENT
AB Wear particle-induced periprosthetic osteolysis has been a clinical problem driving the development of wear resistant ultrahigh molecular weight polyethylene (UHMWPE) for total joint replacement. Radiation crosslinking has been used to decrease wear through decreased plastic deformation; but crosslinking also reduces mechanical properties including fatigue resistance, a major factor limiting the longevity of joint implants. Reducing UHMWPE wear with minimal detriment to mechanical properties is an unaddressed need for articular bearing surface development. Here we report a novel approach to achieve this by limiting crosslinking to the articular surface. The antioxidant vitamin E reduces crosslinking efficiency in UHMWPE during irradiation with increasing concentration, thus we propose to spatially control the crosslink density distribution by controlling the vitamin E concentration profile. Surface crosslinking UHMWPE prepared using this approach had high wear resistance and decreased crosslinking in the bulk resulting in high fatigue crack propagation resistance. The interface region did not represent a weakness in the material due to the gradual change in the crosslink density. Such an implant has the potential of decreasing risk of fatigue fracture of total joint implants as well as expanding the use of UHMWPE to younger and more active patients. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Oral, Ebru; Ghali, Bassem W.; Rowell, Shannon L.; Micheli, Brad R.; Lozynsky, Andrew J.; Muratoglu, Orhun K.] Massachusetts Gen Hosp, Dept Orthopaed Surg, Harris Orthopaed Biomech & Biomat Lab, Boston, MA 02114 USA.
   [Oral, Ebru; Muratoglu, Orhun K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA.
RP Oral, E (reprint author), Massachusetts Gen Hosp, Dept Orthopaed Surg, Harris Orthopaed Biomech & Biomat Lab, 55 Fruit St,GRJ 1206, Boston, MA 02114 USA.
EM eoral@partners.org
FU Zimmer, Inc.
FX This work was funded by laboratory funds and a research grant from
   Zimmer, Inc. Dr. Muratoglu received royalties from Biomet, Inc. and
   Zimmer, Inc. Dr. Oral received royalties from Zimmer, Inc.
CR *ASTM INT, 2008, F221402 ASTM INT
   Baker DA, 2003, J BIOMED MATER RES A, V66A, P146, DOI 10.1002/jbm.a.10606
   Bracco P, 2007, POLYM DEGRAD STABIL, V92, P2155, DOI 10.1016/j.polymdegradstab.2007.02.023
   Bragdon CR, 2001, J ARTHROPLASTY, V16, P658, DOI 10.1054/arth.2001.23718
   BRUNNER L, 2008, AMST NL T 8 WORLD BI
   Calvert GT, 2009, J ARTHROPLASTY, V24, P505, DOI 10.1016/j.arth.2008.02.011
   CHRISTENSEN S, 2006, CHIC IL T 52 ANN M O
   Coates J., 2000, ENCY ANAL CHEM, P1
   COSTA L, 2009, LAS VEG NV T 55 ANN
   Currier BH, 2007, J BONE JOINT SURG AM, V89A, P2023, DOI 10.2106/JBJS.F.00336
   Digas G, 2007, ACTA ORTHOP, V78, P746, DOI 10.1080/17453670710014518
   Edidin AA, 1999, J ARTHROPLASTY, V14, P616, DOI 10.1016/S0883-5403(99)90086-4
   Halley D, 2004, J BONE JOINT SURG AM, V86A, P827, DOI 10.2106/00004623-200404000-00025
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HE S, 2009, LAS VEG NV T 55 ANN
   KEYSER RM, 1968, MACROMOLECULES, V1, P289
   KING R, 2009, LAS VEG NV T 55 ANN
   Kurtz SM, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P1
   Kurtz SM, 2006, CLIN ORTHOP RELAT R, P47, DOI 10.1097/01.blo.0000246547.18187.0b
   LAWTON EJ, 1960, J CHEM PHYS, V33, P405, DOI 10.1063/1.1731156
   Manning DW, 2005, J ARTHROPLASTY, V20, P880, DOI 10.1016/j.arth.2005.03.033
   McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203
   MCKELLOP H, 2000, ORL FL T 46 ANN M OR
   Medel FJ, 2007, J BIOMED MATER RES B, V83B, P380, DOI 10.1002/jbm.b.30807
   Muratoglu OK, 2001, J ARTHROPLASTY, V16, P149, DOI 10.1054/arth.2001.20540
   Muratoglu OK, 2002, BIOMATERIALS, V23, P717, DOI 10.1016/S0142-9612(01)00176-4
   Muratoglu OK, 1999, BIOMATERIALS, V20, P1463, DOI 10.1016/S0142-9612(99)00039-3
   NARAYAN V, 2009, LAS VEG NV T 55 ANN
   OKADA T, 1966, J POLYM SCI POL LETT, V4, P1043, DOI 10.1002/pol.1966.110041225
   Oral E, 2006, BIOMATERIALS, V27, P917, DOI 10.1016/j.bomaterials.2005.06.025
   Oral E, 2005, BIOMATERIALS, V26, P6657, DOI 10.1016/j.biomaterials.2005.04.026
   Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048
   Oral E, 2008, BIOMATERIALS, V29, P3557, DOI 10.1016/j.biomaterials.2008.05.004
   Oral E, 2007, BIOMATERIALS, V28, P5225, DOI 10.1016/j.biomaterials.2007.08.025
   Oral E, 2006, J ARTHROPLASTY, V21, P580, DOI 10.1016/j.arth.2005.07.009
   Pakhomov P., 1975, POLYM SCI USSR, VA17, P2612
   Parth M, 2002, J MATER SCI-MATER M, V13, P917, DOI 10.1023/A:1019892004830
   ROWELL S, 2009, LAS VEG NV T 55 ANN
   Shen FW, 2005, CLIN ORTHOP RELAT R, P80, DOI 10.1097/01.blo.0000149999.17123.e8
   Shia DS, 2009, CLIN ORTHOP RELAT R, V467, P2059, DOI 10.1007/s11999-008-0697-2
   Wannomae KK, 2006, J ARTHROPLASTY, V21, P1005, DOI 10.1016/j.arth.2005.07.019
   Wannomae KK, 2010, J ARTHROPLASTY, V25, P635, DOI 10.1016/j.arth.2009.04.005
NR 42
TC 45
Z9 50
U1 2
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2010
VL 31
IS 27
BP 7051
EP 7060
DI 10.1016/j.biomaterials.2010.05.041
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 634WJ
UT WOS:000280616300017
PM 20579730
DA 2018-10-19
ER

PT J
AU Lu, BY
   Zheng, JA
   Chen, DL
   Li, M
AF Lu Baoyong
   Zheng Jian
   Chen Denglong
   Li Min
TI Evaluation of a new type of wound dressing made from recombinant spider
   silk protein using rat models
SO BURNS
LA English
DT Article
DE Burn; Recombinant spider silk protein; Biomaterial dressing; Burn model
ID BIOMATERIALS
AB This study investigates the feasibility of recombinant spider silk protein as a wound-dressing material for coverage of deep second-degree burn wounds using an animal model. Sixty Sprague-Dawley (SD) rats were randomly divided into four groups (15 rats in each group). Two types of recombinant spider silk proteins, pNSR-16 and pNSR-32, as well as collagen (as a control) were applied on the wound; the fourth group was left untreated as a negative control. Each group was evaluated on the 3rd, 5th, 7th, 14th and 21st days for wound-healing rate, histological test, levels of hydroxyproline synthesis and the samples were stained for immunohistochemical detection of the basic fibroblast growth factor (bFGF). The results of implantation testing showed that wound healing in the treatment groups - recombinant spider silk protein pNSR-16 and pNSR-32 - was much better than that in the control group (p < 0.01). On the 7th, 14th and 21st days, higher expression of bFGF and the increase of hydroxyproline content of the skin indicated good regeneration of wound skin in the treatment groups. Preliminarily, we conclude that the recombinant spider silk protein membrane promotes the recovery of wound skin by increasing the expression and secretion of the growth factor bFGF and hydroxyproline. (C) 2009 Elsevier Ltd and ISBI. All rights reserved.
C1 [Lu Baoyong; Zheng Jian; Li Min] Fujian Normal Univ, Coll Life Sci, Fuzhou 350108, Fujian, Peoples R China.
   [Chen Denglong] Fujian Normal Univ, Coll Chem & Mat Sci, Fuzhou 350108, Fujian, Peoples R China.
RP Li, M (reprint author), Fujian Normal Univ, Coll Life Sci, Fuzhou 350108, Fujian, Peoples R China.
EM mli@fjnu.edu.cn
FU National Natural Science Foundation of China [30370414, 30570956];
   Development and Reform Commission Foundation of Fujian [2006-781]
FX We are grateful to the National Natural Science Foundation of China
   (30370414, 30570956) and the Development and Reform Commission
   Foundation of Fujian (2006-781) for their support for our research.
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Aoyagi S, 2007, INT J PHARM, V330, P138, DOI 10.1016/j.ijpharm.2006.09.016
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Chen Xiang-fang, 2007, Zhonghua Yi Xue Za Zhi, V87, P1812
   Chen Ying-hua, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1621
   Dell H, 2006, NATURE, V441, P821, DOI 10.1038/441821a
   Holland AJA, 2007, J BURN CARE RES, V28, P871, DOI 10.1097/BCR.0b013e318159a3ed
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Huang MH, 2008, INT J PHARM, V346, P38, DOI 10.1016/j.ijpharm.2007.06.021
   Liu M, 2008, PLANTA MED, V74, P809, DOI 10.1055/s-2008-1074533
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Pan Hong-Chun, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P446
   Ruan Chao-Ran, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P858
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
   Silver GM, 2007, J BURN CARE RES, V28, P715, DOI 10.1097/BCR.0B013E318148C9E4
   Singh R, 2008, J BURN CARE RES, V29, P64, DOI 10.1097/BCR.0b013e31815f5a0f
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
NR 18
TC 47
Z9 50
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-4179
EI 1879-1409
J9 BURNS
JI Burns
PD SEP
PY 2010
VL 36
IS 6
BP 891
EP 896
DI 10.1016/j.burns.2009.12.001
PG 6
WC Critical Care Medicine; Dermatology; Surgery
SC General & Internal Medicine; Dermatology; Surgery
GA 642CW
UT WOS:000281182100024
PM 20171017
DA 2018-10-19
ER

PT J
AU Guilak, F
   Estes, BT
   Diekman, BO
   Moutos, FT
   Gimble, JM
AF Guilak, Farshid
   Estes, Bradley T.
   Diekman, Brian O.
   Moutos, Franklin T.
   Gimble, Jeffrey M.
TI 2010 Nicolas Andry Award: Multipotent Adult Stem Cells from Adipose
   Tissue for Musculoskeletal Tissue Engineering
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID MESENCHYMAL PROGENITOR CELLS; ARTICULAR-CARTILAGE REPAIR; AUTOLOGOUS
   CHONDROCYTE TRANSPLANTATION; ELASTIN-LIKE POLYPEPTIDE; INFRAPATELLAR FAT
   PAD; MARROW STROMAL CELLS; IN-VITRO; CHONDROGENIC DIFFERENTIATION;
   EXTRACELLULAR-MATRIX; MOLECULAR-DIFFUSION
AB Cell-based therapies such as tissue engineering provide promising therapeutic possibilities to enhance the repair or regeneration of damaged or diseased tissues but are dependent on the availability and controlled manipulation of appropriate cell sources.
   The goal of this study was to test the hypothesis that adult subcutaneous fat contains stem cells with multilineage potential and to determine the influence of specific soluble mediators and biomaterial scaffolds on their differentiation into musculoskeletal phenotypes.
   We reviewed recent studies showing the stem-like characteristics and multipotency of adipose-derived stem cells (ASCs), and their potential application in cell-based therapies in orthopaedics.
   Under controlled conditions, ASCs show phenotypic characteristics of various cell types, including chondrocytes, osteoblasts, adipocytes, neuronal cells, or muscle cells. In particular, the chondrogenic differentiation of ASCs can be induced by low oxygen tension, growth factors such as bone morphogenetic protein-6 (BMP-6), or biomaterial scaffolds consisting of native tissue matrices derived from cartilage. Finally, focus is given to the development of a functional biomaterial scaffold that can provide ASC-based constructs with mechanical properties similar to native cartilage.
   Adipose tissue contains an abundant source of multipotent progenitor cells. These cells show cell surface marker profiles and differentiation characteristics that are similar to but distinct from other adult stem cells, such as bone marrow mesenchymal stem cells (MSCs).
   The availability of an easily accessible and reproducible cell source may greatly facilitate the development of new cell-based therapies for regenerative medicine applications in the musculoskeletal system.
C1 [Guilak, Farshid] Duke Univ, Med Ctr, Dept Surg, Orthopaed Res Labs,Div Orthopaed Surg, Durham, NC 27710 USA.
   [Guilak, Farshid; Estes, Bradley T.; Diekman, Brian O.; Moutos, Franklin T.] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
   [Gimble, Jeffrey M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Stem Cell Lab, Baton Rouge, LA 70808 USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Surg, Orthopaed Res Labs,Div Orthopaed Surg, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
OI Diekman, Brian/0000-0001-9055-4282; Guilak, Farshid/0000-0001-7380-0330
FU NCRR NIH HHS [UL1 RR024128, RR24128]; NIAMS NIH HHS [AR48182, P01
   AR050245, R01 AR048182, R01 AR048852, AR48852, AR50245]; NIA NIH HHS
   [R01 AG015768, AG15768]
CR Akizuki S, 1997, ARTHROSCOPY, V13, P9, DOI 10.1016/S0749-8063(97)90204-8
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Blevins FT, 1998, ORTHOPEDICS, V21, P761
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   *DEP HLTH HUM SERV, 2001, STEM CELLS SCI PROGR
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Diekman BO, 2010, J BIOMED MATER RES A, V93A, P994, DOI 10.1002/jbm.a.32589
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Estes BT, 2008, BIOTECHNOL BIOENG, V99, P986, DOI 10.1002/bit.21662
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Estes BT, 2004, CURR TOP DEV BIOL, V60, P91
   Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Ghivizzani S C, 2000, Phys Med Rehabil Clin N Am, V11, P289
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Guilak F, 2004, BIORHEOLOGY, V41, P389
   Guilak F, 2001, Clin Orthop Relat Res, pS295, DOI 10.1097/00003086-200110001-00027
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   Hanson AD, 2009, ANN BIOMED ENG, V37, P955, DOI 10.1007/s10439-009-9648-7
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005
   Huang BI, 2002, PLAST RECONSTR SURG, V109, P1042
   Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jurgens WJFM, 2009, CYTOTHERAPY, V11, P1052, DOI 10.3109/14653240903219122
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Leddy HA, 2004, J BIOMED MATER RES B, V70B, P397, DOI 10.1002/jbm.b.30053
   Leddy HA, 2003, ANN BIOMED ENG, V31, P753, DOI 10.1114/1.1581879
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Lee WCC, 2007, BIOMECH MODEL MECHAN, V6, P265, DOI 10.1007/s10237-006-0053-y
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   LITTLE D, 2010, TISSUE ENG A    0420
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   MOBASHERI A, 2008, ADV ANAT EMBRYOL CEL, V200
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   O'Driscoll SW, 2001, CLIN ORTHOP S, V391, pS397
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 2001, CYTOTHERAPY, V3, P393, DOI 10.1080/146532401753277229
   Prockop DJ, 2002, NAT BIOTECHNOL, V20, P791, DOI 10.1038/nbt0802-791
   Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Solchaga LA, 2001, CLIN ORTHOP RELAT R, pS161
   Stok KS, 2010, J BIOMED MATER RES A, V93A, P37, DOI 10.1002/jbm.a.32503
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Verfaillie CM, 2002, TRENDS CELL BIOL, V12, P502, DOI 10.1016/S0962-8924(02)02386-3
   Waldman SD, 2003, J BONE JOINT SURG AM, V85A, P101, DOI 10.2106/00004623-200300002-00013
   Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 87
TC 82
Z9 86
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD SEP
PY 2010
VL 468
IS 9
BP 2530
EP 2540
DI 10.1007/s11999-010-1410-9
PG 11
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 634PA
UT WOS:000280594200030
PM 20625952
OA Green Published
DA 2018-10-19
ER

PT J
AU Beggs, AD
   Irukulla, S
   Sultan, AH
   Ness, W
   Abulafi, AM
AF Beggs, A. D.
   Irukulla, S.
   Sultan, A. H.
   Ness, W.
   Abulafi, A. M.
TI A pilot study of ultrasound guided Durasphere injection in the treatment
   of faecal incontinence
SO COLORECTAL DISEASE
LA English
DT Article
DE Faecal incontinence; Durasphere; endoanal ultrasound; anal sphincter
ID INJECTABLE SILICONE BIOMATERIAL; QUALITY-OF-LIFE; BULKING AGENT;
   PREVALENCE; COMMUNITY
AB Aim
   To assess injection of Durasphere under direct endoanal ultrasound guidance as a treatment for faecal incontinence.
   Method
   A total of 23 patients with varying degrees of persistent faecal leakage and/or soiling were recruited. Durasphere was injected in the intersphincteric plane under direct ultrasound guidance. All patients were given a general anaesthetic. Patients had ano-rectal physiology, endoanal ultrasound, continence scoring and quality of life measures assessed at 0, 1, 3, 6 and 12 months.
   Results
   A total of 21 patients were followed up for at least 12 months, with two being excluded at the follow-up stage. Friedman two-way analysis of variance of the Cleveland Clinic Score, Faecal Incontinence Quality of Life Score and Diary Response Score demonstrated a significant sustained improvement. There was no significant improvement in number of bowel movements. There was a significant difference in anal squeeze pressure after therapy, but no significant difference in anal resting pressure. Six patients reported no improvement after Durasphere therapy.
   Conclusions
   Durasphere gave sustained improvements in quality of life and continence scores in this study group. Strict criteria are needed to ascertain suitability for Durasphere therapy.
C1 [Beggs, A. D.; Irukulla, S.; Ness, W.; Abulafi, A. M.] Mayday Univ Hosp, Colorectal Surg Unit, Croydon CR7 7YE, England.
   [Sultan, A. H.; Ness, W.] Mayday Univ Hosp, Urogynaecol Unit, Croydon CR7 7YE, England.
RP Abulafi, AM (reprint author), Mayday Univ Hosp, Colorectal Surg Unit, 530 London Rd, Croydon CR7 7YE, England.
EM muti.abulafi@mayday.nhs.uk
RI Beggs, Andrew/A-6912-2013
OI Beggs, Andrew/0000-0003-0784-2967
CR Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Hosker G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001310.pub2
   Lightner D, 2001, UROLOGY, V58, P12, DOI 10.1016/S0090-4295(01)01148-7
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P17
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   Thakar R, 2004, BEST PRACT RES CL OB, V18, P157, DOI 10.1016/j.bpobgyn.2003.09.007
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   Walter S, 2002, SCAND J GASTROENTERO, V37, P911, DOI 10.1080/003655202760230865
NR 13
TC 7
Z9 7
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD SEP
PY 2010
VL 12
IS 9
BP 935
EP 940
DI 10.1111/j.1463-1318.2009.01927.x
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 639QU
UT WOS:000280990100018
PM 19438887
DA 2018-10-19
ER

PT J
AU Chakravarty, UK
AF Chakravarty, Uttam Kumar
TI An investigation on the dynamic response of polymeric, metallic, and
   biomaterial foams
SO COMPOSITE STRUCTURES
LA English
DT Review
DE Foams; Dynamic response; Strain rate; Compressive strength; Energy
   absorption; Mechanical properties
ID CELL ALUMINUM FOAM; RATE COMPRESSIVE BEHAVIOR; STRAIN-RATE SENSITIVITY;
   ENERGY-ABSORPTION; MECHANICAL RESPONSE; STRUCTURAL FOAMS; CORE
   MATERIALS; ALLOY FOAMS; BALSA WOOD; DENSITY
AB Mechanical characterization of foams at varying strain rates is indispensable for the selection of foam as core material for the proficient sandwich structure design at dynamic loading application. Both servo-hydraulically controlled Material Testing System (MTS) and Instron machines are generally considered for quasi-static testing at strain rates on the order of 10(-3) s(-1). Split Hopkinson pressure bar (SHPB) with steel bars is typically utilized for characterizing metallic foams at high strain rates, however modified SHPB with polycarbonate or soft martial bars are used for characterizing polymeric and biomaterial foams at high strain rates on the order of 10(3) s(-1) for impedance match between the foam specimens and bars. This paper reviews the effect of strain rate of loading, density, environmental temperature, and microstructure on compressive strength and energy absorption capacity of various closed-cell polymeric, metallic, and biomaterial foams. Compressive strength and energy absorption capacity increase with the increase in both strain rate of loading and density of foams, but decrease with the increase in surrounding temperature. Foams of same density can have different strength and can absorb unequal amount of energy at the same strain rate of loading due to the variation of microstructure. (C) 2010 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Sch Aerosp Engn, Atlanta, GA 30332 USA.
RP Chakravarty, UK (reprint author), Georgia Inst Technol, Sch Aerosp Engn, 270 Ferst Dr, Atlanta, GA 30332 USA.
EM uc4@mail.gatech.edu
CR Amsterdam E, 2008, ACTA MATER, V56, P609, DOI 10.1016/j.actamat.2007.10.034
   Avalle M, 2001, INT J IMPACT ENG, V25, P455, DOI 10.1016/S0734-743X(00)00060-9
   Bouix R, 2009, INT J IMPACT ENG, V36, P329, DOI 10.1016/j.ijimpeng.2007.11.007
   Cady CM, 2009, MAT SCI ENG A-STRUCT, V525, P1, DOI 10.1016/j.msea.2009.07.007
   Chakravarty U, 2003, ACTA MATER, V51, P1469, DOI 10.1016/S1359-6454(02)00541-4
   Chen W, 2002, EXP MECH, V42, P65
   Chen W, 2002, J APPL MECH-T ASME, V69, P214, DOI 10.1115/1.1464871
   Dannemann KA, 2000, MAT SCI ENG A-STRUCT, V293, P157, DOI 10.1016/S0921-5093(00)01219-3
   Deshpande VS, 2000, INT J IMPACT ENG, V24, P277, DOI 10.1016/S0734-743X(99)00153-0
   Dou ZY, 2007, SCRIPTA MATER, V57, P945, DOI 10.1016/j.scriptamat.2007.07.024
   Gibson L. J., 1997, CELLULAR SOLIDS
   Hall IW, 2000, SCRIPTA MATER, V43, P515, DOI 10.1016/S1359-6462(00)00460-7
   Jones R. M., 1999, MECH COMPOSITE MAT
   Kitazono K, 2006, SCRIPTA MATER, V55, P501, DOI 10.1016/j.scriptamat.2006.06.001
   Mahfuz H, 2006, COMPOS SCI TECHNOL, V66, P2465, DOI 10.1016/j.compscitech.2006.02.020
   Mondal DP, 2009, MAT SCI ENG A-STRUCT, V507, P102, DOI 10.1016/j.msea.2009.01.019
   Mondal DP, 2009, MATER DESIGN, V30, P1268, DOI 10.1016/j.matdes.2008.06.059
   Mukai T, 1999, SCRIPTA MATER, V40, P921, DOI 10.1016/S1359-6462(99)00038-X
   Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005
   PAN F, 2008, T ASME, V130
   Paul A, 2000, MAT SCI ENG A-STRUCT, V281, P1, DOI 10.1016/S0921-5093(99)00750-9
   Peroni L, 2008, INT J IMPACT ENG, V35, P644, DOI 10.1016/j.ijimpeng.2007.02.007
   Raj RE, 2009, MAT SCI ENG A-STRUCT, V526, P11, DOI 10.1016/j.msea.2009.07.017
   Ruan D, 2002, COMPOS STRUCT, V57, P331, DOI 10.1016/S0263-8223(02)00100-9
   Saha MC, 2005, MAT SCI ENG A-STRUCT, V406, P328, DOI 10.1016/j.msea.2005.07.006
   Silva AD, 2007, INT J SOLIDS STRUCT, V44, P8685
   Song B, 2007, J MATER SCI, V42, P7502, DOI 10.1007/s10853-007-1612-z
   Subhash G, 2006, INT J IMPACT ENG, V32, P1113, DOI 10.1016/j.ijimpeng.2004.11.006
   Tagarielli VL, 2008, COMPOS PART B-ENG, V39, P83, DOI 10.1016/j.compositesb.2007.02.005
   Tan PJ, 2005, J MECH PHYS SOLIDS, V53, P2174, DOI 10.1016/j.jmps.2005.05.007
   Tekalur SA, 2008, COMPOS STRUCT, V84, P271, DOI 10.1016/j.compstruct.2007.08.008
   Viot P, 2008, COMPOS STRUCT, V86, P314, DOI 10.1016/j.compstruct.2008.07.021
   Viot P, 2009, INT J IMPACT ENG, V36, P975, DOI 10.1016/j.ijimpeng.2008.11.010
   Vural M, 2004, COMPOS PART B-ENG, V35, P639, DOI 10.1016/j.compositesb.2004.04.010
   Vural M, 2003, MECH MATER, V35, P523, DOI 10.1016/S0167-6636(02)00268-5
   Vural M, 2003, INT J SOLIDS STRUCT, V40, P2147, DOI 10.1016/S0020-7683(03)00057-X
   Yi F, 2001, MATER CHARACT, V47, P417, DOI 10.1016/S1044-5803(02)00194-8
   ZHANG J, 1994, J MATER SCI, V29, P157, DOI 10.1007/BF00356587
   Zhao H, 1997, POLYM TEST, V16, P507, DOI 10.1016/S0142-9418(97)00012-3
   Zhihua W., 2006, SCRIPTA MATER, V54, P83
NR 40
TC 18
Z9 18
U1 3
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0263-8223
EI 1879-1085
J9 COMPOS STRUCT
JI Compos. Struct.
PD SEP
PY 2010
VL 92
IS 10
BP 2339
EP 2344
DI 10.1016/j.compstruct.2010.02.013
PG 6
WC Materials Science, Composites
SC Materials Science
GA 605LE
UT WOS:000278348300001
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Kanetaka, H
   Sano, Y
   Kano, M
   Kudo, T
   Shimizu, Y
AF Zhang, Ye
   Kanetaka, Hiroyasu
   Sano, Yuya
   Kano, Mitsuhiro
   Kudo, Tada-aki
   Shimizu, Yoshinaka
TI MPC polymer regulates fibrous tissue formation by modulating cell
   adhesion to the biomaterial surface
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE 2-methacryloyloxyethyl phosphorylcholine polymer; Fibrous tissue; Cell
   adhesion plaque
ID POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); 2-METHACRYLOYLOXYETHYL
   PHOSPHORYLCHOLINE; PHOSPHOLIPID POLYMERS; INTRAOCULAR-LENS; FOCAL
   ADHESIONS; DIFFERENTIATION; SUPPRESSION; ADSORPTION; BEHAVIOR; SCAFFOLD
AB The aim of this study was to analyze the effects of 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer on fibrous tissue formation and cell adhesion plaque (CAP)-forming reactions. Silastic elastomer (SE) plates coated (experimental group) and uncoated (control group) with MPC polymer were prepared for in vivo and in vitro experiments. For the in vivo animal experiments, SE plates were implanted subcutaneously in the rat dorsal region. At 4, 8, and 12 weeks, thicknesses of the fibrous tissue capsules in the experimental group were lower than in the control group. Likewise, the amount of collagen in the experimental group was lower than that of the control group. For the in vitro cell culture experiments. KMST-6 fibroblast cells in the experimental group demonstrated enhanced cell migration, accompanied with a weaker expression of vinculin and a larger amount of filopodia. Furthermore, weaker expressions of paxillin, talin, and ROCK1, but stronger expression of cofilin, were observed in the experimental group. Taken together, these results suggested that MPC polymer regulated fibrous tissue formation by modulating cell adhesion through changes in local CAPs and downstream signaling.
C1 [Zhang, Ye; Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Biomed Engn, Dept Phys Med & Rehabil, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Kanetaka, Hiroyasu; Sano, Yuya] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Kano, Mitsuhiro; Shimizu, Yoshinaka] Tohoku Univ, Grad Sch Dent, Div Oral & Craniofacial Anat, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Kudo, Tada-aki] Tohoku Univ, Grad Sch Dent, Div Oral Physiol, Aoba Ku, Sendai, Miyagi 9808575, Japan.
RP Zhang, Y (reprint author), Tohoku Univ, Grad Sch Biomed Engn, Dept Phys Med & Rehabil, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM zhangye@m.tains.tohoku.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology, Japan
FX This work is supported in part by the special coordination funds for
   Promoting Science and Technology from the Ministry of Education,
   Culture, Sports, Science, and Technology, Japan.
CR Abraham S, 2004, P ANN INT IEEE EMBS, V26, P5036
   Al-Attar A, 2006, PLAST RECONSTR SURG, V117, P286, DOI 10.1097/01.prs.0000195073.73580.46
   Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107
   BELL WT, 1985, J PROSTHET DENT, V54, P404, DOI 10.1016/0022-3913(85)90561-X
   Brown MH, 2005, PLAST RECONSTR SURG, V116, P768, DOI 10.1097/01.prs.0000176259.66948.e7
   Chang PP, 2009, J PROSTHODONT, V18, P23, DOI 10.1111/j.1532-849X.2008.00371.x
   Cohen ED, 2007, J NEURAL ENG, V4, pS124, DOI 10.1088/1741-2560/4/1/S14
   Cornelis MA, 2008, CLIN ORAL IMPLAN RES, V19, P1054, DOI 10.1111/j.1600-0501.2008.01553.x
   Dubash AD, 2009, INT REV CEL MOL BIO, V277, P1, DOI 10.1016/S1937-6448(09)77001-7
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Heckmann L, 2007, J BIOMED MATER RES B, V81B, P82, DOI 10.1002/jbm.b.30640
   Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006
   Ho SP, 2003, BIOMATERIALS, V24, P5121, DOI 10.1016/S0142-9612(03)00450-2
   Huang XD, 2007, CLIN EXP OPHTHALMOL, V35, P462, DOI 10.1111/j.1442-9071.2007.01516.x
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   Kaji H, 2006, LANGMUIR, V22, P10784, DOI 10.1021/la0610654
   Konno T, 2006, J BIOSCI BIOENG, V102, P304, DOI 10.1263/jbb.102.304
   Kyomoto M, 2008, J BIOMED MATER RES B, V84B, P320, DOI 10.1002/jbm.b.30874
   Kyomoto M, 2010, BIOMATERIALS, V31, P658, DOI 10.1016/j.biomaterials.2009.09.083
   Lehle K, 2004, BIOMATERIALS, V25, P5457, DOI 10.1016/j.biomaterials.2003.12.055
   LEWIS DH, 1980, J PROSTHET DENT, V43, P426, DOI 10.1016/0022-3913(80)90215-2
   Machesky L, 2008, EMBO REP, V9, P139, DOI 10.1038/sj.embor.7401162
   Mandalia V, 2008, J BONE JOINT SURG BR, V90B, P265, DOI 10.1302/0301-620X.90B3.20140
   Mang A, 2005, Diabetes Technol Ther, V7, P163, DOI 10.1089/dia.2005.7.163
   Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6
   Nam K, 2007, BIOMATERIALS, V28, P3153, DOI 10.1016/j.biomaterials.2007.03.001
   Okajima Y, 2006, J CATARACT REFR SURG, V32, P666, DOI 10.1016/j.jcrs.2006.01.039
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Seo JH, 2008, BIOMATERIALS, V29, P1367, DOI 10.1016/j.biomaterials.2007.11.039
   Shigeta M, 2006, J CATARACT REFR SURG, V32, P859, DOI 10.1016/j.jcrs.2006.02.010
   Sibarani J, 2007, COLLOID SURFACE B, V54, P88, DOI 10.1016/j.colsurfb.2006.09.024
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006
   Waide V, 2003, CLIN BIOMECH, V18, P523, DOI 10.1016/S0268-0033(03)00072-X
   Wang WD, 2009, ARCH PHARM RES, V32, P1727, DOI 10.1007/s12272-009-2210-1
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1375, DOI 10.1021/bm025652p
   Xu Y, 2009, BIOMACROMOLECULES, V10, P267, DOI 10.1021/bm801279y
NR 39
TC 4
Z9 4
U1 0
U2 9
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD SEP
PY 2010
VL 29
IS 5
BP 518
EP 528
DI 10.4012/dmj.2009-138
PG 11
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 679WU
UT WOS:000284192300004
PM 20827031
OA Bronze
DA 2018-10-19
ER

PT J
AU Fukushima, T
   Ohno, J
   Hayakawa, T
   Imayoshi, R
   Kawaguchi, M
   Doi, Y
   Kanaya, K
   Mitarai, M
AF Fukushima, Tadao
   Ohno, Jun
   Hayakawa, Tohru
   Imayoshi, Rieko
   Kawaguchi, Minoru
   Doi, Yutaka
   Kanaya, Keiichi
   Mitarai, Makoto
TI Polycationic protamine for water-insoluble complex formation with DNA
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Protamine; DNA; DNA/protamine complex
ID IN-VITRO CYTOTOXICITY; CHITOSAN COMPLEXES; LIPID FILMS; BEHAVIOR;
   SYSTEMS; SIZE
AB The DNA/protamine complex was prepared by a reaction between DNA and protamine sulfate solutions with stirring, and its cell viability, antibacterial effect and histopathological responses were examined. A water-insoluble white powder, DNA/protamine complex, with a porous structure was obtained. The molar binding ratio of the complex prepared from a solution containing equal amounts of DNA and protamine sulfate by weight was 0.038 and the efficiency of complex formation was 61%. In a cell culture test using MC-3T3-E1 mouse osteoblast cells, the complex showed less cytotoxicity than protamine sulfate alone and cell viabilities were more than 98%. A porous disk could be prepared easily and showed an antibacterial effect against Staphyrococcus aureus, Porphyromonas gingivalis and Prevotella intermedia in an antibacterial sensitivity test and a mild tissue response in vivo test. These results suggested that the DNA/protamine complex could be a useful biodegradable biomaterial with antibacterial effects.
C1 [Fukushima, Tadao; Kawaguchi, Minoru] Fukuoka Dent Coll, Dept Dent Engn, Bioengn Sect, Sawara Ku, Fukuoka 8140193, Japan.
   [Ohno, Jun] Fukuoka Dent Coll, Dept Morphol Biol, Pathol Sect, Sawara Ku, Fukuoka 8140193, Japan.
   [Hayakawa, Tohru] Tsurumi Univ, Dept Dent Engn, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan.
   [Imayoshi, Rieko] Fukuoka Dent Coll, Dept Funct Biosci, Infect Biol Sect, Sawara Ku, Fukuoka 8140193, Japan.
   [Doi, Yutaka] Asahi Univ, Dept Dent Mat & Technol, Sch Dent, Mizuho 5010296, Japan.
   [Kanaya, Keiichi] Asahi Univ, Div Oral Infect & Hlth Sci, Dept Periodontol, Sch Dent, Mizuho 5010296, Japan.
   [Mitarai, Makoto] Maruha Nichiro Holdings Inc, Cent Res Inst, Tsukuba, Ibaraki 3004247, Japan.
RP Fukushima, T (reprint author), Fukuoka Dent Coll, Dept Dent Engn, Bioengn Sect, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM tadaof@college.fdcnet.ac.jp
FU Japan Society for the Promotion of Science [19390505, 20659308]
FX This study was supported in part by Grants-in-aid for Scientific
   Research (B) (19390505) and Challenging Exploratory Research (20659308)
   from the Japan Society for the Promotion of Science.
CR BOLTZ DF, 1948, ANAL CHEM, V20, P749, DOI 10.1021/ac60020a021
   Cherng JY, 1996, PHARMACEUT RES, V13, P1038, DOI 10.1023/A:1016054623543
   CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U
   DIXON GH, 1968, ACID RES MOL BIOL, V8, P9
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Fukushima T, 2006, J BIOMED MATER RES B, V76B, P121, DOI 10.1002/jbm.b.30334
   Fukushima T, 2004, BIOMATERIALS, V25, P5491, DOI 10.1016/j.biomaterials.2004.01.006
   Fukushima T, 2001, J DENT RES, V80, P1772, DOI 10.1177/00220345010800081801
   Fukushima T, 2008, J ORAL TISSUE ENG, V6, P24
   Fukushima T, 2007, DENT MATER J, V26, P854, DOI 10.4012/dmj.26.854
   Fukushima T, 2009, J BIOMED MATER RES B, V91B, P746, DOI 10.1002/jbm.b.31451
   Garnett MC, 1999, CRIT REV THER DRUG, V16, P147
   HORROW JC, 1985, ANESTH ANALG, V64, P348
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   JOHANSEN C, 1995, J APPL BACTERIOL, V78, P297, DOI 10.1111/j.1365-2672.1995.tb05029.x
   KISHIDA A, 1991, BIOMATERIALS, V12, P786, DOI 10.1016/0142-9612(91)90031-5
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   SIE P, 1989, THROMB RES, V54, P63, DOI 10.1016/0049-3848(89)90337-X
   STRYER L, 1988, BIOCHEMISTRY-US, P830
NR 20
TC 14
Z9 14
U1 0
U2 9
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD SEP
PY 2010
VL 29
IS 5
BP 529
EP 535
DI 10.4012/dmj.2009-131
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 679WU
UT WOS:000284192300005
PM 20733264
DA 2018-10-19
ER

PT J
AU Salvay, DM
   Zelivyanskaya, M
   Shea, LD
AF Salvay, D. M.
   Zelivyanskaya, M.
   Shea, L. D.
TI Gene delivery by surface immobilization of plasmid to tissue-engineering
   scaffolds
SO GENE THERAPY
LA English
DT Article
DE biomaterials; regenerative medicine; non-viral vectors;
   substrate-mediated delivery
ID IN-VIVO; TRANSGENE EXPRESSION; PERITONEAL-MACROPHAGES; POROUS SCAFFOLDS;
   MOUSE MUSCLE; DNA; MICROSPHERES; MATRIX; CELLS; MICE
AB Biomaterial scaffolds that serve as vehicles for gene delivery to promote expression of inductive factors have numerous regenerative medicine applications. In this report, we investigate plasmid delivery from biomaterial scaffolds using a surface immobilization strategy. Porous scaffolds were fabricated from poly(D, L-lactide-co-glycolide) (PLG), and plasmids were immobilized by drying. In vitro plasmid release indicated that the majority (> 70%) of adsorbed plasmids were released within 24 h and > 98% within 3 days; however, in vivo implantation of the scaffolds at the subcutaneous site yielded transgene expression that persisted for at least 28 weeks and was localized to the site of implantation. Histological analysis of DNA-adsorbed scaffolds indicated that macrophages at the scaffold were transfected in the first 2 weeks after implantation, whereas muscle cells adjacent to the implant primarily expressed the transgene at 4 weeks. In addition to localized gene expression, a secreted protein (human factor IX) was retained at the implant site and not available systemically after 3 days, indicating minimal off-target effects. These findings show that surface immobilization of plasmid onto microporous PLG scaffolds can produce localized and long-term gene expression in vivo, which may be used to enhance the bioactivity of scaffolds used for regenerative medicine. Gene Therapy (2010) 17, 1134-1141; doi:10.1038/gt.2010.79; published online 20 May 2010
C1 [Salvay, D. M.; Zelivyanskaya, M.; Shea, L. D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, L. D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
   [Shea, L. D.] Northwestern Univ, Inst Bionanotechnol Med, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Tech E 156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIH [RO1EB003806, RO1EB005678]
FX We thank Prof. Michele Calos for helpful discussions and the human
   Factor IX construct. Financial support for this research was provided by
   NIH RO1EB003806 and RO1EB005678.
CR Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Blum JS, 2008, J CONTROL RELEASE, V129, P66, DOI 10.1016/j.jconrel.2008.04.002
   Bowman K, 2008, J CONTROL RELEASE, V132, P252, DOI 10.1016/j.jconrel.2008.06.019
   Chandler LA, 2000, WOUND REPAIR REGEN, V8, P473, DOI 10.1046/j.1524-475x.2000.00473.x
   Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917
   DE LAPORTE L, 2007, ADV DRUG DELIVER REV, V59, P292
   DE LAPORTE L, 2009, MOL THER, V17, P318
   El-Ayoubi R, 2008, TISSUE ENG PT A, V14, P1037, DOI [10.1089/ten.tea.2006.0418, 10.1089/tea.2006.0418]
   Endo M, 2006, TISSUE ENG, V12, P489, DOI 10.1089/ten.2006.12.489
   Guo T, 2006, BIOMATERIALS, V27, P1095, DOI 10.1016/j.biomaterials.2005.08.015
   Huang GT, 2009, TISSUE ENG PART A, V16, P605
   Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2006, J CONTROL RELEASE, V112, P120, DOI 10.1016/j.jconrel.2006.01.013
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Kong HJ, 2008, PHARM RES, V25, P1230, DOI 10.1007/s11095-007-9526-7
   Meilander-Lin NJ, 2005, TISSUE ENG, V11, P546, DOI 10.1089/ten.2005.11.546
   Meuli M, 2001, J INVEST DERMATOL, V116, P131, DOI 10.1046/j.1523-1747.2001.00139.x
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Nathwani AC, 2002, BLOOD, V100, P1662, DOI 10.1182/blood-2002-02-0589
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   RIVES CB, 2008, BIOMATERIALS
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Sarkar N, 2002, J CARDIOVASC PHARM, V39, P215, DOI 10.1097/00005344-200202000-00008
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Stern M, 2003, GENE THER, V10, P1282, DOI 10.1038/sj.gt.3301994
   Sun XD, 2009, BIOMATERIALS, V30, P1222, DOI 10.1016/j.biomaterials.2008.10.020
   Takagi T, 1998, BIOCHEM BIOPH RES CO, V245, P729, DOI 10.1006/bbrc.1998.8521
   Takakura Y, 1999, PHARMACEUT RES, V16, P503, DOI 10.1023/A:1018842210588
   VAN DEUTEKOM JCT, 1998, MOL MED TODAY, V4, P214
   Whittlesey KJ, 2004, EXP NEUROL, V190, P1, DOI 10.1016/j.expneurol.2004.06.020
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363
NR 37
TC 18
Z9 19
U1 0
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
J9 GENE THER
JI Gene Ther.
PD SEP
PY 2010
VL 17
IS 9
BP 1134
EP 1141
DI 10.1038/gt.2010.79
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 649HC
UT WOS:000281757900008
PM 20485383
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Harris, LG
   El-Bouri, K
   Johnston, S
   Rees, E
   Frommelt, L
   Siemssen, N
   Christner, M
   Davies, AP
   Rohde, H
   Mack, D
AF Harris, Llinos G.
   El-Bouri, Khalid
   Johnston, Stuart
   Rees, Eugene
   Frommelt, Lars
   Siemssen, Nicolaus
   Christner, Martin
   Davies, Angharad P.
   Rohde, Holger
   Mack, Dietrich
TI Rapid identification of staphylococci from prosthetic joint infections
   using MALDI-TOF mass-spectrometry
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Staphylococcus; Species identification; Typing; Pulsed-field gel
   electrophoresis; MALDI-TOF/MS; Biomaterial-related infection
ID LASER-DESORPTION IONIZATION; POLYSACCHARIDE INTERCELLULAR ADHESIN;
   DESORPTION/IONIZATION-TIME; BIOFILM FORMATION; MICROBIOLOGY
   LABORATORIES; EPIDERMIDIS; BACTERIA; AUREUS; DISCRIMINATION;
   ACCUMULATION
AB Hospital-acquired infections associated with implanted medical devices are most commonly caused by staphylococci. Current methods of species identification are slow, costly, and sometimes unreliable. We evaluated the ability of a Bruker Daltonics Microflex MALDI-TOF/MS in conjunction with MALDI Biotyper software to identify 158 characterized staphylococcal isolates from prosthetic joint infections, including 36 Staphylococcus aureus, 100 Staphylococcus epidermidis, 10 Staphylococcus capitis, 8 Staphylococcus lugdunensis, 2 Staphylococcus warneri, and 2 Staphylococcus haemolyticus isolates using the extraction method recommended by Bruker Daltonics. The suggested species identification by the MALDI Biotyper software was correct for all isolates, indicating reliable differentiation between S. aureus and coagulase-negative staphylococci. Applying the recommended criteria of the MALDI Biotyper software all 158 isolates gave scores >= 2.0, implying secure genus and probable species identification for all isolates. 34/36 S. aureus, 36/100 S. epidermidis, 5/10 S. capitis, 6/8 S. lugdunensis, 2/2 S. haemolyticus, 0/2 S. warneri displayed scores >= 2.3 implying highly probable species identification. For S. epidermidis 25/100 additional isolates had a score close to 2.3. It appears that additional clinically relevant staphylococcal isolates in the data base might aid in identification at scores implying highly probable species identification. The ability of the MALDI Biotyper software to recognize clonally-related strains within a species group (i.e. sub-typing) was investigated, and showed great potential. In conclusion, the MALDI-TOF/MS MALDI Biotyper system provides a promising rapid and reliable method of identifying clinical isolates from prosthetic joint infections to the species level, and has potential for sub-typing.
C1 [Harris, Llinos G.; Davies, Angharad P.; Mack, Dietrich] Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales.
   [El-Bouri, Khalid; Johnston, Stuart; Rees, Eugene; Davies, Angharad P.; Mack, Dietrich] Abertawe Bro Morgannwg Univ Hlth Board, Publ Hlth Wales Microbiol ABM Swansea, Singleton Hosp, Swansea, W Glam, Wales.
   [Frommelt, Lars; Siemssen, Nicolaus] ENDO Klin Hamburg GmbH, Hamburg, Germany.
   [Christner, Martin; Rohde, Holger] Univ Hosp, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.
RP Harris, LG (reprint author), Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales.
EM l.g.harris@swansea.ac.uk
OI Harris, Llinos/0000-0002-0295-3038
FU Medical Research Council [G0801929]
CR Bernardo K, 2002, PROTEOMICS, V2, P747, DOI 10.1002/1615-9861(200206)2:6<747::AID-PROT747>3.0.CO;2-V
   Bright JJ, 2002, J MICROBIOL METH, V48, P127, DOI 10.1016/S0167-7012(01)00317-7
   Carbonnelle E, 2007, J CLIN MICROBIOL, V45, P2156, DOI 10.1128/JCM.02405-06
   Dubois D, 2010, J CLIN MICROBIOL, V48, P941, DOI 10.1128/JCM.00413-09
   Edwards-Jones V, 2000, J MED MICROBIOL, V49, P295, DOI 10.1099/0022-1317-49-3-295
   Euzeby J. P., LIST PROKARYOTIC NAM
   Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004
   Harris LG, 2009, INT J ARTIF ORGANS, V32, P555
   Jager S, 2009, INT J ARTIF ORGANS, V32, P584
   Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Mack D, 1999, INFECT IMMUN, V67, P1004
   Mack D., 2006, BIOFILMS INFECT ANTI, P109
   Parisi D, 2008, ANAL BIOANAL CHEM, V391, P2127, DOI 10.1007/s00216-008-2161-2
   Rajakaruna L, 2009, INFECT GENET EVOL, V9, P507, DOI 10.1016/j.meegid.2009.01.012
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Samek O, 2008, LASER PHYS LETT, V5, P465, DOI 10.1002/lapl.200810011
   Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885
   SPANU T, 2010, CLIN MICROBIOL  0202
   Szabados F, 2010, J MED MICROBIOL, V59, P787, DOI 10.1099/jmm.0.016733-0
   Takahashi T, 1999, INT J SYST BACTERIOL, V49, P725, DOI 10.1099/00207713-49-2-725
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233
   Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06
   van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09
NR 25
TC 38
Z9 40
U1 2
U2 9
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2010
VL 33
IS 9
BP 568
EP 574
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 669LY
UT WOS:000283353500002
PM 20963723
DA 2018-10-19
ER

PT J
AU Cao, ZF
   Jin, Y
   Zhang, BA
   Miao, Q
   Ma, CY
AF Cao, Zhifeng
   Jin, Yong
   Zhang, Biao
   Miao, Qing
   Ma, Chunyan
TI A Novel Temperature-and pH-responsive Polymer-biomolecule Conjugate
   Composed of Casein and Poly(N-isopropylacrylamide)
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE biopolymers; conjugated polymers; core-shell polymers; stimuli-sensitive
   polymers; water-soluble polymers
ID BLOCK-COPOLYMER MICELLES; CONTROLLED DRUG-DELIVERY; THERMOSENSITIVE
   HYDROGELS; GRAFT-COPOLYMERIZATION; RADICAL POLYMERIZATION; RAFT
   POLYMERIZATION; HYBRID AMPHIPHILES; RELEASE; POLYSACCHARIDES;
   NANOPARTICLES
AB A sort of novel stimuli-responsive water-soluble polymer-biomolecule conjugate, casein-g-poly(N-isopropylacrylamide) (PNIPAAm), was synthesized by free radical graft copolymerization of N-isopropylacrylamide (NIPAAm) from casein. The graft polymerization was induced by a small amount of t-butyl hydroperoxide (TBHP) in water under general condition. Free radicals on the amino groups of casein and t-butoxy radicals were generated concurrently, which initiated the graft copolymerization and homopolymerization of NIPAAm, respectively. The graft copolymers and homopolymer of NIPAAm were isolated and the chemical structure of the graft copolymer was characterized by Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC). The phase-transition behaviours of the graft copolymers in aqueous solutions were investigated by the turbidity measurements. Casein-g-PNIPAAm did not precipitate at around the isoelectric pH (IP) of casein at 25 C and the lowest transmittance was changed as the pH changed. These results suggest that the PNIPAAm offers a greater hindrance to the aggregation of casein at 25 C and the casein offers a hindrance to the aggregation of PNIPAAm at the temperature of lower critical solution temperature (LCST) and at the pH apart from the IP. In addition, casein almost has no effect on LCST. The graft copolymer is stimuli-sensitive with respect to both temperature and pH in aqueous solutions and the polymeric micelles with different structures can be obtained simply by changing the environmental conditions. It associates into core-shell micelles in aqueous solution with collapsed PNIPAAm as a core as well as inverse core-hair micelles with expanded casein as a core on changing temperature or pH, indicated by transmission electron microscopy (TEM). With the casein being a nature protein and the graft copolymers are metal ion-free therefore, they may have great potential for biomedical and biomaterial applications.
C1 [Cao, Zhifeng; Jin, Yong; Zhang, Biao; Miao, Qing; Ma, Chunyan] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Cao, Zhifeng; Zhang, Biao; Miao, Qing; Ma, Chunyan] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China.
RP Jin, Y (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM jinyong@cioc.ac.cn
FU National Natural Science Foundation of China (NSFC) [20874102]; Project
   of Science and Technology Commission of Jiaxing [2007A22018]; Ningbo of
   Zhejiang [2006B100056]
FX The work is supported by National Natural Science Foundation of China
   (NSFC; No.20874102) and Project of Science and Technology Commission of
   Jiaxing (No.2007A22018) and Ningbo (No.2006B100056) of Zhejiang.
CR Bai L, 2008, IRAN POLYM J, V17, P325
   Berrada M, 2005, BIOMATERIALS, V26, P2115, DOI 10.1016/j.biomaterials.2004.06.013
   Binks BP, 2005, ANGEW CHEM INT EDIT, V44, P4795, DOI 10.1002/anie.200501073
   Bontempo D, 2006, BIOMACROMOLECULES, V7, P2154, DOI 10.1021/bm0601373
   Boyer C, 2007, J AM CHEM SOC, V129, P7145, DOI 10.1021/ja070956a
   Chakraborty A, 2007, J PHOTOCH PHOTOBIO B, V87, P191, DOI 10.1016/j.jphotobiol.2007.04.004
   Chung JE, 2000, J CONTROL RELEASE, V65, P93, DOI 10.1016/S0168-3659(99)00242-4
   de Kruif CG, 1999, INT DAIRY J, V9, P183, DOI 10.1016/S0958-6946(99)00058-8
   De P, 2008, J AM CHEM SOC, V130, P11288, DOI 10.1021/ja804495v
   Dirks AJ, 2008, ADV MATER, V20, P3953, DOI 10.1002/adma.200801383
   Dong QZ, 2000, J APPL POLYM SCI, V77, P2543
   Fujii S, 2005, J AM CHEM SOC, V127, P7304, DOI 10.1021/ja050049a
   Ge ZS, 2007, MACROMOLECULES, V40, P3538, DOI 10.1021/ma070550i
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Glangchai LC, 2008, J CONTROL RELEASE, V125, P263, DOI 10.1016/j.jconrel.2007.10.021
   Hannink JM, 2001, ANGEW CHEM INT EDIT, V40, P4732, DOI 10.1002/1521-3773(20011217)40:24<4732::AID-ANIE4732>3.0.CO;2-P
   He CL, 2008, J POLYM SCI POL CHEM, V46, P4140, DOI 10.1002/pola.22760
   Hu J, 2008, LANGMUIR, V24, P13376, DOI 10.1021/la802598z
   Idziak I, 1999, MACROMOLECULES, V32, P1260, DOI 10.1021/ma981171f
   JAYAKRISHNAN A, 1994, INT J PHARM, V106, P221, DOI 10.1016/0378-5173(94)90005-1
   Jinsmaa Y, 1999, PEPTIDES, V20, P957, DOI 10.1016/S0196-9781(99)00088-1
   Kamiya N, 2005, BIOMACROMOLECULES, V6, P35, DOI 10.1021/bm0494895
   Khorram M, 2003, IRAN POLYM J, V12, P315
   Klok HA, 2005, J POLYM SCI POL CHEM, V43, P1, DOI 10.1002/pola.20527
   Ko J, 2007, J CONTROL RELEASE, V123, P109, DOI 10.1016/j.jconrel.2007.07.012
   Leung MF, 2004, MACROMOL RAPID COMM, V25, P1819, DOI 10.1002/marc.200400362
   Li GY, 2008, J POLYM SCI POL CHEM, V46, P5028, DOI 10.1002/pola.22831
   Li P, 2002, LANGMUIR, V18, P8641, DOI 10.1021/la0261343
   Li YX, 2008, J POLYM SCI POL CHEM, V46, P6907, DOI 10.1002/pola.23000
   Liu F, 2008, MACROMOLECULES, V41, P6531, DOI 10.1021/ma8006784
   Liu Y, 2008, BIOPHYS CHEM, V136, P67, DOI 10.1016/j.bpc.2008.03.012
   Mano V, 2004, J APPL POLYM SCI, V92, P743, DOI 10.1002/app.20027
   Morinloto N, 2008, MACROMOLECULES, V41, P5985, DOI 10.1021/ma801332x
   Morris GA, 2000, BIOMACROMOLECULES, V1, P764, DOI 10.1021/bm0055087
   Narambuena CF, 2005, J AGR FOOD CHEM, V53, P459, DOI 10.1021/jf049202v
   Pelah A, 2009, SOFT MATTER, V5, P1006, DOI 10.1039/b815691c
   Qiu QY, 1985, CHIN J POLYM SCI, V01, P76
   Rao KSVK, 2010, IRAN POLYM J, V19, P265
   Sahu A, 2008, BIOMACROMOLECULES, V9, P2905, DOI 10.1021/bm800683f
   Shome A, 2008, LANGMUIR, V24, P4280, DOI 10.1021/la704024p
   Stubenrauch K, 2009, J POLYM SCI POL CHEM, V47, P1178, DOI 10.1002/pola.23229
   Sun YH, 1984, SCI CHINA B, V04, P349
   Tao L, 2004, J AM CHEM SOC, V126, P13220, DOI 10.1021/ja0456454
   Wang G, 2004, MACROMOLECULES, V37, P8911, DOI 10.1021/ma048416a
   Yin J, 2009, J POLYM SCI POL CHEM, V47, P2608, DOI 10.1002/pola.23346
   Zhang YF, 2008, J POLYM SCI POL CHEM, V46, P2379, DOI 10.1002/pola.22572
   Xiong ZC, 2007, IRAN POLYM J, V16, P425
NR 47
TC 8
Z9 8
U1 2
U2 20
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD SEP
PY 2010
VL 19
IS 9
BP 689
EP 698
PG 10
WC Polymer Science
SC Polymer Science
GA 664YK
UT WOS:000282999900005
DA 2018-10-19
ER

PT J
AU Doody, J
   Zeugolisa, D
   Kelly, G
   Devocellec, M
   Kilcoync, M
   Joshi, L
   Kelly, J
   Pandit, A
AF Doody, J.
   Zeugolisa, D.
   Kelly, G.
   Devocellec, M.
   Kilcoync, M.
   Joshi, L.
   Kelly, J.
   Pandit, A.
TI A STRATEGY FOR SIALYLATION OF A COLLAGEN SCAFFOLD TO PROMOTE NEURAL
   REGENERATION AND MODULATES HOST INFLAMMATORY RESPONSE WHEN USED AS A
   NERVE GRAFTING BIOMATERIAL
SO IRISH JOURNAL OF MEDICAL SCIENCE
LA English
DT Meeting Abstract
C1 [Zeugolisa, D.; Joshi, L.; Pandit, A.] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Doody, J.; Kelly, J.] Galway Univ Hosp, Dept Plast Surg, Galway, Ireland.
   [Kelly, G.; Devocellec, M.] RCSI, Dept Pharmaceut & Med Chem, Dublin, Ireland.
   [Kilcoync, M.; Joshi, L.] Natl Univ Ireland, AGRC, NCBES, Galway, Ireland.
CR Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005
   Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0
   MARINO, 2009, EXP NEUROL, V218, P163
NR 3
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0021-1265
J9 IRISH J MED SCI
JI Irish J. Med. Sci.
PD SEP
PY 2010
VL 179
SU 9
MA 78
BP S359
EP S359
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA 651UU
UT WOS:000281953500079
DA 2018-10-19
ER

PT J
AU Raffaini, G
   Ganazzoli, F
AF Raffaini, Giuseppina
   Ganazzoli, Fabio
TI Protein adsorption on biomaterial and nanomaterial surfaces: a molecular
   modeling approach to study non-covalent interactions
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Review
DE Protein adsorption; Computer simulations; Molecular dynamics;
   Interfaces; Non-covalent interactions
ID WALLED CARBON NANOTUBES; MONTE-CARLO-SIMULATION; VACUUM-WATER INTERFACE;
   LIPID TRANSFER PROTEIN; COMPUTER-SIMULATION; DYNAMICS SIMULATIONS;
   GRAPHITE SURFACE; SERUM-ALBUMIN; MECHANICAL-PROPERTIES; HYDROPHOBIC
   SURFACES
AB Atomistic computer simulations of protein adsorption on the heterogeneous surface of biomaterials and nanomaterials are reviewed. First, we present a very brief introduction to some relevant issues concerning force fields and the computational methodologies currently used, in particular molecular dynamics simulations for studying non-covalent interactions in general. The main results are then discussed, considering the adsorption of different protein subdomains and of whole proteins on different surfaces of an unlike nature. In particular, we review our results for lysozyme and some protein subdomains with a different secondary structure on a strongly hydrophobic graphite surface and on a highly hydrophilic polymeric surface, and preliminary results of protein adsorption on single-walled carbon nanotubes, focusing on the effect of the surface topography and curvature. We also discuss the results obtained in other groups for other proteins or protein subdomains being adsorbed on ceramic materials, either purely ionic (MgO, hydroxyapatite) or covalent (SiO(2), taken as a model for mica), and on self-assembled monolayers terminated with various chemical functionalities. The insights gained from these simulations are commented on critically, in particular the use of an implicit solvent or the use of explicit water and the lack of final equilibrium usually achieved in the latter case. Finally, we present some open issues for computer simulations of protein adsorption at an interface, and provide an outlook about possible future work in this area.
C1 [Raffaini, Giuseppina; Ganazzoli, Fabio] Politecn Milan, Dept Chem Mat & Chem Engn G Natta, I-20131 Milan, Italy.
   [Raffaini, Giuseppina; Ganazzoli, Fabio] Politecn Milan, Interuniv Res Ctr Prot Biotechnol Prot Factory, I-20131 Milan, Italy.
RP Raffaini, G (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Via Mancinelli 7, I-20131 Milan, Italy.
EM giuseppina.raffaini@polimi.it
RI Raffaini, Giuseppina/N-1578-2014; Ganazzoli, Fabio/F-9543-2013
OI Raffaini, Giuseppina/0000-0003-3462-6514; Ganazzoli,
   Fabio/0000-0002-9762-4535
CR *ACC INC, 2000, INSIGHT2 2000 CERIUS
   Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   Allen M. P., 1987, COMPUTER SIMULATION
   Anand G, 2010, LANGMUIR, V26, P10803, DOI 10.1021/la1006132
   Artali R, 2008, J R SOC INTERFACE, V5, P273, DOI 10.1098/rsif.2007.1137
   Barrett DA, 2001, ANAL CHEM, V73, P5232, DOI 10.1021/ac010368u
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Binder K, 1995, MONTE CARLO MOL DYNA
   BRASH JL, 1995, ACS S SERIES, V602
   Castells V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031912
   Chiu CC, 2008, J PHYS CHEM B, V112, P16326, DOI 10.1021/jp805313p
   Cormack AN, 2004, J PHYS CHEM B, V108, P20408, DOI 10.1021/jp0463417
   DAUBEROSGUTHORP.P, 1998, PROTEIN-STRUCT FUNCT, V4, P31
   DILL KA, 1995, PROTEIN SCI, V4, P561
   Euston SR, 2008, BIOMACROMOLECULES, V9, P3024, DOI 10.1021/bm8004325
   Euston SR, 2008, BIOMACROMOLECULES, V9, P1443, DOI 10.1021/bm701227g
   Frenkel D., 2001, UNDERSTANDING MOL SI
   Ganazzoli F, 2005, PHYS CHEM CHEM PHYS, V7, P3651, DOI 10.1039/b506813d
   Ganazzoli F, 1998, J CHEM PHYS, V108, P9924, DOI 10.1063/1.476431
   Ganazzoli F, 2000, J CHEM PHYS, V112, P1547, DOI 10.1063/1.480701
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Karajanagi SS, 2006, LANGMUIR, V22, P1392, DOI 10.1021/la0528201
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kubiak K, 2009, J PHYS CHEM B, V113, P12189, DOI 10.1021/jp901521x
   Latour RA, 2008, BIOINTERPHASES, V3, pFC2, DOI 10.1116/1.2965132
   Lu JR, 1998, J COLLOID INTERF SCI, V206, P212, DOI 10.1006/jcis.1998.5680
   Lu Jr, 1999, ANN RP CH C, V95, P3
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   MAPLE JR, 1988, P NATL ACAD SCI USA, V85, P5350, DOI 10.1073/pnas.85.15.5350
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Nednoor P, 2004, BIOCONJUGATE CHEM, V15, P12, DOI 10.1021/bc0341526
   Nordgren CE, 2002, BIOPHYS J, V83, P2906, DOI 10.1016/S0006-3495(02)75300-9
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545
   Oscarsson S, 1997, J CHROMATOGR B, V699, P117, DOI 10.1016/S0378-4347(97)00224-7
   Pricl S, 2006, BIOMED MICRODEVICES, V8, P277, DOI 10.1007/s10544-006-0031-2
   Raffaini G, 2006, PHYS CHEM CHEM PHYS, V8, P2765, DOI 10.1039/b604540e
   Raffaini G, 2006, J BIOMED MATER RES A, V77A, P618, DOI 10.1002/jbm.a.30670
   Raffaini G, 2006, J BIOMED MATER RES A, V76A, P638, DOI 10.1002/jbm.a.30546
   Raffaini G, 2004, J PHYS CHEM B, V108, P13850, DOI 10.1021/jp0477452
   Raffaini G, 2004, LANGMUIR, V20, P3371, DOI 10.1021/la0357716
   Raffaini G, 2003, LANGMUIR, V19, P3403, DOI 10.1021/la026853h
   Raffaini G, 2007, J INCL PHENOM MACRO, V57, P683, DOI 10.1007/s10847-006-9265-0
   Raffaini G, 2007, J MATER SCI-MATER M, V18, P309, DOI 10.1007/s10856-006-0694-5
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Raffaini G, 2010, LANGMUIR, V26, P5679, DOI 10.1021/la903769c
   Raffaini G, 2010, J BIOMED MATER RES A, V92A, P1382, DOI 10.1002/jbm.a.32483
   Raffaini G, 2009, J PHYS CHEM B, V113, P9110, DOI 10.1021/jp901581e
   Ratner B.D., 2004, BIOMATERIALS SCI
   Roman T, 2006, EUR PHYS J D, V38, P117, DOI 10.1140/epjd/e2006-00043-1
   ROTH CM, 1995, LANGMUIR, V11, P3500, DOI 10.1021/la00009a036
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Sethuraman A, 2004, PROTEINS, V56, P669, DOI 10.1002/prot.20183
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Sowerby SJ, 2001, ASTROBIOLOGY, V1, P481, DOI 10.1089/153110701753593883
   SUN H, 1994, J AM CHEM SOC, V116, P2978, DOI 10.1021/ja00086a030
   Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v
   Svaldo-Lanero T, 2008, SOFT MATTER, V4, P965, DOI 10.1039/b800621k
   Sweryda-Krawiec B, 2004, LANGMUIR, V20, P2054, DOI 10.1021/la034870g
   TABORELLI M, 1995, J BIOMED MATER RES, V29, P707, DOI 10.1002/jbm.820290606
   THEODOROU DN, 1986, MACROMOLECULES, V19, P139, DOI 10.1021/ma00155a022
   Tobias DJ, 1996, BIOPHYS J, V71, P2933, DOI 10.1016/S0006-3495(96)79497-3
   VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921
   WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Wertz CF, 2002, LANGMUIR, V18, P1190, DOI 10.1021/la0108813
   Zhdanov VP, 1998, PROTEINS, V30, P177, DOI 10.1002/(SICI)1097-0134(19980201)30:2<177::AID-PROT7>3.3.CO;2-Y
   Zhdanov VP, 1998, PROTEINS, V30, P168, DOI 10.1002/(SICI)1097-0134(19980201)30:2<168::AID-PROT6>3.0.CO;2-J
   Zhdanov VP, 2001, LANGMUIR, V17, P5407, DOI 10.1021/la0104222
   Zhdanov VP, 2001, PROTEINS, V42, P481, DOI 10.1002/1097-0134(20010301)42:4<481::AID-PROT70>3.0.CO;2-N
   Zheng J, 2005, BIOPHYS J, V89, P158, DOI 10.1529/biophysj.105.059428
NR 74
TC 22
Z9 23
U1 4
U2 92
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD SEP-DEC
PY 2010
VL 8
IS 3
BP 135
EP 145
DI 10.5301/JABB.2010.6093
PG 11
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 731GP
UT WOS:000288094600001
PM 21337304
DA 2018-10-19
ER

PT J
AU Ma, X
   Hu, YY
   Lv, R
   Wang, J
   Wu, XM
   Yan, YN
AF Ma, Xing
   Hu, Yunyu
   Lv, Rong
   Wang, Jun
   Wu, Xiaoming
   Yan, Yongnian
TI Multilevel Posterior Lumbar Interlaminar Fusion in Rabbits Using Bovine
   Bone Protein Extract Delivered by a RP-synthesized 3D Biopolymer
   Construct
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE biomaterial; bovine bone protein extract (BBPE); rapid prototyping (RP);
   poly(DL-lactic-co-glycolic acid)/tricalcium phosphate (PLGA/TCP); porous
   scaffolds; spine fusion
ID BIOMIMETIC GRAFTING MATERIAL; MESENCHYMAL STEM-CELLS; SPINAL-FUSION;
   CALCIUM-PHOSPHATE; MORPHOGENETIC PROTEIN-2; SCAFFOLD; BMP; FABRICATION;
   OSTEOBLAST; XENOGRAFT
AB Rapid prototyping (RP)-based highly porous poly(DL-lactic-co- glycolic acid)/tricalcium phosphate (PLGA/TCP(RP)) scaffolds were fabricated. PLGA/TCP constructs (PLGA/TCP(TS)) were also made via thermally induced phase separation with solvent casting and by particulate leaching approach. Both scaffolds were loaded with bovine bone protein extract (BBPE). Sixty-four New Zealand white rabbits were randomized into four groups (groups of A, B, C, and D) and unilaterally underwent posterior lumbar interlaminar fusion at L2-L4 level. Spinal fusions were systematically evaluated. In groups of A (PLGA/TCP(RP)/BBPE constructs) and C (autogenous iliac bone grafts), good bone fusions occurred in vivo. Histological analyses indicated that endochondral ossification played an essential role in initiation of bone fusions in group A, whereas in group B (PLGA/TCP(TS)/BBPE constructs), few bone fusions were observed. In group D (PLGA/TCP(RP) scaffolds alone), the scaffolds were biocompatible and biodegradable; however, no newly formed bone mass or bone fusion was found. Twelve weeks after surgery, the fusion was significantly higher in groups of A and C compared with groups B and D (p<0.01). The PLGA/TCP(RP)/BBPE biomaterials have potential as grafting substitutes for bone healing and spinal fusion.
C1 [Ma, Xing] Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 1, Sch Med, Xian 710061, Peoples R China.
   [Hu, Yunyu; Lv, Rong; Wang, Jun] Fourth Mil Med Univ, Inst Orthopaed Surg, Xijing Hosp, Xian 710032, Peoples R China.
   [Hu, Yunyu; Lv, Rong; Wang, Jun] Fourth Mil Med Univ, Dept Orthopaed, Xijing Hosp, Xian 710032, Peoples R China.
   [Wu, Xiaoming] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.
   [Yan, Yongnian] Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.
   [Yan, Yongnian] Tsinghua Univ, Ctr Organ Mfg, Dept Mech Engn, Beijing 100084, Peoples R China.
RP Ma, X (reprint author), Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 1, Sch Med, Xian 710061, Peoples R China.
EM medscience@yahoo.cn
FU Hi-tech Research and Development Program of China [715009-0160];
   National Natural Science Foundation of China [30300356]
FX We would like to thank the Hi-tech Research and Development Program of
   China for supporting this work under grant number 715009-0160. This work
   was also financially supported by the National Natural Science
   Foundation of China (No. 30300356). Ma, X. and Hu, Y. had equal
   contributions to this article.
CR Asti Annalia, 2008, Technol Health Care, V16, P401
   Bezer M, 2005, EUR SPINE J, V14, P227, DOI 10.1007/s00586-004-0781-6
   Bi L, 2007, J BIOMED MATER RES B, V82B, P418, DOI 10.1002/jbm.b.30747
   Cui TK, 2009, J BIOACT COMPAT POL, V24, P5, DOI 10.1177/0883911509102349
   Gigante A, 2008, EUR J HISTOCHEM, V52, P169
   Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018
   Hu YY, 2003, J BIOMED MATER RES A, V67A, P591, DOI 10.1002/jbm.a.10070
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kujala S, 2008, ACTA ORTHOP BELG, V74, P132
   Kyriakidou K, 2008, J BIOACT COMPAT POL, V23, P227, DOI 10.1177/0883911508091905
   Lian Q, 2009, J BIOACT COMPAT POL, V24, P113, DOI 10.1177/0883911509103784
   Liu L, 2009, J BIOACT COMPAT POL, V24, P18, DOI 10.1177/0883911509102347
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Ma X, 2009, MATER SCI FORUM, V626-627, P553, DOI 10.4028/www.scientific.net/MSF.626-627.553
   MA X, 2008, WU YI XUE GONG CHENG, V25, P571
   Ma X, 2009, J BIOACT COMPAT POL, V24, P457, DOI 10.1177/0883911509343497
   Ma X, 2009, J BIOACT COMPAT POL, V24, P146, DOI 10.1177/0883911509103830
   Ma Xing, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P795
   Maire M, 2005, BIOMATERIALS, V26, P5085, DOI 10.1016/j.biomaterials.2005.01.020
   Matsuno T, 2008, DENT MATER J, V27, P827, DOI 10.4012/dmj.27.827
   Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Sun H, 2008, TRANSPL P, V40, P2645, DOI 10.1016/j.transproceed.2008.07.096
   SUN QM, 2004, ZHONG GUO LIN CHUANG, V8, P1436
   Sun XT, 2006, J PEDIATR ORTHOP B, V15, P113, DOI 10.1097/01.bpb.0000191866.93022.c1
   White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x
   Xiong Z, 2005, RAPID PROTOTYPING J, V11, P160, DOI 10.1108/13552540510601282
   Zhang HL, 2010, J BIOACT COMPAT POL, V25, P241, DOI 10.1177/0883911509359486
   Zhu HY, 2005, J BIOACT COMPAT POL, V20, P271, DOI 10.1177/0883911505053384
NR 30
TC 4
Z9 5
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD SEP
PY 2010
VL 25
IS 5
BP 513
EP 526
DI 10.1177/0883911510377556
PG 14
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 647EB
UT WOS:000281598800006
DA 2018-10-19
ER

PT J
AU Li, QQ
   Chau, Y
AF Li, Qianqian
   Chau, Ying
TI Neural differentiation directed by self-assembling peptide scaffolds
   presenting laminin-derived epitopes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomimetic material; self-assembling peptide; peptide signal; laminin;
   neural differentiation
ID NERVE GROWTH-FACTOR; EMBRYONIC STEM-CELLS; EXTENSION IN-VITRO; NEURITE
   OUTGROWTH; PC12 CELLS; CHONDROGENIC DIFFERENTIATION; 3-DIMENSIONAL
   CULTURE; NANOFIBER SCAFFOLD; PROGENITOR CELLS; ATTACHMENT
AB We prepared biofunctionalized matrices for cell growth using (RADA)(3)IKVAV(RADA)(3) ((Arg-Ala-Asp-Ala)(3)-Ile-Lys-Val-Ala-Val-(Arg-Ala-Asp-Ala)(3)) and (RADA)(4)-IKVAV ((Arg-Ala-Asp-Ala)(4)-Ile-Lys-Val-Ala-Val), self-assembling peptides with a laminin-derived sequence inserted between and attached terminally to the repeats of RADA, respectively. The material cell interactions were investigated with PC12, a cell line commonly used as a model for studying neural differentiation. The behavior of PC12 and especially the neural differentiation was guided by the presence of IKVAV. Furthermore, the cell material interactions were dependent on the culture dimensionality and the position of IKVAV in the self-assembling peptide template. In the two-dimensional (2-D) culture, matrices containing IKVAV stimulated significantly longer neurite outgrowths from PC12 cells than did (RADA)(4). More pronounced effect was observed in (RADA)(3)IKVAV(RADA)(3) than in (RADA)(4)IKVAV. In the three-dimensional (3-D) culture, neurite outgrowth was not observed in the biofunctionalized matrices. Instead, cells displayed higher proliferation rate and survived longer culture time than in the 2-D culture, with such enhancement being most significant in (RADA)(3)IKVAV(RADA)(3). Despite the lack of differentiation phenotype, the cells grown in 3-D biofunctionalized matrices were primed for differentiation, as evident by enhanced neurite outgrowth, increased neurite networking, and up-regulated expression of differentiation markers upon their reintroduction to the 2-D culture condition on petri dish. With the ease of incorporating biofunctional epitopes, and the flexibility to support either 2-D or 3-D culture, self-assembling peptides provide versatile scaffolds to study the multiple facets of biomaterial cell interactions. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res 94A: 688499, 2010
C1 [Li, Qianqian; Chau, Ying] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Kowloon, Hong Kong, Peoples R China.
RP Chau, Y (reprint author), Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Kowloon, Hong Kong, Peoples R China.
EM ying.chau@ust.hk
OI Chau, Ying/0000-0003-1759-934X
FU Hong Kong Research Grants Council
FX We are grateful to Prof. King Lau Chow at the Hong Kong University of
   Science and Technology (HKUST) for his advice on molecular biology,
   Prof. Andrew Miller at HKUST for generously providing access to and
   technical support of confocal laser microscopy, and Dr. Qian Luo at
   HKUST for providing the PC12 cell line. We thank Dr. Shuguang Zhang at
   the Massachusetts Institute of Technology for the helpful suggestion of
   experiments and Yusuke Nagai at Menico Co. for the assistance in drawing
   the peptide molecular models. Funding is provided by the Hong Kong
   Research Grants Council.
CR Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   BLACK MM, 1986, J CELL BIOL, V103, P545, DOI 10.1083/jcb.103.2.545
   BRUGG B, 1988, J CELL BIOL, V107, P643, DOI 10.1083/jcb.107.2.643
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   CIRULLI V, 1993, J CLIN INVEST, V91, P1868, DOI 10.1172/JCI116403
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Cusack SM, 2004, EXP CELL RES, V299, P442, DOI 10.1016/j.yexcr.2004.05.035
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   Gelain F, 2006, PLOS ONE, V1, P1, DOI DOI 10.1371/JOURNAL.PONE.0000119
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Huber M, 1998, J BIOMED MATER RES, V41, P278, DOI 10.1002/(SICI)1097-4636(199808)41:2<278::AID-JBM13>3.0.CO;2-H
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Massia SP, 2004, J BIOMED MATER RES A, V68A, P177, DOI 10.1002/jbm.a.20009
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Ohuchi T, 2002, J NEUROSCI METH, V118, P1, DOI 10.1016/S0165-0270(02)00116-4
   PARSONSWINGERTER PA, 1993, BIOTECHNOL PROGR, V9, P600, DOI 10.1021/bp00024a006
   Patel N, 1998, FASEB J, V12, P1447
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schimmelpfeng J, 2004, J NEUROSCI METH, V139, P299, DOI 10.1016/j.jneumeth.2004.05.010
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703
   Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG ZY, 1993, J BIOL CHEM, V268, P5557
NR 41
TC 27
Z9 27
U1 0
U2 28
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2010
VL 94A
IS 3
BP 688
EP 699
DI 10.1002/jbm.a.32707
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 633WA
UT WOS:000280536300004
PM 20730926
DA 2018-10-19
ER

PT J
AU Ren, PG
   Huang, ZN
   Ma, T
   Biswal, S
   Smith, RL
   Goodman, SB
AF Ren, Pei-Gen
   Huang, Zhinong
   Ma, Ting
   Biswal, Sandip
   Smith, Robert L.
   Goodman, Stuart B.
TI Surveillance of systemic trafficking of macrophages induced by UHMWPE
   particles in nude mice by noninvasive imaging
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage trafficking; polyethylene particles; bioluminescence;
   noninvasive in vivo imaging
ID TOTAL HIP-ARTHROPLASTY; NECROSIS-FACTOR-ALPHA; DEBRIS IN-VITRO;
   PERIPROSTHETIC OSTEOLYSIS; BONE-RESORPTION; BIOMATERIAL PARTICLES; WEAR
   PARTICLES; GROWTH-FACTOR; LAK CELLS; EXPRESSION
AB Macrophages constitute a major part of the cell response to wear particles produced at articulating and nonarticulating interfaces of joint replacements. This foreign body reaction can result in periprosthetic osteolysis and implant loosening. We demonstrate that ultra-high molecular weight polyethylene (UHMWPE) particles induce systemic trafficking of macrophages by noninvasive in vivo imaging and immunohistochemistry. The distal femora of nude mice were injected with 60 mg/mL UHMWPE suspension or saline alone. Reporter RAW264.7 macrophages that stably expressed the bioluminescent reporter gene and the fluorescence reporter gene were injected intravenously. Bioluminescence imaging was performed using an in vivo imaging system immediately after macrophage injection and at 2-day intervals. Compared with the nonoperated contralateral femora, at day 4, 6, and 8, the bioluminescent signal of femora containing UHMWPE suspension increased 1.30 +/- 0.09-, 2.36 +/- 0.92-, and 10.32 +/- 7.61-fold, respectively. The values at same time points for saline-injected control group were 1.08 +/- 0.07-, 1.14 +/- 0.27-, and 1.14 +/- 0.35-fold, respectively. The relative bioluminescence of the UHMWPE group was higher at all postinjection days and significantly greater than the saline group at day 8 (p < 0.05). Histological analysis confirmed the presence of reporter macrophages within the medullary canal of mice with implanted UHMWPE particles. The presence of UHMWPE particles induced enhanced bone remodeling activity. Clinically relevant UHMWPE particles stimulated the systemic recruitment of macrophages during an early time course using the murine femoral implant model. Interference with systemic macrophage trafficking may potentially mitigate UHMWPE particle-induced periprosthetic osteolysis. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Has Part A: 94A: 706-711, 2010
C1 [Ren, Pei-Gen; Huang, Zhinong; Ma, Ting; Smith, Robert L.; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA.
   [Biswal, Sandip] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.
RP Goodman, SB (reprint author), Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA.
EM goodbone@stanford.edu
RI Ren, Pei-Gen/A-4099-2009
FU National Institute of Health [R01 AR055650]; Ellenburg Chair in Surgery
   at Stanford University
FX Contract grant sponsor: National Institute of Health; contract grant
   number: R01 AR055650; Contract grant sponsor: The Ellenburg Chair in
   Surgery at Stanford University
CR Archibeck M J, 2001, Instr Course Lect, V50, P185
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P138, DOI 10.1097/01.blo.00000038467.05771.90
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4
   Decaris E, 1999, ARTHRITIS RHEUM, V42, P1951, DOI 10.1002/1529-0131(199909)42:9<1951::AID-ANR22>3.3.CO;2-4
   DONALDSON LF, 1993, J NEUROSCI METH, V49, P5, DOI 10.1016/0165-0270(93)90103-X
   Drees P, 2007, NAT CLIN PRACT RHEUM, V3, P165, DOI 10.1038/ncprheum0428
   FELGAR RE, 1990, CELL IMMUNOL, V129, P288, DOI 10.1016/0008-8749(90)90205-6
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   GIANT TT, 1993, J BONE MINER RES, V8, P1071
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   Kelly S, 2007, EUR J NEUROSCI, V26, P935, DOI 10.1111/j.1460-9568.2007.05737.x
   Kinov P, 2006, J ORTHOP RES, V24, P55, DOI 10.1002/jor.20013
   Kumagai K, 2008, J ORTHOP RES, V26, P165, DOI 10.1002/jor.20477
   KUPPEN PJK, 1992, INT J CANCER, V52, P266, DOI 10.1002/ijc.2910520219
   LOTZE MT, 1980, J IMMUNOL, V125, P1487
   MAGHAZACHI A A, 1988, Cellular Immunology, V115, P179
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Miyanishi K, 2003, J BONE MINER RES, V18, P1573, DOI 10.1359/jbmr.2003.18.9.1573
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   Quinn JMW, 1998, CALCIFIED TISSUE INT, V62, P527, DOI 10.1007/s002239900473
   Ren PG, 2008, BIOMATERIALS, V29, P4760, DOI 10.1016/j.biomaterials.2008.09.004
   Sabokbar A, 1998, ARCH ORTHOP TRAUM SU, V117, P136, DOI 10.1007/s004020050213
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Talmo CT, 2006, CLIN ORTHOP RELAT R, P254, DOI 10.1097/01.blo.0000246531.59876.a8
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Zilber S, 2008, J BIOMED MATER RES B, V84B, P286, DOI 10.1002/jbm.b.30872
NR 34
TC 17
Z9 17
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2010
VL 94A
IS 3
BP 706
EP 711
DI 10.1002/jbm.a.32744
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 633WA
UT WOS:000280536300006
PM 20213815
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Araujo, MA
   Cunha, AM
   Mota, M
AF Araujo, Maria Alberta
   Cunha, Antonio M.
   Mota, Manuel
TI Changes on surface morphology of corn starch blend films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE MATERBI 1128RR; surface analysis; starch blend; alpha-amylase
   degradation; biomaterial
ID DRUG-DELIVERY CARRIERS; BIODEGRADABLE POLYMERS; ENZYMATIC DEGRADATION;
   POTENTIAL APPLICATION; THERMOPLASTIC BLENDS; MOLECULAR-WEIGHT; BONE
   CEMENTS; IN-VITRO; BEHAVIOR; BIOCOMPATIBILITY
AB This study aims at evaluating the influence of enzymatic degradation solution on the surface morphology and thermal properties of a poly(ethylene-vinyl alcohol) copolymer-corn starch thermoplastic blend (SEVA-C), as a function of immersion time. To perform this study, three different batches were assessed using SEVA-C samples of different thicknesses and a fixed weight of 1.6 g, immersed in a-amylase (50 u/L) up to 90 days at 37 degrees C. TGA, contact angle measurements, scanning electron microscopy (SEM) and atomic force microscopy (AFM) techniques were used. Three degradation mechanisms are considered in these systems: namely, mass loss due to plasticizer leaching (glycerol), starch enzymatic cleavage, and synthetic polymer fractions degradation. Enzymatic hydrolysis of the starch fraction and subsequent leaching from the internal bulk structure led to an increase in surface porosity, pore size, roughness, and to the development of small pits throughout the surface, as observed by SEM and AFM. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 720-729, 2010
C1 [Araujo, Maria Alberta] IPVC, Escola Super Tecnol & Gestao, P-4900348 Viana Do Castelo, Portugal.
   [Araujo, Maria Alberta; Mota, Manuel] Univ Minho, IBB, Ctr Biol Engn, P-4710057 Braga, Portugal.
   [Cunha, Antonio M.] Univ Minho, Dept Polymer Engn, Inst Polymers & Composites, P-4800058 Guimaraes, Portugal.
RP Araujo, MA (reprint author), IPVC, Escola Super Tecnol & Gestao, Avenida Atlantico, P-4900348 Viana Do Castelo, Portugal.
EM alberta@estg.ipvc.pt
OI Cunha M., Antonio/0000-0003-3860-7732; Araujo,
   Alberta/0000-0002-4239-8876; Mota, Manuel/0000-0002-1084-2688
CR ANDERSON JM, 1991, MRS BULL, V16, P75
   ANDRIANO KP, 1994, J APPL BIOMATER, V5, P133, DOI 10.1002/jab.770050206
   Araujo A, 2004, J BIOMAT SCI-POLYM E, V15, P1263
   Araujo MA, 2009, J MATER SCI-MATER M, V20, P607, DOI 10.1007/s10856-008-3601-4
   Araujo MA, 2004, BIOMATERIALS, V25, P2687, DOI 10.1016/j.biomaterials.2003.09.093
   BASTIOLI C, 1994, STUD POLYM SCI, V12, P200
   Bastioli C, 1998, POLYM DEGRAD STABIL, V59, P263, DOI 10.1016/S0141-3910(97)00156-0
   Bastioli C, 1993, J ENVIRON POLYM DEGR, V1, P181
   Boesel LF, 2006, BIOMACROMOLECULES, V7, P2600, DOI 10.1021/bm060387j
   ELIZABETH RB, 2008, J MATER SCI-MATER M, V19, P1617
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Farrar DF, 2002, BIOMATERIALS, V23, P3905, DOI 10.1016/S0142-9612(02)00140-0
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hakkarainen M, 1996, POLYM DEGRAD STABIL, V52, P283, DOI 10.1016/0141-3910(96)00009-2
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Leonor IB, 2007, J TISSUE ENG REGEN M, V1, P425, DOI 10.1002/term.54
   Malafaya PB, 2006, J MATER SCI-MATER M, V17, P371, DOI 10.1007/s10856-006-8240-z
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Otey F. H., 1984, STARCH CHEM TECHNOLO, p[154, 667]
   Pachence J. M., 1997, PRINCIPLES TISSUE EN, P263
   Pashkuleva I, 2008, MACROMOL BIOSCI, V8, P210, DOI 10.1002/mabi.200700076
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   REIS AL, 1996, POLYM ADVAN TECHNOL, V7, P784
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.0.CO;2-T
   Reis RL, 1997, POLYM INT, V43, P347
   Salgado AJ, 2007, J BIOMED MATER RES A, V80A, P983, DOI 10.1002/jbm.a.30946
   Van Oss C. J., 1994, INTERFACIAL FORCES A, P89
   Yoshida Y., 1994, BIODEGRADABLE PLASTI
   Zhang GY, 2006, BIOMACROMOLECULES, V7, P3259, DOI 10.1021/bm060343a
NR 35
TC 5
Z9 5
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2010
VL 94A
IS 3
BP 720
EP 729
DI 10.1002/jbm.a.32725
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 633WA
UT WOS:000280536300008
PM 20225217
DA 2018-10-19
ER

PT J
AU Lyle, DB
   Breger, JC
   Baeva, LF
   Shallcross, JC
   Durfor, CN
   Wang, NS
   Langone, JJ
AF Lyle, Daniel B.
   Breger, Joyce C.
   Baeva, Larissa F.
   Shallcross, Jonathan C.
   Durfor, Charles N.
   Wang, Nam Sun
   Langone, John J.
TI Low molecular weight hyaluronic acid effects on murine macrophage nitric
   oxide production
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; nitric oxide; inflammation; macrophage; hyaluronic acid
ID NF-KAPPA-B; RAT ALVEOLAR MACROPHAGES; CHEMOKINE GENE-EXPRESSION; MOUSE
   MACROPHAGES; FRAGMENTS INDUCE; CELL-DEATH; IFN-GAMMA; TECHNICAL
   CONSIDERATIONS; ARTICULAR CHONDROCYTES; INTERFERON-GAMMA
AB Hyaluronic acid (HA) is increasingly used for a number of medical device applications. Since the chemical structure of HA is identical no matter its bacterial or animal origin, it should be the ideal biomaterial. However, short term transient inflammatory reactions are common, while rare long-term adverse events may correlate with subclinical chronic inflammation. Concern has been raised that low molecular weight components or degradation fragments from implanted HA may directly stimulate inflammatory reactions. This study examined a panel of HA molecular weights from the unitary disaccharide up to 1.7 x 10(6) Dalton lengths, in which endotoxin was assayed at a very low level (less than 0.03 EU/mg). The murine cell line RAW 264.7, rat splenocytes, and rat adherent differentiated primary macrophages were assayed for nitric oxide production under a variety of inflammatory conditions plus or minus HA. Under the highest inflammatory states, nitric oxide production was mildly suppressed by HMW-HA while slightly augmented by LMW-HA at mg/mL concentrations. However, at micromolar concentrations fragments below 5000 Daltons, thought to have drug-like qualities, were without effect. These data support the hypothesis that if endotoxin is reduced to an extremely low level, LMW-HA may not directly provoke normal tissue macrophage-mediated inflammatory reactions. (C) 2010 Wiley Periodicals, Inc.* J Biomed Mater Res Part A: 94A: 893-904, 2010
C1 [Lyle, Daniel B.; Breger, Joyce C.; Baeva, Larissa F.; Shallcross, Jonathan C.; Durfor, Charles N.; Langone, John J.] US FDA, Ctr Devices & Radiol Hlth, Off Sci, Silver Spring, MD 20993 USA.
   [Lyle, Daniel B.; Breger, Joyce C.; Baeva, Larissa F.; Shallcross, Jonathan C.; Durfor, Charles N.; Langone, John J.] US FDA, Engn Labs, Silver Spring, MD 20993 USA.
   [Breger, Joyce C.; Wang, Nam Sun] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
RP Langone, JJ (reprint author), US FDA, Ctr Devices & Radiol Hlth, Off Sci, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
EM john.langone@fda.hhs.gov
RI Wang, Nam Sun/E-4253-2016
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Alaniz L, 2006, GLYCOBIOLOGY, V16, P359, DOI 10.1093/glycob/cwj085
   Ariyoshi W, 2005, J BIOL CHEM, V280, P18967, DOI 10.1074/jbc.M412740200
   Balazs EA, 2008, CURR PHARM BIOTECHNO, V9, P236, DOI 10.2174/138920108785161596
   Bhattacharyya J, 2004, CURR MED CHEM, V11, P359, DOI 10.2174/0929867043456098
   Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200
   Breborowicz A, 2001, AM J KIDNEY DIS, V37, P594, DOI 10.1053/ajkd.2001.22086
   Breger JC, 2009, J BIOMED MATER RES B, V91B, P755, DOI 10.1002/jbm.b.31452
   Calciu-Rusu D, 2007, BIOMACROMOLECULES, V8, P1287, DOI 10.1021/bm061039k
   Camillieri G, 2004, J OCUL PHARMACOL TH, V20, P151, DOI 10.1089/108076804773710821
   Carruthers A, 2007, PLAST RECONSTR SURG, V120, p33S, DOI 10.1097/01.prs.0000248808.75700.5f
   Chajara A, 2003, ATHEROSCLEROSIS, V171, P15, DOI 10.1016/S0021-9150(03)00303-4
   Christensen L, 2007, DERMATOL SURG, V33, pS168, DOI 10.1111/j.1524-4725.2007.33357.x
   Clark CP, 2007, PLAST RECONSTR SURG, V120, p27S, DOI 10.1097/01.prs.0000248806.70402.7b
   Cohen JL, 2008, DERMATOL SURG, V34, pS92, DOI 10.1111/j.1524-4725.2008.34249.x
   Conrozier T, 2008, EXPERT OPIN PHARMACO, V9, P1797, DOI [10.1517/14656560802193856, 10.1517/14656566.9.10.1797 ]
   COOPERSTOCK MS, 1974, ANTIMICROB AGENTS CH, V6, P422, DOI 10.1128/AAC.6.4.422
   Diks SH, 2001, J ENDOTOXIN RES, V7, P335, DOI 10.1179/096805101101532909
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Filion MC, 2001, J PHARM PHARMACOL, V53, P555, DOI 10.1211/0022357011775677
   Fioravanti A, 2005, OSTEOARTHR CARTILAGE, V13, P688, DOI 10.1016/j.joca.2005.03.006
   Fujii K, 1999, J IMMUNOL, V162, P2391
   Gao CJ, 2003, BIOCHEM BIOPH RES CO, V309, P120, DOI 10.1016/S0006-291X(03)01534-1
   Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499
   Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103
   Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.32549
   Goodstone NJ, 2004, TISSUE ENG, V10, P621, DOI 10.1089/107632704323061979
   Habara T, 2002, J BIOMED MATER RES, V61, P628, DOI 10.1002/jbm.10247
   Haslinger B, 2001, CELL TISSUE RES, V305, P79, DOI 10.1007/s004410100409
   HodgeDufour J, 1997, J IMMUNOL, V159, P2492
   Horton MR, 1999, J IMMUNOL, V162, P4171
   Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088
   Horton MR, 1998, J IMMUNOL, V160, P3023
   Horton MR, 2002, J BIOL CHEM, V277, P43757, DOI 10.1074/jbc.M206007200
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Joddar B, 2006, BIOMATERIALS, V27, P2994, DOI 10.1016/j.biomaterials.2006.01.020
   Judodihardjo H, 2008, DERMATOL SURG, V34, pS110, DOI 10.1111/j.1524-4725.2008.34252.x
   Kanj RS, 2005, J TOXICOL ENV HEAL A, V68, P185, DOI 10.1080/15287390590890509
   KAWABE T, 1992, IMMUNOLOGY, V76, P72
   Kelly Michael A, 2004, Am J Orthop (Belle Mead NJ), V33, P23
   Kerscher M, 2008, DERMATOL SURG, V34, P720, DOI 10.1111/j.1524-4725.2008.34176.x
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   Kim C, 1996, IMMUNOPHARMACOLOGY, V34, P89, DOI 10.1016/0162-3109(96)00113-0
   Lemaire I, 1996, J LEUKOCYTE BIOL, V60, P509
   LePage C, 1996, IMMUNOLOGY, V89, P274, DOI 10.1046/j.1365-2567.1996.d01-728.x
   LYLE DB, 2008, J BIOMED MATER RES A, V90, P82
   Maneiro E, 2004, CLIN EXP RHEUMATOL, V22, P307
   Mascarenhas MM, 2004, AM J RESP CELL MOL, V30, P51, DOI 10.1165/rcmb.2002-0167OC
   McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765
   McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013
   McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054
   Migliore A, 2008, CLIN INTERV AGING, V3, P365, DOI 10.2147/CIA.S778
   MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449
   Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189
   Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x
   Nicolau PJ, 2007, PLAST RECONSTR SURG, V119, P2271, DOI 10.1097/01.prs.0000260710.30934.a1
   NOBLE PW, 1996, J EXP MED, V183, P2372
   Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200
   PENDINO KJ, 1993, J IMMUNOL, V151, P7196
   Powell JD, 2005, IMMUNOL RES, V31, P207, DOI 10.1385/IR:31:3:207
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414
   RAFIJANAJREH AQ, 1998, FRONT BIOSCI, V3, P665
   Roth A, 2005, ARTHRITIS RES THER, V7, pR677, DOI 10.1186/ar1725
   Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272
   Schimizzi Aimee L, 2006, Spine J, V6, P550, DOI 10.1016/j.spinee.2005.12.005
   Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038
   Sheehan KM, 2003, J ORTHOPAED RES, V21, P744, DOI 10.1016/S0736-0266(03)00007-X
   STEIN CS, 1993, CELL IMMUNOL, V150, P281, DOI 10.1006/cimm.1993.1197
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Tabata T, 2007, ENDOCR J, V54, P685, DOI 10.1507/endocrj.K05-120
   Takahashi T, 2004, J ORAL PATHOL MED, V33, P224, DOI 10.1111/j.0904-2512.2004.00024.x
   Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200
   Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tezel A, 2008, J COSMET LASER THER, V10, P35, DOI 10.1080/14764170701774901
   Tsujimura S, 2006, J BIOL CHEM, V281, P38089, DOI 10.1074/jbc.M601030200
   Vitanzo Peter C Jr, 2006, Am J Orthop (Belle Mead NJ), V35, P421
   Wang MJ, 2006, J NEUROCHEM, V97, P857, DOI 10.1111/j.1471-4159.2006.03776.x
   Wang MJ, 2004, J NEUROIMMUNOL, V146, P50, DOI 10.1016/j.jneuroim.2003.10.034
   Wiest L, 2008, J DTSCH DERMATOL GES, V6, P176, DOI 10.1111/j.1610-0387.2008.06639.x
   Yadav AK, 2008, J DRUG TARGET, V16, P91, DOI [10.1080/10611860701794296, 10.1080/10611860802095494 ]
   Yasuda T, 2007, INFLAMM RES, V56, P246, DOI 10.1007/s00011-007-6168-5
   Yung S, 2007, INT J ARTIF ORGANS, V30, P477
NR 85
TC 13
Z9 15
U1 1
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2010
VL 94A
IS 3
BP 893
EP 904
DI 10.1002/jbm.a.32760
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 633WA
UT WOS:000280536300026
PM 20336750
DA 2018-10-19
ER

PT J
AU Wang, SJ
   Ren, LQ
   Liu, Y
   Han, ZW
   Yang, Y
AF Wang, Shujie
   Ren, Luquan
   Liu, Yan
   Han, Zhiwu
   Yang, Yue
TI Mechanical Characteristics of Typical Plant Leaves
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE bionics; plant leaf; hardness; tensile strength
ID SURFACES; BAMBOO
AB Plant leaf is a natural composite biomaterial, and its strength is closely related to the microstructure. In this paper, the mechanical characteristics of eight species of plant leaves were investigated and analyzed. The ultimate strength of leaves and the hardness of leaf surfaces were measured by using universal testing machine and nanoindenter tester, respectively. The tensile strength of the parallel microstructure was investigated based on its cross-sectional mechanical model. The results of tension tests indicate that the ultimate strength of a leaf is related to the material composition and structure. The coriaceous leaves usually exhibit higher tensile strength. For example, the Phyllostachys pubescens leaf can achieve the maximum ultimate strength of 5.9091 N-mm(-2). It is concluded from the results of hardness tests that material components of leaf surface can influence the surface hardness evidently. The leaf surface composed of more lignin and cellulose materials shows a higher surface hardness than that composed of more carbohydrates materials.
C1 [Wang, Shujie; Ren, Luquan; Liu, Yan; Han, Zhiwu; Yang, Yue] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun 130022, Peoples R China.
RP Ren, LQ (reprint author), Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun 130022, Peoples R China.
EM lqren@jlu.edu.cn
FU National Natural Science Foundation of China [50635030, 50905071];
   Chinese Ministry of Education [105059]; Program for the Development of
   Science and Technology of Jilin Province [20090539]
FX This study is financial supported by the National Natural Science
   Foundation of China (Grant No. 50635030 and 50905071), the Key Project
   of Chinese Ministry of Education (Grant No. 105059), and the Program for
   the Development of Science and Technology of Jilin Province (Grant No.
   20090539).
CR Ahmad M, 2005, WOOD SCI TECHNOL, V39, P448, DOI 10.1007/s00226-005-0016-y
   Armanios EA, 1997, COMPOSITE MAT FATIGU
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   BARTHLOTT W, 1993, EVOLUTION SYSTEMATIC, P75
   Chawla K. K., 1998, COMPOSITE MAT SCI EN
   HALYK R M, 1968, Transactions of the ASAE (American Society of Agricultural Engineers), V11, P256
   Horn JW, 2009, AM J BOT, V96, P1462, DOI 10.3732/ajb.0800396
   Moulia B, 2000, J PLANT GROWTH REGUL, V19, P19, DOI 10.1007/s003440000004
   Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400
   Obataya E, 2007, WOOD SCI TECHNOL, V41, P385, DOI 10.1007/s00226-007-0127-8
   Read J, 2003, NEW PHYTOL, V160, P81, DOI 10.1046/j.1469-8137.2003.00855.x
   Ren LQ, 2007, J BIONIC ENG, V4, P33, DOI 10.1016/S1672-6529(07)60010-9
   [王淑杰 Wang Shujie], 2005, [科技通报, Bulletin of Science and Technology], V21, P553
   Wang ShuJie, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P16
   Zebrowski J, 1999, PLANTA, V207, P410, DOI 10.1007/s004250050499
NR 15
TC 5
Z9 5
U1 2
U2 25
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD SEP
PY 2010
VL 7
IS 3
BP 294
EP 300
DI 10.1016/S1672-6529(10)60253-3
PG 7
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 667QN
UT WOS:000283208800011
DA 2018-10-19
ER

PT J
AU Shen, C
   Zhang, NZ
   Anusavice, KJ
AF Shen, C.
   Zhang, N-Z.
   Anusavice, K. J.
TI Fluoride and Chlorhexidine Release from Filled Resins
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE controlled release; sealants; biomaterial
ID ANTIBACTERIAL; INVITRO; METHACRYLATE; SYSTEMS; DEVICE; SALTS
AB Resin-based materials that release either fluoride or chlorhexidine have been formulated for inhibiting caries activity. It is not known if the two agents, when incorporated into one material, would interact and affect their release potential. We hypothesized that the ratio of fluoride to chlorhexidine incorporated into a resin, and the pH of the storage medium, will affect their releases from the material. The material investigated contained 23 wt% of filler, and the ratios of calcium fluoride to chlorhexidine diacetate were 8/2, 5/5, and 2/8. The release was conducted in pH 4, 5, and 6 acetate buffers. The results showed that release of either agent increased as the pH of the medium decreased. The presence of fluoride salt substantially reduced the chlorhexidine release, while the presence of a specific quantity of chlorhexidine significantly increased fluoride release. This interaction can be utilized to optimize the release of either agent for therapeutic purposes.
C1 [Shen, C.] Univ Florida, Coll Dent, Dept Prosthodont, Gainesville, FL 32610 USA.
   [Anusavice, K. J.] Univ Florida, Coll Dent, Dept Operat Dent, Gainesville, FL 32610 USA.
RP Shen, C (reprint author), Univ Florida, Coll Dent, Dept Prosthodont, POB 100435,1600 SW Archer Rd, Gainesville, FL 32610 USA.
EM cshen@dental.ufl.edu
FU National Institute of Dental and Craniofacial Research, NIH, Bethesda,
   MD, USA [DE13412]
FX The study was supported by the National Institute of Dental and
   Craniofacial Research [Grant DE13412], NIH, Bethesda, MD, USA.
CR Anusavice KJ, 2006, J DENT RES, V85, P950, DOI 10.1177/154405910608501016
   Anusavice Kenneth J, 2005, J Dent Educ, V69, P538
   Anusavice KJ, 2005, J DENT RES, V84, P440, DOI 10.1177/154405910508400508
   BARKVOLL P, 1988, SCAND J DENT RES, V96, P30
   DeMoor RJG, 1996, DENT MATER, V12, P88, DOI 10.1016/S0109-5641(96)80074-1
   Eichmiller FC, 2005, J AM DENT ASSOC, V136, P67, DOI 10.14219/jada.archive.2005.0028
   FEATHERSTONE JD, 2006, BMC ORAL HLTH S1, V6, P8
   FRIEDMAN M, 1990, PHARMACEUT RES, V7, P313, DOI 10.1023/A:1015898717936
   Hoszek A, 2008, OPER DENT, V33, P696, DOI 10.2341/08-20
   Mirth D B, 1980, Pharmacol Ther Dent, V5, P59
   MIRTH DB, 1989, J DENT RES, V68, P1285, DOI 10.1177/00220345890680081401
   MIRTH DB, 1982, J AM DENT ASSOC, V105, P791, DOI 10.14219/jada.archive.1982.0481
   NERURKAR MJ, 1995, J CONTROL RELEASE, V33, P357, DOI 10.1016/0168-3659(94)00104-3
   Palmer G, 2004, BIOMATERIALS, V25, P5423, DOI 10.1016/j.biomaterials.2003.12.051
   RIBEIRO J, 1991, SCAND J DENT RES, V99, P533
   Riggs PD, 2000, BIOMATERIALS, V21, P345, DOI 10.1016/S0142-9612(99)00187-8
   Sanders BJ, 2002, J ORAL REHABIL, V29, P553, DOI 10.1046/j.1365-2842.2002.00876.x
   Tay Franklin R, 2002, J Adhes Dent, V4, P91
   Twetman S, 1997, CARIES RES, V31, P361, DOI 10.1159/000262419
   vanLoveren C, 1996, CARIES RES, V30, P45, DOI 10.1159/000262136
   Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022
   Yue IC, 2004, BIOMATERIALS, V25, P3743, DOI 10.1016/j.biomaterials.2003.09.113
   Zeng PY, 2009, INT J PHARM, V367, P73, DOI 10.1016/j.ijpharm.2008.09.031
NR 23
TC 9
Z9 9
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD SEP
PY 2010
VL 89
IS 9
BP 1002
EP 1006
DI 10.1177/0022034510374055
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 640VI
UT WOS:000281081500021
PM 20581354
OA Green Published
DA 2018-10-19
ER

PT J
AU Sensenig, A
   Agnarsson, I
   Blackledge, TA
AF Sensenig, A.
   Agnarsson, I.
   Blackledge, T. A.
TI Behavioural and biomaterial coevolution in spider orb webs
SO JOURNAL OF EVOLUTIONARY BIOLOGY
LA English
DT Article
DE biomechanics; functional morphology; silk; tensile properties; web
ID VISCOUS CAPTURE THREADS; INDIAN ANOLIS LIZARDS; MECHANICAL-PROPERTIES;
   WEAVING SPIDERS; BUILDING SPIDERS; CONFIDENCE-INTERVALS; YOUNGS-MODULUS;
   MUSSEL BYSSUS; MESH HEIGHT; EVOLUTION
AB Mechanical performance of biological structures, such as tendons, byssal threads, muscles, and spider webs, is determined by a complex interplay between material quality (intrinsic material properties, larger scale morphology) and proximate behaviour. Spider orb webs are a system in which fibrous biomaterials-silks-are arranged in a complex design resulting from stereotypical behavioural patterns, to produce effective energy absorbing traps for flying prey. Orb webs show an impressive range of designs, some effective at capturing tiny insects such as midges, others that can occasionally stop even small birds. Here, we test whether material quality and behaviour (web design) co-evolve to fine-tune web function. We quantify the intrinsic material properties of the sticky capture silk and radial support threads, as well as their architectural arrangement in webs, across diverse species of orb-weaving spiders to estimate the maximum potential performance of orb webs as energy absorbing traps. We find a dominant pattern of material and behavioural coevolution where evolutionary shifts to larger body sizes, a common result of fecundity selection in spiders, is repeatedly accompanied by improved web performance because of changes in both silk material and web spinning behaviours. Large spiders produce silk with improved material properties, and also use more silk, to make webs with superior stopping potential. After controlling for spider size, spiders spinning higher quality silk used it more sparsely in webs. This implies that improvements in silk quality enable 'sparser' architectural designs, or alternatively that spiders spinning lower quality silk compensate architecturally for the inferior material quality of their silk. In summary, spider silk material properties are fine-tuned to the architectures of webs across millions of years of diversification, a coevolutionary pattern not yet clearly demonstrated for other important biomaterials such as tendon, mollusc byssal threads, and keratin.
C1 [Sensenig, A.; Agnarsson, I.; Blackledge, T. A.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Sensenig, A.; Agnarsson, I.; Blackledge, T. A.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
   [Agnarsson, I.] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR USA.
RP Sensenig, A (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
EM andrew6@uakron.edu
FU National Science Foundation [DBI-0521261, DEB-0516038, IOS-0745379]
FX We thank Rachel Stevenson for assisting with the measurements of web
   architecture and Marlena Abraham, Sarah Anderson, Taylor Gondek, and
   Jacki Stegner for assisting with the measurements of silk diameters.
   Matjaz Kuntner collected spiders in Slovenia. This research was
   supported by National Science Foundation awards DBI-0521261, DEB-0516038
   and IOS-0745379 to TAB. This is publication no. 25 of the University of
   Akron Field Station and was conducted under permit 2005-004.
CR Ackerly DD, 1998, AM NAT, V152, P767, DOI 10.1086/286208
   Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x
   ALEXANDER RM, 1984, AM ZOOL, V24, P85
   ANDERSON JF, 1979, Q REV BIOL, V54, P139, DOI 10.1086/411153
   ARNOLD SJ, 1983, AM ZOOL, V23, P347
   Bell EC, 1996, J EXP BIOL, V199, P1005
   Bell EC, 1997, MAR ECOL PROG SER, V159, P197, DOI 10.3354/meps159197
   Bennett A.F., 1990, Oxford Surveys in Evolutionary Biology, V7, P251
   BERTRAM JEA, 1987, J EXP BIOL, V130, P121
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2004, P NATL ACAD SCI USA, V101, P16228, DOI 10.1073/pnas.0407395101
   Blackledge TA, 2003, ANN ZOOL FENN, V40, P293
   Blackledge TA, 2002, J ARACHNOL, V30, P70, DOI 10.1636/0161-8202(2002)030[0070:EOCAOS]2.0.CO;2
   Blackledge TA, 2007, BIOLOGY LETT, V3, P456, DOI 10.1098/rsb1.2007.0218
   Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x
   Blackledge Todd A., 2009, Communicative & Integrative Biology, V2, P459
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   BONSER RHC, 1995, J EXP BIOL, V198, P1029
   Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487
   Brazee SL, 2006, BIOL BULL-US, V211, P263, DOI 10.2307/4134548
   Cameron GJ, 2003, J STRUCT BIOL, V143, P118, DOI 10.1016/S1047-8477(03)00142-4
   Carrano MT, 1998, PALEOBIOLOGY, V24, P450
   COMSTOCK JH, 1940, SPIDER BOOK
   CRAIG CL, 1986, ANIM BEHAV, V34, P54, DOI 10.1016/0003-3472(86)90006-0
   CRAIG CL, 1987, AM NAT, V129, P47, DOI 10.1086/284622
   DEEMMANUEL M, 2005, ANAT REC PART A, V282, P49
   Eberhard W.G., 1989, Bulletin of the British Arachnological Society, V8, P45
   EBERHARD W G, 1986, P70
   EBERHARD WG, 1986, J ARACHNOL, V14, P125
   EBERHARD WG, 1988, J ARACHNOL, V16, P295
   EBERHARD WG, 1990, ANNU REV ECOL SYST, V21, P341, DOI 10.1146/annurev.es.21.110190.002013
   FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325
   GALILEI G, 1638, 2 NEW SCI, P169
   Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327
   Garland T, 1999, AM ZOOL, V39, P374
   GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503
   Garland Theodore Jr., 1994, P240
   Goloboff P., 2003, TNT TREE ANAL USING
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1
   Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Herberstein ME, 2000, J ARACHNOL, V28, P180, DOI 10.1636/0161-8202(2000)028[0180:EOFTET]2.0.CO;2
   Herberstein ME, 1998, EUR J ENTOMOL, V95, P367
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Japyassu HF, 1998, BEHAVIOUR, V135, P931, DOI 10.1163/156853998792640378
   Krink T, 2000, NATURWISSENSCHAFTEN, V87, P90, DOI 10.1007/s001140050017
   Kuntner M, 2009, INVERTEBR SYST, V23, P193, DOI 10.1071/IS09002
   LANGER RM, 1969, AM ZOOL, V9, P97
   LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0
   LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062
   LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x
   Maddison W.P., 2008, MESQUITE MODULAR SYS
   MADRELL S, 1998, PRINCIPLES ANIMAL DE, P63
   MIDFORD PE, 2005, PADA PACKAGE MESQUIT
   Opell BD, 2002, J ARACHNOL, V30, P494, DOI 10.1636/0161-8202(2002)030[0494:ETSOIA]2.0.CO;2
   Opell BD, 2001, EVOL ECOL RES, V3, P567
   Opell BD, 2007, J EXP BIOL, V210, P2352, DOI 10.1242/jeb.004952
   Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682
   Opell BD, 2009, J EXP ZOOL PART A, V311A, P217, DOI 10.1002/jez.526
   Ortlepp C, 2008, J EXP BIOL, V211, P2832, DOI 10.1242/jeb.014191
   Osaki S, 1999, INT J BIOL MACROMOL, V24, P283, DOI 10.1016/S0141-8130(98)00091-9
   POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Prenter J, 1999, EVOLUTION, V53, P1987, DOI [10.2307/2640458, 10.1111/j.1558-5646.1999.tb04580.x]
   Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x
   SANDOVAL CP, 1994, FUNCT ECOL, V8, P701, DOI 10.2307/2390229
   SHERMAN PM, 1994, ANIM BEHAV, V48, P19, DOI 10.1006/anbe.1994.1208
   Summers AP, 2002, COMP BIOCHEM PHYS A, V133, P1159, DOI 10.1016/S1095-6433(02)00241-6
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   SWARTZ SM, 1992, NATURE, V359, P726, DOI 10.1038/359726a0
   Tritton D. J., 1988, PHYS FLUID DYNAMICS
   Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114
   Vogel S., 2003, COMP BIOMECHANICS LI
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Wheeler TJ, 2007, BIOINFORMATICS, V23, pi559, DOI DOI 10.1093/BI0INF0RMATICS/BTM226.PUBMED:17646343
   WIRTH E, 1992, J COMP PHYSIOL A, V171, P359
   Zschokke S, 2005, J ARACHNOL, V33, P205, DOI 10.1636/CT04-72.1
   ZWICKL DJ, 2006, SCH BIOL SCI
NR 81
TC 66
Z9 67
U1 2
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1010-061X
EI 1420-9101
J9 J EVOLUTION BIOL
JI J. Evol. Biol.
PD SEP
PY 2010
VL 23
IS 9
BP 1839
EP 1856
DI 10.1111/j.1420-9101.2010.02048.x
PG 18
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA 641PS
UT WOS:000281141800003
PM 20629854
OA Bronze
DA 2018-10-19
ER

PT J
AU Cohen, I
   Weihs, D
AF Cohen, Itai
   Weihs, Daphne
TI Rheology and microrheology of natural and reduced-calorie Israeli honeys
   as a model for high-viscosity Newtonian liquids
SO JOURNAL OF FOOD ENGINEERING
LA English
DT Article
DE Honey rheology; Arrhenius model; Particle-tracking microrheology;
   Mean-square displacement; Reduced-calorie honey
ID DARK-COLORED HONEY; AUSTRALIAN HONEYS; TRACKING MICRORHEOLOGY; BEHAVIOR;
   TRANSPORT; MECHANICS; CELLS
AB Honey is a food biomaterial that has been used as a natural therapeutic agent against infections and to stimulate wound healing; its flow behavior is interesting as it affects processing and consumption. The temperature- and composition-dependence of honey viscosity was measured in selected Israeli varieties. Classical rheology was compared to thermal-fluctuation particle-tracking microrheology. In particle-tracking, the viscosity is measured on a sub-micron scale, providing contributions of different regions in the sample. Honey viscosity was Newtonian, even in reduced-calorie varieties, and adhered to the Arrhenius equation, viscosity exponentially decreasing with temperature. The Arrhenius activation energy and viscosity were moisture-dependent. Our data are comparable to previously reported honey rheology from different regions in the world. In conclusion, we show that rheology agrees with microrheology, as expected for a Newtonian liquid. Moreover, we have shown that high-viscosity samples can be accurately characterized using particle-tracking microrheology, providing additional information to rheology. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Cohen, Itai; Weihs, Daphne] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
RP Weihs, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM daphnew@tx.technion.ac.il
RI Weihs, Daphne/C-2860-2009
OI Weihs, Daphne/0000-0002-9670-3418
FU Technion VPR; Henri Gutwirth Funds for the Promotion of Research
FX Partially funded by the Technion VPR and the Henri Gutwirth Funds for
   the Promotion of Research. The authors would like to thank Prof.
   Christopher W. Macosko for his invaluable input and discussions.
CR Abu-Jdayil B, 2002, J FOOD ENG, V51, P33, DOI 10.1016/S0260-8774(01)00034-6
   Al-Malah KIM, 2001, J FOOD PROCESS ENG, V24, P341, DOI 10.1111/j.1745-4530.2001.tb00548.x
   Bhandari B, 1999, J FOOD ENG, V41, P65, DOI 10.1016/S0260-8774(99)00078-3
   Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Crocker JC, 2007, CELL MECH, P141
   Einstein A., 1956, INVESTIGATION THEORY
   Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302
   Gomez-Diaz D, 2006, EUR FOOD RES TECHNOL, V222, P439, DOI 10.1007/s00217-005-0120-0
   Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103
   Juszczak L, 2006, J FOOD ENG, V75, P43, DOI 10.1016/j.jfoodeng.2005.03.049
   LARSEN TH, 2008, PHYS REV LETT, V100, P4
   Lazaridou A, 2004, J FOOD ENG, V64, P9, DOI 10.1016/j.jfoodeng.2003.09.007
   Liu J., 2006, PHYS REV LETT, V96
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   Mossel B, 2000, LEBENSM-WISS TECHNOL, V33, P545, DOI 10.1006/fstl.2000.0714
   Munro JA, 1943, J ECON ENTOMOL, V36, P769, DOI 10.1093/jee/36.5.769
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Sopade PA, 2003, J FOOD ENG, V56, P67, DOI 10.1016/S0260-8774(02)00149-8
   Steffe J. F., 1996, RHEOLOGICAL METHODS
   Valentine MT, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061506
   Weihs D, 2007, MICROFLUID NANOFLUID, V3, P227, DOI 10.1007/s10404-006-0117-4
   Weihs D, 2006, BIOPHYS J, V91, P4296, DOI 10.1529/biophysj.106.081109
   Weihs D, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2795130
   Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7
   Yanniotis S, 2006, J FOOD ENG, V72, P372, DOI 10.1016/j.jfoodeng.2004.12.017
   Zaitoun S, 2001, INT J FOOD PROP, V4, P139, DOI 10.1081/JFP-100002192
NR 27
TC 20
Z9 23
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0260-8774
J9 J FOOD ENG
JI J. Food Eng.
PD SEP
PY 2010
VL 100
IS 2
BP 366
EP 371
DI 10.1016/j.jfoodeng.2010.04.023
PG 6
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA 621IW
UT WOS:000279570800025
DA 2018-10-19
ER

PT J
AU Oduwole, KO
   Glynn, AA
   Molony, DC
   Murray, D
   Rowe, S
   Holland, LM
   McCormack, DJ
   O'Gara, JP
AF Oduwole, Kayode O.
   Glynn, Aaron A.
   Molony, Diarmuid C.
   Murray, David
   Rowe, Sarah
   Holland, Linda M.
   McCormack, Damian J.
   O'Gara, James P.
TI Anti-Biofilm Activity of Sub-Inhibitory Povidone-Iodine Concentrations
   against Staphylococcus Epidermidis and Staphylococcus Aureus
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE biofilm; biomaterial related infection; povidone-iodine; Staphylococci
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   POLYMERASE CHAIN-REACTION; TOTAL HIP-ARTHROPLASTY; ELECTRICAL
   ENHANCEMENT; ANTIBIOTIC-RESISTANCE; ICAADBC TRANSCRIPTION;
   GENE-EXPRESSION; IN-VITRO; INFECTION
AB Biomaterial-related infections continue to hamper the success of reconstructive and arthroplasty procedures in orthopaedic surgery. Staphylococci are the most common etiologic agents, with biofilm formation representing a major virulence factor. Biofilms increase bacterial resistance to antimicrobial agents and host immune responses. In staphylococci, production of polysaccharide intercellular adhesin (PIA) by the enzyme products of the icaADBC operon is the best understood mechanism of biofilm development, making the ica genes a potential target for biofilm inhibitors. In this study we report that the antibacterial agent povidone-iodine (PI) also has anti-biofilm activity against Staphylococcus epidertnidis and Staphylococcus aureus at sub-inhibitory concentrations (p < 0.001). Inhibition of biofilm by PI correlated with decreased transcription of the icaADBC operon, which in turn correlated with activation of the icaR transcriptional repressor in Staphylococcus epidertnidis. These data reveal an additional therapeutic benefit of PI and suggest that studies to evaluate suitability of PI as biomaterial coating agent to reduce device-related infections are merited. (C) 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 28:1252-1256, 2010
C1 [Oduwole, Kayode O.; Glynn, Aaron A.; Molony, Diarmuid C.; McCormack, Damian J.] Mater Misericordiea Univ Hosp, Dept Trauma & Orthopaed Surg, Dublin, Ireland.
   [Oduwole, Kayode O.; Murray, David] Univ Coll Dublin, Clin Res Ctr, Sch Med & Med Sci, Mater Misericordiea Univ Hosp, Dublin 4, Ireland.
   [Rowe, Sarah; Holland, Linda M.; O'Gara, James P.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland.
RP Oduwole, KO (reprint author), Mater Misericordiea Univ Hosp, Dept Trauma & Orthopaed Surg, Dublin, Ireland.
EM odukayolajide@yahoo.com
OI O'Gara, James/0000-0003-3866-7161
FU UCD Clinical Research Center
FX The authors thank Dr. Peter Doran and all the staff of UCD Clinical
   Research Center, for their supports. No financial support was received
   from internal source or any other organization for this research work.
CR Balaban N, 2003, J INFECT DIS, V187, P625, DOI 10.1086/345879
   Barrack RL, 1996, ORTHOPEDICS, V19, P780
   Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x
   Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06
   Caubet R, 2004, ANTIMICROB AGENTS CH, V48, P4662, DOI 10.1128/AAC.48.12.4662-4664.2004
   Cheng MT, 2005, SPINE, V30, P1689, DOI 10.1097/01.brs.0000171907.60775.85
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   DAROUICHE RO, 1994, J INFECT DIS, V170, P720, DOI 10.1093/infdis/170.3.720
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   FABREGUETTE A, 1994, PATHOL BIOL, V42, P888
   Fisman DN, 2001, CLIN INFECT DIS, V32, P419, DOI 10.1086/318502
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Glynn AA, 2009, J ORTHOP RES, V27, P627, DOI 10.1002/jor.20758
   Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000
   Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08
   Houari A, 2007, LETT APPL MICROBIOL, V45, P652, DOI 10.1111/j.1472-765X.2007.02249.x
   Iwasaki N, 1989, Nihon Shishubyo Gakkai Kaishi, V31, P836
   Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004
   KAYSINGER KK, 1995, J ORTHOP TRAUMA, V9, P303, DOI 10.1097/00005131-199509040-00006
   KHARDORI N, 1995, J IND MICROBIOL, V15, P148, DOI 10.1007/BF01569818
   Klingenberg C, 2005, PEDIATR INFECT DIS J, V24, P817, DOI 10.1097/01.inf.0000176735.20008.cd
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0
   Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   Milisavljevic V, 2008, AM J INFECT CONTROL, V36, P552, DOI 10.1016/j.ajic.2007.10.025
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   NICKEL JC, 1985, EUR J CLIN MICROBIOL, V4, P213, DOI 10.1007/BF02013600
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Pickering SAW, 2003, J BONE JOINT SURG BR, V85B, P588, DOI 10.1302/0301-620X.85B4.12644
   Pitt WG, 2003, BIOTECHNOL PROGR, V19, P1038, DOI 10.1021/bp0340685
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753
   Stewart PS, 1999, ANTIMICROB AGENTS CH, V43, P292, DOI 10.1128/AAC.43.2.292
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   Wattanakaroon W, 2000, ARCH ORAL BIOL, V45, P167, DOI 10.1016/S0003-9969(99)00132-6
   Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085
   Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9
NR 51
TC 28
Z9 30
U1 2
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD SEP
PY 2010
VL 28
IS 9
BP 1252
EP 1256
DI 10.1002/jor.21110
PG 5
WC Orthopedics
SC Orthopedics
GA 638LT
UT WOS:000280897100021
PM 20187117
OA Bronze
DA 2018-10-19
ER

PT J
AU Miclau, T
   Schmidt, AH
   Wenke, JC
   Webb, LX
   Harro, JM
   Prabhakara, R
   Shirtliff, ME
AF Miclau, Theodore
   Schmidt, Andrew H.
   Wenke, Joseph C.
   Webb, Lawrence X.
   Harro, Janette M.
   Prabhakara, Ranjani
   Shirtliff, Mark E.
TI Infection
SO JOURNAL OF ORTHOPAEDIC TRAUMA
LA English
DT Review
DE musculoskeletal infection; biofilm; bacteria; biomaterial
ID STABILIZED SEGMENTAL DEFECT; RAT FEMUR; BONE-FORMATION; BIOFILMS;
   RHBMP-2; MODEL
AB Musculoskeletal infection is a clinical problem with significant direct healthcare costs The prevalence of infection after closed, elective surgery is frequently estimated to be less than 2%. but in se ere injuries. pot:mum:ale infection rates have been reported as 10% or greater Although clinical infections are found outside the realm of medical devices, it is deal that the enormous increase of infections associated with the use of implants presents a major challenge worldwide This review summarizes recent advances in the understanding. diagnosis, and treatment of musculoskeletal Infections
C1 [Miclau, Theodore] Univ Calif San Francisco, San Francisco Gen Hosp, Orthopaed Trauma Inst, Dept Orthopaed Surg, San Francisco, CA 94110 USA.
   [Schmidt, Andrew H.] Univ Minnesota, Dept Orthopaed Surg, Hennepin Cty Med Ctr, Minneapolis, MN 55455 USA.
   [Wenke, Joseph C.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA.
   [Webb, Lawrence X.] Med Ctr Cent Georgia, Georgia Orthopaed Trauma Inst, Macon, GA USA.
   [Harro, Janette M.; Prabhakara, Ranjani; Shirtliff, Mark E.] Univ Maryland, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA.
RP Miclau, T (reprint author), Univ Calif San Francisco, San Francisco Gen Hosp, Orthopaed Trauma Inst, Dept Orthopaed Surg, 2550 23rd St,Bldg 9,2nd Floor, San Francisco, CA 94110 USA.
RI Shirtliff, Mark/H-2563-2017
OI Shirtliff, Mark/0000-0002-8913-3445
FU NIAID NIH HHS [R01 AI069568]
CR Allen RT, 2007, SPINE, V32, P2996, DOI 10.1097/BRS.0b013e31815cde3e
   Beckham JD, 2009, J VIROL, V83, P5035, DOI 10.1128/JVI.02433-08
   Berkes M, 2010, J BONE JOINT SURG AM, V92A, P823, DOI 10.2106/JBJS.I.00470
   Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P291, DOI 10.1016/S0168-6445(97)00012-0
   Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06
   Brick KE, 2009, CLIN ORTHOP RELAT R, V467, P3096, DOI 10.1007/s11999-008-0599-3
   Chen XQ, 2007, J ORTHOP TRAUMA, V21, P693, DOI 10.1097/BOT.0b013e31815a7e91
   Chen XQ, 2006, J BONE JOINT SURG AM, V88A, P1510, DOI 10.2106/JBJS.E.01136
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Chen XQ, 2004, J ORTHOP TRAUMA, V18, P436, DOI 10.1097/00005131-200408000-00008
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Golden JD, 2008, J BONE JOINT SURG AM, V90A, P1168
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Megyeri K, 2002, CYTOKINE, V19, P206, DOI 10.1006/cyto.2002.0876
   Owens BD, 2009, J BONE JOINT SURG AM, V91A, P92, DOI 10.2106/JBJS.G.01566
   Pillai RR, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034114
   Shirtlif ME, 2000, PERSISTENT BACTERIAL, P375
   Webb Lawrence X, 2007, J Surg Orthop Adv, V16, P73
NR 19
TC 19
Z9 20
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0890-5339
J9 J ORTHOP TRAUMA
JI J. Orthop. Trauma
PD SEP
PY 2010
VL 24
IS 9
BP 583
EP 586
DI 10.1097/BOT.0b013e3181eebf12
PG 4
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 647FL
UT WOS:000281603100015
PM 20736799
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Trombelli, L
   Simonelli, A
   Pramstraller, M
   Wikesjo, UME
   Farina, R
AF Trombelli, Leonardo
   Simonelli, Anna
   Pramstraller, Mattia
   Wikesjoe, Ulf M. E.
   Farina, Roberto
TI Single Flap Approach With and Without Guided Tissue Regeneration and a
   Hydroxyapatite Biomaterial in the Management of Intraosseous Periodontal
   Defects
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Alveolar bone loss; periodontitis; reconstructive surgical procedures;
   surgical flaps
ID INVASIVE SURGICAL TECHNIQUE; INTRA-BONY DEFECTS; POLYTETRAFLUOROETHYLENE
   BARRIER MEMBRANES; ANORGANIC BOVINE BONE; CLINICAL-OUTCOMES;
   RECONSTRUCTIVE PROCEDURES; MICROVASCULAR RESPONSE; WOUND STABILIZATION;
   COLLAGEN MEMBRANE; HEALING RESPONSE
AB Background: The single flap approach (SFA) is a minimally invasive procedure designed for periodontal reconstructive procedures of intraosseous periodontal defects characterized by a dominant unilateral, buccal or oral, extension. This study evaluates the adjunctive effect of guided tissue regeneration (GTR) combined with a hydroxyapatite (HA) biomaterial in the management of intraosseous periodontal defects accessed with SFA compared to SFA alone.
   Methods: Twenty-four intraosseous defects (in 24 patients) were randomly allocated to treatment with SFA or SFA + HA/GTR. Clinical outcomes were assessed 6 months post-surgery.
   Results: Five sites in the SFA + HA/GTR group showed incomplete closure at week 2, which resolved spontaneously. There were no statistically significant or clinically meaningful differences in mean (+/- SD) clinical attachment gain (4.7 +/- 2.5 versus 4.4 +/- 1.5 mm), probing depth reduction (5.3 +/- 2.4 versus 5.3 +/- 1.5 mm), and gingival recession increase (0.4 +/- 1.4 versus 0.8 +/- 0.8 mm) between the SFA + HA/GTR and SFA groups.
   Conclusions: SFA with and without HA/GTR seems to be a valuable minimally invasive approach in the treatment of deep intraosseous periodontal defects. Under the present experimental conditions, the additional HA/GTR protocol offers no significant adjunctive effect. J Periodontol 2010;81:1256-1263.
C1 [Trombelli, Leonardo; Simonelli, Anna; Pramstraller, Mattia; Farina, Roberto] Univ Ferrara, Res Ctr Study Periodontal Dis, I-44100 Ferrara, Italy.
   [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, Dept Periodont, Lab Appl Periodontal & Craniofacial Regenerat, Augusta, GA 30912 USA.
   [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA.
RP Trombelli, L (reprint author), Univ Ferrara, Res Ctr Study Periodontal Dis, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM leonardo.trombelli@unife.it
RI Trombelli, Leonardo/I-4671-2015; Farina, Roberto/D-6561-2015; Wikesjo,
   Ulf/A-4159-2009; Pramstraller, Mattia/I-7419-2015; Simonelli,
   Anna/K-4653-2015
OI Trombelli, Leonardo/0000-0002-1147-2199; Farina,
   Roberto/0000-0002-4621-7809; Wikesjo, Ulf/0000-0003-1607-0583;
   Pramstraller, Mattia/0000-0002-5448-6574; Simonelli,
   Anna/0000-0003-2332-7332
FU Research Centre for the Study of Periodontal Diseases, University of
   Ferrara; GABA International, Munchenstein, Switzerland; University of
   Ferrara (STAMINA); GABA International
FX This study was supported by the Research Centre for the Study of
   Periodontal Diseases, University of Ferrara; by GABA International,
   Munchenstein, Switzerland; and by a grant from the University of Ferrara
   (STAMINA). Dr. Trombelli has received consulting fees from GABA
   International. The authors report no conflicts of interest related to
   this study.
CR Binderman I, 2001, J PERIODONTOL, V72, P1348, DOI 10.1902/jop.2001.72.10.1348
   Camargo PM, 2000, J CLIN PERIODONTOL, V27, P889, DOI 10.1034/j.1600-051x.2000.027012889.x
   Christgau M, 1997, Clin Oral Investig, V1, P109, DOI 10.1007/s007840050021
   Cortellini P, 2005, J PERIODONTOL, V76, P341, DOI 10.1902/jop.2005.76.3.341
   Cortellini P, 2008, J CLIN PERIODONTOL, V35, P605, DOI 10.1111/j.1600-051X.2008.01242.x
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P1082, DOI 10.1111/j.1600-051X.2007.01144.x
   Cortellini P, 2009, J CLIN PERIODONTOL, V36, P157, DOI 10.1111/j.1600-051X.2008.01352.x
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P87, DOI 10.1111/j.1600-051X.2006.01020.x
   Guida L, 2007, J PERIODONTOL, V78, P231, DOI 10.1902/jop.2007.060142
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Harrel S K, 1995, Compend Contin Educ Dent, V16, ppassim
   Harrel SK, 1999, J PERIODONTOL, V70, P1547, DOI 10.1902/jop.1999.70.12.1547
   Hartman CA, 2004, INT J PERIODONT REST, V24, P127
   HIATT WH, 1968, J PERIODONTOL, V39, P11, DOI 10.1902/jop.1968.39.1.11
   Lang NP, 2000, PERIODONTOL 2000, V22, P51, DOI 10.1034/j.1600-0757.2000.2220105.x
   Ling LJ, 2003, J PERIODONTAL RES, V38, P57, DOI 10.1034/j.1600-0765.2003.01641.x
   LINGHORNE WJ, 1950, J DENT RES, V29, P419, DOI 10.1177/00220345500290040301
   Murphy Kevin G, 2003, Ann Periodontol, V8, P266, DOI 10.1902/annals.2003.8.1.266
   Needleman IG, 2006, COCHRANE DB SYST REV, V19, DOI DOI 10.1002/14651858.CD001724.PUB2
   Nobuto T, 2005, J PERIODONTOL, V76, P1346, DOI 10.1902/jop.2005.76.8.1346
   Nobuto T, 2003, J PERIODONTOL, V74, P521, DOI 10.1902/jop.2003.74.4.521
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   Paolantonio M, 2002, J PERIODONTOL, V73, P158, DOI 10.1902/jop.2002.73.2.158
   POLSON AM, 1983, J PERIODONTOL, V54, P141, DOI 10.1902/jop.1983.54.3.141
   Sculean A, 2005, J CLIN PERIODONTOL, V32, P720, DOI 10.1111/j.1600-051X.2005.00758.x
   SELVIG KA, 1993, J PERIODONTOL, V64, P730, DOI 10.1902/jop.1993.64.8.730
   TAL H, 1984, J PERIODONTOL, V55, P149, DOI 10.1902/jop.1984.55.3.149
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P770, DOI 10.1111/j.1600-051X.2004.00562.x
   TONETTI MS, 1993, J PERIODONTOL, V64, P934, DOI 10.1902/jop.1993.64.10.934
   Trombelli L, 2005, PERIODONTOL 2000, V37, P88, DOI 10.1111/j.1600-0757.2004.03798.x
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Trombelli L, 1997, J CLIN PERIODONTOL, V24, P366, DOI 10.1111/j.1600-051X.1997.tb00199.x
   Trombelli L, 2002, J CLIN PERIODONTO S3, V29, P160
   Trombelli L, 2007, DENT CADMOS, V8, P15
   TROMBELLI L, 2008, DENT CLIN, V3, P5
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   Trombelli L, 2009, J PERIODONTOL, V80, P353, DOI [10.1902/jop.2009.080420, 10.1902/jop.2009.080420 ]
   Wachtel H, 2003, J CLIN PERIODONTOL, V30, P496, DOI 10.1034/j.1600-051X.2003.00013.x
   WIKESJO UME, 1990, J PERIODONTOL, V61, P719, DOI 10.1902/jop.1990.61.12.719
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P60, DOI 10.1111/j.1600-051X.1991.tb01120.x
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   Windisch P, 2008, CLIN ORAL INVEST, V12, P257, DOI 10.1007/s00784-008-0194-8
   Zanetta-Barbosa D, 1993, Clin Oral Implants Res, V4, P35, DOI 10.1034/j.1600-0501.1993.040105.x
NR 43
TC 35
Z9 36
U1 0
U2 11
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD SEP
PY 2010
VL 81
IS 9
BP 1256
EP 1263
DI 10.1902/jop.2010.100113
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 665GJ
UT WOS:000283023100003
PM 20528696
DA 2018-10-19
ER

PT J
AU Santo, VE
   Duarte, ARC
   Gomes, ME
   Mano, JF
   Reis, RL
AF Santo, Vitor E.
   Duarte, Ana Rita C.
   Gomes, Manuela E.
   Mano, Joao F.
   Reis, Rui L.
TI Hybrid 3D structure of poly(D,L-lactic acid) loaded with
   chitosan/chondroitin sulfate nanoparticles to be used as carriers for
   biomacromolecules in tissue engineering
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article; Proceedings Paper
CT Workshop on Supercritical Fluid Processing of Biopolymers and Biomedical
   Materials
CY NOV 16-17, 2010
CL Madeira, PORTUGAL
SP Univ Minho, Res Grp, Res Grp European Inst Excellence Tissue Engn Regenerative Med
DE Supercritical fluid foaming; Poly(D,L-lactic acid); Scaffolds; Tissue
   engineering; Chitosan; Chondroitin sulfate; Controlled release
ID GROWTH-FACTOR DELIVERY; BIODEGRADABLE POLYMER SCAFFOLDS;
   SUPERCRITICAL-FLUID TECHNOLOGY; MARROW STROMAL CELLS; IN-VITRO
   DEGRADATION; BONE REGENERATION; PROTEIN RELEASE; COMPOSITES; CHITOSAN;
   CO2
AB In the tissue engineering (TE) field, the concept of producing multifunctional scaffolds, capable not only of acting as templates for cell transplantation but also of delivering bioactive agents in a controlled manner, is an emerging strategy aimed to enhance tissue regeneration. In this work, a complex hybrid release system consisting in a three-dimensional (3D) structure based on poly(D,L-lactic acid) (PDLLA) impregnated with chitosan/chondroitin sulfate nanoparticles (NPs) was developed. The scaffolds were prepared by supercritical fluid foaming at 200 bar and 35 degrees C, and were then characterized by scanning electron microscopy (SEM) and micro-CT. SEM also allowed to assess the distribution of the NPs within the structure, showing that the particles could be found in different areas of the scaffold, indicating a homogeneous distribution within the 3D structure. Water uptake and weight loss measurements were also carried out and the results obtained demonstrated that weight loss was not significantly enhanced although the entrapment of the NPs in the 3D structure clearly enhances the swelling of the structure. Moreover, the hybrid porous biomaterial displayed adequate mechanical properties for cell adhesion and support. The possibility of using this scaffold as a multifunctional material was further evaluated by the incorporation of a model protein, bovine serum albumin (BSA), either directly into the PDLLA foam or in the NPs that were eventually included in the scaffold. The obtained results show that it is possible to achieve different release kinetics, suggesting that this system is a promising candidate for dual protein delivery system for TE applications. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Santo, Vitor E.; Duarte, Ana Rita C.; Gomes, Manuela E.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
RP Santo, VE (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM v.espirito.santo@dep.uminho.pt
RI Duarte, Ana Rita/B-9640-2011; Espirito Santo, Vitor/K-7668-2015; E.
   Santo, Vitor/B-3345-2013; Reis, Rui L./A-8938-2008; Mano,
   Joao/A-4418-2009; Gomes, Manuela/B-6282-2009; Group, 3Bs/E-4374-2012
OI Duarte, Ana Rita/0000-0003-0800-0112; Espirito Santo,
   Vitor/0000-0002-0854-0197; Reis, Rui L./0000-0002-4295-6129; Mano,
   Joao/0000-0002-2342-3765; Gomes, Manuela/0000-0002-2036-6291; Group,
   3Bs/0000-0002-5195-3456
CR Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Baker KC, 2009, J MECH BEHAV BIOMED, V2, P620, DOI 10.1016/j.jmbbm.2008.11.006
   Bolland BJRF, 2008, BIOMATERIALS, V29, P3221, DOI 10.1016/j.biomaterials.2008.04.017
   Chen AZ, 2009, ACTA BIOMATER, V5, P2913, DOI 10.1016/j.actbio.2009.04.032
   Cleland JL, 2001, CURR OPIN BIOTECH, V12, P212, DOI 10.1016/S0958-1669(00)00202-0
   Conway SE, 2001, J APPL POLYM SCI, V80, P1155, DOI 10.1002/app.1199
   Duarte ARC, 2009, INT MATER REV, V54, P214, DOI 10.1179/174328009X411181
   Duarte ARC, 2009, MAT SCI ENG C-MATER, V29, P2110, DOI 10.1016/j.msec.2009.04.012
   Duarte ARC, 2009, ACTA BIOMATER, V5, P2054, DOI 10.1016/j.actbio.2009.01.047
   Duarte ARC, 2009, J SUPERCRIT FLUID, V49, P279, DOI 10.1016/j.supflu.2008.12.008
   Duarte ARC, 2009, J BIOACT COMPAT POL, V24, P385, DOI 10.1177/0883911509105796
   Ferdous Z, 2007, TISSUE ENG, V13, P1893, DOI 10.1089/ten.2006.0056
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P43, DOI 10.1098/rspa.1982.0088
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Janorkar AV, 2004, MACROMOLECULES, V37, P9151, DOI 10.1021/ma049056u
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Lee CT, 2007, BIOMOL ENG, V24, P131, DOI 10.1016/j.bioeng.2006.05.010
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139
   Mano JF, 2008, MAT SCI ENG C-BIO S, V28, P1356, DOI 10.1016/j.msec.2008.03.005
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   NAOKI M, 2007, J TISSUE ENG REGEN M, V1, P306
   Palocci C, 2007, LANGMUIR, V23, P8243, DOI 10.1021/la700947g
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Putney SD, 1998, CURR OPIN CHEM BIOL, V2, P548, DOI 10.1016/S1367-5931(98)80133-6
   Quirk RA, 2004, CURR OPIN SOLID ST M, V8, P313, DOI 10.1016/j.cossms.2003.12.004
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Salerno A, 2009, ACTA BIOMATER, V5, P1082, DOI 10.1016/j.actbio.2008.10.012
   Salvay DM, 2006, MOL BIOSYST, V2, P36, DOI 10.1039/b514174p
   SANTO VE, CHITOSAN CHOND UNPUB
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Weiner AA, 2008, INT J PHARM, V360, P107, DOI 10.1016/j.ijpharm.2008.04.037
   Whitaker MJ, 2005, J CONTROL RELEASE, V101, P85, DOI 10.1016/j.jconrel.2004.07.017
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yeo Y, 2004, ARCH PHARM RES, V27, P1, DOI 10.1007/BF02980037
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Zhang XF, 2007, POLYMER, V48, P1005, DOI 10.1016/j.polymer.2006.12.028
NR 61
TC 32
Z9 37
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD SEP
PY 2010
VL 54
IS 3
SI SI
BP 320
EP 327
DI 10.1016/j.supflu.2010.05.021
PG 8
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 660EN
UT WOS:000282622900006
DA 2018-10-19
ER

PT J
AU Mimura, Y
   Imamura, T
   Kinebuchi, Y
   Aizawa, N
   Ishizuka, O
   Nishizawa, O
AF Mimura, Yuji
   Imamura, Tetsuya
   Kinebuchi, Yoshiaki
   Aizawa, Naoki
   Ishizuka, Osamu
   Nishizawa, Osamu
TI Rat Bladders Augmented with a Novel Bovine Pericardium-Derived
   Biomaterial Reconstruct Functional Tissue Structures
SO LUTS-LOWER URINARY TRACT SYMPTOMS
LA English
DT Article
DE bladder augmentation; bladder reconstruction; biomaterial; bovine
   pericardium; partial cystectomy
ID SMALL-INTESTINAL SUBMUCOSA; ACELLULAR MATRIX GRAFT; MODEL; REGENERATION;
   MEMBRANE
AB Objectives: To determine if rat bladders augmented with an acellular Japanese bovine pericardium-derived biomaterial (CardioDISC [CD]) could support bladder reconstruction, and increase bladder volume and compliance.
   Methods: Female Sprague-Dawley rats were randomly divided into three groups (n = 5 each). After partial cystectomy, bladders were closed without augmentation (non-augmentation) or augmented with porcine small intestinal submucosa (SIS) or CD, both of which are acellular. At 1, 2, 4 and 8 weeks after surgery, bladder volume and compliance were measured. The bladders were then analyzed by immunohistochemistry for smooth muscle actin (SMA), urothelium uroplakin III (UPIII), and nerve fiber S100.
   Results: At 4 weeks after augmentation, the SMA-positive cells from the host bladder tissues were present near the regions augmented with CD. In addition, S100-positive cells were present within the CD-augmented tissues. At 8 weeks after surgery, the CD-augmented tissues contained layered SMA-positive cells, urothelium uroplakin III -positive urothelium, and S100 fibers, similar to normal bladder tissue. The SIS-augmented bladders showed similar results. At 8 weeks after augmentation, the bladder volume of CD-augmented bladders was larger than that at 4 weeks, while the SIS-augmented bladders were the same as those at 4 weeks. The bladder volume of the non-augmented group did not increase. The bladder compliance of the CD-augmented bladders at 8 weeks was significantly higher than at earlier times. The bladder compliance of neither the non-augmented nor the SIS-augmented groups increased during the study period.
   Conclusion: Acellular bovine pericardium-derived material could be a suitable biomaterial for bladder augmentations
C1 [Mimura, Yuji; Imamura, Tetsuya; Kinebuchi, Yoshiaki; Aizawa, Naoki; Ishizuka, Osamu; Nishizawa, Osamu] Shinshu Univ, Sch Med, Dept Urol, Matsumoto, Nagano 3908621, Japan.
RP Imamura, T (reprint author), Shinshu Univ, Sch Med, Dept Urol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.
EM imatetu@shinshu-u.ac.jp
CR Ayyildiz A, 2008, ANZ J SURG, V78, P82, DOI 10.1111/j.1445-2197.2007.04361.x
   Ayyildiz Ali, 2006, Int. braz j urol., V32, P88, DOI 10.1590/S1677-55382006000100015
   Azzarello J, 2007, BIOMED MATER, V2, P55, DOI 10.1088/1748-6041/2/2/001
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   Iijima K, 2007, TISSUE ENG, V13, P513, DOI 10.1089/ten.2006.0170
   Kim HJ, 2007, BIOMED MATER, V2, pS111, DOI 10.1088/1748-6041/2/3/S05
   Lopes Eduardo J., 2007, Int. braz j urol., V33, P74, DOI 10.1590/S1677-55382007000100012
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   Mirsadraee S, 2007, J SURG RES, V143, P407, DOI 10.1016/j.jss.2007.01.026
   Obara T, 2006, UROLOGY, V68, P892, DOI 10.1016/j.urology.2006.04.030
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   Santucci Richard A., 2005, Int. braz j urol., V31, P192, DOI 10.1590/S1677-55382005000300002
   Urakami S, 2007, WORLD J UROL, V25, P207, DOI 10.1007/s00345-006-0142-7
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
NR 20
TC 2
Z9 2
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1757-5664
J9 LUTS
JI LUTS
PD SEP
PY 2010
VL 2
IS 2
BP 76
EP 82
DI 10.1111/j.1757-5672.2010.00067.x
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 759DW
UT WOS:000290221900004
PM 26676287
DA 2018-10-19
ER

PT J
AU deAzevedo, ER
   Ayrosa, AMIB
   Faria, GC
   Cervantes, HJ
   Huster, D
   Bonagamba, TJ
   Pitombo, RNM
   Rabbani, SR
AF deAzevedo, E. R.
   Ayrosa, A. M. I. B.
   Faria, G. C.
   Cervantes, H. J.
   Huster, D.
   Bonagamba, T. J.
   Pitombo, R. N. M.
   Rabbani, S. R.
TI The effects of anticalcification treatments and hydration on the
   molecular dynamics of bovine pericardium collagen as revealed by C-13
   solid-state NMR
SO MAGNETIC RESONANCE IN CHEMISTRY
LA English
DT Article
DE NMR; C-13; collagen; bovine pericardium; phenetylamine-diepoxide;
   glutaraldehyde; heart valve prostheses
ID NUCLEAR-MAGNETIC-RESONANCE; ANGLE-SPINNING NMR; ARTICULAR-CARTILAGE;
   CHAIN DYNAMICS; CALCIFICATION; SPECTROSCOPY; RELAXATION; BACKBONE;
   BIOMATERIAL; PREVENTION
AB This article describes a solid-state NMR (SSNMR) investigation of the influence of hydration and chemical cross-linking on the molecular dynamics of the constituents of the bovine pericardium (BP) tissues and its relation to the mechanical properties of the tissue. Samples of natural phenetylamine-diepoxide (DE)- and glutaraldehyde (GL)-fixed BP were investigated by C-13 cross-polarization SSNMR to probe the dynamics of the collagen, and the results were correlated to the mechanical properties of the tissues, probed by dynamical mechanical analysis. For samples of natural BP, the NMR results show that the higher the hydration level the more pronounced the molecular dynamics of the collagen backbone and sidechains, decreasing the tissue's elastic modulus. In contrast, in DE- and GL-treated samples, the collagen molecules are more rigid, and the hydration seems to be less effective in increasing the collagen molecular dynamics and reducing the mechanical strength of the samples. This is mostly attributed to the presence of cross-links between the collagen plates, which renders the collagen mobility less dependent on the water absorption in chemically treated samples. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [deAzevedo, E. R.; Faria, G. C.; Bonagamba, T. J.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   [Ayrosa, A. M. I. B.; Pitombo, R. N. M.] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05315970 Sao Paulo, Brazil.
   [Cervantes, H. J.; Rabbani, S. R.] Univ Sao Paulo, Inst Fis, BR-05315970 Sao Paulo, Brazil.
   [Huster, D.] Inst Med Phys & Biophys, D-04107 Leipzig, Germany.
RP deAzevedo, ER (reprint author), Univ Sao Paulo, Inst Fis Sao Carlos, Caixa Postal 369, BR-13560970 Sao Carlos, SP, Brazil.
EM azevedo@ifsc.usp.br
RI Cervantes, Hernan/D-2291-2010; Faria, Gregorio/A-7479-2013; Sao Carlos
   Institute of Physics, IFSC/USP/M-2664-2016; Rabbani, Said/G-1516-2012;
   deAzevedo, Eduardo/A-1906-2013; Bonagamba, Tito/A-2166-2008; Institute
   of Physics, USP/H-5191-2017
OI Cervantes, Hernan/0000-0002-2558-4941; deAzevedo,
   Eduardo/0000-0003-2461-4755; 
FU FAPESP; CNPq; CAPES; DFG [Transregio-SFB 67, A6]
FX Financial supports of the Brazilian funding agencies FAPESP, CNPq, and
   CAPES are gratefully acknowledged. Authors thank Prof R. M. Faria for
   providing the DMA facility. DH acknowledges support from the DFG
   (Transregio-SFB 67, A6).
CR Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Aliev AE, 2005, BIOPOLYMERS, V77, P230, DOI 10.1002/bip.20217
   Aliev AE, 2004, CHEM PHYS LETT, V398, P522, DOI 10.1016/j.cplett.2004.09.114
   Arnold AA, 2009, CONCEPT MAGN RESON A, V34A, P24, DOI 10.1002/cmr.a.20132
   Baias M, 2009, J PHYS CHEM B, V113, P2184, DOI 10.1021/jp8094616
   BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372
   BLOISE AC, 2004, PHYS REV B, V71, P12001
   Chaikof EL, 2007, NEW ENGL J MED, V357, P1368, DOI 10.1056/NEJMp078175
   Cobo MF, 2009, PHYS CHEM CHEM PHYS, V11, P7036, DOI 10.1039/b907674c
   Deazevedo ER, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2831798
   DeAzevedo ER, 2005, PROG NUCL MAG RES SP, V47, P137, DOI 10.1016/j.pnmrs.2005.08.003
   deAzevedo ER, 2003, J CHEM PHYS, V119, P2923, DOI 10.1063/1.1585024
   Du CL, 2009, MAT SCI ENG C-BIO S, V29, P62, DOI 10.1016/j.msec.2008.05.010
   Duer MJ, 2008, ARTERIOSCL THROM VAS, V28, P2030, DOI 10.1161/ATVBAHA.108.172387
   HARDINGHAM TE, 1992, FASEB J, V6, P861
   Hong M, 1997, J PHYS CHEM B, V101, P5869, DOI 10.1021/jp970887u
   Hong M, 2002, J PHYS CHEM B, V106, P7355, DOI 10.1021/jp0156064
   Hong M, 2003, BIOPOLYMERS, V70, P158, DOI 10.1002/bip.10431
   Huster D, 2005, PROG NUCL MAG RES SP, V46, P79, DOI 10.1016/j.pnmrs.2005.01.001
   Huster D, 2004, APPL MAGN RESON, V27, P471, DOI 10.1007/BF03166744
   Jastrzebska M, 2003, J BIOMAT SCI-POLYM E, V14, P185, DOI 10.1163/156856203321142605
   JELINSKI L, 1980, NATURE, V284, P284
   Leirner AA, 2009, ARTIF ORGANS, V33, P221, DOI 10.1111/j.1525-1594.2009.00712.x
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   LOZZO RV, 1998, ANNU REV BIOCHEM, V67, P609
   Maestro MM, 2006, ACTA BIOMATER, V2, P213, DOI 10.1016/j.actbio.2005.11.004
   Mavrilas D, 2005, J BIOMECH, V38, P761, DOI 10.1016/j.jbiomech.2004.05.019
   MUNOWITZ M, 1982, J CHEM PHYS, V77, P1686, DOI 10.1063/1.444064
   Perry A, 2002, BIOPHYS J, V82, P1086, DOI 10.1016/S0006-3495(02)75468-4
   Reichert D, 2004, MAGN RESON CHEM, V42, P276, DOI 10.1002/mrc.1334
   Reichert D, 2001, J MAGN RESON, V151, P129, DOI 10.1006/jmre.2001.2337
   ROTHWELL WP, 1981, J CHEM PHYS, V74, P2721, DOI 10.1063/1.441433
   Samouillan V, 2003, J BIOMED MATER RES A, V64A, P330, DOI 10.1002/jbm.a.10326
   SARKAR SK, 1985, BIOCHEMISTRY-US, V24, P2348, DOI 10.1021/bi00330a033
   TAKEGOSHI K, 1991, J CHEM PHYS, V94, P3200, DOI 10.1063/1.460707
   Vinogradov E, 1999, CHEM PHYS LETT, V314, P443, DOI 10.1016/S0009-2614(99)01174-4
   Vyavahare NR, 2000, J HEART VALVE DIS, V9, P561
   Vyavahare NR, 1998, J BIOMED MATER RES, V40, P577, DOI 10.1002/(SICI)1097-4636(19980615)40:4<577::AID-JBM9>3.3.CO;2-B
   Zernia G, 2006, NMR BIOMED, V19, P1010, DOI 10.1002/nbm.1061
NR 39
TC 4
Z9 4
U1 0
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0749-1581
J9 MAGN RESON CHEM
JI Magn. Reson. Chem.
PD SEP
PY 2010
VL 48
IS 9
BP 704
EP 711
DI 10.1002/mrc.2653
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Spectroscopy
SC Chemistry; Spectroscopy
GA 643AE
UT WOS:000281263300006
PM 20641133
DA 2018-10-19
ER

PT J
AU Misra, RDK
AF Misra, R. D. K.
TI Core-shell magnetic nanoparticle carrier for targeted drug delivery:
   challenges and design
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Magnetic nanocarrier; Nanoparticles; Targeted drug delivery;
   Stimuli-response polymer
ID REVERSE MICELLE TECHNIQUE; NANOCRYSTALLINE NICKEL FERRITE; COMPOSITE
   NANOPARTICLES; BIOMATERIAL SYSTEM; CONTROLLED-RELEASE; FOLATE RECEPTORS;
   DOXORUBICIN; BEHAVIOR; POLYMER; COPOLYMERS
AB The primary challenge in the delivery of a drug to a tumor site is to target the anticancer drug specifically into and around tumors at concentrations that will decrease their growth and/or viability. Excellent vehicles to achieve targeted drug delivery are magnetic nanocarriers. An approach to accomplish this objective is to fabricate a novel temperature and pH responsive magnetic nanocarrier that combines tumor targeting and controlled release. In addition to controlled release, these carriers simultaneously offer the possibility of imaging the delivery process by magnetic resonance imaging. The novel aspect of this approach is the combination of thermal and pH sensitivity of the drug containing shell with magnetic properties of the core in a single unit. Furthermore, application of an external magnetic field will heat the nanoparticles and thus nanoparticle containing cells. The targeted heat will aid in the killing of tumor cells.
C1 Univ Louisiana Lafayette, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441
   Christie RJ, 2003, ADV DRUG DELIVER REV, V55, P421, DOI 10.1016/S0169-409X(02)00229-6
   Detty MR, 2004, J MED CHEM, V47, P3897, DOI 10.1021/jm040074b
   Etrych T, 2001, J CONTROL RELEASE, V73, P89, DOI 10.1016/S0168-3659(01)00281-4
   Firestone RA, 1996, J CONTROL RELEASE, V39, P251, DOI 10.1016/0168-3659(95)00160-3
   Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819
   Grief AD, 2005, J MAGN MAGN MATER, V293, P455, DOI 10.1016/j.jmmm.2005.02.040
   Grinberg V. Y., 2001, BIOMACROMOLECULES, V2, P874
   Gu HW, 2005, CHEM COMMUN, P4270, DOI 10.1039/b507779f
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   Gupta A.K, 2004, IEEE T NANOBIOSCI, V41, P4137
   Hafeli UO, 2004, INT J PHARM, V277, P19, DOI 10.1016/j.ijpharm.2003.03.002
   Huh KM, 2001, POLYM J, V33, P108, DOI 10.1295/polymj.33.108
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Kale A, 2004, J MAGN MAGN MATER, V277, P350, DOI 10.1016/j.jmmm.2003.11.015
   King HD, 1999, BIOCONJUGATE CHEM, V10, P279, DOI 10.1021/bc980100i
   Kono K, 2001, ADV DRUG DELIVER REV, V53, P307, DOI 10.1016/S0169-409X(01)00204-6
   Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016
   Liu TY, 2006, LANGMUIR, V22, P5974, DOI 10.1021/la060371e
   Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X
   Maziarz KM, 1999, J BIOL CHEM, V274, P11086, DOI 10.1074/jbc.274.16.11086
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   Nathani H, 2005, MAT SCI ENG B-SOLID, V121, P126, DOI 10.1016/j.mseb.2005.03.016
   Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2
   Orive G, 2003, CURR OPIN BIOTECH, V14, P659, DOI 10.1016/j.copbio.2003.10.007
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Roux E, 2003, BIOMACROMOLECULES, V4, P240, DOI 10.1021/bm025651x
   Soppimath KS, 2002, DRUG DEV IND PHARM, V28, P957, DOI 10.1081/DDC-120006428
   Trail PA, 1997, CANCER RES, V57, P100
   WEITMAN SD, 1992, CANCER RES, V52, P3396
   WILLNER D, 1993, BIOCONJUGATE CHEM, V4, P521, DOI 10.1021/bc00024a015
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   You YZ, 2004, ADV MATER, V16, P1953, DOI 10.1002/adma.200400362
   Zhang J, 2008, ACTA BIOMATER, V4, P40, DOI 10.1016/j.actbio.2007.06.006
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
NR 40
TC 16
Z9 16
U1 3
U2 17
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2010
VL 25
IS 3-4
BP 118
EP 126
DI 10.1179/175355510X12723642365241
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 642HM
UT WOS:000281199100002
DA 2018-10-19
ER

PT J
AU Tripathi, G
   Choudhury, P
   Basu, B
AF Tripathi, G.
   Choudhury, P.
   Basu, B.
TI Development of polymer based biocomposites: a review
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Biomaterial; Polymer; Hydroxyapatite; tissue replacement; mechanical
   properties
ID HYDROXYAPATITE-POLYETHYLENE COMPOSITES; HIGH-DENSITY POLYETHYLENE;
   COUPLING AGENTS; MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; TIBIAL
   COMPONENTS; WEAR PROPERTIES; HIP-PROSTHESIS; IN-VIVO; BONE
AB The last few decades have witnessed an impressive advance in the development of materials for skeletal repair and reconstruction. In this review, our focus is placed upon the use of polymers and polymeric biocomposites as implants for the repair and reconstruction of diseased or damaged hard tissue. In particular, the challenges and recent results related to the designing, processing and physical properties of biopolymers and polymer-ceramic composites are discussed. The biocompatibility property of these materials is also discussed.
C1 [Tripathi, G.; Basu, B.] Indian Inst Technol, Dept Mat & Met Engn, Lab Biomat, Kanpur 208016, Uttar Pradesh, India.
   [Choudhury, P.] CSJM Univ, Dept Mat Sci & Met, Kanpur 208016, Uttar Pradesh, India.
RP Basu, B (reprint author), Indian Inst Technol, Dept Mat & Met Engn, Lab Biomat, Kanpur 208016, Uttar Pradesh, India.
EM bikram@iitk.ac.in
RI BASU, BIKRAMJIT/A-9967-2013
FU Department of Biotechnology, New Delhi, India; Department of Science and
   Technology, Government of India; Council for Scientific and Industrial
   Research
FX A large number of research reports based on the work carried out in the
   research group of B. Basu are sponsored by the Department of
   Biotechnology, Government of India, Department of Science and
   Technology, Government of India, and Council for Scientific and
   Industrial Research. This project was sponsored by the Department of
   Biotechnology, New Delhi, India. In particular, G. Tripathi wants to
   acknowledge the Fast Track Scheme of the Department of Science and
   Technology, Government of India, for financial support towards her
   research at IIT Kanpur.
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Abu Bakar MS, 2003, MAT SCI ENG A-STRUCT, V345, P55, DOI 10.1016/S0921-5093(02)00289-7
   Akay M, 1996, J BIOMED MATER RES, V31, P167
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   Bakar M. S. A., 2003, COMPOS SCI TECHNOL, V63, P421, DOI DOI 10.1016/S0266-3538(02)00230-0
   Basu B, 2009, ADV BIOMATERIALS FUN
   Black J., 1988, ORTHOPAEDIC BIOMATER
   BLUMENTHAL NC, 1994, J APPL BIOMATER, V5, P191, DOI 10.1002/jab.770050303
   Bodhak S, 2008, J BIOMED MATER RES A, V85A, P83, DOI 10.1002/jbm.a.31393
   Bodhak S, 2009, J BIOMATER APPL, V23, P407, DOI 10.1177/0885328208090012
   BONEFIELD W, 1988, ANN NY ACAD SCI, V523, P173
   Choubey A, 2004, J ALLOY COMPD, V381, P288, DOI 10.1016/j.jallcom.2004.03.096
   Choubey A, 2004, MAT SCI ENG A-STRUCT, V379, P234, DOI 10.1016/j.msea.2004.02.027
   CHRISTEL P, 1987, J BIOMED MATER RES-A, V21, P191
   CORCORAN S, 1981, CURRENT CONCEPTS INT, P136
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DEVANATHAN D, 1991, INT ENCY COMPOSITES, V4, P74
   Du SG, 1997, J APPL POLYM SCI, V63, P1259
   DUBEY A, 2009, J APPL PHYS, V105
   Elliott JC, 1994, STRUCTURE CHEM APATI
   ESSLINGER JO, 1973, J BIOMED MATER RES, V7, P187, DOI 10.1002/jbm.820070312
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Friedrich K, 2002, P I MECH ENG J-J ENG, V216, P415, DOI 10.1243/135065002762355334
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Harris B., 1980, S SOC EXP BIOL, V34, P37
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   HELEN H, 2003, J BIOMED MATER RES A, V64, P645
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HUNT KN, 1988, POLYM ENG SCI, V28, P1572, DOI 10.1002/pen.760282308
   Itokawa H, 2007, BIOMATERIALS, V28, P4922, DOI 10.1016/j.biomaterials.2007.08.001
   Iwashita N, 1998, COMPOS PART A-APPL S, V29, P965, DOI 10.1016/S1359-835X(97)00095-X
   Kharade AY, 1999, J APPL POLYM SCI, V72, P1321, DOI 10.1002/(SICI)1097-4628(19990606)72:10<1321::AID-APP12>3.0.CO;2-9
   Kikuchi M, 1999, J BIOMED MATER RES, V48, P108, DOI 10.1002/(SICI)1097-4636(1999)48:2<108::AID-JBM2>3.3.CO;2-6
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kong YM, 1999, J AM CERAM SOC, V82, P2963
   Kuijer R, 1998, J MATER SCI-MATER M, V9, P449, DOI 10.1023/A:1008867300634
   Kumar R, 2009, J MATER SCI-MATER M, V20, P1689, DOI 10.1007/s10856-009-3725-1
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000
   LYCKFELDT O, J EUR CERAM SOC, V2, P131
   MENON N, 1994, J APPL POLYM SCI, V54, P113, DOI 10.1002/app.1994.070540112
   MONTE SJ, 1984, POLYM ENG SCI, V24, P1369, DOI 10.1002/pen.760241802
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   Nagata F, 2004, KEY ENG MAT, V254-2, P293, DOI 10.4028/www.scientific.net/KEM.254-256.293
   Nath S, 2007, J BIOMED MATER RES A, V83A, P191, DOI 10.1002/jbm.a.31203
   Nath S, 2008, J KOREAN CERAM SOC, V45, P1, DOI 10.4191/kcers.2008.45.1.001
   Nath S, 2009, MAT SCI ENG C-BIO S, V29, P97, DOI 10.1016/j.msec.2008.05.019
   Nath S, 2009, J BIOMED MATER RES B, V88B, P1, DOI 10.1002/jbm.b.31050
   Olhero SM, 2000, J EUR CERAM SOC, V20, P423, DOI 10.1016/S0955-2219(99)00182-X
   OONISHI H, J BIOMED MAT RES, V44, P31
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PETER T, 1991, P 9 C BIOM ENG SING, P317
   PURCEK G, 2003, MAT SCI ENG A-STRUCT, V490, P403
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P526
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rothon R., 1995, PARTICULATE FILLED P, P294
   Rothon R. N., 1995, PARTICULATE FILLED P
   RUSHTON N, 1984, BIOMATERIALS, V5, P352, DOI 10.1016/0142-9612(84)90034-6
   Sadi AY, 2004, J MATER SCI-MATER M, V15, P853, DOI 10.1023/B:JMSM.0000036272.28022.3a
   SAGGIOWOYANSKY J, 1992, AM CERAM SOC BULL, V71, P1674
   SARASUA JR, 1995, J MATER SCI, V30, P3501, DOI 10.1007/BF00349901
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, V248, P200
   Schwartzwalder K., 1963, Patent US, Patent No. [3090094 A, 3090094, 3,090,094]
   SCLIPPA E, 1973, J BIOMED MATER RES, V7, P59, DOI 10.1002/jbm.820070105
   SENAPATI SK, 2002, TRENDS BIOMATER ARTI, V16, P5
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Silverton C, 1996, J BONE JOINT SURG AM, V78A, P340, DOI 10.2106/00004623-199603000-00004
   Silvio L. D., 2002, BIOMATERIALS, V23, P101
   Singh B, 1998, J APPL POLYM SCI, V70, P1847, DOI 10.1002/(SICI)1097-4628(19981128)70:9<1847::AID-APP24>3.3.CO;2-G
   SIVAKUMAR M, 1993, J MATER SCI, V28, P6081, DOI 10.1007/BF00365025
   Sousa RA, 2003, COMPOS SCI TECHNOL, V63, P389, DOI 10.1016/S0266-3538(02)00213-0
   Sousa RA, 2003, J APPL POLYM SCI, V89, P2079, DOI 10.1002/app.12324
   Szycher M., 1983, BIOCOMPATIBLE POLYM, P861
   Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908
   TRIPATHI G, 2009, J BIOMED B IN PRESS
   WALTON PL, 1978, J MATER SCI, V13, P1075, DOI 10.1007/BF00544703
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang M, 2000, MATER LETT, V44, P119, DOI 10.1016/S0167-577X(00)00026-4
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
   Wang SW, 2004, AUTOMAT CONSTR, V13, P607, DOI [10.1016/j.autcon.2004.04.008, 10.1016/j.autcon.2004.04.009]
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, P67
   Wintermantel E., 1998, MAT MED, P1
   WRIGHT TM, 1981, J BIOMED MATER RES, V15, P719, DOI 10.1002/jbm.820150508
   XAVIER SF, 1990, J MATER SCI, V25, P2425
   Yildiz H, 1998, J BIOMED MATER RES, V39, P102, DOI 10.1002/(SICI)1097-4636(199801)39:1<102::AID-JBM13>3.0.CO;2-H
   Yu SC, 2005, BIOMATERIALS, V26, P2343, DOI 10.1016/j.biomaterials.2004.07.028
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   ZIMMERMAN M, 1987, J BIOMED MATER RES-A, V21, P345
   ZIMMERMAN MC, 1991, ACS SYM SER, V457, P132
NR 95
TC 7
Z9 7
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2010
VL 25
IS 3-4
BP 158
EP 176
DI 10.1179/175355510X12723642365089
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA 642HM
UT WOS:000281199100007
DA 2018-10-19
ER

PT J
AU Sridhar, TM
AF Sridhar, T. M.
TI Nanobioceramic coatings for biomedical applications
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Metallic implants; Hydroxyapatite coatings; Electrochemical coatings;
   Biomimetic; Scaffolds; Tissue engineering
ID ORTHOPEDIC IMPLANT DEVICES; 316L STAINLESS-STEEL; SIMULATED BODY-FLUID;
   ANODIC TIO2 NANOTUBES; FLUORIDATED HYDROXYAPATITE COATINGS;
   CALCIUM-PHOSPHATE COATINGS; BETA-TRICALCIUM PHOSPHATE; NITROGEN
   ION-IMPLANTATION; ELECTROPHORETIC DEPOSITION; IN-VITRO
AB The development of biomaterials for the repair or replacement of hard tissue is a challenging and a promising area of research. Engineering cell and tissue behaviour at biomaterial surfaces at the nanoscale level can be accomplished by chemically modifying surfaces with biologically active macromolecules or physically modifying the surface topography at the nanoscale. Bioceramics have been used very successfully within the human body for many years. They are commonly used in orthopaedic surgery and dentistry but they are potentially suitable for a wide range of important applications within the medical device industry. The fabrication, microstructure and properties of this highly active area of research and the significance of a range of nanobioceramic coatings by electrochemical techniques are discussed. Bio-inspired materials open new approaches for manufacturing implants for bone replacement. The application of these nanobioceramic coating techniques to develop biomimetic coatings and scaffolds along with tissue engineering would set new trends in health care delivery system. The clinical applications of bioceramic coatings in joint replacement, bone grafts, tissue engineering, drug delivery systems and dentistry would serve as a useful resource for biomaterials scientists and engineers, as well as for clinicians and the academic community.
C1 SMK FOMRA Inst Technol, Dept Biomed Engn, Madras 603103, Tamil Nadu, India.
RP Sridhar, TM (reprint author), SMK FOMRA Inst Technol, Dept Biomed Engn, Madras 603103, Tamil Nadu, India.
EM tmsridhar@gmail.com
CR ANDERSON BJ, 1972, J BONE JOINT SURG BR, V54, P590
   Asoh H, 2003, ELECTROCHIM ACTA, V48, P3171, DOI 10.1016/S0013-4686(03)00347-5
   ASOH H, J SOC INORG IN PRESS
   Balamurugan A, 2006, MATER LETT, V60, P2288, DOI 10.1016/j.matlet.2005.12.126
   Barinov SM, 2003, INORG MATER+, V39, P877, DOI 10.1023/A:1025041817017
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Berndt C. C., 1990, Materials Forum, V14, P161
   Bohner M, 2000, INJURY, V31, pS37
   Bow JS, 2004, BIOMATERIALS, V25, P3155, DOI 10.1016/j.biomaterials.2003.10.046
   CATLEDGE SA, 2003, ENCY NANOSCIENCE NAN, V10, P14
   Chen F, 2007, J BIOMED MATER RES B, V82B, P183, DOI 10.1002/jbm.b.30720
   Chen YM, 2008, APPL SURF SCI, V255, P375, DOI 10.1016/j.apsusc.2008.06.110
   Cheng K, 2005, SURF COAT TECH, V198, P242, DOI 10.1016/j.surfcoat.2004.10.024
   COLLIER JP, 1991, CLIN ORTHOP RELAT R, V271, P305
   CORTEZ PM, 2003, ADV ENG MATER, V5, P812
   de Jong WF, 1926, RECL TRAV CHIM PAY-B, V45, P445
   de Sena LA, 2003, SURF COAT TECH, V166, P254, DOI 10.1016/S0257-8972(02)00822-8
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   dos Santos EA, 2009, J BIOMED MATER RES A, V89A, P510, DOI 10.1002/jbm.a.31991
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Eliaz N, 2005, SURF ENG, V21, P238, DOI 10.1179/174329405X50091
   Eliaz N., 2008, CORROSION SCI TECHNO, P356
   Eliaz N, 2008, CRYST GROWTH DES, V8, P3965, DOI 10.1021/cg800016h
   Eliaz N, 2007, J BIOMED MATER RES A, V83A, P546, DOI 10.1002/jbm.a.31429
   Eliaz N, 2007, J BIOMED MATER RES A, V80A, P621, DOI 10.1002/jbm.a.30944
   Eliaz N, 2009, J BIOMED MATER RES A, V89A, P270, DOI 10.1002/jbm.a.32129
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Fu Q, 2005, J BIOMED MATER RES A, V74A, P156, DOI 10.1002/jbm.a.30322
   Fuming H, 2008, J ORAL REHABIL, V35, P754, DOI 10.1111/j.1365-2842.2008.01859.x
   Gilbert JL, 1997, AM SOC TEST MATER, V1301, P45, DOI 10.1520/STP12020S
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guo LH, 2004, SURF COAT TECH, V185, P268, DOI 10.1016/j.surfcoat.2004.01.013
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HIJON N, 2004, KEY ENG MATER, V254, P363
   Hong SB, 2001, J DENT RES, V80, P860, DOI 10.1177/00220345010800030301
   Hong SB, 2001, CORROS SCI, V43, P1781, DOI 10.1016/S0010-938X(00)00181-5
   Hulbert S. F., 1987, HIGH TECH CERAMICS, P189
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   JUAN XF, 2009, T NONFERR METAL SOC, V19, P125
   Kannan S, 2005, CHEM MATER, V17, P3065, DOI [10.1021/cm050342+, 10.1021/cm.050342+]
   KARTHEGA M, 2006, TRENDS BIOMATER ARTI, V20, P31
   Kaya C, 2008, CERAM INT, V34, P1843, DOI 10.1016/j.ceramint.2007.06.007
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2919, DOI 10.1016/j.biomaterials.2003.09.074
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   Kodama A, 2009, ACTA BIOMATER, V5, P2322, DOI 10.1016/j.actbio.2009.02.032
   Kokubo T, 2000, BONE ENG, P190
   Krupa D, 2003, VACUUM, V70, P109, DOI 10.1016/S0042-207X(02)00628-0
   Krupa D, 2002, BIOMATERIALS, V23, P3329, DOI 10.1016/S0142-9612(02)00020-0
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   Kumar S, 2010, CORROS SCI, V52, P711, DOI 10.1016/j.corsci.2009.10.029
   Kumar S, 2010, MATER CHEM PHYS, V119, P337, DOI 10.1016/j.matchemphys.2009.09.007
   Kumar S, 2009, MAT SCI ENG C-MATER, V29, P1942, DOI 10.1016/j.msec.2009.03.007
   Kunze J, 2008, ELECTROCHIM ACTA, V53, P6995, DOI 10.1016/j.electacta.2008.01.027
   Kwok CT, 2009, APPL SURF SCI, V255, P6736, DOI 10.1016/j.apsusc.2009.02.086
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Laurencin C. T., 2008, NANOTECHNOLOGY TISSU, P163
   Lee EJ, 2005, BIOMATERIALS, V26, P3843, DOI 10.1016/j.biomaterials.2004.10.019
   Lee HJ, 2007, EUR POLYM J, V43, P1602, DOI 10.1016/j.eurpolymj.2007.02.030
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   Liu Q, 1996, J MATER SCI-MATER M, V7, P551, DOI 10.1007/BF00122178
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459
   Masuda Y., 1990, J CERAM SOC JPN, V98, P84
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Meng XW, 2006, J BIOMED MATER RES B, V78B, P373, DOI 10.1002/jbm.b.30497
   Mondragon-Cortez P, 2004, MATER LETT, V58, P1336, DOI 10.1016/j.matlet.2003.09.024
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   Mudali UK, 2003, CORROS REV, V21, P231
   MUSTER D, 1995, ENCY HDB BIOMATERIAL, V1, P785
   Narayanan R, 2007, MATER CHEM PHYS, V106, P406, DOI 10.1016/j.matchemphys.2007.06.026
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Narayanan R, 2008, MAT SCI ENG C-BIO S, V28, P1265, DOI 10.1016/j.msec.2007.11.009
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Ono S, 2004, ELECTROCHEM SOLID ST, V7, pB21, DOI 10.1149/1.1738553
   Ono Sachiko, 2008, Journal of Japan Institute of Light Metals, V58, P593, DOI 10.2464/jilm.58.593
   Ono S, 2008, ECS T, V11, P1
   Prabakaran K, 2009, SPECTROCHIM ACTA A, V74, P1127, DOI 10.1016/j.saa.2009.09.021
   Qiu CF, 2008, CERAM INT, V34, P1747, DOI 10.1016/j.ceramint.2007.06.001
   Qu HB, 2006, ACTA BIOMATER, V2, P113, DOI 10.1016/j.actbio.2005.09.003
   Raman V, 2007, ELECTROCHIM ACTA, V52, P7418, DOI 10.1016/j.electacta.2007.06.040
   Ratner B. D., 2001, TITANIUM MED, P2
   Rokusek D, 2005, J BIOMED MATER RES A, V75A, P588, DOI 10.1002/jbm.a.30459
   Sanosh KP, 2009, CURR APPL PHYS, V9, P1459, DOI 10.1016/j.cap.2009.03.024
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469
   SIVAKUMAR M, 1992, J MATER SCI LETT, V11, P1039, DOI 10.1007/BF00729754
   Sivakumar M, 1996, J MATER SCI LETT, V15, P2192
   SIVAKUMAR M, 1994, J MATER ENG PERFORM, V3, P744, DOI 10.1007/BF02818375
   SIVAKUMAR M, 1995, J MATER SCI LETT, V14, P148, DOI 10.1007/BF00456573
   SIVAKUMAR M, 1995, J MATER SCI LETT, V14, P351, DOI 10.1007/BF00592147
   Smith IO, 2006, INT J NANOMED, V1, P189, DOI 10.2147/nano.2006.1.2.189
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sridhar TM, 2009, CORROS REV, P287
   Sridhar TM, 2003, CORROS SCI, V45, P2337, DOI 10.1016/S0010-938X(03)00063-5
   Sridhar TM, 2003, T INDIAN I METALS, V56, P221
   Sridhar TM, 2003, CORROS SCI, V45, P237, DOI 10.1016/S0010-938X(02)00091-4
   Sridhar TM, 2002, CORROS REV, V20, P255
   Sridhar TM, 1997, J MATER SCI LETT, V16, P1964, DOI 10.1023/A:1018511406374
   Stitzel JD, 2001, J BIOMATER APPL, V16, P22, DOI 10.1106/U2UU-M9QH-Y0BB-5GYL
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sun B, 2008, BIOMATERIALS, V29, P475, DOI 10.1016/j.biomaterials.2007.09.038
   Sundararajan T, 1999, J MATER ENG PERFORM, V8, P252, DOI 10.1361/105994999770347115
   Sundararajan T, 1999, MATER CORROS, V50, P344, DOI 10.1002/(SICI)1521-4176(199906)50:6<344::AID-MACO344>3.0.CO;2-4
   Sundararajan T, 1998, MATER T JIM, V39, P756, DOI 10.2320/matertrans1989.39.756
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   Thair L, 2003, CORROS SCI, V45, P1951, DOI 10.1016/S0010-938X(03)00027-1
   Thair L, 2002, CORROS SCI, V44, P2439, DOI 10.1016/S0010-938X(02)00034-3
   Tian T, 2008, MAT SCI ENG C-BIO S, V28, P57, DOI 10.1016/j.msec.2007.10.049
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   TULLOCH AJD, 2009, J BIOMED MATER RES A, V90, P586
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   VANBLITTERSWIJK CA, 1992, BONE BONDING BIOMATE, P153
   Veerabadran KM, 1999, MATER SCI FORUM, V318-3, P561, DOI 10.4028/www.scientific.net/MSF.318-320.561
   von Wilmowsky C, 2009, J BIOMED MATER RES B, V89B, P165, DOI 10.1002/jbm.b.31201
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Wang J, 2009, ACTA BIOMATER, V5, P1798, DOI 10.1016/j.actbio.2009.01.005
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei M, 1999, J BIOMED MATER RES, V45, P11, DOI 10.1002/(SICI)1097-4636(199904)45:1<11::AID-JBM2>3.0.CO;2-7
   WEVERS HW, 1987, CLIN MATER, V2, P67
   WILLIAMS DF, 1987, MATER SCI TECH SER, V3, P797, DOI 10.1179/mst.1987.3.10.797
   Williams DF, 1986, P CONS C EUR SOC BIO
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xu JL, 2004, MAT SCI ENG A-STRUCT, V374, P101, DOI 10.1016/j.msea.2003.12.040
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang CW, 2008, J EUR CERAM SOC, V28, P2151, DOI 10.1016/j.jeurceramsoc.2008.02.015
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yasuda K, 2007, ELECTROCHIM ACTA, V52, P4053, DOI 10.1016/j.electacta.2006.11.023
   Yin MZ, 2006, J WUHAN UNIV TECHNOL, V21, P102
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhang E, 2009, MAT SCI ENG C-BIO S, V29, P298, DOI 10.1016/j.msec.2008.07.001
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhang W, 2003, J AM CERAM SOC, V86, P1052, DOI 10.1111/j.1151-2916.2003.tb03422.x
   Zhitomirsky I, 2002, ADV COLLOID INTERFAC, V97, P279, DOI 10.1016/S0001-8686(01)00068-9
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhu XL, 2006, J BIOMED MATER RES A, V79A, P114, DOI 10.1002/jbm.a.30706
NR 148
TC 6
Z9 6
U1 1
U2 27
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2010
VL 25
IS 3-4
BP 184
EP 195
DI 10.1179/175355510X12723642365449
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 642HM
UT WOS:000281199100009
DA 2018-10-19
ER

PT J
AU He, HX
   Liu, HC
AF He, H. X.
   Liu, H. C.
TI Stem cell behaviours and functions modulated by biomaterials
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Biomaterial; Stem cell; Tissue engineering
ID RAPID PROTOTYPING TECHNIQUES; DIFFERENTIATION; SURFACES; MATRIX
AB Stem cells have shown the great potential as a candidate for tissue engineering and regenerative medicine. However, the main challenge must be overcome about the controlled regulation of stem cell growth and differentiation before its wide clinical applications. Recent advances in biomaterial engineering and scaffold fabrication may provide a powerful tool towards solving this problem. In this article, silk based biomaterials, nanoscale biomaterials and polymer-ceramic hybrid composites are introduced which represent the new biomaterials in the field of tissue engineering. Moreover, researchers have incorporated signals directly into the biomaterials by novel processing techniques such as surface modification techniques, self-assembly process and rapid prototyping techniques. Additionally, we review the recent research in the area of high throughput approaches towards characterisation and optimisation of stem cell-material interactions and discuss the future directions of biomaterials in tissue engineering.
C1 [Liu, H. C.] Chinese Peoples Liberat Army Gen Hosp, Inst Dent Res, Beijing 100853, Peoples R China.
   Postgrad Mil Med Sch, Beijing 100853, Peoples R China.
RP Liu, HC (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Dent Res, Beijing 100853, Peoples R China.
EM liu_hch@yahoo.com.cn
FU China Postdoctoral Science Foundation [20070420077, 200801061]; National
   Science Foundation [30772450]
FX This work was supported by the grants from China Postdoctoral Science
   Foundation (project no. 20070420077), special grade of the financial aid
   from China Postdoctoral Science foundation (project no. 200801061) and
   the National Science Foundation (project no. 30772450).
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Boland T, 2007, MAT SCI ENG C-BIO S, V27, P372, DOI 10.1016/j.msec.2006.05.047
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   He HX, 2010, STEM CELL REV REP, V6, P137, DOI 10.1007/s12015-009-9110-0
   HE HX, J BIOMATER IN PRESS
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   KESELOWSKY BG, 2009, BIOMATERIALS, V30, P6835
   Kokona B, 2009, BIOMACROMOLECULES, V10, P1454, DOI 10.1021/bm9000553
   Kozarova A, 2006, J PROTEOME RES, V5, P1051, DOI 10.1021/pr050432e
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Liuyun J., 2009, J BIOMED SCI, V14, P16
   Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Rim NG, 2009, MACROMOL BIOSCI, V9, P795, DOI 10.1002/mabi.200800358
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sanz-Herrera JA, 2009, BIOMATERIALS, V30, P6674, DOI 10.1016/j.biomaterials.2009.08.053
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076
   VACANTI JP, 1999, LANCET S1, V354, pS132
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yang F, 2009, COMB CHEM HIGH T SCR, V12, P554, DOI 10.2174/138620709788681916
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
NR 28
TC 2
Z9 2
U1 0
U2 13
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2010
VL 25
IS 3-4
BP 231
EP 236
DI 10.1179/175355510X12723642365205
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 642HM
UT WOS:000281199100013
DA 2018-10-19
ER

PT J
AU Milicevic, D
   Trifunovic, S
   Dojcilovic, J
   Ignjatovic, N
   Suljovrujic, E
AF Milicevic, D.
   Trifunovic, S.
   Dojcilovic, J.
   Ignjatovic, N.
   Suljovrujic, E.
TI The influence of gamma radiation on the molecular weight and glass
   transition of PLLA and HAp/PLLA nanocomposite
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article
DE Poly L-lactide; Hydroxyapatite; Gamma radiation; Molecular weight; Glass
   transition
ID LACTIDE COMPOSITE BIOMATERIAL; POLY-L-LACTIDE; CROSS-LINKING; STRUCTURAL
   RELAXATION; POLY(L-LACTIC ACID); ENTHALPY RELAXATION; POLY(LACTIC ACID);
   IN-VITRO; IRRADIATION; BONE
AB The influence of gamma radiation on the molecular weight and glass transition behaviour of poly-L-lactide (PLLA) and hydroxyapatite/poly-L-lactide (HAp/PLLA) nanocomposite has been studied Since PLLA exposed to high-energy radiation in the presence of air is prone to chain scission reactions and large degradation, changes in molecular weight were obtained by gel permeation chromatography (GPC). Alterations in the glass transition behaviour were investigated by differential scanning calorimetry (DSC) The apparent activation energy (Delta H*) for glass transition was determined on the basis of the heating rate dependence of the glass transition temperature (T-g). Our findings support the fact that chain scission is the main reason for the decrease of T-g and Delta H* with the absorbed dose Furthermore, more intensive chain scission degradation of PLLA was observed in HAp/PLLA and can only be ascribed to the presence of HAp nanoparticles. Consequently, initial differences in the glass transition temperature and/or apparent activation energy of PLLA and HAp/PLLA became more pronounced with absorbed dose. This study reveals that radiation-induced changes in molecular weight and glass transition temperature occur in a predictable and fairly accurate manner Therefore, gamma radiation can be used not only for sterilization but also for tailoring desirable end-use properties of these biomaterials (C) 2010 Elsevier B V. All rights reserved
C1 [Milicevic, D.; Trifunovic, S.; Suljovrujic, E.] Vinca Inst Nucl Sci, Belgrade 11001, Serbia.
   [Dojcilovic, J.] Univ Belgrade, Fac Phys, Belgrade 11000, Serbia.
   [Ignjatovic, N.] SASA, Belgrade, Serbia.
RP Suljovrujic, E (reprint author), Vinca Inst Nucl Sci, POB 522, Belgrade 11001, Serbia.
RI Ignjatovic, Nenad/C-4489-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Suljovrujic,
   Edin/0000-0001-8774-4341; Milicevic, Dejan/0000-0001-7746-0708
FU Ministry of Science and Technology of the Republic of Serbia [141013]
FX This work has been supported by the Ministry of Science and Technology
   of the Republic of Serbia (Grant No 141013).
CR ALBANO C, 2006, NUCL INSTRUM METH B, V247, P331, DOI DOI 10.1016/J.NIMB.2006.03.004
   Black J., 1992, BIOL PERFORMANCE MAT
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   EITENMULLER J, 1989, J BIOACT COMPAT POLY, V4, P215
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Fambri L, 2003, POLYM COMPOSITE, V24, P100, DOI 10.1002/pc.10010
   Ferrer M. C. H., 2007, DEV CHARACTERISATION
   FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711
   FRIEDL JR, 1995, POLYM SCI TECHNOLOGY
   Godard ME, 1998, J NON-CRYST SOLIDS, V235, P635, DOI 10.1016/S0022-3093(98)00571-7
   GUPTA MC, 1983, POLYMER, V24, P827, DOI 10.1016/0032-3861(83)90198-2
   HODGE IM, 1994, J NON-CRYST SOLIDS, V169, P211, DOI 10.1016/0022-3093(94)90321-2
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Isama K, 2002, J BIOMAT SCI-POLYM E, V13, P153, DOI 10.1163/156856202317414348
   JAMSHIDI K, 1988, POLYMER, V29, P2229, DOI 10.1016/0032-3861(88)90116-4
   Jin FZ, 2002, MACROMOL RAPID COMM, V23, P909, DOI 10.1002/1521-3927(20021001)23:15<909::AID-MARC909>3.0.CO;2-8
   Kelen T., 1983, OXIDATIVE DEGRADATIO
   Kim HD, 2004, BIOMATERIALS, V25, P2319, DOI 10.1016/j.biomaterials.2003.09.011
   KOLESOV SN, 1975, STRUKTURNAYA ELEKTRO
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Mano JF, 2005, POLYMER, V46, P8258, DOI 10.1016/j.polymer.2005.06.096
   Milicevic D, 2007, RADIAT PHYS CHEM, V76, P1376, DOI 10.1016/j.radphyschem.2007.02.035
   Mitomo H, 2005, POLYMER, V46, P4695, DOI 10.1016/j.polymer.2005.03.088
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Moynihan CT, 1996, THERMOCHIM ACTA, V280, P153, DOI 10.1016/0040-6031(95)02781-5
   MOYNIHAN CT, 1974, J PHYS CHEM-US, V78, P2673, DOI 10.1021/j100619a008
   Nagasawa N, 2005, NUCL INSTRUM METH B, V236, P611, DOI 10.1016/j.nimb.2005.04.052
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Nijsen JFW, 2002, BIOMATERIALS, V23, P1831, DOI 10.1016/S0142-9612(01)00309-X
   Park JB, 1992, BIOMATERIALS INTRO
   PRIVALKO VP, 1986, MACROMOLECULES, V19, P901, DOI 10.1021/ma00157a071
   Rabek J., 1980, EXPT METHODS POLYM C
   Sciucca SD, 2007, MACROMOL S, V247, P35, DOI 10.1002/masy.200750105
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Singh A, 1991, RAD PROCESSING POLYM
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   Suljovrujic E, 2007, RADIAT PHYS CHEM, V76, P722, DOI 10.1016/j.radphyschem.2006.02.013
   Suljovrujic E., 2003, RADIAT PHYS CHEM, V67, P375
   Tsuji H, 2000, J APPL POLYM SCI, V77, P1452, DOI 10.1002/1097-4628(20000815)77:7<1452::AID-APP7>3.0.CO;2-S
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076
NR 44
TC 8
Z9 8
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
EI 1872-9584
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD SEP
PY 2010
VL 268
IS 17-18
BP 2744
EP 2749
DI 10.1016/j.nimb.2010.06.036
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 645XG
UT WOS:000281498900031
DA 2018-10-19
ER

PT J
AU Reeves, R
   Ribeiro, A
   Lombardo, L
   Boyer, R
   Leach, JB
AF Reeves, Robert
   Ribeiro, Andreia
   Lombardo, Leonard
   Boyer, Richard
   Leach, Jennie B.
TI Synthesis and Characterization of Carboxymethylcellulose-Methacrylate
   Hydrogel Cell Scaffolds
SO POLYMERS
LA English
DT Article
DE hydrogel; natural biomaterial; carboxymethylcellulose; fibroblast
   adhesion
AB Many carbohydrates pose advantages for tissue engineering applications due to their hydrophilicity, degradability, and availability of chemical groups for modification. For example, carboxymethylcellulose (CMC) is a water-soluble cellulose derivative that is degradable by cellulase. Though this enzyme is not synthesized by mammalian cells, cellulase and the fragments derived from CMC degradation are biocompatible. With this in mind, we created biocompatible, selectively degradable CMC-based hydrogels that are stable in routine culture, but degrade when exposed to exogenous cellulase. Solutions of CMC-methacrylate and polyethylene glycol dimethacrylate (PEG-DM) were co-crosslinked to form stable hydrogels; we found that greater CMC-methacrylate content resulted in increased gel swelling, protein diffusion and rates of degradation by cellulase, as well as decreased gel shear modulus. CMC-methacrylate/PEG-DM gels modified with the adhesive peptide RGD supported fibroblast adhesion and viability. We conclude that hydrogels based on CMC-methacrylate are suitable for bioengineering applications where selective degradability may be favorable, such as cell scaffolds or controlled release devices.
C1 [Reeves, Robert; Ribeiro, Andreia; Lombardo, Leonard; Boyer, Richard; Leach, Jennie B.] UMBC, Dept Chem & Biochem Engn, Baltimore, MD 21250 USA.
RP Leach, JB (reprint author), UMBC, Dept Chem & Biochem Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.
EM reeves1@umbc.edu; andreia1@umbc.edu; llom1@umbc.edu; richboy1@umbc.edu;
   jleach@umbc.edu
FU UMBC College of Engineering and Information Technology; Henry Luce
   Foundation; Department of Energy [DE-FG09-93ER-20097]
FX This work was funded by the UMBC College of Engineering and Information
   Technology and the Henry Luce Foundation; CMC <SUP>1</SUP>H-NMR analysis
   was carried out at the University of Georgia Complex Carbohydrate
   Research Center, which is supported in part by the Department of
   Energy-funded (DE-FG09-93ER-20097) Center for Plant and Microbial
   Complex Carbohydrates.
CR Barbucci R, 2004, J BIOMAT SCI-POLYM E, V15, P607, DOI 10.1163/156856204323046870
   CARRINO D, 1977, P NATL ACAD SCI USA, V74, P3874, DOI 10.1073/pnas.74.9.3874
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Crank J, 1975, MATH DIFFUSION
   Han JH, 2000, J AGR FOOD CHEM, V48, P5658, DOI 10.1021/jf0002239
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021
   Jeon O., 2010, TISSUE EN A IN PRESS
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Leach RE, 1998, FERTIL STERIL, V69, P415, DOI 10.1016/S0015-0282(97)00573-6
   Lee JH, 2005, J APPL POLYM SCI, V96, P1138, DOI 10.1002/app.21558
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu LS, 2002, J BIOMED MATER RES, V63, P326, DOI 10.1002/jbm.10211
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Narasimhan B., 1999, ENCY CONTROLLED DRUG, P921
   Pal K, 2006, BIOMED MATER, V1, P85, DOI 10.1088/1748-6041/1/2/006
   Rodriguez R, 2003, J CONTROL RELEASE, V86, P253, DOI 10.1016/S0168-3659(02)00410-8
   Siddiqui KS, 1997, FOLIA MICROBIOL, V42, P312, DOI 10.1007/BF02816941
   Tas Cetin, 2003, Farmaco (Lausanne), V58, P605, DOI 10.1016/S0014-827X(03)00080-6
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
NR 24
TC 26
Z9 26
U1 2
U2 24
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD SEP
PY 2010
VL 2
IS 3
BP 252
EP 264
DI 10.3390/polym2030252
PG 13
WC Polymer Science
SC Polymer Science
GA V27GF
UT WOS:000208601000009
PM 22708058
OA DOAJ Gold, Green Accepted
DA 2018-10-19
ER

PT J
AU Kundu, B
   Kundu, SC
AF Kundu, Banani
   Kundu, Subhas C.
TI Osteogenesis of human stem cells in silk biomaterial for regenerative
   therapy
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Silk; Stem cells; Osteogenesis; Bioreactors; Regenerative medicine
ID UMBILICAL-CORD BLOOD; MARROW STROMAL CELLS; BONE MORPHOGENETIC
   PROTEIN-2; COMBINED MAGNETIC-FIELDS; TROPICAL TASAR SILKWORM;
   OSTEOBLAST-LIKE CELLS; POROUS 3-D SCAFFOLDS; HUMAN ADIPOSE-TISSUE;
   GROWTH-FACTOR-BETA; IN-VITRO CULTURE
AB The limitations of therapeutic options such as bone grafting and protein based therapy in the repair of massive bone defects shift interest to stem cell based regenerative medicine. Stem cells are able to perform the dual roles in regenerative medicine of cellular machinery and gene delivery vehicles. However, the discussion of stem cells in this review is narrowed to the current status of genetically unmodified human mesenchymal stem cells in clinical purpose. Nevertheless, the constructs are prepared ex vivo, which lacks the multitude cues of in vivo microenvironments. Scaffolds provide control to the local environment, along with the sustainable release of different growth factors and the delivery of therapeutic proteins. The review focuses the present approaches on fabricating biomimetic extra cellular matrices such as engineered porous scaffolds of silk fibroin protein origin, with appropriate fundamental mechanisms of stem cell regulation to specific lineage under the defined environment of bioreactors by key signaling molecules. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Kundu, Banani; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Banani/O-9320-2016
OI Kundu, Banani/0000-0003-1251-700X; Kundu, Subhas C./0000-0002-7170-2291
FU Indo-Australia Biotechnology Fund; Department of Biotechnology,
   Government of India, Indo-US Science and Technology Forum, New Delhi;
   Department of Science and Technology, New Delhi
FX The work of our laboratory is financially supported by Indo-Australia
   Biotechnology Fund and Department of Biotechnology, Government of India,
   Indo-US Science and Technology Forum, New Delhi and Indo-Russian Joint
   Programme, Department of Science and Technology, New Delhi. We are
   grateful to the Editors for their helpful advice.
CR Aaron RK, 1996, J ORTHOPAED RES, V14, P582, DOI 10.1002/jor.1100140412
   Aaron RK, 2004, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000118698.46535.83
   Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x
   Ahmad R, 2004, DNA CELL BIOL, V23, P149, DOI 10.1089/104454904322964742
   Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Akin FA, 2001, J BIOMED MATER RES, V57, P588, DOI 10.1002/1097-4636(20011215)57:4<588::AID-JBM1206>3.0.CO;2-Y
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Andrades JA, 1999, EXP CELL RES, V250, P485, DOI 10.1006/excr.1999.4528
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592
   ASAKURA T, 1986, MAKROMOL CHEM-RAPID, V7, P755
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Asakura T, 2007, BIOMACROMOLECULES, V8, P175, DOI 10.1021/bm060874z
   AUBIN JE, 2002, PRINCIPLES BONE BIOL, V1, P59
   Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1
   Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   BODEN SD, 1999, CLIN ORTHOP S, V367, P84
   Bolgen N, 2008, TISSUE ENG PT A, V14, P1743, DOI 10.1089/ten.tea.2007.0277
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Cao T, 2005, TISSUE CELL, V37, P325, DOI 10.1016/j.tice.2005.03.008
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chaudhry GR, 2004, J BIOMED BIOTECHNOL, P203, DOI 10.1155/S111072430431003X
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chesnick IE, 2007, BONE, V40, P904, DOI 10.1016/j.bone.2006.10.020
   CHIBA H, 1993, CELL STRUCT FUNCT, V18, P419, DOI 10.1247/csf.18.419
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   Chunqiu Z., 2008, BIOSCI HYPOTHESES, V1, P319, DOI DOI 10.1016/J.BIHY.2008.05.008
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Damoulis PD, 2007, ANN NY ACAD SCI, V1117, P367, DOI 10.1196/annals.1402.038
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003
   Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395
   EGRISE D, 2009, Patent No. 20090081169
   ELGENDY R, 2008, EURO CELLS MAT, V16, P53
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fassina L, 2007, Technol Health Care, V15, P33
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   FITZSIMMONS RJ, 1994, CLIN PLAST SURG, V21, P401
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   FITZSIMMONS RJ, 1995, J BONE MINER RES, V10, P812
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Godara P, 2008, J CHEM TECHNOL BIOT, V83, P408, DOI 10.1002/jctb.1918
   Goodwin HS, 2001, BIOL BLOOD MARROW TR, V7, P581, DOI 10.1053/bbmt.2001.v7.pm11760145
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Heermeier K, 1998, BIOELECTROMAGNETICS, V19, P222, DOI 10.1002/(SICI)1521-186X(1998)19:4<222::AID-BEM4>3.0.CO;2-3
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Holt GE, 2005, J ORTHOP RES, V23, P916, DOI 10.1016/j.orthres.2004.10.005
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Ingber D, 2002, ANN NY ACAD SCI, V961, P162, DOI 10.1111/j.1749-6632.2002.tb03074.x
   INGBER DE, 1994, INT REV CYTOL, V150, P173
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Jagodzinski M, 2004, Eur Cell Mater, V7, P35
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005
   KLEINNULEND J, 1995, FASEB J, V9, P441
   Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670
   Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005
   LI C, 2007, EURO CELLS MAT S1, V14, P76
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li K, 2007, LIFE SCI J, V4, P21
   Li M, 2008, POLYM ADVAN TECHNOL, V19, P207, DOI 10.1002/pat.998
   LIMEM C, 2006, MATER RES SOC S P, V5, P99
   LINDVALL O, 2004, NAT MED, V10, P42
   Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nakazawa Y, 2002, MACROMOLECULES, V35, P2393, DOI 10.1021/ma011999t
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   OCHI IC, 2003, J CELL PHYSL, V194, P45
   Olivier V, 2007, BIOMED MATER, V2, P174, DOI 10.1088/1748-6041/2/3/002
   Ortiz-Gonzalez XR, 2004, CURR NEUROVASC RES, V1, P207, DOI 10.2174/1567202043362342
   Parekkadan B, 2007, TISSUE ENG, V13, P2465, DOI 10.1089/ten.2007.0054
   Park KS, 2006, J VET SCI, V7, P343, DOI 10.4142/jvs.2006.7.4.343
   Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Perillo A, 2004, PANMINERVA MED, V46, P49
   PIENKOWSKI D, 1983, Journal of Orthopaedic Research, V1, P30, DOI 10.1002/jor.1100010105
   POLLACK SR, 1984, J BIOMECH, V17, P627, DOI 10.1016/0021-9290(84)90094-0
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Rollini P, 2004, BLOOD, V103, P1166, DOI 10.1182/blood-2003-06-1815
   Rosenberg N, 2002, CYTOTECHNOLOGY, V39, P125, DOI 10.1023/A:1023925230651
   Rousselle AV, 2002, BONE, V30, P533, DOI 10.1016/S8756-3282(02)00672-5
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711
   Sanmano B, 2005, J DERMATOL SCI, V37, P29, DOI 10.1016/j.jdermsci.2004.10.008
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   Sellke FW, 1998, ANN THORAC SURG, V65, P1540, DOI 10.1016/S0003-4975(98)00340-3
   SHIGRONTHOS S, 2003, J BONE MINER RES, V18, P696
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Skutek M, 2001, EUR J APPL PHYSIOL, V86, P48, DOI 10.1007/s004210100502
   Smalt R., 1997, AM J PHYSIOL, V273, P751
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sottile V, 2003, CLONING STEM CELLS, V5, P149, DOI 10.1089/153623003322234759
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Togel F, 2007, DEV DYNAM, V236, P3321, DOI 10.1002/dvdy.21258
   TOKUTAKE S, 1980, BIOCHEM J, V187, P413, DOI 10.1042/bj1870413
   TSUKADA M, 1988, J POLYM SCI POL PHYS, V26, P949, DOI 10.1002/polb.1988.090260418
   Tuan RS, 2004, CLIN ORTHOP RELAT R, pS105, DOI 10.1097/01.blo.0000143560.41767.ee
   Tzukerman M, 2003, P NATL ACAD SCI USA, V100, P13507, DOI 10.1073/pnas.2235551100
   UEBERSAX L, 2005, EURO CELL MAT, V10, P35
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
   Yamada H., 2001, INT J WILD SILKMOTH, V6, P17
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
   Zhu HB, 2008, VET MED-CZECH, V53, P501
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 177
TC 23
Z9 24
U1 1
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD SEP
PY 2010
VL 35
IS 9
BP 1116
EP 1127
DI 10.1016/j.progpolymsci.2010.04.004
PG 12
WC Polymer Science
SC Polymer Science
GA 657XR
UT WOS:000282453100002
DA 2018-10-19
ER

PT J
AU Sheng, YB
   Wang, W
   Chen, P
AF Sheng, Yuebiao
   Wang, Wei
   Chen, P.
TI Interaction of an ionic complementary peptide with a hydrophobic
   graphite surface
SO PROTEIN SCIENCE
LA English
DT Article
DE ionic complementarity; peptide; adsorption; graphite
ID PROTEIN ADSORPTION; SOLID-SURFACES; CELL ADHESION; GROWTH;
   COMPATIBILITY; SIMULATION; DYNAMICS; BLOOD
AB Protein adsorption on a surface plays an important role in biomaterial science and medicine. It is strongly related to the interaction between the protein residues and the surface. Here we report all-atom molecular dynamics simulations of the adsorption of an ionic complementary peptide, EAK16-II, to the hydrophobic highly ordered pyrolytic graphite surface. We find that, the hydrophobic interaction is the main force to govern the adsorption, and the peptide interchain electrostatic interaction affects the adsorption rate. Under neutral pH condition, the interchain electrostatic attraction facilitates the adsorption, whereas under acidic and basic conditions, because of the protonation and deprotonation of glutamic acid and lysine residues, respectively, the resulting electrostatic repulsion slows down the adsorption. We also found that under basic condition, during the adsorption peptide Chain II will be up against a choice to adsorb to the surface through the hydrophobic interaction or to form a temporary hydrophobic core with the deposited peptide Chain I. These results provide a basis for understanding some of the fundamental interactions governing peptide adsorption on the surface, which can shed new light on novel applications, such as the design of implant devices and drug delivery materials.
C1 [Sheng, Yuebiao; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
   [Sheng, Yuebiao; Wang, Wei] Nanjing Univ, Dept Phys, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China.
   [Sheng, Yuebiao; Wang, Wei] Nanjing Univ, Inst Biophys, Nanjing 210093, Peoples R China.
RP Chen, P (reprint author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
EM p4chen@uwaterloo.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canada Research Chairs (CRC); China Postdoctoral Science Foundation
   (CPSF)
FX Grant sponsors: Natural Sciences and Engineering Research Council of
   Canada (NSERC); Canada Research Chairs (CRC); China Postdoctoral Science
   Foundation (CPSF).
CR ANDRADE JD, 1992, PURE APPL CHEM, V64, P1777, DOI 10.1351/pac199264111777
   BROOKS BR, 1983, J COMPUT CHEM, V4, P217
   Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J
   Crespi VH, 2009, NATURE, V462, P858, DOI 10.1038/462858a
   Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002
   Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Karsai A, 2008, EUR BIOPHYS J BIOPHY, V37, P1133, DOI 10.1007/s00249-007-0253-0
   Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Latour RA, 2008, BIOINTERPHASES, V3, pFC2, DOI 10.1116/1.2965132
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Lu D R, 1990, J Biomater Sci Polym Ed, V1, P243
   Malmsten M, 1998, J COLLOID INTERF SCI, V207, P186, DOI 10.1006/jcis.1998.5763
   Mirny L, 2001, ANNU REV BIOPH BIOM, V30, P361, DOI 10.1146/annurev.biophys.30.1.361
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NOINVILLE V, 1995, J PHYS CHEM-US, V99, P1516, DOI 10.1021/j100005a023
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Patra N, 2009, NANO LETT, V9, P3766, DOI 10.1021/nl9019616
   Prpich AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008281
   Ravichandran S, 2001, J PHYS CHEM B, V105, P3610, DOI 10.1021/jp010223r
   Roth CM, 1998, SURF SCI SERIES, V75, P89
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   Sheng YB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.021915
   Sheng YB, 2010, J PHYS CHEM C, V114, P454, DOI 10.1021/jp908629g
   Toublan FJJ, 2006, J AM CHEM SOC, V128, P3472, DOI 10.1021/ja0544455
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Willett RL, 2005, P NATL ACAD SCI USA, V102, P7817, DOI 10.1073/pnas.0408565102
   WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447
   Wu Xiongwu, 2002, J Am Chem Soc, V124, P5282, DOI 10.1021/ja0257321
   Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013
   Yang H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001325
   Yang H, 2007, J AM CHEM SOC, V129, P12200, DOI 10.1021/ja073168u
NR 39
TC 21
Z9 22
U1 0
U2 39
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD SEP
PY 2010
VL 19
IS 9
BP 1639
EP 1648
DI 10.1002/pro.444
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 646SL
UT WOS:000281563000004
PM 20572020
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Kim, MK
   Baik, J
   Jeon, C
   Song, I
   Nam, JH
   Hwang, HN
   Hwang, CC
   Woo, SH
   Park, CY
   Ahn, JR
AF Kim, M. K.
   Baik, J.
   Jeon, C.
   Song, I.
   Nam, J. H.
   Hwang, H. -N.
   Hwang, C. C.
   Woo, S. H.
   Park, C. -Y.
   Ahn, J. R.
TI Biological functionalization of the amine-terminated Si(100) surface by
   glycine
SO SURFACE SCIENCE
LA English
DT Article
DE Glycine; Amino acid; Photoemission; Silicon
ID RAY PHOTOELECTRON-SPECTROSCOPY; ADSORPTION STRUCTURE; PEPTIDES; BINDING;
   ACIDS; INTERFACES; NH3; XPS
AB A peptide reaction of glycine on an amine-terminated Si(100) surface was investigated using C 1s, N 1s, O 1s, and Si 2p core-level spectroscopy, where the amine-terminated Si(100) surface was prepared using NH(3). In-situ thermal treatments at a mild temperature of 50 degrees C after the adsorption of glycine on a room-temperature amine-terminated Si(100) surface induced the peptide reaction between the carboxyl group of glycine and the amine group of the surface. This suggests that the amine-terminated Si(100) surface can be an excellent template for constructing a junction between a biomaterial and a Si surface using a dry process. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kim, M. K.; Jeon, C.; Song, I.; Nam, J. H.; Park, C. -Y.; Ahn, J. R.] Sungkyunkwan Univ, Phys Res Div BK21, Suwon 440746, South Korea.
   [Baik, J.; Hwang, H. -N.; Hwang, C. C.] Pohang Accelerator Lab, Beamline Res Div, Pohang 790784, Kyungbuk, South Korea.
   [Woo, S. H.] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea.
   [Park, C. -Y.] Sungkyunkwan Univ, Dept Energy Sci, Suwon 440746, South Korea.
   [Ahn, J. R.] Sungkyunkwan Univ, SKKU Adv Inst Technol SAINT, Suwon 440746, South Korea.
RP Park, CY (reprint author), Sungkyunkwan Univ, Phys Res Div BK21, 300 Cheoncheon Dong, Suwon 440746, South Korea.
EM cypark@skku.edu; jrahn@skku.ed
RI Jeon, Cheolho/A-2876-2012
OI Jeon, Cheolho/0000-0001-7236-133X
FU Korea government (MEST) [2009-0080512]; National Research Foundation of
   Korea (NRF) [20090094026]; Ministry of Education, Science and Technology
   [R31-2008-000-10029-0]; Converging Research Center Program
   [2009-0081966]
FX This study was supported by the Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korea government (MEST) (No. 2009-0080512)
   and Priority Research Centers Program through the National Research
   Foundation of Korea (NRF) (20090094026) and World Class University (WCU)
   program (R31-2008-000-10029-0) through the National Research Foundation
   of Korea (NRF) funded by the Ministry of Education, Science and
   Technology and the Converging Research Center Program (2009-0081966).
CR BOLAND JJ, 1990, PHYS REV LETT, V65, P3325, DOI 10.1103/PhysRevLett.65.3325
   BOZSO F, 1986, PHYS REV LETT, V57, P1185, DOI 10.1103/PhysRevLett.57.1185
   Campbell M.K., 2006, BIOCHEMISTRY
   Cho Y, 2006, LANGMUIR, V22, P8670, DOI 10.1021/la060492e
   CLARK DT, 1976, BIOCHIM BIOPHYS ACTA, V453, P533, DOI 10.1016/0005-2795(76)90149-5
   DIETRICH C, 1995, P NATL ACAD SCI USA, V92, P9014, DOI 10.1073/pnas.92.20.9014
   Filler MA, 2006, J AM CHEM SOC, V128, P770, DOI 10.1021/ja0549502
   Huang JY, 2007, LANGMUIR, V23, P6218, DOI 10.1021/la700305b
   Hwang HN, 2004, J PHYS CHEM B, V108, P8379, DOI 10.1021/jp0498769
   Jedlicka SS, 2007, J PHYS CHEM B, V111, P11850, DOI 10.1021/jp0744230
   Kim JW, 2003, SURF SCI, V546, pL820, DOI 10.1016/j.susc.2003.09.024
   Lasseter TL, 2004, J AM CHEM SOC, V126, P10220, DOI 10.1021/ja047642x
   Lerotholi TJ, 2009, SURF SCI, V603, P2305, DOI 10.1016/j.susc.2009.05.009
   Lin Z, 2002, LANGMUIR, V18, P788, DOI 10.1021/la010892w
   Lofgren P, 1997, SURF SCI, V370, P277, DOI 10.1016/S0039-6028(96)00961-2
   Petrovykh DY, 2003, J AM CHEM SOC, V125, P5219, DOI 10.1021/ja029450c
   Plekan O, 2007, J PHYS CHEM A, V111, P10998, DOI 10.1021/jp075384v
   PRABHAKARAN K, 1993, SURF SCI, V290, P239, DOI 10.1016/0039-6028(93)90707-Q
   SLAUGHTER AR, 1988, J PHYS CHEM-US, V92, P2165, DOI 10.1021/j100319a017
   Stutzmann M, 2006, PHYS STATUS SOLIDI A, V203, P3424, DOI 10.1002/pssa.200622512
   Wampler HP, 2008, LANGMUIR, V24, P3164, DOI [10.1021/la703543g, 10.1021/1a703543g]
   Whaley SR, 2000, NATURE, V405, P665
   WU CR, 1987, PHYS SCRIPTA, V35, P586, DOI 10.1088/0031-8949/35/4/034
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
   Youn YS, 2009, LANGMUIR, V25, P7438, DOI 10.1021/la9003565
   Zhang L, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3106762
   Zhao XY, 2006, SURF SCI, V600, P2113, DOI 10.1016/j.susc.2006.02.043
NR 27
TC 6
Z9 6
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD SEP
PY 2010
VL 604
IS 19-20
BP 1598
EP 1602
DI 10.1016/j.susc.2010.05.031
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 652HB
UT WOS:000281993200010
DA 2018-10-19
ER

PT J
AU Kim, DB
   Gweon, B
   Moon, SY
   Choe, W
AF Kim, Dan Bee
   Gweon, B.
   Moon, S. Y.
   Choe, W.
TI Surface treatment comparison using atmospheric helium plasma jets with
   different frequencies and target objects
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Microelectronics and Plasma Technology
CY 2009
CL Int Organizing Comm, Korean Vacuum Soc, SOUTH KOREA
SP Sungkyunkwan Univ, Ctr Adv Plasma Surface Technol, Kookmin Univ, Ctr Materials & Proc Self-Assembly, Hanyang Univ, Quantum Photonic Sci Res Ctr, Kwangwoon Univ, PDP Res Ctr, Jeju Natl Univ, Res Inst Basic Sci, Korean Phys Soc, Korean Information Display Soc, Korean Federation Sci & Technol Soc, Mat Res Soc of Korea, Electrochem Soc of Japan
HO Int Organizing Comm, Korean Vacuum Soc
DE Atmospheric pressure plasma; Corona; Frequency; Surface treatment
ID GLOW-DISCHARGE PLASMA; ESCHERICHIA-COLI; PRESSURE; DEACTIVATION;
   MICROPLASMAS; NEEDLE; MODEL
AB This paper details a plasma surface treatment feasibility study conducted for different driving frequencies of low frequency (LF, 50 kHz) and radio-frequency (RF, 13.56 MHz) sources by adding a target plate to a single pin electrode plasma jet system. The plasmas were generated in ambient air with a helium gas supply. The electrical characteristics of the plasmas were studied and compared for cases with and without a plane electrode. The LF plasma was more affected by the presence of the dielectric plate than was the RF plasma, showing a larger increase in its current. In addition, pork samples were treated to assess the electrical and thermal safety of plasma biomaterial surface treatments. The LF plasma conduction current and temperature during the pork treatment were 0.5 mA and 22 degrees C, and those of the RF plasma were 40 mA and 31 degrees C at maximum. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kim, Dan Bee; Gweon, B.; Moon, S. Y.; Choe, W.] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea.
RP Choe, W (reprint author), Korea Adv Inst Sci & Technol, Dept Phys, 335 Gwahangno, Taejon 305701, South Korea.
EM wchoe@kaist.ac.kr
RI Choe, Wonho/C-1556-2011
OI Choe, Wonho/0000-0002-8952-8252
CR Becker KH, 2006, J PHYS D APPL PHYS, V39, pR55, DOI 10.1088/0022-3727/39/3/R01
   Franzke J, 2003, J ANAL ATOM SPECTROM, V18, P802, DOI 10.1039/b300193h
   Gweon B, 2009, CURR APPL PHYS, V9, P625, DOI 10.1016/j.cap.2008.06.001
   Kelly-Wintenberg K, 1999, J VAC SCI TECHNOL A, V17, P1539, DOI 10.1116/1.581849
   Kim DB, 2007, THIN SOLID FILMS, V515, P4913, DOI 10.1016/j.tsf.2006.10.069
   Kim SJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114407
   Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385
   Kunhardt EE, 2000, IEEE T PLASMA SCI, V28, P189, DOI 10.1109/27.842901
   Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179
   Meyer W, 1996, HAUTARZT, V47, P178, DOI 10.1007/s001050050399
   Moon SY, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3002397
   Moon SY, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3043451
   Moon SY, 2004, APPL PHYS LETT, V84, P188, DOI 10.1063/1.1639135
   Moon SY, 2003, SPECTROCHIM ACTA B, V58, P249, DOI 10.1016/S0584-8547(02)00259-8
   Moon SY, 2002, PHYS PLASMAS, V9, P4045, DOI 10.1063/1.1495872
   Moon SY, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2177590
   Nave C., 1985, PHYS HLTH SCI
   Park J, 2001, J APPL PHYS, V89, P20, DOI 10.1063/1.1323753
   SABOUNI A, 2006, IFMBE P, V3, P148
   Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223
   Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012
   Stoffels E, 2003, J PHYS D APPL PHYS, V36, P2908, DOI 10.1088/0022-3727/36/23/007
   Yang Y, 2002, IND ENG CHEM RES, V41, P5918, DOI 10.1021/ie02023220
   Yonson S, 2006, J PHYS D APPL PHYS, V39, P3508, DOI 10.1088/0022-3727/39/16/S08
NR 24
TC 6
Z9 7
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD SEP 1
PY 2010
VL 518
IS 22
SI SI
BP 6700
EP 6703
DI 10.1016/j.tsf.2010.02.069
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 655II
UT WOS:000282242600122
DA 2018-10-19
ER

PT J
AU Li, WM
   Lee, M
   Whang, J
   Siu, RK
   Zhang, XL
   Liu, C
   Wu, BM
   Wang, JC
   Ting, K
   Soo, C
AF Li, Weiming
   Lee, Min
   Whang, Julie
   Siu, Ronald K.
   Zhang, Xinli
   Liu, Chen
   Wu, Benjamin M.
   Wang, Jeffrey C.
   Ting, Kang
   Soo, Chia
TI Delivery of Lyophilized Nell-1 in a Rat Spinal Fusion Model
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CRANIOSYNOSTOSIS-ASSOCIATED GENE; BONE-GRAFT MATERIALS; EGF-LIKE
   REPEATS; EXTRACELLULAR-MATRIX; CERVICAL-SPINE; SITE MORBIDITY;
   STEM-CELLS; IN-VITRO; PROTEIN; ANTERIOR
AB Nell-1 (Nel-like molecule-1; Nel: protein strongly expressed in neural tissue containing epidermal growth factor-like domain) is a promising osteoblast-specific growth factor for osteoinductive therapies that may circumvent adverse effects, such as nonspecific function and ectopic bone formation, associated with more established osteogenic growth factors such as bone morphogenetic proteins. Beta-tricalcium phosphate (beta-TCP), an osteoconductive, biodegradable ceramic biomaterial, has been used successfully to deliver osteoinducers for bone regeneration. The aim of this study was to develop a carrier system for efficiently delivering biologically active Nell-1 protein. After a 40% initial burst release, beta-TCP particles retained the majority of adsorbed Nell-1 protein in vitro. To test this system in vivo, L4/L5 spinal fusion was performed in three groups of rats (n=8 each): (1) 5 mu g Nell-1 in beta-TCP/demineralized bone matrix putty (DBX); (2) 2.5 mu g Nell-1 in beta-TCP/DBX; (3) beta-TCP/DBX only. Fusion was assessed by radiography, palpation, microcomputed tomography, and histological analysis. After 4 weeks, 75% of Nell-1-treated animals exhibited fusion, with a significant increase in new bone volume, whereas only 25% of Nell-free control animals exhibited fusion. Our findings suggest that beta-TCP/DBX can increase both the biochemical stability and biological efficiency of Nell-1 protein.
C1 [Wang, Jeffrey C.; Soo, Chia] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.
   [Siu, Ronald K.; Wu, Benjamin M.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   [Lee, Min; Wu, Benjamin M.] Univ Calif Los Angeles, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90095 USA.
   [Li, Weiming] Harbin Med Coll, Clin Hosp 1, Dept Orthopaed, Harbin, Peoples R China.
   [Li, Weiming; Whang, Julie; Siu, Ronald K.; Zhang, Xinli; Liu, Chen; Ting, Kang] Univ Calif Los Angeles, Dent & Craniofacial Res Inst, Los Angeles, CA 90095 USA.
RP Soo, C (reprint author), Univ Calif Los Angeles, Dept Orthopaed Surg, 675 Charles E Young Dr S,Room 2641A MRL, Los Angeles, CA 90095 USA.
EM bsoo@ucla.edu
FU NIH/NIDCR [R21 DE0177711-01, DE01607-01]; U.S. Army USAMRAA [07128099];
   UC [Bio07-10677]; MTF [20082668]
FX The authors would like to thank the Translational Pathology Core
   Laboratory and Surgical Pathology divisions of the UCLA Department of
   Pathology and Laboratory Medicine for technical assistance with
   histology, and the MTF and Arthur Gertzman for the donation of DBX and
   advice on its use. This work was supported by NIH/NIDCR (grants R21
   DE0177711-01 and DE01607-01), U.S. Army USAMRAA Log Number 07128099, UC
   Discovery Grant Bio07-10677, and MTF grant 20082668.
CR Aghaloo T, 2007, MOL THER, V15, P1872, DOI 10.1038/sj.mt.6300270
   Aghaloo T, 2006, AM J PATHOL, V169, P903, DOI 10.2353/ajpath.2006.051210
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Bauer TW, 2007, ARCH PATHOL LAB MED, V131, P217
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Beaman FD, 2006, RADIOL CLIN N AM, V44, P451, DOI 10.1016/j.rcl.2006.01.001
   Benglis D., 2008, NEUROSURGERY, V62
   Benglis D, 2008, NEUROSURGERY, V62, DOI DOI 10.1227/01.NEU.0000326030.24220.D8
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   BROWN TJ, 1991, EXP PHYSIOL, V76, P125, DOI 10.1113/expphysiol.1991.sp003474
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381
   Hecht BP, 1999, SPINE, V24, P629, DOI 10.1097/00007632-199904010-00004
   Hsu WK, 2008, J BONE JOINT SURG AM, V90A, P1043, DOI 10.2106/JBJS.G.00292
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638
   Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P752, DOI 10.1006/bbrc.1999.1753
   Lee JY, 2004, PHARM RES, V21, P1790, DOI 10.1023/B:PHAM.0000045230.14287.73
   Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lind M, 2001, BIOMATERIALS, V22, P189, DOI 10.1016/S0142-9612(00)00165-4
   Lu SS, 2007, SPINE J, V7, P50, DOI 10.1016/j.spinee.2006.04.020
   MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894
   MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209
   Miyazaki M, 2008, SPINE, V33, P863, DOI 10.1097/BRS.0b013e31816b45c3
   Miyazaki M, 2009, SPINE J, V9, P22, DOI 10.1016/j.spinee.2008.08.009
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   Nedergaard H, 2008, CLIN THER, V30, P1309, DOI 10.1016/j.clinthera.2008.07.015
   Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Oudshoorn MHM, 2007, POLYMER, V48, P1915, DOI 10.1016/j.polymer.2007.01.068
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   SANFILIPPO JA, 2007, SPINE J, V7, pS5
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Sohier J, 2010, J BIOMED MATER RES A, V92A, P1105, DOI 10.1002/jbm.a.32467
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80
   Truong T, 2007, J BONE MINER RES, V22, P7, DOI 10.1359/JBMR.061012
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wang JC, 2003, J BONE JOINT SURG AM, V85A, P905, DOI 10.2106/00004623-200305000-00020
   Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
   Zhang X, 2007, J BONE MINER RES, V22, pS31
   Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375
   Zhang XL, 2003, J BONE MINER RES, V18, P2126, DOI 10.1359/jbmr.2003.18.12.2126
   ZOMA A, 1987, J BONE JOINT SURG BR, V69, P8
NR 57
TC 39
Z9 43
U1 0
U2 7
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2010
VL 16
IS 9
BP 2861
EP 2870
DI 10.1089/ten.tea.2009.0550
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 643IJ
UT WOS:000281288500014
PM 20528102
OA Green Published
DA 2018-10-19
ER

PT J
AU Jeon, O
   Powell, C
   Ahmed, SM
   Alsberg, E
AF Jeon, Oju
   Powell, Caitlin
   Ahmed, Shaoly M.
   Alsberg, Eben
TI Biodegradable, Photocrosslinked Alginate Hydrogels with Independently
   Tailorable Physical Properties and Cell Adhesivity
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TISSUE-ENGINEERING SCAFFOLDS; HUMAN CHONDROCYTES; CARTILAGE; RGD;
   PEPTIDES; PROTEIN; GROWTH; DIFFERENTIATION; APOPTOSIS; CULTURE
AB Biocompatible polymers capable of photopolymerization are of immense interest for tissue engineering applications as they can be injected in a minimally invasive manner into a defect site and, then upon application of ultraviolet light, rapidly form hydrogels in situ. Cell adhesion interactions with a biomaterial are known to be important in regulating cell behaviors such as proliferation and differentiation. Therefore, we have covalently modified photocrosslinkable alginate with cell adhesion ligands containing the Arg-Gly-Asp amino acid sequence to form biodegradable, photocrosslinked alginate hydrogels with controlled cell adhesivity. This unique polymer system allows for independent modulation of the physical and biochemical signaling environment presented to cells. The physical properties of the hydrogels such as elastic moduli, swelling ratios, and degradation profiles were similar at the same crosslinking density regardless of the presence of adhesion ligands. Chondrocytes seeded on the surface of the adhesion ligand-modified hydrogels were able to attach and spread, whereas those seeded on unmodified hydrogels exhibited minimal adherence. Importantly, the adhesion-ligand-modified hydrogels enhanced the proliferation and chondrogenic differentiated function of encapsulated chondrocytes as demonstrated by increased DNA content and production of glycosaminoglycans compared to unmodified control hydrogels. This new photocrosslinkable, biodegradable biomaterial system in which the soluble (e.g., growth factors) and insoluble (e.g., cell adhesion ligands) biochemical signaling environment and the biomaterial physical properties (e.g., the elastic moduli) can be independently controlled may be a powerful tool for elucidating the individual and combined effects of these parameters on cell function for cartilage tissue engineering and other regenerative medicine applications.
C1 [Jeon, Oju; Powell, Caitlin; Ahmed, Shaoly M.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Jeon, Oju/K-7227-2018
OI Jeon, Oju/0000-0003-3972-9272; Alsberg, Eben/0000-0002-3487-4625
FU Ellison Medical Foundation; Muskuloskeletal Transplant Foundation; Ohio
   Department of Development [08-081]
FX The authors thank Rachel Manthe for technical assistance and acknowledge
   funding support from a New Scholar in Aging Award from the Ellison
   Medical Foundation, the Muskuloskeletal Transplant Foundation, and
   Biomedical Research and Technology Transfer Grant 08-081 from the Ohio
   Department of Development.
CR Akdemir ZS, 2008, MACROMOL BIOSCI, V8, P852, DOI 10.1002/mabi.200700319
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023
   Bryant SJ, 2008, PHARM RES-DORDR, V25, P2379, DOI 10.1007/s11095-008-9619-y
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cao L, 1999, MATRIX BIOL, V18, P343, DOI 10.1016/S0945-053X(99)00027-X
   Chiang HS, 2005, J ORTHOP RES, V23, P584, DOI 10.1016/j.orthres.2004.11.003
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   Goldberg AJ, 2005, J BONE JOINT SURG BR, V87B, P128, DOI 10.1302/0301-620X.87B1.14154
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hsiong SX, 2008, J BIOMED MATER RES A, V85A, P145, DOI 10.1002/jbm.a.31521
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Mayo KH, 1996, BBA-PROTEIN STRUCT M, V1296, P95, DOI 10.1016/0167-4838(96)00057-X
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Park KM, 2008, MACROMOL RES, V16, P517, DOI 10.1007/BF03218553
   PIERSCHBACHER MD, 1982, J BIOL CHEM, V257, P9593
   Poon YF, 2009, BIOMACROMOLECULES, V10, P2043, DOI 10.1021/bm801367n
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200
   Svoboda KKH, 1998, MICROSC RES TECHNIQ, V43, P111, DOI 10.1002/(SICI)1097-0029(19981015)43:2<111::AID-JEMT4>3.0.CO;2-O
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
NR 39
TC 49
Z9 50
U1 3
U2 32
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2010
VL 16
IS 9
BP 2915
EP 2925
DI 10.1089/ten.tea.2010.0096
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 643IJ
UT WOS:000281288500019
PM 20486798
DA 2018-10-19
ER

PT J
AU Neumann, M
   Wagner, S
   Noske, R
   Tiersch, B
   Strauch, P
AF Neumann, Mike
   Wagner, Sandra
   Noske, Robert
   Tiersch, Brigitte
   Strauch, Peter
TI Morphology and Structure of Biomorphous Silica Isolated from Equisetum
   hyemale and Equisetum telmateia
SO ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES
LA English
DT Article
DE Equisetum hyemale; Equisetum telmateia; Horsetail; Biomorphous; Silica;
   Silicon Dioxide
AB The family of horsetails (Equisetaceae) is characterized through their high content of silica (SiO2) which is the highest in known vascular plants This work has focussed on two species of this family Equisetum hyemale and Equisetum telmateia where the biomorphous silica is deposited basically as amorphous SiO2 in the outer epidermis of the plants As source of SiO2 the original plant material was air-dried and carved or powdered For the isolation process the biomaterial was pre-treated with aceotropic HCl This pre treatment has the advantage of the extraction of high amounts of the natural inorganic matrix In a second step the organic matrix was removed by a thermal oxidative process in the temperature range of 275 1200 degrees C to isolate the biogenic silicon dioxide from the perennial plant Parameters of time, temperature and the thermal gradient were varied to optimize the process and to get products with the highest possible surface area Furthermore the particle morphology of the biogenic SiO2 horn leaves and stems was examined separately The silica deposits were characterized by optical microscopy scanning electron microscopy infrared spectroscopy gravimetry nitrogen sorption analysis, and sedimentation analysis
C1 [Neumann, Mike; Wagner, Sandra; Noske, Robert; Tiersch, Brigitte; Strauch, Peter] Univ Potsdam, Inst Chem, D-14476 Potsdam, Germany.
RP Strauch, P (reprint author), Univ Potsdam, Inst Chem, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany.
CR ASHOKAN R, 1990, PHYS STATUS SOLIDI A, V121, P533, DOI 10.1002/pssa.2211210223
   BODE E, 1994, DEUT TIERARZTL WOCH, V101, P367
   BRUNNAUER P, 1938, J AM CHEM SOC, V960, P309
   DARTNOFF LE, 1992, PLANT DIS, V76, P1011
   EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11
   Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641
   JUNKER R, 2000, SAMENFARNE BARLAPPBA, P103
   Krassig H. A., 1993, CELLULOSE STRUCTURE, P215
   LEWIN J, 1969, ANN REV PLANT PHYSIO, V20, P289, DOI 10.1146/annurev.pp.20.060169.001445
   Ma J. F., 2002, SOIL FERTILIZER PLAN, P1
   MENGEL K, 2001, PRINCIPLES PLANT NUT, P643
   MEUSEL W, 1971, SCHACHTEL HALME EURO, P5
   Morikawa CK, 2004, PLANT SOIL, V258, P1, DOI 10.1023/B:PLSO.0000016489.69114.55
   Nakamoto K., 1997, INFRARED RAMAN SPECT, P1
   PASTUSIAK R, 2003, THESIS TU MUNICH MUN, P21
   Real C, 1996, J AM CERAM SOC, V79, P2012, DOI 10.1111/j.1151-2916.1996.tb08931.x
   Sandermann W., 1963, EUR J WOOD PROD, V21, P256
   SANGSTER AG, 1986, CIBA F SYMP, V121, P90
   SAPEI L, 2007, ANAL BIOANAL CHEM, V289, P1249
   Sapei L, 2008, CHEM MATER, V20, P2020, DOI 10.1021/cm702991f
   SEMKE H, 2001, THESIS A LUDWIGS U F, P7
   TROUILLET V, 2000, 6468 FZKA
   VORONKOV MG, 1975, SILICIUM LEBEN, P56
   WEYMAR H, 1958, BUCH FARNE BARLAPPE, P40
   YOSHIDA SHOICHI, 1965, BULL NAT INST AGR SCI SER B [JAP], V15, P1
NR 25
TC 3
Z9 3
U1 1
U2 8
PU VERLAG Z NATURFORSCH
PI TUBINGEN
PA POSTFACH 2645, 72016 TUBINGEN, GERMANY
SN 0932-0776
J9 Z NATURFORSCH B
JI Z.Naturforsch.(B)
PD SEP
PY 2010
VL 65
IS 9
BP 1113
EP 1120
PG 8
WC Chemistry, Inorganic & Nuclear; Chemistry, Organic
SC Chemistry
GA 681GX
UT WOS:000284300500010
DA 2018-10-19
ER

PT J
AU Fang, P
   Gao, Q
   Liu, WJ
   Qi, XX
   Li, GB
   Zhang, J
   Li, ZH
   Sun, JL
   Sun, JH
   Gao, YM
AF Fang, Peng
   Gao, Qing
   Liu, Wen-jing
   Qi, Xiao-xia
   Li, Gui-bao
   Zhang, Jing
   Li, Zhen-hua
   Sun, Jin-long
   Sun, Jin-hao
   Gao, Ying-mao
TI Survival and Differentiation of Neuroepithelial Stem Cells on Chitosan
   Bicomponent Fibers
SO CHINESE JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE neuroepithelial stem cells; biocompatibility; differentiation; chitosan
   fiber
ID PERIPHERAL-NERVE REGENERATION; SPINAL-CORD-INJURY; SCHWANN-CELLS;
   TISSUE; SCAFFOLD; REPAIR; CONDUITS; CULTURES; THERAPY
AB Chitosan is a popular biomaterial used in tissue engineering. Fibers of chitosan could provide a favorable anatomical substrate for cell growth which provides a promising application for axonal regeneration during peripheral injury. Neuroepithelial stem cells (NEPs) are the most primitive neural stem cells with multipotential for neuronal and glia differentiation. To assess the biocompatibility between NEPs and chitosan fibers, and to explore whether the NEPs have the ability to differentiation on chitosan fibers, NEPs were harvested from the neural tube and seeded on chitosan fibers in in vitro culture. The biocompatibility of chitosan fibers was tested by MTT assays. The growth and survival were observed by light and scanning electronic microscope at different times in culture. And, the differentiation of NEPs was examined by immunocytochemical staining. The results indicated that NEPs could grow on the chitosan fibers and attach firmly to the surface of fibers. On chitosan fibers, NEPs could differentiate into neurons and glia. Our study demonstrated that chitasan fibers had a good biocompatibility with NEPs which affords a potential alternative for the repair of peripheral nerve injury.
C1 [Gao, Ying-mao] Shandong Univ, Sch Med, Key Lab, Dept Histol & Embryol,Minist Educ Expt Teratol, Jinan 250012, Shandong, Peoples R China.
   [Fang, Peng; Liu, Wen-jing; Qi, Xiao-xia; Li, Gui-bao; Zhang, Jing; Li, Zhen-hua; Sun, Jin-long; Sun, Jin-hao] Shandong Univ, Sch Med, Key Lab, Dept Anat,Minist Educ Expt Teratol, Jinan 250012, Shandong, Peoples R China.
RP Gao, YM (reprint author), Shandong Univ, Sch Med, Key Lab, Dept Histol & Embryol,Minist Educ Expt Teratol, Jinan 250012, Shandong, Peoples R China.
EM sunjinhao@sdu.edu.cn
FU Shandong Provincial Natural Science Foundation [Y2007C003]; National
   Natural Science Foundation [30870839]; Shandong Province [2006BS03017]
FX This work was supported by a grant of Shandong Provincial Natural
   Science Foundation (No. Y2007C003), a grant of the National Natural
   Science Foundation (No. 30870839), and a grant of the excellent Young
   Scholar Project from Shandong Province (No. 2006BS03017). The authors
   thank Dr. Jing Zhang for her excellent technique in immuostaining.
CR Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P791, DOI 10.1163/1568562053992496
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Kemp SWP, 2008, NEUROL RES, V30, P1030, DOI 10.1179/174313208X362505
   Kim JH, 2008, BIOMATERIALS, V29, P1920, DOI 10.1016/j.biomaterials.2007.12.038
   Kingham PJ, 2006, J ANAT, V209, P511, DOI 10.1111/j.1469-7580.2006.00623.x
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Machado CB, 2007, BIOMED MATER, V2, P124, DOI 10.1088/1748-6041/2/2/010
   Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   Risbud M, 2000, Cell Transplant, V9, P25
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Skotak M, 2008, BIOMACROMOLECULES, V9, P1902, DOI 10.1021/bm800158c
   Sun JH, 2007, NEUROREPORT, V18, P543, DOI 10.1097/WNR.0b013e3280b07bf4
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Uchida K, 2005, NEUROSCI RES, V52, P276, DOI 10.1016/j.neures.2005.03.015
   Uchida K, 1999, CELL MOL NEUROBIOL, V19, P79, DOI 10.1023/A:1006916624755
   Xu XM, 2008, J BIOMED MATER RES A, V84A, P1038, DOI 10.1002/jbm.a.31479
   Yamada M, 2004, CELL TRANSPLANT, V13, P421, DOI 10.3727/000000004783983783
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
NR 24
TC 7
Z9 7
U1 0
U2 5
PU CHINESE PHYSIOLOGICAL SOC
PI TAIPEI
PA NATL YANG-MING UNIV, TAIPEI, TAIWAN
SN 0304-4920
J9 CHINESE J PHYSIOL
JI Chin. J. Physiol.
PD AUG 31
PY 2010
VL 53
IS 4
BP 208
EP 214
DI 10.4077/CJP.2010.AMK047
PG 7
WC Physiology
SC Physiology
GA 641LA
UT WOS:000281126000002
PM 21793330
DA 2018-10-19
ER

PT J
AU Sun, JH
   Zheng, QX
   Wu, YC
   Liu, YD
   Guo, XD
   Wu, WG
AF Sun, Jianhua
   Zheng, Qixin
   Wu, Yongchao
   Liu, Yudong
   Guo, Xiaodong
   Wu, Weigang
TI Culture of nucleus pulposus cells from intervertebral disc on
   self-assembling KLD-12 peptide hydrogel scaffold
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Peptide; Self-assembly; Biological scaffolds; Three-dimensional cell
   culture; Intervertebral disc
ID ANNULUS FIBROSUS CELLS; IN-VITRO; COMPLEMENTARY OLIGOPEPTIDE;
   HYDROSTATIC-PRESSURE; DEGENERATION; MATRIX; THERAPY; PHENOTYPE;
   MEMBRANE; SYSTEM
AB KLD-12 peptide is a new self-assembling biomaterial and it has been used as cell scaffold for cartilage repair. In this study, self-assembled KLD-12 peptide nanofiber was fabricated and the biocompatibility of this scaffold for nucleus pulposus (NP) cells was evaluated. The structure of this scaffold was characterized by atomic force microscopy (AFM). This hydrogel was structurally integral and homogeneous. KLD-12 peptide was able to self-assemble into nanofibers with a diameter of 10-30 nm (mean: 13.7 +/- 4.7 nm) and a length of hundreds of nanometers. Two-week culture of rabbits NP cells in this scaffold showed that the self-assembled hydrogel maintained the live cell number by 93% and the cell viability increased gradually with the culture time. The expression of type II collagen mRNA was further confirmed by reverse transcription polymerase chain reaction (RT-PCR). The expression of type II collagen was high in the hydrogel, however, type I collagen expression was observed in few cells. Furthermore, GAG content increased gradually accompanied with the extension of culture time. In conclusion, this self-assembled nanofiber scaffold provided a conducive microenvironment for NP cell to survive and proliferate in vitro. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.
C1 [Sun, Jianhua; Zheng, Qixin; Wu, Yongchao; Liu, Yudong; Guo, Xiaodong; Wu, Weigang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
   [Sun, Jianhua] Shihezi Univ, Affiliated Hosp 1, Dept Orthoped, Xinjiang 832008, Peoples R China.
RP Zheng, QX (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
EM zheng-qx@163.com
RI guo, xiaodong/K-2600-2013
FU National High Technology Research and Development Program of China
   [2006AA02A124]
FX This study was sponsored by a grant from the "863" Key Project of the
   National High Technology Research and Development Program of China
   (Grant No. 2006AA02A124).
CR Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Anderson DG, 2005, SPINE, V30, pS14, DOI 10.1097/01.brs.0000175174.50235.ba
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Chiba K, 1998, SPINE, V23, P1821, DOI 10.1097/00007632-199809010-00002
   COVENTRY MB, 1945, J BONE JOINT SURG, V27, P233
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gan JC, 2003, CLIN ORTHOP RELAT R, P305, DOI 10.1097/01.blo.0000063796.98363.9a
   Gan JC, 2000, J BIOMED MATER RES, V51, P596, DOI 10.1002/1097-4636(20000915)51:4<596::AID-JBM7>3.0.CO;2-O
   Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001
   Gruber HE, 2003, EXPERT OPIN BIOL TH, V3, P1209, DOI 10.1517/eobt.3.8.1209.21290
   Gruber HE, 2003, BIOTECH HISTOCHEM, V78, P109, DOI 10.1080/10520290310001593793
   Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/01.BRS.0000018788.88555.21
   Hohaus C, 2008, EUR SPINE J, V17, pS492, DOI 10.1007/s00586-008-0750-6
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Jullig M, 2004, ANZ J SURG, V74, P46, DOI 10.1046/j.1445-1433.2003.documendoc.doc.x
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   LEHMANN TR, 1987, SPINE, V12, P97, DOI 10.1097/00007632-198703000-00004
   Leung VYL, 2006, EUR SPINE J, V15, pS406, DOI 10.1007/s00586-006-0183-z
   Neidlinger-Wilke C, 2005, J NEUROSURG-SPINE, V2, P457, DOI 10.3171/spi.2005.2.4.0457
   Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3
   Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765
   Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   SAKAI J, 2005, EUR CELLS MATER, V10, P43
   Sato M, 2003, SPINE, V28, P548, DOI 10.1097/00007632-200303150-00007
   Sato M, 2003, MED BIOL ENG COMPUT, V41, P365, DOI 10.1007/BF02348444
   Sato M, 2003, J BIOMED MATER RES A, V64A, P249
   SEBASTINE M, 2007, C P IEEE ENG MED BIO, P6401
   SUN J, 2009, MED SCI, V29, P645
   Thonar E, 2002, BIOCHEM SOC T, V30, P874, DOI 10.1042/bst0300874
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 34
TC 12
Z9 17
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 30
PY 2010
VL 30
IS 7
BP 975
EP 980
DI 10.1016/j.msec.2010.04.018
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 632UK
UT WOS:000280454200007
DA 2018-10-19
ER

PT J
AU Wu, GL
   Zeng, SJ
   Ou, EC
   Yu, PR
   Lu, YB
   Xu, WJ
AF Wu, Guoliang
   Zeng, Songjun
   Ou, Encai
   Yu, Puren
   Lu, Yanbing
   Xu, Weijian
TI Photoinitiator grafted styrene-butadiene-styrene triblock copolymer
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE SBS; 4-Maleimidobenzophenone; Grafting; Medical pressure-sensitive
   adhesive; Biomaterial
ID PHOTO-CROSS-LINKING; BIOMEDICAL APPLICATIONS; FUNCTIONALIZED RUBBERS;
   MECHANICAL-PROPERTIES; BLOCK-COPOLYMERS; ACRYLIC-ACID;
   PHOTOPOLYMERIZATION; NANOCOMPOSITES; RADIATION; MEMBRANE
AB Grafting of photoinitiator-4-maleimidobenzophenone (4-MBP) onto styrene-butadiene-styrene (SBS) triblock copolymer was carried out by free radical polymerization. The grafting ratio was evaluated by varying initiator concentrations, and the structure of grafted copolymer (SBS-g-MBP) was characterized by attenuated total reflectance infrared Fourier transform spectroscopy (ATR-FTIR), proton nuclear magnetic resonance ((1)H NMR) and X-ray photoelectron spectroscopy (XPS). The results confirmed that 4-MBP was successfully grafted onto the SBS backbone. Thermal gravimetric analyzer (TGA), dynamic mechanical thermal analysis (DMTA), scanning electron microscopy (SEM), and atomic force microscopy (AFM) were used to study the thermal properties and morphology of the SBS-g-MBP. From the data of TGA, the SBS-g-MBP had better thermal stability compared with that of SBS. DMTA testing indicated that the glass transition temperature (T(g)) of SBS-g-MBP was higher than that of SBS. With the aid of SEM and AFM, the structure of micro-phase separation can be observed obviously. What is more, the aggregates become smaller compared with those of pure SBS. The experiment of UV-crosslinked SBS-g-MBP revealed that the gel fraction could be facilely controlled by adjusting grafting ratio and exposure time. The results suggested that this novel grafted copolymer could be attractive for its application in biomedical materials such as medical pressure-sensitive adhesive. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wu, Guoliang; Zeng, Songjun; Ou, Encai; Yu, Puren; Lu, Yanbing; Xu, Weijian] Hunan Univ, Coll Chem & Chem Engn, Inst Polymer Sci & Engn, Changsha 410082, Hunan, Peoples R China.
RP Xu, WJ (reprint author), Hunan Univ, Coll Chem & Chem Engn, Inst Polymer Sci & Engn, Changsha 410082, Hunan, Peoples R China.
EM weijianxu_59@163.com
FU Baling Petrochemical Co., Ltd., China
FX This work is financially supported by Baling Petrochemical Co., Ltd.,
   China.
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   ALLEN PEM, 1989, MACROMOLECULES, V22, P809, DOI 10.1021/ma00192a050
   ANDRADY AL, 1983, J POLYM SCI POL PHYS, V21, P2453, DOI 10.1002/pol.1983.180211203
   Chandrasiri JA, 1996, J POLYM SCI POL CHEM, V34, P1113, DOI 10.1002/(SICI)1099-0518(19960430)34:6<1113::AID-POLA21>3.0.CO;2-9
   Decker C, 1999, MACROMOL CHEM PHYSIC, V200, P1965, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1965::AID-MACP1965>3.0.CO;2-W
   Decker C, 2000, POLYMER, V41, P3905, DOI 10.1016/S0032-3861(99)00649-7
   Decker C, 2000, J APPL POLYM SCI, V77, P1902, DOI 10.1002/1097-4628(20000829)77:9<1902::AID-APP6>3.0.CO;2-6
   Florian S, 2004, J MATER SCI, V39, P649, DOI 10.1023/B:JMSC.0000011522.74404.fc
   Hsieh H. L., 1996, ANIONIC POLYMERIZATI
   Jiang DD, 1997, J POLYM SCI POL CHEM, V35, P965, DOI 10.1002/(SICI)1099-0518(19970415)35:5<965::AID-POLA11>3.3.CO;2-G
   Kennedy JE, 2010, J MATER SCI, V45, P599, DOI 10.1007/s10853-009-3933-6
   Kennedy JE, 2009, MAT SCI ENG C-BIO S, V29, P1655, DOI 10.1016/j.msec.2009.01.015
   Kennedy JE, 2009, J MATER SCI, V44, P889, DOI 10.1007/s10853-008-3156-2
   Kim GM, 2001, POLYMER, V42, P1095, DOI 10.1016/S0032-3861(00)00468-7
   Kim JK, 2002, POLYMER, V43, P5005, DOI 10.1016/S0032-3861(02)00327-0
   Lassalle VL, 2006, J APPL POLYM SCI, V102, P4468, DOI 10.1002/app.24775
   Legge NR, 1987, THERMOPLASTIC ELASTO
   Li CS, 2006, J APPL POLYM SCI, V102, P4425, DOI 10.1002/app.24314
   LIM DH, 2007, J ADHES SCI TECHNOL, V1, P589
   Madhusudhan RB, 1999, POLYM PLASTIC TECHNO, V38, P967
   Mateo JL, 2000, EUR POLYM J, V36, P1903, DOI 10.1016/S0014-3057(99)00260-8
   Mrrov Z, 1993, EUR POLYM J, V29, P597
   Murata H, 2004, SURF SCI, V570, P111, DOI 10.1016/j.susc.2004.06.185
   MURYAMA T, 1970, J POLYM SCI PP, V2, P437
   Nagura M, 2009, J APPL POLYM SCI, V113, P2462, DOI 10.1002/app.30027
   Roberts G. E., 1973, Physics of glassy polymers, P153
   Rohr T, 2003, ADV FUNCT MATER, V13, P264, DOI 10.1002/adfm.200304229
   Wang HY, 2006, POLYM INT, V55, P930, DOI 10.1002/pi.2041
   Wang HY, 2006, POLYMER, V47, P4967, DOI 10.1016/j.polymer.2006.04.027
   XU X, 2001, POLYMER, V42, P807
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang SL, 2008, POLYM TEST, V27, P957, DOI 10.1016/j.polymertesting.2008.08.009
   Zhang A, 2003, EUR POLYM J, V39, P1291
NR 35
TC 10
Z9 11
U1 2
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 30
PY 2010
VL 30
IS 7
BP 1030
EP 1037
DI 10.1016/j.msec.2010.05.004
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 632UK
UT WOS:000280454200015
DA 2018-10-19
ER

PT J
AU DeForest, CA
   Sims, EA
   Anseth, KS
AF DeForest, Cole A.
   Sims, Evan A.
   Anseth, Kristi S.
TI Peptide-Functionalized Click Hydrogels with Independently Tunable
   Mechanics and Chemical Functionality for 3D Cell Culture
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; AZIDE-ALKYNE CYCLOADDITION; ADHESION
   PEPTIDES; CHEMISTRY; MIGRATION; GROWTH; ANALOGS; PHOTOPOLYMERIZATION;
   MICROENVIRONMENTS; GRADIENTS
AB Click chemistry offers highly selective and orthogonal reactions that proceed rapidly and under a variety of mild conditions with the opportunity to create highly defined and multifunctional materials. This work illustrates a strategy where step-growth networks are formed rapidly via a copper-free, azide-alkyne click chemistry between tetrafunctional poly(ethylene glycol) molecules and difunctionalized synthetic polypeptides. The molecular weight of the polymer precursors (10, 15, or 20 kDa PEG) and the stoichiometry of reactive end group functionalities (1.5:1 to 1:1.5) provide control over the material cross-linking density, enabling elastic materials with tunable moduli (G' = 1000-6000 Pa). A sequential photochemically activated thiol-ene chemistry allows subsequent functionalization of the network through reaction with pendant alkene moieties on the peptide. Because the thiol-ene reaction is light-driven, the degree of modification is directly related to the dosage of light delivered to the system (0-6 J cm(-2)). We exploit this feature to create complex biochemical gradients of multiple peptides with well-defined magnitude and slope throughout the three-dimensional (3D) network. Since both reactions can occur in the presence of cells, this material ultimately enables independent and in situ tuning of biochemical and biomechanical properties of biomaterial networks, suggesting an avenue to direct cell function throughout specific regions within a 3D material.
C1 [DeForest, Cole A.; Sims, Evan A.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
EM Kristi.Anseth@colorado.edu
RI DeForest, Cole/C-8688-2014
OI DeForest, Cole/0000-0003-0337-3577
FU U.S. Department of Education; National Institutes of Health [T32
   GM-065103]
FX The authors thank Dr. April Kloxin and Dr. Benjamin Fairbanks for
   discussion on photopatterning, Radhika Rawat for initial assistance with
   gradient generation, Mark Tibbitt for communication on network
   nonidealities, and Alex Aimetti for useful discussion on peptide
   synthesis. Fellowship assistance to C.A.D. was awarded by the U.S.
   Department of Education's Graduate Assistantships in Areas of National
   Need program and the National Institutes of Health (T32 GM-065103).
CR Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja0449981
   Aimetti AA, 2009, BIOMACROMOLECULES, V10, P1484, DOI 10.1021/bm9000926
   Binder WH, 2007, MACROMOL RAPID COMM, V28, P15, DOI 10.1002/marc.200600625
   Bock VD, 2006, ORG LETT, V8, P919, DOI 10.1021/ol053095o
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107
   Codelli JA, 2008, J AM CHEM SOC, V130, P11486, DOI 10.1021/ja803086r
   Cramer NB, 2003, MACROMOLECULES, V36, P7964, DOI 10.1021/ma034667s
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dondoni A, 2008, ANGEW CHEM INT EDIT, V47, P8995, DOI 10.1002/anie.200802516
   Engler AC, 2009, ANGEW CHEM INT EDIT, V48, P9334, DOI 10.1002/anie.200904070
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Franke R, 2005, TETRAHEDRON LETT, V46, P4479, DOI 10.1016/j.tetlet.2005.04.107
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366
   HUISGEN R, 1963, ANGEW CHEM INT EDIT, V75, P604, DOI 10.1002/ange.19630751304
   Jagasia R, 2009, J ORG CHEM, V74, P2964, DOI 10.1021/jo802097m
   Johnson PM, 2005, POLYMER, V46, P3300, DOI 10.1016/j.polymer.2005.02.085
   Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Lee TY, 2007, MACROMOLECULES, V40, P1466, DOI 10.1021/ma062494b
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Lin-Gibson S, 2005, MACROMOLECULES, V38, P2897, DOI 10.1021/ma0487002
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Malkoch M, 2006, CHEM COMMUN, P2774, DOI 10.1039/b603438a
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Patch JA, 2002, CURR OPIN CHEM BIOL, V6, P872, DOI 10.1016/S1367-5931(02)00385-X
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Rydholm AE, 2007, POLYMER, V48, P4589, DOI 10.1016/j.polymer.2007.05.063
   Salinas CN, 2008, MACROMOLECULES, V41, P6019, DOI 10.1021/ma800621h
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 57
TC 113
Z9 113
U1 5
U2 94
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD AUG 24
PY 2010
VL 22
IS 16
BP 4783
EP 4790
DI 10.1021/cm101391y
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 637YR
UT WOS:000280855100034
PM 20842213
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Coury, AJ
AF Coury, Arthur J.
TI Controlling biomaterial-tissue interfacial interactions for implantable
   device performance
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Coury, Arthur J.] Coury Consulting Servicews, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 22
PY 2010
VL 240
MA 497-COLL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V20UK
UT WOS:000208164702064
DA 2018-10-19
ER

PT J
AU Marimuthu, M
   Kandasamy, K
   Kim, S
AF Marimuthu, Mohana
   Kandasamy, Karthikeyan
   Kim, Sanghyo
TI Innovative biomaterial synthesis to minimize post-implant inflammatory
   response
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Marimuthu, Mohana; Kandasamy, Karthikeyan; Kim, Sanghyo] Kyungwon Univ, Songnam, Gyeonggi Do, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 22
PY 2010
VL 240
MA 235-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V20UK
UT WOS:000208164706728
DA 2018-10-19
ER

PT J
AU Park, KR
   Bryers, JD
AF Park, Kyung R.
   Bryers, James D.
TI Surface modification to control biomaterial-adherent macrophage
   activation
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Park, Kyung R.; Bryers, James D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 1
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 22
PY 2010
VL 240
MA 264-COLL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V20UK
UT WOS:000208164701740
DA 2018-10-19
ER

PT J
AU Boutros, C
   Somasundar, P
   Espat, NJ
AF Boutros, Cherif
   Somasundar, Ponandai
   Espat, N. Joseph
TI Early results on the use of biomaterials as adjuvant to abdominal wall
   closure following cytoreduction and hyperthermic intraperitoneal
   chemotherapy
SO WORLD JOURNAL OF SURGICAL ONCOLOGY
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; SHORT-TERM OUTCOMES; PERITONEAL
   CARCINOMATOSIS; MITOMYCIN-C; COLORECTAL ORIGIN; CANCER-PATIENTS;
   SURGERY; SURGISIS; HERNIA; REPAIR
AB Background: Hyperthermic chemotherapy applies thermal energy to both abdominal wall as well as the intra-abdominal viscera. The combination of the hyperthemia, chemotherapy and cytoreductive surgery (CRS) is associated with a defined risk of abdominal wall and intestinal morbidity reported to be as high as 15%, respectively to date, no studies have evaluated the use of biomaterial mesh as adjuvant to abdominal wall closure in this group of patients. In the present report, we hypothesized that post HIPEC closure with a biomaterial can reduce abdominal wall morbidity after CRS and hyperthermic intraperitoneal chemotherapy.
   Materials and methods: All patients treated with HIPEC in a tertiary care center over 12 months (2008-2009) period were included. Eight patients received cytoreductive surgery followed by HIPEC for 90 minutes using Mitomycin C (15 mg q 45 minutes x 2). Abdominal wall closure was performed using Surgisis (Cook Biotech.) mesh in an underlay position with 3 cm fascial overlap-closure. Operative time, hospital length of stay (LOS) as well as postoperative outcome with special attention to abdominal wall and bowel morbidity were assessed.
   Results: Eight patients, mean age 59.7 ys (36-80) were treated according to the above protocol. The primary pathology was appendiceal mucinous adenocarcinoma (n = 3) colorectal cancer (n = 3), and ovarian cancer (n = 2). Four patients (50%) presented initially with abdominal wall morbidity including incisional ventral hernia (n = 3) and excessive abdominal wall metastatic implants (n = 1). The mean peritoneal cancer index (PCI) was 8.75. Twenty eight CRS were performed (3.5 CRS/patient). The mean operating time was 6 hours. Seven patients had no abdominal wall or bowel morbidity, the mean LOS for these patients was 8 days. During the follow up period (mean 6.3 months), one patient required exploratory laparotomy 2 weeks after surgery and subsequently developed an incisional hernia and enterocutaneous fistula.
   Conclusion: The use of biomaterial mesh in concert with HIPEC enables the repair of concomitant abdominal wall hernia and facilitates abdominal wall closure following the liberal resection of abdominal wall tumors. Biomaterial mesh prevents evisceration on repeat laparotomy and resists infection in immunocompromised patients even when associated with bowel resection.
C1 [Boutros, Cherif; Somasundar, Ponandai; Espat, N. Joseph] Roger Williams Med Ctr, Providence, RI USA.
RP Espat, NJ (reprint author), Roger Williams Med Ctr, Providence, RI USA.
EM jespat@hepaticsurgery.com
CR Aarts F, 2008, ANN SURG ONCOL, V15, P3299, DOI 10.1245/s10434-008-0070-4
   Adachi S, 2009, INT J HYPERTHER, V25, P210, DOI 10.1080/02656730802657036
   Ansaloni L, 2009, J LAPAROENDOSC ADV S, V19, P369, DOI 10.1089/lap.2008.0366
   Beaujard AC, 2000, CANCER-AM CANCER SOC, V88, P2512, DOI 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J
   Cordon CR, 2009, ANN PLAS SURG, V62, P707, DOI 10.1097/SAP.0b013e3181828141
   da Costa RG, 2009, ACTA CIR BRAS, V24, P128, DOI 10.1590/S0102-86502009000200010
   Dasgupta Roshni, 2007, Pediatr Surg Int, V23, P923, DOI 10.1007/s00383-007-1909-7
   De Ugarte DA, 2003, J SURG RES, V112, P65, DOI 10.1016/S0022-4804(03)00107-0
   Esquivel J, 2007, ANN SURG ONCOL, V14, P128, DOI 10.1245/s10434-006-9185-7
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Franko J, 2008, ANN SURG ONCOL, V15, P3065, DOI 10.1245/s10434-008-0105-x
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Hodde J, 2007, ACTA CHIR BELG, V107, P641, DOI 10.1080/00015458.2007.11680139
   Jacquet P, 1998, ONCOLOGY-BASEL, V55, P130, DOI 10.1159/000011847
   Johnson EK, 2007, MIL MED, V172, P1119, DOI 10.7205/MILMED.172.10.1119
   Kianmanesh R, 2007, ANN SURG, V245, P597, DOI 10.1097/01.sla.0000255561.87771.11
   LAMBERT LA, 2009, ANN SURG ONCOL
   Landercasper J, 2005, ARCH SURG-CHICAGO, V140, P560
   Larson G, 1996, SURGERY, V120, P743
   Lim MC, 2009, ANN SURG ONCOL, V16, P993, DOI 10.1245/s10434-008-0299-y
   Novitsky YW, 2006, J AM COLL SURGEONS, V203, P283, DOI 10.1016/j.jamcollsurg.2006.05.297
   Ong ES, 2006, J GASTROINTEST SURG, V10, P202, DOI 10.1016/j.gassur.2005.07.004
   Pelz JOW, 2007, INT J COLORECTAL DIS, V22, P941, DOI 10.1007/s00384-006-0246-y
   Shukla VK, 2007, CHEMOTHERAPY, V53, P275, DOI 10.1159/000104472
   Stewart JH, 2006, ANN SURG ONCOL, V13, P624, DOI 10.1007/s10434-006-9708-2
   Sugarbaker PH, 2006, ANN SURG ONCOL, V13, P635, DOI 10.1245/ASO.2006.03.079
   SUGARBAKER PH, 1995, ANN SURG, V221, P124, DOI 10.1097/00000658-199502000-00002
   Vazquez VD, 2003, CANCER CHEMOTH PHARM, V52, P108, DOI 10.1007/s00280-003-0626-8
   WANG X, 2009, APOPTOSIS
   Witkamp AJ, 2001, EUR J CANCER, V37, P979, DOI 10.1016/S0959-8049(01)00058-2
NR 31
TC 12
Z9 12
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7819
J9 WORLD J SURG ONCOL
JI World J. Surg. Oncol.
PD AUG 20
PY 2010
VL 8
AR 72
DI 10.1186/1477-7819-8-72
PG 7
WC Oncology; Surgery
SC Oncology; Surgery
GA 660AW
UT WOS:000282611200001
PM 20727181
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sathishkumar, M
   Mahadevan, A
   Vijayaraghavan, K
   Pavagadhi, S
   Balasubramanian, R
AF Sathishkumar, M.
   Mahadevan, A.
   Vijayaraghavan, K.
   Pavagadhi, S.
   Balasubramanian, R.
TI Green Recovery of Gold through Biosorption, Biocrystallization, and
   Pyro-Crystallization
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID ALGA FUCUS-VESICULOSUS; BACTERICIDAL ACTIVITY; BIOLOGICAL SYNTHESIS;
   TRAMETES-VERSICOLOR; PRETREATED BIOMASS; DILUTE-SOLUTIONS; WASTE-WATER;
   NANOPARTICLES; SILVER; BIOSYNTHESIS
AB Gold recovery from dilute solutions has always been a subject of great interest due to ever increasing demand of this precious metal. In the present study, an attempt had been made to recover this noble metal in ionic, nanocrystalline, and metallic form using a combination of biosorption, biocrystallization, and pyro-crystallization techniques with Sargassum biomass as biomaterial. Optimization of process parameters revealed that the biosorption capacity increased with a decrease in pH due to an ion-pairing effect. Kinetic studies showed that the biosorption of Au(III) onto Sargassum biomass was a rapid process with more than 90% removal at the initial 15 min. Nonlinear forms of pseudofirst-order and pseudosecond-order models were used to fit the experimental data. The adsorption capacity (Q(max)) from the Langmuir model was found to be 32.94 mg/g at pH 2. Maximum desorption of 97.8% was achieved with 2 N NaOH used as desorption medium. Biocrystallization of ionic gold through bioreduction was observed from 30 min with high productivity at pH 8. The X-ray diffraction analysis (XRD) patterns of the gold nanoparticles revealed their biphasic nature. Recovery of the biosorbed ionic gold in metallic form through pyro-crystallization technique showed the possibility of 91.44% recovery of the metal in pure form as revealed by XRD analysis. The overall results indicate that gold from dilute solutions can be recovered through green processes in ionic, nanocrystalline, or metallic form as desired by the end-consumer using Sargassum biomass as biomaterial.
C1 [Sathishkumar, M.; Mahadevan, A.; Vijayaraghavan, K.; Pavagadhi, S.; Balasubramanian, R.] Singapore Delft Water Alliance, Singapore 117576, Singapore.
   [Pavagadhi, S.; Balasubramanian, R.] Natl Univ Singapore, Div Environm Sci & Engn, Singapore 117576, Singapore.
RP Balasubramanian, R (reprint author), Singapore Delft Water Alliance, Singapore 117576, Singapore.
EM eserbala@nus.eud.sg
RI Kuppusamy, Vijayaraghavan/A-3554-2009; Balasubramanian,
   Rajasekhar/C-2243-2011
OI Kuppusamy, Vijayaraghavan/0000-0001-8076-4278; Balasubramanian,
   Rajasekhar/0000-0002-5627-3628
FU Singapore-Delft Water Alliance (SDWA) [R-264-001-013-272]
FX The authors gratefully acknowledge the support and contributions of this
   project to the Singapore-Delft Water Alliance (SDWA). The research
   presented in this work was carried out as part of the Singapore-Delft
   Water Alliance (SDWA)'s research programme (R-264-001-013-272).
CR Agnihotri M, 2009, MATER LETT, V63, P1231, DOI 10.1016/j.matlet.2009.02.042
   ASFOUR HM, 1985, J CHEM TECH BIOT A, V35, P21, DOI 10.1002/jctb.5040350105
   Binupriya AR, 2008, BIORESOURCE TECHNOL, V99, P1080, DOI 10.1016/j.biortech.2007.02.022
   Binupriya AR, 2007, J CHEM TECHNOL BIOT, V82, P350, DOI 10.1002/jctb.1668
   Binupriya AR, 2010, J HAZARD MATER, V177, P539, DOI 10.1016/j.jhazmat.2009.12.066
   Binupriya AR, 2010, IND ENG CHEM RES, V49, P852, DOI 10.1021/ie9014183
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087
   Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2
   Feng YZ, 2007, CURR MICROBIOL, V55, P402, DOI 10.1007/s00284-007-9007-6
   Govindaraju K, 2008, J MATER SCI, V43, P5115, DOI 10.1007/s10853-008-2745-4
   He SY, 2007, MATER LETT, V61, P3984, DOI 10.1016/j.matlet.2007.01.018
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Koivikko R, 2005, J CHEM ECOL, V31, P195, DOI 10.1007/s10886-005-0984-2
   Kratochvil D, 1998, ENVIRON SCI TECHNOL, V32, P2693, DOI 10.1021/es971073u
   KUYUCAK N, 1989, Biorecovery, V1, P189
   Lim SN, 2002, J AGR FOOD CHEM, V50, P3862, DOI 10.1021/jf020096b
   Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010
   Lin ZY, 2005, SPECTROCHIM ACTA A, V61, P761, DOI 10.1016/j.saa.2004.03.029
   Link S, 2000, INT REV PHYS CHEM, V19, P409, DOI 10.1080/01442350050034180
   Liu B, 2005, J PHYS CHEM B, V109, P15256, DOI 10.1021/jp051449n
   Mata YN, 2009, J HAZARD MATER, V166, P612, DOI 10.1016/j.jhazmat.2008.11.064
   Moore BA, 2008, MINER ENG, V21, P55, DOI 10.1016/j.mineng.2007.08.005
   Narayanan KB, 2008, MATER LETT, V62, P4588, DOI 10.1016/j.matlet.2008.08.044
   Raghunandan D., 2009, NANOBIOTECHNOL, V5, P34, DOI DOI 10.1007/S12030-009-9030-8
   Raize O, 2004, BIOTECHNOL BIOENG, V87, P451, DOI 10.1002/bit.20136
   Ramesh A, 2008, BIORESOURCE TECHNOL, V99, P3801, DOI 10.1016/j.biortech.2007.07.008
   Sathishkumar M, 2008, B ENVIRON CONTAM TOX, V81, P316, DOI 10.1007/s00128-008-9496-4
   Sathishkumar M, 2007, BIORESOURCE TECHNOL, V98, P866, DOI 10.1016/j.biortech.2006.03-002
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Sathishkumar M, 2009, J HAZARD MATER, V171, P400, DOI 10.1016/j.jhazmat.2009.06.014
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Singaravelu G, 2007, COLLOID SURFACE B, V57, P97, DOI 10.1016/j.colsurfb.2007.01.010
   Song HP, 2008, CHEMOSPHERE, V72, P616, DOI 10.1016/j.chemosphere.2008.02.064
   Torres E, 2005, LANGMUIR, V21, P7951, DOI 10.1021/la046852k
   Vijayaraghavan K, 2008, BIORESOURCE TECHNOL, V99, P2864, DOI 10.1016/j.biortech.2007.06.008
   Won SW, 2010, BIORESOURCE TECHNOL, V101, P1135, DOI 10.1016/j.biortech.2009.09.056
   Yan XJ, 1996, J APPL PHYCOL, V8, P201
NR 40
TC 28
Z9 32
U1 2
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD AUG 18
PY 2010
VL 49
IS 16
BP 7129
EP 7135
DI 10.1021/ie100104j
PG 7
WC Engineering, Chemical
SC Engineering
GA 636EO
UT WOS:000280711600003
DA 2018-10-19
ER

PT J
AU Petrie, TA
   Raynor, JE
   Dumbauld, DW
   Lee, TT
   Jagtap, S
   Templeman, KL
   Collard, DM
   Garcia, AJ
AF Petrie, Timothy A.
   Raynor, Jenny E.
   Dumbauld, David W.
   Lee, Ted T.
   Jagtap, Subodh
   Templeman, Kellie L.
   Collard, David M.
   Garcia, Andres J.
TI Multivalent Integrin-Specific Ligands Enhance Tissue Healing and
   Biomaterial Integration
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID CELL-ADHESION; OSTEOBLAST DIFFERENTIATION; TITANIUM IMPLANTS;
   BONE-FORMATION; RGD; FIBRONECTIN; OSSEOINTEGRATION; PEPTIDES; SURFACES;
   BINDING
AB Engineered biointerfaces covered with biomimetic motifs, including short bioadhesive ligands, are a promising material-based strategy for tissue repair in regenerative medicine. Potentially useful coating molecules are ligands for the integrins, major extracellular matrix receptors that require both ligand binding and nanoscale clustering for maximal signaling efficiency. We prepared coatings consisting of well-defined multimer constructs with a precise number of recombinant fragments of fibronectin (monomer, dimer, tetramer, and pentamer) to assess how nanoscale ligand clustering affects integrin binding, stem cell responses, tissue healing, and biomaterial integration. Clinical-grade titanium was grafted with polymer brushes that presented monomers, dimers, trimers, or pentamers of the alpha(5)beta(1) integrin-specific fibronectin III(7 to 10) domain (FNIII(7-10)). Coatings consisting of trimers and pentamers enhanced integrin-mediated adhesion in vitro, osteogenic signaling, and differentiation in human mesenchymal stem cells more than did surfaces presenting monomers and dimers. Furthermore, ligand clustering promoted bone formation and functional integration of the implant into bone in rat tibiae. This study establishes that a material-based strategy in which implants are coated with clustered bioadhesive ligands can promote robust implant-tissue integration.
C1 [Petrie, Timothy A.; Dumbauld, David W.; Lee, Ted T.; Templeman, Kellie L.; Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Petrie, Timothy A.; Dumbauld, David W.; Lee, Ted T.; Templeman, Kellie L.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Raynor, Jenny E.; Jagtap, Subodh; Collard, David M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU NIH [R01 EB-004496, R01 GM-06591]; Medtronic Foundation
FX We thank H. Erickson for providing complementary DNA for fibronectin
   constructs and M. Mathews for implant machining. Funding: This work was
   supported by NIH grants R01 EB-004496 and R01 GM-06591. T.A. P.
   acknowledges support from the Medtronic Foundation. Author
   contributions: T.A.P., J.E.R., D.W.D., T.T.L., S.J., and K.L.T.
   contributed to collection of experimental data; T.A.P. and A.J.G.
   analyzed the data; T.A.P., D.M.C., and A.J.G. contributed to writing the
   paper. Competing interests: A.J.G. has consulted for Synthes Inc.
   Georgia Tech Research Corporation has applied for a U.S. patent on the
   use of FNIII<INF>7-10</INF> for orthopedic repair. The authors declare
   that they have no competing interests.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Brinkerhoff CJ, 2005, TISSUE ENG, V11, P865, DOI 10.1089/ten.2005.11.865
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Coussen F, 2002, J CELL SCI, V115, P2581
   Garanger E, 2007, ANTI-CANCER AGENT ME, V7, P552, DOI 10.2174/187152007781668706
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Globus RK, 2005, CALCIFIED TISSUE INT, V76, P39, DOI 10.1007/s00223-004-0309-4
   Globus RK, 1998, J CELL SCI, V111, P1385
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Koo LY, 2002, J CELL SCI, V115, P1423
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   M P, 2005, NAT BIOTECHNOL, V23, P47
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Petrie TA, 2009, J CELL MOL MED, V13, P2602, DOI 10.1111/j.1582-4934.2008.00476.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Raynor JE, 2007, ADV MATER, V19, P1724, DOI 10.1002/adma.200602129
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Tamura Y, 2001, J BONE MINER RES, V16, pS483
   Villard V, 2006, J PEPT SCI, V12, P206, DOI 10.1002/psc.707
   Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002
NR 38
TC 77
Z9 77
U1 2
U2 40
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD AUG 18
PY 2010
VL 2
IS 45
AR 45ra60
DI 10.1126/scitranslmed.3001002
PG 6
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 735RT
UT WOS:000288435500004
PM 20720217
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Adachi, T
   Wang, XB
   Murata, T
   Obara, M
   Akutsu, H
   Machida, M
   Umezawa, A
   Tomita, M
AF Adachi, Takahiro
   Wang, Xiaobiao
   Murata, Tomoko
   Obara, Masanobu
   Akutsu, Hidenori
   Machida, Masakazu
   Umezawa, Akirihiro
   Tomita, Masahiro
TI Production of a Non-Triple Helical Collagen alpha Chain in Transgenic
   Silkworms and Its Evaluation as a Gelatin Substitute for Cell Culture
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE transgenic silkworm; cocoon; collagen; gelatin; cell culture
ID SECRETES RECOMBINANT PROTEINS; BOMBYX-MORI; PROLYL 4-HYDROXYLASE;
   OSTEOGENESIS IMPERFECTA; REQUIRES COEXPRESSION; PICHIA-PASTORIS; SERICIN
   LAYER; III COLLAGEN; PROCOLLAGEN; EXPRESSION
AB We generated transgenic silkworms that synthesized human type I collagen alpha 1 chain [alpha 1(I) chain] in the middle silk glands and secreted it into cocoons. The initial content of the recombinant alpha 1(I) chain in the cocoons of the transgenic silkworms was 0.8%. The IE1 gene, a trans-activator from the baculovirus, was introduced into the transgenic silkworm to increase the content of the chain. We also generated silkworms homozygous for the transgenes. These manipulations increased the alpha 1(I) chain content to 8.0% (4.24 mg per cocoon). The alpha 1 (I) chain was extracted and purified from the cocoons using a very simple method. The alpha 1(I) chain contained no hydroxyprolines due to the absence of prolyl-hydroxylase activity in the silk glands. Circular dichroism analysis showed that the secondary structure of the alpha 1(I) chain is similar to that of denatured type I collagen, demonstrating the absence of the triple helical structure. Human skin fibroblasts were seeded on the alpha 1(I) chain-coated dishes. The cells attached and spread, although at decreased chain concentrations the spreading rate was lower than that of the collagen and gelatin. Cynomolgus monkey embryonic stem cells cultured on the alpha 1(I) chain-coated dishes maintained an undifferentiated state after 30 passages, and their pluripotency was confirmed by teratoma formation in severe combined immunodeficient mice. These results show that the recombinant human alpha 1 (I) chain is a promising candidate biomaterial as a high-quality and safe gelatin substitute for cell culture. Biotechnol. Bioeng. 2010;106: 860-870. (C) 2010 Wiley Periodicals, Inc.
C1 [Adachi, Takahiro; Wang, Xiaobiao; Murata, Tomoko; Tomita, Masahiro] Neosilk Co Ltd, Hiroshima 7390046, Japan.
   [Adachi, Takahiro] Hiroshima Prefectural Inst Ind Sci & Technol, Hiroshima, Japan.
   [Obara, Masanobu] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Dev Biol Lab, Hiroshima, Japan.
   [Akutsu, Hidenori; Machida, Masakazu; Umezawa, Akirihiro] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan.
RP Tomita, M (reprint author), Neosilk Co Ltd, 3-13-26 Kagamiyama, Hiroshima 7390046, Japan.
EM mtomita@neosilk.co.jp
CR Adachi T, 2005, MATRIX BIOL, V24, P136, DOI 10.1016/j.matbio.2005.01.007
   Adachi T, 2006, J BIOTECHNOL, V126, P205, DOI 10.1016/j.jbiotec.2006.04.035
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   BRADLEY R, 1993, DEV BIOL STAND, V80, P157
   Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919
   DOEGE KJ, 1986, J BIOL CHEM, V261, P8924
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   Gill J, 2001, DRUG SAFETY, V24, P223, DOI 10.2165/00002018-200124030-00005
   GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Iizuka M, 2008, J BIOSCI BIOENG, V105, P595, DOI 10.1263/jbb.105.595
   Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LIN MS, 1976, CAN J GENET CYTOL, V18, P545, DOI 10.1139/g76-068
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   MICHALOPOULOS G, 1975, EXP CELL RES, V94, P70, DOI 10.1016/0014-4827(75)90532-7
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P3
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Mullins RJ, 1996, AUST NZ J OPHTHALMOL, V24, P257, DOI 10.1111/j.1442-9071.1996.tb01589.x
   NICHOLLS AC, 1979, LANCET, V1, P1193
   Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200
   PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P162, DOI 10.1073/pnas.77.1.162
   ROSENBLOOM J, 1976, J BIOL CHEM, V251, P2070
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   TOMITA M, 2005, TRANSGENIC SILKWORMS
   Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   Werten MWT, 1999, YEAST, V15, P1087, DOI 10.1002/(SICI)1097-0061(199908)15:11<1087::AID-YEA436>3.0.CO;2-F
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
NR 40
TC 22
Z9 29
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG 15
PY 2010
VL 106
IS 6
BP 860
EP 870
DI 10.1002/bit.22752
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 631IY
UT WOS:000280341200003
PM 20589667
DA 2018-10-19
ER

PT J
AU Mendes, RM
   Silva, GAB
   Caliari, MV
   Silva, EE
   Ladeira, LO
   Ferreira, AJ
AF Mendes, Renato M.
   Silva, Gerluza A. B.
   Caliari, Marcelo V.
   Silva, Edelma E.
   Ladeira, Luiz Orlando
   Ferreira, Anderson J.
TI Effects of single wall carbon nanotubes and its functionalization with
   sodium hyaluronate on bone repair
SO LIFE SCIENCES
LA English
DT Article
DE Carbon nanotubes; Hyaluronan; Healing process; Sockets; Hyaluronic acid;
   Tooth
ID IN-VITRO; BIOCOMPATIBILITY; SCAFFOLDS; GROWTH; OSTEOGENESIS; DEFECTS;
   BIOLOGY; CELLS; RATS
AB Aims: Sodium hyaluronate (HY) accelerates the repair of bone defects. However, the weak stability of HY formulations in aqueous environments has hindered its wide utilization. The functionalization of carbon nanotubes (SWCNT) with NY (HY-SWCNT) results in a reinforced hydrogel with an increased stability. Nevertheless, the biological effects of HY-SWCNT have not been explored. Thus, our objective was to evaluate whether this biomaterial preserves the bioactivity of the HY.
   Main methods: Wistar rats were subjected to molar extraction and the sockets were treated with SWCNT (50-400 mu g/mL), 1% HY, HY-SWCNT (50-400 mu g/mL) or carbopol (vehicle). After seven days of surgery, histological and morphometric analyses were performed to evaluate the trabecular bone formation and the number of cell nuclei in the sockets. Expression of collagen types I and Ill was determined by immunohistochemistry.
   Key findings: Treatment with SWCNT did not alter the bone deposition, as well as the cell nuclei counting. Additionally, no significant evidence of toxicity was observed in SWCNT-treated sockets. Contrastingly, both HY and HY-SWCNT induced a marked increase in the bone formation (NY: 10.10 +/- 1.99%; HY-SWCNT 100 mu g/mL: 10.90 +/- 1.13%; control: 3.69 +/- 1.17%) and decreased the cell nuclei amount in the sockets. Moreover, collagen type I expression was more pronounced in HY- and HY-SWCNT-treated sockets. No significant differences were viewed in the expression of collagen type Ill.
   Significance: Our results indicate that SWCNT is a feasible material to deliver HY to bone defects. Importantly, the functionalization of SWCNT with HY preserved the beneficial biological properties of HY in the healing process, thereby suggesting that HY-SWCNT scaffolds are potentially useful biomaterials for the restoration of bone defects. (c) 2010 Elsevier Inc. All rights reserved.
C1 [Ferreira, Anderson J.] Univ Fed Minas Gerais, Dept Morphol, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Caliari, Marcelo V.] Univ Fed Minas Gerais, Dept Gen Pathol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva, Edelma E.; Ladeira, Luiz Orlando] Univ Fed Minas Gerais, Dept Phys, BR-31270901 Belo Horizonte, MG, Brazil.
RP Ferreira, AJ (reprint author), Univ Fed Minas Gerais, Dept Morphol, ICB, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM anderson@icb.ufmg.br
RI Nbiofar, Inct/J-9539-2013; Caliari, Marcelo/N-1171-2016
OI Caliari, Marcelo/0000-0001-8354-8407; Eleto da Silva,
   Edelma/0000-0002-1498-9134
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico);
   CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior);
   FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)
FX This study was supported in part by CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior) and FAPEMIG (Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais). The authors RMM, GABS, LOL
   and AJF declare that they have deposited a patent covering the use of
   HY-SWCNT as a biomaterial for bone repair. The data presented is part of
   the Ph.D. thesis of RMM.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1
   Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Arepalli S, 2004, CARBON, V42, P1783, DOI 10.1016/j.carbon.2004.03.038
   Arosarena OA, 2005, OTOLARYNG HEAD NECK, V132, P592, DOI 10.1016/j.otohns.2004.09.137
   Bhattacharyya S, 2008, BIOMACROMOLECULES, V9, P505, DOI 10.1021/bm7009976
   Bouletreau PJ, 2002, J CRANIO MAXILL SURG, V30, P1, DOI 10.1054/jems.2001.0263
   Cherukuri P, 2006, P NATL ACAD SCI USA, V103, P18882, DOI 10.1073/pnas.0609265103
   Chlopek J, 2006, CARBON, V44, P1106, DOI 10.1016/j.carbon.2005.11.022
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x
   Dechert TA, 2006, WOUND REPAIR REGEN, V14, P252, DOI 10.1111/j.1743-6109.2006.00119.x
   Deschrevel B, 2008, MATRIX BIOL, V27, P475, DOI 10.1016/j.matbio.2008.01.007
   Flahaut E, 2006, CARBON, V44, P1093, DOI 10.1016/j.carbon.2005.11.007
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Jorio A, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/139
   Kappler J, 2009, MATRIX BIOL, V28, P396, DOI 10.1016/j.matbio.2009.06.002
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mendes RM, 2008, ARCH ORAL BIOL, V53, P1155, DOI 10.1016/j.archoralbio.2008.07.001
   Moseley R, 2002, BIOMATERIALS, V23, P2255, DOI 10.1016/S0142-9612(01)00360-X
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Rugheimer L, 2009, MATRIX BIOL, V28, P390, DOI 10.1016/j.matbio.2009.07.002
   SHI X, 2007, J BIOMEDICAL MAT RES, V86, P813
   Silva EE, 2009, NANO RES, V2, P462, DOI [10.1007/s12274-009-9042-7, DOI 10.1007/S12274-009-9042-7]
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x
   Teofilo JM, 2004, ARCH ORAL BIOL, V49, P755, DOI 10.1016/j.archoralbio.2004.02.013
   Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200
   Trigueiro JPC, 2007, J NANOSCI NANOTECHNO, V7, P3477, DOI 10.1166/jnn.2007.831
   Tutak W, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/25/255101
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
   Zhou W, 2001, CHEM PHYS LETT, V350, P6, DOI 10.1016/S0009-2614(01)01237-4
NR 35
TC 27
Z9 26
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD AUG 14
PY 2010
VL 87
IS 7-8
BP 215
EP 222
DI 10.1016/j.lfs.2010.06.010
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 638QR
UT WOS:000280910800002
PM 20600151
DA 2018-10-19
ER

PT J
AU Jeong, SI
   Krebs, MD
   Bonino, CA
   Khan, SA
   Alsberg, E
AF Jeong, Sung In
   Krebs, Melissa D.
   Bonino, Christopher A.
   Khan, Saad A.
   Alsberg, Eben
TI Electrospun Alginate Nanofibers with Controlled Cell Adhesion for Tissue
   Engineering
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; cell adhesion; electrospinning; nanofibers; tissue
   engineering
ID SODIUM ALGINATE; POLY(ETHYLENE OXIDE); HYDROGELS; DEGRADATION;
   SCAFFOLDS; BEHAVIOR; MATRIX
AB Alginate, a natural polysaccharide that has shown great potential as a cell scaffold for the regeneration of many tissues, has only been nominally explored as an electrospun biomaterial due to cytotoxic chemicals that have typically been used during nanofiber formation and crosslinking. Alginate cannot be electrospun by itself and is often co-spun with poly(ethylene oxide) (PEO). In this work, a cell adhesive peptide (GRGDSP) modified alginate (RA) and unmodified alginate (UA) were blended with PEO at different concentrations and blending ratios, and then electrospun to prepare uniform nanofibers. The ability of electrospun RA scaffolds to support human dermal fibroblast cell attachment, spreading, and subsequent proliferation was greatly enhanced on the adhesion ligand-modified nanofibers, demonstrating the promise of this electrospun polysaccharide material with defined nanoscale architecture and cell adhesive properties for tissue regeneration applications.
C1 [Jeong, Sung In; Krebs, Melissa D.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Bonino, Christopher A.; Khan, Saad A.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Wickenden Bldg,Room 204,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Krebs, Melissa/L-4878-2015
OI Krebs, Melissa/0000-0002-5170-7116; Alsberg, Eben/0000-0002-3487-4625
FU Ohio Department of Development [08-081]; National Science Foundation
FX We would like to thank FMC Biopolymers for their assistance with the
   characterization of the alginate molecular weight and G/M ratio. The
   authors gratefully acknowledge funding support for this work from
   Biomedical Research and Technology Transfer Grant 08-081 from the Ohio
   Department of Development (E.A.) and a National Science Foundation
   Graduate Research Fellowship (M.D.K.).
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Ashammakhi N, 2008, REGEN MED, V3, P547, DOI 10.2217/17460751.3.4.547
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Bhattarai N, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455601
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326
   CORY AH, 1991, CANCER COMMUN, V3, P207
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Krebs MD, 2010, J BIOMED MATER RES A, V92A, P1131, DOI 10.1002/jbm.a.32441
   Leduc PR, 2007, ADV MATER, V19, P3761, DOI 10.1002/adma.200701286
   Lee WR, 2009, WOUND REPAIR REGEN, V17, P505, DOI 10.1111/j.1524-475X.2009.00496.x
   Lu JW, 2006, POLYMER, V47, P8026, DOI 10.1016/j.polymer.2006.09.027
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Moon S, 2009, POLYM ENG SCI, V49, P52, DOI 10.1002/pen.21216
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   Nie HR, 2008, BIOMACROMOLECULES, V9, P1362, DOI 10.1021/bm701349j
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Safi S, 2007, J APPL POLYM SCI, V104, P3245, DOI 10.1002/app.25696
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
NR 25
TC 63
Z9 65
U1 3
U2 66
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG 11
PY 2010
VL 10
IS 8
BP 934
EP 943
DI 10.1002/mabi.201000046
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 644OI
UT WOS:000281387900013
PM 20533533
DA 2018-10-19
ER

PT J
AU Kampf, MM
   Christen, EH
   Ehrbar, M
   Daoud-El Baba, M
   Charpin-El Hamri, G
   Fussenegger, M
   Weber, W
AF Kaempf, Michael M.
   Christen, Erik H.
   Ehrbar, Martin
   Daoud-El Baba, Marie
   Charpin-El Hamri, Ghislaine
   Fussenegger, Martin
   Weber, Wilfried
TI A Gene Therapy Technology-Based Biomaterial for the Trigger-Inducible
   Release of Biopharmaceuticals in Mice
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID CELL PROLIFERATION; HYDROGELS; EXPRESSION; POLYMERS; SYSTEM; GROWTH
AB Gene therapy scientists have developed expression systems for therapeutic transgenes within patients, which must be seamlessly integrated into the patient's physiology by developing sophisticated control mechanisms to titrate expression levels of the transgenes into the therapeutic window. However, despite these efforts, gene-based medicine still faces security concerns related to the administration of the therapeutic transgene vector. Here, molecular tools developed for therapeutic transgene expression can readily be transferred to materials science to design a humanized drug depot that can be implanted into mice and enables the trigger-inducible release of a therapeutic protein in response to a small-molecule inducer. The drug depot is constructed by embedding the vascular endothelial growth factor (VEGF(121)) as model therapeutic protein into a hydrogel consisting of linear polyacrylamide crosslinked with a homodimeric variant of the human FK-binding protein 12 (F(M)), originally developed for gene therapeutic applications, as well as with dimethylsuberimidate. Administrating increasing concentrations of the inducer molecule FK506 triggers the dissociation of F(M) thereby loosening the hydrogel structure and releasing the VEGF(121) payload in a dose-adjustable manner. Subcutaneous implantation of the drug depot into mice and subsequent administration of the inducer by injection or by oral intake triggers the release of VEGF(121) as monitored in the mouse serum. This study is the first demonstration of a stimuli-responsive hydrogel that can be used in mammals to release a therapeutic protein on demand by the application of a small-molecule stimulus. This trigger-inducible release is a starting point for the further development of externally controlled drug depots for patient-compliant administration of biopharmaceuticals.
C1 [Kaempf, Michael M.; Christen, Erik H.; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
   [Weber, Wilfried] Univ Freiburg, Bioss Ctr Biol Signalling Studies, Fac Biol, D-79108 Freiburg, Germany.
   [Ehrbar, Martin] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland.
   [Daoud-El Baba, Marie; Charpin-El Hamri, Ghislaine] Univ Lyon, F-69622 Lyon, France.
RP Kampf, MM (reprint author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.
EM wilfried.weber@biologie.uni-freiburg.de
RI Weber, Wilfried/B-4732-2012; Ehrbar, Martin/F-4578-2012
OI Ehrbar, Martin/0000-0003-2707-4870
FU Excellence Initiative of the German Federal and State Governments [EXC
   294]; GEBERT ROE STIFTUNG [GRS-042/07]; Roche Research Foundation
   [151-2008]
FX We are grateful to Matthias Lutolf and Samy Gobaa for advice on the
   rheology measurements. We thank Ronald Schoenmakers for advice on the
   hydrogel design. This project has been made possible owing to the
   Excellence Initiative of the German Federal and State Governments (EXC
   294), the GEBERT ROE STIFTUNG (Grant No. GRS-042/07), and the Roche
   Research Foundation (Grant No. 151-2008). Supporting Information is
   available online from Wiley InterScience or from the author.
CR Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Hotz HG, 2005, SURGERY, V137, P192, DOI 10.1016/j.surg.2004.07.015
   Jalota S, 2008, MAT SCI ENG C-BIO S, V28, P129, DOI 10.1016/j.msec.2007.10.058
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501
   Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826
   Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028
   Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Weber CC, 2005, BIOTECHNOL BIOENG, V89, P9, DOI 10.1002/bit.20224
   Weber W, 2006, J GENE MED, V8, P535, DOI 10.1002/jgm.903
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
NR 19
TC 24
Z9 24
U1 3
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG 9
PY 2010
VL 20
IS 15
BP 2534
EP 2538
DI 10.1002/adfm.200902377
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 640NS
UT WOS:000281058900019
DA 2018-10-19
ER

PT J
AU Kuhbier, JW
   Allmeling, C
   Reimers, K
   Hillmer, A
   Kasper, C
   Menger, B
   Brandes, G
   Guggenheim, M
   Vogt, PM
AF Kuhbier, Joern W.
   Allmeling, Christina
   Reimers, Kerstin
   Hillmer, Anja
   Kasper, Cornelia
   Menger, Bjoern
   Brandes, Gudrun
   Guggenheim, Merlin
   Vogt, Peter M.
TI Interactions between Spider Silk and Cells - NIH/3T3 Fibroblasts Seeded
   on Miniature Weaving Frames
SO PLOS ONE
LA English
DT Article
ID PERIPHERAL-NERVE REGENERATION; CLAVIPES DRAGLINE SILK; NEPHILA-CLAVIPES;
   IN-VITRO; FIBROIN; SCAFFOLDS; FIBERS; PROTEINS; PROLIFERATION;
   BIOMATERIALS
AB Background: Several materials have been used for tissue engineering purposes, since the ideal matrix depends on the desired tissue. Silk biomaterials have come to focus due to their great mechanical properties. As untreated silkworm silk has been found to be quite immunogenic, an alternative could be spider silk. Not only does it own unique mechanical properties, its biocompatibility has been shown already in vivo. In our study, we used native spider dragline silk which is known as the strongest fibre in nature.
   Methodology/Principal Findings: Steel frames were originally designed and manufactured and woven with spider silk, harvesting dragline silk directly out of the animal. After sterilization, scaffolds were seeded with fibroblasts to analyse cell proliferation and adhesion. Analysis of cell morphology and actin filament alignment clearly revealed adherence. Proliferation was measured by cell count as well as determination of relative fluorescence each after 1, 2, 3, and 5 days. Cell counts for native spider silk were also compared with those for trypsin-digested spider silk. Spider silk specimens displayed less proliferation than collagen-and fibronectin-coated cover slips, enzymatic treatment reduced adhesion and proliferation rates tendentially though not significantly. Nevertheless, proliferation could be proven with high significance (p<0.01).
   Conclusion/Significance: Native spider silk does not require any modification to its application as a biomaterial that can rival any artificial material in terms of cell growth promoting properties. We could show adhesion mechanics on intracellular level. Additionally, proliferation kinetics were higher than in enzymatically digested controls, indicating that spider silk does not require modification. Recent findings concerning reduction of cell proliferation after exposure could not be met. As biotechnological production of the hierarchical composition of native spider silk fibres is still a challenge, our study has a pioneer role in researching cellular mechanics on native spider silk fibres.
C1 [Kuhbier, Joern W.; Allmeling, Christina; Reimers, Kerstin; Hillmer, Anja; Menger, Bjoern; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.
   [Kasper, Cornelia] Leibniz Univ Hannover, Inst Tech Chem, Hannover, Germany.
   [Brandes, Gudrun] Hannover Med Sch, Ctr Anat, Inst Cell Biol & Electron Microscopy, D-3000 Hannover, Germany.
   [Guggenheim, Merlin] Univ Zurich Hosp, Dept Surg, Div Reconstruct Surg, CH-8091 Zurich, Switzerland.
RP Kuhbier, JW (reprint author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.
EM joernkuhbier@gmx.de
FU Braukmann-Wittenberg Foundation
FX This study was funded by a grant from the Braukmann-Wittenberg
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a
   BRINI E, 2006, BIOMATERIAL BIOMACRO, V7, P3139
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Gebert A, 1998, J MICROSC-OXFORD, V191, P297
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   JACKSON C, 1995, MACROMOLECULES, V28, P5975, DOI 10.1021/ma00121a042
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liu CH, 2000, WORLD J GASTROENTERO, V6, P361
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Michal CA, 1996, BIOPHYS J, V70, P489, DOI 10.1016/S0006-3495(96)79594-2
   MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Riekel C, 2004, NATURWISSENSCHAFTEN, V91, P30, DOI 10.1007/s00114-003-0482-8
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SALTHOUSE TN, 1980, OTOLARYNG HEAD NECK, V88, P658, DOI 10.1177/019459988008800606
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sponner A., 2007, PLOS ONE, V10, P1
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 2002, IN VIVO, V16, P229
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   WORK RW, 1982, J ARACHNOL, V10, P1
   WORK RW, 1976, TEXT RES J, V46, P485, DOI 10.1177/004051757604600704
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 54
TC 22
Z9 22
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 9
PY 2010
VL 5
IS 8
AR e12032
DI 10.1371/journal.pone.0012032
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 636XC
UT WOS:000280776800014
PM 20711495
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rosales-Leal, JI
   Rodriguez-Valverde, MA
   Mazzaglia, G
   Ramon-Torregrosa, PJ
   Diaz-Rodriguez, L
   Garcia-Martinez, O
   Vallecillo-Capilla, M
   Ruiz, C
   Cabrerizo-Vilchez, MA
AF Rosales-Leal, J. I.
   Rodriguez-Valverde, M. A.
   Mazzaglia, G.
   Ramon-Torregrosa, P. J.
   Diaz-Rodriguez, L.
   Garcia-Martinez, O.
   Vallecillo-Capilla, M.
   Ruiz, C.
   Cabrerizo-Vilchez, M. A.
TI Effect of roughness, wettability and morphology of engineered titanium
   surfaces on osteoblast-like cell adhesion
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT 4th International Workshop on Bubble and Drop Interfaces
CY SEP 23-25, 2009
CL Thessaloniki, GREECE
DE Titanium; Surface treatment; Topography; Wettability; Cell culture
ID HYDROFLUORIC-ACID TREATMENT; CONTACT-ANGLE HYSTERESIS; DENTAL IMPLANT
   SURFACES; CHEMICAL-MODIFICATION; PROTEIN-SYNTHESIS; FREE-ENERGY;
   BEHAVIOR; BIOMATERIALS; TOPOGRAPHY; MICROSCOPY
AB Texturization of surfaces is usually advantageous in biomaterial engineering. However, the details of the textured surfaces can be more determining on cell adhesion and proliferation, rather than their roughness degree. Titanium is extensively used as a dental implant material in the human body. In this paper, the effect of four surface treatments on commercially pure titanium has been evaluated. These treatments were polishing (pTi); hydrofluoric acid (HF) etching (eTi); Al(2)O(3) blasting (bTi); Al(2)O(3) blasting+ HF etching (beTi). Roughness and fractal dimensions were obtained from atomic force microscopy. Wettability was measured using water sessile drops. Morphology and surface chemical composition were analyzed with scanning electron microscopy and energy dispersive X-ray (EDX). MG-63 cell cultures were performed at different times (180 min, 24 h, 48 h, 72 h). Lowest roughness was found in pTi samples followed by eTi, bTi and beTi samples. Etching generated surfaces with the highest fractal dimension and negative skewness. Young contact angles were similar except for pTi and bTi surfaces. Silicon and aluminum traces were found in pTi and bTi samples, respectively. Cell adhesion (<= 24h) was greater on bTi and beTi surfaces. After 48 h, cell proliferation, mediated by specific morphologies, was improved in eTi samples followed by beTi surfaces. For the same surface chemistry, cell growth was driven by topography features. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Rodriguez-Valverde, M. A.; Ramon-Torregrosa, P. J.; Cabrerizo-Vilchez, M. A.] Univ Granada, Dept Appl Phys, Biocolloid & Fluid Phys Grp, E-18071 Granada, Spain.
   [Rosales-Leal, J. I.; Mazzaglia, G.; Vallecillo-Capilla, M.] Univ Granada, Fac Odontol, E-18071 Granada, Spain.
   [Diaz-Rodriguez, L.; Garcia-Martinez, O.; Ruiz, C.] Univ Granada, Sch Hlth Sci, Physiol Sect, Dept Nursing, E-18071 Granada, Spain.
RP Rodriguez-Valverde, MA (reprint author), Univ Granada, Dept Appl Phys, Biocolloid & Fluid Phys Grp, Campus Fuentenueva, E-18071 Granada, Spain.
EM marodri@ugr.es
RI Diaz Rodriguez, Lourdes/L-8433-2014; Ruiz, Concepcion/L-2808-2014;
   Garcia-Martinez, Olga/L-2782-2014; Rodriguez-Valverde, Miguel
   Angel/B-7938-2009; Cabrerizo-Vilchez, Miguel/A-3179-2012
OI Diaz Rodriguez, Lourdes/0000-0001-7906-5656; Ruiz,
   Concepcion/0000-0003-4332-6812; Garcia-Martinez,
   Olga/0000-0003-1912-4639; Rodriguez-Valverde, Miguel
   Angel/0000-0003-4361-6721; Cabrerizo-Vilchez, Miguel/0000-0001-8759-1373
CR Adamson A. W., 1997, PHYS CHEM SURFACES
   Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   AMADA S, 2000, J ADHES SCI TECHNOL, V14, P2741
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Baier RE, 2006, J MATER SCI-MATER M, V17, P1057, DOI 10.1007/s10856-006-0444-8
   Bathomarco RV, 2004, APPL SURF SCI, V233, P29, DOI 10.1016/j.apsusc.2004.04.007
   Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P35, DOI 10.1034/j.1600-0501.2003.140105.x
   BRANEMARK PI, 1977, SCAND J PLAST RECONS, V11, P171
   Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   DOUKETIS C, 1995, PHYS REV B, V51, P11022, DOI 10.1103/PhysRevB.51.11022
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   GIAVARESI G, 2003, BIOMATERIALS, V24, P1538
   Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032
   Ha SW, 1997, J MATER SCI-MATER M, V8, P891, DOI 10.1023/A:1018562023599
   Hao L, 2005, J MATER SCI-MATER M, V16, P719, DOI 10.1007/s10856-005-2608-3
   Janssen MI, 2004, BIOMATERIALS, V25, P2731, DOI 10.1016/j.biomaterials.2003.09.060
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Mandelbrot BB, 1983, FRACTAL GEOMETRY NAT
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MORRA M, 1990, ADV COLLOID INTERFAC, V32, P79, DOI 10.1016/0001-8686(90)80012-O
   Morra M, 1997, SURF INTERFACE ANAL, V25, P983, DOI 10.1002/(SICI)1096-9918(199712)25:13<983::AID-SIA345>3.0.CO;2-X
   Morra M, 2006, J BIOMED MATER RES A, V79A, P752, DOI 10.1002/jbm.a.31044
   Palasantzas G, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021604
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ramon-Torregrosa PJ, 2008, COLLOID SURFACE A, V323, P83, DOI 10.1016/j.colsurfa.2007.10.032
   Rodriguez-Valverde MA, 2008, ADV COLLOID INTERFAC, V138, P84, DOI 10.1016/j.cis.2007.12.002
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Rupp F, 2002, CHEM ENG TECHNOL, V25, P877, DOI 10.1002/1521-4125(20020910)25:9<877::AID-CEAT877>3.0.CO;2-D
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Wege HA, 2002, COLLOID SURFACE A, V206, P469, DOI 10.1016/S0927-7757(02)00088-2
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Zahn W, 1999, FRESEN J ANAL CHEM, V365, P168, DOI 10.1007/s002160051466
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 44
TC 127
Z9 129
U1 3
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD AUG 5
PY 2010
VL 365
IS 1-3
SI SI
BP 222
EP 229
DI 10.1016/j.colsurfa.2009.12.017
PG 8
WC Chemistry, Physical
SC Chemistry
GA 633WW
UT WOS:000280538700032
DA 2018-10-19
ER

PT J
AU Sask, KN
   Zhitomirsky, I
   Berry, LR
   Chan, AKC
   Brash, JL
AF Sask, Kyla N.
   Zhitomirsky, Igor
   Berry, Leslie R.
   Chan, Anthony K. C.
   Brash, John L.
TI Surface modification with an antithrombin-heparin complex for
   anticoagulation: Studies on a model surface with gold as substrate
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Blood compatibility; Heparin; Antithrombin; Gold; Polyethylene oxide
ID SELF-ASSEMBLED MONOLAYERS; POLY(ETHYLENE OXIDE); PROTEIN ADSORPTION;
   PLASMA-PROTEINS; COVALENT COMPLEX; IDENTIFICATION; CHEMISORPTION;
   ELLIPSOMETRY; REACTIVITY; CONTACT
AB Gold was used as a substrate for immobilization of an antithrombin-heparin (ATH) covalent complex to investigate ATH as a surface modifier to prevent blood coagulation Three different surface modification methods were used to attach ATH to gold: (i) direct chemisorption, (ii) using dithiobis(succinimidyl propionate) (DSP) as a linker molecule and (in) using polyethylene oxide (PEO) as a linker/spacer. The ATH-modified sui faces were compared to analogous heparinized surfaces. Water contact angles and X-ray photoelectron spectroscopy confirmed the modifications and provided data on surface properties and possible orientation Ellipsometry measurements showed that surface coverage of DSP and PEO was high ATH and heparin densities were quantified using radioiodination and quartz crystal microbalance, respectively The surface density of ATH was greatest on the DSP surface (0 17 mu g cm(-2)) and lowest on the PEO (0.05 mu g cm(-2)) The low uptake on the PEO surface was likely due to the protein resistance of the PEO component Using radioiodinated antithrombin (AT), it was shown that ATH-immobilized surfaces bound significantly greater amounts from both buffer and plasma than the analogous heparinized surfaces. Immunoblot analysis of proteins adsorbed from plasma demonstrated that surfaces chemisorbed with PEO, whether or not subsequently modified with ATH, inhibited non-specific adsorption The immunoblot response for AT was stronger on the DSP-ATH than on the heparin surfaces, thus confirming the results from radiolabelling. The ATH surfaces again showed higher selectivity for AT binding than analogous heparin-modified surfaces, indicating the enhanced anticoagulant potential of ATH for biomaterial surface modification. (C) 2010 Acta Materialia Inc Published by Elsevier Ltd All rights reserved.
C1 [Sask, Kyla N.; Zhitomirsky, Igor; Chan, Anthony K. C.; Brash, John L.] McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4K1, Canada.
   [Zhitomirsky, Igor] McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON L8S 4L7, Canada.
   [Berry, Leslie R.; Chan, Anthony K. C.] McMaster Univ, David Braley Res Inst, Hamilton, ON L8L 2X2, Canada.
RP Brash, JL (reprint author), McMaster Univ, Sch Biomed Engn, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.
OI Chan, Anthony K. C./0000-0003-1551-3995
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   CIHR [FRN79846]; Heart and Stroke Foundation of Canada
FX This work was supported by the Natural Sciences and Engineering Research
   Council of Canada (NSERC) and in part by a CIHR team grant in venous
   thromboembolism (FRN79846). A.K.C.C. is supported by a Career
   Investigator award from the Heart and Stroke Foundation of Canada. The
   assistance of Feng Sun with the QCM experiments is acknowledged.
CR Berry L, 1998, J BIOL CHEM, V273, P34730, DOI 10.1074/jbc.273.52.34730
   BERRY LR, 2000, POLYM BIOMATERIALS
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   CARRELL R, 1995, MOL MED TODAY, V1, P226, DOI 10.1016/S1357-4310(95)91494-3
   Chan A, 1997, J BIOL CHEM, V272, P22111, DOI 10.1074/jbc.272.35.22111
   Chen H, 2005, BIOMATERIALS, V26, P7418, DOI 10.1016/j.biomaterials.2005.05.053
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Dordi B, 2003, LANGMUIR, V19, P5780, DOI 10.1021/la0343066
   Du YJ, 2005, THROMB HAEMOSTASIS, V94, P366, DOI 10.1160/TH04-09-0581
   Du YJ, 2000, COLLOID SURFACE B, V17, P59, DOI 10.1016/S0927-7765(99)00053-3
   GOLANDER CG, 1982, COLLOID SURFACE, V5, P1, DOI 10.1016/0166-6622(82)80053-X
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   HARRIS JM, 1992, J OPT SOC AM A, V9, P14, DOI 10.1364/JOSAA.9.000014
   Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683
   JOANNY JF, 1984, J CHEM PHYS, V81, P552, DOI 10.1063/1.447337
   Klement P, 2002, BIOMATERIALS, V23, P527, DOI 10.1016/S0142-9612(01)00135-1
   Klement P, 2006, BIOMATERIALS, V27, P5107, DOI 10.1016/j.biomaterials.2006.05.005
   Manson L, 1997, J LAB CLIN MED, V130, P649, DOI 10.1016/S0022-2143(97)90115-3
   McClung WG, 2000, J BIOMED MATER RES, V49, P409, DOI 10.1002/(SICI)1097-4636(20000305)49:3<409::AID-JBM14>3.0.CO;2-0
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   SAUERBREY G, 1959, Z PHYS, V155, P155
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Storri S, 1998, BIOSENS BIOELECTRON, V13, P347, DOI 10.1016/S0956-5663(97)00119-X
   STRONG L, 1988, LANGMUIR, V4, P546, DOI 10.1021/la00081a009
   TROUGHTON EB, 1988, LANGMUIR, V4, P365, DOI 10.1021/la00080a021
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   Unsworth LD, 2005, J COLLOID INTERF SCI, V281, P112, DOI 10.1016/j.jcis.2004.08.022
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   YOUNG E, 1992, THROMB HAEMOSTASIS, V67, P639
NR 33
TC 27
Z9 28
U1 2
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2010
VL 6
IS 8
BP 2911
EP 2919
DI 10.1016/j.actbio.2010.02.043
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 621MQ
UT WOS:000279583400006
PM 20197127
DA 2018-10-19
ER

PT J
AU Chen, X
   Thibeault, SL
AF Chen, Xia
   Thibeault, Susan L.
TI Biocompatibility of a synthetic extracellular matrix on immortalized
   vocal fold fibroblasts in 3-D culture
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Human vocal fold fibroblasts; Three-dimensional culture; Extracellular
   matrix; HA hydrogel (Carbylan GSX); Cell proliferation
ID BASEMENT-MEMBRANE; LAMINA PROPRIA; CELL-CULTURE; IN-VITRO; HYALURONAN
   HYDROGELS; ENDOTHELIAL-CELLS; EXPRESSION; DIFFERENTIATION; INJECTION;
   GROWTH
AB In order to promote wound repair and Induce tissue regeneration, an engineered hyaluronan (HA) hydrogel - Carbylan GSX, which contains di(thiopropionyl) bishydrazide-modified hyaluronic acid, di(thiopropionyl) bishydrazide-modified gelatin and polyethylene glycol diacrylate - has been developed for extracellular matrix (ECM) defects of the superficial and middle layers of the lamina propria The purpose of this study was to evaluate the biocompatibility of Carbylan GSX in a previously established immortalized human vocal fold fibroblast (hVFF) cell line prior to human clinical trials Immortalized hVFF proliferation, viability, apoptosis and transcript analysis for both ECM constituents and inflammatory markers were measured for two-dimensional and three-dimensional (3-D) culture conditions There were no significant differences in morphology, cell marker protein expression, proliferation, viability and apoptosis of hVFF cultured with Carbylan GSX compared to Matrigel. a commercial 3-D control, after 1 week. Gene expression levels for fibromodulin, transforming growth factor-beta I and tumor necrosis factor-alpha were similar between Carbylan GSX and Matrigel Fibronectin, hyaluronidase 1 and cyclooxygenase II expression levels were induced by Carbylan GSX, whereas interleukins 6 and 8, Col I and hyaluronic acid synthase 3 expression levels were decreased by Carbylan GSX This investigation demonstrates that Carbylan GSX may serve as a natural biomaterial for tissue-engineering of human vocal folds (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd All rights reserved
C1 [Chen, Xia; Thibeault, Susan L.] Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Madison, WI 53705 USA.
RP Thibeault, SL (reprint author), Univ Wisconsin, Div Otolaryngol Head & Neck Surg, 5136 WIMR,1111 Highland Ave, Madison, WI 53705 USA.
FU National Institute of Deafness and Other Communication Disorders [R21
   DC008428]
FX The authors would like to acknowledge the National Institute of Deafness
   and Other Communication Disorders - R21 DC008428 for supporting this
   research project.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Agren UM, 1997, J INVEST DERMATOL, V109, P219, DOI 10.1111/1523-1747.ep12319412
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Chan RW, 2000, J ACOUST SOC AM, V107, P565, DOI 10.1121/1.428354
   Chen J, 1999, ULTRAMICROSCOPY, V79, P89, DOI 10.1016/S0304-3991(99)00060-1
   Chen X, 2008, LARYNGOSCOPE, V118, P1700, DOI [10.1097/MLG.0b013e31817aec6c, 10.1097/MLG.0b013e31817acc6c]
   Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390
   CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DEDO HH, 1973, ANN OTO RHINOL LARYN, V82, P661, DOI 10.1177/000348947308200509
   DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405, DOI 10.1128/MCB.11.9.4405
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   FORD CN, 1993, AM J OTOLARYNG, V14, P257, DOI 10.1016/0196-0709(93)90071-E
   Gantenbein-Ritter B, 2008, TISSUE ENG PART C-ME, V14, P353, DOI 10.1089/ten.tec.2008.0313
   Gao JP, 2004, EXP EYE RES, V78, P823, DOI 10.1016/j.exer.2003.10.024
   GRAY SD, 1994, J VOICE, V8, P48, DOI 10.1016/S0892-1997(05)80318-2
   Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115
   Hammond TH, 1997, J VOICE, V11, P59, DOI 10.1016/S0892-1997(97)80024-0
   Hudalla GA, 2008, BIOMACROMOLECULES, V9, P842, DOI 10.1021/bm701179s
   Isaji M, 1997, BRIT J PHARMACOL, V122, P1061, DOI 10.1038/sj.bjp.0701493
   Jongpaiboonkit L, 2008, BIOMATERIALS, V29, P3346, DOI 10.1016/j.biomaterials.2008.04.040
   KANGAS L, 1984, MED BIOL, V62, P338
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Munoz-Pinto DJ, 2009, BIOTECHNOL BIOENG, V104, P821, DOI 10.1002/bit.22436
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   PASSANITI A, 1992, LAB INVEST, V67, P519
   Pawlak AS, 1996, ANN OTO RHINOL LARYN, V105, P6, DOI 10.1177/000348949610500102
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Prestwich GD, 2006, ADV EXP MED BIOL, V585, P125
   Roy N, 2004, J SPEECH LANG HEAR R, V47, P542, DOI 10.1044/1092-4388(2004/042)
   Saika S, 1996, GRAEF ARCH CLIN EXP, V234, P251, DOI 10.1007/BF00430418
   Serban MA, 2008, ACTA BIOMATER, V4, P67, DOI 10.1016/j.actbio.2007.09.006
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221
   Thibeault SL, 2008, ANN OTO RHINOL LARYN, V117, P221, DOI 10.1177/000348940811700310
   Thibeault SL, 2008, OTOLARYNG HEAD NECK, V139, P816, DOI 10.1016/j.otohns.2008.09.009
   TITZE IR, 1992, J ACOUST SOC AM, V91, P2926, DOI 10.1121/1.402928
   TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910
   WANG XM, 1993, HUM IMMUNOL, V37, P264
NR 48
TC 42
Z9 43
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2010
VL 6
IS 8
BP 2940
EP 2948
DI 10.1016/j.actbio.2010.01.032
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 621MQ
UT WOS:000279583400009
PM 20109588
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Carlisle, CR
   Coulais, C
   Guthold, M
AF Carlisle, C. R.
   Coulais, C.
   Guthold, M.
TI The mechanical stress-strain properties of single electrospun collagen
   type I nanofibers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE AFM; Electrospinning; Collagen; Mechanical properties; Biomaterial
ID AVERAGING THEORY; PROTEIN FIBERS; FIBRIN FIBERS; ELASTICITY; NETWORKS;
   MATRICES; BEHAVIOR; TISSUES; FIELD
AB Knowledge of the mechanical properties of electrospun fibers is Important for their successful application in tissue engineering, material composites, filtration and drug delivery In particular, electrospun collagen has great potential for biomedical applications due to its biocompatibility and promotion of cell growth and adhesion. Using a combined atomic force microscopy (AFM)/optical microscopy technique, the single fiber mechanical properties of dry, electrospun collagen type I were determined. The fibers were electrospun from a 80 mg ml(-1) collagen solution in 1,1,1,3,3,3-hexafluro-2-propanol and collected on a striated surface suitable for lateral force manipulation by AFM The small strain modulus, calculated from three-point bending analysis, was 2.82 GPa. The modulus showed significant softening as the strain increased. The average extensibility of the fibers was 33% of their initial length, and the average maximum stress (rupture stress) was 25 MPa The fibers displayed significant energy loss and permanent deformations above 2% strain (C) 2010 Acta Materialia Inc Published by Elsevier Ltd All rights reserved.
C1 [Carlisle, C. R.; Coulais, C.; Guthold, M.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA.
RP Guthold, M (reprint author), Wake Forest Univ, Dept Phys, 7507 Reynolda Stn, Winston Salem, NC 27109 USA.
RI Coulais, Corentin/P-3920-2015
OI Coulais, Corentin/0000-0002-3174-5836
FU NIH [R41 CA103120, P41 EB002025]; NSF [CMMI-0646627]; American Heart
   Association [081503E]
FX This research was supported by the NIH, R41 CA103120 (M.G); NSF,
   CMMI-0646627 (M.G.); and the American Heart Association, 081503E
   (C.R.C.). The authors thank the NIH research resource P41 EB002025 for
   general support.
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   AKIHIRO T, 1996, MEAS SCI TECHNOL, V2, P179
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006
   Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369
   Chen ZG, 2009, J POLYM SCI POL PHYS, V47, P1949, DOI 10.1002/polb.21793
   Chen ZG, 2009, MAT SCI ENG C-MATER, V29, P2428, DOI 10.1016/j.msec.2009.07.006
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102
   Creighton T. E., 1993, PROTEINS STRUCTURES
   DUNN MG, 1983, CONNECT TISSUE RES, V12, P59, DOI 10.3109/03008208309005612
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087
   Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4
   He JH, 2008, FIBER POLYM, V9, P140, DOI 10.1007/s12221-008-0023-3
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Im JS, 2010, ACTA BIOMATER, V6, P102, DOI 10.1016/j.actbio.2009.06.017
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Li D, 2004, ADV MATER, V16, P361, DOI 10.1002/adma.200306226
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lim CT, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857478
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Liu W, 2010, J THROMB HAEMOST, V8, P1030, DOI 10.1111/j.1538-7836.2010.03745.x
   Liu WH, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2745733
   Lodish H., 2000, MOL CELL BIOL, P154
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Pai CL, 2009, MACROMOLECULES, V42, P2102, DOI 10.1021/ma802529h
   Peng L, 2007, MICROSC RES TECHNIQ, V70, P372, DOI 10.1002/jemt.20421
   PIEZ KA, 1963, BIOCHEMISTRY-US, V2, P58, DOI 10.1021/bi00901a012
   REILLY DT, 1974, J BONE JOINT SURG AM, VA 56, P1001, DOI 10.2106/00004623-197456050-00012
   Rutledge GC, 2007, ADV DRUG DELIVER REV, V59, P1384, DOI 10.1016/j.addr.2007.04.020
   Sattin BD, 2004, NUCLEIC ACIDS RES, V32, P4876, DOI 10.1093/nar/gkh826
   Schmitt FO, 1942, J CELL COMPAR PHYSL, V20, P11, DOI 10.1002/jcp.1030200103
   Shin YM, 2001, APPL PHYS LETT, V78, P1149, DOI 10.1063/1.1345798
   Silver F., 1987, BIOL MAT STRUCTURE M
   Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Tian M, 2007, POLYMER, V48, P2720, DOI 10.1016/j.polymer.2007.03.032
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zussman E, 2005, CARBON, V43, P2175, DOI 10.1016/j.carbon.2005.03.031
   ZUSSMAN E, 2003, APPL PHYS LETT, V82
NR 53
TC 42
Z9 43
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2010
VL 6
IS 8
BP 2997
EP 3003
DI 10.1016/j.actbio.2010.02.050
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 621MQ
UT WOS:000279583400015
PM 20197123
DA 2018-10-19
ER

PT J
AU Nyangoga, H
   Aguado, E
   Goyenvalle, E
   Basle, MF
   Chappard, D
AF Nyangoga, Herve
   Aguado, Eric
   Goyenvalle, Eric
   Basle, Michel Felix
   Chappard, Daniel
TI A non-steroidal anti-inflammatory drug (ketoprofen) does not delay
   beta-TCP bone graft healing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE beta-TCP; Bone healing; Non-steroidal anti-inflammatory drugs; Bone
   graft; MicroCT
ID CALCIUM-PHOSPHATE BIOCERAMICS; SINUS FLOOR AUGMENTATION; TRICALCIUM
   PHOSPHATE; VASCULAR-PERMEABILITY; COX-2 INHIBITORS; SURGERY; RABBITS;
   TUMOR; HYDROXYAPATITE; REGENERATION
AB B-Tricalcium phosphate (beta-TCP) is a suitable Immaterial in oral and maxillofacial surgery since it can induce a rapid proliferation of woven bone Granules, prepared by the polyurethane foam method, were implanted in critical size defects performed in the femoral condyles of New Zealand rabbits Animals were studied after 8 and 28 days. Ketoprofen (a non-steroidal anti-inflammatory drug (NSAID)) was given for 8 and 28 days to evaluate its effects on the healing of the graft Before euthanasia, the rabbits received an intravenous injection of fluorescent microbeads Bones were analyzed by microcomputed tomography beta-TCP granules induced metaplastic bone trabeculae as early as 8 days post-surgery. At 28 days, the amount of bone was increased and the biomaterial volume decreased due to simultaneous macrophagic resorption The amount of macrophages labeled with microbeads was less in the grafted area than in the vicinal intact marrow spaces. Ketoprofen had no effect on the amount of bone formed and on the number of labeled macrophages The influence of small doses of NSAID, given in a short duration period. did not present deleterious effects on bone graft healing (C) 2010 Acta Materialia Inc Published by Elsevier Ltd All rights reserved
C1 [Nyangoga, Herve; Aguado, Eric; Goyenvalle, Eric; Basle, Michel Felix; Chappard, Daniel] Fac Med, LHEA, INSERM, U922, F-49045 Angers, France.
   [Aguado, Eric; Goyenvalle, Eric] Ecole Natl Vet, BBTOCEX, F-44307 Nantes, France.
RP Chappard, D (reprint author), Fac Med, LHEA, INSERM, U922, F-49045 Angers, France.
FU INSERM; Contrat Region Pays de la Loire (Bioregos2 program)
FX This work was made possible by grants from INSERM and Contrat Region
   Pays de la Loire (Bioregos2 program). The authors thank Mrs Laurence
   Lechat for secretarial assistance and Kasios ZI La Croix, 31140
   Launaguet - France for providing the biomaterial. They also thank Mrs
   Florence Pascaretti-Grizon for skilful assistance with the histological
   technique and Romani Mallet for help with scanning electron microscopy.
   SEM analysis was done at SCIAM (Service Commun d'Imagerie et Analyses
   Microscopiques), Universite d'Angers.
CR Aunoble S, 2006, J BIOMED MATER RES A, V78A, P416, DOI 10.1002/jbm.a.30749
   Beck A, 2003, ARCH ORTHOP TRAUM SU, V123, P327, DOI 10.1007/s00402-003-0537-5
   Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P1034, DOI 10.1111/j.1600-0501.2008.01573.x
   Boursinos LA, 2009, J MUSCULOSKEL NEURON, V9, P44
   Bouvard B, 2010, CLIN REV BONE MINER, V8, P15, DOI 10.1007/s12018-009-9051-9
   Chappard D, 2010, BONE CANCER: PROGRESSION AND THERAPEUTIC APPROACHES, P203
   Chazono M, 2008, J ORTHOP SCI, V13, P550, DOI 10.1007/s00776-008-1271-1
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Dimmen S, 2009, KNEE SURG SPORT TR A, V17, P835, DOI 10.1007/s00167-009-0763-7
   DRIESSEN AA, 1982, BIOMATERIALS, V3, P113
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Endo K, 2005, ACTA ORTHOP, V76, P470, DOI 10.1080/17453670510041439
   Filmon R, 2009, IMAGE ANAL STEREOL, V28, P1
   Fransen M, 2004, CONTROL CLIN TRIALS, V25, P223, DOI 10.1016/j.cct.2003.11.008
   Galois L, 2002, INT ORTHOP, V26, P109, DOI 10.1007/s00264-001-0329-x
   Gerstenfeld LC, 2003, J ORTHOPAED RES, V21, P670, DOI 10.1016/S0736-0266(03)00003-2
   Giannoudis PV, 2000, J BONE JOINT SURG BR, V82B, P655, DOI 10.1302/0301-620X.82B5.9899
   Giordano V, 2003, INJURY, V34, P85, DOI 10.1016/S0020-1383(02)00199-7
   Goodman SB, 2005, J BIOMED MATER RES A, V72A, P279, DOI 10.1002/jbm.a.30231
   Harder AT, 2003, J CLIN PHARMACOL, V43, P807, DOI 10.1177/0091270003256061
   Horak D, 1999, BIOTECHNOL PROGR, V15, P208, DOI 10.1021/bp990006w
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4
   Karachalios T, 2007, J BONE JOINT SURG BR, V89B, P1253, DOI 10.1302/0301-620X.89B9.19050
   KIM YH, 2008, J KOR CERAM SOC, V45, P618
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Mabilleau G, 2004, BIOMATERIALS, V25, P5155, DOI 10.1016/j.biomaterials.2003.12.026
   Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Meyer C, 2009, REV STOMATOL CHIR, V110, P69, DOI 10.1016/j.stomax.2008.10.006
   MONTHEARD JP, 1997, DESK REFERENCE FUNCT, P699
   Muschik M, 2001, EUR SPINE J, V10, pS178, DOI 10.1007/s005860100271
   NAGAHARA K, 1992, International Journal of Oral and Maxillofacial Implants, V7, P72
   Nyangoga H, 2009, J BIOMED MATER RES B, V89B, P501, DOI 10.1002/jbm.b.31240
   Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136
   Partlow D. P., 1987, Journal of Materials Research, V2, P595, DOI 10.1557/JMR.1987.0595
   Pountos I, 2008, INJURY, V39, P384, DOI 10.1016/j.injury.2007.10.035
   RO J, 1976, ACTA ORTHOP SCAND, V47, P588, DOI 10.3109/17453677608988744
   Schwartzwalder K., 1963, Patent US, Patent No. [3090094 A, 3090094, 3,090,094]
   Seidenberg AB, 2004, PHARMACOL RES, V50, P151, DOI 10.1016/j.phrs.2003.12.017
   Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E
   SUDMANN E, 1979, ACTA ORTHOP SCAND, V50, P621, DOI 10.3109/17453677908991283
   Suzuki Y, 2007, J ORTHOP SCI, V12, P568, DOI 10.1007/s00776-007-1180-8
   Zecheru T, 2009, BIOPOLYMERS, V91, P966, DOI 10.1002/bip.21286
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
NR 50
TC 17
Z9 18
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2010
VL 6
IS 8
BP 3310
EP 3317
DI 10.1016/j.actbio.2010.01.042
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 621MQ
UT WOS:000279583400051
PM 20132910
DA 2018-10-19
ER

PT J
AU Bernstein, M
   Gotman, I
   Makarov, C
   Phadke, A
   Radin, S
   Ducheyne, P
   Gutmanas, EY
AF Bernstein, Michael
   Gotman, Irena
   Makarov, Carina
   Phadke, A.
   Radin, Shulmit
   Ducheyne, Paul
   Gutmanas, Elazar Y.
TI Low Temperature Fabrication of beta-TCP-PCL Nanocomposites for Bone
   Implants
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID TRICALCIUM PHOSPHATE; IN-VITRO; COMPOSITE BIOMATERIAL;
   MECHANICAL-PROPERTIES; HYDROXYAPATITE HA; SCAFFOLDS; SURGERY;
   BIOCERAMICS; DISSOLUTION; COATINGS
AB A method to fabricate strong bioresorbable calcium phosphate-polymer nanocomposites with low polymer content without exposing the material to excessively high-processing temperatures is reported. Dense beta-TCP-based nanocomposites containing 5 or 15 vol% of uniformly distributed polycaprolactone (PCL) polymer were obtained by mixing beta-TCP nano powder with PCL dissolved in chloroform followed by room temperature consolidation at the high pressure of 2.5 GPa (cold sintering). The composites had an attractive combination of compressive strength and ductility, and their dissolution behavior was similar to that of pure cold sintered beta-TCP. The immersion of beta-TCP PCL composites in simulated body fluid (SBF) yielded in vitro deposition of a bone-like apatite layer suggesting the ability of these materials to bind to native bone tissue upon implantation.
C1 [Bernstein, Michael; Gotman, Irena; Makarov, Carina; Gutmanas, Elazar Y.] Technion Israel Inst Technol, Fac Mat Engn, IL-32000 Haifa, Israel.
   [Phadke, A.; Radin, Shulmit; Ducheyne, Paul] Univ Penn, Ctr Bioact Mat, Philadelphia, PA 19104 USA.
RP Bernstein, M (reprint author), Technion Israel Inst Technol, Fac Mat Engn, IL-32000 Haifa, Israel.
EM gotman@tx.technion.ac.il
RI Gutmanas, Elazar/J-5025-2017
OI Gutmanas, Elazar/0000-0003-4570-1700
FU U.S.-Israel Binational Science Foundation (BSF) [2004-293]
FX The research was supported by U.S.-Israel Binational Science Foundation
   (BSF) through research grant no. 2004-293.
CR Ang KC, 2007, J BIOMED MATER RES A, V80A, P655, DOI 10.1002/jbm.a.30996
   Aunoble S, 2006, J BIOMED MATER RES A, V78A, P416, DOI 10.1002/jbm.a.30749
   Bow JS, 2004, BIOMATERIALS, V25, P3155, DOI 10.1016/j.biomaterials.2003.10.046
   Brossmann U, 1999, J APPL PHYS, V85, P7646, DOI 10.1063/1.370567
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   FUCHS S, 2010, ACTA BIOMATER
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   Gutmanas E.Y., 1998, ASM HDB, V7, P574
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Huttunen M, 2006, ACTA BIOMATER, V2, P575, DOI 10.1016/j.actbio.2006.03.008
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   ISHIKAWA K, 1993, J MATER SCI-MATER M, V4, P165, DOI 10.1007/BF00120386
   Jalota S, 2006, J BIOMED MATER RES A, V78A, P481, DOI 10.1002/jbm.a.30851
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P825, DOI 10.1002/1097-4636(20001215)52:4<825::AID-JBM28>3.0.CO;2-M
   LEGEROS RZ, 1989, SCANNING MICROSCOPY, V3, P129
   LEGEROS RZ, 1984, PHOSPHATE MINERALS, V351
   MAKAROV C, 2010, J MAT SCI
   MAKAROV C, 2010, J MAT SCI MAT MED
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Musumeci AW, 2007, SPECTROCHIM ACTA A, V67, P649, DOI 10.1016/j.saa.2006.07.045
   Neumann M., 2006, EUR J TRAUMA, V2, P125
   Ozkan S, 2010, J BIOMED MATER RES A, V92A, P1007, DOI 10.1002/jbm.a.32425
   Pezzotti G, 2003, J BIOMED MATER RES A, V65A, P229, DOI 10.1002/jbm.a.10447
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   Rai B, 2004, BIOMATERIALS, V25, P5499, DOI 10.1016/j.biomaterials.2004.01.007
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Simon J A, 1997, Am J Orthop (Belle Mead NJ), V26, P665
   Suggs L.J., 2007, PHYS PROPERTIES POLY, P939
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Todo M, 2007, ENG FRACT MECH, V74, P1872, DOI 10.1016/j.engfracmech.2006.05.021
   Yang HY, 2008, J MATER SCI-MATER M, V19, P3345, DOI 10.1007/s10856-008-3473-7
   YUBAO L, 1994, J MATER SCI-MATER M, V5, P263, DOI 10.1007/BF00122395
NR 40
TC 13
Z9 13
U1 2
U2 13
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD AUG
PY 2010
VL 12
IS 8
SI SI
BP B341
EP B347
DI 10.1002/adem.201080027
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 670UC
UT WOS:000283451800023
DA 2018-10-19
ER

PT J
AU Lelli, M
   Foltran, I
   Foresti, E
   Martinez-Fernandez, J
   Torres-Raya, C
   Varela-Feria, FM
   Roveri, N
AF Lelli, M.
   Foltran, I.
   Foresti, E.
   Martinez-Fernandez, J.
   Torres-Raya, C.
   Varela-Feria, F. M.
   Roveri, N.
TI Biomorphic Silicon Carbide Coated with an Electrodeposition of
   Nanostructured Hydroxyapatite/Collagen as Biomimetic Bone Filler and
   Scaffold
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID MECHANICAL-PROPERTIES; CERAMICS; GROWTH; MICROSTRUCTURE; COMPOSITES;
   DEPOSITION; TITANIUM; WOOD
AB The paper describes the method of preparation and chemical/physical characterization of a new biomaterial to be used as a bone substitute and bone-tissue engineering scaffold, which synergistically joins a porous bio-inspired morphology and the mechanical properties of biomorphic silicon carbide (BioSiC) with the surface bioactivity of a nanostructured hydroxyapatite/collagen biomimetic coating. FT-IR spectroscopy and XRD techniques are utilized to determine the chemical coating's composition. The morphology and size of the inorganic and protein components are investigated by TEM. The characteristic morphology of BioSiC channels and pores, which differ as a function of the transversal or longitudinal cross-section and with etching time, are investigated by SEM. Natural wood transformed into BioSiC acts as a cathode in an electrochemically assisted process that produces on its surface a biomimetic coating of hydroxyapatite nanocrystals and reconstituted type I collagen fibrils, producing an innovative apatite/collagen biomimetic porous bone filler and scaffold for tissue engineering.
C1 [Lelli, M.; Foltran, I.; Foresti, E.; Roveri, N.] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Foltran, I.] Univ Eastern Piedmont Amedeo Avogadro, Dept Med Sci, I-28100 Novara, Italy.
   [Martinez-Fernandez, J.; Torres-Raya, C.; Varela-Feria, F. M.] Univ Seville, Dept Fis Mat Condensada, E-41080 Seville, Spain.
RP Lelli, M (reprint author), Univ Bologna, Dept Chem G Ciamician, Via F Selmi 2, I-40126 Bologna, Italy.
EM norberto.roveri@unibo.it
RI MARTINEZ FERNANDEZ, JULIAN/K-1826-2012
OI MARTINEZ FERNANDEZ, JULIAN/0000-0002-1199-6638
FU European Commission [NMP4-CT-2006-033277]; Inter-University Consortium
   for Research on Metal Chemistry in Biological Systems (C.I.R.C.M.S.B);
   Piedmont Region
FX The authors gratefully acknowledge the European Commission for financial
   support under FP6 contract number NMP4-CT-2006-033277 (TEM-PLANT) and
   the Inter-University Consortium for Research on Metal Chemistry in
   Biological Systems (C.I.R.C.M.S.B). IF is the recipient of a fellowship
   from Piedmont Region.
CR Burzynska L, 2008, SURF COAT TECH, V202, P2545, DOI 10.1016/j.surfcoat.2007.09.020
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   DE ARELLANOLOPEZ, 2004, INT J APPL CERAM TEC, V1, P56
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Falini G, 2004, J MATER CHEM, V14, P2297, DOI 10.1039/b401393j
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   FERNANDEZ JM, 2001, Patent No. 200102278
   FOLTRAN I, 2009, 1 INT C MULT HYBR NA
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   GONZALES P, 2009, J BIOMED MATER RES A, V3, P807
   Greil P, 1998, J EUR CERAM SOC, V18, P1961, DOI 10.1016/S0955-2219(98)00156-3
   KANEKO T, 2004, J CRYST GROWTH, V275, P1097
   KARUNAKAR K, 2006, J BIOL CHEM, V281, P33238
   Katharria YS, 2007, NUCL INSTRUM METH B, V254, P78, DOI 10.1016/j.nimb.2006.09.016
   Li XF, 2006, J EUR CERAM SOC, V26, P3657, DOI 10.1016/j.jeurceramsoc.2005.10.015
   Lin XY, 2005, KEY ENG MAT, V288-289, P195, DOI 10.4028/www.scientific.net/KEM.288-289.195
   Lu X, 2005, J CRYST GROWTH, V284, P506, DOI 10.1016/j.jcrysgro.2005.07.032
   Manara S, 2008, INORG CHIM ACTA, V361, P1634, DOI 10.1016/j.ica.2007.03.044
   Martinez-Fernandez J, 2001, CERAM ENG SCI PROC, V22, P135
   Martinez-Fernandez J, 2000, ENVIRONMENT CONSCIOUS MATERIALS - ECOMATERIALS, P733
   MARTINEZFERNAND.J, 2000, SCRIPTA MATER, V43, P818
   MEEK KM, 1979, J BIOL CHEM, V254, P710
   MELEMEJEAN T, 1995, J MOL STRUCT, V349, P105
   *PANALYTICAL B V, 2004, XPERT HIGH SCOR VERS
   Parma B, 2002, [No title captured], Patent No. [WO 02097990, 02097990]
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Roveri N, 2009, J NANOMATER, DOI 10.1155/2009/746383
   Ruiz-Hitzky E, 2003, CHEM REC, V3, P88, DOI 10.1002/tcr.10054
   Sepulveda R, 2005, BOL SOC ESP CERAM V, V44, P357, DOI 10.3989/cyv.2005.v44.i5.370
   Singh M, 2003, CURR OPIN SOLID ST M, V7, P247, DOI 10.1016/j.cossms.2003.09.004
   Socha RP, 2004, COLLOID SURFACE A, V235, P45, DOI 10.1016/j.colsurfa.2004.01.011
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Tampieri A, 2009, J MATER CHEM, V19, P4973, DOI 10.1039/b900333a
   Torres-Raya C, 2008, J MATER RES, V23, P3247, DOI 10.1557/JMR.2008.0392
   VALERAFERIA FM, 2006, CERAM T, V177, P93
   VALERAFERIA FM, 2008, J MAT SC, V43, P933
   Varela-Feria FM, 2002, J EUR CERAM SOC, V22, P2719, DOI 10.1016/S0955-2219(02)00137-1
   VARELAFERIA FM, 2002, CERAMICS ENG SCI P, V23, P854
   Vincent JFV, 2006, J R SOC INTERFACE, V3, P471, DOI 10.1098/rsif.2006.0127
   Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935
   Yousefpour M, 2006, J ELECTROANAL CHEM, V589, P96, DOI 10.1016/j.jelechem.2006.01.020
   Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154
   Zimmerman AF, 2002, MAT SCI ENG A-STRUCT, V328, P137, DOI 10.1016/S0921-5093(01)01692-6
NR 44
TC 8
Z9 8
U1 3
U2 46
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD AUG
PY 2010
VL 12
IS 8
SI SI
BP B348
EP B355
DI 10.1002/adem.200980086
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 670UC
UT WOS:000283451800024
DA 2018-10-19
ER

PT J
AU Naveen, N
   Kumar, R
   Balaji, S
   Uma, TS
   Natrajan, TS
   Sehgal, PK
AF Naveen, N.
   Kumar, R.
   Balaji, S.
   Uma, T. S.
   Natrajan, T. S.
   Sehgal, P. K.
TI Synthesis of Nonwoven Nanofibers by Electrospinning - A Promising
   Biomaterial for Tissue Engineering and Drug Delivery
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID POLY 3-HYDROXYBUTYRATE; FIBER MATS; IN-VITRO; POLY(3-HYDROXYBUTYRATE);
   DEGRADATION; KANAMYCIN; SCAFFOLDS; RELEASE;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); PARAMETERS
AB PHB nanofibers are synthesized by electros pinning of a PHB solution prepared using HFIP as the solvent. The nanofibrous scaffold supports rapid cell growth with normal morphology and attains a viability of 87% after 48 h. Kanamycin sulphate-loaded PHB nanofiber mats are synthesized, with the antibiotic on the surface and sandwiched within the nanofiber mats: their antimicrobial property is proved by the good zone of inhibition tested against Staphylococcus aureus. The drug shows more than 95% release within 8 h. These results indicate that nanofibers loaded with the antibiotic have potential applications as a template for tissue engineering and as a drug carrier.
C1 [Naveen, N.; Kumar, R.; Balaji, S.; Uma, T. S.; Sehgal, P. K.] Cent Leather Res Inst, Council Sci & Ind Res, Bioprod Lab, Biomat Div, Madras 600020, Tamil Nadu, India.
   [Natrajan, T. S.] Indian Inst Technol, Dept Phys, Conducting Polymer Lab, Madras 600036, Tamil Nadu, India.
RP Naveen, N (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Bioprod Lab, Biomat Div, Madras 600020, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
RI Tirichurapalli Sivagnanam, uma/E-1325-2017
OI Tirichurapalli Sivagnanam, uma/0000-0002-1401-2569
FU CSIR, Government of India
FX We are grateful to Dr A. B. Mandal, Director, CLRI, Chennai, for his
   kind permission to publish this work. The authors N.N, R.K and S.B
   acknowledge CSIR, Government of India for the financial assistance in
   the form of Senior Research Fellowships.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   CRON MJ, 1958, ANN NY ACAD SCI, V76, P27, DOI 10.1111/j.1749-6632.1958.tb54689.x
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Guan DH, 2008, APPL SURF SCI, V255, P324, DOI 10.1016/j.apsusc.2008.06.093
   Herek LCS, 2006, BRAZ J CHEM ENG, V23, P227, DOI 10.1590/S0104-66322006000200010
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   HUANG ZM, 2006, J BIOMED MATER RES A, V77, P1699
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ishii D, 2007, J BIOTECHNOL, V132, P318, DOI 10.1016/j.jbiotec.2007.03.019
   JIANG H, 2002, J BIOMAT SCI-POLYM E, V15, P279
   Kansiz M, 2000, APPL ENVIRON MICROB, V66, P3415, DOI 10.1128/AEM.66.8.3415-3420.2000
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim GM, 2007, J APPL POLYM SCI, V103, P1860, DOI 10.1002/app.25348
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Li SD, 2003, J APPL POLYM SCI, V89, P1530, DOI 10.1002/app.12249
   Long YH, 2003, J CHROMATOGR B, V784, P255, DOI 10.1016/S1570-0232(02)00804-8
   Lu XQ, 2004, J INORG BIOCHEM, V98, P582, DOI 10.1016/j.jinorgbio.2003.12.019
   Maretschek S, 2008, J CONTROL RELEASE, V127, P180, DOI 10.1016/j.jconrel.2008.01.011
   Min BM, 2004, POLYMER, V45, P7137, DOI 10.1016/j.polymer.2004.08.048
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Piras AM, 2008, J BIOACT COMPAT POL, V23, P423, DOI 10.1177/0883911508093357
   Puius YA, 2006, CARBOHYD RES, V341, P2871, DOI 10.1016/j.carres.2006.09.008
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Shabani I, 2009, BIOCHEM BIOPH RES CO, V382, P129, DOI 10.1016/j.bbrc.2009.02.150
   Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006
   Tan S, 2007, POLYM INT, V56, P1330, DOI 10.1002/pi.2354
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zhao DM, 2007, J BIOACT COMPAT POL, V22, P379, DOI 10.1177/0883911507079802
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 35
TC 29
Z9 29
U1 2
U2 32
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD AUG
PY 2010
VL 12
IS 8
SI SI
BP B380
EP B387
DI 10.1002/adem.200980067
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 670UC
UT WOS:000283451800028
DA 2018-10-19
ER

PT J
AU Giannini, GT
   Boothby, JT
   Sabelman, EE
AF Giannini, Gina T.
   Boothby, John T.
   Sabelman, Eric E.
TI Infected Wound Model Development of an In Vitro Biomaterial-Protected
   Wound Infection Model to Study Microbial Activity and Antimicrobial
   Treatment through Microdialysis
SO ADVANCES IN SKIN & WOUND CARE
LA English
DT Article
AB OBJECTIVE: Skin injuries provide a favorable environment for microbial infection if left untreated. This is problematic especially in nosocomial situations having a high prevalence of Staphylococcus aureus that can cause suppuration of wounds, systemic disease, and toxic shock. The objective of this investigation was to use a wound model system to study the interactions between microbial activity, host tissue, therapeutic treatments, and wound biomaterials.
   DESIGN: An in vitro wound model was developed using Sykes-Moore chambers filled with 1 of 2 biomaterials used for wound treatment (1% alginate and dialyzed HyFil hydrogel (B. Braun Medical, Inc, Bethlehem, Pennsylvania) and seeded with fibroblasts. The chambers were inoculated with S aureus, and half were later treated with antibiotics through in situ microdialysis tubing.
   MAIN OUTCOME MEASURES: The chambers were monitored by obtaining fluid samples and biomaterial samples at specific time intervals (0, 2, 8, and 24 hours) and were analyzed for (1) S aureus protein A (SPA) concentration, (2) viable S aureus numbers, and (3) fibroblast numbers and viability. Chambers containing each biomaterial with and without antibiotics were compared to controls.
   MAIN RESULTS: There was an inverse relationship between postinfection S aureus numbers and fibroblast viability. S aureus numbers were usually consistent with SPA concentration, which may have been underestimated because of SPA interactions with the biomaterials.
   CONCLUSION: This wound model may be useful to gain an understanding about the interactions between microbial activity, host tissue, therapeutic treatments, and wound biomaterials. Hypotheses about wound treatments derived by means of this model may direct future in vivo studies.
C1 [Giannini, Gina T.; Boothby, John T.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.
   [Giannini, Gina T.; Sabelman, Eric E.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr, Palo Alto, CA USA.
   [Giannini, Gina T.] Experien Grp LLC, Sunnyvale, CA USA.
   [Sabelman, Eric E.] Kaiser Permanente Med Ctr, Dept Neurosurg, Redwood City, CA USA.
RP Giannini, GT (reprint author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.
CR Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
   Chaurasia CS, 1999, BIOMED CHROMATOGR, V13, P317, DOI 10.1002/(SICI)1099-0801(199908)13:5<317::AID-BMC891>3.0.CO;2-I
   CLOUGH GF, 2003, LOW EXTREM WOUNDS, V2, P233
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   GIANNINI GT, 2007, THESIS SAN JOSE STAT
   GIANNINI GT, 2006, AM SOC MICR 106 GEN
   Kratz G, 1998, MICROSC RES TECHNIQ, V42, P345, DOI 10.1002/(SICI)1097-0029(19980901)42:5<345::AID-JEMT5>3.0.CO;2-O
   PAULSON DS, 2005, AORN, V81, P491
   Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017
   PRESCOTT LM, 2002, MICROBIOLOGY, P132
   SEE RH, 1989, J CLIN MICROBIOL, V27, P2050
   Stolle LB, 2004, ACTA ORTHOP SCAND, V75, P106, DOI 10.1080/00016470410001708210
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   SYKES JOHN A., 1960, TEXAS REPTS BIOL AND MED, V18, P288
   Wills QF, 2005, ANTIMICROB AGENTS CH, V49, P1220, DOI 10.1128/AAC.49.3.1120-1221.2005
   Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004
NR 16
TC 0
Z9 0
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1527-7941
J9 ADV SKIN WOUND CARE
JI Adv. Skin Wound Care
PD AUG
PY 2010
VL 23
IS 8
BP 358
EP 364
DI 10.1097/01.ASW.0000383199.56007.ef
PG 7
WC Dermatology; Nursing; Surgery
SC Dermatology; Nursing; Surgery
GA 832YU
UT WOS:000295847700004
PM 20664329
DA 2018-10-19
ER

PT J
AU Mikolasch, A
   Hahn, V
   Manda, K
   Pump, J
   Illas, N
   Gordes, D
   Lalk, M
   Salazar, MG
   Hammer, E
   Julich, WD
   Rawer, S
   Thurow, K
   Lindequist, U
   Schauer, F
AF Mikolasch, Annett
   Hahn, Veronika
   Manda, Katrin
   Pump, Judith
   Illas, Nicole
   Goerdes, Dirk
   Lalk, Michael
   Salazar, Manuela Gesell
   Hammer, Elke
   Juelich, Wolf-Dieter
   Rawer, Stephan
   Thurow, Kerstin
   Lindequist, Ulrike
   Schauer, Frieder
TI Laccase-catalyzed cross-linking of amino acids and peptides with
   dihydroxylated aromatic compounds
SO AMINO ACIDS
LA English
DT Article
DE Laccase; Mussel adhesive proteins; Cross-link; Biomaterial;
   epsilon-Amino group
ID CALIFORNIANUS BYSSAL THREADS; RESONANCE MASS-SPECTROMETRY;
   MYTILUS-CALIFORNIANUS; ADHESIVE PROTEIN; MUSSEL BYSSUS;
   L-BETA-3,4-DIHYDROXYPHENYL-ALPHA-ALANINE DOPA; SEQUENTIAL POLYPEPTIDES;
   MUSHROOM TYROSINASE; FUNGAL LACCASES; MARINE MUSSEL
AB In order to design potential biomaterials, we investigated the laccase-catalyzed cross-linking between l-lysine or lysine-containing peptides and dihydroxylated aromatics. l-Lysine is one of the major components of naturally occurring mussel adhesive proteins (MAPs). Dihydroxylated aromatics are structurally related to 3,4-dihydroxyphenyl-l-alanine, another main component of MAPs. Mass spectrometry and nuclear magnetic resonance analyses show that the epsilon-amino group of l-lysine is able to cross-link dihydroxylated aromatics. Additional oligomer and polymer cross-linked products were obtained from di- and oligopeptides containing l-lysine. Potential applications in medicine or industry for biomaterials synthesised via the three component system consisting of the oligopeptide [Tyr-Lys](10), dihydroxylated aromatics and laccase are discussed.
C1 [Mikolasch, Annett; Hahn, Veronika; Pump, Judith; Illas, Nicole; Schauer, Frieder] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany.
   [Manda, Katrin] Univ Rostock, Dept Radiotherapy, D-18059 Rostock, Germany.
   [Goerdes, Dirk] Univ Rostock, Inst Automat, D-18119 Rostock, Germany.
   [Lalk, Michael; Juelich, Wolf-Dieter; Lindequist, Ulrike] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany.
   [Salazar, Manuela Gesell; Hammer, Elke] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany.
   [Rawer, Stephan] Appl Biosyst Inc, D-64293 Darmstadt, Germany.
   [Thurow, Kerstin] Ctr Life Sci Automat, D-18119 Rostock, Germany.
RP Mikolasch, A (reprint author), Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Friedrich Ludwig Jahn Str 15, D-17487 Greifswald, Germany.
EM annett.mikolasch@uni-greifswald.de
RI Lalk, Michael/C-1618-2010; Manda, Katrin/A-8920-2018; Schauer,
   Frieder/N-8070-2017; Lindequist, Ulrike/M-8545-2013
OI Lalk, Michael/0000-0002-9230-0267; Manda, Katrin/0000-0002-6911-022X; 
FU European Union; Stryker Trauma GmbH (Schonkirchen); Aesculap AG & Co. KG
   (Tuttlingen); BSN medical GmbH & Co. KG (Hamburg)
FX Financial support from the government of Mecklenburg-Vorpommern and from
   the European Union (Landesforschungsschwerpunkt "Neue Wirkstoffe und
   Biomaterialien - Innovative Screeningverfahren and Produktentwicklung'',
   Stiftung Industrieforschung" Weich- und Hartteilkleber fur medizinische
   Anwendungen, hergestellt durch Vernetzung von Proteinen durch
   Polyphenoloxidasen, inKombination mit Blutstillung Projekt-Nr. S 752)
   and from Stryker Trauma GmbH (Schonkirchen), from Aesculap AG & Co. KG
   (Tuttlingen), and from BSN medical GmbH & Co. KG (Hamburg) is gratefully
   acknowledged. We thank R. Jack (Institute of Immunology, University of
   Greifswald) for help in preparing the manuscript.
CR Amster IJ, 1996, J MASS SPECTROM, V31, P1325
   Berka RM, 1997, APPL ENVIRON MICROB, V63, P3151
   BOURBONNAIS R, 1990, FEBS LETT, V267, P99, DOI 10.1016/0014-5793(90)80298-W
   BraunLullemann A, 1997, APPL MICROBIOL BIOT, V47, P150, DOI 10.1007/s002530050904
   Burzio LA, 2000, COMP BIOCHEM PHYS B, V126, P383, DOI 10.1016/S0305-0491(00)00188-7
   Burzio LO, 1997, CURR OPIN BIOTECH, V8, P309, DOI 10.1016/S0958-1669(97)80008-0
   Deming TJ, 2007, PROG POLYM SCI, V32, P858, DOI 10.1016/j.progpolymsci.2007.05.010
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09
   Eggert C, 1996, APPL ENVIRON MICROB, V62, P1151
   Feng BB, 1996, BIOCHEMISTRY-US, V35, P7316, DOI 10.1021/bi952526f
   GREEN K, 1995, SURG ADHESIVE SEALAN, P19
   Hahn V, 2009, AMINO ACIDS, V37, P315, DOI 10.1007/s00726-008-0154-2
   Hahn V, 2009, J MOL CATAL B-ENZYM, V60, P76, DOI 10.1016/j.molcatb.2009.04.002
   HANSEN DC, 1991, ACS SYM SER, V444, P256
   Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753
   HOLL SM, 1993, ARCH BIOCHEM BIOPHYS, V302, P255, DOI 10.1006/abbi.1993.1207
   Holten-Andersen N, 2008, J DENT RES, V87, P701, DOI 10.1177/154405910808700808
   Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012
   Holten-Andersen N, 2009, BIOCHEMISTRY-US, V48, P2752, DOI 10.1021/bi900018m
   Jonas U, 1997, BIODEGRADATION, V8, P321, DOI 10.1023/A:1008220120431
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   Manda K, 2006, AMINO ACIDS, V31, P409, DOI 10.1007/s00726-005-0276-8
   MARSHALL AG, 1992, INT J MASS SPECTROM, V118, P37, DOI 10.1016/0168-1176(92)85058-8
   Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K
   MARUMO K, 1986, BIOCHIM BIOPHYS ACTA, V872, P98, DOI 10.1016/0167-4838(86)90152-4
   MCBRIDE MB, 1988, ENVIRON SCI TECHNOL, V22, P703, DOI 10.1021/es00171a014
   McDowell LM, 1999, J BIOL CHEM, V274, P20293, DOI 10.1074/jbc.274.29.20293
   Mikolasch A, 2007, CHEM PHARM BULL, V55, P412, DOI 10.1248/cpb.55.412
   Niedermeyer THJ, 2005, J ORG CHEM, V70, P2002, DOI 10.1021/jo048454s
   Ooka AA, 2000, BIOPOLYMERS, V57, P92
   ROBIN JB, 1988, ARCH OPHTHALMOL-CHIC, V106, P973
   Rzepecki L. M., 1991, Molecular Marine Biology and Biotechnology, V1, P78
   STRAUSBERG RL, 1990, TRENDS BIOTECHNOL, V8, P53, DOI 10.1016/0167-7799(90)90134-J
   Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   WAITE JH, 1990, INT J BIOL MACROMOL, V12, P139, DOI 10.1016/0141-8130(90)90065-I
   WAITE JH, 1989, J COMP PHYSIOL B, V159, P517, DOI 10.1007/BF00694376
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   WAITE JH, 1985, BIOCHEMISTRY-US, V24, P5010, DOI 10.1021/bi00340a008
   WAITE JH, 1992, BIOL BULL, V183, P178, DOI 10.2307/1542421
   Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078
   YAMAMOTO H, 1982, BIOPOLYMERS, V21, P1137, DOI 10.1002/bip.360210610
   YAMAMOTO H, 1979, BIOPOLYMERS, V18, P3067, DOI 10.1002/bip.1979.360181212
   Yamamoto H, 2000, BIOMACROMOLECULES, V1, P543, DOI 10.1021/bm000061p
   Yamamoto H, 1997, J MAR BIOTECHNOL, V5, P133
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200
   Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200
NR 49
TC 7
Z9 7
U1 3
U2 28
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0939-4451
EI 1438-2199
J9 AMINO ACIDS
JI Amino Acids
PD AUG
PY 2010
VL 39
IS 3
BP 671
EP 683
DI 10.1007/s00726-010-0488-4
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 629YO
UT WOS:000280237600006
PM 20143113
DA 2018-10-19
ER

PT J
AU Lo, HY
   Kuo, HT
   Huang, YY
AF Lo, Hsien-Yi
   Kuo, Hsuan-Ting
   Huang, Yi-You
TI Application of Polycaprolactone as an Anti-Adhesion Biomaterial Film
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Polycaprolactone; Adhesion; Barrier
ID ADHESIONS; SCAFFOLDS; MULTICENTER; PREVENTION; REDUCTION; MEMBRANE;
   RELEASE; BONE
AB Adhesions are unavoidable consequences of surgery and other trauma. How to prevent the adhesions remains a big issue in healthcare system. The objective of this study is to test the efficacy of polycaprolactone (PCL) films as physical barriers in reducing postoperative intra-abdominal adhesions in the rat cecum-abdominal wall model. PCL is quite cheap compared with the agents recently used in the market. The fabrication method is also very easy to perform. Scanning electron microscope (SEM) showed multiple pores over upper and bottom surfaces but too small to per cells to migrate from one surface onto another surface. Those pores were proven to be not interconnected. The PCL film did not show any evidence of cytotoxic effects as it did not induce any significant increase in cytoplasmic lactate dehydrogenase release from the NIH3T3 cells that it came in contact with. In animal studies, the PCL films led to fewer adhesions than Seprafilm in rat adhesion model. PCL films were efficacious in reducing postoperative intra-abdominal adhesion formation in rat cecum-abdominal wall models.
C1 [Lo, Hsien-Yi; Kuo, Hsuan-Ting; Huang, Yi-You] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Coll Engn, Taipei 100, Taiwan.
   [Lo, Hsien-Yi] Taipei City Hosp, Ren Ai Branch, Dept Plast Surg, Taipei, Taiwan.
RP Huang, YY (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Coll Engn, 1,Sec 1,Ren Ai Rd,, Taipei 100, Taiwan.
EM yyhuang@ntu.edu.tw
CR Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   BUCKMAN RF, 1976, J SURG RES, V21, P67, DOI 10.1016/0022-4804(76)90064-0
   DIAMOND M P, 1987, Microsurgery, V8, P103, DOI 10.1002/micr.1920080215
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DiZerega GS, 2000, PERITONEAL SURG, P379
   Fukuhira Y, 2008, J BIOMED MATER RES B, V86B, P353, DOI 10.1002/jbm.b.31026
   Holmdahl Lena, 1999, European Journal of Surgery, V165, P1012
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kumari T. V., 2002, TRENDS BIOMATER ARTI, V15, P37
   Lee MW, 2005, BIOMATERIALS, V26, P3793, DOI 10.1016/j.biomaterials.2004.10.009
   Liu YC, 2007, FERTIL STERIL, V87, P940, DOI 10.1016/j.fertnstert.2006.07.1532
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Pamula E, 2005, J MOL STRUCT, V744, P557, DOI 10.1016/j.molstruc.2004.11.016
   Rutkowska M, 1998, REACT FUNCT POLYM, V38, P27, DOI 10.1016/S1381-5148(98)00029-7
   SEIFER DB, 1990, J GYNECOL SURG, V6, P3, DOI 10.1089/gyn.1990.6.3
   TROMPKE R, 1956, ARCH KLIN CHIR, V281, P323
   Wang YW, 2007, BIOMATERIALS, V28, P4619, DOI 10.1016/j.biomaterials.2007.07.006
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
   Zuhlke H V, 1990, Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir, P1009
NR 20
TC 27
Z9 27
U1 1
U2 27
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 2010
VL 34
IS 8
BP 648
EP 653
DI 10.1111/j.1525-1594.2009.00949.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 635JJ
UT WOS:000280651100010
PM 20698842
DA 2018-10-19
ER

PT J
AU Orive, G
   Ali, OA
   Anitua, E
   Pedraz, JL
   Emerich, DF
AF Orive, G.
   Ali, O. A.
   Anitua, E.
   Pedraz, J. L.
   Emerich, D. F.
TI Biomaterial-based technologies for brain anti-cancer therapeutics and
   imaging
SO BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
LA English
DT Review
DE Biomaterials; Brain tumors; Nanoparticles; Imaging; Immunotherapy; Drug
   delivery
ID IRON-OXIDE NANOPARTICLES; SOLID LIPID NANOPARTICLES;
   CENTRAL-NERVOUS-SYSTEM; CONVECTION-ENHANCED DELIVERY; CELL ADOPTIVE
   IMMUNOTHERAPY; RAT GLIOMA MODEL; DRUG-DELIVERY; QUANTUM DOTS; MALIGNANT
   GLIOMA; IN-VIVO
AB Treating malignant brain tumors represents one of the most formidable challenges in oncology. Contemporary treatment of brain tumors has been hampered by limited drug delivery across the blood-brain barrier (BBB) to the tumor bed. Biomaterials are playing an increasingly important role in developing more effective brain tumor treatments. In particular, polymer (nano)particles can provide prolonged drug delivery directly to the tumor following direct intracerebral injection, by making them physiochemically able to cross the BBB to the tumor, or by functionalizing the material surface with peptides and ligands allowing the drug-loaded material to be systemically administered but still specifically target the tumor endothelium or tumor cells themselves. Biomaterials can also serve as targeted delivery devices for novel therapies including gene therapy, photodynamic therapy, anti-angiogenic and thermotherapy. Nanoparticles also have the potential to play key roles in the diagnosis and imaging of brain tumors by revolutionizing both preoperative and intraoperative brain tumor detection, allowing early detection of pre-cancerous cells, and providing real-time, longitudinal, non-invasive monitoring/imaging of the effects of treatment. Additional efforts are focused on developing biomaterial systems that are uniquely capable of delivering tumor-associated antigens, immunotherapeutic agents or programming immune cells in situ to identify and facilitate immune-mediated tumor cell killing. The continued translation of current research into clinical practice will rely on solving challenges relating to the pharmacology of nanoparticles but it is envisioned that novel biomaterials will ultimately allow clinicians to target tumors and introduce multiple, pharmaceutically relevant entities for simultaneous targeting, imaging, and therapy in a unique and unprecedented manner. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Ali, O. A.; Emerich, D. F.] InCytu Inc, Lincoln, RI 02865 USA.
   [Ali, O. A.] Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA.
   [Orive, G.; Pedraz, J. L.] Univ Basque Country, Lab Pharm & Pharmaceut Technol, Fac Pharm, Vitoria, Spain.
   [Orive, G.; Anitua, E.] Inst Eduardo Anitua, Biotechnol Inst BTI, Vitoria 10005, Spain.
   [Orive, G.; Anitua, E.] SLFPB EHU, Networking Biomed Res Ctr Bioengn Biomat & Nanome, CIBER BBN, Vitoria 01006, Spain.
RP Emerich, DF (reprint author), InCytu Inc, 701 George Washington Highway, Lincoln, RI 02865 USA.
EM ED3FJM@aol.com
RI Anitua, Eduardo/O-1154-2018
OI Anitua, Eduardo/0000-0002-8386-5303; PEDRAZ MUNOZ, JOSE
   LUIS/0000-0002-3938-2267
CR AIL OA, 2009, NAT MATER, V2, P151
   Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Allard E, 2009, BIOMATERIALS, V30, P2302, DOI 10.1016/j.biomaterials.2009.01.003
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Bargoni A, 2001, PHARMACOL RES, V43, P497, DOI 10.1006/phrs.2001.0813
   Beduneau A, 2007, BIOMATERIALS, V28, P4947, DOI 10.1016/j.biomaterials.2007.06.011
   Bredel M, 2002, LANCET ONCOL, V3, P397, DOI 10.1016/S1470-2045(02)00786-6
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   Britz GW, 2002, J NEURO-ONCOL, V56, P227, DOI 10.1023/A:1015035213228
   Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Doi A, 2008, J NEURO-ONCOL, V87, P287, DOI 10.1007/s11060-008-9522-8
   Ewend MG, 2007, CLIN CANCER RES, V13, P3637, DOI 10.1158/1078-0432.CCR-06-2095
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003
   Gelperina S, 2000, P 3 WORLD M APV APGI, P441
   Grauer OM, 2008, J IMMUNOL, V181, P6720, DOI 10.4049/jimmunol.181.10.6720
   Grauer OM, 2009, BRAIN PATHOL, V19, P674, DOI 10.1111/j.1750-3639.2009.00315.x
   Gulyaev AE, 1999, PHARMACEUT RES, V16, P1564, DOI 10.1023/A:1018983904537
   Holladay FP, 1996, J NEURO-ONCOL, V27, P179
   Hor Y, 2009, BIOMATERIALS, V30, P6757, DOI 10.1016/j.biomaterials.2009.08.037
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   INGRAM M, 1990, Neurological Research, V12, P265
   Jackson H, 2007, NEUROSURGERY, V60, P524, DOI 10.1227/01.NEU.0000255334.95532.DD
   Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kircher MF, 2003, CANCER RES, V63, P8122
   Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x
   Kohler N, 2006, SMALL, V2, P785, DOI 10.1002/smll.200600009
   Kohler N, 2005, LANGMUIR, V21, P8858, DOI 10.1021/la0503451
   Koo YEL, 2007, APPL OPTICS, V46, P1924, DOI 10.1364/AO.46.001924
   Koziara JM, 2004, J CONTROL RELEASE, V99, P259, DOI 10.1016/j.jconrel.2004.07.006
   Kruse CA, 1997, CANCER IMMUNOL IMMUN, V45, P77, DOI 10.1007/s002620050405
   Kuroda JI, 2009, INT J CANCER, V124, P2505, DOI 10.1002/ijc.24171
   Labhasetwar V, 2005, CURR OPIN BIOTECH, V16, P674, DOI 10.1016/j.copbio.2005.10.009
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382
   Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Manninger SP, 2005, AM J NEURORADIOL, V26, P2290
   Misra A, 2003, J PHARM PHARM SCI, V6, P252
   Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moghimi SM, 2003, FEBS LETT, V540, P241, DOI 10.1016/S0014-5793(03)00273-4
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Moghimi SM, 2001, PHARMACEUT RES, V18, P1, DOI 10.1023/A:1011054123304
   Moghimi SM, 1999, ADV DRUG DELIVER REV, V37, P295, DOI 10.1016/S0169-409X(98)00099-4
   Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Murray JC, 2003, CRIT REV THER DRUG, V20, P139, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.20
   Nair RE, 2006, J IMMUNOTHER, V29, P10, DOI 10.1097/01.cji.0000175489.19314.d2
   Neuwelt EA, 2004, NEUROPATH APPL NEURO, V30, P456, DOI 10.1111/j.1365-2990.2004.00557.x
   Neuwelt EA, 2007, NEUROSURGERY, V60, P601, DOI 10.1227/01.NEU.0000255350.71700.37
   Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580
   Okada H, 2009, ANN NY ACAD SCI, V1174, P18, DOI 10.1111/j.1749-6632.2009.04932.x
   Okada H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-67
   Orive G, 2004, TRENDS PHARMACOL SCI, V25, P382, DOI 10.1016/j.tips.2004.05.006
   Ou ZM, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/10/105102
   Ozawa T, 2005, NEUROSURGERY, V57, P1041, DOI 10.1227/01.NEU.0000180036.42193.f6
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Pardridge William M, 2005, NeuroRx, V2, P3
   Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057
   Pasqualini R, 2002, TRENDS MOL MED, V8, P563, DOI 10.1016/S1471-4914(02)02429-2
   Perkins E, 2003, MOL BRAIN RES, V111, P42, DOI 10.1016/S0169-328X(02)00668-X
   Plautz GE, 1998, J NEUROSURG, V89, P42, DOI 10.3171/jns.1998.89.1.0042
   Plautz GE, 2000, CLIN CANCER RES, V6, P2209
   Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Remsen LG, 1996, AM J NEURORADIOL, V17, P411
   Roney C, 2005, J CONTROL RELEASE, V108, P193, DOI 10.1016/j.jconrel.2005.07.024
   Ruoslahti E, 2002, DRUG DISCOV TODAY, V7, P1138, DOI 10.1016/S1359-6446(02)02501-1
   Sheleg SV, 2002, J NEURO-ONCOL, V60, P53, DOI 10.1023/A:1020288015457
   Singh M, 2004, EXPERT OPIN BIOL TH, V4, P483, DOI 10.1517/14712598.4.4.483
   Soni V, 2008, J DRUG TARGET, V16, P73, DOI [10.1080/10611860701725381, 10.1080/10611860701725381 ]
   St Croix B, 2000, SCIENCE, V289, P1197
   Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Trehin R, 2006, NEOPLASIA, V8, P302, DOI 10.1593/neo.05751
   UCHIDA M, 2006, VACCINE, V15, P20
   Varallyay CG, 2009, J CEREBR BLOOD F MET, V29, P853, DOI 10.1038/jcbfm.2008.162
   Varallyay P, 2002, AM J NEURORADIOL, V23, P510
   Vasir JK, 2005, TECHNOL CANCER RES T, V4, P363, DOI 10.1177/153303460500400405
   Veiseh O, 2005, NANO LETT, V5, P1003, DOI 10.1021/nl0502569
   Veiseh O, 2009, CANCER RES, V69, P6200, DOI 10.1158/0008-5472.CAN-09-1157
   Voges J, 2003, ANN NEUROL, V54, P479, DOI 10.1002/ana.10688
   Vukelja SJ, 2007, ANTI-CANCER DRUG, V18, P283, DOI 10.1097/CAD.0b013e328011a51d
   WAECKERLEMEN Y, 2005, ADV DRUG DELIV REV, V10
   Wang XY, 2007, J CONTROL RELEASE, V119, P236, DOI 10.1016/j.jconrel.2007.02.010
   Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79
   Wieder ME, 2006, PHOTOCH PHOTOBIO SCI, V5, P727, DOI 10.1039/b602830f
   Xiang LZ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3078809
   Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268
   Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505
   Zara GP, 2002, J DRUG TARGET, V10, P327, DOI 10.1080/10611860290031868
   Zara GP, 2002, J PHARM SCI, V91, P1324, DOI 10.1002/jps.10129
NR 101
TC 43
Z9 43
U1 3
U2 71
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-419X
EI 0006-3002
J9 BBA-REV CANCER
JI Biochim. Biophys. Acta-Rev. Cancer
PD AUG
PY 2010
VL 1806
IS 1
BP 96
EP 107
DI 10.1016/j.bbcan.2010.04.001
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Oncology
SC Biochemistry & Molecular Biology; Biophysics; Oncology
GA 619YA
UT WOS:000279465000012
PM 20406668
DA 2018-10-19
ER

PT J
AU Yuce, M
   Nazir, H
   Donmez, G
AF Yuce, Meral
   Nazir, Hasan
   Donmez, Goenuel
TI A voltammetric Rhodotorula mucilaginosa modified microbial biosensor for
   Cu(II) determination
SO BIOELECTROCHEMISTRY
LA English
DT Article
DE Microbial biosensor; Carbon paste electrode; Copper; Rhodotorula
   mucilaginosa; Voltammetry
ID CARBON-PASTE ELECTRODE; AMPEROMETRIC DETECTION; YEAST-CELLS; IONS;
   COPPER(II); SENSOR; BIOACCUMULATION; METALS
AB It is the first report about the usage of Rhodotorula mucilaginosa as a biomaterial to construct a microbial biosensor based on carbon paste for determination of copper. Cu(II) was preconcentrated electrode surface at open circuit and then detected with electrochemical techniques, including Cyclic Voltammetry (CV) and Differential Pulse Stripping Voltammetry (DPSV). Some parameters such as pH of preconcentration solution. preconcentration time, scan rate and effect of interfering heavy metal ions were carried out for optimum responses. The best defined cathodic peak was obtained at pH 5 with 0.05 M NaNO(3) and a scan rate of 100 mV/s. The linear range for the developed microbial biosensor was found in the range of 1.0 x 10(-7) and 1.0 x 10(-5) M (0.0064 and 0.64 mg/L) at the response time of 15 min (R(2) = 0.98). The easy fabrication, sensitivity, low cost and fast response time showed the advantages of the biosensor to conventional techniques. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Donmez, Goenuel] Fac Sci, Dept Biol, TR-06100 Besevler, Turkey.
   [Yuce, Meral] Ankara Univ, Inst Biotechnol, TR-06100 Besevler, Turkey.
   [Nazir, Hasan] Fac Sci, Dept Chem, TR-06100 Besevler, Turkey.
RP Donmez, G (reprint author), Fac Sci, Dept Biol, TR-06100 Besevler, Turkey.
EM gdonmez@science.ankara.edu.tr
FU Scientific and Technical Research Council of Turkey (TUBITAK-BIDEB)
FX Financial support was provided by the Scientific and Technical Research
   Council of Turkey (TUBITAK-BIDEB).
CR AGRAZ R, 1993, ANAL CHIM ACTA, V273, P205, DOI 10.1016/0003-2670(93)80159-I
   Aksuner N, 2009, DYES PIGMENTS, V83, P211, DOI 10.1016/j.dyepig.2009.04.012
   Akyilmaz E, 2005, BIOSENS BIOELECTRON, V20, P1263, DOI 10.1016/j.bios.2004.04.010
   Alpat S, 2008, SENSOR ACTUAT B-CHEM, V134, P175, DOI 10.1016/j.snb.2008.04.044
   Alpat SK, 2005, ELECTROCHEM COMMUN, V7, P130, DOI 10.1016/j.elecom.2004.11.017
   D'Souza SF, 2001, BIOSENS BIOELECTRON, V16, P337, DOI 10.1016/S0956-5663(01)00125-7
   Donmez G, 2001, WATER RES, V35, P1425, DOI 10.1016/S0043-1354(00)00394-8
   Donmez G, 1999, PROCESS BIOCHEM, V35, P135, DOI 10.1016/S0032-9592(99)00044-8
   Ertugrul S, 2009, ECOL ENG, V35, P128, DOI 10.1016/j.ecoleng.2008.09.015
   Gardea-Torresdey JL, 1999, J HAZARD MATER, V69, P41, DOI 10.1016/S0304-3894(99)00057-6
   HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9
   Lehmann M, 2000, BIOSENS BIOELECTRON, V15, P211, DOI 10.1016/S0956-5663(00)00060-9
   Lei Y, 2006, ANAL CHIM ACTA, V568, P200, DOI 10.1016/j.aca.2005.11.065
   Mahendra N, 2003, SENSOR ACTUAT B-CHEM, V90, P118, DOI 10.1016/S0925-4005(03)00044-3
   Malitesta C, 2005, BIOSENS BIOELECTRON, V20, P1643, DOI 10.1016/j.bios.2004.08.003
   Reshetilov AN, 1997, BIOSENS BIOELECTRON, V12, P241, DOI 10.1016/S0956-5663(97)85342-0
   Safavi A, 1996, ANAL CHIM ACTA, V335, P275, DOI 10.1016/S0003-2670(96)00369-8
   Tag K, 2007, SENSOR ACTUAT B-CHEM, V122, P403, DOI 10.1016/j.snb.2006.06.007
   WANG J, 2003, BIOTECHNOL ADV, V27, P195
NR 19
TC 28
Z9 29
U1 4
U2 23
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1567-5394
J9 BIOELECTROCHEMISTRY
JI Bioelectrochemistry
PD AUG
PY 2010
VL 79
IS 1
BP 66
EP 70
DI 10.1016/j.bioelechem.2009.11.003
PG 5
WC Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Biophysics; Electrochemistry
GA 609OL
UT WOS:000278666300011
PM 20004626
DA 2018-10-19
ER

PT J
AU Yu, L
   Zhang, Z
   Zhang, HA
   Ding, JD
AF Yu, Lin
   Zhang, Zheng
   Zhang, Huan
   Ding, Jiandong
TI Biodegradability and Biocompatibility of Thermoreversible Hydrogels
   Formed from Mixing a Sol and a Precipitate of Block Copolymers in Water
SO BIOMACROMOLECULES
LA English
DT Article
ID IN-VITRO DEGRADATION; PEG-PCL-PEG; AQUEOUS-SOLUTIONS; POLY(ETHYLENE
   GLYCOL); TRIBLOCK COPOLYMERS; HYDROLYTIC DEGRADATION; DIBLOCK
   COPOLYMERS; DRUG-DELIVERY; THERMOSENSITIVE HYDROGEL; CONTROLLED-RELEASE
AB This study examines in vitro and in vivo biodegradation and biocompatibility of a thermogelling polymeric material, which we call a mixture hydrogel. The mixture contains two ABA-type triblock copolymers poly(D,L-lactic acidco-glycolic acid)-b-poly(ethylene glycol)-b-poly(D,L-lactic acid-co-glycolic acid) (PLGA-PEG-PLGA) with different block ratios, and one polymer is soluble in water, but the other is not. The aqueous solutions of some mixtures with appropriate mix ratios form hydrogels at the body temperature. The degradation of mixture hydrogels proceeded by hydrolysis of ester bonds followed by the erosion of gel in phosphate saline buffer solution at 37 C for nearly one month. The mass loss and reduction of molecular weight were detected. The mix ratio was found to significantly influence the degradation profiles. The rapid in vivo gel formation was confirmed after subcutaneous injection of the thermogelling copolymer mixtures into Sprague Dawley rats. The in vivo degradation was a bit accelerated than in vitro hydrolysis, and the persistence time of injected hydrogels in vivo was found to be tuned by mix ratio. MYT assay and histological observations were used to examine the copolymer mixtures. Both in vitro and in vivo results illustrate acceptable biocompatibility of our materials. As such, the thermosensitive hydrogel of copolymer mixture is confirmed to be a promising candidate of an injectable biomaterial for drug delivery and tissue engineering.
C1 [Yu, Lin; Zhang, Zheng; Zhang, Huan; Ding, Jiandong] Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Adv Mat Lab,Dept Macromol Sci, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Adv Mat Lab,Dept Macromol Sci, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI Zhang, Huan/O-7352-2014
OI Zhang, Huan/0000-0001-8625-8050
FU Chinese Ministry of Science and Technology [2009CB930000]; NSF of China
   [20774020, 50903021]; Science and Technology Developing Foundation of
   Shanghai [074319117, 09ZR1403700]; Specialized Research Fund for the
   Doctoral Program of Higher Education of China [20090071120014]; Shanghai
   Education Committee [B112]
FX The group was supported by Chinese Ministry of Science and Technology
   (973 Program No. 2009CB930000), NSF of China (Grant Nos. 20774020 and
   50903021), Science and Technology Developing Foundation of Shanghai
   (Grant Nos. 074319117 and 09ZR1403700), the Specialized Research Fund
   for the Doctoral Program of Higher Education of China (Grant No.
   20090071120014), and Shanghai Education Committee (Project No. B112).
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Bos GW, 2005, BIOMATERIALS, V26, P3901, DOI 10.1016/j.biomaterials.2004.10.008
   Buwalda SJ, 2010, BIOMACROMOLECULES, V11, P224, DOI 10.1021/bm901080d
   Cai Q, 2003, BIOMATERIALS, V24, P629, DOI 10.1016/S0142-9612(02)00377-0
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Choi S, 2003, PHARM RES, V20, P2008, DOI 10.1023/B:PHAM.0000008050.99985.5c
   Chun C, 2009, BIOMATERIALS, V30, P6295, DOI 10.1016/j.biomaterials.2009.08.011
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hou QP, 2008, J PHARM SCI-US, V97, P3972, DOI 10.1002/jps.21310
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Jiang ZQ, 2007, J POLYM SCI POL CHEM, V45, P4091, DOI 10.1002/pola.22222
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kallrot M, 2007, BIOMACROMOLECULES, V8, P2492, DOI 10.1021/bm700442j
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Kim EH, 2009, BIOMACROMOLECULES, V10, P2476, DOI 10.1021/bm9004436
   Kim HK, 2009, TISSUE ENG PT A, V15, P923, DOI 10.1089/ten.tea.2007.0407
   Kim MS, 2006, TISSUE ENG, V12, P2863, DOI 10.1089/ten.2006.12.2863
   Kim MS, 2006, J POLYM SCI POL CHEM, V44, P5413, DOI 10.1002/pola.21659
   Kirkland SE, 2008, BIOMACROMOLECULES, V9, P481, DOI 10.1021/bm700968t
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Lee SJ, 2008, POLYM J, V40, P171, DOI 10.1295/polymj.PJ2007179
   Li ZH, 2003, PHARMACEUT RES, V20, P884, DOI 10.1023/A:1023887203111
   Li Z, 2009, BIOMACROMOLECULES, V10, P3306, DOI 10.1021/bm900900e
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Madsen J, 2008, BIOMACROMOLECULES, V9, P2265, DOI 10.1021/bm8005006
   Mortisen D, 2010, BIOMACROMOLECULES, V11, P1261, DOI 10.1021/bm100046n
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Nguyen MK, 2009, BIOMACROMOLECULES, V10, P728, DOI 10.1021/bm900183j
   Park SH, 2008, MACROMOLECULES, V41, P6486, DOI 10.1021/ma800562s
   Recillas M, 2009, BIOMACROMOLECULES, V10, P1633, DOI 10.1021/bm9002317
   Rhodes NP, 2007, BIOMATERIALS, V28, P5131, DOI 10.1016/j.biomaterials.2007.08.004
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Sandor M, 2002, BIOMATERIALS, V23, P4413, DOI 10.1016/S0142-9612(02)00183-7
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   Tai HY, 2009, BIOMACROMOLECULES, V10, P2895, DOI 10.1021/bm900712j
   Tang Y, 2009, INT J PHARM, V365, P34, DOI 10.1016/j.ijpharm.2008.08.018
   Tanodekaew S, 1997, MACROMOL CHEM PHYSIC, V198, P3385, DOI 10.1002/macp.1997.021981105
   Wang WX, 2009, ADV MATER, V21, P1809, DOI 10.1002/adma.200800382
   Wang YC, 2009, BIOMACROMOLECULES, V10, P66, DOI 10.1021/bm800808q
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
NR 58
TC 92
Z9 94
U1 5
U2 123
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD AUG
PY 2010
VL 11
IS 8
BP 2169
EP 2178
DI 10.1021/bm100549q
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 634LQ
UT WOS:000280583400036
PM 20690723
DA 2018-10-19
ER

PT J
AU Shokouhi, B
   Coban, C
   Hasirci, V
   Aydin, E
   Dhanasingh, A
   Shi, NA
   Koyama, S
   Akira, S
   Zenke, M
   Sechi, AS
AF Shokouhi, Behnaz
   Coban, Cevayir
   Hasirci, Vasif
   Aydin, Erkin
   Dhanasingh, Anandhan
   Shi, Nian
   Koyama, Shohei
   Akira, Shizuo
   Zenke, Martin
   Sechi, Antonio S.
TI The role of multiple toll-like receptor signalling cascades on
   interactions between biomedical polymers and dendritic cells
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Biocompatibility; Immune response; Dendritic cells;
   Inflammation; TLR
ID IN-VITRO; ACTIN CYTOSKELETON; POLY(LACTIC-CO-GLYCOLIC ACID); MACROPHAGE
   ACTIVATION; VASCULAR PROSTHESES; CYTOKINE EXPRESSION; IMMUNE-RESPONSES;
   BONE-MARROW; BIOMATERIALS; NEUTROPHILS
AB Biomaterials are used in several health-related applications ranging from tissue regeneration to antigen-delivery systems. Yet, biomaterials often cause inflammatory reactions suggesting that they profoundly alter the homeostasis of host immune cells such as dendritic cells (DCs). Thus, there is a major need to understand how biomaterials affect the function of these cells. In this study, we have analysed the influence of chemically and physically diverse biomaterials on DCs using several murine knockouts. DCs can sense biomedical polymers through a mechanism, which involves multiple TLR/MyD88-dependent signalling pathways, in particular TLR2. TLR4 and TLR6. TLR biomaterial interactions induce the expression of activation markers and pro-inflammatory cytokines and are sufficient to confer on DCs the ability to activate antigen-specific T cells. This happens through a direct biomaterial DC interaction although, for degradable biomaterials, soluble polymer molecules can also alter DC function. Finally, the engagement of TLRs by biomaterials profoundly alters DC adhesive properties. Our findings could be useful for designing structure function studies aimed at developing more bioinert materials. Moreover, they could also be exploited to generate biomaterials for studying the molecular mechanisms of TLR signalling and DC activation aiming at fine-tuning desired and pre-determined immune responses. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Shokouhi, Behnaz; Shi, Nian; Zenke, Martin; Sechi, Antonio S.] Univ Klinikum Aachen, Inst Biomed Engn, Dept Cell Biol, Rhein Westfal TH Aachen, D-52074 Aachen, Germany.
   [Coban, Cevayir; Koyama, Shohei; Akira, Shizuo] Osaka Univ, Host Def Lab, Immunol Frontier Res Ctr iFREC, World Premier Immunol Inst WPI, Osaka 5650871, Japan.
   [Hasirci, Vasif; Aydin, Erkin] METU, BIOMAT, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
   [Dhanasingh, Anandhan] Rhein Westfal TH Aachen, DWI eV, D-52074 Aachen, Germany.
   [Dhanasingh, Anandhan] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52074 Aachen, Germany.
RP Sechi, AS (reprint author), Univ Klinikum Aachen, Inst Biomed Engn, Dept Cell Biol, Rhein Westfal TH Aachen, Pauwelsstr 30, D-52074 Aachen, Germany.
EM antonio.sechi@rwth-aachen.de
RI Coban, Cevayir/B-2129-2012; Akira, Shizuo/C-3134-2009; Sechi,
   Antonio/A-5595-2009; Aydin, Erkin/D-9422-2012
OI Sechi, Antonio/0000-0002-1374-1794; COBAN, Cevayir/0000-0002-4467-7799;
   Koyama, Shohei/0000-0002-6897-9417
FU Interdisciplinary Centre for Clinical Research "BIOMAT" of the Medical
   Faculty of RWTH Aachen University
FX We thank Dr. Taiki Aoshi and Dr. Ken J. Ishii for invaluable discussions
   and Yukiko Fujita for technical assistance. We also thank Dr. J. Salber
   for support during the initial stage of this work. This work was
   supported by the Interdisciplinary Centre for Clinical Research "BIOMAT"
   of the Medical Faculty of RWTH Aachen University.
CR Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Coppolino MG, 2001, J CELL SCI, V114, P4307
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903
   Hieronymus T, 2005, J IMMUNOL, V174, P2552, DOI 10.4049/jimmunol.174.5.2552
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Jones KS, 2008, TISSUE ENG PART B-RE, V14, P407, DOI 10.1089/ten.teb.2008.0264
   Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181
   Li YW, 2005, BIOMATERIALS, V26, P1081, DOI 10.1016/j.biomaterials.2004.04.018
   Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008
   Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Malissen B, 2005, NAT IMMUNOL, V6, P749, DOI 10.1038/ni0805-749
   Moore MA, 2001, J BIOMED MATER RES, V55, P257, DOI 10.1002/1097-4636(20010605)55:3<257::AID-JBM1013>3.0.CO;2-H
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Pastor JC, 2001, OPHTHALMIC RES, V33, P87, DOI 10.1159/000055649
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Ross R, 2000, J INVEST DERMATOL, V115, P658, DOI 10.1046/j.1523-1747.2000.00112.x
   Santos TC, 2007, J BIOTECHNOL, V132, P218, DOI 10.1016/j.jbiotec.2007.07.497
   Schlosser M, 2002, J BIOMED MATER RES, V61, P450, DOI 10.1002/jbm.10096
   Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   SHANKAR SP, 2009, J BIOMED MATER RES A, V92, P1487
   Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996
   Shutt DC, 2000, CELL MOTIL CYTOSKEL, V46, P200, DOI 10.1002/1097-0169(200007)46:3<200::AID-CM5>3.0.CO;2-M
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   Spurrell DR, 2009, J IMMUNOL, V183, P310, DOI 10.4049/jimmunol.0802096
   Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Takeuchi O, 2007, CURR OPIN CELL BIOL, V19, P185, DOI 10.1016/j.ceb.2007.02.006
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tarbell KV, 2006, SEMIN IMMUNOL, V18, P93, DOI 10.1016/j.smim.2006.01.009
   van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567
   West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153
   Wilhelm L, 2007, J BIOMED MATER RES A, V83A, P104, DOI 10.1002/jbm.a.31209
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
   Zippel R, 2001, EUR J VASC ENDOVASC, V21, P202, DOI 10.1053/ejvs.2000.1298
NR 64
TC 35
Z9 35
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2010
VL 31
IS 22
BP 5759
EP 5771
DI 10.1016/j.biomaterials.2010.04.015
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 614XK
UT WOS:000279092900005
PM 20452017
DA 2018-10-19
ER

PT J
AU Park, SH
   Gil, ES
   Shi, H
   Kim, HJ
   Lee, K
   Kaplan, DL
AF Park, Sang-Hyug
   Gil, Eun Seok
   Shi, Hai
   Kim, Hyeon Joo
   Lee, Kyongbum
   Kaplan, David L.
TI Relationships between degradability of silk scaffolds and osteogenesis
SO BIOMATERIALS
LA English
DT Article
DE Silk; Scaffold degradation; Osteogenesis; Stem cell metabolism; Tissue
   Regeneration
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; BONE
   REGENERATION; EXTRACELLULAR-MATRIX; MATHEMATICAL APPROACH;
   GENE-EXPRESSION; 3-D SCAFFOLDS; TISSUE; COLLAGEN
AB Bone repairs represent a major focus in orthopedic medicine with biomaterials as a critical aspect of the regenerative process. However, only a limited set of biomaterials are utilized today and few studies relate biomaterial scaffold design to degradation rate and new bone formation. Matching biomaterial remodeling rate towards new bone formation is important in terms of the overall rate and quality of bone regeneration outcomes. We report on the osteogenesis and metabolism of human bone marrow derived mesenchymal stem cells (hMSCs) in 3D silk scaffolds. The scaffolds were prepared with two different degradation rates in order to study relationships between matrix degradation, cell metabolism and bone tissue formation in vitro. SEM, histology, chemical assays, real-time PCR and metabolic analyses were assessed to investigate these relationships. More extensively mineralized ECM formed in the scaffolds designed to degrade more rapidly, based on SEM, von Kossa and type I collagen staining and calcium content. Measures of osteogenic ECM were significantly higher in the more rapidly degrading scaffolds than in the more slowly degrading scaffolds over 56 days of study in vitro. Metabolic analysis, including glucose and lactate levels, confirmed the degradation rate differences with the two types of scaffolds, with the more rapidly degrading scaffolds supporting higher levels of glucose consumption and lactate synthesis by the hMSCs upon osteogenesis, in comparison to the more slowly degrading scaffolds. The results demonstrate that scaffold degradation rates directly impact the metabolism of hMSCs, and in turn the rate of osteogenesis. An understanding of the interplay between cellular metabolism and scaffold degradability should aid in the more rational design of scaffolds for bone regeneration needs both in vitro and in vivo. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Park, Sang-Hyug; Gil, Eun Seok; Kim, Hyeon Joo; Kaplan, David L.] Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA.
   [Shi, Hai; Lee, Kyongbum; Kaplan, David L.] Tufts Univ, Sch Engn, Dept Biol & Chem Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Sch Engn, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Shi, Hai/K-6254-2012; Lee, Kyongbum/D-9230-2013
FU NIH [EB003210P41, EB002520]; Korean Government (MOEHRD)
   [KRF-2007-357-D00296]
FX This work was supported by the NIH through grants EB003210P41 and
   EB002520. Sang-Hyug Park was partially supported by a Korea Research
   Foundation Grant funded by the Korean Government (MOEHRD),
   KRF-2007-357-D00296.
CR Abraham LC, 2004, J BIOMED MATER RES A, V70A, P39, DOI 10.1002/jbm.a.30057
   Abraham LC, 2007, BIOMATERIALS, V28, P151, DOI 10.1016/j.biomaterials.2006.07.001
   Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Andermahr J, 2006, J NEUROTRAUM, V23, P708, DOI 10.1089/neu.2006.23.708
   Bakker AD, 2008, TISSUE ENG PT C-METH, V14, P251, DOI 10.1089/ten.tec.2008.0022
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bertolo RF, 2008, J NUTR, V138, p2032S
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104
   Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Cartmell S, 2009, J PHARM SCI-US, V98, P430, DOI 10.1002/jps.21431
   COHEN SA, 1994, J CHROMATOGR A, V661, P25, DOI 10.1016/0021-9673(93)E0821-B
   Diegelmann RF, 2003, METH MOLEC MED, V78, P349
   Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007
   Drosse I, 2008, INJURY, V39, pS9, DOI 10.1016/S0020-1383(08)70011-1
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Follmar KE, 2006, TISSUE ENG, V12, P3525, DOI 10.1089/ten.2006.12.3525
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Ge ZG, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/021001
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   Guarino V, 2007, EXPERT REV MED DEVIC, V4, P405, DOI 10.1586/17434440.4.3.405
   Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477, DOI 10.1152/ajprenal.1999.277.4.F477
   Heywood HK, 2006, J CELL PHYSIOL, V206, P402, DOI 10.1002/jcp.20491
   Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9
   Holtorf HL, 2005, BIOMATERIALS, V26, P6208, DOI 10.1016/j.biomaterials.2005.04.006
   Hwang DY, 2002, ARCH BIOCHEM BIOPHYS, V399, P206, DOI 10.1006/abbi.2002.2758
   Imai Yuuki, 2008, Clin Calcium, V18, P1693, DOI CliCa081216931700
   KASUGAI S, 1992, J CELL PHYSIOL, V152, P467, DOI 10.1002/jcp.1041520305
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim W, 2009, J BIOMECH, V42, P395, DOI 10.1016/j.jbiomech.2008.11.014
   Knabe C, 2004, J BIOMED MATER RES A, V69A, P145, DOI 10.1002/jbm.a.20131
   Knabe C, 2004, BIOMATERIALS, V25, P335, DOI 10.1016/S0142-9612(03)00525-8
   Koukourakis MI, 2006, CANCER SCI, V97, P1056, DOI 10.1111/j.1349-7006.2006.00298.x
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lee K, 2003, BIOTECHNOL BIOENG, V83, P400, DOI 10.1002/bit.10682
   Lee RB, 1997, BIOCHEM J, V321, P95, DOI 10.1042/bj3210095
   LEHMANN HW, 1992, BIOCHEM J, V282, P313, DOI 10.1042/bj2820313
   Leong David Tai, 2008, Curr Drug Discov Technol, V5, P319, DOI 10.2174/157016308786733537
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lian J B, 1993, J Oral Implantol, V19, P95
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lian J. B., 1993, J ORAL IMPLANTOL, V19, P136
   LOOMIS ME, 1961, J LAB CLIN MED, V57, P966
   Mason Deborah J, 2004, Eur Cell Mater, V7, P12
   MASON DJ, 2004, EUR CELLS MATER, V7, P25
   Mazurek S, 1999, J CELL PHYSIOL, V181, P136
   Mischen BT, 2008, PLAST RECONSTR SURG, V122, P725, DOI 10.1097/PRS.0b013e318180ec9f
   MYLLYLA R, 1981, BIOCHIM BIOPHYS ACTA, V674, P238, DOI 10.1016/0304-4165(81)90381-0
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Phang JM, 2008, J NUTR, V138, p2008S
   PISKIN E, 1995, J BIOMAT SCI-POLYM E, V6, P775, DOI 10.1163/156856295X00175
   Pollok J M, 1996, Semin Pediatr Surg, V5, P191
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Saha AK, 2003, IEEE T NANOBIOSCI, V2, P89, DOI 10.1109/TNB.2003.813921
   Sanz-Herrera JA, 2009, PHILOS T R SOC A, V367, P2055, DOI 10.1098/rsta.2009.0055
   Sanz-Herrera JA, 2009, ACTA BIOMATER, V5, P219, DOI 10.1016/j.actbio.2008.06.021
   Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1
   SEMENZA GL, 1994, J BIOL CHEM, V269, P23757
   Shur I, 2005, J BIOMED MATER RES A, V75A, P870, DOI 10.1002/jbm.a.30507
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Skerry T. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P166
   SMITH R, 1980, CLIN SCI, V59, P215, DOI 10.1042/cs0590215
   Stucki U, 2001, CLIN ORAL IMPLAN RES, V12, P121, DOI 10.1034/j.1600-0501.2001.012002121.x
   TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158
   Tsuji N, 2008, KEY ENG MATER, V361-363, P1189, DOI 10.4028/www.scientific.net/KEM.361-363.1189
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wu CT, 2008, ACTA BIOMATER, V4, P343, DOI 10.1016/j.actbio.2007.08.010
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Young MF, 2003, CALCIFIED TISSUE INT, V72, P2, DOI 10.1007/s00223-002-1017-6
NR 80
TC 59
Z9 64
U1 5
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2010
VL 31
IS 24
BP 6162
EP 6172
DI 10.1016/j.biomaterials.2010.04.028
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 621WK
UT WOS:000279616200005
PM 20546890
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Yang, LA
   Hedhammar, M
   Blom, T
   Leifer, K
   Johansson, J
   Habibovic, P
   van Blitterswijk, CA
AF Yang, Liang
   Hedhammar, My
   Blom, Tobias
   Leifer, Klaus
   Johansson, Jan
   Habibovic, Pamela
   van Blitterswijk, Clemens A.
TI Biomimetic calcium phosphate coatings on recombinant spider silk fibres
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BONE-GRAFT SUBSTITUTES; POROUS METAL IMPLANTS; OCTACALCIUM PHOSPHATE;
   MECHANICAL-PROPERTIES; TITANIUM IMPLANTS; BIOMATERIALS; APATITE;
   NUCLEATION; PROTEINS; DEGRADATION
AB Calcium phosphate ceramic coatings, applied on surfaces of metallic and polymeric biomaterials, can improve their performance in bone repair and regeneration. Spider silk is biocompatible, strong and elastic, and hence an attractive biomaterial for applications in connective tissue repair. Recently, artificial spider silk, with mechanical and structural characteristics similar to those of native spider silk, has been produced from recombinant minispidroins. In the present study, supersaturated simulated body fluid was used to deposit calcium phosphate coatings on recombinant spider silk fibres. The mineralization process was followed in time using scanning electron microscopy equipped with an energy dispersive x-ray (EDX) detector and Raman spectroscope. Focused ion beam technology was used to produce a cross section of a coated fibre, which was further analysed by EDX. Preliminary in vitro experiments using a culture of bone marrow-derived human mesenchymal stem cells (hMSCs) on coated fibres were also performed. This study showed that recombinant spider silk fibres were successfully coated with a homogeneous and thick crystalline calcium phosphate layer. In the course of the mineralization process from modified simulated body fluid, sodium chloride crystals were first deposited on the silk surface, followed by the deposition of a calcium phosphate layer. The coated silk fibres supported the attachment and growth of hMSCs.
C1 [Yang, Liang; Habibovic, Pamela; van Blitterswijk, Clemens A.] Univ Twente, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Hedhammar, My; Johansson, Jan] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.
   [Blom, Tobias; Leifer, Klaus] Uppsala Univ, Dept Engn Sci, S-75121 Uppsala, Sweden.
RP Yang, LA (reprint author), Univ Twente, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
OI Leifer, Klaus/0000-0002-8360-1877; van Blitterswijk,
   Clemens/0000-0003-2371-4615
FU EC [G5RD-CT-2002-00738]
FX This study was financially supported by the EC 'Spiderman' project
   (G5RD-CT-2002-00738).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Barrere F, 2004, BIOMATERIALS, V25, P2901, DOI 10.1016/j.biomaterials.2003.09.063
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Barrere F, 2003, J BIOMED MATER RES A, V64A, P378, DOI 10.1002/jbm.a.10291
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   Bauer TW, 2007, ARCH PATHOL LAB MED, V131, P217
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   COLLINS MJ, 1995, J ARCHAEOL SCI, V22, P175, DOI 10.1006/jasc.1995.0019
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Du C, 2002, J BIOMED MATER RES, V59, P535, DOI 10.1002/jbm.1267
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Grip S, 2009, PROTEIN SCI, V18, P1012, DOI 10.1002/pro.111
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Zaffe D, 2005, MICRON, V36, P583, DOI 10.1016/j.micron.2005.05.008
NR 39
TC 17
Z9 18
U1 0
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2010
VL 5
IS 4
SI SI
AR 045002
DI 10.1088/1748-6041/5/4/045002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 634KW
UT WOS:000280580900014
PM 20539057
DA 2018-10-19
ER

PT J
AU Wang, JP
   Wu, LX
   Xu, F
   Lv, J
   Jin, HJ
   Chen, SF
AF Wang, Jian-Ping
   Wu, Li-Xian
   Xu, Feng
   Lv, Jing
   Jin, Hao-Jie
   Chen, San-Feng
TI Metabolic engineering for ethylene production by inserting the
   ethylene-forming enzyme gene (efe) at the 16S rDNA sites of Pseudomonas
   putida KT2440
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Ethylene; Ethylene-forming enzyme gene (efe); Pseudomonas putida; 16S
   rDNA site; Bioreactor
ID SYRINGAE PV. GLYCINEA; RANGE CLONING VECTOR; EXPRESSION; PBBR1MCS;
   PLASMID
AB The ethylene-forming enzyme gene (efe) from Pseudomonas syringae pv. glycinea was transferred into Pseudomonas putida KT2440 by recombination at five of the seven 16S rDNA sites. PCR analysis demonstrated that strains DC1, DC2 and DC3 contained three, four and five copies of efe, respectively. In contrast to the parent strain which produced ethylene at 14.7 mg h(-1) g(-1) dry weight. strains DC1, DC2 and DC3 produced ethylene at 36.2, 47.2 and 53.8 mg h(-1) g(-1) dry weight, respectively. Quantitative PCR showed that efe mRNA levels increased with increasing efe copy numbers. When additional copies of efe were introduced into strain DC3 via the broad-host-range plasmid pBBR1MCS2 an ethylene production rate of 80.2 mg h(-1) g(-1) dry weight was obtained and 489 mg ethylene was produced in 24 h corresponding to a conversion rate of 21.7 mg ethylene g(-1) glucose. Our results indicated that P. putida KT2440 could be genetically modified to be a promising biomaterial producer. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Wang, Jian-Ping; Wu, Li-Xian; Xu, Feng; Lv, Jing; Jin, Hao-Jie; Chen, San-Feng] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China.
   [Wang, Jian-Ping; Wu, Li-Xian; Xu, Feng; Jin, Hao-Jie; Chen, San-Feng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.
RP Chen, SF (reprint author), China Agr Univ, Coll Biol Sci, 2 Yuanmingyuan W Rd, Beijing 100193, Peoples R China.
EM chensf@cau.edu.cn
FU National Key Technology R&D Program of China [2006BAD07A01]
FX This research was supported by the National Key Technology R&D Program
   of China (Grant No. 2006BAD07A01).
CR [Anonymous], 1982, FED REGISTER, V47, P17197
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chague V, 2002, FEMS MICROBIOL ECOL, V40, P143, DOI [10.1111/j.1574-6941.2002.tb00946.x, 10.1016/S0168-6496(02)00222-2]
   CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x
   Ding Y, 2005, J APPL MICROBIOL, V99, P1271, DOI 10.1111/j.1365-2672.2005.02738.x
   Dong HongJun, 2007, Journal of Agricultural Biotechnology, V15, P698
   ISHIHARA K, 1995, J FERMENT BIOENG, V79, P205, DOI 10.1016/0922-338X(95)90604-X
   Ishihara K, 1996, J FERMENT BIOENG, V82, P509, DOI 10.1016/S0922-338X(97)86994-2
   Kniel L., 1980, ETHYLENE KEYSTONE PE
   KOVACH ME, 1994, BIOTECHNIQUES, V16, P800
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   NAGAHAMA K, 1991, J GEN MICROBIOL, V137, P1641, DOI 10.1099/00221287-137-7-1641
   NAGAHAMA K, 1991, J GEN MICROBIOL, V137, P2281, DOI 10.1099/00221287-137-10-2281
   Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x
   Pirkov I, 2008, METAB ENG, V10, P276, DOI 10.1016/j.ymben.2008.06.006
   SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7
   Smith H.S., 2007, NATURE, V5, P248
   Takahama K, 2003, J BIOSCI BIOENG, V95, P302, DOI 10.1263/jbb.95.302
   Tao L, 2008, APPL MICROBIOL BIOT, V80, P573, DOI 10.1007/s00253-008-1562-7
   Thuesen MH, 2003, PROTEIN EXPRES PURIF, V27, P175, DOI 10.1016/S1046-5928(02)00575-2
   Volksch B, 1997, EUR J PLANT PATHOL, V103, P795, DOI 10.1023/A:1008686609138
   Watanabe K, 1998, PHYTOPATHOLOGY, V88, P1205, DOI 10.1094/PHYTO.1998.88.11.1205
   Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006
NR 23
TC 12
Z9 14
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD AUG
PY 2010
VL 101
IS 16
BP 6404
EP 6409
DI 10.1016/j.biortech.2010.03.030
PG 6
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 605OH
UT WOS:000278356400018
PM 20399645
DA 2018-10-19
ER

PT J
AU Manukyan, K
   Amirkhanyan, N
   Aydinyan, S
   Danghyan, V
   Grigoryan, R
   Sarkisyan, N
   Gasparyan, G
   Aroutiounian, R
   Kharatyan, S
AF Manukyan, Khachatur
   Amirkhanyan, Narine
   Aydinyan, Sofiya
   Danghyan, Vardan
   Grigoryan, Ruzanna
   Sarkisyan, Natalia
   Gasparyan, Gennadi
   Aroutiounian, Rouben
   Kharatyan, Suren
TI Novel NiZr-based porous biomaterials: Synthesis and in vitro testing
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE NiZr biomaterial; Combustion synthesis; Porosity; Cytotoxicity;
   Genotoxicity
ID BEARING MEDICAL APPLICATIONS; HIGH-TEMPERATURE SYNTHESIS; SHAPE-MEMORY
   ALLOYS; COMBUSTION SYNTHESIS; MICRONUCLEUS TECHNIQUE; NITI;
   MICROSTRUCTURE; FABRICATION; COMPOSITES; MECHANISM
AB Novel porous NiZr-based potential biomaterials for orthopaedic application were developed using the combustion reaction in the Ni + Zr + additive mixtures. The effect of various additives (ZrH(2), CaCO(3), NH(4)F and Teflon) on the combustion behaviour in the low-caloric Ni + Zr mixtures was investigated. To obtain molten porous NiZr-based product Teflon was chosen as an optimal additive. Combustion conditions of the Ni + Zr + Teflon mixtures depending on various factors were investigated. NiZr-based materials with 55-65% porosity and 50-550 mu m pore sizes were obtained. The cyto- and genotoxicity of the materials was tested in vitro using HeLa and KCL-22 cell lines. After several extractions the obtained porous materials expressed no toxicity. Produced materials were non-genotoxic and had no effect on the cell proliferation. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Manukyan, Khachatur; Amirkhanyan, Narine; Aydinyan, Sofiya; Danghyan, Vardan; Kharatyan, Suren] Yerevan State Univ, Dept Inorgan Chem, Yerevan 0025, Armenia.
   [Grigoryan, Ruzanna; Sarkisyan, Natalia; Gasparyan, Gennadi] Inst Mol Biol NAS Armenia, Grp Cytol, Yerevan 0014, Armenia.
   [Gasparyan, Gennadi; Aroutiounian, Rouben] Yerevan State Univ, Dept Genet & Cytol, Yerevan 0025, Armenia.
   [Manukyan, Khachatur; Kharatyan, Suren] AB Nalbandyan Inst Chem Phys NAS Armenia, Lab Kinet SHS Proc, Yerevan 0014, Armenia.
RP Manukyan, K (reprint author), Yerevan State Univ, Dept Inorgan Chem, 1 Manoogian Str, Yerevan 0025, Armenia.
EM khachat@ichph.sci.am
OI Raj, kannan/0000-0002-8009-008X
FU Armenian National Science and Education Fund [EN-matsc-646]; State
   Committee of Science (SCS) of Armenia [354]; National Foundation for
   Science and Advanced Technology (NFSAT) [ECSP-09-13/840]; State
   Committee of Science (SCS) of Armenia; USA Civilian Research and
   Development Foundation (CRDF)
FX The authors would like to thank for the financial support provided by
   the Armenian National Science and Education Fund (ANSEF Project No.
   EN-matsc-646), State Committee of Science (SCS) of Armenia (Project No.
   354), Joint Project No ECSP-09-13/840 of National Foundation for Science
   and Advanced Technology (NFSAT), State Committee of Science (SCS) of
   Armenia and USA Civilian Research and Development Foundation (CRDF).;
   Authors are grateful to Dr. T. Liehr (Institute of Human Genetics and
   Anthropology, Germany) for providing HeLa and KCL-22 cell lines, to Dr.
   O. Niazyan, Ms. Y. Grigoryan and Mrs. K. Asatryan (Institute of Chemical
   Physics, NAS of Armenia) for DTA/DTG and microstructural analyses.
CR AYERS RA, 2006, J BIOMED MATER RES A, V81, P634
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Besne M., 2004, International Journal of Self-Propagating High-Temperature Synthesis, V13, P209
   Biswas A, 2005, ACTA MATER, V53, P1415, DOI 10.1016/j.actamat.2004.11.036
   Burkes DE, 2006, J MATER SCI, V41, P7944, DOI 10.1007/s10853-006-0863-4
   Burkes DE, 2006, COMPOS SCI TECHNOL, V66, P1931, DOI 10.1016/j.compscitech.2006.01.017
   Chu CL, 2005, J MATER PROCESS TECH, V169, P103, DOI 10.1016/j.jmatprotec.2005.03.002
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   Fenech M, 1997, MUTAT RES-GEN TOX EN, V392, P11, DOI 10.1016/S0165-1218(97)00041-4
   FENECH M, 1993, MUTAT RES, V285, P35, DOI 10.1016/0027-5107(93)90049-L
   GASPARYAN G, 2007, INT J TOXICOL, V26, P479
   Gennari A, 2004, ATLA-ALTERN LAB ANIM, V32, P437
   Goh CW, 2007, INTERMETALLICS, V15, P461, DOI 10.1016/j.intermet.2006.06.002
   Good V, 2005, MATER DESIGN, V26, P618, DOI 10.1016/j.matdes.2004.08.014
   Han YC, 2004, MATER RES BULL, V39, P25, DOI 10.1016/j.materresbull.2003.09.022
   HEDDLE JA, 1973, MUTAT RES, V18, P187, DOI 10.1016/0027-5107(73)90035-3
   Hunter G., 2005, US patent, Patent No. [6,974,625 B2, 6974625]
   Hunter G., 2004, US Patent, Patent No. [6,726,725, 6726725]
   Jin HB, 2006, J AM CERAM SOC, V89, P1099, DOI 10.1111/j.1551-2916.2005.00809.x
   Kharatyan S. L., 2003, International Journal of Self-Propagating High-Temperature Synthesis, V12, P19
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li BY, 2003, MATER RES INNOV, V7, P245, DOI 10.1007/s10019-003-0260-4
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   MARKS U, 2007, DRUG TESTING IN VITR
   Massalski T. B., 1990, BINARY ALLOY PHASE D
   Merzhanov AG, 1996, J MATER PROCESS TECH, V56, P222, DOI 10.1016/0924-0136(95)01837-9
   Munir Z.A., 1989, MATER SCI REP, V3, P227
   Pan XM, 2007, MATER SCI FORUM, V561-565, P329
   Parry J.M, 1998, PROPOSAL NEW OECD GU
   PUSZYNSKI JA, 2006, NSTI NANOTECHNOL, V1, P397
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rosenband V, 2007, EXP THERM FLUID SCI, V31, P461, DOI 10.1016/j.expthermflusci.2006.04.015
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Shtansky DV, 2005, BIOMATERIALS, V26, P2909, DOI 10.1016/j.biomaterials.2004.09.010
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Strober W, 1997, CURR PROTOC IMMUNOL
   Vardurnyan LE, 2008, J ALLOY COMPD, V454, P389, DOI 10.1016/j.jallcom.2006.12.114
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Zhang Z., 2008, US Patent, Patent No. [73,20,799 B2, 7320799]
NR 39
TC 13
Z9 13
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD AUG 1
PY 2010
VL 162
IS 1
BP 406
EP 414
DI 10.1016/j.cej.2010.05.042
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 634ZO
UT WOS:000280625500050
DA 2018-10-19
ER

PT J
AU Zhu, ZH
   Qu, LN
   Li, X
   Zeng, Y
   Sun, W
   Huang, XT
AF Zhu, Zhihong
   Qu, Lining
   Li, Xia
   Zeng, Yan
   Sun, Wei
   Huang, Xintang
TI Direct electrochemistry and electrocatalysis of hemoglobin with carbon
   nanotube-ionic liquid-chitosan composite materials modified carbon ionic
   liquid electrode
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE Chitosan; Hemoglobin; Ionic liquid; Multi-walled carbon nanotube;
   Electrochemical biosensor
ID SURFACTANT FILMS; PASTE ELECTRODE; MYOGLOBIN; PROTEINS;
   BIOELECTROCHEMISTRY; BIOSENSORS; BEHAVIOR; SENSORS; NAFION
AB A novel composite biomaterial was prepared by combining chitosan, multi-walled carbon nanotubes (MWCNTs), hemoglobin (Hb) and ionic liquid (IL) 1-butyl-3-methyl-imidazolium bromide together, which was further modified on the surface of a carbon ionic liquid electrode (CILE) with another ionic liquid 1-ethyl-3-methylimidazolium ethylsulphate as the binder. Ultraviolet-visible and Fourier transform infrared spectroscopic results indicated that Hb molecules in the composite film retained the native structure. Cyclic voltammetric results showed that a pair of well-defined redox peaks appeared in 0.1 mol/L phosphate buffer solution, indicating that the direct electron transfer of Hb in the composite film with the underlying electrode was realized. The results were attributed to the synergistic effect of MWCNTs and IL in the composite film, which promoted the electron transfer rate of Hb. The composite material modified electrode showed excellent electrocatalytic ability towards the reduction of different substrates such as trichloroacetic acid and NaNO(2) with good stability and reproducibility. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Qu, Lining; Li, Xia; Sun, Wei] Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Qingdao 266042, Peoples R China.
   [Zhu, Zhihong; Zeng, Yan; Huang, Xintang] Huazhong Normal Univ, Inst Nanosci, Wuhan 430079, Peoples R China.
   [Zhu, Zhihong; Zeng, Yan; Huang, Xintang] Huazhong Normal Univ, Ctr Technol, Wuhan 430079, Peoples R China.
RP Sun, W (reprint author), Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Qingdao 266042, Peoples R China.
EM sunwei@qust.edu.cn
FU National Science Foundation of China [50802032]; Young Scientist
   Chenguang Project of Wuhan; Shandong Province Natural Science Foundation
   [ZR2009BL017]
FX We are grateful to the financial support of the National Science
   Foundation of China (No. 50802032), Young Scientist Chenguang Project of
   Wuhan and Shandong Province Natural Science Foundation (ZR2009BL017).
CR ARMSTRONG FA, 1988, ACCOUNTS CHEM RES, V21, P407, DOI 10.1021/ar00155a004
   Bianco P., 2002, REV MOL BIOTECHNOL, V82, P393, DOI DOI 10.1016/S1389-0352(01)54-X
   Buzzeo MC, 2004, CHEMPHYSCHEM, V5, P1106, DOI 10.1002/cphc.200301017
   Feher E, 2007, BIOCHEM SOC T, V35, P1624, DOI 10.1042/BST0351624
   Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289
   Gu HY, 2001, J ELECTROANAL CHEM, V516, P119, DOI 10.1016/S0022-0728(01)00669-6
   He PL, 2002, BIOMACROMOLECULES, V3, P139, DOI 10.1021/bm015599p
   Kachoosangi RT, 2009, ANAL CHEM, V81, P435, DOI 10.1021/ac801853r
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   Klotzbach T, 2006, J MEMBRANE SCI, V282, P276, DOI 10.1016/j.memsci.2006.05.029
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Li QW, 2001, ELECTROANAL, V13, P359, DOI 10.1002/1521-4109(200104)13:5<359::AID-ELAN359>3.0.CO;2-J
   Lin MS, 2005, ELECTROANAL, V17, P2068, DOI 10.1002/elan.200503335
   Liu HT, 2005, ELECTROCHEM COMMUN, V7, P1357, DOI 10.1016/j.elecom.2005.09.018
   Liu Y, 2005, GREEN CHEM, V7, P655, DOI 10.1039/b504689k
   Liu Y, 2006, ELECTROCHEM COMMUN, V8, P1429, DOI 10.1016/j.elecom.2006.06.024
   Lu HY, 2006, J PHYS CHEM B, V110, P23710, DOI 10.1021/jp063550d
   Lu XB, 2006, BIOMACROMOLECULES, V7, P975, DOI 10.1021/bm050933t
   Lu ZQ, 1997, J ELECTROANAL CHEM, V423, P59, DOI 10.1016/S0022-0728(96)04843-7
   Maleki N, 2007, ANAL BIOCHEM, V369, P149, DOI 10.1016/j.ab.2007.04.024
   Maleki N, 2006, ANAL CHEM, V78, P3820, DOI 10.1021/ac060070+
   NASSAR AEF, 1995, ANAL CHEM, V67, P2386, DOI 10.1021/ac00110a010
   Rajkumar T, 2008, J CHEM SCI, V120, P587, DOI 10.1007/s12039-008-0089-x
   RUSLING JF, 1993, J AM CHEM SOC, V115, P11891, DOI 10.1021/ja00078a030
   Shan WJ, 2005, ELECTROCHIM ACTA, V51, P432, DOI 10.1016/j.electacta.2005.04.039
   SONG YP, 1992, LANGMUIR, V8, P257, DOI 10.1021/la00037a048
   Sun W, 2007, ELECTROCHEM COMMUN, V9, P1159, DOI 10.1016/j.elecom.2007.01.003
   Sun W, 2007, J PHYS CHEM B, V111, P4560, DOI 10.1021/jp067933n
   Sun W, 2009, ELECTROANAL, V21, P959, DOI 10.1002/elan.200804498
   Sun W, 2009, TALANTA, V78, P695, DOI 10.1016/j.talanta.2008.12.034
   Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113
   Wang SF, 2005, LANGMUIR, V21, P9260, DOI 10.1021/la050947k
   Wei D, 2008, ANAL CHIM ACTA, V607, P126, DOI 10.1016/j.aca.2007.12.011
   Yomathan J.N., 1992, INORG CHEM, P3280
   Zhang YJ, 2005, LANGMUIR, V21, P4797, DOI 10.1021/la050026+
   Zhao F, 2004, ANAL CHEM, V76, P4960, DOI 10.1021/ac0494026
   Zhao Q, 2005, FRONT BIOSCI, V10, P326, DOI 10.2741/1530
   Zhao YD, 2005, TALANTA, V65, P489, DOI 10.1016/j.talanta.2004.06.028
NR 38
TC 44
Z9 47
U1 1
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD AUG 1
PY 2010
VL 55
IS 20
BP 5959
EP 5965
DI 10.1016/j.electacta.2010.05.050
PG 7
WC Electrochemistry
SC Electrochemistry
GA 632KO
UT WOS:000280422800063
DA 2018-10-19
ER

PT J
AU Roupret, M
   Misrai, V
   Vaessen, C
   Cour, F
   Haertig, A
   Chartier-Kastler, E
AF Roupret, Morgan
   Misrai, Vincent
   Vaessen, Christophe
   Cour, Florence
   Haertig, Alain
   Chartier-Kastler, Emmanuel
TI Laparoscopic Surgical Complete Sling Resection for Tension-Free Vaginal
   Tape-Related Complications Refractory to First-Line Conservative
   Management: A Single-Centre Experience
SO EUROPEAN UROLOGY
LA English
DT Article
DE Biomaterial; Complications; Urinary incontinence; Voiding disorders;
   Suburethral slings; Surgical tape; Laparoscopy
ID STRESS URINARY-INCONTINENCE; EROSION; PAIN; TRANSOBTURATOR;
   METAANALYSIS; OBSTRUCTION; STRATEGY; OUTCOMES; SURGERY; TRIALS
AB Background: Tension-free vaginal tape (TVT) has been largely used for the management of stress urinary incontinence. In certain cases, however, this procedure results in bothersome complications that lead to a complete resection.
   Objective: We assessed the technical feasibility and functional outcome after complete laparoscopic resection of TVT.
   Design, setting, and participants: Thirty-eight women with TVT-related complications refractory to first-line management underwent a complete laparoscopic tape resection between 2001 and 2009.
   Surgical procedure: Complete laparoscopic resection was achieved with either an intra- or extraperitoneal laparoscopic approach. Laparoscopy was performed with four ports: a 10-mm umbilical telescope port, two 5-mm ports placed medially to the anterior superior iliac spines, and a 10-mm port placed at the midpoint between the pubis and umbilicus. The two half-tapes were dissected towards the urethra and removed.
   Measurements: All data referring to patient demographics, surgery, tape-related complication, and perioperative outcomes were recorded.
   Results and limitations: The mean age of the patients was 66.2 yr (range: 45-79 yr). TVT-related complications included bladder erosion, vaginal extrusion, and bladder outlet obstruction or groin pain. The resection took place at a mean time of 25 mo (range: 6-80 mo) after TVT placement. Resection was complete in all patients, within a mean operative time of 110 min (range: 50-240 min). All women reported a total decrease of symptom-related complications within a mean follow-up period of 37.9 mo (range: 2-80 mo). However, recurrent incontinence occurred in 65.7% (n = 25) of the patients. The main limitation of the study was the lack of a validated questionnaire to assess the evolution of functional disorders.
   Conclusions: Complete laparoscopic resection of TVT is safe and technically feasible. In the limited number of women who have persisting disabling symptoms after conservative management, urologists must be aware that a complete resection can help resolve the symptoms. (C) 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
C1 [Roupret, Morgan; Misrai, Vincent; Vaessen, Christophe; Cour, Florence; Haertig, Alain; Chartier-Kastler, Emmanuel] Univ Paris 06, Fac Med Pierre & Marie Curie, Pitie Salpetriere Hosp, Grp Hosp Univ EST,AP HP,Dept Urol, Paris, France.
   [Misrai, Vincent] Clin Pasteur, Dept Urol, Toulouse, France.
RP Roupret, M (reprint author), Hosp Pitie Salpetriere, Acad Urol Dept, 47-83 Blvd Hop, F-75013 Paris, France.
EM morgan.roupret@psl.aphp.fr
CR Abouassaly R, 2004, BJU INT, V94, P110, DOI 10.1111/j.1464-410X.2004.04910.x
   Amundsen CL, 2000, J UROLOGY, V164, P434, DOI 10.1016/S0022-5347(05)67378-8
   Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010
   Bourrat M, 2003, PROG UROL, V13, P1358
   Clemens JQ, 2000, UROLOGY, V56, P589, DOI 10.1016/S0090-4295(00)00740-8
   Daneshgari F, 2008, J UROLOGY, V180, P1890, DOI 10.1016/j.juro.2008.07.029
   Delorme E, 2004, EUR UROL, V45, P203, DOI 10.1016/j.eururo.2003.12.001
   Doo CK, 2006, EUR UROL, V50, P333, DOI 10.1016/j.eururo.2006.04.007
   Duckett JRA, 2005, BJU INT, V95, P95, DOI 10.1111/j.1464-410X.2005.05258.x
   Fischer A, 2005, EUR UROL, V48, P799, DOI 10.1016/j.eururo.2005.07.019
   Giri SK, 2006, J UROLOGY, V175, P1788, DOI 10.1016/S0022-5347(05)01023-2
   Hammad FT, 2005, EUR UROL, V47, P641, DOI 10.1016/j.eururo.2004.11.019
   Huwyler M, 2008, BJU INT, V102, P582, DOI 10.1111/j.1464-410X.2008.07734.x
   Kobashi KC, 2003, J UROLOGY, V169, P2242, DOI 10.1097/01.ju.0000060119.43064.f6
   Latthe PM, 2007, BJOG-INT J OBSTET GY, V114, P522, DOI 10.1111/j.1471-0528.2007.01268.x
   Laurikainen E, 2007, OBSTET GYNECOL, V109, P4, DOI 10.1097/01.AOG.0000249607.82768.a1
   Lee KS, 2010, EUR UROL, V57, P973, DOI 10.1016/j.eururo.2010.02.018
   Misrai V, 2006, PROG UROL, V16, P368
   Misrai V, 2009, J UROLOGY, V181, P2198, DOI 10.1016/j.juro.2009.01.036
   Nilsson CG, 2008, INT UROGYNECOL J, V19, P1043, DOI 10.1007/s00192-008-0666-z
   Novara G, 2007, EUR UROL, V52, P663, DOI 10.1016/j.eururo.2007.06.018
   Pikaart Dirk P, 2006, JSLS, V10, P220
   Roupret M, 2010, EUR UROL, V57, P499, DOI 10.1016/j.eururo.2009.03.045
   Sweat SD, 2002, J UROLOGY, V168, P144, DOI 10.1016/S0022-5347(05)64848-3
   Tartaglia E, 2009, J UROLOGY, V182, P612, DOI 10.1016/j.juro.2009.04.027
   Tsivian A, 2004, J UROLOGY, V172, P998, DOI 10.1097/01.ju.0000135072.27734.4a
   Tsivian A, 2004, J UROLOGY, V171, P762, DOI 10.1097/01.ju.0000106083.51860.ca
NR 27
TC 19
Z9 19
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0302-2838
J9 EUR UROL
JI Eur. Urol.
PD AUG
PY 2010
VL 58
IS 2
BP 270
EP 274
DI 10.1016/j.eururo.2010.04.025
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 623MR
UT WOS:000279745100021
PM 20462686
DA 2018-10-19
ER

PT J
AU Hseu, YC
   Huang, HC
   Hsiang, CY
AF Hseu, You-Cheng
   Huang, Hui-Chi
   Hsiang, Chien-Yun
TI Antrodia camphorata suppresses lipopolysaccharide-induced nuclear
   factor-kappa B activation in transgenic mice evaluated by
   bioluminescence imaging
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Antrodia camphorata; Nuclear factor-kappa B; Lipopolysaccharide;
   Transgenic mice; Anti-inflammation
ID BREAST-CANCER CELLS; HOST-BIOMATERIAL INTERACTION; ANTIINFLAMMATORY
   ACTIVITY; THERAPEUTIC TARGET; SUBMERGED CULTURE; IN-VIVO; MYCELIA;
   INHIBITION; INFLAMMATION; INDUCTION
AB In an earlier study, we found that Antrodia camphorata inhibited the production of lipopolysaccharide (LPS)-induced cytokines, inducible nitric oxide synthase, and cyclooxygenase-2 by blocking nuclear factor-kappa B (NF-kappa B) activation in cultured RAW 264.7 macrophages. This study was aimed at evaluating the inhibitory effects of the fermented culture broth of A. camphorata in terms of LPS-induced NF-kappa B activation in transgenic mice by using a non-invasive, real-time NF-kappa B bioluminescence imaging technique. Transgenic mice carrying the luciferase gene under the control of NF-kappa B were given A. cam phorata (570 mg/kg, p.o.) for three consecutive days and then injected with LPS (4 mg/kg, i.p.). In vivo imaging showed that treatment with LPS increased the luminescent signal, whereas A. cam phorata suppressed the LPS-induced inflammatory response significantly. Ex vivo imaging showed that A. camphorata suppressed LPS-induced NF-kappa B activity in the small intestine, mesenteric lymph nodes, liver, spleen, and kidney. Immunohistochemical staining revealed that A. camphorata suppressed production of the LPS-induced tumour necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and NF-kappa B p65 subunit in these organs. Furthermore, A. camphorata attenuated the productions of LPS-induced TNF-alpha and IL-1 beta in serum from transgenic mice. We report the first confirmation of the anti-inflammatory action in vivo of this potentially beneficial mushroom. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung 40402, Taiwan.
   [Hseu, You-Cheng] China Med Univ, Dept Cosmeceut, Taichung 40402, Taiwan.
   [Huang, Hui-Chi] China Med Univ, Dept Chinese Med Resources, Taichung 40402, Taiwan.
RP Hsiang, CY (reprint author), China Med Univ, Dept Microbiol, 91 Huseh Shih Rd, Taichung 40402, Taiwan.
EM cyhsiang@mail.cmu.edu.tw
RI Huang, Hui-Chi/D-2042-2012; Hsiang, Chien-Yun/O-3853-2015
OI Huang, Hui-Chi/0000-0002-3645-6726; 
FU National Science Council [NSC 96-2628-B-039-030-NY3]; Committee on
   Chinese Medicine and Pharmacy, Department of Health [CCMP 97-RD-201];
   China Medical University [CMU97-190, CMU96-207, CMU97-CMC-004]
FX This work was supported by the National Research Program for Genomic
   Medicine, National Science Council (NSC 96-2628-B-039-030-NY3), the
   Committee on Chinese Medicine and Pharmacy, Department of Health (CCMP
   97-RD-201) and the China Medical University (CMU97-190, CMU96-207, and
   CMU97-CMC-004).
CR Ao ZH, 2009, J ETHNOPHARMACOL, V121, P194, DOI 10.1016/j.jep.2008.10.039
   BALDWIN AS, 1996, ANNU REV IMMUNOL, V14, P483
   Chen CC, 2007, J AGR FOOD CHEM, V55, P5007, DOI 10.1021/jf063484c
   Chen JJ, 2007, J NAT PROD, V70, P989, DOI 10.1021/np070045e
   Csizmadia V, 2001, TRANSPLANTATION, V71, P835, DOI 10.1097/00007890-200104150-00003
   De Nardin E, 2001, Ann Periodontol, V6, P30, DOI 10.1902/annals.2001.6.1.30
   GEETHANGILI M, 2010, EVID BASED IN PRESS
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hseu YC, 2005, INT IMMUNOPHARMACOL, V5, P1914, DOI 10.1016/j.intimp.2005.06.013
   Hseu YC, 2004, NUTR CANCER, V48, P189, DOI 10.1207/s15327914nc4802_9
   Hseu YC, 2002, LIFE SCI, V71, P469, DOI 10.1016/S0024-3205(02)01686-7
   Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P2680, DOI 10.1016/j.fct.2008.04.036
   Hseu YC, 2008, J ETHNOPHARMACOL, V118, P237, DOI 10.1016/j.jep.2008.04.004
   Hseu YC, 2007, FOOD CHEM TOXICOL, V45, P1107, DOI 10.1016/j.fct.2006.12.012
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Hsiang CY, 2005, BIOCHEM PHARMACOL, V69, P1603, DOI 10.1016/j.bcp.2005.03.008
   LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655
   Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291
   Lee JI, 1998, J CLIN PHARMACOL, V38, P981, DOI 10.1177/009127009803801101
   Liu DZ, 2007, J ETHNOPHARMACOL, V113, P45, DOI 10.1016/j.jep.2007.03.037
   Ma Q, 2003, MOL PHARMACOL, V64, P211, DOI 10.1124/mol.64.2.211
   Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1
   Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI [10.1016/j.jep.2007.07.028, 10.1016/jjep.2007.07.028]
   Roth DJ, 2006, TRANSPLANTATION, V81, P1185, DOI 10.1097/01.tp.0000203808.84963.13
   Sadikot Ruxana T, 2005, Proc Am Thorac Soc, V2, P537, DOI 10.1513/pats.200507-067DS
   Shen YC, 2004, PLANTA MED, V70, P310, DOI 10.1055/s-2004-818941
   Shen YC, 2004, FEMS MICROBIOL LETT, V231, P137, DOI 10.1016/S0378-1097(03)00953-4
   Song TY, 2002, J AGR FOOD CHEM, V50, P3322, DOI 10.1021/jf011671z
   Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387
   Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X
   Tsai Z. T., 1985, USE EFFECT GANODERMA, P116
   Wu MD, 2007, J CHIL CHEM SOC, V52, P1338, DOI 10.4067/S0717-97072007000400016
   Wu YY, 2007, ACTA PHARMACOL SIN, V28, P258, DOI 10.1111/j.1745-7254.2007.00500.x
   Yang HL, 2006, AM J CHINESE MED, V34, P217, DOI 10.1142/S0192415X06003783
   Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004
   ZANG M, 1990, Acta Botanica Yunnanica, V12, P395
NR 36
TC 31
Z9 31
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD AUG-SEP
PY 2010
VL 48
IS 8-9
BP 2319
EP 2325
DI 10.1016/j.fct.2010.05.066
PG 7
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA 639RD
UT WOS:000280991100046
PM 20621584
DA 2018-10-19
ER

PT J
AU Zaat, SAJ
   Broekhuizen, CAN
   Riool, M
AF Zaat, S. A. J.
   Broekhuizen, C. A. N.
   Riool, M.
TI Host tissue as a niche for biomaterial-associated infection
SO FUTURE MICROBIOLOGY
LA English
DT Editorial Material
DE antibiotic; biofilm; biomaterial; biomaterial-associated infection;
   cytokine; foreign body response; intracellular survival; Staphylococcus
ID PERI-IMPLANT TISSUE; SUBCUTANEOUS ABSCESS FORMATION;
   STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; MICE; CATHETERS;
   RIFAMPIN; COMBINATION; DAPTOMYCIN; VIRULENCE
C1 [Zaat, S. A. J.; Broekhuizen, C. A. N.; Riool, M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
RP Zaat, SAJ (reprint author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
RI Riool, Martijn/A-8404-2018
OI Riool, Martijn/0000-0002-5444-3179
CR Baldoni D, 2009, ANTIMICROB AGENTS CH, V53, P1142, DOI 10.1128/AAC.00775-08
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bosse MJ, 2005, J BONE JOINT SURG AM, V87A, P1343, DOI 10.2106/JBJS.D.02649
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Burns CA, 2006, SCAND J INFECT DIS, V38, P133, DOI 10.1080/00365540500277292
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   ENGELSMAN AF, 2009, THESIS U GRONINGEN G
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   John AK, 2009, ANTIMICROB AGENTS CH, V53, P2719, DOI 10.1128/AAC.00047-09
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   NOBLE WC, 1965, BRIT J EXP PATHOL, V46, P254
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x
   Vaudaux P., 2000, INFECT ASS INDWELLIN, P1
   VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610
   Waldvogel FA, 2000, INFECT ASS INDWELLIN
   Wilcox MH, 2001, J ANTIMICROB CHEMOTH, V47, P171, DOI 10.1093/jac/47.2.171
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Yao YF, 2006, J INFECT DIS, V193, P841, DOI 10.1086/500246
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 31
TC 26
Z9 26
U1 0
U2 9
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD AUG
PY 2010
VL 5
IS 8
BP 1149
EP 1151
DI 10.2217/FMB.10.89
PG 3
WC Microbiology
SC Microbiology
GA 648VA
UT WOS:000281721300001
PM 20722591
DA 2018-10-19
ER

PT J
AU Casado, PL
   Duarte, MEL
   Carvalho, W
   da Silva, LE
   Barboza, EP
AF Casado, Priscila Ladeira
   Leite Duarte, Maria Eugenia
   Carvalho, Waldimir
   da Silva, Licinio Esmeraldo
   Barboza, Eliane Porto
TI Ridge Bone Maintenance in Human After Extraction
SO IMPLANT DENTISTRY
LA English
DT Article
DE guided bone regeneration; ridge maintenance; biomaterials; BMP;
   biological barrier; histologic analysis
ID MORPHOGENETIC PROTEIN BMP; PURIFICATION; AUGMENTATION; GELATIN
AB Purpose: The aim of this study was to evaluate, clinically and histologically, the tissues formed in human alveolar sockets filled with bovine morphogenetic protein/bovine organic matrix (BOM) and absorbable membrane (AM) immediately after extraction.
   Materials: Forty-six human alveolar sockets, exhibiting buccal bone defects were selected for this study. Group 1 received no biomaterial to serve as control. Sockets from group 2 were filled with bovine bone morphogenetic protein (bBMP) associated with bOM. The association of bBMP/bOM/AM filled the alveolar defects from group 3. AMwas placed over the defects from group 4. Clinical evaluation analyzed ridge width before biomaterial filling and 4 months after filling. Fifteen specimens were collected from groups 2, 3, and 4 for histologic analyses.
   Results: Clinical results showed no significant augmentation on the control group (-0.16 +/- 0.28 mm). All test sites, groups 2, 3, and 4, showed relevant ridge width augmentation (3.0 +/- 0.5 mm, 2.4 +/- 0.3 mm, and 2.9 +/- 0.6 mm, respectively) and no resorption. Histologically, all experimental alveolar sockets showed active bone formation with osteoid, osteoblasts, and cell differentiation.
   Conclusion: On the basis of this study, we concluded that bBMP/bOM with or without AM could preserve the ridge showing viable bone formation for future implant placement. (Implant Dent 2010;19:314-322)
C1 [Casado, Priscila Ladeira] Veiga Almeida Univ, Dept Master Course Dent, Rio De Janeiro, Brazil.
   [Carvalho, Waldimir] Univ Fed Fluminense, Dept Prosthodont, Rio De Janeiro, Brazil.
   [da Silva, Licinio Esmeraldo] Univ Fed Fluminense, Dept Stat, Rio De Janeiro, Brazil.
   [Barboza, Eliane Porto] Brazilian Inst Periodontol, Rio De Janeiro, Brazil.
RP Casado, PL (reprint author), Rua Gaviao Peixoto 148 Sala 1101, BR-24230101 Niteroi, RJ, Brazil.
EM priscilalcasado@terra.com.br
CR Abrams L, 1980, Compend Contin Educ Gen Dent, V1, P205
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Atwood DA, 2001, J PROSTHET DENT, V86, P119, DOI 10.1067/mpr.2001.117609
   Barboza E P, 1999, Implant Dent, V8, P167, DOI 10.1097/00008505-199908020-00010
   Barboza EP, 1999, INT J PERIODONT REST, V19, P601
   BARBOZA EP, 1993, THESIS BOSTON U
   Bartee B K, 2001, J Oral Implantol, V27, P187, DOI 10.1563/1548-1336(2001)027<0187:ESRFAR>2.3.CO;2
   BAUER FCH, 1981, CLIN ORTHOP RELAT R, P291
   Becker William, 2002, Clin Implant Dent Relat Res, V4, P143, DOI 10.1111/j.1708-8208.2002.tb00165.x
   CONOVER MA, 1982, P 1 INT C CHEM BIOL, P597
   HANAMURA H, 1980, CLIN ORTHOP RELAT R, P232
   JORTIKKA L, 1993, ANN CHIR GYNAECOL, V82, P25
   KAMIJOU T, 1994, BONE, V15, P629, DOI 10.1016/8756-3282(94)90311-5
   Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003
   MIZUTANI H, 1982, CLIN ORTHOP RELAT R, P213
   Nemcovsky CE, 1996, J PERIODONTOL, V67, P390, DOI 10.1902/jop.1996.67.4.390
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   Sclar A G, 1999, Atlas Oral Maxillofac Surg Clin North Am, V7, P39
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   URIST MR, 1973, P NATL ACAD SCI USA, V70, P3511, DOI 10.1073/pnas.70.12.3511
   URIST MR, 1983, P SOC EXP BIOL MED, V173, P194
   URIST MR, 1982, CLIN ORTHOP RELAT R, P219
   Wang HL, 2007, IMPLANT DENT, V16, P33, DOI 10.1097/ID.0b013e318031ece6
   Wang Hom-Lay, 2004, Implant Dent, V13, P286
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
NR 27
TC 11
Z9 12
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD AUG
PY 2010
VL 19
IS 4
BP 314
EP 322
DI 10.1097/ID.0b013e3181dec322
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 634AT
UT WOS:000280551400007
PM 20683288
DA 2018-10-19
ER

PT J
AU Manso, MC
   Wassal, T
AF Manso, Marcelo C.
   Wassal, Thomas
TI A 10-Year Longitudinal Study of 160 Implants Simultaneously Installed in
   Severely Atrophic Posterior Maxillas Grafted With Autogenous Bone and a
   Synthetic Bioactive Resorbable Graft
SO IMPLANT DENTISTRY
LA English
DT Article
DE atrophic maxilla; sinus lift; synthetic bioactive graft; bone graft
ID SINUS FLOOR AUGMENTATION; PLACEMENT; PHOSPHATE; SUCCESS; 5-YEAR; RATES
AB Purpose: This study intended to evaluate by clinical and imaging parameters the long-term predictability of osseointegrated implants inserted with specific simultaneous sinus lift approach in very atrophic posterior maxillas using a synthetic bioactive resorbable graft and autogenous bone graft.
   Patients and Methods: A total of 160 implants were inserted in 57 maxillary sinus of 45 consecutive patients (16 men, 29 women) presenting 4 mm or less of residual subsinus bone in a simultaneous approach with the sinus lift procedure. All patients were surgically treated by the same surgeon and received the same modified technical and biomaterial protocol with a composite graft made of autogenous bone and a synthetic bioactive resorbable graft (OsteoGen, Impladent, Holliswood, NY) in a 1:1 rate. Among the inclusions criteria was a minimum loading time of 6 months to assure bone response activity. All patients were followed up for a mean period of 61.7 months (range, 20-132 months) with clinical, digital pictures, and radiographic aspects. Specific cases were followed up with computerized tomography scans (27.2%) with the consent form signed.
   Results: Survival and success rates were 98.05% and 94.85%, respectively.
   Conclusion: Advanced posterior maxillary resorption with extensive expanded sinus (SA-4 condition) can be safely treated by a simultaneous sinus lift approach and implant insertion using the technical protocol and biomaterials studied. (Implant Dent 2010;19:351-360)
C1 [Manso, Marcelo C.] Brazilian Inst Implant Dent, Head Grad Program, Rio De Janeiro, Brazil.
   [Manso, Marcelo C.] Brazilian Inst Implant Dent, Adv Implant Dent Program, Rio De Janeiro, Brazil.
   [Wassal, Thomas] Sao Leopoldo Mandic Dent Sch, Head Master Program, Sao Paulo, Brazil.
   [Wassal, Thomas] Sao Leopoldo Mandic Dent Sch, Post Doctoral Program, Sao Paulo, Brazil.
   [Wassal, Thomas] Dent Res Ctr, Sao Paulo, Brazil.
RP Manso, MC (reprint author), Largo Machado 54,Conj 907, Rio De Janeiro, Brazil.
EM marcelo@manso.odo.br
CR Abrahamsson I, 1999, J CLIN PERIODONTOL, V26, P600, DOI 10.1034/j.1600-051X.1999.260907.x
   Acocella A, 2008, IMPLANT DENT, V17, P382, DOI 10.1097/ID.0b013e31818d3bbe
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Avera SP, 1997, INT J ORAL MAX IMPL, V12, P88
   Block MS, 1998, J ORAL MAXIL SURG, V56, P706, DOI 10.1016/S0278-2391(98)90801-1
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   BLOCK MS, 1993, J AM DENT ASSOC, V124, P139, DOI 10.14219/jada.archive.1993.0127
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Buchmann R, 1999, CLIN ORAL IMPLAN RES, V10, P103, DOI 10.1034/j.1600-0501.1999.100204.x
   Daelemans P, 1997, Int J Periodontics Restorative Dent, V17, P27
   Fugazzotto PA, 2003, J PERIODONTOL, V74, P1534, DOI 10.1902/jop.2003.74.10.1534
   Fugazzotto PA, 2002, INT J ORAL MAX IMPL, V17, P113
   Ganz Scott D, 2002, J Oral Implantol, V28, P178, DOI 10.1563/1548-1336(2002)028<0178:PSBGPF>2.3.CO;2
   HAAS R, 1995, J PROSTHET DENT, V73, P274, DOI 10.1016/S0022-3913(05)80205-7
   Hallman M, 2002, J ORAL MAXIL SURG, V60, P277, DOI 10.1053/joms.2002.30576
   Herzberg R, 2006, INT J ORAL MAX IMPL, V21, P103
   Hurzeler MB, 1997, INT J ORAL MAX IMPL, V12, P168
   Krennmair G, 2007, INT J ORAL MAX IMPL, V22, P351
   Manso MC, 2001, REV BRAS IMPLANT, V7, P8
   MANSO MC, 2002, REV BRAS IMPLANT, V8, P7
   Mardinger O, 2007, J PERIODONTOL, V78, P1872, DOI 10.1902/jop.2007.070175
   MISCH CE, 2008, CONT IMPLANT DENT, V42, P1073
   Peleg M, 2006, INT J ORAL MAX IMPL, V21, P94
   Peleg M, 1998, J PERIODONTOL, V69, P1397, DOI 10.1902/jop.1998.69.12.1397
   RAGHOEBAR GM, 1993, J ORAL MAXIL SURG, V51, P1198, DOI 10.1016/S0278-2391(10)80288-5
   RICCI JL, 1992, J ORAL MAXIL SURG, V50, P969, DOI 10.1016/0278-2391(92)90058-8
   Roos J, 1997, INT J ORAL MAX IMPL, V12, P504
   SHULMAN LB, 1999, SINUS BONE GRAFT, V19, P209
   Suba Z, 2006, CLIN ORAL IMPLAN RES, V17, P102, DOI 10.1111/j.1600-0501.2005.01166.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   TULASNE JF, 1993, IMPLANTS         MAY, P101
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   WAGNER JR, 1992, DENT IMPLANTOL UPDAT, V3, P89
   WATZEK G, 1999, SINUS BONE GRAFT, V4, P31
NR 35
TC 22
Z9 24
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD AUG
PY 2010
VL 19
IS 4
BP 351
EP 360
DI 10.1097/ID.0b013e3181e59d03
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 634AT
UT WOS:000280551400011
PM 20683292
DA 2018-10-19
ER

PT J
AU Ibrahim, S
   Kang, QK
   Ramamurthi, A
AF Ibrahim, Samir
   Kang, Qian K.
   Ramamurthi, Anand
TI The impact of hyaluronic acid oligomer content on physical, mechanical,
   and biologic properties of divinyl sulfone-crosslinked hyaluronic acid
   hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyaluronic acid; endothelial cells; oligomers; hydrogel; divinyl sulfone
ID SCAFFOLDS; SULFATE; GELS
AB In recent studies, we showed that exogenous hyaluronic acid oligomers (HA-o) stimulate functional endothelialization, though native long-chain HA is more bioinert and possibly more biocompatible. Thus, in this study, hydrogels containing high molecular weight (HMW) HA (1 x 10(6) Da) and HA-o mixtures (HA-o: 0.75-10 kDa) were created by crosslinking with divinyl sulfone (DVS). The incorporation of HA-o was found to compromise the physical and mechanical properties of the gels (rheology, apparent crosslinking density, swelling ratio, degradation) and to very mildly enhance inflammatory cell recruitment in vivo; increasing the DVS crosslinker content within the gels in general, had the opposite effect, though the relatively high concentration of DVS within these gels (necessary to create a solid gel) also stimulated a mild subcutaneous inflammatory response in vivo and VCAM-1 expression by endothelial cells (ECs) cultured atop; ICAM-expression levels remained very low irrespective extent of DVS crosslinking or HA-o content. The greatest EC attachment and proliferation (MTT assay) was observed on gels that contained the highest amount of HA-o. The study shows that the beneficial EC response to HA-o and biocompatibility of HA is mostly unaltered by their chemical derivatization and crosslinking into a hydrogel. However, the study also demonstrates that the relatively high concentrations of DVS, necessary to create solid gels, compromise their biocompatibility. Moreover, the poor mechanics of even these heavily crosslinked gels, in the context of vascular implantation, necessitates the investigation of other, more appropriate crosslinking agents. Alternately, the outcomes of this study may be used to guide an approach based on chemical immobilization and controlled surface-presentation of both bioactive HA-o and more biocompatible HMW HA on synthetic or tissue engineered grafts already in use, without the use of a crosslinker, so that improved, predictable, and functional endothelialization can be achieved, and the need to create a mechanically compliant biomaterial for standalone use, circumvented. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res 94A: 355-370, 2010
C1 [Ibrahim, Samir; Kang, Qian K.; Ramamurthi, Anand] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   [Kang, Qian K.] Med Univ S Carolina, Dept Orthoped Surg, Charleston, SC 29425 USA.
   [Ramamurthi, Anand] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.
RP Ramamurthi, A (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
EM aramamu@clemson.edu
FU National Institutes of Health [EB 006078-01A1, CO6RR01882, P20RR016461];
   American Heart Association [SDG 0335085N]
FX Contract grant sponsor: National Institutes of Health; contract grant
   numbers: EB 006078-01A1, CO6RR01882, P20RR016461; Contract grant
   sponsor: American Heart Association; contract grant number: SDG 0335085N
CR ARSHINOFF S, 2002, HYALURONAN BIOMEDICA, P119
   Borzacchiello A, 2007, BIOMATERIALS, V28, P4399, DOI 10.1016/j.biomaterials.2007.06.007
   Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273
   Chen J, 1999, ULTRAMICROSCOPY, V79, P89, DOI 10.1016/S0304-3991(99)00060-1
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P277
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   LEPIDI S, 2006, FASEB J, V20, P103, DOI DOI 10.1096/FJ.05-4802FJE
   Lesley J, 2000, J BIOL CHEM, V275, P26967
   Manna F, 1999, J EUR ACAD DERMATOL, V13, P183
   Monheit Gary D, 2004, Facial Plast Surg, V20, P153, DOI 10.1055/s-2004-861757
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   MURATA K, 1988, BLOOD VESSELS, V25, P1
   Pavesio A., 2003, NOVART FDN SYMP, V249, P234
   Pavesio A., 2003, NOVART FDN SYMP, V249, P239
   Pavesio A., 2003, NOVART FDN SYMP, V249, P229
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Prestwich G. D., 2002, HYALURONAN BIOMEDICA, V277
   Price RD, 2005, AM J CLIN DERMATOL, V6, P393, DOI 10.2165/00128071-200506060-00006
   Ramamurthi A, 2002, J BIOMED MATER RES, V60, P196
   Ramamurthi A, 2003, J BIOMED MATER RES A, V66A, P317, DOI 10.1002/jbm.a.10588
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SOK DE, 1993, BIOCHEM BIOPH RES CO, V195, P1224, DOI 10.1006/bbrc.1993.2175
   Srinivas A, 2007, TISSUE ENG, V13, P447, DOI 10.1089/ten.2006.0196
   Tan S W, 1990, Aust J Biotechnol, V4, P38
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   WEISS C, 2002, HYALURONAN, P467
NR 29
TC 37
Z9 40
U1 2
U2 33
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2010
VL 94A
IS 2
BP 355
EP 370
DI 10.1002/jbm.a.32704
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 620EU
UT WOS:000279482600003
PM 20186732
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Chang, SCN
   Chung, HY
   Tai, CL
   Chen, PKT
   Lin, TM
   Jeng, LB
AF Chang, Sophia Chia Ning
   Chung, Hui-Ying
   Tai, Ching-Lung
   Chen, Philips Kuo Ting
   Lin, Tsung-Min
   Jeng, Long-Bin
TI Repair of large cranial defects by hBMP-2 expressing bone marrow stromal
   cells: Comparison between alginate and collagen type I systems
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE alginate; collagen type I; bone marrow stromal cells; BMP-2
ID CONTROLLED SCAFFOLD DEGRADATION; SYNTHETIC EXTRACELLULAR-MATRIX;
   MORPHOGENETIC PROTEIN-2; SODIUM ALGINATE; STEM-CELLS; ACID-HYDROLYSIS;
   GENE-TRANSFER; VIVO; DIFFERENTIATION; HYDROGELS
AB Despite a wide range of available sources for bone repair, significant limitations persist. To bioengineer bone, we have previously transferred adenovirus-mediated human BMP-2 gene into autologous bone marrow stromal cells (MSC). We have successfully repaired large, full thickness, cranial defects using this approach. We report now the effectiveness of various hydrogels as the scaffold for this type of bone regeneration, comparing specifically alginate with Type I collagen. Cultured MSC of miniature swine were infected with BMP-2 or beta-gal adenovirus 7 days before implantation. These cells were mixed with alginate, ultrapure alginate, alginate-RGD, or type I collagen to fabricate the MSC/biomaterial constructs. The results of cranial bone regeneration were assessed by gross examination, histology, 3D CT, and biomechanical tests at 6 weeks and 3 months after implantation. We found that the BMP-2 MSC/collagen type I construct, but not the beta-gal control, effectively achieved nearly complete repair of the cranial defects. No bone regeneration was observed with the other hydrogels. Biomechanical testing showed that the new bone strength was very close and only slightly inferior to that of normal cranial bone. Controlling for the integration of stem cells and ex vivo gene transfer, the alginate scaffolds has a significant negative impact on the success of the construct. Our study demonstrates better bone regeneration by collagen type I over alginate. This may have therapeutic implications for tissue engineered bone repair. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res 94A: 433-441, 2010
C1 [Chang, Sophia Chia Ning; Jeng, Long-Bin] China Med Univ, Sch Med, Taichung 404, Taiwan.
   [Chang, Sophia Chia Ning] China Med Univ Hosp, Dept Plast Surg, Taichung 404, Taiwan.
   [Chung, Hui-Ying; Lin, Tsung-Min] China Med Univ Hosp, Dept Med Res, Taichung 404, Taiwan.
   [Tai, Ching-Lung] Chang Gung Univ, Grad Inst Med Mechatron, Dept Mech Engn, Tao Yuan 333, Taiwan.
   [Chen, Philips Kuo Ting] Chang Gung Mem Hosp, Dept Plast Surg, Taipei 104, Taiwan.
   [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Taichung 404, Taiwan.
RP Jeng, LB (reprint author), China Med Univ, Sch Med, Taichung 404, Taiwan.
EM jeng.longbin@gmail.com
RI Chang, Sophia Chia-Ning/K-1600-2014
OI Chang, Sophia Chia-Ning/0000-0003-3751-1720
FU National Science Council Foundation, Taiwan [NSC-95-2314-B-039-005,
   NSC-96-2314-B-039-022-MY2]
FX Contract grant sponsor: National Science Council Foundation, Taiwan;
   contract grant numbers: NSC-95-2314-B-039-005, NSC-96-2314-B-039-022-MY2
CR AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bouhadir KH, 2000, J PHARM SCI-US, V89, P910, DOI 10.1002/1520-6017(200007)89:7<910::AID-JPS8>3.0.CO;2-#
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Cai XX, 2007, CELL BIOL INT, V31, P776, DOI 10.1016/j.cellbi.2007.01.011
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   COOK SD, 1994, SPINE, V19, P1856, DOI 10.1097/00007632-199408150-00011
   d'Ayala GG, 2007, J BIOMED MATER RES A, V81A, P811, DOI 10.1002/jbm.a.31009
   Dard M, 2000, Clin Oral Investig, V4, P126, DOI 10.1007/s007840050128
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   GITELMAN SE, 1994, J CELL BIOL, V126, P1595, DOI 10.1083/jcb.126.6.1595
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639
   Hopper RA, 2001, PLAST RECONSTR SURG, V107, P454, DOI 10.1097/00006534-200102000-00022
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   KUME T, 1983, AGR BIOL CHEM TOKYO, V47, P889, DOI 10.1080/00021369.1983.10865740
   LANGER R, 1993, SCIENCE, V920, P260
   Lansdown A B, 1994, J R Coll Surg Edinb, V39, P284
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Lou J, 1996, J ORTHOPAED RES, V14, P513, DOI 10.1002/jor.1100140403
   Lou JR, 1999, J ORTHOPAED RES, V17, P43, DOI 10.1002/jor.1100170108
   METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0
   MUSCHLER GF, 1994, CLIN ORTHOP RELAT R, P229
   Nagasawa N, 2000, POLYM DEGRAD STABIL, V69, P279, DOI 10.1016/S0141-3910(00)00070-7
   NAKADA HI, 1967, J BIOL CHEM, V242, P845
   Niederwanger M, 1996, J Oral Implantol, V22, P210
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Pound JC, 2007, BIOMATERIALS, V28, P2839, DOI 10.1016/j.biomaterials.2007.02.029
   Preece A., 1972, MANUAL HISTOLOGIC TE, P57
   QUINN TM, 1993, MACROMOLECULES, V26, P4332, DOI 10.1021/ma00068a040
   Rabie ABM, 2000, AM J ORTHOD DENTOFAC, V117, P288, DOI 10.1016/S0889-5406(00)70233-2
   Rammelt S, 2004, CELLS TISSUES ORGANS, V178, P146, DOI 10.1159/000082245
   ROSEN V, 1994, J BONE MINER RES, V9, P1759
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shimokawa T, 1996, BIOSCI BIOTECH BIOCH, V60, P1532, DOI 10.1271/bbb.60.1532
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   TSUJINO I, 1961, NATURE, V192, P970, DOI 10.1038/192970a0
   van den Dolder J, 2007, J BIOMED MATER RES A, V83A, P712, DOI 10.1002/jbm.a.31428
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Wang Z, 2006, TISSUE ENG, V12, P1753, DOI 10.1089/ten.2006.12.1753
   Weinand C, 2007, TISSUE ENG, V13, P757, DOI 10.1089/ten.2006.0083
   WILES MV, 1991, DEVELOPMENT, V111, P259
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
NR 59
TC 26
Z9 28
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2010
VL 94A
IS 2
BP 433
EP 441
DI 10.1002/jbm.a.32685
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 620EU
UT WOS:000279482600011
PM 20186742
DA 2018-10-19
ER

PT J
AU Hesse, E
   Hefferan, TE
   Tarara, JE
   Haasper, C
   Meller, R
   Krettek, C
   Lu, LC
   Yaszemski, MJ
AF Hesse, Eric
   Hefferan, Theresa E.
   Tarara, James E.
   Haasper, Carl
   Meller, Rupert
   Krettek, Christian
   Lu, Lichun
   Yaszemski, Michael J.
TI Collagen type I hydrogel allows migration, proliferation, and osteogenic
   differentiation of rat bone marrow stromal cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen type I hydrogel; bone marrow stromal cells; cell migration;
   osteogenic differentiation; bone regeneration
ID MESENCHYMAL STEM-CELLS; SILK-BASED BIOMATERIALS; BIOMEDICAL
   APPLICATIONS; GENE-EXPRESSION; SITE MORBIDITY; GROWTH; VITRO;
   ENCAPSULATION; DELIVERY; ANTERIOR
AB Hydrogels are potentially useful for many purposes in regenerative medicine including drug and growth factor delivery, as single scaffold for bone repair or as a filler of pores of another biomaterial in which host mesenchymal progenitor cells can migrate in and differentiate into matrix-producing osteoblasts. Collagen type I is of special interest as it is a very important and abundant natural matrix component. The purpose of this study was to investigate whether rat bone marrow stromal cells (rBMSCs) are able to adhere to, to survive, to proliferate and to migrate in collagen type I hydrogels and whether they can adopt an osteoblastic fate. rBMSCs were obtained from rat femora and plated on collagen type I hydrogels. Before harvest by day 7, 14, and 21, hydrogels were fluorescently labeled, cryo-cut and analyzed by fluorescent-based and laser scanning confocal microscopy to determine cell proliferation, migration, and viability. Osteogenic differentiation was determined by alkaline phosphatase activity. Collagen type I hydrogels allowed the attachment of rBMSCs to the hydrogel, their proliferation, and migration towards the inner part of the gel. rBMSCs started to differentiate into osteoblasts as determined by an increase in alkaline phosphatase activity after two weeks in culture. This study therefore suggests that collagen type I hydrogels could be useful for musculoskeletal regenerative therapies. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res 94A: 442-449, 2010
C1 [Hesse, Eric; Haasper, Carl; Meller, Rupert; Krettek, Christian] Hannover Med Sch, Dept Trauma Surg, D-30625 Hannover, Germany.
   [Hesse, Eric; Hefferan, Theresa E.; Lu, Lichun; Yaszemski, Michael J.] Mayo Clin, Coll Med, Dept Orthoped Surg, Tissue Engn & Biomat Lab, Rochester, MN 55905 USA.
   [Tarara, James E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.
RP Hesse, E (reprint author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.
EM eric_hesse@hsdm.harvard.edu
RI Haasper, Carl/F-3804-2010
OI Krettek, Christian/0000-0001-9807-0020
FU Mayo Foundation; National Institutes of Health; Sanofi-Aventis;
   Niedersachsisches Ministerium fur Wissenschaft und Kultur
FX Contract grant sponsors: Mayo Foundation, National Institutes of Health,
   Sanofi-Aventis, Niedersachsisches Ministerium fur Wissenschaft und
   Kultur
CR Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   Barralet JE, 2005, J MAT SCI MAT MED, V16, P515
   Batorsky A, 2005, BIOTECHNOL BIOENG, V92, P492, DOI 10.1002/bit.20614
   Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640
   Bikram M, 2007, ANN BIOMED ENG, V35, P796, DOI 10.1007/s10439-007-9263-4
   Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0
   CAPLAN AI, 2009, TISSUE ENG B
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Giannoni P, 2008, J TISSUE ENG REGEN M, V2, P253, DOI 10.1002/term.90
   Goessler U. R., 2008, J CELL MOL MED
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hong Y, 2006, J BIOMED MATER RES A, V79A, P913, DOI 10.1002/jbm.a.30837
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   LIN YC, 2009, ACTA BIOMATER, V5, P2540
   Mankani MH, 2007, EXP HEMATOL, V35, P995, DOI 10.1016/j.exphem.2007.01.051
   Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pou Anna M, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P240, DOI 10.1097/00020840-200308000-00004
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   STEIN GS, 1990, FASEB J, V4, P3111
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
NR 41
TC 49
Z9 53
U1 4
U2 40
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2010
VL 94A
IS 2
BP 442
EP 449
DI 10.1002/jbm.a.32696
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 620EU
UT WOS:000279482600012
PM 20186733
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Nakaoka, R
   Yamakoshi, Y
   Isama, K
   Tsuchiya, T
AF Nakaoka, Ryusuke
   Yamakoshi, Yoko
   Isama, Kazuo
   Tsuchiya, Toshie
TI Effects of surface chemistry prepared by self-assembled monolayers on
   osteoblast behavior
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE self assembled monolayer; surface chemistry; cell differentiation; gap
   junctional intercellular communication
ID TUMOR-PROMOTING ACTIVITY; METABOLIC COOPERATION; CELL-ATTACHMENT;
   EXTRACELLULAR-MATRIX; GENE-EXPRESSION; IN-VITRO; DIFFERENTIATION;
   ADHESION; GOLD; COMMUNICATION
AB A surface of biomaterials is known to affect the behavior of cells after their adhesion on the surface, indicating that surface characteristics of biomaterials play an important role in cell adhesion, proliferation, and differentiation. To assess the effects of functional groups on biomaterial surface, normal human osteoblasts (NHOsts) were cultured on surfaces coated with self-assembled monolayers (SAMs) containing various functional groups, and the adhesion, proliferation, differentiation, and gap junctional intercellular communication (GJIC) of the NHOsts were investigated. In the case of SAM with terminal methyl groups (hydrophobic surface), NHOst adhesion and proliferation was less prevalent. In contrast, NHOsts were adhered well on SAMs with hydroxyl, carboxyl, amino, phosphate, and sulfate group, which are relatively hydrophilic, their proliferation and differentiation level were dependent on the type of functional groups. Especially, when they were cultured on either SAMs with phosphate or sulfate group, both their alkaline phosphate activity and the calcium deposition by them were enhanced more than those cultured on a collagen-coated dish. More interestingly, GJIC of NHOsts, which has been reported to play a role in cell differentiation as well as homeostasis of cells, were not significantly different among the SAM surfaces tested. These suggest that a specific functional group on a material surface can regulate NHOst adhesion, proliferation, and differentiation via cell-functional group interaction without influencing their homeostasis. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 94A: 524-532, 2010
C1 [Nakaoka, Ryusuke; Isama, Kazuo; Tsuchiya, Toshie] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
   [Yamakoshi, Yoko] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.
   [Yamakoshi, Yoko] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.
RP Nakaoka, R (reprint author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.
EM nakaoka@nihs.go.jp
FU Health and Labour Sciences Research Grants for Research on Advanced
   Medical Technology; Ministry of Health, Labour and Welfare; Division of
   Medical Devices, NIHS, Japan
FX Contract grant sponsors: Health and Labour Sciences Research Grants for
   Research on Advanced Medical Technology; Research on Regenerative
   Medicine and Research on Regulatory Science of Pharmaceuticals and
   Medical Devices by Ministry of Health, Labour and Welfare; Authors are
   grateful to Professor Toshiaki Enoki and Associate Professor Ken-ichi
   Fukui (currently Professor of Osaka University), Tokyo Institute
   Technology for their kind permission to utilize electron-beam
   evaporation equipment for chromium precoating. Authors are also grateful
   to Dr. Rumi Sawada, Division of Medical Devices, NIHS, Japan, for her
   kind support in real-time PCR experiments.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   BERTILSSON L, 1993, LANGMUIR, V9, P141, DOI 10.1021/la00025a032
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   Cox JD, 2002, BIOMATERIALS, V23, P929, DOI 10.1016/S0142-9612(01)00205-8
   DONAHUE HJ, 2000, AM J PHYSIOL-CELL PH, V278, P315
   Fujimoto H, 2006, BIOCONJUGATE CHEM, V17, P1404, DOI 10.1021/bc060105c
   HAMANO T, 2002, POLYM ADVAN TECHNOL, V13, P46
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   HIRANO Y, 1993, J BIOMAT SCI-POLYM E, V4, P235, DOI 10.1163/156856293X00546
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kidoaki S, 2002, COLLOID SURFACE B, V23, P153, DOI 10.1016/S0927-7765(01)00232-6
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249
   MAIO AD, 2002, J CELL PHYSL, V191, P269
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nagahata M, 2005, BIOMATERIALS, V26, P5138, DOI 10.1016/j.biomaterials.2005.01.041
   Nagira T, 2007, BIOMATERIALS, V28, P844, DOI 10.1016/j.biomaterials.2006.09.041
   Nakaoka R, 2006, KEY ENG MATER, V309-311, P1293, DOI 10.4028/www.scientific.net/KEM.309-311.1293
   Nakaoka R, 2003, J BIOMED MATER RES A, V64A, P439, DOI 10.1002/jbm.a.10430
   Nakaoka R, 2001, J BIOMED MATER RES, V57, P567, DOI 10.1002/1097-4636(20011215)57:4<567::AID-JBM1203>3.0.CO;2-D
   Nakaoka R, 2001, J BIOMED MATER RES, V57, P279, DOI 10.1002/1097-4636(200111)57:2<279::AID-JBM1168>3.0.CO;2-E
   Ohyama M, 2002, J PERIODONTOL, V73, P543, DOI 10.1902/jop.2002.73.5.543
   Peterson WJ, 2002, CELL PROLIFERAT, V35, P9, DOI 10.1046/j.1365-2184.2002.00219.x
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Shin SK, 2006, CURR OPIN CHEM BIOL, V10, P423, DOI 10.1016/j.cbpa.2006.08.006
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P835, DOI 10.1002/jbm.820290708
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P113, DOI 10.1002/jbm.820290116
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 38
TC 21
Z9 22
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2010
VL 94A
IS 2
BP 524
EP 532
DI 10.1002/jbm.a.32714
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 620EU
UT WOS:000279482600022
PM 20186768
DA 2018-10-19
ER

PT J
AU Ghavi, FF
   Mirzadeh, H
   Imani, M
   Jolly, C
   Farhadi, M
AF Ghavi, Farhid Farahmand
   Mirzadeh, Hamid
   Imani, Mohammad
   Jolly, Claude
   Farhadi, Mohammad
TI Corticosteroid-releasing cochlear implant: A novel hybrid of biomaterial
   and drug delivery system
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE drug delivery; cochlear implant; dexamethasone; silicone rubber; release
   profile
ID TECHNICAL REPORT; SCALA TYMPANI; HEARING-LOSS; INNER-EAR; DEXAMETHASONE;
   ELECTRODE; MODEL; PHARMACOKINETICS; MICROSPHERES; FLUIDS
AB In this study, drug-eluting cochlear implant (Cl) electrodes were prepared, and the amount of drug released was determined. Dexamethasone (DEX) (0.25-2% w/w, the weight percent of the final cured polymer) was used as a bioactive agent to suppress postsurgical inflammations upon mixing with a two-part nonrestricted pourable medical-grade silicone elastomer. Batch reproducibility analysis was performed on three consecutive batches. Drug release experiments were accomplished in normal saline medium, where DEX was analyzed via a validated HPLC method. The drug loading percentage and the device surface area were the most dominant parameters explored to monitor the drug release behavior from Cl coatings. Total cumulative amount of DEX released from various loaded samples was in the order of 2 > 1 > 0.5 > 0.35 > 0.25% w/w, but the cumulative percentage of drug released showed a reverse order. The DEX dosages between 0.1 and 1 mu g were released from samples of smallest to highest loadings during the initial 24 h, and dosages <1-5 mu g were released from similar samples of various loadings at the first patency 2 weeks. The extent of crosslinking was only effective on release profile at lower drug loadings of 0.25% w/w relative to 0.5%. It was also found that release profile was not affected by postcuring. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 94B: 388-398, 2010.
C1 [Mirzadeh, Hamid] Iran Polymer & Petrochem Inst, Dept Biomat, Tehran 14965115, Iran.
   [Ghavi, Farhid Farahmand; Imani, Mohammad] Iran Polymer & Petrochem Inst, Dept Novel Drug Delivery Syst, Tehran 14965115, Iran.
   [Jolly, Claude] MED EL Co, Electrode Res Sect, Innsbruck, Austria.
   [Farhadi, Mohammad] Iran Univ Med Sci, Ear Nose Throat Head & Neck Res Ctr, Tehran, Iran.
RP Mirzadeh, H (reprint author), Iran Polymer & Petrochem Inst, Dept Biomat, Tehran 14965115, Iran.
EM h.mirzadeh@ippi.ac.ir
FU MED-EL Medical Electronics, Innsbruck, Austria; Iran Polymer and
   Petrochemical Institute (IPPI), Tehran, Iran; Iran National Science
   Foundation (INSF)
FX The authors would like to express their appreciation to MED-EL Medical
   Electronics, Innsbruck, Austria, Iran Polymer and Petrochemical
   Institute (IPPI), Tehran, Iran and Iran National Science Foundation
   (INSF) for both technical and financial support of this work.
CR Bacigalupo A, 2004, HEMATOL J, V5, P189, DOI 10.1038/sj.thj.6200399
   BAKER R, 1987, CONTROLLED RELEASE B
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   BHATT PP, 1997, Patent No. 5597584
   Brackmann DE, 2001, OTOLOGIC SURG
   CARRASCO VN, 1997, REVISION OTOLOGIC SU, P97
   Chandrasekhar SS, 2001, OTOL NEUROTOL, V22, P18, DOI 10.1097/00129492-200101000-00005
   CHIEN YM, 1992, NOVEL DRUG DELIVERY, V14
   CHRISTIANSEN JOHN B, 2002, COCHLEAR IMPLANTS CH
   Chute P. M., 2002, PARENTS GUIDE COCHLE
   Clark G.M., 2003, COCHLEAR IMPLANTS FU
   DINGNI MN, 2002, Patent No. 0822788
   Dinh CT, 2008, NEUROSCIENCE, V157, P405, DOI 10.1016/j.neuroscience.2008.09.012
   DOMB AJ, 1994, POLYM SITE SPECIFIC
   Eljarrat-Binstock E, 2005, J CONTROL RELEASE, V106, P386, DOI 10.1016/j.jcornel.2005.05.020
   GERSEMA L, 1992, J ORAL MAXIL SURG, V50, P270, DOI 10.1016/0278-2391(92)90325-T
   GRANHAM C, 2003, P 4 INT S EL IMPL OT
   Hahn H, 2006, HEARING RES, V212, P236, DOI 10.1016/j.heares.2005.12.001
   Hesketh R. P., 2002, CHEM ENG EDUC, V36, P198
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Hochmair Ingeborg, 2006, Trends Amplif, V10, P201, DOI 10.1177/1084713806296720
   Hoep LS, 2006, EUR ARCH OTO-RHINO-L, V263, P895, DOI 10.1007/s00405-006-0091-1
   Hughes GB, 2007, CLIN OTOLOGY
   JAHN AF, 2001, PHYSL EAR
   James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780
   JERSCHOW DP, 2007, 99 RUBB C G MEX CTR
   Johnson TA, 2007, OTOLARYNG HEAD NECK, V136, P577, DOI 10.1016/j.otohns.2006.11.006
   Kaila Rajiv, 2005, Cochlear Implants Int, V6, P141, DOI 10.1179/cim.2005.6.3.141
   KUZMA JA, 2001, Patent No. 6309410
   Lanotte P, 2001, EUR J CLIN MICROBIOL, V20, P880, DOI 10.1007/s10096-001-0633-9
   Lustig LR, 2003, CLIN NEUROTOLOGY DIA
   Madell JR, 2008, PEDIAT AUDIOLOGY DIA
   Mikos A. G., 1994, BIOMATERIALS DRUG CE
   Paasche G, 2006, HEARING RES, V212, P74, DOI 10.1016/j.heares.2005.10.013
   Paasche G, 2003, OTOL NEUROTOL, V24, P222, DOI 10.1097/00129492-200303000-00016
   PAASCHE G, 2005, 28 ANN MIDW RES M AS, V28, P38
   Parnes LS, 1999, LARYNGOSCOPE, V109, P1, DOI 10.1097/00005537-199907001-00001
   Plontke SK, 2008, OTOL NEUROTOL, V29, P401, DOI 10.1097/MAO.0b013e318161aaae
   Popovic N, 2006, INT J PHARM, V314, P120, DOI 10.1016/j.ijpharm.2005.09.040
   Prieskorn DM, 2000, HEARING RES, V140, P212, DOI 10.1016/S0378-5955(99)00193-8
   Rathbone MJ, 2008, MODIFIED RELEASE DRU, V2
   Salt AN, 2005, VOLTA REV, V105, P277
   *SIGM, PROD INF DEX CRYST
   TROY DB, 2006, EXTENDED RELEASE TAR
   VANDEWATER TR, 2009, ACTA OTO-LARYNGOL, V4, P1
   Vivero RJ, 2008, LARYNGOSCOPE, V118, P2028, DOI 10.1097/MLG.0b013e31818173ec
   WALLINE KS, 2004, DRUG DELIVERY COATIN
   WALTZMAN SB, 2006, COMPLICATIONS COCHLE, P126
   WEBSTER JG, 2006, ENCY MEDL DEVICES IN
   WIET RJ, 2006, AVOIDING COMPLICATIO, P102
   YE Q, 2005, 28 ANN MIDW RES M AS
   VALIDATION ANAL METH
   1999, BRIT PHARMACOPOEIA, V3
NR 53
TC 29
Z9 29
U1 0
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2010
VL 94B
IS 2
BP 388
EP 398
DI 10.1002/jbm.b.31666
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 627AK
UT WOS:000280009900014
PM 20583307
DA 2018-10-19
ER

PT J
AU Oldinski, RA
   Cranson, CN
   James, SP
AF Oldinski, Rachael A.
   Cranson, Cody N.
   James, Susan P.
TI Synthesis and characterization of a hyaluronan-polyethylene copolymer
   for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial; polymer; hyaluronan; viscoelastic; osteoblast
ID IN-VITRO; CARTILAGE; BONE; DIFFERENTIATION; HYDROGELS; COMPOSITE;
   BEHAVIOR
AB Hyaluronan (HA)-based biomaterials are of interest for bone and cartilage tissue engineering because HA plays an important role in orthopedic tissue development, function, and repair. The goal of this project was to develop a biomaterial that incorporated the constituents of both a hydrogel and a hydrophobic polymer for biomedical applications. A series of amphiphilic graft copolymers consisting of HA, a glycosaminoglycan, and high-density polyethylene (HDPE), that is, HA-co-HDPE, were fabricated. The chemical characteristics, physical and viscoelastic properties, and cytocompatibility of novel HA-co-HDPE materials were characterized via Fourier Transform infrared (FTIR) spectroscopy, solid state nuclear magnetic resonance (ssNMR) spectroscopy, differential scanning calorimetry (DSC), dynamic shear testing, and an in vitro human osteoblast cell study. The esterification reaction between HA and functionalized HDPE resulted in semicrystalline, insoluble powder. The dynamic shear properties of HA-co-HDPE concentrated solutions were more like natural proteoglycans than the HA control. HA-co-HDPE was successfully compression molded into disks that swelled upon hydration. Osteoblasts were viable and expressed the osteoblast phenotype after 7 days of culture on HA-co-HDPE materials. These HA-co-HDPE materials may have several biomaterial applications in saline suspension or molded form, including orthopedic tissue repair. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 94B: 441-446, 2010.
C1 [Oldinski, Rachael A.; Cranson, Cody N.; James, Susan P.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [James, Susan P.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP James, SP (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM sjames@engr.colostate.edu
FU Schwartz Biomedical, LLC; Indiana 21st Century Research and Technology
FX Contract grant sponsors: Schwartz Biomedical, LLC, and the Indiana 21st
   Century Research and Technology Fund
CR Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Ambrosio L, 1998, P I MECH ENG H, V212, P93, DOI 10.1243/0954411981533863
   Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z
   Chua PH, 2008, J BIOMED MATER RES A, V87A, P1061, DOI 10.1002/jbm.a.31854
   Coleman PJ, 1997, J PHYSIOL-LONDON, V503, P645, DOI 10.1111/j.1469-7793.1997.645bg.x
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Iatridis JC, 1997, J BIOMECH, V30, P1005, DOI 10.1016/S0021-9290(97)00069-9
   MARK J., 2004, PHYS PROPERTIES POLY
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   Mow V. C., 1990, FUNDAMENTALS ARTICUL, P1
   OLDINSKI RA, 2008, 54 ANN M ORTH RES SO
   Painter P. C., 2000, FUNDAMENTALS POLYM S
   Pelletier S, 2000, CARBOHYD POLYM, V43, P343, DOI 10.1016/S0144-8617(00)00188-0
   Puertolas JA, 2006, J BIOMED MATER RES B, V76B, P346, DOI 10.1002/jbm.b.30378
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Solchaga L.A., 2000, HYALURONAN, P45
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Zhai HB, 2004, EUR POLYM J, V40, P2539, DOI 10.1016/j.eurpolymj.2004.07.009
   Zhang FR, 2002, J MATER CHEM, V12, P24
   Zhang M, 2005, J MATER SCI-MATER M, V16, P587, DOI 10.1007/s10856-005-0536-x
   Zhang M, 2005, POLYMER, V46, P3639, DOI 10.1016/j.polymer.2005.03.022
   Zhao X, 2006, J BIOMAT SCI-POLYM E, V17, P419, DOI 10.1163/156856206776374115
   Zou LJ, 2008, J ORTHOP RES, V26, P713, DOI 10.1002/jor.20539
NR 26
TC 7
Z9 9
U1 5
U2 25
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2010
VL 94B
IS 2
BP 441
EP 446
DI 10.1002/jbm.b.31672
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 627AK
UT WOS:000280009900020
PM 20583303
DA 2018-10-19
ER

PT J
AU Peng, HT
AF Peng, Henry T.
TI Thromboelastographic study of biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE thromboelastography; biomaterials; blood coagulation; blood
   compatibility; hemorrhage control
ID LACTATED RINGERS SOLUTION; IN-VITRO; WHOLE-BLOOD; HYDROXYETHYL STARCH;
   MOLECULAR-WEIGHT; BIOMEDICAL APPLICATIONS; COAGULATION ANALYSIS;
   HEMOSTATIC ACTIVITY; PLASMA SUBSTITUTES; HEMORRHAGE CONTROL
AB Thromboelastography (TEG) is drawing more attention for clinical and in vitro studies of blood coagulation. It can be applied to evaluate the effects of both blood-soluble and insoluble biomaterials on whole blood coagulation from the beginning of coagulation through clot formation to the ending with fibrinolysis. TEG may also identify the relative contributions of various clotting factors, such as fibrinogen and platelets, to the overall coagulation process based on profiles of its variables using whole and partial blood components. A comprehensive review has been conducted on its applications for the assessment of a wide range of blood-contacting biomaterials ranging from polymers to ceramics and biomedical devices involved in many applications. The methodology is different in terms of instrumentation, the methods to activate blood coagulation, the type of blood (citrated versus fresh blood), and study settings (in vitro, in vivo, and clinical trials). The author's own work and future directions are discussed as well. TEG should be considered as one of the most useful tools for evaluating in vitro and in vivo blood-biomaterial interactions for different applications. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 94B: 469-485, 2010.
C1 Def Res & Dev Canada Toronto, Toronto, ON M3M 3B9, Canada.
RP Peng, HT (reprint author), Def Res & Dev Canada Toronto, 1133 Sheppard Ave W, Toronto, ON M3M 3B9, Canada.
EM henry.peng@drdc-rddc.gc.ca
OI Peng, Henry/0000-0001-5276-9573
CR Alam HB, 2004, J TRAUMA, V56, P974, DOI 10.1097/01.TA.0000127763.90890.31
   Avidan MS, 2001, ANESTHESIOLOGY, V95, P1169, DOI 10.1097/00000542-200111000-00021
   Banerjee R, 1997, J BIOMATER APPL, V12, P57, DOI 10.1177/088532829701200104
   Bennett SL, 2003, J CARDIAC SURG, V18, P494, DOI 10.1046/j.0886-0440.2003.00303.x
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   BIRD RL, 1988, THROMB RES, V51, P471
   BIRD RL, 1989, J BIOMED ENG, V11, P231, DOI 10.1016/0141-5425(89)90148-9
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   BOLZ A, 1993, MED BIOL ENG COMPUT, V31, pS123, DOI 10.1007/BF02446660
   Bonaros N, 2004, ASAIO J, V50, P424, DOI 10.1097/01.MAT.0000136515.97686.A2
   Bowbrick VA, 2000, ANESTH ANALG, V90, P1086, DOI 10.1097/00000539-200005000-00015
   Camenzind V, 2000, ANESTHESIOLOGY, V92, P1242, DOI 10.1097/00000542-200005000-00011
   Carr Marcus E Jr, 2004, Clin Lab, V50, P529
   Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHEPUROV AK, 1980, B EXP BIOL MED+, V89, P289, DOI 10.1007/BF00834230
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038
   Donahue SM, 2005, J VET EMERG CRIT CAR, V15, P9, DOI 10.1111/j.1476-4431.2005.04025.x
   Farndale RW, 2004, J THROMB HAEMOST, V2, P561, DOI 10.1111/j.1538-7836.2004.00665.x
   Faybik P, 2006, CRIT CARE, V10, DOI 10.1186/cc3985
   Felfernig M, 2006, EUR SURG, V38, P213, DOI 10.1007/s10353-006-0222-3
   Fenger-Eriksen C, 2005, BRIT J ANAESTH, V94, P324, DOI 10.1093/bja/aei052
   Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877
   Fries D, 2002, ANESTH ANALG, V94, P1280, DOI 10.1097/00000539-200205000-00043
   Gennisson JL, 2006, ULTRASOUND MED BIOL, V32, P1529, DOI 10.1016/j.ultrasmedbio.2006.06.008
   Glidden PF, 2000, CLIN APPL THROMB-HEM, V6, P226, DOI 10.1177/107602960000600408
   Greaves M, 2004, VOX SANG, V87, P47, DOI 10.1111/j.1741-6892.2004.00429.x
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   *HAEM CORP, TEG 5000 US MAN 2004, P149
   Haisch G, 2001, J CARDIOTHOR VASC AN, V15, P316, DOI 10.1053/jcan.2001.23276
   Haisch G, 2001, ANESTH ANALG, V92, P565, DOI 10.1213/00000539-200103000-00003
   HALL B, 1989, ANGEW MAKROMOL CHEM, V166, P169, DOI 10.1002/apmc.1989.051660112
   HALL B, 1989, BIOMATERIALS, V10, P219, DOI 10.1016/0142-9612(89)90096-3
   Hansi C, 2009, CATHETER CARDIO INTE, V73, P488, DOI 10.1002/ccd.21834
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   Holt AW, 2002, INTENS CARE MED, V28, P1649, DOI 10.1007/s00134-002-1506-0
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   Jones SB, 2003, ANESTH ANALG, V96, P363, DOI 10.1213/01.ANE.0000046983.68602.4E
   Jovanovic AV, 2006, BIOMACROMOLECULES, V7, P945, DOI 10.1021/bm050820+
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   KAMARAJ J, 2009, TRENDS BIOMATER ARTI, V22, P165
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Karoutsos S, 1999, BRIT J ANAESTH, V82, P175, DOI 10.1093/bja/82.2.175
   Katori N, 2005, ANESTH ANALG, V100, P1781, DOI 10.1213/01.ANE.0000149902.73689.64
   Kawaguchi C, 2002, THROMB HAEMOSTASIS, V88, P768
   KAWAMOTO Y, 1990, BIOCHIM BIOPHYS ACTA, V1035, P361, DOI 10.1016/0304-4165(90)90101-2
   Kawasaki J, 2007, ACTA ANAESTH SCAND, V51, P1237, DOI 10.1111/j.1399-6576.2007.01434.x
   Kheirabadi BS, 2009, J TRAUMA, V66, P316, DOI [10.1097/TA.0b013e31819634a1, 10.1097/TA.0b0l3e31819634a1]
   Kidane AG, 2003, MED BIOL ENG COMPUT, V41, P740, DOI 10.1007/BF02349983
   Kirshbom PM, 2006, J THORAC CARDIOV SUR, V132, P675, DOI 10.1016/j.jtcvs.2006.05.035
   KLOCKING HP, 1993, THROMB RES, V72, P501, DOI 10.1016/0049-3848(93)90110-A
   KOPECEK J, 1973, J BIOMED MATER RES, V7, P179, DOI 10.1002/jbm.820070206
   Kozen BG, 2008, ACAD EMERG MED, V15, P74, DOI 10.1111/j.1553-2712.2007.00009.x
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Landskroner KA, 2005, HAEMOPHILIA, V11, P346, DOI 10.1111/j.1365-2516.2005.01104.x
   Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19
   Lang T, 2004, J THROMB HAEMOST, V2, P147, DOI 10.1111/j.1538-7836.2004.00555.x
   Lee DW, 2004, CARBOHYD POLYM, V58, P371, DOI 10.1016/j.carbpol.2004.06.033
   Lee DW, 2004, BIOMACROMOLECULES, V5, P1310, DOI 10.1021/bm049935o
   LEWIS KB, 2004, Patent No. 6780411
   Linkins LA, 2005, ANNU REV MED, V56, P63, DOI 10.1146/annurev.med.56.082103.104708
   Lomas-Niera JL, 2005, SHOCK, V24, P33, DOI 10.1097/01.shk.0000191411.48719.ab
   Luddington RJ, 2005, CLIN LAB HAEMATOL, V27, P81, DOI 10.1111/j.1365-2257.2005.00681.x
   Madjdpour C, 2005, BRIT J ANAESTH, V94, P569, DOI 10.1093/bja/aei108
   Marchand C, 2009, OSTEOARTHR CARTILAGE, V17, P953, DOI 10.1016/j.joca.2008.12.002
   MARCHISIO MA, 1970, EUR J PHARMACOL, V12, P236, DOI 10.1016/0014-2999(70)90070-1
   McNulty SE, 1998, J CARDIOTHOR VASC AN, V12, P533, DOI 10.1016/S1053-0770(98)90096-9
   McNulty SE, 1998, J CARDIOTHOR VASC AN, V12, P639, DOI 10.1016/S1053-0770(98)90234-8
   Michanetzis GPA, 2002, J MATER SCI-MATER M, V13, P757, DOI 10.1023/A:1016166807299
   Mittermayr M, 2007, ANESTH ANALG, V105, P905, DOI 10.1213/ol.ane.000020481.18570.27
   Morey TE, 2004, J NANOPART RES, V6, P159, DOI 10.1023/B:NANO.0000034625.30336.c1
   Mortier E, 1997, ANAESTHESIA, V52, P1061, DOI 10.1111/j.1365-2044.1997.220-az0354.x
   Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468
   Murugesan S, 2006, J BIOMED MATER RES B, V79B, P298, DOI 10.1002/jbm.b.30542
   Neuffer MC, 2004, MIL MED, V169, P716, DOI 10.7205/MILMED.169.9.716
   Nielsen VG, 2007, BLOOD COAGUL FIBRIN, V18, P247, DOI 10.1097/MBC.0b013e328092ee05
   Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P222, DOI 10.1111/j.1399-6576.2004.00602.x
   Nielsen VG, 2000, ANESTH ANALG, V90, P541, DOI 10.1097/00000539-200003000-00008
   Niemi TT, 2005, ACTA ANAESTH SCAND, V49, P373, DOI 10.1111/j.1399-6576.2004.00619.x
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   ORLIKOWSKI CEP, 1993, J CLIN MONITOR, V9, P5, DOI 10.1007/BF01627630
   Ostomel TA, 2006, J THROMB THROMBOLYS, V22, P55, DOI 10.1007/s11239-006-7658-y
   Ostomel TA, 2006, J AM CHEM SOC, V128, P8384, DOI 10.1021/ja061717a
   Ostomel TA, 2007, LANGMUIR, V23, P11233, DOI 10.1021/la701281t
   Ostomel TA, 2006, SMALL, V2, P1261, DOI 10.1002/smll.200600177
   Peng HT, 2009, J MATER SCI-MATER M, V20, P1753, DOI 10.1007/s10856-009-3721-5
   Peng HT, 2009, J BIOMED MATER RES B, V89B, P199, DOI 10.1002/jbm.b.31206
   Petroianu GA, 2000, ANESTH ANALG, V90, P795
   Prasad S, 2008, BLOOD, V111, P672, DOI 10.1182/blood-2007-07-098913
   Pusateri AE, 2004, J TRAUMA, V57, P555, DOI 10.1097/01.TA.0000136155.97758.CD
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Ramstrom S, 2005, BLOOD COAGUL FIBRIN, V16, P447, DOI 10.1097/01.mbc.0000178827.52242.89
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Roche AM, 2002, ANAESTHESIA, V57, P950, DOI 10.1046/j.1365-2044.2002.02707.x
   Romlin B, 2007, ACTA ANAESTH SCAND, V51, P198, DOI 10.1111/j.1399-6576.2006.01181.x
   Rossi NAA, 2009, BIOMATERIALS, V30, P638, DOI 10.1016/j.biomaterials.2008.09.057
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Salooja N, 2001, BLOOD COAGUL FIBRIN, V12, P327, DOI 10.1097/00001721-200107000-00001
   Samama CM, 2003, VOX SANG, V84, P251, DOI 10.1046/j.1423-0410.2003.00304.x
   SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006
   Senzolo M, 2007, BLOOD COAGUL FIBRIN, V18, P227, DOI 10.1097/MBC.0b013e328010bd3d
   SHAMASH Y, 1969, BIOCHIM BIOPHYS ACTA, V194, P449, DOI 10.1016/0005-2795(69)90105-6
   Shepherd R, 1997, GLYCOCONJUGATE J, V14, P535, DOI 10.1023/A:1018524207224
   Shimojoh M, 1998, CARBOHYD POLYM, V35, P223, DOI 10.1016/S0144-8617(97)00244-0
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Smith SA, 2008, J THROMB HAEMOST, V6, P1750, DOI 10.1111/j.1538-7836.2008.03104.x
   Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x
   Srinivasa V, 2001, Int Anesthesiol Clin, V39, P35, DOI 10.1097/00004311-200101000-00005
   Tan HK, 2004, ANN ACAD MED SINGAP, V33, P329
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
   Valeri CR, 2004, J TRAUMA, V57, pS22, DOI 10.1097/01.TA.0000136744.12440.47
   Vig S, 2001, BLOOD COAGUL FIBRIN, V12, P555, DOI 10.1097/00001721-200110000-00008
   Viswanathan G, 2006, BIOMACROMOLECULES, V7, P415, DOI 10.1021/bm050837s
   von Roten I, 2006, BRIT J ANAESTH, V96, P455, DOI 10.1093/bja/ael019
   Waner M, 2004, SEMIN HEMATOL, V41, P163, DOI 10.1053/j.seminhematol.2003.11.027
   Weiss BM, 1996, J CARDIOTHOR VASC AN, V10, P464, DOI 10.1016/S1053-0770(05)80005-9
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Westbrook AJ, 2009, HEART LUNG CIRC, V18, P277, DOI 10.1016/j.hlc.2008.08.016
   Whang HS, 2005, J MACROMOL SCI-POL R, VC45, P309, DOI 10.1080/15321790500304122
   Zambruni A, 2004, BLOOD COAGUL FIBRIN, V15, P103, DOI 10.1097/01.mbc.0000114364.44793.84
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 124
TC 29
Z9 29
U1 1
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2010
VL 94B
IS 2
BP 469
EP 485
DI 10.1002/jbm.b.31626
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 627AK
UT WOS:000280009900024
PM 20586076
DA 2018-10-19
ER

PT J
AU Shuai, CJ
   Gao, CD
   Nie, Y
   Hu, HL
   Qu, HY
   Peng, SP
AF Shuai, Cijun
   Gao, Chengde
   Nie, Yi
   Hu, Huanglong
   Qu, Hongyi
   Peng, Shuping
TI Structural Design and Experimental Analysis of a Selective Laser
   Sintering System with Nano-Hydroxyapatite Powder
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Laser Selective Sintering; Nano Hydroxyapatite; Microstructure
ID SOL-GEL METHOD; IN-VITRO; NANOCRYSTALLINE HYDROXYAPATITE; BONE;
   FABRICATION; BIOMATERIAL; COMPOSITES; SCAFFOLD; VIVO
AB Hydroxyapatite (HA) is a ceramic transposition material which has been widely used for artificial bone. However, its applications are limited to a small implantation for non-bearing bone repair due to its high brittleness, low strength and poor mechanical properties. Thus, nanotechnology has been employed to improve the mechanical properties (torsion modulus, tensile strength and fatigue resistance, etc.) of HA for bone implantation. In this study, we developed a selective laser sintering system for fabrication of artificial bone with nano-HA powder. The key characteristics of this novel system is the laser with fast heating and fast cooling properties, which efficiently prevents the nanosize particles from forming micron size ones in the process of the sintering. The microstructure of the sintered nano-HA scaffolds produced in this system was investigated under Scanning Electron Microscopy (SEM). We showed that the size of nano particles were increased with the prolonged sintering time. Moreover, they are more in shape of granules instead of the original shape of needle. We suggest that the nano HA scaffolds which meet the requirements for the mechanical and biological properties of bone can be obtained by optimizing the sintering time.
C1 [Peng, Shuping] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.
   [Shuai, Cijun; Gao, Chengde; Nie, Yi; Hu, Huanglong; Qu, Hongyi] Cent S Univ, Minist Educ, Key Lab Modern Complex Equipment Design & Extreme, Changsha 410083, Peoples R China.
   [Shuai, Cijun] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.
RP Peng, SP (reprint author), Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.
RI Gao, Chengde/T-1587-2017
OI Gao, Chengde/0000-0002-1938-7538
FU Natural Science Foundation of China [50875267, 50605063]; Program for
   New Century Excellent Talents in University [NCET-10-0792]
FX This work was supported by the following funds: (1) the Natural Science
   Foundation of China (50875267 and 50605063); (2) Program for New Century
   Excellent Talents in University (NCET-10-0792). We thank Dr. Lintao Qu
   (Yale University) for reading this manuscript and helpful comments.
CR Bose S, 2003, J AM CERAM SOC, V86, P1055, DOI 10.1111/j.1151-2916.2003.tb03423.x
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Fathi MH, 2007, MATER LETT, V61, P3978, DOI 10.1016/j.matlet.2007.01.028
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Li ZM, 2009, J ADV MATER-COVINA, V41, P28
   Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718
   Liu Y, 2007, J APPL POLYM SCI, V106, P2780, DOI 10.1002/app.26917
   Liu Y, 2007, CURR APPL PHYS, V7, P547, DOI 10.1016/j.cap.2006.11.002
   Ma WM, 2008, MAT SCI ENG A-STRUCT, V477, P100, DOI 10.1016/j.msea.2007.06.058
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Nichols HL, 2007, J BIOMED MATER RES A, V82A, P373, DOI 10.1002/jbm.a.31066
   Qu HB, 2008, J AM CERAM SOC, V91, P3211, DOI 10.1111/j.1551-2916.2008.02634.x
   Ran JN, 2007, KEY ENG MATER, V336-338, P1666, DOI 10.4028/www.scientific.net/KEM.336-338.1666
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Shuai CJ, 2010, ADV MATER RES-SWITZ, V97-101, P3997, DOI [10.4028/www.scientific.net/AMR.97-101.3997, 10.4028/www..scientific.net/AMR.97-101.3997]
   Sun Tian-sheng, 2004, Chin J Traumatol, V7, P18
   Wang XH, 2002, NEUROBIOL AGING, V23, pS170
   YOUFA W, 2003, T NONFERR METAL SOC, V13, P69
NR 19
TC 39
Z9 39
U1 3
U2 46
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD AUG
PY 2010
VL 6
IS 4
BP 370
EP 374
DI 10.1166/jbn.2010.1139
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 718LP
UT WOS:000287123200009
PM 21323110
DA 2018-10-19
ER

PT J
AU Vahlsing, T
   Damm, U
   Kondepati, VR
   Leonhardt, S
   Brendel, MD
   Wood, BR
   Heise, HM
AF Vahlsing, Thorsten
   Damm, Uwe
   Kondepati, Venkata Radhakrishna
   Leonhardt, Steffen
   Brendel, Mathias D.
   Wood, Bayden R.
   Heise, H. Michael
TI Transmission infrared spectroscopy of whole blood - complications for
   quantitative analysis from leucocyte adhesion during continuous
   monitoring
SO JOURNAL OF BIOPHOTONICS
LA English
DT Article; Proceedings Paper
CT Workshop on FTIR Spectroscopy in Microbiological and Medical Diagnostics
CY OCT 15-16, 2009
CL Robert Koch Inst, Berlin, GERMANY
HO Robert Koch Inst
DE mid-infrared spectroscopy; whole blood measurements; leucocyte
   adsorption; glucose quantification; haemocompatibility testing
ID FOREIGN-BODY REACTION; MIDINFRARED SPECTROSCOPY; BIOMATERIAL SURFACES;
   PROTEIN ADSORPTION; OXIDATIVE STRESS; CONFORMATIONAL-CHANGES;
   LYMPHOCYTE-ACTIVATION; MOLECULAR-DYNAMICS; LEUKEMIA-CELLS; T-CELLS
AB Infrared spectroscopy has been applied to analyse glucose and cellular components in whole blood with the aim of developing an online clinical diagnostic and monitoring modality. Leucocyte adsorption onto the CaF2 windows was observed over a period of several hours under continuous blood flow using a transmission cell of 30 mu m path length. This build-up of cellular material on the windows is responsible for diminishing the sample path length under the flow conditions chosen. The adsorption dynamics have been characterised and their impact on glucose monitoring is reported. For short-term monitoring (<2 hours) a standard error of prediction of 11 mg/dL with human citrated blood samples from three different subjects was achieved. Furthermore, the leucocyte build-up was also reported for porcine EDTA blood monitoring. Consequences and testing opportunities with regard to the first stages in the immune cell reaction to the exposure of body-foreign materials to anticoagulated whole blood are discussed.
   [GRAPHICS]
   Infrared spectra of build-up of immobilized leucocytes from porcine EDTA-blood during whole blood monitoring
C1 [Damm, Uwe; Kondepati, Venkata Radhakrishna; Heise, H. Michael] Tech Univ Dortmund, Leibniz Inst Analyt Wissensch ISAS eV, D-44139 Dortmund, Germany.
   [Vahlsing, Thorsten; Leonhardt, Steffen] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
   [Brendel, Mathias D.] Tech Univ Dresden, Carl Gustav Carus Univ Hosp, Med Dept & Policlin 3, D-01307 Dresden, Germany.
   [Wood, Bayden R.] Monash Univ, Sch Chem, Ctr Biospect, Clayton, Vic 3800, Australia.
RP Heise, HM (reprint author), Tech Univ Dortmund, Leibniz Inst Analyt Wissensch ISAS eV, Bunsen Kirchhoff Str 11, D-44139 Dortmund, Germany.
OI Leonhardt, Steffen/0000-0002-6898-6887
CR Abbitt KB, 2003, AM J PHYSIOL-HEART C, V285, pH229, DOI 10.1152/ajpheart.00408.2002
   Alam MK, 2004, VIB SPECTROSC, V34, P3, DOI 10.1016/j.vibspec.2003.07.002
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Boydston-White S, 2006, BBA-BIOMEMBRANES, V1758, P908, DOI 10.1016/j.bbamem.2006.04.018
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Diessel E, 2005, APPL SPECTROSC, V59, P442, DOI 10.1366/0003702053641360
   Fabian H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1917844
   Freund JB, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2472479
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Heise H. M., 2008, BIOMEDICAL VIBRATION, p9 
   Heise HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714907
   HEISE HM, 1989, ANAL CHEM, V61, P2009, DOI 10.1021/ac00193a004
   HEISE HM, 1994, APPL SPECTROSC, V48, P85, DOI 10.1366/0003702944027598
   HEISE HM, 2008, P SPIE, V6863
   HEISE HM, 2001, INFRARED RAMAN SPECT, P259
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hosafci G, 2007, ANAL BIOANAL CHEM, V387, P1815, DOI 10.1007/s00216-006-0841-3
   Ivanov IB, 1998, BIOPHYS J, V75, P545, DOI 10.1016/S0006-3495(98)77544-7
   Jain A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007104
   Kim YJ, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2342076
   Krafft C, 2005, CYTOM PART A, V64A, P53, DOI 10.1002/cyto.a.20117
   LENTNER C, 1979, WISSENSCHAFTLICHE TA, P66
   Liu KZ, 2007, BRIT J HAEMATOL, V136, P713, DOI 10.1111/j.1365-2141.2006.06474.x
   Liu KZ, 2005, BLOOD CELL MOL DIS, V35, P404, DOI 10.1016/j.bcmd.2005.06.009
   Liu KZ, 2001, APOPTOSIS, V6, P269, DOI 10.1023/A:1011383408381
   Low-Ying S, 2002, VIB SPECTROSC, V28, P111, DOI 10.1016/S0924-2031(01)00150-3
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Otto M, 2003, J MATER SCI-MATER M, V14, P263, DOI 10.1023/A:1022840909038
   Petibois C, 2005, CELL BIOL INT, V29, P709, DOI 10.1016/j.cellbi.2005.04.007
   Petibois C, 2005, ARCH MED RES, V36, P524, DOI 10.1016/j.arcmed.2005.03.047
   Petibois C, 2004, ANALYST, V129, P912, DOI 10.1039/b408931f
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rohleder D, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1911847
   Romeo M, 2006, VIB SPECTROSC, V42, P9, DOI 10.1016/j.vibspec.2006.04.009
   Schultz CP, 1996, LEUKEMIA RES, V20, P649, DOI 10.1016/0145-2126(96)00019-7
   Steiner G, 2007, ANAL CHEM, V79, P1311, DOI 10.1021/ac061341j
   Strokotov DI, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275471
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Vonach R, 1998, APPL SPECTROSC, V52, P820, DOI 10.1366/0003702981944553
   WERNER C, 2007, J MATER CHEM, V17, P1
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wood BR, 1998, BIOSPECTROSCOPY, V4, P75, DOI 10.1002/(SICI)1520-6343(1998)4:2<75::AID-BSPY1>3.0.CO;2-R
   Wood BR, 2000, HUM IMMUNOL, V61, P1307, DOI 10.1016/S0198-8859(00)00164-6
   Wood BR, 2000, APPL SPECTROSC, V54, P353, DOI 10.1366/0003702001949627
NR 48
TC 8
Z9 8
U1 0
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1864-063X
EI 1864-0648
J9 J BIOPHOTONICS
JI J. Biophotonics
PD AUG
PY 2010
VL 3
IS 8-9
BP 567
EP 578
DI 10.1002/jbio.201000021
PG 12
WC Biochemical Research Methods; Biophysics; Optics
SC Biochemistry & Molecular Biology; Biophysics; Optics
GA 640ML
UT WOS:000281055600010
PM 20449832
DA 2018-10-19
ER

PT J
AU Kwon, HR
   Wikesjo, UME
   Park, JC
   Kim, YT
   Bastone, P
   Pippig, SD
   Kim, CK
AF Kwon, Hyuk-Rak
   Wikesjoe, Ulf M. E.
   Park, Jung-Chul
   Kim, Young-Taek
   Bastone, Patrizia
   Pippig, Susanne D.
   Kim, Chong-Kwan
TI Growth/differentiation factor-5 significantly enhances periodontal wound
   healing/regeneration compared with platelet-derived growth factor-BB in
   dogs
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE dog; beta-TCP; periodontal regeneration; rhGDF-5; rhPDGF; tissue
   engineering
ID GUIDED TISSUE REGENERATION; BONE MORPHOGENETIC PROTEIN-2; WALL INTRABONY
   DEFECTS; ALVEOLAR BONE; DIFFERENTIATION FACTORS; SPACE PROVISION;
   GENE-EXPRESSION; RAT MODEL; REPAIR; RHBMP-2
AB P>Objective
   Recombinant human growth/differentiation factor-5 (rhGDF-5) in a particulate beta-tricalcium phosphate (beta-TCP) carrier is being evaluated to support periodontal regeneration. The objective of this study was to evaluate periodontal wound healing/regeneration following an established clinical (benchmark) protocol including surgical implantation of rhGDF-5/beta-TCP in comparison with that following implantation of recombinant human platelet-derived growth factor-BB (rhPDGF) combined with a particulate beta-TCP biomaterial using an established canine defect model.
   Materials and Methods
   Bilateral, 4 x 5 mm (width x depth), one-wall, critical-size, intrabony periodontal defects were surgically created at the mandibular second and fourth pre-molar teeth in five adult Beagle dogs. Defect sites were randomized to receive rhGDF-5/beta-TCP or the rhPDGF construct followed by wound closure for primary intention healing. The animals were sacrificed following an 8-week healing interval for histological and histometric examination.
   Results
   Clinical healing was generally uneventful. Sites receiving rhGDF-5/beta-TCP exhibited a significantly enhanced cementum formation compared with sites receiving the rhPDGF construct, averaging (+/- SD) 4.49 +/- 0.48 versus 2.72 +/- 0.91 mm (p < 0.001). Similarly, bone regeneration height and area were significantly enhanced at sites receiving rhGDF-5/beta-TCP versus that of the rhPDGF construct averaging, 3.08 +/- 0.74 versus 1.29 +/- 0.78 mm (p < 0.001) and 6.03 +/- 1.28 versus 2.98 +/- 2.61 mm2 (p < 0.01), respectively. Cementum regeneration included cellular/acellular mixed (extrinsic/intrinsic) fibre cementum at sites receiving rhGDF-5/beta-TCP; sites receiving the rhPDGF/beta-TCP showed a pre-dominantly acellular cementum. Newly formed cementum generally extended above the adjoining alveolar bone. Both protocols displayed beta-TCP residues apparently undergoing resorption. Application of both materials appears safe, as they were associated with limited, if any, adverse events.
   Conclusion
   rhGDF-5/beta-TCP shows a significant potential to support/accelerate periodontal wound healing/regeneration. Application of rhGDF-5/beta-TCP appears safe and should be further evaluated in human clinical trials.
C1 [Kwon, Hyuk-Rak; Park, Jung-Chul; Kim, Young-Taek; Kim, Chong-Kwan] Yonsei Univ, Coll Dent, Dept Periodontol, Res Inst Periodontal Regenerat, Seoul 120752, South Korea.
   [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, Dept Periodont, LAPCR, Augusta, GA 30912 USA.
   [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA.
   [Bastone, Patrizia; Pippig, Susanne D.] Scil Technol GmbH, Martinsried, Germany.
RP Kim, CK (reprint author), Yonsei Univ, Coll Dent, Dept Periodontol, Res Inst Periodontal Regenerat, 134 Shinchon Dong, Seoul 120752, South Korea.
EM ckkim@yuhs.ac
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Bolt P, 2007, J BONE JOINT SURG AM, V89A, P1315, DOI 10.2106/JBJS.F.00257
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   Dines JS, 2007, J SHOULDER ELB SURG, V16, p215S, DOI 10.1016/j.jse.2007.03.001
   Forslund C, 2003, J ORTHOPAED RES, V21, P617, DOI 10.1016/S0736-0266(03)00010-X
   Gruber RM, 2008, CLIN ORAL IMPLAN RES, V19, P522, DOI 10.1111/j.1600-0501.2007.01494.x
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Heden G, 2006, J PERIODONTOL, V77, P295, DOI 10.1902/jop.2006.050071
   HOTTEN G, 1994, BIOCHEM BIOPH RES CO, V204, P646, DOI 10.1006/bbrc.1994.2508
   Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567
   Kim CS, 2005, J CLIN PERIODONTOL, V32, P583, DOI 10.1111/j.1600-051X.2005.00729.x
   Kim CS, 2004, J PERIODONTOL, V75, P229, DOI 10.1902/jop.2004.75.2.229
   Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x
   Lee JS, 2010, J CLIN PERIODONTOL, V37, P382, DOI 10.1111/j.1600-051X.2010.01544.x
   Moore YR, 2010, J CLIN PERIODONTOL, V37, P288, DOI 10.1111/j.1600-051X.2009.01527.x
   Morotome Y, 1998, BIOCHEM BIOPH RES CO, V244, P85, DOI 10.1006/bbrc.1998.8213
   Nakamura T, 2003, J PERIODONTAL RES, V38, P597, DOI 10.1034/j.1600-0765.2003.00695.x
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Pohling S., 2006, J PERIODONTOL, V77, P1582
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Polimeni G, 2009, J CLIN PERIODONTOL, V36, P258, DOI 10.1111/j.1600-051X.2008.01369.x
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P642, DOI 10.1111/j.1600-0501.2008.01537.x
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P817, DOI 10.1111/j.1600-051X.2008.01295.x
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Sena K, 2003, J DENT RES, V82, P166, DOI 10.1177/154405910308200304
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   Sorensen RG, 2004, J CLIN PERIODONTOL, V31, P796, DOI 10.1111/j.1600-051X.2004.00544.x
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Weng D, 2009, INT J ORAL MAX IMPL, V24, P31
   Wikesjo UME, 1998, J CLIN PERIODONTOL, V25, P475, DOI 10.1111/j.1600-051X.1998.tb02476.x
   Wikesjo UME, 2004, J CLIN PERIODONTOL, V31, P662, DOI 10.1111/j.1600-051X.2004.00541.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J PERIODONTOL, V74, P957, DOI 10.1902/jop.2003.74.7.957
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P715, DOI 10.1034/j.1600-051X.2003.00364.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537
NR 38
TC 28
Z9 30
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD AUG
PY 2010
VL 37
IS 8
BP 739
EP 746
DI 10.1111/j.1600-051X.2010.01576.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 624RI
UT WOS:000279837300007
PM 20618546
DA 2018-10-19
ER

PT J
AU Wu, TF
   Pan, YZ
   Li, L
AF Wu, Tongfei
   Pan, Yongzheng
   Li, Lin
TI Study on superhydrophobic hybrids fabricated from multiwalled carbon
   nanotubes and stearic acid
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Superhydrophobic hybrids; Carbon nanotubes; Stearic acid; Bionic
   fabrication
ID SUPER-HYDROPHOBIC SURFACES; SOLUTION-IMMERSION PROCESS; FILMS;
   WETTABILITY; LOTUS; TRANSPARENT; DEPOSITION; REPELLENT; CHEMISTRY;
   ALUMINUM
AB A waterproof biomaterial, stearic acid (STA), which is one of components of the wax present on the lotus leaf surface, was used as the material with low surface energy to fabricate superhydrophobic multiwalled carbon nanotube (MWCNT) hybrids through a solution method. This method involved preparation of a sodium stearate (SST)-stabilized MWCNT dispersion, followed by a precipitating process. STA was assembled on the MWCNT-SST hybrid surface by a reaction of SST with acetic acid. The rough surface with multiscale protuberances was revealed by scanning electron microscopy (SEM). The effect of SST/MWCNT weight ratio on water contact angle (CA) and the temperature dependence and alkali resistance of superhydrophobicity of MWCNT hybrids have been investigated. With increasing the SST/MWCNT weight ratio, the water CA of MWCNT hybrid increased and then decreased after a maximum value of 163 at the ratio of 1/1. It was interesting that the wetting property of MWCNT hybrids (SST/MWCNT = 0.5/1 and 1/1) was tunable between superhydrophobicity and superhydrophilicity by changing temperature. Potential applications of these superhydrophobic materials to make large-area superhydrophobic coatings have been proposed. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Wu, Tongfei; Pan, Yongzheng; Li, Lin] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
RP Li, L (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mlli@ntu.edu.sg
RI Wu, Tongfei/K-1469-2014; Li, Lin/G-5107-2010; pan, yongzheng/H-2314-2011
OI Wu, Tongfei/0000-0002-0060-4408; 
FU A*STAR SERC, Singapore [0721010018]
FX This work was supported by the A*STAR SERC Grant (0721010018),
   Singapore.
CR Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Bergin SD, 2008, J PHYS CHEM C, V112, P972, DOI 10.1021/jp076915i
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s
   Ci LJ, 2007, ADV MATER, V19, P3300, DOI 10.1002/adma.200602974
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011
   Han JT, 2008, ADV MATER, V20, P3724, DOI 10.1002/adma.200800239
   Huang L, 2005, J PHYS CHEM B, V109, P7746, DOI 10.1021/jp046549s
   Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u
   Jiang L, 2004, ANGEW CHEM INT EDIT, V43, P4338, DOI 10.1002/anie.200460333
   Khorasani MT, 2005, APPL SURF SCI, V242, P339, DOI 10.1016/j.apsusc.2004.08.035
   Khorasani MT, 2004, J APPL POLYM SCI, V91, P2042, DOI 10.1002/app.13355
   Koch K, 2006, CRYST GROWTH DES, V6, P2571, DOI 10.1021/cg060035w
   Lau KKS, 2003, NANO LETT, V3, P1701, DOI 10.1021/nl034704t
   Li HJ, 2001, ANGEW CHEM INT EDIT, V40, P1743, DOI 10.1002/1521-3773(20010504)40:9<1743::AID-ANIE17430>3.0.CO;2-#
   Li Y, 2007, LANGMUIR, V23, P2169, DOI 10.1021/la0620758
   Liu H, 2004, LANGMUIR, V20, P5659, DOI 10.1021/la036280o
   Luo C, 2008, NANO LETT, V8, P4454, DOI 10.1021/nl802411d
   Ma ML, 2005, LANGMUIR, V21, P5549, DOI 10.1021/la047064y
   Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u
   Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682
   Men XH, 2008, APPL SURF SCI, V254, P2563, DOI 10.1016/j.apsusc.2007.08.084
   Michielsen S, 2007, LANGMUIR, V23, P6004, DOI 10.1021/la063157z
   Nakajima A, 1999, ADV MATER, V11, P1365, DOI 10.1002/(SICI)1521-4095(199911)11:16<1365::AID-ADMA1365>3.0.CO;2-F
   Nakajima A, 2000, THIN SOLID FILMS, V376, P140, DOI 10.1016/S0040-6090(00)01417-6
   Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400
   OGAWA K, 1993, JPN J APPL PHYS 2, V32, pL614, DOI 10.1143/JJAP.32.L614
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   Qu MN, 2007, ADV FUNCT MATER, V17, P593, DOI 10.1002/adfm.200600472
   Quere D, 2002, NAT MATER, V1, P14, DOI 10.1038/nmat715
   Ren SL, 2003, SURF SCI, V546, P64, DOI 10.1016/j.susc.2003.09.018
   Riekerink MBO, 1999, LANGMUIR, V15, P4847, DOI 10.1021/la990020i
   Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p
   SHEPHERD T, 1995, PHYTOCHEMISTRY, V40, P407, DOI 10.1016/0031-9422(95)00281-B
   Shi F, 2007, ADV FUNCT MATER, V17, P1821, DOI 10.1002/adfm.200700267
   Shirtcliffe NJ, 2005, LANGMUIR, V21, P937, DOI 10.1021/la048630s
   Shirtcliffe NJ, 2003, LANGMUIR, V19, P5626, DOI 10.1021/la034204f
   Sun T, 2003, J AM CHEM SOC, V125, P14996, DOI 10.1021/ja038026o
   Thieme M, 2001, ADV ENG MATER, V3, P691, DOI 10.1002/1527-2648(200109)3:9<691::AID-ADEM691>3.0.CO;2-8
   Tsoi S, 2004, LANGMUIR, V20, P10771, DOI 10.1021/la0482507
   Tsujii K, 1997, ANGEW CHEM INT EDIT, V36, P1011, DOI 10.1002/anie.199710111
   Wang Q, 2008, APPL SURF SCI, V254, P2009, DOI 10.1016/j.apsusc.2007.08.039
   Wang ST, 2006, ADV MATER, V18, P767, DOI 10.1002/adma.200501794
   Xu DH, 2006, CARBON, V44, P3226, DOI 10.1016/j.carbon.2006.06.030
   Zhang G, 2005, LANGMUIR, V21, P9143, DOI 10.1021/la0511945
   Zhang X, 2004, J AM CHEM SOC, V126, P3064, DOI 10.1021/ja0398722
   Zhao N, 2005, MACROMOL RAPID COMM, V26, P1075, DOI 10.1002/marc.200500188
   Zou JH, 2008, ADV MATER, V20, P3337, DOI 10.1002/adma.200703094
NR 50
TC 32
Z9 33
U1 0
U2 37
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD AUG 1
PY 2010
VL 348
IS 1
BP 265
EP 270
DI 10.1016/j.jcis.2010.04.006
PG 6
WC Chemistry, Physical
SC Chemistry
GA 612SY
UT WOS:000278924600035
PM 20427047
DA 2018-10-19
ER

PT J
AU Reyes-Carmona, JF
   Santos, AS
   Figueiredo, CP
   Baggio, CH
   Felippe, MCS
   Felippe, WT
   Cordeiro, MM
AF Reyes-Carmona, Jessie F.
   Santos, Adair S.
   Figueiredo, Claudia P.
   Baggio, Cristiane H.
   Felippe, Mara C. S.
   Felippe, Wilson T.
   Cordeiro, Mabel M.
TI Host-Mineral Trioxide Aggregate Inflammatory Molecular Signaling and
   Biomineralization Ability
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Apatite; bioactivity; biomineralization; inflammation; mineral trioxide
   aggregate; wound healing
ID PHOSPHATE-CONTAINING FLUID; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B;
   BIOMATERIAL INTERACTION; GENE-EXPRESSION; PORTLAND-CEMENT; IN-VIVO;
   CELLS; DENTIN; CYCLOOXYGENASE-2
AB Introduction: The biological processes underlying the ability of mineral trioxide aggregate (MTA) to promote hard-tissue deposition and wound healing remain unclear. To further study these processes, specific signaling molecules related to the inflammatory response and the biomineralization process were analyzed to assess host-MTA interactions in vivo. Methods: For cytokine level quantification and immunohistochemical analysis, human dentin tubes were filled with Pro Root MTA (Dentsply, Tulsa Dental, OK) or kept empty and were implanted in subcutaneous tissues in the backs of mice. Dentin tubes were retrieved and subsequently observed using a scanning electron microscope. Results: MTA induced a time-dependent proinflammatory cytokine up-regulation up to 3 days. lmmunohistochemical analyses showed an up-regulated expression of myeloperoxidase, nuclear factor-kappa B, activating protein-1, cyclooxygenase-2, inducible nitric oxide synthase, and vascular endothelial growth factor on day 1. Scanning electron microscopic examination revealed the presence of apatite-like clusters on collagen fibrils over the surface of tubes containing MTA. With the increase in time after implantation, a more extensive mineralization showing a compact layer of apatite was observed. Conclusion: MTA induced a proinflammatory and pro wound healing environment. The biomineralization process occurred simultaneously at the biomaterial-dentin-tissue interface, with the acute inflammatory response. This promoted the integration of the biomaterial into the environment. (J Endod 2010;36:1347-1353)
C1 [Reyes-Carmona, Jessie F.; Felippe, Mara C. S.; Felippe, Wilson T.] Univ Fed Santa Catarina, Postgrad Dent Program, Florianopolis, SC, Brazil.
   [Reyes-Carmona, Jessie F.] Univ Costa Rica, Dept Restorat Sci, San Jose, Costa Rica.
   [Santos, Adair S.; Figueiredo, Claudia P.; Baggio, Cristiane H.] Univ Fed Santa Catarina, Dept Physiol Sci, Florianopolis, SC, Brazil.
   [Cordeiro, Mabel M.] Univ Fed Santa Catarina, Dept Morphol Sci, Florianopolis, SC, Brazil.
RP Reyes-Carmona, JF (reprint author), Univ Costa Rica, Dept Endodont, Sch Dent, San Jose, Costa Rica.
EM jessreyesc@hotmail.com
RI Reyes-Carmona, Jessie/B-4828-2013; Baggio, Cristiane/C-5633-2013;
   Cordeiro, Mabel/F-7635-2010
OI Reyes-Carmona, Jessie/0000-0003-2872-6623; Baggio,
   Cristiane/0000-0001-5536-7561; Santos, Adair/0000-0002-6435-4698
FU University of Costa Rica; Federal University of Santa Catarina
FX Supported in part by Grants in Aid for Scientific Research from the
   University of Costa Rica and Federal University of Santa Catarina.
CR Akarasereenont P, 2002, MEDIAT INFLAMM, V11, P17, DOI 10.1080/09629350120117257
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barbosa Silva MJ, 2008, ORAL SURG ORAL MED O, V105, P70
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Chen CL, 2009, J ENDODONT, V35, P682, DOI 10.1016/j.joen.2009.02.002
   DAYER JM, 1993, AM REV RESPIR DIS, V148, P70
   DEMORAES MT, 2008, ORAL SURG ORAL MED O, V105, P814
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Gomes AC, 2008, ORAL SURG ORAL MED O, V106, P450, DOI 10.1016/j.tripleo.2008.03.022
   Guven G, 2007, J ENDODONT, V33, P18, DOI 10.1016/j.joen.2006.07.014
   Hakki SS, 2009, J ENDODONT, V35, P513, DOI 10.1016/j.joen.2008.12.016
   Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020
   Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Huang TH, 2005, J BIOMED MATER RES B, V73B, P123, DOI 10.1002/jbm.b.30182
   LARSEN GL, 1983, ANNU REV IMMUNOL, V1, P335, DOI 10.1146/annurev.iy.01.040183.002003
   Minamikawa H, 2009, J ENDODONT, V35, P843, DOI 10.1016/j.joen.2009.03.008
   Myers HM, 1991, MONOGRAPHS ORAL SCI, V15, P4
   Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064
   PITA D, 2009, J ENDODONT, V35, P529
   Reyes-Carmona JF, 2010, J ENDODONT, V36, P286, DOI 10.1016/j.joen.2009.10.009
   Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145
   Tay FR, 2009, J DENT RES, V88, P719, DOI 10.1177/0022034509341826
   Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   THOMSON PL, 2007, J DENT, V35, P636
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Zakharova M, 2005, J IMMUNOL, V175, P5024, DOI 10.4049/jimmunol.175.8.5024
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 32
TC 18
Z9 18
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD AUG
PY 2010
VL 36
IS 8
BP 1347
EP 1353
DI 10.1016/j.joen.2010.04.029
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 635XT
UT WOS:000280691900014
PM 20647094
DA 2018-10-19
ER

PT J
AU Wang, HB
   Zhang, XL
   Li, YM
   Ma, YT
   Zhang, Y
   Liu, ZG
   Zhou, J
   Lin, QX
   Wang, YM
   Duan, CM
   Wang, CY
AF Wang, Haibin
   Zhang, Xuelian
   Li, Yanmin
   Ma, Yitong
   Zhang, Ye
   Liu, Zhigiang
   Zhou, Jin
   Lin, Qiuxia
   Wang, Yanmeng
   Duan, Cuimi
   Wang, Changyong
TI Improved myocardial performance in infarcted rat heart by co-injection
   of basic fibroblast growth factor with temperature-responsive Chitosan
   hydrogel
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
DE growth factor; chitosan; myocardial infarction; tissue engineering;
   biomaterial
ID PHOTOCROSSLINKABLE CHITOSAN; VENTRICULAR-FUNCTION; DOUBLE-BLIND;
   STEM-CELLS; IN-SITU; ANGIOGENESIS; EFFICACY; MODEL; INJECTION; OCCLUSION
AB BACKGROUND: Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. The sustained release of bFGF by using biomaterials helped to enhance its angiogenic activity in vivo. In this study we investigated the effects of co-injection of bFGF with temperature-responsive chitosan hydrogel on myocardial performance in a rat model of infarction.
   METHODS: Myocardial infarction was induced in rats using coronary artery ligation. Temperature-responsive chitosan hydrogel was prepared and injected intramyocardially into the left ventricular wall of rat infarction models alone or together with bFGF. Detailed histologic analysis and echocardiography were used to determine the structural and functional consequences 4 weeks after injection.
   RESULTS: Heart function improved significantly in the chitosan+bFGF group compared with the phosphate-buffered saline (PBS)+bFGF group with regard to left ventricular ejection fraction (LVEF) and LV fractional shortening (LVFS) 4 weeks after transplantation (p < 0.05, n = 8 per group). In addition, arteriole densities within the infarcted area improved significantly (p < 0.01) in the chitosan+bFGF group (259 +/- 22/mm(2)) compared with the PBS+bFGF group (95 +/- 18/mm(2); n = 8 per group) at 4 weeks after transplantation. Infarct size and fibrotic area decreased significantly (p < 0.05) in the chitosan+bFGF group (39.64 +/- 1.75% and 25.09 +/- 3.31%, respectively) compared with the PBS+bFGF group (48.91 +/- 1.39% and 48.0 +/- 3.83%, respectively; n = 8 per group). No significant difference (p > 0.05) was noted between the PBS and PBS +bFGF groups.
   CONCLUSIONS: Co-injection of bFGF with temperature-responsive chitosan hydrogels enhanced the effects of bFGF on arteriogenesis, ventricular remodeling and cardiac function. Our findings suggest a new approach to improve infarcted repairs in the prevention of adverse remodeling after myocardial infarction. J Heart Lung Transplant 2010;29:881-7 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.
C1 [Wang, Haibin; Li, Yanmin; Zhang, Ye; Liu, Zhigiang; Zhou, Jin; Lin, Qiuxia; Wang, Yanmeng; Duan, Cuimi; Wang, Changyong] Acad Mil Med Sci, Dept Tissue Engn, Inst Basic Med Sci, Beijing 100850, Peoples R China.
   [Wang, Haibin; Li, Yanmin; Zhang, Ye; Liu, Zhigiang; Zhou, Jin; Lin, Qiuxia; Wang, Yanmeng; Duan, Cuimi; Wang, Changyong] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing 100850, Peoples R China.
   [Zhang, Xuelian; Ma, Yitong] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Peoples R China.
RP Wang, CY (reprint author), Acad Mil Med Sci, Dept Tissue Engn, Inst Basic Med Sci, 27 Taiping Rd, Beijing 100850, Peoples R China.
EM wcy2000@yahoo.com
FU National High Technology Research and Development Program of China
   [2006AA02A105]; Nature Science Foundation of China [30530220]; Beijing
   Nature Science Foundation of China [7062053]; Technology Support
   Foundation for Xinjiang Uygur Autonomous Region of China [200891127]
FX Supported by the National High Technology Research and Development
   Program of China (grant no. 2006AA02A105), Nature Science Foundation of
   China (grant no. 30530220), Beijing Nature Science Foundation of China
   (grant no. 7062053) and the Technology Support Foundation for Xinjiang
   Uygur Autonomous Region of China (grant no. 200891127).
CR Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chow KS, 2000, BIOMACROMOLECULES, V1, P61, DOI 10.1021/bm005503b
   CHRISTMAN KL, 2006, J AM COLL CARDIOL, V48, P7
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952
   Hoemann CD, 2007, J BIOMED MATER RES A, V83A, P521, DOI 10.1002/jbm.a.31365
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Kanemitsu N, 2006, J HEART LUNG TRANSPL, V25, P1253, DOI 10.1016/j.healun.2006.05.012
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   LAZAROUS DF, 1995, CIRCULATION, V91, P145, DOI 10.1161/01.CIR.91.1.145
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503
   Post MJ, 2001, CARDIOVASC RES, V49, P522, DOI 10.1016/S0008-6363(00)00216-9
   Quick DJ, 2004, J CONTROL RELEASE, V97, P333, DOI 10.1016/j.jconrel.2004.03.001
   Rajanayagam MAS, 2000, J AM COLL CARDIOL, V35, P519, DOI 10.1016/S0735-1097(99)00550-1
   Sakakibara Y, 2003, EUR J CARDIO-THORAC, V24, P105, DOI 10.1016/S1010-7940(03)00159-3
   Scheinowitz M, 2002, ISRAEL MED ASSOC J, V4, P109
   Shao ZQ, 2006, CIRC J, V70, P471, DOI 10.1253/circj.70.471
   Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpat.2007.070003
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
NR 30
TC 55
Z9 56
U1 4
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD AUG
PY 2010
VL 29
IS 8
BP 881
EP 887
DI 10.1016/j.healun.2010.03.016
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA 634GY
UT WOS:000280570000009
PM 20466563
DA 2018-10-19
ER

PT J
AU Walsh, PJ
   Walker, GM
   Maggs, CA
   Buchanan, FJ
AF Walsh, P. J.
   Walker, G. M.
   Maggs, C. A.
   Buchanan, F. J.
TI Thermal preparation of highly porous calcium phosphate bone filler
   derived from marine algae
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 29th Northern Ireland Biomedical Engineering Conference
CY APR 08, 2009
CL Queens Univ Belfast, Belfast, NORTH IRELAND
SP No Ireland Biomed Engn Soc, Univ Ulster
HO Queens Univ Belfast
ID CORALLINE ALGAE; HYDROXYAPATITE; AUGMENTATION; SINUS
AB A sustainable marine-derived bioceramic with a unique porous structure has been developed for hard tissue repair. The conversion of alga was achieved through a novel technique, involving well controlled thermal processing followed by low pressure-temperature hydrothermal synthesis. In its preparation, a heat treatment step was required to remove the organic compounds from the algae, which reinforces the mineralised matrices. Its removal is necessary to prevent issue such as immune biocompatibility and ensure phase purity of the resultant biomaterial. This paper investigates the hydrothermal technique used for the transformation of mineralised red algae to hydroxyapatite that preserves the algae's unique structure. It specifically focuses on the effects of heat treatment on the morphology of the algae, TGA, SEM and hot stage XRD to quantity the changes.
C1 [Walsh, P. J.; Buchanan, F. J.] Queens Univ Belfast, Sch Mech & Aerosp Engn, Belfast BT9 5AH, Antrim, North Ireland.
   [Walker, G. M.] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT9 5AH, Antrim, North Ireland.
   [Maggs, C. A.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 5AH, Antrim, North Ireland.
RP Walsh, PJ (reprint author), Queens Univ Belfast, Sch Mech & Aerosp Engn, Ashby Bldg,Stranmillis Rd, Belfast BT9 5AH, Antrim, North Ireland.
EM pamelajwalsh@qub.ac.uk
OI Maggs, Christine/0000-0003-0495-7064; Walker, Gavin/0000-0003-4102-0019
CR *BS ISO, 1377912000E BS IEO, P2
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Carrasco F, 2004, J APPL POLYM SCI, V93, P1913, DOI 10.1002/app.20675
   DIGBY PSB, 1977, J MAR BIOL ASSOC UK, V57, P1111, DOI 10.1017/S0025315400026163
   Ewers R, 2005, J ORAL MAXIL SURG, V63, P1712, DOI 10.1016/j.joms.2005.08.020
   EWERS R, 1988, Patent No. 4770860
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Green DW, 2009, BIOMATERIALS, V30, P1918, DOI 10.1016/j.biomaterials.2008.12.052
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Reina J, 1998, IND ENG CHEM RES, V37, P4290, DOI 10.1021/ie980083g
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   Walsh PJ, 2008, CHEM ENG J, V137, P173, DOI 10.1016/j.cej.2007.10.016
   Wilson S, 2004, BIOL CONSERV, V120, P279, DOI 10.1016/j.biocon.2004.03.001
NR 15
TC 5
Z9 5
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2010
VL 21
IS 8
BP 2281
EP 2286
DI 10.1007/s10856-010-4056-y
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637JY
UT WOS:000280814800005
PM 20333540
DA 2018-10-19
ER

PT J
AU Boyd, AR
   Burke, GA
   Meenan, BJ
AF Boyd, A. R.
   Burke, G. A.
   Meenan, B. J.
TI Monitoring cellular behaviour using Raman spectroscopy for tissue
   engineering and regenerative medicine applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 29th Northern Ireland Biomedical Engineering Conference
CY APR 08, 2009
CL Queens Univ Belfast, Belfast, NORTH IRELAND
SP No Ireland Biomed Engn Soc, Univ Ulster
HO Queens Univ Belfast
ID EMBRYONIC STEM-CELLS; LIVING CELLS; IN-VITRO; MICROSPECTROSCOPY
AB Raman spectroscopy has been used to determine the chemical composition of materials for over 70 years. Recent spectacular advances in laser and CCD camera technology creating instruments with higher sensitivity and lower cost have initiated a strong resurgence in the technique, ranging from fundamental research to process control methodology. One such area of increased potential is in tissue engineering and regenerative medicine (TERM), where autologous cell culture, stem cell biology and growth of human cells on biomaterial scaffolds are of high importance. Traditional techniques for the in vitro analysis of biochemical cell processes involves cell techniques such as fixation, lysis or the use of radioactive or chemical labels which are time consuming and can involve the perpetuation of artefacts. Several studies have already shown the potential of Raman spectroscopy to provide useful information on key biochemical markers within cells, however, many of these studies have utilised micro- or confocal Raman to do this, which are not suited to the rapid and non-invasive monitoring of cells. For this study a versatile fit-for-purpose Raman spectrometer was used, employing a macro-sampling optical platform (laser spot size 100 mu m at focus on the sample) to discriminate between different TERM relevant cell types and viable and non-viable cells. The results clearly show that the technique is capable of obtaining Raman spectra from live cells in a non-destructive, rapid and non-invasive manner, however, in these experiments it was not possible to discriminate between different cell lines. Despite this, notable differences were observed in the spectra obtained from viable and non-viable cells, showing significant changes in the spectral profiles of protein, DNA/RNA and lipid cell constituents after cell death. It is evident that the method employed here shows significant potential for further utilisation in TERM, providing data directly from live cells that fits within a quality assurance framework and provides the opportunity to analyse cells in a non-destructive manner.
C1 [Boyd, A. R.; Burke, G. A.; Meenan, B. J.] Univ Ulster, Sch Engn, NIBEC, Newtownabbey BT37 0QB, Antrim, North Ireland.
RP Boyd, AR (reprint author), Univ Ulster, Sch Engn, NIBEC, Room 25A18,Shore Rd, Newtownabbey BT37 0QB, Antrim, North Ireland.
EM ar.boyd@ulster.ac.uk
FU Engineering and Physical Sciences Research Council [EP/C534247/1]
CR JEANNESSON P, 1983, ANAL BIOCHEM, V129, P305, DOI 10.1016/0003-2697(83)90554-7
   Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1
   Mather ML, 2007, REGEN MED, V2, P145, DOI 10.2217/174607451.2.2.145
   Matthaus C, 2006, APPL SPECTROSC, V60, P1, DOI 10.1366/000370206775382758
   Notingher I, 2004, J CELL BIOCHEM, V92, P1180, DOI 10.1002/jcb.20136
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378
   Notingher I, 2005, BIOCERAMICS, V17, P545
   Notingher I, 2006, EXPERT REV MED DEVIC, V3, P215, DOI 10.1586/17434440.3.2.215
   Notingher L, 2004, VIB SPECTROSC, V35, P199, DOI 10.1016/j.vibspec.2004.01.014
   Owen CA, 2006, J MATER SCI-MATER M, V17, P1019, DOI 10.1007/s10856-006-0438-6
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   Short KW, 2005, BIOPHYS J, V88, P4274, DOI 10.1529/biophysj.103.038604
   Swain RJ, 2007, BIOCHEM SOC T, V35, P544, DOI 10.1042/BST0350544
   Uzunbajakava N, 2003, BIOPOLYMERS, V72, P1, DOI 10.1002/bip.10246
   Verrier S, 2004, BIOPOLYMERS, V74, P157, DOI 10.1002/bip.20063
   Xie CG, 2004, OPT EXPRESS, V12, P6208, DOI 10.1364/OPEX.12.006208
NR 17
TC 10
Z9 10
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2010
VL 21
IS 8
BP 2317
EP 2324
DI 10.1007/s10856-009-3965-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637JY
UT WOS:000280814800010
PM 20020185
DA 2018-10-19
ER

PT J
AU Mir, A
   Mallik, D
   Bhattacharyya, S
   Mahata, D
   Sinha, A
   Nayar, S
AF Mir, Aparna
   Mallik, Dhriti
   Bhattacharyya, Soumya
   Mahata, Dipankar
   Sinha, Arvind
   Nayar, Suprabha
TI Aqueous ferrofluids as templates for magnetic hydroxyapatite
   nanocomposites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 29th Northern Ireland Biomedical Engineering Conference
CY APR 08, 2009
CL Queens Univ Belfast, Belfast, NORTH IRELAND
SP No Ireland Biomed Engn Soc, Univ Ulster
HO Queens Univ Belfast
ID BIOMEDICAL APPLICATIONS; IRON-OXIDES; NANOPARTICLES; BONE
AB Poly (vinyl) alcohol stabilized aqueous ferrofluids (PVA-ff) were used as nanotemplates for the crystallization of calcium hydroxyapatite (HAp). Four sets of PVA-ff-HAp nanocomposites were synthesized using 20, 40, 60 and 80 ml of PVA-ff for the same initial constituents of HAp. Various physico-chemical analyses suggest that the HAp lattice structure accommodates PVA-ff to a certain extent, beyond which the magnetic intra-molecular interactions predominate and PVA-ff starts to be pushed out of the HAp matrix. The in situ incorporation of PVA-ff during HAp synthesis results in a novel magnetic biomaterial with potential applications as targeted delivery vehicles.
C1 [Mir, Aparna; Mallik, Dhriti; Bhattacharyya, Soumya; Sinha, Arvind; Nayar, Suprabha] Natl Met Lab, Jamshedpur 831007, Bihar, India.
   [Mahata, Dipankar] Univ Burdwan, Burdwan 713104, W Bengal, India.
RP Mallik, D (reprint author), Natl Met Lab, Jamshedpur 831007, Bihar, India.
EM dhritimallik@nmlindia.org
RI Sahu, Anjani/E-7590-2015
CR Berry CC, 2005, J MATER CHEM, V15, P543, DOI 10.1039/b409715g
   Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017
   Dobson J, 2001, FEBS LETT, V496, P1, DOI 10.1016/S0014-5793(01)02386-9
   GLIMCHER MJ, 1959, REV MOD PHYS, V31, P359, DOI 10.1103/RevModPhys.31.359
   Gross K.A., 2002, EUR CELLS MATER, V3, P114
   Guha AK, 2009, COLLOID SURFACE B, V73, P146, DOI 10.1016/j.colsurfb.2009.05.009
   Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Marinescu G, 2006, J NANOPART RES, V8, P1045, DOI 10.1007/s11051-006-9134-1
   MATSUMOTO T, 2004, BIOMATERIALS, V25, P2807
   Mizushima Y, 2006, J CONTROL RELEASE, V110, P260, DOI 10.1016/j.jconrel.2005.09.051
   Morrissey R, 2005, J MATER SCI-MATER M, V16, P387, DOI 10.1007/s10856-005-6976-5
   Nakahira A, 2007, IEEE T MAGN, V43, P2465, DOI 10.1109/TMAG.2007.894358
   Namduri H, 2008, CORROS SCI, V50, P2493, DOI 10.1016/j.corsci.2008.06.034
   Nazarpak MH, 2009, J CERAM PROCESS RES, V10, P54
   Wang J, 2008, J MATER SCI-MATER M, V19, P2663, DOI 10.1007/s10856-007-3365-2
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Wu HC, 2010, ADV FUNCT MATER, V20, P67, DOI 10.1002/adfm.200901108
   Yamasaki K, 2009, TOXICOL LETT, V191, P211, DOI 10.1016/j.toxlet.2009.08.023
NR 20
TC 7
Z9 7
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2010
VL 21
IS 8
BP 2365
EP 2369
DI 10.1007/s10856-010-4090-9
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637JY
UT WOS:000280814800016
PM 20505984
DA 2018-10-19
ER

PT J
AU Nita, LE
   Chiriac, AP
AF Nita, Loredana E.
   Chiriac, Aurica P.
TI Effect of emulsion polymerization and magnetic field on the adsorption
   of albumin on poly(methyl methacrylate)-based biomaterial surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 29th Northern Ireland Biomedical Engineering Conference
CY APR 08, 2009
CL Queens Univ Belfast, Belfast, NORTH IRELAND
SP No Ireland Biomed Engn Soc, Univ Ulster
HO Queens Univ Belfast
ID PROTEIN ADSORPTION; IONIC-STRENGTH; POLYMERS; IMMOBILIZATION;
   MICROSPHERES; ATTACHMENT; COLLAGEN; ENZYME; FILMS
AB The adsorption of bovine serum albumin (BSA) onto the surfaces of poly(methyl methacrylate) (PMMA) and of methyl methacrylate copolymer with 2,3-epoxypropyl methacrylate, it was investigated. The polymeric matrices were obtained through radical emulsion polymerization with and without the presence of a continuous external magnetic field (MF) of 1,500 Gs intensity. Two types of surfactant agents were used for polymers' synthesis: a classic one sodium lauryl sulphate (SLS) and beta-cyclodextrin (CD). The protein adsorption was conducted in the presence as well as in the absence of MF, by varying the coupling conditions, respectively, the temperature, pH and albumin/polymer ratio. The study underlines the assistance of MF during the adsorption process, materialized into growth of the BSA adsorbed quantity. Thus, MF presence during adsorption determines the doubling of the BSA adsorbed quantity onto the surface of polymers prepared in the MF. The adsorption process was also related to the tensioactive used for the synthesis of polymeric matrices. The higher content of the adsorbed BSA corresponds to the polymers with CD instead of SLS. The fact was attributed to the catalytic activity of the MF, which determines the molecules distortions, the growth of distance interactions and the modifications of the angles between bonds, with benefit effect upon adsorption.
C1 [Nita, Loredana E.; Chiriac, Aurica P.] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
RP Chiriac, AP (reprint author), Petru Poni Inst Macromol Chem, Grigore Ghica Voda Alley 41A, Iasi 700487, Romania.
EM achiriac1@yahoo.com
RI Nita, Loredana Elena/B-3612-2012; Chiriac, Aurica/B-9627-2012
OI Nita, Loredana Elena/0000-0002-5788-3882; Chiriac,
   Aurica/0000-0002-8452-1780
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   AINSLIE KM, 2005, MAT RES SOC P S S
   Bajpai AK, 2000, J APPL POLYM SCI, V78, P933, DOI 10.1002/1097-4628(20001031)78:5<933::AID-APP10>3.3.CO;2-7
   Bi HY, 2006, LAB CHIP, V6, P769, DOI 10.1039/b600326e
   Brown DA, 2005, J BIOMED MATER RES A, V74A, P419, DOI 10.1002/jbm.a.30344
   Brown L, 2006, LAB CHIP, V6, P66, DOI 10.1039/b512179e
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chiriac AP, 2004, J POLYM SCI POL CHEM, V42, P5678, DOI 10.1002/pola.20337
   Chiriac AP, 1996, J POLYM SCI POL CHEM, V34, P567, DOI 10.1002/(SICI)1099-0518(199603)34:4<567::AID-POLA2>3.3.CO;2-Y
   Chiriac AP, 2000, PROG POLYM SCI, V25, P219, DOI 10.1016/S0079-6700(99)00037-4
   Chiriac AP, 2007, J OPT ADV MAT, V9, P4331
   DOUZOU P, 1984, ADV PROTEIN CHEM, V36, P245, DOI 10.1016/S0065-3233(08)60299-5
   Hanamoto LK, 2004, BRAZ J PHYS, V34, P687, DOI 10.1590/S0103-97332004000400044
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim HJ, 2005, CLIN ORAL IMPLAN RES, V16, P557, DOI 10.1111/j.1600-0501.2005.01164.x
   Li SJ, 2004, METHOD FIND EXP CLIN, V26, P507, DOI 10.1358/mf.2004.26.7.863732
   Liu BL, 2006, APPL SURF SCI, V252, P7830, DOI 10.1016/j.apsusc.2005.09.058
   Liu JK, 2004, ANAL CHEM, V76, P6948, DOI 10.1021/ac040094l
   Malpass CA, 2002, J BIOMED MATER RES, V63, P822, DOI 10.1002/jbm.10410
   Nita L.E., 2008, OPEN MACROMOL J, V2, P26
   Nita LE, 2008, POLYM INT, V57, P342, DOI 10.1002/pi.2355
   Nita LE, 2007, J APPL POLYM SCI, V104, P3029, DOI 10.1002/app.25223
   ORLANDO L, 2003, BIOMED MAT ENG, V2, P147
   Quiquampoix H, 1995, ACS SYM SER, V602, P321
   SALIKHOV KM, 1984, SPIN POLARIZATION MA
   Serizawa T, 2002, LANGMUIR, V18, P8381, DOI 10.1021/la0204491
   Sharma S, 2001, J COLLOID INTERF SCI, V243, P61, DOI 10.1006/jcis.2001.7846
   SIMIONESCU CI, 1991, POLYM BULL, V27, P31, DOI 10.1007/BF00296321
   Sinha A, 2005, COLLOID SURFACE B, V43, P7, DOI 10.1016/j.colsurfb.2005.03.006
   TANAHASHI M, 1994, J APPL BIOMATER, V5, P339, DOI 10.1002/jab.770050409
   Varma HK, 2003, BIOMATERIALS, V24, P297, DOI 10.1016/S0142-9612(02)00318-6
   Yan MD, 2003, ADV MATER, V15, P244, DOI 10.1002/adma.200390057
   Yang Y, 2003, NUCL INSTRUM METH B, V207, P165, DOI 10.1016/S0168-583X(03)00456-7
   Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0
   Zhang SP, 2002, AICHE J, V48, P178, DOI 10.1002/aic.690480118
   2004, Patent No. 20040263302
   5315997
NR 37
TC 4
Z9 4
U1 0
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2010
VL 21
IS 8
BP 2443
EP 2452
DI 10.1007/s10856-010-4099-0
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637JY
UT WOS:000280814800024
PM 20502947
DA 2018-10-19
ER

PT J
AU Subramanian, E
   Ramalakshmi, RD
AF Subramanian, E.
   Ramalakshmi, R. Dhana
TI Pristine, purified and polyaniline-coated tamarind seed (Tamarindus
   indica) biomaterial powders for defluoridation: Synergism and
   enhancement in fluoride-adsorption by polyaniline coating
SO JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH
LA English
DT Article
DE Deflouridation; Polyaniline-coating; Tamarind seed
ID WATER
AB This study reports defluoridation performed with tamarind seed (TS) (Tamarindus indica) powders. From three types [pristine (PriTS), purified (PurTS) and polyaniline (Pani)] coated (50 and 90% w/w) TS, PriTS and PurTS powders were used in batch mode for adsorption of fluoride ion (F(-)) (1-10 mg/l solutions). Adsorption capacities (Q) of PriTS 75, 150 and 300 mu particles were 10.6, 7.1 and 4.8 mg/g respectively. ER characterization of Pani-loaded TS without/with F(-) in conjunction with adsorption data demonstrated synergism between Pani 50% and TS components in F- uptake. Thus, with highest Q (10.7 mg/g) and avoidance of leaching, Pani-coated PriTS 50% is most efficient and employable adsorbent for domestic defluoridation.
C1 [Subramanian, E.; Ramalakshmi, R. Dhana] Manonmaniam Sundaranar Univ, Dept Chem, Abishekapatti 627012, Tirunelveli, India.
RP Subramanian, E (reprint author), Manonmaniam Sundaranar Univ, Dept Chem, Abishekapatti 627012, Tirunelveli, India.
EM esubram@yahoo.com
CR DE AK, 2003, ENVIRON CHEM, P242
   Kim BJ, 2002, POLYMER, V43, P111, DOI 10.1016/S0032-3861(01)00614-0
   KOTAIAH B, 1994, ENV ENG LAB MANUAL, P106
   LANGMUIR I, 1918, J AM CHEM SOC, V40, P1403
   Mishra SP, 2010, J SCI IND RES INDIA, V69, P249
   Murugan M., 2006, Journal of Water and Health, V4, P453, DOI 10.2166/wh.2006.014
   Murugan M, 2002, INDIAN J ENV PROT, V22, P1034
   SHIRKE PA, 1991, FLUORIDE, V24, P109
   Sivasamy A, 2001, J CHEM TECHNOL BIOT, V76, P717, DOI 10.1002/jctb.440
   Subramanian E, 2007, J APPL POLYM SCI, V106, P673, DOI 10.1002/app.26566
   Trivedi D. C., 1997, HDB ORGANIC CONDUCTI, V2, P505
NR 11
TC 8
Z9 8
U1 0
U2 3
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0022-4456
J9 J SCI IND RES INDIA
JI J. Sci. Ind. Res.
PD AUG
PY 2010
VL 69
IS 8
BP 621
EP 628
PG 8
WC Engineering, Multidisciplinary
SC Engineering
GA 636ZX
UT WOS:000280785100008
DA 2018-10-19
ER

PT J
AU Ghanaati, S
   Orth, C
   Unger, RE
   Barbeck, M
   Webber, MJ
   Motta, A
   Migliaresi, C
   Kirkpatrick, CJ
AF Ghanaati, Shahram
   Orth, Carina
   Unger, Ronald E.
   Barbeck, Mike
   Webber, Matthew J.
   Motta, Antonella
   Migliaresi, Claudio
   Kirkpatrick, C. James
TI Fine-tuning scaffolds for tissue regeneration: effects of formic acid
   processing on tissue reaction to silk fibroin
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE vascularization; biocompatibility; immune response; tissue engineering;
   degradation; silk fibroin
ID OUTGROWTH ENDOTHELIAL-CELLS; IN-VITRO; BIOMATERIALS; VIVO;
   VASCULARIZATION; OSTEOBLASTS; RESPONSES; FILMS
AB Formic acid (FA) plays a key role in the preparation of silk fibroin (SF) scaffolds from cocoons of Bombyx mori and is used for fibre distribution. In this study, we used a subcutaneous implantation model in Wistar rats to examine SF scaffolds prepared by treating the degummed cocoon with FA for either 30 or 60 min. The tissue reaction and inflammatory response to SF was assessed by qualitative histology at intervals from 3 to 180 days. Additionally, dynamic biomaterial-induced vascularization and biomaterial degradation were quantified using a technique for analysing an image of the entire implanted biomaterial. Varying the FA treatment time led to different scaffold morphologies and resulted in two distinct pen-implant tissue reactions. The 30 min-treated scaffold was integrated into the surrounding tissue beginning at day 3 after implantation and vascularization increased 10-fold from 15 to 180 days, while the scaffold was continuously degraded throughout the first 90 days. In contrast, the 60 min-treated SF scaffold appeared as bulk for the first 90 days after implantation, after which a rapid degradation and vascularization process began. After 180 days, the tissue response was similar for both scaffolds, with eventual formation of a well vascularized connective tissue integrating the SF fibres. This study indicates that by modifying the FA treatment time, the tissue reaction to SF scaffolds can be tailored for different tissue-engineering applications. The tunability and biocompatibility of SF make it an attractive scaffold for exploration in regenerative medicine and clinical tissue engineering. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Ghanaati, Shahram; Orth, Carina; Unger, Ronald E.; Barbeck, Mike; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   [Webber, Matthew J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60201 USA.
   [Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38050 Trento, Italy.
   [Motta, Antonella; Migliaresi, Claudio] Univ Trent, BIOtech Res Ctr, I-38050 Trento, Italy.
RP Ghanaati, S (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM ghanaati@uni-mainz.de
RI Webber, Matthew/D-4847-2011
OI Barbeck, Mike/0000-0002-3001-1347; Webber, Matthew/0000-0003-3111-6228;
   Motta, Antonella/0000-0003-4893-6863
FU European Commission [500283-2]
FX The authors would like to thank C. Braun, A. Valentino, U. Hilbig and K.
   Molter for their excellent technical assistance. This work was
   financially supported by grants from the European Commission
   (EXPERTISSUES Contract No. 500283-2).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ANDERSON GW, 1993, INT MATH RES NOTICES, V2, P41
   Armato U., 2002, Patent PTC, Patent No. [WO 02/29141 A1, 0229141]
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Egana JT, 2009, TISSUE ENG PT A, V15, P1191, DOI 10.1089/ten.tea.2008.0097
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
NR 21
TC 38
Z9 40
U1 0
U2 18
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD AUG
PY 2010
VL 4
IS 6
BP 464
EP 472
DI 10.1002/term.257
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 641TK
UT WOS:000281152400006
PM 20112273
OA Bronze
DA 2018-10-19
ER

PT J
AU Cheng, HLM
   Loai, Y
   Beaumont, M
   Farhat, WA
AF Cheng, Hai-Ling Margaret
   Loai, Yasir
   Beaumont, Marine
   Farhat, Walid A.
TI The Acellular Matrix (ACM) for Bladder Tissue Engineering: A
   Quantitative Magnetic Resonance Imaging Study
SO MAGNETIC RESONANCE IN MEDICINE
LA English
DT Article
DE MRI; magnetic resonance imaging; ACM; acellular tissue matrix; HA;
   hyaluronic acid/hyaluronan; GAGs; glycosaminoglycans
ID HYALURONIC-ACID; IN-VIVO; ARTICULAR CHONDROCYTES; DIFFUSION; SCAFFOLDS;
   WATER; RELAXATION; CARTILAGE; NMR; GLYCOSAMINOGLYCANS
AB Bladder acellular matrices (ACMs) derived from natural tissue are gaining increasing attention for their role in tissue engineering and regeneration. Unlike conventional scaffolds based on biodegradable polymers or gels, ACMs possess native biomechanical and many acquired biologic properties. Efforts to optimize ACM-based scaffolds are ongoing and would be greatly assisted by a noninvasive means to characterize scaffold properties and monitor interaction with cells. MRI is well suited to this role, but research with MRI for scaffold characterization has been limited. This study presents initial results from quantitative MRI measurements for bladder ACM characterization and investigates the effects of incorporating hyaluronic acid, a natural biomaterial useful in tissue-engineering and regeneration. Measured MR relaxation times (T-1, T-2) and diffusion coefficient were consistent with increased water uptake and glycosaminoglycan content observed on biochemistry in hyaluronic acid ACMs. Multicomponent MRI provided greater specificity, with diffusion data showing an acellular environment and T-2 components distinguishing the separate effects of increased glycosaminoglycans and hydration. These results suggest that quantitative MRI may provide useful information on matrix composition and structure, which is valuable in guiding further development using bladder AGMs for organ regeneration and in strategies involving the use of hyaluronic acid. Magn Reson Med 64:341-348, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Cheng, Hai-Ling Margaret; Beaumont, Marine] Hosp Sick Children, Dept Diagnost Imaging, Res Inst, Toronto, ON M5G 1X8, Canada.
   [Cheng, Hai-Ling Margaret] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.
   [Loai, Yasir; Farhat, Walid A.] Hosp Sick Children, Res Inst, Div Urol & Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.
RP Cheng, HLM (reprint author), Hosp Sick Children, Dept Diagnost Imaging, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM hai-ling.cheng@sickkids.ca
RI Cheng, Hai-Ling/E-5551-2011
OI Cheng, Hai-Ling/0000-0002-0733-9512
FU Canadian Institutes of Health Research (Institute of Human Development,
   Child, and Youth Health); Hospital for Sick Children Foundation
FX This work was supported by funds from the Canadian Institutes of Health
   Research (Institute of Human Development, Child, and Youth Health) and
   The Hospital for Sick Children Foundation to H.-L.M.C. We thank Dr. Greg
   Stanisz for the CPMG sequence.
CR Ababneh Z, 2005, MAGNET RESON MED, V54, P524, DOI 10.1002/mrm.20610
   Akmal M, 2005, J BONE JOINT SURG BR, V87B, P1143, DOI 10.1302/0301-620X.87B8
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Atala A, 2008, PEDIATR RES, V63, P569, DOI 10.1203/PDR.0b013e3181660639
   BENCHETRIT LC, 1977, ANAL BIOCHEM, V79, P431, DOI 10.1016/0003-2697(77)90418-3
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Buckley DL, 1999, MAGNET RESON MED, V41, P137, DOI 10.1002/(SICI)1522-2594(199901)41:1<137::AID-MRM19>3.3.CO;2-P
   Cartwright LM, 2006, J BIOMED MATER RES A, V77A, P180, DOI 10.1002/jbm.a.30652
   Cheng HLM, 2006, MAGN RESON MED, V55, P566, DOI 10.1002/mrm.20791
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   COLE WC, 1993, MAGNET RESON MED, V29, P19, DOI 10.1002/mrm.1910290106
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fantazzini P, 2007, J BIOMED MATER RES A, V83A, P345, DOI 10.1002/jbm.a.31239
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   GOLDBERG RL, 1990, CONNECT TISSUE RES, V24, P265, DOI 10.3109/03008209009152154
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   HOMER KA, 1993, ANAL BIOCHEM, V214, P435, DOI 10.1006/abio.1993.1520
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ikada Y., 2006, TISSUE ENG FUNDAMENT
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   Mather ML, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015011
   Miyata S, 2007, J BIOMECH, V40, P2990, DOI 10.1016/j.jbiomech.2007.02.002
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Pilatus U, 1997, MAGNET RESON MED, V37, P825, DOI 10.1002/mrm.1910370605
   POON CS, 1992, J MAGN RESON IMAGING, V2, P541, DOI 10.1002/jmri.1880020512
   Potter K, 1998, MATRIX BIOL, V17, P513, DOI 10.1016/S0945-053X(98)90099-3
   Roth Y, 2008, MAGN RESON IMAGING, V26, P88, DOI 10.1016/j.mri.2007.04.013
   Sadeghi N, 2003, AM J ROENTGENOL, V181, P235, DOI 10.2214/ajr.181.1.1810235
   Tang SQ, 2007, BIOMED MATER, V2, pS135, DOI 10.1088/1748-6041/2/3/S10
   Tjia JS, 1998, J BIOMED MATER RES, V43, P291, DOI 10.1002/(SICI)1097-4636(199823)43:3<291::AID-JBM10>3.0.CO;2-J
   Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   VANZIJL PCM, 1991, P NATL ACAD SCI USA, V88, P3228, DOI 10.1073/pnas.88.8.3228
   WATANABE T, 1992, MAGNET RESON MED, V27, P118, DOI 10.1002/mrm.1910270112
   Zavan B, 2008, FASEB J, V22, P2853, DOI 10.1096/fj.08-107284
NR 36
TC 10
Z9 14
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0740-3194
J9 MAGN RESON MED
JI Magn. Reson. Med.
PD AUG
PY 2010
VL 64
IS 2
BP 341
EP 348
DI 10.1002/mrm.22404
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 632KG
UT WOS:000280422000004
PM 20665777
OA Bronze
DA 2018-10-19
ER

PT J
AU Pan, YS
AF Pan, Yusong
TI Swelling properties of nano-hydroxyapatite reinforced poly(vinyl
   alcohol) gel biocomposites
SO MICRO & NANO LETTERS
LA English
DT Article
ID ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; PVA HYDROGEL; BIOMATERIAL;
   COMPOSITES; BEHAVIOR
AB Nano-hydroxyapatite reinforced poly(vinyl alcohol) (nano-HA/PVA) gel composites is proposed as a promising biomaterial to replace diseased or damaged articular cartilage. Nano-HA/PVA gel composites were prepared by in situ synthesis of nano-HA particles in PVA solution and accompanied by freeze/thaw method. The influences of freeze/thaw cycle times, nano-HA content, PVA concentration and swelling media on the swelling characteristics of the gel composites were investigated. The results showed that the swelling ratio of the gel composites increased, but its swelling rate decreased with the rise of swelling time. Both the swelling ratio and equilibrium swelling ratio of the gel composites in the different swelling media presented an increasing trend with the rise of freeze/thaw cycle times. Contrarily, the equilibrium swelling ratio of the gel composites decreased with the rise of nano-HA and PVA concentration. Swelling media have significant influence on the swelling behaviour of the gel composites. The equilibrium swelling ratio of the gel composites in distilled water was the largest and it reached the lowest in bovine serum. Simultaneously, the equilibrium swelling ratio in bovine serum was far lower than that in inorganic swelling media, such as distilled water and physiological saline.
C1 An Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
RP Pan, YS (reprint author), An Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
EM yusongpan@163.com
FU Natural Science Research of key projects of Anhui Provincial
   Universities [KJ2010A099]; Anhui University of Science and Technology
   [2008yb034]
FX The research reported in this Letter was funded by the Natural Science
   Research of key projects of Anhui Provincial Universities (project
   KJ2010A099) and by the professional talent introduction project of Anhui
   University of Science and Technology (project 2008yb034).
CR Arvind S., 2007, MAT SCI ENG C, V27, P70
   Auclair-Daigle C, 2005, J BIOMED MATER RES A, V73A, P398, DOI 10.1002/jbm.a.30284
   Bai YL, 2002, ACTA MECH SINICA, V18, P1
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   GERALD G, 2005, SENSOR ACTUATOR, V111, P556
   Gu Zheng-Qiu, 1998, Bio-Medical Materials and Engineering, V8, P75
   Gu Zhengqiu, 2004, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V21, P347
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   HICKEY AS, 1995, J MEMBRANE SCI, V107, P229, DOI 10.1016/0376-7388(95)00119-0
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   Rosa R., 2004, MACROMOLECULES, V37, P1921
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   TENG SH, 2008, J MATER PROCESS TECH, V202, P536
   TONG Z, 1993, MACROMOLECULES, V26, P4964, DOI 10.1021/ma00070a035
NR 21
TC 8
Z9 9
U1 0
U2 8
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1750-0443
J9 MICRO NANO LETT
JI Micro Nano Lett.
PD AUG
PY 2010
VL 5
IS 4
BP 237
EP 240
DI 10.1049/mnl.2010.0061
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 644DT
UT WOS:000281353300012
DA 2018-10-19
ER

PT J
AU George, A
   Ravindran, S
AF George, Anne
   Ravindran, Sriram
TI Protein templates in hard tissue engineering
SO NANO TODAY
LA English
DT Review
DE Tissue engineering; Scaffold; Bone; Teeth; Cartilage; Self-assembly;
   Biomaterial; Proteins
ID PEPTIDE NANOFIBER SCAFFOLDS; SILK-BASED BIOMATERIALS; MESENCHYMAL
   STEM-CELLS; MARROW STROMAL CELLS; COLLAGEN TYPE-I; BONE REGENERATION;
   SPIDER SILK; OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   STRUCTURAL-MATERIALS
AB Biomineralization processes such as formation of bones and teeth require controlled mineral deposition and self-assembly into hierarchical biocomposites with unique mechanical properties. Ideal biomaterials for regeneration and repair of hard tissues must be biocompatible, possess micro and macroporosity for vascular invasion, provide surface chemistry and texture that facilitate cell attachment, proliferation, differentiation of lineage specific progenitor cells, and induce deposition of calcium phosphate mineral. To expect in vivo like cellular response several investigators have used extracellular matrix proteins as templates to recreate in vivo microenvironment for the regeneration of hard tissues. Several novel methods of designing tissue repair and restoration materials using bioinspired strategies are currently being formulated. Nanoscale structured materials can be fabricated via the spontaneous organization of self-assembling proteins to construct hierarchically organized nanomaterials. The advantage of such a method is that polypeptides can be specifically designed as building blocks incorporated with molecular recognition features and spatially distributed bioactive ligands that would provide a physiological environment for cells in vitro and in vivo. This is a rapidly evolving area and provides a promising platform for future development of nanostructured templates for hard tissue engineering. In this review we try to highlight the importance of proteins as templates for regeneration and repair of hard tissues as well as the potential of peptide based nanomaterials for regenerative therapies. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [George, Anne] Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Dept Oral Biol, Coll Dent, Chicago, IL 60612 USA.
RP George, A (reprint author), Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Dept Oral Biol, Coll Dent, 801 S Paulina St,M-C 841, Chicago, IL 60612 USA.
EM anneg@uic.edu
OI GEORGE, ANNE/0000-0002-9008-7642
FU National Institutes of Health [DE 11657, DE 16533]
FX We gratefully acknowledge support from National Institutes of Health
   Grant DE 11657 and DE 16533. The authors would like to thank Mr. An
   Salinger for compiling the published papers in this area.
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Allemann M, 2001, J BIOMED MATER RES, V55, P13
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amos JR, 2009, BIORHEOLOGY, V46, P439, DOI 10.3233/BIR-2009-0553
   Boskey AL, 2005, CELLS TISSUES ORGANS, V181, P144, DOI 10.1159/000091376
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dickson Glenn, 2007, Technol Health Care, V15, P57
   Dinca V, 2008, NANO LETT, V8, P538, DOI 10.1021/nl072798r
   Evans ND, 2010, BIOMATERIALS, V31, P3244, DOI 10.1016/j.biomaterials.2010.01.039
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Fischer SE, 2007, BIOMATERIALS, V28, P3325, DOI 10.1016/j.biomaterials.2007.03.026
   Fischer SE, 2009, BIOMACROMOLECULES, V10, P2408, DOI 10.1021/bm900202z
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603
   Gajjeraman S, 2008, ADV FUNCT MATER, V18, P3972, DOI 10.1002/adfm.200801215
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   GEORGE A, 1993, J BIOL CHEM, V268, P12624
   George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Gribbon C, 2008, BIOCHEMISTRY-US, V47, P10365, DOI 10.1021/bi801072s
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   He XZ, 2007, BIOMACROMOLECULES, V8, P780, DOI 10.1021/bm060671a
   Hirschmann RF, 2009, ACCOUNTS CHEM RES, V42, P1511, DOI 10.1021/ar900020x
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Isogai N, 2000, PLAST RECONSTR SURG, V105, P953, DOI 10.1097/00006534-200003000-00019
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   Justesen J, 2009, J BIOMED MATER RES A, V89A, P885, DOI 10.1002/jbm.a.32032
   KAWAZOE N, 2009, BIOTECHNOL PROG
   Khetan Sudhir, 2009, J Vis Exp, DOI 10.3791/1590
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim JY, 2010, BMB REP, V43, P52, DOI 10.5483/BMBRep.2010.43.1.052
   Kim KW, 2003, J FOOD PROTECT, V66, P1495, DOI 10.4315/0362-028X-66.8.1495
   KIM MK, 2009, KNEE SURG SPORTS TRA
   Kisiday JD, 2009, ANN BIOMED ENG, V37, P1368, DOI 10.1007/s10439-009-9699-9
   Kokubun K, 2008, BIOMACROMOLECULES, V9, P3098, DOI 10.1021/bm800638z
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liebmann T, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-88
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   LIU B, 2009, BIOMACROMOLECULES
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2009, INTEGR BIOL, V1, P235, DOI 10.1039/b902243k
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Mann S, 2004, CHEM COMMUN, P1, DOI 10.1039/b310010n
   Mauth C, 2009, EUR CELLS MATER, V18, P27, DOI 10.22203/eCM.v018a03
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369
   Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5
   Narayanan K, 2009, BIOMATERIALS, V30, P4309, DOI 10.1016/j.biomaterials.2009.04.049
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Ravindran S, 2010, TISSUE ENG PT A, V16, P327, DOI [10.1089/ten.tea.2009.0110, 10.1089/ten.TEA.2009.0110]
   REXEISEN EL, 2009, LANGMUIR
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Ryadnov MG, 2009, J AM CHEM SOC, V131, P13240, DOI 10.1021/ja905539h
   Ryadnov Maxim G., 2008, V474, P35, DOI 10.1007/978-1-59745-480-3_3
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Stevens MM, 2005, BIOMACROMOLECULES, V6, P1266, DOI 10.1021/bm049369x
   Stevens MM, 2004, LANGMUIR, V20, P7747, DOI 10.1021/la030440e
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   Sun JH, 2009, J HUAZHONG U SCI-MED, V29, P512, DOI 10.1007/s11596-009-0424-6
   Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23
   Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Watson D, 2010, AM J RHINOL ALLERGY, V24, pE19, DOI 10.2500/ajra.2010.24.3433
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Wheeldon IR, 2008, P NATL ACAD SCI USA, V105, P15275, DOI 10.1073/pnas.0805249105
   Wheeldon IR, 2009, J MOL BIOL, V392, P129, DOI 10.1016/j.jmb.2009.06.075
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Xu CY, 2008, PHARM RES, V25, P674, DOI 10.1007/s11095-007-9343-z
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Zhang LJ, 2008, INT J NANOMED, V3, P323
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   2003, OSTEOPOROS INT S5, V14, pS16
NR 103
TC 61
Z9 64
U1 2
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-0132
EI 1878-044X
J9 NANO TODAY
JI Nano Today
PD AUG
PY 2010
VL 5
IS 4
BP 254
EP 266
DI 10.1016/j.nantod.2010.05.005
PG 13
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 642MF
UT WOS:000281217600007
PM 20802848
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kundu, B
   Soundrapandian, C
   Nandi, SK
   Mukherjee, P
   Dandapat, N
   Roy, S
   Datta, BK
   Mandal, TK
   Basu, D
   Bhattacharya, RN
AF Kundu, Biswanath
   Soundrapandian, Chidambaram
   Nandi, Samit K.
   Mukherjee, Prasenjit
   Dandapat, Nandadulal
   Roy, Subhasis
   Datta, Bakul K.
   Mandal, Tapan K.
   Basu, Debabrata
   Bhattacharya, Rupnarayan N.
TI Development of New Localized Drug Delivery System Based on
   Ceftriaxone-Sulbactam Composite Drug Impregnated Porous Hydroxyapatite:
   A Systematic Approach for In Vitro and In Vivo Animal Trial
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE ceftriaxone-sulbactam composite; in vivo animal trial; osteomyelitis and
   new bone formation; porous hydroxyapatite; SBF
ID CELL-MATERIALS INTERACTION; CALCIUM-PHOSPHATE; CONTROLLED-RELEASE;
   EXPERIMENTAL OSTEOMYELITIS; SYNTHETIC HYDROXYAPATITES; BONE-FORMATION;
   IMPLANTS; MINERALIZATION; DENSIFICATION; NANOPOWDERS
AB Present investigation deals with an extensive approach incorporating in vitro and in vivo experimentation to treat chronic osteomyelitis, using hydroxyapatite porous scaffolds.
   Hydroxyapatite was synthesized in the laboratory by wet chemical method, different porous scaffolds have been fabricated. In vitro studies include variation of porosity with interconnectivity, pore-drug interfacial studies by SEM-EDAX and drug elution studies (by HPLC) both in contact with PBS and SBF at similar to 37A degrees C. In vivo trials were based on experimental osteomyelitis in rabbit model induced in tibia by Staphylococcus aureus. Characterizations included observation of histopathology, radiology and estimation of drug in both bone and serum for 42 days by HPLC method and subsequent bone-biomaterial interface by SEM.
   It was established that lower pore percentage with a distribution of mainly micro-pores were found to be superior over the higher pore percentage both in vitro and in vivo. The criteria was matched with the 50N50H samples which had 50-55% porosity with an average pore size similar to 110 mu m, having higher interconnectivity (10-100 mu m), moderately high adsorption efficiency (similar to 50%) when loaded with CFS (drug combinations consisting of irreversible b-lactamase inhibitor and b-lactam antibiotic). CFS release from HAp implants were faster in PBS than SBF. Further, both the results of in vitro and in vivo drug elution after 42 days showed release higher than minimum inhibitory concentration of CFS against Staphylococcus aureus. In vivo studies also proved the superiority of CFS loaded HAp implants than parenteral group based on eradication of infection and new bone formation.
   HAp based porous scaffold loaded with CFS and designed porosity (in terms of micro- and macro-porosity, interconnectivity) was found to be an ideal delivery system which could locally, sustainably release the composite antibiotic in reliable manner both in terms of in vitro drug elution behaviour in contact with SBF and in vivo animal trial.
C1 [Nandi, Samit K.; Mukherjee, Prasenjit; Roy, Subhasis] W Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata, India.
   [Kundu, Biswanath; Soundrapandian, Chidambaram; Dandapat, Nandadulal; Basu, Debabrata] Cent Glass & Ceram Res Inst, Bioceram & Coating Div, Kolkata, India.
   [Datta, Bakul K.; Mandal, Tapan K.] W Bengal Univ Anim & Fishery Sci, Dept Vet Pharmacol & Toxicol, Kolkata, India.
   [Bhattacharya, Rupnarayan N.] RG Kar Med Coll & Hosp, Dept Plast Surg, Kolkata, India.
RP Nandi, SK (reprint author), W Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata, India.
EM biswa_kundu@rediffmail.com; soundr@rediffmail.com;
   samitnandi1967@gmail.com; vetprasenjit@gmail.com;
   nanda_dandapat@yahoo.co.in; subhasisvet@yahoo.co.in; drbkd75@gmail.com;
   drtkm48@yahoo.co.in; dbasu@cgcri.res.in;
   rupnarayan.bhattacharya@gmail.com
FU Department of Science and Technology, India [T.1 (7)/TIFA/2006-CGCRI];
   CGCRI, India; West Bengal University of Animal and Fishery Sciences,
   Kolkata, India
FX The authors wish to express their sincere thanks for the financial
   support by Department of Science and Technology, India [T.1
   (7)/TIFA/2006-CGCRI] and the Director, CGCRI, India and Vice Chancellor,
   West Bengal University of Animal and Fishery Sciences, Kolkata, India
   for their generous and kind support to this work. All the personnel
   related to the characterization of the materials are sincerely
   acknowledged.
CR Al-Sokanee ZN, 2009, AAPS PHARMSCITECH, V10, P772, DOI 10.1208/s12249-009-9265-7
   Banerjee A, 2007, MAT SCI ENG C-BIO S, V27, P729, DOI 10.1016/j.msec.2006.07.010
   Bodhak S, 2010, ACTA BIOMATER, V6, P641, DOI 10.1016/j.actbio.2009.08.008
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Bose S, 2009, J AM CERAM SOC, V92, P323, DOI 10.1111/j.1551-2916.2008.02881.x
   Burgos AE, 2002, BIOMATERIALS, V23, P2519, DOI 10.1016/S0142-9612(01)00386-6
   Bush K, 1998, ADV EXP MED BIOL, V456, P71
   Bush Karen, 2002, Curr Opin Investig Drugs, V3, P1284
   CARON F, 1990, ANTIMICROB AGENTS CH, V34, P2070, DOI 10.1128/AAC.34.11.2070
   Castro C, 2003, J CONTROL RELEASE, V93, P341, DOI 10.1016/j.jconrel.2003.09.004
   Chanda A, 2009, MAT SCI ENG C-BIO S, V29, P1201, DOI 10.1016/j.msec.2008.09.023
   Choi DW, 2004, MATER RES BULL, V39, P417, DOI 10.1016/j.materresbull.2003.10.013
   Colilla M, 2008, INT J NANOMED, V3, P403
   Conterno LO, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004439.pub2
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FOULDS G, 1983, ANTIMICROB AGENTS CH, V23, P692, DOI 10.1128/AAC.23.5.692
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Girschick HJ, 2007, NAT CLIN PRACT RHEUM, V3, P733, DOI 10.1038/ncprheum0653
   Hasegawa M, 2004, J BIOMED MATER RES B, V70B, P332, DOI 10.1002/jbm.b.30047
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Houghton TJ, 2008, J MED CHEM, V51, P6955, DOI 10.1021/jm801007z
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Kilian O, 2009, J BIOMED MATER RES B, V90B, P210, DOI 10.1002/jbm.b.31275
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Korkusuz F, 2001, J BIOMED MATER RES, V55, P217, DOI 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y
   Krajewski A, 2000, J MATER SCI-MATER M, V11, P763, DOI 10.1023/A:1008988127294
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Lebugle A, 2002, BIOMATERIALS, V23, P3517, DOI 10.1016/S0142-9612(02)00082-0
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Nandi SK, 2009, CERAM INT, V35, P1367, DOI 10.1016/j.ceramint.2008.07.022
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Netz DJA, 2001, INT J PHARM, V213, P117, DOI 10.1016/S0378-5173(00)00659-1
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410
   Oudadesse H, 2005, EUR PHYS J-APPL PHYS, V31, P217, DOI 10.1051/epjap:2005062
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Pham Hai H, 2002, AAPS PharmSciTech, V3, pE1
   Rai B, 2005, J CONTROL RELEASE, V107, P330, DOI 10.1016/j.jconrel.2005.07.002
   Rao N, 2007, DRUGS, V67, P195, DOI 10.2165/00003495-200767020-00003
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P1847, DOI 10.1016/S0142-9612(00)00366-5
   Rokusek D, 2005, J BIOMED MATER RES A, V75A, P588, DOI 10.1002/jbm.a.30459
   Sanchez E, 2001, EUR J PHARM BIOPHARM, V52, P151, DOI 10.1016/S0939-6411(01)00169-2
   Sedrakyan S, 2006, TISSUE ENG, V12, P2675, DOI 10.1089/ten.2006.12.2675
   Shrivastava SM, 2009, CURR DRUG THER, V4, P73, DOI 10.2174/157488509787081840
   SOUNDRAPANDIAN C, 2009, ORGANIC INORGANIC CO
   Soundrapandian C, 2007, CRIT REV THER DRUG, V24, P493, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i6.10
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Suetsugu Y, 1998, J AM CERAM SOC, V81, P746
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tampieri A, 2000, MATER CHEM PHYS, V64, P54, DOI 10.1016/S0254-0584(99)00252-7
   Turco G, 2009, BIOMACROMOLECULES, V10, P1575, DOI 10.1021/bm900154b
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Vallet-Regi Maria, 2007, Drug Metab Lett, V1, P37, DOI 10.2174/187231207779814382
   Walenkamp GHIM, 1998, ACTA ORTHOP SCAND, V69, P518, DOI 10.3109/17453679808997790
   Weng WJ, 1998, J MATER SCI-MATER M, V9, P159, DOI 10.1023/A:1008819703551
   Wu YJ, 2005, LANGMUIR, V21, P3232, DOI 10.1021/la046754z
   Xue WC, 2009, J BIOMED MATER RES B, V91B, P831, DOI 10.1002/jbm.b.31464
   Xue WC, 2009, ACTA BIOMATER, V5, P1686, DOI 10.1016/j.actbio.2009.01.012
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus
NR 63
TC 44
Z9 46
U1 0
U2 22
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD AUG
PY 2010
VL 27
IS 8
BP 1659
EP 1676
DI 10.1007/s11095-010-0166-y
PG 18
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 620NH
UT WOS:000279506100016
PM 20464462
DA 2018-10-19
ER

PT J
AU Mandinic, Z
   Curcic, M
   Antonijevic, B
   Carevic, M
   Mandic, J
   Djukic-Cosic, D
   Lekic, CP
AF Mandinic, Zoran
   Curcic, Marijana
   Antonijevic, Biljana
   Carevic, Momir
   Mandic, Jelena
   Djukic-Cosic, Danijela
   Lekic, Charles P.
TI Fluoride in drinking water and dental fluorosis
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Fluoride; Drinking water; Hair; Schoolchildren; Dental fluorosis
ID HAIR; RISK; EXPOSURE; CHILDREN; URINE; POPULATIONS; GROUNDWATER;
   NORTHERN; IMPACT; REGION
AB In this study we determined the fluoride content in drinking water and hair of 12-year-old schoolchildren from different Serbian municipalities, i.e. Valley, Veliko Gradiste, Kacarevo and Vranjska Banja. The analyses were performed using composite fluoride ion-selective electrode. Average fluoride levels were 0.10, 0.15, 0.79 and 11 ppm in well water, 0.07, 0.10, 0.17 and 0.15 ppm in tap water, 19.3, 21.5, 25.4, and 32.5 ppm in hair samples, in Valjevo, Veliko Gradiste, Kacarevo and Vranjska Banja, respectively. Correlation analysis indicated statistically significant positive relationship between fluoride in wells water and fluoride in hair, for all municipalities: correlation coefficients were 0.54 (p<0.05), 0.89, 0.97 and 0.99 (p<0.001), in Vranjska Banja, Valjevo, Veliko Gradiste, and Kacarevo, respectively. Positive correlation was obtained also between fluoride in tap water and hair samples in all regions under the study, with statistical significance only in Valjevo municipality, p<0.05. Dental examination of schoolchildren confirmed dental fluorosis only in the region of Vranjska Banja. Moreover, in endemic fluorotic region of Vranjska Banja, positive and statistically significant correlations were confirmed between fluoride in well water and dental fluorosis level (r = 0.61; p<0.01) and additionally between fluoride in hair and dental fluorosis level (0.62; p<0.01). The primary findings from this study have shown that fluoride content in hair is highly correlated with fluoride content in drinking water and dental fluorosis level, indicating that hair may be regarded as biomaterial of high informative potential in evaluating prolonged exposure to fluorides and to individuate children at risk of fluorosis regardless of the phase of teeth eruption. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Mandinic, Zoran; Carevic, Momir; Mandic, Jelena] Univ Belgrade, Sch Dent, Clin Paediat & Prevent Dent, Belgrade 11000, Serbia.
   [Curcic, Marijana; Antonijevic, Biljana; Djukic-Cosic, Danijela] Univ Belgrade, Fac Pharm, Inst Toxicol Acad Danilo Soldatov, Belgrade 11221, Serbia.
   [Lekic, Charles P.] Univ Manitoba, Fac Dent, Dept Prevent Dent Sci, Winnipeg, MB R3E 0W2, Canada.
RP Mandinic, Z (reprint author), Univ Belgrade, Sch Dent, Clin Paediat & Prevent Dent, Dr Subotica 11, Belgrade 11000, Serbia.
EM zoran.mandinic@stomf.bg.ac.rs
FU Ministry of Science and Technological Development [20212]
FX This study is part of the Project No. 20212 granted by Ministry of
   Science and Technological Development of the R. Serbia.
CR Bailey K, 2006, WHO DRINKING WATER Q
   Bellomo S, 2007, J VOLCANOL GEOTH RES, V165, P87, DOI 10.1016/j.jvolgeores.2007.04.013
   Binbin W., 2004, ENVIRON INT, V30, P1067
   Cao J, 2000, FLUORIDE, V33, P205
   CAREVIC M, 1993, STOMATOL GLAS SRB, V40, P1
   CZARNOWSKI W, 1990, BRIT J IND MED, V47, P349
   Czarnowski W, 1996, SCI TOTAL ENVIRON, V191, P177, DOI 10.1016/0048-9697(96)05259-X
   CZARNOWSKI W, 1990, FLUORIDE, V23, P119
   DEAN HT, 1942, FLUORINE DENT HLTH, P29
   Erdal S, 2005, ENVIRON HEALTH PERSP, V113, P111, DOI 10.1289/ehp.7077
   Fantaye W., 2004, COMMUNITY DENT ORAL, V32, P337
   GAJIC M, 1989, THESIS BELGRADE U
   Garg V K, 2004, J HAZARD MAT B, V106, P85
   Gikunju JK, 2002, FLUORIDE, V35, P193
   GRANDJEAN P, 1984, HUM TOXICOL, V3, P223, DOI 10.1177/096032718400300306
   Grobleri S R, 2001, Int J Paediatr Dent, V11, P372, DOI 10.1046/j.0960-7439.2001.00293.x
   Hac E, 1997, SCI TOTAL ENVIRON, V206, P249
   Harrison PTC, 2005, J FLUORINE CHEM, V126, P1448, DOI 10.1016/j.jfluchem.2005.09.009
   Indermitte E, 2009, INT J ENV RES PUB HE, V6, P710, DOI 10.3390/ijerph6020710
   Ivanovic M, 1991, Stomatol Glas Srb, V37, P511
   Kahama RW, 1997, FLUORIDE, V30, P19
   Kaseva ME, 2006, SCI TOTAL ENVIRON, V366, P92, DOI 10.1016/j.scitotenv.2005.08.049
   Kokot Z, 2000, FLUORIDE, V33, P196
   KONO K, 1993, INT ARCH OCC ENV HEA, V65, P95
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   MANDINIC Z, 2007, TOXICOL LETT, pS119
   Mandinic Z, 2009, FOOD CHEM TOXICOL, V47, P1080, DOI 10.1016/j.fct.2009.01.038
   Mascarenhas Ana Karina, 2008, J Evid Based Dent Pract, V8, P15, DOI 10.1016/j.jebdp.2007.12.015
   MIKASA H, 1988, BIOL TRACE ELEM RES, V16, P59, DOI 10.1007/BF02795334
   Msonda KWM, 2007, PHYS CHEM EARTH, V32, P1178, DOI 10.1016/j.pce.2007.07.050
   NEDELJKOVIC M, 1991, ANALYST, V116, P477, DOI 10.1039/an9911600477
   NOHARA M, 1998, FLUORIDE, V31, pS32
   Pendrys DG, 2000, J AM DENT ASSOC, V131, P746, DOI 10.14219/jada.archive.2000.0273
   Souad C, 2006, SCI TOTAL ENVIRON, V370, P337, DOI 10.1016/j.scitotenv.2006.06.020
   Stewart C, 2006, J VOLCANOL GEOTH RES, V158, P296, DOI 10.1016/j.jvolgeores.2006.07.002
   STOLARSKA K, 2000, FLUORIDE, pS22
   Sukumar A, 2007, SCI TOTAL ENVIRON, V372, P474, DOI 10.1016/j.scitotoenv.2006.10.020
   Tamer MN, 2007, SCI TOTAL ENVIRON, V373, P43, DOI 10.1016/j.scitotenv.2006.10.051
   Tekle-Haimanot R, 2006, SCI TOTAL ENVIRON, V367, P182, DOI 10.1016/j.scitotenv.2005.11.003
   Viswanathan G, 2009, SCI TOTAL ENVIRON, V407, P1579, DOI 10.1016/j.scitotenv.2008.10.020
   Whelton HP, 2004, COMMUNITY DENT ORAL, V32, P9, DOI 10.1111/j.1600-0528.2004.00134.x
   *WHO, 1994, TECHN REP SER WHO, V846
   World Health Organization, 2002, ENV HLTH CRIT, V227
   World Health Organization, 1987, OR HLTH SURV BAS MET
   Yoder KM, 1998, COMMUNITY DENT ORAL, V26, P382, DOI 10.1111/j.1600-0528.1998.tb01976.x
   Yoshimura K, 2006, J ARCHAEOL SCI, V33, P1411, DOI 10.1016/j.jas.2006.01.016
   ZAKRZEWSKA H, 2000, FLUORIDE, pS36
   Zemek F, 2006, SCI TOTAL ENVIRON, V370, P491, DOI 10.1016/j.scitotenv.2006.04.027
NR 48
TC 57
Z9 61
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD AUG 1
PY 2010
VL 408
IS 17
BP 3507
EP 3512
DI 10.1016/j.scitotenv.2010.04.029
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 626RV
UT WOS:000279985500002
PM 20580811
DA 2018-10-19
ER

PT J
AU Kim, JH
   Kim, HJ
   Kim, J
   Kong, WH
   Seo, SW
AF Kim, Jin Hoon
   Kim, Ho Joong
   Kim, Jhingook
   Kong, Won Ho
   Seo, Soo Won
TI Comparative Study between PLGA and Dermal Tissue for Tracheal
   Regeneration
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE trachea; biomaterials; tissue engineering; transplantation; PKH26
ID SMALL-INTESTINAL SUBMUCOSA; IN-VIVO DEGRADATION; ENGINEERED SKIN;
   RECONSTRUCTION; SCAFFOLD; SHEET; TRANSPLANTATION; ANGIOGENESIS; VITRO
AB Various kinds of biomaterials that have biocompatibility and biodegradability have been used for the tissue engineered organ reconstruction Their characteristics have relationship with functional and morphological reconstruction However, it is not clear which types of biomaterials provide the best outcomes after transplantation For the reason, in this study, to compare synthetic biomaterial and natural biomaterial, we developed two kinds of patches to compare affects of biomaterials for cell transplantation and organ reconstruction The one was coated with PLGA sheet and the other was coated with autologous dermal sheet Cultured PK H26-labeled cells were seeded on the patches and then the patches were transplanted onto tracheas After three months, we found that each biomaterial had a different tracheal reconstruction pattern. the PLGA patch was suited for airway patency(tracheal passage with stable inside diameter for air exchange) but not for epithelial layer reconstruction whereas the dermal patch was suited for epithelial layer reconstruction but not for airway patency. Consequently, while selecting biomaterials for transplantation and reconstruction, not only their biological effects on the body but also their effects on organ morphology and function should be considered.
C1 [Kim, Jin Hoon; Kong, Won Ho; Seo, Soo Won] Sungkyunkwan Univ, Sch Med Biomed Engn Interdisciplinary Course, Samsung Biomed Res, Seoul, South Korea.
   [Kim, Ho Joong] Inst Samsung Med Ctr, Dept Pulm Med, Seoul, South Korea.
   [Kim, Jhingook] Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
RP Seo, SW (reprint author), Sungkyunkwan Univ, Sch Med Biomed Engn Interdisciplinary Course, Samsung Biomed Res, Seoul, South Korea.
RI Kim, Jhingook/C-9663-2011
FU Korean Government [KRF-2006-311-D01014]; Ministry of Health & Welfare of
   Korea [0405-MNO1-0604-0007]
FX This work was supported by the Korea Research Foundation Grant funded by
   the Korean Government (MOEHRD, Basic Research Promotion Fund)
   (KRF-2006-311-D01014) and a Ministry of Health & Welfare
   (0405-MNO1-0604-0007) of Korea
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Badylak S., 1999, CLIN ORTHOP RELAT R, V367, P333
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x
   DARRYL K, 2001, IMMUNOL CELL BIO, V79, P160
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Kim CH, 2006, ACTA OTO-LARYNGOL, V126, P594, DOI 10.1080/00016480500443375
   Kinoshita S, 2004, EXP EYE RES, V78, P483, DOI 10.1016/j.exer.2003.09.004
   Lotze MT, 2007, CLIN IMMUNOL, V124, P1, DOI 10.1016/j.clim.2007.02.006
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   MATTHIAS WL, 2006, TISSUE ENG, V12, P2093
   Mcguigan AP, 2007, TISSUE ENG, V13, P1079, DOI 10.1089/ten.2006.0245
   NGA KW, 2006, BIOMATERIALS, V27, P4591
   OKUMURA N, 1994, J THORAC CARDIOV SUR, V108, P337
   Rahman MS, 2001, TISSUE ENG, V7, P781, DOI 10.1089/107632701753337726
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Rickey FA, 2000, NUCL INSTRUM METH B, V172, P904, DOI 10.1016/S0168-583X(00)00344-X
   Sahota PS, 2004, WOUND REPAIR REGEN, V12, P635, DOI 10.1111/j.1067-1927.2004.12608.x
   SAMUEL P, 2006, OTOLARYNGOLOGY HEAD, V134, P1028
   SanMartin A, 2006, CELL TRANSPLANT, V15, P665, DOI 10.3727/000000006783981666
   SHIGERU K, 2004, EXP EYE RES, V78, P483
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Stephen FB, 2002, SEMIN CELL DEV BIOL, V13, P377
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   YUKIO N, 2008, ANN OTO RHINOL LARYN, V117, P59
NR 32
TC 1
Z9 1
U1 1
U2 7
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JEONJU
PA CHONBUK NATIONAL UNIV, DEPT POLYMER-NANO SCIENCE & TECH, 664-14,
   DUCKJIN, JEONJU, 561-756, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD AUG
PY 2010
VL 7
IS 3
BP 309
EP 315
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 635CD
UT WOS:000280632300007
DA 2018-10-19
ER

PT J
AU Skardal, A
   Zhang, JX
   McCoard, L
   Xu, XY
   Oottamasathien, S
   Prestwich, GD
AF Skardal, Aleksander
   Zhang, Jianxing
   McCoard, Lindsi
   Xu, Xiaoyu
   Oottamasathien, Siam
   Prestwich, Glenn D.
TI Photocrosslinkable Hyaluronan-Gelatin Hydrogels for Two-Step Bioprinting
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CROSS-LINKED HYALURONAN; SYNTHETIC EXTRACELLULAR MATRICES; TISSUE
   ENGINEERING SCAFFOLDS; FIBROBLAST-GROWTH-FACTOR; IN-SITU; STEM-CELLS;
   GLYCOSAMINOGLYCAN HYDROGELS; REPAIR; CONSTRUCTS; RELEASE
AB Bioprinting by the codeposition of cells and biomaterials is constrained by the availability of printable materials. Herein we describe a novel macromonomer, a new two-step photocrosslinking strategy, and the use of a simple rapid prototyping system to print a proof-of-concept tubular construct. First, we synthesized the methacrylated ethanolamide derivative of gelatin (GE-MA). Second, partial photochemical cocrosslinking of GE-MA with methacrylated hyaluronic acid (HA-MA) gave an extrudable gel-like fluid. Third, the new HA-MA: GE-MA hydrogels were biocompatible, supporting cell attachment and proliferation of HepG2 C3A, Int-407, and NIH 3T3 cells in vitro. Moreover, hydrogels injected subcutaneously in nude mice produced no inflammatory response. Fourth, using the Fab@Home printing system, we printed a tubular tissue construct. The partially crosslinked hydrogels were extruded from a syringe into a designed base layer, and irradiated again to create a firmer structure. The computer-driven protocol was iterated to complete a cellularized tubular construct with a cell-free core and a cell-free structural halo. Cells encapsulated within this printed construct were viable in culture, and gradually remodeled the synthetic extracellular matrix environment to a naturally secreted extracellular matrix. This two-step photocrosslinkable biomaterial addresses an unmet need for printable hydrogels useful in tissue engineering.
C1 [Skardal, Aleksander; Zhang, Jianxing; McCoard, Lindsi; Xu, Xiaoyu; Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Ctr Therapeut Biomat, Salt Lake City, UT 84108 USA.
   [Skardal, Aleksander; Prestwich, Glenn D.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84108 USA.
   [Oottamasathien, Siam] Univ Utah, Div Pediat Urol, Dept Surg, Salt Lake City, UT 84108 USA.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, Ctr Therapeut Biomat, 419 Wakara Way,Suite 205, Salt Lake City, UT 84108 USA.
EM glenn.prestwich@pharm.utah.edu
FU NSF [EF-0526854]; State of Utah Centers of Excellence
FX This research was supported by an NSF FIBR Grant (EF-0526854) and by the
   State of Utah Centers of Excellence Program. The authors thank Glycosan
   BioSystems Inc. for providing the Extracel kits and selected
   crosslinkable sECM components.
CR Abbah SA, 2006, BIOCHEM BIOPH RES CO, V347, P185, DOI 10.1016/j.bbrc.2006.06.072
   Abdel-Sayed Philippe, 2009, Interact Cardiovasc Thorac Surg, V8, P599, DOI 10.1510/icvts.2009.204149
   Boland T, 2003, ANAT REC PART A, V272A, P497, DOI 10.1002/ar.a.10059
   Brown AL, 2006, MACROMOL BIOSCI, V6, P648, DOI 10.1002/mabi.200600052
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Jakab K, 2004, BIORHEOLOGY, V41, P371
   Jakab K, 2008, DEV DYNAM, V237, P2438, DOI 10.1002/dvdy.21684
   Jakab K, 2006, BIORHEOLOGY, V43, P509
   Kalejs Martins, 2009, Interact Cardiovasc Thorac Surg, V8, P182, DOI 10.1510/icvts.2008.194134
   Kasyanov VA, 2009, J MATER SCI-MATER M, V20, P329, DOI 10.1007/s10856-008-3590-3
   KENCHINGTON AW, 1958, BIOCHEM J, V68, P458, DOI 10.1042/bj0680458
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Klein TJ, 2009, MACROMOL BIOSCI, V9, P1049, DOI 10.1002/mabi.200900176
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Liu YC, 2008, J ORTHOP RES, V26, P562, DOI 10.1002/jor.20499
   Liu YC, 2007, WOUND REPAIR REGEN, V15, P245, DOI 10.1111/j.1524-475X.2007.00211.x
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297
   Liu YC, 2006, J ORTHOP RES, V24, P1454, DOI 10.1002/jor.20148
   Liu YC, 2004, J BIOMED MATER RES A, V68A, P142, DOI 10.1002/jbm.a.10142
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Marga Francoise, 2007, Birth Defects Research, V81, P320, DOI 10.1002/bdrc.20109
   Miki D, 2002, CORNEA, V21, P393, DOI 10.1097/00003226-200205000-00012
   Mironov V, 2005, BIOMATERIALS, V26, P7628, DOI 10.1016/j.biomaterials.2005.05.061
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mironov V, 2008, EXPERT OPIN BIOL TH, V8, P143, DOI 10.1517/14712598.8.2.143 
   Mironov V, 2008, REGEN MED, V3, P93, DOI 10.2217/17460751.3.1.93
   Mironov V, 2007, J MATER CHEM, V17, P2054, DOI 10.1039/b617903g
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Norris M K, 1990, Dimens Crit Care Nurs, V9, P251
   OPTN/ SRTR, 2010, ORG PROC TRANSPL NET
   PRESTWICH GD, 2001, BIOMATERIALS CHEMICA
   Prestwich GD, 2007, ADV ENZYME REGUL, V47, P196, DOI 10.1016/j.advenzreg.2006.12.012
   Prestwich GD, 2006, ADV EXP MED BIOL, V585, P125
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Riley CM, 2006, BIOMATERIALS, V27, P5935, DOI 10.1016/j.biomaterials.2006.08.029
   Sabnis A, 2009, J BIOMED MATER RES A, V91A, P52, DOI 10.1002/jbm.a.32194
   SERBAN MA, 2008, CURR PROTOC CELL BIO, V1, P10
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
   Victoroff Michael S, 2004, Manag Care, V13, P6
   Zhang JX, 2008, BIOMATERIALS, V29, P4521, DOI 10.1016/j.biomaterials.2008.08.008
NR 54
TC 152
Z9 157
U1 5
U2 71
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2010
VL 16
IS 8
BP 2675
EP 2685
DI 10.1089/ten.tea.2009.0798
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 635IL
UT WOS:000280648700024
PM 20387987
OA Green Published
DA 2018-10-19
ER

PT J
AU Hidalgo-Bastida, LA
   Cartmell, SH
AF Hidalgo-Bastida, Lilia Araida
   Cartmell, Sarah H.
TI Mesenchymal Stem Cells, Osteoblasts and Extracellular Matrix Proteins:
   Enhancing Cell Adhesion and Differentiation for Bone Tissue Engineering
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID OSTEOGENIC DIFFERENTIATION; IN-VITRO; INTEGRIN EXPRESSION;
   SURFACE-DENSITY; SERUM-PROTEINS; RGD PEPTIDES; FIBRONECTIN; COLLAGEN;
   ATTACHMENT; HYDROXYAPATITE
AB Cell adhesion to scaffolds has remained one of the challenges in tissue engineering. Although protein surface modification has been proven to enhance cell adhesion and retention, its specificity depending on cell and biomaterial types means that the best protein and concentration must be established for each specific application. This review focuses on the improvement of cell adhesion for human mesenchymal stem cells with an osteogenesis approach. A brief outline of the cell adhesion process and extracellular matrix proteins precedes an overview of works focused on the adhesion of mesenchymal stem cells and osteoblasts to biomaterials and this effect in their differentiation into osteoblasts.
C1 [Hidalgo-Bastida, Lilia Araida; Cartmell, Sarah H.] Univ Keele, Guy Hilton Res Ctr, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
RP Cartmell, SH (reprint author), Univ Keele, Guy Hilton Res Ctr, Inst Sci & Technol Med, Thornburrow Dr,Hartshill, Stoke On Trent ST4 7QB, Staffs, England.
EM s.h.cartmell@keele.ac.uk
RI Cartmell, Sarah/J-8506-2012
OI Cartmell, Sarah/0000-0001-6864-0846; Hidalgo-Bastida, Lilia
   Araida/0000-0003-2652-2395
FU Biotechnology and Biological Sciences Research Council (BBSRC)
   [BB/F013892/1]; Biotechnology and Biological Sciences Research Council
   [BB/F013892/2, BB/F013892/1]
FX Financial support was provided by the Biotechnology and Biological
   Sciences Research Council (BBSRC; grant reference code BB/F013892/1).
CR Amato I, 2007, BIOMATERIALS, V28, P3668, DOI 10.1016/j.biomaterials.2007.04.038
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Athanassiou G, 2001, J MATER SCI-MATER M, V12, P965, DOI 10.1023/A:1012809115479
   BECK K, 1990, FASEB J, V4, P148
   BIZIOS R, 1994, BIOTECHNOL BIOENG, V43, P582, DOI 10.1002/bit.260430707
   BRIGHTON CT, 1992, J ORTHOPAED RES, V10, P766, DOI 10.1002/jor.1100100604
   BRONZINO JD, 2006, TISSUE ENG ARTIFICIA
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Castoldi M, 1997, CELL BIOL INT, V21, P7, DOI 10.1006/cbir.1996.0110
   Chang CF, 2007, J BIOMED MATER RES A, V80A, P466, DOI 10.1002/jbm.a.30963
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen WLK, 2010, BIOMATERIALS, V31, P2489, DOI 10.1016/j.biomaterials.2009.12.002
   Chen Y, 2008, J MATER SCI-MATER M, V19, P2563, DOI 10.1007/s10856-007-3195-2
   Chun C, 2009, BIOMATERIALS, V30, P6295, DOI 10.1016/j.biomaterials.2009.08.011
   Cooke MJ, 2008, CYTOTECHNOLOGY, V56, P71, DOI 10.1007/s10616-007-9119-7
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Davis JM, 2002, BASIC CELL CULTURE
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Dennis J E, 1993, J Oral Implantol, V19, P106
   ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf
   Garcia AJ, 1997, TISSUE ENG, V3, P197, DOI 10.1089/ten.1997.3.197
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   GOLD LI, 1980, BIOCHEM J, V186, P551, DOI 10.1042/bj1860551
   Gordon JAR, 2009, CELLS TISSUES ORGANS, V189, P138, DOI 10.1159/000151728
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Huang Hui, 2003, J Oral Implantol, V29, P73, DOI 10.1563/1548-1336(2003)029<0073:EOFORI>2.3.CO;2
   Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Iba K., 1996, J BONE MINER METAB, V14, P214
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Jang JH, 2002, BIOTECHNOL LETT, V24, P1659, DOI 10.1023/A:1020617904251
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Klees RF, 2005, MOL BIOL CELL, V16, P881
   Klees RF, 2008, EXP CELL RES, V314, P763, DOI 10.1016/j.yexcr.2007.12.007
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Kleinman HK, 1999, P INDIAN AS-CHEM SCI, V111, P179
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   Kuschel C, 2006, BIOTECHNIQUES, V40, P523, DOI 10.2144/000112134
   Lan CW, 2003, J BIOMED MATER RES A, V66A, P38, DOI 10.1002/jbm.a.10507
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lee JY, 2009, BIOTECHNOL APPL BIOC, V52, P69, DOI 10.1042/BA20070169
   LIMPER AH, 1992, CHEST, V101, P1663, DOI 10.1378/chest.101.6.1663
   MAJESKA RJ, 1993, J BONE MINER RES, V8, P277
   Marletta G, 2005, BIOMATERIALS, V26, P4793, DOI 10.1016/j.biomaterials.2004.11.047
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Meyer U., 2006, BONE CARTILAGE ENG
   Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207
   Orner BP, 2004, J AM CHEM SOC, V126, P10808, DOI 10.1021/ja0474291
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Park IS, 2009, BIOMATERIALS, V30, P6835, DOI 10.1016/j.biomaterials.2009.08.057
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Sogo Y, 2007, BIOMED MATER, V2, P116, DOI 10.1088/1748-6041/2/2/009
   Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100
   Tsuchiya K, 2001, MAT SCI ENG C-BIO S, V17, P79, DOI 10.1016/S0928-4931(01)00341-1
   van den Dolder J, 2007, J BIOMED MATER RES A, V83A, P712, DOI 10.1002/jbm.a.31428
   Vohra S, 2008, J MATER SCI-MATER M, V19, P3567, DOI 10.1007/s10856-008-3525-z
   WEISS RE, 1981, J CELL BIOL, V88, P630, DOI 10.1083/jcb.88.3.630
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7
   Zhang L, 2009, BIOMATERIALS, V30, P1309, DOI 10.1016/j.biomaterials.2008.11.020
   ZHANG Y, 2009, ACTA BIOMATER
NR 80
TC 81
Z9 82
U1 3
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD AUG
PY 2010
VL 16
IS 4
BP 405
EP 412
DI 10.1089/ten.teb.2009.0714
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 631UQ
UT WOS:000280375800004
PM 20163206
DA 2018-10-19
ER

PT J
AU Eitan, Y
   Sarig, U
   Dahan, N
   Machluf, M
AF Eitan, Yuval
   Sarig, Udi
   Dahan, Nitsan
   Machluf, Marcelle
TI Acellular Cardiac Extracellular Matrix as a Scaffold for Tissue
   Engineering: In Vitro Cell Support, Remodeling, and Biocompatibility
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR; POLYURETHANE SCAFFOLDS;
   REPLACEMENT THERAPY; INTERSTITIAL-CELLS; HEART-MUSCLE; CARDIOMYOCYTES;
   GLYCOSAMINOGLYCANS; REGENERATION; FIBROBLASTS
AB We have developed an efficient decellularization process for the isolation of extracellular matrix (ECM) from native cardiac tissue. The isolated ECM exhibited desirable mechanical properties in terms of elasticity, strength and durability-properties required from scaffolds used for cardiac tissue repair. This study further investigates the potential use of this scaffold for cardiac tissue engineering in terms of interactions with seeded cells and biocompatibility. We used the commonly studied fibroblasts, cardiomyocytes, and mesenchymal stem cells, which were isolated and seeded onto the scaffold. Cell density and distribution were followed by 3,3'-dioctadecyloxacarbocyanine perchlorate staining, and their proliferation and viability were assessed by AlamarBlue(R) assay and fluorecein-diacetate/propidium iodide staining. Fibroblast-seeded scaffolds shrank to 1-2 mm(3) spheroids, and their glycosaminoglycans significantly increased by 23%. The expression of ECM remodeling-related mRNAs of collagens I and III, matrix metalloproteinase 2, and type 1 tissue inhibitor of metalloproteinases was quantified by real-time polymerase chain reaction, and was found significantly elevated in fibroblast-seeded scaffold, compared with the control cells on plates. Fibroblast-seeded scaffolds lost some flexibility, yet gained strength compared with the acellular scaffolds, as shown by mechanical testing. Scaffold seeded with cardiomyocyte began to beat in concert few days after seeding, and the myocytes expressed typical functional cardiac markers such as a-actinin, troponin I, and connexin43. The cells revealed aligned elongated morphology, as presented by immunofluorescent staining and scanning electron microscopy. Mesenchymal stem cell-seeded scaffolds maintained viability over 24 days in culture. These findings further strengthen the potential use of acellular cardiac ECM as a biomaterial for heart regeneration.
C1 [Eitan, Yuval; Sarig, Udi; Dahan, Nitsan; Machluf, Marcelle] Technion Israel Inst Technol, Lab Canc Drug Delivery & Mammalian Cell Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.
RP Machluf, M (reprint author), Technion Israel Inst Technol, Lab Canc Drug Delivery & Mammalian Cell Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.
EM machlufm@tx.technion.ac.il
OI Sarig, Udi/0000-0001-5260-4023
CR Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001
   Badylak SF, 2006, CELL TRANSPLANT, V15, pS29, DOI 10.3727/000000006783982368
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   CARRINO DA, 1991, BIOCHEM INT, V24, P485
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Costa KD, 2003, TISSUE ENG, V9, P567, DOI 10.1089/107632703768247278
   Cui JH, 2005, CARDIOVASC REVASCULA, V6, P113, DOI 10.1016/j.carrev.2005.07.006
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Dreger SA, 2006, TISSUE ENG, V12, P2533, DOI 10.1089/ten.2006.12.2533
   Feng Zhonggang, 2003, J Artif Organs, V6, P192, DOI 10.1007/s10047-003-0230-z
   Fromstein JD, 2008, TISSUE ENG PT A, V14, P369, DOI 10.1089/tea.2006.0410
   Fuchs JR, 2006, SURGERY, V140, P100, DOI 10.1016/j.surg.2006.01.016
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Fukuda Keiichi, 2003, Hum Cell, V16, P83, DOI 10.1111/j.1749-0774.2003.tb00138.x
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gupta V, 2007, TISSUE ENG, V13, P41, DOI 10.1089/ten.2006.0091
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kochupura P.V., 2005, CIRCULATION, V112, P1144
   Lai PH, 2006, TISSUE ENG, V12, P2499, DOI 10.1089/ten.2006.12.2499
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2003, HEART FAIL REV, V8, P197, DOI 10.1023/A:1024791311566
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Ota T, 2007, J THORAC CARDIOV SUR, V133, P979, DOI 10.1016/j.jtcvs.2006.11.035
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozawa T, 2002, CIRCULATION, V106, P1176
   Pallante Benedetta A, 2006, Am Heart Hosp J, V4, P95, DOI 10.1111/j.1541-9215.2006.04651.x
   Pauschinger M, 1998, CARDIOVASC RES, V37, P123, DOI 10.1016/S0008-6363(97)00217-4
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Roccio M, 2008, PANMINERVA MED, V50, P19
   Sales VL, 2007, TISSUE ENG, V13, P525, DOI 10.1089/ten.2006.0128
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Schmidt D, 2005, EUR J CARDIO-THORAC, V27, P795, DOI 10.1016/j.ejcts.2005.01.064
   Schuleri K. H., 2007, V180, P195
   Siepe M, 2007, ARTIF ORGANS, V31, P425, DOI 10.1111/j.1525-1594.2007.00385.x
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Zeevi-Levin N, 2005, CARDIOVASC RES, V66, P64, DOI 10.1016/j.cardiores.2005.01.014
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zimmermann Wolfram-Hubertus, 2007, Trends Cardiovasc Med, V17, P134, DOI 10.1016/j.tcm.2007.02.007
NR 52
TC 74
Z9 76
U1 2
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD AUG
PY 2010
VL 16
IS 4
BP 671
EP 683
DI 10.1089/ten.tec.2009.0111
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 629VN
UT WOS:000280228300012
PM 19780649
DA 2018-10-19
ER

PT J
AU Park, SW
   Kang, SW
   Goo, TW
   Kim, SR
   Lee, GG
   Paik, SY
AF Park, Seung-Won
   Kang, Seok-Woo
   Goo, Tae-Won
   Kim, Seong Ryul
   Lee, Gwang-gill
   Paik, Soon-Young
TI Tissue-specific gene expression analysis of silkworm (Bombyx mori) by
   quantitative real-time RT-PCR
SO BMB REPORTS
LA English
DT Article
DE Biomaterial; Biomedical insect; Real-time RT-PCR; Silkworm;
   Tissue-specific expression
ID PROFILES; GENOME
AB The Bombyx mori Microarray Database (BmMDB; http://silkworm.swu.edu.cn/microarray) provides information for tissue-specific gene expression by using the whole-genome oligonucleotide microarray in the silkworm. We analyzed the tissue-specific expression patterns in the silk gland, fat body, and midgut five days of fifth instar larvae during the development of B. mori. To verify the tissue-specific expression, analysis was conducted using quantitative Real-time RT-PCR and the highly expressed endogenous Actin RNA as an intrinsic reference. Finally, we confirmed five genes, (sw15872, sw00692, sw20990, sw05300, and sw2250), out of 18 candidates expressed in two different tissues, which was consistent with the data published by Dr. Xiang's group, thereby supporting the BmMDB. Further studies for promoter regions of candidate genes can be applied in creating transgenic silkworms as biomedical insects for use in producing biomaterials, and to serve as well-characterized models for understanding the mechanism for the genetic regulation of tissue-specific development. [BMB reports 2010; 43(7): 480-484]
C1 [Park, Seung-Won; Kang, Seok-Woo; Goo, Tae-Won; Kim, Seong Ryul; Lee, Gwang-gill] Rural Dev Assoc, Natl Acad Agr Sci, Dept Agr Biol, Suwon, South Korea.
   [Paik, Soon-Young] Catholic Univ Korea, Dept Microbiol, Coll Med, Seoul, South Korea.
RP Park, SW (reprint author), Rural Dev Assoc, Natl Acad Agr Sci, Dept Agr Biol, Suwon, South Korea.
EM microsw@korea.kr; paik@catholic.ac.kr
FU Rural Development Administration, Republic of Korea [200901FHT010102502]
FX This study was supported by the Agenda Program (grant no.
   200901FHT010102502) of the Rural Development Administration, Republic of
   Korea. We are thankful to Waterborne Virus Bank for helping with the
   Real-Time RT-PCR.
CR Castello R, 2002, CLIN CHEM, V48, P1288
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Gong ZH, 2005, J BIOCHEM MOL BIOL, V38, P717
   Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27
   Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100
   Ote M, 2004, INSECT BIOCHEM MOLEC, V34, P775, DOI 10.1016/j.ibmb.2004.04.002
   Parthasarathy R, 2005, GENE EXPR PATTERNS, V5, P323, DOI 10.1016/j.modgep.2004.10.006
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162
   Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI 10.1016/j.ibmb.2008.11.004
   Yun EY, 2009, DEV COMP IMMUNOL, V33, P1064, DOI 10.1016/j.dci.2009.05.008
   Zavallo D, 2010, PLANT CELL REP, V29, P239, DOI 10.1007/s00299-010-0816-x
NR 12
TC 2
Z9 2
U1 1
U2 4
PU KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, # 801,  635-4 , YEOKSAM-DONG,
   KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-6696
J9 BMB REP
JI BMB Rep.
PD JUL 31
PY 2010
VL 43
IS 7
BP 480
EP 484
DI 10.5483/BMBRep.2010.43.7.480
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 633RJ
UT WOS:000280521600005
PM 20663409
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Scopelliti, PE
   Borgonovo, A
   Indrieri, M
   Giorgetti, L
   Bongiorno, G
   Carbone, R
   Podesta, A
   Milani, P
AF Scopelliti, Pasquale Emanuele
   Borgonovo, Antonio
   Indrieri, Marco
   Giorgetti, Luca
   Bongiorno, Gero
   Carbone, Roberta
   Podesta, Alessandro
   Milani, Paolo
TI The Effect of Surface Nanometre-Scale Morphology on Protein Adsorption
SO PLOS ONE
LA English
DT Article
ID ELECTRICAL DETECTION; NANOSTRUCTURED TIO2; DRUG-DELIVERY; STEM-CELLS;
   CANCER; DIFFERENTIATION; FILMS; NANOTECHNOLOGY; PROLIFERATION;
   NANOPARTICLES
AB Background: Protein adsorption is the first of a complex series of events that regulates many phenomena at the nano-bio interface, e. g. cell adhesion and differentiation, in vivo inflammatory responses and protein crystallization. A quantitative understanding of how nanoscale morphology influences protein adsorption is strategic for providing insight into all of these processes, however this understanding has been lacking until now.
   Methodology/Principal Findings: Here we introduce novel methods for quantitative high-throughput characterization of protein-surface interaction and we apply them in an integrated experimental strategy, to study the adsorption of a panel of proteins on nanostructured surfaces. We show that the increase of nanoscale roughness ( from 15 nm to 30 nm) induces a decrease of protein binding affinity (<= 90%) and a relevant increase in adsorbed proteins (<= 500%) beyond the corresponding increase of specific area. We demonstrate that these effects are caused by protein nucleation on the surface, which is promoted by surface nanoscale pores.
   Conclusions/Significance: These results show that the adsorption of proteins depends significantly on surface nanostructure and that the relevant morphological parameter regulating the protein adsorption process is the nanometric pore shape. These new findings improve our understanding of the role of nanostructures as a biomaterial design parameter and they have important implications for the general understanding of cell behavior on nanostructured surfaces.
C1 [Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Podesta, Alessandro; Milani, Paolo] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy.
   [Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Podesta, Alessandro; Milani, Paolo] Univ Milan, Dept Phys, Milan, Italy.
   [Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Bongiorno, Gero; Milani, Paolo] Fdn Filarete, Milan, Italy.
   [Giorgetti, Luca] European Inst Oncol, Dept Expt Oncol, Milan, Italy.
   [Carbone, Roberta] Tethis Srl, Milan, Italy.
RP Scopelliti, PE (reprint author), Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy.
EM paolo.milani@mi.infn.it
RI Podesta, Alessandro/E-6568-2010; Zhou, Feng/E-9510-2011
OI Podesta, Alessandro/0000-0002-4169-6679; 
FU University of Milan
FX This work was supported by the University of Milan. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Barborini E, 2002, APPL PHYS LETT, V81, P3052, DOI 10.1063/1.1510579
   Benesch T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021401
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056
   Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958
   Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Giorgetti L, 2008, LANGMUIR, V24, P11637, DOI 10.1021/la801910p
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Han M, 2003, LANGMUIR, V19, P9868, DOI 10.1021/la030132g
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT2608, 10.1038/nmat2608, 10.1038/NMAT260B]
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Lutolf M. P., 2009, NATURE, V426, P433
   MANUS JB, 2009, BIOMATERIALS, V30, P5094
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Page AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.065701
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   PAWLEY J, 2008, HDB BIOL CONFOCAL MI, P635
   Podesta A, 2009, J PHYS CHEM C, V113, P18264, DOI 10.1021/jp905930r
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Riedel M, 2001, BIOMATERIALS, V22, P2307, DOI 10.1016/S0142-9612(01)00011-4
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]
   Saridakis E, 2009, TRENDS BIOTECHNOL, V27, P99, DOI 10.1016/j.tibtech.2008.10.008
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4
   Vicent MJ, 2006, TRENDS BIOTECHNOL, V24, P39, DOI 10.1016/j.tibtech.2005.11.006
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138
NR 52
TC 126
Z9 126
U1 2
U2 89
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 29
PY 2010
VL 5
IS 7
AR e11862
DI 10.1371/journal.pone.0011862
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 633QY
UT WOS:000280520200026
PM 20686681
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Katagiri, F
   Takeyama, K
   Ohga, Y
   Hozumi, K
   Kikkawa, Y
   Kadoya, Y
   Nomizu, M
AF Katagiri, Fumihiko
   Takeyama, Kazuki
   Ohga, Yukiko
   Hozumi, Kentaro
   Kikkawa, Yamato
   Kadoya, Yuichi
   Nomizu, Motoyoshi
TI Amino Acid Sequence Requirements of Laminin beta 1 Chain Peptide B133
   (DISTKYFQMSLE) for Amyloid-like Fibril Formation, Syndecan Binding, and
   Neurite Outgrowth Promotion
SO BIOCHEMISTRY
LA English
DT Article
ID ALPHA-1 CHAIN; G-DOMAIN; SYNTHETIC PEPTIDES; GLOBULAR DOMAIN; CELL
   ATTACHMENT; CONGO RED; IDENTIFICATION; PROTEIN; FIBRILLOGENESIS; SITES
AB Peptide B133 (DSITKYFQMSLE), derived from mouse laminin beta 1 chain (residues 1298-1309), promotes cell attachment, neurite outgrowth, and amyloid-like fibril formation. Previously, we showed that the N-terminal Asp-deleted peptide B133a (SITKYFQMSLE) promotes integrin alpha 2 beta 1-mediated cell attachment and spreading but does not form amyloid-like fibrils, and that the C-terminal Glu-deleted peptide B133g (DSITKYFQMSL) attaches cells without cell spreading and forms amyloid-like fibrils. In this study, we further investigated the amino acid sequence requirements of B133 for biological function using a set of truncated and Ala-substituted peptides. Attachment of cells to B133g was inhibited by only heparin, and Congo Red analysis indicated that the amyloid-like fibril formation activity of B133g was stronger than that of B133. Alanine scan analysis for the B133g peptide indicated that Asp and Ile residues are essential for cell attachment. Additionally, the N-terminal Asp residue was required for neurite outgrowth. Further, amyloid-like fibril formation required Asp and Ile residues. These data suggest that the amyloid-like fibril formation of B133g is required for cell attachment activity. We also evaluated the attachment of cells to the peptides using syndecan- and glypican-overexpressing cells. B133g attached to syndecan-overexpressing cells but not to glypican-overexpressing cells, suggesting that the amyloidogenic peptides promote syndecan-mediated cell attachment. These findings were useful for clarifying the mechanism of amyloid-like fibril formation and biological functions. The B133 peptide promotes amyloid-like fibril formation, syndecan-mediated cell attachment, and neurite outgrowth and has the potential for use as a biomaterial for tissue engineering.
C1 [Katagiri, Fumihiko; Takeyama, Kazuki; Ohga, Yukiko; Hozumi, Kentaro; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan.
   [Kadoya, Yuichi] Kitasato Univ, Sch Allied Hlth Sci, Dept Anat, Kanagawa 2288555, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, 1432-1 Horinouchi, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
RI Kikkawa, Yamato/D-1503-2010
CR Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200
   Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s
   Castillo GM, 2000, J NEUROSCI RES, V62, P451, DOI 10.1002/1097-4547(20001101)62:3<451::AID-JNR15>3.0.CO;2-F
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   COOPER JH, 1974, LAB INVEST, V31, P232
   FRASER PE, 1994, J MOL BIOL, V244, P64, DOI 10.1006/jmbi.1994.1704
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200
   Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   KATAGIRI F, 2010, ARCH BIOCH IN PRESS
   Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V
   Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933
   KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748
   Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965
   Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825
   Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155
   Marks N, 2010, NEUROCHEM RES, V35, P181, DOI 10.1007/s11064-009-0054-1
   MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047
   NARINDRASORASAK S, 1992, LAB INVEST, V67, P643
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Ohga Y, 2009, BIOMATERIALS, V30, P6731, DOI 10.1016/j.biomaterials.2009.08.044
   Ohnishi S, 2000, J MOL BIOL, V301, P477, DOI 10.1006/jmbi.2000.3980
   POP V, 2010, NEUROBIOL A IN PRESS
   Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200
   Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221
   Sohma Y, 2005, J PEPT SCI, V11, P441, DOI 10.1002/psc.649
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   TAKADERA T, 1993, NEUROSCI LETT, V161, P41, DOI 10.1016/0304-3940(93)90135-8
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200
   Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006
   Urushibata S, 2009, BIOCHEMISTRY-US, V48, P10522, DOI 10.1021/bi901421t
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
NR 47
TC 1
Z9 1
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 20
PY 2010
VL 49
IS 28
BP 5909
EP 5918
DI 10.1021/bi100748s
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 623EW
UT WOS:000279722100010
PM 20550135
DA 2018-10-19
ER

PT J
AU Zhang, FJ
   Oh, WC
AF Zhang, Feng-Jun
   Oh, Won-Chun
TI Characterization and Photonic Effect of Novel Ag-CNT/TiO2 Composites and
   their Bactericidal Activities
SO BULLETIN OF THE KOREAN CHEMICAL SOCIETY
LA English
DT Article
DE Sliver; CNT; TiO2; Photocatalysis; Bactericidal activity
ID SOL-GEL METHOD; CARBON NANOTUBES; ESCHERICHIA-COLI; BIOMATERIAL SYSTEM;
   NANOPARTICLES; SILVER; TIO2; METAL; NANOCOMPOSITES; PHOTOCATALYSIS
AB A novel composite (Ag-CNT/TiO2) of silver treated carbon nanotubes (Ag-CNT) and TiO2 was synthesized via wet chemistry followed by a heat treatment. The dispersion and structure of the silver in the synthesized composites determined by X-ray diffraction (XRD), energy dispersive X-ray (EDX) spectroscopy, scanning electron microscopy (SEM), and transmission electron microscopy(TEM). XRD patterns of the composites showed that the composites contained a mixing anatase and rutile phase. The EDX spectra showed the presence of C, O, Ti and Ag peaks. The TiO2 particles were distributed uniformly in the CNT network, and silver particles were virtually fixed on the surface of the tube. The photocatalysis degraded behaviors of the Ag-CNT/TiO2 composites of the methylene blue, which increased with an increase of the silver component. The Ag-CNT/TiO2 composites have excellent antibacterial activities against Escherichia coli (E. Cob), Pseudomonas aeruginosa (P. Aeru) and Bacillus subtilis (B. Sub) under visible light.
C1 [Zhang, Feng-Jun; Oh, Won-Chun] Hanseo Univ, Dept Adv Mat & Sci Engn, Seosan 356706, Chungnam, South Korea.
   [Zhang, Feng-Jun] Anhui Univ Architecture, Sch Mat & Chem Engn, Hefei 230022, Anhui, Peoples R China.
RP Oh, WC (reprint author), Hanseo Univ, Dept Adv Mat & Sci Engn, Seosan 356706, Chungnam, South Korea.
EM wc_oh@hanseo.ac.kr
CR AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0
   Atrih A, 2002, INT DAIRY J, V12, P217, DOI 10.1016/S0958-6946(01)00157-1
   Berman E., 1980, TOXIC METALS THEIR A, P116
   Chen M-L, 2006, CARBON SCI, V7, P259
   Chen ML, 2006, B KOR CHEM SOC, V27, P1423
   Christensen PA, 2003, APPL CATAL B-ENVIRON, V41, P371, DOI 10.1016/S0926-3373(02)00172-8
   Fu PF, 2004, J MOL CATAL A-CHEM, V221, P81, DOI 10.1016/j.molcata.2004.06.016
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Inagaki M, 2003, CARBON, V41, P2619, DOI 10.1016/S0008-6223(03)00340-3
   Jitianu A, 2004, CARBON, V42, P1147, DOI 10.1016/j.carbon.2003.12.041
   Joint Committee on Powder Diffraction Standards, POWD DIFFR FIL
   Lee SH, 2005, COLLOID SURFACE B, V40, P93, DOI 10.1016/j.colsurfb.2004.05.005
   LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013
   Liu T, 2007, NUCL INSTRUM METH B, V264, P282, DOI 10.1016/j.nimb.2007.08.095
   Oh WC, 2004, B KOR CHEM SOC, V25, P639
   Oh WC, 2003, J IND ENG CHEM, V9, P117
   Oh WC, 2008, MAT SCI ENG C, V29, P1338
   Oh WC, 2008, J CERAM PROCESS RES, V9, P100
   Oh WC, 2008, B KOREAN CHEM SOC, V29, P159
   Oh WC, 2007, J IND ENG CHEM, V13, P1208
   OLLIS DF, 1993, PHOTCATALYTIC PURIFI, P265
   Park SJ, 2003, J COLLOID INTERF SCI, V261, P238, DOI 10.1016/S0021-9797(03)00083-3
   Phang SW, 2008, SYNTHETIC MET, V158, P251, DOI 10.1016/j.synthmet.2008.01.012
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Ray AK, 1999, CHEM ENG SCI, V54, P3113, DOI 10.1016/S0009-2509(98)00507-7
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Ugarte D, 1996, SCIENCE, V274, P1897, DOI 10.1126/science.274.5294.1897
   Wang WD, 2005, J MOL CATAL A-CHEM, V235, P194, DOI 10.1016/j.molcata.2005.02.027
   Wang WD, 2005, APPL CATAL B-ENVIRON, V56, P305, DOI 10.1016/j.apcatb.2004.09.018
   Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007
   Zhang F. J., 2008, MAT RES SOC KOREA, V18, P583
   Zhang ST, 2004, CARBON, V42, P3209, DOI 10.1016/j.carbon.2004.08.004
   Zhang Y, 2000, CHEM PHYS LETT, V331, P35, DOI 10.1016/S0009-2614(00)01162-3
   Zhao J, 2006, NUCL INSTRUM METH B, V243, P299, DOI 10.1016/j.nimb.2005.08.189
NR 36
TC 3
Z9 3
U1 2
U2 19
PU KOREAN CHEMICAL SOC
PI SEOUL
PA 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 0253-2964
J9 B KOREAN CHEM SOC
JI Bull. Korean Chem. Soc.
PD JUL 20
PY 2010
VL 31
IS 7
BP 1981
EP 1987
DI 10.5012/bkcs.2010.31.7.1981
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 630AY
UT WOS:000280244700035
OA Bronze
DA 2018-10-19
ER

PT J
AU Gon, S
   Bendersky, M
   Ross, JL
   Santore, MM
AF Gon, Saugata
   Bendersky, Marina
   Ross, Jennifer L.
   Santore, Maria M.
TI Manipulating Protein Adsorption using a Patchy Protein-Resistant Brush
SO LANGMUIR
LA English
DT Article
ID POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL) LAYERS; SELF-ASSEMBLED
   MONOLAYERS; METAL-OXIDE SURFACES; FIBRINOGEN ADSORPTION;
   CONFORMATIONAL-CHANGES; HYDROPHOBIC SURFACES; POLYMER BRUSHES; SCALE
   ADHESION; KINETICS; NANOPARTICLES
AB Toward the development of surfaces for the precise manipulation of proteins, this study explores the fabrication and protein-interactive behavior of a new type of surface containing extremely small (on the order of 10 nm or less) Bat adhesive "patches" or islands embedded in and partially concealed by a protein-repellant PEG (poly(ethylene glycol)) brush. The adsorption of fibrinogen, the model protein chosen to probe the biomaterial interactions of these surfaces, is very sensitive to the surface density of the adhesive patches, occurring only above a threshold. This suggests that two or more adhesive patches are needed to capture each protein. When the average spacing of the adhesive patches exceeds the fibrinogen length, no adsorption occurs because individual patches are too weakly binding for protein capture, as a result of being at least partially obstructed by the brush. The small size of the adhesive patches relative to the 47 nm fibrinogen length thus defines a limiting regime of surface design, distinct from surfaces where larger features can adhere single isolated proteins or multiple proteins together. The restricted protein-surface contact may comprise a means of preserving protein structure and function in the adsorbed state. This article demonstrates several additional interesting features of PEG brushes relevant to biomaterial design. First a moderate amount of adhesive material can be buried at the base of a brush without a measurable impact on the corona density. Second, a different amount of material at the base of a brush can be rendered ineffective to capturing adhesive proteins, despite a modest compromise of the brush corona. From this will follow insight into the design of patterned biomaterial surfaces, the bioactivity of the edges of patterned features, and an understanding of how flaws in brushes compromise protein resistance or allow access to small adhesive sites.
C1 [Santore, Maria M.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
   [Ross, Jennifer L.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA.
   [Gon, Saugata; Bendersky, Marina] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
RP Santore, MM (reprint author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
RI Ross, Jennifer/D-7208-2012; GON, Stephanie/O-8324-2016
OI Ross, Jennifer/0000-0002-4838-3798; GON, Stephanie/0000-0002-1513-5018
FU NSF [DMR-08-05061, CBET-04-28455, DBI 0923318, CMMI-0531171]
FX This work was supported by NSF DMR-08-05061, CBET-04-28455, and (to
   j.L.R.) NSF DBI 0923318. Zeta potential measurements were made on an
   instrument within the UMass Center for Hierarchical Manufacturing,
   supported by NSF CMMI-0531171.
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P977, DOI 10.1051/jphys:01977003808097700
   BILLSTEN P, 1995, J COLLOID INTERF SCI, V175, P77, DOI 10.1006/jcis.1995.1431
   Bos MA, 2001, ADV COLLOID INTERFAC, V91, P437
   Brittain WJ, 2007, J POLYM SCI POL CHEM, V45, P3505, DOI 10.1002/pola.22180
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   de Gennes P. G., 1976, J PHYS LES ULIS, V38, P1443
   Dickinson E, 1999, COLLOID SURFACE B, V15, P161, DOI 10.1016/S0927-7765(99)00042-9
   Duffadar R, 2009, J COLLOID INTERF SCI, V337, P396, DOI 10.1016/j.jcis.2009.05.046
   FENG L, 1994, PROTEINS INTERFACE 2, V602, P66
   FLEER GJ, 1993, POLYM INTERFACES, P2993
   Fu ZG, 1998, COLLOID SURFACE A, V135, P63, DOI 10.1016/S0927-7757(97)00218-5
   Gao P, 2008, LANGMUIR, V24, P10334, DOI 10.1021/la801020b
   Hansupalak N, 2004, MACROMOLECULES, V37, P1621, DOI 10.1021/ma0343636
   Hansupalak N, 2003, LANGMUIR, V19, P7423, DOI 10.1021/la0302145
   HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P113
   Huang NP, 2002, LANGMUIR, V18, P220, DOI 10.1021/la010913m
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Jiang M, 2010, COLLOID SURFACE A, V360, P20, DOI 10.1016/j.colsurfa.2010.01.070
   Kalasin S, 2008, LANGMUIR, V24, P4435, DOI 10.1021/la8000202
   Karajanagi SS, 2004, LANGMUIR, V20, P11594, DOI 10.1021/la047994h
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   KENT MS, 1995, J CHEM PHYS, V103, P2320, DOI 10.1063/1.469707
   Kozlova N, 2006, LANGMUIR, V22, P1135, DOI 10.1021/la0515221
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   NORDE W, 1995, CELL MATER, V5, P97
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   Rebar VA, 1996, MACROMOLECULES, V29, P6262, DOI 10.1021/ma9512364
   Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s
   Santore MM, 2005, CURR OPIN COLLOID IN, V10, P176, DOI 10.1016/j.cocis.2005.05.005
   Shang L, 2007, LANGMUIR, V23, P2714, DOI 10.1021/la062064e
   SHIBATA CT, 1992, J COLLOID INTERF SCI, V148, P485, DOI 10.1016/0021-9797(92)90185-O
   Shin Y, 2002, MACROMOLECULES, V35, P4090, DOI 10.1021/ma0115390
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   Teichroeb JH, 2008, EUR PHYS J E, V26, P411, DOI 10.1140/epje/i2007-10342-9
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Toscano A, 2006, LANGMUIR, V22, P2588, DOI 10.1021/la051641g
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   YAMAKAWA H, 1971, MODERN THEORY POLYM
   Zhang J, 2008, LANGMUIR, V24, P6404, DOI 10.1021/la800857v
NR 51
TC 30
Z9 30
U1 3
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 20
PY 2010
VL 26
IS 14
BP 12147
EP 12154
DI 10.1021/la1016752
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 623QK
UT WOS:000279756700078
PM 20557060
DA 2018-10-19
ER

PT J
AU Yamazoe, H
   Oyane, A
   Nashima, T
   Ito, A
AF Yamazoe, Hironori
   Oyane, Ayako
   Nashima, Takeshi
   Ito, Atsuo
TI Reduced platelet adhesion and blood coagulation on cross-linked albumin
   films
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Recombinant human serum albumin; Cilostazol; Blood compatibility;
   Platelet adhesion; Blood coagulation
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; COMPLEMENT ACTIVATION;
   SERUM-ALBUMIN; CELL-ADHESION; SURFACES; COMPATIBILITY; BINDING; MODEL;
   PHOSPHORYLCHOLINE
AB Surface-induced thrombosis is a major complication associated with blood-contacting biomaterials. Crosslinked albumin films possessing native albumin characteristics such as resistance to cell adhesion and drug binding ability are available for improving the blood compatibility of biomaterial surfaces. In the present study, we aimed to evaluate the blood compatibility of cross-linked albumin films. Platelet adhesion analysis showed that albumin film coated substrates exhibited very low platelet adhesion, and platelet adhesion was further suppressed by loading the antiplatelet drug, cilostazol, into the film. Monitoring the coagulation process of whole blood using a coaxial-cylinder rotational viscometer showed that the initial time of coagulation in albumin film coated cylinders was delayed compared with that in uncoated cylinders, suggesting that activation of the intrinsic coagulation cascade was reduced on the albumin film coated surface. Thus, surface coating with cross-linked albumin films is a promising approach to conferring biomaterials with antithrombogenic surfaces due to the resistance to platelet adhesion and the antiplatelet drug-releasing capability afforded by the films. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Yamazoe, Hironori; Oyane, Ayako] Natl Inst Adv Ind Sci & Technol, Nanotechnol Res Inst, Tsukuba, Ibaraki 3058562, Japan.
   [Nashima, Takeshi] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058562, Japan.
   [Ito, Atsuo] Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, Tsukuba, Ibaraki 3058562, Japan.
RP Yamazoe, H (reprint author), Natl Inst Adv Ind Sci & Technol, Nanotechnol Res Inst, Cent 4-1,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.
EM hironori-yamazoe@aist.go.jp
RI Ito, Atsuo/M-6785-2018; Yamazoe, Hironori/A-3143-2015
OI Ito, Atsuo/0000-0003-3318-040X; Yamazoe, Hironori/0000-0003-2948-8786
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Arima Y, 2008, BIOMATERIALS, V29, P551, DOI 10.1016/j.biomaterials.2007.10.015
   Arima Y, 2007, J MATER CHEM, V17, P4079, DOI 10.1039/b708099a
   BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   Cao L, 2007, J BIOMED MATER RES A, V81A, P827, DOI 10.1002/jbm.a.31091
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   FEHSKE KJ, 1981, BIOCHEM PHARMACOL, V30, P687, DOI 10.1016/0006-2952(81)90151-9
   Frautschi JR, 1995, J BIOMAT SCI-POLYM E, V7, P563
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GUIDOIN R, 1984, ANN THORAC SURG, V37, P457, DOI 10.1016/S0003-4975(10)61131-9
   GUIDOIN RG, 1983, T AM SOC ART INT ORG, V29, P290
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   ISHIKAWA Y, 1984, THROMB RES, V35, P193, DOI 10.1016/0049-3848(84)90214-7
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Keogh James R., 1996, Cells and Materials, V6, P209
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Kobayashi K, 1998, Ther Apher, V2, P257, DOI 10.1111/j.1744-9987.1998.tb00118.x
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17
   Lin WC, 2005, COLLOID SURFACE B, V44, P82, DOI 10.1016/j.colsurfb.2005.05.015
   LYMAN DJ, 1970, THROMB DIATH HAEMO, V42, P109
   McNicol A, 2003, J PHARMACOL SCI, V93, P381, DOI 10.1254/jphs.93.381
   Mori D, 2007, J ATHEROSCLER THROMB, V14, P213, DOI 10.5551/jat.E492
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2431, DOI 10.1016/S0142-9612(03)00113-3
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Subramanian Anu, 2004, Biomed Sci Instrum, V40, P1
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   YAMAZOE H, 2010, SCI POLYM ED, V21, P647
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
NR 33
TC 9
Z9 9
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 20
PY 2010
VL 30
IS 6
BP 812
EP 816
DI 10.1016/j.msec.2010.03.015
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 620VB
UT WOS:000279527600004
DA 2018-10-19
ER

PT J
AU Chen, X
   Li, CW
   Wang, J
   Li, J
   Luan, XY
   Li, Y
   Xu, R
   Wang, BX
AF Chen, Xia
   Li, Chengwu
   Wang, Jun
   Li, Jia
   Luan, Xiaoyu
   Li, Ying
   Xu, Rui
   Wang, Baoxin
TI Investigation on solar photocatalytic activity of TiO2 loaded composite:
   TiO2/Eggshell, TiO2/Clamshell and TiO2/CaCO3
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; TiO2 composite; Solar light; Photocatalytic degradation;
   Organic dye
ID ACTIVATED CARBON; SUPPORTED TIO2; METHYL-ORANGE; DEGRADATION
AB The TiO2/Eggshell, TiO2/Clamshell and TiO2/CaCO3 loaded composites were prepared by sol-gel method and characterized by XRD and SEM Their photocatalytic activities were measured through the degradation of Acid Red B under solar light irradiation The influences of TiO2 loaded content, heat-treated temperature and time on the photocatalytic activities were reviewed The effects of irradiation time and dye initial concentration on the photocatalytic degradation were also investigated The results showed that the photocatalytic activity can be greatly enhanced by appropriate TiO2 loaded content (C) 2010 Elsevier B.V All rights reserved
C1 [Chen, Xia; Li, Chengwu; Wang, Jun; Li, Jia; Luan, Xiaoyu; Li, Ying; Xu, Rui; Wang, Baoxin] Liaoning Univ, Dept Chem, Shenyang 110036, Peoples R China.
RP Wang, J (reprint author), Liaoning Univ, Dept Chem, Shenyang 110036, Peoples R China.
FU Liaoning Province Natural Science Foundation of Education Department;
   Science and Technology Department
FX The authors greatly acknowledge the Liaoning Province Natural Science
   Foundation of Education Department and Science and Technology Department
   for financial support.
CR Bhattacharyya A, 2004, CATAL TODAY, V98, P431, DOI 10.1016/j.cattod.2004.08.010
   Chen B, 2008, COMP MATER SCI, V44, P201, DOI 10.1016/j.commatsci.2008.01.013
   He DP, 2007, MATER LETT, V61, P3385, DOI 10.1016/j.matlet.2006.11.075
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Li YJ, 2005, CATAL COMMUN, V6, P650, DOI 10.1016/j.catcom.2005.06.008
   LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013
   Mahalakshmi M, 2009, J HAZARD MATER, V161, P336, DOI 10.1016/j.jhazmat.2008.03.098
   Meldrum FC, 2003, INT MATER REV, V48, P187, DOI 10.1179/095066003225005836
   Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P113, DOI 10.1016/j.msec.2005.01.004
   Tryba B, 2003, APPL CATAL B-ENVIRON, V46, P203, DOI 10.1016/S0926-3373(03)00214-5
   Wang GH, 2008, J CHEM TECHNOL BIOT, V83, P601, DOI 10.1002/jctb.1837
   Wang Q, 2009, J NANOPART RES, V11, P375, DOI 10.1007/s11051-008-9390-3
   Wang XJ, 2009, J HAZARD MATER, V169, P1061, DOI 10.1016/j.jhazmat.2009.04.058
   Wang YM, 2006, MATER LETT, V60, P974, DOI 10.1016/j.matlet.2005.10.061
   Zhang X, 2009, J MOL CATAL A-CHEM, V301, P134, DOI 10.1016/j.molcata.2008.11.022
NR 15
TC 16
Z9 17
U1 3
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL 15
PY 2010
VL 64
IS 13
BP 1437
EP 1440
DI 10.1016/j.matlet.2010.03.048
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 609FH
UT WOS:000278640700009
DA 2018-10-19
ER

PT J
AU Cassano, R
   Trombino, S
   Ferrarelli, T
   Barone, E
   Arena, V
   Mancuso, C
   Picci, N
AF Cassano, Roberta
   Trombino, Sonia
   Ferrarelli, Teresa
   Barone, Eugenio
   Arena, Vincenzo
   Mancuso, Cesare
   Picci, Nevio
TI Synthesis, Characterization, and Anti-Inflammatory Activity of
   Diclofenac-Bound Cotton Fibers
SO BIOMACROMOLECULES
LA English
DT Article
ID WOUND DRESSINGS; CHITOSAN; OSTEOARTHRITIS; DERIVATIVES; FABRICATION;
   MEMBRANE; COX-2
AB In the present work, we report on the synthesis of cellulose cotton fibers covalently linked to diclofenac moieties and the evaluation of the anti-inflammatory activity of this new biomaterial. In spite of recent progress in experimental and clinical medicine, the problem of chronic wounds treatment is still debated. In fact, conventional methods are based on the use of ointment-soaked bandages, but several physical and biological factors contribute to making the efficacy of this method quite low. For this reason, we developed the idea to using modified cotton gauzes to prevent inflammation during wound healing. In this light, diclofenac, a nonsteroidal anti-inflammatory drug, was covalently linked to the cellulose backbone of hydrophilic cotton fibers by a heterogeneous synthesis to produce a functionalized biopolymer with a satisfactory degree of substitution and anti-inflammatory activity. Diclofenac was directly linked to fiber microfibril hydroxylic groups using THF with thionyl chloride. The obtained biopolymer was characterized by infrared spectroscopy (FT-IR) to confirm ester linkages. Finally, the anti-inflammatory activity was evaluated in a well-established in vivo model. The results suggested that these biomaterials possess an excellent anti-inflammatory activity in vivo, so they can be efficiently employed in biomedical fields for chronic wound management to ensure a valid protection against inflammation.
C1 [Cassano, Roberta; Trombino, Sonia; Ferrarelli, Teresa; Picci, Nevio] Univ Calabria, Dept Pharmaceut Sci, I-87036 Arcavacata Di Rende, CS, Italy.
   [Barone, Eugenio; Mancuso, Cesare] Catholic Univ, Sch Med, Inst Pharmacol, I-00168 Rome, Italy.
   [Arena, Vincenzo] Catholic Univ, Sch Med, Inst Pathol, I-00168 Rome, Italy.
RP Trombino, S (reprint author), Univ Calabria, Dept Pharmaceut Sci, I-87036 Arcavacata Di Rende, CS, Italy.
EM sonia.trombino@unical.it
OI Mancuso, Cesare/0000-0001-6532-483X; Trombino,
   Sonia/0000-0001-9939-4457; Barone, Eugenio/0000-0002-7028-4251; Picci,
   Nevio/0000-0003-1985-2724
CR Adamopoulos L, 2007, CARBOHYD POLYM, V69, P805, DOI 10.1016/j.carbpol.2007.02.019
   Alvarez-Soria MA, 2006, ANN RHEUM DIS, V65, P998, DOI 10.1136/ard.2005.046920
   Alvarez-Soria MA, 2008, OSTEOARTHR CARTILAGE, V16, P1484, DOI 10.1016/j.joca.2008.04.022
   Cassano R, 2007, J AGR FOOD CHEM, V55, P9489, DOI 10.1021/jf071711k
   Degim Z, 2008, J DRUG TARGET, V16, P437, DOI 10.1080/10611860802088572 
   Denkbas EB, 2004, J BIOMATER APPL, V18, P291, DOI 10.1177/0885328204041510
   Edwards JV, 2004, INT J PHARM, V284, P1, DOI 10.1016/j.ijpharm.2004.06.003
   Huang MH, 2008, INT J PHARM, V346, P38, DOI 10.1016/j.ijpharm.2007.06.021
   Kim IY, 2007, INT J PHARM, V341, P35, DOI 10.1016/j.ijpharm.2007.03.042
   KLEMN D, 1998, COMPRENSIVE CELLULOS, V2, P197
   Lin FH, 2007, MATER CHEM PHYS, V102, P152, DOI 10.1016/j.matchemphys.2006.11.017
   Lou CW, 2008, FIBER POLYM, V9, P286, DOI 10.1007/s12221-008-0046-9
   MEIER R, 1950, EXPERIENTIA, V6, P469, DOI 10.1007/BF02154110
   MEIER RK, 1953, P SOC EXP BIOL MED, V84, P624
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Miraftab M, 2003, CARBOHYD POLYM, V53, P225, DOI 10.1016/S0144-8617(03)00108-5
   MUZZARELLI RAA, 2005, BIOMATERIALS, V26, P44
   Trombino S, 2008, MACROMOL BIOSCI, V8, P86, DOI 10.1002/mabi.200700110
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 19
TC 12
Z9 12
U1 0
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL 12
PY 2010
VL 11
IS 7
BP 1716
EP 1720
DI 10.1021/bm100404q
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 622QS
UT WOS:000279679300004
PM 20536117
DA 2018-10-19
ER

PT J
AU Ma, ZW
   Nelson, DM
   Hong, Y
   Wagner, WR
AF Ma, Zuwei
   Nelson, Devin M.
   Hong, Yi
   Wagner, William R.
TI Thermally Responsive Injectable Hydrogel Incorporating
   Methacrylate-Polylactide for Hydrolytic Lability
SO BIOMACROMOLECULES
LA English
DT Article
ID CRITICAL SOLUTION TEMPERATURE; VOLUME PHASE-TRANSITION;
   N-ISOPROPYLACRYLAMIDE COPOLYMERS; ARTIFICIAL EXTRACELLULAR-MATRIX;
   MYOCARDIAL-INFARCTION; THERMOSENSITIVE POLYMER; NUCLEUS PULPOSUS;
   DRUG-DELIVERY; POLY(N-ISOPROPYLACRYLAMIDE); INJECTION
AB Injectable thermoresponsive hydrogels are of interest for a variety of biomedical applications, including regional tissue mechanical support as well as drug and cell delivery. Within this class of materials there is a need to provide options for eels with stronger mechanical properties as well as variable degradation profiles. To address this need, the hydrolytically labile monomer, methacrylate-polylactide (MAPLA), with an average 2.8 lactic acid units, was synthesized and copolymerized with N-isopropylacrylamide (NIPAAm) and 2-hydroxyethyl methacrylate (HEMA) to obtain bioabsorbable thermally responsive hydrogels. Poly(NIPAAm-co-HEMA-co-MAPLA) with three monomer feed ratios (84/10/6, 82/10/8, and 80/10/10) was synthesized and characterized with NMR, FTIR, and GPC. The copolymers were soluble in saline at reduced temperature (<10 degrees C), forming clear solutions that increased in viscosity with the MAPLA feed ratio. The copolymers underwent sol gel transition at lower critical solution temperatures of 12.4, 14.0, and 16.2 degrees C, respectively, and solidified immediately upon being placed in a 37 degrees C water bath. The warmed hydrogels gradually excluded water to reach final water contents of similar to 45%. The hydrogels as formed were mechanically strong, with tensile strengths as high as 100 kPa and shear moduli of 60 kPa. All three hydrogels were completely degraded (solubilized) in PBS over a 6-7 month period at 37 degrees C, with a higher MAPLA feed ratio resulting in a faster degradation period. Culture of primary vascular smooth muscle cells with degradation solutions demonstrated a lack of cytotoxicity. The synthesized hydrogels provide new options for biomaterial injection therapy where increased mechanical strength and relatively slow resorption rates would be attractive.
C1 [Ma, Zuwei; Hong, Yi; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Ma, Zuwei; Hong, Yi; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Nelson, Devin M.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
FU National Institutes of Health (NIH) [HL069368, T32-HL076124];
   Commonwealth of Pennsylvania
FX This work was supported by the National Institutes of Health (NIH),
   grant #HL069368 and the Commonwealth of Pennsylvania. Mr. Nelson was
   supported by NIH training grant #T32-HL076124.
CR Ahmed Z, 2009, J PHYS CHEM B, V113, P4248, DOI 10.1021/jp810685g
   APPELL RA, 1994, UROL CLIN N AM, V21, P177
   BAE YH, 1996, POLYM MAT ENCY, V4, P3492
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Cui ZW, 2007, BIOMACROMOLECULES, V8, P1280, DOI 10.1021/bm061045g
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Ghoniem G M, 1998, Urol Nurs, V18, P125
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Guan JJ, 2008, BIOMACROMOLECULES, V9, P1283, DOI 10.1021/bm701265j
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Henderson E, 2009, J BIOMED MATER RES A, V90A, P1186, DOI 10.1002/jbm.a.32179
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee BH, 2005, MACROMOL BIOSCI, V5, P629, DOI 10.1002/mabi.200500029
   Lee BH, 2005, POLYM INT, V54, P418, DOI 10.1002/pi.1709
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Li Z, 2009, BIOMACROMOLECULES, V10, P3306, DOI 10.1021/bm900900e
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Neradovic D, 1999, MACROMOL RAPID COMM, V20, P577, DOI 10.1002/(SICI)1521-3927(19991101)20:11<577::AID-MARC577>3.0.CO;2-D
   Ohya S, 2005, J BIOMAT SCI-POLYM E, V16, P809, DOI 10.1163/1568562054255736
   Ohya S, 2005, BIOMATERIALS, V26, P655, DOI 10.1016/j.biomaterials.2004.03.002
   Ohya S, 2001, BIOMACROMOLECULES, V2, P856, DOI 10.1021/bm010040a
   ONO O, 2006, J AM CHEM SOC, V128, P10030
   Ono Y, 2007, J PHYS CHEM B, V111, P1511, DOI 10.1021/jp068954k
   Overstreet DJ, 2010, BIOMACROMOLECULES, V11, P1154, DOI 10.1021/bm100035f
   Peppas NA, 2006, J DRUG DELIV SCI TEC, V16, P11, DOI 10.1016/S1773-2247(06)50002-4
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Rzaev ZMO, 2007, PROG POLYM SCI, V32, P534, DOI 10.1016/j.progpolymsci.2007.01.006
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Su J, 2010, TISSUE ENG PT A, V16, P905, DOI [10.1089/ten.tea.2009.0488, 10.1089/ten.TEA.2009.0488]
   Tian J, 2004, MACROMOLECULES, V37, P9994, DOI 10.1021/ma049475r
   Vernengo J, 2008, J BIOMED MATER RES B, V84B, P64, DOI 10.1002/jbm.b.30844
   Vihola H, 2005, BIOMATERIALS, V26, P3055, DOI 10.1016/j.biomaterials.2004.09.008
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang F, 2009, ACTA BIOMATER, V5, P2901, DOI 10.1016/j.actbio.2009.04.016
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Wu C, 1998, POLYMER, V39, P4609, DOI 10.1016/S0032-3861(97)10130-6
   Wu C, 1997, MACROMOLECULES, V30, P574, DOI 10.1021/ma960499a
   WU DQ, 2009, ACS APPL MAT INTERF, V2, P312
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 52
TC 44
Z9 45
U1 1
U2 55
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL 12
PY 2010
VL 11
IS 7
BP 1873
EP 1881
DI 10.1021/bm1004299
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 622QS
UT WOS:000279679300024
PM 20575552
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Pan, HB
   Zhao, XL
   Zhang, X
   Zhang, KB
   Li, LC
   Li, ZY
   Lam, WM
   Lu, WW
   Wang, DP
   Huang, WH
   Lin, KL
   Chang, J
AF Pan, H. B.
   Zhao, X. L.
   Zhang, X.
   Zhang, K. B.
   Li, L. C.
   Li, Z. Y.
   Lam, W. M.
   Lu, W. W.
   Wang, D. P.
   Huang, W. H.
   Lin, K. L.
   Chang, J.
TI Strontium borate glass: potential biomaterial for bone regeneration
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE borate glass; strontium; cytotoxicity; bone regeneration
ID BIOACTIVE BOROSILICATE GLASS; IN-VITRO; REFERENCE RANGES;
   TRACE-ELEMENTS; ICP-MS; BORON; 45S5; BIOCOMPATIBILITY; HYDROXYAPATITE;
   CYTOTOXICITY
AB Boron plays important roles in many life processes including embryogenesis, bone growth and maintenance, immune function and psychomotor skills. Thus, the delivery of boron by the degradation of borate glass is of special interest in biomedical applications. However, the cytotoxicity of borate glass which arises with the rapid release of boron has to be carefully considered. In this study, it was found that the incorporation of strontium into borate glass can not only moderate the rapid release of boron, but also induce the adhesion of osteoblast-like cells, SaOS-2, thus significantly increasing the cyto-compatibility of borate glass. The formation of multilayers of apatite with porous structure indicates that complete degradation is optimistic, and the spread of SaOS-2 covered by apatite to form a sandwich structure may induce bone-like tissue formation at earlier stages. Therefore, such novel strontium-incorporated borosilicate may act as a new generation of biomaterial for bone regeneration, which not only renders boron as a nutritious element for bone health, but also delivers strontium to stimulate formation of new bones.
C1 [Pan, H. B.; Zhao, X. L.; Li, L. C.; Li, Z. Y.; Lam, W. M.; Lu, W. W.] Univ Hong Kong, Dept Orthopead & Traumatol, Pokfulam, Hong Kong, Peoples R China.
   [Zhang, X.; Wang, D. P.; Huang, W. H.] Tongji Univ, Dept Mat Sci & Engn, Shanghai 200092, Peoples R China.
   [Zhang, K. B.] Sun Yat Sen Univ, Dept Spine Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.
   [Lin, K. L.; Chang, J.] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Lu, WW (reprint author), Univ Hong Kong, Dept Orthopead & Traumatol, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.
EM wwlu@hkusua.hku.hk; whhuang@tongji.edu.cn
FU Shanghai Committee of Science and Technology [08441900500]; Hong Kong
   RGC [HKU7147/07E]; Electron Microscopy Unit of the University of Hong
   Kong
FX This work was funded by Shanghai Committee of Science and Technology
   (grant no. 08441900500) and Hong Kong RGC HKU7147/07E. The authors are
   grateful for all the technical support and guidance from the Electron
   Microscopy Unit of the University of Hong Kong.
CR Brown PW, 1994, HYDROXYAPATITE RELAT
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Forrer R, 2001, BIOL TRACE ELEM RES, V80, P77, DOI 10.1385/BTER:80:1:77
   Forrer R, 2001, BIOL TRACE ELEM RES, V81, P47, DOI 10.1385/BTER:81:1:47
   GARRETT DH, 1998, BORATES
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   *INT STAND ORG, 1992, 10993 INT STAND ORG
   JONES JR, 2006, ENCY MED DEVICES INS, P283
   Kaga M, 2001, DENT MATER, V17, P333, DOI 10.1016/S0109-5641(00)00091-9
   Lao J, 2009, J MATER CHEM, V19, P2940, DOI 10.1039/b822214b
   Lao J, 2008, CHEM MATER, V20, P4969, DOI 10.1021/cm800993s
   Li Y, 2007, J AM CERAM SOC, V90, P3804, DOI 10.1111/j.1551-2916.2007.02057.x
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Liu X, 2009, J MATER SCI-MATER M, V20, P1237, DOI 10.1007/s10856-009-3691-7
   Liu X, 2009, J MATER SCI-MATER M, V20, P365, DOI 10.1007/s10856-008-3582-3
   NIELSEN FH, 1987, FASEB J, V1, P394
   NIELSEN FH, 1990, MAGNESIUM TRACE ELEM, V9, P61
   Nielsen FH, 2000, NUTRITION, V16, P512, DOI 10.1016/S0899-9007(00)00324-5
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Pan HB, 2009, CRYST GROWTH DES, V9, P3342, DOI 10.1021/cg900038k
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rizzoli R, 2005, J Endocrinol Invest, V28, P50
   Scharnweber T, 2008, MOLECULES, V13, P2729, DOI 10.3390/molecules13112729
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shirtliff VJ, 2003, J MATER SCI, V38, P4697, DOI 10.1023/A:1027414700111
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x
NR 33
TC 75
Z9 76
U1 2
U2 50
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUL 6
PY 2010
VL 7
IS 48
BP 1025
EP 1031
DI 10.1098/rsif.2009.0504
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 600MU
UT WOS:000277991600002
PM 20031984
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Chakravarty, R
   Shukla, R
   Ram, R
   Venkatesh, M
   Dash, A
   Tyagi, AK
AF Chakravarty, Rubel
   Shukla, Rakesh
   Ram, Ramu
   Venkatesh, Meera
   Dash, Ashutosh
   Tyagi, A. K.
TI Nanoceria-PAN Composite-Based Advanced Sorbent Material: A Major Step
   Forward in the Field of Clinical-Grade Ge-68/Ga-68 Generator
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nanocrystalline; ceria; nanocomposite; biomaterial; radiopharmaceuticals
ID POLYACRYLONITRILE BINDING MATRIX; INORGANIC-ION-EXCHANGERS; GA-68;
   SYSTEMS; SEPARATION; ADSORBENT; POLYMER; ROUTINE; OXIDE
AB The Ge-68/Ga-68 generator has high potential for clinical positron emission tomography (PET) imaging. However, because of the unavailability of a suitable sorbent material, the commercially available Ge-68/Ga-68 generators are not directly adaptable for the preparation of Ga-68-labeled radiopharmaceuticals. In view of this, a new nanoceria-polyacrylonitrile (PAN) composite sorbent has been synthesized by decomposition of a cerium oxalate precursor to cerium oxide and its subsequent incorporation in PAN matrix for the development of a clinical grade Ge-68/Ga-68 generator. The X-ray diffraction (XRD) studies and BET nitrogen adsorption technique revealed that nanocrystalline ceria had an average particle size of similar to 10 nm, surface area of 72 +/- 3 m(2)/g and an average pore size of 3.8 +/- 0.1 angstrom. Investigation of the distribution ratio (K-d) values for the prepared sorbent in 0.01 N HCl medium revealed the suitability of the sorbent for the quantitative retention of Ge-68 and efficient elution of clinical grade Ga-68. A 370 MBq (10 mCi) Ge-68/Ga-68 chromatographic generator was developed using this sorbent. Ga-68 could be regularly eluted from this generator with >80% elution yield. The eluted Ga-68 possess high radionuclidic purity (<1 x 10(-5)% of Ge-68 impurity), chemical purity (<0.1 ppm of Ce, Fe and Mn ions) and was amenable for the preparation of Ga-68-labeled radiopharmaceuticals. The generator gave a consistent performance with respect to the elution yield and purity of Ga-68 over an extended period of 7 months.
C1 [Chakravarty, Rubel; Venkatesh, Meera; Dash, Ashutosh] Bhabha Atom Res Ctr, Radiopharmaceut Div, Bombay 400085, Maharashtra, India.
   [Shukla, Rakesh; Tyagi, A. K.] Bhabha Atom Res Ctr, Div Chem, Bombay 400085, Maharashtra, India.
RP Dash, A (reprint author), Bhabha Atom Res Ctr, Radiopharmaceut Div, Bombay 400085, Maharashtra, India.
EM adash@barc.gov.in; aktyagi@barc.gov.in
OI Dash, Ashutosh/0000-0001-7541-7298
FU Radiochemistry and Isotope Group, Bhabha Atomic Research Centre
FX The authors are grateful to Prof. V. Venugopal, Director, Radiochemistry
   and Isotope Group, Bhabha Atomic Research Centre, for his support to
   this program. Thanks are due to Dr. Tapas Das and Dr, Sudipta
   Chakraborty, Radiopharmaceuticals Division, BARC, for their help in
   carrying out the radiolabeling experiments.
CR AARDANEH K, 2006, J RADIOANAL NUCL CH, V268, P25, DOI DOI 10.1007/S10967-006-0118-5
   ARINO H, 1978, INT J APPL RADIAT IS, V29, P117, DOI 10.1016/0020-708X(78)90035-2
   Asti M, 2008, NUCL MED BIOL, V35, P721, DOI 10.1016/j.nucmedbio.2008.04.006
   Azhdarinia A, 2007, NUCL MED BIOL, V34, P121, DOI 10.1016/j.nucmedbio.2006.10.011
   Bai XM, 2010, SCIENCE, V327, P1631, DOI 10.1126/science.1183723
   Bao B, 1996, J RADIOAN NUCL CH LE, V213, P233, DOI 10.1007/BF02163569
   Benhong C., 1998, J RADIOANAL NUCL CHE, V238, P175
   Breeman WAP, 2007, EUR J NUCL MED MOL I, V34, P978, DOI 10.1007/s00259-007-0387-4
   Chakravarty R, 2008, J NANOSCI NANOTECHNO, V8, P4447, DOI 10.1166/jnn.2008.280
   Chakravarty R, 2010, APPL RADIAT ISOTOPES, V68, P229, DOI 10.1016/j.apradiso.2009.10.031
   Chakravarty R, 2009, CHROMATOGRAPHIA, V69, P1363, DOI 10.1365/s10337-009-1070-7
   Chen HI, 2005, CERAM INT, V31, P795, DOI 10.1016/j.ceramint.2004.09.006
   Chengyun W., 1996, MAT SCI ENG B, V39, P160
   Czerwinski F, 1997, J SOL-GEL SCI TECHN, V9, P103, DOI 10.1007/BF02439341
   Decristoforo C, 2007, NUCL MED COMMUN, V28, P870, DOI 10.1097/MNM.0b013e3282f1753d
   EVEREST DA, 1954, J CHEM SOC, P2438, DOI 10.1039/jr9540002438
   Fani M, 2008, CONTRAST MEDIA MOL I, V3, P53, DOI 10.1002/cmmi.232
   GEBHARDT P, 2010, APPL RAD IS IN PRESS
   Kim HT, 2003, SEP SCI TECHNOL, V38, P695, DOI 10.1081/SS-120016660
   Leofanti G, 1998, CATAL TODAY, V41, P207, DOI 10.1016/S0920-5861(98)00050-9
   MCELVANY KD, 1984, INT J APPL RADIAT IS, V35, P521, DOI 10.1016/0020-708X(84)90174-1
   Meyer GJ, 2004, EUR J NUCL MED MOL I, V31, P1097, DOI 10.1007/s00259-004-1486-0
   Mirzadeh S, 1996, J RADIOAN NUCL CH AR, V203, P471, DOI 10.1007/BF02041524
   Nakayama M, 2003, APPL RADIAT ISOTOPES, V58, P9, DOI 10.1016/S0969-8043(02)00268-3
   NEIRINCKX RD, 1979, J NUCL MED, V20, P1075
   Nilchi A, 2007, APPL RADIAT ISOTOPES, V65, P482, DOI 10.1016/j.apradiso.2006.12.003
   Nilchi A, 2006, J HAZARD MATER, V137, P1271, DOI 10.1016/j.jhazmat.2006.04.043
   Pagou M, 2009, HELL J NUCL MED, V12, P102
   Pierroa DD, 2008, APPL RADIAT ISOTOPES, V66, P1091
   ROSE M, 1997, NUCL INSTRUM METH B, V119, P127
   Sebesta F, 1997, J RADIOANAL NUCL CH, V220, P77, DOI 10.1007/BF02035352
   SEBESTA F, 1995, 952729 SNL
   SHUO S, 1999, J DISPERSION SCI TEC, V20, P1247
   Vega I, 2006, REACT FUNCT POLYM, V66, P1609, DOI 10.1016/j.reactfunctpolym.2006.06.004
   Velikyan I, 2004, BIOCONJUGATE CHEM, V15, P554, DOI 10.1021/bc030078f
   WATERS SL, 1983, INT J APPL RADIAT IS, V34, P1023, DOI 10.1016/0020-708X(83)90086-8
   Xue TJ, 1997, POLYM DEGRAD STABIL, V58, P193, DOI 10.1016/S0141-3910(97)00048-7
   Zhernosekov KP, 2007, J NUCL MED, V48, P1741, DOI 10.2967/jnumed.107.040378
NR 38
TC 37
Z9 37
U1 3
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUL
PY 2010
VL 2
IS 7
BP 2069
EP 2075
DI 10.1021/am100325s
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 631SB
UT WOS:000280367000042
PM 20568699
DA 2018-10-19
ER

PT J
AU Stella, JA
   D'Amore, A
   Wagner, WR
   Sacks, MS
AF Stella, John A.
   D'Amore, Antonio
   Wagner, William R.
   Sacks, Michael S.
TI On the biomechanical function of scaffolds for engineering load-bearing
   soft tissues
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Tissue engineering; Mechanical behavior, Scaffold; Extracellular matrix
ID INDUCED PHASE-SEPARATION; STRUCTURAL CONSTITUTIVE MODEL; AORTIC-VALVE
   LEAFLET; MICROPOROUS MEMBRANE FORMATION; EXTRACELLULAR-MATRIX SYNTHESIS;
   BIAXIAL MECHANICAL-PROPERTIES; POPULATED COLLAGEN GELS;
   SMOOTH-MUSCLE-CELLS; HEART-VALVE; IN-VITRO
AB Replacement or regeneration of load-bearing soft tissues has long been the impetus for the development of bioactive materials. While maturing, current efforts continue to be confounded by our lack of understanding of the intricate multi-scale hierarchical arrangements and interactions typically found in native tissues. The current state of the art in biomaterial processing enables a degree of controllable microstructure that can be used for the development of model systems to deduce fundamental biological implications of matrix morphologies on cell function. Furthermore, the development of computational frameworks which allow for the simulation of experimentally derived observations represents a positive departure from what has mostly been an empirically driven field, enabling a deeper understanding of the highly complex biological mechanisms we wish to ultimately emulate. Ongoing research is actively pursuing new materials and processing methods to control material structure down to the micro-scale to sustain or improve cell viability, guide tissue growth, and provide mechanical integrity, all while exhibiting the capacity to degrade in a controlled manner. The purpose of this review is not to focus solely on material processing but to assess the ability of these techniques to produce mechanically sound tissue surrogates, highlight the unique structural characteristics produced in these materials, and discuss how this translates to distinct macroscopic biomechanical behaviors. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Stella, John A.; D'Amore, Antonio; Wagner, William R.; Sacks, Michael S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Swanson Sch Engn, Dept Chem Engn, Pittsburgh, PA 15219 USA.
   [Stella, John A.; D'Amore, Antonio; Wagner, William R.; Sacks, Michael S.] Univ Pittsburgh, Sch Med, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15219 USA.
   [D'Amore, Antonio] Univ Palermo, Dipartimento Meccan, I-90133 Palermo, Italy.
RP Sacks, MS (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 450 Technol Dr,Room 327, Pittsburgh, PA 15219 USA.
EM msacks@pitt.edu
RI Sacks, Michael/F-3703-2011; D'Amore, Antonio/E-7111-2012
OI D'Amore, Antonio/0000-0002-3151-3170
FU US National Institutes of Health [R01 HL68816, HL089750, R01 HL069368]
FX Funding for this work was provided by the US National Institutes of
   Health through Grant Nos. R01 HL68816, HL089750, and R01 HL069368.
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Atkinson PM, 2000, J MEMBRANE SCI, V175, P225, DOI 10.1016/S0376-7388(00)00422-1
   AUBERT JH, 1985, POLYMER, V26, P2047, DOI 10.1016/0032-3861(85)90186-7
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Balguid A, 2009, TISSUE ENG PT A, V15, P437, DOI 10.1089/ten.tea.2007.0294
   BARNES CP, 2007, ADV DRUG DELIV REV, V83, P408
   Bibekananda S., 2004, APPL PHYS LETT, V84, P1222
   BIDANDA B, 2008, VIRTUAL PROTOTYPING, V15, P299
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   Burd HJ, 2009, BIOMECH MODEL MECHAN, V8, P217, DOI 10.1007/s10237-008-0130-5
   Bursac N, 2003, TISSUE ENG, V9, P1243, DOI 10.1089/10763270360728152
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Butcher JT, 2008, J HEART VALVE DIS, V17, P62
   CANEBA GT, 1985, MACROMOLECULES, V18, P2538, DOI 10.1021/ma00154a031
   Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493
   Chen M, 2007, TISSUE ENG, V13, P579, DOI 10.1089/ten.2006.0205
   CHOI HS, 1990, J BIOMECH ENG-T ASME, V112, P153, DOI 10.1115/1.2891166
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Cui H, 2009, NANO LETT, V9, P945, DOI 10.1021/nl802813f
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   David G, 2007, J BIOMECH ENG-T ASME, V129, P97, DOI 10.1115/1.2401188
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Driessen NJB, 2005, J BIOMECH ENG-T ASME, V127, P494, DOI 10.1115/1.1894373
   Engelmayr GC, 2005, BIOMATERIALS, V26, P175, DOI 10.1016/j.biomaterials.2004.02.035
   Engelmayr GC, 2008, BIOMECH MODEL MECHAN, V7, P309, DOI 10.1007/s10237-007-0102-1
   Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045
   Engelmayr GC, 2006, J BIOMECH ENG-T ASME, V128, P610, DOI 10.1115/1.2205371
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Fink C, 2000, FASEB J, V14, P669
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Frey MW, 2007, J ENG FIBER FABR, V2, P31
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   FUNG YC, 1979, AM J PHYSIOL, V237, pH620
   FUNG YC, 1988, J APPL PHYSIOL, V64, P2132
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gilbert TW, 2006, J BIOMECH ENG-T ASME, V128, P890, DOI 10.1115/1.2354200
   Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Guan J, 2008, PHARM RES-DORDR, V25, P2400, DOI 10.1007/s11095-008-9628-x
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   Gupta V, 2006, CARDIOVASC RES, V72, P375, DOI 10.1016/j.cardiores.2006.08.017
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Holzapfel GA, 2006, J THEOR BIOL, V238, P290, DOI 10.1016/j.jtbi.2005.05.006
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Huang HYS, 2007, J BIOMECH ENG-T ASME, V129, P880, DOI 10.1115/1.2801670
   HUMPHREY JD, 1987, J BIOMECH ENG-T ASME, V109, P115, DOI 10.1115/1.3138652
   HUMPHREY JD, 1987, BIOPHYS J, V52, P563, DOI 10.1016/S0006-3495(87)83245-9
   Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333
   Isenberg BC, 2006, ANN BIOMED ENG, V34, P971, DOI 10.1007/s10439-006-9101-0
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462
   Johnson J, 2007, J APPL POLYM SCI, V104, P2919, DOI 10.1002/app.25965
   Kanit T, 2003, INT J SOLIDS STRUCT, V40, P3647, DOI 10.1016/S0020-7683(03)00143-4
   Karamichos D, 2007, J BIOMED MATER RES A, V83A, P887, DOI 10.1002/jbm.a.31423
   Khisaeva ZF, 2006, J ELASTICITY, V85, P153, DOI 10.1007/s10659-006-9076-y
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KOICHI M, 2003, J ORTHOP RES, V21, P139
   KULIK TJ, 1993, J CELL PHYSIOL, V157, P615, DOI 10.1002/jcp.1041570322
   Lanir Y, 1996, J BIOMECH ENG-T ASME, V118, P10, DOI 10.1115/1.2795935
   LANIR Y, 1994, J APPL MECH-T ASME, V61, P695, DOI 10.1115/1.2901516
   LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6
   Lebourg M, 2008, J MATER SCI-MATER M, V19, P2047, DOI 10.1007/s10856-007-3282-4
   Lee DA, 2004, METH MOLEC MED, V100, P307
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao J, 2008, BIOMATERIALS, V29, P1065, DOI 10.1016/j.biomaterials.2007.11.007
   Lips PAM, 2005, POLYMER, V46, P9396, DOI 10.1016/j.polymer.2005.07.052
   Liu J, 2009, PATTERN RECOGN LETT, V30, P103, DOI 10.1016/j.patrec.2008.02.011
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   LLOYD DR, 1990, J MEMBRANE SCI, V52, P239, DOI 10.1016/S0376-7388(00)85130-3
   LLOYD DR, 1991, J MEMBRANE SCI, V64, P1, DOI 10.1016/0376-7388(91)80073-F
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MARC S, 2007, POLYM ENG SCI, V47, P2020
   Marquez JP, 2005, BIOPHYS J, V88, P765, DOI 10.1529/biophysj.104.040808
   Marquez JP, 2005, BIOPHYS J, V88, P778, DOI 10.1529/biophysj.104.041947
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Matsumoto T, 2007, TISSUE ENG, V13, P207, DOI 10.1089/ten.2006.0058
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   Merryman WD, 2007, CARDIOVASC PATHOL, V16, P268, DOI 10.1016/j.carpath.2007.03.006
   MEYERS RA, 1995, MOL BIOL BIOTECHNOLO, V38, P1034
   Mol A, 2003, THORAC CARDIOV SURG, V51, P78, DOI 10.1055/s-2003-38993
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   MURAT E, 1998, ARTIF ORGANS, V22, P837
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   NEDOVIAC V, 2005, APPL CELL IMMOBILISA, V6, P573
   Neidert MR, 2006, TISSUE ENG, V12, P891, DOI 10.1089/ten.2006.12.891
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Pavia FC, 2008, J BIOMED MATER RES A, V86A, P459, DOI 10.1002/jbm.a.31621
   Pedicini A, 2003, POLYMER, V44, P6857, DOI 10.1016/j.polymer.2003.08.040
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   PREETHI LC, 2007, J BIOMECH ENG, V129, P137
   RACHEL G, 2000, BIOTECHNOL BIOENG, V67, P344
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Robinson PS, 2008, TISSUE ENG PT A, V14, P83, DOI 10.1089/ten.a.2007.0148
   Rockwood DN, 2007, J BIOMAT SCI-POLYM E, V18, P743, DOI 10.1163/156856207781034115
   Roeder BA, 2004, J BIOMECH ENG-T ASME, V126, P699, DOI 10.1115/1.1824127
   Rosner BI, 2005, EXP NEUROL, V195, P81, DOI 10.1016/j.expneurol.2005.04.003
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sacks MS, 2000, COMPUT MECH, V26, P243, DOI 10.1007/s004660000175
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   SACKS MS, 2003, FUNCTIONAL TISSUE EN
   SACKS MS, 1996, P 11 C ENG ENG ENG M
   Sander EA, 2009, J BIOMED MATER RES A, V88A, P322, DOI 10.1002/jbm.a.31847
   SARKADI B, 1991, BIOCHIM BIOPHYS ACTA, V1071, P407, DOI 10.1016/0304-4157(91)90005-H
   Schoen FJ, 1999, J HEART VALVE DIS, V8, P350
   Screen HRC, 2005, BIOCHEM BIOPH RES CO, V336, P424, DOI 10.1016/j.bbro.2005.08.102
   Seidel JO, 2004, BIORHEOLOGY, V41, P445
   Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095
   Shelton JC, 2003, CELLS TISSUES ORGANS, V175, P140, DOI 10.1159/000074630
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   Smith DB, 1999, J HEART VALVE DIS, V8, P25
   Song GB, 2007, COLLOID SURFACE B, V58, P271, DOI 10.1016/j.colsurfb.2007.04.001
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   STELLA JA, 2009, J BIOMED MAT RES
   Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029
   Stella JA, 2007, J BIOMECH, V40, P3169, DOI 10.1016/j.jbiomech.2007.04.001
   Stella JA, 2007, J BIOMECH ENG-T ASME, V129, P757, DOI 10.1115/1.2768111
   Stylianopoulos T, 2008, J MECH BEHAV BIOMED, V1, P326, DOI 10.1016/j.jmbbm.2008.01.003
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   TAYLOR G, 1966, PROC R SOC LON SER-A, V291, P145, DOI 10.1098/rspa.1966.0085
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   THOMAS B, 2003, ANAT REC PART A, V272, P497
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Thomopoulos S, 2005, J BIOMECH ENG-T ASME, V127, P742, DOI 10.1115/1.1992525
   Thomopoulos S, 2007, J BIOMECH ENG-T ASME, V129, P642, DOI [10.1115/1.2768104, 10.1115/1.2768378]
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   van der Meulen MCH, 2002, J BIOMECH, V35, P401, DOI 10.1016/S0021-9290(01)00184-1
   vandeWitte P, 1996, J MEMBRANE SCI, V113, P223, DOI 10.1016/0376-7388(95)00068-2
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   VESELY I, 1993, J BIOMECH, V26, P121, DOI 10.1016/0021-9290(93)90043-E
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z
   Williams C, 2006, TISSUE ENG, V12, P1489, DOI 10.1089/ten.2006.12.1489
   Xu W, 2008, J BIOACT COMPAT POL, V23, P103, DOI 10.1177/0883911507088271
   Yanagisawa M, 2007, LIFE SCI, V81, P405, DOI 10.1016/j.lfs.2007.06.004
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yarin AL, 2004, POLYMER, V45, P2977, DOI 10.1016/j.polymer.2004.02.066
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 180
TC 65
Z9 67
U1 1
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2010
VL 6
IS 7
BP 2365
EP 2381
DI 10.1016/j.actbio.2010.01.001
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 612AK
UT WOS:000278868000001
PM 20060509
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Guarnieri, D
   De Capua, A
   Ventre, M
   Borzacchiello, A
   Pedone, C
   Marasco, D
   Ruvo, M
   Netti, PA
AF Guarnieri, D.
   De Capua, A.
   Ventre, M.
   Borzacchiello, A.
   Pedone, C.
   Marasco, D.
   Ruvo, M.
   Netti, P. A.
TI Covalent immobilized RGD gradient on PEG hydrogel scaffold influences
   cell migration parameters
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell instructive materials; Hydrogels; Biological cues; Signal
   gradients; Cell migration
ID MICROPATTERN IMMOBILIZATION; FIBRONECTIN GRADIENTS; ADHESION PEPTIDE;
   GEL ASSAY; GROWTH; FIBRIN; CHEMOTAXIS; PROTEIN; BIOMATERIALS; ALIGNMENT
AB Understanding the influence of a controlled spatial distribution of biological cues on cell activities can be useful to design "cell instructive" materials, able to control and guide the formation of engineered tissues in vivo and in vitro. To this purpose, biochemical and mechanical properties of the resulting biomaterial must be carefully designed and controlled. In this work, the effect of covalently immobilized RGD peptide gradients on poly(ethylene glycol) diacrylate hydrogels on cell behaviour was studied. We set up a mechanical device generating gradients based on a fluidic chamber. Cell response to RGD gradients with different slope (0.7, 1 and 2 mM cm(-1)) was qualitatively and quantitatively assessed by evaluating cell adhesion and, in particular, cell migration, compared to cells seeded on hydrogels with uniform distribution of RGD peptides. To evaluate the influence of RGD gradient and to exclude any concentration effect on cell response, all analyses were carried out in a specific region of the gradients which displayed the same average concentration of RGD (1.5 mM). Results suggest that cells recognize the RGD gradient and adhere onto it assuming a stretched shape. Moreover, cells tend to migrate in the direction of the gradient, as their speed is higher than that of cells migrating on hydrogels with a uniform distribution of RGD and increases by increasing RGD gradient steepness. This increment is due to an augmentation of bias speed component of the mean squared speed, that is, the drift of the cell population migrating on the anisotropic surface provided by the RGD gradient. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Guarnieri, D.; De Capua, A.; Ventre, M.; Netti, P. A.] Univ Naples Federico 2, Interdisciplinary Res Ctr Biomat CRIB, I-80125 Naples, Italy.
   [Guarnieri, D.; De Capua, A.; Ventre, M.; Netti, P. A.] IIT, I-80125 Naples, Italy.
   [Borzacchiello, A.] CNR, Inst Biomed & Composite Mat, I-80125 Naples, Italy.
   [Pedone, C.; Ruvo, M.] CNR, Inst Biostruct & Bioimages, I-80134 Naples, Italy.
   [Pedone, C.; Ruvo, M.] Univ Naples Federico 2, I-80134 Naples, Italy.
   [Marasco, D.] Univ Naples Federico 2, Sect Biostruct, Dept Biol Sci, I-80134 Naples, Italy.
RP Netti, PA (reprint author), Univ Naples Federico 2, Interdisciplinary Res Ctr Biomat CRIB, I-80125 Naples, Italy.
EM nettipa@unina.it
RI Marasco, Daniela/H-4848-2015
OI Guarnieri, Daniela/0000-0002-0947-7724; Ventre,
   Maurizio/0000-0003-3375-9112; NETTI, PAOLO/0000-0002-2435-7181
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Bhangale SM, 2005, ADV MATER, V17, P809, DOI 10.1002/adma.200500547
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0
   Bryant SJ, 2008, PHARM RES-DORDR, V25, P2379, DOI 10.1007/s11095-008-9619-y
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Distasi C, 2002, EUR BIOPHYS J BIOPHY, V31, P81, DOI 10.1007/s00249-001-0194-y
   Dunn G A, 1983, Agents Actions Suppl, V12, P14
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   Ito Y, 2001, J BIOMAT SCI-POLYM E, V12, P367, DOI 10.1163/156856201750195270
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Kipper MJ, 2007, BIOPHYS J, V93, P1797, DOI 10.1529/biophysj.106.096800
   Kipper MJ, 2007, ANAL BIOCHEM, V363, P175, DOI 10.1016/j.ab.2007.01.036
   Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   NELSON RD, 1975, J IMMUNOL, V115, P1650
   Plummer ST, 2003, LANGMUIR, V19, P7528, DOI 10.1021/la030075r
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Sarvestani AS, 2009, BIOTECHNOL BIOENG, V103, P424, DOI 10.1002/bit.22273
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Smith JT, 2006, EXP CELL RES, V312, P2424, DOI 10.1016/j.yexcr.2006.04.005
   Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763
   STOKES CL, 1991, J CELL SCI, V99, P419
   Tranquillo R T, 1991, ASGSB Bull, V4, P75
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Walmod PS, 2001, METH MOL B, V161, P59
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 47
TC 86
Z9 86
U1 4
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2010
VL 6
IS 7
BP 2532
EP 2539
DI 10.1016/j.actbio.2009.12.050
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 612AK
UT WOS:000278868000019
PM 20051270
DA 2018-10-19
ER

PT J
AU Zaborowska, M
   Bodin, A
   Backdahl, H
   Popp, J
   Goldstein, A
   Gatenholm, P
AF Zaborowska, Magdalena
   Bodin, Aase
   Backdahl, Henrik
   Popp, Jenni
   Goldstein, Aaron
   Gatenholm, Paul
TI Microporous bacterial cellulose as a potential scaffold for bone
   regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bacterial cellulose; Porogen; MC3T3-E1; Bone tissue engineering;
   Mineralization
ID BIOMIMETIC SYNTHESIS; CELLS; DIFFERENTIATION; BIOMATERIALS;
   PROLIFERATION; CARTILAGE
AB Nanoporous cellulose biosynthesized by bacteria is an attractive biomaterial scaffold for tissue engineering due to its biocompatibility and good mechanical properties. However, for bone applications a microscopic pore structure is needed to facilitate osteoblast ingrowth and formation of a mineralized tissue. Therefore, in this study microporous bacterial cellulose (BC) scaffolds were prepared by incorporating 300-500 mu m paraffin wax microspheres into the fermentation process. The paraffin wax microspheres were subsequently removed, and scanning electron microscopy confirmed a microporous surface of the scaffolds while Fourier transform infrared spectroscopy verified the elimination of paraffin and tensile measurements showed a Young's modulus of approximately 1.6 MPa. Microporous BC and nanoporous (control) BC scaffolds were seeded with MC3T3-E1 osteoprogenitor cells, and examined by confocal microscopy and histology for cell distribution and mineral deposition. Cells clustered within the pores of microporous BC, and formed denser mineral deposits than cells grown on control BC surfaces. This work shows that microporous BC is a promising biomaterial for bone tissue engineering applications. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zaborowska, Magdalena; Bodin, Aase; Backdahl, Henrik; Gatenholm, Paul] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
   [Gatenholm, Paul] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.
   [Popp, Jenni; Goldstein, Aaron; Gatenholm, Paul] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
RP Gatenholm, P (reprint author), Chalmers, Dept Chem & Biol Engn, Kemivagen 4, SE-41296 Gothenburg, Sweden.
EM paul.gatenholm@chalmers.se
FU ICTAS; EU [NMP3-CT-2004-500283]
FX Financial support was received from ICTAS (at Virginia Tech) and EU
   Expertissues NMP3-CT-2004-500283. Thanks to Hector Martinez Avila,
   Behzad Damadzadeh, Daniel Kali, Sara Lundgren, Johan Sundberg, Nikolaj
   Vest, students at Chalmers who helped with Alizarin Red S staining.
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   BACKDAHL H, 2008, J TISSUE ENG REGEN M, V1, P22
   BODIN A, 2006, MODERN MULTIDISCIPLI
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Dee KC, 2003, INTRO TISSUE BIOMATE
   Deng HW, 2005, CURRENT TOPICS IN BONE BIOLOGY, P1, DOI 10.1142/9789812701176
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fang B, 2009, TISSUE ENG PT A, V15, P1091, DOI 10.1089/ten.tea.2008.0110
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FRESHNEY RI, 2000, BIOL CULTURED CELLS
   Goldstein AS, 2001, TISSUE ENG, V7, P817, DOI 10.1089/107632701753337753
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Langer R, 2000, AICHE J, V46, P1286, DOI 10.1002/aic.690460702
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030
   Palsson B.O., 2004, TISSUE ENG
   Rambo CR, 2008, MAT SCI ENG C-BIO S, V28, P549, DOI 10.1016/j.msec.2007.11.011
   Ratner BD, 2004, BIOMATERIALS SCI INT
   SALGADO AJ, 2004, MACROMOL BIOSCI, V743, P765
   Smith LA, 2009, BIOMATERIALS, V30, P2516, DOI 10.1016/j.biomaterials.2009.01.009
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
NR 35
TC 128
Z9 139
U1 7
U2 96
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2010
VL 6
IS 7
BP 2540
EP 2547
DI 10.1016/j.actbio.2010.01.004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 612AK
UT WOS:000278868000020
PM 20060935
OA Green Published
DA 2018-10-19
ER

PT J
AU Faxalv, L
   Ekblad, T
   Liedberg, B
   Lindahl, TL
AF Faxalv, Lars
   Ekblad, Tobias
   Liedberg, Bo
   Lindahl, Tomas L.
TI Blood compatibility of photografted hydrogel coatings
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Biomaterial; Protein adsorption; Coagulation; Platelet
ID VON-WILLEBRAND-FACTOR; PROTEIN ADSORPTION; PLATELET-ADHESION;
   POLY(ETHYLENE GLYCOL); WHOLE-BLOOD; POLY(2-HYDROXYETHYL METHACRYLATE);
   PROCOAGULANT ACTIVITY; ADHERENT PLATELETS; CONTACT ACTIVATION; POLYMER
   SURFACES
AB In this work, we have evaluated the haemocompatibility of different surface modifications, intended for biomaterials and bioanalytical applications. Polystyrene slides were coated with thin hydrogel films by self-initiated photografting and photopolymerization (SIPGP) of four different monomers. The hydrogel surface modifications were thoroughly characterized and tested for their protein resistance and ability to resist platelet adhesion and activation of the coagulation system. There was very little protein adsorption from human plasma on the hydrogels prepared from poly(ethylene glycol) methacrylate and 2-hydroxyethyl methacrylate. Platelet adhesion tests performed under both static and flow conditions showed that these coatings also demonstrated very high resistance towards platelet adhesion. A small amount of platelets were found to adhere to hydrogels formed from ethylene glycol methyl ether methacrylate and 2-carboxyethyl methacrylate. The polystyrene substrates themselves facilitated large amounts of platelet adhesion under both static and flow conditions. Utilizing a novel setup for imaging of coagulation, it was confirmed that none of the hydrogel surfaces activated the coagulation system to any great extent. We suggest that this simple fabrication method can be used to produce hydrogel coatings with unusually high blood compatibility, suitable for demanding biomaterials applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Faxalv, Lars; Lindahl, Tomas L.] Linkoping Univ, Div Clin Chem, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.
   [Ekblad, Tobias; Liedberg, Bo] Linkoping Univ, Div Mol Phys, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden.
RP Faxalv, L (reprint author), Linkoping Univ, Div Clin Chem, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.
EM lars.faxalv@liu.se
RI Liedberg, Bo/N-6093-2014
FU Materials in Medicine, County Council of Ostergotland and Linkoping
   University, Sweden; EC; VR the Swedish Research Council
FX This work was supported by the strategic initiative Materials in
   Medicine, County Council of Ostergotland and Linkoping University,
   Sweden (L.F., T.L.), the EC FP 6 NMP program AMBIO (Advanced
   Nanostructured Surfaces for the Control of Biofouling) (T.E., B.L.), and
   VR the Swedish Research Council (T.E., B.L.).
CR Andersson O, 2009, BIOMACROMOLECULES, V10, P142, DOI 10.1021/bm801029b
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032
   CASTILLO EJ, 1984, BIOMATERIALS, V5, P319, DOI 10.1016/0142-9612(84)90029-2
   Deng JP, 2001, MACROMOL RAPID COMM, V22, P535, DOI 10.1002/1521-3927(20010401)22:7<535::AID-MARC535>3.0.CO;2-3
   Ekblad T, 2008, BIOMACROMOLECULES, V9, P2775, DOI 10.1021/bm800547m
   FAXALV L, 2007, J BIOMED MATER RES, V85, P1129
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30
   Johansson BL, 2002, J APPL POLYM SCI, V86, P2618, DOI 10.1002/app.11209
   Larsson A, 2002, J COLLOID INTERF SCI, V246, P214, DOI 10.1006/jcis.2001.8032
   Larsson A, 2007, LANGMUIR, V23, P11319, DOI 10.1021/la700729q
   Larsson A, 2007, BIOMACROMOLECULES, V8, P287, DOI 10.1021/bm060685g
   LOPEZ GP, 1993, MACROMOLECULES, V26, P3247, DOI 10.1021/ma00065a001
   McArthur SL, 2001, BIOMATERIALS, V22, P3295, DOI 10.1016/S0142-9612(01)00166-1
   Pyun J, 2003, MACROMOL RAPID COMM, V24, P1043, DOI 10.1002/marc.200300078
   Ramstrom S, 2003, THROMB HAEMOSTASIS, V89, P132
   Schmelmer U, 2004, MACROMOL SYMP, V217, P223, DOI 10.1002/masy.200451318
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   Steenackers M, 2007, J AM CHEM SOC, V129, P15655, DOI 10.1021/ja075378c
   Steenackers M, 2009, LANGMUIR, V25, P2225, DOI 10.1021/la803386c
   Steigert J, 2006, LAB CHIP, V6, P1040, DOI 10.1039/b607051p
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Wang HL, 2004, MACROMOL RAPID COMM, V25, P1095, DOI 10.1002/marc.200400010
   Wang J, 2005, SURF COAT TECH, V196, P307, DOI 10.1016/j.surfcoat.2004.08.161
   West J, 2007, LAB CHIP, V7, P981, DOI 10.1039/b706788g
   YASUDA T, 1994, LANGMUIR, V10, P2435, DOI 10.1021/la00019a068
   Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhou Y, 2004, MICROCHIM ACTA, V146, P193, DOI 10.1007/s00604-003-0174-2
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 38
TC 29
Z9 29
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2010
VL 6
IS 7
BP 2599
EP 2608
DI 10.1016/j.actbio.2009.12.046
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 612AK
UT WOS:000278868000027
PM 20045090
DA 2018-10-19
ER

PT J
AU Kou, PM
   Babensee, JE
AF Kou, Peng Meng
   Babensee, Julia E.
TI Validation of a high-throughput methodology to assess the effects of
   biomaterials on dendritic cell phenotype
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Dendritic cells; Biomaterials; High-throughput screening; Tissue
   engineering; Vaccine delivery
ID POLY(LACTIC-CO-GLYCOLIC ACID); IMMUNE-RESPONSES; ANTIGEN PRESENTATION;
   B-LYMPHOCYTES; IN-VITRO; DC-SIGN; MATURATION; RECEPTOR; CD1;
   DIFFERENTIATION
AB A variety of combination products composed of biomaterials and biologics have been developed for tissue regeneration or vaccine delivery. The host immune response to the immunogenic biological components in such products may be modulated by the biomaterial component. Distinct biomaterials have been shown to differentially affect the maturation of dendritic cells (DCs). DCs are professional antigen-presenting cells (APCs) that bridge innate and adaptive immunity and play a central role in inducing immunity or initiating immune tolerance. However, the biomaterials systems used to study DC response thus far have been insufficient to draw a clear conclusion as to which biomaterial properties are the key to controlling DC phenotype. In this study, we developed a 96-well filter plate-based high-throughput (HTP) methodology to assess DC maturation upon biomaterial treatment. Equivalent biomaterial effects on DC phenotype were measured using the conventional flow cytometric and filter-plate method, which validated the HTP methodology. This methodology will be used to screen a large number of biomaterials simultaneously and to draw correlations between material properties and DC phenotype, thereby providing biomaterial design criteria and immunomodulatory strategies for both tissue engineering and vaccine delivery applications. (C) 2010 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU Wallace H. Coulter GT/Emory-PKU BME Collaborative Research Seed;
   National Institutes of Health [1RO1 EB004633-01A1]
FX The authors thank Drs. Philip Santangelo, Andres J. Garcia and Barbara
   Boyan for helpful discussions. The project was supported by a Wallace H.
   Coulter GT/Emory-PKU BME Collaborative Research Seed Grant and by the
   National Institutes of Health Grant 1RO1 EB004633-01A1
CR Alving C.R., 2002, VACCINE, V20, P56
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bayry J, 2005, J IMMUNOL, V175, P15, DOI 10.4049/jimmunol.175.1.15
   Bayry J, 2004, P NATL ACAD SCI USA, V101, P14210, DOI 10.1073/pnas.0402183101
   Beckman EM, 1996, J IMMUNOL, V157, P2795
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608
   Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Cao XC, 2002, J IMMUNOL, V169, P4770, DOI 10.4049/jimmunol.169.9.4770
   Folzenlogen D, 1997, CLIN IMMUNOL IMMUNOP, V83, P199, DOI 10.1006/clin.1997.4353
   Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6
   Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   Gordon EM, 1996, ACCOUNTS CHEM RES, V29, P144, DOI 10.1021/ar950170u
   Greenwalt DE, 2001, J BIOMOL SCREEN, V6, P383, DOI 10.1177/108705710100600604
   GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O
   Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200
   JANEWAY CA, 1999, CURR BIOL, V9, P879
   JANSEN JH, 1989, J EXP MED, V170, P577, DOI 10.1084/jem.170.2.577
   Jeannin P, 1997, J BIOL CHEM, V272, P15613, DOI 10.1074/jbc.272.25.15613
   Jefford M, 2003, BLOOD, V102, P1753, DOI 10.1182/blood-2002-12-3854
   Jotwani R, 2003, EUR J IMMUNOL, V33, P2980, DOI 10.1002/eji.200324392
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Kaser A, 2000, J IMMUNOL, V165, P2474, DOI 10.4049/jimmunol.165.5.2474
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kwissa M, 2007, EXPERT REV VACCINES, V6, P673, DOI 10.1586/14760584.6.5.673
   Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Mei Y, 2006, J BIOMED MATER RES A, V79A, P974, DOI 10.1002/jbm.a.30883
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8
   Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83
   Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056
   Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P791, DOI 10.1002/jbm.a.32406
   Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746
   Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Sozzani S, 1997, FEBS LETT, V418, P98, DOI 10.1016/S0014-5793(97)01358-6
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153
   Woltman AM, 2004, J IMMUNOL, V172, P6482, DOI 10.4049/jimmunol.172.10.6482
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
NR 54
TC 13
Z9 13
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2010
VL 6
IS 7
BP 2621
EP 2630
DI 10.1016/j.actbio.2010.01.023
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 612AK
UT WOS:000278868000029
PM 20097314
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Santos, HA
   Riikonen, J
   Salonen, J
   Makila, E
   Heikkila, T
   Laaksonen, T
   Peltonen, L
   Lehto, VP
   Hirvonen, J
AF Santos, Helder A.
   Riikonen, Joakim
   Salonen, Jarno
   Makila, Ermei
   Heikkila, Teemu
   Laaksonen, Timo
   Peltonen, Leena
   Lehto, Vesa-Pekka
   Hirvonen, Jouni
TI In vitro cytotoxicity of porous silicon microparticles: Effect of the
   particle concentration, surface chemistry and size
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Porous silicon; Microparticles; Cytotoxicity; Oral drug delivery; Caco-2
   cells
ID ORAL-DRUG DELIVERY; MESOPOROUS SILICON; CELLS; MACROPHAGES; TOXICITY;
   MODEL; NANOPARTICLES; BIOMATERIAL; MOLECULES; ACETYLENE
AB We report here the in vitro cytotoxicity of mesoporous silicon (PSI) microparticles on the Caco-2 cells as a function of particle size fractions (1.2-75 mu m), particle concentration (0.2-4 mg ml(-1)) and incubation times (3, 11 and 24 h). The particle size (smaller PSI particles showed higher cytotoxicity) and the surface chemistry treatment of the PSi microparticles were considered to be the key factors regarding the toxicity aspects. These effects were significant after the 11 and 24 h exposure times, and were explained by cell-particle interactions involving mitochondrial disruption resulting from ATP depletion and reactive oxygen species production induced by the PSi surface. These events further induced an increase in cell apoptosis and consequent cell damage and cell death in a dose-dependent manner and as a function of the PSi particle size. These effects were, however, less pronounced with thermally oxidized PSi particles. Under the experimental conditions tested and at particle sizes >25 mu m, the non-toxic threshold concentration for thermally hydrocarbonized and carbonized PSi particles was <2 mg ml(-1), and for thermally oxidized PSI microparticles was <4 mg ml(-1). (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Santos, Helder A.; Laaksonen, Timo; Peltonen, Leena; Hirvonen, Jouni] Univ Helsinki, Fac Pharm, Div Pharmaceut Technol, FI-00014 Helsinki, Finland.
   [Riikonen, Joakim; Lehto, Vesa-Pekka] Univ Kuopio, Dept Phys, FI-70211 Kuopio, Finland.
   [Salonen, Jarno; Makila, Ermei; Heikkila, Teemu] Univ Turku, Dept Phys, Lab Ind Phys, FI-20014 Turku, Finland.
RP Santos, HA (reprint author), Univ Helsinki, Fac Pharm, Div Pharmaceut Technol, FI-00014 Helsinki, Finland.
EM helder.santos@helsinki.fi
RI Riikonen, Joakim/A-6217-2010; Santos, Helder/B-5253-2009; Laaksonen,
   Timo/C-7141-2009
OI Riikonen, Joakim/0000-0002-5304-9479; Santos,
   Helder/0000-0001-7850-6309; Makila, Ermei/0000-0002-8300-6533;
   Laaksonen, Timo/0000-0002-6699-3004
FU Academy of Finland [127099, 123037, 122314]; University of Helsinki
FX Academy of Finland (Grants Numbers 127099, 123037 and 122314) and
   University of Helsinki Research Funds.
CR Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x
   Buriak J.M., 2002, CHEM REV, V102, P1272
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Choi J, 2009, J APPL TOXICOL, V29, P52, DOI 10.1002/jat.1382
   Delie F, 1997, CRIT REV THER DRUG, V14, P221
   Fenoglio I, 2000, CHEM RES TOXICOL, V13, P489, DOI 10.1021/tx990169u
   Foraker AB, 2003, PHARMACEUT RES, V20, P110, DOI 10.1023/A:1022211127890
   Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7
   Fujii M., 2006, J APPL PHYS, V100
   GROSS E, 2003, PHYS REV B, V68
   Halliwell B., 1991, AM J MED S3C, V91, P14, DOI DOI 10.1016/0002-9343(91)90279-7
   Heikkila T, 2007, DRUG DELIV, V14, P337, DOI 10.1080/10717540601098823
   IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616
   Jiang J, 2009, BIOMATERIALS, V30, P2661, DOI 10.1016/j.biomaterials.2009.01.044
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kaukonen AM, 2007, EUR J PHARM BIOPHARM, V66, P348, DOI 10.1016/j.ejpb.2006.11.021
   Kilpelainen M, 2009, J CONTROL RELEASE, V137, P166, DOI 10.1016/j.jconrel.2009.03.017
   Laaksonen T, 2007, CHEM RES TOXICOL, V20, P1913, DOI 10.1021/tx700326b
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577
   Padera RF, 1996, BIOMATERIALS, V17, P277, DOI 10.1016/0142-9612(96)85565-7
   Reffitt DM, 1999, J INORG BIOCHEM, V76, P141, DOI 10.1016/S0162-0134(99)00126-9
   Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238
   Riikonen J, 2009, LANGMUIR, V25, P6137, DOI 10.1021/la804055s
   Rosengren A, 2000, PHYS STATUS SOLIDI A, V182, P527, DOI 10.1002/1521-396X(200011)182:1<527::AID-PSSA527>3.0.CO;2-K
   Salonen J, 2005, PHYS STATUS SOLIDI A, V202, P1629, DOI 10.1002/pssa.200461204
   Salonen J, 2005, J CONTROL RELEASE, V108, P362, DOI 10.1016/j.jconrel.2005.08.017
   Salonen J, 2004, APPL SURF SCI, V225, P389, DOI 10.1016/j.apsusc.2003.10.028
   Salonen J, 2002, J APPL PHYS, V91, P456, DOI 10.1063/1.1421221
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019
   Thibodeau M, 2003, TOXICOL SCI, V76, P91, DOI 10.1093/toxsci/kfg178
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Wang SZ, 2004, J MATER CHEM, V14, P487, DOI 10.1039/b311429e
   Wu EC, 2008, ACS NANO, V2, P2401, DOI 10.1021/nn800592q
   Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.0.CO;2-H
NR 43
TC 103
Z9 103
U1 1
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2010
VL 6
IS 7
BP 2721
EP 2731
DI 10.1016/j.actbio.2009.12.043
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 612AK
UT WOS:000278868000041
PM 20036766
DA 2018-10-19
ER

PT J
AU Paulo, NM
   Malmonge, SM
   de Menezes, LB
   de Lima, FG
   Faria, AD
   Andrasckho, MM
   Moreira, NM
   Atayde, IB
   Silva, MSDE
AF Paulo, Neusa Margarida
   Malmonge, Sonia Maria
   de Menezes, Liliana Borges
   de Lima, Flavia Gontijo
   Faria, Aline de Moraes
   Andrasckho, Mariana Moreira
   Moreira, Natalia Menezes
   Atayde, Ingrid Bueno
   Silva, Marcelo Seixo de Brito E.
TI Evaluation of peritoneal adhesions formation and tissue response to
   polypropylene - poli (2-hydroxyethyl methacrylate)-(polyHEMA) implant on
   rats' abdominal wall
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Peritoneum; Tissue Adhesions; Hydrogel; Polymers; Surgical Mesh;
   Polypropylenes; Biocompatible Materials; Rats
ID MESH; BIOMATERIALS; PREVENTION; REPAIR; MODEL
AB Purpose: To verify if the composit poli (2-hydroxyethyl methacrylate)-PolyHEMA/polypropylene mesh implanted in the female rat's abdominal wall could be suitable for the prevention of peritoneal adhesions, and for the evaluation of the tecidual response produced by this biomaterial. Methods: Polypropylene meshes (Group PP, n=20) and polypropylene meshes coated with a layer of poli (2-hydroxyethyl methacrylate)-PolyHEMA (Group PH, n=20) were implanted on the abdominal wall of Wistar female rats. Ten animals from each group were submitted to euthanasia at 15 and 30 days of the postoperative period. Results: The animals from the group PP presented visceral adhesions on the mesh surface, which was not observed in the ones from group PH. At the histopathological examination foreign body response was observed in both groups, whilst there was a greater intensity of inflammatory response in group PH on both moments. Conclusion: The poli (2-hydroxyethyl methacrylate) polyHEMA hydrogel associated to polypropylene mesh reduces visceral adhesion formation in rats, although it may be associated to greater inflammatory reaction.
C1 [Paulo, Neusa Margarida] Univ Fed Goias, Escola Vet, Dept Vet Med, BR-74001970 Goiania, Go, Brazil.
   [Malmonge, Sonia Maria] Fed Univ ABC, Ctr Engn Modeling & Socials Applies Sci, Santo Andre, SP, Brazil.
   [de Menezes, Liliana Borges] Univ Fed Goias, Dept Microbiol Immunol Parasitol & Pathol, IPTSP, BR-74001970 Goiania, Go, Brazil.
   [de Lima, Flavia Gontijo] Univ Fed Goias, Postgrad Program Anim Sci, Sch Vet, BR-74001970 Goiania, Go, Brazil.
   [Faria, Aline de Moraes; Andrasckho, Mariana Moreira; Moreira, Natalia Menezes] Univ Fed Goias, Sch Vet Med, BR-74001970 Goiania, Go, Brazil.
   [Atayde, Ingrid Bueno] UNIP, Anim Physiol, Goiania, Go, Brazil.
   [Silva, Marcelo Seixo de Brito E.] Univ Fed Goias, Dept Morphol, BR-74001970 Goiania, Go, Brazil.
RP Paulo, NM (reprint author), Univ Fed Goias, Escola Vet, Dept Vet Med, BR-74001970 Goiania, Go, Brazil.
EM nmp@vet.ufg.br
RI Biofabris, Inct/I-2418-2013; Malmonge, Sonia/I-4610-2012
FU CNPQ
FX Financial source: CNPQ
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Bellon JM, 2001, WORLD J SURG, V25, P147, DOI 10.1007/s002680020069
   Bellon JM, 1998, BIOMATERIALS, V19, P669, DOI 10.1016/S0142-9612(97)00162-2
   Borrazzo E C, 2004, Hernia, V8, P108, DOI 10.1007/s10029-003-0181-6
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Dinsmore RC, 2000, J AM COLL SURGEONS, V191, P131, DOI 10.1016/S1072-7515(00)00337-9
   Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004
   Greca F H, 2001, Hernia, V5, P59
   Hsiue GH, 2001, BIOMATERIALS, V22, P1763, DOI 10.1016/S0142-9612(00)00336-7
   Klinge U, 1999, EUR J SURG, V165, P665
   Losanoff J E, 2002, Hernia, V6, P144
   Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Sahin M, 2007, INFLAMMATION, V30, P244, DOI 10.1007/s10753-007-9043-1
   Suh H, 2000, YONSEI MED J, V41, P681, DOI 10.3349/ymj.2000.41.6.681
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   Vural B, 1999, HUM REPROD, V14, P49, DOI 10.1093/humrep/14.1.49
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
NR 18
TC 5
Z9 5
U1 0
U2 5
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD JUL-AUG
PY 2010
VL 25
IS 4
BP 337
EP 341
DI 10.1590/S0102-86502010000400007
PG 5
WC Surgery
SC Surgery
GA 634TC
UT WOS:000280607200006
PM 20676491
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Ozturkmen, Y
   Caniklioglu, M
   Karamehmetoglu, M
   Sukur, E
AF Ozturkmen, Yusuf
   Caniklioglu, Mustafa
   Karamehmetoglu, Mahmut
   Sukur, Erhan
TI Calcium phosphate cement augmentation in the treatment of depressed
   tibial plateau fractures with open reduction and internal fixation
SO ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA
LA English
DT Article
DE Calcium phosphate cement; fracture fixation; internal/open reduction;
   tibia fractures/plateau/surgery
ID BONE-GRAFT SUBSTITUTE; ALLOGRAFT; SULFATE; DEFECTS
AB Objectives: We aimed to evaluate the clinical and radiological outcomes of open reduction and internal fixation augmented with calcium phosphate cement (CPC) in the treatment of depressed tibial plateau fractures.
   Methods: Twenty-eight knees of 28 patients [19 males and 9 females; mean age, 41.2 years (range 22-72 years)] who had open reduction and internal fixation combined with CPC augmentation were included in this study. Seventeen fractures were Schatzker type II, 5 were type HI, 3 were type IV, 2 were type V, and 1 was type VI. CPC was used to fill the subchondral bone defects in all knees. Fixation of the fragments was done with screws in 3 knees (10%). Standard proximal tibial plates or buttress plates were used in 25 knees (90%) with an additional split fragment extending distally to achieve internal fixation. Full weight-bearing was allowed in 6.4 weeks (range 6-12 weeks) after surgery. Resorption of CPC granules was defined as the decrease in the size and density of grafting material on radiographs. Rasmussen's radiological and clinical scores were determined postoperatively. Functionality was assessed with Lysholm knee scoring system. Activity was graded with Tegner's activity scale.
   Results: Union was achieved in all patients with a mean follow-up of 22.2 months (range 6-36 months). There were no intraoperative complications. At the latest follow-up radiographs, resorption of the graft was observed in 25 knees (89%). Rasmussen's radiologic score was excellent in 17 patients (61%), good in 9 patients (32%), and fair in 2 patients (7%). Rasmussen's clinical score was excellent in 9 patients (32%), good in 18 patients (64%), and fair in 1 patient (4%). According to the Lysholm knee score, functional results were excellent in 16 patients (57%), good in 8 patients (29%), and fair in 4 patients (14%). Twenty-two patients (78%) achieved the preoperative activity level after surgery, and there was no significant difference between the mean preoperative and postoperative Tegner scores (4.11 +/- 0.68 and 4.04 +/- 0.64, respectively, p=0.161).
   Conclusion: CPC is a safe biomaterial with many advantages in augmenting the open reduction and internal fixation of depressed tibial plateau fractures, including elimination of morbidity associated with bone graft harvesting, the unlimited supply of bone substitute, the optimum filling of irregular bone defects, and shortening of the postoperative full weight-bearing time.
C1 [Ozturkmen, Yusuf; Caniklioglu, Mustafa; Karamehmetoglu, Mahmut; Sukur, Erhan] Istanbul Training & Res Hosp, Minist Hlth, Dept Orthoped & Traumatol, Istanbul, Turkey.
RP Ozturkmen, Y (reprint author), Atakoy 7-8 Kisim,Mimar Sinan Sitesi,L4 Blok,Daire, TR-34159 Istanbul, Turkey.
EM yozturkmen@yahoo.com.tr
CR Bajammal SS, 2008, J BONE JOINT SURG AM, V90A, P1186, DOI 10.2106/JBJS.G.00241
   Bansal MR, 2009, INT ORTHOP, V33, P779, DOI 10.1007/s00264-008-0526-y
   Ceyhan Taskin, 2007, Acta Orthop Traumatol Turc, V41, P307
   Duwelius PJ, 1997, CLIN ORTHOP RELAT R, P47
   EGOL KA, 2006, FRACTURE ADULTS, V2, P1999
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Horstmann WG, 2003, INJURY, V34, P141, DOI 10.1016/S0020-1383(02)00105-5
   Keating JF, 2003, J BONE JOINT SURG BR, V85B, P68, DOI 10.1302/0301-620X.85B1.12575
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   LACHIEWICZ PF, 1990, CLIN ORTHOP RELAT R, P210
   LARSSON S, 2002, CLIN ORTHOP RELAT R, V395, P23
   Lasanianos N, 2008, INJURY, V39, P1106, DOI 10.1016/j.injury.2008.04.005
   Lind-Hansen T, 2009, KNEE SURG SPORT TR A, V17, P1425, DOI 10.1007/s00167-009-0862-5
   Lobenhoffer P, 2002, J ORTHOP TRAUMA, V16, P143, DOI 10.1097/00005131-200203000-00001
   Manzotti A, 2006, ARCH ORTHOP TRAUM SU, V126, P594, DOI 10.1007/s00402-006-0127-4
   Musahl V, 2009, J BONE JOINT SURG BR, V91B, P426, DOI 10.1302/0301-620X.91B4.20966
   RASMUSSEN PS, 1973, J BONE JOINT SURG AM, VA 55, P1331, DOI 10.2106/00004623-197355070-00001
   Russell TA, 2008, J BONE JOINT SURG AM, V90A, P2057, DOI 10.2106/JBJS.G.01191
   Schildhauer TA, 2000, J ORTHOP TRAUMA, V14, P309, DOI 10.1097/00005131-200006000-00001
   Segur JM, 1998, ARCH ORTHOP TRAUM SU, V117, P357, DOI 10.1007/s004020050265
   Shen C, 2009, KNEE SURG SPORT TR A, V17, P1406, DOI 10.1007/s00167-009-0726-z
   Simpson D, 2004, INJURY, V35, P913, DOI 10.1016/S0020-1383(03)00109-8
   SIMSEK A, 2004, TOTBID DERGISI, V3, P79
   TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43
   Trenholm A, 2005, J ORTHOP TRAUMA, V19, P698, DOI 10.1097/01.bot.0000183455.01491.bb
   Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a
   Welch RD, 2003, J BONE JOINT SURG AM, V85A, P222, DOI 10.2106/00004623-200302000-00007
   Wheeler DL, 2005, J ORTHOP TRAUMA, V19, P85, DOI 10.1097/00005131-200502000-00003
   Whittle AP, 2003, CAMPBELLS OPERATIVE, V3, P2725
   Wu Wei, 2006, Ulus Travma Acil Cerrahi Derg, V12, P268
   Yetkinler DN, 2001, J ORTHOP TRAUMA, V15, P197, DOI 10.1097/00005131-200103000-00009
   YU B, 2009, INT ORTHOP, V33, P127
NR 32
TC 18
Z9 20
U1 1
U2 7
PU TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY
PI ISTANBUL
PA TIP FAKULTESI ORTOPEDI VE TRAVMATOLOJI KLINIGI, ISTANBUL, TOPKAPI 34390,
   TURKEY
SN 1017-995X
J9 ACTA ORTHOP TRAUMATO
JI Acta Orthop. Traumatol. Turc.
PD JUL-AUG
PY 2010
VL 44
IS 4
BP 262
EP 269
DI 10.3944/AOTT.2010.2406
PG 8
WC Orthopedics
SC Orthopedics
GA 729IP
UT WOS:000287942400003
PM 21252602
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Wang, ZK
   Hu, QL
AF Wang Zheng-Ke
   Hu Qiao-Ling
TI Chitosan Rods Reinforced by N-Carboxyl Propionyl Chitosan Sodium
SO ACTA PHYSICO-CHIMICA SINICA
LA English
DT Article
DE Chitosan; N-Carboxyl propionyl chitosan sodium; Composite;
   Reinforcement; Biomaterial
ID IN-SITU PRECIPITATION; INTERNAL-FIXATION; BONE-FRACTURE
AB N-carboxyl propionyl chitosan sodium (CPCS) was used to reinforce chitosan (CS) rods by an in-situ precipitation method. Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), thermogravimetric (TG) analysis, scanning electron microscopy (SEM), and mechanical test were used to study the properties of the composite rods. The FTIR spectra confirmed that the amino and acetamido groups on CS had a strong electrostatic attraction to the carboxylate groups on CPCS. The XRD patterns showed that the crystals in CS were destroyed because of the addition of CPCS. The thermal stability of the CPCS/CS composite rods was better than those of pure CS rods and pure CPCS as a strong interaction exists between CS and CPCS molecules. The layer. by. layer structure of the CPCS/CS composite rods became tighter compared with that of pure CS rods, which resulted in improved mechanical properties for the composite rods. As 15% (w) CPCS in the composite rods, the bending strength and the bending modulus were 156.0 MPa and 5.3 GPa, which increased by 68.8% and 29.3% compared with that of pure CS rods, respectively. Therefore, CPCS reinforces CS rods effectively and these composite rods with excellent mechanical properties can be used in novel biomedical devices to fix the bone fracture.
C1 [Wang Zheng-Ke; Hu Qiao-Ling] Zhejiang Univ, Dept Polymer Sci & Engn, Inst Biomed Macromol, Key Lab Macromol Synth & Functionalizat,Minist Ed, Hangzhou 310027, Peoples R China.
RP Hu, QL (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Inst Biomed Macromol, Key Lab Macromol Synth & Functionalizat,Minist Ed, Hangzhou 310027, Peoples R China.
EM huql@zju.edu.cn
RI Wang, Zhengke/D-7691-2013
OI Wang, Zhengke/0000-0002-1474-1075
FU National Natural Science Foundation of China [50773070]; National Key
   Basic Research Program of China (973) [2005CB623902]; Grand Science and
   Technology Special Project of Zhejiang Province, China [2008C11087]
FX The project was supported by the National Natural Science Foundation of
   China (50773070), National Key Basic Research Program of China (973)
   (2005CB623902) and Grand Science and Technology Special Project of
   Zhejiang Province, China (2008C11087).
CR CHANG J, 2007, J FUNCTIONAL MAT, V38, P1839
   Chen FP, 2006, ACTA POLYM SIN, P756
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   El-Shafei AM, 2008, J APPL POLYM SCI, V110, P1289, DOI 10.1002/app.28352
   Hu QL, 2003, CHEM J CHINESE U, V24, P528
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Li BQ, 2002, ACTA POLYM SIN, P828
   LIU J, 2005, CHINESE J POLYM B, P84
   Liu ZH, 2007, J APPL POLYM SCI, V103, P3164, DOI 10.1002/app.24867
   Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016
   WANG J, 2006, SHANGHAI PAPER MAKIN, V37, P40
   Wang Y, 2007, J APPL POLYM SCI, V106, P3136, DOI 10.1002/app.25967
   Wang ZK, 2010, CHINESE J POLYM SCI, V28, P801, DOI 10.1007/s10118-010-9158-y
   Wang ZK, 2009, POLYM COMPOSITE, V30, P1517, DOI 10.1002/pc.20724
   Wongpanit P, 2005, MACROMOL BIOSCI, V5, P1001, DOI 10.1002/mabi.200500081
   ZHANG LL, 2007, CHINA PHARM, V10, P1191
   Zhuang Zhao-xia, 2003, Shanghai Kou Qiang Yi Xue, V12, P362
NR 18
TC 5
Z9 7
U1 0
U2 7
PU PEKING UNIV PRESS
PI BEIJING
PA PEKING UNIV, CHEMISTRY BUILDING, BEIJING 100871, PEOPLES R CHINA
SN 1000-6818
J9 ACTA PHYS-CHIM SIN
JI Acta Phys.-Chim. Sin.
PD JUL
PY 2010
VL 26
IS 7
BP 2053
EP 2056
DI 10.3866/PKU.WHXB20100711
PG 4
WC Chemistry, Physical
SC Chemistry
GA 623WE
UT WOS:000279776400046
DA 2018-10-19
ER

PT J
AU Jallot, E
   Raissle, O
   Soulie, J
   Lao, J
   Guibert, G
   Nedelec, JM
AF Jallot, Edouard
   Raissle, Olivier
   Soulie, Jeremy
   Lao, Jonathan
   Guibert, Geoffroy
   Nedelec, Jean-Marie
TI Quantitative Chemical Mapping of Relevant Trace Elements at
   Biomaterials/Biological Media Interfaces by Ion Beam Methods
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT European Congress on Advanced Materials and Processes (Euromat 2009)
CY SEP 07-10, 2009
CL Glasgow, SCOTLAND
SP FEMS, Inst Mat, Minerals & Min
ID BIOACTIVE GLASS PARTICLES; IN-VITRO BIOACTIVITY; TERM PHYSICOCHEMICAL
   REACTIONS; X-RAY MICROANALYSIS; PROTEIN ADSORPTION; PIXE-RBS; ORTHOPEDIC
   IMPLANTS; BIOLOGICAL-FLUIDS; WEAR DEBRIS; ZINC
AB The definition of biomaterial as proposed by the European Society for Biomaterials in 1986 puts forward the overall importance of the notion of contact between the biomaterial and biological medium (cell, tissue, fluid, ...). The underlying concept of biocompatibility makes the interface between biomaterial and biological medium a privileged zone of interest. In this paper, we would like to give an exhaustive view of how ion beams techniques can contribute to a better understanding of such interface taking several examples dealing with bone tissue substitution. After a short presentation of ion beams techniques the paper will focus on PIXE/RBS spectroscopies and will give the basics of these coupled technique. Three examples will then be presented to illustrate the interest of these techniques to study biomaterials/biological interactions. The first example deals with metallic alloys based joint prostheses. The ionic release from the prosthesis and the wear behavior of total knee prostheses will be presented. In the last two examples, bioactive materials will be studied. The common characteristic of bioactive ceramics is the kinetic modification of their surface upon interaction which is ideally monitored by PIXE chemical mapping. The second example will review the benefit of using PIXE/RBS technique to study the effect of doping of bioactive glasses on the very first steps involved in the bioactivity mechanisms like dissolution, ionic release, and biomineralization onto the surface of the glasses. Finally, protein delivery systems based upon meso porous hydroxyapatites will be studied. Chemical mapping allowing the quantitative determination of protein distribution inside the HAp grains will be presented for the first time.
C1 [Jallot, Edouard; Raissle, Olivier; Soulie, Jeremy; Lao, Jonathan; Guibert, Geoffroy] Univ Clermont Ferrand, Clermont Univ, Phys Corpusculaire Lab BP 10448, CNRS,IN2P3, F-63000 Clermont Ferrand, France.
   [Raissle, Olivier; Soulie, Jeremy; Nedelec, Jean-Marie] Clermont Univ, ENSCCF, Lab Mat Inorgan BP 10448, F-63000 Clermont Ferrand, France.
   [Raissle, Olivier; Soulie, Jeremy; Nedelec, Jean-Marie] CNRS, UMR 6002 LMI, F-63177 Clermont Ferrand, France.
RP Jallot, E (reprint author), Univ Clermont Ferrand, Clermont Univ, Phys Corpusculaire Lab BP 10448, CNRS,IN2P3, F-63000 Clermont Ferrand, France.
EM j-marie.nedelec@univ-bpclermont.fr
RI NEDELEC, jean-marie/A-6920-2008
OI NEDELEC, jean-marie/0000-0002-8243-6849
CR Bao B, 2003, AM J PHYSIOL-ENDOC M, V285, P1095
   Braemer W, 2001, ADV ENG MATER, V3, P753, DOI 10.1002/1527-2648(200110)3:10<753::AID-ADEM753>3.0.CO;2-G
   BREEN DJ, 1993, CLIN RADIOL, V47, P274, DOI 10.1016/S0009-9260(05)81138-9
   CHANDLER JA, 1979, MICROBEAM ANAL BIOL, P457
   Courtheoux L, 2008, J PHYS CHEM C, V112, P13663, DOI 10.1021/jp8044498
   El Hammari L, 2007, MATER CHEM PHYS, V104, P448, DOI 10.1016/j.matchemphys.2007.04.002
   Gorustovich A, 2007, BONE, V41, pS4, DOI 10.1016/j.bone.2007.09.015
   Guibert G, 2006, NUCL INSTRUM METH B, V251, P246, DOI 10.1016/j.nimb.2006.06.032
   HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737
   Hayakawa S, 2007, J AM CERAM SOC, V90, P565, DOI 10.1111/j.1551-2916.2006.01396.x
   HAYNES H, 2000, J BIOMED MATER RES, V49, P167
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hodgkinson GN, 2007, CROAT CHEM ACTA, V80, P405
   Ichinose S, 2003, J MATER SCI-MATER M, V14, P79, DOI 10.1023/A:1021557605458
   Incerti S, 2007, NUCL INSTRUM METH B, V260, P20, DOI 10.1016/j.nimb.2007.01.274
   Incerti S, 2006, NUCL INSTRUM METH B, V249, P738, DOI 10.1016/j.nimb.2006.03.130
   IZQUIERDOBARBA I, 2008, J NANOMATER, P14
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jallot E, 1999, NUCL INSTRUM METH B, V155, P315, DOI 10.1016/S0168-583X(99)00375-4
   Jallot E, 2003, LANGMUIR, V19, P3840, DOI 10.1021/la0265629
   Jallot E, 2001, LANGMUIR, V17, P4467, DOI 10.1021/la001669m
   Jensen J., 1997, BONE, V20, P104
   Jones JR, 2001, J BIOMED MATER RES, V58, P720, DOI 10.1002/jbm.10053
   Josset Y, 2003, J BIOMED MATER RES A, V67A, P1205, DOI 10.1002/jbm.a.20035
   Kaar SG, 2001, J ORTHOPAED RES, V19, P171, DOI 10.1016/S0736-0266(00)00033-4
   KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   Lao J, 2008, NUCL INSTRUM METH B, V266, P2412, DOI 10.1016/j.nimb.2008.03.013
   Lao J, 2008, J PHYS CHEM C, V112, P9418, DOI 10.1021/jp800583m
   Lao J, 2008, SURF INTERFACE ANAL, V40, P162, DOI 10.1002/sia.2700
   Lao J, 2006, NUCL INSTRUM METH B, V245, P511, DOI 10.1016/j.nimb.2005.12.049
   Lao J, 2009, J MATER CHEM, V19, P2940, DOI 10.1039/b822214b
   Lao J, 2008, CHEM MATER, V20, P4969, DOI 10.1021/cm800993s
   Laquerriere P, 2001, J BIOMED MATER RES, V58, P238, DOI 10.1002/1097-4636(2001)58:3<238::AID-JBM1012>3.3.CO;2-9
   Laquerriere P, 2003, J BIOMED MATER RES A, V65A, P441, DOI 10.1002/jbm.a.10498
   MANITHA BN, 2008, ACTA BIOMATER, V4, P173
   Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005
   MEUNIER PJ, 2002, OSTEOPOROS INT S3, V13, P66
   Miyahara M, 2006, THIN SOLID FILMS, V499, P13, DOI 10.1016/j.tsf.2005.07.046
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Oki A, 2004, J BIOMED MATER RES A, V69A, P216, DOI 10.1002/jbm.a.20070
   OLIVIER V, 2003, CELL BIOL TOXICOL, V19, P45
   Ortega R, 2005, NUCL INSTRUM METH B, V231, P218, DOI 10.1016/j.nimb.2005.01.060
   Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749
   Salinas AJ, 2000, BIOMATERIALS, V21, P251, DOI 10.1016/S0142-9612(99)00150-7
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   Savio J. A. Iii, 1994, Clinical Materials, V15, P101, DOI 10.1016/0267-6605(94)90076-0
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   SOULIE J, 2009, PHYS CHEM CHEM PHYS, V44, P10473
   Stendig-Lindberg Gustawa, 1993, Magnesium Research, V6, P155
   Suh CW, 2004, J BIOTECHNOL, V112, P267, DOI 10.1016/j.jbiotec.2004.05.005
   Takata MK, 2005, J RADIOANAL NUCL CH, V264, P5, DOI [10.1007/s10967-005-0666-0, 10.1007/s10967-005-0688-y]
   Vallet-Regi M, 1999, J MATER CHEM, V9, P515, DOI 10.1039/a808679f
   Vallet-Regi M, 2008, PROG SOLID STATE CH, V36, P163, DOI 10.1016/j.progsolidstchem.2007.10.002
   YAMAGUCHI M, 1986, RES EXP MED, V186, P337, DOI 10.1007/BF01852099
   Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0
   ZIEROLD K, 1991, J MICROSC-OXFORD, V161, P357, DOI 10.1111/j.1365-2818.1991.tb03096.x
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 60
TC 4
Z9 4
U1 1
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD JUL
PY 2010
VL 12
IS 7
SI SI
BP B245
EP B255
DI 10.1002/adem.201080001
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 643LB
UT WOS:000281296800022
DA 2018-10-19
ER

PT J
AU Maczynska, B
   Smutnicka, D
   Przondo-Mordarska, A
   Bartoszewicz, M
   Junka, A
   Janczura, A
   Nowicka, J
AF Maczynska, Beata
   Smutnicka, Danuta
   Przondo-Mordarska, Anna
   Bartoszewicz, Marzenna
   Junka, Adam
   Janczura, Adriana
   Nowicka, Joanna
TI Biofilm Formation by Clinical Klebsiella Strains Expressing Various
   Types of Adhesins on Catheters Made of Different Materials
SO ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Klebsiella; adhesins; biofilm formation; biomaterials
ID INFECTIONS; PNEUMONIAE; DIARRHEA; BACTERIA
AB Background. Klebsiella bacilli are frequent causes of nosocomial infections associated with the use of urinary (CAUTI) and intravenous catheters (CR-BSI) due to their ability to form biofilm on biomaterials. The adhesive properties of Klebsiella bacilli connected with the presence of fimbrial and non-fimbrial adhesins play a very important role in the pathogenicity of these bacteria.
   Objectives. Investigation of the correlation between the pathogenic properties of the clinical Klebsiella strains (the capsule, adhesin types), the type of biomaterial and the degree of in vitro biofilm formation on catheters.
   Material and Methods. Sixty-nine clinical Klebsiella strains isolated from patients hospitalised in different hospital wards were tested using hemagglutination test for fimbriae occurrence and Richard's method and electron microscopy for biofilm formation.
   Results. Level of adhesion of the clinical Klebsiella strains to biomaterials was associated with the catheter material. Electron microscope images showed various biofilm structures produced by different Klebsiella strains.
   Conclusions. There exists a direct connection between the degree of biofilm formation by the tested Klebsiella strains and the chemical composition of the catheter. Surprisingly, it seems there is no direct correlation between the ability of strain to biofilm formation and the type of fimbriae expressed by the strain. In light of own research, strains which do not express fimbriae are able to form biofilm as well (Adv Clin Exp Med 2010, 19, 4, 443-453).
C1 [Maczynska, Beata; Smutnicka, Danuta; Przondo-Mordarska, Anna; Bartoszewicz, Marzenna; Junka, Adam; Janczura, Adriana; Nowicka, Joanna] Wroclaw Med Univ, Dept Microbiol, PL-50368 Wroclaw, Poland.
RP Maczynska, B (reprint author), Wroclaw Med Univ, Dept Microbiol, Chalubinskiego 4, PL-50368 Wroclaw, Poland.
EM beciam@mbio.am.wroc.pl
CR BARTOSZEWIEZ M, 2003, MIKROBIOL MED, V1, P20
   CAFUSO V, 2004, CLIN MICROBIOL INFEC, V10, P1081
   CANO ME, 2005, CLIN MICROBIOL INFEC, V11, P236
   DAMJANOWA I, 2005, CLIN MICROBIOL INFEC, V11, P110
   DONLAN R, 2001, EMERG INFECT DIS, V7
   DUGUID JP, 1980, BACTERIAL ADHERENCE, P187
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   GUARINO A, 1989, PEDIATR RES, V25, P514, DOI 10.1203/00006450-198905000-00018
   Janczura A, 2009, ADV CLIN EXP MED, V18, P283
   LANGSTRAAT J, 2001, TYPE 3 FIMBRIAL SHAF, P5805
   MACZYNSKA B, 2003, MED DOSW MICROBIOL, V59, P333
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   Murga R, 2001, J CLIN MICROBIOL, V39, P2294, DOI 10.1128/JCM.39.6.2294-2297.2001
   PODSCHUN R, 1991, ZBL HYG UMWELTMED, V191, P46
   PROVIDENCIA J, 1999, CLIN MICROBIOL INFEC, V5, P382
   PRZONDOMORDARSK.A, 1994, ZBL BAKT S25, V59, P291
   Rozalska B, 1994, Postepy Hig Med Dosw, V48, P143
   Rozalska Barbara, 1998, Medycyna Doswiadczalna i Mikrobiologia, V50, P115
   SALYERS AA, 2005, WHITT MICROBIOLOGY D
   Staniszewska M, 2000, Postepy Hig Med Dosw, V54, P727
   STRUVE C, 2001, THESIS STATENS SERUM
   Tambyah PA, 1999, MAYO CLIN PROC, V74, P131, DOI 10.4065/74.2.131
   Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Wolska Katarzyna, 2003, Medycyna Doswiadczalna i Mikrobiologia, V55, P371
   YUEHUEI HA, 2000, HDB BACTERIAL ADHESI, P1
NR 29
TC 2
Z9 2
U1 1
U2 5
PU WROCLAW MEDICAL UNIV
PI WROCLAW
PA T CHALUBINSKIEGO 6A, WROCLAW, 50-368, POLAND
SN 1230-025X
J9 ADV CLIN EXP MED
JI Adv. Clin. Exp. Med.
PD JUL-AUG
PY 2010
VL 19
IS 4
BP 443
EP 453
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 677FT
UT WOS:000283975200005
DA 2018-10-19
ER

PT J
AU Stabile, KJ
   Odom, D
   Smith, TL
   Northam, C
   Whitlock, PW
   Smith, BP
   Van Dyke, ME
   Ferguson, CM
AF Stabile, Kathryne J.
   Odom, Devin
   Smith, Thomas L.
   Northam, Casey
   Whitlock, Patrick W.
   Smith, Beth P.
   Van Dyke, Mark E.
   Ferguson, Cristin M.
TI An Acellular, Allograft-Derived Meniscus Scaffold in an Ovine Model
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Article
ID TISSUE-ENGINEERED CARTILAGE; MEDIAL MENISCUS; FOLLOW-UP; PARTIAL
   MENISCECTOMY; COLORIMETRIC ASSAY; DOGS KNEES; TRANSPLANTATION;
   REGENERATION; REPLACEMENT; BIOMATERIAL
AB Purpose: The purpose of this study was to develop a meniscus scaffold that has increased porosity and maintains the native meniscus extracellular matrix in an ovine model. Methods: The medial menisci of skeletally mature ovine (n = 16) were harvested; half were made into meniscus scaffolds (n = 8), and half remained intact (n = 8). Intact and scaffold meniscus tissues were compared by use of histology, DNA content analysis, in vitro cellular biocompatibility assays, and ultrastructural analysis. An additional 16 knees were used to investigate the biomechanics of the intact meniscus compared with the meniscus scaffold. Results: DNA content and histology showed a significant decrease in cellular and nuclear content in the meniscus scaffold (P < .003). Biocompatibility was supported through in vitro cellular assays. Scanning electron microscopy and micro-computed tomography showed a substantial increase in porosity and pore connectivity in the meniscus scaffold compared with the intact meniscus (P < .01). There was no statistical difference between the ultimate load or elastic modulus of the intact and meniscus scaffolds. Conclusions: In this study a meniscus scaffold was evaluated for potential clinical application as a meniscus transplant construct in an ovine model. The data showed that a decellularized meniscus scaffold with increased porosity was comparable to the intact meniscus, with an absence of in vitro cellular toxicity. Although some compositional alterations of the extracellular matrix are to be expected during processing, it is evident that many of the essential structural components remained functional with maintenance of biomechanical properties. Clinical Relevance: This meniscus scaffold has potential for future clinical application as a meniscus transplant construct.
C1 [Stabile, Kathryne J.; Odom, Devin; Smith, Thomas L.; Northam, Casey; Whitlock, Patrick W.; Smith, Beth P.; Ferguson, Cristin M.] Wake Forest Univ, Dept Orthopaed Surg, Sch Med, Orthopaed Res Lab, Winston Salem, NC 27157 USA.
   [Van Dyke, Mark E.] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Ferguson, CM (reprint author), Wake Forest Univ, Dept Orthopaed Surg, Sch Med, Orthopaed Res Lab, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM ferguson@wfubmc.edu
FU Musculoskeletal Transplant Foundation; Orthopaedic Research and
   Education Foundation
FX Supported by the Musculoskeletal Transplant Foundation and the
   Orthopaedic Research and Education Foundation, as well as resident
   educational grants from Zimmer and Smith & Nephew. The authors report no
   conflict of interest.
CR ALLEN PR, 1984, J BONE JOINT SURG BR, V66, P666
   Anderson EJ, 2007, TISSUE ENG, V13, P2525, DOI 10.1089/ten.2006.0443
   Angele P, 2007, J BIOMED MATER RES A, V85, P445
   [Anonymous], 2009, 1099352009 ISO
   ARNOCZKY SP, 1992, ARTHROSCOPY, V8, P428, DOI 10.1016/0749-8063(92)90003-T
   ARNOCZKY SP, 1988, J ORTHOP RES, V6, P1, DOI 10.1002/jor.1100060102
   BARATZ ME, 1986, AM J SPORT MED, V14, P270, DOI 10.1177/036354658601400405
   BOLANO LE, 1993, AM J SPORT MED, V21, P432, DOI 10.1177/036354659302100318
   BOURNE RB, 1984, J BONE JOINT SURG AM, V66A, P1431, DOI 10.2106/00004623-198466090-00017
   BROWN KLB, 1982, J BONE JOINT SURG AM, V64, P270, DOI 10.2106/00004623-198264020-00020
   Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X
   Buma P, 2007, EXPERT REV MED DEVIC, V4, P507, DOI 10.1586/17434440.4.4.507
   Chia HN, 2008, J ORTHOP RES, V26, P951, DOI 10.1002/jor.20573
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   COX JS, 1975, CLIN ORTHOP RELAT R, P178
   COX JS, 1977, CLIN ORTHOP RELAT R, P236
   DEBOER HH, 1994, CLIN ORTHOP RELAT R, V155, P162
   DeHaven KE., 1992, KNEE MENISCUS BASIC, P131
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Hommen JP, 2007, ARTHROSCOPY, V23, P388, DOI 10.1016/j.arthro.2006.11.032
   KHOURY MA, 1994, J ORTHOPAED RES, V12, P751, DOI 10.1002/jor.1100120602
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283
   Lewis PB, 2008, J ORTHOP RES, V26, P49, DOI 10.1002/jor.20473
   Maier D, 2007, J ORTHOP RES, V25, P1598, DOI 10.1002/jor.20405
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1
   McKinley TO, 2003, CLIN ORTHOP RELAT R, P259, DOI 10.1097/01.blo.0000043053.62337.2f
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Muckle D S, 1983, Br J Sports Med, V17, P88
   Packer JD, 2008, CLIN SPORTS MED, V28, pviii
   Packer JD, 2009, CLIN SPORT MED, V28, P259, DOI 10.1016/j.csm.2008.10.011
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
   RADIN EL, 1984, CLIN ORTHOP RELAT R, P290
   Rodeo SA, 2000, J BONE JOINT SURG AM, V82A, P1071, DOI 10.2106/00004623-200008000-00002
   Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   SAFRAN MR, 2004, TXB ARTHROSCOPY, P497
   Scheller G, 2001, ARTHROSCOPY, V17, P946, DOI 10.1053/jars.2001.28952
   Sekiya JK, 2006, J AM ACAD ORTHOP SUR, V14, P164, DOI 10.5435/00124635-200603000-00007
   Sekiya JK, 2006, ARTHROSCOPY, V22, P771, DOI 10.1016/j.arthro.2006.02.007
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Steadman JR, 2005, ARTHROSCOPY, V21, P515, DOI 10.1016/j.arthro.2005.01.006
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   STONE KR, 1995, ARTHROSCOPY, V11, P395, DOI 10.1016/0749-8063(95)90189-2
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   STONE KR, 1989, Patent No. 4880429
   STONE KR, 1992, KNEE MENISCUS BASIC, P165
   SUTHERLAND DH, 1994, HUMAN WALKING, V2, P23
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   van der Wal RJP, 2009, AM J SPORT MED, V37, P2134, DOI 10.1177/0363546509336725
   VANARKEL ERA, 1995, J BONE JOINT SURG BR, V77B, P589
   VANDYKE ME, 2007, Patent No. 11738258
   Verdonk PCM, 2005, J BONE JOINT SURG AM, V87A, P715, DOI 10.2106/JBJS.C.01344
   Verdonk R, 2007, SPORTS MED ARTHROSC, V15, P121, DOI 10.1097/JSA.0b013e318140002c
   WALKER PS, 1975, CLIN ORTHOP RELAT R, P184
   Welch JA, 2002, AM J VET RES, V63, P427, DOI 10.2460/ajvr.2002.63.427
   Welsing RTC, 2008, AM J SPORT MED, V36, P1978, DOI 10.1177/0363546508319900
   Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029
   Wirth CJ, 2002, AM J SPORT MED, V30, P174, DOI 10.1177/03635465020300020501
   Woo S L, 1983, J Orthop Res, V1, P22, DOI 10.1002/jor.1100010104
   WOO SLY, 1987, J ORTHOP RES, V5, P425, DOI 10.1002/jor.1100050315
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
NR 69
TC 41
Z9 43
U1 0
U2 13
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
J9 ARTHROSCOPY
JI Arthroscopy
PD JUL
PY 2010
VL 26
IS 7
BP 936
EP 948
DI 10.1016/j.arthro.2009.11.024
PG 13
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 623RH
UT WOS:000279759000013
PM 20620793
DA 2018-10-19
ER

PT J
AU Hamada, H
   Ohshima, H
   Ito, A
   Higuchi, WI
   Otsuka, M
AF Hamada, Hideyuki
   Ohshima, Hiroyuki
   Ito, Atsuo
   Higuchi, William I.
   Otsuka, Makoto
TI Effect of Geometrical Structure on the Biodegradation of a
   Three-Dimensionally Perforated Porous Apatite/Collagen Composite Bone
   Cell Scaffold
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE geometrical structure; biodegradation; three-dimensionally perforated
   pore; self-setting apatite/collagen composite cement; X-ray computed
   tomography
ID CALCIUM-PHOSPHATE CEMENT; BMP-INDUCED OSTEOGENESIS; DRUG-RELEASE RATE;
   HYDROXYAPATITE/COLLAGEN COMPOSITE; IN-VITRO; COLLAGEN; INDOMETHACIN;
   CHONDROGENESIS; BIOMATERIAL; SUBSTRATUM
AB A Biodegradable artificial bone with inter-connective pores was prepared using a self-setting apatite/collagen composite cement as a cell scaffold for bone regenerative medicine, and investigated as to biocompatibility by X-ray computed tomography (CT) after its implantation into rats. Blocks (APN, APC and ACC) of apatite cement, apatite cement with continuous holes, and apatite/collagen composite cement with continuous holes were prepared. The APC and ACC blocks had 16 (8x2) interconnecting holes 500 mu m in diameter. After the APN, APC, and ACC blocks were implanted in the back of the rats, X-ray CT images were measured every week. Before and after implantation, powder X-ray diffraction profiles of APN, APC and ACC showed diffraction patterns of hydroxyapatite with low crystallinity. Changes in the volume, inorganic content and density of the blocks in the rats were evaluated based on X-ray CT images. The volume and inorganic content of ACC decreased continuously at a constant rate. In contrast, the volume and inorganic content of APN and APC didn't show major changes. After implantation, the absorption of X-rays by ACC decreased with time. This suggested that the block was bioabsorbed significantly with time. In contrast, the absorption of APC and APN did not decrease, indicating that the blocks were not bioabsorbed.
C1 [Otsuka, Makoto] Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Tokyo 2028585, Japan.
   [Hamada, Hideyuki; Ohshima, Hiroyuki] Tokyo Univ Sci, Fac Pharmaceut Sci, Chiba 2788510, Japan.
   [Ito, Atsuo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.
   [Higuchi, William I.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
RP Otsuka, M (reprint author), Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Tokyo 2028585, Japan.
EM motsuka@musashino-u.ac.jp
RI Ito, Atsuo/M-6785-2018
OI Ito, Atsuo/0000-0003-3318-040X; Ohshima, Hiroyuki/0000-0002-0044-8257
FU Ministry of Education, Culture, Sports, Science and Techology, Japan;
   MEXT
FX This study was supported in part by a grant, MEXT. HAITEKU (2004-2008),
   from the Ministry of Education, Culture, Sports, Science and Techology,
   Japan.
CR Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   Hirota Kazushi, 1993, Bio-Medical Materials and Engineering, V3, P147
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.3.CO;2-T
   John A, 2001, J BIOMAT SCI-POLYM E, V12, P689, DOI 10.1163/156856201316883485
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2002, KEY ENG MAT, V218-2, P449, DOI 10.4028/www.scientific.net/KEM.218-220.449
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Kuboki Y, 2001, DENT JPN, V37, P42
   Kuboki Y., 2001, J BONE JOINT SURG AM, V83, P105
   Martins VCA, 1998, ARTIF ORGANS, V22, P215, DOI 10.1046/j.1525-1594.1998.06004.x
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P658
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   OTSUKA M, 1994, J PHARM SCI, V83, P611, DOI 10.1002/jps.2600830502
   Otsuka M, 1997, J CONTROL RELEASE, V43, P115, DOI 10.1016/S0168-3659(96)01493-9
   OTSUKA M, 1994, J PHARM SCI, V83, P1569, DOI 10.1002/jps.2600831110
   OTSUKA M, 1994, J PHARM SCI, V83, P259, DOI 10.1002/jps.2600830230
   Otsuka M, 1997, J PHARM PHARMACOL, V49, P1182, DOI 10.1111/j.2042-7158.1997.tb06067.x
   Otsuka M, 2006, J BIOMED MATER RES B, V79B, P176, DOI 10.1002/jbm.b.30528
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   ZARDIACKAS LD, 1994, J APPL BIOMATER, V5, P277, DOI 10.1002/jab.770050402
NR 27
TC 9
Z9 9
U1 0
U2 5
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD JUL
PY 2010
VL 33
IS 7
BP 1228
EP 1232
DI 10.1248/bpb.33.1228
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 616HN
UT WOS:000279199800025
PM 20606318
OA Bronze
DA 2018-10-19
ER

PT J
AU Gallardo-Moreno, AM
   Pacha-Olivenza, MA
   Fernandez-Calderon, MC
   Perez-Giraldo, C
   Bruque, JM
   Gonzalez-Martin, ML
AF Gallardo-Moreno, Amparo M.
   Pacha-Olivenza, Miguel A.
   Fernandez-Calderon, Maria-Coronada
   Perez-Giraldo, Ciro
   Bruque, Jose M.
   Gonzalez-Martin, Maria-Luisa
TI Bactericidal behaviour of Ti6Al4V surfaces after exposure to UV-C light
SO BIOMATERIALS
LA English
DT Article
DE Titanium dioxide; Titanium alloy; Ultraviolet; Infection; Antimicrobial
ID CENTRAL VENOUS CATHETERS; COATED TITANIUM-DIOXIDE; IN-VITRO;
   STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; SOS RESPONSE; TIO2 POWDER;
   CELLS; PHOTOCATALYST; BIOMATERIALS
AB TiO(2)-coated biomaterials that have been excited with UV irradiation have demonstrated biocidal properties in environmental applications, including drinking water decontamination. However, this procedure has not been successfully applied towards the killing of pathogens on medical titanium-based implants, mainly because of practical concerns related to irradiating the inserted biomaterial in situ. Previous researchers assumed that the photocatalysis on the TiO(2) surface during UV application causes the bactericidal effects. However, we show that a residual post-irradiation bactericidal effect exists on the surface of Ti6Al4V, not related with photocatalysis. Using a combination of staining, serial dilutions, and a biofilm assay, we show a significant and time-dependent loss in viability of different bacterial strains of Staphylococcus epidermidis and Staphylococcus aureus on the post-irradiated surface. Although the duration of this antimicrobial effect depends on the strains selected, our experiments suggest that the effect lasts at least 60 min after surface irradiation. The origin of such phenomena is discussed in terms of the physical properties of the irradiated surfaces, which include the emission of energy and changes in surfaces charge occurring during electron-hole recombination processes. The method here proposed for the preparation of antimicrobial titanium surfaces could become especially useful in total implant surgery for which the antimicrobial challenge is mainly during or shortly after surgery. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Gallardo-Moreno, Amparo M.; Pacha-Olivenza, Miguel A.; Bruque, Jose M.; Gonzalez-Martin, Maria-Luisa] Univ Extremadura, Fac Ciencias, Dept Fis Aplicada, E-06071 Badajoz, Spain.
   [Gallardo-Moreno, Amparo M.; Pacha-Olivenza, Miguel A.; Fernandez-Calderon, Maria-Coronada; Perez-Giraldo, Ciro; Bruque, Jose M.; Gonzalez-Martin, Maria-Luisa] CIBER BBN, Badajoz, Spain.
   [Fernandez-Calderon, Maria-Coronada; Perez-Giraldo, Ciro] Univ Extremadura, Fac Med, Dept Microbiol, E-06071 Badajoz, Spain.
RP Gonzalez-Martin, ML (reprint author), Univ Extremadura, Fac Ciencias, Dept Fis Aplicada, Avda Elvas S-N, E-06071 Badajoz, Spain.
EM mlglez@unex.es
RI Gonzalez Martin, Maria Luisa/L-3476-2014; Pacha Olivenza,
   Miguel/M-8285-2014; Fernandez-Calderon, Maria Coronada/N-3985-2014;
   Morales Bruque, Jose/N-2521-2014
OI Gonzalez Martin, Maria Luisa/0000-0002-9207-444X; Pacha Olivenza,
   Miguel/0000-0003-3505-9320; Fernandez-Calderon, Maria
   Coronada/0000-0001-8567-6787; Morales Bruque, Jose/0000-0002-9336-4350;
   Perez-Giraldo, Ciro/0000-0002-2358-1982
FU Ministerio de Ciencia e Innovacion [MAT2006-12948-004-(03-04),
   MAT2009-14695-004-(01-03)]; "Consejeria de Economia, Comercio e
   Innovacion" of the "Junta de Extremadura" [PRI08A124]
FX This work was supported by Grants MAT2006-12948-004-(03-04) and
   MAT2009-14695-004-(01-03) from the "Ministerio de Ciencia e Innovacion",
   Grant PRI08A124 from the "Consejeria de Economia, Comercio e Innovacion"
   of the "Junta de Extremadura". The authors thank the contribution of
   E.M. Rodriguez from the Department of Chemical Engineering and
   Physical-Chemistry of the UEx for the HPLC measurements. Thanks also to
   V. Vadillo-Rodriguez from the Department of Applied Physics of the UEx
   and T.A. Camesano from the Department of Chemical Engineering of the
   Worcester Polytechnique Institute (MA, USA) for the useful
   corrections-comments in the elaboration of this manuscript.
CR Aertsen A, 2004, J BACTERIOL, V186, P6133, DOI 10.1128/jb.186.18.6133-6141.2004
   BECK P, 1997, FEMS MICROBIOL LETT, V147, P11
   Blake DM, 1999, SEPAR PURIF METHOD, V28, P1, DOI 10.1080/03602549909351643
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   BUSSCHER HJ, 2009, BIOMATERIALS, V30, P4047
   Byrne JA, 1998, APPL CATAL B-ENVIRON, V17, P25, DOI 10.1016/S0926-3373(97)00101-X
   CAI R, 1991, B CHEM SOC JPN, V64, P1268, DOI 10.1246/bcsj.64.1268
   CAI R, 1988, PHOTOMED PHOTOBIOL, V10, P253
   Carbon RT, 1999, INFECTION, V27, pS69, DOI 10.1007/BF02561623
   Chen CC, 2008, DESALINATION, V219, P89, DOI 10.1016/j.desal.2007.05.009
   Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7
   Cho M, 2005, APPL ENVIRON MICROB, V71, P270, DOI 10.1128/AEM.71.1.270-275.2005
   Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604
   Choi JY, 2009, ANGLE ORTHOD, V79, P528, DOI 10.2319/012108-169.1
   Crnigoj M, 2008, WORLD J MICROB BIOT, V24, P2115, DOI 10.1007/s11274-008-9717-3
   CROWLEY DJ, 2002, J BIOMED BIOTECHNOL, V2, P67
   Cushnie TPT, 2009, CHEMOSPHERE, V74, P1374, DOI 10.1016/j.chemosphere.2008.11.012
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   Gaswami DY, 1997, J SOL ENERGY ENG, V119, P92
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Gracia E, 1999, LUMINESCENCE, V14, P23, DOI 10.1002/(SICI)1522-7243(199901/02)14:1<23::AID-BIO513>3.0.CO;2-M
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   Guillemot F, 2003, APPL PHYS A-MATER, V77, P899, DOI 10.1007/s00339-003-2162-0
   Harm W., 1980, BIOL EFFECTS ULTRAVI
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HUANG Z, 2000, J PHOTOCH PHOTOBIO A, V130, P163, DOI DOI 10.1016/S1010-6030(99)00205-1
   Jagger J., 1967, INTRO RES ULTRAVIOLE
   Kangwansupamonkon W, 2009, NANOMED-NANOTECHNOL, V5, P240, DOI 10.1016/j.nano.2008.09.004
   Kim B, 2003, CHEMOSPHERE, V52, P277, DOI 10.1016/S0045-6535(03)00051-1
   Liu HL, 2003, PROCESS BIOCHEM, V39, P475, DOI 10.1016/S0032-9592(03)00084-0
   Madrid P. A., 2002, FEMS MICROBIOL LETT, V211, P183
   Maneerat C, 2006, INT J FOOD MICROBIOL, V107, P99, DOI 10.1016/j.ijfoodmicro.2005.08.018
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   Mesak LR, 2008, ANTIMICROB AGENTS CH, V52, P3394, DOI 10.1128/AAC.01599-07
   MUSK P, 1989, MUTAT RES, V227, P25, DOI 10.1016/0165-7992(89)90064-X
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nonami T, 2004, CATAL TODAY, V96, P113, DOI 10.1016/j.cattod.2004.06.112
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   Pacha-Olivenza MA, 2008, J COLLOID INTERF SCI, V320, P117, DOI 10.1016/j.jcis.2007.11.060
   PILCH PF, 1977, J CHEM EDUC, V54, P449, DOI 10.1021/ed054p449
   Prasad GK, 2009, J HAZARD MATER, V165, P506, DOI 10.1016/j.jhazmat.2008.10.009
   Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002
   Riley DJ, 2005, DENT MATER, V21, P756, DOI 10.1016/j.dental.2005.01.010
   Rodriguez E, 2007, WATER RES, V41, P1325, DOI 10.1016/j.watres.2006.12.007
   SANG C, 2009, APPL CATAL B-ENVIRON, V89, P536
   SHAW DJ, 1989, INTRO COLLOID SURFAC
   Shiraishi K, 2009, SURF INTERFACE ANAL, V41, P17, DOI 10.1002/sia.2965
   Siemon U, 2002, J PHOTOCH PHOTOBIO A, V148, P247, DOI 10.1016/S1010-6030(02)00050-3
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Sousa FJR, 2006, J MOL BIOL, V359, P1059, DOI 10.1016/j.jmb.2006.03.069
   Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x
   van der Borden AJ, 2004, APPL ENVIRON MICROB, V70, P6871, DOI 10.1128/AEM.70.11.6871-6874.2004
   Veenstra DL, 1999, JAMA-J AM MED ASSOC, V281, P261, DOI 10.1001/jama.281.3.261
   Yatskiv VI, 2003, THEOR EXP CHEM, V39, P172
NR 58
TC 37
Z9 38
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2010
VL 31
IS 19
BP 5159
EP 5168
DI 10.1016/j.biomaterials.2010.03.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 606YW
UT WOS:000278466100014
PM 20362330
DA 2018-10-19
ER

PT J
AU Agrawal, AA
   Nehilla, BJ
   Reisig, KV
   Gaborski, TR
   Fang, DZ
   Striemer, CC
   Fauchet, PM
   McGrath, JL
AF Agrawal, A. A.
   Nehilla, B. J.
   Reisig, K. V.
   Gaborski, T. R.
   Fang, D. Z.
   Striemer, C. C.
   Fauchet, P. M.
   McGrath, J. L.
TI Porous nanocrystalline silicon membranes as highly permeable and
   molecularly thin substrates for cell culture
SO BIOMATERIALS
LA English
DT Article
DE Porosity; Silicon; Cell culture; Nanoporous; Cell adhesion;
   Biocompatibility
ID BLOOD-BRAIN-BARRIER; IN-VITRO MODEL; ENDOTHELIAL-CELLS; OSTEOGENIC
   DIFFERENTIATION; NANOPOROUS SILICON; MAMMALIAN-CELLS; ADHESION;
   PROLIFERATION; COMPATIBILITY; HEPATOCYTES
AB Porous nanocrystalline silicon (pnc-Si) is new type of silicon nanomaterial with potential uses in lab-on-a-chip devices, cell culture, and tissue engineering. The pnc-Si material is a 15 nm thick, freestanding, nanoporous membrane made with scalable silicon manufacturing. Because pnc-Si membranes are approximately 1000 times thinner than any polymeric membrane, their permeability to small solutes is orders-of-magnitude greater than conventional membranes. As cell culture substrates, pnc-Si membranes can overcome the shortcomings of membranes used in commercial transwell devices and enable new devices for the control of cellular microenvironments. The current study investigates the feasibility of pnc-Si as a cell culture substrate by measuring cell adhesion, morphology, growth and viability on pnc-Si compared to conventional culture substrates. Results for immortalized fibroblasts and primary vascular endothelial cells are highly similar on pnc-Si, polystyrene and glass. Significantly, pnc-Si dissolves in cell culture media over several days without cytotoxic effects and stability is tunable by modifying the density of a superficial oxide. The results establish pnc-Si as a viable substrate for cell culture and a degradable biomaterial. Pnc-Si membranes should find use in the study of molecular transport through cell monolayers, in studies of cell-cell communication, and as biodegradable scaffolds for three-dimensional tissue constructs. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Agrawal, A. A.; Nehilla, B. J.; Gaborski, T. R.; McGrath, J. L.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.
   [Reisig, K. V.] SiMPore Inc, Rochester, NY 14627 USA.
   [Fang, D. Z.; Striemer, C. C.; Fauchet, P. M.] Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA.
RP McGrath, JL (reprint author), Univ Rochester, Dept Biomed Engn, 601 Elmwood Ave, Rochester, NY 14627 USA.
EM jmcgrath@bme.rochester.edu
RI Gaborski, Thomas/F-4306-2012
FU NYSTAR Center for Emerging and Innovative Sciences (CEIS); SiMPore Inc.
FX We would like to thank members of the Nanomembrane Research Group at the
   University of Rochester for their scientific and technical help. TEM
   images for porosity measurements were taken by Karen Bentley and HUVEC
   were provided by Loel Turpin from the Microbiology & Immunology Lab at
   University of Rochester Medical Centre. Silicon microprocessing was
   conducted at the Hopeman Microfabrication Facility at the University of
   Rochester and the Semiconductor and Microsystems Fabrication Laboratory
   (SMFL) at the Rochester Institute of Technology. This work was partially
   supported by a grant from the NYSTAR Center for Emerging and Innovative
   Sciences (CEIS) and SiMPore Inc. As founders of SiMPore Inc., JLM, TRG,
   PMF, and CSS declare a competing financial interest in this work.
CR Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Alvarez SD, 2009, BIOMATERIALS, V30, P26, DOI 10.1016/j.biomaterials.2008.09.005
   Anderson IC, 2000, CANCER RES, V60, P269
   Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Avdeef A, 2005, EUR J PHARM SCI, V24, P333, DOI 10.1016/j.ejps.2004.11.011
   Bayliss SC, 2000, J POROUS MAT, V7, P191, DOI 10.1023/A:1009686704506
   Bayliss SC, 1999, ADV MATER, V11, P318, DOI 10.1002/(SICI)1521-4095(199903)11:4<318::AID-ADMA318>3.0.CO;2-Z
   Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395
   Bordoni V, 2004, HEPATOLOGY, V39, P1508, DOI 10.1002/hep.20234
   Brischwein M, 2003, LAB CHIP, V3, P234, DOI 10.1039/b308888j
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   Cappi B., 2009, J BIOMED MATER RES A, V93, P67
   Chin V, 2001, ADV MATER, V13, P1877, DOI 10.1002/1521-4095(200112)13:24<1877::AID-ADMA1877>3.0.CO;2-4
   Franco L, 2001, J BIOL CHEM, V276, P21642, DOI 10.1074/jbc.M010536200
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   Gaborski TR, 2008, BIOPHYS J, V95, P4934, DOI 10.1529/biophysj.108.132886
   GABORSKI TR, NAT NANOTECHNO UNPUB
   Gautam N, 1998, BRIT J PHARMACOL, V125, P1109, DOI 10.1038/sj.bjp.0702186
   GRATTAROLA M, 1988, BIOMATERIALS, V9, P101, DOI 10.1016/0142-9612(88)90079-8
   Guo ML, 2008, BIOSENS BIOELECTRON, V23, P865, DOI 10.1016/j.bios.2007.09.006
   Harris SG, 2003, BIOTECHNOL BIOPROC E, V8, P246, DOI 10.1007/BF02942273
   Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303
   Hultman K, 2010, NEUROSCIENCE, V166, P408, DOI 10.1016/j.neuroscience.2010.01.002
   Ichijo H, 1998, J NEUROSCI, V18, P5008
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kim E, 2008, J AM CHEM SOC, V130, P4230, DOI 10.1021/ja711258w
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Kornyei Z, 2005, GLIA, V49, P430, DOI 10.1002/glia.20123
   Lakard S, 2004, BIOELECTROCHEMISTRY, V62, P19, DOI 10.1016/j.bioelechem.2003.03.009
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Ma SH, 2005, LAB CHIP, V5, P74, DOI 10.1039/b405713a
   MAN S, 2008, CLIN DEV IMMUNOL
   Matsson P, 2005, J MED CHEM, V48, P604, DOI 10.1021/jm049711o
   Mayne AH, 2000, PHYS STATUS SOLIDI A, V182, P505, DOI 10.1002/1521-396X(200011)182:1<505::AID-PSSA505>3.0.CO;2-#
   Morita M, 1990, J APPL PHYS, V68, P1271
   Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rifas L, 1999, J BONE MINER RES, V14, P1096, DOI 10.1359/jbmr.1999.14.7.1096
   SCHRAMM CA, 1994, DEV BIOL, V163, P467, DOI 10.1006/dbio.1994.1163
   Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x
   Striemer CC, 2007, NATURE, V445, P749, DOI 10.1038/nature05532
   TSAI MA, 1993, BIOPHYS J, V65, P2078, DOI 10.1016/S0006-3495(93)81238-4
   Van Rijn C.J.M., 2004, NANO MICROENGINEERED
   Voger E A, 1987, J Biomed Mater Res, V21, P1197
   ZHANG X, 2004, J ELECTROCHEM SOC, V151, P856
NR 49
TC 45
Z9 45
U1 3
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2010
VL 31
IS 20
BP 5408
EP 5417
DI 10.1016/j.biomaterials.2010.03.041
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 608GP
UT WOS:000278571800013
PM 20398927
DA 2018-10-19
ER

PT J
AU Chen, YC
   Lee, DC
   Tsai, TY
   Hsiao, CY
   Liu, JW
   Kao, CY
   Lin, HK
   Chen, HC
   Palathinkal, TJ
   Pong, WF
   Tai, NH
   Lin, IN
   Chiu, IM
AF Chen, Ying-Chieh
   Lee, Don-Ching
   Tsai, Tsung-Yen
   Hsiao, Chao-Yang
   Liu, Jen-Wea
   Kao, Chien-Yu
   Lin, Hua-Kuo
   Chen, Huang-Chin
   Palathinkal, Thomas Joseph
   Pong, Way-Faung
   Tai, Nyan-Hwa
   Lin, I-Nan
   Chiu, Ing-Ming
TI Induction and regulation of differentiation in neural stem cells on
   ultra-nanocrystalline diamond films
SO BIOMATERIALS
LA English
DT Article
DE Ultra-nanocrystalline diamond; Neural stem cells; Differentiation
ID CENTRAL-NERVOUS-SYSTEM; STEM/PROGENITOR CELLS; NEUROTROPHIC FACTORS;
   SIGNALING PATHWAY; MESENCHYMAL STEM; PRECURSOR CELLS; MAP KINASE;
   GROWTH; ADHESION; INTEGRINS
AB The interaction of ultra-nanocrystalline diamond (UNCD) with neural stem cells (NSCs) has been studied in order to evaluate its potential as a biomaterial. Hydrogen-terminated UNCD (H-UNCD) films were compared with standard grade polystyrene in terms of their impact on the differentiation of NSCs. When NSCs were cultured on these substrates in medium supplemented with low concentration of serum and without any differentiating factors, H-UNCD films spontaneously induced neuronal differentiation on NSCs. By direct suppression of mitogen-activated protein kinase/extracellular signaling-regulated kinase1/2 (MAPK/Erk1/2) signaling pathway in NSCs using U0126, known to inhibit the activation of Erk1/2, we demonstrated that the enhancement of Erk1/2 pathway is one of the effects of H-UNCD-induced NSCs differentiation. Moreover, functional-blocking antibody directed against integrin beta 1 subunit inhibited neuronal differentiation on H-UNCD films. This result demonstrated the involvement of integrin beta 1 in H-UNCD-mediated neuronal differentiation. Mechanistic studies revealed the cell adhesion to H-UNCD films associated with focal adhesion kinase (Fak) and initiated MAPK/Erk1/2 signaling. Our study demonstrated that H-UNCD films-mediated NSCs differentiation involves fibronectin-integrin beta 1 and Fak-MAPK/Erk signaling pathways in the absence of differentiation factors. These observations raise the potential for the use of UNCD as a biomaterial for central nervous system transplantation and tissue engineering. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Chen, Ying-Chieh; Lee, Don-Ching; Hsiao, Chao-Yang; Liu, Jen-Wea; Kao, Chien-Yu; Lin, Hua-Kuo; Chiu, Ing-Ming] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli 35053, Taiwan.
   [Chen, Ying-Chieh; Tsai, Tsung-Yen; Tai, Nyan-Hwa] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
   [Liu, Jen-Wea; Chiu, Ing-Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung 420, Taiwan.
   [Kao, Chien-Yu; Chiu, Ing-Ming] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan.
   [Chen, Huang-Chin; Palathinkal, Thomas Joseph; Pong, Way-Faung; Lin, I-Nan] Tamkang Univ, Dept Phys, Tamsui 251, Taiwan.
   [Chiu, Ing-Ming] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.
RP Chiu, IM (reprint author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli 35053, Taiwan.
EM nhtai@mx.nthu.edu.tw; ingming@nhri.org.tw
RI Chiu, Ing-Ming/B-1534-2008
FU National Science Council, Taiwan [NSC 98-2314-B-400-003-MY3, NSC
   98-2627-B-400-003, NSC 95-2221-E-007-045-MY3, NSC 96-2112-M032-011-MY3];
   National Health Research Institute, Taiwan [99A1-CSPP02-014]
FX The present study was supported from the National Science Council,
   Taiwan under project number NSC 98-2314-B-400-003-MY3, NSC
   98-2627-B-400-003, NSC 95-2221-E-007-045-MY3 and NSC
   96-2112-M032-011-MY3. The authors also acknowledge National Health
   Research Institute, Taiwan for financial support under project number
   99A1-CSPP02-014. Moreover, we would like to thank Cell Sorter Core
   Facility at National Health Research Institutes, Taiwan for flow
   cytometry services.
CR AHMED S, 1995, J NEUROSCI, V15, P5765
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Bakowicz-Mitura K, 2007, SURF COAT TECH, V201, P6131, DOI 10.1016/j.surfcoat.2006.08.142
   Bijnens N, 2009, PHYS STATUS SOLIDI A, V206, P520, DOI 10.1002/pssa.200880485
   Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477
   Campos LS, 2004, J NEUROSCI RES, V78, P761, DOI 10.1002/jnr.20333
   Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240
   Chang MY, 2003, MOL CELL NEUROSCI, V23, P414, DOI 10.1016/S1044-7431(03)00068-X
   Chekhonin VP, 2007, NEUROCHEM J, V1, P113, DOI 10.1134/S181971240702002X
   Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   Ciccolini F, 1998, J NEUROSCI, V18, P7869
   Clem WC, 2008, BIOMATERIALS, V29, P3461, DOI 10.1016/j.biomaterials.2008.04.045
   Espinosa HD, 2003, EXP MECH, V43, P256, DOI 10.1007/BF02410524
   Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604
   Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076
   Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516
   Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x
   Hsu YC, 2007, CELL TRANSPLANT, V16, P133
   Hsu YC, 2009, DEV DYNAM, V238, P302, DOI 10.1002/dvdy.21753
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036
   Lanfer B, 2009, BIOMATERIALS, V30, P5950, DOI 10.1016/j.biomaterials.2009.07.039
   Lechleitner T, 2008, BIOMATERIALS, V29, P4275, DOI 10.1016/j.biomaterials.2008.07.023
   Lee DC, 2009, MOL CELL NEUROSCI, V41, P348, DOI 10.1016/j.mcn.2009.04.010
   Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002
   Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057
   Liu KK, 2009, BIOMATERIALS, V30, P4249, DOI 10.1016/j.biomaterials.2009.04.056
   Ma W, 2008, BMC DEV BIOL, V8, P13
   Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008
   Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158
   Puzyr AP, 2007, DIAM RELAT MATER, V16, P2124, DOI 10.1016/j.diamond.2007.07.025
   QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762
   Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335
   Shetty AK, 2007, STEM CELLS, V25, P2396, DOI 10.1634/stemcells.2007-0313
   Smith LA, 2009, BIOMATERIALS, V30, P2516, DOI 10.1016/j.biomaterials.2009.01.009
   Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x
   Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.men.2004.05.001
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Yamaki K, 2009, BIOMATERIALS, V30, P1421, DOI 10.1016/j.biomaterials.2008.11.036
   Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x
   Yang L, 2009, BIOMATERIALS, V30, P3458, DOI 10.1016/j.biomaterials.2009.03.014
NR 50
TC 48
Z9 49
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2010
VL 31
IS 21
BP 5575
EP 5587
DI 10.1016/j.biomaterials.2010.03.061
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 614XH
UT WOS:000279092600010
PM 20427083
DA 2018-10-19
ER

PT J
AU Nigro, J
   White, JF
   Ramshaw, JAM
   Haylock, DN
   Nilsson, SK
   Werkmeister, JA
AF Nigro, Julie
   White, Jacinta F.
   Ramshaw, John A. M.
   Haylock, David N.
   Nilsson, Susan K.
   Werkmeister, Jerome A.
TI The effect of bovine endosteum-derived particles on the proliferation of
   human mesenchymal stem cells
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cell; Bioreactor; Glycosaminoglycan; Cell
   proliferation; Bone marrow; Cell adhesion
ID HUMAN BONE-MARROW; EXTRACELLULAR-MATRIX COMPONENTS; SMALL-INTESTINAL
   SUBMUCOSA; EX-VIVO EXPANSION; PROGENITOR CELLS; MYOCARDIAL-INFARCTION;
   CARTILAGE DEFECTS; CHONDROGENIC DIFFERENTIATION; STROMAL CELLS;
   GROWTH-FACTOR
AB There is a large biomanufacturing and clinical need for cost-effective and simple techniques to expand mesenchymal stem cells whilst retaining their multipotency. Endosteum-derived particles were prepared, characterised and examined as a biomaterial to facilitate the in vitro expansion of human mesenchymal stem cells. Bovine endosteum-derived particles are composed of chondroitin sulphate glycosaminoglycans with 4- and 6-sulphation and N-sulphated heparan sulphate glycosaminoglycans. The particles were positive for perlecan, laminin and fibronectin by immunohistochemistry and alpha-mannose, alpha-glucose, terminal N-acetyl-alpha-D-glucosamine, N-acetyl-alpha-galactosamine and alpha-fucose, using lectin binding. Human mesenchymal stem cells showed greater than 96% attachment to the particles after one day in spinner culture. After 7 days, the stem cells on decalcified particles were viable and had a 5-fold higher growth than the stem cells grown on Cytodex-2 beads. Significantly more stem cells were recovered from decalcified particles compared with mineralised particles (P < 0.05). Differentiation to chondrogenic, osteogenic and adipogenic lineages was maintained after culturing stem cells on the demineralised particles. We conclude that bovine endosteum-derived particles can be extracted from bone marrow to retain sulphated proteoglycans and glycosylated proteins. These particles are a suitable biomaterial for supporting the growth and retaining the multipotency of human mesenchymal stem cells. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Nigro, Julie; White, Jacinta F.; Ramshaw, John A. M.; Haylock, David N.; Nilsson, Susan K.; Werkmeister, Jerome A.] CSIRO, Clayton, Vic 3168, Australia.
   [Nigro, Julie; White, Jacinta F.; Ramshaw, John A. M.; Haylock, David N.; Nilsson, Susan K.; Werkmeister, Jerome A.] Cooperat Res Ctr Polymers, Notting Hill, Vic 3168, Australia.
   [Nigro, Julie; Haylock, David N.; Nilsson, Susan K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3168, Australia.
   [Haylock, David N.; Nilsson, Susan K.] Australian Stem Cell Ctr, Clayton, Vic 3168, Australia.
RP Nigro, J (reprint author), CSIRO, 343 Royal Parade, Parkville, Vic 3052, Australia.
EM julie.nigro@csiro.au
RI White, Jacinta/D-6961-2013; Nilsson, Susie/C-5563-2015
OI White, Jacinta/0000-0002-4855-0170; Nilsson, Susie/0000-0002-7926-7335
FU Australian Stem Cell Centre
FX We would like to thank Ms. Brenda Williams, Dr. Rosa McCarty and Ms
   Genevieve Whitty all from the Australian Stem Cell Centre, Clayton,
   Australia, for technical assistance with immunofluorescence, the MSC
   differentiation experiments and MSC cultures, respectively. We are
   grateful to the St Vincent's Hospital for providing the human bone
   marrow for the isolation of the MSC. Dr. Laurence Meagher and Dr. Kjiana
   Schwab, both from CSIRO Clayton, Australia, are acknowledged for their
   critical evaluation of the manuscript. This work was partly supported by
   the Australian Stem Cell Centre.
CR BADYLAK S, 2008, Patent No. 260831
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Chu L, 2001, CURR OPIN BIOTECH, V12, P180, DOI 10.1016/S0958-1669(00)00197-X
   Dixon JA, 2009, CIRCULATION, V120, pS220, DOI 10.1161/CIRCULATIONAHA.108.842302
   Doctor J, 2002, DEV BIOL, V247, P505
   GIMBLE JM, 1998, MARROW STROMAL CELL, P67
   GRONTHOS S, 1994, BLOOD, V84, P4164
   Hamamoto H, 2009, ANN THORAC SURG, V87, P794, DOI 10.1016/j.athoracsur.2008.11.057
   HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945
   Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1063/stemcells.2006-0528
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199
   KLEIN G, 1995, MATRIX BIOL, V14, P457, DOI 10.1016/0945-053X(95)90003-9
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557
   Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001
   Li F, 2001, BLOOD, V98, P335, DOI 10.1182/blood.V98.2.335
   LIVESEY SA, 2003, Patent No. 143207
   Lu HX, 2009, J BIOMAT SCI-POLYM E, V20, P577, DOI 10.1163/156856209X426402
   Lum LY, 2003, IEEE ENG MED BIOL, V22, P71, DOI 10.1109/MEMB.2003.1256275
   Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211
   Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422
   Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311
   Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   SAMPATH TK, 1984, P NATL ACAD SCI-BIOL, V81, P3419, DOI 10.1073/pnas.81.11.3419
   Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73
   Tew SR, 2008, METHODS, V45, P2, DOI 10.1016/j.ymeth.2008.01.006
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747
   Weber Christian, 2007, Open Biomed Eng J, V1, P38, DOI 10.2174/1874120700701010038
   Wu Qing-Fa, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P15
   Yang Y, 2007, BIOMATERIALS, V28, P3110, DOI 10.1016/j.biomaterials.2007.03.015
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184
   2009, MKMK2496496
NR 49
TC 8
Z9 8
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2010
VL 31
IS 21
BP 5689
EP 5699
DI 10.1016/j.biomaterials.2010.03.054
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 614XH
UT WOS:000279092600022
PM 20434212
DA 2018-10-19
ER

PT J
AU Suehiro, T
   Kojima, C
   Tsumura, S
   Harada, A
   Kono, K
AF Suehiro, Tomoyuki
   Kojima, Chie
   Tsumura, Sayako
   Harada, Atsushi
   Kono, Kenji
TI Higher Order Structure of Short Collagen Model Peptides Attached to
   Dendrimers and Linear Polymers
SO BIOPOLYMERS
LA English
DT Article
DE collagen; dendrimer; peptide; linear polymer; triple helix
ID MIMETIC DENDRIMERS; BLOCK-COPOLYMERS; DELIVERY; SEQUENCES
AB Collagen, which is used as a biomaterial, is the most abundant protein in mammals. We have previously reported that a dendrimer modified with collagen model peptides, (Gly-Pro-Pro)(5), formed a collagen-like triple-helical structure, showing thermal reversibility. In this study, various collagen-mimic dendrimers of different generations and at different binding ratios were synthesized, to investigate the relationship between the peptide clustering effect and the higher order structure formation. The formation of the higher order structure was influenced by the binding ratios of the peptide to the dendrimer, but was not influenced by the dendrimer generation. A spacer, placed between the dendrimer terminal group and the peptide, negatively contributed to the formation of the higher order structure. The collagen model peptides were also attached to poly(allylamine) (PAA) and poly-L-lysine (poly(Lys)) to compare them with the collagen-mimic dendrimers. The PAA-based collagen-mimic compound, bearing more collagen model peptides than the dendrimer, exhibited a thermally stable higher order structure. In contrast, this was not observed for the collagen-mimic polymers based on poly(Lys). Therefore, dendrimers and vinyl polymers act as a scaffold for collagen model peptides and subsequently induce higher order structures. (C) 2010 Wiley Periodicals, Inc. Biopolymers 93: 640-648, 2010.
C1 [Kojima, Chie] Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, Osaka 5998570, Japan.
   [Suehiro, Tomoyuki; Tsumura, Sayako; Harada, Atsushi; Kono, Kenji] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Osaka 5998531, Japan.
RP Kojima, C (reprint author), Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, 1-2 Gakuen Cho, Osaka 5998570, Japan.
EM c-kojima@21c.osakafu-u.ac.jp
FU Cosmetology Research Foundation; Ministry of Education, Culture, Sports,
   Science, and Technology of Japan (MEXT)
FX Contract grant sponsors: Cosmetology Research Foundation and Ministry of
   Education, Culture, Sports, Science, and Technology of Japan (MEXT)
CR Alberts B, 2002, MOL BIOL CELL
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   Cai W, 2007, BIOORG CHEM, V35, P327, DOI 10.1016/j.bioorg.2007.01.003
   FASMAN GD, 1996, CIRCULAR DICHROISM C
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023
   Kinberger GA, 2002, J AM CHEM SOC, V124, P15162, DOI 10.1021/ja021203l
   Kinberger GA, 2006, TETRAHEDRON, V62, P5280, DOI 10.1016/j.tet.2006.01.107
   Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518
   Kojima C, 2007, BIOCONJUGATE CHEM, V18, P663, DOI 10.1021/bc060244u
   Kojima C, 2009, J AM CHEM SOC, V131, P6052, DOI 10.1021/ja809639c
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j
   Namazi H, 2005, J POLYM SCI POL CHEM, V43, P28, DOI 10.1002/pola.20471
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Tekade RK, 2009, CHEM REV, V109, P49, DOI 10.1021/cr068212n
   Tomalia DA, 2003, TETRAHEDRON, V59, P3799, DOI 10.1016/S0040-4020(03)00430-7
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wolinsky JB, 2008, ADV DRUG DELIVER REV, V60, P1037, DOI 10.1016/j.addr.2008.02.012
   Yuba E, 2008, J CONTROL RELEASE, V130, P77, DOI 10.1016/j.jconrel.2008.05.007
   Yusa SI, 2005, BIOMACROMOLECULES, V6, P663, DOI 10.1021/bm0495553
NR 23
TC 15
Z9 15
U1 0
U2 17
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD JUL
PY 2010
VL 93
IS 7
BP 640
EP 648
DI 10.1002/bip.21413
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 600KF
UT WOS:000277983900005
PM 20162722
DA 2018-10-19
ER

PT J
AU Hinze, MC
   Wiedmann-Al-Ahmad, M
   Glaum, R
   Gutwald, R
   Schmelzeisen, R
   Sauerbier, S
AF Hinze, Marc Christian
   Wiedmann-Al-Ahmad, Margit
   Glaum, Ricarda
   Gutwald, Ralf
   Schmelzeisen, Rainer
   Sauerbier, Sebastian
TI Bone engineering-vitalisation of alloplastic and allogenic bone grafts
   by human osteoblast-like cells
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
DE Bone engineering; Human osteoblast-like cells; Demineralised bone
   matrix; Hydroxyapatite; Cell proliferation
ID IN-VITRO; BIOMATERIALS; ROUGHNESS; ALLOGRAFT; ADHESION; CULTURE;
   PROTEIN; GROWTH
AB Human osteoblasts on non-sintered hydroxyapatite and demineralised bone matrix (DBX (R)) were analysed in vitro to find out whether they would be suitable for reconstruction of bones in oral surgery. Human osteoblasts were isolated from the jaw during routine dental operations and seeded onto the two biomaterials. Cells were characterised by assay of alkaline phosphatase, detection of type I collagen, and production of osteocalcin. After 21 days of cultivation, the cell/biomaterial constructs were examined by scanning electron microscopy, thin sections, and propidium iodide/fluorescein diacetate staining. The osteoblasts formed a vital multiple cell layer on DBX (R) within 3 weeks of cultivation. On hydroxyapatite, the cells showed no tendency to proliferate or migrate onto the synthetic biomaterial, or to form well-spread and viable cell constructs. These findings suggest that surface morphology or the presence of osteoinductive factors may have an important role in the adhesion and proliferation of osteoblasts. Human DBX can be colonised by human osteoblast-like cells in vitro, indicating the potential of allogeneic carriers for future procedures in bone engineering. (C) 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Hinze, Marc Christian; Wiedmann-Al-Ahmad, Margit; Glaum, Ricarda; Gutwald, Ralf; Schmelzeisen, Rainer; Sauerbier, Sebastian] Univ Hosp Freiburg, Dept Oral & Craniomaxillofacial Surg, Freiburg, Germany.
RP Sauerbier, S (reprint author), Univ Klin Zahn Mund & Kieferheilkunde, Abt Klin & Poliklin Mund Kiefer & Gesichtschirurg, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM sebastian.sauerbier@uniklinik-freiburg.de
OI Schmelzeisen, Rainer/0000-0002-9686-6989
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   KASPERK C, 1995, J CLIN ENDOCR METAB, V80, P2511, DOI 10.1210/jc.80.8.2511
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LANGER R, 1993, SCIENCE, V920, P260
   LEUNG KS, 1993, J BONE JOINT SURG BR, V75, P288
   Malekzadeh R, 1998, J PERIODONTOL, V69, P1256, DOI 10.1902/jop.1998.69.11.1256
   MARK DE, 1990, PLAST RECONSTR SURG, V86, P623, DOI 10.1097/00006534-199010000-00001
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NOLAN PC, 1992, J BONE JOINT SURG BR, V74, P284
   Pradel W, 2006, ORAL SURG ORAL MED O, V101, P285, DOI 10.1016/j.tripleo.2005.06.001
   Redlich A, 1999, J MATER SCI-MATER M, V10, P767, DOI 10.1023/A:1008994715605
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   SHIGEYAMA Y, 1995, J PERIODONTOL, V66, P478, DOI 10.1902/jop.1995.66.6.478
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Vacanti CA, 2000, ORTHOP CLIN N AM, V31, P351, DOI 10.1016/S0030-5898(05)70155-3
   Vlassis J M, 1993, Pract Periodontics Aesthet Dent, V5, P15
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
NR 25
TC 5
Z9 5
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD JUL
PY 2010
VL 48
IS 5
BP 369
EP 373
DI 10.1016/j.bjoms.2009.06.011
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 625IZ
UT WOS:000279890000009
PM 19596502
DA 2018-10-19
ER

PT J
AU Wei, JC
   Sun, JR
   Wang, HJ
   Chen, XS
   Jing, XB
AF Wei, Jun-chao
   Sun, Jing-ru
   Wang, Hai-juan
   Chen, Xue-si
   Jing, Xia-bin
TI ISOTHERMAL CRYSTALLIZATION BEHAVIOR AND UNIQUE BANDED SPHERULITES OF
   HYDROXYAPATITE/POLY(L-LACTIDE) NANOCOMPOSITES
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE Hydroxyapatite; Polylactide; Crystallization; Nanocomposites;
   Spherulites
ID TISSUE ENGINEERING SCAFFOLDS; BIODEGRADABLE POLYMERS; POLY(L-LACTIC
   ACID); COMPOSITE SCAFFOLDS; HYDROXYAPATITE; POLYLACTIDE; ADHESION;
   BLENDS; BIOMATERIAL; DEGRADATION
AB Hydroxyapatite/poly(L-lactide) (HA/PLLA) nanocomposites were prepared by the solvent mixing method. The isothermal crystallization behavior was studied by differential scanning calorimetry (DSC) and polarized optical microscopy (POM). The results show that the crystallization behavior of HA/PLLA composites was strongly affected by the content of HA and crystallization temperature, and the addition of HA could promote nucleation and enhance the crystallization rate. When isothermal crystallization was carried out at 110 C, the HA/PLLA nanocomposite with 1% HA content crystallized most rapidly among all the composites and the half crystallization time was only 1.0 min. Banded spherulites were observed for the HA/PLLA composites, but no banded spherulites were seen in the crystals of PLLA under the same condition.
C1 [Wei, Jun-chao; Sun, Jing-ru; Wang, Hai-juan; Chen, Xue-si; Jing, Xia-bin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   [Wei, Jun-chao; Chen, Xue-si; Jing, Xia-bin] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
RP Chen, XS (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
EM xschen@ciac.jl.cn
FU National Natural Science Foundation of China [50733003, 20604030];
   Ministry of Science and Technology of China [20071314]; Chinese Academy
   of Sciences [KGCX-YW-208]
FX This work was supported by the National Natural Science Foundation of
   China (Key Project No. 50733003 and Project No. 20604030), the
   International Cooperation fund of Science and Technology (Key project
   20071314) from the Ministry of Science and Technology of China, and the
   fund from Chinese Academy of Sciences (KGCX-YW-208).
CR Bigi A, 2004, J MATER CHEM, V14, P274, DOI 10.1039/b308687a
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Bordes P, 2009, PROG POLYM SCI, V34, P125, DOI 10.1016/j.progpolymsci.2008.10.002
   Cai Q, 2002, BIOMATERIALS, V23, P4483, DOI 10.1016/S0142-9612(02)00168-0
   Chang JH, 2007, J MATER CHEM, V17, P238, DOI 10.1039/b609409k
   Chao CC, 2008, MACROMOLECULES, V41, P3949, DOI 10.1021/ma702416n
   DUNCAN MC, 1961, SCIENCE, V133, P281
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P328, DOI 10.1002/mabi.200700107
   Krikorian V, 2004, MACROMOLECULES, V37, P6480, DOI 10.1021/ma049283w
   Lee HJ, 2006, CHEM MATER, V18, P5111, DOI 10.1021/cm061139x
   Lotz B, 2006, POLYMER, V47, P3267, DOI 10.1016/j.polymer.2006.03.026
   Mathieu LM, 2006, COMPOS SCI TECHNOL, V66, P1606, DOI 10.1016/j.compscitech.2005.11.012
   Meaurio E, 2006, J PHYS CHEM B, V110, P5790, DOI 10.1021/jp055203u
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nam JY, 2003, MACROMOLECULES, V36, P7126, DOI 10.1021/ma034623j
   Neuendorf RE, 2008, ACTA BIOMATER, V4, P1288, DOI 10.1016/j.actbio.2008.04.006
   Pan PJ, 2008, J POLYM SCI POL PHYS, V46, P2222, DOI 10.1002/polb.21554
   Russias J, 2006, J MATER SCI, V41, P5127, DOI 10.1007/s10853-006-0449-1
   Sarasua JR, 2005, MACROMOLECULES, V38, P8362, DOI 10.1021/ma051266z
   Suljovrujic E, 2007, RADIAT PHYS CHEM, V76, P722, DOI 10.1016/j.radphyschem.2006.02.013
   Wang YM, 2007, J APPL POLYM SCI, V105, P3500, DOI 10.1002/app.26494
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wildemann B, 2004, J CONTROL RELEASE, V95, P249, DOI 10.1016/j.jconrel.2003.11.014
   Xu J, 2005, POLYMER, V46, P9176, DOI 10.1016/j.polymer.2005.07.010
   Yang ZW, 2005, J MATER CHEM, V15, P1807, DOI 10.1039/b418015c
   Yu L, 2006, PROG POLYM SCI, V31, P576, DOI 10.1016/j.progpolymsci.2006.03.002
   Zhao YY, 2008, J PHYS CHEM B, V112, P16461, DOI 10.1021/jp805230e
NR 32
TC 21
Z9 23
U1 4
U2 34
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7679
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD JUL
PY 2010
VL 28
IS 4
BP 499
EP 507
DI 10.1007/s10118-010-9060-7
PG 9
WC Polymer Science
SC Polymer Science
GA 615DC
UT WOS:000279111600005
DA 2018-10-19
ER

PT J
AU von Wilmowsky, C
   Stockmann, P
   Metzler, P
   Harsch, IA
   Amann, K
   Schlegel, KA
AF von Wilmowsky, Cornelius
   Stockmann, Philipp
   Metzler, Philipp
   Harsch, Igor Alexander
   Amann, Kerstin
   Schlegel, Karl Andreas
TI Establishment of a streptozotocin-induced diabetic domestic pig model
   and a systematic evaluation of pathological changes in the hard and soft
   tissue over a 12-month period
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE angiopathies; bone; diabetes; domestic pig
ID IMPLANT BONE DEFECTS; MINIATURE PIG; MELLITUS; REGENERATION; METABOLISM;
   EXPRESSION
AB Objective
   The number of diabetic patients in need of medical treatment is growing steadily. Therefore, a diabetic animal model with high degree of similarities with humans, which is suitable for the systematic evaluation of biomaterials and medical devices, is needed.
   Materials and methods
   Twenty domestic pigs were used for the study. Fifteen received Streptozotocin (STZ) to induce diabetes mellitus. Internal parameters were measured and bone as well as soft tissues biopsies were taken after 0, 6 and 12 months and evaluated qualitatively and quantitatively by means of scanning electronic microscopy, light microscopy and microradiography.
   Results
   The results of the clinical internal parameters, determined by the American Diabetes Association for the definition of diabetes mellitus could be fulfilled. Pathological changes of the skin vasculatures were already visible after 6 months with a significant wall thickening in the diabetic group. The bone mineralization was lower in the diabetic group after 6 months and with a significant difference after 12 months.
   Conclusion
   From the present results, it can be concluded that a STZ dosage of 90 mg/kg body weight in the domestic pig is suitable for the induction of an apparent diabetes, leading to histolopathological changes in the hard and soft tissues already after 6 months. The high degree of similarities with humans makes it an interesting diabetic animal model for biomaterial research in a compromised animal model.
   To cite this article:von Wilmowsky C, Stockmann P, Metzler P, Harsch IA, Amann K, Schlegel KA. Establishment of a streptozotocin-induced diabetic domestic pig model and a systematic evaluation of pathological changes in the hard and soft tissue over a 12-month period.Clin. Oral Impl. Res. 21, 2010; 709-717.doi: 10.1111/j.1600-0501.2010.01914.x.
C1 [von Wilmowsky, Cornelius; Stockmann, Philipp; Metzler, Philipp; Schlegel, Karl Andreas] Univ Erlangen Nurnberg, Dept Oral & Maxillofacial Surg, D-91054 Erlangen, Germany.
   [Harsch, Igor Alexander] Univ Erlangen Nurnberg, Div Endocrinol & Metab, Dept Med 1, D-91054 Erlangen, Germany.
   [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany.
RP von Wilmowsky, C (reprint author), Univ Erlangen Nurnberg, Dept Oral & Maxillofacial Surg, Ulmenweg 18, D-91054 Erlangen, Germany.
EM cornelius.von-wilmowsky@uk-erlangen.de
RI Schlegel, Karl Andreas/D-1015-2010; Stockmann, Philipp/E-5846-2010
FU University of Erlangen [ELAN-07.02.26.1]; ITI Foundation/Research
   Committee [ITI-5052007]; University of Erlangen-Nurnberg [20051011]
FX This project was founded by the ELAN-Fond of the University of Erlangen
   (ELAN-07.02.26.1) and the ITI Foundation/Research Committee
   (ITI-5052007) as well as the IZKF (Interdisciplinary Centre of Clinical
   Research of the University of Erlangen-Nurnberg, 20051011). The work of
   Susanne Schonherr, Andrea Krautheim-Zenk and Heidemarie Heider is highly
   appreciated. Furthermore, we would like to thank Elfriede Tissera of the
   Department of Manufacturing Technology for the electron microscopy
   scanning pictures and Sandra Romeis (Department of Method and Product
   Development [GfK SE], Nuremberg, Germany) for the statistical advisory.
CR American Diabetes Association, 2006, DIABETES CARE, V29, P43, DOI DOI 10.2337/DC09-S062
   Barth C. A., 1990, J ANIM PHYSIOL AN N, V20, P39
   BEDDOE AH, 1978, CALC TISS RES, V25, P273, DOI 10.1007/BF02010781
   Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Fricker Janet, 2001, Drug Discovery Today, V6, P921, DOI 10.1016/S1359-6446(01)01973-0
   GRUESSNER RWG, 1990, J SURG RES, V49, P366, DOI 10.1016/0022-4804(90)90039-5
   Jehle PM, 1998, J ENDOCRINOL, V159, P297, DOI 10.1677/joe.0.1590297
   KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775
   LAIBLIN C, 1979, BERL MUNCH TIERARZTL, V92, P124
   Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072
   Lutz R, 2008, CLIN ORAL IMPLAN RES, V19, P590, DOI 10.1111/j.1600-0501.2007.01526.x
   MARSHALL M, 1980, RES EXP MED, V177, P145, DOI 10.1007/BF01851843
   MARSHALL M, 1979, RES EXP MED, V175, P187, DOI 10.1007/BF01851826
   Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024
   Mellado-Valero A, 2007, MED ORAL PATOL ORAL, V12, P38
   Morris H F, 2000, Ann Periodontol, V5, P157, DOI 10.1902/annals.2000.5.1.157
   NUNAMAKER DM, 1998, CLIN ORTHOP S, V355, P56
   Olson JW, 2000, INT J ORAL MAX IMPL, V15, P811
   Park J, 2007, BIOMATERIALS, V28, P2772, DOI 10.1016/j.biomaterials.2007.012.009
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Petersen M, 2003, DIABETES CARE, V26, P917
   Schlegel KA, 2006, ORAL SURG ORAL MED O, V102, P7, DOI 10.1016/j.tripleo.2005.09.011
   Schlegel KA, 2006, CLIN ORAL IMPLAN RES, V17, P666, DOI 10.1111/j.1600-0501.2006.01214.x
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schwartz-Arad Devorah, 2005, Implant Dent, V14, P131, DOI 10.1097/01.id.0000165031.33190.0d
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Suzuki M, 2000, J DIABETES COMPLICAT, V14, P40, DOI 10.1016/S1056-8727(00)00052-0
   Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077
   Taylor George W, 2004, Compend Contin Educ Dent, V25, P179
   Tornig J, 1996, J AM SOC NEPHROL, V7, P667
   von Wilmowsky C, 2009, J BIOMED MATER RES B, V89B, P165, DOI 10.1002/jbm.b.31201
   WEIBEL ER, 1989, J MICROSC-OXFORD, V155, P393, DOI 10.1111/j.1365-2818.1989.tb02898.x
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   World Health Organization, 1999, DEF DIAGN CLASS DI 1
   Zhang LP, 2009, ACTA DIABETOL, V46, P119, DOI 10.1007/s00592-008-0068-1
NR 37
TC 16
Z9 16
U1 2
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2010
VL 21
IS 7
BP 709
EP 717
DI 10.1111/j.1600-0501.2010.01914.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 607PJ
UT WOS:000278517900005
PM 20636725
DA 2018-10-19
ER

PT J
AU Yu, L
   Zhang, HA
   Ding, JD
AF Yu, Lin
   Zhang, Huan
   Ding, Jiandong
TI Effects of precipitate agents on temperature-responsive sol-gel
   transitions of PLGA-PEG-PLGA copolymers in water
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE Sol-gel transition; Intelligent hydrogel; Physical gel; Precipitate
   agent effect; Injectable biomaterial; Amphiphilic block copolymer
ID BIODEGRADABLE BLOCK-COPOLYMERS; TRIBLOCK COPOLYMERS; AQUEOUS-SOLUTIONS;
   THERMOREVERSIBLE GELATION; DIBLOCK COPOLYMERS; DRUG-RELEASE; IN-SITU;
   HYDROGELS; DELIVERY; MICELLIZATION
AB This paper reports the effects of precipitate agents used in the collection of block copolymers composed of poly(lactic acid-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) on their thermogelling aqueous behaviors. We synthesized PLGA-PEG-PLGA triblock copolymers with a relatively wide distribution of molecular weight (MW) and then separated the crude polymers via three different precipitate agents (diethyl ether, hexane, or methanol). The obtained products exhibited, however, significantly different macroscopic states in water: some were sols, some were precipitates, and some underwent sol-gel transition upon heating. We found that by using different precipitate agents, ingredients of different MW were collected from the synthesized polymers, which accounted for the different states of the separated products in water. Our study strengthens the importance of an appropriate precipitate agent and reveals the subtle balance of hydrophobicity and hydrophilicity in this sort of amphiphilic block copolymers.
C1 [Yu, Lin; Zhang, Huan; Ding, Jiandong] Fudan Univ, Dept Macromol Sci, Adv Mat Lab, Key Lab Mol Engn Polymers,Minist Educ, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, Adv Mat Lab, Key Lab Mol Engn Polymers,Minist Educ, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI Zhang, Huan/O-7352-2014
OI Zhang, Huan/0000-0001-8625-8050
FU Chinese Ministry of Science and Technology [2009CB930000]; NSF of China
   [20774020, 50903021]; Science and Technology Developing Foundation of
   Shanghai [074319117, 09ZR1403700]; Specialized Research Fund for the
   Doctoral Program of Higher Education of China (SRFDP) [20090071120014];
   Shanghai Education Committee [B112]
FX The group was supported by the Chinese Ministry of Science and
   Technology (973 Program No. 2009CB930000), NSF of China (Grants No.
   20774020 and No. 50903021), Science and Technology Developing Foundation
   of Shanghai (Grants No. 074319117 and No. 09ZR1403700), the Specialized
   Research Fund for the Doctoral Program of Higher Education of China
   (SRFDP; No. 20090071120014), and Shanghai Education Committee (Project
   No. B112).
CR Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chen SB, 2005, INT J PHARM, V288, P207, DOI 10.1016/j.ijpharm.2004.09.026
   Cheng CJ, 2008, COLLOID POLYM SCI, V286, P571, DOI 10.1007/s00396-007-1817-3
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho J, 2008, COLLOID POLYM SCI, V286, P427, DOI 10.1007/s00396-007-1789-3
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Dayananda K, 2007, POLYMER, V48, P758, DOI 10.1016/j.polymer.2006.11.040
   DuValla GA, 2009, ANTI-CANCER DRUG, V20, P89, DOI 10.1097/CAD.0b013e3283222c12
   Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hou QP, 2008, J PHARM SCI-US, V97, P3972, DOI 10.1002/jps.21310
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong BM, 1999, J POLYM SCI POL CHEM, V37, P751
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kim MS, 2004, J POLYM SCI POL CHEM, V42, P5784, DOI 10.1002/pola.20430
   Kuckling D, 2009, COLLOID POLYM SCI, V287, P881, DOI 10.1007/s00396-009-2060-x
   Lally S, 2009, COLLOID POLYM SCI, V287, P335, DOI 10.1007/s00396-008-1994-8
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Lee SJ, 2006, J POLYM SCI POL CHEM, V44, P888, DOI 10.1002/pola.21193
   LI YX, 1993, J CONTROL RELEASE, V27, P248
   Liu RX, 2009, COLLOID POLYM SCI, V287, P627, DOI 10.1007/s00396-009-2028-x
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Madsen J, 2008, BIOMACROMOLECULES, V9, P2265, DOI 10.1021/bm8005006
   Meng ZY, 2009, COLLOID POLYM SCI, V287, P277, DOI 10.1007/s00396-008-1986-8
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   ODIAN G, 1991, PRINCIPLES POLYM
   Qiao MX, 2005, INT J PHARM, V294, P103, DOI 10.1016/j.ijpharm.2005.01.017
   Shim WS, 2006, BIOMACROMOLECULES, V7, P1935, DOI 10.1021/bm0600567
   Takeuchi Y, 2006, J POLYM SCI POL CHEM, V44, P671, DOI 10.1002/pola.21189
   Troll K, 2008, COLLOID POLYM SCI, V286, P1079, DOI 10.1007/s00396-008-1871-5
   Wong JE, 2009, MACROMOLECULES, V42, P1229, DOI 10.1021/ma802072c
   Xiang ML, 2000, MACROMOLECULES, V33, P6106, DOI 10.1021/ma992111s
   Yang J, 2004, MACROMOL BIOSCI, V4, P1092, DOI 10.1002/mabi.200400128
   Yang ZG, 2008, MACROMOL RAPID COMM, V29, P751, DOI 10.1002/marc.200700872
   Yoshida E, 2008, COLLOID POLYM SCI, V286, P1621, DOI 10.1007/s00396-008-1937-4
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhang Q, 2000, J AM CHEM SOC, V122, P3642, DOI 10.1021/ja993941o
   Zhang XZ, 2004, BIOMATERIALS, V25, P3793, DOI 10.1016/j.biomaterials.2003.10.065
   Zhang Y, 2005, J CONTROL RELEASE, V105, P260, DOI 10.1016/j.jconrel.2005.04.001
NR 47
TC 23
Z9 23
U1 3
U2 64
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-402X
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD JUL
PY 2010
VL 288
IS 10-11
BP 1151
EP 1159
DI 10.1007/s00396-010-2246-2
PG 9
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 616MY
UT WOS:000279214700011
DA 2018-10-19
ER

PT J
AU Cairns, ML
   Meenan, BJ
   Burke, GA
   Boyd, AR
AF Cairns, M. L.
   Meenan, B. J.
   Burke, G. A.
   Boyd, A. R.
TI Influence of surface topography on osteoblast response to fibronectin
   coated calcium phosphate thin films
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Calcium phosphate thin films; Cell adhesion; Fibronectin; Osteoblast;
   Surface topography
ID CELL-ADHESION; PROTEIN ADSORPTION; INTEGRIN BINDING; FOCAL ADHESION;
   PROLIFERATION; TITANIUM; DIFFERENTIATION; CONFORMATION; BIOMATERIAL;
   MODULATION
AB The ability to engineer biomaterial surfaces that are capable of a dynamic interaction with cells and tissues is central to the development of medical implants with improved functionality. An important consideration in this regard is the role played by the extracellular proteins that bind to an implant surface in vivo. Deliberate use of an ad-layer of such proteins on an implant surface has been observed to guide and direct cell response. However, the role that changes in surface topography might play in determining the nature of this cell-protein-surface interaction has not been investigated in detail. In this study, calcium phosphate (CaP) thin films have been deposited onto substrates with varying topography such that this is reflected in the (conformal) CaP surface features. A fibronectin (FN) ad-layer was then deposited from solution onto each surface and the response of MG63 osteoblast-like cells investigated. The results revealed that in all cases, the presence of the adsorbed FN layer on the CaP thin films improved MG63 cell adhesion, proliferation and promoted early onset differentiation. Moreover, the nature and scale of the response were shown to be influenced by the underlying CaP surface topography. Specifically, MG63 cell on FN-coated CaP thin films with regular topographical features in the nanometer range showed statistically significant differences in focal adhesion assembly, osteocalcin expression and alkaline phosphase activity compared to CaP thin films that lacked these topographical features. As such, these data indicate that surface topography can be used to further influence cell adhesion and downstream differentiation by enhancing the effects of a surface adsorbed FN layer. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Cairns, M. L.; Meenan, B. J.; Burke, G. A.; Boyd, A. R.] Univ Ulster, Nanotechnol & Integrated Bioengn Ctr NIBEC, Newtownabbey BT37 0QB, Antrim, North Ireland.
RP Cairns, ML (reprint author), Queens Univ Belfast, Sch Mech & Aerosp Engn, Ashby Bldg, Belfast BT9 5AH, Antrim, North Ireland.
EM m.cairns@qub.ac.uk; bj.meenan@ulster.ac.uk; g.burke@ulster.ac.uk;
   ar.boyd@ulster.ac.uk
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Calonder C, 2005, J BIOMED MATER RES A, V75A, P316, DOI 10.1002/jbm.a.30417
   CANNAS M, 1988, J ORTHOPAED RES, V6, P58, DOI 10.1002/jor.1100060108
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kreke MR, 2005, BIOMATERIALS, V26, P2975, DOI 10.1016/j.biomaterials.2004.08.013
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Miller T, 2003, LANGMUIR, V19, P1723, DOI 10.1021/la0261500
   MIRANTI CK, 2002, NATURE CELL BIOL, V4, P83
   Mosher D. F., 1989, FIBRONECTIN
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   RUOSLAHTI E, 1982, TRENDS BIOCHEM SCI, V7, P188, DOI 10.1016/0968-0004(82)90136-0
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Sommerfeldt DW, 2001, BIOCHEM BIOPH RES CO, V285, P355, DOI 10.1006/bbrc.2001.5198
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Thull R, 2002, BIOMOL ENG, V19, P43, DOI 10.1016/S1389-0344(02)00009-6
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   Yen MH, 2002, J IMMUNOL, V169, P722, DOI 10.4049/jimmunol.169.2.722
NR 38
TC 23
Z9 23
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2010
VL 78
IS 2
BP 283
EP 290
DI 10.1016/j.colsurfb.2010.03.013
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 602VN
UT WOS:000278167100019
PM 20392613
DA 2018-10-19
ER

PT J
AU Stan, GE
   Marcov, DA
   Popa, AC
   Husanu, MA
AF Stan, G. E.
   Marcov, D. A.
   Popa, A. C.
   Husanu, M. A.
TI POLYMER-LIKE AND DIAMOND-LIKE CARBON COATINGS PREPARED BY RF-PECVD FOR
   BIOMEDICAL APPLICATIONS
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE Diamond-like carbon; Polymer-like carbon; RF-PECVD; Biomaterial; Surface
   energy; aPTT
ID HYDROGENATED AMORPHOUS-CARBON; CHEMICAL-VAPOR-DEPOSITION; A-C-H;
   THIN-FILMS; DLC FILMS; OPTICAL-PROPERTIES; PLASMA; MICROSTRUCTURE;
   SURFACE; RAMAN
AB Hydrogenated amorphous carbon (a-C: H) films were grown by radio-frequency (1.78 MHz) plasma enhanced chemical vapour deposition technique onto medical grade Ti6Al4V substrates. By varying the deposition pressure (13.33 Pa and 53.33 Pa, respectively) and methane dilution (20% and 60%, respectively) several types of carbonic films were obtained, presenting different bonding structures, surface energies and morphological features reflected in their biological behaviour. FTIR, Raman, UV-Vis, XPS and AFM measurements were used for characterizing these structures. The surface energy was determined by contact angle measurements, and their thrombogenicity was tested by the activated partial thromboplastin time (aPTT) method. We have noticed that at the same values of methane in argon dilution but at different pressure values, the film structure was totally changed: soft polymer-like carbon (PLC) type at the higher pressure and hard diamond-like carbon (DLC) type at the lower pressure. Raman spectroscopy and XPS suggested that the highest sp(3) ratio (similar to 52%), was found for DLC films prepared in a 60% methane dilution in argon. It has been found that for both PLC and DLC structures the surface energy has a decreasing tendency with the methane concentration increase in the deposition atmosphere. Excellent aPTT results were obtained for the DLC-60 (18.6.+/- 0.3 min) and PLC-20 (17.4 +/- 0.5 min) structures, superior to those recorded for Ti6Al4V and PMMA commercial materials. These values recommend the prepared carbonic structures for medical applications: harder coatings (DLC) for metal prostheses (heart valves, acetabular cups etc.), while softer and flexible coatings (PLC) for the textile vessels or stents biofunctionalization.
C1 [Stan, G. E.; Marcov, D. A.; Husanu, M. A.] Natl Inst Mat Phys, Bucharest 077125, Romania.
   [Popa, A. C.] Army Ctr Med Res, Bucharest 020012, Romania.
   [Popa, A. C.] Carol Davila Univ Med & Pharm, Dept Cellular & Mol Med, Bucharest, Romania.
RP Stan, GE (reprint author), Natl Inst Mat Phys, POB MG 7, Bucharest 077125, Romania.
EM george_stan@infim.ro
RI Stan, George/B-5690-2011; Husanu, Marius Adrian/B-9335-2012; Popa,
   Adrian Claudiu/K-4606-2012; Popa, Adrian-Claudiu/A-3096-2017
OI Stan, George/0000-0003-0289-8988; Husanu, Marius
   Adrian/0000-0003-4510-6653; Popa, Adrian-Claudiu/0000-0002-9679-0507
FU Core Program [PN09-45]
FX GES and DAM want to express their gratitude to their scientific
   coordinator, Dr. Constantin-Octavian Morosanu, who sadly passed away in
   2009 after a long and painful sufferance. Authors also thank Dr.
   Cristian-Mihail Teodorescu for the professional assistance with XPS
   measurements. The financial support of Core Program - Contract PN09-45
   is acknowledged.
CR Ahmad I, 2009, CURR APPL PHYS, V9, P937, DOI 10.1016/j.cap.2008.09.006
   Beghi MG, 2002, DIAM RELAT MATER, V11, P1062, DOI 10.1016/S0925-9635(01)00642-2
   Bonelli M, 2002, EUR PHYS J B, V25, P269, DOI 10.1140/epjb/e20020031
   Cheng YH, 2000, SURF COAT TECH, V135, P27, DOI 10.1016/S0257-8972(00)00736-2
   Choi BG, 2005, J CERAM PROCESS RES, V6, P101
   DEARNALEY G, 2005, SURF COAT TECH, V200, P2818
   Druz B, 2001, DIAM RELAT MATER, V10, P931, DOI 10.1016/S0925-9635(00)00547-1
   Eskusson J, 2008, APPL PHYS A-MATER, V93, P745, DOI 10.1007/s00339-008-4706-9
   Fedosenko G, 2001, SURF COAT TECH, V142, P693, DOI 10.1016/S0257-8972(01)01104-5
   Fontaine J, 2005, THIN SOLID FILMS, V482, P99, DOI 10.1016/j.tsf.2004.11.126
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Jackson M.J., 2007, SURFACE ENG SURG TOO
   Jelinek M, 2010, MATER SCI ENG B-ADV, V169, P89, DOI 10.1016/j.mseb.2010.01.010
   Kim YT, 2003, SURF COAT TECH, V169, P291, DOI 10.1016/S0257-8972(03)00069-0
   Kocourek T, 2008, APPL PHYS A-MATER, V93, P627, DOI 10.1007/s00339-008-4728-3
   Lazar G, 2005, J OPTOELECTRON ADV M, V7, P647
   LIU C, 2006, THIN SOLID FILMS, V496, P257
   Luca D, 2007, THIN SOLID FILMS, V515, P8605, DOI 10.1016/j.tsf.2007.03.115
   Marciano FR, 2009, DIAM RELAT MATER, V18, P1010, DOI 10.1016/j.diamond.2009.02.014
   Mardare D, 2007, SURF SCI, V601, P4515, DOI 10.1016/j.susc.2007.04.156
   MARGOLIS J, 1958, J CLIN PATHOL, V11, P406, DOI 10.1136/jcp.11.5.406
   MCGLASSON DL, 1989, CLIN LAB SCI, V2, P109
   Narayan RJ, 2006, INT MATER REV, V51, P127, DOI 10.1179/174328406X79432
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Paik N, 2005, SURF COAT TECH, V200, P2170, DOI 10.1016/j.surfcoat.2004.08.073
   Ristein J, 1998, J APPL PHYS, V84, P3836, DOI 10.1063/1.368563
   Sanchez-Gonzalez J, 2006, APPL SURF SCI, V252, P6013, DOI 10.1016/j.apsusc.2005.11.009
   Schwan J, 1996, J APPL PHYS, V80, P440, DOI 10.1063/1.362745
   Shin JK, 2001, APPL PHYS LETT, V78, P631, DOI 10.1063/1.1343840
   Socrates G., 2007, INFRARED RAMAN CHARA
   Stan GE, 2009, APPL SURF SCI, V255, P9132, DOI 10.1016/j.apsusc.2009.06.117
   Stan GE, 2010, UNIV POLITEH BUCHAR, V72, P187
   SWANEPOEL R, 1983, J PHYS E SCI INSTRUM, V16, P1214, DOI 10.1088/0022-3735/16/12/023
   TEODORESCU CM, 1994, NUCL INSTRUM METH A, V345, P141, DOI 10.1016/0168-9002(94)90983-0
   Tinchev SS, 2006, J OPTOELECTRON ADV M, V8, P308
   Valentini L, 2001, J MATER SCI, V36, P5295, DOI 10.1023/A:1012422618327
   VANDENTOP GJ, 1990, PHYS REV B, V41, P3200, DOI 10.1103/PhysRevB.41.3200
   Vojs M, 2009, MICROELECTRON J, V40, P650, DOI 10.1016/j.mejo.2008.06.083
   WNEK GE, 2004, ENCY BIOMATERIALS BI, V3
   Ye X, 2009, APPL SURF SCI, V255, P6686, DOI 10.1016/j.apsusc.2009.02.068
   Zeng A, 2002, INT J MOD PHYS B, V16, P1024, DOI 10.1142/S0217979202010804
   Zhang S, 2000, SURF COAT TECH, V123, P256, DOI 10.1016/S0257-8972(99)00523-X
NR 42
TC 18
Z9 18
U1 0
U2 32
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD JUL-SEP
PY 2010
VL 5
IS 3
BP 705
EP 718
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 677OF
UT WOS:000284001000004
DA 2018-10-19
ER

PT J
AU Trubiani, O
   Fulle, S
   Traini, T
   Paludi, M
   la Rovere, R
   Orciani, M
   Caputi, S
   Piattelli, A
AF Trubiani, Oriana
   Fulle, Stefania
   Traini, Tonino
   Paludi, Maya
   la Rovere, Rita
   Orciani, Monia
   Caputi, Sergio
   Piattelli, Adrian
TI FUNCTIONAL ASSAY, EXPRESSION OF GROWTH FACTORS AND PROTEINS MODULATING
   BONE-ARRANGEMENT IN HUMAN OSTEOBLASTS SEEDED ON AN ANORGANIC BOVINE BONE
   BIOMATERIAL
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Dental; regenerative repair; osteoblasts; bone; biomaterials;
   osteoconduction/ osteoinduction; signalling molecules; growth factors
ID MAXILLARY SINUS AUGMENTATION; GENE-RELATED PEPTIDE; STEM-CELLS;
   IN-VITRO; HISTOMORPHOMETRIC EVALUATION; BIO-OSS((R)) PARTICLES; TISSUE;
   CALCITONIN; DIFFERENTIATION; RECONSTRUCTION
AB The basic aspects of bone tissue engineering include chemical composition and geometry of the scaffold design, because it is very important to improve not only cell attachment and growth but especially osteodifferentiation, bone tissue formation, and vascularization. Geistlich Bio-Oss (R) (GBO) is a xenograft consisting of deproteinized, sterilized bovine bone, chemically and physically identical to the mineral phase of human bone.
   In this study, we investigated the growth behaviour and the ability to form focal adhesions on the substrate, using vinculin, a cytoskeletal protein. as a marker. Moreover, the expression of bone specific proteins and growth factors such as type I collagen. osteopontin. bone sialoprotein, bone morphogenetic protein-2 (BMP-2). BMP-7 and de novo synthesis of osteocalcin in normal human osteoblasts (NHOst) seeded on xenogenic GBO were evaluated. Our observations suggest that after tour weeks of culture in differentiation medium. the NHOst showed a high affinity for the three dimensional biomaterial; in fact, cellular proliferation, migration and colonization were clearly evident. The osteogenic differentiation process, as demonstrated by morphological, histochemical, energy dispersive X-ray microanalysis and biochemical analysis was mostly obvious in the NHOst grown on three-dimensional inorganic bovine bone biomaterial. Functional studies displayed a clear and significant response to calcitonin when the cells were differentiated. In addition, the presence of the biomaterial improved the response, suggesting that it could drive the differentiation of these cells towards a more differentiated osteogenic phenotype. These results encourage us to consider GBO an adequate biocompatible three-dimensional biomaterial, indicating its potential use for the development of tissue-engineering techniques.
C1 [Trubiani, Oriana; Traini, Tonino; Paludi, Maya; Caputi, Sergio; Piattelli, Adrian] Univ G dAnnunzio, Dept Oral Sci Nano & Biotechnol, I-66100 Chieti, Italy.
   [Fulle, Stefania; la Rovere, Rita] Univ G dAnnunzio, Dept Basic & Appl Med Sci, I-66100 Chieti, Italy.
   [Orciani, Monia] Marche Polytech Univ, Dept Mol Pathol & Innovat Therapies, Ancona, Italy.
RP Trubiani, O (reprint author), Univ G dAnnunzio, Dept Oral Sci Nano & Biotechnol, Via Vestini 31, I-66100 Chieti, Italy.
EM trubiani@unich.it
RI Fulle, Stefania/F-3328-2013
OI Fulle, Stefania/0000-0003-4557-9127; orciani, monia/0000-0003-4503-3693;
   Traini, Tonino/0000-0002-0265-8709
FU Osteology Foundation, Lucerne, Switzerland; Carichieti Foundation,
   Chieti, Italy
FX This work has been funded by a grant from the Osteology Foundation,
   Lucerne, Switzerland and the Carichieti Foundation, Chieti, Italy.
CR Acil Y, 2002, J CELL BIOCHEM, V86, P90, DOI 10.1002/jcb.10197
   Alonso M, 2008, CYTOTHERAPY, V10, P597, DOI 10.1080/14653240802242084
   ALSAFFAR N, 2000, BONE ENG, P152
   Anderson HC, 2000, J HISTOCHEM CYTOCHEM, V48, P1493, DOI 10.1177/002215540004801106
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   AUSTIN LA, 1981, NEW ENGL J MED, V304, P269, DOI 10.1056/NEJM198101293040505
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Born AK, 2009, EUR CELLS MATER, V18, P49
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Cornish J, 2001, BONE, V29, P162, DOI 10.1016/S8756-3282(01)00494-X
   Cowan CM, 2005, CURR TOP DEV BIOL, V66, P239, DOI 10.1016/S0070-2153(05)66008-5
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423
   HUBBELL JA, 1999, CURR OPIN BIOTECH, V10, P121
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Lalani Z, 2003, J ORAL MAXIL SURG, V61, P1061, DOI 10.1016/S0278-2391(03)00319-7
   Lauer G, 2001, J ORAL MAXIL SURG, V59, P169, DOI 10.1053/joms.2001.20489
   Lerner U. H., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P154
   Lerner UH, 2002, PRINCIPLES BONE BIOL, P773
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   MAURIZI M, 1988, AM J OTOLARYNG, V9, P68, DOI 10.1016/S0196-0709(88)80010-3
   Orciani M, 2009, ACTA HISTOCHEM, V111, P15, DOI 10.1016/j.acthis.2008.02.005
   Orsini G, 2007, ORAL DIS, V13, P586, DOI 10.1111/j.1601-0825.2006.01343.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   PIATTELLI NI, 1999, INT J ORAL MAXILLOF, V14, P835
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Ryder KD, 2001, J BONE MINER RES, V16, P240, DOI 10.1359/jbmr.2001.16.2.240
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Schmitt SC, 2008, J MATER SCI-MATER M, V19, P1441, DOI 10.1007/s10856-007-3238-8
   SODEK J, 2000, BONE ENG, P31
   Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Trubiani O, 2007, Int J Immunopathol Pharmacol, V20, P87
   Trubiani O, 2008, J BIOMED MATER RES A, V87A, P986, DOI 10.1002/jbm.a.31837
   Turhani D, 2005, INT J ORAL MAX SURG, V34, P543, DOI 10.1016/j.ijom.2004.10.023
   Villa I, 2006, AM J PHYSIOL-CELL PH, V291, pC529, DOI 10.1152/ajpcell.00354.2005
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
   Yamada Y, 2004, CLIN ORAL IMPLAN RES, V15, P589, DOI 10.1111/j.1600-0501.2004.01038.x
   YAMAGUCHI DT, 1987, J BIOL CHEM, V262, P14967
   Zietek M, 2008, J PHYSIOL PHARMACOL, V59, P81
NR 46
TC 27
Z9 32
U1 0
U2 4
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2010
VL 20
BP 72
EP 83
PG 12
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 652LA
UT WOS:000282006700004
PM 20648427
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Pina, S
   Vieira, SI
   Rego, P
   Torres, PMC
   Silva, OABDE
   Silva, EFDE
   Ferreira, JMF
AF Pina, S.
   Vieira, S. I.
   Rego, P.
   Torres, P. M. C.
   da Cruz e Silva, O. A. B.
   da Cruz e Silva, E. F.
   Ferreira, J. M. F.
TI BIOLOGICAL RESPONSES OF BRUSHITE-FORMING Zn- AND ZnSr-SUBSTITUTED
   beta-TRICALCIUM PHOSPHATE BONE CEMENTS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Zinc; strontium; brushite cement; osteoblast proliferation; alkaline
   phosphatase; MC3T3-E1 cell adhesion; Type-1 collagen; trabecular bone
   regeneration
ID CALCIUM-PHOSPHATE; IN-VIVO; ZINC RELEASE; STRONTIUM; DIFFERENTIATION;
   INJECTABILITY; CYTOCOMPATIBILITY; HYDROXYAPATITE; PROLIFERATION;
   BIOMATERIAL
AB The core aim of this study was to investigate zinc (Zn)and zinc and strontium (ZnSr)-containing brushite-forming beta-tricalcium phosphate (TCP) cements for their effects on proliferation and differentiation of osteoblastic-like cells (MC3T3-E1 cell line) as well as for their in vivo behaviour in trabecular bone cylindrical defects in a pilot study. In vitro proliferation and maturation responses of MC3T3-El osteoblastic-like cells to bone cements were studied at the cellular and molecular levels. The Zn- and Sr-containing brushite cements were found to stimulate pre-osteoblastic proliferation and osteoblastic maturation. Indeed, MC3T3-E1 cells exposed to the powdered cements had increased proliferative rates and higher adhesiveness capacity, in comparison to control cells. Furthermore, they exhibited higher alkaline phosphatase (ALP) activity and increased Type-I collagen secretion and fibre deposition into the extracellular matrix. Proliferative and collagen deposition properties were more evident for cells grown in cements doped with Sr. The in vivo osteoconductivc properties of the ZnCPC and ZnSrCPC cements were also pursued. Histological and histomorphometric analyses were performed at 1 and 2 months after implantation, using carbonated apatite cement (Norian SRS (R)) as control. There was no evidence of cement-induced adverse foreign body reactions, and furthermore ZnCPC and ZnSrCPC cements revealed better in vivo performance in comparison to the control apatite cement. Additionally, the presence of both zinc and strontium resulted in the highest I:ate of new bone formation, These novel results indicate that the investigated ZnCPC and ZnSrCPC cements are both biocompatible and osteoconductive, being good candidate materials to use as bone substitutes.
C1 [Pina, S.; Torres, P. M. C.; Ferreira, J. M. F.] Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
   [Vieira, S. I.; da Cruz e Silva, O. A. B.] Univ Aveiro, Dept Hlth Sci, Ctr Biol Celular, P-3810193 Aveiro, Portugal.
   [Rego, P.] Univ Lisbon, Fac Med, Orthopaed Clin, P-1600190 Lisbon, Portugal.
   [da Cruz e Silva, E. F.] Univ Aveiro, Dept Biol, Ctr Biol Celular, P-3810193 Aveiro, Portugal.
RP Pina, S (reprint author), Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
EM sandra.pina@ua.pt
RI da Cruz e Silva, Odete/F-4072-2010; Vieira, Sandra/F-6589-2011;
   Universidade de Aveiro, Centro Biologia Celu/C-2179-2011; da Cruz e
   Silva, Edgar/G-2647-2010; Pina, Sandra/H-8133-2013
OI da Cruz e Silva, Odete/0000-0003-3718-9874; Vieira,
   Sandra/0000-0003-1053-1107; Pina, Sandra/0000-0002-4361-1253; Torres,
   Paula M C/0000-0001-7136-984X; Ferreira, Jose/0000-0002-7520-2809
FU CICECO; CBC; Portuguese Foundation for Science and Technology
   [REEQ/1023/BIO/2005, SFRH/BPD/64119/2009, SERH/BPD/19515/2004,
   SFRH/BD/62021/2009]
FX To CICECO and to CBC for the support and to the Portuguese Foundation
   for Science and Technology for the project REEQ/1023/BIO/2005 and for
   the fellowship grants of S.P. (SFRH/BPD/64119/2009), S.I.V.
   (SERH/BPD/19515/2004) and P.M.CT. (SFRH/BD/62021/2009). The authors are
   also very grateful to Prof. Doutor Henrique Bicha Castel, Director of
   the Service of Medicine and Experimental Surgery, Hospital of Santa
   Maria, Lisbon, for the facilities supply in experimental animal studies,
   according to European regulations and following permission granted by
   the Ethical Committee. In addition, the authors are thankful to A.
   Pinto, Institute of Molecular Medicine, Lisbon, for the preparation of
   the sections for histological and histomorphometric analysis.
CR Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Baroud G, 2005, ACTA BIOMATER, V1, P357, DOI 10.1016/j.actbio.2005.01.003
   Boesel LF, 2006, BIOMATERIALS, V27, P5627, DOI 10.1016/j.biomaterials.2006.07.022
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bohner M, 2003, BIOMATERIALS, V24, P3463, DOI 10.1016/S0142-9612(03)00234-5
   BROWN WE, 1983, J DENT RES, V62, P672
   Burguera EF, 2008, J BIOMED MATER RES B, V84B, P493, DOI 10.1002/jbm.b.30896
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   DEMPSTER DW, 1992, BONE REMODELING DISO, P355
   FUA CY, 2006, P INT C BIOM PHARM E
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gisep A, 2003, J BIOMED MATER RES A, V66A, P532, DOI 10.1002/jbm.a.10593
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   JOHAL KK, 2002, J MATER SCI-MATER M, V13, P543
   Kannan S, 2008, J AM CERAM SOC, V91, P1, DOI 10.1111/j.1551-2916.2007.02117.x
   Kannan S, 2006, J AM CERAM SOC, V89, P3277, DOI 10.1111/j.1551-2916.2006.01203.x
   Kannan S, 2009, J AM CERAM SOC, V92, P1592, DOI 10.1111/j.1551-2916.2009.03093.x
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Kurdy NMG, 1998, J ORTHOP TRAUMA, V12, P122, DOI 10.1097/00005131-199802000-00010
   LAREU RR, 2006, 3 KUAL LUMP INT C BI, P15, DOI DOI 10.1007/978-3-540-68017-8
   Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2
   LENART G, 1972, CLIN ORTHOP RELAT R, P263
   Alves HLR, 2008, J MATER SCI-MATER M, V19, P2241, DOI 10.1007/s10856-007-3329-6
   Li X, 2009, MAT SCI ENG C-BIO S, V29, P969, DOI 10.1016/j.msec.2008.08.021
   MALIK MA, 1992, BIOMATERIALS, V13, P123, DOI 10.1016/0142-9612(92)90008-C
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   McComb RB, 1979, ALKALINE PHOSPHATASE
   NAJI A, 1991, BIOMATERIALS, V12, P690, DOI 10.1016/0142-9612(91)90118-T
   Nelson D.L., 2005, LEHNINGERS PRINCIPLE
   Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040
   Otsuka M, 2000, J BIOMED MATER RES, V52, P819, DOI 10.1002/1097-4636(20001215)52:4<819::AID-JBM27>3.3.CO;2-F
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pina S, 2010, J BIOMED MATER RES B, V94B, P414, DOI 10.1002/jbm.b.31669
   Pina S, 2010, ACTA BIOMATER, V6, P928, DOI 10.1016/j.actbio.2009.09.001
   PULEO DA, 1993, BIOMATERIALS, V14, P111, DOI 10.1016/0142-9612(93)90220-V
   ROKITA E, 1993, J CRYST GROWTH, V130, P543, DOI 10.1016/0022-0248(93)90543-6
   SEEMAN E, 1993, OSTEOPOROSIS INT, V3, pS40
   STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996
   Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200
   Ueno A, 2006, J CELL PHYSIOL, V209, P322, DOI 10.1002/jcp.20735
   Wang XP, 2006, J BIOMED MATER RES B, V78B, P259, DOI 10.1002/jbm.b.30481
   WEN HB, 1995, J STRUCT BIOL, V114, P115, DOI 10.1006/jsbi.1995.1011
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 45
TC 44
Z9 46
U1 1
U2 25
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2010
VL 20
BP 162
EP 177
PG 16
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 652LA
UT WOS:000282006700011
PM 20821372
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Ye, QS
   Xing, QA
   Ren, YJ
   Harmsen, MC
   Bank, RA
AF Ye, Qingsong
   Xing, Quan
   Ren, Yijin
   Harmsen, Martin C.
   Bank, Ruud A.
TI ENDO180 AND MT1-MMP ARE INVOLVED IN THE PHAGOCYTOSIS OF COLLAGEN
   SCAFFOLDS BY MACROPHAGES AND IS REGULATED BY INTERFERON-GAMMA
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Phagocytosis; foreign body reaction; collagen receptor; Endo180;
   interferon-gamma
ID FOREIGN-BODY REACTION; RECEPTOR-ASSOCIATED PROTEIN/ENDO180; DERMAL SHEEP
   COLLAGEN; BIODEGRADABLE BIOMATERIAL; MATRIX-METALLOPROTEINASE;
   PERITONEAL-MACROPHAGES; ENDOCYTIC RECEPTOR; GENE-EXPRESSION;
   DEGRADATION; CELLS
AB Subcutaneously implanted disks of hexamethylenediisocyanate or glutaraldehyde cross-linked sheep collagen (referred to as HDSC and GDSC, respectively) in mice show large differences in degradation rate. Although comparable numbers of macrophages are seen in HDSC and GDSC, phagocytosis of collagen by macrophages occurred only in GDSC. The molecular mechanisms involved in the phagocytosis of collagen by macrophages are essentially unknown. Immunofluorescence and RT-PCR showed that Endo180 was expressed in GDSC only. TissueFaxs showed that Endo180 co-localized with MT1-MMP on F4/80 positive cells, which is likely responsible for the phagocytosis in GDSC. RT-PCR further showed that Endo180 expression correlated with high levels of IFN-gamma mRNA. In vitro, IFN-gamma induced the expression Endo180 and MT1-MMP in murine macrophages cultured on collagen type I (although too high levels of IFN-gamma dampened the expression of Endo180 and MT1-MMP). Moreover, the expression of Endo180 and MT1-MMP induced by IFN-gamma can be inhibited through IL-10. The differences in microenvironment between GDSC and HDSC (high IFN-gamma and low IL-10 levels in GDSC, low IFN-gamma and high IL-10 levels in HDSC) provide an explanation why phagocytosis of collagen by macrophages is only seen in GDSC. In summary, we show for the first time that the IFN-gamma dependent co-expression of Endo180 and MT1-MMP on macrophages coincides with collagen phagocytosis, thus providing evidence that the mechanism of collagen phagocytosis operating in the foreign body reaction by macrophages is comparable with the mechanism of intracellular collagen degradation by fibroblasts seen under physiological conditions.
C1 [Bank, Ruud A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Stem Cell & Tissue Engn Res Grp, NL-9713 GZ Groningen, Netherlands.
RP Bank, RA (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Stem Cell & Tissue Engn Res Grp, Hanzepl 1,EA11, NL-9713 GZ Groningen, Netherlands.
EM qingsongye@hotmail.com; R.A.Bank@med.umcg.nl
OI Ye, Qingsong/0000-0002-2868-9247
FU RuG Jan Kornelis de Cock-Stiching
FX This study was supported by RuG Jan Kornelis de Cock-Stiching (Q. Ye).
   The authors wish to acknowledge the excellent technical support of Mr.
   Jasper Koerts, Ms. Saskia de Rond and Mrs. Linda Brouwer.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Beertsen W, 2002, EUR J ORAL SCI, V110, P445, DOI 10.1034/j.1600-0722.2002.21384.x
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Ciapetti G, 1996, BIOMATERIALS, V17, P1703, DOI 10.1016/0142-9612(96)87650-2
   Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   DEPORTER DA, 1979, J PERIODONTAL RES, V14, P323, DOI 10.1111/j.1600-0765.1979.tb00796.x
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882
   Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091
   Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011
   Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200
   Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x
   INOUYE S, 1983, VIRCHOWS ARCH B, V42, P243, DOI 10.1007/BF02890387
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008
   KNAPP W, 1974, Z IMMUNITATSFORSCH, V146, P283
   Lee H, 2007, BIOCHEM SOC T, V35, P704, DOI 10.1042/BST0350704
   Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486
   Lucattelli M, 2003, EUR RESPIR J, V22, P728, DOI 10.1183/09031936.03.00047603
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mousavi SA, 2005, BIOCHEM J, V387, P39, DOI 10.1042/BJ20040966
   Munirah S, 2008, EUR CELLS MATER, V15, P41, DOI 10.22203/eCM.v015a04
   PARAKKAL PF, 1969, J CELL BIOL, V41, P345, DOI 10.1083/jcb.41.1.345
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Sheikh H, 2000, J CELL SCI, V113, P1021
   SVOBODA ELA, 1980, J ULTRA MOL STRUCT R, V72, P169, DOI 10.1016/S0022-5320(80)90054-4
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Thomas EK, 2005, J BIOL CHEM, V280, P22596, DOI 10.1074/jbc.M501155200
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van Putten SM, 2009, BIOMATERIALS, V30, P730, DOI 10.1016/j.biomaterials.2008.10.043
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-03-0814
   Yeghiazaryan K, 2007, AMINO ACIDS, V32, P109, DOI 10.1007/s00726-006-0376-0
NR 42
TC 11
Z9 11
U1 0
U2 2
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2010
VL 20
BP 197
EP 209
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 678OZ
UT WOS:000284090300002
PM 20931490
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU D'Angelo, F
   Armentano, I
   Mattioli, S
   Crispoltoni, L
   Tiribuzi, R
   Cerulli, GG
   Palmerini, CA
   Kenny, JM
   Martino, S
   Orlacchio, A
AF D'Angelo, F.
   Armentano, I.
   Mattioli, S.
   Crispoltoni, L.
   Tiribuzi, R.
   Cerulli, G. G.
   Palmerini, C. A.
   Kenny, J. M.
   Martino, S.
   Orlacchio, A.
TI MICROPATTERNED HYDROGENATED AMORPHOUS CARBON GUIDES MESENCHYMAL STEM
   CELLS TOWARDS NEURONAL DIFFERENTIATION
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biological response; cell/protein-material interactions; biomaterial
   surfaces; tissue engineering; regenerative medicine; cytoskeleton; stem
   cell differentiation
ID MARROW STROMAL CELLS; NERVE GROWTH-FACTOR; BONE-MARROW; NITRIC-OXIDE;
   ADHESION FORMATION; GUIDANCE; FILMS; BRAIN; MECHANOTRANSDUCTION;
   TOPOGRAPHY
AB This study investigated how the design of surface topography may stimulate stem cell differentiation towards a neural lineage. To this end, hydrogenated amorphous carbon (a-C: H) groove topographies with width/spacing ridges ranging from 80/40 mu m, 40/30 mu m and 30/20 mu m and depth of 24 nm were used as a single mechanotransducer stimulus to generate neural cells from human bone marrow mesenchymal stem cells (hBM-MSCs) in vitro. As comparative experiments, soluble brain-derived neurotrophic factor (BDNF) was used as additional biochemical inducer agent. Despite simultaneous presence of a-C: H micropatterned nanoridges and soluble BDNF resulted in the highest percentage of neuronal-like differentiated cells our findings demonstrate that the surface topography with micropatterned nanoridge width/spacing of 40/30 mu m (single stimulus) induced hBM-MSCs to acquire neuronal characteristics in the absence of differentiating agents. On the other hand, the alternative a-C:H ridge dimensions tested failed to induce stem cell differentiation towards neuronal properties, thereby suggesting the occurrence of a mechanotransducer effect exerted by optimal nano/microstructure dimensions on the hBM-MSCs responses.
C1 [D'Angelo, F.; Crispoltoni, L.; Tiribuzi, R.; Martino, S.; Orlacchio, A.] Univ Perugia, Dept Expt Med & Biochem Sci, Sect Biochem & Mol Biol, I-06100 Perugia, Italy.
   [Armentano, I.; Mattioli, S.] Univ Perugia, NIPLAB, UdR INSTM, Mat Engn Ctr, Terni, Italy.
   [Cerulli, G. G.] Univ Perugia, Dept Orthoped & Traumatol, I-06100 Perugia, Italy.
   [Palmerini, C. A.] Univ Perugia, Dept Internal Med, Biochem Lab, I-06100 Perugia, Italy.
   [Kenny, J. M.] Univ Perugia, UdR INBB, Mat Engn Ctr, Terni, Italy.
RP Orlacchio, A (reprint author), Via del Giochetto, I-06126 Perugia, Italy.
EM martinos@unipg.it; orly@unipg.it
RI Kenny, Jose/F-9372-2010; Martino, Sabata/F-2309-2014
OI Kenny, Jose/0000-0001-6329-3048; Martino, Sabata/0000-0002-3942-237X
FU Ministero della Salute, Italy [UMB-2006-339457]; Fondazione Cassa di
   Risparmio di Perugia, Italy [2009.020.0050]; Ministero dell'Istruzione,
   dell'Universita e della Ricerca, Italy [RBIP06FH7J_002, 20084XRSBS_001];
   Istituto Nazionale Biostrutture e Biosistemi
FX This study was supported by the Ministero della Salute, Italy (grant no.
   RF-UMB-2006-339457 to A.O.), the Fondazione Cassa di Risparmio di
   Perugia, Italy (grant no. 2009.020.0050 to A.O.), the Ministero
   dell'Istruzione, dell'Universita e della Ricerca, Italy (grants: FIRB
   Idea Progettuale no. RBIP06FH7J_002 and PRIN no. 20084XRSBS_001 to
   A.O.), and the Istituto Nazionale Biostrutture e Biosistemi.
CR Baskey JC, 2002, J NEUROCHEM, V80, P501, DOI 10.1046/j.0022-3042.2001.00730.x
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Bonilla S, 2005, NEUROSCIENCE, V133, P85, DOI 10.1016/j.neuroscience.2005.02.019
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Cappelletti G, 2003, EXP CELL RES, V288, P9, DOI 10.1016/S0014-4827(03)00209-X
   Charras GT, 2002, BIOPHYS J, V82, P2970, DOI 10.1016/S0006-3495(02)75638-5
   Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061
   Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A S G, 2004, Eur Cell Mater, V8, P27
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2009, NANOMEDICINE-UK, V4, P247, DOI [10.2217/nnm.09.1, 10.2217/NNM.09.1]
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186
   INGBER DE, 1993, J CELL SCI, V104, P613
   Jin CY, 2008, J MATER SCI-MATER M, V19, P2215, DOI 10.1007/s10856-007-3323-z
   Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436
   Li JM, 2008, J BIOMED MATER RES A, V87A, P392, DOI 10.1002/jbm.a.31814
   Magaki T, 2005, NEUROSCI LETT, V384, P282, DOI 10.1016/j.neulet.2005.05.025
   Martino S, 2009, TISSUE ENG PT A, V15, P3139, DOI [10.1089/ten.tea.2008.0552, 10.1089/ten.TEA.2008.0552]
   Martino S, 2009, J NEUROCHEM, V109, P135, DOI 10.1111/j.1471-4159.2009.05919.x
   Orlacchio A, 2010, CURR MED CHEM, V17, P595, DOI 10.2174/092986710790416272
   Orlacchio A, 2010, DISCOV MED, V9, P546
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Palmerini CA, 2003, TALANTA, V61, P37, DOI 10.1016/S0039-9140(03)00357-6
   Palmerini CA, 2000, NITRIC OXIDE-BIOL CH, V4, P546, DOI 10.1006/niox.2000.0306
   Palmerini CA, 1998, NITRIC OXIDE-BIOL CH, V2, P375, DOI 10.1006/niox.1998.0197
   Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001
   Popov C, 2009, DIAM RELAT MATER, V18, P895, DOI 10.1016/j.diamond.2009.02.004
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   SANCHEZRAMOS RJ, 2002, J NEUROSCI RES, V69, P880
   Stewart R, 2002, BIOESSAYS, V24, P708, DOI 10.1002/bies.10124
   Vasilchina H, 2009, NATO SCI PEACE SEC B, P501, DOI 10.1007/978-1-4020-9916-8_52
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 54
TC 38
Z9 38
U1 1
U2 15
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2010
VL 20
BP 231
EP 244
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 678OZ
UT WOS:000284090300005
PM 20925022
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Chang, CW
   Davoudabadi, M
   Mashayek, F
AF Chang, Chien-Wei
   Davoudabadi, Mohammad
   Mashayek, Farzad
TI One-Dimensional Fluid Model of Methane Plasma for Diamond-Like Coating
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Article
DE Biomaterial; diamond-like coating; plasma-enhanced chemical vapor
   deposition (CVD); simulation
ID BIOMEDICAL APPLICATIONS; DEPOSITION; ELECTRON
AB Physical modeling with numerical simulation is very useful for researchers to understand and improve the plasma-enhanced chemical vapor deposition process for coating of diamond-like carbon (DLC) films. In this paper, we implement a fluid model including a chemical reaction mechanism for methane plasmas. Employing a finite-difference method, we solve for the low-pressure RF plasma phase in a parallel-plate reactor via the local field equilibrium approximation model, based on which the distribution of the electrons and ions along with the electric potential is obtained. The validation of our simulation is carried out by comparing the model predictions with the results from a previous particle-in-cell work. Our simulations show that the concentration of neutral species is much higher than that of charged species. CH(3) is found to be the major contributing species for deposition as its concentration and boundary flux are higher than those of the other depositing species. The effects of the electrode gap, reactor pressure, and RF voltage amplitude on the species density distributions and depositing species boundary fluxes are studied. Although the deposition rate may be increased (when the number density and boundary flux of depositing species increase) by changing the operating conditions, the variation of C(2)H(5) concentration and boundary flux requires more attention because it may affect the quality of DLC coating.
C1 [Chang, Chien-Wei] Nan Ya Printed Circuit Board Corp, Tao Yuan 33859, Taiwan.
   [Mashayek, Farzad] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA.
   [Davoudabadi, Mohammad] ANSYS Inc, Evanston, IL 60201 USA.
RP Chang, CW (reprint author), Nan Ya Printed Circuit Board Corp, Tao Yuan 33859, Taiwan.
EM mohammad.davoudabadi@ansys.com
FU U.S. National Science Foundation [CBET-0651362]
FX This work was supported by the U.S. National Science Foundation under
   Grant CBET-0651362.
CR DAVOUDABADI M, 2008, THESIS U ILLINOIS CH
   GOGOLIDES E, 1995, JPN J APPL PHYS 1, V34, P261, DOI 10.1143/JJAP.34.261
   Gomathi N, 2008, CURR SCI INDIA, V94, P1478
   Herrebout D, 2001, J APPL PHYS, V90, P570, DOI 10.1063/1.1378059
   HERREBOUT D, 2003, THESIS U ANTWERP WIL
   KLINE LE, 1989, J APPL PHYS, V65, P70, DOI 10.1063/1.343378
   Maric D, 2005, EUR PHYS J D, V35, P313, DOI 10.1140/epjd/e2005-00172-y
   Nagayama K, 1998, IEEE T PLASMA SCI, V26, P125, DOI 10.1109/27.669604
   NAGAYAMA K, 2008, COMMUNICATION
   NAGAYAMA K, 1999, THESIS DREXEL U PHIL
   PICRAUX ST, 1984, SCIENCE, V226, P615, DOI 10.1126/science.226.4675.615
   RATNER BD, 2004, BIOMATERIALS SCI INT, P140
   RHALLABI A, 1991, IEEE T PLASMA SCI, V19, P313
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Sebastian AA, 2005, J PHYS D APPL PHYS, V38, P1577, DOI 10.1088/0022-3727/38/10/013
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   von Recum Andreas F., 1999, HDB BIOMATERIALS EVA
   YARIN AL, 2006, J APPL PHYS, V99
NR 18
TC 2
Z9 2
U1 2
U2 18
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0093-3813
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD JUL
PY 2010
VL 38
IS 7
BP 1603
EP 1614
DI 10.1109/TPS.2010.2049750
PG 12
WC Physics, Fluids & Plasmas
SC Physics
GA 651YG
UT WOS:000281963100011
DA 2018-10-19
ER

PT J
AU Kon, E
   Delcogliano, M
   Filardo, G
   Pressato, D
   Busacca, M
   Grigolo, B
   Desando, G
   Marcacci, M
AF Kon, E.
   Delcogliano, M.
   Filardo, G.
   Pressato, D.
   Busacca, M.
   Grigolo, B.
   Desando, G.
   Marcacci, M.
TI A novel nano-composite multi-layered biomaterial for treatment of
   osteochondral lesions: Technique note and an early stability pilot
   clinical trial
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Osteochondral defect; Biomimetic scaffold; Cartilage regeneration;
   Autologous chondrocytes
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; CARTILAGE DEFECTS; HYALINE
   CARTILAGE; REPAIR TISSUE; KNEE; TRANSPLANTATION
AB Introduction: Osteochondral articular defects are a key concern in orthopaedic surgery. Current surgical techniques to repair osteochondral defects lead to poor subchondral bone regeneration and fibrocartilage formation, which is often associated with joint pain and stiffness. The objective of this pilot clinical study is to evaluate the performance and the intrinsic stability of a newly developed biomimetic osteochondral scaffold and to test the safety and the feasibility of the surgical procedure.
   Methods: A gradient composite osteochondral scaffold based on type I collagen-hydroxyapatite was obtained by nucleating collagen fibrils with hydroxyapatite nanoparticles.
   Thirteen patients (15 defect sites) were treated with scaffold implantation from January 2007 to July 2007: four at the medial femoral condyle, two at the lateral femoral condyles, five at the patellas and four at the trochleas. The mean size of the defects was 2.8 cm(2) (range: 1.5-5.9 cm(2)).
   All patients were followed up prospectively. High-resolution magnetic resonance imaging (MRI) was used to determine "the early postoperative adherence rate" at 4-5 weeks and 25-26 weeks after scaffold implantation. Moreover, the magnetic resonance observation of cartilage repair tissue (MOCART)(13,14) score was performed on every MRI. Two second-looks were performed at 6 months; cartilage repair was assessed using the International Cartilage Repair Society (ICRS) visual scoring system and histological and immunohistochemical analysis of the two biopsies was carried out.
   Results: A completely attached graft and repair tissue were found in 13 of 15 lesions (86.7%). A partial detachment was observed in two patients (13.3%). No detached grafts were found.
   Complete filling of the cartilage defect and congruency of the articular surface were seen in 10 lesions (66.7%) with MRI evaluation at 6 months. The complete integration of the grafted cartilage was detected in eight lesions (53.3%). Subchondral bone changes (oedema or sclerosis) were found in eight defects (53.3%). Statistical analysis showed a significant improvement in the International Knee Documentation Committee (IKDC) subjective and objective scores from preoperative to 6 months' follow-up (p < 0.0005).
   Visual scoring of the repaired tissue at second-look revealed a normal repair score in one case and a near-normal repair score in the other case. Histological analysis showed the formation of subchondral bone without the presence of biomaterial. The cartilage repair tissue appeared to be engaged in an ongoing maturation process.
   Conclusions: The technique is safe and MRI evaluation at short-term follow-up has demonstrated good stability of the scaffold without any other fixation device. The preliminary clinical results at short-term follow-up are encouraging. A clinical and MRI study with longer follow-up and randomised studies will be done to confirm the high potential of this novel osteochondral scaffold. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Delcogliano, M.] San Carlo Nancy Hosp, I-00165 Rome, Italy.
   [Kon, E.; Filardo, G.; Marcacci, M.] Rizzoli Orthopaed Inst, Div & Biomech Lab 9, I-40136 Bologna, Italy.
   [Pressato, D.] Fin Ceram Faenza SpA, Faenza, Italy.
RP Delcogliano, M (reprint author), San Carlo Nancy Hosp, Via Aurelia 275, I-00165 Rome, Italy.
EM m.delcogliano@biomec.ior.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745; Filardo,
   Giuseppe/0000-0002-8136-0977
CR Adachi N, 2006, ARTHROSCOPY, V22, P107, DOI 10.1016/j.arthro.2005.10.019
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Jubel A, 2008, AM J SPORT MED, V36, P1555, DOI 10.1177/0363546508321474
   Kon E., 2007, OSTEOARTHR CARTIL S2, V15, pB76
   Kon E, 2008, SPORTS MED ARTHROSC, V16, P221, DOI 10.1097/JSA.0b013e31818cdbc5
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marcacci M, 2007, KNEE SURG SPORT TR A, V15, P610, DOI 10.1007/s00167-006-0265-9
   Marlovits S, 2005, KNEE SURG SPORT TR A, V13, P451, DOI 10.1007/s00167-004-0535-3
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   MARLOVITS S, 2007, OSTEOARTHRITIS CA SB, V15, P105
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Schagemann J.C., 2008, TISSUE ENG A
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Trattnig S, 2008, EUR RADIOL, V18, P1251, DOI 10.1007/s00330-008-0859-3
   Williams Riley J, 2008, Instr Course Lect, V57, P563
   ZHENG MH, 2006, BASIC SCI CLIN REPAI, P517
   ICRS CARTILAGE INJUR
NR 22
TC 88
Z9 92
U1 0
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUL
PY 2010
VL 41
IS 7
BP 693
EP 701
DI 10.1016/j.injury.2009.11.014
PG 9
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 832EL
UT WOS:000295784800009
PM 20035935
DA 2018-10-19
ER

PT J
AU Murthy, KVR
   Reddy, SJ
   Prasad, DV
AF Murthy, Kusuma V. R.
   Reddy, S. Jayaram
   Prasad, D. V.
TI Endourological Management of Forgotten Encrusted Ureteral Stents
SO INTERNATIONAL BRAZ J UROL
LA English
DT Article
DE stents; ureteral; forgotten; lithiasis; management; endourology
ID REDUCES ENCRUSTATION; BIOMATERIAL; COMPLICATIONS; BIOFILM; CANCER
AB Purpose: To present our experience and discuss the various endourological approaches for treating forgotten encrusted ureteral stents associated with stone formation.
   Materials and Methods: From July 2006 to December 2008, 14 patients (11 men and 3 women) with encrusted ureteral stents were analyzed. The average indwelling time of the stent was 4.9 years (range 1 to 12). Plain-film radiography was used to evaluate encrustation, stone burden, and fragmentation of the stents. Intravenous urogram and a Tc99m diethylene triamine penta acetic-acid renogram was used to assess renal function.
   Results: In seven patients, the entire stent was encrusted, in three patients the encrustation was confined to the ureteral and lower coil part of the stent, two patients had encrustation of the lower coil, and minimal encrustation was observed in two patients. Percutaneous nephrolithotomy was performed in 5 cases and retrograde ureteroscopy with intra-corporeal lithotripsy in 9 patients. Cystolithotripsy was used to manage the distal coil of the encrusted stent in eight patients. Simple cystoscopic removal of the stents with minimal encrustation was carried-out in two cases. Looposcopy and removal of the stent was performed in one patient with an ileal conduit and retained stent. Only one patient required open surgical removal of the stent. Thirteen out of 14 patients were rendered stone and stent free in one session. All except two stents were removed intact and stone analysis of encrustation and calcification revealed calcium oxalate and calcium phosphate in the majority of the cases.
   Conclusion: Endourological management of forgotten encrusted stents is highly successful and often avoids the need for open surgical techniques.
C1 [Murthy, Kusuma V. R.; Reddy, S. Jayaram; Prasad, D. V.] Osmania Gen Hosp, Dept Urol, Hyderabad 500012, Andhra Pradesh, India.
RP Murthy, KVR (reprint author), Osmania Gen Hosp, Dept Urol, Hyderabad 500012, Andhra Pradesh, India.
EM murthy.kusuma@rediffmail.com
CR Ather M H, 2000, Tech Urol, V6, P189
   Borboroglu PG, 2000, J UROLOGY, V164, P648, DOI 10.1016/S0022-5347(05)67272-2
   Bukkapatnam R, 2003, J UROLOGY, V170, P1111, DOI 10.1097/01.ju.0000086042.36616.1b
   Chew BH, 2004, CURR OPIN UROL, V14, P111, DOI 10.1097/01.mou.0000120257.13439.75
   Damiano R, 2002, UROL INT, V69, P136, DOI 10.1159/000065563
   Eisner Brian, 2006, Int. braz j urol., V32, P308, DOI 10.1590/S1677-55382006000300009
   ELFAQIH SR, 1991, J UROLOGY, V146, P1487, DOI 10.1016/S0022-5347(17)38146-6
   FLAM TA, 1990, UROLOGY, V36, P164, DOI 10.1016/0090-4295(90)80218-C
   Gogas J, 2001, EUR J SURG, V167, P715
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   HEPPERLEN TW, 1979, J UROLOGY, V121, P17, DOI 10.1016/S0022-5347(17)56643-4
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   Kuno K, 1998, UROLOGY, V52, P1004, DOI 10.1016/S0090-4295(98)00382-3
   Lam JS, 2002, J ENDOUROL, V16, P733, DOI 10.1089/08927790260472881
   Lingeman JE, 2003, J UROLOGY, V169, P1682, DOI 10.1097/01.ju.0000055600.18515.a1
   Lojanapiwat Bannakij, 2005, Journal of the Medical Association of Thailand, V88, P1203
   Mohan-Pillai K, 1999, J ENDOUROL, V13, P377, DOI 10.1089/end.1999.13.377
   MONGA M, 1995, J UROLOGY, V153, P1817, DOI 10.1016/S0022-5347(01)67319-1
   Park DS, 2002, J ENDOUROL, V16, P153, DOI 10.1089/089277902753716106
   Riedl CR, 2002, INT J ANTIMICROB AG, V19, P507, DOI 10.1016/S0924-8579(02)00097-3
   Robert M, 1997, UROL INT, V58, P100, DOI 10.1159/000282959
   SALTZMAN B, 1988, UROL CLIN N AM, V15, P481
   SCHULZE KA, 1985, UROLOGY, V25, P616, DOI 10.1016/0090-4295(85)90293-6
   Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6
   Singh V, 2005, INT UROL NEPHROL, V37, P541, DOI 10.1007/s11255-004-4704-6
   Somers WJ, 1996, UROLOGY, V47, P431, DOI 10.1016/S0090-4295(99)80468-3
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Watterson JD, 2003, J ENDOUROL, V17, P269, DOI 10.1089/089277903322145431
   Wollin TA, 1998, J ENDOUROL, V12, P101, DOI 10.1089/end.1998.12.101
   ZISMAN A, 1995, J UROLOGY, V153, P718, DOI 10.1016/S0022-5347(01)67697-3
   Zupkas P, 2000, J ENDOUROL, V14, P483, DOI 10.1089/end.2000.14.483
NR 31
TC 18
Z9 19
U1 0
U2 1
PU BRAZILIAN SOC UROL
PI RIO DE JANEIRO
PA RUA BAMBINA, 153, RIO DE JANEIRO, 2251-050, BRAZIL
SN 1677-5538
J9 INT BRAZ J UROL
JI Int. Braz J Urol
PD JUL-AUG
PY 2010
VL 36
IS 4
BP 420
EP 429
DI 10.1590/S1677-55382010000400005
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA 668RZ
UT WOS:000283288700006
PM 20815948
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Maccauro, G
   Cittadini, A
   Magnani, G
   Sangiorgi, S
   Muratori, F
   Manicone, PF
   Iommetti, PR
   Marotta, D
   Chierichini, A
   Raffaelli, L
   Sgambato, A
AF Maccauro, G.
   Cittadini, A.
   Magnani, G.
   Sangiorgi, S.
   Muratori, F.
   Manicone, P. F.
   Iommetti, P. Rossi
   Marotta, D.
   Chierichini, A.
   Raffaelli, L.
   Sgambato, A.
TI IN VIVO CHARACTERIZATION OF ZIRCONIA TOUGHENED ALUMINA MATERIAL: A
   COMPARATIVE ANIMAL STUDY
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE ceramics; carcinogenicity; biocompatibility
ID VITRO; WEAR; COMPOSITE; CERAMICS; FRACTURE; HEAD
AB The development of a new chromia-doped Zirconia Toughened Alumina (ZTA) material was previously reported as displaying mechanical properties suitable for implants with load bearing applications, such as orthopaedic and dental implants. This type of biomaterial is expected to be in contact with living tissues for a long period of time and its long-term toxicity must be carefully evaluated. In this study the suitability of this ZTA material as a candidate biomaterial for orthopaedic implants and dental devices was further investigated in vivo in comparison to alumina and zirconia, which are currently used in orthopaedic and dental surgery. Cylinders of the materials were implanted in vivo in white rabbits, and local and systemic tissue reactions were analyzed at different time intervals after surgery. Radiologic examinations displayed the absence of radiolucence around cylinders and no signs of implant loosening up to twelve months. No tumours developed in the animals either locally (at the site of implantation), or systemically in the peripheral organs. The results obtained suggest that this new ZTA material does not display any long term pathogenic effect in vivo. These findings extend our previous observations on the biocompatibility and the absence of any long-term carcinogenic effect in vitro of this material which displays interesting properties for biomedical applications. In conclusion, we report the in vivo characterization of a new chromia-doped ZTA material and confirm its suitability as a candidate biomaterial for orthopaedic implants and dental devices since it does not give any local nor systemic toxicity even after a long period of time after implantation.
C1 [Manicone, P. F.; Iommetti, P. Rossi; Raffaelli, L.] Catholic Univ, Inst Clin Dent, I-00168 Rome, Italy.
   [Maccauro, G.; Muratori, F.; Marotta, D.] Catholic Univ, Dept Orthopaed & Traumatol, I-00168 Rome, Italy.
   [Cittadini, A.; Sgambato, A.] Catholic Univ, Inst Gen Pathol, I-00168 Rome, Italy.
   [Magnani, G.; Sangiorgi, S.] Faenza Res Ctr, ENEA, Faenza, Italy.
   [Chierichini, A.] Catholic Univ, Inst Anesthesiol, I-00168 Rome, Italy.
RP Raffaelli, L (reprint author), Catholic Univ, Inst Clin Dent, Largo A Gemelli 8, I-00168 Rome, Italy.
EM lraffaelli@rm.unicatt.it
OI MACCAURO, Giulio/0000-0002-7359-268X; Manicone, Paolo
   Francesco/0000-0003-0283-2903; Sgambato, Alessandro/0000-0002-9487-4563
FU EU [GRD1-199-10585]
FX This work was supported by the EU project GRD1-199-10585 "HYPERCER".
CR Affatato S, 2006, J BIOMED MATER RES B, V78B, P76, DOI 10.1002/jbm.b.30462
   Cales B, 2000, CLIN ORTHOP RELAT R, P94
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   Fischer-Brandies E, 1991, Dtsch Zahnarztl Z, V46, P688
   HE C, 1993, WEAR, V162, P314, DOI 10.1016/0043-1648(93)90514-M
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Maccauro G, 2000, INT ORTHOP, V24, P239, DOI 10.1007/s002640000149
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Maccauro G, 2009, INT J IMMUNOPATH PH, V22, P773, DOI 10.1177/039463200902200323
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   MANICONE PF, 2007, INT J IMMUNOPATH PH, V1, P9
   Morita Y, 2004, BIO-MED MATER ENG, V14, P263
   Piconi C, 2006, J MATER SCI-MATER M, V17, P289, DOI 10.1007/s10856-006-7316-0
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Roualdes O, 2010, BIOMATERIALS, V31, P2043, DOI 10.1016/j.biomaterials.2009.11.107
   THOMPSON I, 1990, BIOMATERIALS, V11, P505, DOI 10.1016/0142-9612(90)90066-Y
NR 16
TC 7
Z9 7
U1 0
U2 8
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JUL-SEP
PY 2010
VL 23
IS 3
BP 841
EP 846
DI 10.1177/039463201002300319
PG 6
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA 671AM
UT WOS:000283471700019
PM 20943055
DA 2018-10-19
ER

PT J
AU Rao, U
   Kumar, R
   Balaji, S
   Sehgal, PK
AF Rao, Urmila
   Kumar, Ramadhar
   Balaji, S.
   Sehgal, P. K.
TI A Novel Biocompatible Poly (3-hydroxy-co-4-hydroxybutyrate) Blend as a
   Potential Biomaterial for Tissue Engineering
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE tissue engineering; poly(3-hydroxybutyrate-co-4-hydroxybutyrate);
   immunoblotting; poly(3-hydroxybutyrate-co-4-hydroxybutyrate) blends;
   cytocompatibility; pro-inflammatory response; cell culture
ID IN-VITRO; POLYHYDROXYALKANOATES; BIOSYNTHESIS; FIBROBLAST; OSTEOBLAST;
   APOPTOSIS; SURFACES; ADHESION; PHBHHX; GROWTH
AB Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) P(3HB-co-4HB) biopolymer was subjected to a depyrogenation treatment followed by blending with vitamin E (P(3HB-co-4HB)/Vit E blend), collagen (Col blend) or both (P(3HB-co-4HB)/Vit E/Col hybrid blend) to improve its biological performance. The cytocompatibility and pro-inflammatory response to the biopolymer after the treatment and blending were evaluated by cellular responses in vitro. Cell attachment and spreading of murine NIH 3T3 fibroblasts seeded on the films were found to be the highest on the hybrid P(3HB-co-4HB)/Vit E/Col blend film. The P(3HB-co-4HB) blends showed increased cell proliferation and negligible cytotoxicity. The pro-inflammatory cytokines, IL6 and TNF alpha expression in the murine macrophage cell line J774 A-1 monocyte/macrophage cells cultured on the biopolymer films were assessed by immunoblotting and RT-PCR analyses which revealed that the combined blending strategy was the most effective in reducing the pro-inflammatory activity. The depyrogenated P(3HB-co-4HB) blends significantly extend the range of biomaterials suitable for tissue engineering.
C1 [Rao, Urmila; Kumar, Ramadhar; Balaji, S.; Sehgal, P. K.] Cent Leather Res Inst, Biomat Div, Bioprod Lab, Madras 20, Tamil Nadu, India.
RP Sehgal, PK (reprint author), Cent Leather Res Inst, Biomat Div, Bioprod Lab, Madras 20, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
FU CSIR, Government of India
FX We are grateful to Dr. A. B. Mandal, Director, CLRI, Chennai for his
   kind permission to publish this work. The authors Urmila Rao, Ramadhar
   Kumar and S. Balaji acknowledge CSIR, Government of India for the
   financial assistance in the form of Senior Research Fellowships.
CR Chen SQ, 2001, J BIOL CHEM, V276, P39259, DOI 10.1074/jbc.M105335200
   CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444
   Kim HW, 2002, INT J BIOL MACROMOL, V30, P129, DOI 10.1016/S0141-8130(02)00012-0
   Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034
   Lee SY, 1999, APPL ENVIRON MICROB, V65, P2762
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Mabilleau G, 2004, BIOMATERIALS, V25, P5155, DOI 10.1016/j.biomaterials.2003.12.026
   Martin D, 2003, BIOCH ENG J, V3738, P1
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Rao U, 2010, BIOCHEM ENG J, V49, P13, DOI 10.1016/j.bej.2009.11.005
   Reno F, 2005, BIOMATERIALS, V26, P5594, DOI 10.1016/j.biomaterials.2005.02.015
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   WANG Y, 2007, J BIOMEDICAL MED R A, V88, P616
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Zhang DX, 1997, CANCER RES, V57, P2410
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 25
TC 9
Z9 12
U1 0
U2 14
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2010
VL 25
IS 4
BP 419
EP 436
DI 10.1177/0883911510369037
PG 18
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 610SD
UT WOS:000278754600006
DA 2018-10-19
ER

PT J
AU Hauser, J
   Koeller, M
   Bensch, S
   Halfmann, H
   Awakowicz, P
   Steinau, HU
   Esenwein, S
AF Hauser, Joerg
   Koeller, Manfred
   Bensch, Sebastian
   Halfmann, Helmut
   Awakowicz, Peter
   Steinau, Hans-Ulrich
   Esenwein, Stefan
TI Plasma mediated collagen-I-coating of metal implant materials to improve
   biocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE low-pressure plasma; metal implant materials; collagen-I;
   biocompatibility; coating
ID LOW-PRESSURE PLASMA; TITANIUM IMPLANTS; HYDROXYAPATITE COATINGS;
   BIOMATERIAL SURFACES; POLYMERIZATION; STERILIZATION; WETTABILITY;
   PROTEINS; ADHESION; GROWTH
AB This study describes the collagen-I coating of titanium and steel implants via cold low-pressure gas plasma treatment. To analyze the coatings in terms of bio-compatibility osteoblast-like osteosarcoma cells and human leukocytes were cultivated on the metal surfaces. Two different implant materials were assessed (Ti6Al4V, X2CrNiMo18) and four different surface properties were evaluated: (a) plasma pretreated and collagen-I coated implant materials; (b) collagen-I dip-coated without plasma pretreatment; (c) plasma treated but not collagen-I coated; (d) standard implant materials served as control. The different coating characteristics were analyzed by scanning electron microscopy (SEM). For adhesion and viability tests calcein-AM staining of the cells and Alamar blue assays were performed. The quantitative analysis was conducted by computer assisted microfluorophotography and spectrometer measurements. SEM analysis revealed that stable collagen-I coatings could not be achieved on the dip-coated steel and titanium alloys. Only due to pretreatment with low-pressure gas plasma a robust deposition of collagen I on the surface could be achieved. The cell viability and cell attachment rate on the plasma pretreated, collagen coated surfaces was significantly (p < 0.017) increased compared to the non coated surfaces. Gas plasma treatment is a feasible method for the deposition of proteins on metal implant materials resulting in an improved biocompatibility in vitro. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res 94A: 19-26, 2010
C1 [Hauser, Joerg; Steinau, Hans-Ulrich] Bergmannsheil Univ Hosp, BG Trauma Ctr, Dept Plast Surg, Bochum, Germany.
   [Koeller, Manfred; Bensch, Sebastian] Bergmannsheil Univ Hosp, BG Trauma Ctr, Dept Surg Res, Bochum, Germany.
   [Halfmann, Helmut; Awakowicz, Peter] Ruhr Univ Bochum, Inst Plasma Technol, Bochum, Germany.
   [Esenwein, Stefan] Univ Duisburg Essen, Dept Orthopaed, Essen, Germany.
RP Hauser, J (reprint author), Bergmannsheil Univ Hosp, BG Trauma Ctr, Dept Plast Surg, Bochum, Germany.
EM joerg.hauser@rub.de
CR Auclair-Daigle C, 2005, J BIOMED MATER RES A, V73A, P398, DOI 10.1002/jbm.a.30284
   Baier R E, 1984, J BIOMED MATER RES, V18, P327
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Dean J W 3rd, 1995, Int J Oral Maxillofac Implants, V10, P721
   ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4
   GOLANDER CG, 1992, J BIOMAT SCI-POLYM E, V4, P25
   Hauser J, 2008, BIOMED TECH, V53, P199, DOI 10.1515/BMT.2008.024
   Klages CP, 1999, MATERIALWISS WERKST, V30, P767, DOI 10.1002/(SICI)1521-4052(199912)30:12<767::AID-MAWE767>3.0.CO;2-S
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lee JH, 2005, BIOMATERIALS, V26, P3249, DOI 10.1016/j.biomaterials.2004.08.033
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R
   Liu XY, 2005, J BIOMED MATER RES A, V74A, P356, DOI 10.1002/jbm.a.30273
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Shard AG, 2006, REGEN MED, V1, P789, DOI 10.2217/17460751.1.6.789
   Stadlinger B, 2008, J MATER SCI-MATER M, V19, P1043, DOI 10.1007/s10856-007-3077-7
   Toth C, 2002, SMART MATER STRUCT, V11, P813, DOI 10.1088/0964-1726/11/5/329
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Wagner W C, 1992, J Oral Implantol, V18, P231
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   Zhu L, 2007, J BIOMED MATER RES A, V83A, P1165, DOI 10.1002/jbm.a.31401
NR 25
TC 15
Z9 16
U1 2
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2010
VL 94A
IS 1
BP 19
EP 26
DI 10.1002/jbm.a.32672
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 606DC
UT WOS:000278400800003
PM 20091709
DA 2018-10-19
ER

PT J
AU Mirnajafi, A
   Zubiate, B
   Sacks, MS
AF Mirnajafi, Ali
   Zubiate, Brett
   Sacks, Michael S.
TI Effects of cyclic flexural fatigue on porcine bioprosthetic heart valve
   heterograft biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE heart valve bioprostheses; heterograft biomaterial fatigue; flexure
ID MECHANICAL FATIGUE; STRESS-STRAIN; TISSUE; CALCIFICATION; BEHAVIOR;
   BISPHOSPHONATE; BIOMECHANICS; PERICARDIUM; PATHOLOGY; FAILURE
AB Although bioprosthetic heart valves (BHV) remain the primary treatment modality for adult heart valve replacement, continued problems with durability remain. Several studies have implicated flexure as a major damage mode in porcine-derived heterograft biomaterials used in BHV fabrication. Although conventional accelerated wear testing can provide valuable insights into BHV damage phenomena, the constituent tissues are subjected to complex, time-varying deformation modes (i.e., tension and flexure) that do not allow for the control of the amount, direction, and location of flexure. Thus, in this study, customized fatigue testing devices were developed to subject circumferentially oriented porcine BHV tissue strips to controlled cyclic flexural loading. By using this approach, we were able to study layer-specific structural damage induced by cyclic flexural tensile and compressive stresses alone. Cycle levels of 10 x 10(6), 25 x 10(6), and 50 x 10(6) were used, with resulting changes in flexural stiffness and collagen structure assessed. Results indicated that flexural rigidity was markedly reduced after only 10 x 10(6) cycles, and progressively decayed at a lower rate with cycle number thereafter. Moreover, the against-curvature fatigue direction induced the most damage, suggesting that the ventricularis and fibrosa layers have low resistance to cyclic flexural compressive and tensile loads, respectively. The histological analyses indicated progressive collagen fiber delamination as early as 10 x 10(6) cycles but otherwise no change in gross collagen orientation. Our results underscore that porcine-derived heterograft biomaterials are very sensitive to flexural fatigue, with delamination of the tissue layers the primary underlying mechanism. This appears to be in contrast to pericardial BHV, wherein high tensile stresses are considered to be the major cause of structural failure. These findings point toward the need for the development of chemical fixation technologies that minimize flexure-induced damage to extend porcine heterograft biomaterial durability. (c) 2010 Wiley Periodicals, Inc. J Biomed Mater Res 94A: 205-213, 2010
C1 [Sacks, Michael S.] Univ Pittsburgh, Dept Bioengn, Cardiovasc Biomech Lab, Pittsburgh, PA 15219 USA.
   Univ Pittsburgh, McGowan Inst, Pittsburgh, PA 15219 USA.
RP Sacks, MS (reprint author), Univ Pittsburgh, Dept Bioengn, Cardiovasc Biomech Lab, 300 Technol Dr, Pittsburgh, PA 15219 USA.
EM msacks@pitt.edu
RI Sacks, Michael/F-3703-2011
FU NIH [HL-063026, HL-070969]
FX Contract grant sponsor: NIH; contract grant numbers: HL-063026,
   HL-070969
CR Alferiev IS, 2005, J ORGANOMET CHEM, V690, P2543, DOI 10.1016/j.jorganchem.2004.10.011
   BILLIAR K, 1998, INT MECH ENG C EXP A
   BROOM ND, 1978, J THORAC CARDIOV SUR, V76, P202
   BROOM ND, 1978, CONNECT TISSUE RES, V6, P37, DOI 10.3109/03008207809152285
   BROOM ND, 1980, BIOMATERIALS, V1, P3, DOI 10.1016/0142-9612(80)90049-6
   BROOM ND, 1977, J BIOMECH, V10, P707, DOI 10.1016/0021-9290(77)90086-0
   Christie G W, 1999, Semin Thorac Cardiovasc Surg, V11, P201
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   FERRANS VJ, 1978, AM J CARDIOL, V41, P1159, DOI 10.1016/0002-9149(78)90873-1
   Frisch-Fay R, 1962, FLEXIBLE BARS
   Fung YC, 1993, BIOMECHANICS MECH PR
   Glasmacher B, 1997, INT J ARTIF ORGANS, V20, P267
   GLASMACHERSEILER B, 1992, J LONG-TERM EFF MED, V2, P113
   Gloeckner DC, 1999, ASAIO J, V45, P59, DOI 10.1097/00002480-199901000-00014
   Lovekamp J, 2001, J BIOMED MATER RES, V56, P478, DOI 10.1002/1097-4636(20010915)56:4<478::AID-JBM1119>3.0.CO;2-C
   Lovekamp JJ, 2006, BIOMATERIALS, V27, P1507, DOI 10.1016/j.biomaterials.2005.08.003
   Prosthetic Devices Branch D.o.C., 1993, RESP NEUR DEV REPL H
   PURINYA B, 1994, J BIOMECH, V27, P1, DOI 10.1016/0021-9290(94)90027-2
   Rapoport HS, 2007, BIOMATERIALS, V28, P690, DOI 10.1016/j.biomaterials.2006.09.029
   SACKS M, 1988, RES DEV, V30, P75
   Sacks M S, 2001, J Long Term Eff Med Implants, V11, P231
   Sacks MS, 2007, BIOMATERIALS, V28, P5390, DOI 10.1016/j.biomaterials.2007.08.021
   Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122
   Sacks MS, 2006, EXPERT REV MED DEVIC, V3, P817, DOI 10.1586/17434440.3.6.817
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   SACKS MS, COLLAGEN FIBER UNPUB
   Sacks MS, 1999, CALCIFICATION INDEPE
   SACKS MS, 1994, ASAIO J, V40, P632
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1997, J HEART VALVE DIS, V6, P1
   SCHOEN FJ, 1994, J CARDIAC SURG, V9, P222, DOI 10.1111/j.1540-8191.1994.tb00932.x
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCHOEN FJ, 1991, REPLACEMENT CARDIAC, P125
   Schoen FJ, 2006, CARDIOVASC PATHOL, V15, P271, DOI 10.1016/j.carpath.2006.05.001
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   SMITH DB, 1996, EFFECTS IN VITRO ACC, P78
   Stella JA, 2007, J BIOMECH ENG-T ASME, V129, P757, DOI 10.1115/1.2768111
   Sugimoto H, ANN BIOMED IN PRESS
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Thubrikar MJ, 1990, AORTIC VALVE
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   Wells S. M., 2003, PHYS CAN, V59, P67
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
NR 47
TC 20
Z9 20
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2010
VL 94A
IS 1
BP 205
EP 213
DI 10.1002/jbm.a.32659
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 606DC
UT WOS:000278400800022
PM 20166221
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ignjatovic, NL
   Ajdukovic, ZR
   Savic, VP
   Uskokovic, DP
AF Ignjatovic, Nenad L.
   Ajdukovic, Zorica R.
   Savic, Vojin P.
   Uskokovic, Dragan P.
TI Size effect of calcium phosphate coated with
   poly-DL-lactide-co-glycolide on healing processes in bone reconstruction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE calcium phosphate/poly-DL-lactide-co-glycolide (CP/PLGA);
   microparticles; nanoparticles; autologous plasma; alveolar bone
ID MESENCHYMAL STEM-CELLS; IN-VITRO; POLY(LACTIC-CO-GLYCOLIC ACID);
   OSTEOGENIC DIFFERENTIATION; PARTICULATE FORM; REPAIR; OSTEOPOROSIS;
   OSTEOBLASTS; COMPOSITES; CERAMICS
AB In this article, synthesis and application of calcium phosphate/poly-n-lactide-co-glycolide (CP/PLGA) composite biomaterial in particulate form, in which each CP granule/particle is coated with PLGA, are described. Two types of the particulate material having different particle sizes were synthesized: one with an average particle diameter between 150 and 250 mu m (micron-sized particles, MPs) and the other with an average particle diameter smaller than 50 nm (nanoparticles, NPs). A comparative in vivo analysis was done by reconstructing defects in osteoporotic alveolar bones using both composites. The material, CP granules/particles covered with polymer, was characterized using X-ray structural analysis, scanning electron microscopy, and atomic force microscopy. Changes in reparatory functions of tissues affected by osteoporosis were examined in mice in vivo, using these two kinds of composite materials, with and without autologous plasma. Having defined the target segment, histomor-phometric parameters-bone area fraction, area, and mean density-were determined. The best results in the regeneration and recuperation of alveolar bone damaged by osteoporosis were achieved with the implantation of a mixture of nanoparticulate CP/PLGA composite and autologous plasma. After the implantation of microparticulate CP/PLGA, in the form of granules, mixed with autologous plasma, into an artificial defect in alveolar bone, new bone formation was also observed, although its formation rate was slower. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 946:108-117, 2010.
C1 [Ignjatovic, Nenad L.; Uskokovic, Dragan P.] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
   [Ajdukovic, Zorica R.] Dept Prosthodont, Clin Stomatol, Nish, Serbia.
   [Savic, Vojin P.] Inst Biomed Res, Nish, Serbia.
   [Ajdukovic, Zorica R.; Savic, Vojin P.] Fac Med, Nish, Serbia.
RP Uskokovic, DP (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
EM uskok@itn.sanu.ac.yu
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X
FU Ministry of Science and Technological Development of the Republic of
   Serbia [142006, 145068]
FX Contract grant sponsor: Ministry of Science and Technological
   Development of the Republic of Serbia; contract grant numbers: 142006,
   145068
CR Ajdukovic Z, 2005, J BIOMATER APPL, V20, P179, DOI 10.1177/0885328205050519
   Ajdukovic Z, 2007, J BIOMATER APPL, V21, P317, DOI 10.1177/0885328207073760
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Boonen S, 2008, J CLIN ENDOCR METAB, V93, P852, DOI 10.1210/jc.2007-0711
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Cochrane C, 1999, BIOMATERIALS, V20, P1237, DOI 10.1016/S0142-9612(99)00025-3
   Costantino L, 2006, BIOMATERIALS, V27, P4635, DOI 10.1016/j.biomaterials.2006.04.026
   Dereka XE, 2006, GROWTH FACTORS, V24, P260, DOI 10.1080/08977190601060990
   DEWOLFF P, 090432 PDF ICDD GRAN
   DEWOLFF P, 090169 PDF ICDD GRAN
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Grigor'ian A S, 2000, Stomatologiia (Mosk), V79, P9
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934
   Ignjatovic N, 2008, ADV APPL CERAM, V107, P142, DOI 10.1179/174367608X263421
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Ignjatovic N, 2006, MICROSC RES TECHNIQ, V69, P976, DOI 10.1002/jemt.20374
   Jevtic M, 2009, ACTA BIOMATER, V5, P208, DOI 10.1016/j.actbio.2008.07.026
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Liu YK, 2009, J BIOMED MATER RES A, V90A, P1083, DOI 10.1002/jbm.a.32192
   Miao XG, 2008, ACTA BIOMATER, V4, P638, DOI 10.1016/j.actbio.2007.10.006
   Miller Derick C, 2002, IEEE Trans Nanobioscience, V1, P61, DOI 10.1109/TNB.2002.806917
   Mirkin CA, 1999, SCIENCE, V286, P2095, DOI 10.1126/science.286.5447.2095
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   Sabino MA, 2002, J MATER SCI, V37, P35, DOI 10.1023/A:1013129421038
   Schenk RK, 1998, PERIODONTOL 2000, V17, P22, DOI 10.1111/j.1600-0757.1998.tb00120.x
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P4, DOI 10.1002/term.2
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Tanaka T, 2007, MAT SCI ENG C-BIO S, V27, P817, DOI 10.1016/j.msec.2006.09.019
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Xu QG, 2008, J CONTROL RELEASE, V127, P146, DOI 10.1016/j.jconrel.2009.01.017
   Yang DH, 2000, CYTOKINE, V12, P1271, DOI 10.1006/cyto.2000.0707
   Zhao Y, 2007, J BIOMED MATER RES B, V83B, P121, DOI 10.1002/jbm.b.30774
   Zhou DS, 2006, J BIOACT COMPAT POL, V21, P373, DOI 10.1177/0883911506068554
NR 43
TC 19
Z9 20
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2010
VL 94B
IS 1
BP 108
EP 117
DI 10.1002/jbm.b.31630
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 609ZI
UT WOS:000278697400012
PM 20524184
DA 2018-10-19
ER

PT J
AU Calarco, A
   Petillo, O
   Bosetti, M
   Torpedine, A
   Cannas, M
   Perrone, L
   Galderisi, U
   Melone, MAB
   Peluso, G
AF Calarco, Anna
   Petillo, Orsolina
   Bosetti, Michela
   Torpedine, Angela
   Cannas, Mario
   Perrone, Lorena
   Galderisi, Umberto
   Melone, Mariarosa A. B.
   Peluso, Gianfranco
TI Controlled Delivery of the Heparan Sulfate/FGF-2 Complex by a
   Polyelectrolyte Scaffold Promotes Maximal hMSC Proliferation and
   Differentiation
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE MESENCHYMAL STEM CELLS; FGF-2; CONTROLLED DELIVERY; POLYELECTROLYTE
   POLYMER
ID FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS;
   IN-VITRO; BIODEGRADABLE HYDROGELS; BONE REGENERATION; BINDING; FGF-2;
   RETENTION; SCLERAXIS
AB Growth factors and other regulatory molecules are required to direct differentiation of hone marrow-derived human mesenchymal stem cells (hMSC) along specific lineages. However, the therapeutic use of growth factors is limited by their susceptibility to degradation, and the need to maintain prolonged local release of growth factor at levels sufficient to stimulate hMSC. The aim of this study was to investigate whether a device containing heparan sulfate (HS), which is a co-factor in growth factor-mediated cell proliferation and differentiation, could potentiate and prolong the delivery of fibroblast growth factor-2 (FGF-2) and thus enhance hMSC stimulation. 10 this aim, we synthesized cationic polyelectrolyte polymers covalently and non-covalently anchored to HS and evaluated their effect on hMSC proliferation. Polymers non-covalently bound to HS resulted in the release of an HS/FGF-2 complex rather than FGF-2 alone. The release of this complex significantly restored hMSC proliferation, which was abolished in serum-free medium and only partially restored by the release of FGF-2 alone as occurred with polymer covalently bound to HS. We also demonstrate that exposure to HS/FGF-2 during early growth hut not during post-confluence is essential for hMSC differentiation down the fibroblast lineage, which suggests that both factors arc required to establish the correct stem cell commitment that is necessary to support subsequent differentiation. In conclusion, the delivery platform described here is a step towards the development of a new class of biomaterial that enables the prolonged, non-covalent binding and controlled delivery of growth factors and cofactors without altering their potency. J. Cell. Biochem. 110: 903-909, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Calarco, Anna; Petillo, Orsolina; Torpedine, Angela; Peluso, Gianfranco] CNR, Inst Prot Biochem, I-80131 Naples, Italy.
   [Bosetti, Michela] Univ Piemonte Orientale, DiSCAFF, Novara, Italy.
   [Cannas, Mario] Univ Piemonte Orientale, Dept Clin & Expt Med, Novara, Italy.
   [Perrone, Lorena] Univ Aix Marseille 2, Fac Med Secteur Nord, CNRS, NICN UMR 6184, Marseille, France.
   [Galderisi, Umberto] Univ Naples 2, Sect Biotechnol & Mol Biol, Dept Expt Med, Naples, Italy.
   [Melone, Mariarosa A. B.] Univ Naples 2, Div Neurol 1, Dept Neurol Sci, Naples, Italy.
RP Peluso, G (reprint author), CNR, Inst Prot Biochem, Via Pietro Castellino 11, I-80131 Naples, Italy.
EM g.peluso@ibp.cnr.it
RI TERRACCIANO, CHIARA/C-2955-2018; Melone, Mariarosa/N-6788-2015
OI TERRACCIANO, CHIARA/0000-0002-1853-5578; Melone,
   Mariarosa/0000-0002-7213-9277; Bosetti, Michela/0000-0002-3682-8702;
   GALDERISI, Umberto/0000-0003-0909-7403
FU Italian Ministry of University and Research [2006-prot. RBIP06ZJ78_002,
   2004061452_003]; AFM [11916-SR-Group]; Piedmont Region Funds
   [2005-prot.1634/27.001]
FX Grant sponsor: Italian Ministry of University and Research; Grant
   number: 2006-prot. RBIP06ZJ78_002; Grant sponsor: Italian Ministry of
   University and Research; Grant number: 2004061452_003; Grant sponsor:
   AFM 2006/Project n degrees 11916-SR-Group. Grant sponsor: Piedmont
   Region Funds; Grant number: 2005-prot.1634/27.001
CR Altman Greg, 2002, FASEB Journal, V16, P270
   ARAKAWA T, 1994, ARCH BIOCHEM BIOPHYS, V308, P267, DOI 10.1006/abbi.1994.1037
   Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bush MA, 2001, J CLIN PHARMACOL, V41, P378, DOI 10.1177/00912700122010230
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Chan BP, 2000, ACTA ORTHOP SCAND, V71, P513, DOI 10.1080/000164700317381234
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   CSERJESI P, 1995, DEVELOPMENT, V121, P1099
   De Rosa M, 2004, J CELL PHYSIOL, V198, P133, DOI 10.1002/jcp.10397
   DEBLOIS C, 1994, BIOMATERIALS, V15, P665, DOI 10.1016/0142-9612(94)90164-3
   Denizli A, 1999, J APPL POLYM SCI, V74, P655, DOI 10.1002/(SICI)1097-4628(19991017)74:3<655::AID-APP19>3.0.CO;2-N
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Friedl A, 1997, AM J PATHOL, V150, P1443
   Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813
   Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031
   Laham RJ, 2000, J AM COLL CARDIOL, V36, P2132, DOI 10.1016/S0735-1097(00)00988-8
   Lalan S, 2001, WORLD J SURG, V25, P1458
   Lee JH, 2005, EXP CELL RES, V307, P174, DOI 10.1016/j.yexcr.2005.03.008
   LIU LS, 1998, P 25 INT S CONTR REL, V25, P996
   Long XX, 2005, STEM CELLS DEV, V14, P65, DOI 10.1089/scd.2005.14.65
   MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271
   Mauney JR, 2005, BIOMATERIALS, V26, P6167, DOI 10.1016/j.biomaterials.2005.03.024
   Moreau JE, 2005, J ORTHOP RES, V23, P164, DOI 10.1016/j.orthres.2004.05.004
   Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933
   Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020
   Nilasaroya A, 2008, BIOMATERIALS, V29, P4658, DOI 10.1016/j.biomaterials.2008.08.011
   Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Speicher T, 2007, STEM CELLS DEV, V16, P305
   Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6
   THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3
   Watanabe Kie, 2004, Kokubyo Gakkai Zasshi, V71, P11
   WINER J, 1999, ANAL BIOCHEM, V270
   Yamada K, 1997, J NEUROSURG, V86, P871, DOI 10.3171/jns.1997.86.5.0871
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 44
TC 9
Z9 11
U1 1
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD JUL 1
PY 2010
VL 110
IS 4
BP 903
EP 909
DI 10.1002/jcb.22602
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 619OS
UT WOS:000279440100012
PM 20564189
DA 2018-10-19
ER

PT J
AU Buntem, R
   Intasiri, A
   Lueangchaichaweng, W
AF Buntem, Radchada
   Intasiri, Amarawan
   Lueangchaichaweng, Warunee
TI Facile synthesis of silica monolith doped with
   meso-tetra(p-carboxyphenyl)-porphyrin as a novel metal ion sensor
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Metal ion sensor; Optical sensor; Porphyrin-doped silica monolith; Sol
   gel silica
ID SOL-GEL GLASS; OPTICAL SENSOR; SIO2 GELS; PORPHYRIN; SYSTEMS; COBALT;
   LEAD
AB A novel metal ion sensor was prepared using silica monolith doped with meso-tetra(p-carboxyphenyl)porphyrin. The doped material was prepared using TEOS:EtOH:H(2)O:HCl:porphyrin molar ratios of 1:5:7:3.1 x 10(-2):2.3 x 10(-5), respectively. The mixture was kept 16 days for the gelation process and then the wet gel was dried at 55-60 degrees C for 3 days. The porphyrin-doped monolith obtained was kept in 1 M metal salt solution for 2 days. The visible spectrum of the metal-coordinated porphyrin-doped monolith was compared with the uncoordinated porphyrin-doped monolith. The spectra show the characteristic maxima for Cu(2+) at 543 nm, for Zn(2+) at 522, 559, and 596 nm, for Pb(2+) at 531 and 559 nm, and for Ni(2+) at 522 and 551 nm. The metal coordinated to the silica monolith could be removed by washing with 1 M HNO(3). However the Cu(2+) could not be eluted by acidic solution due to its strong bonding to the porphyrin. The results show that this porphyrin-doped monolithic biomaterial is a promising sensor for metal ions in wastewater and other harsh environments. Crown Copyright (C) 2010 Published by Elsevier Inc. All rights reserved.
C1 [Buntem, Radchada; Lueangchaichaweng, Warunee] Silpakorn Univ, Fac Sci, Dept Chem, Nakhon Pathom 73000, Thailand.
   [Intasiri, Amarawan] Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok 10330, Thailand.
RP Buntem, R (reprint author), Silpakorn Univ, Fac Sci, Dept Chem, Nakhon Pathom 73000, Thailand.
EM radchadab@yahoo.com
CR ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053
   BELLACCHIO E, 1998, J CHEM SOC CHEM COMM, P1333
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   DEOLIVEIRA WA, 1992, TALANTA, V39, P1499, DOI 10.1016/0039-9140(92)80132-W
   DOROUGH GD, 1951, J AM CHEM SOC, V73, P4315, DOI 10.1021/ja01153a085
   Fakhari AR, 2001, ANAL LETT, V34, P1097, DOI 10.1081/AL-100104956
   Garcia Sanchez MA, 2006, J SOL-GEL SCI TECHN, V37, P93, DOI 10.1007/s10971-006-6425-z
   Garcia-Sanchez MA, 2004, J NON-CRYST SOLIDS, V333, P226, DOI 10.1016/j.jnoncrysol.2003.10.009
   Garcia-Sanchez MA, 2001, J NON-CRYST SOLIDS, V296, P50, DOI 10.1016/S0022-3093(01)00888-2
   Gupta VK, 2007, TALANTA, V73, P803, DOI 10.1016/j.talanta.2007.04.049
   KLIMANT I, 1992, MIKROCHIM ACTA, V108, P11, DOI 10.1007/BF01240367
   Klyueva M. E., 2003, THEOR EXP CHEM, V39, P309
   LAVALLEE DK, 1974, INORG CHEM, V13, P2004, DOI 10.1021/ic50138a042
   Lee SK, 1997, ANALYST, V122, P81, DOI 10.1039/a604885d
   Malcik N, 1998, SENSOR ACTUAT B-CHEM, V53, P211, DOI 10.1016/S0925-4005(99)00004-0
   POLLARD FH, 1959, ANAL CHIM ACTA, V20, P26, DOI 10.1016/0003-2670(59)80004-0
   Radloff D, 1996, SENSOR ACTUAT B-CHEM, V35, P207, DOI 10.1016/S0925-4005(97)80056-1
   Schiavon MA, 2001, J MOL CATAL A-CHEM, V174, P213, DOI 10.1016/S1381-1169(01)00176-5
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Smith K.M., 1978, PORPHYRINS METALLOPO
   Stern A, 1936, Z PHYS CHEM A-CHEM T, V175, P405
   STONE A, 1968, J AM CHEM SOC, V90, P2735, DOI 10.1021/ja01013a001
   Weng YQ, 2007, INORG CHEM COMMUN, V10, P443, DOI 10.1016/j.inoche.2006.12.023
   Yang Y, 2009, ANAL CHIM ACTA, V636, P83, DOI 10.1016/j.aca.2009.01.038
   Zaitoun MA, 2005, SPECTROCHIM ACTA A, V61, P1715, DOI 10.1016/j.saa.2004.07.001
NR 25
TC 38
Z9 38
U1 3
U2 26
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 1
PY 2010
VL 347
IS 1
BP 8
EP 14
DI 10.1016/j.jcis.2010.03.035
PG 7
WC Chemistry, Physical
SC Chemistry
GA 602RY
UT WOS:000278157700002
PM 20417520
DA 2018-10-19
ER

PT J
AU Busscher, HJ
   Rinastiti, M
   Siswomihardjo, W
   van der Mei, HC
AF Busscher, H. J.
   Rinastiti, M.
   Siswomihardjo, W.
   van der Mei, H. C.
TI Biofilm Formation on Dental Restorative and Implant Materials
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Review
DE oral biofilm; restorative materials; antimicrobials
ID SURFACE FREE-ENERGY; STREPTOCOCCUS-MUTANS BIOFILM; COMPOSITE RESIN
   RESTORATIONS; GLASS-IONOMER CEMENTS; CANDIDA-ALBICANS; IN-VIVO;
   ANTIBACTERIAL PROPERTIES; FLUORIDE RELEASE; MICROBIAL ADHESION;
   BACTERIAL-COLONIZATION
AB Biomaterials for the restoration of oral function are prone to biofilm formation, affecting oral health. Oral bacteria adhere to hydrophobic and hydrophilic surfaces, but due to fluctuating shear, little biofilm accumulates on hydrophobic surfaces in vivo. More biofilm accumulates on rough than on smooth surfaces. Oral biofilms mostly consist of multiple bacterial strains, but Candida species are found on acrylic dentures. Biofilms on gold and amalgam in vivo are thick and fully covering, but barely viable. Biofilms on ceramics are thin and highly viable. Biofilms on composites and glass-ionomer cements cause surface deterioration, which enhances biofilm formation again. Residual monomer release from composites influences biofilm growth in vitro, but effects in vivo are less pronounced, probably due to the large volume of saliva into which compounds are released and its continuous refreshment. Similarly, conflicting results have been reported on effects of fluoride release from glass-ionomer cements. Finally, biomaterial-associated infection of implants and devices elsewhere in the body is compared with oral biofilm formation. Biomaterial modifications to discourage biofilm formation on implants and devices are critically discussed for possible applications in dentistry. It is concluded that, for dental applications, antimicrobial coatings killing bacteria upon contact are more promising than antimicrobial-releasing coatings.
C1 [Busscher, H. J.; Rinastiti, M.; van der Mei, H. C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Busscher, H. J.; Rinastiti, M.; van der Mei, H. C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Rinastiti, M.] Gadjah Mada Univ, Fac Dent, Dept Conservat Dent, Yogyakarta, Indonesia.
   [Siswomihardjo, W.] Gadjah Mada Univ, Fac Dent, Dept Biomat, Yogyakarta, Indonesia.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
FU University Medical Center Groningen-University of Groningen, Groningen,
   The Netherlands
FX This study was supported by the University Medical Center
   Groningen-University of Groningen, Groningen, The Netherlands.
CR Al-Naimi OT, 2008, J MATER SCI-MATER M, V19, P1243, DOI 10.1007/s10856-006-0023-z
   Auschill TM, 2002, EUR J ORAL SCI, V110, P48, DOI 10.1046/j.0909-8836.2001.101160.x
   Avon SL, 2007, J PROSTHET DENT, V97, P32, DOI 10.1016/j.prosdent.2006.12.001
   Bakker DP, 2004, APPL ENVIRON MICROB, V70, P3758, DOI 10.1128/AEM.70.6.3758-3760.2004
   Bamford CV, 2009, INFECT IMMUN, V77, P3696, DOI 10.1128/IAI.00438-09
   Beyth N, 2008, DENT MATER, V24, P732, DOI 10.1016/j.dental.2007.08.003
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Brambilla E, 2009, DENT MATER, V25, P1067, DOI 10.1016/j.dental.2009.02.012
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   BUSSCHER HJ, 1992, FEMS MICROBIOL LETT, V88, P199, DOI 10.1111/j.1574-6968.1992.tb04988.x
   Carlen A, 2001, BIOMATERIALS, V22, P481, DOI 10.1016/S0142-9612(00)00204-0
   Carvalho RM, 1996, OPER DENT, V21, P17
   Cenci MS, 2006, J ADHES DENT, V8, P127
   Chan WLD, 2006, DENT MATER, V22, P366, DOI 10.1016/j.dental.2005.04.028
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   Coco BJ, 2008, ORAL MICROBIOL IMMUN, V23, P377, DOI 10.1111/j.1399-302X.2008.00439.x
   Collins CJ, 1998, J DENT, V26, P311, DOI 10.1016/S0300-5712(97)00019-5
   De Soete M, 2005, J DENT RES, V84, P48, DOI 10.1177/154405910508400108
   Ebi N, 2001, DENT MATER, V17, P485, DOI 10.1016/S0109-5641(01)00006-9
   Elguezabal N, 2008, OPEN DENT J, V2, P1, DOI 10.2174/1874210600802010001
   Everaert EPJM, 1997, EUR ARCH OTO-RHINO-L, V254, P261, DOI 10.1007/BF02905983
   Fucio SBP, 2008, J DENT, V36, P833, DOI 10.1016/j.jdent.2008.06.002
   FUNDEANU I, 2010, J BIOMED MA IN PRESS
   Furnes O, 2001, BONE CEMENTS AND CEMENTING TECHNIQUE, P135
   Glantz PO, 1969, ODONT REVY S17, V20, P1
   Gorecki A, 2009, INFECTED IMPLANT, P19, DOI 10.1007/978-3-540-92836-2_6
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grossner-Schreiber B, 2009, CLIN ORAL IMPLAN RES, V20, P817, DOI 10.1111/j.1600-0501.2009.01729.x
   HAHN R, 1993, DENT MATER, V9, P312, DOI 10.1016/0109-5641(93)90049-V
   Halperin A, 2007, LANGMUIR, V23, P10603, DOI 10.1021/la701007j
   Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3
   Hansel C, 1998, J DENT RES, V77, P60, DOI 10.1177/00220345980770010601
   HATIBOVICKOFMAN S, 1991, SWED DENT J, V15, P253
   Hengtrakool C, 2006, J DENT, V34, P588, DOI 10.1016/j.jdent.2005.02.011
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Herrera M, 2000, OPER DENT, V25, P265
   HOLMES AR, 1995, J IND MICROBIOL, V15, P208, DOI 10.1007/BF01569827
   IMAZATO S, 1994, J DENT RES, V73, P1437, DOI 10.1177/00220345940730080701
   Imazato S, 2003, DENT MATER, V19, P449, DOI 10.1016/S0109-5641(02)00102-1
   Imazato S, 1999, J DENT, V27, P279, DOI 10.1016/S0300-5712(98)00006-2
   IMAZATO S, 1994, J DENT RES, V73, P1641, DOI 10.1177/00220345940730100901
   JANSSON L, 1994, J CLIN PERIODONTOL, V21, P577, DOI 10.1111/j.1600-051X.1994.tb00746.x
   JOSEPH I, 1997, SWED DENT J, V21, P77
   Kawai K, 2000, J BIOMED MATER RES, V51, P123, DOI 10.1002/(SICI)1097-4636(200007)51:1<123::AID-JBM16>3.0.CO;2-7
   Khalichi P, 2009, BIOMATERIALS, V30, P452, DOI 10.1016/j.biomaterials.2008.09.053
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   KOOPMANS ASF, 1988, J DENT RES, V67, P1246, DOI 10.1177/00220345880670091901
   KUHN KD, 2000, BONE CEMENTS, P149
   LEONHARDT A, 1995, J DENT RES, V74, P1607, DOI 10.1177/00220345950740091701
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Majumdar P, 2009, POLYMER, V50, P1124, DOI 10.1016/j.polymer.2009.01.009
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   Mitchell L, 1992, Br J Orthod, V19, P199
   Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431
   Morgan TD, 2000, J APPL MICROBIOL, V89, P617, DOI 10.1046/j.1365-2672.2000.01158.x
   Mulligan AM, 2003, J BIOMED MATER RES A, V67A, P401, DOI 10.1002/jbm.a.10052
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Nakajo K, 2009, DENT MATER, V25, P703, DOI [10.1016/j.dental.2008.10.014, 10.1016/j.denta1.2008.10.014]
   Nalbant AD, 2008, YONSEI MED J, V49, P647, DOI 10.3349/ymj.2008.49.4.647
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Nicholson JW, 2000, BIOMATERIALS, V21, P1989, DOI 10.1016/S0142-9612(00)00085-5
   Norde W, 2008, COLLOID SURFACE B, V61, P1, DOI 10.1016/j.colsurfb.2007.09.029
   Omori S, 2009, J DENT RES, V88, P957, DOI 10.1177/0022034509343426
   Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400.3409.2003
   Papaioannou W, 2007, ANGLE ORTHOD, V77, P1090, DOI 10.2319/091706-375.1
   PASHLEY DH, 1990, J ENDODONT, V16, P70, DOI 10.1016/S0099-2399(06)81567-0
   Petti S, 2001, ARCH ORAL BIOL, V46, P705, DOI 10.1016/S0003-9969(01)00033-4
   Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1
   POWERS JM, 2006, CRAIGS RESTORATIVE D, P514
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   Radford DR, 1998, J DENT, V26, P577, DOI 10.1016/S0300-5712(97)00034-1
   Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002
   Ready D, 2003, FEMS MICROBIOL LETT, V223, P107, DOI 10.1016/S0378-1097(03)00351-3
   Ready D, 2007, INT J ANTIMICROB AG, V30, P34, DOI 10.1016/j.ijantimicag.2007.02.009
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Samaranayake YH, 2001, CLIN MICROBIOL REV, V14, P398, DOI 10.1128/CMR.14.2.398-429.2001
   Sbordone L, 2003, CLIN ORAL INVEST, V7, P181, DOI 10.1007/s00784-003-0236-1
   Schmalz G, 2004, J ENDODONT, V30, P352, DOI 10.1097/00004770-200405000-00011
   SEPPA L, 1995, EUR J ORAL SCI, V103, P182, DOI 10.1111/j.1600-0722.1995.tb00022.x
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Sousa RP, 2009, J DENT, V37, P44, DOI 10.1016/j.jdent.2008.08.009
   Takahashi Y, 2004, J DENT RES, V83, P302, DOI 10.1177/154405910408300406
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   van der Mei HC, 2006, J CLIN PERIODONTOL, V33, P14, DOI 10.1111/j.1600-051X.2005.000859.x
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3
   VERRAN J, 1987, J DENT, V15, P73, DOI 10.1016/0300-5712(87)90003-0
   Vroman L, 2008, COLLOID SURFACE B, V62, P1, DOI 10.1016/j.colsurfb.2007.11.017
   Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Yap AUJ, 1999, OPER DENT, V24, P297
NR 94
TC 181
Z9 193
U1 14
U2 125
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JUL
PY 2010
VL 89
IS 7
BP 657
EP 665
DI 10.1177/0022034510368644
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 611OU
UT WOS:000278829300001
PM 20448246
DA 2018-10-19
ER

PT J
AU Yuan, ZL
   Peng, B
   Jiang, H
   Bian, ZA
   Yan, P
AF Yuan, Zhenglin
   Peng, Bin
   Jiang, Han
   Bian, Zhuan
   Yan, Ping
TI Effect of Bioaggregate on Mineral-associated Gene Expression in
   Osteoblast Cells
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Bioaggregate; cytotoxicity; mineral trioxide aggregate; mineralization;
   osteoblast cells; real-time polymerase chain reaction
ID END FILLING MATERIAL; TRIOXIDE AGGREGATE; IN-VITRO; PHENOTYPE
   EXPRESSION; QUANTITATIVE PCR; HYDROXYAPATITE; CALCIUM; CULTURE;
   DIFFERENTIATION; CERAMICS
AB Introduction: This study investigated the cytotoxicity of bioaggregate (BA) and the effect of BA on mineral associated gene expression in osteoblast cells. Methods: The cytotoxicity of BA to mouse MC3T3-E1 osteoblast cells was evaluated via the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after 1, 2, and 3 days of culture. The expression of mineral associated genes (collagen type 1, osteocalcin, and osteopontin) was assessed by quantitative real-time polymerase chain reaction (qRT-PCR) and compared expression after exposure to BA or mineral trioxide aggregate (MTA). The data were analyzed by one-way analysis of variance and the Tukey test. Results: BA was essentially nontoxic to osteoblast cells. The expression of collagen type 1, osteocalcin, and osteopontin genes significantly increased in the BA group compared with that in the MTA group on the second or third day of culture. Conclusion: BA appears to be a novel nontoxic root-end filling biomaterial and be able to induce mineralization-associated gene expression in osteoblast cells. (J Endod 2010;36:1145-1148)
C1 [Bian, Zhuan] Wuhan Univ, Sch Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Peoples R China.
   Wuhan Univ, Sch Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Peoples R China.
   Wuhan Univ, Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Peoples R China.
   Wuhan Univ, Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Peoples R China.
RP Bian, ZA (reprint author), Wuhan Univ, Sch Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, 237 Luoyu Rd, Wuhan 430079, Peoples R China.
EM kqyywjtx@hotmail.com; yanpingjh@hotmail.com
FU National Natural Scientific Foundation of China [30772417]; China Hubei
   Provincial Science & Technology Department [304131587]
FX This study was supported by a grant (no. 30772417) from the National
   Natural Scientific Foundation of China, and a grant (no. 304131587) from
   the China Hubei Provincial Science & Technology Department.
CR Bodrumlu E, 2008, AUST ENDOD J, V34, P30, DOI 10.1111/j.1747-4477.2007.00085.x
   Bogen G, 2009, J ENDODONT, V35, P777, DOI 10.1016/j.joen.2009.03.006
   Chen CL, 2009, J ENDODONT, V35, P682, DOI 10.1016/j.joen.2009.02.002
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Costa A T, 2008, Minerva Stomatol, V57, P295
   De-Deus G, 2009, J ENDODONT, V35, P1387, DOI 10.1016/j.joen.2009.06.022
   Eldeniz AU, 2006, J ENDODONT, V32, P345, DOI 10.1016/j.joen.2005.09.009
   GREEN J, 1988, J GEN PHYSIOL, V92, P239, DOI 10.1085/jgp.92.2.239
   Hakki SS, 2009, J ENDODONT, V35, P513, DOI 10.1016/j.joen.2008.12.016
   Jun IK, 2005, J MATER SCI, V40, P2891, DOI 10.1007/s10853-005-2428-3
   Kim M, 2009, ORAL SURG ORAL MED O, V108, pE111, DOI 10.1016/j.tripleo.2009.07.020
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Mao KY, 2005, J BIOACT COMPAT POL, V20, P541, DOI 10.1177/0883911505059040
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   Nakayama A, 2005, INT ENDOD J, V38, P203, DOI 10.1111/j.1365-2591.2004.00917.x
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.3.CO;2-3
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85
   SPECTOR JA, 2001, AM J PHYSIOL-CELL PH, V280, P72
   Tani-Ishii N, 2007, J ENDODONT, V33, P836, DOI 10.1016/j.joen.2007.02.003
   TORABINEJAD M, 1993, J ENDODONT, V19, P591, DOI 10.1016/S0099-2399(06)80271-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 2009, INT ENDOD J, V42, P408, DOI 10.1111/j.1365-2591.2009.01556.x
   Tsatsas DV, 2005, INT DENT J, V55, P133, DOI 10.1111/j.1875-595X.2005.tb00310.x
   VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776
   Whited BM, 2006, J BIOMED MATER RES A, V76A, P596, DOI 10.1002/jbm.a.30573
   Wutticharoenmongkol P, 2007, BIOMACROMOLECULES, V8, P2602, DOI 10.1021/bm700451p
   Yasuda Y, 2008, J ENDODONT, V34, P679, DOI 10.1016/j.joen.2008.02.038
   Zhang H, 2009, J ENDODONT, V35, P221, DOI 10.1016/j.joen.2008.11.001
   Zhang Z, 2009, BRIEF BIOINFORM, V10, P1, DOI 10.1093/bib/bbn041
NR 32
TC 35
Z9 38
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD JUL
PY 2010
VL 36
IS 7
BP 1145
EP 1148
DI 10.1016/j.joen.2010.03.025
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 624FL
UT WOS:000279802000006
PM 20630287
DA 2018-10-19
ER

PT J
AU George, S
   Basrani, B
   Kishen, A
AF George, Saji
   Basrani, Bettina
   Kishen, Anil
TI Possibilities of Gutta-Percha-centered Infection in Endodontically
   Treated Teeth: An In Vitro Study
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE E. faecalis; endodontic biofilm; environmental conditions; gutta-percha;
   surface conditioning
ID ENTEROCOCCUS-FAECALIS; APICAL PERIODONTITIS; BIOFILM FORMATION; ROOT
   CANALS; BACTERIA; FAILURE; THERAPY; SEALERS; DEVICES; TIME
AB Introduction: Implanted biomaterials could provide surface for bacterial adherence and formation of biofilm, eventually leading to biomaterial-centered infections (BCIs). In this in vitro study, we examined the biofilm-forming capacity of Enterococcus faecalis on gutta-percha (GP) points under different nutrient status and surface conditioning with saliva and serum. Methods: GP points (n = 420) coated with different root canal sealers (Sealapex or Roth) were conditioned with saliva or serum for 2-, 4-, and 12-week intervals and subsequently were incubated with E. faecalis for 2 weeks under nutrient-rich and nutrient-deprived environments. The biofilm-forming capacity and the nature of biofilm formed on GP were assessed by using a viable cell assay and scanning electron microscopy (SEM). Results: E. faecalis produced biofilms on GP points (with and without root canal sealers) under both nutrient-rich and nutrient-deprived environments after conditioning with saliva or serum. SEM reflected that the biofilms formed under nutrient-rich conditions were regular, whereas the biofilms formed under nutrient-deprived conditions were irregular and scanty. Under nutrient-deprived conditions, longer conditioning periods in saliva or serum were required for bacterial adherence. Conclusions: Under the conditions of this study, saliva and serum conditioning of GP points plays an important role in the biofilm formation under tough environmental conditions. (J Endod 2010;36:1241-1244)
C1 [George, Saji; Basrani, Bettina; Kishen, Anil] Univ Toronto, Fac Dent, Discipline Endodont, Toronto, ON M5G 1G6, Canada.
RP Kishen, A (reprint author), Univ Toronto, Fac Dent, Discipline Endodont, 124 Edward St, Toronto, ON M5G 1G6, Canada.
EM anil.kishen@dentistry.utoronto.ca
OI George, Saji/0000-0002-8807-0737
FU National University of Singapore (NUS)
FX The authors wish to thank the Faculty of Dentistry, National University
   of Singapore (NUS), and former Undergraduate Research Opportunities
   Program Students (K S. Tang, R. S. Zhang, T. Foo Chia-Wei, and R. Yap
   Li-Chen) at the Faculty of Dentistry, National University of Singapore
   (NUS), for the support.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Bowden G H, 1997, Adv Dent Res, V11, P81
   Distel JW, 2002, J ENDODONT, V28, P689, DOI 10.1097/00004770-200210000-00003
   Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004
   George S, 2005, J ENDODONT, V31, P867, DOI 10.1097/01.don.0000164855.98346.fc
   GRISTINA AG, 1985, SURGERY, V98, P12
   Hancock HH, 2001, ORAL SURG ORAL MED O, V91, P579, DOI 10.1067/moe.2001.113587
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Khoury A E, 1992, ASAIO J, V38, pM174, DOI 10.1097/00002480-199207000-00013
   Kishen A, 2006, J BIOMED MATER RES A, V77A, P406, DOI 10.1002/jbm.a.30622
   Kishen A, 2005, INT ENDOD J, V38, P597, DOI 10.1111/j.1365-2591.2005.00986.x
   Lim LM, 2005, J AM DENT ASSOC, V136, P187
   Love RM, 2001, INT ENDOD J, V34, P399, DOI 10.1046/j.1365-2591.2001.00437.x
   Mejare B, 1975, Odontol Revy, V26, P291
   Molander A, 1998, INT ENDOD J, V31, P1, DOI 10.1046/j.1365-2591.1998.t01-1-00111.x
   Nair PNR, 1999, ORAL SURG ORAL MED O, V87, P617, DOI 10.1016/S1079-2104(99)70145-9
   NAIR PNR, 1990, J ENDODONT, V16, P580, DOI 10.1016/S0099-2399(07)80201-9
   Nair PNR, 2005, ORAL SURG ORAL MED O, V99, P231, DOI 10.1016/j.tripleo.2004.10.005
   Noda M, 2000, J ENDODONT, V26, P221, DOI 10.1097/00004770-200004000-00005
   Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001
   Orstavik D, 2001, DENT MATER, V17, P512, DOI 10.1016/S0109-5641(01)00011-2
   RAY HA, 1995, INT ENDOD J, V28, P12, DOI 10.1111/j.1365-2591.1995.tb00150.x
   Retamozo B, 2010, J ENDODONT, V36, P520, DOI 10.1016/j.joen.2009.12.005
   SAUNDERS WP, 1994, ENDOD DENT TRAUMATOL, V10, P105
   Sedgley C, 2006, J ENDODONT, V32, P173, DOI 10.1016/j.joen.2005.10.037
   Sedgley CM, 2004, ORAL MICROBIOL IMMUN, V19, P95, DOI 10.1111/j.0902-0055.2004.00122.x
   Slutzky-Goldberg I, 2008, J ENDODONT, V34, P735, DOI 10.1016/j.joen.2008.03.012
   Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8
   Tronstad L, 2003, ENDODONTIC TOPICS, V6, P57
   Zhang H, 2009, J ENDODONT, V35, P1051, DOI 10.1016/j.joen.2009.04.022
NR 30
TC 11
Z9 14
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD JUL
PY 2010
VL 36
IS 7
BP 1241
EP 1244
DI 10.1016/j.joen.2010.03.024
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 624FL
UT WOS:000279802000027
PM 20630308
DA 2018-10-19
ER

PT J
AU Sha, JM
   Yan, ZY
   Cheng, GC
   Wei, XY
   Tao, YQ
   Li, YM
   Luo, L
AF Sha, Ji-ming
   Yan, Zhong-ya
   Cheng, Guang-cun
   Wei, Xiao-yong
   Tao, Yi-qin
   Li, Yue-ming
   Luo, Le
TI In-Vitro Seeding of Human Umbilical Cord Vein Endothelial Cells on
   Hydroxyapatite for Mechanical Heart Valve Applications
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article
ID PHENOTYPE EXPRESSION; BLOOD COMPATIBILITY; REPLACEMENT; EXPERIENCE;
   BIOCOMPATIBILITY; HYDROXYLAPATITE; BIOPROSTHESES; COMPLICATIONS;
   DEPOSITION; PROSTHESES
AB Background and aim of the study: Although heart valve replacement with either a mechanical or biological prosthesis is an effective method to treat valvular heart disease, both approaches have limitations, including thrombus formation, thromboembolism and degeneration problems. The study aim was to demonstrate the in-vitro endothelialization of hydroxyapatite (HAp) to be used as a biomaterial in heart valve prostheses.
   Methods: The HAp samples were characterized using X-ray diffractometry to identify the crystalline phase, while the surface morphology of HAp discs was examined using scanning electron microscopy (SEM). Human umbilical vein endothelial cells (HUVECs) were cultured on HAp discs for 1, 3, 5, and 7 days, and on pyrolytic carbon discs for 7 days; cytotoxicity was assessed using the methyl thiazolyl tetrazolium (MTT) assay. The cells were incubated in three groups: (i) an experimental group (cultured with HAp extract); (ii) a negative control (cultured with high-density polyethylene chaff); and (iii) a positive control (culture medium containing 0.1% phenol solution).
   Results: A morphological examination of the HAp discs revealed the presence of micropores on the disc surface, together with cultured HUVECs. After seven days of culture, the HUVECs began to form a confluent endothelial cell layer covering the HAp discs. There were no visible cells attached to the pyrolytic carbon surface. The MTT assay indicated that HAp did not exert any cytotoxic effect on HUVECs, and low optical density values were obtained in the positive controls.
   Conclusion: The study results showed that HUVECs were able to grow well on HAp discs, and that HAP possessed a good in-vitro bioactivity and biocompatibility towards these cells. Consequently, HAp might be used as a film on mechanical heart valve prostheses, and serve as a promising biomaterial for heart valve replacement.
C1 [Sha, Ji-ming; Yan, Zhong-ya; Cheng, Guang-cun; Wei, Xiao-yong] Anhui Med Univ, Affiliated Prov Hosp, Dept Cardiac Surg, Hefei, Peoples R China.
   [Sha, Ji-ming; Tao, Yi-qin; Li, Yue-ming] Chaohu First Peoples Hosp, Dept Cardiothorac Surg, Chaohu, Peoples R China.
   [Luo, Le] Hefei Univ Technol, Dept Appl Phys, Hefei, Peoples R China.
RP Yan, ZY (reprint author), Anhui Med Univ, Affiliated Prov Hosp, Dept Cardiac Surg, Hefei, Peoples R China.
EM shajiming@163.com
FU Anhui Provincial Natural Science Foundation [090413073]
FX These studies were supported by the Anhui Provincial Natural Science
   Foundation (090413073).
CR Akahane M, 1999, J BONE MINER RES, V14, P561, DOI 10.1359/jbmr.1999.14.4.561
   AKINS CW, 1991, ANN THORAC SURG, V52, P161, DOI 10.1016/0003-4975(91)91453-3
   BARTHELL HL, 1989, MATER RES SOC S P, V110, P709
   Bartlett HL, 2007, CIRCULATION, V115, P319, DOI 10.1161/CIRCULATIONAHA.106.618652
   Blind O, 2005, DENT MATER, V21, P1017, DOI 10.1016/j.dental.2004.12.003
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Bottio T, 2007, CARDIOVASC PATHOL, V16, P1, DOI 10.1016/j.carpath.2006.09.008
   Butchart EG, 2001, J THORAC CARDIOV SUR, V121, P1090, DOI 10.1067/mtc.2001.113754
   COOK SD, 1986, J DENT RES, V65, P222
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   EDMUNDS LH, 1987, ANN THORAC SURG, V44, P430, DOI 10.1016/S0003-4975(10)63816-7
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Grunkemeier GL, 2000, CURR PROB CARDIOLOGY, V25, P78, DOI 10.1053/cd.2000.v25.a103682
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HOFFMAN D, 1992, CIRCULATION, V86, P75
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kadner A, 2004, EUR J CARDIO-THORAC, V25, P635, DOI 10.1016/j.ejcts.2003.12.038
   Knight Richard, 2004, V11, P72
   Laczkovics A, 2001, J HEART VALVE DIS, V10, P94
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Maria V. R., 2004, PROG SOLID STATE CHE, V32, P1
   Michelson AD, 1998, CHEST, V114, p748S, DOI 10.1378/chest.114.5_Supplement.748S
   Minami K, 2005, ANN THORAC SURG, V80, P1699, DOI 10.1016/j.athoracsur.2005.04.053
   Mitamura Y, 1989, J Biomater Appl, V4, P33, DOI 10.1177/088532828900400103
   Mol A, 2004, INT J CARDIOL, V95, pS57, DOI 10.1016/j.ijcard.2004.04.000
   MONMA H, 1993, J CERAM SOC JPN, V101, P718
   North RA, 1999, CIRCULATION, V99, P2669, DOI 10.1161/01.CIR.99.20.2669
   OGUCHI H, 1992, BIOMATERIALS, V13, P471, DOI 10.1016/0142-9612(92)90169-O
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.3.CO;2-3
   Punchard MA, 2007, J BIOMECH, V40, P3146, DOI 10.1016/j.jbiomech.2007.03.029
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Sankarkumar R, 2001, J HEART VALVE DIS, V10, P619
   Sha JM, 2009, THORAC CARDIOV SURG, V57, P74, DOI 10.1055/s-2008-1038986
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Sjogren J, 2006, J HEART VALVE DIS, V15, P197
   Sodian R, 2006, ANN THORAC SURG, V81, P2207, DOI 10.1016/j.athoracsur.2005.12.073
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
NR 45
TC 5
Z9 5
U1 0
U2 5
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD JUL
PY 2010
VL 19
IS 4
BP 506
EP 512
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 694FR
UT WOS:000285280900016
PM 20845900
DA 2018-10-19
ER

PT J
AU Wren, AW
   Cummins, NM
   Coughlan, A
   Towler, MR
AF Wren, A. W.
   Cummins, N. M.
   Coughlan, A.
   Towler, M. R.
TI The effect of adding organic polymers on the handling properties,
   strengths and bioactivity of a Ca-Sr-Zn-Si glass polyalkenoate cement
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID IONOMER CEMENTS; MECHANICAL-PROPERTIES; COLLAGEN COMPOSITE;
   SODIUM-CITRATE; BONE CEMENTS; IN-VIVO; CHITIN; CHITOSAN; SPECTROSCOPY;
   BIOMATERIAL
AB This work demonstrates the addition of a number of naturally occurring proteins/polymers to a zinc based glass polyalkenoate cements (GPCs). Chitin (Chi.), collagen (Col.), cysteine (Cys.) and keratin (Ker.) were added with the intention of improving the bioactivity of this cement. Initial testing involved characterization of the glass with X-ray diffraction (XRD) and differential thermal analysis (DTA) before and after sterilization with gamma-irradiation. No significant changes occurred as a result of sterilization. Handling properties of the modified cements were not significantly different from those of the control, BT 101 (Working T (w)-36 s, and setting time T (s)-70 s) except for Chi. (30 s, p a parts per thousand currency sign 0.016) and Cys. (105 s, p a parts per thousand currency sign 0.0001) respectively. Comparison of the mechanical properties of BT 101 (compression-sigma(c) and biaxial flexural-sigma(f)) to the modified cements revealed a significant decrease in sigma(c) with Chi. and Col., after 1, 7 and 30 days. However, there were little changes occurring in sigma(f). Cement structural testing was investigated and found that the addition of these polymers greatly reduced the cements surface area, however, the only significant change to occur in the solubility testing was Ker. (p a parts per thousand currency sign 0.009). Simulated body fluid (SBF) testing resulted in increased calcium phosphate (CaP) deposition of Chi. and Col. compared to BT 101. Cell culture studies determined only Col. significantly increased (p a parts per thousand currency sign 0.0001) in comparison to the control cement.
C1 [Wren, A. W.; Coughlan, A.; Towler, M. R.] Alfred Univ, Inamori Sch Engn, Alfred, NY 14802 USA.
   [Cummins, N. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
RP Wren, AW (reprint author), Alfred Univ, Inamori Sch Engn, Alfred, NY 14802 USA.
EM wren@alfred.edu
CR AN YH, 1997, J MICROBIOL METH, V30, P1997
   [Anonymous], 1991, 9917 INT ORG STAND
   Boyd D, 2008, J MATER SCI, V43, P1170, DOI 10.1007/s10853-007-2362-7
   Boyd D, 2006, J MATER SCI-MATER M, V17, P489, DOI 10.1007/s10856-006-8930-6
   Boyd D, 2005, J MATER SCI-MATER M, V16, P843, DOI 10.1007/s10856-005-3578-1
   Boyd D, 2009, J NON-CRYST SOLIDS, V355, P2285, DOI 10.1016/j.jnoncrysol.2009.07.014
   Branden C., 1999, INTRO PROTEIN STRUCT
   Cho SB, 1998, J MATER SCI-MATER M, V9, P279, DOI 10.1023/A:1008808828567
   Ciapetti G, 2002, BIOMATERIALS, V23, P617, DOI 10.1016/S0142-9612(01)00149-1
   Coradin T, 2007, ACCOUNTS CHEM RES, V40, P819, DOI 10.1021/ar068129m
   Coughlan A, 2008, J MATER SCI-MATER M, V19, P3555, DOI 10.1007/s10856-008-3519-x
   da Silva RC, 2007, J MATER SCI-MATER M, V18, P1859, DOI 10.1007/s10856-007-3035-4
   De Bruyne MAA, 2004, INT ENDOD J, V37, P91, DOI 10.1111/j.0143-2885.2004.00769.x
   DONGHUI F, 2002, J WUHAN UNIV TECHNOL, V17, P44
   Edwards HGM, 1999, SPECTROCHIM ACTA A, V55, P2691, DOI 10.1016/S1386-1425(99)00099-2
   Epstein R.J., 2003, HUMAN MOL BIOL INTRO
   Furlan L, 1996, POLYMER, V37, P843, DOI 10.1016/0032-3861(96)87263-6
   Hatton PV, 2006, J DENT, V34, P598, DOI 10.1016/j.jdent.2004.10.027
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   *INT STAND, 1999, 109935 INT STAND
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Knobloch LA, 2000, J PROSTHET DENT, V83, P204, DOI 10.1016/S0022-3913(00)80013-X
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Loof J, 2008, DENT MATER, V24, P653, DOI 10.1016/j.dental.2007.06.028
   Mai R, 2008, ORAL SURG ORAL MED O, V105, pE9, DOI 10.1016/j.tripleo.2007.09.016
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MUZZARELLI RAA, 1977, CHITIN
   Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2
   Pelin IM, 2009, MAT SCI ENG C-MATER, V29, P2188, DOI 10.1016/j.msec.2009.04.021
   Polizzi S, 2002, NEUROTOXICOLOGY, V23, P761, DOI 10.1016/S0161-813X(02)00097-9
   PROSSER HJ, 1986, J DENT RES, V65, P146, DOI 10.1177/00220345860650021101
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   RATHKE TD, 1994, J MACROMOL SCI R M C, VC34, P375, DOI 10.1080/15321799408014163
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Reusche E, 2001, HUM PATHOL, V32, P1136, DOI 10.1053/hupa.2001.28251
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Roberts G, 1992, CHITIN CHEM
   Schneiders W, 2007, BONE, V40, P1048, DOI 10.1016/j.bone.2006.11.019
   Stanislawski L, 2003, J BIOMED MATER RES A, V66A, P476, DOI 10.1002/jbm.a.10600
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   SUN J, 2008, J NONCRYST SOLIDS S, V35, P3799
   Takahashi Y, 2006, DENT MATER, V22, P647, DOI 10.1016/j.dental.2005.08.003
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tsukimura N, 2009, BIOMATERIALS, V30, P3378, DOI 10.1016/j.biomaterials.2009.02.043
   Tyas MJ, 2004, AUST DENT J, V49, P112, DOI 10.1111/j.1834-7819.2004.tb00059.x
   Vincent J. F. V, 2000, ARTHROPOD STRUCT DEV, V46, P187
   Williams JA, 2002, DENT MATER, V18, P376, DOI 10.1016/S0109-5641(01)00053-7
   Wren AW, 2009, J BIOMED MATER RES B, V90B, P700, DOI 10.1002/jbm.b.31337
   Xie D, 2000, DENT MATER, V16, P129, DOI 10.1016/S0109-5641(99)00093-7
   Yamada M, 2009, ACTA BIOMATER, V5, P2963, DOI 10.1016/j.actbio.2009.04.027
   Yamamura S, 2002, BIOCHEM BIOPH RES CO, V294, P1138, DOI 10.1016/S0006-291X(02)00580-6
NR 54
TC 3
Z9 3
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JUL
PY 2010
VL 45
IS 13
BP 3554
EP 3562
DI 10.1007/s10853-010-4398-3
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 590QZ
UT WOS:000277243400023
DA 2018-10-19
ER

PT J
AU Zhang, EL
   Chen, HY
   Shen, F
AF Zhang, Erlin
   Chen, Haiyan
   Shen, Feng
TI Biocorrosion properties and blood and cell compatibility of pure iron as
   a biodegradable biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID 316L STAINLESS-STEEL; IN-VITRO CORROSION; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; SURFACE MODIFICATION; MAGNESIUM ALLOYS;
   BIOCOMPATIBILITY; TOXICITY; COAGULATION; OVERLOAD
AB Biocorrosion properties and blood- and cell compatibility of pure iron were studied in comparison with 316L stainless steel and Mg-Mn-Zn magnesium alloy to reveal the possibility of pure iron as a biodegradable biomaterial. Both electrochemical and weight loss tests showed that pure iron showed a relatively high corrosion rate at the first several days and then decreased to a low level during the following immersion due to the formation of phosphates on the surface. However, the corrosion of pure iron did not cause significant increase in pH value to the solution. In comparison with 316L and Mg-Mn-Zn alloy, the pure iron exhibited biodegradable property in a moderate corrosion rate. Pure iron possessed similar dynamic blood clotting time, prothrombin time and plasma recalcification time to 316L and Mg-Mn-Zn alloy, but a lower hemolysis ratio and a significant lower number density of adhered platelets. MTT results revealed that the extract except the one with 25% 24 h extract actually displayed toxicity to cells and the toxicity increased with the increasing of the iron ion concentration and the incubation time. It was thought there should be an iron ion concentration threshold in the effect of iron ion on the cell toxicity.
C1 [Zhang, Erlin; Chen, Haiyan] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   [Chen, Haiyan] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China.
   [Shen, Feng] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Zhang, EL (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
EM zhangerlin2009@163.com
RI Zhang, Erlin/N-6608-2014
OI Zhang, Erlin/0000-0002-6152-6546
FU Institute of Metal Research (IMR); Chinese Academy of Sciences (CAS);
   Shenyang Science and Technology Institute [1062109-1-100]; Heilongjiang
   Provincial Nature Science Fund [E2007-18]
FX One of the authors (Erlin Zhang) would like to acknowledge the financial
   support from the Institute of Metal Research (IMR), Chinese Academy of
   Sciences (CAS), Shenyang Science and Technology Institute (Program No.
   1062109-1-100), and Heilongjiang Provincial Nature Science Fund (No.
   E2007-18).
CR *AM SCO TEST MAT, 2004, ANN BOOK ASTM STAND
   Anderson GJ, 2007, AM J HEMATOL, V82, P1128, DOI 10.1002/ajh.21075
   [Anonymous], 1991, ISO8407
   [Anonymous], 2002, ISO1099312 ANSIAAMI
   [Anonymous], 1999, ISO109934 ANSIAAMI
   [Anonymous], 1999, ISO109935 ANSIAAMI
   Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010
   Binet JL, 2005, B ACAD NAT MED PARIS, V189, P1647
   Boldt DH, 1999, AM J MED SCI, V318, P207, DOI 10.1097/00000441-199910000-00001
   Britton RS, 2002, INT J HEMATOL, V76, P219, DOI 10.1007/BF02982791
   Buckett PD, 2009, AM J PHYSIOL-GASTR L, V296, P798
   Cai KY, 2007, ACTA BIOMATER, V3, P597, DOI 10.1016/j.actbio.2006.12.005
   Cheung HY, 2008, COMPOS PART B-ENG, V39, P1026, DOI 10.1016/j.compositesb.2007.11.009
   Choi JW, 1998, J AM CERAM SOC, V81, P1743
   CRICHTON RR, 2002, J INORG BIOCHEM, V91, P652
   Dey A, 2009, CERAM INT, V35, P2295, DOI 10.1016/j.ceramint.2009.01.002
   Eaton JW, 2002, FREE RADICAL BIO MED, V32, P833, DOI 10.1016/S0891-5849(02)00772-4
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Harhaji L, 2004, CLIN EXP IMMUNOL, V137, P109, DOI 10.1111/j.1365-2249.2004.02515.x
   Hassan SF, 2002, MATER RES BULL, V37, P377, DOI 10.1016/S0025-5408(01)00772-3
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HERSHKO C, 2007, FOOD NUTR BULL, V28, P500
   Jones DT, 2006, CANCER RES, V66, P2749, DOI 10.1158/0008-5472.CAN-05-3857
   Khan W, 2007, ACTA BIOMATER, V3, P541, DOI 10.1016/j.actbio.2007.01.006
   Kolnagou A, 2008, HEMOGLOBIN, V32, P17, DOI 10.1080/03630260701726491
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leonarduzzi G, 1997, FASEB J, V11, P851
   Li GY, 2004, SURF COAT TECH, V176, P215, DOI 10.1016/S0257-8972(03)00736-9
   Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6
   LILL R, 2006, ACTA MOL CELL RES, V1763, P652
   Liu SJ, 2007, INT J PHARM, V330, P45, DOI 10.1016/j.ijpharm.2006.08.036
   MA YX, 2006, AM J PHYSIOL-GASTR L, V290, P417
   Nurden AT, 2007, ENDOCRINOLOGY, V148, P3053, DOI 10.1210/en.2007-0506
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Ouared R, 2008, COMPUT PHYS COMMUN, V179, P128, DOI 10.1016/j.cpc.2008.01.021
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Saber-Samandari S, 2009, ACTA BIOMATER, V5, P2206, DOI 10.1016/j.actbio.2009.02.009
   Siah CW, 2005, CLIN CHIM ACTA, V358, P24, DOI 10.1016/j.cccn.2005.02.022
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Paragkumar NT, 2006, APPL SURF SCI, V253, P2758, DOI 10.1016/j.apsusc.2006.05.047
   TIAN WS, 1990, J TAIYUAN HEAVY MACH, V2, P18
   Triplett DA, 2000, CLIN CHEM, V46, P1260
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   XU CC, 2005, SCI CONSERV ARCHAEOL, V17, P55
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2009, J MATER SCI-MATER M, V20, P859, DOI 10.1007/s10856-008-3648-2
   Yang HJ, 2006, ACTA METALL SIN, V42, P959
   YANG J, 2003, AM J PHYSIOL-RENAL, V285, P9
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Yang SL, 2008, POLYM TEST, V27, P957, DOI 10.1016/j.polymertesting.2008.08.009
   Yang Z, 2008, ACTA METALL SIN, V21, P313, DOI DOI 10.1016/S1006-7191(08)60054-X
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang KM, 2007, ACTA METALL SIN, V43, P71
   Zhang Zhen, 2008, Corrosion Science and Protection Technology, V20, P260
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 64
TC 44
Z9 47
U1 1
U2 35
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2010
VL 21
IS 7
BP 2151
EP 2163
DI 10.1007/s10856-010-4070-0
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 621PH
UT WOS:000279592600017
PM 20396936
DA 2018-10-19
ER

PT J
AU Lin, S
   Fujikura, K
   Obata, A
   Kasuga, T
AF Lin, Sen
   Fujikura, Kie
   Obata, Akiko
   Kasuga, Toshihiro
TI Preparation of siloxane-containing vaterite/poly (lactic acid) hybrid
   fibermats with improved ductility for bone regeneration
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Vaterite; Siloxane; Poly (lactic acid); Fibermats; Ductility; Ion
   releasability; Biomaterial
ID POLY(LACTIC ACID); SCAFFOLDS; FILLER
AB Siloxane-containing vaterite (SiV)/poly (L-lactic acid) (PLLA) hybrid (SiPVH) fibermats have superior potential for bone regeneration applications. Present work aims to optimise its performance as bone filler materials by improving its mechanical properties and maintaining its bioactivity. The SiPVH fibermats were prepared with melt-blending and electrospinning protocols and modified by increasing PLLA content from 40 to 70 wt To. The tensile strength of the modified fibermat was 10 times higher than that of the original one. The elongation before failure of the modified fibermat was twice as large as that of the original one. The mechanism of their enhancement was investigated by observing failure points in the fibermats after the tensile tests: necking of fibers, which occurred in the modified fibermats, was believed to contribute to the enhanced mechanical properties. The modified fibermat showed the relatively constant release of ionic silicon-species in Tris-buffer solution and could be coated with hydroxyapatite by soaking in simulated body fluid. (C)2010 The Ceramic Society of Japan All rights
C1 [Lin, Sen; Fujikura, Kie; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp
FU Japan Society for Promotion of Science [20390497]; The Ministry of
   Education, Culture, Sports, Science and Technology (MEXT) for Young
   Scientists [21700487]
FX The authors are indebted to Dr. Yoshio Ota of Yabashi Industries, Co.
   Ltd., and Dr. Kazuya Oribe of Showa Ika Kogyo Co. Ltd., for their
   helpful discussion. This work was supported in part by Grant-in-Aids for
   Scientific Research from Japan Society for Promotion of Science
   (20390497) and from The Ministry of Education, Culture, Sports, Science
   and Technology (MEXT) for Young Scientists (21700487).
CR Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Juhasz JA, 2004, BIOMATERIALS, V25, P949, DOI 10.1016/j.biomaterials.2003.07.005
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Obata A, 2010, ACTA BIOMATER, V6, P1248, DOI 10.1016/j.actbio.2009.11.013
   Palade LI, 2001, MACROMOLECULES, V34, P1384, DOI 10.1021/ma001173b
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Wakita T, 2009, MATER TRANS, V50, P1737, DOI 10.2320/matertrans.MF200912
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zeng CS, 2009, CLAY MINER, V44, P411, DOI 10.1180/claymin.2009.044.3.411
NR 14
TC 1
Z9 1
U1 0
U2 7
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JUL
PY 2010
VL 118
IS 1379
BP 623
EP 625
DI 10.2109/jcersj2.118.623
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA 628NK
UT WOS:000280126900015
OA Bronze
DA 2018-10-19
ER

PT J
AU Byrom, MJ
   Bannon, PG
   White, GH
   Ng, MKC
AF Byrom, Michael J.
   Bannon, Paul G.
   White, Geoffrey H.
   Ng, Martin K. C.
TI Animal models for the assessment of novel vascular conduits
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID WALL SHEAR-STRESS; EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS; SUCCESSFULLY
   ACCELERATES ENDOTHELIALIZATION; MICROVASCULAR ANASTOMOTIC SYSTEM;
   STIMULATES INTIMAL HYPERPLASIA; SMALL-INTESTINAL SUBMUCOSA; ENGINEERED
   BLOOD-VESSELS; SMALL-DIAMETER; IN-VIVO; COMPARATIVE HEMATOLOGY
AB The development of an ideal small-diameter conduit for use in vascular bypass surgery has yet to be achieved. The ongoing innovation in biomaterial design generates novel conduits that require preclinical assessment in vivo, and a number of animal models have been used for this purpose. This article examines the rationale behind animal models used in the assessment of small-diameter vascular conduits encompassing the commonly used species: baboons, sheep, pigs, dogs, rabbits, and rodents. Studies on the comparative hematology for these species relative to humans are summarized, and the hydrodynamic values for common implant locations are also compared. The large- and small-animal models are then explored, highlighting the characteristics of each that determine their relative utility in the assessment of vascular conduits. Where possible, the performance of expanded polytetrafluoroethylene is given in each animal and in each location to allow direct comparisons between species. New challenges in animal modeling are outlined for the assessment of tissue-engineered graft designs. Finally, recommendations are given for the selection of animal models for the assessment of future vascular conduits. ( J Vase Surg 2010;52:176-95.)
   Clinical Relevance: The limitations of autologous arterial and venous segments used in vascular surgery drives the development of novel vascular conduits which ultimately require assessment in vivo. The abundance of articles proclaiming successful development of new conduits contrasts starkly with the handful of candidates reaching clinical trials, a discrepancy due at least in part to a lack of standardised approach to the selection and utilisation of appropriate animal models. This review seeks to provide for the first time a broad comparison of the pertinent variables determining the utility of species used for vascular conduit assessment, relevant to researchers and to clinicians evaluating reports of novel conduit development.
C1 [Byrom, Michael J.; Bannon, Paul G.] Baird Inst, Sydney, NSW, Australia.
   [Byrom, Michael J.; Bannon, Paul G.; White, Geoffrey H.; Ng, Martin K. C.] Univ Sydney, Sydney, NSW 2006, Australia.
   [Bannon, Paul G.; White, Geoffrey H.; Ng, Martin K. C.] Royal Prince Alfred Hosp, Sydney, NSW, Australia.
   [Byrom, Michael J.; Bannon, Paul G.] Heart Res Inst, Sydney, NSW, Australia.
RP Ng, MKC (reprint author), Heart Res Inst, 7 Eliza St, Newton, NSW 2042, Australia.
EM martin.ng@email.cs.nsw.gov.au
FU National Heart Foundation [G07S 3049]; St. Jude Medical
FX This work was supported by the National Heart Foundation (Grant-In-Aid
   award number G07S 3049). Competition of interest: Michael Byrom is
   funded by a scholarship from St. Jude Medical.
CR ABBOTT WM, 1993, J VASC SURG, V17, P746, DOI 10.1016/0741-5214(93)90120-B
   AKERS RM, 2008, ANATOMY PHYSL DOMEST
   Akiyama N, 1997, SURG TODAY, V27, P840, DOI 10.1007/BF02385275
   Ao PY, 2000, EUR J VASC ENDOVASC, V20, P241, DOI 10.1053/ejvs.2000.1177
   *ASS ADV MED INSTR, 2000, VP201994 ANSIAAMI
   *ASS ADV MED INSTR, 2004, 719819982001R2004 AN
   BABATASI G, 1997, INT J ANGIOL, V6, P118
   BAGSHAW RJ, 1977, BRIT J ANAESTH, V49, P735, DOI 10.1093/bja/49.8.735
   BALDWIN BA, 1963, J PHYSIOL-LONDON, V167, P463, DOI 10.1113/jphysiol.1963.sp007162
   BALDWIN BA, 1963, ELECTROEN CLIN NEURO, V15, P465, DOI 10.1016/0013-4694(63)90067-1
   BALDWIN BA, 1963, J PHYSIOL-LONDON, V167, P448, DOI 10.1113/jphysiol.1963.sp007161
   BALDWIN BA, 1963, J ANAT, V97, P203
   BALDWIN BA, 1964, AM J ANAT, V115, P101, DOI 10.1002/aja.1001150107
   BENNION RS, 1994, VASCULAR SURG PRINCI, P1025
   BENZEL EC, 1992, NEUROSURGERY, V31, P108
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BEZUIDENHOUT D, 2001, ENCY MAT SCI TECHNOL, P9513
   Bhattacharya V, 2000, BLOOD, V95, P581
   BIANCO RW, 2004, BIOMATERIALS SCI INT, P379
   BINNS RL, 1989, J VASC SURG, V10, P326
   BLUNT M H, 1975, P29
   BOERBOOM LE, 1985, J THORAC CARDIOV SUR, V90, P756
   BROPHY CM, 1991, J BIOMED MATER RES, V25, P1031, DOI 10.1002/jbm.820250809
   BROTHERS TE, 1990, J BIOMED MATER RES, V24, P761, DOI 10.1002/jbm.820240610
   BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010
   Calasso M, 2008, SLEEP, V31, P701, DOI 10.1093/sleep/31.5.701
   Campbell J B, 1988, Eur J Vasc Surg, V2, P365, DOI 10.1016/S0950-821X(88)80013-6
   Campbell JH, 1999, CIRC RES, V85, P1173
   Cassel W S, 1989, J Invest Surg, V2, P181, DOI 10.3109/08941938909015349
   Cebotari S, 2002, CIRC RES, V90, pE71, DOI 10.1161/01.RES.0000017729.02720.6F
   Cejna M, 2001, J VASC INTERV RADIOL, V12, P351, DOI 10.1016/S1051-0443(07)61916-2
   CHARD RB, 1987, J THORAC CARDIOV SUR, V94, P132
   Chen CG, 2000, J VASC SURG, V31, P354, DOI 10.1016/S0741-5214(00)90165-4
   CHOW SP, 1982, BRIT J PLAST SURG, V35, P82, DOI 10.1016/0007-1226(82)90092-3
   CHRISTENSON IT, 1991, EUR J VASCULAR SURG, V5, P271
   CHRISTENSON JT, 1983, EUR J NUCL MED, V8, P389
   Clarke DR, 2001, ANN THORAC SURG, V71, pS433, DOI 10.1016/S0003-4975(01)02556-5
   CLOWES AW, 1986, J VASC SURG, V3, P877, DOI 10.1067/mva.1986.avs0030877
   CLOWES AW, 1985, AM J PATHOL, V118, P43
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   Connell JM, 2007, ASAIO J, V53, P229, DOI 10.1097/MAT.0b013e31802e192b
   Conte MS, 1998, FASEB J, V12, P43
   Contreras MA, 2000, MICROSURG, V20, P15, DOI 10.1002/(SICI)1098-2752(2000)20:1<15::AID-MICR3>3.3.CO;2-G
   COX RH, 1976, AM J PHYSIOL, V230, P211
   Daly Chris D, 2005, Expert Rev Cardiovasc Ther, V3, P659, DOI 10.1586/14779072.3.4.659
   DANIEL RK, 1985, PLAST RECONSTR SURG, V76, P753, DOI 10.1097/00006534-198511000-00016
   DAVIES AH, 1994, EUR J VASCULAR SURG, V8, P389, DOI 10.1016/S0950-821X(05)80955-7
   Decherd Michael E, 2003, Arch Facial Plast Surg, V5, P83
   Demiri E C, 1999, Handchir Mikrochir Plast Chir, V31, P102, DOI 10.1055/s-1999-13504
   DIDISHEIM P, 1985, ASAIO J, V8, P123
   Dixit P, 2001, J BIOMED MATER RES, V56, P545, DOI 10.1002/1097-4636(20010915)56:4<545::AID-JBM1126>3.0.CO;2-V
   Doyle B, 2005, CIRCULATION, V112, pE359, DOI 10.1161/CIRCULATIONAHA.105.575688
   Drasler W J, 1993, ASAIO J, V39, P114, DOI 10.1097/00002480-199304000-00008
   DUKES HH, 2004, DUKES PHYSL DOMESTIC
   DUNCAN JR, 1994, VET LAB MED CLIN PAT
   Dunn PF, 1996, CIRCULATION, V93, P1439, DOI 10.1161/01.CIR.93.7.1439
   Durante K R, 1990, Ann Vasc Surg, V4, P171, DOI 10.1007/BF02001374
   EDWARDS G A, 1992, Clinical Materials, V9, P211, DOI 10.1016/0267-6605(92)90102-Y
   FEINGOLD HM, 1986, AM J VET RES, V47, P2197
   Feldman B.F., 2000, SCHALMS VET HEMATOLO
   FIFE WP, SAMTR6650
   Fischer EIC, 2005, ARTIF ORGANS, V29, P122, DOI 10.1111/j.1525-1594.2005.29023.x
   GANONG WF, 1999, REV MED PHYSL
   Gherardini G, 1997, PLAST RECONSTR SURG, V99, P472, DOI 10.1097/00006534-199702000-00024
   Giannoukas AD, 1997, EUR J VASC ENDOVASC, V14, P37, DOI 10.1016/S1078-5884(97)80223-7
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Grabenwoger M, 1998, ANN THORAC SURG, V66, pS110, DOI 10.1016/S0003-4975(98)00982-5
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1992, J BIOMED MATER RES, V26, P1383, DOI 10.1002/jbm.820261009
   Gross DR, 1997, INT J ARTIF ORGANS, V20, P195
   GROSS DR, 1994, ANIMAL MODELS CARDIO
   HARKER LA, 1991, CIRCULATION, V83, P41
   Harris JR, 2002, J OTOLARYNGOL, V31, P89, DOI 10.2310/7070.2002.18928
   Hawthorne WJ, 2002, ANZ J SURG, V72, P623, DOI 10.1046/j.1445-2197.2002.t01-1-02506.x
   HAYASHIDA N, 1995, ANN VASC SURG, V9, P369, DOI 10.1007/BF02139409
   He HB, 2003, J THORAC CARDIOV SUR, V126, P455, DOI 10.1016/S0022-5223(02)73264-9
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   Hirata K, 2006, STROKE, V37, P2552, DOI 10.1161/01.STR.0000242289.20381.f4
   Holland CK, 1998, ULTRASOUND MED BIOL, V24, P1079, DOI 10.1016/S0301-5629(98)00103-3
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   HRAPKIEWICZ K, 2007, CLIN LAB ANIMAL MED
   Hussain ST, 1996, ULTRASOUND MED BIOL, V22, P287, DOI 10.1016/0301-5629(95)02050-0
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Ilsar R, 2009, CLIN EXP PHARMACOL P, V36, P797, DOI 10.1111/j.1440-1681.2009.05160.x
   *INT ORG STAND, 1998, 7198 ISO
   Ishii Y, 2008, J THORAC CARDIOV SUR, V135, P1237, DOI 10.1016/j.jtcvs.2007.09.077
   Ishii Y, 2007, ANN THORAC SURG, V83, P517, DOI 10.1016/j.athoracsur.2006.09.053
   Izhar U, 2001, J SURG RES, V95, P152, DOI 10.1006/jsre.2000.6042
   Jackson ZS, 2002, CIRC RES, V90, P918, DOI 10.1161/01.RES.0000016481.87703.CC
   JAMES NL, 1992, ARTIF ORGANS, V16, P346
   JOHNSTON KW, 1994, VASCULAR SURG PRINCI, P409
   JONES DN, 1991, J VASC SURG, V14, P441, DOI 10.1016/0741-5214(91)90237-O
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kalra M, 2000, J VASC RES, V37, P576, DOI 10.1159/000054091
   KANEKO JJ, 2008, CLIN BIOCHEMISNY DOM
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kelly B, 2006, NEPHROL DIAL TRANSPL, V21, P2425, DOI 10.1093/ndt/gfl250
   Kelly Darren J, 2005, Diab Vasc Dis Res, V2, P76, DOI 10.3132/dvdr.2005.013
   Kenney D A, 1988, ASAIO Trans, V34, P661
   Kidd KR, 2003, J SURG RES, V113, P234, DOI 10.1016/S0022-4804(03)00210-5
   Kissin M, 2000, J VASC SURG, V31, P69, DOI 10.1016/S0741-5214(00)70069-3
   KOBAYASHI H, 1992, J NEUROSURG, V77, P397, DOI 10.3171/jns.1992.77.3.0397
   KOHLER TR, 1992, SURGERY, V112, P901
   Kohler TR, 1999, J VASC SURG, V30, P744, DOI 10.1016/S0741-5214(99)70114-X
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   KONYA A, 2008, SOURCEBOOK MODELS BI, P369
   KOUCHOUKOS NT, 2003, KIRKLIN BARRATTBOYES
   KOVER G, 1991, ACTA PHYSIOL HUNG, V78, P309
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   LANZETTA M, 1992, MICROSURG, V13, P313, DOI 10.1002/micr.1920130605
   LANZETTA M, 1993, J RECONSTR MICROSURG, V9, P173, DOI 10.1055/s-2007-1006642
   Laredo J, 2003, AM J SURG, V186, P556, DOI 10.1016/j.amjsurg.2003.07.015
   LEAROYD BM, 1966, CIRC RES, V18, P278, DOI 10.1161/01.RES.18.3.278
   LEE JS, 1994, STROKE, V25, P501, DOI 10.1161/01.STR.25.2.501
   LEE YS, 1993, ASAIO, V39, P740
   LEWIS JC, 1983, CELL MOTIL CYTOSKEL, V3, P589, DOI 10.1002/cm.970030525
   LEWIS JH, 1992, COMP BIOCHEM PHYS A, V102, P507, DOI 10.1016/0300-9629(92)90202-2
   LEWIS JH, 1985, COMP BIOCHEM PHYS A, V82, P211, DOI 10.1016/0300-9629(85)90728-5
   LEWIS JH, 1976, AM J VET RES, V37, P601
   LEWIS JH, 1976, COMP BIOCHEM PHYS A, V55, P367, DOI 10.1016/0300-9629(76)90063-3
   LIDMAN D H, 1980, Journal of Microsurgery, V1, P447
   Lin PH, 2003, J SURG RES, V112, P84, DOI 10.1016/S0022-4804(03)00124-0
   Lopez-Soler RI, 2007, J SURG RES, V139, P1, DOI 10.1016/j.jss.2006.07.040
   Lundell A, 1991, Eur J Vasc Surg, V5, P321, DOI 10.1016/S0950-821X(05)80516-X
   LUNDELL A, 1993, EUR J VASCULAR SURG, V7, P698, DOI 10.1016/S0950-821X(05)80719-4
   Luo ZY, 2005, CIRCULATION, V111, P1679, DOI 10.1161/01.CIR.0000160357.80517.92
   Lutty GA, 2006, EXP EYE RES, V83, P183, DOI 10.1016/j.exer.2005.09.025
   Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175
   Mangell P, 1996, EUR J VASC ENDOVASC, V12, P189, DOI 10.1016/S1078-5884(96)80105-5
   Margovsky A, 2002, EUR J VASC ENDOVASC, V23, P39, DOI 10.1053/ejvs.2001.1538
   Margovsky AI, 1996, J VASC SURG, V24, P200, DOI 10.1016/S0741-5214(96)70094-0
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   MATTHIASSON SE, 1995, EUR J VASC ENDOVASC, V9, P284, DOI 10.1016/S1078-5884(05)80132-7
   MAY NDS, 1968, J ANAT, V103, P171
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   Merzkirch C, 2001, ANAT REC, V263, P379, DOI 10.1002/ar.1118
   Min SK, 2008, J VASC SURG, V47, P1039, DOI 10.1016/j.jvs.2007.12.043
   MULLERGLAUSER W, 1993, EUR J VASCULAR SURG, V7, P324, DOI 10.1016/S0950-821X(05)80017-9
   Nazzal M, 1991, Eur J Vasc Surg, V5, P169, DOI 10.1016/S0950-821X(05)80683-8
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niu S, 1993, ASAIO J, V39, pM750
   NORDESTGAARD AG, 1986, BRIT J EXP PATHOL, V67, P839
   Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037
   OBRIEN CJ, 1986, BRIT J PLAST SURG, V39, P103, DOI 10.1016/0007-1226(86)90012-3
   OKOSHI T, 1993, J THORAC CARDIOV SUR, V105, P791
   Onuki Y, 1997, ANN VASC SURG, V11, P604, DOI 10.1007/s100169900098
   ORTENWALL P, 1988, SURGERY, V103, P199
   PANEPINTO LM, 1986, LAB ANIM SCI, V36, P344
   Park SG, 2003, ARTIF ORGANS, V27, P576, DOI 10.1046/j.1525-1594.2003.07090.x
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Pelagalli A, 2003, J COMP PATHOL, V128, P127, DOI 10.1016/S0021-9975(02)00121-4
   Pelagalli A, 2002, J COMP PATHOL, V127, P126, DOI 10.1053/jcpa.2002.0570
   RANDALL RD, 1982, AM SURGEON, V48, P622
   Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2
   Ratner BD, 2004, BIOMATERIALS SCI INT
   RECCE WO, 2005, FUNCTIONAL ANATOMY P
   RICHARDSON RL, 1970, J THORAC CARDIOV SUR, V59, P635
   RICOTTA JJ, 2005, VASCULAR SURG
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   Rodrigues M, 1999, EUR J NUCL MED, V26, P1614, DOI 10.1007/s002590050503
   Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407
   RUCKEBUSCH Y, 1991, PHYSL SMALL LARGE AN
   Sardelic F, 1994, Cardiovasc Surg, V2, P237
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Sato M, 2002, ASAIO J, V48, P360, DOI 10.1097/00002480-200207000-00006
   SAUSAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   SCREMIN OU, 1982, J CEREBR BLOOD F MET, V2, P55, DOI 10.1038/jcbfm.1982.6
   SHEELER P, 1964, COMP BIOCHEM PHYSIOL, V11, P139, DOI 10.1016/0010-406X(64)90101-X
   Shi Q, 2004, DNA CELL BIOL, V23, P502, DOI 10.1089/1044549041562294
   SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8
   SHINDO S, 1987, J VASC SURG, V6, P325, DOI 10.1067/mva.1987.avs0060325
   Sho E, 2004, J VASC SURG, V39, P601, DOI 10.1016/j.jvs.2003.10.058
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   SHUMTIM D, 1999, ANN THORAC SURG, V68, P2305
   Simoni G, 1996, INT ANGIOL, V15, P50
   SLATTERY CW, 1989, THROMB RES, V55, P569, DOI 10.1016/0049-3848(89)90389-7
   Snow HM, 2001, J PHYSIOL-LONDON, V531, P843, DOI 10.1111/j.1469-7793.2001.0843h.x
   SNOW HM, 1994, EXP PHYSIOL, V79, P635, DOI 10.1113/expphysiol.1994.sp003796
   Sottiurai V S, 1988, Eur J Vasc Surg, V2, P245, DOI 10.1016/S0950-821X(88)80034-3
   SPANOS HG, 1993, THROMB RES, V72, P175, DOI 10.1016/0049-3848(93)90184-P
   Sparks SR, 2002, ANN VASC SURG, V16, P73, DOI 10.1007/s10016-001-0133-5
   STEPHENSON R, 2007, TXB VET PHYSL, P185
   STIMPSON C, 1989, BIOMATER ARTIF CELL, V17, P31, DOI 10.3109/10731198909118267
   Sui BB, 2008, J BIOMECH, V41, P3024, DOI 10.1016/j.jbiomech.2008.07.026
   Sun Y, 2008, LUNG, V186, P375, DOI 10.1007/s00408-008-9099-1
   SWEDBERG SH, 1989, CIRCULATION, V80, P1726, DOI 10.1161/01.CIR.80.6.1726
   TABBARA M, 1994, VASCULAR SURG PRINCI, P523
   Taylor A, 1996, AUST NZ J SURG, V66, P764, DOI 10.1111/j.1445-2197.1996.tb00739.x
   TERLECKI S, 1967, ACTA NEUROPATHOL, V7, P185, DOI 10.1007/BF00686371
   Thrall M., 2004, VET HEMATOLOGY CLIN
   Tian W, 2006, J ENDOVASC THER, V13, P616, DOI 10.1583/05-1802MR.1
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   TILLMAN P, 1981, LAB ANIM SCI, V31, P263
   Toledo-Pereyra LH, 2003, J INVEST SURG, V16, P119, DOI 10.1080/08941930390205755
   TOMIZAWA Y, 1995, J VASC SURG, V21, P542, DOI 10.1016/S0741-5214(95)70303-9
   Tortoli P, 2006, ULTRASOUND MED BIOL, V32, P1661, DOI 10.1016/j.ultrasmedbio.2006.07.023
   Trantina-Yates A, 2001, ANN THORAC SURG, V71, pS422, DOI 10.1016/S0003-4975(01)02502-4
   Trubel W, 2004, BRIT J SURG, V91, P159, DOI 10.1002/bjs.4388
   TRUBEL W, 1995, EUR J VASC ENDOVASC, V10, P415, DOI 10.1016/S1078-5884(05)80163-7
   Tsukagoshi T, 1999, J RECONSTR MICROSURG, V15, P127, DOI 10.1055/s-2007-1000083
   Ueberrueck T, 2005, J SURG RES, V124, P305, DOI 10.1016/j.jss.2004.10.021
   Urayama H, 1996, ARTIF ORGANS, V20, P24, DOI 10.1111/j.1525-1594.1996.tb04414.x
   *US FDA, REC CONS STAND CARD
   VANDERLEI B, 1989, BRIT J PLAST SURG, V42, P59, DOI 10.1016/0007-1226(89)90114-8
   VANDERLEI B, 1987, SURGERY, V101, P459
   VEITH FJ, 1979, SURGERY, V85, P253
   Walpoth BH, 2001, EUR J CARDIO-THORAC, V19, P487, DOI 10.1016/S1010-7940(01)00582-6
   WALTER JP, 1986, RADIOLOGY, V159, P545, DOI 10.1148/radiology.159.2.3515426
   WATANABE K, 1980, Journal of Microsurgery, V2, P11
   Werchan PM, 1996, AVIAT SPACE ENVIR MD, V67, P751
   Werkmeister JA, 1999, J BIOMED MATER RES, V47, P316, DOI 10.1002/(SICI)1097-4636(19991205)47:3<316::AID-JBM5>3.0.CO;2-W
   WHITE KC, 1994, CIRC RES, V75, P637, DOI 10.1161/01.RES.75.4.637
   WHITTLE BJR, 1978, PROSTAGLANDINS, V16, P373, DOI 10.1016/0090-6980(78)90216-2
   Wilson G J, 1993, ASAIO J, V39, pM526
   Wilson G J, 1995, ASAIO J, V41, pM728, DOI 10.1097/00002480-199507000-00109
   Wilson YG, 1998, ANN ROY COLL SURG, V80, P3
   Wu MHD, 1997, J VASC SURG, V25, P528, DOI 10.1016/S0741-5214(97)70264-7
   Yamaoka T, 2005, AM J PHYSIOL-HEART C, V289, pH1865, DOI 10.1152/ajpheart.00353.2005
   Yavuz K, 2006, J VASC INTERV RADIOL, V17, P873, DOI 10.1097/01.RVI.0000217938.20787.BB
   YOUNG MA, 1987, CIRC RES, V61, P88
   YUE X, 1988, SURGERY, V103, P206
   ZIERLER BK, 1992, J VASC SURG, V16, P520, DOI 10.1016/0741-5214(92)90159-6
   ZILLA P, 1994, SURGERY, V116, P524
   Zilla P, 1997, J HEART VALVE DIS, V6, P502
   Zilla P, 2008, J THORAC CARDIOV SUR, V136, P717, DOI 10.1016/j.jtcvs.2008.02.068
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 231
TC 62
Z9 65
U1 1
U2 22
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD JUL
PY 2010
VL 52
IS 1
BP 176
EP 195
DI 10.1016/j.jvs.2009.10.080
PG 20
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 625IP
UT WOS:000279889000027
PM 20299181
OA Bronze
DA 2018-10-19
ER

PT J
AU Khoushab, F
   Yamabhai, M
AF Khoushab, Feisal
   Yamabhai, Montarop
TI Chitin Research Revisited
SO MARINE DRUGS
LA English
DT Review
DE chitin; chitosan; chito-oligosaccharide; application; nanotechnology;
   biotechnology; nanobiotechnology
ID BACILLUS-CIRCULANS WL-12; N-ACETYLCHITOOLIGOSACCHARIDE ELICITOR; ATOMIC
   EMISSION-SPECTROMETRY; AFFINITY BINDING-PROTEIN; MARINE SHELLFISH
   WASTES; WATER-SOLUBLE CHITOSAN; O-GLCNAC MODIFICATION;
   X-RAY-DIFFRACTION; SERRATIA-MARCESCENS; ESCHERICHIA-COLI
AB Two centuries after the discovery of chitin, it is widely accepted that this biopolymer is an important biomaterial in many aspects. Numerous studies on chitin have focused on its biomedical applications. In this review, various aspects of chitin research including sources, structure, biosynthesis, chitinolytic enzyme, chitin binding protein, genetic engineering approach to produce chitin, chitin and evolution, and a wide range of applications in bio- and nanotechnology will be dealt with.
C1 [Khoushab, Feisal; Yamabhai, Montarop] Suranaree Univ Technol, Sch Biotechnol, Nakhon Ratchasima 30000, Thailand.
RP Yamabhai, M (reprint author), Suranaree Univ Technol, Sch Biotechnol, Nakhon Ratchasima 30000, Thailand.
EM fl.khoushab@gmail.com; montarop@g.sut.ac.th
FU Suranaree University of Technology (SUT); International Foundation for
   Sciences (IFS)
FX FK and MY are supported by Suranaree University of Technology (SUT) and
   International Foundation for Sciences (IFS). We would like to thank
   Kenneth J. Haller for his critical reading of the manuscript and Julian
   David Pieniazek for proofreading. Moreover, we highly appreciate the
   comments and suggestions from the referees, who critically reviewed this
   manuscript.
CR Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   AMATAYAKULCHANT.S, 1975, J CELL SCI, V99, P485
   Asensio JL, 2000, CHEM BIOL, V7, P529, DOI 10.1016/S1074-5521(00)00136-8
   ATKINS E, 1985, J BIOSCIENCE, V8, P375, DOI 10.1007/BF02703990
   AUSTIN PR, 1981, SCIENCE, V212, P749, DOI 10.1126/science.7221561
   Bakkers J, 1997, P NATL ACAD SCI USA, V94, P7982, DOI 10.1073/pnas.94.15.7982
   Bautista-Banos S, 2003, CROP PROT, V22, P1087, DOI 10.1016/S0261-2194(03)00117-0
   Begin A, 1999, INT J BIOL MACROMOL, V26, P63, DOI 10.1016/S0141-8130(99)00064-1
   Bhattacharya D, 2007, CRIT REV BIOTECHNOL, V27, P21, DOI 10.1080/07388550601168223
   BLUMENTHAL HJ, 1957, J BACTERIOL, V74, P222
   BODMEIER R, 1989, PHARMACEUT RES, V6, P413, DOI 10.1023/A:1015987516796
   BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252
   Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200
   Bormann C, 1999, J BACTERIOL, V181, P7421
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Brimble S, 2010, CURR SIGNAL TRANSD T, V5, P12, DOI 10.2174/157436210790226465
   BROEKAERT WF, 1989, SCIENCE, V245, P1100, DOI 10.1126/science.245.4922.1100
   BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505
   Burton-Freeman B., 2000, J NUTR S, V130, P272
   Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Chae KS, 1999, COMP BIOCHEM PHYS B, V124, P475, DOI 10.1016/S0305-0491(99)00143-1
   Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200
   Chatham JC, 2010, CURR SIGNAL TRANSD T, V5, P49, DOI 10.2174/157436210790226492
   Cheng JC, 2008, J MICROELECTROMECH S, V17, P402, DOI 10.1109/JMEMS.2008.916325
   CHIGALEICHIK A G, 1976, Prikladnaya Biokhimiya i Mikrobiologiya, V12, P581
   CHIPMAN DM, 1967, J BIOL CHEM, V242, P4388
   Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4
   Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001
   Cohen E, 2001, PEST MANAG SCI, V57, P946, DOI 10.1002/ps.363
   Cohen-Kupiec R, 1998, CURR OPIN BIOTECH, V9, P270, DOI 10.1016/S0958-1669(98)80058-X
   Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2
   Cottaz S, 2005, METAB ENG, V7, P311, DOI 10.1016/j.ymben.2005.05.004
   COULSON AFW, 1994, FEBS LETT, V354, P41, DOI 10.1016/0014-5793(94)01084-6
   da Silva KMP, 2004, COLLOID SURFACE A, V237, P15, DOI 10.1016/j.colsurfa.2003.12.031
   Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7
   Dai TH, 2009, ANTIMICROB AGENTS CH, V53, P393, DOI 10.1128/AAC.00760-08
   Day RB, 2001, PLANT PHYSIOL, V126, P1162, DOI 10.1104/pp.126.3.1162
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   DEBOLLE MFC, 1993, PLANT MOL BIOL, V22, P1187, DOI 10.1007/BF00028991
   DEJONG AJ, 1993, PLANT CELL, V5, P615, DOI 10.1105/tpc.5.6.615
   Dev A, 2010, CARBOHYD POLYM, V79, P1073, DOI 10.1016/j.carbpol.2009.10.038
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   Duverger E, 1996, GLYCOBIOLOGY, V6, P381, DOI 10.1093/glycob/6.4.381
   Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004
   ELGHAOUTH A, 1992, MYCOL RES, V96, P769, DOI 10.1016/S0953-7562(09)80447-4
   Endo T, 2000, CURR OPIN STRUC BIOL, V10, P536, DOI 10.1016/S0959-440X(00)00127-5
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   Evvyernie D, 2000, J BIOSCI BIOENG, V89, P596, DOI 10.1016/S1389-1723(00)80063-8
   Felix G, 1998, PLANT PHYSIOL, V117, P643, DOI 10.1104/pp.117.2.643
   Ferrandon S, 2003, BBA-GEN SUBJECTS, V1621, P31, DOI 10.1016/S0304-4165(03)00029-1
   Franco LD, 2004, BRAZ J MICROBIOL, V35, P243, DOI 10.1590/S1517-83822004000200013
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96
   Gallaher CM, 2000, J NUTR, V130, P2753
   Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103
   Gong YP, 2009, MICROSURG, V29, P650, DOI 10.1002/micr.20686
   Gopalan N. K., 2003, BIOMACROMOLECULES, V4, P657, DOI DOI 10.1021/BM020127B
   Guinez C, 2005, INT J BIOCHEM CELL B, V37, P765, DOI 10.1016/j.biocel.2004.12.001
   Haidar ZS, 2008, BIOMATERIALS, V29, P1207, DOI 10.1016/j.biomaterials.2007.11.012
   HAKALA BE, 1993, J BIOL CHEM, V268, P25803
   Hakim L, 2008, TALANTA, V76, P1256, DOI 10.1016/j.talanta.2008.05.025
   Hakim L, 2008, TALANTA, V74, P977, DOI 10.1016/j.talanta.2007.08.012
   Hakim L, 2007, ANAL CHIM ACTA, V588, P73, DOI 10.1016/j.aca.2007.01.066
   Hamodrakas SJ, 2002, INSECT BIOCHEM MOLEC, V32, P1577, DOI 10.1016/S0965-1748(02)00079-6
   Hardt M, 2004, ARCH BIOCHEM BIOPHYS, V426, P286, DOI 10.1016/j.abb.2004.03.017
   Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815
   Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315
   HAWTIN RE, 1995, VIROLOGY, V212, P673, DOI 10.1006/viro.1995.1525
   Hayes Maria, 2008, Biotechnology Journal, V3, P878, DOI 10.1002/biot..200800027
   Hayes Maria, 2008, Biotechnology Journal, V3, P871, DOI 10.1002/biot.200700197
   HERRING PJ, 1979, PURE APPL CHEM, V51, P1901, DOI 10.1351/pac197951091901
   Hosoba M, 2009, ANAL CHIM ACTA, V639, P51, DOI 10.1016/j.aca.2009.02.050
   Howard MB, 2003, J IND MICROBIOL BIOT, V30, P627, DOI 10.1007/s10295-003-0096-3
   Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415
   Huang X, 2000, FEBS LETT, V478, P123, DOI 10.1016/S0014-5793(00)01834-2
   Hurtado-Guerrero R, 2008, CURR OPIN STRUC BIOL, V18, P551, DOI 10.1016/j.sbi.2008.09.005
   IEROPOULOS I, 2004, CITESEERX SCI LIT DI
   Iglesias M, 1996, NEUROSCI LETT, V207, P81, DOI 10.1016/0304-3940(96)12506-4
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x
   Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011
   Je JY, 2006, BIOMACROMOLECULES, V7, P3448, DOI 10.1021/bm060373d
   Je JY, 2006, BIOORG MED CHEM LETT, V16, P1884, DOI 10.1016/j.bmcl.2005.12.077
   Jee JG, 2002, J BIOL CHEM, V277, P1388, DOI 10.1074/jbc.M109726200
   Jeong HJ, 2000, INT J IMMUNOPHARMACO, V22, P923, DOI 10.1016/S0192-0561(00)00055-2
   Jeuniaux C., 1996, ADV CHITIN SCI, P1
   Johansen JS, 2001, ARTHRITIS RHEUM-US, V44, P826
   Johansen JS, 2006, DAN MED BULL, V53, P172
   Jolles P., 1999, CHITIN CHITINASES
   Kageyama C, 2006, PLANT PHYSIOL BIOCH, V44, P901, DOI 10.1016/j.plaphy.2006.09.010
   Kamiyama K, 1999, BIOL PHARM BULL, V22, P179
   Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014
   Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351
   Karasuda S, 2003, BIOSCI BIOTECH BIOCH, V67, P221, DOI 10.1271/bbb.67.221
   Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809
   Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003
   Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253
   Kawasaki T, 2002, VIROLOGY, V302, P123, DOI 10.1006/viro.2002.1572
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764
   Klokkevold PR, 1999, J ORAL MAXIL SURG, V57, P49, DOI 10.1016/S0278-2391(99)90632-8
   KOEV ST, 2006, BIOM NAN C 2006 BMN, P82
   Kolbe S, 1998, MICROBIOL-UK, V144, P1291, DOI 10.1099/00221287-144-5-1291
   Kolstad G, 2002, ACTA CRYSTALLOGR D, V58, P377, DOI 10.1107/S0907444901018972
   Krykbaev R, 2010, GENE, V452, P63, DOI 10.1016/j.gene.2009.12.005
   KURANDA MJ, 1991, J BIOL CHEM, V266, P19758
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128
   Lavall RL, 2007, BIORESOURCE TECHNOL, V98, P2465, DOI 10.1016/j.biortech.2006.09.002
   Lazarus BD, 2009, INT J BIOCHEM CELL B, V41, P2134, DOI 10.1016/j.biocel.2009.03.008
   Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0
   Li B, 2008, CARBOHYD POLYM, V72, P287, DOI 10.1016/j.carbpol.2007.08.012
   MAEZAKI Y, 1993, BIOSCI BIOTECH BIOCH, V57, P1439, DOI 10.1271/bbb.57.1439
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MATHUR NK, 1990, J CHEM EDUC, V67, P938, DOI 10.1021/ed067p938
   MAZEAU K, 1994, MACROMOLECULES, V27, P7606, DOI 10.1021/ma00104a015
   MCMURROUGH I, 1971, J BIOL CHEM, V246, P3999
   Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Minami E, 1996, MOL PLANT MICROBE IN, V9, P574, DOI 10.1094/MPMI-9-0574
   Minami S, 1998, CARBOHYD POLYM, V36, P151, DOI 10.1016/S0144-8617(98)00015-0
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Mizuochi Tsuguo, 1999, J Infect Chemother, V5, P190, DOI 10.1007/s101560050033
   Morimoto K, 2005, FEMS MICROBIOL LETT, V246, P229, DOI 10.1016/j.femsle.2005.04.014
   Mostafa SA, 2009, J GEN APPL MICROBIOL, V55, P241
   Muzzarelli RAA, 2009, WOODHEAD PUBL FOOD S, P849, DOI 10.1533/9781845695873.849
   Muzzarelli R. A. A., 2006, FUNCTIONAL FOOD CARB, P215, DOI DOI 10.1201/9781420003512.CH6
   MUZZARELLI RAA, 1977, CHITIN
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Nakazaki T, 2006, GENOME, V49, P619, DOI 10.1139/G06-020
   Ngo DN, 2009, J FUNCT FOODS, V1, P188, DOI 10.1016/j.jff.2009.01.008
   Okada M, 2001, J PLANT PHYSIOL, V158, P121, DOI 10.1078/0176-1617-00231
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Oshita K, 2008, ANAL BIOANAL CHEM, V390, P1927, DOI 10.1007/s00216-008-1931-1
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279
   Pappa A, 2010, CURR SIGNAL TRANSD T, V5, P41, DOI 10.2174/157436210790226500
   PARK I, 2007, APPL PHYS LETT, V90
   Park PJ, 2004, CARBOHYD POLYM, V55, P17, DOI 10.1016/j.carbpol.2003.05.002
   Park YK, 2000, J CONTROL RELEASE, V69, P97, DOI 10.1016/S0168-3659(00)00298-4
   Patil RS, 2000, ENZYME MICROB TECH, V26, P473, DOI 10.1016/S0141-0229(00)00134-4
   RAZDAN A, 1994, BRIT J NUTR, V72, P277, DOI 10.1079/BJN19940029
   RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7
   RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x
   SAKAGUCHI T, 1981, AGR BIOL CHEM TOKYO, V45, P2191, DOI 10.1080/00021369.1981.10864862
   SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296
   Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6
   Samain E, 1997, CARBOHYD RES, V302, P35, DOI 10.1016/S0008-6215(97)00107-9
   San-Lang W, 2002, ENZYME MICROB TECH, V31, P321, DOI 10.1016/S0141-0229(02)00130-8
   Schiffman JD, 2009, MAT SCI ENG C-BIO S, V29, P1370, DOI 10.1016/j.msec.2008.11.006
   Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001
   SEMINO CE, 1995, P NATL ACAD SCI USA, V92, P3498, DOI 10.1073/pnas.92.8.3498
   Semino CE, 1996, P NATL ACAD SCI USA, V93, P4548, DOI 10.1073/pnas.93.10.4548
   SENDAI Y, 1994, BIOL REPROD, V50, P927, DOI 10.1095/biolreprod50.4.927
   SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076
   Shelma R., 2008, TRENDS BIOMATER ARTI, V22, P111
   Shen KT, 2009, FOOD CHEM TOXICOL, V47, P1864, DOI 10.1016/j.fct.2009.04.044
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008
   Songsiriritthigul C, 2010, BIORESOURCE TECHNOL, V101, P4096, DOI 10.1016/j.biortech.2010.01.036
   Songsiriritthigul Chomphunuch, 2009, Biotechnology Journal, V4, P501, DOI [10.1002/biot.200900258, 10.1002/biot.200800258]
   Struszczyk M. H., 2006, POLISH CHITIN SOC MO, VXI, P95
   Suginta W, 2005, FEBS J, V272, P3376, DOI 10.1111/j.1742-4658.2005.04753.x
   Suginta W, 2007, BBA-GEN SUBJECTS, V1770, P1151, DOI 10.1016/j.bbagen.2007.03.012
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200
   TANAHASHI I, 1990, B CHEM SOC JPN, V63, P3611, DOI 10.1246/bcsj.63.3611
   Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010
   THARANATHAN RN, 2003, CRIT REV FOOD SCI NU, V87, P43
   Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239
   Tsioptsias C, 2009, MAT SCI ENG C-BIO S, V29, P159, DOI 10.1016/j.msec.2008.06.003
   Tsujibo H, 2003, APPL ENVIRON MICROB, V69, P894, DOI 10.1128/AEM.69.2.894-900.2003
   TSUKADA K, 1990, JPN J CANCER RES, V81, P259, DOI 10.1111/j.1349-7006.1990.tb02559.x
   Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200
   Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014
   van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842
   Van Dellen KL, 2006, EUKARYOT CELL, V5, P836, DOI 10.1128/EC.5.5.836-848.2006
   van der Holst PPG, 2001, CURR OPIN STRUC BIOL, V11, P608, DOI 10.1016/S0959-440X(00)00255-4
   Varki Ajit, 1995, Seminars in Developmental Biology, V6, P127, DOI 10.1016/S1044-5781(06)80022-8
   Verhage HG, 1998, BIOL REPROD, V58, P1098, DOI 10.1095/biolreprod58.5.1098
   Veronico P, 2001, MOL GENET GENOMICS, V266, P28, DOI 10.1007/s004380100513
   WAGNER GP, 1993, EXPERIENTIA, V49, P317, DOI 10.1007/BF01923410
   Wang BL, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025606
   Wang JL, 2001, J BIOTECHNOL, V87, P273, DOI 10.1016/S0168-1656(00)00379-5
   Wang SL, 2008, BIORESOURCE TECHNOL, V99, P4386, DOI 10.1016/j.biortech.2007.08.035
   WATANABE T, 1993, J BIOL CHEM, V268, P18567
   WATANABE T, 1994, BIOSCI BIOTECH BIOCH, V58, P2283, DOI 10.1271/bbb.58.2283
   Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419
   Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X
   Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818
   Willis JH, 1999, AM ZOOL, V39, P600
   Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001
   Xie WM, 2001, BIOORG MED CHEM LETT, V11, P1699, DOI 10.1016/S0960-894X(01)00285-2
   Yamazaki S, 2009, ELECTROCHEM COMMUN, V11, P68, DOI 10.1016/j.elecom.2008.10.039
   Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170
   You Y, 2004, J MATER SCI-MATER M, V15, P297, DOI 10.1023/B:JMSM.0000015491.91918.64
   YOUNG DH, 1982, PLANT PHYSIOL, V70, P1449, DOI 10.1104/pp.70.5.1449
   Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007
   Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005
   Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678
   Zhang G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-93
   Zhao Yu, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P338
   Zia KM, 2009, COLLOID SURFACE B, V72, P248, DOI 10.1016/j.colsurfb.2009.04.011
NR 216
TC 131
Z9 139
U1 0
U2 74
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD JUL
PY 2010
VL 8
IS 7
BP 1988
EP 2012
DI 10.3390/md8071988
PG 25
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 631LA
UT WOS:000280347100002
PM 20714419
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Leung, BO
   Brash, JL
   Hitchcock, AP
AF Leung, Bonnie O.
   Brash, John L.
   Hitchcock, Adam P.
TI Characterization of Biomaterials by Soft X-Ray Spectromicroscopy
SO MATERIALS
LA English
DT Review
DE photoemission electron microscopy; X-PEEM; NEXAFS; scanning transmission
   X-ray microscopy; STXM; mapping; protein adsorption; human serum
   albumin; fibrinogen; polymers; blend; topography
ID QUARTZ-CRYSTAL MICROBALANCE; SURFACE-PLASMON RESONANCE; RELEVANT
   ABSORPTION EDGES; SILICA-WATER INTERFACE; ADVANCED LIGHT-SOURCE; HUMAN
   SERUM-ALBUMIN; PROTEIN ADSORPTION; POLY(ETHYLENE OXIDE); NEXAFS
   SPECTROSCOPY; CROSS-LINKING
AB Synchrotron-based soft X-ray spectromicroscopy techniques are emerging as useful tools to characterize potentially biocompatible materials and to probe protein interactions with model biomaterial surfaces. Simultaneous quantitative chemical analysis of the near surface region of the candidate biomaterial, and adsorbed proteins, peptides or other biological species can be obtained at high spatial resolution via scanning transmission X-ray microscopy (STXM) and X-ray photoemission electron microscopy (X-PEEM). Both techniques use near-edge X-ray absorption fine structure (NEXAFS) spectral contrast for chemical identification and quantitation. The capabilities of STXM and X-PEEM for the analysis of biomaterials are reviewed and illustrated by three recent studies: (1) characterization of hydrophobic surfaces, including adsorption of fibrinogen (Fg) or human serum albumin (HSA) to hydrophobic polymeric thin films, (2) studies of HSA adsorption to biodegradable or potentially biocompatible polymers, and (3) studies of biomaterials under fully hydrated conditions. Other recent applications of STXM and X-PEEM to biomaterials are also reviewed.
C1 [Leung, Bonnie O.; Hitchcock, Adam P.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M, Canada.
   [Brash, John L.] McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4M1, Canada.
RP Hitchcock, AP (reprint author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M, Canada.
EM leungbo@mcmaster.ca; brashjl@mcmaster.ca; aph@mcmaster.ca
FU Department of Energy [DE-AC03-76SF00098]; NSERC; NRC; CIHR; University
   of Saskatchewan; National Sciences and Engineering Council of Canada
   (NSERC); Canada Research Chair
FX Measurements were performed at beamlines 5.3.2 (STXM) and 7.3.1 (PEEM)
   at the Advanced Light Source. The ALS is funded by the Department of
   Energy under contract DE-AC03-76SF00098. PEEM measurements were also
   performed at beamlines 11ID1 (SGM) and 10ID1 (SM) at the CLS. The CLS is
   supported by NSERC, NRC, CIHR, and the University of Saskatchewan. We
   thank the staff scientists at the ALS (Tolek Tyliszczak and David
   Kilcoyne for STXM, Andreas Scholl and Andrew Doran for X-PEEM) and at
   CLS (Tom Regier and Rob Blyth for SGM and Chithra Karunakaran and Uday
   Lanke for SM) for their assistance and expert support of the
   instrumentation. Research supported by the National Sciences and
   Engineering Council of Canada (NSERC) and the Canada Research Chair
   program.
CR Ade H., 1998, EXPT METHODS PHYS SC, V32, P225
   Ade H, 2008, POLYMER, V49, P643, DOI 10.1016/j.polymer.2007.10.030
   Al-Azzam W, 2002, BIOPHYS J, V83, P3637, DOI 10.1016/S0006-3495(02)75364-2
   Anders S, 1999, REV SCI INSTRUM, V70, P3973, DOI 10.1063/1.1150023
   Andruzzi L, 2005, LANGMUIR, V21, P2495, DOI 10.1021/la047574s
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bauer E, 2001, J PHYS-CONDENS MAT, V13, P11391, DOI 10.1088/0953-8984/13/49/316
   Bauer E., 2001, J ELECT SPECTROSC RE, V975, P114
   BLOOM AL, 1987, HAEMOSTASIS THROMBOS
   Campbell IM., 1994, INTRO SYNTHETIC POLY
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cheng JJ, 2006, PHARM RES, V23, P557, DOI 10.1007/s11095-005-9444-5
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Denisov VP, 1999, NAT STRUCT BIOL, V6, P253, DOI 10.1038/6692
   Dimitrov M., 2004, ACTA PHARM TURCICA, V46, P49
   Doycheva M, 2004, MACROMOL MATER ENG, V289, P676, DOI 10.1002/mame.200400073
   DOYCHEVA M, 1998, POLYMER, V39, P6715
   Doytcheva M, 2001, MACROMOL MATER ENG, V286, P30, DOI 10.1002/1439-2054(20010101)286:1<30::AID-MAME30>3.3.CO;2-Y
   Ekblad T, 2009, LANGMUIR, V25, P3755, DOI 10.1021/la803443d
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FOGHANDERSEN N, 1993, CLIN CHEM, V39, P48
   FOSTER JF, 1977, ALBUMIN STRUCTURE FU, P53, DOI DOI 10.1016/B978-0-08-019603-9.50010-7
   Fujii S, 2009, LANGMUIR, V25, P2588, DOI 10.1021/la804212y
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969
   GROS G, 1976, J BIOL CHEM, V251, P4398
   Hale P, 2008, LANGMUIR, V24, P7897, DOI 10.1021/la8002788
   Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113
   Hitchcock AP, 2005, J ELECTRON SPECTROSC, V144, P259, DOI 10.1016/j.elspec.2005.01.279
   Hitchcock AP, 2005, AUST J CHEM, V58, P423, DOI 10.1071/CH05054
   Hitchcock AP, 2002, J BIOMAT SCI-POLYM E, V13, P919, DOI 10.1163/156856202320401960
   Hitchcock AP, 2001, ULTRAMICROSCOPY, V88, P33, DOI 10.1016/S0304-3991(00)00113-3
   Holtz JH, 1997, NATURE, V389, P829
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jacobsen C, 2000, J MICROSC-OXFORD, V197, P173
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kilcoyne ALD, 2003, J SYNCHROTRON RADIAT, V10, P125, DOI 10.1107/S0909049502017739
   KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139
   Kofinas P, 1996, BIOMATERIALS, V17, P1547, DOI 10.1016/0142-9612(96)89781-X
   Koprinarov IN, 2002, J PHYS CHEM B, V106, P5358, DOI 10.1021/jp0132811
   Lensen MC, 2007, LANGMUIR, V23, P7841, DOI 10.1021/la7007683
   Leung B. O., 2008, BIOINTERPHASES, V3, pF27
   LEUNG BO, 2010, ADV BIOMATE IN PRESS
   Leung BO, 2009, LANGMUIR, V25, P13332, DOI 10.1021/la9037155
   Leung BO, 2009, MACROMOLECULES, V42, P1679, DOI 10.1021/ma802176b
   Leung BO, 2009, BIOMACROMOLECULES, V10, P1838, DOI 10.1021/bm900264w
   LEVITT M, 1993, STRUCTURE, V1, P223, DOI 10.1016/0969-2126(93)90011-5
   LEWIS F, 2008, J PHYS D, V41
   Li L, 2008, J PHYS CHEM B, V112, P2150, DOI 10.1021/jp076583h
   Li L, 2006, J PHYS CHEM B, V110, P16763, DOI 10.1021/jp062442o
   Liu Y, 2003, J PHYS CHEM B, V107, P9774, DOI 10.1021/jp0277513
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   MERRILL EW, 1993, BIOMATERIALS, V14, P1117, DOI 10.1016/0142-9612(93)90154-T
   Mohamed A, 2007, J APPL POLYM SCI, V106, P1689, DOI 10.1002/app.26783
   Morin C, 2004, J ELECTRON SPECTROSC, V137, P785, DOI 10.1016/j.elspec.2004.02.158
   Morin C, 2001, J ELECTRON SPECTROSC, V121, P203, DOI 10.1016/S0368-2048(01)00335-8
   Morris GE, 1997, J COLLOID INTERF SCI, V190, P198, DOI 10.1006/jcis.1997.4843
   Murthy N, 2002, J AM CHEM SOC, V124, P12398, DOI 10.1021/ja026925r
   Nayak S, 2004, J AM CHEM SOC, V126, P10258, DOI 10.1021/ja0474143
   PACHE S, 2008, J PHYS CHEM B, V109, P17545
   PETERS T, 1995, ALL ALBUMIN BIOCH GE
   Petrov P, 2006, J MATER CHEM, V16, P2192, DOI 10.1039/b517028a
   QUINN CP, 1995, BIOMATERIALS, V16, P389, DOI 10.1016/0142-9612(95)98856-9
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Samuel NT, 2006, J ELECTRON SPECTROSC, V152, P134, DOI 10.1016/j.elspec.2006.04.004
   Sengonul M, 2009, COLLOID SURFACE B, V73, P152, DOI 10.1016/j.colsurfb.2009.05.004
   Seo JH, 2009, BIOMATERIALS, V30, P5330, DOI 10.1016/j.biomaterials.2009.06.031
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SNOWDEN MJ, 1993, ANALYST, V118, P1367, DOI 10.1039/an9931801367
   Solomon D, 2009, SOIL SCI SOC AM J, V73, P1817, DOI 10.2136/sssaj2008.0228
   Song L, 2006, COLLOID SURFACE B, V49, P66, DOI 10.1016/j.colsurfb.2005.12.003
   Sousa A, 2006, LANGMUIR, V22, P6286, DOI 10.1021/la053081r
   Steinmann S, 2001, POLYMER, V42, P6619, DOI 10.1016/S0032-3861(01)00100-8
   Stewart-Ornstein J, 2007, J PHYS CHEM B, V111, P7691, DOI 10.1021/jp0720993
   STRANG G, 1988, LINEAR ALGEBRA ITS A
   Stringer JL, 1996, J CONTROL RELEASE, V42, P195, DOI 10.1016/0168-3659(96)01457-5
   Su TJ, 1998, J PHYS CHEM B, V102, P8100, DOI 10.1021/jp981239t
   Su TJ, 1998, J COLLOID INTERF SCI, V203, P419, DOI 10.1006/jcis.1998.5545
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TOBIAS W, 2009, LANGMUIR
   URQUHART SG, 2002, CHEM APPL SYNCHROTRO, P285
   UTRACKI LA, 1991, RHEOLOGY, V35, P1615
   Wang J, 2009, J ELECTRON SPECTROSC, V170, P25, DOI 10.1016/j.elspec.2008.01.002
   Warwick T, 2002, J SYNCHROTRON RADIAT, V9, P254, DOI 10.1107/S0909049502005502
   WU S, 1970, J PHYS CHEM-US, V74, P632, DOI 10.1021/j100698a026
   Zubavichus Y, 2006, J PHYS CHEM B, V110, P3420, DOI 10.1021/jp056118p
   Zubavichus Y, 2005, J PHYS CHEM A, V109, P6998, DOI 10.1021/jp0535846
   Zubavichus Y, 2005, J PHYS CHEM B, V109, P884, DOI 10.1021/jp047626m
   Zubavichus Y, 2004, RADIAT RES, V161, P346, DOI 10.1667/RR3114.1
   Zubavichus Y, 2004, J ELECTRON SPECTROSC, V134, P25, DOI 10.1016/j.elspec.2003.09.006
   Zubavichus Y, 2009, NUCL INSTRUM METH A, V603, P111, DOI 10.1016/j.nima.2008.12.171
   Zubavichus Y, 2007, J PHYS CHEM B, V111, P9803, DOI 10.1021/jp073922y
   AXIS2000 IS FREE NON
NR 103
TC 18
Z9 18
U1 2
U2 74
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2010
VL 3
IS 7
BP 3911
EP 3938
DI 10.3390/ma3073911
PG 28
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LS
UT WOS:000298242200005
PM 28883316
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bolles, KM
   Cheng, F
   Burk-Rafel, J
   Dubey, M
   Ratner, DM
AF Bolles, Kathryn M.
   Cheng, Fang
   Burk-Rafel, Jesse
   Dubey, Manish
   Ratner, Daniel M.
TI Imaging Analysis of Carbohydrate-Modified Surfaces Using ToF-SIMS and
   SPRi
SO MATERIALS
LA English
DT Article
DE carbohydrate microarray; ToF-SIMS; SPR; glycomics
ID THIN-FILMS; BINDING; IMMOBILIZATION; MICROARRAYS; MONOLAYERS; PROTEINS;
   POLYMERS; CULTURE
AB Covalent modification of surfaces with carbohydrates (glycans) is a prerequisite for a variety of glycomics-based biomedical applications, including functional biomaterials, glycoarrays, and glycan-based biosensors. The chemistry of glycan immobilization plays an essential role in the bioavailability and function of the surface bound carbohydrate moiety. However, the scarcity of analytical methods to characterize carbohydrate-modified surfaces complicates efforts to optimize glycan surface chemistries for specific applications. Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) is a surface sensitive technique suited for probing molecular composition at the biomaterial interface. Expanding ToF-SIMS analysis to interrogate carbohydrate-modified materials would increase our understanding of glycan surface chemistries and advance novel tools in the nascent field of glycomics. In this study, a printed glycan microarray surface was fabricated and subsequently characterized by ToF-SIMS imaging analysis. A multivariate technique based on principal component analysis (PCA) was used to analyze the ToF-SIMS dataset and reconstruct ToF-SIMS images of functionalized surfaces. These images reveal chemical species related to the immobilized glycan, underlying glycan-reactive chemistries, gold substrates, and outside contaminants. Printed glycoarray elements (spots) were also interrogated to resolve the spatial distribution and spot homogeneity of immobilized glycan. The bioavailability of the surface-bound glycan was validated using a specific carbohydrate-binding protein (lectin) as characterized by Surface Plasmon Resonance Imaging (SPRi). Our results demonstrate that ToF-SIMS is capable of characterizing chemical features of carbohydrate-modified surfaces and, when complemented with SPRi, can play an enabling role in optimizing glycan microarray fabrication and performance.
C1 [Cheng, Fang; Burk-Rafel, Jesse; Ratner, Daniel M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Bolles, Kathryn M.] Whitman Coll, Walla Walla, WA 99362 USA.
   [Dubey, Manish] Univ Washington, NESAC Bio, Seattle, WA 98195 USA.
RP Ratner, DM (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM bolleskm@whitman.edu; ffcheng@u.washington.edu;
   jbrafel@u.washington.edu; mdubey@lanl.gov; dratner@u.washington.edu
RI Ratner, Daniel/J-6391-2013
OI Burk-Rafel, Jesse/0000-0003-3785-2154
FU Washington Research Foundation; University of Washington; University of
   Washington Department of Bioengineering; NESAC/BIO (NIH) [P41 EB002027];
   UWEB National Science Foundation [EEC-0647918]; Mary Gates Research
   Scholarship
FX The authors gratefully acknowledge support from the Washington Research
   Foundation, the University of Washington Royalty Research Fund, and the
   University of Washington Department of Bioengineering. Surface analysis
   and support for MD was provided by NESAC/BIO (NIH Grant P41 EB002027).
   Dan Graham of NESAC/Bio is thanked for his valuable input on PCA image
   analysis. Support for KMB was generously provided by the UWEB National
   Science Foundation REU program (EEC-0647918). The authors also wish to
   thank the Mary Gates Research Scholarship for JBR's research award.
CR Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101
   Cheng F, 2008, ANAL CHEM, V80, P2564, DOI 10.1021/ac702380w
   Cheng F, 2007, ANAL CHEM, V79, P8781, DOI 10.1021/ac0715423
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Deng Y, 2006, J AM CHEM SOC, V128, P2768, DOI 10.1021/ja057669w
   Dhayal M, 2009, LANGMUIR, V25, P2181, DOI 10.1021/la8031122
   Dietrich PM, 2010, SURF INTERFACE ANAL, V42, P1188, DOI 10.1002/sia.3255
   Dubey M, 2009, SURF INTERFACE ANAL, V41, P645, DOI 10.1002/sia.3056
   Esaki K, 2009, BIOMACROMOLECULES, V10, P1265, DOI 10.1021/bm900089j
   Hasenbank MS, 2008, ANAL CHIM ACTA, V611, P80, DOI 10.1016/j.aca.2008.01.048
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Iwasaki Y, 2007, BIOMACROMOLECULES, V8, P2788, DOI 10.1021/bm700478d
   Jelinek R, 2004, CHEM REV, V104, P5987, DOI 10.1021/cr0300284
   LANG H, 1994, LANGMUIR, V10, P197, DOI 10.1021/la00013a029
   Onodera T, 2006, BIOMACROMOLECULES, V7, P2949, DOI 10.1021/bm060027w
   Ratner DM, 2004, CHEMBIOCHEM, V5, P1375, DOI 10.1002/cbic.200400106
   Shi JJ, 2007, J AM CHEM SOC, V129, P5954, DOI 10.1021/ja069375w
   Smith EA, 2003, J AM CHEM SOC, V125, P6140, DOI 10.1021/ja034165u
   Song XZ, 2008, GLYCOCONJUGATE J, V25, P15, DOI 10.1007/s10719-007-9066-8
   Takahashi H, 2008, ADV FUNCT MATER, V18, P2079, DOI 10.1002/adfm.200800105
   Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106
   Xia N, 2002, LANGMUIR, V18, P3255, DOI 10.1021/la011423x
   Yoon JJ, 2002, BIOTECHNOL BIOENG, V78, P1, DOI 10.1002/bit.10239
NR 23
TC 8
Z9 9
U1 0
U2 23
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2010
VL 3
IS 7
BP 3948
EP 3964
DI 10.3390/ma3073948
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LS
UT WOS:000298242200007
PM 24175018
OA DOAJ Gold, Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Li, Y
   Zhang, L
   Zuo, Y
   Yang, WH
   Shen, J
   Li, Y
AF Li, Y.
   Zhang, L.
   Zuo, Y.
   Yang, W. H.
   Shen, J.
   Li, Y.
TI Poly(N-isopropyl acrylamide)/chitosan composite membrane with smart
   thermoresponsive performance
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Thermoresponsive; PNIPAAm; Chitosan; Membrane; Smart biomaterial
ID ARTIFICIAL SKIN; IN-VITRO; CHITOSAN; TISSUE
AB In this study, poly(N-isopropylacrylamide)/chitosan (PNIPAAm/CS) composite membranes with different weight ratios were fabricated using a one-step method, in which PNIPAAm was directly synthesised using NIPAAm monomers by means of free radical polymerisation. Fourier transform infrared spectroscopy and X-ray diffraction were employed to characterise the interactions. The lower critical solution temperature (LCST) of the swollen membrane was determined by differential scanning calorimetry. The morphologies of the obtained membranes were observed using SEM. The results showed that there was hydrogen bonding formed between CS and PNIPAAm. The LCST of the PNIPAAm/CS membranes was about 31.3-31.8 degrees C. Obvious phase conversion and shape change of the composite membrane can occur below and above the LCST, indicating that when the weight ratio of PNIPAAm to CS is 7 : 3 to 5 : 5, the composite membranes have the potential to be used as a smart artificial skin or wound dressings.
C1 [Li, Y.; Zhang, L.; Zuo, Y.; Yang, W. H.; Shen, J.; Li, Y.] Sichuan Univ, Res Ctr Nanobiomat Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
   [Li, Y.] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.
RP Li, Y (reprint author), Sichuan Univ, Res Ctr Nanobiomat Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
EM nic7504@scu.edu.cn
FU China 973 fund [2007CB936102]
FX This work was supported by China 973 fund (grant no. 2007CB936102).
CR ATNIP RG, 1985, CONT ORTHOP, V10, P13
   Bucio E, 2007, RADIAT PHYS CHEM, V76, P1724, DOI 10.1016/j.radphyschem.2007.02.109
   Chen J, 2007, RADIAT PHYS CHEM, V76, P1425, DOI 10.1016/j.radphyschem.2007.02.045
   Chen KS, 2005, MAT SCI ENG C-BIO S, V25, P472, DOI 10.1016/j.msec.2004.12.006
   Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008
   DOMARD A, 1983, INT J BIOL MACROMOL, V5, P49, DOI 10.1016/0141-8130(83)90078-8
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   King P, 2000, BURNS, V26, P501, DOI 10.1016/S0305-4179(99)00186-2
   Lafrance ML, 1999, TISSUE ENG, V5, P153, DOI 10.1089/ten.1999.5.153
   LI J, 2008, BIOMED MATER, V3, P1
   Liu YY, 2005, BIOMATERIALS, V26, P6367, DOI 10.1016/j.biomaterials.2005.04.011
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   Phillips TJ, 1998, ARCH DERMATOL, V134, P344, DOI 10.1001/archderm.134.3.344
   PHILLIPS TJ, 1990, J AM ACAD DERMATOL, V23, P189, DOI 10.1016/0190-9622(90)70197-P
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SHERIDAN RL, 1994, EUR J PLAST SURG, V17, P91
   VANSTRAELEN P, 1992, BURNS, V18, P145, DOI 10.1016/0305-4179(92)90014-L
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 21
TC 1
Z9 1
U1 2
U2 25
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD JUL
PY 2010
VL 14
IS 3
BP 252
EP 257
DI 10.1179/143307510X12719005364828
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 630YB
UT WOS:000280311000014
DA 2018-10-19
ER

PT J
AU He, W
   Chuang, A
   Cao, Z
   Liaw, PK
AF He, Wei
   Chuang, Andrew
   Cao, Zheng
   Liaw, Peter K.
TI Biocompatibility Study of Zirconium-Based Bulk Metallic Glasses for
   Orthopedic Applications
SO METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND
   MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT International Conference on Bulk Metallic Glasses held at the 2009 TMS
   Annual Meeting
CY 2009
CL San Francisco, CA
SP Minerals, Met & Mat Soc
ID MECHANICAL-PROPERTIES; CORROSION-RESISTANCE; BEHAVIOR; ALLOYS;
   CYTOTOXICITY; INTERFACE; PHOSPHATE; ADHESION
AB Bulk metallic glasses (BMGs) represent an emerging class of materials that offer an attractive combination of properties, such as high strength, low modulus, good fatigue limit, and near-net-shape formability. The BMGs have been explored in mechanical, chemical, and magnetic applications. However, little research has been attracted in the biomedical field. In this work, we study the potential of BMGs for the orthopedic repair and replacement. We report the biocompatibility study of zirconium (Zr)-based solid BMGs using mouse osteoblast cells. Cell attachment, proliferation, and differentiation are compared to Ti-6Al-4V, a well-studied alloy biomaterial. Our in-vitro study has demonstrated that cells cultured on the Zr-based BMG substrate showed higher attachment, alkaline phosphatase activity, and bone matrix deposition compared to those grown on the control Ti alloy substrate. Cytotoxicity staining also revealed the remarkable viability of cells growing on the BMG substrates.
C1 [He, Wei; Chuang, Andrew; Cao, Zheng; Liaw, Peter K.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [He, Wei] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
RP He, W (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM whe5@utk.edu
RI BAI, JIE/D-7448-2016; He, Wei/K-7218-2013
OI He, Wei/0000-0002-6638-9691
CR Barnard BR, 2008, CORROS SCI, V50, P2135, DOI 10.1016/j.corsci.2008.04.025
   BELLOWS CG, 1991, BONE MINER, V14, P27, DOI 10.1016/0169-6009(91)90100-E
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Brothers AH, 2007, MRS BULL, V32, P639, DOI 10.1557/mrs2007.126
   BRUNETTE DM, 2001, TITANIUM MED MAT SCI, P174
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Demetriou MD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.145702
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Gilbert CJ, 1997, APPL PHYS LETT, V71, P476, DOI 10.1063/1.119610
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Gundberg CM, 2000, CLIN LAB MED, V20, P489
   Hiromoto S, 2002, MATER TRANS, V43, P261, DOI 10.2320/matertrans.43.261
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   Inoue A, 2007, MRS BULL, V32, P651, DOI 10.1557/mrs2007.128
   Kulakov O B, 2005, Morfologiia, V127, P52
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   Liu YH, 2007, SCIENCE, V315, P1385, DOI 10.1126/science.1136726
   Morrison ML, 2005, J BIOMED MATER RES A, V74A, P430, DOI 10.1002/jbm.a.30361
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Schroers J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255506
   Spoerke ED, 2005, ACTA BIOMATER, V1, P523, DOI 10.1016/j.actbio.2005.04.005
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Wada T, 2004, MATER TRANS, V45, P2761, DOI 10.2320/matertrans.45.2761
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
NR 28
TC 26
Z9 26
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1073-5623
J9 METALL MATER TRANS A
JI Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.
PD JUL
PY 2010
VL 41A
IS 7
BP 1726
EP 1734
DI 10.1007/s11661-009-0150-5
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 600BQ
UT WOS:000277958700020
DA 2018-10-19
ER

PT J
AU Nova, A
   Keten, S
   Pugno, NM
   Redaelli, A
   Buehler, MJ
AF Nova, Andrea
   Keten, Sinan
   Pugno, Nicola M.
   Redaelli, Alberto
   Buehler, Markus J.
TI Molecular and Nanostructural Mechanisms of Deformation, Strength and
   Toughness of Spider Silk Fibrils
SO NANO LETTERS
LA English
DT Article
DE Nanomechanics; biological material; spider silk; protein; H-bond;
   nanostructure
ID DRAGLINE SILK; PROTEIN; ORIENTATION; MODEL; BIOMATERIAL; RESONANCE;
   FAILURE; LESSONS; DOMAINS; POLYMER
AB Spider dragline silk is one of the strongest, most extensible and toughest biological materials known, exceeding the properties of many engineered materials including steel Silk features a hierarchical architecture where highly organized, densely H-bonded beta-sheet nanocrystals are arranged within a semiamorphous protein matrix consisting of 3(1)-helices and beta-turn protein structures By using a bottom-up molecular-based approach, here we develop the first spider silk mesoscale model, bridging the scales from Angstroms to tens to potentially hundreds of nanometers We demonstrate that the specific nanoscale combination of a crystalline phase and a semiamorphous matrix is crucial to achieve the unique properties of silks Our results reveal that the superior mechanical properties of spider silk can be explained solely by structural effects, where the geometric confinement of beta-sheet nanocrystals. combined with highly extensible semiamorphous domains, is the key to reach great strength and great toughness, despite the dominance of mechanically inferior chemical interactions such as H-bonding Our model directly shows that semiamorphous regions govern the silk behavior at small deformation, unraveling first when silk is being stretched and leading to the large extensibility of the material Conversely, beta-sheet nanocrystals play a significant role in defining the mechanical behavior of silk at large-deformation In particular, the ultimate tensile strength of silk is controlled by the strength of beta-sheet nanocrystals, which is directly related to their size, where small beta-sheet nanocrystals are crucial to reach outstanding levels of strength and toughness Our results and mechanistic insight directly explain recent experimental results, where it was shown that a significant change in the strength and toughness of silk can be achieved solely by tuning the size of beta-sheet nanocrystals Our findings help to unveil the material design strategy that enables silk to achieve superior material performance despite simple and inferior material constituents This concept could lead to a new materials design paradigm, where enhanced functionality is not achieved using complex building blocks but rather through the utilization of simple repetitive constitutive elements arranged in hierarchical structures from nano to macro
C1 [Nova, Andrea; Keten, Sinan; Pugno, Nicola M.; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA.
   [Nova, Andrea; Redaelli, Alberto] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
   [Pugno, Nicola M.; Buehler, Markus J.] Politecn Torino, Dept Struct Engn & Geotech, Lab Bioinspired Nanomech Giuseppe Maria Pugno, I-10129 Turin, Italy.
   [Pugno, Nicola M.] Ist Nazl Fis Nucl, Nazl Frascati Lab, Natl Inst Nucl Phys, I-00044 Frascati, Italy.
   [Pugno, Nicola M.] Natl Inst Metrol Res INRIM, I-10135 Turin, Italy.
RP Buehler, MJ (reprint author), MIT, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RI Pugno, Nicola/C-2289-2014; Keten, Sinan/F-4080-2010; Buehler,
   Markus/C-4580-2008; redaelli, alberto/K-3137-2018
OI Buehler, Markus/0000-0002-4173-9659; redaelli,
   alberto/0000-0002-9020-2188
FU Office of Naval Research [N00014-08-1-00844]; MIT-Italy; National
   Science Foundation [CMMI-0642545, MRSEC DMR-0819762]; Army Research
   Office [W911NF-06-1-0291]; DARPA [HR0011-08-1-0067]; MIT Energy
   Initiative; METREGEN
FX This work was primarily supported by the Office of Naval Research
   (N00014-08-1-00844) Support from the MIT-Italy program (MITOR) is
   greatly acknowledged Additional support from the National Science
   Foundation (CMMI-0642545 and MRSEC DMR-0819762), Army Research Office
   (W911NF-06-1-0291), DARPA (HR0011-08-1-0067), and the MIT Energy
   Initiative is acknowledged N M P is supported by the METREGEN grant
   (2009-2012) "Metrology on a cellular and macromolecular scale for
   regenerative medicine" All simulations have been carried out at MIT's
   Laboratory for Atomistic and Molecular Mechanics
CR Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968
   Buehler MJ, 2010, REV MOD PHYS, V82, P1459, DOI 10.1103/RevModPhys.82.1459
   Buehler MJ, 2010, NAT NANOTECHNOL, V5, P172, DOI 10.1038/nnano.2010.28
   Buehler MJ, 2009, NAT MATER, V8, P175, DOI 10.1038/nmat2387
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   Eom K, 2003, J PHYS CHEM B, V107, P8730, DOI 10.1021/jp035178x
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   FOSSEY SA, 1991, BIOPOLYMERS, V31, P1529, DOI 10.1002/bip.360311309
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c
   Hartmann MA, 2009, NANO LETT, V9, P3603, DOI 10.1021/nl901816s
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Keten S., 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   KETEN S, 2010, J R SOC INTERFACE, DOI DOI 10.1098/RSIF.2010.0149
   Keten S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198301
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Krasnov I., 2008, PHYS REV LETT, V100
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Leduc PR, 2007, ADV MATER, V19, P3761, DOI 10.1002/adma.200701286
   Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Marszalek PE, 1999, NATURE, V402, P100
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Michal CA, 1998, J BIOMOL NMR, V12, P231, DOI 10.1023/A:1008286004222
   Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499
   Papadopoulos P, 2009, COLLOID POLYM SCI, V287, P231, DOI 10.1007/s00396-008-1968-x
   Philip M. C., 1994, POLYM ADVAN TECHNOL, V5, P401
   Porter D, 2008, SOFT MATTER, V4, P328, DOI 10.1039/b713972a
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   SULKOWSKA JI, 2007, J PHYS CONDENS MATT, V19, pR20
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Xiao SB, 2009, BIOPHYS J, V96, P3997, DOI 10.1016/j.bpj.2009.02.052
NR 47
TC 184
Z9 186
U1 14
U2 176
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD JUL
PY 2010
VL 10
IS 7
BP 2626
EP 2634
DI 10.1021/nl101341w
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 632IP
UT WOS:000280416200056
PM 20518518
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Zou, J
   Zhang, W
   Poe, D
   Qin, J
   Fornara, A
   Zhang, Y
   Ramadan, UA
   Muhammed, M
   Pyykko, I
AF Zou, Jing
   Zhang, Weikai
   Poe, Dennis
   Qin, Jjian
   Fornara, Andrea
   Zhang, Ya
   Ramadan, Usama Abo
   Muhammed, Mamoun
   Pyykko, Ilmari
TI MRI manifestation of novel superparamagnetic iron oxide nanoparticles in
   the rat inner ear
SO NANOMEDICINE
LA English
DT Article
DE animal; biological barrier; biomaterial; contrast agent inner ear
   fluids; MRI; nanoparticle; superparamagnetic iron oxide nanoparticles;
   tight junction
ID DTPA-BMA UPTAKE; IN-VIVO; ENDOLYMPHATIC HYDROPS; GUINEA-PIG; REISSNERS
   MEMBRANE; MENIERES-DISEASE; GENE TRANSCRIPTS; LIVE ANIMALS; COCHLEA;
   VISUALIZATION
AB Aim: Superparamagnetic iron oxide nanoparticles hierarchically coated with oleic acid and Pluronic F127 copolymers (POA@SPION) have shown exceptional 12 contrast enhancement. The aim of the present work was to investigate the MRI manifestation of POA@SPION in the inner ear. Materials & methods: A total of 26 male Wister rats were selected for testing POA@SPION administered through intracochlear, intratympanic and intravenous routes. MRI was performed with a 4.7 T MR scanner. Results & conclusion: POA@SPION can be introduced into the perilymph space, after which it becomes widely distributed and can demonstrate the integrity of the perilymph-endolymph barrier. Positive highlighting of the endolymph compartment against the darkened perilymph was visualized for the first time. POA@SPION passed through the middle-inner ear barriers in only small amounts, but stayed in the perilymph for 3 days. They did not traverse the blood-perilymph barrier or blood-endolymph barrier. The inner ear distribution of POA@SPION was confirmed by histology. POA@SPION is a promising T2 negative contrast agent.
C1 [Zou, Jing; Zhang, Weikai; Poe, Dennis; Zhang, Ya; Pyykko, Ilmari] Tampere Univ, Dept Otolaryngol, Tampere 33520, Finland.
   Royal Inst Technol, KTH, Funct Mat Div, S-16440 Stockholm, Sweden.
   Univ Cent Hosp, Dept Neurol, Expt MRI Lab, Helsinki, Finland.
RP Zou, J (reprint author), Tampere Univ, Dept Otolaryngol, FM1,3rd Floor,Bakatu 6, Tampere 33520, Finland.
EM zoujinghb@hotmial.com
RI Fornara, Andrea/L-4974-2013
OI Fornara, Andrea/0000-0001-6636-1958
FU European Community [NMP4-CT-2006-026556]
FX This study was supported by the European Community 6th Framework
   Programme on Research, Technological Development and Demonstration
   (Nanotechnology-based Targeted Drug Delivery Contract number
   NMP4-CT-2006-026556, Project acronym NANOEAR) The authors have no other
   relevant affiliations in financial involvement with any organization or
   entity with a financial interest in or financial conflict with the
   subject matter or materials discussed m the manuscript apart from those
   disclosed
CR CHEPER V, 2009, NANOMEDICINE-UK, V4, P623
   Counter SA, 1999, NEUROREPORT, V10, P473, DOI 10.1097/00001756-199902250-00006
   Counter SA, 2003, NEUROREPORT, V14, P1707, DOI 10.1097/01.wnr.0000088599.08608.a5
   Counter SA, 2000, NEUROREPORT, V11, P3979, DOI 10.1097/00001756-200012180-00015
   Flock A, 2003, AUDIOL NEURO-OTOL, V8, P59, DOI 10.1159/000069002
   FRAYSSE BG, 1980, ANN OTO RHINOL LARYN, V89, P2
   JOHNSTON T P, 1985, Journal of Parenteral Science and Technology, V39, P83
   KABANOV AN, KHIRURGIA, V1985, P141
   Kabanov AV, 2003, ADV DRUG DELIVER REV, V55, P151, DOI 10.1016/S0169-409X(02)00176-X
   Kakigi A, 2008, ACTA OTO-LARYNGOL, V128, P841, DOI 10.1080/00016480701769776
   KONISHI T, 1982, ACTA OTO-LARYNGOL, V94, P395, DOI 10.3109/00016488209128927
   Liaw J, 2000, J CONTROL RELEASE, V68, P273, DOI 10.1016/S0168-3659(00)00268-6
   Liu CH, 2008, FASEB J, V22, P1193, DOI 10.1096/fj.07-9557com
   Liu CH, 2007, FASEB J, V21, P3004, DOI 10.1096/fj.07-8203com
   Liu CH, 2007, J NEUROSCI, V27, P713, DOI 10.1523/JNEUROSCI.4660-06.2007
   Liu CH, 2009, J NEUROSCI, V29, P3508, DOI 10.1523/JNEUROSCI.5332-08.2009
   Mahmoudi M, 2009, J COLLOID INTERF SCI, V336, P510, DOI 10.1016/j.jcis.2009.04.046
   Mahmoudi M, 2009, J PHYS CHEM C, V113, P2322, DOI 10.1021/jp809453v
   MARK AS, 1992, ANN OTO RHINOL LARYN, V101, P459, DOI 10.1177/000348949210100601
   NALBANDIAN RM, 1987, J BIOMED MATER RES, V21, P1135, DOI 10.1002/jbm.820210907
   *NAN, 2009, 3G NAN BAS TARG DRUG
   Qin J, 2007, ADV MATER, V19, P1874, DOI 10.1002/adma.200602326
   Rask-Andersen H, 2006, EAR HEARING, V27, P457, DOI 10.1097/01.aud.0000233864.32183.81
   Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4
   Smith BR, 2007, BIOMED MICRODEVICES, V9, P719, DOI 10.1007/s10544-007-9081-3
   Sosnovik DE, 2008, BASIC RES CARDIOL, V103, P122, DOI 10.1007/s00395-008-0710-7
   Thakral C, 2009, J CUTAN PATHOL, V36, P1244, DOI 10.1111/j.1600-0560.2009.01283.x
   Valk WL, 2006, ACTA OTO-LARYNGOL, V126, P1030, DOI 10.1080/00016480600621722
   Zou J, 2005, AUDIOL NEURO-OTOL, V10, P145, DOI 10.1159/000084024
   Zou J, 2005, HEARING RES, V202, P13, DOI 10.1016/j.heares.2004.10.008
   Zou J, 2003, ANN OTO RHINOL LARYN, V112, P1059, DOI 10.1177/000348940311201212
   ZOU J, 2010, OTOL NEUROT IN PRESS
   Zou J, 2008, J BIOMED MATER RES B, V87B, P10, DOI 10.1002/jbm.b.31058
   Zou Jing, 2010, Hear Res, V259, P36, DOI 10.1016/j.heares.2009.09.015
   Zou J, 2009, ACTA OTO-LARYNGOL, V129, P22, DOI 10.1080/00016480902729850
NR 35
TC 15
Z9 18
U1 0
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD JUL
PY 2010
VL 5
IS 5
BP 739
EP 754
DI 10.2217/NNM.10.45
PG 16
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 632UM
UT WOS:000280454400015
PM 20662645
DA 2018-10-19
ER

PT J
AU Rustad, KC
   Sorkin, M
   Levi, B
   Longaker, MT
   Gurtner, GC
AF Rustad, Kristine C.
   Sorkin, Michael
   Levi, Benjamin
   Longaker, Michael T.
   Gurtner, Geoffrey C.
TI Strategies for organ level tissue engineering
SO ORGANOGENESIS
LA English
DT Review
DE tissue engineering; biomaterials; stem cells; adipose-derived stromal
   cells; growth factors; regenerative medicine; scale up
ID HUMAN ADIPOSE-TISSUE; PLURIPOTENT STEM-CELLS; MARROW STROMAL CELLS; VIVO
   BONE-FORMATION; IN-VIVO; NERVE REGENERATION; CALVARIAL DEFECTS; HUMAN
   FIBROBLASTS; SMOOTH-MUSCLE; DIFFERENTIATION
AB The field of tissue engineering has made considerable strides since it was first described in the late 1980s. The advent and subsequent boom in stem cell biology, emergence of novel technologies for biomaterial development, and further understanding of developmental biology have contributed to this accelerated progress. However, continued efforts to translate tissue-engineering strategies into clinical therapies have been hampered by the problems associated with scaling up laboratory methods to produce large, complex tissues. The significant challenges faced by tissue engineers include the production of an intact vasculature within a tissue-engineered construct and recapitulation of the size and complexity of a whole organ. Here we review the basic components necessary for bioengineering organs-biomaterials, cells and bioactive molecules-and discuss various approaches for augmenting these principles to achieve organ level tissue engineering. Ultimately, the successful translation of tissue-engineered constructs into everyday clinical practice will depend upon the ability of the tissue engineer to "scale up" every aspect of the research and development process.
C1 [Rustad, Kristine C.; Sorkin, Michael; Levi, Benjamin; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.
RP Gurtner, GC (reprint author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.
EM ggurtner@stanford.edu
CR ASAKAWA N, 2010, BIOMATERIALS
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003
   BAPTISTA PM, 2009, C P IEEE ENG MED BIO, V1, P6526
   Bartolovic K, 2010, ANALYST, V135, P157, DOI 10.1039/b917813a
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Chang EI, 2009, FASEB J, V23, P906, DOI 10.1096/fj.08-114868
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Geutjes PJ, 2010, PROTEIN EXPRES PURIF, V69, P76, DOI 10.1016/j.pep.2009.08.015
   GRONTHOS S, 1994, BLOOD, V84, P4164
   Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Halvorsen YC, 2000, INT J OBESITY, V24, P41
   Hammerick KE, 2010, TISSUE ENG PT A, V16, P917, DOI [10.1089/ten.tea.2009.0267, 10.1089/ten.TEA.2009.0267]
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hardwicke J, 2008, SURG-J R COLL SURG E, V6, P172, DOI 10.1016/S1479-666X(08)80114-X
   HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   Jayasinghe SN, 2007, NANOMEDICINE-UK, V2, P555, DOI 10.2217/17435889.2.4.555
   Joung YK, 2008, EXPERT OPIN DRUG DEL, V5, P1173, DOI 10.1517/17425240802431811 
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   KATO R, 2010, TISSUE ENG C
   Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0
   Kulakov AA, 2008, B EXP BIOL MED+, V146, P522, DOI 10.1007/s10517-009-0322-8
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   LEVI B, 2009, PLOS ONE UNPUB
   Li WQ, 2010, J CELL PHYSIOL, V222, P492, DOI 10.1002/jcp.22000
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Malladi P., 2006, AM J PHYSIOL-CELL PH, V94305, P1139
   Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101
   Martinez-Fernandez A, 2009, CIRC RES, V105, P648, DOI 10.1161/CIRCRESAHA.109.203109
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Moya ML, 2009, MICROVASC RES, V78, P142, DOI 10.1016/j.mvr.2009.06.006
   Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98
   NAGAOKA M, 2010, ANN BIOMED ENG
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Ogawa Rei, 2004, Journal of Nippon Medical School, V71, P240, DOI 10.1272/jnms.71.240
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pang YG, 2010, BIOMATERIALS, V31, P878, DOI 10.1016/j.biomaterials.2009.10.007
   Pera MF, 2008, NATURE, V451, P135, DOI 10.1038/451135a
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   PRAMATAROV I., 1965, GIG TR PROF ZABOLEVANIYA, V9, P41
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   Quarto N, 2008, GENE, V424, P130, DOI 10.1016/j.gene.2008.07.029
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   Roessner ED, 2009, J BIOMATER APPL
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   RUSSELL PS, 1985, ANN SURG, V201, P255, DOI 10.1097/00000658-198503000-00001
   SAHOO S, 2010, BIOTECHNOL BIOENG
   Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   SUTHERLAND DER, 1977, SURGERY, V82, P124
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thangarajah H, 2009, STEM CELLS, V27, P266, DOI 10.1634/stemcells.2008-0276
   U.S. Department of Health and Human Services, 2008, ORG PROC TRANSPL NET
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   Visconti RP, 2010, EXPERT OPIN BIOL TH, V10, P409, DOI 10.1517/14712590903563352
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Xu Y, 2007, BIOCHEM BIOPH RES CO, V359, P311, DOI 10.1016/j.bbrc.2007.05.098
   Yanaga H, 2009, PLAST RECONSTR SURG, V124, P817, DOI 10.1097/PRS.0b013e3181b17c0e
   Yang M, 2005, CYTOTHERAPY, V7, P273, DOI 10.1080/14653240510027244
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhang XJ, 2009, BIOMATERIALS, V30, P2666, DOI 10.1016/j.biomaterials.2009.01.018
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 94
TC 47
Z9 49
U1 2
U2 37
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1547-6278
J9 ORGANOGENESIS
JI Organogenesis
PD JUL-SEP
PY 2010
VL 6
IS 3
BP 151
EP 157
DI 10.4161/org.6.3.12139
PG 7
WC Biochemistry & Molecular Biology; Developmental Biology; Engineering,
   Biomedical
SC Biochemistry & Molecular Biology; Developmental Biology; Engineering
GA 759RO
UT WOS:000290266200003
PM 21197216
OA Green Published
DA 2018-10-19
ER

PT J
AU Davies, JE
   Matta, R
   Mendes, VC
   de Carvalho, PSP
AF Davies, John E.
   Matta, Rano
   Mendes, Vanessa C.
   Perri de Carvalho, Paulo S.
TI Development, characterization and clinical use of a biodegradable
   composite scaffold for bone engineering in oro-maxillo-facial surgery
SO ORGANOGENESIS
LA English
DT Review
DE bone regeneration; scaffold; composite; biodegradable; clot retention;
   osteoconduction; cell delivery; extraction socket; sinus lift; clinical
ID BOVINE BONE; TISSUE
AB We have developed a biodegradable composite scaffold for bone tissue engineering applications with a pore size and interconnecting macroporosity similar to those of human trabecular bone. The scaffold is fabricated by a process of particle leaching and phase inversion from poly(lactide-co-glycolide) (PLGA) and two calcium phosphate (CaP) phases both of which are resorbable by osteoclasts; the first a particulate within the polymer structure and the second a thin ubiquitous coating. The 3-5 mu m thick osteoconductive surface CaP abrogates the putative foreign body giant cell response to the underlying polymer, while the internal CaP phase provides dimensional stability in an otherwise highly compliant structure. The scaffold may be used as a biomaterial alone, as a carrier for cells or a three-phase drug delivery device. Due to the highly interconnected macroporosity ranging from 81% to 91%, with macropores of 0.8 similar to 1.8 mm, and an ability to wick up blood, the scaffold acts as both a clot-retention device and an osteoconductive support for host bone growth. As a cell delivery vehicle, the scaffold can be first seeded with human mesenchymal cells which can then contribute to bone formation in orthotopic implantation sites, as we show in immune-compromised animal hosts. We have also employed this scaffold in both lithomorph and particulate forms in human patients to maintain alveolar bone height following tooth extraction, and augment alveolar bone height through standard sinus lift approaches. We provide a clinical case report of both of these applications; and we show that the scaffold served to regenerate sufficient bone tissue in the wound site to provide a sound foundation for dental implant placement. At the time of writing, such implants have been in occlusal function for periods of up to 3 years in sites regenerated through the use of the scaffold.
C1 [Davies, John E.; Matta, Rano; Mendes, Vanessa C.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Davies, John E.] Univ Toronto, Fac Dent, Toronto, ON, Canada.
   [Perri de Carvalho, Paulo S.] Univ Estadual Paulista, Fac Dent, Sao Paulo, Brazil.
   [Perri de Carvalho, Paulo S.] Univ Sao Paulo, Sao Paulo, Brazil.
RP Davies, JE (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
EM davies@ecf.utoronto.ca
RI de Carvalho, Paulo Sergio/H-4279-2012
FU BoneTec Corporation; Ontario Research and Development Challenge Fund
   (ORDCF); Canadian Institutes for Health Research
FX The authors acknowledge the generous help of Limin Guan who fabricated
   all the scaffolds for our studies, and the financial support from
   BoneTec Corporation, the Ontario Research and Development Challenge Fund
   (ORDCF grant to J.E.D) and the Canadian Institutes for Health Research
   (industry-partnered CIHR scholarship awarded to V.C.M).
CR Davies J.E., 2000, BONE ENG, P1
   DAVIES JE, 2000, TISSUE ENG THERAPEUT, V4, P15
   Davies John E, 2003, J Dent Educ, V67, P932
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   HOLY CE, 1999, THESIS U TORONTO CAN
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Krekmanov L, 2000, INT J ORAL MAX IMPL, V15, P405
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Lickorish D, 2004, Eur Cell Mater, V8, P12
   LICKORISH D, 2004, EUR CELLS MATER, V8, P20
   MATTA R, 2009, THESIS U TORONTO CAN
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
NR 20
TC 29
Z9 33
U1 1
U2 12
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1547-6278
J9 ORGANOGENESIS
JI Organogenesis
PD JUL-SEP
PY 2010
VL 6
IS 3
BP 161
EP 166
DI 10.4161/org.6.3.12392
PG 6
WC Biochemistry & Molecular Biology; Developmental Biology; Engineering,
   Biomedical
SC Biochemistry & Molecular Biology; Developmental Biology; Engineering
GA 759RO
UT WOS:000290266200005
PM 21197218
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Rossi, CA
   Pozzobon, M
   De Coppi, P
AF Rossi, Carlo Alberto
   Pozzobon, Michela
   De Coppi, Paolo
TI Advances in musculoskeletal tissue engineering Moving towards therapy
SO ORGANOGENESIS
LA English
DT Review
DE tissue engineering; muscle; stem cell; satellite cell; biomaterial;
   niche; reconstruction
ID MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE REGENERATION; DUCHENNE
   MUSCULAR-DYSTROPHY; SATELLITE CELLS; CHONDROGENIC DIFFERENTIATION;
   GENE-THERAPY; MYOBLAST TRANSPLANTATION; MESODERMAL TISSUES; IN-SITU;
   HYDROGELS
AB Skeletal muscle can self-repair, but is unable to restore significant tissue loss, as consequence of trauma, congenital defects, tumor ablation or denervation. Intramuscular injection of autologous or allogenic derived myogenic cells (namely satellite cells and myoblasts) did not lead to efficient regeneration because of poor cell retention and survival, as well as immunorejection. In the last decade, tissue engineering looked at overcoming these problems by investigating alternative treatment options, i.e., the suspension of myogenic precursors in temporary matrix, formed by biodegradable and biocompatible materials. This approach allows to engineer custom architectured preconditioned implants, and locally deliver paracrine factors.
   This article reviews current and potential strategies for the repair of damaged muscle and suggests some innovative approaches for the translation to the clinical setting.
C1 [Rossi, Carlo Alberto; De Coppi, Paolo] UCL Inst Child Hlth, Surg Unit, London, England.
   [Rossi, Carlo Alberto; De Coppi, Paolo] Great Ormond St Hosp Sick Children, London, England.
   [Rossi, Carlo Alberto; Pozzobon, Michela; De Coppi, Paolo] Univ Padua, Dept Pediat, Stem Cell Proc Lab, Padua, Italy.
RP De Coppi, P (reprint author), UCL Inst Child Hlth, Surg Unit, London, England.
EM p.decoppi@ich.ucl.ac.uk
RI Pozzobon, Michela/G-7974-2018
OI Pozzobon, Michela/0000-0001-9213-402X; De Coppi,
   Paolo/0000-0002-1659-0207
FU Great Ormond Street Hospital Childrens Charity [V1230]
CR Acarturk TO, 1999, J BIOMED MATER RES, V44, P355, DOI 10.1002/(SICI)1097-4636(19990315)44:4<355::AID-JBM1>3.3.CO;2-2
   Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533
   BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212
   Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113
   Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Deans TL, 2009, CURR OPIN BIOTECH, V20, P537, DOI 10.1016/j.copbio.2009.10.005
   Deasy BM, 2002, CURR OPIN MOL THER, V4, P382
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   DiEdwardo CA, 1999, CLIN PLAST SURG, V26, P647
   El Oakley RM, 1998, J THORAC CARDIOV SUR, V115, P1
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085
   Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Law PK, 1997, TRANSPL P, V29, P2234, DOI 10.1016/S0041-1345(97)00312-6
   LAW PK, 1993, CELL TRANSPLANT, V2, P485, DOI 10.1177/096368979300200607
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U
   Minasi MG, 2002, DEVELOPMENT, V129, P2773
   MITCHELL KJ, 2010, NAT CELL BI IN PRESS
   Molgo J, 2004, BIOL RES, V37, P635, DOI 10.4067/S0716-97602004000400019
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   PITTENGER MF, 1999, SCIENCE, V284, P333
   Powell C, 1999, HUM GENE THER, V10, P565, DOI 10.1089/10430349950018643
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Prelle K, 2000, BIOCHEM BIOPH RES CO, V277, P631, DOI 10.1006/bbrc.2000.3737
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9
   RANDO TA, 1995, EXP CELL RES, V220, P383, DOI 10.1006/excr.1995.1329
   ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773
   ROSSI CA, ISSCR C 2009
   Rossi CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008523
   SACCO A, 2008, NATURE, V456, P503
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016
   Tatsumi R., 2006, AM J PHYSIOL-CELL PH, V290, P1487
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064
   Vandenburgh HH, 2002, ANN NY ACAD SCI, V961, P201, DOI 10.1111/j.1749-6632.2002.tb03083.x
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   WONG DJ, 2008, CELL STEM CELL, V284, P143
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
NR 62
TC 58
Z9 59
U1 1
U2 21
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1547-6278
J9 ORGANOGENESIS
JI Organogenesis
PD JUL-SEP
PY 2010
VL 6
IS 3
BP 167
EP 172
DI 10.4161/org.6.3.12419
PG 6
WC Biochemistry & Molecular Biology; Developmental Biology; Engineering,
   Biomedical
SC Biochemistry & Molecular Biology; Developmental Biology; Engineering
GA 759RO
UT WOS:000290266200006
PM 21197219
OA Bronze
DA 2018-10-19
ER

PT J
AU Wang, JY
   Zhang, DM
   Liu, F
   Yu, XX
   Zhao, CS
   Wan, CX
AF Wang, Jianyun
   Zhang, Dongming
   Liu, Fei
   Yu, Xixun
   Zhao, Changsheng
   Wan, Changxiu
TI Structure and properties of chitosan derivatives modified calcium
   polyphosphate scaffolds
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Calcium polyphosphate; Chitosan derivatives; Alginate dialdehyde;
   Degradation; Non-cytotoxicity
ID BONE SUBSTITUTE APPLICATIONS; IN-VITRO; CARBOXYMETHYL-CHITOSAN;
   MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS; PHYSICAL-PROPERTIES; GROWTH;
   FILMS; DEGRADATION; CARTILAGE
AB Organic and inorganic composite material is becoming a solution on making the mechanical and degradation properties of biomaterial more suited. Porous calcium polyphosphate was immersed into different concentrations of carboxymethyl chitosan before immersing 10% alginate dialdegyde. After freeze-drying, the scaffolds were performed in physiologic saline. At stated day, the weightloss. Ca(2+) concentration, pH value and morphology were measured. The biocompatibility of the composite was demonstrated by extract and direct contact tests. As the results showed, the degradation rates of composites were faster, and the compressive strength became bigger because of the cross-linked network formed by Carboxymethyl chitosan (CMC) and alginate dialdehyde (ADA). The pH value of composite was higher than that of calcium polyphosphate (CPP) due to the organic part of composite's pH was in slight alkaline. From the SEM, the cross-linked network structure could be observed clearly. Because the glycosaminoglycans-like chains in CMC molecules, which are typically presented in extracellular matrix (ECM), extractions of composite material gave the cells good adhesion and growth condition. All the results testified the composite scaffold was a good candidate for bone repair. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Wang, Jianyun; Zhang, Dongming; Liu, Fei; Yu, Xixun; Zhao, Changsheng; Wan, Changxiu] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Sichuan, Peoples R China.
   [Wang, Jianyun; Liu, Fei; Yu, Xixun] Sichuan Univ, Suzhou Inst, Suzhou 215123, Peoples R China.
RP Wan, CX (reprint author), Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Sichuan, Peoples R China.
EM wanchangxiu@163.com
FU National Science Foundation of China [30870614, 30870616]; National
   Science Foundation of Jiangsu Province, China [BK2008152]
FX This work was supported by the National Science Foundation of China
   (No.30870614 and No. 30870616) and National Science Foundation of
   Jiangsu Province, China (BK2008152). SEMs were provided by the Center of
   Forecasting and Analysis of Sichuan University.
CR Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   FILIAGGI MJ, 1998, CONDENSED CALCIUM PH, V11, P341
   Gross KA, 2004, BIOMATERIALS, V25, P4955, DOI 10.1016/j.biomaterials.2004.01.046
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jennifer LM, 2009, BIOMATERIALS, V30, P2675
   Jin J, 2004, BIOMACROMOLECULES, V5, P162, DOI 10.1021/bm034286m
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   Kang HS, 2007, J APPL POLYM SCI, V103, P386, DOI 10.1002/app.24623
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   LAUREN EJ, 2005, CHEM MATER, V17, P4642
   Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   Oprea S, 2002, EUR POLYM J, V38, P1465, DOI 10.1016/S0014-3057(02)00003-4
   Park MS, 1998, DENT MATER, V14, P137, DOI 10.1016/S0109-5641(98)00020-7
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Qiu K, 2006, J MATER SCI, V41, P2429, DOI 10.1007/s10853-006-5182-2
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Qiu K, 2005, KEY ENG MAT, V288-289, P553, DOI 10.4028/www.scientific.net/KEM.288-289.553
   SONG W, 2008, J BIOMED MATER RES B, V89, P430
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wang LC, 2008, J POLYM SCI POL PHYS, V46, P1419, DOI 10.1002/polb.21475
   Wendt D, 2005, J BIOSCI BIOENG, V100, P489, DOI 10.1263/jbb.100.489
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
NR 26
TC 6
Z9 6
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JUL
PY 2010
VL 95
IS 7
BP 1205
EP 1210
DI 10.1016/j.polymdegradstab.2010.04.004
PG 6
WC Polymer Science
SC Polymer Science
GA 618XE
UT WOS:000279388600009
DA 2018-10-19
ER

PT J
AU Beachley, V
   Wen, XJ
AF Beachley, Vince
   Wen, Xuejun
TI Polymer nanofibrous structures: Fabrication, biofunctionalization, and
   cell interactions
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Polymer; Nanofiber; Scaffold; Biomaterial; Tissue engineering;
   Regeneration; Electrospinning; Phase Separation; Self assembly
ID ASSEMBLING PEPTIDE NANOFIBER; MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERING
   SCAFFOLDS; BIODEGRADABLE POLY(EPSILON-CAPROLACTONE) NANOWIRES;
   HEMATOPOIETIC STEM/PROGENITOR CELLS; GUIDED BONE REGENERATION; IN-VITRO;
   EXTRACELLULAR-MATRIX; ELECTROSPUN NANOFIBERS; HYALURONIC-ACID
AB Extracellular matrix fibers (ECM) such as collagen, elastin, and keratin provide biological and physical support for cell attachment, proliferation, migration, differentiation and ultimately cell fate. Therefore, ECM fibers are an important component in tissue and organ development and regeneration. Meanwhile, polymer nanofibers could play the same critical role in tissue regeneration process. Fibrous structures can be fabricated from a variety of materials and methods with diameters ranging throughout the size scale where cells can sense individual fibers (several nanometers to several microns). Polymer nanofiber scaffolds can be designed in a way that predictably modulates a variety of important cell behaviors towards a desired overall function. The nanofibrous topography itself, independent of the fiber material, has demonstrated the potential to modulate cell behaviors desirable in tissue engineering such as: unidirectional alignment; increased viability, attachment, and ECM production; guided migration; and controlled differentiation. The versatility of polymer nanofibers for functionalization with biomolecules opens the door to vast opportunities for the design of tissue engineering scaffolds with even greater control over cell incorporation and function. Despite the promise of polymer nanofibers as tissue engineering scaffolds there have been few clinically relevant successes because no single fabrication technique currently combines control over structural arrangement, material composition, and biofunctionalization, while maintaining reasonable cost and yield. Promising strategies are currently being investigated to allow for the fabrication of optimal polymer nanofiber tissue engineering scaffolds with the goal of treating damaged and degenerated tissues in a clinical setting. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Beachley, Vince; Wen, Xuejun] Clemson Univ, Dept Bioengn, Clemson MUSC Bioengn Program, Charleston, SC 29425 USA.
   [Wen, Xuejun] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA.
   [Wen, Xuejun] Med Univ S Carolina, Dept Orthoped Surg, Charleston, SC 29425 USA.
   [Wen, Xuejun] Tongji Univ, Inst Adv Mat & Nanobiomed iNANO, Shanghai 200072, Peoples R China.
RP Wen, XJ (reprint author), Clemson Univ, Dept Bioengn, Clemson MUSC Bioengn Program, 173 Ashley Ave,CRI 605B, Charleston, SC 29425 USA.
EM xjwen@clemson.edu
FU NIH/NINDS USA [R01 NS050243]; American Heart Association [09PRE2060154]
FX This work was made possible by the NIH/NINDS USA (R01 NS050243) and
   American Heart Association (09PRE2060154).
CR *A BROOK FARMS, 2009, LARG 3 3 BAL BRIGHT
   Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029
   Araujo JV, 2008, J BIOMAT SCI-POLYM E, V19, P1261, DOI 10.1163/156856208786052335
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Bakowsky U, 2002, BIOCHEMISTRY-US, V41, P4704, DOI 10.1021/bi0117596
   Balguid A, 2009, TISSUE ENG PT A, V15, P437, DOI 10.1089/ten.tea.2007.0294
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Beachley V, 2009, MAT SCI ENG C-MATER, V29, P2448, DOI 10.1016/j.msec.2009.07.008
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Brown EE, 2007, BIOMACROMOLECULES, V8, P3074, DOI 10.1021/bm700448x
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   Catledge SA, 2007, BIOMED MATER, V2, P142, DOI 10.1088/1748-6041/2/2/013
   Chen F, 2008, J BIOMAT SCI-POLYM E, V19, P677, DOI 10.1163/156856208784089661
   Chen JL, 2006, J BIOMED MATER RES A, V79A, P307, DOI 10.1002/jbm.a.30799
   Chen M, 2007, TISSUE ENG, V13, P579, DOI 10.1089/ten.2006.0205
   Chen ZCC, 2008, J BIOMAT SCI-POLYM E, V19, P693, DOI 10.1163/156856208784089580
   Chew SY, 2006, NANOTECHNOLOGY, V17, P3880, DOI 10.1088/0957-4484/17/15/045
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chu XH, 2009, BIOTECHNOL LETT, V31, P347, DOI 10.1007/s10529-008-9892-1
   Chua KN, 2007, EXP HEMATOL, V35, P771, DOI 10.1016/j.exphem.2007.02.002
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   da Silva MA, 2009, TISSUE ENG PT A, V15, P377, DOI 10.1089/ten.tea.2007.0327
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Deng XL, 2007, J BIOMAT SCI-POLYM E, V18, P117, DOI 10.1163/156856207779146123
   Dong YX, 2008, TISSUE ENG PT A, V14, P1321, DOI 10.1089/ten.tea.2007.0395
   Duan Y, 2007, J BIOMAT SCI-POLYM E, V18, P1153, DOI 10.1163/156856207781554019
   Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Erisken C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/16/165302
   Fan YM, 2008, BIOMACROMOLECULES, V9, P1919, DOI 10.1021/bm800178b
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   Finne-Wistrand A, 2008, MACROMOL BIOSCI, V8, P951, DOI 10.1002/mabi.200700328
   FISCHER TH, 2008, BIOMED MATER, V3
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   GAUTHAMAN K, J CELL MOL IN PRESS
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Grimm S, 2008, NANO LETT, V8, P1954, DOI 10.1021/nl080842c
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Han I, 2007, ARTIF ORGANS, V31, P801, DOI 10.1111/j.1525-1594.2007.00466.x
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hashemi SM, 2009, CELLS TISSUES ORGANS, V190, P135, DOI 10.1159/000187716
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   He W, 2009, J BIOMED MATER RES A, V90A, P205, DOI 10.1002/jbm.a.32081
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hosseinkhani H, 2007, TISSUE ENG, V13, P11, DOI 10.1089/ten.2006.0120
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Inanc B, 2009, J BIOMED MATER RES A, V90A, P186, DOI 10.1002/jbm.a.32066
   Inoguchi H, 2006, BIOMATERIALS, V27, P1470, DOI 10.1016/j.biomaterials.2005.08.029
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Jang J, 2005, ADV MATER, V17, P1616, DOI 10.1002/adma.200401909
   Janjanin S, 2008, J SURG RES, V149, P47, DOI 10.1016/j.jss.2007.12.788
   Jeong HE, 2006, NANO LETT, V6, P1508, DOI 10.1021/nl061045m
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P328, DOI 10.1002/mabi.200700107
   Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Ji Y, 2006, MACROMOL BIOSCI, V6, P811, DOI 10.1002/mabi.200600132
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Jing XL, 2007, ULTRASON SONOCHEM, V14, P75, DOI 10.1016/j.ultsonch.2006.02.001
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Ki CS, 2007, J APPL POLYM SCI, V106, P3922, DOI 10.1002/app.26914
   Kim HW, 2008, J BIOMED MATER RES A, V87A, P25, DOI 10.1002/jbm.a.31677
   Kim HW, 2008, J BIOMED MATER RES A, V85A, P651, DOI 10.1002/jbm.a.31339
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P698, DOI 10.1002/jbm.a.30848
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Kong H, 2006, CHEM COMMUN, P3010, DOI 10.1039/b605286j
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208
   Leong MF, 2009, J BIOMED MATER RES A, V89A, P1040, DOI 10.1002/jbm.a.32061
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li D, 2009, ACCOUNTS CHEM RES, V42, P135, DOI 10.1021/ar800080n
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2008, TISSUE ENG PT A, V14, P639, DOI 10.1089/tea.2007.0136
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Li XM, 2009, J BIOMED MATER RES A, V91A, P132, DOI 10.1002/jbm.a.32203
   Li XQ, 2009, J BIOMED MATER RES A, V91A, P878, DOI 10.1002/jbm.a.32286
   Liu DJ, 2003, MACROMOLECULES, V36, P8489, DOI 10.1021/ma0348573
   Liu GJ, 1997, ADV MATER, V9, P437, DOI 10.1002/adma.19970090517
   Liu Y, 2009, J BIOMED MATER RES A, V90A, P1092, DOI 10.1002/jbm.a.32165
   Loscertales IG, 2004, J AM CHEM SOC, V126, P5376, DOI 10.1021/ja049443j
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma K, 2008, BIOMATERIALS, V29, P2096, DOI 10.1016/j.biomaterials.2008.01.024
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Mankidy PJ, 2006, CHEM COMMUN, P1139, DOI 10.1039/b514600c
   Maretschek S, 2008, J CONTROL RELEASE, V127, P180, DOI 10.1016/j.jconrel.2008.01.011
   Matsuda T, 2005, J BIOMED MATER RES A, V73A, P125, DOI 10.1002/jbm.a.30260
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   McManus M, 2007, BIOMED MATER, V2, P257, DOI 10.1088/1748-6041/2/4/008
   McManus MC, 2007, J BIOMED MATER RES A, V81A, P299, DOI 10.1002/jbm.a.30989
   MENG H, 2009, BIOMED MAT RES B, V89, P379
   Meng J, 2009, J BIOMED MATER RES A, V88A, P105, DOI 10.1002/jbm.a.31862
   Meng W, 2008, J MATER SCI-MATER M, V19, P2799, DOI 10.1007/s10856-007-3356-3
   Meng W, 2007, J BIOMAT SCI-POLYM E, V18, P81, DOI 10.1163/156856207779146114
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   NAIN AS, 2006, APPL PHYS LETT, V89
   Nair S, 2007, BIOMACROMOLECULES, V8, P1266, DOI 10.1021/bm061004k
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P111, DOI 10.3727/000000008783907125
   Navarro-Alvarez N, 2006, CELL TRANSPLANT, V15, P921, DOI 10.3727/000000006783981387
   Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   Nottelet B, 2009, J BIOMED MATER RES A, V89A, P865, DOI 10.1002/jbm.a.32023
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Ohkawa K, 2006, BIOMACROMOLECULES, V7, P3291, DOI 10.1021/bm0604395
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Park SH, 2008, ACTA BIOMATER, V4, P1198, DOI 10.1016/j.actbio.2008.03.019
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Pietramaggiori G, 2008, J TRAUMA, V64, P803, DOI 10.1097/01.ta.0000244382.13937.a8
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Powell HM, 2008, J BIOMED MATER RES A, V84A, P1078, DOI 10.1002/jbm.a.31498
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Qi HX, 2006, BIOMACROMOLECULES, V7, P2327, DOI 10.1021/bm060264z
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   Rollings DAE, 2007, LANGMUIR, V23, P5275, DOI 10.1021/la063604a
   Rubenstein D, 2007, MICROCIRCULATION, V14, P723, DOI 10.1080/107396807014173
   Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712
   Sanders EH, 2003, MACROMOLECULES, V36, P3803, DOI 10.1021/ma021771l
   Sangsanoh P, 2007, BIOMACROMOLECULES, V8, P1587, DOI 10.1021/bm061152a
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Sargeant TD, 2008, J TISSUE ENG REGEN M, V2, P455, DOI 10.1002/term.117
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song JH, 2008, J MATER SCI-MATER M, V19, P95, DOI 10.1007/s10856-007-3169-4
   SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3
   Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z
   Stankus JJ, 2007, BIOMATERIALS, V28, P2738, DOI 10.1016/j.biomaterials.2007.02.012
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Taepaiboon P, 2007, EUR J PHARM BIOPHARM, V67, P387, DOI 10.1016/j.ejpb.2007.03.018
   Tao SL, 2007, NANO LETT, V7, P1463, DOI 10.1021/nl0700346
   Teo WE, 2008, CURR NANOSCI, V4, P361, DOI 10.2174/157341308786306080
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Valmikinathan CM, 2008, J NEURAL ENG, V5, P422, DOI 10.1088/1741-2560/5/4/007
   van Aalst JA, 2008, ANN PLAS SURG, V60, P577, DOI 10.1097/SAP.0b013e318168db3e
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Wu Yongchao, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P594, DOI 10.1007/s11596-006-0530-7
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Xing XB, 2008, OPT EXPRESS, V16, P10815, DOI 10.1364/OE.16.010815
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang XC, 2009, TISSUE ENG PT A, V15, P945, DOI 10.1089/ten.tea.2007.0280
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709
   Yuan Y, 2008, TRANSPL P, V40, P2571, DOI 10.1016/j.transproceed.2008.08.017
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang DM, 2008, J MATER SCI-MATER M, V19, P443, DOI 10.1007/s10856-006-0043-8
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051
NR 226
TC 235
Z9 240
U1 14
U2 304
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD JUL
PY 2010
VL 35
IS 7
BP 868
EP 892
DI 10.1016/j.progpolymsci.2010.03.003
PG 25
WC Polymer Science
SC Polymer Science
GA 620IZ
UT WOS:000279494300002
PM 20582161
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Fujie, T
   Kinoshita, M
   Shono, S
   Saito, A
   Okamura, Y
   Saitoh, D
   Takeoka, S
AF Fujie, Toshinori
   Kinoshita, Manabu
   Shono, Satoshi
   Saito, Akihiro
   Okamura, Yosuke
   Saitoh, Daizoh
   Takeoka, Shinji
TI Sealing effect of a polysaccharide nanosheet for murine cecal puncture
SO SURGERY
LA English
DT Article
ID FILMS; ADHESIVE; CHITOSAN; ROBUST; FABRICATION; MEMBRANES; BEHAVIOR
AB Background. Recent developments in nanobiotechnology have led us to develop a method of producing a free-standing polymer nanosheet composed of polysaccharides (ie, polysaccharide nanosheet) with a thickness of tens of nanometers. Owing to its enormous aspect ratio, the polysaccharide nanosheet is semi-absorbent and has a physical adhesive strength 7 5-fold greater than that of conventional films of > 1 mu m thickness. Herein, we have investigated the therapeutic sealing effect of this polysaccharide nanosheet on murine cecal puncture as a wound dressing material.
   Methods. Murine cecum was punctured and then overlapped with the polysaccharide nanosheet Thereafter, we evaluated its sealing effect on bacterial peritonitis as well as the protection offered by the polysaccharide nanosheet against bacterial permeability using an in vitro transmembrane assay
   Results. The 39-nm-thick polysaccharide nanosheet overlapped tightly the perforated recant. No adhering agents were required because of the ability of the polysaccharide nanosheet to adhere to the tissue surface by physical adsorption (eg, van der Waals interaction) Sealing the perforated cecum with the polysaccharide nanosheet increased survival rate without postoperative adhesion by comparison with untreated mice (90 vs 30%, P < .01) These data were supported by the improvement in peritonitis related to bacterial counts, white blood cell counts, and the serum tumor necrosis factor level. Moreover, using an. in vitro transmembrane assay, we showed that the polysaccharide nanosheet inhibited effectively bacterial penetration.
   Conclusion. We have demonstrated the potential clinical benefits of the nanosheet-type biomaterial that can be used for repairing a cecal colotomy without chemical bonding agents (Surgery 2010;148 48-58)
C1 [Fujie, Toshinori; Saito, Akihiro; Okamura, Yosuke; Takeoka, Shinji] Waseda Univ, Dept Life Sci & Med Biosci, Grad Sch Adv Sci & Engn, Tokyo, Japan.
   [Takeoka, Shinji] Waseda Univ, Ctr Adv Biomed Sci, High Tech Res Project MEXT, Tokyo, Japan.
   [Kinoshita, Manabu; Shono, Satoshi] Natl Def Med Coll, Dept Immunol & Microbiol, Saitama, Japan.
   [Shono, Satoshi; Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Saitama, Japan.
RP Takeoka, S (reprint author), Waseda Univ TWIns, Dept Life Sci & Med Biosci, Grad Sch Adv Sci & Engn, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.
RI Fujie, Toshinori/O-1493-2018
OI Fujie, Toshinori/0000-0003-1417-8670
FU COE; SCOF; MEXT (ST); JSPS [(B) 21300181]; National Defense Medical
   College (DS)
FX Supported by Global COE "Practical Chemical Wisdom", SCOF. "Consolidated
   Research Institute for Advanced Science and Medical Care" from MEXT
   (ST), grant-in-aid for Scientific Research (B) 21300181 From the JSPS.
   and a grant-in-aid for the Special Research Program from the National
   Defense Medical College (DS)
CR Baba S, 1999, APPL SURF SCI, V144-45, P344, DOI 10.1016/S0169-4332(98)00824-1
   Cho J, 2001, ADV MATER, V13, P1076, DOI 10.1002/1521-4095(200107)13:14<1076::AID-ADMA1076>3.0.CO;2-M
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Decher G., 2003, MULTILAYER THIN FILM
   Endo H, 2006, MACROMOLECULES, V39, P5559, DOI 10.1021/ma052410j
   Fabian T, 2003, ANN THORAC SURG, V75, P1587, DOI 10.1016/S0003-4975(02)04994-9
   FUJIE T, 2009, NATURE NANOTECH, V4, P472
   Fujie T, 2007, ADV MATER, V19, P3549, DOI 10.1002/adma.200700661
   Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103
   HOLLAUS P, 1994, J CARDIOVASC SURG, V35, P169
   Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212
   Jiang CY, 2006, ADV MATER, V18, P829, DOI 10.1002/adma.200502444
   Jiang CY, 2004, ADV MATER, V16, P157, DOI 10.1002/adma.200306010
   Kim HJ, 1999, J BIOMAT SCI-POLYM E, V10, P543, DOI 10.1163/156856299X00478
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Liao IC, 2005, J CONTROL RELEASE, V104, P347, DOI 10.1016/j.jconrel.2005.02.013
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Nivasu VM, 2004, BIOMATERIALS, V25, P3283, DOI 10.1016/j.biomaterials.2003.09.091
   Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016
   Ohya S, 2005, BIOMATERIALS, V26, P655, DOI 10.1016/j.biomaterials.2004.03.002
   Ono S, 2001, AM J SURG, V182, P491, DOI 10.1016/S0002-9610(01)00754-1
   Ono SS, 2006, NANO LETT, V6, P592, DOI 10.1021/nl0515504
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Stroock AD, 2003, LANGMUIR, V19, P2466, DOI 10.1021/la026379f
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Vendamme R, 2006, NAT MATER, V5, P494, DOI 10.1038/nmat1655
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
NR 28
TC 22
Z9 22
U1 1
U2 25
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD JUL
PY 2010
VL 148
IS 1
BP 48
EP 58
DI 10.1016/j.surg.2009.12.009
PG 11
WC Surgery
SC Surgery
GA 620JN
UT WOS:000279495800007
PM 20117815
DA 2018-10-19
ER

PT J
AU Zheng, BZ
   Qian, L
   Yuan, HY
   Xiao, D
   Yang, XP
   Paau, MC
   Choi, MMF
AF Zheng, Baozhan
   Qian, Lei
   Yuan, Hongyan
   Xiao, Dan
   Yang, Xiupei
   Paau, Man Chin
   Choi, Martin M. F.
TI Preparation of gold nanoparticles on eggshell membrane and their
   biosensing application
SO TALANTA
LA English
DT Article
DE Gold nanoparticles; Eggshell membrane; Biocatalysis; Glucose biosensors
ID SHAPE-CONTROLLED SYNTHESIS; GLUCOSE BIOSENSOR; METAL NANOPARTICLES;
   SILVER NANOPARTICLES; AQUEOUS-SOLUTIONS; GREEN SYNTHESIS; CHITOSAN;
   SURFACE; GROWTH; CORE
AB A facile green biosynthesis method has been successfully developed to prepare gold nanoparticles (AuNPs) of various core sizes (25 +/- 7 nm) using a natural biomaterial, eggshell membrane (ESM) at ambient conditions. In situ synthesis of AuNPs-immobilized ESM is conducted in a simple manner by immersing ESM in a pH 6.0 aqueous solution of HAuCI(4) without adding any reductant. The formation of AuNPs on ESM protein fibers is attributed to the reduction of Au(III) ions to Au(0) by the aldehyde moieties of the natural ESM fibers. Energy dispersive X-ray spectroscopy, scanning electron microscopy, X-ray photoelectron spectroscopy, and X-ray powder diffraction unambiguously identify the presence of AuNPs on ESM. The effect of pH on the in situ synthesis of AuNPs on ESM has been investigated in detail. The pH of the gold precursor (HAuCI(4)) solution can influence the formation rate, dispersion and size of AuNPs on ESM. At pH <= 3.0 and >= 7.0, no AuNPs are observed on ESM while small AuNPs are homogeneously dispersed on ESM at pH 4.0-6.0. The optimal pH for AuNPs formation on ESM is 6.0. AuNPs/ESMs are used to immobilize glucose oxidase (GO(x)) for glucose biosensing. AuNPs on ESM can increase the enzyme activity of GO(x). The linear response range of the glucose biosensor is 20 mu M to 0.80 mM glucose with a detection limit of 17 mu M (S/N = 3). The biosensor has been successfully applied to determine the glucose content in commercial glucose injections. Our work provides a very simple, non-toxic, convenient, and green route to synthesize AuNPs on ESM which is potentially useful in the biosensing field. (C) 2010 Elsevier BM. All rights reserved.
C1 [Zheng, Baozhan; Yuan, Hongyan; Xiao, Dan] Sichuan Univ, Coll Chem Engn, Chengdu 610064, Peoples R China.
   [Qian, Lei; Xiao, Dan] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.
   [Yang, Xiupei] China W Normal Univ, Coll Chem & Chem Engn, Nanchong 637002, Peoples R China.
   [Paau, Man Chin; Choi, Martin M. F.] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.
RP Xiao, D (reprint author), Sichuan Univ, Coll Chem Engn, Chengdu 610064, Peoples R China.
EM xiaodan@scu.edu.cn; mfchoi@hkbu.edu.hk
RI Choi, Martin/N-9552-2013
OI Choi, Martin/0000-0001-9583-8866; Zheng, Baozhan/0000-0003-4060-5912
FU Research Grants Council of the Hong Kong Special Administrative Region,
   China [HKBU 200907]
FX We would express our sincere thanks to Mr. Tommy W.H. Poon of the
   Department of Chemistry, Hong Kong Baptist University for acquiring the
   SEM images and EDS. and Ms. Y.K. Wu of the Centre for Surface Analysis
   and Research, Hong Kong Baptist University for the XPS and XRD
   measurements. Financial support from the Research Grants Council of the
   Hong Kong Special Administrative Region, China (project no. HKBU 200907)
   is gratefully acknowledged.
CR Allen SJ, 2000, ADSORPTION SCIENCE AND TECHNOLOGY, P46, DOI 10.1142/9789812793331_0009
   Annadurai G, 2008, J HAZARD MATER, V152, P337, DOI 10.1016/j.jhazmat.2007.07.002
   Arami M, 2006, CHEMOSPHERE, V65, P1999, DOI 10.1016/j.chemosphere.2006.06.074
   ARISTOV V, 2000, RUSS J ELECTROCHEM+, V36, P323
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Cao YW, 2001, J AM CHEM SOC, V123, P7961, DOI 10.1021/ja011342n
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Choi MMF, 2001, ANALYST, V126, P1558, DOI 10.1039/b103205b
   Corbierre MK, 2005, CHEM MATER, V17, P5691, DOI 10.1021/cm051115a
   CREIGHTON JA, 1991, J CHEM SOC FARADAY T, V87, P3881, DOI 10.1039/ft9918703881
   Das SK, 2009, LANGMUIR, V25, P8192, DOI 10.1021/la900585p
   Engelbrekt C, 2009, J MATER CHEM, V19, P7839, DOI 10.1039/b911111e
   He JH, 2003, CHEM MATER, V15, P4401, DOI 10.1021/cm034720r
   Hostetler MJ, 1998, LANGMUIR, V14, P17, DOI 10.1021/la970588w
   Huang HZ, 2004, BIOMACROMOLECULES, V5, P2340, DOI 10.1021/bm0497116
   Kaushika A, 2008, BIOSENS BIOELECTRON, V24, P676, DOI 10.1016/j.bios.2008.06.032
   Kharlampieva E, 2008, CHEM MATER, V20, P5822, DOI 10.1021/cm801475v
   Koumanova B, 2002, J CHEM TECHNOL BIOT, V77, P539, DOI 10.1002/jctb.601
   Kozlovskaya V, 2009, CHEM MATER, V21, P2158, DOI 10.1021/cm900314p
   Lapkin A, 2004, ENVIRON SCI TECHNOL, V38, P5815, DOI 10.1021/es035414h
   Lee Y, 2010, CHEM MATER, V22, P755, DOI 10.1021/cm9013046
   LI YF, 2008, CHINESE J ANAL CHEM, V6, P819
   Li Z, 2003, ANGEW CHEM INT EDIT, V42, P2306, DOI 10.1002/anie.200351231
   Liu YC, 2003, J PHYS CHEM B, V107, P12383, DOI 10.1021/jp035680h
   LOTT JA, 1975, CLIN CHEM, V21, P1754
   Maeda K, 1981, BURNS, V8, P313
   Mayya KS, 2003, ADV FUNCT MATER, V13, P183, DOI 10.1002/adfm.200390028
   Mukherjee P, 2001, ANGEW CHEM INT EDIT, V40, P3585, DOI 10.1002/1521-3773(20011001)40:19<3585::AID-ANIE3585>3.0.CO;2-K
   Nadagouda MN, 2009, CRYST GROWTH DES, V9, P4979, DOI 10.1021/cg9007685
   Nakano T, 2003, POULTRY SCI, V82, P510, DOI 10.1093/ps/82.3.510
   Nune SK, 2009, J MATER CHEM, V19, P2912, DOI 10.1039/b822015h
   Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029
   Qi ZM, 2004, J PHYS CHEM B, V108, P7006, DOI 10.1021/jp035972i
   Rauf S, 2006, J BIOTECHNOL, V121, P351, DOI 10.1016/j.jbiotec.2005.08.019
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Ren XL, 2009, MAT SCI ENG C-MATER, V29, P2234, DOI 10.1016/j.msec.2009.05.007
   Ren XL, 2005, SENSOR ACTUAT B-CHEM, V110, P358, DOI 10.1016/j.snb.2005.02.016
   Santhosh P, 2009, BIOELECTROCHEMISTRY, V75, P61, DOI 10.1016/j.bioelechem.2008.12.001
   Sardar R, 2009, LANGMUIR, V25, P13840, DOI 10.1021/la9019475
   SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002
   Shipway AN, 2000, CHEMPHYSCHEM, V1, P18, DOI 10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L
   Su HL, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/1/015045
   Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229
   TAVASSOLI M, 1983, EXPERIENTIA, V39, P411, DOI 10.1007/BF01963153
   Wei G, 2005, J PHYS CHEM B, V109, P8738, DOI 10.1021/jp044314a
   Willner I, 2006, ADV MATER, V18, P1109, DOI 10.1002/adma.200501865
   WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2
   Wu BL, 2004, TALANTA, V64, P546, DOI 10.1016/j.talanta.2004.03.050
   Xia YN, 2005, MRS BULL, V30, P338, DOI 10.1557/mrs2005.96
   Xiao D, 2002, ANAL CHEM, V74, P863, DOI 10.1021/ac001097a
   Xu Q, 2006, BIOSENS BIOELECTRON, V22, P768, DOI 10.1016/j.bios.2006.02.010
   Yang D, 2002, ADV MATER, V14, P1543, DOI 10.1002/1521-4095(20021104)14:21<1543::AID-ADMA1543>3.0.CO;2-B
   Yao K, 2008, MAT SCI ENG C-BIO S, V28, P1236, DOI 10.1016/j.msec.2007.11.004
   Zhang Y, 2007, BIOSENS BIOELECTRON, V22, P1791, DOI 10.1016/j.bios.2006.08.038
NR 54
TC 48
Z9 49
U1 1
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-9140
J9 TALANTA
JI Talanta
PD JUN 30
PY 2010
VL 82
IS 1
BP 177
EP 183
DI 10.1016/j.talanta.2010.04.014
PG 7
WC Chemistry, Analytical
SC Chemistry
GA 620HE
UT WOS:000279488900027
PM 20685454
DA 2018-10-19
ER

PT J
AU Tan, QG
   Ren, J
   Chen, C
AF Tan, Qinggang
   Ren, Jie
   Chen, Chu
TI Development of synthetic extracellular bone matrix on poly(L-lactic
   acid) substrates via electrostatic self-assembly and biomimetic
   mineralization technologies
SO E-POLYMERS
LA English
DT Article
DE electrostatic self assembly; biomimetic mineralization; extracellular
   matrix; bonelike apatite; simulated body fluids
ID SIMPLE SURFACE MODIFICATION; APATITE-FORMING ABILITY; SIMULATED
   BODY-FLUID; BY-LAYER DEPOSITION; POLYELECTROLYTE MULTILAYERS;
   HYALURONIC-ACID; COLLAGEN; GROWTH; FILMS; POLY(EPSILON-CAPROLACTONE)
AB Biomimetic formation of extracellular matrix (ECM) like coatings on artificial biomaterials provides a promising route to gain bioactive materials for tissue engineering applications. Organic ECM is also a template for apatite mineralization in bone tissue. This study was aimed at designing a multilayer film containing an ECM-like molecule on biomaterial surfaces to direct apatite mineralization and to develop biomimetic biomaterials for bone tissue engineering. A multilayer film consisting of gelatin and poly(ethylenimine) molecules was formed on a poly(L-lactic acid) substrate via electrostatic self-assembly technique. Bone-like apatite coating was formed on the multilayer film modified poly(L-lactic acid) substrate in simulated body fluids (SBFs). The amount of forming apatite could be controlled by the Ca2(+) and HPO4 2- concentrations in SBF and also through the mineralization time. Gelatin terminated multilayer film can induce the apatite formation with a weak orientation in the (002) plane and the apatite is similar in composition to the natural bone. The gelatin multilayer film/apatite composite coating may serve as a promising microenvironment for bone tissue formation and growth.
C1 [Tan, Qinggang; Ren, Jie; Chen, Chu] Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, Shanghai 200092, Peoples R China.
   [Tan, Qinggang; Ren, Jie] Tongji Univ, Sch Mat Sci & Engn, Key Lab Adv Civil Engn Mat, Minist Educ, Shanghai 200092, Peoples R China.
RP Tan, QG (reprint author), Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, 1239 Siping Rd, Shanghai 200092, Peoples R China.
EM qgtan@tongji.edu.cn
RI Ren, Jie/J-2811-2012
FU national science foundation of china [NSFC-50603019]; key basic research
   foundation for development of science and technology of shanghai, P.R.
   of china [05DJ14006]
FX The project was sponsored by the national science foundation of china
   (NSFC-50603019) and the key basic research foundation for development of
   science and technology of shanghai, P.R. of china (Number: 05DJ14006).
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   CHEN D, 2008, ACTA BIOMATER, P553
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Elliott J. C., 1994, STRUCTURE CHEM APATI, P404
   Forsgren J, 2007, ACTA BIOMATER, V3, P980, DOI 10.1016/j.actbio.2007.03.006
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GONG YH, 2007, ACTA BIOMATER, P677
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Johansson JA, 2005, BIOMACROMOLECULES, V6, P1353, DOI 10.1021/bm0493741
   Kawai T, 2004, BIOMATERIALS, V25, P4529, DOI 10.1016/j.biomaterials.2003.11.039
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kim HM, 2001, BIOMATERIALS, V22, P2489, DOI 10.1016/S0142-9612(00)00437-3
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1991, J CERAM SOC JPN, V99, P965
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LINDSLEY H, 1971, J EXP MED, V133, P1309, DOI 10.1084/jem.133.6.1309
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Oyane A, 2005, J BIOMED MATER RES A, V75A, P138, DOI 10.1002/jbm.a.30397
   Oyane A, 2005, BIOMATERIALS, V26, P2407, DOI 10.1016/j.biomaterials.2004.07.048
   Oyane A, 2003, BIOMATERIALS, V24, P1729, DOI 10.1016/S0142-9612(02)00581-1
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
   Zhang J, 2005, BIOMATERIALS, V26, P3353, DOI 10.1016/j.biomaterials.2004.08.019
   Zhu HG, 2004, BIOMACROMOLECULES, V5, P1933, DOI 10.1021/bm049753u
   Zhu HG, 2003, BIOMACROMOLECULES, V4, P378, DOI 10.1021/bm025773p
NR 33
TC 0
Z9 0
U1 1
U2 6
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD JUN 22
PY 2010
AR 058
PG 10
WC Polymer Science
SC Polymer Science
GA 614OI
UT WOS:000279069100003
DA 2018-10-19
ER

PT J
AU Ifkovits, JL
   Tous, E
   Minakawa, M
   Morita, M
   Robb, JD
   Koomalsingh, KJ
   Gorman, JH
   Gorman, RC
   Burdick, JA
AF Ifkovits, Jamie L.
   Tous, Elena
   Minakawa, Masahito
   Morita, Masato
   Robb, J. Daniel
   Koomalsingh, Kevin J.
   Gorman, Joseph H., III
   Gorman, Robert C.
   Burdick, Jason A.
TI Injectable hydrogel properties influence infarct expansion and extent of
   postinfarction left ventricular remodeling in an ovine model
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE infarction; cardiac; mechanics; polymer; biomaterial
ID ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; INJECTION; RESTRAINT;
   GEOMETRY; THERAPY; IMPACT; WALL; CARDIOMYOPATHY; LIMITATION
AB A recent trend has emerged that involves myocardial injection of biomaterials, containing cells or acellular, following myocardial infarction (MI) to influence the remodeling response through both biological and mechanical effects. Despite the number of different materials injected in these approaches, there has been little investigation into the importance of material properties on therapeutic outcomes. This work focuses on the investigation of injectable hyaluronic acid (MeHA) hydrogels that have tunable mechanics and gelation behavior. Specifically, two MeHA formulations that exhibit similar degradation and tissue distribution upon injection but have differential moduli (similar to 8 versus similar to 43 kPa) were injected into a clinically relevant ovine MI model to evaluate the associated salutary effect of intramyocardial hydrogel injection on the remodeling response based on hydrogel mechanics. Treatment with both hydrogels significantly increased the wall thickness in the apex and basilar infarct regions compared with the control infarct. However, only the higher-modulus (MeHA High) treatment group had a statistically smaller infarct area compared with the control infarct group. Moreover, reductions in normalized end-diastolic and end-systolic volumes were observed for the MeHA High group. This group also tended to have better functional outcomes (cardiac output and ejection fraction) than the low-modulus (MeHA Low) and control infarct groups. This study provides fundamental information that can be used in the rational design of therapeutic materials for treatment of MI.
C1 [Ifkovits, Jamie L.; Tous, Elena; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Minakawa, Masahito; Morita, Masato; Robb, J. Daniel; Koomalsingh, Kevin J.; Gorman, Joseph H., III; Gorman, Robert C.] Univ Penn, Gorman Cardiovasc Res Grp, Glenolden, PA 19036 USA.
   [Minakawa, Masahito; Morita, Masato; Robb, J. Daniel; Koomalsingh, Kevin J.; Gorman, Joseph H., III; Gorman, Robert C.] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
FU American Heart Association; Ashton Foundation; Wallace H. Coulter Early
   Career Investigator Award; National Institutes of Health [HL63954,
   HL73021, HL76560]
FX This work was supported by an American Heart Association Predoctoral
   Fellowship and an Ashton Foundation Fellowship (to J.L.I.), a Wallace H.
   Coulter Early Career Investigator Award (to J.A.B.), National Institutes
   of Health Grants HL63954 (to R.C.G.), HL73021 (to J.H.G.), and HL76560
   (to J.H.G.), and individual Established Investigator Awards from the
   American Heart Association (to J.H.G. and R.C.G.).
CR BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Blom AS, 2005, HEART FAIL REV, V10, P125, DOI 10.1007/s10741-005-4640-2
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   EATON LW, 1979, NEW ENGL J MED, V300, P57, DOI 10.1056/NEJM197901113000202
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Epstein FH, 2002, MAGNET RESON MED, V48, P399, DOI 10.1002/mrm.10210
   ERLEBACHER JA, 1984, J AM COLL CARDIOL, V4, P201, DOI 10.1016/S0735-1097(84)80203-X
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282
   Gorman RC, 2004, SURG CLIN N AM, V84, P45, DOI 10.1016/S0039-6109(03)00216-0
   HOCHMAN JS, 1987, CIRCULATION, V75, P299, DOI 10.1161/01.CIR.75.1.299
   Jackson BM, 2003, AM J PHYSIOL-HEART C, V284, pH475, DOI 10.1152/ajpheart.00360.2002
   Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6
   Jneid H, 2008, CIRCULATION, V117, P2502, DOI 10.1161/CIRCULATIONAHA.107.752113
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kloner RA, 2008, CIRC RES, V103, P1, DOI 10.1161/CIRCRESAHA.108.180216
   Kofidis T., 2005, CIRCULATION, V112, pI173
   KRAMER CM, 1993, CIRCULATION, V88, P1279, DOI 10.1161/01.CIR.88.3.1279
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   LIMA JAC, 1985, CIRCULATION, V71, P1048, DOI 10.1161/01.CIR.71.5.1048
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   MARKOVITZ LJ, 1989, ANN THORAC SURG, V48, P838, DOI 10.1016/0003-4975(89)90682-6
   Miura T, 2008, BASIC RES CARDIOL, V103, P501, DOI 10.1007/s00395-008-0743-y
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   OPIE LH, 2005, ESSENTIAL CARDIOLOGY, P37
   Pilla JJ, 2009, ANN THORAC SURG, V87, P803, DOI 10.1016/j.athoracsur.2008.11.044
   Pilla JJ, 2005, ANN THORAC SURG, V80, P2257, DOI 10.1016/j.athoracsur.2005.05.089
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   WEISMAN HF, 1987, PROG CARDIOVASC DIS, V30, P73, DOI 10.1016/0033-0620(87)90004-1
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 39
TC 155
Z9 155
U1 4
U2 45
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 22
PY 2010
VL 107
IS 25
BP 11507
EP 11512
DI 10.1073/pnas.1004097107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 614KS
UT WOS:000279058000064
PM 20534527
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Anitua, E
   Sanchez, M
   Orive, G
AF Anitua, Eduardo
   Sanchez, Mikel
   Orive, Gorka
TI Potential of endogenous regenerative technology for in situ regenerative
   medicine
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Growth factors; Endogenous regenerative medicine; Platelets; Fibrin;
   Scaffolds; Biomaterials
ID PLATELET-RICH PLASMA; ANTERIOR CRUCIATE LIGAMENT; GROWTH-FACTOR-BETA;
   AUTOLOGOUS PREPARATION RICH; GUIDED BONE REGENERATION; TISSUE-ENGINEERED
   BONE; HUMAN TENDON CELLS; DENTAL IMPLANTS; DRUG-DELIVERY; STROMAL CELLS
AB Endogenous regenerative technology (Endoret) involves the use of patient's own biologically active proteins. growth factors and biomaterial scaffolds for therapeutic purposes. This technology provides a new approach for the stimulation and acceleration of tissue healing and bone regeneration. The versatility and biocompatibility of using patient-derived fibrin scaffold as an autologous, biocompatible and biodegradable drug delivery system open the door to a personalized medicine that is currently being used in numerous medical and scientific fields including dentistry, oral implantology, orthopaedics, ulcer treatment, sports medicine and tissue engineering among others. This review discusses the state of the art and new directions in the use of endogenous technology in the repair and regeneration of injured tissues by means of a controlled and local protein and growth factor delivery. The next generations of engineering strategies together with some of the most interesting therapeutic applications are discussed together with the future challenges in the field. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Anitua, Eduardo; Orive, Gorka] BTI, Vitoria, Spain.
   [Sanchez, Mikel] Unidad Cirugia Artroscop Mikel Sanchez, Vitoria 01005, Spain.
RP Orive, G (reprint author), Inst Eduardo Anitua, C Jose Maria Cajigal 19, Vitoria 10005, Spain.
EM gorka.orive@ehu.es
RI Anitua, Eduardo/O-1154-2018
OI Anitua, Eduardo/0000-0002-8386-5303
FU Basque government; Spanish government
FX The work of this group is partially funded by the Basque and Spanish
   governments.
CR Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234
   ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   ALIO JL, 2007, OPHTHALMOLOGY, V14, P1286
   ALIO JL, 2007, OPHTHAL RES, V19, P124
   Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241
   American Diabetes Association, 1999, DIABETES CARE, V22, P1354, DOI DOI 10.2337/DIACARE.22.8.1354
   Andreopoulos FM, 2006, BIOMATERIALS, V27, P2468, DOI 10.1016/j.biomaterials.2005.11.019
   Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   Anitua E, 2006, J BIOMED MATER RES A, V77A, P285, DOI 10.1002/jbm.a.30585
   Anitua E, 2005, J ORTHOP RES, V23, P281, DOI 10.1016/j.orthres.2004.08.015
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   ANITUA E, ITAL ORAL S IN PRESS
   ANITUA E, CLIN IMPL B IN PRESS
   Anitua E, 2008, J CLIN PERIODONTOL, V35, P724, DOI 10.1111/j.1600-051X.2008.01248.x
   Anitua E, 2008, J PERIODONTOL, V79, P1168, DOI [10.1902/jop.2008.070580, 10.1902/jop.2008.070580 ]
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Anitua E, 2008, J BIOMED MATER RES B, V84B, P415, DOI 10.1002/jbm.b.30886
   Anitua E, 2008, J PERIODONTOL, V79, P42, DOI [10.1902/jop.2008.070142, 10.1902/jop.2008.070142 ]
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Anitua E, 2007, PLAST RECONSTR SURG, V119, P950, DOI 10.1097/01.prs.0000255543.43695.1d
   Anitua Eduardo, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe23, DOI 10.1111/j.1708-8208.2009.00159.x
   Anitua Eduardo, 2008, Pract Proced Aesthet Dent, V20, P123
   Anitua E, 2009, J BIOMED MATER RES A, V91A, P158, DOI 10.1002/jbm.a.32217
   Anitua Eduardo A, 2006, J Oral Implantol, V32, P72, DOI 10.1563/736.1
   Aparicio Carlos, 2003, Clin Implant Dent Relat Res, V5, P57, DOI 10.1111/j.1708-8208.2003.tb00183.x
   ATRI SC, 1990, SURGERY, V108, P508
   Bachoud-Levi AC, 2000, HUM GENE THER, V11, P1723, DOI 10.1089/10430340050111377
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Basu P, 2003, NAT MED, V9, P1100, DOI 10.1038/nm0903-1100
   Bays R., 1986, RECONSTRUC PREPOSTHE, V1, P1
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Blanton MW, 2009, PLAST RECONSTR SURG, V123, p56S, DOI 10.1097/PRS.0b013e318191be2d
   Brown CH, 1999, CLIN SPORT MED, V18, P109, DOI 10.1016/S0278-5919(05)70133-2
   Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324
   CANALIS E, 1980, J CLIN INVEST, V66, P709, DOI 10.1172/JCI109908
   CARDA C, 2005, INT J ARTIF ORGANS, V28, P363
   Celotti F, 2006, WOUND REPAIR REGEN, V14, P195, DOI 10.1111/j.1743-6109.2006.00110.x
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   CHO MI, 1995, J PERIODONTOL, V66, P522, DOI 10.1902/jop.1995.66.6.522
   Cochran DL, 2004, INT J ORAL MAX IMPL, V19, P109
   Conover CA, 2000, GROWTH HORM IGF RES, V10, pS107
   Dean J W 3rd, 1995, Int J Oral Maxillofac Implants, V10, P721
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   DOUCETTE MM, 1989, ARCH PHYS MED REHAB, V70, P780
   Driver VR, 2006, OSTOMY WOUND MANAG, V52, P68
   Farrag TY, 2007, LARYNGOSCOPE, V117, P157, DOI 10.1097/01.mlg.0000249726.98801.77
   Field LD, 1998, SPORTS MED, V26, P193, DOI 10.2165/00007256-199826030-00005
   Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23
   Furst G, 2003, CLIN ORAL IMPLAN RES, V14, P500, DOI 10.1034/j.1600-0501.2003.00859.x
   FYLLING CP, 1990, DIABETIC NEUROPATHY, P567
   FYLLING CP, 1992, DIABETES SA, V41, pA82
   Garbayo E, 2009, J CONTROL RELEASE, V135, P119, DOI 10.1016/j.jconrel.2008.12.010
   Glauser R., 2001, CLIN IMPLANT DENT R, V3, P182
   Glover J. L., 1997, ADV WOUND CARE, V10, P27
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141
   Gruber R, 2002, CLIN ORAL IMPLAN RES, V13, P529, DOI 10.1034/j.1600-0501.2002.130513.x
   Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224
   Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209
   Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Ito K, 2005, J BIOMED MATER RES A, V73A, P63, DOI 10.1002/jbm.a.30248
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Jaffin RA, 2000, J PERIODONTOL, V71, P833, DOI 10.1902/jop.2000.71.5.833
   Johnson DL, 1998, AM J SPORT MED, V26, P409, DOI 10.1177/03635465980260031101
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P362, DOI 10.1016/j.joms.2004.07.016
   KELM RJ, 1994, J BIOL CHEM, V269, P30147
   KEYSER JE, 1993, SOUTH MED J, V86, P311, DOI 10.1097/00007611-199303000-00013
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kikuchi N, 2007, J ENDODONT, V33, P1198, DOI 10.1016/j.joen.2007.07.025
   KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kitoh H, 2004, BONE, V35, P892, DOI 10.1016/j.bone.2004.06.013
   KNIGHTON DR, 1990, SURG GYNECOL OBSTET, V170, P56
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   KON E, 2009, KNEE SURG SPORT 1017
   Lariviere B, 2003, WOUND REPAIR REGEN, V11, P79, DOI 10.1046/j.1524-475X.2003.11112.x
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lee Ernesto A, 2006, Pract Proced Aesthet Dent, V18, P17
   Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046
   Li HW, 2007, BIOCHEM BIOPH RES CO, V356, P836, DOI 10.1016/j.bbrc.2007.02.165
   Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757
   Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037
   Lu HH, 2008, J BIOMED MATER RES A, V15, P1128
   MALONE JD, 1982, J CELL BIOL, V92, P227, DOI 10.1083/jcb.92.1.227
   MANI R, 1999, CHRONIC WOUND HEALIN, P17
   Margolis DJ, 2001, DIABETES CARE, V24, P483, DOI 10.2337/diacare.24.3.483
   MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121
   Matsumoto T, 2006, ADV BIOCHEM ENG BIOT, V102, P113, DOI 10.1007/b137207
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Montjovent MO, 2004, BONE, V35, P1323, DOI 10.1016/j.bone.2004.07.001
   Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Moya ML, 2009, MICROVASC RES, V78, P142, DOI 10.1016/j.mvr.2009.06.006
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Niklason LE, 2001, JAMA-J AM MED ASSOC, V285, P573, DOI 10.1001/jama.285.5.573
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Okuda K, 2003, J PERIODONTOL, V74, P849, DOI 10.1902/jop.2003.74.6.849
   Orive G, 2004, TRENDS PHARMACOL SCI, V25, P382, DOI 10.1016/j.tips.2004.05.006
   Orive G, 2003, CURR OPIN BIOTECH, V14, P659, DOI 10.1016/j.copbio.2003.10.007
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pallua N, 2010, BURNS, V36, P4, DOI 10.1016/j.burns.2009.05.002
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513
   Peers KHE, 2005, SPORTS MED, V35, P71, DOI 10.2165/00007256-200535010-00006
   Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834
   PRICE PA, 1985, VITAM HORM, V42, P65
   RALL K L, 1964, Mo Med, V61, P435
   Reed GL, 2004, SEMIN THROMB HEMOST, V30, P441, DOI 10.1055/s-2004-833479
   ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sanchez M, 2003, MED SCI SPORT EXER, V35, P1648, DOI 10.1249/01.MSS.0000089344.44434.50
   Sanchez M, 2008, CLIN EXP RHEUMATOL, V26, P910
   Sanchez M., 2003, CUADER ARTROSCOPIA, V10, P12
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x
   Schnabel LV, 2007, J ORTHOP RES, V25, P230, DOI 10.1002/jor.20278
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Schnitman PA, 1997, INT J ORAL MAX IMPL, V12, P495
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   STEED DL, 1993, WOUNDS, V5, P160
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Suresh SPS, 2006, BRIT J SPORT MED, V40, P935, DOI 10.1136/bjsm.2006.029983
   Tabata Y., 2003, TISSUE ENG, V9, P5
   Takayama S, 2001, J DENT RES, V80, P2075, DOI 10.1177/00220345010800121001
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   THIEDE MA, 1994, ENDOCRINOLOGY, V135, P929, DOI 10.1210/en.135.3.929
   Torrella F, 1998, INT J ORAL MAX IMPL, V13, P697
   Trippel SB, 1998, CLIN ORTHOP RELAT R, pS301
   Tsay RC, 2005, J ORAL MAXIL SURG, V63, P521, DOI 10.1016/j.joms.2004.09.012
   Urwin M, 1998, ANN RHEUM DIS, V57, P649, DOI 10.1136/ard.57.11.649
   VANDERHAGEN SJ, 2009, COLORECTAL DIS  0703
   Virchenko O, 2006, ACTA ORTHOP, V77, P806, DOI 10.1080/17453670610013033
   von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
   Weibrich G, 2002, Mund Kiefer Gesichtschir, V6, P168
   WEISS RE, 1981, EXP CELL RES, V133, P247, DOI 10.1016/0014-4827(81)90316-5
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Weyrich AS, 2002, CIRCULATION, V106, P1433, DOI 10.1161/01.CIR.0000033634.60453.22
   Yamada Y, 2004, CELL TRANSPLANT, V13, P343, DOI 10.3727/000000004783983909
   Ye L, 2006, J ENDODONT, V32, P736, DOI 10.1016/j.joen.2006.01.007
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   ZHOU YQ, 1993, BLOOD, V82, P800
   Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633
NR 152
TC 101
Z9 109
U1 1
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JUN 15
PY 2010
VL 62
IS 7-8
BP 741
EP 752
DI 10.1016/j.addr.2010.01.001
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 626LM
UT WOS:000279967500007
PM 20102730
DA 2018-10-19
ER

PT J
AU Noth, U
   Rackwitz, L
   Steinert, AF
   Tuan, RS
AF Noeth, Ulrich
   Rackwitz, Lars
   Steinert, Andre F.
   Tuan, Rocky S.
TI Cell delivery therapeutics for musculoskeletal regeneration
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Cell-based therapy; Cell delivery; Mesenchymal stem cells; Embryonic
   stem cells; Natural and synthetic biomaterials; Gene delivery;
   Musculoskeletal regeneration
ID MESENCHYMAL STEM-CELLS; ANTERIOR CRUCIATE LIGAMENT; MARROW STROMAL
   CELLS; HUMAN INTERVERTEBRAL-DISC; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   MEDIATED GENE-TRANSFER; TISSUE-ENGINEERED BONE; NUCLEUS PULPOSUS CELLS;
   RECEPTOR ANTAGONIST GENE; FIBROBLAST-GROWTH-FACTOR
AB The last decade has witnessed the development of cell-based therapy as a major biomedical research area, including the treatment of musculoskeletal diseases. Both differentiated and undifferentiated stem cells have been used as starting cell sources. In particular, the use of multipotent adult mesenchymal stem cells holds great promise for future therapeutic strategies. In addition to the cell type used, the cell delivery system is also of critical importance in cell-based therapy. Cell delivery may be achieved by direct cell injection or by grafting engineered constructs derived by cell seeding into natural or synthetic biomaterial scaffolds. While direct injection is the most direct and convenient means of cell delivery, the latter approach is capable of producing three-dimensional engineered tissues with mechanical properties compatible with those of various musculoskeletal tissues. This review will focus on the functional approach of using biomaterial scaffold materials as cell carriers for musculoskeletal applications, as well as the use of cell-based gene therapy for tissue engineering and regeneration. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, Pittsburgh, PA 15219 USA.
   [Noeth, Ulrich; Rackwitz, Lars; Steinert, Andre F.] Univ Wurzburg, Dept Orthopaed Surg, Orthopaed Ctr Musculoskeletal Res, Wurzburg, Germany.
RP Tuan, RS (reprint author), Univ Pittsburgh, Sch Med, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
RI Steinert, Prof. Dr., Andre/P-4559-2015
OI Steinert, Prof. Dr., Andre/0000-0002-4397-8434
FU Deutsche Forschungsgemeinschaft [DFG RA1820/2-1, DFG STE1051/2-1];
   Interdisziplinares Zentrum fur Klinische Forschung (IZKF) [Z-3/8, D-137,
   D-23/1, D-101AFS]; Bayerische Forschungsstiftung (FORZEBRA) [TP2WP5];
   Commonwealth of Pennsylvania Department of Health
FX This work is supported by the Deutsche Forschungsgemeinschaft (DFG
   RA1820/2-1, LR and UN; DFG STE1051/2-1, AFS and UN), the
   Interdisziplinares Zentrum fur Klinische Forschung (IZKF Z-3/8, LR; IZKF
   D-137, UN and LR; IZKF D-23/1, D-101AFS), Bayerische Forschungsstiftung
   (FORZEBRA TP2WP5, AFS and UN), and the Commonwealth of Pennsylvania
   Department of Health (RST).
CR ADAMS P, 1977, RHEUMATOL REHABIL, V16, P22, DOI 10.1093/rheumatology/16.1.22
   Adams Samuel B Jr, 2005, J Knee Surg, V18, P25
   Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008
   Alison MR, 2002, J PATHOL, V197, P419, DOI 10.1002/path.1187
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Andereya S, 2006, Z ORTHOP GRENZGEB, V144, P272, DOI 10.1055/s-2006-933445
   Anwer Khursheed, 2008, V423, P77, DOI 10.1007/978-1-59745-194-9_5
   AufderHeide AC, 2004, ANN BIOMED ENG, V32, P1161
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Baltzer AWA, 2004, GENE THER, V11, P344, DOI 10.1038/sj.gt.3302195
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   Bertone AL, 2004, J ORTHOP RES, V22, P1261, DOI 10.1016/j.orthres.2004.03.014
   Bertram H, 2005, BIOCHEM BIOPH RES CO, V331, P1185, DOI 10.1016/j.bbrc.2005.04.034
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   Boden SD, 1995, SPINE, V20, pS113, DOI 10.1097/00007632-199512151-00007
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2008, INJURY, V39, pS40, DOI 10.1016/j.injury.2008.01.040
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X
   Buma P, 2007, EXPERT REV MED DEVIC, V4, P507, DOI 10.1586/17434440.4.4.507
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Carlisle Elliot, 2005, Spine J, V5, p240S, DOI 10.1016/j.spinee.2005.02.014
   Cha CW, 2003, SPINE, V28, pS74, DOI 10.1097/00007632-200308011-00013
   Chen CW, 2005, J ORTHOP RES, V23, P446, DOI 10.1016/j.orthres.2004.09.002
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x
   Chen Y, 2004, BIOCHEM BIOPH RES CO, V317, P675, DOI 10.1016/j.bbrc.2004.03.098
   Chen Y, 2003, GENE THER, V10, P1345, DOI 10.1038/sj.gt.3301999
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   Colwell CW, 2001, CLIN ORTHOP RELAT R, pS116
   Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657
   D'Lima DD, 2001, CLIN ORTHOP RELAT R, pS90, DOI 10.1097/00003086-200110001-00009
   D'Lima DD, 2001, J BONE JOINT SURG AM, V83A, P22, DOI 10.2106/00004623-200100021-00005
   D'Lima DD, 2001, J BONE JOINT SURG AM, V83A, P19, DOI 10.2106/00004623-200100021-00004
   D'Lima DD, 2001, OSTEOARTHR CARTILAGE, V9, P712, DOI 10.1053/joca.2001.0468
   Danielsson C, 2006, BIOMATERIALS, V27, P1054, DOI 10.1016/j.biomaterials.2005.07.027
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Dharmavaram RM, 1999, ARTHRITIS RHEUM, V42, P1433, DOI 10.1002/1529-0131(199907)42:7<1433::AID-ANR17>3.0.CO;2-G
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81
   Djouad F, 2009, TISSUE ENG PT A, V15, P2825, DOI [10.1089/ten.tea.2008.0663, 10.1089/ten.TEA.2008.0663]
   DONOHUE PJ, 1988, BIOCHEM J, V251, P739, DOI 10.1042/bj2510739
   Doroski DM, 2007, BIOMATERIALS, V28, P187, DOI 10.1016/j.biomaterials.2006.08.040
   Dumont RJ, 2002, NEUROSURGERY, V51, P1239, DOI 10.1227/01.NEU.0000031573.07141.02
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS120, DOI 10.1007/s00198-004-1817-9
   Erggelet C, 2003, ARTHROSCOPY, V19, P108, DOI 10.1053/jars.2003.50025
   Evans C, 2006, J BONE JOINT SURG AM, V88A, P95, DOI 10.2106/JBJS.E.01328
   Evans CH, 2009, GENE THER, V16, P944, DOI 10.1038/gt.2009.73
   Evans CH, 1999, CLIN ORTHOP RELAT R, pS410
   Evans CH, 2005, J AM ACAD ORTHOP SUR, V13, P230, DOI 10.5435/00124635-200507000-00003
   Evans CH, 2005, P NATL ACAD SCI USA, V102, P8698, DOI 10.1073/pnas.0502854102
   Evans CH, 2004, CLIN ORTHOP RELAT R, P316, DOI 10.1097/01.blo.0000148854.14399.ec
   EVANS CH, 2004, ORTHOPAEDIC TISSUE E, P389
   Evans CH, 2007, TISSUE ENG, V13, P1987, DOI 10.1089/ten.2006.0302
   Evans CH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2411
   Evans CH, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2563
   Evans CH, 2009, MOL THER, V17, P231, DOI 10.1038/mt.2008.265
   Facchini A, 2006, BIORHEOLOGY, V43, P471
   Fecek C, 2008, TISSUE ENG PT A, V14, P1403, DOI 10.1089/tea.2007.0293
   Feeley BT, 2006, J ORTHOP RES, V24, P1709, DOI 10.1002/jor.20229
   Ferdous Z, 2007, TISSUE ENG, V13, P1893, DOI 10.1089/ten.2006.0056
   Fernandes J, 1999, AM J PATHOL, V154, P1159, DOI 10.1016/S0002-9440(10)65368-0
   FICAT F, 1971, PRESSE MED, V79, P581
   Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Frisbie DD, 2002, GENE THER, V9, P12, DOI 10.1038/sj.gt.3301608
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gafni Y, 2004, MOL THER, V9, P587, DOI 10.1016/j.ymthe.2003.12.009
   Gaissmaier C, 2005, BIOMATERIALS, V26, P1953, DOI 10.1016/j.biomaterials.2004.06.031
   Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157
   Gangji Valerie, 2005, J Bone Joint Surg Am, V87 Suppl 1, P106, DOI 10.2106/JBJS.D.02662
   Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009
   Ge ZG, 2005, CELL TRANSPLANT, V14, P763, DOI 10.3727/000000005783982486
   Ge ZG, 2005, CELL TRANSPLANT, V14, P573, DOI 10.3727/000000005783982819
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Gerich T G, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P118, DOI 10.1007/s001670050037
   Gerich TG, 1997, UNFALLCHIRURG, V100, P354, DOI 10.1007/s001130050130
   Ghivizzani SC, 1997, J IMMUNOL, V159, P3604
   Ghivizzani SC, 1998, P NATL ACAD SCI USA, V95, P4613, DOI 10.1073/pnas.95.8.4613
   Ghivizzani SC, 2001, DRUG DISCOV TODAY, V6, P259, DOI 10.1016/S1359-6446(01)01685-3
   Ghivizzani SC, 2008, CURR GENE THER, V8, P273, DOI 10.2174/156652308785160638
   GILLE J, 2010, KNEE SURG SPORTS TRA
   Goto H, 2000, OSTEOARTHR CARTILAGE, V8, P266, DOI 10.1053/joca.1999.0300
   Goto H, 1999, J BONE JOINT SURG AM, V81A, P918, DOI 10.2106/00004623-199907000-00003
   Gottfried ON, 2008, NEUROSURGERY, V63, P380, DOI 10.1227/01.NEU.0000324990.04818.13
   Goyenvalle E, 2003, J MATER SCI-MATER M, V14, P219, DOI 10.1023/A:1022876522242
   [顾海伦 Gu Hailun], 2006, [中国修复重建外科杂志, Chinese Journal of Reparative and Reconstructive Surgery], V20, P820
   Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Hairfield-Stein M, 2007, TISSUE ENG, V13, P703, DOI 10.1089/ten.2006.0203
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Hall SL, 2009, J GENE MED, V11, P877, DOI 10.1002/jgm.1369
   Haupt JL, 2005, J ORTHOP RES, V23, P118, DOI 10.1016/j.orthres.2004.06.020
   Heckmann L, 2008, BIOTECHNOL APPL BIOC, V49, P185, DOI 10.1042/BA20070071
   Heckmann L, 2007, J BIOMED MATER RES B, V81B, P82, DOI 10.1002/jbm.b.30640
   Hernigou P, 2002, CLIN ORTHOP RELAT R, P14, DOI 10.1097/01.blo.0000038472.05771.79
   Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289
   Heymer A, 2009, J TISSUE ENG REGEN M, V3, P389, DOI 10.1002/term.175
   Hidaka C, 2003, SPINE, V28, P2049, DOI 10.1097/01.BRS.0000091661.11228.C3
   Hidaka C, 2002, TISSUE ENG, V8, P93, DOI 10.1089/107632702753503090
   Hildebrand KA, 2004, GENE THER, V11, P368, DOI 10.1038/sj.gt.3302198
   Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114
   Hoffmann A, 2007, INT ORTHOP, V31, P791, DOI 10.1007/s00264-007-0395-9
   Hoffmann A, 2006, REGEN MED, V1, P563, DOI 10.2217/17460751.1.4.563
   Hohaus C, 2008, EUR SPINE J, V17, pS492, DOI 10.1007/s00586-008-0750-6
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001
   HUNGERFORD DS, 1981, CAN J SURG, V24, P583
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Ito A, 2003, J BIOSCI BIOENG, V95, P196, DOI 10.1016/S1389-1723(03)80129-9
   Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691
   Jiang X, 2006, INT J ORAL MAX SURG, V35, P1133, DOI 10.1016/j.ijom.2006.07.005
   Jiang XQ, 2005, CHINESE MED J-PEKING, V118, P281
   JOHNSTONE B, 1995, SPINE, V20, P674, DOI 10.1097/00007632-199503150-00008
   Jukes JM, 2008, TISSUE ENG PT A, V14, P135, DOI 10.1089/ten.a.2006.0397
   Jukes JM, 2010, J TISSUE ENG REGEN M, V4, P165, DOI 10.1002/term.234
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kall S, 2004, Handchir Mikrochir Plast Chir, V36, P205, DOI 10.1055/s-2004-815745
   Kan I., 2007, V180, P219
   Kawate K, 2006, ARTIF ORGANS, V30, P960, DOI 10.1111/j.1525-1594.2006.00333.x
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   KIAER T, 1990, J BONE JOINT SURG BR, V72, P1023
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kuh SU, 2008, ACTA NEUROCHIR, V150, P1073, DOI 10.1007/s00701-008-0029-z
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429
   Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Levicoff EA, 2008, SPINE, V33, P1509, DOI 10.1097/BRS.0b013e318178866c
   Li F, 2007, KNEE SURG SPORT TR A, V15, P1219, DOI 10.1007/s00167-007-0385-x
   Li JZ, 2003, GENE THER, V10, P1735, DOI 10.1038/sj.gt.3302075
   Li KW, 2006, TISSUE ENG, V12, P2611, DOI 10.1089/ten.2006.12.2611
   Li W. J., 2009, CURR PROTOC CELL BIO
   Li WJ, 2008, TISSUE ENG PT A, V14, P639, DOI 10.1089/tea.2007.0136
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Lieberman JR, 2002, MOL THER, V6, P141, DOI 10.1006/mthe.2000.0663
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035
   Lippiello L, 2003, OSTEOARTHR CARTILAGE, V11, P335, DOI 10.1016/S1063-4584(03)00026-8
   Lotz M, 2001, CLIN ORTHOP RELAT R, pS108
   Lou JR, 2001, J ORTHOPAED RES, V19, P1199, DOI 10.1016/S0736-0266(01)00042-0
   Lou JR, 1999, CLIN ORTHOP RELAT R, P333
   Lu FZ, 2005, J LAB CLIN MED, V146, P271, DOI 10.1016/j.lab.2005.07.003
   Luk KDK, 2003, BIOCHEM BIOPH RES CO, V308, P636, DOI 10.1016/S0006-291X(03)01429-3
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Majewski M, 2008, GENE THER, V15, P1139, DOI 10.1038/gt.2008.48
   Makarov SS, 1996, P NATL ACAD SCI USA, V93, P402, DOI 10.1073/pnas.93.1.402
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Martin C, 1996, BIOMATERIALS, V17, P2373, DOI 10.1016/S0142-9612(96)00075-0
   Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1
   Martinek V, 2002, TISSUE ENG, V8, P107, DOI 10.1089/107632702753503108
   Maus U, 2008, Z ORTHOP UNFALLCHIR, V146, P31, DOI 10.1055/s-2007-989353
   MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335
   Menetrey J, 1999, TISSUE ENG, V5, P435, DOI 10.1089/ten.1999.5.435
   MILLER JAA, 1988, SPINE, V13, P173, DOI 10.1097/00007632-198802000-00008
   Minamide A, 2005, SPINE, V30, P1134, DOI 10.1097/01.brs.0000162394.75425.04
   Miyazaki M, 2008, SPINE, V33, P1410, DOI 10.1097/BRS.0b013e3181761003
   Moon SH, 2008, SPINE, V33, P1850, DOI 10.1097/BRS.0b013e31817e1cd7
   Moon SH, 2000, SPINE, V25, P2573, DOI 10.1097/00007632-200010150-00006
   Morrey ME, 2008, SPINE J, V8, P796, DOI 10.1016/j.spinee.2007.05.010
   Mueller SM, 1999, J BIOMED MATER RES, V45, P157, DOI 10.1002/(SICI)1097-4636(19990605)45:3<157::AID-JBM1>3.0.CO;2-B
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Nakajima T, 2007, SPINE, V32, P2432, DOI 10.1097/BRS.0b013e3181573924
   Nakamura N, 2000, J ORTHOPAED RES, V18, P517, DOI 10.1002/jor.1100180402
   Nakamura N, 1998, GENE THER, V5, P1165, DOI 10.1038/sj.gt.3300712
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nehrer S, 2009, AM J SPORT MED, V37, p81S, DOI 10.1177/0363546509350704
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Niemeyer P, 2008, ARCH ORTHOP TRAUM SU, V128, P1223, DOI 10.1007/s00402-007-0413-9
   Nishida K, 1999, SPINE, V24, P2419, DOI 10.1097/00007632-199912010-00002
   Nishida K, 1998, SPINE, V23, P2437, DOI 10.1097/00007632-199811150-00016
   Nishida K, 2000, CLIN ORTHOP RELAT R, pS234
   Nixon AJ, 2005, GENE THER, V12, P177, DOI 10.1038/sj.gt.3302396
   Noel D, 2007, LEUKEMIA LYMPHOMA, V48, P1283, DOI 10.1080/10428190701361869
   Noth U, 2007, ORTHOPADE, V36, P466, DOI 10.1007/s00132-007-1087-2
   Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816
   Noth U, 2005, CYTOTHERAPY, V7, P447, DOI 10.1080/14653240500319093
   NOTH U, 2007, J BIOMED MAT RES A
   NOTH U, 2006, EUROPEAN MUSCULOSKEL, P62
   Oakes DA, 2000, CLIN ORTHOP RELAT R, pS101
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Pascher A, 2004, GENE THER, V11, P133, DOI 10.1038/sj.gt.3302155
   Pascher A, 2004, MOL THER, V10, P327, DOI 10.1016/j.ymthe.2004.03.012
   Paul R, 2003, SPINE, V28, P755, DOI 10.1097/00007632-200304150-00006
   Pavesio A., 2003, NOVART FDN SYMP, V249, P234
   Pavesio A., 2003, NOVART FDN SYMP, V249, P239
   Pavesio A., 2003, NOVART FDN SYMP, V249, P229
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Payne RG, 2002, BIOMATERIALS, V23, P4381, DOI 10.1016/S0142-9612(02)00186-2
   Pelinkovic D, 2003, TISSUE ENG, V9, P143, DOI 10.1089/107632703762687627
   Pelletier JP, 1997, ARTHRITIS RHEUM-US, V40, P1012, DOI 10.1002/art.1780400604
   Peterson L, 2002, AM J SPORT MED, V30, P2, DOI 10.1177/03635465020300011601
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Petrigliano FA, 2007, CLIN ORTHOP RELAT R, P53, DOI 10.1097/BLO.0b013e3181591c92
   Phillips FM, 2003, SPINE, V28, pS99, DOI 10.1097/00007632-200308011-00017
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Plenk H, 2000, ORTHOPADE, V29, P389
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Reichert JC, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065001
   Ren CC, 2008, STEM CELLS, V26, P2332, DOI 10.1634/stemcells.2008-0084
   Rethwilm A, 2007, CURR GENE THER, V7, P261
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Riew KD, 2003, J BONE JOINT SURG AM, V85A, P866, DOI 10.2106/00004623-200305000-00014
   Robbins PD, 1998, PHARMACOL THERAPEUT, V80, P35, DOI 10.1016/S0163-7258(98)00020-5
   Robbins PD, 2003, GENE THER, V10, P902, DOI 10.1038/sj.gt.3302040
   Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007
   Romano G, 2007, DRUG NEWS PERSPECT, V20, P227, DOI 10.1358/dnp.2007.20.4.1103528
   Rose T, 2005, UNFALLCHIRURG, V108, P25, DOI 10.1007/s00113-004-0888-6
   Rose T, 2003, LANGENBECK ARCH SURG, V388, P347, DOI 10.1007/s00423-003-0401-7
   Rose T, 2003, LANGENBECK ARCH SURG, V388, P356, DOI 10.1007/s00423-003-0403-5
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sarkar MR, 2001, J BIOMED MATER RES, V58, P329, DOI 10.1002/1097-4636(2001)58:3<329::AID-JBM1025>3.3.CO;2-0
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Sawin PD, 1998, J NEUROSURG, V88, P255, DOI 10.3171/jns.1998.88.2.0255
   Schantz JT, 2002, CELL TRANSPLANT, V11, P125
   Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209
   SCHMIDT CC, 1995, J ORTHOP RES, V13, P184, DOI 10.1002/jor.1100130206
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schoenfeld Andrew J, 2007, Am J Orthop (Belle Mead NJ), V36, P614
   Scotti C, 2009, KNEE SURG SPORT TR A, V17, P645, DOI 10.1007/s00167-009-0745-9
   Sefcik LS, 2008, J TISSUE ENG REGEN M, V2, P210, DOI 10.1002/term.85
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Smith RKW, 2008, DISABIL REHABIL, V30, P1752, DOI 10.1080/09638280701788241
   Sobajima S, 2004, GENE THER, V11, P390, DOI 10.1038/sj.gt.3302200
   Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011
   Southwood LL, 2004, J ORTHOPAED RES, V22, P66, DOI 10.1016/S0736-0266(03)00129-3
   Starke C, 2009, ARTHROSCOPY, V25, P1033, DOI 10.1016/j.arthro.2008.12.010
   Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Steinert AF, 2008, INJURY, V39, pS97, DOI 10.1016/j.injury.2008.01.034
   Steinert AF, 2008, BIOMATERIALS, V29, P904, DOI 10.1016/j.biomaterials.2007.10.054
   Steinert AF, 2007, TISSUE ENG, V13, P2227, DOI 10.1089/ten.2006.0270
   Steinwachs M, 2007, ARTHROSCOPY, V23, P381, DOI 10.1016/j.arthro.2006.12.003
   Steinwachs M, 2009, ARTHROSCOPY, V25, P208, DOI 10.1016/j.arthro.2008.10.009
   Sweigart MA, 2001, TISSUE ENG, V7, P111, DOI 10.1089/107632701300062697
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Tang TT, 2007, J BONE JOINT SURG BR, V89B, P127, DOI 10.1302/0301-620X.89B1.18350
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tienen TG, 2006, AM J SPORT MED, V34, P64, DOI 10.1177/0363546505280905
   Tienen TG, 2003, BIOMATERIALS, V24, P2541, DOI 10.1016/S0142-9612(03)00053-X
   Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001
   Vadala G, 2008, SPINE J, V8, P804, DOI 10.1016/j.spinee.2007.07.394
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
   van Tienen TG, 2009, CLIN SPORT MED, V28, P143, DOI 10.1016/j.csm.2008.08.003
   Varady P, 2001, HUM GENE THER, V12, P697, DOI 10.1089/104303401300057423
   Viggeswarapu M, 2001, J BONE JOINT SURG AM, V83A, P364, DOI 10.2106/00004623-200103000-00008
   Virk MS, 2008, BONE, V42, P921, DOI 10.1016/j.bone.2007.12.216
   Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024
   Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747
   Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94
   Wallach CJ, 2003, SPINE, V28, pS93
   Wallach Corey J, 2006, Spine J, V6, P107, DOI 10.1016/j.spinee.2005.05.002
   Wang H, 2004, J MOL MED-JMM, V82, P126, DOI 10.1007/s00109-003-0507-y
   Wang JC, 2003, J BONE JOINT SURG AM, V85A, P905, DOI 10.2106/00004623-200305000-00020
   Wang QW, 2005, J BIOSCI BIOENG, V100, P418, DOI 10.1263/jbb.100.418
   Wang XT, 2004, J HAND SURG-AM, V29A, P884, DOI 10.1016/j.jhsa.2004.05.016
   Wang XT, 2005, J HAND SURG-AM, V30A, P222, DOI 10.1016/j.jhsa.2004.09.002
   Watanabe N, 2002, MICROSC RES TECHNIQ, V58, P39, DOI 10.1002/jemt.10115
   Wehling P, 2009, HUM GENE THER, V20, P97, DOI 10.1089/hum.2008.075
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
   Wong YP, 2005, ACTA ORTHOP, V76, P421, DOI 10.1080/17453670510041330
   Yamasaki T, 2005, J BIOMED MATER RES A, V75A, P23, DOI 10.1002/jbm.a.30369
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yoon ST, 2004, GENE THER, V11, P360, DOI 10.1038/sj.gt.3302203
   Yoon ST, 2004, ORTHOP CLIN N AM, V35, P95, DOI 10.1016/S0030-5898(03)00097-X
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zantop T, 2006, KNEE SURG SPORT TR A, V14, P982, DOI 10.1007/s00167-006-0076-z
   Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046
   Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09
   Zhang YJ, 2005, SPINE, V30, P2601, DOI 10.1097/01.brs.0000187880.39298.f0
   Zhu W, 2004, J BONE MINER RES, V19, P2021, DOI 10.1359/JBMR.040821
NR 314
TC 67
Z9 69
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JUN 15
PY 2010
VL 62
IS 7-8
BP 765
EP 783
DI 10.1016/j.addr.2010.04.004
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 626LM
UT WOS:000279967500009
PM 20398712
DA 2018-10-19
ER

PT J
AU Minuth, WW
   Denk, L
   Glashauser, A
AF Minuth, Will W.
   Denk, Lucia
   Glashauser, Anne
TI Cell and drug delivery therapeutics for controlled renal parenchyma
   regeneration
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Kidney; Stem/progenitor cells; Tubules; Aldosterone; Perfusion culture;
   Artificial interstitium; Biomaterial; Drug delivery
ID ARTIFICIAL INTERSTITIUM; CULTURE; TUBULES; DIFFERENTIATION; RECEPTOR;
   TUBULOGENESIS; MORPHOGENESIS; INHIBITION; EXPRESSION; GENERATION
AB In regenerative medicine much attention is given to stem/progenitor cells for a future therapy of acute and chronic renal failure. However, up to date sound cell biological knowledge about nephron renewal in kidney is lacking. For that reason molecular mechanisms are under intense investigation leading from stem/progenitor cells to regenerated tubules. In this coherence new biomaterials and drug delivery systems have to be elaborated showing an intense stimulation on the renewal of parenchyma.
   To analyze tubule regeneration a powerful culture system is of fundamental importance. An advanced technique stimulates renal stem/progenitor cells to develop numerous tubules between layers of a polyester fleece. Use of chemically defined Iscove's Modified Dulbecco's Medium (IMDM) containing aldosterone (1 x 10(-7) M) results in spatial development of renal tubules within 13 days of perfusion culture.
   Immunohistochemistry exhibits that numerous features of a polarized epithelium are expressed in generated tubules. Transmission electron microscopy (TEM) illuminates that generated tubules contain a polarized epithelium with a tight junctional complex and an intact basal lamina at the basal aspect.
   Development of tubules depends on applied aldosterone concentration and cannot be mimicked by precursors of its synthesis pathway or by other steroid hormones. Antagonists such as spironolactone or canrenoate prevent the development of tubules. This result illuminates that the tubulogenic development is mediated via the mineralocorticoid receptor (MR). Application of geldanamycin, radicicol, quercetin or KNK 437 in combination with aldosterone blocks development of tubules by disturbing the contact between MR and heat shock proteins 90 and 70.
   In conclusion, for the first time generation of renal tubules can be simulated under controlled in-vitro conditions. Using this model the effect of numerous innovative biomaterials and drug delivery system can be critically analyzed. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Minuth, Will W.; Denk, Lucia; Glashauser, Anne] Univ Regensburg, Dept Mol & Cellular Anat, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Mol & Cellular Anat, Univ St 31, D-93053 Regensburg, Germany.
EM will.minuth@vkl.uni-regensburg.de
CR ALCALAY NI, 2009, FRONT BIOSCI, P4978
   ASH SR, 1975, KIDNEY INT, V1, P55
   Bae Y., 2009, ADV DRUG DELIV REV, V10, P768
   BAER PC, 2008, NEPHROLOGY CARLTON V, V4, P316
   BAKEINE GJ, 2007, J BIOMED MATER RES A, V4, P965
   Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9
   Barginear MF, 2008, CURR CANCER DRUG TAR, V6, P522
   Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017
   Bawa P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/022001
   BLATTMANN A, 2008, BIOMATERIALS, V18, P2749
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   BRAKEMAN PR, 2009, AM J PHYSIOL-RENAL, V3, pF564
   BROWN CDA, 2008, TOXICOL APPL PHARM, V3, P428
   BRUNER KL, 1997, RECEPTORS DIGNAL TRA, V2, P85
   Bush KT, 2006, DEV BIOL, V298, P571, DOI 10.1016/j.ydbio.2006.07.006
   BUSSOLATI B, 2009, CURR STEM CELL RES T, V1, P2
   CALDAS HC, 2008, TRANSPL P, V3, P853
   CALDORERAMOORE M, 2009, ADV DRUG DELIV REV, V15, P1391
   CHADE AR, 2009, CIRCULATION, V4, P547
   CHEN X, 2009, TRANSPLANTATION, V4, P496
   CHEVALIER RL, 2009, KIDNEY INT, V11, P1145
   CHHABRA P, 2009, CURR OPIN ORGAN TRAN, V1, P72
   CHUNG IM, 2008, BIOMATERIALS, V17, P2637
   Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771
   CURTIS LM, 2008, AM J PHYSIOL-RENAL, V1, pF310
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434
   DOTSCH J, 2009, J MOL MED, V9, P841
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028
   DUNCAN AW, 2009, GASTROENTEROLOGY, V2, P466
   ESCOUBET B, 1996, AM J PHYSL 1, V5, pC1343
   Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110
   Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578
   GUARINO M, 2009, HUM PATHOL, V10, P1365
   Hammerman MR, 2001, CURR OPIN NEPHROL HY, V10, P13, DOI 10.1097/00041552-200101000-00003
   HAMMERMAN MR, 2005, TRANSPL IMMUNOL, V1, P1
   Han HJ, 2004, J CELL SCI, V117, P1821, DOI 10.1242/jcs.01020
   HAN SY, 2009, BIOCHEM BIOPH RES CO, V3, P548
   Heber S, 2007, TISSUE ENG, V13, P281, DOI 10.1089/ten.2006.0199
   Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Hopkins C, 2009, J PATHOL, V217, P265, DOI 10.1002/path.2477
   HORSTER M, 1979, PFLUGERS ARCH, V3, P209
   HU K, 2007, BIOTECHNOL J, V8, P992
   Humphreys B D, 2006, Minerva Urol Nefrol, V58, P13
   Inoue CN, 2003, IN VITRO CELL DEV-AN, V39, P364
   ISHIBE S, 2008, CURR OPIN NEPHROL HY, V4, P379
   JORAKU A, 2009, METHODS, V2, P129
   KARNER CM, 2009, NAT GENET, V7, P793
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   KREBS MD, 2009, J AM CHEM SOC, V26, P9204
   KRIZ W, 2007, NEPHRON EXP NEPHROL, V2, pE44
   LEIMEISTER C, 1999, DEV GENET, V3, P273
   LERMA EV, 2009, CLIN GERIATR MED, V3, P325
   LI F, 2004, ENDOTHELIUM, V3, P199
   LITTLE MH, 2009, NEPHROLOGY CARLTON V, V6, P544
   LITTLE MH, 2009, J AM SOC NEPHROL, V10, P2112
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Manwell LA, 2007, COMP BIOCHEM PHYS A, V148, P521, DOI 10.1016/j.cbpa.2007.06.422
   MAO GH, 2009, BIOMATERIALS, V9, P1706
   MARLIER A, 2009, MECH DEVELOP, V3, P91
   MASEREEUW R, 2009, MINERVA UROL NEFROL, V4, P373
   MINUTH WW, 1987, DIFFERENTIATION, V36, P12, DOI 10.1111/j.1432-0436.1987.tb00177.x
   Minuth WW, 2004, CELL PHYSIOL BIOCHEM, V14, P387, DOI 10.1159/000080348
   Minuth WW, 2004, TISSUE ENG, V10, P285, DOI 10.1089/107632704322791925
   MINUTH WW, 2008, TISSUE ENG PART C-ME, V1, P3
   Minuth WW, 2008, J EPITHEL BIOL PHARM, V11, P24
   MINUTH WW, 2007, CENTRAL EUROPEAN J B, V2, P3307
   MINUTH WW, 2009, LANGMUIR, V8, P4621
   MINUTH WW, 2007, BIOMATERIALS, V30, P4418
   Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795
   RACITI D, 2008, GENOME BIOL, V5, pR84
   Rafestin-Oblin ME, 2002, MOL PHARMACOL, V62, P1306, DOI 10.1124/mol.62.6.1306
   Ramirez V, 2004, CELL STRESS CHAPERON, V9, P198, DOI 10.1379/CSC-22R.1
   REIDY KJ, 2009, SEMIN NEPHROL, V4, P321
   Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041
   ROMAGNANI P, 2009, STEM CELLS, V9, P2247
   ROSINES E, 2007, P NATL ACAD SCI USA, V52, P20938
   Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196
   Saifudeen Z, 2009, J AM SOC NEPHROL, V20, P2328, DOI 10.1681/ASN.2008121224
   SANCHOBRU P, 2009, GUT, V4, P594
   SCHLUTER MA, 2009, J AM SOC NEPHROL, V7, P1444
   SHAH MM, 2009, AM J PHYSIOL-RENAL, V5, pF1330
   SHARPLES EJ, 2007, CURR OPIN CRIT CARE, V6, P652
   Simon Jorg, 2008, BMC Urol, V8, P8, DOI 10.1186/1471-2490-8-8
   STOOP R, 2008, INJURY, pS77
   Strehl R, 2004, TISSUE ENG, V10, P1196, DOI 10.1089/1076327041887853
   STREHL R, 1999, CELL TISSUE RES, V3, P539
   STUART RO, 1995, SEMIN NEPHROL, V4, P315
   Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128
   TERRYN S, 2007, AM J PHYSIOL-RENAL, V2, pF476
   Thomas W, 2010, STEROIDS, V75, P550, DOI 10.1016/j.steroids.2009.09.008
   Vesey DA, 2009, METHOD MOL BIOL, P19
   Wei WC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-5
   WORONIECKI RP, 2009, SEMIN NEPHROL, V4, P412
   YOKOO T, 2009, J NEPHROL, V3, P312
   ZHANG H, 2009, BIOMATERIALS, V15, P2899
   Zhang KX, 2004, MOL CANCER RES, V2, P242
   ZHANG Z, 2009, BIOMATERIALS, V7, P1372
NR 100
TC 9
Z9 9
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JUN 15
PY 2010
VL 62
IS 7-8
BP 841
EP 854
DI 10.1016/j.addr.2010.01.004
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 626LM
UT WOS:000279967500014
PM 20122975
DA 2018-10-19
ER

PT J
AU Tian, Y
   Wang, YJ
   Zhou, CR
   Zeng, QH
AF Tian, Ye
   Wang, Yingjun
   Zhou, Changren
   Zeng, Qinhui
TI Preparation of Regular Micropitted Polylactide Films via Phase
   Separation and Their Cell Affinity Evaluation
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE adhesion; biomaterials; films; phase separation
ID OSTEOBLAST-LIKE CELLS; SURFACE-ROUGHNESS; SOFT LITHOGRAPHY; IN-VITRO;
   ACID); ADHESION; TOPOGRAPHY; PROLIFERATION; FABRICATION; COPOLYMERS
AB The microscale topography of biomaterial surfaces has a great effect on the adhesion and proliferation behavior of cells. In this study, polylactide (PLA) films with regular micropitted surfaces were prepared by a phase-separation technique. The effect of the surface topography on the wettability and cell affinity was investigated with contact angle measurements and osteoblast incubation, respectively. The results showed that the shape of the pits could be controlled by changes in the film-forming parameters, including the PLA solution concentration, nonsolvent content, temperature, and solvent volatilization speed. These patterned films had significantly enhanced hydrophobicity because of the existence of micropits on the surface, and their hydrophobicity increased with the pit size increasing. Osteoblast spreading was improved on the patterned surface, and so was cell adhesion. However, the proliferation of cells on micropitted surfaces showed no distinction from the proliferation on smooth surfaces, and this indicated that the pit pattern had a great effect on the spreading and adhesion of cells but little on the proliferation of cells. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 116: 3162-3170, 2010
C1 [Zhou, Changren; Zeng, Qinhui] Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Tian, Ye; Wang, Yingjun] S China Univ Technol, Minist Educ, Key Lab Special Funct Mat, Guangzhou 510641, Guangdong, Peoples R China.
   [Tian, Ye; Wang, Yingjun] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Zhou, CR (reprint author), Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
EM tcrz9@jnu.edu.cn
CR Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Chen VJ, 2006, BIOMATERIALS, V27, P3708, DOI 10.1016/j.biomaterials.2006.02.020
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   DAHM M, 2001, ANN THORAC SURG S, V71, P437
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Fukuhira Y, 2006, BIOMATERIALS, V27, P1797, DOI 10.1016/j.biomaterials.2005.10.019
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Huang N, 2004, SURF COAT TECH, V186, P218, DOI 10.1016/j.surfcoat.2004.04.041
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee CJ, 2004, LANGMUIR, V20, P4155, DOI 10.1021/la035467c
   LEE JH, 2000, J COLLOID INTERF SCI, V230, P869
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   NISHIDA J, 2002, POLYM J, V34, P1581
   Otsuka H, 2001, CURR OPIN COLLOID IN, V6, P3, DOI 10.1016/S1359-0294(00)00082-0
   Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9
   Shu J., 2006, J APPL POLYM SCI, V100, P2244
   Stenzel MH, 2006, J POLYM SCI POL CHEM, V44, P2363, DOI 10.1002/pola.21334
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tian Y, 2006, J APPL POLYM SCI, V100, P1013, DOI 10.1002/app.22926
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang Y, 2005, ADV FUNCT MATER, V15, P655, DOI 10.1002/adfm.200400201
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   Zhao B, 2005, POLYMER, V46, P9508, DOI 10.1016/j.polymer.2005.07.035
   Zhao XY, 2003, J APPL POLYM SCI, V90, P1846, DOI 10.1002/app.12836
   Zhu HG, 2003, BIOMACROMOLECULES, V4, P378, DOI 10.1021/bm025773p
NR 29
TC 3
Z9 4
U1 3
U2 9
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 15
PY 2010
VL 116
IS 6
BP 3162
EP 3170
DI 10.1002/app.31069
PG 9
WC Polymer Science
SC Polymer Science
GA 583WF
UT WOS:000276710000007
DA 2018-10-19
ER

PT J
AU Peng, YY
   Glattauer, V
   Ramshaw, JAM
   Werkmeister, JA
AF Peng, Yong Y.
   Glattauer, Veronica
   Ramshaw, John A. M.
   Werkmeister, Jerome A.
TI Evaluation of the immunogenicity and cell compatibility of avian
   collagen for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; immunology; hypersensitivity; avian; scaffold; cell growth
ID HUMORAL IMMUNE-RESPONSE; I COLLAGEN; SACCHAROMYCES-CEREVISIAE;
   INFORMATION-CONTENT; BOVINE COLLAGEN; III COLLAGEN; GUINEA PIG;
   PROCOLLAGEN; YEAST; SKIN
AB There have been concerns regarding the suitability of bovine collagen as a biomaterial since the emergence of bovine spongiform encephalopathy. Consequently, collagens from other species may be used if they can meet appropriate standards, including negligible or lack of immunogenicity. In this study, the potential immunogenicity of both monomeric and pepsin-solubilized chicken collagens have been compared with a commercial, pepsin-solubilized bovine collagen that is approved for biomedical implantation. All collagens were poor immunogens compared with ovalbumin. No IgE responses were detected in sera of three strains of mice, and no hypersensitivity reactions were found in guinea pigs in maximization and Buehler tests. IgG(1) antibodies were found although the titre was substantially lower than against ovalbumin. All responses in mice and rabbits were found only when immunizations were performed with adjuvant, and after multiple injections over a long period of time. The response from the monomeric chicken collagen was less than for pepsin-solubilized collagens. Collagen sponges prepared from the two chicken collagen preparations both supported the attachment and growth of mouse fibroblasts. These data indicate that chicken collagen, particularly when monomeric, may be useful in certain biomedical applications. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 1235-1244, 2010
C1 [Peng, Yong Y.; Glattauer, Veronica; Ramshaw, John A. M.; Werkmeister, Jerome A.] CSIRO Mol & Hlth Technol, Clayton, Vic 3168, Australia.
RP Werkmeister, JA (reprint author), CSIRO Mol & Hlth Technol, Bayview Ave, Clayton, Vic 3168, Australia.
EM Jerome.Werkmeister@csiro.au
RI Glattauer, veronica/A-9435-2018; Ramshaw, John/A-9411-2011
CR ADELMANN BC, 1972, IMMUNOLOGY, V23, P723
   BUEHLER EV, 1965, ARCH DERMATOL, V91, P171, DOI 10.1001/archderm.1965.01600080079017
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P647, DOI 10.1016/S0190-9622(84)80272-8
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   FERRANS VJ, 1919, COLLAGEN, V8, P145
   FERRARI FA, 1993, Patent No. 5243038
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Furthmayr H, 1976, Int Rev Connect Tissue Res, V7, P61
   Grunewald SM, 1998, J IMMUNOL, V160, P4004
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   KIRRANE JA, 1968, IMMUNOLOGY, V14, P139
   Kumar KVSS, 2002, J BIOMED MATER RES, V61, P197, DOI 10.1002/jbm.10016
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lin YK, 2007, J BIOMATER APPL, V21, P265, DOI 10.1177/0885328206063502
   MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42
   MCCOY JP, 1985, ARCH DERMATOL, V121, P990, DOI 10.1001/archderm.121.8.990
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   Misra S, 2008, HERNIA, V12, P247, DOI 10.1007/s10029-007-0319-z
   Myllyharju J, 2000, METH MOL B, V139, P39
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nagai N, 2009, J BIOMAT SCI-POLYM E, V20, P567, DOI 10.1163/156856209X426394
   NAGELSCHMIDT M, 1974, ARCH DERMATOL FORSCH, V250, P237, DOI 10.1007/BF00561190
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   PACHENCE JM, 1992, Patent No. 5138030
   Peng Y, 2004, J COSMET SCI, V55, P327
   PRAGER EM, 1993, METHOD ENZYMOL, V224, P140, DOI 10.1016/0076-6879(93)24012-J
   RARNSHAW JAM, 1995, BIOTECHNOL GENET ENG, V13, P335
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   SUNDARRAJ N, 1982, BIOCHEM BIOPH RES CO, V106, P48, DOI 10.1016/0006-291X(82)92056-3
   Takagi Y, 2007, J NANOSCI NANOTECHNO, V7, P757, DOI 10.1166/jnn.2007.503
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   TRELSTAD RL, 1976, ANAL BIOCHEM, V71, P114, DOI 10.1016/0003-2697(76)90016-6
   Vaughan PR, 1998, DNA CELL BIOL, V17, P511, DOI 10.1089/dna.1998.17.511
   Wallace D. G., 1988, COLLAGEN, V3, P117
   WERKMEISTER JA, 1994, MED PROG TECHNOL, V20, P231
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
   Werkmeister JA, 2000, HDB BIOMATERIALS ENG, P739
   WU TT, 1974, ANNU REV BIOCHEM, V43, P539, DOI 10.1146/annurev.bi.43.070174.002543
   Yamauchi M., 1988, COLLAGEN, P157
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 46
TC 19
Z9 20
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2010
VL 93A
IS 4
BP 1235
EP 1244
DI 10.1002/jbm.a.32616
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 594GG
UT WOS:000277523600002
PM 19777573
DA 2018-10-19
ER

PT J
AU Shin, S
   Salvay, DM
   Shea, LD
AF Shin, Seungjin
   Salvay, David M.
   Shea, Lonnie D.
TI Lentivirus delivery by adsorption to tissue engineering scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PLC; lentivirus; tissue-engineering scaffold; surface immobilization;
   extracellular matrix
ID GENE-THERAPY; IN-VIVO; PLASMID DELIVERY; VIRAL VECTORS; DNA; EXPRESSION;
   ADENOVIRUS; IMMOBILIZATION; REGENERATION; STENT
AB Biomaterial scaffolds capable of localized gene delivery are being investigated for numerous regenerative medicine applications and as model systems for fundamental studies of tissue formation. In this manuscript, we investigate the delivery of lentivirus from a tissue engineering scaffold using a surface immobilization strategy. Poly(lactide-co-glycolide) (PLC) was employed as the biomaterial for delivery, which has been widely used for a number of tissue engineering applications. The virus was immobilized by freezing and subsequent lyophilization of the virus with the scaffold. The presence of sucrose during freezing and lyophilization maintained the activity of the lentivirus, and was similar to an adenovirus control. Collagen and fibronectin were investigated for their ability to enhance surface immobilization. Fibronectin modestly increased binding and transduction of the adenovirus, yet did not significantly impact the lentivirus delivery. Most of the immobilized lentivirus was released from the scaffold within 24 h. In vivo implantation of the scaffolds yielded transgene expression that persisted for at least 4 weeks. These findings indicate the potential for delivering lentivirus from tissue engineering scaffolds using a surface immobilization strategy. To our knowledge, this report is the first to investigate lentivirus delivery from porous tissue engineering scaffolds. Delivery of lentiviral vectors from PLC scaffolds could provide an efficient and versatile gene delivery system for use with in vitro and in vivo models of tissue formation, and ultimately for therapeutic applications. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 1252-1259, 2010
C1 [Shin, Seungjin; Salvay, David M.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIH [RO1 EB005678, R21 EB006520, RO1 EB003806]
FX Contract grant sponsor: NIH; contract grant numbers: RO1 EB005678, R21
   EB006520, RO1 EB003806
CR Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   BENGALI Z, 2009, BIOTECHNOL BIOENG, V30, P2361
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   Bennett J, 2003, GENE THER, V10, P977, DOI 10.1038/sj.gt.3302030
   BONDI A, 1982, HISTOCHEMISTRY, V76, P153, DOI 10.1007/BF00501918
   Cheema SK, 2007, WOUND REPAIR REGEN, V15, P286, DOI 10.1111/j.1524-475X.2007.00228.x
   Croyle MA, 2001, GENE THER, V8, P1281, DOI 10.1038/sj.gt.3301527
   De Laporte L, 2006, BIOMATERIALS, V27, P947, DOI 10.1016/j.biomaterials.2005.09.036
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Dull T, 1998, J VIROL, V72, P8463
   Fishbein I, 2008, CIRCULATION, V117, P2096, DOI 10.1161/CIRCULATIONAHA.107.746412
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Hu WW, 2008, J GENE MED, V10, P1102, DOI 10.1002/jgm.1233
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   Huang YC, 2005, HUM GENE THER, V16, P609, DOI 10.1089/hum.2005.16.609
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jin X, 2008, J GENE MED, V10, P421, DOI 10.1002/jgm.1165
   LAPORTE LD, 2008, MOL THER
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Parrott MB, 2003, MOL THER, V8, P688, DOI 10.1016/S1525-0016(03)00213-2
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Riddle KW, 2007, MOL THER, V15, P361, DOI 10.1038/sj.mt.6300017
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   Uhlenhaut C, 2005, BIOMATERIALS, V26, P6558, DOI 10.1016/j.biomaterials.2005.04.049
   Whittlesey KJ, 2006, BIOMATERIALS, V27, P2477, DOI 10.1016/j.biomaterials.2005.11.016
NR 33
TC 22
Z9 22
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2010
VL 93A
IS 4
BP 1252
EP 1259
DI 10.1002/jbm.a.32619
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 594GG
UT WOS:000277523600004
PM 19827108
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wang, L
   Sun, B
   Ziemer, KS
   Barabino, GA
   Carrier, RL
AF Wang, Lin
   Sun, Bing
   Ziemer, Katherine S.
   Barabino, Gilda A.
   Carrier, Rebecca L.
TI Chemical and physical modifications to poly(dimethylsiloxane) surfaces
   affect adhesion of Caco-2 cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Caco-2 cells; Polydimethylsiloxane (PDMS); surface modification; cell
   attachment
ID SILICONE-RUBBER; FIBRONECTIN; CULTURE; ATTACHMENT; LAMININ;
   MICROFABRICATION; TOPOGRAPHIES; ABSORPTION; EXPRESSION; SUBSTRATUM
AB Polydimethylsiloxane (PDMS) silicone elastomer is extensively used in soft lithography processes to fabricate microscale or nano scale systems for microfluidic or cell culture applications. Though PDMS is biocompatible, it is not an ideal material for cell culture due to its poor cell adhesion properties. In this study, PDMS surfaces were modified to promote intestinal cell adhesion, in the interest of testing feasibility of using microfabricated PDMS systems for high throughput drug screening. Modification techniques included changing chemical composition of PDMS (i.e., varying curing to mixing agent ratio, and oxidization of PDMS surface by oxygen plasma), surface treatment of PDMS by coating with charged molecules (i.e., poly-D-lysine, L-alpha-phosphatidylcholine, and a layer by layer coating), and deposition of extracellular matrix (ECM) proteins (i.e., laminin, fibronectin, and collagen). The influence of these modifications on PDMS properties, including elastic modulus and surface properties (wettability, chemical composition, topography, and protein adsorption) were characterized. Modification techniques were all found to change PDMS properties and influence the attachment and proliferation of Caco-2 cells over three days of culture to varying degrees. Generally, Caco-2 cells preferred to attach on collagen-coated, fibronectin-coated, and fibronectin-coated oxygen-plasma treated PDMS. The results highlight the importance of considering multiple physical and chemical factors that may be influenced by biomaterial modification and result in altered cell attachment to microfabricated systems, including surface hydrophobicity, chemical composition, stiffness, and topography. This study provides a foundation for further miniaturization, utilizing soft lithography techniques, of Caco-2 cell-based system for high-throughput screening of drug intestinal absorption during lead optimization in drug discovery. The understanding of different surface modifications on adjusting cell adhesion on PDMS allows systemic design of Biomicroelectromechanical Systems (BioMEMS) with tunable cell adhesion properties. (C) 2009 Wiley Periodicals, inc. J Biomed Mater Res 93A: 1260-1271, 2010
C1 [Wang, Lin; Sun, Bing; Ziemer, Katherine S.; Carrier, Rebecca L.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
   [Barabino, Gilda A.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Carrier, RL (reprint author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
EM r.carrier@neu.edu
RI Sun, Bing/D-6506-2014
OI Barabino, Gilda/0000-0001-7660-2807
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V38, P103, DOI 10.1385/CBB:38:2:103
   Andersson AS, 2003, J BIOMED MATER RES A, V64A, P622, DOI 10.1002/jbm.a.10442
   Barthe L, 1999, FUND CLIN PHARMACOL, V13, P154, DOI 10.1111/j.1472-8206.1999.tb00334.x
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   CARLSSON R, 1981, P NATL ACAD SCI-BIOL, V78, P2403, DOI 10.1073/pnas.78.4.2403
   Cunningham JJ, 2002, BIOTECHNIQUES, V32, P876, DOI 10.2144/02324rr05
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Delie F, 1997, CRIT REV THER DRUG, V14, P221
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004
   HAYMAN EG, 1981, J CELL BIOL, V88, P352, DOI 10.1083/jcb.88.2.352
   KATCHALSKY A, 1959, BIOCHIM BIOPHYS ACTA, V33, P120
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kidambi S, 2007, TISSUE ENG, V13, P2105, DOI 10.1089/ten.2006.0151
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lekmine F, 1999, MOL CELL ENDOCRINOL, V157, P181, DOI 10.1016/S0303-7207(99)00138-0
   Li Nianzhen, 2003, Crit Rev Biomed Eng, V31, P423, DOI 10.1615/CritRevBiomedEng.v31.i56.20
   Pins GD, 2000, FASEB J, V14, P593
   PITT AM, 1987, BIOTECHNIQUES, V5, P162
   Qin D., 1998, MICROSYST TECHNOL, P2
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   RANALDI G, 1992, ANTIMICROB AGENTS CH, V36, P1374, DOI 10.1128/AAC.36.7.1374
   RATNER BD, 2004, BIOMATERIALS SCI INT, P133
   Ricco AJ, 2006, BIOSENSING: INTERNATIONAL RESEARCH AND DEVELOPMENT, P79, DOI 10.1007/1-4020-4058-X_6
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   SIMONASSMANN P, 1995, EXPERIENTIA, V51, P883, DOI 10.1007/BF01921739
   Sud D, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2355665
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wilder EA, 2006, MACROMOLECULES, V39, P4138, DOI 10.1021/ma060266b
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   Yurchenco P. D., 1994, EXTRACELLULAR MATRIX, P468
NR 36
TC 72
Z9 75
U1 4
U2 60
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2010
VL 93A
IS 4
BP 1260
EP 1271
DI 10.1002/jbm.a.32621
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 594GG
UT WOS:000277523600005
PM 19827104
DA 2018-10-19
ER

PT J
AU Fassina, L
   Saino, E
   Sbarra, MS
   Visai, L
   De Angelis, MGC
   Magenes, G
   Benazzo, F
AF Fassina, Lorenzo
   Saino, Enrica
   Sbarra, Maria Sonia
   Visai, Livia
   De Angelis, Maria Gabriella Cusella
   Magenes, Giovanni
   Benazzo, Francesco
TI In vitro electromagnetically stimulated SAOS-2 osteoblasts inside porous
   hydroxyapatite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; electromagnetic stimulation; osteoblast; cell
   proliferation; bone extracellular matrix; decorin; osteocalcin;
   osteopontin; type-I collagen; type-III collagen; surface modification;
   biomimetics
ID CALCIFIED MATRIX PRODUCTION; BONE-FORMATION; CELLS; CALCIFICATION;
   DEGRADATION; BIOREACTOR; SCAFFOLD; REPAIR
AB One of the key challenges in reconstructive bone surgery is to provide living constructs that possess the ability to integrate in the surrounding tissue. Bone graft substitutes, such as autografts, allografts, xenografts, and biomaterials have been widely used to heal critical-size long bone defects due to trauma, tumor resection, congenital deformity, and tissue degeneration. In particular, porous hydroxyapatite is widely used in reconstructive bone surgery owing to its biocompatibility. In addition, the in vitro modification of hydroxyapatite with osteogenic signals enhances the tissue regeneration in vivo, suggesting that the biomaterial modification could play an important role in tissue engineering. In this study we have followed a biomimetic strategy where electromagnetically stimulated SAOS-2 human osteoblasts proliferated and built their extracellular matrix inside a porous hydroxyapatite scaffold. The electromagnetic stimulus had the following parameters: intensity of the magnetic field equal to 2 mT, amplitude of the induced electric tension equal to 5 mV, frequency of 75 and pulse duration of 1.3 ms. In comparison with control conditions, the electromagnetic stimulus increased the cell proliferation and the surface coating with bone proteins (decorin, osteocalcin, osteopontin, type-I collagen, and type-III collagen). The physical stimulus aimed at obtaining a better modification of the biomaterial internal surface in terms of cell colonization and coating with bone matrix. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 1272-1279, 2010
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
   [Fassina, Lorenzo; Saino, Enrica; Sbarra, Maria Sonia; Visai, Livia; De Angelis, Maria Gabriella Cusella; Magenes, Giovanni; Benazzo, Francesco] Univ Pavia, Ctr Tissue Engn, I-27100 Pavia, Italy.
   [Saino, Enrica; Sbarra, Maria Sonia; Visai, Livia] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   [De Angelis, Maria Gabriella Cusella] Univ Pavia, Dipartimento Med Sperimentale, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, Dipartimento SMEC, IRCCS San Matteo, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Fassina, Lorenzo/K-9283-2015; Magenes, Giovanni/C-4202-2012
OI Fassina, Lorenzo/0000-0002-5587-4632; Magenes,
   Giovanni/0000-0002-7558-1490; Cusella De Angelis, Maria
   Gabriella/0000-0003-2642-3346
FU Fondazione Cariplo [2004.1424/10.8485, 2006.0581/10.8485]; FIRB (Italian
   Ministry of Education) [RBIP06FH7J]; PRIN (Italian Ministry of
   Education)
FX Contract grant sponsor: Fondazione Cariplo; contract grant numbers:
   2004.1424/10.8485, 2006.0581/10.8485; Contract grant sponsor: FIRB Grant
   (Italian Ministry of Education); contract grant number: RBIP06FH7J;
   Contract grant sponsor: PRIN Grant (Italian Ministry of Education) to
   L.V.
CR Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338
   Artzi Z, 2001, INT J PERIODONT REST, V21, P395
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   COHEN RE, 1994, J PERIODONTOL, V65, P1008, DOI 10.1902/jop.1994.65.11.1008
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ripamonti U, 2006, J ANAT, V209, P447, DOI 10.1111/j.1469-7580.2006.00635.x
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Stephan EB, 1999, J PERIODONTOL, V70, P364, DOI 10.1902/jop.1999.70.4.364
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
NR 22
TC 26
Z9 26
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2010
VL 93A
IS 4
BP 1272
EP 1279
DI 10.1002/jbm.a.32620
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 594GG
UT WOS:000277523600006
PM 19827111
OA Green Accepted
DA 2018-10-19
ER

EF